data_5m1g_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5m1g _Structure_validation_residue.Date_analyzed 2016-10-28 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 386' ' ' PHE . . . . . 0.816 ' CZ ' HG11 ' A' ' 394' ' ' VAL . 3.4 t80 . . . . . 0 CA--C 1.531 0.239 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . 0.577 ' HG2' ' OD1' ' B' ' 393' ' ' ASN . 35.6 Cg_endo -66.88 64.14 0.59 Allowed 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 123.91 3.073 . . . . 0.0 113.562 176.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 388' ' ' MET . . . . . 0.774 ' SD ' HG13 ' A' ' 394' ' ' VAL . 5.2 tpp -68.15 164.79 19.59 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.868 176.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 389' ' ' HIS . . . . . 0.595 ' CE1' ' HA ' ' A' ' 393' ' ' ASN . 30.6 m170 -65.25 -160.77 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 172.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -71.34 1.48 6.15 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.196 170.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.56 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.1 pt? -155.23 -63.73 0.12 Allowed 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -177.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . 0.611 ' HA2' ' SD ' ' A' ' 388' ' ' MET . . . -158.98 74.93 0.21 Allowed Glycine 0 CA--C 1.523 0.583 0 C-N-CA 120.055 -1.069 . . . . 0.0 114.203 -172.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . 0.595 ' HA ' ' CE1' ' A' ' 389' ' ' HIS . 0.0 OUTLIER -65.76 -42.01 91.38 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 177.696 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . 0.816 HG11 ' CZ ' ' A' ' 386' ' ' PHE . 0.6 OUTLIER -57.3 -46.23 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 179.754 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.583 HG23 HG22 ' A' ' 425' ' ' ILE . 4.1 mp -57.43 -52.15 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 CA-C-O 117.743 -1.122 . . . . 0.0 113.301 -173.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . 0.628 ' O ' HG21 ' A' ' 399' ' ' VAL . 0.1 OUTLIER -62.14 -50.6 71.22 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-N 122.025 2.193 . . . . 0.0 112.198 -176.776 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.76 -44.65 70.14 Favored Glycine 0 N--CA 1.434 -1.463 0 C-N-CA 119.911 -1.138 . . . . 0.0 110.898 -175.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . 0.696 ' CD1' HD12 ' A' ' 410' ' ' LEU . 27.1 mt -71.22 -34.04 52.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . 0.628 HG21 ' O ' ' A' ' 396' ' ' LYS . 16.1 m -62.7 -40.0 86.86 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 C-N-CA 118.898 -1.121 . . . . 0.0 108.576 -174.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -71.25 -36.99 71.98 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 176.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . 0.42 HE21 ' HB3' ' A' ' 401' ' ' GLN . 4.1 mm100 -88.61 -46.79 8.77 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -171.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . 0.451 ' HB3' ' HB ' ' A' ' 406' ' ' THR . 2.5 mm-40 -120.35 -20.29 7.31 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.484 -171.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 106.58 162.04 22.34 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.922 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . 0.63 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.5 m -53.61 -45.25 59.53 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.81 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -175.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . 0.469 ' HB3' HG22 ' A' ' 457' ' ' ILE . . . -64.37 -30.82 71.86 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 119.784 -0.766 . . . . 0.0 112.489 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 406' ' ' THR . . . . . 0.704 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 85.2 m -76.96 -42.53 38.71 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.03 173.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.529 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.57 -36.96 74.78 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 122.141 0.972 . . . . 0.0 109.363 177.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 408' ' ' TYR . . . . . 0.63 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -66.2 -52.1 51.25 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 113.469 -1.696 . . . . 0.0 109.686 176.404 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 409' ' ' THR . . . . . 0.547 HG22 HD22 ' A' ' 410' ' ' LEU . 12.3 m -55.15 -47.46 75.08 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.541 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . 0.704 ' HG ' ' O ' ' A' ' 406' ' ' THR . 13.7 mt -72.25 -35.79 68.88 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.041 0.448 . . . . 0.0 109.983 -175.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.86 -34.72 79.37 Favored Glycine 0 N--CA 1.439 -1.13 0 C-N-CA 120.238 -0.982 . . . . 0.0 110.755 172.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 412' ' ' MET . . . . . 0.413 ' HE1' ' HA ' ' A' ' 417' ' ' GLN . 0.5 OUTLIER -69.8 -48.01 60.74 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-O 120.532 0.206 . . . . 0.0 111.362 178.33 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 413' ' ' MET . . . . . 0.93 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.5 OUTLIER -70.56 -42.0 71.69 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 119.082 -1.047 . . . . 0.0 112.256 -178.289 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . 0.93 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 19.4 mt -75.25 -46.45 33.63 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -177.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 25.2 t -86.44 -16.87 35.81 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.757 0.789 . . . . 0.0 109.763 -173.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . 0.464 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 106.4 -178.26 22.5 Favored Glycine 0 N--CA 1.43 -1.702 0 N-CA-C 109.934 -1.267 . . . . 0.0 109.934 -171.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 417' ' ' GLN . . . . . 0.413 ' HA ' ' HE1' ' A' ' 412' ' ' MET . 33.4 mm-40 -79.76 24.19 0.4 Allowed 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.262 0.554 . . . . 0.0 111.001 -174.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 418' ' ' ASN . . . . . 0.464 ' H ' ' C ' ' A' ' 416' ' ' GLY . 3.8 m-20 -70.99 75.55 0.65 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.864 -177.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 419' ' ' TYR . . . . . 0.577 ' CD1' ' HB3' ' A' ' 453' ' ' ALA . 2.3 p90 -49.11 -40.1 30.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.763 176.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -55.39 -45.85 76.61 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.926 0.393 . . . . 0.0 111.007 178.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.74 -48.75 62.96 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.254 -176.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . 0.438 ' HB ' ' CD1' ' A' ' 408' ' ' TYR . 0.1 OUTLIER -66.14 -41.36 89.26 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.515 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.126 -175.737 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.8 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 76.9 p -66.95 -39.45 87.29 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.906 -178.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.0 -38.91 93.08 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.442 -0.885 . . . . 0.0 111.883 176.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . 0.583 HG22 HG23 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.94 -52.9 20.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.308 0.099 . . . . 0.0 111.232 -176.956 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . 0.57 ' CD1' HG21 ' A' ' 395' ' ' ILE . 1.1 mm -74.18 -23.6 18.65 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.758 0 O-C-N 122.199 -0.313 . . . . 0.0 110.21 -171.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.8 ' HB2' ' O ' ' A' ' 423' ' ' SER . 2.3 tmm_? -55.4 -31.5 61.88 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.266 0.555 . . . . 0.0 111.022 -177.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -85.37 -12.3 73.33 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.168 178.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.516 ' HD1' ' CG2' ' A' ' 395' ' ' ILE . 7.5 m-30 -113.15 -0.08 14.77 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.588 0.709 . . . . 0.0 109.297 -173.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . 0.545 HD13 ' HD2' ' A' ' 431' ' ' PRO . 0.1 OUTLIER -65.97 129.69 94.3 Favored Pre-proline 0 N--CA 1.446 -0.631 0 CA-C-N 114.476 -1.238 . . . . 0.0 109.268 178.159 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 431' ' ' PRO . . . . . 0.545 ' HD2' HD13 ' A' ' 430' ' ' LEU . 95.4 Cg_exo -24.05 -60.46 0.05 OUTLIER 'Trans proline' 0 C--N 1.359 1.099 1 C-N-CA 125.709 4.273 . . . . 0.0 115.012 179.736 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . 0.549 ' O ' HG13 ' A' ' 435' ' ' VAL . . . -152.68 -170.6 19.26 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 177.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . 0.539 ' O ' HG12 ' A' ' 436' ' ' VAL . 17.2 tp60 -66.76 -26.63 67.07 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 118.026 0.913 . . . . 0.0 110.402 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -65.88 -43.27 88.81 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -177.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 435' ' ' VAL . . . . . 0.549 HG13 ' O ' ' A' ' 432' ' ' GLY . 7.5 p -67.32 -42.19 87.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-O 121.082 0.467 . . . . 0.0 110.409 -177.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . 0.539 HG12 ' O ' ' A' ' 433' ' ' GLN . 0.1 OUTLIER -68.08 -30.66 48.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.83 175.643 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 437' ' ' THR . . . . . 0.405 HG22 ' N ' ' A' ' 438' ' ' ALA . 0.9 OUTLIER -67.88 -51.84 43.37 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -179.871 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . 0.801 ' O ' ' HG2' ' A' ' 442' ' ' ARG . . . -58.02 -38.92 77.08 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.929 177.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 439' ' ' LEU . . . . . 0.541 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 1.9 tm? -69.94 -46.96 64.18 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.1 -39.17 74.51 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.109 174.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 441' ' ' GLN . . . . . 0.508 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 8.4 mm-40 -54.46 -49.65 69.57 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 123.776 0.83 . . . . 0.0 110.747 174.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . 0.801 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 0.9 OUTLIER -56.29 -39.92 73.47 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.729 172.294 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 443' ' ' LEU . . . . . 0.542 ' O ' ' HB2' ' A' ' 446' ' ' GLU . 46.9 mt -71.64 -33.02 68.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.268 0.556 . . . . 0.0 110.062 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -60.55 -37.77 82.31 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.502 174.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -73.02 -28.69 62.5 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.584 177.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 446' ' ' GLU . . . . . 0.542 ' HB2' ' O ' ' A' ' 443' ' ' LEU . 42.0 tt0 31.41 97.06 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.247 1.202 . . . . 0.0 114.247 172.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 49.3 mt -66.34 -36.05 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 121.294 0.569 . . . . 0.0 110.402 178.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . 0.61 ' O ' ' HG3' ' A' ' 452' ' ' ARG . 19.7 m-20 -166.05 -172.4 2.29 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 -179.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -77.58 -61.13 2.09 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.442 175.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.17 -26.1 64.68 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 176.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 451' ' ' THR . . . . . 0.505 ' OG1' ' HB2' ' A' ' 448' ' ' ASP . 18.3 m -71.73 -22.24 61.65 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.437 -175.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . 0.61 ' HG3' ' O ' ' A' ' 448' ' ' ASP . 13.5 mtp180 -52.97 -54.22 38.25 Favored 'General case' 0 C--O 1.218 -0.567 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 170.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 453' ' ' ALA . . . . . 0.577 ' HB3' ' CD1' ' A' ' 419' ' ' TYR . . . -56.99 -50.06 73.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.443 -1.253 . . . . 0.0 112.623 175.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . 0.456 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 40.7 mm-40 -51.41 -35.93 41.33 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.892 -177.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 28.3 p -118.48 16.07 13.79 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.283 -176.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . 0.568 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.9 OUTLIER -56.58 -47.73 78.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.06 0.457 . . . . 0.0 111.656 -171.33 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . 0.528 ' CG1' ' HB3' ' A' ' 408' ' ' TYR . 1.9 mp -77.32 -33.06 19.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.964 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -58.05 -35.18 70.97 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.889 0.852 . . . . 0.0 109.385 171.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . 0.722 ' O ' HG23 ' A' ' 463' ' ' VAL . 62.1 m-70 -73.81 -28.69 61.75 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.712 177.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . 0.725 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -73.85 -34.69 64.62 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.891 0.853 . . . . 0.0 108.968 178.869 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . 0.458 ' O ' ' HB2' ' A' ' 464' ' ' TYR . 22.4 m-80 -73.37 -37.3 66.06 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.922 0.868 . . . . 0.0 108.899 176.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 462' ' ' ALA . . . . . 0.642 ' O ' HD11 ' A' ' 466' ' ' ILE . . . -56.54 -34.2 66.84 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.848 169.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.725 ' HB ' ' O ' ' A' ' 460' ' ' LEU . 56.0 t -61.69 -50.16 81.37 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.796 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.051 175.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 464' ' ' TYR . . . . . 0.571 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 18.6 m-30 -53.1 -28.45 25.49 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.611 177.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.86 -40.35 22.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.842 0.829 . . . . 0.0 109.596 -178.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.642 HD11 ' O ' ' A' ' 462' ' ' ALA . 3.4 mt -58.02 -55.23 23.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 114.196 -1.366 . . . . 0.0 112.308 177.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.734 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -102.26 -10.04 19.89 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -172.89 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . 0.511 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 93.42 31.9 8.08 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 119.173 -1.489 . . . . 0.0 113.932 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 469' ' ' LEU . . . . . 0.734 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.2 mt -89.56 162.84 15.46 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 117.78 0.79 . . . . 0.0 110.732 175.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . 0.477 ' HB3' ' CG2' ' A' ' 476' ' ' ILE . 39.0 p30 -102.64 -179.65 4.03 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.902 171.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 471' ' ' ALA . . . . . 0.536 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -61.04 -22.01 64.16 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -175.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 472' ' ' ARG . . . . . 0.445 ' HA ' ' O ' ' A' ' 402' ' ' GLU . 17.4 mmt180 -88.61 6.79 36.56 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.507 -171.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 473' ' ' GLY . . . . . 0.431 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 74.34 13.08 81.78 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.455 -0.879 . . . . 0.0 111.114 -177.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -100.6 152.71 20.1 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 24.0 p -91.03 126.79 36.22 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.297 0.57 . . . . 0.0 110.573 176.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 476' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.7 pp . . . . . 0 C--N 1.315 -0.933 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.701 -179.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 386' ' ' PHE . . . . . 0.81 ' CZ ' HG11 ' B' ' 394' ' ' VAL . 3.5 t80 . . . . . 0 CA--C 1.53 0.184 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 387' ' ' PRO . . . . . 0.582 ' HG2' ' OD1' ' A' ' 393' ' ' ASN . 35.1 Cg_endo -66.83 63.89 0.58 Allowed 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.928 3.085 . . . . 0.0 113.628 177.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 388' ' ' MET . . . . . 0.766 ' SD ' HG13 ' B' ' 394' ' ' VAL . 5.2 tpp -68.05 164.53 19.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.888 176.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 389' ' ' HIS . . . . . 0.59 ' CE1' ' HA ' ' B' ' 393' ' ' ASN . 30.6 m170 -65.2 -160.49 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 172.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -71.59 1.43 6.62 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.241 170.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 391' ' ' LEU . . . . . 0.562 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.2 pt? -155.15 -64.14 0.12 Allowed 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -176.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 392' ' ' GLY . . . . . 0.612 ' HA2' ' SD ' ' B' ' 388' ' ' MET . . . -158.55 74.94 0.21 Allowed Glycine 0 CA--C 1.524 0.635 0 C-N-CA 119.988 -1.101 . . . . 0.0 114.243 -172.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 393' ' ' ASN . . . . . 0.59 ' HA ' ' CE1' ' B' ' 389' ' ' HIS . 0.0 OUTLIER -65.74 -42.03 91.49 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 177.697 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 394' ' ' VAL . . . . . 0.81 HG11 ' CZ ' ' B' ' 386' ' ' PHE . 0.6 OUTLIER -57.27 -46.18 85.06 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 179.72 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 395' ' ' ILE . . . . . 0.565 HG23 HG22 ' B' ' 425' ' ' ILE . 4.1 mp -57.53 -52.06 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.575 0 CA-C-O 117.792 -1.099 . . . . 0.0 113.381 -173.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 396' ' ' LYS . . . . . 0.628 ' O ' HG21 ' B' ' 399' ' ' VAL . 0.1 OUTLIER -62.19 -50.67 70.88 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 122.021 2.191 . . . . 0.0 112.178 -176.838 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.7 -44.62 69.47 Favored Glycine 0 N--CA 1.435 -1.421 0 C-N-CA 119.904 -1.141 . . . . 0.0 110.848 -175.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 398' ' ' ILE . . . . . 0.699 ' CD1' HD12 ' B' ' 410' ' ' LEU . 27.0 mt -71.25 -34.08 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -178.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 399' ' ' VAL . . . . . 0.628 HG21 ' O ' ' B' ' 396' ' ' LYS . 16.1 m -62.58 -40.07 86.93 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 C-N-CA 118.778 -1.169 . . . . 0.0 108.594 -174.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -71.28 -36.76 71.82 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 176.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 401' ' ' GLN . . . . . . . . . . . . . 4.2 mm100 -88.73 -46.72 8.77 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -171.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 402' ' ' GLU . . . . . 0.461 ' HB3' ' HB ' ' B' ' 406' ' ' THR . 2.4 mm-40 -120.52 -20.11 7.27 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.504 -171.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 106.49 162.08 22.42 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.834 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 404' ' ' VAL . . . . . 0.634 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.5 m -53.66 -45.35 60.28 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.802 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -175.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 405' ' ' ALA . . . . . 0.489 ' HB3' HG22 ' B' ' 457' ' ' ILE . . . -64.28 -30.89 71.92 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.425 -177.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 406' ' ' THR . . . . . 0.686 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 87.6 m -76.93 -42.61 38.69 Favored 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 120.099 -0.64 . . . . 0.0 109.986 173.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 407' ' ' ALA . . . . . 0.515 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.56 -37.06 74.93 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 122.171 0.986 . . . . 0.0 109.434 176.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 408' ' ' TYR . . . . . 0.634 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -66.04 -52.08 52.35 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 113.452 -1.704 . . . . 0.0 109.682 176.395 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 409' ' ' THR . . . . . 0.545 HG22 HD22 ' B' ' 410' ' ' LEU . 10.1 m -55.35 -47.4 75.78 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.69 -0.687 . . . . 0.0 112.571 178.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 410' ' ' LEU . . . . . 0.699 HD12 ' CD1' ' B' ' 398' ' ' ILE . 13.7 mt -72.14 -35.93 69.23 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 120.992 0.425 . . . . 0.0 109.925 -175.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.77 -34.75 78.85 Favored Glycine 0 N--CA 1.438 -1.192 0 C-N-CA 120.236 -0.983 . . . . 0.0 110.779 172.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 412' ' ' MET . . . . . 0.425 ' HE1' ' HA ' ' B' ' 417' ' ' GLN . 0.5 OUTLIER -69.85 -47.87 61.03 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-O 120.574 0.226 . . . . 0.0 111.346 178.381 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 413' ' ' MET . . . . . 0.927 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.5 OUTLIER -70.58 -42.11 71.49 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 119.035 -1.066 . . . . 0.0 112.211 -178.334 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 414' ' ' LEU . . . . . 0.927 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 19.4 mt -75.32 -46.34 33.96 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -176.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 24.8 t -86.34 -16.99 35.71 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.806 0.812 . . . . 0.0 109.717 -173.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 416' ' ' GLY . . . . . 0.47 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 106.33 -178.26 22.55 Favored Glycine 0 N--CA 1.431 -1.662 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 -171.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 417' ' ' GLN . . . . . 0.425 ' HA ' ' HE1' ' B' ' 412' ' ' MET . 33.0 mm-40 -79.72 24.44 0.38 Allowed 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.151 0.5 . . . . 0.0 110.94 -174.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 418' ' ' ASN . . . . . 0.47 ' H ' ' C ' ' B' ' 416' ' ' GLY . 3.9 m-20 -71.19 75.87 0.7 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.807 -177.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 419' ' ' TYR . . . . . 0.575 ' CD1' ' HB3' ' B' ' 453' ' ' ALA . 2.2 p90 -49.27 -40.06 33.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.801 -1.09 . . . . 0.0 111.789 176.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -55.33 -46.12 76.37 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.774 0.321 . . . . 0.0 110.963 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.66 -48.81 63.01 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.172 -176.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 422' ' ' VAL . . . . . 0.438 ' HB ' ' CD1' ' B' ' 408' ' ' TYR . 0.1 OUTLIER -66.03 -41.4 89.59 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 C-N-CA 120.371 -0.531 . . . . 0.0 111.076 -175.898 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 423' ' ' SER . . . . . 0.791 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 76.3 p -66.89 -39.33 87.44 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.883 -178.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.08 -38.98 92.8 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.922 176.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 425' ' ' ILE . . . . . 0.565 HG22 HG23 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -73.05 -52.79 20.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.318 0.104 . . . . 0.0 111.161 -176.869 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 426' ' ' ILE . . . . . 0.56 ' CD1' HG21 ' B' ' 395' ' ' ILE . 1.1 mm -74.23 -23.55 18.55 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.863 0 O-C-N 122.185 -0.322 . . . . 0.0 110.164 -171.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 427' ' ' ARG . . . . . 0.791 ' HB2' ' O ' ' B' ' 423' ' ' SER . 2.3 tmm_? -55.58 -31.36 62.13 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.221 0.534 . . . . 0.0 110.928 -177.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -85.38 -12.27 73.4 Favored Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.429 -0.891 . . . . 0.0 111.11 178.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 429' ' ' TYR . . . . . 0.512 ' HD1' ' CG2' ' B' ' 395' ' ' ILE . 7.3 m-30 -113.26 0.27 14.81 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.558 0.694 . . . . 0.0 109.227 -173.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 430' ' ' LEU . . . . . 0.534 ' HA ' HG13 ' B' ' 404' ' ' VAL . 0.1 OUTLIER -66.27 129.71 94.21 Favored Pre-proline 0 N--CA 1.445 -0.696 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.23 178.101 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 431' ' ' PRO . . . . . 0.531 ' HD2' HD13 ' B' ' 430' ' ' LEU . 95.0 Cg_exo -24.06 -60.35 0.05 OUTLIER 'Trans proline' 0 C--N 1.36 1.148 1 C-N-CA 125.602 4.201 . . . . 0.0 115.094 179.747 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 432' ' ' GLY . . . . . 0.571 ' O ' HG13 ' B' ' 435' ' ' VAL . . . -153.18 -171.5 20.53 Favored Glycine 0 N--CA 1.443 -0.887 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 177.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 433' ' ' GLN . . . . . 0.548 ' O ' HG12 ' B' ' 436' ' ' VAL . 16.3 tp60 -66.09 -26.89 67.68 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 118.088 0.944 . . . . 0.0 110.368 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -65.44 -43.42 90.51 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -178.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 435' ' ' VAL . . . . . 0.571 HG13 ' O ' ' B' ' 432' ' ' GLY . 7.6 p -67.32 -42.31 87.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 121.104 0.478 . . . . 0.0 110.423 -176.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 436' ' ' VAL . . . . . 0.548 HG12 ' O ' ' B' ' 433' ' ' GLN . 0.1 OUTLIER -68.02 -30.58 48.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.838 175.698 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 437' ' ' THR . . . . . 0.403 HG22 ' N ' ' B' ' 438' ' ' ALA . 1.0 OUTLIER -67.93 -51.9 42.4 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 438' ' ' ALA . . . . . 0.806 ' O ' ' HG2' ' B' ' 442' ' ' ARG . . . -58.11 -38.65 76.86 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.916 177.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 439' ' ' LEU . . . . . 0.551 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 1.9 tm? -70.27 -46.93 63.38 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.03 -39.23 74.41 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.127 174.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 441' ' ' GLN . . . . . 0.497 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 8.3 mm-40 -54.24 -49.89 68.44 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 123.888 0.875 . . . . 0.0 110.795 174.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 442' ' ' ARG . . . . . 0.806 ' HG2' ' O ' ' B' ' 438' ' ' ALA . 0.9 OUTLIER -56.17 -39.86 73.03 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.65 172.364 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 443' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 47.1 mt -71.74 -32.85 68.16 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.217 0.532 . . . . 0.0 110.119 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -60.76 -37.61 82.4 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.463 174.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -73.28 -28.42 62.1 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.554 177.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 446' ' ' GLU . . . . . 0.545 ' HB2' ' O ' ' B' ' 443' ' ' LEU . 41.3 tt0 31.26 97.02 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 172.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 49.9 mt -66.7 -35.83 75.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.37 0.605 . . . . 0.0 110.343 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 448' ' ' ASP . . . . . 0.617 ' O ' ' HG3' ' B' ' 452' ' ' ARG . 17.5 m-20 -166.12 -172.62 2.34 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -77.51 -61.15 2.08 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.432 175.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.05 -26.14 64.82 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 176.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 451' ' ' THR . . . . . 0.501 ' OG1' ' HB2' ' B' ' 448' ' ' ASP . 18.6 m -71.72 -22.1 61.68 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.538 -175.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 452' ' ' ARG . . . . . 0.617 ' HG3' ' O ' ' B' ' 448' ' ' ASP . 13.4 mtp180 -53.07 -54.1 40.54 Favored 'General case' 0 C--O 1.218 -0.553 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 170.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 453' ' ' ALA . . . . . 0.575 ' HB3' ' CD1' ' B' ' 419' ' ' TYR . . . -57.09 -50.11 73.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.381 -1.281 . . . . 0.0 112.585 175.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 454' ' ' GLU . . . . . 0.447 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 45.5 mm-40 -51.4 -36.0 41.6 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.803 -177.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 27.2 p -118.36 16.1 13.89 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.264 -176.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 456' ' ' PHE . . . . . 0.579 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 0.9 OUTLIER -56.65 -47.76 79.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.076 0.465 . . . . 0.0 111.612 -171.178 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 457' ' ' ILE . . . . . 0.538 ' CG1' ' HB3' ' B' ' 408' ' ' TYR . 1.9 mp -77.16 -33.14 19.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.979 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -58.05 -35.14 70.9 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.88 0.848 . . . . 0.0 109.393 172.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 459' ' ' HIS . . . . . 0.715 ' O ' HG23 ' B' ' 463' ' ' VAL . 62.0 m-70 -73.83 -28.77 61.77 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.731 177.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 460' ' ' LEU . . . . . 0.727 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -73.89 -34.64 64.5 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.906 0.86 . . . . 0.0 108.994 178.881 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 461' ' ' ASN . . . . . 0.448 ' O ' ' HB2' ' B' ' 464' ' ' TYR . 21.7 m-80 -73.25 -37.28 66.39 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.877 0.846 . . . . 0.0 108.869 176.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 462' ' ' ALA . . . . . 0.65 ' O ' HD11 ' B' ' 466' ' ' ILE . . . -56.61 -34.05 66.85 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.981 169.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 463' ' ' VAL . . . . . 0.727 ' HB ' ' O ' ' B' ' 460' ' ' LEU . 55.9 t -61.71 -50.07 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-N 114.642 -1.163 . . . . 0.0 107.999 175.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 464' ' ' TYR . . . . . 0.557 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 18.5 m-30 -53.1 -28.34 24.88 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 114.678 -1.147 . . . . 0.0 110.633 177.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.11 -40.24 22.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.906 0.86 . . . . 0.0 109.62 -178.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 466' ' ' ILE . . . . . 0.65 HD11 ' O ' ' B' ' 462' ' ' ALA . 3.4 mt -57.91 -55.35 22.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 114.209 -1.36 . . . . 0.0 112.235 176.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 467' ' ' LEU . . . . . 0.735 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -102.42 -10.0 19.79 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 114.474 1.286 . . . . 0.0 114.474 -172.821 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 468' ' ' GLY . . . . . 0.521 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 93.46 31.87 8.08 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 119.081 -1.533 . . . . 0.0 113.91 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 469' ' ' LEU . . . . . 0.735 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.2 mt -89.76 162.53 15.49 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 117.677 0.738 . . . . 0.0 110.795 175.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 470' ' ' ASN . . . . . 0.487 ' HB3' ' CG2' ' B' ' 476' ' ' ILE . 39.4 p30 -102.48 -179.54 4.01 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.889 171.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 471' ' ' ALA . . . . . 0.54 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -61.6 -21.64 64.52 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -175.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 472' ' ' ARG . . . . . 0.448 ' HA ' ' O ' ' B' ' 402' ' ' GLU . 17.2 mmt180 -88.67 6.74 37.01 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.431 -171.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 473' ' ' GLY . . . . . 0.429 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 74.5 12.8 82.21 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.145 -177.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -100.4 152.92 19.78 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 25.1 p -91.06 127.03 36.32 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.367 0.603 . . . . 0.0 110.522 176.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 476' ' ' ILE . . . . . 0.521 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.7 pp . . . . . 0 C--N 1.315 -0.894 0 CA-C-N 114.92 -1.037 . . . . 0.0 110.621 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 386' ' ' PHE . . . . . 0.652 ' CE2' HG13 ' A' ' 394' ' ' VAL . 1.4 t80 . . . . . 0 CA--C 1.537 0.462 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -49.27 -72.84 0.04 OUTLIER 'Trans proline' 0 N--CA 1.485 0.995 0 C-N-CA 124.309 3.339 . . . . 0.0 114.418 -178.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 388' ' ' MET . . . . . 0.559 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 38.9 ttm 74.36 49.36 0.11 Allowed 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 172.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 389' ' ' HIS . . . . . 0.684 ' CG ' ' HB2' ' A' ' 393' ' ' ASN . 40.7 m170 47.31 -99.44 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.25 0.62 . . . . 0.0 110.642 -175.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -146.36 15.71 1.3 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.469 -0.787 . . . . 0.0 108.884 174.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.465 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.4 pt? -169.15 -50.97 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -168.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . 0.465 ' N ' ' HG ' ' A' ' 391' ' ' LEU . . . -176.47 50.89 0.11 Allowed Glycine 0 C--N 1.335 0.495 0 C-N-CA 119.609 -1.282 . . . . 0.0 114.214 -172.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . 0.684 ' HB2' ' CG ' ' A' ' 389' ' ' HIS . 0.4 OUTLIER -54.21 -41.31 68.48 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 117.401 0.6 . . . . 0.0 109.679 176.761 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . 0.652 HG13 ' CE2' ' A' ' 386' ' ' PHE . 0.9 OUTLIER -56.85 -47.08 83.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 -179.249 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.534 HG21 HG22 ' A' ' 425' ' ' ILE . 4.3 mp -57.87 -52.22 60.66 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 CA-C-O 117.938 -1.03 . . . . 0.0 113.307 -175.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . 0.688 ' HG3' ' CZ ' ' A' ' 429' ' ' TYR . 0.1 OUTLIER -62.98 -49.88 72.95 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 121.692 2.042 . . . . 0.0 112.069 -174.165 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . 0.542 ' O ' ' HG3' ' A' ' 401' ' ' GLN . . . -54.32 -44.67 76.02 Favored Glycine 0 N--CA 1.435 -1.387 0 C-N-CA 120.099 -1.048 . . . . 0.0 111.035 -177.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . 0.594 ' CD1' HD12 ' A' ' 410' ' ' LEU . 45.4 mt -71.6 -34.37 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -177.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 396' ' ' LYS . 5.4 m -64.09 -39.99 87.46 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 C-N-CA 118.738 -1.185 . . . . 0.0 108.408 -174.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -64.74 -41.24 96.08 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 174.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . 0.542 ' HG3' ' O ' ' A' ' 397' ' ' GLY . 32.1 mt-30 -93.07 -48.39 6.52 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -169.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . 0.423 ' HG3' ' HE1' ' B' ' 413' ' ' MET . 3.0 mm-40 -113.42 -20.11 11.44 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.448 -171.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 104.77 163.21 24.15 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.125 -0.559 . . . . 0.0 113.137 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . 0.659 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.5 m -53.43 -45.21 57.37 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.752 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 -176.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . 0.485 ' HB2' HG22 ' A' ' 457' ' ' ILE . . . -66.41 -30.87 71.34 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.994 -175.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 406' ' ' THR . . . . . 0.701 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 92.4 m -77.23 -42.35 37.68 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.241 173.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.52 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.21 -37.71 75.37 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 122.049 0.928 . . . . 0.0 109.215 176.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 408' ' ' TYR . . . . . 0.659 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.64 -52.39 52.15 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 113.593 -1.64 . . . . 0.0 109.961 177.115 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 409' ' ' THR . . . . . 0.55 HG22 HD23 ' A' ' 410' ' ' LEU . 2.7 m -56.22 -46.23 79.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.505 178.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . 0.701 ' HG ' ' O ' ' A' ' 406' ' ' THR . 13.4 mt -72.03 -36.74 69.75 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 -175.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.6 -34.66 77.25 Favored Glycine 0 N--CA 1.44 -1.094 0 C-N-CA 120.085 -1.055 . . . . 0.0 110.708 172.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 412' ' ' MET . . . . . 0.41 ' HB2' ' O ' ' A' ' 409' ' ' THR . 0.4 OUTLIER -67.19 -48.21 68.6 Favored 'General case' 0 C--O 1.221 -0.438 0 C-N-CA 122.129 0.172 . . . . 0.0 111.403 177.672 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 413' ' ' MET . . . . . 0.941 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.7 OUTLIER -71.52 -47.73 53.4 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 118.848 -1.141 . . . . 0.0 112.103 -179.935 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . 0.941 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 23.3 mt -67.43 -44.24 79.24 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -175.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.438 ' HB2' ' HE1' ' A' ' 388' ' ' MET . 48.1 t -86.97 -23.76 24.96 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.503 0.668 . . . . 0.0 110.011 -177.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . 0.471 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 109.69 -175.62 18.84 Favored Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -170.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -79.65 24.3 0.38 Allowed 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.495 0.664 . . . . 0.0 111.291 -172.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 418' ' ' ASN . . . . . 0.471 ' H ' ' C ' ' A' ' 416' ' ' GLY . 79.6 m-20 -71.67 76.04 0.83 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.651 -178.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 419' ' ' TYR . . . . . 0.536 ' CD1' ' HB1' ' A' ' 453' ' ' ALA . 12.0 p90 -55.21 -39.0 69.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.537 178.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -55.71 -43.48 76.52 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.833 0.349 . . . . 0.0 111.166 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.22 -48.68 64.53 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.951 -177.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . 0.423 ' HB ' ' CD1' ' A' ' 408' ' ' TYR . 0.2 OUTLIER -66.36 -39.52 84.34 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.155 -177.277 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.74 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 68.4 p -66.84 -39.38 87.62 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.93 -39.2 89.41 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.199 176.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . 0.534 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.79 -51.75 25.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 121.176 -0.209 . . . . 0.0 111.114 -177.375 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . 0.519 ' O ' HD23 ' A' ' 430' ' ' LEU . 1.2 mm -74.27 -22.88 18.14 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.625 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -172.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.74 ' HB2' ' O ' ' A' ' 423' ' ' SER . 0.7 OUTLIER -54.86 -31.45 59.65 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.25 0.548 . . . . 0.0 110.149 -179.728 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -85.31 -5.16 85.57 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.667 178.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.688 ' CZ ' ' HG3' ' A' ' 396' ' ' LYS . 24.9 m-85 -119.76 0.69 10.95 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 121.08 0.467 . . . . 0.0 110.666 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . 0.522 HD11 ' HD2' ' A' ' 431' ' ' PRO . 0.1 OUTLIER -65.94 127.9 93.46 Favored Pre-proline 0 N--CA 1.438 -1.044 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.735 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 431' ' ' PRO . . . . . 0.522 ' HD2' HD11 ' A' ' 430' ' ' LEU . 80.9 Cg_exo -23.41 -70.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.892 1 C-N-CA 125.627 4.218 . . . . 0.0 115.082 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . 0.479 ' O ' HG13 ' A' ' 435' ' ' VAL . . . -138.17 -167.4 10.99 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 176.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . 0.503 ' O ' HG13 ' A' ' 436' ' ' VAL . 19.2 tp60 -69.41 -26.92 64.86 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 117.831 0.815 . . . . 0.0 110.165 179.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -68.24 -39.04 82.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.357 -176.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 435' ' ' VAL . . . . . 0.492 ' HA ' ' CG1' ' A' ' 463' ' ' VAL . 7.2 p -69.48 -44.01 80.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-O 120.972 0.415 . . . . 0.0 110.527 -177.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . 0.503 HG13 ' O ' ' A' ' 433' ' ' GLN . 0.2 OUTLIER -65.33 -31.36 53.52 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 174.825 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 1.1 m -67.22 -52.82 36.35 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -178.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . 0.572 ' O ' ' HD2' ' A' ' 442' ' ' ARG . . . -58.89 -39.16 80.62 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.12 177.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 439' ' ' LEU . . . . . 0.626 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 1.9 tm? -68.13 -48.52 65.17 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -178.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.21 -35.02 72.87 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.519 -1.219 . . . . 0.0 111.171 174.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 441' ' ' GLN . . . . . 0.468 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 3.7 mm-40 -55.13 -49.68 71.17 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.122 -177.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . 0.61 ' HG3' ' CG ' ' A' ' 459' ' ' HIS . 0.0 OUTLIER -75.8 -24.64 55.94 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 119.563 -0.855 . . . . 0.0 113.032 175.073 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 443' ' ' LEU . . . . . 0.626 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 70.1 mt -64.18 -35.29 80.3 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-N 118.453 0.569 . . . . 0.0 109.601 175.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -57.0 -37.96 72.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.524 173.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 -74.34 -26.75 60.34 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.312 177.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 27.59 98.86 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 176.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 49.2 mt -60.9 -35.13 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-O 121.266 0.555 . . . . 0.0 110.689 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . 0.462 ' HB2' ' OG1' ' A' ' 451' ' ' THR . 18.4 m-20 -163.66 -161.79 0.67 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 -177.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -82.38 -69.56 0.61 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 172.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -24.78 66.21 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 178.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 451' ' ' THR . . . . . 0.47 ' HA ' ' HB2' ' A' ' 454' ' ' GLU . 14.0 m -70.62 -22.55 62.51 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.788 -173.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . 0.426 HH11 ' HD2' ' A' ' 452' ' ' ARG . 18.3 mtp180 -54.1 -54.22 42.5 Favored 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 171.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 453' ' ' ALA . . . . . 0.536 ' HB1' ' CD1' ' A' ' 419' ' ' TYR . . . -59.13 -47.1 86.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.524 -1.216 . . . . 0.0 112.604 175.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . 0.47 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 12.0 mm-40 -51.58 -38.39 54.23 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.203 0.525 . . . . 0.0 111.478 -177.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 28.1 p -116.36 15.44 15.78 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.422 -175.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . 0.49 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.7 OUTLIER -56.74 -48.99 76.54 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 120.951 0.405 . . . . 0.0 111.777 -171.472 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . 0.519 ' CG1' ' HB3' ' A' ' 408' ' ' TYR . 1.9 mp -75.45 -32.93 26.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 120.841 0.353 . . . . 0.0 110.713 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -57.63 -35.51 70.58 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.694 0.759 . . . . 0.0 109.586 171.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . 0.75 ' O ' HG21 ' A' ' 463' ' ' VAL . 71.3 m-70 -71.74 -29.57 64.67 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.755 -1.112 . . . . 0.0 110.613 176.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . 0.699 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -74.08 -34.81 64.14 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.912 0.863 . . . . 0.0 108.787 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -72.84 -38.17 67.19 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.311 175.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 462' ' ' ALA . . . . . 0.633 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -55.82 -32.93 64.0 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.807 169.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.75 HG21 ' O ' ' A' ' 459' ' ' HIS . 61.6 t -63.89 -50.57 76.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 CA-C-N 114.474 -1.239 . . . . 0.0 107.901 177.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 464' ' ' TYR . . . . . 0.553 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 15.3 m-30 -53.89 -27.16 28.69 Favored 'General case' 0 C--N 1.332 -0.169 0 O-C-N 124.259 0.974 . . . . 0.0 110.324 178.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.68 -40.95 18.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.689 0.757 . . . . 0.0 109.38 -177.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.633 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.7 mt -56.22 -55.82 16.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 114.295 -1.32 . . . . 0.0 112.289 175.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.735 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -103.41 -10.82 18.3 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -171.752 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . 0.547 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 93.73 31.74 8.05 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 119.43 -1.367 . . . . 0.0 114.351 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 469' ' ' LEU . . . . . 0.735 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 2.6 mt -88.91 162.3 16.19 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 117.983 0.892 . . . . 0.0 111.435 177.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 39.5 p30 -105.29 -174.45 2.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.349 173.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -67.02 -17.49 64.94 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -175.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -88.48 -0.43 57.2 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 122.101 -0.375 . . . . 0.0 111.321 -175.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 75.85 17.08 80.25 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -173.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -101.55 151.6 21.78 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 177.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 5.6 p -90.61 127.76 36.38 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.95 0.405 . . . . 0.0 111.169 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 476' ' ' ILE . . . . . 0.547 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.5 pp . . . . . 0 C--N 1.325 -0.462 0 CA-C-O 121.806 0.812 . . . . 0.0 110.282 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 386' ' ' PHE . . . . . 0.656 ' CE2' HG13 ' B' ' 394' ' ' VAL . 1.4 t80 . . . . . 0 CA--C 1.538 0.482 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 387' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -49.32 -72.67 0.04 OUTLIER 'Trans proline' 0 N--CA 1.487 1.13 0 C-N-CA 124.492 3.461 . . . . 0.0 114.375 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 388' ' ' MET . . . . . 0.557 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 38.9 ttm 73.98 49.54 0.12 Allowed 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 112.754 0.649 . . . . 0.0 112.754 172.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 389' ' ' HIS . . . . . 0.697 ' CG ' ' HB2' ' B' ' 393' ' ' ASN . 40.7 m170 47.32 -99.84 0.05 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.22 0.608 . . . . 0.0 110.499 -175.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -145.99 15.49 1.36 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.823 174.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 391' ' ' LEU . . . . . 0.459 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.4 pt? -169.15 -50.89 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -168.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 392' ' ' GLY . . . . . 0.459 ' N ' ' HG ' ' B' ' 391' ' ' LEU . . . -176.51 51.14 0.11 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 119.599 -1.286 . . . . 0.0 114.25 -172.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 393' ' ' ASN . . . . . 0.697 ' HB2' ' CG ' ' B' ' 389' ' ' HIS . 0.4 OUTLIER -54.47 -41.19 69.21 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 117.359 0.579 . . . . 0.0 109.705 176.914 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 394' ' ' VAL . . . . . 0.656 HG13 ' CE2' ' B' ' 386' ' ' PHE . 0.9 OUTLIER -56.86 -47.2 83.41 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 -179.29 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 395' ' ' ILE . . . . . 0.54 HG21 HG22 ' B' ' 425' ' ' ILE . 4.3 mp -57.86 -52.15 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 CA-C-O 117.824 -1.084 . . . . 0.0 113.31 -175.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 396' ' ' LYS . . . . . 0.684 ' HG3' ' CZ ' ' B' ' 429' ' ' TYR . 0.1 OUTLIER -62.95 -49.8 73.31 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 121.714 2.052 . . . . 0.0 112.12 -174.201 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 397' ' ' GLY . . . . . 0.541 ' O ' ' HG3' ' B' ' 401' ' ' GLN . . . -54.51 -44.47 77.96 Favored Glycine 0 N--CA 1.436 -1.355 0 C-N-CA 120.05 -1.071 . . . . 0.0 110.986 -177.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 398' ' ' ILE . . . . . 0.611 ' CD1' HD12 ' B' ' 410' ' ' LEU . 46.2 mt -71.71 -34.27 51.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -177.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 399' ' ' VAL . . . . . 0.488 HG23 ' O ' ' B' ' 396' ' ' LYS . 5.5 m -64.21 -39.82 86.85 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.501 0 C-N-CA 118.836 -1.145 . . . . 0.0 108.457 -174.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -64.96 -41.11 95.75 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 174.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 401' ' ' GLN . . . . . 0.541 ' HG3' ' O ' ' B' ' 397' ' ' GLY . 32.3 mt-30 -93.13 -48.29 6.55 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -169.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 402' ' ' GLU . . . . . 0.427 ' HG3' ' HE1' ' A' ' 413' ' ' MET . 3.0 mm-40 -113.61 -19.99 11.39 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.44 -171.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 104.58 162.83 24.3 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.061 -0.59 . . . . 0.0 113.224 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 404' ' ' VAL . . . . . 0.659 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.4 m -53.21 -45.32 54.73 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.766 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -176.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 405' ' ' ALA . . . . . 0.485 ' HB2' HG22 ' B' ' 457' ' ' ILE . . . -66.23 -30.71 71.22 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 119.711 -0.795 . . . . 0.0 112.062 -175.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 406' ' ' THR . . . . . 0.691 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 88.2 m -77.26 -42.51 36.84 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.303 173.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 407' ' ' ALA . . . . . 0.518 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.09 -37.75 75.1 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 122.093 0.949 . . . . 0.0 109.2 176.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 408' ' ' TYR . . . . . 0.659 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.51 -52.58 51.69 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 113.631 -1.622 . . . . 0.0 109.975 177.028 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 409' ' ' THR . . . . . 0.566 HG22 HD23 ' B' ' 410' ' ' LEU . 2.7 m -56.17 -46.17 79.44 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.569 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 410' ' ' LEU . . . . . 0.691 ' HG ' ' O ' ' B' ' 406' ' ' THR . 13.2 mt -71.95 -36.74 69.98 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.808 0.337 . . . . 0.0 110.2 -175.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.51 -34.8 77.21 Favored Glycine 0 N--CA 1.439 -1.109 0 C-N-CA 120.04 -1.076 . . . . 0.0 110.729 172.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 412' ' ' MET . . . . . 0.411 ' HB2' ' O ' ' B' ' 409' ' ' THR . 0.4 OUTLIER -67.11 -48.14 69.01 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 115.808 -0.196 . . . . 0.0 111.423 177.76 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 413' ' ' MET . . . . . 0.929 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.7 OUTLIER -71.38 -48.1 52.11 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 118.884 -1.126 . . . . 0.0 112.119 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 414' ' ' LEU . . . . . 0.929 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 23.4 mt -67.2 -44.24 80.11 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -175.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 415' ' ' SER . . . . . 0.426 ' HB2' ' HE1' ' B' ' 388' ' ' MET . 48.1 t -86.81 -24.11 25.12 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.592 0.711 . . . . 0.0 109.907 -177.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 416' ' ' GLY . . . . . 0.471 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 109.98 -175.52 18.58 Favored Glycine 0 N--CA 1.43 -1.715 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -170.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -79.71 24.47 0.38 Allowed 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.61 0.719 . . . . 0.0 111.326 -172.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 418' ' ' ASN . . . . . 0.471 ' H ' ' C ' ' B' ' 416' ' ' GLY . 79.9 m-20 -71.75 75.71 0.85 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.785 -178.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 419' ' ' TYR . . . . . 0.529 ' CD1' ' HB1' ' B' ' 453' ' ' ALA . 11.8 p90 -54.89 -38.9 68.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.598 178.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -55.73 -43.57 76.69 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.739 0.304 . . . . 0.0 111.061 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.15 -48.63 64.84 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.013 -177.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 422' ' ' VAL . . . . . 0.424 ' HB ' ' CD1' ' B' ' 408' ' ' TYR . 0.2 OUTLIER -66.41 -39.44 84.07 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.212 -177.365 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 423' ' ' SER . . . . . 0.76 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 67.3 p -66.97 -39.33 87.18 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.98 -39.11 89.24 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.161 176.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 425' ' ' ILE . . . . . 0.54 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -72.79 -51.7 26.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 116.622 0.211 . . . . 0.0 111.121 -177.334 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 426' ' ' ILE . . . . . 0.511 ' O ' HD23 ' B' ' 430' ' ' LEU . 1.2 mm -74.3 -23.06 18.17 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.708 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -172.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 427' ' ' ARG . . . . . 0.76 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.7 OUTLIER -54.75 -31.34 58.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.344 0.592 . . . . 0.0 110.305 -179.769 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -85.5 -4.74 85.47 Favored Glycine 0 N--CA 1.446 -0.7 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.65 178.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 429' ' ' TYR . . . . . 0.684 ' CZ ' ' HG3' ' B' ' 396' ' ' LYS . 24.9 m-85 -120.13 0.52 10.72 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 121.105 0.479 . . . . 0.0 110.693 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 430' ' ' LEU . . . . . 0.515 HD11 ' HD2' ' B' ' 431' ' ' PRO . 0.1 OUTLIER -65.77 127.87 93.4 Favored Pre-proline 0 N--CA 1.44 -0.972 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.634 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 431' ' ' PRO . . . . . 0.515 ' HD2' HD11 ' B' ' 430' ' ' LEU . 84.1 Cg_exo -23.47 -70.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.832 1 C-N-CA 125.665 4.243 . . . . 0.0 115.011 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 432' ' ' GLY . . . . . 0.485 ' O ' HG13 ' B' ' 435' ' ' VAL . . . -138.12 -167.54 11.04 Favored Glycine 0 N--CA 1.442 -0.921 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 176.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 433' ' ' GLN . . . . . 0.499 ' O ' HG13 ' B' ' 436' ' ' VAL . 19.1 tp60 -69.5 -26.82 64.73 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 117.791 0.796 . . . . 0.0 110.074 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -68.07 -39.51 82.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.227 -176.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 435' ' ' VAL . . . . . 0.497 ' HA ' ' CG1' ' B' ' 463' ' ' VAL . 7.3 p -69.05 -44.03 81.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-O 120.968 0.413 . . . . 0.0 110.649 -177.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 436' ' ' VAL . . . . . 0.499 HG13 ' O ' ' B' ' 433' ' ' GLN . 0.2 OUTLIER -65.26 -31.22 52.93 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 CA-C-O 121.08 0.467 . . . . 0.0 109.883 174.795 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 1.1 m -67.28 -52.8 36.21 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 -178.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 438' ' ' ALA . . . . . 0.576 ' O ' ' HD2' ' B' ' 442' ' ' ARG . . . -58.94 -39.19 80.86 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 115.351 -0.841 . . . . 0.0 112.113 177.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 439' ' ' LEU . . . . . 0.618 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 1.9 tm? -68.15 -48.48 65.22 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -178.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.26 -34.99 72.9 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.485 -1.234 . . . . 0.0 111.097 174.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 441' ' ' GLN . . . . . 0.472 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 3.6 mm-40 -54.98 -50.02 70.01 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.017 -177.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 442' ' ' ARG . . . . . 0.613 ' HG3' ' CG ' ' B' ' 459' ' ' HIS . 0.0 OUTLIER -75.67 -24.34 56.32 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 119.547 -0.861 . . . . 0.0 113.095 175.261 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 443' ' ' LEU . . . . . 0.618 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 70.2 mt -64.47 -35.2 80.18 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 175.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -56.99 -38.2 72.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.451 173.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -74.22 -26.85 60.49 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.318 177.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 446' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 27.91 98.94 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.625 1.17 . . . . 0.0 114.147 176.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 49.0 mt -61.13 -35.13 63.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-O 121.151 0.5 . . . . 0.0 110.74 -178.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 448' ' ' ASP . . . . . 0.47 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 19.8 m-20 -163.79 -162.14 0.69 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 -177.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -81.85 -69.67 0.6 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 172.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.76 -24.72 66.24 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 178.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 451' ' ' THR . . . . . 0.471 ' HA ' ' HB2' ' B' ' 454' ' ' GLU . 12.4 m -70.62 -22.53 62.52 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.765 -173.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 452' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' B' ' 452' ' ' ARG . 18.2 mtp180 -54.2 -54.12 44.25 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 171.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 453' ' ' ALA . . . . . 0.529 ' HB1' ' CD1' ' B' ' 419' ' ' TYR . . . -58.94 -47.35 85.41 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.514 -1.221 . . . . 0.0 112.613 174.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 454' ' ' GLU . . . . . 0.471 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 10.5 mm-40 -51.83 -37.38 51.59 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.284 0.564 . . . . 0.0 111.603 -177.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 28.2 p -117.08 15.34 15.04 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.468 -176.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 456' ' ' PHE . . . . . 0.497 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 0.7 OUTLIER -56.57 -49.1 75.85 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.906 0.384 . . . . 0.0 111.879 -171.522 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 457' ' ' ILE . . . . . 0.531 ' CG1' ' HB3' ' B' ' 408' ' ' TYR . 1.9 mp -75.25 -33.08 27.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 120.809 0.337 . . . . 0.0 110.855 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -57.44 -35.63 70.35 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.814 0.816 . . . . 0.0 109.482 171.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 459' ' ' HIS . . . . . 0.743 ' O ' HG21 ' B' ' 463' ' ' VAL . 70.8 m-70 -71.89 -29.4 64.31 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.629 176.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 460' ' ' LEU . . . . . 0.705 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -74.14 -34.74 63.98 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.88 0.848 . . . . 0.0 108.882 179.811 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 461' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -72.82 -38.25 67.21 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.288 175.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 462' ' ' ALA . . . . . 0.646 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -55.72 -32.87 63.72 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.692 169.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 463' ' ' VAL . . . . . 0.743 HG21 ' O ' ' B' ' 459' ' ' HIS . 60.1 t -64.07 -50.6 76.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 CA-C-N 114.433 -1.258 . . . . 0.0 107.961 177.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 464' ' ' TYR . . . . . 0.547 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 15.3 m-30 -53.72 -27.48 28.54 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.327 178.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.62 -40.52 18.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.622 0.725 . . . . 0.0 109.43 -177.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 466' ' ' ILE . . . . . 0.646 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.6 mt -56.42 -55.92 16.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 114.295 -1.321 . . . . 0.0 112.268 175.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 467' ' ' LEU . . . . . 0.748 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -103.36 -10.74 18.4 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -171.884 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 468' ' ' GLY . . . . . 0.571 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 93.84 31.69 8.03 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 119.453 -1.356 . . . . 0.0 114.281 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 469' ' ' LEU . . . . . 0.748 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 2.6 mt -88.91 162.26 16.21 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 117.969 0.885 . . . . 0.0 111.29 177.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 39.7 p30 -105.27 -173.96 2.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.367 173.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 471' ' ' ALA . . . . . . . . . . . . . . . -67.69 -17.06 64.45 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -175.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -88.59 -0.81 57.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.751 0.31 . . . . 0.0 111.136 -176.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 473' ' ' GLY . . . . . . . . . . . . . . . 76.19 16.88 80.38 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 -173.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -101.4 151.96 21.3 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 177.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 5.4 p -90.78 128.21 36.61 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.88 0.372 . . . . 0.0 111.184 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 476' ' ' ILE . . . . . 0.571 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.5 pp . . . . . 0 C--N 1.326 -0.432 0 CA-C-O 121.672 0.748 . . . . 0.0 110.266 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 386' ' ' PHE . . . . . 0.669 ' CE2' HG13 ' A' ' 394' ' ' VAL . 2.6 t80 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 121.082 0.468 . . . . 0.0 110.616 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . 0.588 ' HG2' ' OD1' ' B' ' 393' ' ' ASN . 60.9 Cg_endo -72.0 111.27 3.13 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 124.105 3.203 . . . . 0.0 113.701 175.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 388' ' ' MET . . . . . 0.465 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 40.0 mtt -103.28 172.7 6.67 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 176.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -57.28 -61.76 2.24 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 175.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -175.49 19.66 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.5 -1.227 . . . . 0.0 108.448 173.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.464 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.1 pt? -169.76 -54.8 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.616 -167.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . 0.464 ' N ' ' HG ' ' A' ' 391' ' ' LEU . . . -174.88 54.77 0.13 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 119.93 -1.129 . . . . 0.0 113.703 -174.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . 0.58 ' OD1' ' HG2' ' B' ' 387' ' ' PRO . 0.2 OUTLIER -54.25 -41.9 69.29 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 177.707 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . 0.669 HG13 ' CE2' ' A' ' 386' ' ' PHE . 2.0 m -56.35 -47.05 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.597 ' N ' HG23 ' A' ' 394' ' ' VAL . 3.9 mp -57.47 -52.12 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 CA-C-O 118.04 -0.981 . . . . 0.0 113.254 -175.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . 0.666 ' HG3' ' CZ ' ' A' ' 429' ' ' TYR . 0.1 OUTLIER -61.49 -49.3 77.33 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-N 121.52 1.964 . . . . 0.0 111.857 -173.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -54.26 -45.14 75.07 Favored Glycine 0 N--CA 1.437 -1.279 0 C-N-CA 119.756 -1.212 . . . . 0.0 111.142 -178.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . 0.619 ' CD1' HD11 ' A' ' 410' ' ' LEU . 39.2 mt -70.94 -34.08 54.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -177.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 396' ' ' LYS . 10.6 m -63.5 -39.61 85.96 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 C-N-CA 118.573 -1.251 . . . . 0.0 108.24 -175.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -70.91 -33.99 71.09 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 175.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . 0.442 HE21 ' HB3' ' A' ' 401' ' ' GLN . 3.2 mm100 -90.14 -47.27 7.91 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -172.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . 0.433 ' HG3' ' HE2' ' B' ' 413' ' ' MET . 2.9 mm-40 -121.61 -20.97 6.34 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.576 -170.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 107.21 162.73 21.86 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.823 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . 0.651 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.6 m -53.52 -46.45 59.87 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.771 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -175.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . 0.485 ' HB3' HG21 ' A' ' 457' ' ' ILE . . . -64.25 -30.39 71.45 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 119.891 -0.724 . . . . 0.0 112.452 -176.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 406' ' ' THR . . . . . 0.709 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 91.9 m -77.5 -42.96 33.76 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.223 173.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.496 ' HB2' ' HA ' ' A' ' 395' ' ' ILE . . . -58.46 -37.37 75.33 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 122.117 0.96 . . . . 0.0 109.265 176.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 408' ' ' TYR . . . . . 0.651 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.58 -51.69 57.85 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 113.402 -1.726 . . . . 0.0 109.746 176.687 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 409' ' ' THR . . . . . 0.544 HG21 HD21 ' A' ' 410' ' ' LEU . 14.1 m -55.34 -47.03 76.32 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.588 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . 0.709 ' HG ' ' O ' ' A' ' 406' ' ' THR . 14.8 mt -72.19 -37.12 69.36 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 120.826 0.346 . . . . 0.0 110.164 -174.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.68 -34.46 76.98 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.57 173.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 412' ' ' MET . . . . . 0.426 ' HB2' ' O ' ' A' ' 409' ' ' THR . 0.2 OUTLIER -65.86 -44.03 86.65 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 115.685 -0.258 . . . . 0.0 111.589 177.915 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 413' ' ' MET . . . . . 0.751 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.0 OUTLIER -71.13 -56.49 6.0 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 118.431 -1.308 . . . . 0.0 111.558 177.884 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . 0.751 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 6.8 mt -62.46 -43.52 98.62 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -171.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 37.8 t -85.16 -21.14 29.33 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.701 0.762 . . . . 0.0 109.562 -178.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . 0.469 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 103.69 -173.42 21.85 Favored Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -169.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -79.7 24.43 0.38 Allowed 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.563 0.696 . . . . 0.0 111.206 -171.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 418' ' ' ASN . . . . . 0.469 ' H ' ' C ' ' A' ' 416' ' ' GLY . 89.2 m-20 -71.17 73.4 0.65 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.493 179.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 419' ' ' TYR . . . . . 0.532 ' CD1' ' HB1' ' A' ' 453' ' ' ALA . 29.9 p90 -56.74 -36.58 69.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.002 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -54.72 -42.69 71.86 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.908 178.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.16 -49.14 62.92 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.136 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . 0.49 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.5 OUTLIER -66.17 -38.8 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.244 -176.487 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.717 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 57.6 p -67.3 -38.66 85.35 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.072 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -70.07 -37.5 73.17 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.96 176.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . 0.538 HG22 HG22 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.66 -52.51 22.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 121.305 -0.158 . . . . 0.0 111.097 -178.308 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . 0.513 ' O ' HD23 ' A' ' 430' ' ' LEU . 1.2 mm -73.49 -22.71 19.14 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.699 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -172.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.717 ' HB2' ' O ' ' A' ' 423' ' ' SER . 0.7 OUTLIER -54.04 -32.77 55.48 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.271 0.558 . . . . 0.0 110.119 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -84.74 -6.28 85.6 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.598 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.666 ' CZ ' ' HG3' ' A' ' 396' ' ' LYS . 23.9 m-85 -118.64 0.6 11.54 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 121.105 0.479 . . . . 0.0 110.56 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . 0.531 HD12 ' HD2' ' A' ' 431' ' ' PRO . 0.1 OUTLIER -66.33 127.79 93.48 Favored Pre-proline 0 N--CA 1.437 -1.075 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.348 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 431' ' ' PRO . . . . . 0.531 ' HD2' HD12 ' A' ' 430' ' ' LEU . 83.6 Cg_exo -23.55 -65.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.354 0.836 1 C-N-CA 125.655 4.237 . . . . 0.0 114.983 179.9 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . 0.522 ' O ' HG13 ' A' ' 435' ' ' VAL . . . -143.22 -169.2 12.37 Favored Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 175.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . 0.54 ' O ' HG11 ' A' ' 436' ' ' VAL . 45.1 tp60 -69.93 -26.66 64.24 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 118.19 0.995 . . . . 0.0 110.111 177.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -62.93 -42.47 99.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.268 -0.424 . . . . 0.0 112.035 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 435' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 432' ' ' GLY . 7.5 p -68.8 -43.17 82.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-O 120.947 0.403 . . . . 0.0 110.766 -177.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . 0.54 HG11 ' O ' ' A' ' 433' ' ' GLN . 0.1 OUTLIER -66.22 -31.74 55.01 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.241 175.712 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.56 -52.39 46.13 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -178.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . 0.602 ' O ' ' HD2' ' A' ' 442' ' ' ARG . . . -57.85 -40.09 79.27 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.997 177.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 439' ' ' LEU . . . . . 0.598 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 2.0 tm? -68.03 -48.54 65.37 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -178.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.13 -35.16 72.98 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.1 175.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 441' ' ' GLN . . . . . 0.484 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 3.3 mm-40 -54.87 -49.53 70.94 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.126 -178.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . 0.606 ' HG3' ' CG ' ' A' ' 459' ' ' HIS . 0.0 OUTLIER -76.43 -24.0 53.96 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 119.736 -0.785 . . . . 0.0 113.058 174.899 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 443' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 69.4 mt -64.23 -35.81 82.04 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 118.404 0.547 . . . . 0.0 109.53 174.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -57.46 -37.53 73.02 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.537 173.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -73.73 -27.12 61.03 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.113 177.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 26.68 100.57 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.878 1.271 . . . . 0.0 114.387 176.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 51.8 mt -63.47 -34.94 70.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.046 -178.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . 0.449 ' HB2' ' OG1' ' A' ' 451' ' ' THR . 33.5 m-20 -164.21 -162.04 0.65 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -178.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -79.55 -71.01 0.47 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 172.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -24.82 66.13 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 178.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 451' ' ' THR . . . . . 0.452 ' HA ' ' HB2' ' A' ' 454' ' ' GLU . 15.8 m -70.49 -22.18 62.68 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.104 -0.638 . . . . 0.0 110.836 -173.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 452' ' ' ARG . 20.9 mtp180 -53.43 -53.83 45.6 Favored 'General case' 0 C--O 1.221 -0.406 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 171.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 453' ' ' ALA . . . . . 0.532 ' HB1' ' CD1' ' A' ' 419' ' ' TYR . . . -59.8 -47.83 84.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.388 -1.278 . . . . 0.0 112.58 175.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . 0.452 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 77.4 mm-40 -50.4 -37.19 36.36 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.181 0.515 . . . . 0.0 111.774 -177.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 29.9 p -117.98 15.22 14.23 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.374 -176.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . 0.54 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.8 OUTLIER -56.9 -47.67 79.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.09 0.471 . . . . 0.0 111.718 -171.747 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . 0.516 ' CG1' ' HB3' ' A' ' 408' ' ' TYR . 1.9 mp -76.78 -33.04 20.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.053 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -57.7 -34.49 69.49 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.783 0.802 . . . . 0.0 109.28 171.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . 0.734 ' O ' HG21 ' A' ' 463' ' ' VAL . 59.9 m-70 -73.18 -29.33 62.76 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.828 177.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . 0.695 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.4 OUTLIER -74.16 -34.68 63.91 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.993 0.902 . . . . 0.0 108.753 179.286 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -72.78 -37.89 67.47 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.257 175.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 462' ' ' ALA . . . . . 0.637 ' O ' HD11 ' A' ' 466' ' ' ILE . . . -55.73 -33.23 64.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.674 169.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.734 HG21 ' O ' ' A' ' 459' ' ' HIS . 77.8 t -64.48 -50.75 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 CA-C-N 114.603 -1.181 . . . . 0.0 107.906 177.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 464' ' ' TYR . . . . . 0.541 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 17.3 m-30 -53.34 -25.8 16.49 Favored 'General case' 0 C--N 1.333 -0.143 0 O-C-N 124.313 1.008 . . . . 0.0 110.605 178.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.39 -40.93 15.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.6 0.714 . . . . 0.0 109.437 -178.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.637 HD11 ' O ' ' A' ' 462' ' ' ALA . 3.4 mt -55.94 -55.22 19.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 114.272 -1.331 . . . . 0.0 112.199 175.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.744 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -103.93 -11.01 17.72 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -172.748 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . 0.605 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 93.64 31.82 8.03 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 119.328 -1.415 . . . . 0.0 114.374 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 469' ' ' LEU . . . . . 0.744 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 2.9 mt -89.14 161.84 16.27 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 117.886 0.843 . . . . 0.0 111.361 177.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 38.1 p30 -104.97 -177.01 3.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.569 173.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -60.36 -22.53 63.39 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -176.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -87.89 0.28 56.05 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 122.32 -0.238 . . . . 0.0 111.551 -172.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 473' ' ' GLY . . . . . 0.447 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 77.71 12.31 84.6 Favored Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 110.724 -0.951 . . . . 0.0 110.724 -174.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -101.18 152.48 20.59 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 11.5 p -89.28 129.45 35.83 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.279 0.561 . . . . 0.0 111.118 -178.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 476' ' ' ILE . . . . . 0.605 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.8 pp . . . . . 0 C--N 1.32 -0.712 0 CA-C-O 121.636 0.731 . . . . 0.0 109.953 177.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 386' ' ' PHE . . . . . 0.665 ' CE2' HG13 ' B' ' 394' ' ' VAL . 2.6 t80 . . . . . 0 CA--C 1.528 0.106 0 CA-C-O 120.991 0.424 . . . . 0.0 110.599 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 387' ' ' PRO . . . . . 0.58 ' HG2' ' OD1' ' A' ' 393' ' ' ASN . 60.8 Cg_endo -71.97 111.21 3.11 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 124.059 3.172 . . . . 0.0 113.767 175.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 388' ' ' MET . . . . . 0.46 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 39.9 mtt -103.26 172.62 6.71 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 122.012 -0.43 . . . . 0.0 110.1 177.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 389' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -57.4 -61.49 2.45 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 175.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -175.89 19.84 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.647 -1.16 . . . . 0.0 108.311 173.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 391' ' ' LEU . . . . . 0.458 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.1 pt? -169.91 -54.86 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.562 -167.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 392' ' ' GLY . . . . . 0.458 ' N ' ' HG ' ' B' ' 391' ' ' LEU . . . -174.8 54.9 0.13 Allowed Glycine 0 C--N 1.333 0.408 0 C-N-CA 119.911 -1.138 . . . . 0.0 113.67 -174.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 393' ' ' ASN . . . . . 0.588 ' OD1' ' HG2' ' A' ' 387' ' ' PRO . 0.2 OUTLIER -54.33 -41.89 69.56 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 177.728 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 394' ' ' VAL . . . . . 0.665 HG13 ' CE2' ' B' ' 386' ' ' PHE . 2.0 m -56.34 -47.1 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 -179.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 395' ' ' ILE . . . . . 0.606 ' N ' HG23 ' B' ' 394' ' ' VAL . 3.9 mp -57.44 -52.24 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 CA-C-O 117.935 -1.031 . . . . 0.0 113.246 -175.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 396' ' ' LYS . . . . . 0.666 ' HG3' ' CZ ' ' B' ' 429' ' ' TYR . 0.1 OUTLIER -61.42 -49.18 77.92 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 121.488 1.949 . . . . 0.0 111.818 -173.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -54.39 -45.18 76.23 Favored Glycine 0 N--CA 1.436 -1.31 0 C-N-CA 119.747 -1.216 . . . . 0.0 111.073 -178.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 398' ' ' ILE . . . . . 0.619 ' CD1' HD11 ' B' ' 410' ' ' LEU . 39.2 mt -70.96 -34.1 54.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -176.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 399' ' ' VAL . . . . . 0.496 HG22 ' O ' ' B' ' 396' ' ' LYS . 10.6 m -63.47 -39.73 86.42 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 C-N-CA 118.514 -1.274 . . . . 0.0 108.265 -175.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -70.83 -34.12 71.38 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 175.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 401' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -89.84 -47.48 7.86 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -172.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 402' ' ' GLU . . . . . 0.454 ' HG3' ' HE2' ' A' ' 413' ' ' MET . 2.9 mm-40 -121.4 -21.08 6.41 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.653 -170.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 107.42 162.5 21.62 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.843 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 404' ' ' VAL . . . . . 0.667 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.5 m -53.41 -46.44 58.55 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.71 0 N-CA-C 114.506 1.298 . . . . 0.0 114.506 -175.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 405' ' ' ALA . . . . . 0.472 ' HB3' HG21 ' B' ' 457' ' ' ILE . . . -64.11 -30.5 71.57 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 119.861 -0.736 . . . . 0.0 112.427 -177.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 406' ' ' THR . . . . . 0.707 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 89.0 m -77.36 -43.1 34.06 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 121.749 -0.595 . . . . 0.0 110.282 173.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 407' ' ' ALA . . . . . 0.48 ' HB2' ' HA ' ' B' ' 395' ' ' ILE . . . -58.38 -37.35 75.09 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 122.175 0.988 . . . . 0.0 109.252 176.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 408' ' ' TYR . . . . . 0.667 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.59 -51.67 57.93 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 113.414 -1.721 . . . . 0.0 109.816 176.714 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 409' ' ' THR . . . . . 0.546 HG21 HD21 ' B' ' 410' ' ' LEU . 15.7 m -55.3 -47.1 76.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.568 178.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 410' ' ' LEU . . . . . 0.707 ' HG ' ' O ' ' B' ' 406' ' ' THR . 14.8 mt -72.29 -37.1 69.09 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.093 -174.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.6 -34.42 76.26 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 119.915 -1.136 . . . . 0.0 110.481 173.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 412' ' ' MET . . . . . 0.433 ' HB2' ' O ' ' B' ' 409' ' ' THR . 0.3 OUTLIER -65.92 -44.2 85.87 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 115.667 -0.266 . . . . 0.0 111.597 177.932 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 413' ' ' MET . . . . . 0.739 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.0 OUTLIER -70.97 -56.58 5.89 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 118.414 -1.315 . . . . 0.0 111.47 177.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 414' ' ' LEU . . . . . 0.739 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 6.8 mt -62.45 -43.48 98.72 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 114.19 1.181 . . . . 0.0 114.19 -171.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 37.2 t -85.2 -20.98 29.35 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.797 0.808 . . . . 0.0 109.525 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 416' ' ' GLY . . . . . 0.472 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 103.5 -173.15 21.8 Favored Glycine 0 N--CA 1.428 -1.852 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -169.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -79.9 24.52 0.4 Allowed 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.617 0.722 . . . . 0.0 111.336 -171.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 418' ' ' ASN . . . . . 0.472 ' H ' ' C ' ' B' ' 416' ' ' GLY . 89.6 m-20 -71.25 73.38 0.67 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.344 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 419' ' ' TYR . . . . . 0.531 ' CD1' ' HB1' ' B' ' 453' ' ' ALA . 29.6 p90 -56.68 -36.63 69.81 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.944 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -54.67 -42.59 71.54 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.864 178.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.26 -49.14 62.62 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.123 -178.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 422' ' ' VAL . . . . . 0.476 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.5 OUTLIER -66.23 -38.75 82.59 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.238 -176.422 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 423' ' ' SER . . . . . 0.724 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 59.9 p -67.31 -38.82 85.56 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.124 -178.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -70.01 -37.12 73.54 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.056 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 425' ' ' ILE . . . . . 0.539 HG22 HG22 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -72.82 -52.97 20.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 120.424 0.154 . . . . 0.0 110.996 -178.501 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 426' ' ' ILE . . . . . 0.5 ' O ' HD23 ' B' ' 430' ' ' LEU . 1.2 mm -73.24 -22.82 19.53 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.722 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -172.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 427' ' ' ARG . . . . . 0.724 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.7 OUTLIER -53.92 -32.79 54.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.341 0.591 . . . . 0.0 110.098 -179.827 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -85.03 -5.67 85.75 Favored Glycine 0 N--CA 1.443 -0.839 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.599 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 429' ' ' TYR . . . . . 0.666 ' CZ ' ' HG3' ' B' ' 396' ' ' LYS . 23.8 m-85 -119.15 0.56 11.25 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-O 121.017 0.436 . . . . 0.0 110.454 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 430' ' ' LEU . . . . . 0.524 HD12 ' HD2' ' B' ' 431' ' ' PRO . 0.1 OUTLIER -66.34 127.66 93.41 Favored Pre-proline 0 N--CA 1.439 -1.004 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.402 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 431' ' ' PRO . . . . . 0.524 ' HD2' HD12 ' B' ' 430' ' ' LEU . 84.0 Cg_exo -23.45 -65.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.874 1 C-N-CA 125.728 4.285 . . . . 0.0 115.059 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 432' ' ' GLY . . . . . 0.525 ' O ' HG13 ' B' ' 435' ' ' VAL . . . -143.23 -169.15 12.35 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 175.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 433' ' ' GLN . . . . . 0.536 ' O ' HG11 ' B' ' 436' ' ' VAL . 46.0 tp60 -70.2 -26.54 63.93 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 118.186 0.993 . . . . 0.0 109.893 177.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -62.99 -42.41 99.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.979 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 435' ' ' VAL . . . . . 0.525 HG13 ' O ' ' B' ' 432' ' ' GLY . 7.3 p -69.03 -42.97 82.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 120.933 0.396 . . . . 0.0 110.742 -177.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 436' ' ' VAL . . . . . 0.536 HG11 ' O ' ' B' ' 433' ' ' GLN . 0.1 OUTLIER -66.38 -31.7 54.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.251 175.628 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.57 -52.39 46.0 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 -178.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 438' ' ' ALA . . . . . 0.609 ' O ' ' HD2' ' B' ' 442' ' ' ARG . . . -57.88 -40.03 79.27 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.015 177.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 439' ' ' LEU . . . . . 0.603 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 1.9 tm? -68.26 -48.39 65.19 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -178.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.17 -35.16 73.06 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.515 -1.22 . . . . 0.0 111.061 175.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 441' ' ' GLN . . . . . 0.486 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 3.4 mm-40 -54.7 -49.84 69.72 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.178 -178.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 442' ' ' ARG . . . . . 0.609 ' HD2' ' O ' ' B' ' 438' ' ' ALA . 0.0 OUTLIER -76.17 -23.96 54.75 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 119.663 -0.815 . . . . 0.0 113.092 174.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 443' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 69.4 mt -64.24 -35.78 81.94 Favored 'General case' 0 CA--C 1.519 -0.218 0 O-C-N 121.773 -0.579 . . . . 0.0 109.53 174.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -57.35 -37.64 72.89 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.533 173.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -73.67 -27.42 61.23 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.044 178.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 446' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 26.87 100.59 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 114.422 1.268 . . . . 0.0 114.422 176.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 52.9 mt -63.54 -34.93 70.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.97 -178.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 448' ' ' ASP . . . . . 0.471 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 30.6 m-20 -164.08 -161.95 0.65 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -178.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -79.55 -71.21 0.46 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 171.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.71 -24.97 66.31 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 178.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 451' ' ' THR . . . . . 0.471 ' OG1' ' HB2' ' B' ' 448' ' ' ASP . 13.4 m -70.53 -22.24 62.64 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.775 -173.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 452' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' B' ' 452' ' ' ARG . 20.9 mtp180 -53.39 -53.71 47.22 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 107.481 -1.304 . . . . 0.0 107.481 170.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 453' ' ' ALA . . . . . 0.531 ' HB1' ' CD1' ' B' ' 419' ' ' TYR . . . -59.96 -47.6 85.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.415 -1.266 . . . . 0.0 112.525 175.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 454' ' ' GLU . . . . . 0.445 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 77.5 mm-40 -50.53 -37.65 40.35 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.245 0.545 . . . . 0.0 111.685 -177.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 31.2 p -117.64 15.22 14.54 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.325 -175.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 456' ' ' PHE . . . . . 0.546 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 0.8 OUTLIER -56.91 -47.53 80.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.082 0.468 . . . . 0.0 111.72 -171.82 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 457' ' ' ILE . . . . . 0.526 ' CG1' ' HB3' ' B' ' 408' ' ' TYR . 1.9 mp -77.16 -32.87 19.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.851 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -57.89 -34.28 69.64 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.811 0.815 . . . . 0.0 109.375 170.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 459' ' ' HIS . . . . . 0.726 ' O ' HG21 ' B' ' 463' ' ' VAL . 60.3 m-70 -73.1 -29.58 63.03 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.743 177.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 460' ' ' LEU . . . . . 0.697 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.4 OUTLIER -74.13 -34.67 63.97 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.887 0.851 . . . . 0.0 108.794 179.456 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 461' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -72.85 -37.72 67.3 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.258 175.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 462' ' ' ALA . . . . . 0.644 ' O ' HD11 ' B' ' 466' ' ' ILE . . . -55.9 -33.22 64.45 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.584 -1.189 . . . . 0.0 109.722 169.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 463' ' ' VAL . . . . . 0.726 HG21 ' O ' ' B' ' 459' ' ' HIS . 77.5 t -64.48 -50.77 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 CA-C-N 114.54 -1.209 . . . . 0.0 107.835 177.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 464' ' ' TYR . . . . . 0.538 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 17.3 m-30 -53.08 -26.4 16.04 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 124.339 1.024 . . . . 0.0 110.471 178.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.79 -40.89 16.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.619 0.724 . . . . 0.0 109.526 -177.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 466' ' ' ILE . . . . . 0.644 HD11 ' O ' ' B' ' 462' ' ' ALA . 3.4 mt -56.21 -55.11 20.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 114.339 -1.301 . . . . 0.0 112.117 175.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 467' ' ' LEU . . . . . 0.756 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -103.83 -11.07 17.76 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -172.667 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 468' ' ' GLY . . . . . 0.595 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 93.73 31.87 7.97 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 119.441 -1.362 . . . . 0.0 114.398 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 469' ' ' LEU . . . . . 0.756 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 2.8 mt -89.04 162.06 16.22 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 117.866 0.833 . . . . 0.0 111.417 177.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 38.3 p30 -105.17 -177.0 3.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.692 173.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 471' ' ' ALA . . . . . . . . . . . . . . . -60.3 -22.88 63.68 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -176.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -87.79 0.73 55.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.617 -172.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 473' ' ' GLY . . . . . 0.451 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 77.59 12.05 84.88 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.197 -1.001 . . . . 0.0 110.751 -175.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -101.09 152.7 20.3 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 11.0 p -89.69 129.22 36.15 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.18 0.514 . . . . 0.0 111.134 -178.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 476' ' ' ILE . . . . . 0.595 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.8 pp . . . . . 0 C--N 1.321 -0.664 0 CA-C-O 121.678 0.751 . . . . 0.0 109.889 177.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 386' ' ' PHE . . . . . 0.55 ' CE2' HG13 ' A' ' 394' ' ' VAL . 1.1 t80 . . . . . 0 N--CA 1.473 0.682 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -42.14 -70.73 0.06 OUTLIER 'Trans proline' 0 N--CA 1.484 0.947 0 C-N-CA 124.48 3.453 . . . . 0.0 114.088 -175.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 388' ' ' MET . . . . . 0.583 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 36.4 ttm 77.67 29.65 0.51 Allowed 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 173.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 389' ' ' HIS . . . . . 0.656 ' CG ' ' HB2' ' A' ' 393' ' ' ASN . 42.4 m170 61.35 -82.91 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.291 0.636 . . . . 0.0 110.633 -176.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -167.92 14.47 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.246 -0.888 . . . . 0.0 108.702 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.481 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.5 pt? -169.53 -48.23 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -168.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . 0.499 ' CA ' HD12 ' A' ' 395' ' ' ILE . . . 178.78 48.36 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 119.309 -1.424 . . . . 0.0 114.531 -172.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . 0.656 ' HB2' ' CG ' ' A' ' 389' ' ' HIS . 0.3 OUTLIER -54.14 -39.79 66.83 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 117.58 0.69 . . . . 0.0 109.405 174.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . 0.618 HG22 ' N ' ' A' ' 395' ' ' ILE . 1.8 m -56.23 -49.18 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.618 ' N ' HG22 ' A' ' 394' ' ' VAL . 3.7 mp -56.75 -53.41 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -174.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . 0.729 ' HG3' ' CE1' ' A' ' 429' ' ' TYR . 0.1 OUTLIER -66.25 -47.21 74.47 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 121.349 1.886 . . . . 0.0 112.06 -172.133 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -52.81 -45.16 61.15 Favored Glycine 0 N--CA 1.434 -1.452 0 C-N-CA 120.132 -1.032 . . . . 0.0 110.882 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . 0.711 ' CD1' HD11 ' A' ' 410' ' ' LEU . 31.2 mt -70.75 -33.87 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . 0.613 HG21 ' O ' ' A' ' 396' ' ' LYS . 11.3 m -62.6 -39.58 85.14 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 C-N-CA 118.821 -1.152 . . . . 0.0 108.103 -174.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -70.93 -34.78 71.83 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 175.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . 0.461 HE21 ' HB3' ' A' ' 401' ' ' GLN . 5.5 mm100 -89.17 -47.71 7.89 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -173.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . 0.439 ' HB3' ' HB ' ' A' ' 406' ' ' THR . 3.0 mm-40 -119.75 -20.94 7.44 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.462 -170.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 107.48 162.77 21.61 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.519 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . 0.599 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.7 m -54.12 -45.73 66.28 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.731 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -175.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . 0.488 ' HB1' HG22 ' A' ' 457' ' ' ILE . . . -64.12 -29.61 70.73 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 119.84 -0.744 . . . . 0.0 112.209 -177.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 406' ' ' THR . . . . . 0.695 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 85.7 m -77.59 -43.21 32.42 Favored 'General case' 0 C--O 1.219 -0.54 0 O-C-N 121.888 -0.507 . . . . 0.0 110.227 173.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.489 ' HB2' ' HA ' ' A' ' 395' ' ' ILE . . . -58.18 -36.09 72.55 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 122.106 0.955 . . . . 0.0 109.14 176.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 408' ' ' TYR . . . . . 0.599 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -66.34 -52.65 44.89 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 113.446 -1.707 . . . . 0.0 109.749 175.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 409' ' ' THR . . . . . 0.526 HG21 HD23 ' A' ' 410' ' ' LEU . 17.3 m -55.48 -47.4 76.21 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.673 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . 0.711 HD11 ' CD1' ' A' ' 398' ' ' ILE . 15.0 mt -72.42 -36.68 68.67 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -174.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.73 -35.31 81.11 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.066 -1.064 . . . . 0.0 110.783 172.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -68.64 -48.32 64.33 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 120.644 0.259 . . . . 0.0 111.265 178.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 413' ' ' MET . . . . . 0.961 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 1.2 ppp? -71.02 -43.27 68.27 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 118.888 -1.125 . . . . 0.0 112.155 -177.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . 0.961 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 12.1 mt -71.31 -45.85 62.08 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -177.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 44.5 t -84.98 -24.3 28.33 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.787 0.803 . . . . 0.0 110.277 -175.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . 0.445 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 110.74 -175.69 18.19 Favored Glycine 0 N--CA 1.428 -1.89 0 N-CA-C 109.824 -1.311 . . . . 0.0 109.824 -171.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -80.84 24.24 0.5 Allowed 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 121.407 0.622 . . . . 0.0 111.193 -172.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 418' ' ' ASN . . . . . 0.445 ' H ' ' C ' ' A' ' 416' ' ' GLY . 84.5 m-20 -71.74 76.64 0.85 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.701 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 419' ' ' TYR . . . . . 0.562 ' CD1' ' HB3' ' A' ' 453' ' ' ALA . 17.1 p90 -54.36 -38.84 66.56 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.656 177.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -55.63 -44.07 76.78 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.634 0.254 . . . . 0.0 111.138 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.78 -48.64 65.76 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.055 -177.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . 0.424 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -66.07 -39.42 84.42 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.158 -177.519 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.721 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 64.0 p -67.49 -39.81 85.21 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.024 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -66.26 -39.9 94.56 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.739 -0.743 . . . . 0.0 111.954 175.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . 0.562 HG21 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.72 -51.91 25.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 121.236 -0.185 . . . . 0.0 111.291 -177.094 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . 0.439 HD11 HG22 ' A' ' 395' ' ' ILE . 1.2 mm -73.77 -23.01 18.88 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.885 0 CA-C-O 120.76 0.314 . . . . 0.0 110.176 -171.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.721 ' HB2' ' O ' ' A' ' 423' ' ' SER . 0.8 OUTLIER -54.77 -29.14 53.27 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.981 0.419 . . . . 0.0 110.975 -178.009 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.73 -11.45 68.24 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.641 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.729 ' CE1' ' HG3' ' A' ' 396' ' ' LYS . 15.0 m-85 -113.99 -1.41 13.8 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 121.709 0.766 . . . . 0.0 109.241 -176.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . 0.541 ' HA ' HG13 ' A' ' 404' ' ' VAL . 0.0 OUTLIER -65.94 135.12 95.2 Favored Pre-proline 0 N--CA 1.438 -1.039 0 CA-C-N 114.05 -1.432 . . . . 0.0 108.665 177.694 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 431' ' ' PRO . . . . . 0.683 ' CD ' HG11 ' A' ' 435' ' ' VAL . 43.0 Cg_exo -36.25 -65.71 0.13 Allowed 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 124.804 3.669 . . . . 0.0 114.34 -171.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . 0.559 ' O ' HG13 ' A' ' 435' ' ' VAL . . . -141.85 -163.18 9.5 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 176.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . 0.532 ' O ' HG12 ' A' ' 436' ' ' VAL . 21.7 tp60 -70.73 -27.64 64.12 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 118.103 0.952 . . . . 0.0 110.411 177.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -67.47 -38.89 85.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.031 -176.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 435' ' ' VAL . . . . . 0.683 HG11 ' CD ' ' A' ' 431' ' ' PRO . 7.6 p -68.48 -44.9 82.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.974 0.416 . . . . 0.0 110.602 -178.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . 0.532 HG12 ' O ' ' A' ' 433' ' ' GLN . 0.2 OUTLIER -65.41 -29.35 46.9 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.334 175.965 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 437' ' ' THR . . . . . 0.409 HG23 ' N ' ' A' ' 438' ' ' ALA . 0.9 OUTLIER -70.71 -51.98 23.97 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -179.342 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . 0.804 ' O ' ' HG2' ' A' ' 442' ' ' ARG . . . -58.14 -38.69 77.04 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.692 177.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 439' ' ' LEU . . . . . 0.546 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 2.1 tm? -70.15 -47.21 62.61 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -178.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.53 -39.33 76.35 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.406 174.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 441' ' ' GLN . . . . . 0.484 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 9.5 mm-40 -53.54 -49.7 67.08 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 123.958 0.903 . . . . 0.0 110.663 174.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . 0.804 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 0.6 OUTLIER -56.09 -40.17 73.24 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.762 172.226 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 443' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 31.9 mt -72.21 -32.07 66.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.023 0.44 . . . . 0.0 110.467 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -58.69 -38.2 77.73 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.458 173.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 -74.01 -27.53 61.01 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.219 177.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 446' ' ' GLU . . . . . 0.443 ' HB3' ' O ' ' A' ' 443' ' ' LEU . 10.3 pt-20 19.29 101.01 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 178.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 45.0 mt -61.03 -33.88 57.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.382 0.61 . . . . 0.0 110.438 177.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . 0.401 ' HB2' ' CB ' ' A' ' 451' ' ' THR . 10.8 m-20 -162.92 -156.14 0.38 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -178.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -89.74 -63.97 1.21 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 169.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.07 -25.86 64.66 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 178.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 451' ' ' THR . . . . . 0.456 ' HA ' ' HB2' ' A' ' 454' ' ' GLU . 13.5 m -71.28 -22.57 61.94 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.572 -176.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -54.24 -53.77 49.13 Favored 'General case' 0 C--O 1.22 -0.498 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 171.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 453' ' ' ALA . . . . . 0.562 ' HB3' ' CD1' ' A' ' 419' ' ' TYR . . . -57.43 -48.53 78.9 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 114.624 -1.171 . . . . 0.0 112.396 175.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . 0.456 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 14.7 mm-40 -51.1 -35.11 33.5 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.357 0.599 . . . . 0.0 111.559 -178.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 33.5 p -119.22 16.15 13.15 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.493 -176.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . 0.539 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.9 OUTLIER -57.77 -48.35 79.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.914 0.387 . . . . 0.0 111.693 -171.282 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . 0.537 ' CG1' ' HB3' ' A' ' 408' ' ' TYR . 2.0 mp -76.14 -32.63 23.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 120.8 0.333 . . . . 0.0 110.933 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -57.62 -35.05 69.95 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.978 0.894 . . . . 0.0 109.195 171.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . 0.734 ' O ' HG21 ' A' ' 463' ' ' VAL . 59.8 m-70 -74.84 -28.99 60.91 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.542 -1.208 . . . . 0.0 110.946 177.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . 0.704 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.4 OUTLIER -73.88 -34.94 64.63 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.97 0.89 . . . . 0.0 108.89 179.049 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . 0.434 ' O ' ' HB2' ' A' ' 464' ' ' TYR . 22.1 m-80 -73.34 -37.34 66.14 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.862 0.839 . . . . 0.0 108.78 177.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 462' ' ' ALA . . . . . 0.601 ' O ' HD13 ' A' ' 466' ' ' ILE . . . -56.46 -35.34 67.8 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.377 -1.283 . . . . 0.0 109.656 169.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.734 HG21 ' O ' ' A' ' 459' ' ' HIS . 68.2 t -60.93 -51.6 71.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 175.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 464' ' ' TYR . . . . . 0.607 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 19.9 m-30 -52.01 -28.34 16.68 Favored 'General case' 0 C--N 1.333 -0.125 0 O-C-N 124.363 1.039 . . . . 0.0 110.765 177.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.5 -40.6 17.45 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.5 0.667 . . . . 0.0 109.67 -177.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.601 HD13 ' O ' ' A' ' 462' ' ' ALA . 3.7 mt -56.27 -55.43 18.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 114.395 -1.275 . . . . 0.0 112.198 176.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.771 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -101.9 -10.61 19.68 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 -172.667 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . 0.61 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 93.7 31.97 7.92 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 119.337 -1.411 . . . . 0.0 114.23 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 469' ' ' LEU . . . . . 0.771 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.7 mt -88.98 161.84 16.39 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 117.808 0.804 . . . . 0.0 111.146 176.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 37.9 p30 -104.55 -176.9 3.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.956 172.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 471' ' ' ALA . . . . . 0.439 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -62.28 -20.48 64.34 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -176.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -87.21 -1.8 58.16 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.655 0.265 . . . . 0.0 111.648 -173.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 79.11 14.21 82.09 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.008 -1.092 . . . . 0.0 110.66 -174.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -100.85 148.86 24.47 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 177.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 3.9 p -88.05 126.73 35.25 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.995 0.426 . . . . 0.0 111.168 -178.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 476' ' ' ILE . . . . . 0.61 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.8 pp . . . . . 0 C--N 1.327 -0.392 0 CA-C-O 121.523 0.678 . . . . 0.0 110.307 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 386' ' ' PHE . . . . . 0.545 ' CE2' HG13 ' B' ' 394' ' ' VAL . 1.2 t80 . . . . . 0 N--CA 1.472 0.661 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 387' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -42.01 -71.45 0.06 OUTLIER 'Trans proline' 0 N--CA 1.482 0.851 0 C-N-CA 124.528 3.486 . . . . 0.0 113.967 -176.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 388' ' ' MET . . . . . 0.559 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 36.1 ttm 78.21 29.18 0.47 Allowed 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 173.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 389' ' ' HIS . . . . . 0.648 ' CG ' ' HB2' ' B' ' 393' ' ' ASN . 42.6 m170 61.87 -83.05 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.384 0.674 . . . . 0.0 110.554 -176.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -167.68 14.22 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.731 177.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 391' ' ' LEU . . . . . 0.468 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.5 pt? -169.5 -48.29 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -167.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 392' ' ' GLY . . . . . 0.502 ' CA ' HD12 ' B' ' 395' ' ' ILE . . . 178.61 48.49 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 119.31 -1.424 . . . . 0.0 114.527 -172.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 393' ' ' ASN . . . . . 0.648 ' HB2' ' CG ' ' B' ' 389' ' ' HIS . 0.2 OUTLIER -54.27 -39.61 67.05 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 117.531 0.665 . . . . 0.0 109.355 174.905 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 394' ' ' VAL . . . . . 0.622 HG22 ' N ' ' B' ' 395' ' ' ILE . 1.8 m -56.25 -49.17 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 395' ' ' ILE . . . . . 0.622 ' N ' HG22 ' B' ' 394' ' ' VAL . 3.7 mp -56.8 -53.39 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 CA-C-O 118.255 -0.879 . . . . 0.0 113.323 -174.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 396' ' ' LYS . . . . . 0.723 ' HG3' ' CE1' ' B' ' 429' ' ' TYR . 0.1 OUTLIER -66.27 -47.0 75.09 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 121.42 1.918 . . . . 0.0 112.054 -172.042 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.0 -45.19 62.19 Favored Glycine 0 N--CA 1.432 -1.571 0 C-N-CA 120.099 -1.048 . . . . 0.0 110.893 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 398' ' ' ILE . . . . . 0.704 ' CD1' HD11 ' B' ' 410' ' ' LEU . 31.1 mt -70.67 -33.88 54.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 399' ' ' VAL . . . . . 0.614 HG21 ' O ' ' B' ' 396' ' ' LYS . 11.2 m -62.59 -39.52 84.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 C-N-CA 118.664 -1.214 . . . . 0.0 108.07 -174.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -70.93 -34.8 71.85 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 175.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 401' ' ' GLN . . . . . 0.41 HE21 ' HB3' ' B' ' 401' ' ' GLN . 5.7 mm100 -89.11 -47.71 7.9 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -173.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 402' ' ' GLU . . . . . 0.445 ' HB3' ' HB ' ' B' ' 406' ' ' THR . 3.1 mm-40 -119.85 -20.89 7.4 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.558 -170.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 107.44 162.55 21.61 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.52 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 404' ' ' VAL . . . . . 0.587 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.6 m -53.95 -45.78 64.19 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.754 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -175.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 405' ' ' ALA . . . . . 0.488 ' HB1' HG22 ' B' ' 457' ' ' ILE . . . -64.02 -29.81 70.93 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 119.741 -0.784 . . . . 0.0 112.187 -177.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 406' ' ' THR . . . . . 0.686 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 90.1 m -77.34 -43.14 33.98 Favored 'General case' 0 C--O 1.22 -0.499 0 O-C-N 121.867 -0.521 . . . . 0.0 110.343 172.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 407' ' ' ALA . . . . . 0.493 ' HB2' ' HA ' ' B' ' 395' ' ' ILE . . . -58.16 -36.0 72.37 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 122.162 0.982 . . . . 0.0 109.254 176.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 408' ' ' TYR . . . . . 0.587 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -66.33 -52.74 44.09 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 113.411 -1.722 . . . . 0.0 109.711 176.003 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 409' ' ' THR . . . . . 0.521 HG21 HD23 ' B' ' 410' ' ' LEU . 17.1 m -55.41 -47.37 76.04 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.675 179.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 410' ' ' LEU . . . . . 0.704 HD11 ' CD1' ' B' ' 398' ' ' ILE . 15.1 mt -72.5 -36.46 68.39 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -174.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.91 -35.21 81.94 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.058 -1.068 . . . . 0.0 110.769 172.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 412' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -68.6 -48.41 64.21 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-O 120.514 0.197 . . . . 0.0 111.34 178.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 413' ' ' MET . . . . . 0.953 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 1.2 ppp? -71.07 -43.17 68.33 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 118.954 -1.098 . . . . 0.0 112.116 -177.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 414' ' ' LEU . . . . . 0.953 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 11.9 mt -71.21 -46.31 61.45 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -177.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 43.9 t -84.76 -24.4 28.82 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.649 0.738 . . . . 0.0 110.289 -174.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 416' ' ' GLY . . . . . 0.454 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 111.08 -175.83 18.07 Favored Glycine 0 N--CA 1.426 -2.009 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -171.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -80.54 24.05 0.48 Allowed 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.482 0.658 . . . . 0.0 111.255 -172.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 418' ' ' ASN . . . . . 0.454 ' H ' ' C ' ' B' ' 416' ' ' GLY . 84.9 m-20 -71.55 76.77 0.8 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.74 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 419' ' ' TYR . . . . . 0.573 ' CD1' ' HB3' ' B' ' 453' ' ' ALA . 16.8 p90 -54.4 -39.01 66.84 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.653 177.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -55.73 -43.85 76.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.788 0.328 . . . . 0.0 111.168 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.81 -48.69 65.55 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.033 -178.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 422' ' ' VAL . . . . . 0.425 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.2 OUTLIER -66.23 -39.44 84.3 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.398 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.089 -177.396 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 423' ' ' SER . . . . . 0.738 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 64.4 p -67.32 -39.88 85.92 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.924 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -66.38 -39.71 94.29 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.107 175.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 425' ' ' ILE . . . . . 0.563 HG21 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -72.79 -51.84 25.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 121.219 -0.192 . . . . 0.0 111.329 -177.218 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 426' ' ' ILE . . . . . 0.425 HD11 HG22 ' B' ' 395' ' ' ILE . 1.2 mm -73.87 -23.04 18.76 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.896 0 O-C-N 122.194 -0.316 . . . . 0.0 110.227 -171.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 427' ' ' ARG . . . . . 0.738 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.8 OUTLIER -54.7 -29.32 52.74 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.074 0.464 . . . . 0.0 111.007 -178.106 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.51 -11.4 68.86 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.638 -0.791 . . . . 0.0 111.637 178.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 429' ' ' TYR . . . . . 0.723 ' CE1' ' HG3' ' B' ' 396' ' ' LYS . 14.9 m-85 -114.13 -1.17 13.76 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-O 121.766 0.793 . . . . 0.0 109.256 -176.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 430' ' ' LEU . . . . . 0.542 ' HA ' HG13 ' B' ' 404' ' ' VAL . 0.0 OUTLIER -66.02 135.13 95.11 Favored Pre-proline 0 N--CA 1.438 -1.031 0 CA-C-N 114.017 -1.447 . . . . 0.0 108.649 177.582 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 431' ' ' PRO . . . . . 0.69 ' CD ' HG11 ' B' ' 435' ' ' VAL . 43.9 Cg_exo -36.21 -65.99 0.13 Allowed 'Trans proline' 0 N--CA 1.474 0.365 0 C-N-CA 124.888 3.725 . . . . 0.0 114.226 -171.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 432' ' ' GLY . . . . . 0.564 ' O ' HG13 ' B' ' 435' ' ' VAL . . . -141.63 -163.36 9.56 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 176.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 433' ' ' GLN . . . . . 0.527 ' O ' HG12 ' B' ' 436' ' ' VAL . 21.3 tp60 -70.54 -27.6 64.28 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 118.079 0.94 . . . . 0.0 110.322 177.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -67.52 -38.94 85.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.995 -176.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 435' ' ' VAL . . . . . 0.69 HG11 ' CD ' ' B' ' 431' ' ' PRO . 7.7 p -68.59 -44.85 82.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-O 120.958 0.409 . . . . 0.0 110.623 -178.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 436' ' ' VAL . . . . . 0.527 HG12 ' O ' ' B' ' 433' ' ' GLN . 0.2 OUTLIER -65.19 -29.69 48.06 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.39 175.83 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 437' ' ' THR . . . . . 0.407 HG23 ' N ' ' B' ' 438' ' ' ALA . 0.9 OUTLIER -70.37 -51.99 25.76 Favored 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -179.202 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 438' ' ' ALA . . . . . 0.813 ' O ' ' HG2' ' B' ' 442' ' ' ARG . . . -58.15 -38.73 77.18 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.707 177.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 439' ' ' LEU . . . . . 0.554 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 2.1 tm? -70.23 -47.09 62.92 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -178.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.67 -39.16 76.45 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.34 174.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 441' ' ' GLN . . . . . 0.482 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 9.2 mm-40 -53.76 -49.62 67.8 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 123.826 0.85 . . . . 0.0 110.624 174.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 442' ' ' ARG . . . . . 0.813 ' HG2' ' O ' ' B' ' 438' ' ' ALA . 0.7 OUTLIER -56.15 -40.24 73.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.684 172.228 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 443' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 32.5 mt -72.16 -32.03 66.5 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.995 0.426 . . . . 0.0 110.34 -178.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -58.81 -38.06 77.77 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.682 0.753 . . . . 0.0 110.464 173.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -74.03 -27.54 60.99 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.275 177.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 446' ' ' GLU . . . . . 0.441 ' HB3' ' O ' ' B' ' 443' ' ' LEU . 10.8 pt-20 19.3 100.29 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 178.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 45.2 mt -60.61 -34.03 56.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.382 0.611 . . . . 0.0 110.426 177.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 448' ' ' ASP . . . . . 0.404 ' HB2' ' CB ' ' B' ' 451' ' ' THR . 11.4 m-20 -162.61 -156.31 0.4 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -178.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -89.66 -63.97 1.21 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 169.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.87 -25.94 64.88 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 178.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 451' ' ' THR . . . . . 0.455 ' HA ' ' HB2' ' B' ' 454' ' ' GLU . 12.1 m -71.29 -22.57 61.93 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.602 -176.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 452' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -54.37 -53.65 51.11 Favored 'General case' 0 C--O 1.219 -0.533 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 171.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 453' ' ' ALA . . . . . 0.573 ' HB3' ' CD1' ' B' ' 419' ' ' TYR . . . -57.71 -48.04 80.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 114.609 -1.178 . . . . 0.0 112.53 175.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 454' ' ' GLU . . . . . 0.455 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 11.4 mm-40 -51.53 -34.82 37.98 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.161 0.505 . . . . 0.0 111.578 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 32.4 p -119.63 16.04 12.8 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.424 -176.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 456' ' ' PHE . . . . . 0.544 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 0.9 OUTLIER -57.46 -48.68 78.54 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.664 -171.304 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 457' ' ' ILE . . . . . 0.546 ' CG1' ' HB3' ' B' ' 408' ' ' TYR . 2.0 mp -75.68 -32.83 25.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.986 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -57.39 -35.29 69.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.959 0.885 . . . . 0.0 109.139 171.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 459' ' ' HIS . . . . . 0.732 ' O ' HG21 ' B' ' 463' ' ' VAL . 60.8 m-70 -74.73 -28.91 60.98 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.44 -1.254 . . . . 0.0 110.998 177.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 460' ' ' LEU . . . . . 0.714 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.4 OUTLIER -73.91 -35.04 64.61 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.9 0.857 . . . . 0.0 108.938 178.944 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 461' ' ' ASN . . . . . 0.418 ' O ' ' HB2' ' B' ' 464' ' ' TYR . 23.5 m-80 -73.24 -37.42 66.37 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.743 177.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 462' ' ' ALA . . . . . 0.612 ' O ' HD13 ' B' ' 466' ' ' ILE . . . -56.39 -35.34 67.64 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.711 169.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 463' ' ' VAL . . . . . 0.732 HG21 ' O ' ' B' ' 459' ' ' HIS . 68.3 t -61.01 -51.59 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 175.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 464' ' ' TYR . . . . . 0.592 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 19.9 m-30 -52.0 -28.39 16.8 Favored 'General case' 0 N--CA 1.457 -0.11 0 O-C-N 124.4 1.063 . . . . 0.0 110.764 178.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.41 -40.53 17.69 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.633 0.73 . . . . 0.0 109.736 -177.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 466' ' ' ILE . . . . . 0.612 HD13 ' O ' ' B' ' 462' ' ' ALA . 3.7 mt -56.04 -55.83 16.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 114.402 -1.272 . . . . 0.0 112.184 176.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 467' ' ' LEU . . . . . 0.771 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -101.83 -10.44 19.88 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -172.468 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 468' ' ' GLY . . . . . 0.611 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 93.75 32.03 7.86 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 119.352 -1.404 . . . . 0.0 114.164 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 469' ' ' LEU . . . . . 0.771 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.7 mt -89.05 161.81 16.35 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 117.81 0.805 . . . . 0.0 111.149 176.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 37.9 p30 -104.59 -176.93 3.22 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.901 172.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 471' ' ' ALA . . . . . 0.439 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -62.22 -20.74 64.52 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -175.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -87.11 -1.68 58.07 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.655 0.264 . . . . 0.0 111.647 -173.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 473' ' ' GLY . . . . . . . . . . . . . . . 78.7 14.62 81.87 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 119.986 -1.102 . . . . 0.0 110.61 -174.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -101.11 149.01 24.4 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 177.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 4.2 p -87.86 127.5 35.34 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.05 0.452 . . . . 0.0 111.006 -178.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 476' ' ' ILE . . . . . 0.611 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.9 pp . . . . . 0 C--N 1.326 -0.445 0 CA-C-O 121.625 0.726 . . . . 0.0 110.225 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 386' ' ' PHE . . . . . 0.626 ' CD1' HD23 ' A' ' 414' ' ' LEU . 4.7 t80 . . . . . 0 CA--C 1.53 0.201 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -47.11 -67.72 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.848 3.032 . . . . 0.0 114.5 -174.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 388' ' ' MET . . . . . 0.48 ' HE2' ' CB ' ' A' ' 415' ' ' SER . 34.5 ttm 66.27 160.81 0.14 Allowed 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.792 0.33 . . . . 0.0 111.235 176.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 389' ' ' HIS . . . . . 0.593 ' CE1' ' HA ' ' A' ' 393' ' ' ASN . 34.4 m170 -72.73 -155.68 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 108.353 -0.981 . . . . 0.0 108.353 173.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 5.7 pm0 -77.84 8.77 4.16 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.395 172.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.483 HD22 ' H ' ' A' ' 392' ' ' GLY . 2.1 pt? -159.79 -51.84 0.06 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -176.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . 0.483 ' H ' HD22 ' A' ' 391' ' ' LEU . . . -171.05 72.82 0.11 Allowed Glycine 0 CA--C 1.526 0.766 0 C-N-CA 119.438 -1.363 . . . . 0.0 114.762 -173.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . 0.593 ' HA ' ' CE1' ' A' ' 389' ' ' HIS . 0.0 OUTLIER -66.4 -36.95 84.14 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 175.832 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . 0.574 HG23 ' N ' ' A' ' 395' ' ' ILE . 1.0 OUTLIER -57.07 -49.09 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 CA-C-N 113.032 -1.894 . . . . 0.0 107.248 178.193 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.574 ' N ' HG23 ' A' ' 394' ' ' VAL . 3.7 mp -58.48 -52.61 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 CA-C-O 117.663 -1.161 . . . . 0.0 113.671 -174.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . 0.621 ' O ' HG23 ' A' ' 399' ' ' VAL . 0.0 OUTLIER -61.88 -50.02 73.89 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 122.221 2.282 . . . . 0.0 112.143 -174.56 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . 0.442 ' O ' ' HG3' ' A' ' 401' ' ' GLN . . . -53.29 -44.68 65.24 Favored Glycine 0 N--CA 1.432 -1.571 0 CA-C-N 114.713 -1.13 . . . . 0.0 111.045 -176.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . 0.514 HD13 ' CD1' ' A' ' 410' ' ' LEU . 37.8 mt -71.34 -34.23 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -178.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 396' ' ' LYS . 16.3 m -63.24 -40.33 88.62 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 C-N-CA 118.92 -1.112 . . . . 0.0 108.49 -173.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -64.3 -43.85 93.44 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 175.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . 0.529 ' NE2' ' HA ' ' B' ' 414' ' ' LEU . 14.5 mt-30 -92.9 -48.38 6.56 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -167.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . 0.406 ' HB3' ' HB ' ' A' ' 406' ' ' THR . 1.2 tm-20 -111.52 -19.13 12.66 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.193 0.52 . . . . 0.0 110.82 -173.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 104.51 161.33 24.18 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.846 177.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . 0.645 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.2 m -53.94 -45.13 63.51 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.866 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -175.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . 0.483 ' HB2' HG21 ' A' ' 457' ' ' ILE . . . -63.58 -31.65 72.87 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 119.956 -0.697 . . . . 0.0 112.517 -177.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 406' ' ' THR . . . . . 0.686 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 88.0 m -77.08 -41.48 42.06 Favored 'General case' 0 C--O 1.222 -0.35 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.46 173.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.505 ' HB2' ' HA ' ' A' ' 395' ' ' ILE . . . -58.84 -36.6 74.82 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 122.1 0.953 . . . . 0.0 109.354 175.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 408' ' ' TYR . . . . . 0.645 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -67.18 -51.47 53.23 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 113.525 -1.671 . . . . 0.0 109.729 177.009 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 409' ' ' THR . . . . . 0.571 HG23 HD22 ' A' ' 410' ' ' LEU . 17.1 m -54.55 -47.76 72.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.591 -0.732 . . . . 0.0 112.508 177.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . 0.686 ' HG ' ' O ' ' A' ' 406' ' ' THR . 14.5 mt -72.55 -34.4 67.5 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -175.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.59 -34.01 74.46 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.286 -0.959 . . . . 0.0 110.865 170.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 412' ' ' MET . . . . . 0.402 ' HB2' ' O ' ' A' ' 409' ' ' THR . 0.4 OUTLIER -67.89 -48.09 67.0 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 122.547 -0.384 . . . . 0.0 111.17 177.148 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 413' ' ' MET . . . . . 0.918 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.7 OUTLIER -72.32 -48.21 43.89 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 119.176 -1.01 . . . . 0.0 112.569 -179.778 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . 0.918 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 15.4 mt -69.18 -46.95 66.23 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -174.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.48 ' CB ' ' HE2' ' A' ' 388' ' ' MET . 0.0 OUTLIER -97.08 9.62 41.59 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.432 0.634 . . . . 0.0 110.746 -173.541 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . 0.442 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 85.32 -178.46 50.57 Favored Glycine 0 N--CA 1.435 -1.375 0 CA-C-N 115.437 -0.802 . . . . 0.0 111.554 -178.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -79.94 22.66 0.49 Allowed 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.285 0.564 . . . . 0.0 111.108 -173.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 418' ' ' ASN . . . . . 0.442 ' H ' ' C ' ' A' ' 416' ' ' GLY . 3.5 m-20 -71.94 75.1 0.9 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.083 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 419' ' ' TYR . . . . . 0.57 ' CD1' ' HB3' ' A' ' 453' ' ' ALA . 28.3 p90 -56.6 -36.96 70.0 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.456 177.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -54.81 -42.03 71.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.461 175.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . 0.424 ' O ' HD11 ' A' ' 425' ' ' ILE . 0.0 OUTLIER -68.62 -51.89 37.32 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.624 -179.068 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . 0.516 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -62.77 -37.1 78.24 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.582 -174.705 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.763 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 58.4 p -69.27 -34.07 74.19 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -68.69 -42.18 80.86 Favored Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.3 174.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . 0.562 HG22 HG23 ' A' ' 395' ' ' ILE . 2.6 mp -72.55 -50.98 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 116.921 0.361 . . . . 0.0 111.514 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . 0.5 ' CD1' HG21 ' A' ' 395' ' ' ILE . 1.2 mm -75.19 -23.69 17.26 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.911 0 O-C-N 122.085 -0.384 . . . . 0.0 110.926 -171.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.763 ' HB2' ' O ' ' A' ' 423' ' ' SER . 1.0 OUTLIER -54.3 -33.3 58.44 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.196 0.522 . . . . 0.0 111.009 -177.199 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -84.65 -13.79 71.99 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.316 -0.945 . . . . 0.0 111.021 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.507 ' HD1' ' CG2' ' A' ' 395' ' ' ILE . 7.3 m-30 -110.83 -2.05 16.29 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.913 0.863 . . . . 0.0 108.758 -174.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . 0.533 ' HA ' HG13 ' A' ' 404' ' ' VAL . 0.0 OUTLIER -66.3 138.96 96.12 Favored Pre-proline 0 N--CA 1.441 -0.902 0 CA-C-N 113.972 -1.467 . . . . 0.0 109.027 176.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 431' ' ' PRO . . . . . 0.68 ' CD ' HG11 ' A' ' 435' ' ' VAL . 71.0 Cg_exo -37.81 -65.3 0.16 Allowed 'Trans proline' 0 N--CA 1.473 0.312 0 C-N-CA 124.499 3.466 . . . . 0.0 113.874 -173.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . 0.563 ' O ' HG13 ' A' ' 435' ' ' VAL . . . -143.86 -163.24 9.8 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 176.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . 0.573 ' O ' HG12 ' A' ' 436' ' ' VAL . 43.8 tp60 -71.87 -26.67 62.44 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 118.328 1.064 . . . . 0.0 110.882 177.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -66.29 -40.7 90.22 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -177.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 435' ' ' VAL . . . . . 0.68 HG11 ' CD ' ' A' ' 431' ' ' PRO . 7.5 p -67.08 -44.13 88.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-O 120.962 0.411 . . . . 0.0 110.783 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . 0.573 HG12 ' O ' ' A' ' 433' ' ' GLN . 0.1 OUTLIER -65.98 -31.55 54.19 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.179 176.383 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.2 -52.98 34.58 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -178.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . 0.507 ' HB2' HG12 ' A' ' 463' ' ' VAL . . . -58.56 -40.06 82.02 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.23 177.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 439' ' ' LEU . . . . . 0.592 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 1.9 tm? -68.13 -48.1 66.3 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -178.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.9 -38.44 78.91 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.457 176.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 441' ' ' GLN . . . . . 0.411 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 6.0 mm-40 -53.69 -52.09 61.14 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 123.629 0.771 . . . . 0.0 110.56 177.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . 0.536 ' NH1' ' HB3' ' A' ' 462' ' ' ALA . 0.1 OUTLIER -60.95 -34.9 75.45 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.734 174.848 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 443' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 64.1 mt -68.32 -36.55 79.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.744 178.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -56.57 -37.12 70.13 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.527 0.679 . . . . 0.0 110.284 174.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -74.12 -26.75 60.52 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.577 177.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 446' ' ' GLU . . . . . 0.427 ' HB3' ' O ' ' A' ' 443' ' ' LEU . 10.1 pt-20 19.26 103.36 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 176.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 43.0 mt -60.95 -34.9 61.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.852 178.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . 0.451 ' HB2' ' OG1' ' A' ' 451' ' ' THR . 22.1 m-20 -162.43 -158.8 0.53 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -178.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 449' ' ' ASP . . . . . 0.513 ' HA ' ' CZ ' ' A' ' 452' ' ' ARG . 9.6 m-20 -86.29 -67.2 0.83 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 170.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.94 -25.57 67.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.167 178.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 451' ' ' THR . . . . . 0.491 ' HA ' ' HB2' ' A' ' 454' ' ' GLU . 14.3 m -71.47 -22.6 61.8 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.633 -176.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . 0.513 ' CZ ' ' HA ' ' A' ' 449' ' ' ASP . 48.8 mtt85 -54.65 -53.92 48.4 Favored 'General case' 0 C--O 1.219 -0.535 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 171.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 453' ' ' ALA . . . . . 0.57 ' HB3' ' CD1' ' A' ' 419' ' ' TYR . . . -56.69 -47.91 78.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.706 -1.134 . . . . 0.0 112.404 174.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . 0.491 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 13.3 mm-40 -52.36 -33.09 41.54 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.14 0.495 . . . . 0.0 111.742 -178.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 28.6 p -120.04 13.17 12.11 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.551 -176.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . 0.522 ' CE2' ' HB2' ' A' ' 419' ' ' TYR . 0.6 OUTLIER -56.71 -49.03 76.39 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.003 0.43 . . . . 0.0 111.493 -171.525 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . 0.517 HG13 ' HB3' ' A' ' 408' ' ' TYR . 1.9 mp -75.98 -32.02 22.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.067 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -57.88 -35.45 71.0 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.722 0.772 . . . . 0.0 108.939 171.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . 0.777 ' O ' HG22 ' A' ' 463' ' ' VAL . 74.2 m-70 -74.44 -29.3 61.42 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.294 178.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . 0.715 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -74.1 -35.36 64.17 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.864 0.84 . . . . 0.0 109.241 179.78 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . 0.485 ' O ' ' HB2' ' A' ' 464' ' ' TYR . 23.1 m-80 -73.65 -37.25 65.37 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 121.935 0.874 . . . . 0.0 108.922 177.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 462' ' ' ALA . . . . . 0.587 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -57.26 -34.8 69.0 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.803 169.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.777 HG22 ' O ' ' A' ' 459' ' ' HIS . 63.7 t -60.46 -50.82 78.85 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.851 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 175.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 464' ' ' TYR . . . . . 0.608 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 19.3 m-30 -52.77 -28.25 21.56 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.552 177.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.53 -41.77 19.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.721 0.772 . . . . 0.0 109.457 -178.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.587 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.8 mt -57.24 -55.85 18.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 114.269 -1.332 . . . . 0.0 112.076 177.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.753 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -101.07 -10.12 20.78 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -172.999 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . 0.586 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 94.14 31.59 7.96 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 119.354 -1.403 . . . . 0.0 114.31 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 469' ' ' LEU . . . . . 0.753 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.9 mt -88.58 163.77 15.7 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 117.831 0.815 . . . . 0.0 111.09 176.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 37.4 p30 -105.34 -179.27 3.89 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.521 174.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -60.17 -23.25 63.8 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -177.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -87.24 2.34 50.37 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.325 -172.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 473' ' ' GLY . . . . . 0.472 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 77.8 10.61 86.11 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.501 -0.857 . . . . 0.0 111.3 -177.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -101.23 157.98 16.38 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 176.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 475' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' A' ' 469' ' ' LEU . 16.3 t -94.01 144.3 25.59 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.314 -0.555 . . . . 0.0 110.755 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 476' ' ' ILE . . . . . 0.586 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.5 pp . . . . . 0 C--N 1.323 -0.567 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.513 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 386' ' ' PHE . . . . . 0.633 ' CD1' HD23 ' B' ' 414' ' ' LEU . 4.6 t80 . . . . . 0 CA--C 1.53 0.192 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 387' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -47.22 -67.75 0.11 Allowed 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 123.788 2.992 . . . . 0.0 114.388 -174.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 388' ' ' MET . . . . . 0.493 ' HE2' ' CB ' ' B' ' 415' ' ' SER . 34.6 ttm 66.2 161.01 0.14 Allowed 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.683 0.278 . . . . 0.0 111.247 177.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 389' ' ' HIS . . . . . 0.582 ' CE1' ' HA ' ' B' ' 393' ' ' ASN . 34.5 m170 -72.91 -155.14 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 173.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 5.7 pm0 -77.92 8.8 4.19 Favored 'General case' 0 C--N 1.317 -0.837 0 O-C-N 121.914 -0.491 . . . . 0.0 110.428 171.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 391' ' ' LEU . . . . . 0.477 HD22 ' H ' ' B' ' 392' ' ' GLY . 2.1 pt? -160.06 -51.69 0.05 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -176.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 392' ' ' GLY . . . . . 0.477 ' H ' HD22 ' B' ' 391' ' ' LEU . . . -170.92 72.83 0.11 Allowed Glycine 0 C--N 1.338 0.689 0 C-N-CA 119.513 -1.327 . . . . 0.0 114.746 -173.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 393' ' ' ASN . . . . . 0.582 ' HA ' ' CE1' ' B' ' 389' ' ' HIS . 0.0 OUTLIER -66.28 -37.02 84.46 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 175.711 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 394' ' ' VAL . . . . . 0.557 HG23 ' N ' ' B' ' 395' ' ' ILE . 1.0 OUTLIER -57.04 -49.09 80.55 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 CA-C-N 113.039 -1.892 . . . . 0.0 107.216 178.352 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 395' ' ' ILE . . . . . 0.557 ' N ' HG23 ' B' ' 394' ' ' VAL . 3.7 mp -58.42 -52.6 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.559 0 CA-C-O 117.681 -1.152 . . . . 0.0 113.63 -174.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 396' ' ' LYS . . . . . 0.615 ' O ' HG23 ' B' ' 399' ' ' VAL . 0.0 OUTLIER -62.02 -49.75 74.78 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 122.18 2.264 . . . . 0.0 112.139 -174.4 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 397' ' ' GLY . . . . . 0.445 ' O ' ' HG3' ' B' ' 401' ' ' GLN . . . -53.51 -44.79 67.59 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 114.704 -1.135 . . . . 0.0 110.904 -176.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 398' ' ' ILE . . . . . 0.511 HD11 HG22 ' B' ' 394' ' ' VAL . 38.1 mt -71.24 -34.2 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -178.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 399' ' ' VAL . . . . . 0.615 HG23 ' O ' ' B' ' 396' ' ' LYS . 16.4 m -63.32 -40.19 88.09 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 C-N-CA 118.949 -1.1 . . . . 0.0 108.573 -173.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -64.35 -44.03 92.75 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 174.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 401' ' ' GLN . . . . . 0.53 ' NE2' ' HA ' ' A' ' 414' ' ' LEU . 14.5 mt-30 -92.78 -48.45 6.56 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -167.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 402' ' ' GLU . . . . . 0.4 ' HB3' ' HB ' ' B' ' 406' ' ' THR . 1.2 tm-20 -111.36 -19.28 12.67 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.19 0.519 . . . . 0.0 110.842 -173.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 104.62 161.31 24.08 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.89 177.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 404' ' ' VAL . . . . . 0.648 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.2 m -54.0 -45.13 64.3 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.812 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -175.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 405' ' ' ALA . . . . . 0.487 ' HB2' HG21 ' B' ' 457' ' ' ILE . . . -63.63 -31.46 72.64 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 119.954 -0.698 . . . . 0.0 112.522 -177.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 406' ' ' THR . . . . . 0.683 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 89.6 m -77.14 -41.7 40.76 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.146 -0.622 . . . . 0.0 110.402 173.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 407' ' ' ALA . . . . . 0.493 ' HB2' ' HA ' ' B' ' 395' ' ' ILE . . . -58.7 -36.68 74.63 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 122.154 0.978 . . . . 0.0 109.319 175.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 408' ' ' TYR . . . . . 0.648 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -67.27 -51.39 53.42 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 113.512 -1.677 . . . . 0.0 109.693 177.151 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 409' ' ' THR . . . . . 0.556 HG23 HD22 ' B' ' 410' ' ' LEU . 17.6 m -54.49 -47.88 72.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.478 177.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 410' ' ' LEU . . . . . 0.683 ' HG ' ' O ' ' B' ' 406' ' ' THR . 14.5 mt -72.46 -34.41 67.72 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -175.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.48 -33.94 73.54 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 120.311 -0.947 . . . . 0.0 110.954 170.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 412' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -68.04 -48.09 66.61 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 122.406 -0.467 . . . . 0.0 111.21 177.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 413' ' ' MET . . . . . 0.909 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.7 OUTLIER -72.18 -47.98 46.67 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 119.201 -0.999 . . . . 0.0 112.627 -179.779 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 414' ' ' LEU . . . . . 0.909 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 15.7 mt -69.62 -46.65 65.74 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -174.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 415' ' ' SER . . . . . 0.493 ' CB ' ' HE2' ' B' ' 388' ' ' MET . 0.0 OUTLIER -97.19 9.36 42.41 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.434 0.635 . . . . 0.0 110.769 -173.624 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 416' ' ' GLY . . . . . 0.437 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 85.56 -178.38 50.22 Favored Glycine 0 N--CA 1.435 -1.378 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.64 -178.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -80.08 22.51 0.51 Allowed 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.227 0.537 . . . . 0.0 111.08 -173.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 418' ' ' ASN . . . . . 0.437 ' H ' ' C ' ' B' ' 416' ' ' GLY . 3.5 m-20 -71.76 75.06 0.85 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.108 179.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 419' ' ' TYR . . . . . 0.569 ' CD1' ' HB3' ' B' ' 453' ' ' ALA . 29.0 p90 -56.59 -36.9 69.91 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.484 177.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -54.91 -41.91 71.55 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.505 175.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 421' ' ' LEU . . . . . 0.424 ' O ' HD11 ' B' ' 425' ' ' ILE . 0.0 OUTLIER -68.75 -51.86 36.66 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.71 -179.201 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 422' ' ' VAL . . . . . 0.504 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.2 OUTLIER -62.72 -37.22 78.48 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.57 -174.776 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 423' ' ' SER . . . . . 0.77 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 57.1 p -69.03 -34.55 75.4 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -68.3 -42.18 83.61 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.347 175.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 425' ' ' ILE . . . . . 0.552 HG22 HG23 ' B' ' 395' ' ' ILE . 2.6 mp -72.43 -51.1 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-N 116.723 0.261 . . . . 0.0 111.566 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 426' ' ' ILE . . . . . 0.513 ' CD1' HG21 ' B' ' 395' ' ' ILE . 1.2 mm -75.31 -23.51 17.03 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.925 0 O-C-N 121.978 -0.451 . . . . 0.0 110.95 -171.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 427' ' ' ARG . . . . . 0.77 ' HB2' ' O ' ' B' ' 423' ' ' SER . 1.0 OUTLIER -54.42 -33.21 58.99 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.192 0.52 . . . . 0.0 111.008 -177.194 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -84.88 -13.33 72.38 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.417 -0.897 . . . . 0.0 111.032 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 429' ' ' TYR . . . . . 0.5 ' HD1' ' CG2' ' B' ' 395' ' ' ILE . 7.4 m-30 -111.24 -2.13 15.85 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -174.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 430' ' ' LEU . . . . . 0.539 ' HA ' HG13 ' B' ' 404' ' ' VAL . 0.0 OUTLIER -66.46 138.65 95.8 Favored Pre-proline 0 N--CA 1.441 -0.904 0 CA-C-N 114.001 -1.454 . . . . 0.0 109.08 176.946 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 431' ' ' PRO . . . . . 0.684 ' CD ' HG11 ' B' ' 435' ' ' VAL . 70.0 Cg_exo -37.69 -64.6 0.18 Allowed 'Trans proline' 0 CA--C 1.533 0.426 0 C-N-CA 124.548 3.499 . . . . 0.0 114.045 -173.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 432' ' ' GLY . . . . . 0.574 ' O ' HG13 ' B' ' 435' ' ' VAL . . . -144.7 -163.92 10.29 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 176.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 433' ' ' GLN . . . . . 0.559 ' O ' HG12 ' B' ' 436' ' ' VAL . 43.0 tp60 -71.58 -26.79 62.76 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 118.34 1.07 . . . . 0.0 110.762 178.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -66.09 -40.6 90.92 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 435' ' ' VAL . . . . . 0.684 HG11 ' CD ' ' B' ' 431' ' ' PRO . 7.5 p -67.33 -44.03 87.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-O 120.981 0.42 . . . . 0.0 110.788 -178.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 436' ' ' VAL . . . . . 0.559 HG12 ' O ' ' B' ' 433' ' ' GLN . 0.1 OUTLIER -65.91 -31.55 54.23 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.103 176.485 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.36 -52.91 34.34 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -178.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 438' ' ' ALA . . . . . 0.514 ' HB2' HG12 ' B' ' 463' ' ' VAL . . . -58.52 -39.94 81.52 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.157 177.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 439' ' ' LEU . . . . . 0.585 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 1.9 tm? -68.14 -48.13 66.2 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -178.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.94 -38.28 78.64 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.665 -1.152 . . . . 0.0 111.507 176.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 441' ' ' GLN . . . . . 0.405 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 6.0 mm-40 -53.87 -52.0 61.86 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 123.496 0.718 . . . . 0.0 110.499 177.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 442' ' ' ARG . . . . . 0.542 ' NH1' ' HB3' ' B' ' 462' ' ' ALA . 0.1 OUTLIER -60.96 -35.07 75.82 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.652 174.984 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 443' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 64.9 mt -68.24 -36.47 79.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.803 178.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -56.64 -37.3 70.57 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.511 0.672 . . . . 0.0 110.346 174.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -74.03 -26.87 60.66 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.467 177.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 446' ' ' GLU . . . . . 0.437 ' HB3' ' O ' ' B' ' 443' ' ' LEU . 10.3 pt-20 19.72 103.26 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 176.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 43.3 mt -60.88 -34.68 60.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.927 178.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 448' ' ' ASP . . . . . 0.452 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 21.1 m-20 -162.57 -158.56 0.51 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -178.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 449' ' ' ASP . . . . . 0.506 ' HA ' ' CZ ' ' B' ' 452' ' ' ARG . 11.0 m-20 -86.59 -67.05 0.84 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 170.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.87 -25.68 67.29 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 178.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 451' ' ' THR . . . . . 0.496 ' HA ' ' HB2' ' B' ' 454' ' ' GLU . 14.1 m -71.34 -22.66 61.88 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.615 -176.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 452' ' ' ARG . . . . . 0.506 ' CZ ' ' HA ' ' B' ' 449' ' ' ASP . 48.7 mtt180 -54.65 -53.79 50.19 Favored 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 171.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 453' ' ' ALA . . . . . 0.569 ' HB3' ' CD1' ' B' ' 419' ' ' TYR . . . -56.75 -47.98 78.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.689 -1.141 . . . . 0.0 112.415 174.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 454' ' ' GLU . . . . . 0.496 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 14.4 mm-40 -52.36 -32.92 40.67 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.028 0.442 . . . . 0.0 111.828 -178.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 27.8 p -120.23 13.38 11.98 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.58 -176.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 456' ' ' PHE . . . . . 0.533 ' CE2' ' HB2' ' B' ' 419' ' ' TYR . 0.7 OUTLIER -56.86 -48.91 77.01 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.09 0.471 . . . . 0.0 111.496 -171.479 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 457' ' ' ILE . . . . . 0.526 HG13 ' HB3' ' B' ' 408' ' ' TYR . 1.9 mp -76.19 -32.08 22.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.968 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -57.81 -35.51 70.96 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.696 0.76 . . . . 0.0 109.025 171.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 459' ' ' HIS . . . . . 0.782 ' O ' HG22 ' B' ' 463' ' ' VAL . 73.4 m-70 -74.39 -29.16 61.42 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.312 178.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 460' ' ' LEU . . . . . 0.72 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -74.05 -35.42 64.3 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.907 0.861 . . . . 0.0 109.198 179.679 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 461' ' ' ASN . . . . . 0.467 ' O ' ' HB2' ' B' ' 464' ' ' TYR . 22.4 m-80 -73.65 -37.3 65.35 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.911 0.862 . . . . 0.0 108.857 177.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 462' ' ' ALA . . . . . 0.589 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -57.25 -34.61 68.79 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.383 -1.28 . . . . 0.0 109.84 169.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 463' ' ' VAL . . . . . 0.782 HG22 ' O ' ' B' ' 459' ' ' HIS . 64.6 t -60.57 -50.9 78.53 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.778 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 464' ' ' TYR . . . . . 0.6 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 19.2 m-30 -52.83 -28.12 21.34 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.492 177.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.62 -41.94 18.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.593 0.711 . . . . 0.0 109.382 -178.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 466' ' ' ILE . . . . . 0.589 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.8 mt -57.06 -55.93 17.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 114.405 -1.27 . . . . 0.0 112.154 177.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 467' ' ' LEU . . . . . 0.745 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -100.75 -10.26 20.97 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -173.009 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 468' ' ' GLY . . . . . 0.595 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 94.18 31.57 7.96 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 119.222 -1.466 . . . . 0.0 114.396 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 469' ' ' LEU . . . . . 0.745 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.9 mt -88.5 163.83 15.73 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 117.954 0.877 . . . . 0.0 111.046 176.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 37.4 p30 -105.32 -179.41 3.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.553 174.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 471' ' ' ALA . . . . . . . . . . . . . . . -60.1 -22.84 63.28 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -87.49 2.06 51.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.251 -172.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 473' ' ' GLY . . . . . 0.478 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 78.16 10.47 86.19 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.37 -0.919 . . . . 0.0 111.214 -177.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -101.19 157.87 16.45 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 176.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 475' ' ' SER . . . . . 0.42 ' HA ' ' HA ' ' B' ' 469' ' ' LEU . 16.7 t -93.87 143.83 25.98 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.757 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 476' ' ' ILE . . . . . 0.595 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.5 pp . . . . . 0 C--N 1.322 -0.62 0 CA-C-O 121.498 0.666 . . . . 0.0 110.508 -178.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 386' ' ' PHE . . . . . 0.493 ' CE1' ' HA ' ' B' ' 394' ' ' VAL . 5.0 t80 . . . . . 0 CA--C 1.529 0.161 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . 0.536 ' HG2' ' OD1' ' B' ' 393' ' ' ASN . 1.2 Cg_endo -45.09 -65.21 0.2 Allowed 'Trans proline' 0 CA--C 1.533 0.438 0 C-N-CA 123.667 2.911 . . . . 0.0 114.088 -177.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 388' ' ' MET . . . . . 0.719 ' SD ' HG12 ' A' ' 394' ' ' VAL . 18.2 tpp 67.21 160.69 0.16 Allowed 'General case' 0 N--CA 1.472 0.655 0 O-C-N 123.06 0.225 . . . . 0.0 110.814 178.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 389' ' ' HIS . . . . . 0.566 ' CG ' ' HB2' ' A' ' 393' ' ' ASN . 32.3 m170 -70.69 -161.19 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 171.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -72.76 6.99 2.16 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.288 172.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.557 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.1 pt? -161.01 -64.08 0.06 Allowed 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -175.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . 0.557 ' N ' ' HG ' ' A' ' 391' ' ' LEU . . . -158.36 59.95 0.33 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 119.759 -1.21 . . . . 0.0 114.175 -170.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . 0.566 ' HB2' ' CG ' ' A' ' 389' ' ' HIS . 0.2 OUTLIER -55.11 -44.06 74.63 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.344 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . 0.719 HG12 ' SD ' ' A' ' 388' ' ' MET . 1.1 m -59.08 -44.79 92.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-N 114.32 -1.309 . . . . 0.0 108.247 -177.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.566 HG22 HG23 ' A' ' 425' ' ' ILE . 4.2 mp -57.76 -52.05 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 CA-C-O 117.855 -1.069 . . . . 0.0 113.024 -175.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . 0.625 ' HG3' ' CZ ' ' A' ' 429' ' ' TYR . 0.1 OUTLIER -62.95 -49.2 75.7 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 121.681 2.037 . . . . 0.0 111.662 -175.766 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -54.69 -45.84 77.01 Favored Glycine 0 N--CA 1.432 -1.589 0 C-N-CA 120.072 -1.061 . . . . 0.0 111.31 -178.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . 0.685 ' CD1' HD13 ' A' ' 410' ' ' LEU . 26.9 mt -71.38 -33.86 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -177.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . 0.49 HG21 ' O ' ' A' ' 396' ' ' LYS . 7.9 m -63.68 -39.58 85.89 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 C-N-CA 118.79 -1.164 . . . . 0.0 108.396 -174.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -69.33 -38.53 78.21 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 175.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -86.17 -48.8 8.25 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -170.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . 0.451 ' HA ' ' NH1' ' A' ' 472' ' ' ARG . 10.2 tp10 -120.97 -21.04 6.66 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.868 0.366 . . . . 0.0 111.22 -171.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 109.7 163.64 19.63 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.985 178.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . 0.622 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.7 m -53.41 -45.56 57.53 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -175.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . 0.5 ' HB3' HG21 ' A' ' 457' ' ' ILE . . . -64.81 -31.02 72.06 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.702 -0.799 . . . . 0.0 112.288 -176.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 406' ' ' THR . . . . . 0.725 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 92.8 m -77.79 -41.35 37.63 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.297 173.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.531 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.86 -37.02 75.58 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 122.233 1.015 . . . . 0.0 109.06 176.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 408' ' ' TYR . . . . . 0.622 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.25 -52.47 54.21 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 113.27 -1.786 . . . . 0.0 109.924 175.761 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 409' ' ' THR . . . . . 0.545 HG23 HD22 ' A' ' 410' ' ' LEU . 18.6 m -55.35 -47.83 75.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.508 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . 0.725 ' HG ' ' O ' ' A' ' 406' ' ' THR . 14.3 mt -73.34 -36.86 66.22 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.16 -174.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -59.53 -35.16 84.51 Favored Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.053 -1.07 . . . . 0.0 110.606 172.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 412' ' ' MET . . . . . 0.449 ' HE2' ' HA ' ' A' ' 417' ' ' GLN . 0.0 OUTLIER -66.71 -49.93 64.46 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 120.605 0.24 . . . . 0.0 111.444 178.087 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 413' ' ' MET . . . . . 0.911 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.6 OUTLIER -71.44 -45.0 63.76 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 119.128 -1.029 . . . . 0.0 112.446 -176.069 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . 0.911 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 18.3 mt -72.52 -45.39 59.57 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -176.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 32.8 t -84.81 -19.1 33.03 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.795 0.807 . . . . 0.0 109.618 -173.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . 0.495 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 106.98 179.61 22.61 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -172.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 417' ' ' GLN . . . . . 0.449 ' HA ' ' HE2' ' A' ' 412' ' ' MET . 1.7 mp0 -79.1 25.43 0.29 Allowed 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 121.557 0.694 . . . . 0.0 111.027 -173.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 418' ' ' ASN . . . . . 0.495 ' H ' ' C ' ' A' ' 416' ' ' GLY . 84.1 m-20 -70.55 73.21 0.53 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.11 178.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 419' ' ' TYR . . . . . 0.533 ' CD1' ' HB1' ' A' ' 453' ' ' ALA . 5.7 p90 -51.34 -37.75 49.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.928 175.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -54.23 -45.81 72.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.119 176.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.25 -48.78 60.88 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.215 -177.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . 0.447 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -66.57 -40.61 86.73 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 C-N-CA 120.289 -0.565 . . . . 0.0 111.115 -175.465 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.72 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 79.1 p -67.53 -38.95 85.0 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.921 -178.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -69.34 -36.47 78.47 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.092 176.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . 0.566 HG23 HG22 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -73.53 -51.61 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 O-C-N 122.904 -0.174 . . . . 0.0 111.09 -178.605 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . 0.425 ' O ' HD23 ' A' ' 430' ' ' LEU . 1.1 mm -74.63 -22.89 17.64 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.819 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -172.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.72 ' HB2' ' O ' ' A' ' 423' ' ' SER . 0.8 OUTLIER -55.07 -29.78 58.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.302 0.572 . . . . 0.0 110.463 -178.867 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -88.09 -4.38 78.21 Favored Glycine 0 N--CA 1.443 -0.839 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.702 178.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.625 ' CZ ' ' HG3' ' A' ' 396' ' ' LYS . 23.5 m-85 -119.18 -1.31 10.89 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 121.011 0.434 . . . . 0.0 110.314 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . 0.549 HD11 ' HD2' ' A' ' 431' ' ' PRO . 0.1 OUTLIER -66.07 128.89 94.12 Favored Pre-proline 0 N--CA 1.44 -0.935 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.62 179.485 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 431' ' ' PRO . . . . . 0.549 ' HD2' HD11 ' A' ' 430' ' ' LEU . 99.9 Cg_exo -23.67 -68.31 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.736 1 C-N-CA 125.4 4.067 . . . . 0.0 114.62 179.5 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . 0.52 ' O ' HG11 ' A' ' 435' ' ' VAL . . . -144.54 -165.76 11.2 Favored Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 175.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . 0.547 ' O ' HG11 ' A' ' 436' ' ' VAL . 44.1 tp60 -70.11 -25.81 63.67 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 118.003 0.901 . . . . 0.0 110.568 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -66.84 -40.34 87.91 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -178.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 435' ' ' VAL . . . . . 0.52 HG11 ' O ' ' A' ' 432' ' ' GLY . 7.5 p -68.63 -44.62 82.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 120.901 0.382 . . . . 0.0 110.406 -177.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . 0.547 HG11 ' O ' ' A' ' 433' ' ' GLN . 0.1 OUTLIER -64.4 -30.86 51.33 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 CA-C-O 120.834 0.349 . . . . 0.0 110.643 175.218 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 1.1 m -69.32 -52.03 31.29 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -178.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . 0.78 ' O ' ' HG2' ' A' ' 442' ' ' ARG . . . -58.84 -37.21 75.96 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.551 177.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 439' ' ' LEU . . . . . 0.542 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 2.1 tm? -70.76 -47.8 57.73 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.97 -39.01 73.81 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.339 174.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 441' ' ' GLN . . . . . 0.447 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 37.1 mm-40 -53.2 -50.08 65.42 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 123.586 0.754 . . . . 0.0 110.705 173.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . 0.78 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 0.9 OUTLIER -56.23 -39.63 72.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.78 173.04 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 443' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 43.2 mt -71.89 -36.91 70.17 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.95 0.405 . . . . 0.0 110.28 -178.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -57.86 -37.51 74.05 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.614 173.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -73.16 -26.67 61.28 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.942 178.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 446' ' ' GLU . . . . . 0.411 ' HB3' ' O ' ' A' ' 443' ' ' LEU . 8.9 pt-20 29.3 104.53 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 172.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 447' ' ' ILE . . . . . 0.5 ' HB ' ' HB ' ' A' ' 451' ' ' THR . 64.7 mt -66.08 -32.21 57.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.877 0.846 . . . . 0.0 109.46 171.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -167.34 -153.87 0.15 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -177.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 449' ' ' ASP . . . . . 0.439 ' O ' ' HG3' ' A' ' 452' ' ' ARG . 4.0 m-20 -90.6 -61.62 1.64 Allowed 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 165.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 450' ' ' GLN . . . . . 0.468 ' O ' ' HB3' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -72.59 -26.05 61.56 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.447 -176.794 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 451' ' ' THR . . . . . 0.5 ' HB ' ' HB ' ' A' ' 447' ' ' ILE . 4.0 m -72.8 -21.15 61.03 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.992 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' A' ' 449' ' ' ASP . 18.4 mtm180 -55.91 -47.44 77.46 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 107.138 -1.431 . . . . 0.0 107.138 170.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 453' ' ' ALA . . . . . 0.533 ' HB1' ' CD1' ' A' ' 419' ' ' TYR . . . -57.59 -49.29 76.88 Favored 'General case' 0 N--CA 1.462 0.163 0 O-C-N 124.142 0.901 . . . . 0.0 111.921 171.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . 0.498 ' CG ' ' HA ' ' A' ' 451' ' ' THR . 37.1 mt-10 -46.31 -38.84 9.22 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.471 0.653 . . . . 0.0 111.693 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 30.1 p -121.16 15.74 11.49 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.139 -173.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . 0.581 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.8 OUTLIER -55.45 -47.53 75.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.246 0.546 . . . . 0.0 111.349 -171.442 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . 0.557 ' CG1' ' HB3' ' A' ' 408' ' ' TYR . 2.0 mp -77.08 -34.45 21.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.439 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -57.33 -35.89 70.46 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.948 0.88 . . . . 0.0 109.21 171.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . 0.736 ' O ' HG22 ' A' ' 463' ' ' VAL . 55.5 m-70 -72.78 -29.21 63.1 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.841 176.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . 0.71 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -74.1 -34.16 63.86 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 122.114 0.959 . . . . 0.0 108.683 179.044 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . 0.45 ' O ' ' HB2' ' A' ' 464' ' ' TYR . 1.3 m-80 -73.27 -38.07 66.07 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.2 -0.909 . . . . 0.0 108.909 176.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 462' ' ' ALA . . . . . 0.622 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -56.24 -35.0 66.9 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.659 169.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.736 HG22 ' O ' ' A' ' 459' ' ' HIS . 61.9 t -61.01 -50.95 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 175.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 464' ' ' TYR . . . . . 0.577 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 19.4 m-30 -52.95 -29.13 27.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.612 178.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.82 -40.18 19.03 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.667 0.746 . . . . 0.0 109.347 -176.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.622 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.7 mt -55.95 -55.55 17.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 114.288 -1.324 . . . . 0.0 112.198 175.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.746 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -102.9 -9.87 19.52 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 -172.748 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . 0.523 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 93.38 31.8 8.16 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 119.308 -1.425 . . . . 0.0 114.07 179.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 469' ' ' LEU . . . . . 0.746 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 2.8 mt -89.65 162.77 15.44 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 117.732 0.766 . . . . 0.0 111.272 176.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . 0.413 ' HB3' ' CG2' ' A' ' 476' ' ' ILE . 37.8 p30 -105.07 -177.68 3.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.142 171.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 471' ' ' ALA . . . . . 0.494 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -60.44 -23.51 64.48 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -176.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 472' ' ' ARG . . . . . 0.451 ' NH1' ' HA ' ' A' ' 402' ' ' GLU . 28.5 mmt180 -87.27 1.09 54.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.38 -170.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 473' ' ' GLY . . . . . 0.453 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 79.29 11.27 85.16 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.376 -0.916 . . . . 0.0 111.348 -177.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -101.02 150.82 22.5 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 177.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 11.0 p -88.76 127.81 35.61 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.183 0.516 . . . . 0.0 110.842 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 476' ' ' ILE . . . . . 0.523 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.7 pp . . . . . 0 C--N 1.317 -0.811 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.444 -176.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 386' ' ' PHE . . . . . 0.486 ' CE1' ' HA ' ' A' ' 394' ' ' VAL . 5.1 t80 . . . . . 0 CA--C 1.529 0.142 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 387' ' ' PRO . . . . . 0.54 ' HG2' ' OD1' ' A' ' 393' ' ' ASN . 1.2 Cg_endo -44.96 -65.44 0.19 Allowed 'Trans proline' 0 CA--C 1.532 0.415 0 C-N-CA 123.55 2.833 . . . . 0.0 114.111 -177.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 388' ' ' MET . . . . . 0.717 ' SD ' HG12 ' B' ' 394' ' ' VAL . 18.3 tpp 67.61 160.99 0.17 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.549 0.214 . . . . 0.0 110.779 178.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 389' ' ' HIS . . . . . 0.57 ' CG ' ' HB2' ' B' ' 393' ' ' ASN . 32.5 m170 -70.91 -160.84 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 171.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -73.07 7.22 2.21 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.368 172.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 391' ' ' LEU . . . . . 0.563 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.1 pt? -161.14 -64.14 0.06 Allowed 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 392' ' ' GLY . . . . . 0.563 ' N ' ' HG ' ' B' ' 391' ' ' LEU . . . -158.3 59.88 0.33 Allowed Glycine 0 C--N 1.334 0.431 0 C-N-CA 119.81 -1.186 . . . . 0.0 114.175 -170.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 393' ' ' ASN . . . . . 0.57 ' HB2' ' CG ' ' B' ' 389' ' ' HIS . 0.2 OUTLIER -54.98 -44.0 74.03 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-O 121.091 0.472 . . . . 0.0 109.851 178.304 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 394' ' ' VAL . . . . . 0.717 HG12 ' SD ' ' B' ' 388' ' ' MET . 1.1 m -59.2 -44.63 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 114.23 -1.35 . . . . 0.0 108.24 -177.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 395' ' ' ILE . . . . . 0.571 HG22 HG23 ' B' ' 425' ' ' ILE . 4.2 mp -57.77 -52.13 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-O 117.934 -1.032 . . . . 0.0 113.015 -175.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 396' ' ' LYS . . . . . 0.621 ' HG3' ' CZ ' ' B' ' 429' ' ' TYR . 0.1 OUTLIER -62.91 -49.21 75.7 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 121.661 2.028 . . . . 0.0 111.615 -175.683 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -54.62 -45.91 76.19 Favored Glycine 0 N--CA 1.433 -1.534 0 C-N-CA 120.029 -1.081 . . . . 0.0 111.295 -178.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 398' ' ' ILE . . . . . 0.671 ' CD1' HD13 ' B' ' 410' ' ' LEU . 26.8 mt -71.24 -34.01 52.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 113.531 0.938 . . . . 0.0 113.531 -177.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 399' ' ' VAL . . . . . 0.491 HG21 ' O ' ' B' ' 396' ' ' LYS . 8.0 m -63.67 -39.7 86.32 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.519 0 C-N-CA 118.837 -1.145 . . . . 0.0 108.346 -174.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -69.15 -38.54 78.84 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 175.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 401' ' ' GLN . . . . . . . . . . . . . 4.3 mm100 -86.2 -49.07 8.0 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -170.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 402' ' ' GLU . . . . . 0.456 ' HA ' ' NH1' ' B' ' 472' ' ' ARG . 9.4 tp10 -120.67 -21.0 6.86 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 120.88 0.372 . . . . 0.0 111.324 -170.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 109.72 163.57 19.6 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.956 178.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 404' ' ' VAL . . . . . 0.614 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.7 m -53.3 -45.69 56.26 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.705 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -175.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 405' ' ' ALA . . . . . 0.513 ' HB3' HG21 ' B' ' 457' ' ' ILE . . . -64.85 -30.88 71.91 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 119.725 -0.79 . . . . 0.0 112.319 -176.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 406' ' ' THR . . . . . 0.721 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 92.5 m -77.86 -41.4 36.98 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 119.961 -0.696 . . . . 0.0 110.231 173.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 407' ' ' ALA . . . . . 0.522 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.95 -36.98 75.7 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 122.241 1.019 . . . . 0.0 109.014 176.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 408' ' ' TYR . . . . . 0.614 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.23 -52.44 54.56 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 113.283 -1.78 . . . . 0.0 109.941 175.82 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 409' ' ' THR . . . . . 0.541 HG23 HD22 ' B' ' 410' ' ' LEU . 17.5 m -55.43 -47.72 75.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.572 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 410' ' ' LEU . . . . . 0.721 ' HG ' ' O ' ' B' ' 406' ' ' THR . 14.4 mt -73.34 -37.11 66.21 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.06 -174.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -59.27 -35.32 84.14 Favored Glycine 0 N--CA 1.438 -1.224 0 C-N-CA 120.14 -1.028 . . . . 0.0 110.666 172.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 412' ' ' MET . . . . . 0.462 ' HE2' ' HA ' ' B' ' 417' ' ' GLN . 0.0 OUTLIER -66.51 -49.87 65.09 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-O 120.6 0.238 . . . . 0.0 111.572 177.97 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 413' ' ' MET . . . . . 0.925 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.7 OUTLIER -71.58 -45.21 62.87 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 119.064 -1.054 . . . . 0.0 112.356 -176.196 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 414' ' ' LEU . . . . . 0.925 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 17.9 mt -72.22 -45.64 59.45 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 113.95 1.092 . . . . 0.0 113.95 -176.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 32.8 t -84.89 -18.57 34.34 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.646 0.736 . . . . 0.0 109.599 -173.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 416' ' ' GLY . . . . . 0.492 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 106.61 179.67 22.89 Favored Glycine 0 N--CA 1.429 -1.774 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 -173.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 417' ' ' GLN . . . . . 0.462 ' HA ' ' HE2' ' B' ' 412' ' ' MET . 1.7 mp0 -79.13 25.38 0.29 Allowed 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.532 0.682 . . . . 0.0 111.015 -174.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 418' ' ' ASN . . . . . 0.492 ' H ' ' C ' ' B' ' 416' ' ' GLY . 83.8 m-20 -70.6 73.27 0.54 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.166 177.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 419' ' ' TYR . . . . . 0.54 ' CD1' ' HB1' ' B' ' 453' ' ' ALA . 5.4 p90 -51.38 -37.77 49.86 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.897 175.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -54.25 -45.82 72.47 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.064 176.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.17 -48.84 61.17 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.224 -177.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 422' ' ' VAL . . . . . 0.442 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.2 OUTLIER -66.44 -40.69 87.18 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.096 -175.464 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 423' ' ' SER . . . . . 0.74 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 80.0 p -67.48 -39.29 85.26 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.825 -178.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -68.93 -36.63 82.07 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.067 177.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 425' ' ' ILE . . . . . 0.571 HG23 HG22 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -73.45 -51.7 24.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 121.401 -0.12 . . . . 0.0 111.035 -178.593 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 426' ' ' ILE . . . . . 0.422 ' O ' HD23 ' B' ' 430' ' ' LEU . 1.1 mm -74.76 -22.92 17.48 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.853 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 -172.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 427' ' ' ARG . . . . . 0.74 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.8 OUTLIER -54.97 -29.91 57.91 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.339 0.59 . . . . 0.0 110.407 -179.065 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.49 -5.14 79.42 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.79 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 429' ' ' TYR . . . . . 0.621 ' CZ ' ' HG3' ' B' ' 396' ' ' LYS . 23.5 m-85 -118.88 -1.49 11.01 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.118 0.485 . . . . 0.0 110.44 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 430' ' ' LEU . . . . . 0.529 HD11 ' HD2' ' B' ' 431' ' ' PRO . 0.1 OUTLIER -65.85 128.79 94.07 Favored Pre-proline 0 N--CA 1.44 -0.945 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.641 179.589 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 431' ' ' PRO . . . . . 0.529 ' HD2' HD11 ' B' ' 430' ' ' LEU . 99.6 Cg_exo -23.57 -68.37 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.749 1 C-N-CA 125.484 4.123 . . . . 0.0 114.633 179.599 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 432' ' ' GLY . . . . . 0.496 ' O ' HG11 ' B' ' 435' ' ' VAL . . . -144.13 -165.5 10.97 Favored Glycine 0 N--CA 1.444 -0.83 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 175.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 433' ' ' GLN . . . . . 0.538 ' O ' HG11 ' B' ' 436' ' ' VAL . 43.9 tp60 -70.28 -25.73 63.48 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 118.024 0.912 . . . . 0.0 110.734 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -67.2 -40.09 86.44 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -177.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 435' ' ' VAL . . . . . 0.496 HG11 ' O ' ' B' ' 432' ' ' GLY . 7.4 p -68.87 -44.58 81.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 120.937 0.399 . . . . 0.0 110.39 -177.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 436' ' ' VAL . . . . . 0.538 HG11 ' O ' ' B' ' 433' ' ' GLN . 0.1 OUTLIER -64.39 -31.05 51.92 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.499 175.077 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 1.1 m -69.19 -52.04 31.95 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 438' ' ' ALA . . . . . 0.803 ' O ' ' HG2' ' B' ' 442' ' ' ARG . . . -58.94 -37.28 76.36 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.663 177.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 439' ' ' LEU . . . . . 0.544 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 2.1 tm? -70.75 -47.69 58.35 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -179.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.9 -39.25 74.08 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.326 174.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 441' ' ' GLN . . . . . 0.447 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 36.7 mm-40 -53.12 -50.04 65.31 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 123.576 0.75 . . . . 0.0 110.644 173.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 442' ' ' ARG . . . . . 0.803 ' HG2' ' O ' ' B' ' 438' ' ' ALA . 0.9 OUTLIER -56.25 -39.66 72.93 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.824 173.066 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 443' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 42.4 mt -71.96 -36.73 69.93 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.99 0.424 . . . . 0.0 110.31 -178.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -57.97 -37.5 74.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.609 173.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -73.22 -26.42 61.14 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.986 178.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 446' ' ' GLU . . . . . 0.403 ' HB3' ' O ' ' B' ' 443' ' ' LEU . 8.8 pt-20 29.4 104.28 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 172.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 447' ' ' ILE . . . . . 0.515 ' HB ' ' HB ' ' B' ' 451' ' ' THR . 64.4 mt -66.07 -32.39 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 121.911 0.862 . . . . 0.0 109.443 171.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 448' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -167.04 -153.63 0.15 Allowed 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 -177.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 449' ' ' ASP . . . . . 0.44 ' O ' ' HG3' ' B' ' 452' ' ' ARG . 4.9 m-20 -90.87 -61.64 1.63 Allowed 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 165.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 450' ' ' GLN . . . . . 0.471 ' O ' ' HB3' ' B' ' 453' ' ' ALA . 0.0 OUTLIER -72.55 -26.01 61.58 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.432 -176.908 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 451' ' ' THR . . . . . 0.515 ' HB ' ' HB ' ' B' ' 447' ' ' ILE . 4.1 m -72.77 -21.07 61.06 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.063 -0.655 . . . . 0.0 111.035 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 452' ' ' ARG . . . . . 0.44 ' HG3' ' O ' ' B' ' 449' ' ' ASP . 18.6 mtm180 -56.08 -47.48 77.92 Favored 'General case' 0 C--O 1.215 -0.76 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 170.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 453' ' ' ALA . . . . . 0.54 ' HB1' ' CD1' ' B' ' 419' ' ' TYR . . . -57.51 -49.2 77.09 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.994 171.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 454' ' ' GLU . . . . . 0.502 ' CG ' ' HA ' ' B' ' 451' ' ' THR . 37.2 mt-10 -46.39 -38.91 9.56 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.571 0.7 . . . . 0.0 111.677 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 31.1 p -121.05 15.82 11.59 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.257 -173.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 456' ' ' PHE . . . . . 0.567 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 0.8 OUTLIER -55.59 -47.73 75.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.209 0.528 . . . . 0.0 111.28 -171.524 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 457' ' ' ILE . . . . . 0.563 ' CG1' ' HB3' ' B' ' 408' ' ' TYR . 2.0 mp -76.8 -34.64 23.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.387 -179.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -57.33 -35.82 70.36 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 122.022 0.915 . . . . 0.0 109.291 172.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 459' ' ' HIS . . . . . 0.729 ' O ' HG22 ' B' ' 463' ' ' VAL . 55.4 m-70 -72.82 -29.04 62.93 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.208 -1.36 . . . . 0.0 110.915 176.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 460' ' ' LEU . . . . . 0.711 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -74.24 -34.17 63.56 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.107 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 461' ' ' ASN . . . . . 0.43 ' O ' ' HB2' ' B' ' 464' ' ' TYR . 1.3 m-80 -73.17 -38.29 66.25 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.216 -0.902 . . . . 0.0 108.924 176.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 462' ' ' ALA . . . . . 0.624 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -56.16 -34.83 66.53 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.668 169.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 463' ' ' VAL . . . . . 0.729 HG22 ' O ' ' B' ' 459' ' ' HIS . 62.7 t -61.04 -51.09 77.18 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 175.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 464' ' ' TYR . . . . . 0.562 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 19.4 m-30 -52.87 -29.09 26.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.642 178.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.13 -39.59 19.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.716 0.769 . . . . 0.0 109.501 -176.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 466' ' ' ILE . . . . . 0.624 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.7 mt -56.2 -55.83 16.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 114.344 -1.298 . . . . 0.0 112.115 174.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 467' ' ' LEU . . . . . 0.756 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -102.73 -9.97 19.57 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -172.513 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 468' ' ' GLY . . . . . 0.519 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 93.41 31.92 8.07 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 119.346 -1.407 . . . . 0.0 114.182 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 469' ' ' LEU . . . . . 0.756 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 2.8 mt -89.73 162.81 15.37 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 117.646 0.723 . . . . 0.0 111.062 176.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 470' ' ' ASN . . . . . 0.417 ' HB3' ' CG2' ' B' ' 476' ' ' ILE . 37.4 p30 -105.14 -177.82 3.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.23 171.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 471' ' ' ALA . . . . . 0.483 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -60.25 -23.51 64.16 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -176.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 472' ' ' ARG . . . . . 0.456 ' NH1' ' HA ' ' B' ' 402' ' ' GLU . 28.7 mmt180 -87.48 1.52 53.25 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.407 -170.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 473' ' ' GLY . . . . . 0.447 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 78.76 11.39 85.29 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.564 -0.827 . . . . 0.0 111.37 -177.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -100.94 150.66 22.64 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 177.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 11.9 p -88.35 127.81 35.49 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.207 0.527 . . . . 0.0 110.926 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 476' ' ' ILE . . . . . 0.519 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.7 pp . . . . . 0 C--N 1.317 -0.818 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.485 -176.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 386' ' ' PHE . . . . . 0.782 ' CZ ' HG12 ' A' ' 394' ' ' VAL . 1.6 t80 . . . . . 0 CA--C 1.538 0.495 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -53.55 -51.59 10.54 Favored 'Trans proline' 0 N--CA 1.489 1.214 1 C-N-CA 125.403 4.069 . . . . 0.0 115.952 -176.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 388' ' ' MET . . . . . 0.731 ' SD ' HG11 ' A' ' 394' ' ' VAL . 53.8 tpp 74.29 15.63 3.53 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 165.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 389' ' ' HIS . . . . . 0.789 ' CG ' ' HB2' ' A' ' 393' ' ' ASN . 15.6 m170 64.17 7.1 3.26 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.264 -0.897 . . . . 0.0 110.249 -175.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 66.29 25.09 10.54 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.498 -170.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.467 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.6 pt? -164.51 -53.4 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 170.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . 0.547 ' HA2' ' SD ' ' A' ' 388' ' ' MET . . . -175.39 49.38 0.13 Allowed Glycine 0 CA--C 1.525 0.659 0 C-N-CA 119.796 -1.192 . . . . 0.0 114.521 -176.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . 0.789 ' HB2' ' CG ' ' A' ' 389' ' ' HIS . 0.5 OUTLIER -54.49 -43.31 71.67 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 117.302 0.551 . . . . 0.0 109.81 177.886 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . 0.782 HG12 ' CZ ' ' A' ' 386' ' ' PHE . 0.7 OUTLIER -57.64 -46.12 86.51 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 -177.649 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.595 HG23 HG22 ' A' ' 425' ' ' ILE . 4.1 mp -57.36 -52.3 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-O 118.023 -0.989 . . . . 0.0 113.139 -174.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . 0.615 ' HG3' ' CZ ' ' A' ' 429' ' ' TYR . 0.0 OUTLIER -63.55 -50.23 70.32 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 121.664 2.029 . . . . 0.0 112.335 -175.738 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . 0.573 ' O ' ' HG3' ' A' ' 401' ' ' GLN . . . -54.47 -44.89 77.59 Favored Glycine 0 N--CA 1.435 -1.393 0 C-N-CA 120.04 -1.076 . . . . 0.0 111.025 -177.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . 0.663 ' CD1' HD12 ' A' ' 410' ' ' LEU . 31.2 mt -71.28 -34.47 54.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -178.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 396' ' ' LYS . 9.9 m -63.66 -39.92 87.14 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 C-N-CA 118.973 -1.091 . . . . 0.0 108.594 -173.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -66.67 -40.99 88.85 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 175.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . 0.573 ' HG3' ' O ' ' A' ' 397' ' ' GLY . 36.2 mt-30 -91.84 -47.13 7.49 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -169.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . 0.408 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 3.0 mm-40 -115.15 -20.35 10.45 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.983 0.421 . . . . 0.0 111.377 -173.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 106.14 162.84 22.86 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.874 -0.679 . . . . 0.0 113.027 177.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . 0.679 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.2 m -53.61 -42.89 52.34 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.851 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -175.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . 0.503 ' HB3' HG22 ' A' ' 457' ' ' ILE . . . -69.17 -28.57 66.52 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 119.602 -0.839 . . . . 0.0 112.139 -176.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 406' ' ' THR . . . . . 0.698 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 89.9 m -77.55 -43.1 33.0 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.139 -0.624 . . . . 0.0 109.972 172.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.531 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.3 -37.64 75.47 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 122.125 0.964 . . . . 0.0 109.285 176.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 408' ' ' TYR . . . . . 0.679 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.6 -52.14 54.38 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 113.606 -1.634 . . . . 0.0 109.734 177.155 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 409' ' ' THR . . . . . 0.546 HG22 HD22 ' A' ' 410' ' ' LEU . 13.0 m -55.51 -47.36 76.34 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.743 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . 0.698 ' HG ' ' O ' ' A' ' 406' ' ' THR . 13.8 mt -72.28 -35.71 68.8 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.197 -175.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.92 -35.09 81.48 Favored Glycine 0 N--CA 1.439 -1.142 0 C-N-CA 120.182 -1.009 . . . . 0.0 110.7 172.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -67.55 -47.62 69.31 Favored 'General case' 0 C--O 1.223 -0.309 0 N-CA-C 111.528 0.195 . . . . 0.0 111.528 178.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 413' ' ' MET . . . . . 0.913 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.3 OUTLIER -70.78 -48.26 55.23 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 119.06 -1.056 . . . . 0.0 112.106 -179.461 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . 0.913 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 18.6 mt -69.47 -44.23 71.61 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -175.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.463 ' HB2' ' HE1' ' A' ' 388' ' ' MET . 33.7 t -86.62 -24.04 25.49 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.526 0.679 . . . . 0.0 110.147 -175.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . 0.43 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 112.55 -176.79 18.03 Favored Glycine 0 N--CA 1.429 -1.832 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 -173.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -81.02 22.29 0.64 Allowed 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.367 0.604 . . . . 0.0 111.285 -172.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 418' ' ' ASN . . . . . 0.43 ' H ' ' C ' ' A' ' 416' ' ' GLY . 11.4 m120 -73.04 74.91 1.21 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.984 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 419' ' ' TYR . . . . . 0.601 ' HB2' ' CE2' ' A' ' 456' ' ' PHE . 27.0 p90 -54.2 -37.57 64.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.324 178.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -54.47 -46.27 73.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.908 0.385 . . . . 0.0 110.987 177.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . 0.458 ' O ' HD11 ' A' ' 425' ' ' ILE . 0.0 OUTLIER -68.51 -47.86 65.87 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.085 -177.291 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . 0.462 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -65.33 -38.35 82.34 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 C-N-CA 120.343 -0.543 . . . . 0.0 111.198 -178.451 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.745 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 61.1 p -68.1 -37.46 81.21 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -179.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.51 -39.35 91.12 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.237 175.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . 0.595 HG22 HG23 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.78 -52.53 22.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 O-C-N 122.789 -0.242 . . . . 0.0 111.011 -178.376 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . 0.527 ' O ' HD21 ' A' ' 430' ' ' LEU . 1.2 mm -72.14 -21.76 20.7 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.715 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -172.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.745 ' HB2' ' O ' ' A' ' 423' ' ' SER . 0.7 OUTLIER -54.25 -31.46 53.55 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.52 -179.206 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -84.39 -12.2 76.31 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.463 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.615 ' CZ ' ' HG3' ' A' ' 396' ' ' LYS . 23.3 m-85 -114.69 1.9 14.32 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-O 121.15 0.5 . . . . 0.0 110.45 -176.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . 0.531 ' HA ' HG12 ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.85 128.11 93.58 Favored Pre-proline 0 N--CA 1.439 -1.008 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.759 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 431' ' ' PRO . . . . . 0.509 ' HD2' HD11 ' A' ' 430' ' ' LEU . 59.1 Cg_exo -22.39 -72.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.355 0.906 1 C-N-CA 125.56 4.173 . . . . 0.0 114.855 179.784 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . 0.411 ' O ' HG13 ' A' ' 435' ' ' VAL . . . -132.27 -165.44 11.29 Favored Glycine 0 N--CA 1.439 -1.125 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 175.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . 0.609 ' O ' HG11 ' A' ' 436' ' ' VAL . 1.0 OUTLIER -71.21 -28.1 63.97 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 117.575 0.687 . . . . 0.0 110.631 177.513 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -70.24 -36.62 74.61 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -174.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 435' ' ' VAL . . . . . 0.472 ' HA ' ' CG1' ' A' ' 463' ' ' VAL . 7.5 p -67.24 -41.46 86.73 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-O 121.056 0.455 . . . . 0.0 110.388 -177.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . 0.609 HG11 ' O ' ' A' ' 433' ' ' GLN . 0.2 OUTLIER -64.63 -34.78 72.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.177 175.682 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 437' ' ' THR . . . . . 0.418 HG23 ' N ' ' A' ' 438' ' ' ALA . 0.8 OUTLIER -70.85 -48.53 53.39 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -174.135 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . 0.746 ' O ' ' HG2' ' A' ' 442' ' ' ARG . . . -56.15 -37.24 69.26 Favored 'General case' 0 N--CA 1.432 -1.356 0 O-C-N 123.713 0.633 . . . . 0.0 110.498 175.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 439' ' ' LEU . . . . . 0.547 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 2.1 tm? -67.66 -46.97 70.86 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -178.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . 0.478 ' NE2' HD13 ' A' ' 443' ' ' LEU . 0.4 OUTLIER -62.08 -33.92 75.32 Favored 'General case' 0 CA--C 1.49 -1.353 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.803 176.192 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 441' ' ' GLN . . . . . 0.558 ' O ' ' HG2' ' A' ' 445' ' ' GLN . 8.9 mm-40 -58.26 -49.2 77.96 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.199 175.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . 0.746 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -57.31 -39.79 76.55 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.852 171.208 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 443' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 33.6 mt -72.38 -34.45 67.95 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.201 0.524 . . . . 0.0 109.932 -178.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -57.94 -36.95 73.25 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.793 173.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 445' ' ' GLN . . . . . 0.558 ' HG2' ' O ' ' A' ' 441' ' ' GLN . 30.6 mm-40 -72.26 -27.52 62.54 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.195 178.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 446' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 443' ' ' LEU . 36.7 tt0 35.44 98.09 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 169.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 447' ' ' ILE . . . . . 0.527 ' HB ' ' HB ' ' A' ' 451' ' ' THR . 54.2 mt -73.41 -32.68 37.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.447 0.642 . . . . 0.0 110.447 176.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -170.21 -158.17 0.16 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -87.78 -58.81 2.44 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 166.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 450' ' ' GLN . . . . . 0.45 ' C ' HE21 ' A' ' 450' ' ' GLN . 0.0 OUTLIER -66.88 -33.34 75.38 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.592 -177.523 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 451' ' ' THR . . . . . 0.527 ' HB ' ' HB ' ' A' ' 447' ' ' ILE . 4.8 m -72.05 -23.36 61.36 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.653 -174.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 13.1 mtp180 -55.13 -54.18 46.55 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 172.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 453' ' ' ALA . . . . . 0.515 ' HB1' ' CD1' ' A' ' 419' ' ' TYR . . . -58.57 -48.52 80.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.616 -1.175 . . . . 0.0 112.561 175.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . 0.48 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 27.2 mm-40 -51.2 -37.2 45.32 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.289 0.566 . . . . 0.0 111.597 -178.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 27.6 p -117.9 16.92 14.29 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.352 -176.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . 0.601 ' CE2' ' HB2' ' A' ' 419' ' ' TYR . 1.1 t80 -58.04 -47.15 84.0 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.006 0.432 . . . . 0.0 111.6 -171.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . 0.514 ' CG1' ' HB3' ' A' ' 408' ' ' TYR . 2.0 mp -76.83 -32.43 20.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.044 0.45 . . . . 0.0 110.611 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -57.83 -34.29 69.54 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.717 0.77 . . . . 0.0 109.268 170.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . 0.686 ' O ' HG22 ' A' ' 463' ' ' VAL . 57.9 m-70 -76.08 -28.04 57.44 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.635 178.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . 0.71 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -74.09 -34.63 64.05 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.822 0.82 . . . . 0.0 108.82 178.196 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . 0.546 ' HA ' ' CD2' ' A' ' 464' ' ' TYR . 21.4 m-80 -72.63 -37.74 67.95 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.309 -0.86 . . . . 0.0 108.975 176.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 462' ' ' ALA . . . . . 0.632 ' O ' HD13 ' A' ' 466' ' ' ILE . . . -56.21 -34.4 66.24 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.442 -1.254 . . . . 0.0 109.729 169.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.71 ' HB ' ' O ' ' A' ' 460' ' ' LEU . 64.5 t -61.53 -51.58 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 114.811 -1.086 . . . . 0.0 108.085 176.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 464' ' ' TYR . . . . . 0.734 ' CE2' ' HA ' ' A' ' 471' ' ' ALA . 15.4 m-30 -52.62 -27.37 16.76 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.685 178.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.34 -39.11 21.16 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.593 0.711 . . . . 0.0 109.557 -178.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.632 HD13 ' O ' ' A' ' 462' ' ' ALA . 3.7 mt -60.17 -55.54 23.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 114.23 -1.35 . . . . 0.0 112.268 176.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.716 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -100.36 -10.69 20.96 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -173.469 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . 0.596 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 93.15 31.18 8.65 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 119.556 -1.307 . . . . 0.0 114.165 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 469' ' ' LEU . . . . . 0.716 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.0 mt -89.98 166.56 13.39 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.24 1.02 . . . . 0.0 111.767 178.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 35.1 p30 -106.07 177.57 4.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.271 169.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 471' ' ' ALA . . . . . 0.734 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -71.09 -6.92 42.87 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -173.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -92.2 -0.33 57.42 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.022 0.439 . . . . 0.0 110.6 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 77.47 12.79 84.2 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.571 -0.824 . . . . 0.0 111.085 -175.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -100.91 157.9 16.39 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 175.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 475' ' ' SER . . . . . 0.44 ' HA ' HD21 ' A' ' 469' ' ' LEU . 0.6 OUTLIER -93.45 120.06 33.28 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.538 0.685 . . . . 0.0 112.633 -177.03 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 476' ' ' ILE . . . . . 0.596 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.2 pp . . . . . 0 N--CA 1.436 -1.155 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 162.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 386' ' ' PHE . . . . . 0.786 ' CZ ' HG12 ' B' ' 394' ' ' VAL . 1.6 t80 . . . . . 0 CA--C 1.538 0.506 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 387' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -53.68 -51.54 10.59 Favored 'Trans proline' 0 N--CA 1.49 1.294 1 C-N-CA 125.48 4.12 . . . . 0.0 115.895 -176.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 388' ' ' MET . . . . . 0.723 ' SD ' HG11 ' B' ' 394' ' ' VAL . 53.8 tpp 74.18 15.7 3.6 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 165.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 389' ' ' HIS . . . . . 0.785 ' CG ' ' HB2' ' B' ' 393' ' ' ASN . 16.1 m170 64.03 7.29 3.28 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.203 -0.936 . . . . 0.0 110.257 -175.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 390' ' ' GLN . . . . . 0.4 ' HB2' ' O ' ' B' ' 389' ' ' HIS . 29.3 mt-30 66.31 24.73 10.56 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.527 -170.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 391' ' ' LEU . . . . . 0.461 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.6 pt? -164.32 -53.23 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 171.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 392' ' ' GLY . . . . . 0.546 ' HA2' ' SD ' ' B' ' 388' ' ' MET . . . -175.64 49.51 0.12 Allowed Glycine 0 CA--C 1.524 0.641 0 C-N-CA 119.756 -1.212 . . . . 0.0 114.464 -176.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 393' ' ' ASN . . . . . 0.785 ' HB2' ' CG ' ' B' ' 389' ' ' HIS . 0.5 OUTLIER -54.61 -43.28 72.08 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 117.348 0.574 . . . . 0.0 109.862 177.837 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 394' ' ' VAL . . . . . 0.786 HG12 ' CZ ' ' B' ' 386' ' ' PHE . 0.7 OUTLIER -57.6 -46.13 86.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -177.818 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 395' ' ' ILE . . . . . 0.605 HG23 HG22 ' B' ' 425' ' ' ILE . 4.1 mp -57.42 -52.26 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-O 117.979 -1.01 . . . . 0.0 113.186 -174.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 396' ' ' LYS . . . . . 0.622 ' HG3' ' CZ ' ' B' ' 429' ' ' TYR . 0.0 OUTLIER -63.58 -50.22 70.32 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 121.661 2.028 . . . . 0.0 112.302 -175.684 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 397' ' ' GLY . . . . . 0.583 ' O ' ' HG3' ' B' ' 401' ' ' GLN . . . -54.39 -44.86 76.74 Favored Glycine 0 N--CA 1.434 -1.449 0 C-N-CA 120.03 -1.081 . . . . 0.0 111.089 -177.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 398' ' ' ILE . . . . . 0.66 ' CD1' HD12 ' B' ' 410' ' ' LEU . 31.2 mt -71.33 -34.54 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -178.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 399' ' ' VAL . . . . . 0.545 HG23 ' O ' ' B' ' 396' ' ' LYS . 10.0 m -63.66 -39.94 87.2 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.519 0 C-N-CA 118.971 -1.092 . . . . 0.0 108.577 -173.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -66.41 -41.24 89.55 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 175.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 401' ' ' GLN . . . . . 0.583 ' HG3' ' O ' ' B' ' 397' ' ' GLY . 36.4 mt-30 -91.89 -47.19 7.45 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -168.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 402' ' ' GLU . . . . . 0.409 ' HB3' ' HB ' ' B' ' 406' ' ' THR . 2.9 mm-40 -115.01 -20.56 10.45 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.987 0.422 . . . . 0.0 111.276 -172.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 106.19 162.95 22.82 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.099 177.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 404' ' ' VAL . . . . . 0.671 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.3 m -53.53 -42.89 51.63 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.858 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -175.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 405' ' ' ALA . . . . . 0.488 ' HB3' HG22 ' B' ' 457' ' ' ILE . . . -69.24 -28.64 66.52 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 119.545 -0.862 . . . . 0.0 112.165 -176.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 406' ' ' THR . . . . . 0.696 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 85.9 m -77.4 -43.14 33.69 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.159 -0.616 . . . . 0.0 109.94 172.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 407' ' ' ALA . . . . . 0.518 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.28 -37.54 75.22 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 122.118 0.961 . . . . 0.0 109.351 176.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 408' ' ' TYR . . . . . 0.671 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.69 -52.04 54.65 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 113.568 -1.651 . . . . 0.0 109.8 177.072 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 409' ' ' THR . . . . . 0.54 HG22 HD22 ' B' ' 410' ' ' LEU . 14.8 m -55.46 -47.53 75.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.678 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 410' ' ' LEU . . . . . 0.696 ' HG ' ' O ' ' B' ' 406' ' ' THR . 13.8 mt -72.14 -35.79 69.18 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 120.838 0.351 . . . . 0.0 110.271 -175.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.94 -35.06 81.48 Favored Glycine 0 N--CA 1.439 -1.144 0 C-N-CA 120.229 -0.986 . . . . 0.0 110.71 172.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 412' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -67.46 -47.75 69.2 Favored 'General case' 0 C--O 1.224 -0.267 0 N-CA-C 111.556 0.206 . . . . 0.0 111.556 178.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 413' ' ' MET . . . . . 0.927 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.3 OUTLIER -70.67 -48.26 55.73 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 118.96 -1.096 . . . . 0.0 112.139 -179.367 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 414' ' ' LEU . . . . . 0.927 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 18.7 mt -69.53 -44.3 71.27 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -175.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 415' ' ' SER . . . . . 0.454 ' HB2' ' HE1' ' B' ' 388' ' ' MET . 33.5 t -86.55 -23.98 25.63 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.509 0.671 . . . . 0.0 110.158 -175.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 416' ' ' GLY . . . . . 0.422 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 112.44 -177.06 18.29 Favored Glycine 0 N--CA 1.428 -1.843 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 -173.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -80.93 22.67 0.6 Allowed 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.219 0.533 . . . . 0.0 111.214 -172.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 418' ' ' ASN . . . . . 0.425 ' O ' HD21 ' B' ' 421' ' ' LEU . 11.3 m120 -73.09 75.36 1.24 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.884 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 419' ' ' TYR . . . . . 0.613 ' HB2' ' CE2' ' B' ' 456' ' ' PHE . 26.8 p90 -54.86 -37.42 66.22 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.207 178.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -54.56 -46.31 73.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.961 0.41 . . . . 0.0 110.889 177.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 421' ' ' LEU . . . . . 0.461 ' O ' HD11 ' B' ' 425' ' ' ILE . 0.0 OUTLIER -68.42 -47.83 66.23 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.136 -177.158 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 422' ' ' VAL . . . . . 0.465 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.2 OUTLIER -65.18 -38.56 82.96 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.218 -178.524 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 423' ' ' SER . . . . . 0.753 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 62.3 p -68.05 -37.37 81.24 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.21 -39.76 92.34 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.307 175.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 425' ' ' ILE . . . . . 0.605 HG22 HG23 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -72.55 -52.58 22.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 O-C-N 122.785 -0.244 . . . . 0.0 111.003 -178.081 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 426' ' ' ILE . . . . . 0.519 ' O ' HD21 ' B' ' 430' ' ' LEU . 1.2 mm -72.21 -21.67 20.56 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.821 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -172.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 427' ' ' ARG . . . . . 0.753 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.7 OUTLIER -54.31 -31.33 53.89 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.216 0.531 . . . . 0.0 110.479 -179.265 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -84.25 -12.39 76.27 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.404 178.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 429' ' ' TYR . . . . . 0.622 ' CZ ' ' HG3' ' B' ' 396' ' ' LYS . 23.2 m-85 -114.77 1.87 14.25 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 121.064 0.459 . . . . 0.0 110.372 -176.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 430' ' ' LEU . . . . . 0.534 ' HA ' HG12 ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.77 128.32 93.72 Favored Pre-proline 0 N--CA 1.438 -1.042 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.681 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 431' ' ' PRO . . . . . 0.513 ' HD2' HD11 ' B' ' 430' ' ' LEU . 56.8 Cg_exo -22.48 -73.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.355 0.883 1 C-N-CA 125.702 4.268 . . . . 0.0 114.606 179.563 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 432' ' ' GLY . . . . . 0.444 ' H ' ' HB2' ' B' ' 431' ' ' PRO . . . -132.34 -165.74 11.36 Favored Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 175.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 433' ' ' GLN . . . . . 0.612 ' O ' HG11 ' B' ' 436' ' ' VAL . 1.0 OUTLIER -70.94 -27.96 64.14 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 117.506 0.653 . . . . 0.0 110.643 177.85 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -70.39 -36.43 74.08 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -174.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 435' ' ' VAL . . . . . 0.47 ' HA ' ' CG1' ' B' ' 463' ' ' VAL . 7.5 p -67.36 -41.52 86.45 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 CA-C-O 121.102 0.477 . . . . 0.0 110.346 -177.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 436' ' ' VAL . . . . . 0.612 HG11 ' O ' ' B' ' 433' ' ' GLN . 0.2 OUTLIER -64.67 -34.77 72.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.214 175.64 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 437' ' ' THR . . . . . 0.416 HG23 ' N ' ' B' ' 438' ' ' ALA . 0.8 OUTLIER -70.87 -48.51 53.42 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 -174.211 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 438' ' ' ALA . . . . . 0.739 ' O ' ' HG2' ' B' ' 442' ' ' ARG . . . -56.21 -37.17 69.3 Favored 'General case' 0 N--CA 1.433 -1.32 0 O-C-N 123.631 0.582 . . . . 0.0 110.382 175.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 439' ' ' LEU . . . . . 0.556 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 2.1 tm? -67.72 -47.0 70.57 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 440' ' ' GLN . . . . . 0.487 ' NE2' HD13 ' B' ' 443' ' ' LEU . 0.3 OUTLIER -62.15 -33.89 75.35 Favored 'General case' 0 CA--C 1.489 -1.378 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.828 176.178 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 441' ' ' GLN . . . . . 0.558 ' O ' ' HG2' ' B' ' 445' ' ' GLN . 9.0 mm-40 -58.3 -49.19 78.05 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.258 175.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 442' ' ' ARG . . . . . 0.739 ' HG2' ' O ' ' B' ' 438' ' ' ALA . 0.0 OUTLIER -57.24 -39.93 76.53 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.913 171.067 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 443' ' ' LEU . . . . . 0.556 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 33.3 mt -72.26 -34.34 68.16 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.376 0.608 . . . . 0.0 109.918 -178.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -58.02 -36.96 73.44 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.838 173.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 445' ' ' GLN . . . . . 0.558 ' HG2' ' O ' ' B' ' 441' ' ' GLN . 30.6 mm-40 -72.13 -27.66 62.77 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.161 178.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 446' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' B' ' 443' ' ' LEU . 38.0 tt0 35.6 98.07 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 170.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 447' ' ' ILE . . . . . 0.517 ' HB ' ' HB ' ' B' ' 451' ' ' THR . 54.4 mt -73.41 -32.71 37.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.629 0.728 . . . . 0.0 110.48 176.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 448' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -170.16 -158.42 0.17 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -87.55 -58.92 2.4 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 166.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 450' ' ' GLN . . . . . 0.461 ' C ' HE21 ' B' ' 450' ' ' GLN . 0.0 OUTLIER -66.66 -33.41 75.6 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 115.272 -0.877 . . . . 0.0 112.609 -177.562 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 451' ' ' THR . . . . . 0.517 ' HB ' ' HB ' ' B' ' 447' ' ' ILE . 4.7 m -72.0 -23.26 61.38 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.671 -174.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 452' ' ' ARG . . . . . . . . . . . . . 13.1 mtp180 -55.25 -54.13 47.38 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 172.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 453' ' ' ALA . . . . . 0.506 ' HB1' ' CD1' ' B' ' 419' ' ' TYR . . . -58.51 -48.36 81.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.689 -1.142 . . . . 0.0 112.622 175.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 454' ' ' GLU . . . . . 0.479 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 26.2 mm-40 -51.61 -37.3 49.39 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.399 0.619 . . . . 0.0 111.366 -178.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 29.1 p -117.71 16.82 14.45 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.471 -176.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 456' ' ' PHE . . . . . 0.613 ' CE2' ' HB2' ' B' ' 419' ' ' TYR . 1.1 t80 -58.01 -47.17 83.87 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.035 0.445 . . . . 0.0 111.571 -171.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 457' ' ' ILE . . . . . 0.512 ' CG1' ' HB3' ' B' ' 408' ' ' TYR . 2.0 mp -76.92 -32.31 19.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.622 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -57.93 -34.29 69.71 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.702 0.763 . . . . 0.0 109.214 170.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 459' ' ' HIS . . . . . 0.686 ' O ' HG22 ' B' ' 463' ' ' VAL . 58.4 m-70 -75.97 -28.14 57.76 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.634 178.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 460' ' ' LEU . . . . . 0.715 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.4 OUTLIER -74.06 -34.66 64.11 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.903 0.859 . . . . 0.0 108.82 178.262 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 461' ' ' ASN . . . . . 0.545 ' HA ' ' CD2' ' B' ' 464' ' ' TYR . 22.1 m-80 -72.59 -37.8 68.04 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.965 176.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 462' ' ' ALA . . . . . 0.638 ' O ' HD13 ' B' ' 466' ' ' ILE . . . -56.37 -34.25 66.48 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.688 169.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 463' ' ' VAL . . . . . 0.715 ' HB ' ' O ' ' B' ' 460' ' ' LEU . 65.3 t -61.49 -51.49 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 176.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 464' ' ' TYR . . . . . 0.739 ' CE2' ' HA ' ' B' ' 471' ' ' ALA . 15.5 m-30 -52.76 -27.24 16.97 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 124.354 1.034 . . . . 0.0 110.745 178.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.53 -39.11 20.85 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.703 0.763 . . . . 0.0 109.486 -178.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 466' ' ' ILE . . . . . 0.638 HD13 ' O ' ' B' ' 462' ' ' ALA . 3.6 mt -59.76 -55.92 20.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 114.219 -1.355 . . . . 0.0 112.224 176.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 467' ' ' LEU . . . . . 0.722 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -100.21 -10.62 21.18 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -173.235 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 468' ' ' GLY . . . . . 0.602 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 93.25 31.06 8.67 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 119.604 -1.284 . . . . 0.0 114.122 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 469' ' ' LEU . . . . . 0.722 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 2.9 mt -90.05 166.51 13.39 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.343 1.072 . . . . 0.0 111.723 178.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 34.6 p30 -106.11 177.94 4.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.366 169.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 471' ' ' ALA . . . . . 0.739 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -71.16 -7.08 44.26 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -173.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -92.05 -0.44 57.46 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.022 0.439 . . . . 0.0 110.674 -177.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 473' ' ' GLY . . . . . . . . . . . . . . . 77.45 13.06 83.94 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.136 -175.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -101.25 157.99 16.37 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 175.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 475' ' ' SER . . . . . 0.431 ' HA ' HD21 ' B' ' 469' ' ' LEU . 0.5 OUTLIER -93.61 120.2 33.58 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.729 0.776 . . . . 0.0 112.644 -177.081 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 476' ' ' ILE . . . . . 0.602 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.2 pp . . . . . 0 N--CA 1.435 -1.179 0 N-CA-C 105.426 -2.065 . . . . 0.0 105.426 162.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 386' ' ' PHE . . . . . 0.581 ' CD1' HD23 ' A' ' 414' ' ' LEU . 3.6 t80 . . . . . 0 CA--C 1.531 0.23 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 386' ' ' PHE . 6.5 Cg_endo -46.47 -71.55 0.05 OUTLIER 'Trans proline' 0 N--CA 1.475 0.44 0 C-N-CA 124.163 3.242 . . . . 0.0 114.412 -175.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 388' ' ' MET . . . . . 0.556 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 30.7 ttm 70.38 143.96 0.05 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 122.356 0.262 . . . . 0.0 110.717 178.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 389' ' ' HIS . . . . . 0.589 ' CD2' ' HB2' ' A' ' 393' ' ' ASN . 32.6 m170 -48.49 -76.17 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 121.42 0.629 . . . . 0.0 110.382 -176.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -166.66 19.49 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 173.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.512 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.6 pt? -168.67 -51.83 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.505 -171.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . 0.512 ' N ' ' HG ' ' A' ' 391' ' ' LEU . . . -176.22 60.84 0.1 Allowed Glycine 0 C--N 1.336 0.571 0 C-N-CA 119.751 -1.214 . . . . 0.0 114.028 -176.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . 0.589 ' HB2' ' CD2' ' A' ' 389' ' ' HIS . 0.2 OUTLIER -58.39 -42.08 86.31 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 174.115 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . 0.607 HG23 ' N ' ' A' ' 395' ' ' ILE . 1.7 m -55.24 -47.06 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 -179.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.607 ' N ' HG23 ' A' ' 394' ' ' VAL . 3.6 mp -57.7 -52.65 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 CA-C-O 117.8 -1.095 . . . . 0.0 113.729 -175.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . 0.63 ' O ' HG23 ' A' ' 399' ' ' VAL . 0.0 OUTLIER -62.75 -50.15 72.22 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 122.022 2.192 . . . . 0.0 112.298 -173.525 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . 0.492 ' O ' ' HG3' ' A' ' 401' ' ' GLN . . . -53.86 -42.09 68.64 Favored Glycine 0 N--CA 1.436 -1.344 0 C-N-CA 119.895 -1.145 . . . . 0.0 110.804 -175.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . 0.666 ' CD1' HD13 ' A' ' 410' ' ' LEU . 36.1 mt -71.64 -34.43 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 CA-C-N 114.263 -0.969 . . . . 0.0 113.517 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 396' ' ' LYS . 15.6 m -63.57 -39.94 87.22 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 C-N-CA 118.925 -1.11 . . . . 0.0 108.631 -173.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -68.29 -38.79 82.01 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 176.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . 0.492 ' HG3' ' O ' ' A' ' 397' ' ' GLY . 33.1 mt-30 -93.05 -48.46 6.49 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -171.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . 0.442 ' HG3' ' HE2' ' B' ' 413' ' ' MET . 3.0 mm-40 -113.14 -20.15 11.57 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.2 -172.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 105.48 161.51 23.29 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.849 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . 0.638 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.5 m -53.78 -45.23 61.62 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.78 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 -176.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . 0.469 ' HB1' HG21 ' A' ' 457' ' ' ILE . . . -64.03 -31.16 72.25 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.005 -0.678 . . . . 0.0 112.481 -177.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 406' ' ' THR . . . . . 0.689 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 87.1 m -77.38 -42.43 36.46 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.476 -0.489 . . . . 0.0 110.244 173.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.506 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.4 -36.85 74.19 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 122.245 1.022 . . . . 0.0 109.311 176.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 408' ' ' TYR . . . . . 0.638 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -66.33 -51.92 52.37 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 113.436 -1.711 . . . . 0.0 109.991 176.337 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 409' ' ' THR . . . . . 0.52 HG23 HD23 ' A' ' 410' ' ' LEU . 16.5 m -55.68 -46.91 77.5 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.58 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . 0.689 ' HG ' ' O ' ' A' ' 406' ' ' THR . 14.1 mt -72.36 -34.95 68.37 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -175.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -59.35 -34.22 79.5 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.383 -0.913 . . . . 0.0 110.994 170.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 412' ' ' MET . . . . . 0.42 ' HB2' ' O ' ' A' ' 409' ' ' THR . 0.6 OUTLIER -66.71 -48.25 69.8 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 122.611 -0.346 . . . . 0.0 111.119 177.035 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 413' ' ' MET . . . . . 0.894 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.5 OUTLIER -71.53 -51.45 23.5 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 119.363 -0.935 . . . . 0.0 112.656 -179.357 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . 0.894 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 12.5 mt -67.55 -46.47 72.67 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -174.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.438 ' CB ' ' HE1' ' A' ' 388' ' ' MET . 0.1 OUTLIER -97.58 10.98 38.46 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.364 0.602 . . . . 0.0 111.086 -172.66 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . 0.457 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 84.08 179.82 51.84 Favored Glycine 0 N--CA 1.438 -1.187 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.68 -179.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -79.83 23.06 0.46 Allowed 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.364 0.602 . . . . 0.0 110.789 -173.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 418' ' ' ASN . . . . . 0.457 ' H ' ' C ' ' A' ' 416' ' ' GLY . 64.0 m-80 -72.33 77.36 1.01 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.782 -178.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 419' ' ' TYR . . . . . 0.545 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 7.1 p90 -49.83 -38.23 33.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.977 174.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -54.33 -47.72 72.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.749 177.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -48.65 66.02 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.044 -176.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . 0.455 ' HB ' ' CD1' ' A' ' 408' ' ' TYR . 0.2 OUTLIER -66.01 -40.49 87.45 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.572 0 C-N-CA 120.281 -0.567 . . . . 0.0 111.355 -176.918 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.805 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 80.6 p -69.24 -37.88 78.22 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -178.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.56 -38.96 90.91 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.761 176.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . 0.534 HG23 HG23 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.91 -52.56 21.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.028 -0.086 . . . . 0.0 111.182 -178.279 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . 0.524 ' O ' HD23 ' A' ' 430' ' ' LEU . 1.1 mm -74.69 -23.59 17.91 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.896 0 O-C-N 121.968 -0.457 . . . . 0.0 110.374 -171.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.805 ' HB2' ' O ' ' A' ' 423' ' ' SER . 1.3 tmm_? -55.44 -30.86 61.3 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.325 0.583 . . . . 0.0 111.007 -177.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -86.58 -12.11 70.1 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.203 178.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.474 ' HD1' ' CG2' ' A' ' 395' ' ' ILE . 7.7 m-30 -112.68 -0.5 15.05 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.615 0.722 . . . . 0.0 109.07 -174.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . 0.55 HD11 ' HD2' ' A' ' 431' ' ' PRO . 0.1 OUTLIER -66.07 129.75 94.27 Favored Pre-proline 0 N--CA 1.444 -0.754 0 CA-C-N 114.549 -1.205 . . . . 0.0 108.953 177.508 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 431' ' ' PRO . . . . . 0.55 ' HD2' HD11 ' A' ' 430' ' ' LEU . 81.4 Cg_exo -23.91 -68.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.915 1 C-N-CA 125.489 4.126 . . . . 0.0 114.852 179.117 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . 0.5 ' O ' HG13 ' A' ' 435' ' ' VAL . . . -141.51 -167.81 11.32 Favored Glycine 0 N--CA 1.442 -0.91 0 N-CA-C 110.089 -1.205 . . . . 0.0 110.089 176.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . 0.551 ' O ' HG12 ' A' ' 436' ' ' VAL . 43.6 tp60 -70.4 -26.96 63.93 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 118.083 0.941 . . . . 0.0 110.449 178.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -64.3 -41.98 96.59 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 435' ' ' VAL . . . . . 0.5 HG13 ' O ' ' A' ' 432' ' ' GLY . 7.4 p -67.67 -42.81 86.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 121.018 0.437 . . . . 0.0 110.66 -177.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . 0.551 HG12 ' O ' ' A' ' 433' ' ' GLN . 0.1 OUTLIER -67.26 -31.61 53.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.402 175.735 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.61 -52.76 41.71 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -178.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . 0.559 ' O ' ' HD2' ' A' ' 442' ' ' ARG . . . -58.63 -39.82 81.63 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.936 177.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 439' ' ' LEU . . . . . 0.642 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 1.8 tm? -68.0 -48.39 65.87 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -177.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -60.54 -33.73 73.09 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.074 175.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 441' ' ' GLN . . . . . 0.487 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 3.5 mm-40 -54.83 -50.29 68.96 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.863 -178.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . 0.608 ' HG3' ' CG ' ' A' ' 459' ' ' HIS . 0.0 OUTLIER -77.76 -24.12 49.05 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 174.271 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 443' ' ' LEU . . . . . 0.642 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 56.5 mt -64.04 -27.17 68.93 Favored 'General case' 0 CA--C 1.516 -0.356 0 O-C-N 121.496 -0.753 . . . . 0.0 109.985 173.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -66.5 -37.12 84.37 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.85 178.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 445' ' ' GLN . . . . . 0.478 ' HG3' ' N ' ' A' ' 446' ' ' GLU . 0.0 OUTLIER -80.25 -30.39 38.47 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.479 -179.923 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 446' ' ' GLU . . . . . 0.478 ' N ' ' HG3' ' A' ' 445' ' ' GLN . 8.6 pt-20 15.21 105.03 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.248 0 O-C-N 125.617 1.823 . . . . 0.0 113.841 -177.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 43.6 mt -51.26 -34.44 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.369 -177.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . 0.505 ' HB2' ' OG1' ' A' ' 451' ' ' THR . 13.3 m-20 -160.88 -174.59 4.48 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 449' ' ' ASP . . . . . 0.472 ' O ' ' HB3' ' A' ' 452' ' ' ARG . 25.8 t0 -72.41 -62.49 1.42 Allowed 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 174.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.22 -27.13 64.23 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 176.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 451' ' ' THR . . . . . 0.505 ' OG1' ' HB2' ' A' ' 448' ' ' ASP . 16.0 m -72.12 -23.06 61.26 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.004 -176.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . 0.472 ' HB3' ' O ' ' A' ' 449' ' ' ASP . 43.9 ttt180 -55.96 -52.26 64.79 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 172.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 453' ' ' ALA . . . . . 0.545 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -59.77 -47.21 86.6 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.707 170.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . 0.482 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 14.1 mm-40 -51.73 -36.45 47.11 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.137 0.494 . . . . 0.0 111.917 -175.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 24.9 p -115.46 13.98 16.58 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.271 -176.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . 0.572 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 1.2 t80 -55.06 -46.4 75.39 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.945 0.402 . . . . 0.0 111.746 -172.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . 0.504 ' CG1' ' HB3' ' A' ' 408' ' ' TYR . 1.9 mp -78.19 -33.36 17.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.784 0.326 . . . . 0.0 111.239 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -58.09 -32.71 68.34 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.805 0.812 . . . . 0.0 109.117 171.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . 0.746 ' O ' HG22 ' A' ' 463' ' ' VAL . 56.9 m-70 -74.17 -30.04 62.06 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.8 177.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . 0.696 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -73.99 -34.88 64.35 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.995 0.902 . . . . 0.0 108.988 179.518 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -73.08 -37.02 66.93 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.126 176.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 462' ' ' ALA . . . . . 0.619 ' O ' HD11 ' A' ' 466' ' ' ILE . . . -56.02 -34.25 65.66 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.385 -1.279 . . . . 0.0 109.9 169.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.746 HG22 ' O ' ' A' ' 459' ' ' HIS . 66.1 t -63.57 -50.83 76.57 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 CA-C-N 114.421 -1.263 . . . . 0.0 108.114 177.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 464' ' ' TYR . . . . . 0.564 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 16.9 m-30 -52.4 -29.15 22.73 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 124.348 1.03 . . . . 0.0 110.257 177.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.82 -40.69 22.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.745 0.784 . . . . 0.0 109.498 -177.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.619 HD11 ' O ' ' A' ' 462' ' ' ALA . 3.6 mt -57.84 -56.17 17.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 114.304 -1.316 . . . . 0.0 112.269 176.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.741 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -100.82 -11.23 20.01 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -172.051 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . 0.528 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 94.09 31.6 7.98 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 119.366 -1.397 . . . . 0.0 114.321 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 469' ' ' LEU . . . . . 0.741 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.3 mt -88.47 163.02 16.15 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 117.915 0.857 . . . . 0.0 110.92 177.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 37.9 p30 -105.17 -178.04 3.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.065 172.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -66.05 -14.65 62.07 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -176.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -88.53 -1.6 58.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.675 0.274 . . . . 0.0 111.148 -175.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 473' ' ' GLY . . . . . 0.482 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 79.04 10.66 85.95 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -175.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -101.43 156.22 17.59 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 176.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 32.1 t -93.25 137.52 32.49 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.248 0.547 . . . . 0.0 111.287 -176.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 476' ' ' ILE . . . . . 0.528 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.4 pp . . . . . 0 C--N 1.321 -0.637 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.878 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 386' ' ' PHE . . . . . 0.582 ' CD1' HD23 ' B' ' 414' ' ' LEU . 3.5 t80 . . . . . 0 CA--C 1.53 0.211 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 387' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' B' ' 386' ' ' PHE . 6.7 Cg_endo -46.56 -71.56 0.05 OUTLIER 'Trans proline' 0 N--CA 1.476 0.479 0 C-N-CA 124.17 3.247 . . . . 0.0 114.433 -175.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 388' ' ' MET . . . . . 0.544 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 30.8 ttm 70.39 143.57 0.05 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 122.412 0.285 . . . . 0.0 110.896 178.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 389' ' ' HIS . . . . . 0.584 ' CD2' ' HB2' ' B' ' 393' ' ' ASN . 32.6 m170 -48.14 -75.93 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.1 0 CA-C-O 121.304 0.574 . . . . 0.0 110.417 -176.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -166.92 19.31 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 173.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 391' ' ' LEU . . . . . 0.513 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.6 pt? -168.76 -51.49 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.497 -171.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 392' ' ' GLY . . . . . 0.513 ' N ' ' HG ' ' B' ' 391' ' ' LEU . . . -176.44 60.85 0.1 Allowed Glycine 0 CA--C 1.522 0.522 0 C-N-CA 119.794 -1.193 . . . . 0.0 114.151 -176.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 393' ' ' ASN . . . . . 0.584 ' HB2' ' CD2' ' B' ' 389' ' ' HIS . 0.2 OUTLIER -58.47 -42.07 86.68 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 174.095 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 394' ' ' VAL . . . . . 0.609 HG23 ' N ' ' B' ' 395' ' ' ILE . 1.7 m -55.18 -47.12 77.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 395' ' ' ILE . . . . . 0.609 ' N ' HG23 ' B' ' 394' ' ' VAL . 3.6 mp -57.64 -52.65 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 117.779 -1.105 . . . . 0.0 113.751 -175.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 396' ' ' LYS . . . . . 0.635 ' O ' HG23 ' B' ' 399' ' ' VAL . 0.0 OUTLIER -62.71 -50.18 72.14 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 122.043 2.201 . . . . 0.0 112.347 -173.667 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 397' ' ' GLY . . . . . 0.507 ' O ' ' HG3' ' B' ' 401' ' ' GLN . . . -54.06 -41.86 70.02 Favored Glycine 0 N--CA 1.436 -1.345 0 C-N-CA 119.799 -1.191 . . . . 0.0 110.838 -175.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 398' ' ' ILE . . . . . 0.668 ' CD1' HD13 ' B' ' 410' ' ' LEU . 35.9 mt -71.62 -34.56 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 399' ' ' VAL . . . . . 0.635 HG23 ' O ' ' B' ' 396' ' ' LYS . 15.6 m -63.38 -40.1 87.76 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 C-N-CA 118.94 -1.104 . . . . 0.0 108.68 -174.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -68.53 -38.5 80.9 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 176.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 401' ' ' GLN . . . . . 0.507 ' HG3' ' O ' ' B' ' 397' ' ' GLY . 32.9 mt-30 -92.86 -48.39 6.57 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -171.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 402' ' ' GLU . . . . . 0.451 ' HG3' ' HE2' ' A' ' 413' ' ' MET . 3.1 mm-40 -113.43 -19.89 11.52 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.154 -172.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 105.12 161.42 23.62 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.947 178.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 404' ' ' VAL . . . . . 0.628 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.4 m -53.69 -45.37 60.66 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 N-CA-C 114.409 1.262 . . . . 0.0 114.409 -176.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 405' ' ' ALA . . . . . 0.459 ' HB1' HG21 ' B' ' 457' ' ' ILE . . . -63.97 -31.23 72.35 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 119.954 -0.698 . . . . 0.0 112.504 -177.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 406' ' ' THR . . . . . 0.681 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 89.9 m -77.12 -42.36 38.29 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.298 173.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 407' ' ' ALA . . . . . 0.502 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.48 -36.79 74.27 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 122.203 1.001 . . . . 0.0 109.282 176.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 408' ' ' TYR . . . . . 0.628 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -66.46 -51.87 52.28 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 113.43 -1.714 . . . . 0.0 109.937 176.449 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 409' ' ' THR . . . . . 0.541 HG23 HD23 ' B' ' 410' ' ' LEU . 16.6 m -55.45 -47.07 76.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.591 178.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 410' ' ' LEU . . . . . 0.681 ' HG ' ' O ' ' B' ' 406' ' ' THR . 14.1 mt -72.42 -34.78 68.08 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -175.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -59.41 -34.14 79.39 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.308 -0.948 . . . . 0.0 110.998 170.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 412' ' ' MET . . . . . 0.423 ' HB2' ' O ' ' B' ' 409' ' ' THR . 0.6 OUTLIER -66.88 -48.15 69.64 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 122.612 -0.346 . . . . 0.0 111.072 177.163 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 413' ' ' MET . . . . . 0.912 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.5 OUTLIER -71.59 -51.69 22.01 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 119.336 -0.946 . . . . 0.0 112.678 -179.456 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 414' ' ' LEU . . . . . 0.912 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 12.4 mt -67.21 -46.5 73.67 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -174.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 415' ' ' SER . . . . . 0.434 ' CB ' ' HE1' ' B' ' 388' ' ' MET . 0.1 OUTLIER -97.44 10.61 39.27 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.368 0.604 . . . . 0.0 110.975 -172.556 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 416' ' ' GLY . . . . . 0.468 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 84.16 179.39 51.73 Favored Glycine 0 N--CA 1.438 -1.202 0 C-N-CA 120.638 -0.791 . . . . 0.0 111.609 -178.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -79.5 23.23 0.41 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.564 0.697 . . . . 0.0 110.843 -173.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 418' ' ' ASN . . . . . 0.468 ' H ' ' C ' ' B' ' 416' ' ' GLY . 64.8 m-80 -72.51 77.49 1.06 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.763 -178.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 419' ' ' TYR . . . . . 0.553 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 6.9 p90 -50.0 -38.29 36.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.975 174.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -54.28 -47.64 72.12 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.807 177.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.7 -48.76 65.63 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.963 -176.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 422' ' ' VAL . . . . . 0.454 ' HB ' ' CD1' ' B' ' 408' ' ' TYR . 0.2 OUTLIER -66.01 -40.47 87.38 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.499 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.216 -176.757 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 423' ' ' SER . . . . . 0.8 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 80.3 p -69.15 -37.76 78.43 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -178.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -68.0 -38.61 88.8 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.636 176.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 425' ' ' ILE . . . . . 0.552 HG23 HG23 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -72.95 -52.91 20.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 O-C-N 123.062 -0.081 . . . . 0.0 111.088 -178.289 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 426' ' ' ILE . . . . . 0.519 ' CD1' HG21 ' B' ' 395' ' ' ILE . 1.1 mm -74.34 -23.77 18.53 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.89 0 O-C-N 122.182 -0.324 . . . . 0.0 110.376 -171.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 427' ' ' ARG . . . . . 0.8 ' HB2' ' O ' ' B' ' 423' ' ' SER . 1.3 tmm_? -55.33 -30.76 60.88 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.241 0.544 . . . . 0.0 111.024 -177.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -86.87 -11.8 69.8 Favored Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 120.445 -0.883 . . . . 0.0 111.224 178.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 429' ' ' TYR . . . . . 0.468 ' HD1' ' CG2' ' B' ' 395' ' ' ILE . 7.9 m-30 -112.94 -0.39 14.84 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -174.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 430' ' ' LEU . . . . . 0.541 HD11 ' HD2' ' B' ' 431' ' ' PRO . 0.1 OUTLIER -66.12 129.72 94.25 Favored Pre-proline 0 N--CA 1.442 -0.837 0 CA-C-N 114.477 -1.238 . . . . 0.0 108.938 177.426 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 431' ' ' PRO . . . . . 0.541 ' HD2' HD11 ' B' ' 430' ' ' LEU . 81.0 Cg_exo -24.05 -69.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.357 1.001 1 C-N-CA 125.399 4.066 . . . . 0.0 114.796 179.224 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 432' ' ' GLY . . . . . 0.51 ' O ' HG13 ' B' ' 435' ' ' VAL . . . -141.28 -168.03 11.34 Favored Glycine 0 N--CA 1.443 -0.886 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 177.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 433' ' ' GLN . . . . . 0.555 ' O ' HG12 ' B' ' 436' ' ' VAL . 43.8 tp60 -70.23 -26.93 64.08 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 118.173 0.986 . . . . 0.0 110.411 178.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -63.99 -42.18 97.28 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.964 -178.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 435' ' ' VAL . . . . . 0.51 HG13 ' O ' ' B' ' 432' ' ' GLY . 7.3 p -67.76 -42.77 86.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 120.977 0.417 . . . . 0.0 110.649 -177.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 436' ' ' VAL . . . . . 0.555 HG12 ' O ' ' B' ' 433' ' ' GLN . 0.1 OUTLIER -67.31 -31.57 53.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.323 175.732 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.58 -52.74 42.11 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -178.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 438' ' ' ALA . . . . . 0.56 ' O ' ' HD2' ' B' ' 442' ' ' ARG . . . -58.68 -39.74 81.57 Favored 'General case' 0 N--CA 1.436 -1.128 0 O-C-N 124.042 0.838 . . . . 0.0 111.97 177.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 439' ' ' LEU . . . . . 0.655 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 1.8 tm? -68.03 -48.41 65.73 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -178.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 440' ' ' GLN . . . . . 0.402 ' O ' ' HG3' ' B' ' 440' ' ' GLN . 0.3 OUTLIER -60.45 -33.7 72.94 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.143 175.256 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 441' ' ' GLN . . . . . 0.481 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 3.4 mm-40 -55.0 -50.25 69.47 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.742 -178.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 442' ' ' ARG . . . . . 0.603 ' HG3' ' CG ' ' B' ' 459' ' ' HIS . 0.0 OUTLIER -77.74 -24.0 49.19 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 174.388 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 443' ' ' LEU . . . . . 0.655 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 55.8 mt -64.31 -26.91 68.69 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 118.755 0.707 . . . . 0.0 109.966 173.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -66.71 -37.03 83.89 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.78 178.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 445' ' ' GLN . . . . . 0.472 ' HG3' ' N ' ' B' ' 446' ' ' GLU . 0.0 OUTLIER -80.33 -30.42 38.12 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.584 179.874 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 446' ' ' GLU . . . . . 0.472 ' N ' ' HG3' ' B' ' 445' ' ' GLN . 8.7 pt-20 15.2 105.14 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 O-C-N 125.517 1.761 . . . . 0.0 113.816 -177.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 43.7 mt -51.28 -34.23 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.362 -177.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 448' ' ' ASP . . . . . 0.507 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 13.0 m-20 -161.04 -174.45 4.38 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 449' ' ' ASP . . . . . 0.477 ' O ' ' HB3' ' B' ' 452' ' ' ARG . 27.9 t0 -72.26 -62.69 1.34 Allowed 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 174.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.03 -27.26 64.52 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 176.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 451' ' ' THR . . . . . 0.507 ' OG1' ' HB2' ' B' ' 448' ' ' ASP . 14.6 m -72.07 -23.02 61.29 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 119.749 -0.78 . . . . 0.0 109.946 -176.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 452' ' ' ARG . . . . . 0.477 ' HB3' ' O ' ' B' ' 449' ' ' ASP . 43.5 ttt180 -56.0 -52.15 65.22 Favored 'General case' 0 N--CA 1.415 -2.176 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 172.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 453' ' ' ALA . . . . . 0.553 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -60.05 -46.9 87.99 Favored 'General case' 0 CA--C 1.527 0.081 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 171.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 454' ' ' GLU . . . . . 0.481 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 13.5 mm-40 -51.95 -36.25 48.73 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.157 0.503 . . . . 0.0 111.837 -176.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 24.9 p -115.61 14.18 16.45 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.368 -176.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 456' ' ' PHE . . . . . 0.581 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 1.2 t80 -55.32 -46.29 76.32 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.944 0.402 . . . . 0.0 111.745 -172.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 457' ' ' ILE . . . . . 0.516 ' CG1' ' HB3' ' B' ' 408' ' ' TYR . 1.9 mp -78.16 -33.39 17.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 120.687 0.279 . . . . 0.0 111.273 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -58.06 -32.92 68.49 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.993 0.902 . . . . 0.0 109.078 171.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 459' ' ' HIS . . . . . 0.739 ' O ' HG22 ' B' ' 463' ' ' VAL . 56.4 m-70 -73.98 -29.97 62.25 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.79 177.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 460' ' ' LEU . . . . . 0.699 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -74.16 -34.71 63.91 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.814 0.816 . . . . 0.0 108.923 179.649 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 461' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -73.07 -37.34 66.83 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.016 176.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 462' ' ' ALA . . . . . 0.629 ' O ' HD11 ' B' ' 466' ' ' ILE . . . -55.99 -34.04 65.4 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.758 169.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 463' ' ' VAL . . . . . 0.739 HG22 ' O ' ' B' ' 459' ' ' HIS . 68.4 t -63.49 -51.09 74.95 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-N 114.548 -1.205 . . . . 0.0 108.152 177.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 464' ' ' TYR . . . . . 0.553 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 16.9 m-30 -52.3 -29.15 21.97 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 124.347 1.029 . . . . 0.0 110.311 177.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.68 -40.98 22.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.614 0.721 . . . . 0.0 109.475 -177.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 466' ' ' ILE . . . . . 0.629 HD11 ' O ' ' B' ' 462' ' ' ALA . 3.7 mt -57.42 -56.32 15.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 114.277 -1.329 . . . . 0.0 112.251 176.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 467' ' ' LEU . . . . . 0.743 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -100.78 -11.36 19.95 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 114.66 1.355 . . . . 0.0 114.66 -171.971 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 468' ' ' GLY . . . . . 0.549 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 94.24 31.56 7.93 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 119.368 -1.396 . . . . 0.0 114.32 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 469' ' ' LEU . . . . . 0.743 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.3 mt -88.6 162.93 16.09 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 117.873 0.836 . . . . 0.0 110.879 177.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 37.8 p30 -105.0 -177.95 3.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.109 172.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 471' ' ' ALA . . . . . . . . . . . . . . . -66.41 -14.46 62.19 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -176.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -88.43 -1.71 58.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.624 0.249 . . . . 0.0 111.166 -176.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 473' ' ' GLY . . . . . 0.479 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 78.99 10.82 85.83 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -175.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -101.51 156.46 17.46 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 176.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 34.8 t -93.36 137.56 32.55 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.348 0.594 . . . . 0.0 111.264 -176.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 476' ' ' ILE . . . . . 0.549 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.4 pp . . . . . 0 C--N 1.322 -0.608 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.865 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 386' ' ' PHE . . . . . 0.536 ' CD1' HD21 ' A' ' 414' ' ' LEU . 2.1 t80 . . . . . 0 CA--C 1.54 0.577 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 386' ' ' PHE . 1.5 Cg_endo -39.85 -62.84 0.33 Allowed 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 124.404 3.403 . . . . 0.0 113.764 -174.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 388' ' ' MET . . . . . 0.478 ' C ' ' HB3' ' A' ' 393' ' ' ASN . 6.3 ttp 59.04 38.34 24.11 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 174.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 389' ' ' HIS . . . . . 0.583 ' N ' ' HB3' ' A' ' 393' ' ' ASN . 31.3 m170 51.8 -97.22 0.05 Allowed 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.41 0.624 . . . . 0.0 110.064 -176.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -151.57 23.89 0.7 Allowed 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.186 171.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.45 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.4 pt? -175.77 -47.87 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.221 -172.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . 0.504 ' CA ' HD13 ' A' ' 395' ' ' ILE . . . -173.22 56.37 0.15 Allowed Glycine 0 CA--C 1.524 0.645 0 C-N-CA 119.443 -1.361 . . . . 0.0 114.796 -172.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . 0.583 ' HB3' ' N ' ' A' ' 389' ' ' HIS . 0.0 OUTLIER -61.72 -37.64 84.93 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-N 117.65 0.725 . . . . 0.0 109.061 174.18 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . 0.618 HG23 ' N ' ' A' ' 395' ' ' ILE . 1.0 OUTLIER -57.2 -49.4 79.89 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 CA-C-N 113.674 -1.603 . . . . 0.0 107.047 179.015 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.618 ' N ' HG23 ' A' ' 394' ' ' VAL . 3.6 mp -57.69 -52.82 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 CA-C-O 117.745 -1.121 . . . . 0.0 113.605 -174.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . 0.64 ' O ' HG22 ' A' ' 399' ' ' VAL . 0.0 OUTLIER -62.54 -49.51 75.02 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 122.017 2.189 . . . . 0.0 112.199 -174.715 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.16 -44.48 63.76 Favored Glycine 0 N--CA 1.435 -1.391 0 C-N-CA 119.98 -1.105 . . . . 0.0 110.98 -176.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . 0.673 ' CD1' HD12 ' A' ' 410' ' ' LEU . 28.5 mt -71.09 -33.94 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . 0.64 HG22 ' O ' ' A' ' 396' ' ' LYS . 17.3 m -63.29 -39.81 86.67 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 C-N-CA 118.751 -1.18 . . . . 0.0 108.436 -174.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -70.62 -37.7 73.84 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 175.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . 0.408 HE21 ' HB3' ' A' ' 401' ' ' GLN . 3.3 mm100 -88.15 -48.86 7.39 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -171.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . 0.414 ' HB3' ' HB ' ' A' ' 406' ' ' THR . 1.3 tm-20 -117.93 -19.94 8.98 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.065 0.46 . . . . 0.0 111.213 -170.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 106.45 160.67 22.25 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.673 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . 0.625 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.2 m -54.16 -45.5 66.51 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.862 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -175.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . 0.48 ' HB2' HG23 ' A' ' 457' ' ' ILE . . . -63.15 -31.26 72.36 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 119.794 -0.762 . . . . 0.0 112.403 -177.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 406' ' ' THR . . . . . 0.706 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 92.5 m -76.92 -42.03 41.1 Favored 'General case' 0 C--O 1.221 -0.412 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.164 173.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.472 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.8 -36.79 75.04 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 122.183 0.992 . . . . 0.0 109.301 176.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 408' ' ' TYR . . . . . 0.625 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -66.41 -51.73 53.92 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 113.492 -1.685 . . . . 0.0 109.571 176.762 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 409' ' ' THR . . . . . 0.521 HG22 HD22 ' A' ' 410' ' ' LEU . 17.5 m -55.11 -47.37 75.09 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.436 178.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . 0.706 ' HG ' ' O ' ' A' ' 406' ' ' THR . 15.0 mt -72.59 -35.73 67.99 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -174.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.44 -34.63 76.06 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.15 -1.024 . . . . 0.0 110.893 172.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -69.58 -47.22 64.33 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 413' ' ' MET . . . . . 0.917 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.8 OUTLIER -71.52 -44.84 63.9 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 118.914 -1.114 . . . . 0.0 111.879 -179.425 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . 0.917 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 11.7 mt -70.03 -46.37 65.21 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -177.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.45 ' HB2' ' SD ' ' A' ' 388' ' ' MET . 8.4 t -99.86 16.56 23.37 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.319 0.58 . . . . 0.0 110.349 -172.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . 0.434 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 75.85 -176.66 50.81 Favored Glycine 0 N--CA 1.437 -1.266 0 C-N-CA 120.354 -0.927 . . . . 0.0 111.721 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -80.56 23.12 0.53 Allowed 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.272 0.558 . . . . 0.0 111.402 -172.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 418' ' ' ASN . . . . . 0.434 ' H ' ' C ' ' A' ' 416' ' ' GLY . 4.3 m-20 -71.58 76.98 0.81 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.514 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 419' ' ' TYR . . . . . 0.499 ' CD1' ' HB3' ' A' ' 453' ' ' ALA . 21.4 p90 -56.17 -38.04 70.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.518 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -55.71 -42.57 75.45 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.723 0.297 . . . . 0.0 111.081 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.1 -49.05 63.63 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.287 -178.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . 0.47 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -65.7 -39.51 85.11 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.259 -177.878 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.788 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 61.8 p -67.73 -37.75 82.61 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 -178.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -68.09 -39.25 88.75 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.129 175.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . 0.553 HG22 HG23 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.23 -52.4 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-O 120.352 0.12 . . . . 0.0 111.035 -177.908 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . 0.546 ' CD1' HG21 ' A' ' 395' ' ' ILE . 1.2 mm -74.75 -23.37 17.7 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.91 0 O-C-N 122.135 -0.353 . . . . 0.0 110.555 -172.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.788 ' HB2' ' O ' ' A' ' 423' ' ' SER . 1.5 tmt_? -54.57 -31.8 57.37 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.224 0.535 . . . . 0.0 111.13 -177.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.37 -12.1 67.99 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.217 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.495 ' HD1' ' CG2' ' A' ' 395' ' ' ILE . 6.1 m-30 -112.0 -1.97 15.23 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -173.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . 0.542 ' HA ' HG13 ' A' ' 404' ' ' VAL . 0.0 OUTLIER -66.05 139.97 96.83 Favored Pre-proline 0 N--CA 1.443 -0.815 0 CA-C-N 114.136 -1.393 . . . . 0.0 109.206 177.349 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 431' ' ' PRO . . . . . 0.701 ' CD ' HG12 ' A' ' 435' ' ' VAL . 77.4 Cg_exo -37.99 -75.45 0.04 OUTLIER 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 124.606 3.537 . . . . 0.0 113.92 -173.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . 0.484 ' O ' HG11 ' A' ' 435' ' ' VAL . . . -130.06 -161.63 10.51 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 176.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . 0.547 ' O ' HG11 ' A' ' 436' ' ' VAL . 19.0 tp60 -71.47 -28.78 64.18 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 118.038 0.919 . . . . 0.0 110.569 176.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -67.03 -39.19 86.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 0.0 112.123 -175.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 435' ' ' VAL . . . . . 0.701 HG12 ' CD ' ' A' ' 431' ' ' PRO . 6.8 p -66.55 -45.08 89.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.173 0.511 . . . . 0.0 110.736 -177.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . 0.547 HG11 ' O ' ' A' ' 433' ' ' GLN . 0.2 OUTLIER -66.28 -31.91 55.73 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.105 177.014 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -68.01 -52.26 37.63 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -177.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . 0.684 ' O ' ' HD2' ' A' ' 442' ' ' ARG . . . -57.58 -40.56 79.29 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.179 177.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 439' ' ' LEU . . . . . 0.597 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 1.9 tm? -68.12 -48.13 66.26 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -178.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.86 -34.99 73.85 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.085 175.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 441' ' ' GLN . . . . . 0.508 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 4.4 mm-40 -53.62 -49.6 67.49 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.001 -178.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . 0.684 ' HD2' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -76.89 -25.28 52.84 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 119.133 -1.027 . . . . 0.0 113.368 174.346 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 443' ' ' LEU . . . . . 0.597 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 66.8 mt -65.59 -27.75 68.64 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 118.653 0.66 . . . . 0.0 109.771 175.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -61.29 -38.37 86.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.937 176.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -78.49 -27.63 46.25 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.319 -1.31 . . . . 0.0 111.149 178.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 25.36 101.58 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 41.5 mt -58.61 -33.59 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 121.353 0.597 . . . . 0.0 111.322 -178.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . 0.441 ' HB2' ' OG1' ' A' ' 451' ' ' THR . 8.4 m-20 -162.46 -159.81 0.61 Allowed 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 -178.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 449' ' ' ASP . . . . . 0.476 ' CG ' ' H ' ' A' ' 450' ' ' GLN . 12.3 p-10 -85.39 -64.88 1.08 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 168.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 450' ' ' GLN . . . . . 0.476 ' H ' ' CG ' ' A' ' 449' ' ' ASP . 0.0 OUTLIER -68.24 -26.11 65.53 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 179.012 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 451' ' ' THR . . . . . 0.478 ' HA ' ' HB2' ' A' ' 454' ' ' GLU . 10.4 m -71.44 -23.13 61.79 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 119.859 -0.736 . . . . 0.0 110.732 -175.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 452' ' ' ARG . 14.7 mtp180 -54.02 -53.95 45.91 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 171.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 453' ' ' ALA . . . . . 0.499 ' HB3' ' CD1' ' A' ' 419' ' ' TYR . . . -58.73 -49.08 78.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.354 -1.293 . . . . 0.0 112.53 174.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . 0.478 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 69.0 mm-40 -49.69 -37.15 27.67 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.283 0.563 . . . . 0.0 111.601 -177.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 32.0 p -118.03 15.06 14.18 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.45 -175.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . 0.527 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.8 OUTLIER -57.44 -47.47 81.73 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.089 0.471 . . . . 0.0 111.643 -171.28 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . 0.504 ' CG1' ' HB3' ' A' ' 408' ' ' TYR . 1.9 mp -76.92 -32.54 19.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.831 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -57.96 -34.41 69.9 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.905 0.86 . . . . 0.0 109.143 171.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . 0.767 ' O ' HG23 ' A' ' 463' ' ' VAL . 63.2 m-70 -74.68 -29.45 61.23 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.725 177.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . 0.705 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -73.47 -34.61 65.44 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.793 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . 0.449 ' O ' ' HB2' ' A' ' 464' ' ' TYR . 25.1 m-80 -73.11 -37.2 66.78 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.207 176.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 462' ' ' ALA . . . . . 0.594 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -55.75 -36.46 67.31 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.449 169.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 459' ' ' HIS . 75.5 t -61.9 -51.16 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 CA-C-N 114.274 -1.33 . . . . 0.0 108.098 176.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 464' ' ' TYR . . . . . 0.586 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 18.5 m-30 -51.28 -29.03 13.43 Favored 'General case' 0 N--CA 1.455 -0.195 0 O-C-N 124.551 1.157 . . . . 0.0 110.758 177.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.0 -39.78 19.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.657 0.742 . . . . 0.0 109.76 -176.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.594 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.6 mt -57.89 -55.84 19.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 114.481 -1.236 . . . . 0.0 112.113 176.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.764 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -100.22 -10.51 21.29 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 -172.667 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . 0.657 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 94.24 32.06 7.64 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 119.238 -1.458 . . . . 0.0 114.259 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 469' ' ' LEU . . . . . 0.764 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 4.3 mt -89.2 158.85 17.73 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 117.827 0.814 . . . . 0.0 110.828 174.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . 0.464 HD21 HG23 ' A' ' 476' ' ' ILE . 10.8 p30 -105.8 -178.04 3.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.983 171.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -55.35 -27.42 47.12 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -173.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -85.82 7.32 24.33 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.767 0.318 . . . . 0.0 111.406 -170.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 473' ' ' GLY . . . . . 0.437 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 74.63 10.19 82.77 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.227 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -100.39 154.19 18.71 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 177.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 5.6 p -89.77 130.99 35.95 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.218 0.532 . . . . 0.0 111.221 -178.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 476' ' ' ILE . . . . . 0.657 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.8 pp . . . . . 0 C--N 1.323 -0.567 0 CA-C-O 121.564 0.697 . . . . 0.0 109.686 177.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 386' ' ' PHE . . . . . 0.541 ' CD1' HD21 ' B' ' 414' ' ' LEU . 2.1 t80 . . . . . 0 CA--C 1.539 0.544 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 387' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -39.86 -62.98 0.31 Allowed 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 124.427 3.418 . . . . 0.0 113.872 -175.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 388' ' ' MET . . . . . 0.481 ' C ' ' HB3' ' B' ' 393' ' ' ASN . 6.3 ttp 59.0 38.52 24.17 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 174.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 389' ' ' HIS . . . . . 0.592 ' N ' ' HB3' ' B' ' 393' ' ' ASN . 31.3 m170 51.71 -97.01 0.05 Allowed 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 121.426 0.631 . . . . 0.0 110.268 -176.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -151.8 23.96 0.67 Allowed 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 171.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 391' ' ' LEU . . . . . 0.455 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.4 pt? -175.75 -47.78 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.357 -172.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 392' ' ' GLY . . . . . 0.504 ' CA ' HD13 ' B' ' 395' ' ' ILE . . . -173.2 56.48 0.15 Allowed Glycine 0 CA--C 1.525 0.685 0 C-N-CA 119.477 -1.344 . . . . 0.0 114.778 -172.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 393' ' ' ASN . . . . . 0.592 ' HB3' ' N ' ' B' ' 389' ' ' HIS . 0.0 OUTLIER -61.8 -37.62 85.06 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-N 117.649 0.725 . . . . 0.0 109.046 174.216 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 394' ' ' VAL . . . . . 0.594 HG23 ' N ' ' B' ' 395' ' ' ILE . 1.0 OUTLIER -57.18 -49.4 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 CA-C-N 113.642 -1.617 . . . . 0.0 107.094 179.02 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 395' ' ' ILE . . . . . 0.594 ' N ' HG23 ' B' ' 394' ' ' VAL . 3.6 mp -57.68 -52.72 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.315 0 CA-C-O 117.842 -1.075 . . . . 0.0 113.625 -174.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 396' ' ' LYS . . . . . 0.644 ' O ' HG22 ' B' ' 399' ' ' VAL . 0.0 OUTLIER -62.57 -49.74 74.07 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 121.991 2.178 . . . . 0.0 112.032 -174.666 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.06 -44.58 62.8 Favored Glycine 0 N--CA 1.435 -1.405 0 C-N-CA 119.979 -1.105 . . . . 0.0 110.933 -176.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 398' ' ' ILE . . . . . 0.663 ' CD1' HD12 ' B' ' 410' ' ' LEU . 28.5 mt -71.0 -33.84 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -179.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 399' ' ' VAL . . . . . 0.644 HG22 ' O ' ' B' ' 396' ' ' LYS . 17.2 m -63.42 -39.72 86.37 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 C-N-CA 118.753 -1.179 . . . . 0.0 108.483 -174.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -70.51 -37.98 74.24 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 175.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 401' ' ' GLN . . . . . 0.461 HE21 ' HB3' ' B' ' 401' ' ' GLN . 3.3 mm100 -88.09 -48.61 7.61 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -171.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 402' ' ' GLU . . . . . 0.406 ' HB3' ' HB ' ' B' ' 406' ' ' THR . 1.2 tm-20 -118.14 -19.89 8.86 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.216 -170.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 106.26 160.73 22.44 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.549 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 404' ' ' VAL . . . . . 0.631 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.2 m -54.19 -45.41 66.77 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.886 0 N-CA-C 114.568 1.322 . . . . 0.0 114.568 -175.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 405' ' ' ALA . . . . . 0.483 ' HB2' HG23 ' B' ' 457' ' ' ILE . . . -63.2 -31.18 72.26 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 119.819 -0.753 . . . . 0.0 112.43 -177.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 406' ' ' THR . . . . . 0.703 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 92.0 m -76.78 -42.17 41.85 Favored 'General case' 0 C--O 1.221 -0.4 0 O-C-N 121.682 -0.636 . . . . 0.0 110.226 173.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 407' ' ' ALA . . . . . 0.472 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.89 -36.68 75.06 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 122.204 1.002 . . . . 0.0 109.306 176.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 408' ' ' TYR . . . . . 0.631 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -66.5 -51.69 54.01 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 113.474 -1.694 . . . . 0.0 109.576 176.772 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 409' ' ' THR . . . . . 0.516 HG22 HD22 ' B' ' 410' ' ' LEU . 17.3 m -55.18 -47.29 75.42 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.447 178.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 410' ' ' LEU . . . . . 0.703 ' HG ' ' O ' ' B' ' 406' ' ' THR . 15.2 mt -72.65 -35.75 67.83 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -174.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.4 -34.72 76.13 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.196 -1.002 . . . . 0.0 110.951 172.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 412' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -69.56 -47.03 65.01 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-O 120.64 0.257 . . . . 0.0 111.612 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 413' ' ' MET . . . . . 0.93 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.9 OUTLIER -71.43 -45.27 63.1 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 118.848 -1.141 . . . . 0.0 111.792 -179.459 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 414' ' ' LEU . . . . . 0.93 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 11.7 mt -69.87 -46.39 65.6 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -177.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 415' ' ' SER . . . . . 0.453 ' HB2' ' SD ' ' B' ' 388' ' ' MET . 8.4 t -99.74 16.58 23.12 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.388 0.613 . . . . 0.0 110.515 -172.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 416' ' ' GLY . . . . . 0.421 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 75.84 -176.66 50.81 Favored Glycine 0 N--CA 1.436 -1.361 0 C-N-CA 120.359 -0.924 . . . . 0.0 111.699 -179.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -80.66 23.11 0.54 Allowed 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.222 0.534 . . . . 0.0 111.397 -172.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 418' ' ' ASN . . . . . 0.421 ' H ' ' C ' ' B' ' 416' ' ' GLY . 4.6 m-20 -71.59 76.74 0.81 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.47 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 419' ' ' TYR . . . . . 0.492 ' CD1' ' HB3' ' B' ' 453' ' ' ALA . 21.1 p90 -55.65 -38.15 69.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.66 178.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -55.54 -42.91 75.27 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.952 178.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.73 -49.06 64.57 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.354 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 422' ' ' VAL . . . . . 0.469 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.2 OUTLIER -65.78 -39.29 84.37 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.364 -177.872 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 423' ' ' SER . . . . . 0.8 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 61.6 p -67.98 -37.88 82.03 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -178.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.86 -39.14 89.7 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.241 175.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 425' ' ' ILE . . . . . 0.539 HG22 HG23 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -72.35 -52.3 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 120.367 0.127 . . . . 0.0 111.145 -178.037 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 426' ' ' ILE . . . . . 0.548 ' CD1' HG21 ' B' ' 395' ' ' ILE . 1.2 mm -74.79 -23.42 17.68 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.969 0 O-C-N 122.095 -0.378 . . . . 0.0 110.594 -172.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 427' ' ' ARG . . . . . 0.8 ' HB2' ' O ' ' B' ' 423' ' ' SER . 1.5 tmt_? -54.59 -31.63 57.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.176 0.512 . . . . 0.0 111.134 -177.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.58 -12.19 67.36 Favored Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.501 -0.857 . . . . 0.0 111.141 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 429' ' ' TYR . . . . . 0.479 ' HD1' ' CG2' ' B' ' 395' ' ' ILE . 6.1 m-30 -111.77 -2.12 15.39 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.869 0.842 . . . . 0.0 108.797 -174.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 430' ' ' LEU . . . . . 0.546 ' HA ' HG13 ' B' ' 404' ' ' VAL . 0.0 OUTLIER -66.18 139.94 96.68 Favored Pre-proline 0 N--CA 1.442 -0.865 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.407 177.555 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 431' ' ' PRO . . . . . 0.694 ' CD ' HG12 ' B' ' 435' ' ' VAL . 77.2 Cg_exo -38.19 -75.03 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 124.633 3.555 . . . . 0.0 113.985 -173.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 432' ' ' GLY . . . . . 0.487 ' O ' HG11 ' B' ' 435' ' ' VAL . . . -130.1 -161.65 10.51 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 176.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 433' ' ' GLN . . . . . 0.551 ' O ' HG11 ' B' ' 436' ' ' VAL . 19.8 tp60 -71.38 -29.15 64.6 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 118.058 0.929 . . . . 0.0 110.506 176.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -66.74 -39.3 87.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.215 -0.448 . . . . 0.0 112.093 -175.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 435' ' ' VAL . . . . . 0.694 HG12 ' CD ' ' B' ' 431' ' ' PRO . 6.8 p -66.44 -45.21 89.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.117 0.484 . . . . 0.0 110.69 -177.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 436' ' ' VAL . . . . . 0.551 HG11 ' O ' ' B' ' 433' ' ' GLN . 0.2 OUTLIER -66.26 -31.75 55.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.091 177.124 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -68.16 -52.27 36.51 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -177.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 438' ' ' ALA . . . . . 0.685 ' O ' ' HD2' ' B' ' 442' ' ' ARG . . . -57.63 -40.51 79.36 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.139 177.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 439' ' ' LEU . . . . . 0.598 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 1.9 tm? -67.99 -48.22 66.38 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -178.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.97 -34.76 73.71 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.093 175.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 441' ' ' GLN . . . . . 0.509 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 4.5 mm-40 -53.75 -49.66 67.7 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.967 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 442' ' ' ARG . . . . . 0.685 ' HD2' ' O ' ' B' ' 438' ' ' ALA . 0.0 OUTLIER -76.76 -25.45 53.42 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 119.221 -0.992 . . . . 0.0 113.308 174.441 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 443' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 67.4 mt -65.62 -27.41 68.37 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 118.656 0.662 . . . . 0.0 109.806 175.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -61.7 -38.02 86.33 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.954 176.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 34.5 mm-40 -78.74 -27.39 44.78 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.266 -1.334 . . . . 0.0 111.232 178.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 446' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 24.9 101.35 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 41.6 mt -58.09 -33.91 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 121.35 0.595 . . . . 0.0 111.292 -178.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 448' ' ' ASP . . . . . 0.448 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 8.1 m-20 -162.14 -159.62 0.61 Allowed 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -178.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 449' ' ' ASP . . . . . 0.481 ' CG ' ' H ' ' B' ' 450' ' ' GLN . 12.1 p-10 -85.4 -64.87 1.08 Allowed 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 168.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 450' ' ' GLN . . . . . 0.481 ' H ' ' CG ' ' B' ' 449' ' ' ASP . 0.0 OUTLIER -68.41 -26.05 65.35 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 179.128 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 451' ' ' THR . . . . . 0.465 ' HA ' ' HB2' ' B' ' 454' ' ' GLU . 10.0 m -71.58 -23.09 61.67 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.75 -175.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 452' ' ' ARG . . . . . . . . . . . . . 14.5 mtp180 -53.97 -54.0 45.02 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 171.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 453' ' ' ALA . . . . . 0.492 ' HB3' ' CD1' ' B' ' 419' ' ' TYR . . . -58.68 -49.09 78.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.361 -1.291 . . . . 0.0 112.596 174.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 454' ' ' GLU . . . . . 0.465 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 71.1 mm-40 -49.8 -36.93 28.14 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.218 0.533 . . . . 0.0 111.616 -177.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 32.3 p -118.15 15.0 14.08 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.448 -175.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 456' ' ' PHE . . . . . 0.532 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 0.8 OUTLIER -57.53 -47.27 82.44 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.136 0.493 . . . . 0.0 111.66 -171.266 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 457' ' ' ILE . . . . . 0.518 ' CG1' ' HB3' ' B' ' 408' ' ' TYR . 1.9 mp -77.15 -32.4 19.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.029 0.442 . . . . 0.0 110.853 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -57.87 -34.62 69.96 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.779 0.799 . . . . 0.0 109.113 171.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 459' ' ' HIS . . . . . 0.765 ' O ' HG23 ' B' ' 463' ' ' VAL . 64.1 m-70 -74.65 -29.47 61.27 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.55 -1.204 . . . . 0.0 110.748 177.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 460' ' ' LEU . . . . . 0.717 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -73.33 -34.52 65.72 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.91 0.862 . . . . 0.0 108.758 178.59 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 461' ' ' ASN . . . . . 0.447 ' O ' ' HB2' ' B' ' 464' ' ' TYR . 23.5 m-80 -73.26 -37.26 66.36 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.15 176.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 462' ' ' ALA . . . . . 0.597 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -55.66 -36.33 66.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.636 -1.165 . . . . 0.0 109.495 169.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 463' ' ' VAL . . . . . 0.765 HG23 ' O ' ' B' ' 459' ' ' HIS . 75.6 t -62.07 -51.09 76.64 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-N 114.293 -1.321 . . . . 0.0 107.983 176.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 464' ' ' TYR . . . . . 0.593 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 18.6 m-30 -51.47 -28.97 14.75 Favored 'General case' 0 C--N 1.332 -0.167 0 O-C-N 124.496 1.123 . . . . 0.0 110.644 177.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.94 -39.97 19.11 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.719 0.771 . . . . 0.0 109.712 -176.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 466' ' ' ILE . . . . . 0.597 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.6 mt -57.75 -55.7 19.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 114.35 -1.295 . . . . 0.0 112.249 176.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 467' ' ' LEU . . . . . 0.758 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -100.25 -10.58 21.18 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -172.833 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 468' ' ' GLY . . . . . 0.661 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 94.21 32.12 7.62 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 119.308 -1.425 . . . . 0.0 114.313 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 469' ' ' LEU . . . . . 0.758 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 4.3 mt -89.05 159.05 17.76 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 117.814 0.807 . . . . 0.0 110.742 174.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 470' ' ' ASN . . . . . 0.457 HD21 HG23 ' B' ' 476' ' ' ILE . 10.6 p30 -105.88 -178.11 3.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.001 170.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 471' ' ' ALA . . . . . . . . . . . . . . . -55.36 -27.47 47.56 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -173.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -85.67 7.18 24.38 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 122.159 -0.338 . . . . 0.0 111.438 -171.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 473' ' ' GLY . . . . . 0.441 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 74.87 9.96 83.51 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.322 -0.942 . . . . 0.0 111.306 -178.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -100.54 154.41 18.58 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 177.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 6.4 p -89.69 131.06 35.86 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.27 0.557 . . . . 0.0 111.291 -178.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 476' ' ' ILE . . . . . 0.661 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.8 pp . . . . . 0 C--N 1.323 -0.553 0 CA-C-O 121.539 0.685 . . . . 0.0 109.75 177.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 386' ' ' PHE . . . . . 0.686 ' CE2' HG12 ' A' ' 394' ' ' VAL . 1.4 t80 . . . . . 0 CA--C 1.534 0.363 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 386' ' ' PHE . 10.0 Cg_endo -48.17 -69.77 0.07 OUTLIER 'Trans proline' 0 N--CA 1.483 0.873 0 C-N-CA 124.722 3.615 . . . . 0.0 115.907 -173.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 388' ' ' MET . . . . . 0.523 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 32.6 mtt 72.73 156.24 0.17 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.379 0.671 . . . . 0.0 111.216 -172.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 389' ' ' HIS . . . . . 0.535 ' CG ' ' HB2' ' A' ' 393' ' ' ASN . 32.7 m170 -54.33 -59.67 4.37 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 175.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -177.55 19.96 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.786 -1.097 . . . . 0.0 108.687 175.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.565 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.3 pt? -170.11 -58.53 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.38 -167.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . 0.565 ' N ' ' HG ' ' A' ' 391' ' ' LEU . . . -172.73 51.31 0.17 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.372 -0.918 . . . . 0.0 113.181 -172.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . 0.535 ' HB2' ' CG ' ' A' ' 389' ' ' HIS . 0.6 OUTLIER -57.01 -38.56 73.27 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.138 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . 0.686 HG12 ' CE2' ' A' ' 386' ' ' PHE . 0.9 OUTLIER -55.88 -46.44 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 179.771 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.532 HG22 HG23 ' A' ' 425' ' ' ILE . 4.2 mp -57.82 -51.98 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 CA-C-O 117.902 -1.046 . . . . 0.0 113.047 -175.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . 0.687 ' HG3' ' CZ ' ' A' ' 429' ' ' TYR . 0.2 OUTLIER -62.49 -49.19 76.37 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 121.563 1.983 . . . . 0.0 111.816 -173.689 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -54.48 -44.87 77.71 Favored Glycine 0 N--CA 1.434 -1.471 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.0 -178.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . 0.58 HD13 ' CD1' ' A' ' 410' ' ' LEU . 45.0 mt -70.9 -33.87 53.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -177.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . 0.521 HG22 ' O ' ' A' ' 396' ' ' LYS . 10.9 m -64.23 -39.42 85.45 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 C-N-CA 118.667 -1.213 . . . . 0.0 108.324 -175.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -70.37 -35.29 73.44 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 175.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . 0.427 HE21 ' HB3' ' A' ' 401' ' ' GLN . 2.7 mm100 -89.42 -47.95 7.66 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -172.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . 0.441 ' HG3' ' HE1' ' B' ' 413' ' ' MET . 3.1 mm-40 -121.0 -21.23 6.58 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.795 -170.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 108.03 162.23 20.99 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.952 -0.642 . . . . 0.0 113.046 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . 0.683 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.5 m -53.75 -42.51 52.21 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.772 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -175.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . 0.508 ' HB1' HG21 ' A' ' 457' ' ' ILE . . . -68.86 -29.86 68.26 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 119.708 -0.797 . . . . 0.0 112.073 -175.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 406' ' ' THR . . . . . 0.688 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 90.6 m -77.76 -42.5 33.87 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.074 173.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.502 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.35 -37.91 76.14 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 122.084 0.945 . . . . 0.0 109.229 176.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 408' ' ' TYR . . . . . 0.683 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.4 -51.79 57.91 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 113.517 -1.674 . . . . 0.0 109.851 176.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 409' ' ' THR . . . . . 0.581 HG22 HD22 ' A' ' 410' ' ' LEU . 12.0 m -54.96 -47.08 75.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.586 178.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . 0.688 ' HG ' ' O ' ' A' ' 406' ' ' THR . 14.5 mt -72.24 -36.67 69.15 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.893 0.377 . . . . 0.0 110.213 -174.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.82 -34.94 80.06 Favored Glycine 0 N--CA 1.438 -1.182 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 172.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 412' ' ' MET . . . . . 0.461 ' HB2' ' O ' ' A' ' 409' ' ' THR . 0.6 OUTLIER -66.06 -46.58 77.25 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 115.61 -0.295 . . . . 0.0 111.5 177.252 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 413' ' ' MET . . . . . 0.78 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.0 OUTLIER -70.33 -55.22 9.69 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 118.788 -1.165 . . . . 0.0 111.94 -179.814 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . 0.78 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 6.9 mt -64.76 -43.71 92.43 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -172.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.424 ' HB2' ' HE2' ' A' ' 388' ' ' MET . 40.8 t -86.05 -20.43 28.8 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.677 0.751 . . . . 0.0 110.032 -177.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . 0.425 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 104.03 -175.65 23.2 Favored Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 -171.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 34.5 mm-40 -79.85 24.2 0.41 Allowed 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.186 0.517 . . . . 0.0 111.748 -171.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 418' ' ' ASN . . . . . 0.425 ' H ' ' C ' ' A' ' 416' ' ' GLY . 60.4 m-80 -71.09 75.04 0.67 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.393 178.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 419' ' ' TYR . . . . . 0.491 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 14.0 p90 -52.22 -37.07 53.97 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.947 175.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 420' ' ' GLN . . . . . 0.406 ' HG3' ' H ' ' A' ' 421' ' ' LEU . 2.5 pt20 -53.7 -47.18 70.76 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.95 176.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . 0.406 ' H ' ' HG3' ' A' ' 420' ' ' GLN . 0.0 OUTLIER -68.09 -48.58 65.13 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.192 -177.005 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . 0.457 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.3 OUTLIER -66.48 -40.35 86.26 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.345 -176.584 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.761 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 77.2 p -67.33 -37.08 82.73 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 -179.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -68.51 -38.67 86.81 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.249 175.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . 0.532 HG23 HG22 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -73.44 -51.92 23.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.461 0.172 . . . . 0.0 111.235 -178.452 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . 0.41 HD12 HG23 ' A' ' 395' ' ' ILE . 1.2 mm -74.53 -22.45 17.64 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.845 0 C-N-CA 122.614 0.366 . . . . 0.0 110.092 -171.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.761 ' HB2' ' O ' ' A' ' 423' ' ' SER . 0.5 OUTLIER -54.2 -30.78 51.01 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.227 0.537 . . . . 0.0 110.26 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.92 -4.89 78.19 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.808 179.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.687 ' CZ ' ' HG3' ' A' ' 396' ' ' LYS . 23.7 m-85 -119.09 -2.12 10.81 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 121.573 0.701 . . . . 0.0 110.081 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . 0.51 HD12 ' HD2' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -66.29 135.17 94.81 Favored Pre-proline 0 N--CA 1.439 -0.989 0 CA-C-N 114.664 -1.153 . . . . 0.0 108.881 178.84 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 431' ' ' PRO . . . . . 0.691 ' CD ' HG12 ' A' ' 435' ' ' VAL . 50.6 Cg_exo -36.69 -64.42 0.18 Allowed 'Trans proline' 0 CA--C 1.533 0.442 0 C-N-CA 124.723 3.615 . . . . 0.0 114.247 -172.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . 0.585 ' O ' HG11 ' A' ' 435' ' ' VAL . . . -144.17 -164.96 10.72 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 176.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . 0.522 ' O ' HG13 ' A' ' 436' ' ' VAL . 18.4 tp60 -70.47 -26.93 63.85 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 118.197 0.999 . . . . 0.0 110.347 178.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -67.46 -39.49 85.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.312 -0.404 . . . . 0.0 112.045 -177.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 435' ' ' VAL . . . . . 0.691 HG12 ' CD ' ' A' ' 431' ' ' PRO . 7.0 p -67.96 -44.99 84.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-O 120.953 0.406 . . . . 0.0 110.576 -178.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . 0.535 HG21 ' NE ' ' A' ' 427' ' ' ARG . 0.1 OUTLIER -66.06 -29.31 46.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.343 176.167 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 437' ' ' THR . . . . . 0.422 HG23 ' N ' ' A' ' 438' ' ' ALA . 1.0 OUTLIER -69.35 -52.55 26.13 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.635 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . 0.811 ' O ' ' HG2' ' A' ' 442' ' ' ARG . . . -58.03 -37.99 75.39 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.57 177.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 439' ' ' LEU . . . . . 0.572 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 2.1 tm? -70.16 -47.17 62.78 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -178.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.1 -40.3 76.75 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.21 174.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 441' ' ' GLN . . . . . 0.496 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 11.0 mm-40 -53.51 -49.89 66.58 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 123.751 0.82 . . . . 0.0 110.852 173.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . 0.811 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 1.6 mmp_? -55.89 -39.75 72.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.816 171.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 443' ' ' LEU . . . . . 0.572 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 39.2 mt -72.09 -31.15 65.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.788 0.328 . . . . 0.0 110.862 -178.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -57.25 -38.29 73.6 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.773 0.796 . . . . 0.0 110.081 171.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -76.44 -25.91 54.89 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.528 -1.214 . . . . 0.0 111.96 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 446' ' ' GLU . . . . . 0.472 ' O ' ' HG3' ' A' ' 446' ' ' GLU . 14.5 pt-20 1.92 105.43 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 125.35 1.46 . . . . 0.0 114.393 -178.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 38.4 mt -58.01 -35.54 52.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.877 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . 0.485 ' HB2' ' OG1' ' A' ' 451' ' ' THR . 26.1 m-20 -164.07 -176.55 4.56 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -178.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -66.36 -67.11 0.47 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 173.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.03 -26.88 64.25 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 451' ' ' THR . . . . . 0.485 ' OG1' ' HB2' ' A' ' 448' ' ' ASP . 10.7 m -72.43 -23.81 61.13 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.046 -0.661 . . . . 0.0 110.256 -177.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 19.7 ttm180 -54.62 -53.06 59.71 Favored 'General case' 0 N--CA 1.413 -2.324 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 171.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 453' ' ' ALA . . . . . 0.491 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -58.37 -47.27 84.38 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.673 172.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . 0.459 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 16.5 mm-40 -52.31 -38.5 58.64 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.26 0.552 . . . . 0.0 111.369 -176.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 27.3 p -112.26 12.48 20.31 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.362 -176.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . 0.525 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 1.0 OUTLIER -55.5 -46.93 76.9 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.037 0.446 . . . . 0.0 111.599 -173.052 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . 0.531 ' CG1' ' HB3' ' A' ' 408' ' ' TYR . 2.0 mp -77.77 -34.37 19.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.022 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -57.83 -34.57 69.82 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.946 0.879 . . . . 0.0 109.203 171.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . 0.73 ' O ' HG22 ' A' ' 463' ' ' VAL . 51.3 m-70 -74.0 -28.99 61.73 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.92 176.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . 0.706 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -73.69 -34.54 64.9 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.939 0.875 . . . . 0.0 108.717 179.016 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . 0.429 ' HA ' ' CD2' ' A' ' 464' ' ' TYR . 23.5 m-80 -73.19 -38.33 66.18 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.004 176.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 462' ' ' ALA . . . . . 0.635 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -56.45 -34.91 67.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.723 169.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.73 HG22 ' O ' ' A' ' 459' ' ' HIS . 61.5 t -59.96 -50.97 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 114.611 -1.177 . . . . 0.0 107.845 175.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 464' ' ' TYR . . . . . 0.587 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 17.2 m-30 -53.69 -28.26 32.68 Favored 'General case' 0 C--N 1.333 -0.14 0 O-C-N 124.395 1.06 . . . . 0.0 110.743 178.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.99 -41.34 20.87 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.691 0.758 . . . . 0.0 109.636 -178.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.635 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.5 mt -56.11 -55.35 18.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 114.266 -1.334 . . . . 0.0 112.345 176.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.767 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -102.16 -10.42 19.64 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -173.064 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . 0.561 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 93.86 31.4 8.19 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 119.396 -1.383 . . . . 0.0 114.348 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 469' ' ' LEU . . . . . 0.767 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 4.4 mt -88.59 164.55 15.33 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 118.01 0.905 . . . . 0.0 111.408 177.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 38.5 p30 -105.24 -176.83 3.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.827 170.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 471' ' ' ALA . . . . . 0.491 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -68.17 -13.67 62.4 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -176.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -89.02 -1.19 57.99 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 122.23 -0.294 . . . . 0.0 111.347 -175.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 78.47 12.58 84.12 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.334 -0.936 . . . . 0.0 110.898 -174.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -100.58 151.27 21.79 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 177.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 31.7 t -92.26 136.69 32.98 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.241 0.543 . . . . 0.0 111.023 -177.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 476' ' ' ILE . . . . . 0.561 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.3 pp . . . . . 0 C--N 1.319 -0.738 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.087 -178.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 386' ' ' PHE . . . . . 0.691 ' CE2' HG12 ' B' ' 394' ' ' VAL . 1.4 t80 . . . . . 0 CA--C 1.534 0.333 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 387' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -48.19 -69.9 0.07 OUTLIER 'Trans proline' 0 N--CA 1.484 0.921 0 C-N-CA 124.703 3.602 . . . . 0.0 115.872 -173.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 388' ' ' MET . . . . . 0.538 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 32.5 mtt 72.94 156.56 0.17 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.222 0.609 . . . . 0.0 111.162 -172.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 389' ' ' HIS . . . . . 0.547 ' CG ' ' HB2' ' B' ' 393' ' ' ASN . 32.7 m170 -54.58 -59.9 4.08 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 175.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -177.23 19.77 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.649 175.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 391' ' ' LEU . . . . . 0.557 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.3 pt? -169.97 -58.37 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.451 -167.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 392' ' ' GLY . . . . . 0.557 ' N ' ' HG ' ' B' ' 391' ' ' LEU . . . -172.81 51.51 0.17 Allowed Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.302 -0.951 . . . . 0.0 113.026 -172.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 393' ' ' ASN . . . . . 0.547 ' HB2' ' CG ' ' B' ' 389' ' ' HIS . 0.6 OUTLIER -57.01 -38.54 73.24 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.967 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 394' ' ' VAL . . . . . 0.691 HG12 ' CE2' ' B' ' 386' ' ' PHE . 0.9 OUTLIER -56.07 -46.45 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 395' ' ' ILE . . . . . 0.536 HG22 HG23 ' B' ' 425' ' ' ILE . 4.2 mp -57.63 -52.09 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 CA-C-O 117.973 -1.013 . . . . 0.0 113.04 -175.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 396' ' ' LYS . . . . . 0.692 ' HG3' ' CZ ' ' B' ' 429' ' ' TYR . 0.2 OUTLIER -62.49 -49.27 76.06 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 121.482 1.947 . . . . 0.0 111.8 -173.777 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -54.35 -44.89 76.35 Favored Glycine 0 N--CA 1.434 -1.487 0 C-N-CA 120.103 -1.046 . . . . 0.0 111.02 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 398' ' ' ILE . . . . . 0.573 HD13 ' CD1' ' B' ' 410' ' ' LEU . 45.0 mt -70.94 -33.81 53.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -177.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 399' ' ' VAL . . . . . 0.53 HG22 ' O ' ' B' ' 396' ' ' LYS . 10.8 m -64.22 -39.51 85.75 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 C-N-CA 118.592 -1.243 . . . . 0.0 108.346 -175.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -70.39 -35.26 73.36 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 175.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 401' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -89.43 -47.81 7.75 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -172.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 402' ' ' GLU . . . . . 0.428 ' HG3' ' HE1' ' A' ' 413' ' ' MET . 3.0 mm-40 -121.09 -21.3 6.5 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.771 -170.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 108.02 162.25 21.0 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.954 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 404' ' ' VAL . . . . . 0.683 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.5 m -53.83 -42.56 53.21 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.809 0 N-CA-C 114.698 1.369 . . . . 0.0 114.698 -175.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 405' ' ' ALA . . . . . 0.507 ' HB1' HG21 ' B' ' 457' ' ' ILE . . . -68.82 -29.9 68.34 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 119.77 -0.772 . . . . 0.0 111.991 -175.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 406' ' ' THR . . . . . 0.684 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 92.5 m -77.59 -42.53 34.82 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.161 173.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 407' ' ' ALA . . . . . 0.486 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.3 -37.76 75.7 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 122.182 0.992 . . . . 0.0 109.295 176.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 408' ' ' TYR . . . . . 0.683 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.56 -51.86 56.65 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 113.494 -1.685 . . . . 0.0 109.747 177.12 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 409' ' ' THR . . . . . 0.579 HG22 HD22 ' B' ' 410' ' ' LEU . 10.2 m -54.84 -47.13 74.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.636 178.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 410' ' ' LEU . . . . . 0.684 ' HG ' ' O ' ' B' ' 406' ' ' THR . 14.3 mt -72.05 -36.91 69.73 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.972 0.415 . . . . 0.0 110.263 -174.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.63 -34.87 78.37 Favored Glycine 0 N--CA 1.439 -1.135 0 C-N-CA 120.036 -1.078 . . . . 0.0 110.52 172.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 412' ' ' MET . . . . . 0.464 ' HB2' ' O ' ' B' ' 409' ' ' THR . 0.5 OUTLIER -66.26 -46.47 76.97 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 115.64 -0.28 . . . . 0.0 111.39 177.287 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 413' ' ' MET . . . . . 0.778 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.0 OUTLIER -70.34 -55.02 10.15 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 118.709 -1.197 . . . . 0.0 111.987 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 414' ' ' LEU . . . . . 0.778 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 6.9 mt -64.97 -43.7 91.76 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -172.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 415' ' ' SER . . . . . 0.421 ' HB2' ' HE2' ' B' ' 388' ' ' MET . 43.0 t -86.02 -20.48 28.78 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.79 0.805 . . . . 0.0 109.991 -177.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 416' ' ' GLY . . . . . 0.427 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 104.06 -175.91 23.34 Favored Glycine 0 N--CA 1.43 -1.758 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -171.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 35.4 mm-40 -79.85 24.45 0.39 Allowed 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.22 0.533 . . . . 0.0 111.808 -171.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 418' ' ' ASN . . . . . 0.427 ' H ' ' C ' ' B' ' 416' ' ' GLY . 62.1 m-80 -71.28 74.89 0.72 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.456 178.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 419' ' ' TYR . . . . . 0.487 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 14.4 p90 -52.09 -37.04 52.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.997 175.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -53.67 -47.39 70.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.904 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.98 -48.62 65.3 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.136 -177.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 422' ' ' VAL . . . . . 0.457 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.3 OUTLIER -66.51 -40.26 86.0 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.436 -176.476 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 423' ' ' SER . . . . . 0.763 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 77.7 p -67.39 -36.97 82.39 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 -179.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -68.58 -38.6 86.44 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.292 175.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 425' ' ' ILE . . . . . 0.536 HG23 HG22 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -73.37 -51.72 24.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 O-C-N 122.975 -0.132 . . . . 0.0 111.204 -178.318 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 426' ' ' ILE . . . . . 0.402 HD12 HG23 ' B' ' 395' ' ' ILE . 1.2 mm -74.87 -22.42 17.17 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.873 0 C-N-CA 122.627 0.371 . . . . 0.0 110.019 -171.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 427' ' ' ARG . . . . . 0.763 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.5 OUTLIER -54.26 -30.44 50.47 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.275 0.56 . . . . 0.0 110.294 179.85 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.88 -5.4 77.6 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.809 178.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 429' ' ' TYR . . . . . 0.692 ' CZ ' ' HG3' ' B' ' 396' ' ' LYS . 23.7 m-85 -118.9 -1.72 10.97 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 121.415 0.626 . . . . 0.0 110.152 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 430' ' ' LEU . . . . . 0.497 HD12 ' HD2' ' B' ' 431' ' ' PRO . 0.0 OUTLIER -66.42 135.38 94.72 Favored Pre-proline 0 N--CA 1.439 -0.992 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.855 178.777 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 431' ' ' PRO . . . . . 0.692 ' CD ' HG12 ' B' ' 435' ' ' VAL . 52.5 Cg_exo -36.89 -64.51 0.18 Allowed 'Trans proline' 0 CA--C 1.532 0.391 0 C-N-CA 124.716 3.611 . . . . 0.0 114.209 -172.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 432' ' ' GLY . . . . . 0.567 ' O ' HG11 ' B' ' 435' ' ' VAL . . . -144.09 -164.48 10.45 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 176.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 433' ' ' GLN . . . . . 0.518 ' O ' HG13 ' B' ' 436' ' ' VAL . 17.5 tp60 -70.67 -26.99 63.69 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 118.198 0.999 . . . . 0.0 110.369 178.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -67.64 -39.3 84.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.304 -0.407 . . . . 0.0 112.076 -177.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 435' ' ' VAL . . . . . 0.692 HG12 ' CD ' ' B' ' 431' ' ' PRO . 7.2 p -68.02 -45.08 84.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-O 120.962 0.411 . . . . 0.0 110.562 -178.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 436' ' ' VAL . . . . . 0.539 HG21 ' NE ' ' B' ' 427' ' ' ARG . 0.1 OUTLIER -66.01 -29.15 45.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.465 176.175 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 437' ' ' THR . . . . . 0.417 HG23 ' N ' ' B' ' 438' ' ' ALA . 1.0 OUTLIER -69.53 -52.54 25.44 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.575 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 438' ' ' ALA . . . . . 0.818 ' O ' ' HG2' ' B' ' 442' ' ' ARG . . . -57.94 -37.95 75.04 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.618 177.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 439' ' ' LEU . . . . . 0.587 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 2.1 tm? -70.18 -47.23 62.48 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -178.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.99 -40.37 76.45 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.2 174.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 441' ' ' GLN . . . . . 0.491 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 10.8 mm-40 -53.53 -49.9 66.62 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 123.827 0.851 . . . . 0.0 110.747 174.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 442' ' ' ARG . . . . . 0.818 ' HG2' ' O ' ' B' ' 438' ' ' ALA . 1.5 mmp_? -55.99 -39.66 72.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.754 171.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 443' ' ' LEU . . . . . 0.587 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 39.3 mt -72.08 -31.04 65.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.795 0.331 . . . . 0.0 110.816 -178.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -57.32 -38.43 74.05 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.769 0.795 . . . . 0.0 110.028 171.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -76.49 -25.91 54.75 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.457 -1.247 . . . . 0.0 111.842 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 446' ' ' GLU . . . . . 0.478 ' O ' ' HG3' ' B' ' 446' ' ' GLU . 14.4 pt-20 2.21 105.73 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 125.292 1.437 . . . . 0.0 114.377 -178.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 39.4 mt -58.59 -35.18 53.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.028 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 448' ' ' ASP . . . . . 0.479 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 23.6 m-20 -164.23 -176.52 4.48 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 -178.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -66.72 -66.84 0.5 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 173.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.14 -26.75 64.09 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 179.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 451' ' ' THR . . . . . 0.479 ' OG1' ' HB2' ' B' ' 448' ' ' ASP . 11.3 m -72.42 -23.73 61.12 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.244 -177.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 452' ' ' ARG . . . . . . . . . . . . . 19.6 ttm180 -54.61 -53.17 58.15 Favored 'General case' 0 N--CA 1.412 -2.37 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 171.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 453' ' ' ALA . . . . . 0.487 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -58.47 -47.15 84.98 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.703 172.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 454' ' ' GLU . . . . . 0.46 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 21.9 mm-40 -52.24 -38.69 58.82 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.305 0.574 . . . . 0.0 111.313 -176.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 25.8 p -112.12 12.46 20.52 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.272 -176.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 456' ' ' PHE . . . . . 0.523 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 1.0 OUTLIER -55.57 -46.91 77.13 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.044 0.45 . . . . 0.0 111.615 -172.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 457' ' ' ILE . . . . . 0.543 ' CG1' ' HB3' ' B' ' 408' ' ' TYR . 2.0 mp -77.85 -34.25 19.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.097 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -58.0 -34.39 69.95 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.969 0.89 . . . . 0.0 109.265 171.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 459' ' ' HIS . . . . . 0.725 ' O ' HG22 ' B' ' 463' ' ' VAL . 52.2 m-70 -73.87 -29.24 61.98 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.943 176.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 460' ' ' LEU . . . . . 0.704 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -73.62 -34.58 65.09 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.934 0.873 . . . . 0.0 108.775 179.192 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 461' ' ' ASN . . . . . 0.438 ' HA ' ' CD2' ' B' ' 464' ' ' TYR . 22.4 m-80 -73.2 -38.09 66.24 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.142 176.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 462' ' ' ALA . . . . . 0.617 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -56.6 -35.08 67.83 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.72 169.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 463' ' ' VAL . . . . . 0.725 HG22 ' O ' ' B' ' 459' ' ' HIS . 61.0 t -59.79 -51.11 76.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 175.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 464' ' ' TYR . . . . . 0.574 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 17.4 m-30 -53.48 -28.66 31.98 Favored 'General case' 0 C--O 1.225 -0.2 0 O-C-N 124.322 1.014 . . . . 0.0 110.648 178.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.72 -41.17 21.66 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.572 0.701 . . . . 0.0 109.701 -178.029 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 466' ' ' ILE . . . . . 0.617 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.5 mt -56.2 -55.66 17.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 114.409 -1.269 . . . . 0.0 112.21 176.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 467' ' ' LEU . . . . . 0.775 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -101.88 -10.6 19.71 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -172.941 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 468' ' ' GLY . . . . . 0.561 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 93.99 31.54 8.05 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 119.419 -1.372 . . . . 0.0 114.29 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 469' ' ' LEU . . . . . 0.775 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 4.4 mt -88.62 164.54 15.31 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 118.059 0.929 . . . . 0.0 111.39 177.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 38.2 p30 -105.22 -176.64 3.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.869 170.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 471' ' ' ALA . . . . . 0.495 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -68.47 -13.64 62.45 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -175.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -88.94 -1.58 58.17 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.705 0.288 . . . . 0.0 111.325 -175.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 473' ' ' GLY . . . . . . . . . . . . . . . 78.86 12.63 83.97 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.263 -0.97 . . . . 0.0 110.884 -174.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -100.59 151.61 21.4 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 32.1 t -92.56 136.55 33.12 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.239 0.542 . . . . 0.0 111.023 -177.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 476' ' ' ILE . . . . . 0.561 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.3 pp . . . . . 0 C--N 1.32 -0.709 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.115 -178.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 386' ' ' PHE . . . . . 0.56 ' CD1' HD23 ' A' ' 414' ' ' LEU . 3.4 t80 . . . . . 0 CA--C 1.53 0.189 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -47.06 -70.87 0.06 OUTLIER 'Trans proline' 0 CA--C 1.532 0.407 0 C-N-CA 123.961 3.107 . . . . 0.0 114.091 -174.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 388' ' ' MET . . . . . 0.458 ' HE3' ' HB2' ' A' ' 415' ' ' SER . 40.7 ttm 71.98 155.77 0.16 Allowed 'General case' 0 CA--C 1.547 0.841 0 CA-C-O 121.237 0.542 . . . . 0.0 111.893 175.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 389' ' ' HIS . . . . . 0.591 ' O ' ' HG2' ' A' ' 390' ' ' GLN . 2.7 m170 -76.6 27.72 0.13 Allowed 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.711 0.804 . . . . 0.0 112.917 -171.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . 0.591 ' HG2' ' O ' ' A' ' 389' ' ' HIS . 2.3 pt20 71.2 4.22 4.98 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.562 0.745 . . . . 0.0 109.902 -167.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -164.57 -43.59 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . 0.491 ' CA ' HD12 ' A' ' 395' ' ' ILE . . . -175.89 55.42 0.12 Allowed Glycine 0 C--O 1.223 -0.56 0 C-N-CA 118.088 -2.006 . . . . 0.0 115.88 -176.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . 0.567 ' HB3' ' N ' ' A' ' 389' ' ' HIS . 0.0 OUTLIER -60.89 -36.44 79.23 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 118.095 0.948 . . . . 0.0 108.644 176.294 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . 0.591 HG22 ' N ' ' A' ' 395' ' ' ILE . 1.5 m -58.54 -50.23 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 CA-C-N 113.289 -1.778 . . . . 0.0 107.834 178.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.591 ' N ' HG22 ' A' ' 394' ' ' VAL . 4.0 mp -57.98 -52.5 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 CA-C-O 117.985 -1.007 . . . . 0.0 113.614 -174.018 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . 0.597 ' HG3' ' CZ ' ' A' ' 429' ' ' TYR . 0.0 OUTLIER -64.06 -48.2 77.16 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 121.736 2.062 . . . . 0.0 111.493 -173.82 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -54.0 -45.33 71.94 Favored Glycine 0 N--CA 1.431 -1.636 0 C-N-CA 119.846 -1.169 . . . . 0.0 111.044 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . 0.669 ' CD1' HD12 ' A' ' 410' ' ' LEU . 33.2 mt -70.87 -33.87 53.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -178.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 396' ' ' LYS . 15.3 m -63.75 -39.43 85.34 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 C-N-CA 118.685 -1.206 . . . . 0.0 108.41 -174.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -71.11 -35.24 71.71 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 175.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 -88.69 -48.07 7.8 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -172.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -121.22 -21.36 6.42 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.601 -169.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 108.41 162.61 20.72 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.953 -0.642 . . . . 0.0 113.128 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . 0.68 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.5 m -53.67 -41.86 48.74 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.794 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -176.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . 0.494 ' HB1' HG21 ' A' ' 457' ' ' ILE . . . -68.88 -30.96 69.58 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 119.566 -0.854 . . . . 0.0 111.773 -176.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 406' ' ' THR . . . . . 0.709 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 89.0 m -77.38 -42.56 35.96 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.174 -0.611 . . . . 0.0 110.3 173.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.493 ' HB3' ' HA ' ' A' ' 395' ' ' ILE . . . -58.26 -37.22 74.53 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 122.054 0.931 . . . . 0.0 109.263 176.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 408' ' ' TYR . . . . . 0.68 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.77 -52.12 53.51 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 113.558 -1.655 . . . . 0.0 109.761 176.387 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 409' ' ' THR . . . . . 0.542 HG21 HD23 ' A' ' 410' ' ' LEU . 16.0 m -55.32 -47.37 75.74 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.635 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . 0.709 ' HG ' ' O ' ' A' ' 406' ' ' THR . 14.9 mt -72.65 -36.87 68.08 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -174.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.66 -34.96 78.96 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 119.83 -1.176 . . . . 0.0 110.641 173.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 412' ' ' MET . . . . . 0.405 ' HB2' ' O ' ' A' ' 409' ' ' THR . 0.3 OUTLIER -66.83 -48.67 68.2 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-O 120.597 0.236 . . . . 0.0 111.475 178.033 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 413' ' ' MET . . . . . 0.933 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.8 OUTLIER -71.35 -44.26 65.38 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 119.022 -1.071 . . . . 0.0 112.037 -178.552 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . 0.933 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 17.6 mt -69.02 -45.22 71.04 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -176.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.458 ' HB2' ' HE3' ' A' ' 388' ' ' MET . 45.5 t -86.45 -24.63 25.57 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.819 0.818 . . . . 0.0 110.099 -176.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . 0.433 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 108.93 -174.82 18.81 Favored Glycine 0 N--CA 1.429 -1.779 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -170.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -80.54 23.54 0.51 Allowed 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.244 0.545 . . . . 0.0 111.587 -171.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 418' ' ' ASN . . . . . 0.433 ' H ' ' C ' ' A' ' 416' ' ' GLY . 4.7 m-20 -72.0 75.28 0.92 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.064 179.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 419' ' ' TYR . . . . . 0.511 ' CD1' ' HB1' ' A' ' 453' ' ' ALA . 9.4 p90 -51.1 -39.03 55.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.493 176.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -55.32 -43.99 75.42 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.672 0.272 . . . . 0.0 110.99 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.37 -48.98 63.33 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.073 -178.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . 0.424 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -66.49 -40.67 87.06 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.522 0 C-N-CA 120.409 -0.517 . . . . 0.0 111.299 -177.021 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.783 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 77.6 p -68.09 -36.66 80.16 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -178.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -69.67 -37.95 77.25 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.253 175.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . 0.554 HG21 HG23 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -73.14 -51.92 24.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 O-C-N 122.82 -0.224 . . . . 0.0 111.048 -178.638 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . 0.514 ' O ' HD23 ' A' ' 430' ' ' LEU . 1.2 mm -74.09 -22.68 18.31 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.756 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -172.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.783 ' HB2' ' O ' ' A' ' 423' ' ' SER . 0.8 OUTLIER -54.61 -29.71 52.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.157 0.503 . . . . 0.0 110.484 -179.263 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -88.94 -6.57 71.89 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.693 178.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.597 ' CZ ' ' HG3' ' A' ' 396' ' ' LYS . 22.4 m-85 -117.27 -0.09 12.12 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.095 0.474 . . . . 0.0 110.221 -178.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . 0.538 HD12 ' HD2' ' A' ' 431' ' ' PRO . 0.1 OUTLIER -66.15 129.13 94.19 Favored Pre-proline 0 N--CA 1.441 -0.876 0 CA-C-N 115.353 -0.84 . . . . 0.0 108.857 177.584 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 431' ' ' PRO . . . . . 0.55 ' HG3' ' O ' ' A' ' 473' ' ' GLY . 73.4 Cg_exo -25.46 -69.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.757 1 C-N-CA 125.318 4.012 . . . . 0.0 114.911 179.68 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . 0.524 ' O ' HG11 ' A' ' 435' ' ' VAL . . . -144.07 -165.8 11.09 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 110.061 -1.215 . . . . 0.0 110.061 177.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . 0.496 ' O ' HG11 ' A' ' 436' ' ' VAL . 15.8 tp60 -69.62 -27.58 65.19 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 118.127 0.964 . . . . 0.0 110.449 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -67.32 -39.78 85.91 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -176.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 435' ' ' VAL . . . . . 0.524 HG11 ' O ' ' A' ' 432' ' ' GLY . 8.8 p -68.49 -44.26 83.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-O 121.107 0.479 . . . . 0.0 110.48 -177.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . 0.501 HG21 ' NE ' ' A' ' 427' ' ' ARG . 0.1 OUTLIER -66.95 -31.46 53.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.399 175.305 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.23 -52.45 40.81 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -178.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . 0.625 ' O ' ' HD2' ' A' ' 442' ' ' ARG . . . -57.74 -40.05 78.74 Favored 'General case' 0 N--CA 1.439 -1.023 0 O-C-N 123.883 0.739 . . . . 0.0 111.992 177.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 439' ' ' LEU . . . . . 0.578 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 2.0 tm? -68.3 -48.74 64.13 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -178.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.27 -34.97 72.9 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.442 -1.254 . . . . 0.0 111.135 175.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 441' ' ' GLN . . . . . 0.513 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 3.8 mm-40 -53.39 -49.88 66.31 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.106 -178.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . 0.685 ' HG3' ' CG ' ' A' ' 459' ' ' HIS . 0.0 OUTLIER -76.18 -25.03 54.78 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 119.361 -0.936 . . . . 0.0 113.248 174.898 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 443' ' ' LEU . . . . . 0.578 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 56.2 mt -65.3 -33.72 76.65 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.421 0.629 . . . . 0.0 109.718 175.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -70.57 -33.88 71.6 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.114 -178.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 445' ' ' GLN . . . . . 0.42 ' HG3' ' N ' ' A' ' 446' ' ' GLU . 0.0 OUTLIER -75.29 -31.15 60.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 114.673 -1.149 . . . . 0.0 108.321 178.43 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 446' ' ' GLU . . . . . 0.42 ' N ' ' HG3' ' A' ' 445' ' ' GLN . 34.9 tt0 48.09 98.47 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 114.812 -1.085 . . . . 0.0 113.2 171.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 60.9 mt -65.82 -35.67 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 121.667 0.746 . . . . 0.0 109.785 176.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . 0.516 ' HB2' ' OG1' ' A' ' 451' ' ' THR . 18.7 m-20 -169.83 -175.94 2.22 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 -177.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -72.16 -67.83 0.51 Allowed 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.6 174.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.46 -25.46 66.73 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 178.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 451' ' ' THR . . . . . 0.516 ' OG1' ' HB2' ' A' ' 448' ' ' ASP . 15.3 m -71.13 -23.02 62.0 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.702 -173.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . 0.505 ' HG3' ' O ' ' A' ' 448' ' ' ASP . 55.7 mtm180 -55.06 -54.15 46.75 Favored 'General case' 0 C--O 1.218 -0.553 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 170.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 453' ' ' ALA . . . . . 0.511 ' HB1' ' CD1' ' A' ' 419' ' ' TYR . . . -56.99 -48.03 79.42 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 124.278 0.986 . . . . 0.0 112.571 174.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . 0.451 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 63.9 mm-40 -51.34 -37.49 48.1 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.312 0.577 . . . . 0.0 111.693 -177.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 24.6 p -119.13 16.28 13.23 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.187 -175.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . 0.493 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.9 OUTLIER -55.19 -47.33 75.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.12 0.486 . . . . 0.0 111.728 -171.58 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . 0.522 ' CG1' ' HB3' ' A' ' 408' ' ' TYR . 1.9 mp -77.11 -34.43 21.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.257 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -57.54 -34.09 68.78 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.891 0.853 . . . . 0.0 109.288 171.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . 0.754 ' O ' HG22 ' A' ' 463' ' ' VAL . 52.8 m-70 -73.76 -29.33 62.15 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.357 -1.292 . . . . 0.0 110.926 176.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . 0.703 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -73.59 -33.96 64.86 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.863 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -73.05 -38.12 66.61 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.345 175.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 462' ' ' ALA . . . . . 0.616 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -55.82 -34.0 64.98 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.691 169.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.754 HG22 ' O ' ' A' ' 459' ' ' HIS . 62.6 t -62.8 -50.22 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 CA-C-N 114.363 -1.289 . . . . 0.0 107.996 177.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 464' ' ' TYR . . . . . 0.539 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 14.8 m-30 -53.8 -27.67 30.65 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.66 178.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.31 -40.83 20.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.635 0.731 . . . . 0.0 109.476 -178.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.616 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.6 mt -57.3 -55.63 19.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 114.174 -1.375 . . . . 0.0 112.196 176.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.757 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -102.51 -10.65 19.16 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -172.517 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 93.9 32.22 7.68 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 119.114 -1.517 . . . . 0.0 114.201 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 469' ' ' LEU . . . . . 0.757 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.5 mt -88.45 162.2 16.61 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 117.889 0.844 . . . . 0.0 111.378 176.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 37.7 p30 -100.72 -177.76 3.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.651 170.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 471' ' ' ALA . . . . . 0.483 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -69.43 -12.4 61.62 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.557 0.576 . . . . 0.0 112.557 -176.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -89.12 2.03 54.74 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.79 0.329 . . . . 0.0 111.219 -175.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 473' ' ' GLY . . . . . 0.55 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 76.42 12.6 84.15 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -175.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -101.67 150.43 23.12 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 177.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 30.7 t -86.59 138.15 31.93 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.025 -0.67 . . . . 0.0 109.819 175.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 476' ' ' ILE . . . . . 0.501 ' C ' HD12 ' A' ' 476' ' ' ILE . 2.4 pp . . . . . 0 C--N 1.314 -0.968 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.849 178.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 386' ' ' PHE . . . . . 0.561 ' CD1' HD23 ' B' ' 414' ' ' LEU . 3.3 t80 . . . . . 0 CA--C 1.53 0.199 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 387' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -46.98 -70.88 0.06 OUTLIER 'Trans proline' 0 N--CA 1.475 0.424 0 C-N-CA 123.914 3.076 . . . . 0.0 114.101 -174.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 388' ' ' MET . . . . . 0.463 ' HE3' ' HB2' ' B' ' 415' ' ' SER . 40.6 ttm 71.95 155.53 0.15 Allowed 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.265 0.555 . . . . 0.0 111.852 175.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 389' ' ' HIS . . . . . 0.589 ' O ' ' HG2' ' B' ' 390' ' ' GLN . 2.6 m170 -76.37 27.83 0.12 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.674 0.79 . . . . 0.0 112.941 -171.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 390' ' ' GLN . . . . . 0.589 ' HG2' ' O ' ' B' ' 389' ' ' HIS . 2.4 pt20 71.31 3.88 4.84 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.509 0.724 . . . . 0.0 109.884 -168.072 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 391' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -164.31 -43.55 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 392' ' ' GLY . . . . . 0.499 ' CA ' HD12 ' B' ' 395' ' ' ILE . . . -175.81 55.39 0.12 Allowed Glycine 0 C--N 1.336 0.576 0 C-N-CA 118.037 -2.03 . . . . 0.0 115.792 -176.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 393' ' ' ASN . . . . . 0.564 ' HB3' ' N ' ' B' ' 389' ' ' HIS . 0.0 OUTLIER -60.81 -36.6 79.47 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 118.217 1.008 . . . . 0.0 108.586 176.307 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 394' ' ' VAL . . . . . 0.598 HG22 ' N ' ' B' ' 395' ' ' ILE . 1.5 m -58.36 -50.16 79.56 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 CA-C-N 113.306 -1.77 . . . . 0.0 107.904 178.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 395' ' ' ILE . . . . . 0.598 ' N ' HG22 ' B' ' 394' ' ' VAL . 4.0 mp -58.07 -52.58 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 CA-C-O 118.005 -0.998 . . . . 0.0 113.568 -173.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 396' ' ' LYS . . . . . 0.597 ' HG3' ' CZ ' ' B' ' 429' ' ' TYR . 0.0 OUTLIER -63.96 -48.35 76.81 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 121.65 2.023 . . . . 0.0 111.464 -173.8 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.75 -45.31 69.49 Favored Glycine 0 N--CA 1.432 -1.583 0 C-N-CA 119.9 -1.143 . . . . 0.0 110.961 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 398' ' ' ILE . . . . . 0.668 ' CD1' HD12 ' B' ' 410' ' ' LEU . 33.4 mt -70.93 -33.98 54.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -178.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 399' ' ' VAL . . . . . 0.563 HG23 ' O ' ' B' ' 396' ' ' LYS . 15.3 m -63.73 -39.48 85.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 C-N-CA 118.796 -1.161 . . . . 0.0 108.475 -174.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -70.82 -35.59 72.55 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 175.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 401' ' ' GLN . . . . . 0.412 HE21 ' HB3' ' B' ' 401' ' ' GLN . 3.7 mm100 -88.7 -48.1 7.77 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -172.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 402' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -121.02 -21.48 6.48 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.727 -170.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 108.82 162.89 20.4 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.085 -0.579 . . . . 0.0 113.006 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 404' ' ' VAL . . . . . 0.676 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.5 m -53.76 -41.85 49.55 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.719 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 -176.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 405' ' ' ALA . . . . . 0.517 ' HB1' HG21 ' B' ' 457' ' ' ILE . . . -68.9 -30.7 69.24 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 119.797 -0.761 . . . . 0.0 111.855 -176.038 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 406' ' ' THR . . . . . 0.71 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 90.7 m -77.81 -42.78 32.61 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.068 174.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 407' ' ' ALA . . . . . 0.479 ' HB3' ' HA ' ' B' ' 395' ' ' ILE . . . -58.33 -37.13 74.5 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 122.078 0.942 . . . . 0.0 109.18 176.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 408' ' ' TYR . . . . . 0.676 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -66.0 -52.08 52.52 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 113.595 -1.639 . . . . 0.0 109.725 176.43 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 409' ' ' THR . . . . . 0.541 HG21 HD23 ' B' ' 410' ' ' LEU . 15.9 m -55.33 -47.31 75.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.675 179.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 410' ' ' LEU . . . . . 0.71 ' HG ' ' O ' ' B' ' 406' ' ' THR . 15.0 mt -72.71 -36.82 67.89 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -174.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.67 -34.81 78.43 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 119.868 -1.158 . . . . 0.0 110.629 173.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 412' ' ' MET . . . . . 0.401 ' HB2' ' O ' ' B' ' 409' ' ' THR . 0.3 OUTLIER -67.05 -48.52 68.04 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-O 120.634 0.254 . . . . 0.0 111.387 178.19 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 413' ' ' MET . . . . . 0.925 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.8 OUTLIER -71.47 -44.29 65.02 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 119.009 -1.076 . . . . 0.0 112.16 -178.706 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 414' ' ' LEU . . . . . 0.925 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 17.7 mt -68.93 -45.5 70.65 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -176.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 415' ' ' SER . . . . . 0.463 ' HB2' ' HE3' ' B' ' 388' ' ' MET . 47.0 t -86.05 -24.88 26.18 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.641 0.734 . . . . 0.0 110.004 -176.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 416' ' ' GLY . . . . . 0.421 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 109.17 -174.57 18.37 Favored Glycine 0 N--CA 1.43 -1.734 0 N-CA-C 109.731 -1.347 . . . . 0.0 109.731 -170.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -80.83 23.31 0.55 Allowed 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.287 0.565 . . . . 0.0 111.535 -171.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 418' ' ' ASN . . . . . 0.421 ' H ' ' C ' ' B' ' 416' ' ' GLY . 4.7 m-20 -71.94 75.13 0.9 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.102 179.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 419' ' ' TYR . . . . . 0.517 ' CD1' ' HB1' ' B' ' 453' ' ' ALA . 9.1 p90 -51.04 -38.94 54.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.572 176.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -55.37 -43.95 75.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.737 0.304 . . . . 0.0 111.092 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.29 -48.98 63.53 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.11 -178.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 422' ' ' VAL . . . . . 0.424 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.2 OUTLIER -66.46 -40.84 87.51 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.278 -176.959 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 423' ' ' SER . . . . . 0.782 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 77.3 p -67.97 -36.63 80.37 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -178.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -69.62 -38.22 77.97 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.225 176.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 425' ' ' ILE . . . . . 0.558 HG21 HG23 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -73.02 -51.8 24.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 O-C-N 122.865 -0.197 . . . . 0.0 111.083 -178.52 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 426' ' ' ILE . . . . . 0.503 ' O ' HD23 ' B' ' 430' ' ' LEU . 1.2 mm -74.08 -22.64 18.32 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.796 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -172.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 427' ' ' ARG . . . . . 0.782 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.8 OUTLIER -54.58 -29.85 52.62 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.21 0.529 . . . . 0.0 110.561 -179.251 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -88.58 -7.25 72.22 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.729 178.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 429' ' ' TYR . . . . . 0.597 ' CZ ' ' HG3' ' B' ' 396' ' ' LYS . 22.3 m-85 -116.63 -0.26 12.44 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 121.271 0.557 . . . . 0.0 110.295 -178.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 430' ' ' LEU . . . . . 0.517 HD12 ' HD2' ' B' ' 431' ' ' PRO . 0.1 OUTLIER -66.08 129.04 94.19 Favored Pre-proline 0 N--CA 1.442 -0.842 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.867 177.807 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 431' ' ' PRO . . . . . 0.559 ' HG3' ' O ' ' B' ' 473' ' ' GLY . 75.1 Cg_exo -25.33 -68.86 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 125.283 3.989 . . . . 0.0 114.919 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 432' ' ' GLY . . . . . 0.528 ' O ' HG11 ' B' ' 435' ' ' VAL . . . -144.52 -165.82 11.22 Favored Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 177.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 433' ' ' GLN . . . . . 0.5 ' O ' HG11 ' B' ' 436' ' ' VAL . 15.5 tp60 -69.39 -27.74 65.56 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 118.156 0.978 . . . . 0.0 110.507 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -67.07 -39.89 86.95 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -176.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 435' ' ' VAL . . . . . 0.528 HG11 ' O ' ' B' ' 432' ' ' GLY . 8.8 p -68.66 -44.01 82.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-O 121.013 0.435 . . . . 0.0 110.558 -177.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 436' ' ' VAL . . . . . 0.5 HG11 ' O ' ' B' ' 433' ' ' GLN . 0.1 OUTLIER -66.99 -31.4 53.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.431 175.075 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.23 -52.52 40.05 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -178.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 438' ' ' ALA . . . . . 0.633 ' O ' ' HD2' ' B' ' 442' ' ' ARG . . . -57.9 -39.93 79.1 Favored 'General case' 0 N--CA 1.439 -1.01 0 O-C-N 123.902 0.751 . . . . 0.0 111.969 177.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 439' ' ' LEU . . . . . 0.593 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 2.0 tm? -68.36 -48.73 64.03 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -178.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.22 -35.02 72.89 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.484 -1.234 . . . . 0.0 111.202 175.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 441' ' ' GLN . . . . . 0.507 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 3.8 mm-40 -53.34 -50.04 65.84 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.052 -178.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 442' ' ' ARG . . . . . 0.7 ' HG3' ' CG ' ' B' ' 459' ' ' HIS . 0.0 OUTLIER -75.95 -25.11 55.62 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 119.377 -0.929 . . . . 0.0 113.198 174.892 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 443' ' ' LEU . . . . . 0.593 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 56.5 mt -65.3 -33.84 76.94 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.289 0.566 . . . . 0.0 109.558 175.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -70.37 -34.2 72.32 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.942 -178.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 445' ' ' GLN . . . . . 0.414 ' HG3' ' N ' ' B' ' 446' ' ' GLU . 0.0 OUTLIER -75.1 -31.07 61.06 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.294 178.699 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 446' ' ' GLU . . . . . 0.414 ' N ' ' HG3' ' B' ' 445' ' ' GLN . 34.6 tt0 48.09 98.69 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 114.818 -1.083 . . . . 0.0 113.143 171.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 61.1 mt -65.97 -35.79 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 121.712 0.768 . . . . 0.0 109.811 176.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 448' ' ' ASP . . . . . 0.513 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 17.1 m-20 -169.66 -176.02 2.3 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 -177.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -71.76 -67.77 0.51 Allowed 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.535 173.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.87 -25.34 66.36 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 451' ' ' THR . . . . . 0.513 ' OG1' ' HB2' ' B' ' 448' ' ' ASP . 15.9 m -71.1 -22.92 62.03 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.756 -173.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 452' ' ' ARG . . . . . 0.513 ' HG3' ' O ' ' B' ' 448' ' ' ASP . 55.9 mtm180 -55.21 -54.14 47.16 Favored 'General case' 0 C--O 1.219 -0.525 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 170.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 453' ' ' ALA . . . . . 0.517 ' HB1' ' CD1' ' B' ' 419' ' ' TYR . . . -56.93 -48.14 78.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.576 173.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 454' ' ' GLU . . . . . 0.454 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 65.1 mm-40 -51.18 -37.84 48.85 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.263 0.554 . . . . 0.0 111.572 -177.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 25.2 p -118.81 16.24 13.51 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.335 -175.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 456' ' ' PHE . . . . . 0.498 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 0.9 OUTLIER -55.15 -47.08 75.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.142 0.496 . . . . 0.0 111.747 -171.708 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 457' ' ' ILE . . . . . 0.534 ' CG1' ' HB3' ' B' ' 408' ' ' TYR . 1.9 mp -77.33 -34.3 20.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.198 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -57.68 -34.19 69.15 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.88 0.847 . . . . 0.0 109.234 172.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 459' ' ' HIS . . . . . 0.75 ' O ' HG22 ' B' ' 463' ' ' VAL . 51.5 m-70 -73.61 -29.25 62.27 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.981 176.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 460' ' ' LEU . . . . . 0.699 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -73.64 -33.96 64.75 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.765 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 461' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -72.94 -38.43 66.79 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.195 175.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 462' ' ' ALA . . . . . 0.624 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -55.78 -33.8 64.69 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.76 169.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 463' ' ' VAL . . . . . 0.75 HG22 ' O ' ' B' ' 459' ' ' HIS . 62.9 t -62.91 -50.15 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.008 177.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 464' ' ' TYR . . . . . 0.53 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 15.0 m-30 -53.79 -27.82 31.43 Favored 'General case' 0 C--N 1.332 -0.193 0 O-C-N 124.237 0.961 . . . . 0.0 110.599 178.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.27 -40.86 20.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.693 0.758 . . . . 0.0 109.359 -177.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 466' ' ' ILE . . . . . 0.624 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.6 mt -57.23 -55.6 19.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 114.305 -1.316 . . . . 0.0 112.19 176.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 467' ' ' LEU . . . . . 0.756 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -102.69 -10.63 19.04 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -172.389 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 468' ' ' GLY . . . . . . . . . . . . . . . 93.92 32.24 7.66 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 119.013 -1.565 . . . . 0.0 114.304 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 469' ' ' LEU . . . . . 0.756 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.5 mt -88.58 162.27 16.47 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 117.915 0.857 . . . . 0.0 111.249 177.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 37.6 p30 -100.86 -177.75 3.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.587 170.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 471' ' ' ALA . . . . . 0.485 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -69.81 -11.5 60.9 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -176.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -89.34 1.95 55.07 Favored 'General case' 0 C--N 1.32 -0.682 0 O-C-N 122.262 -0.273 . . . . 0.0 111.213 -176.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 473' ' ' GLY . . . . . 0.559 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 76.43 12.48 84.26 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 -175.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -101.61 150.56 22.97 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 32.3 t -86.81 137.7 32.2 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.147 -0.621 . . . . 0.0 109.893 175.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 476' ' ' ILE . . . . . 0.507 ' C ' HD12 ' B' ' 476' ' ' ILE . 2.4 pp . . . . . 0 C--N 1.315 -0.932 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.923 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 386' ' ' PHE . . . . . 0.496 ' CD1' HD21 ' A' ' 414' ' ' LEU . 2.9 t80 . . . . . 0 N--CA 1.451 -0.394 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -43.01 -75.36 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.821 3.014 . . . . 0.0 113.892 -175.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 388' ' ' MET . . . . . 0.527 ' HE2' ' HB2' ' A' ' 415' ' ' SER . 28.5 ttm 67.22 143.43 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.607 0 O-C-N 123.397 0.435 . . . . 0.0 110.305 -178.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 389' ' ' HIS . . . . . 0.619 ' H ' ' HB3' ' A' ' 393' ' ' ASN . 29.3 m170 -54.85 -79.24 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.694 0.759 . . . . 0.0 110.076 -174.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -153.46 19.35 0.55 Allowed 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 170.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.487 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.6 pt? -173.9 -48.54 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.837 -170.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . 0.494 ' CA ' HD11 ' A' ' 395' ' ' ILE . . . -172.48 53.88 0.17 Allowed Glycine 0 C--O 1.223 -0.593 0 C-N-CA 118.81 -1.662 . . . . 0.0 115.305 -171.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . 0.619 ' HB3' ' H ' ' A' ' 389' ' ' HIS . 0.0 OUTLIER -57.34 -38.06 73.51 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 118.361 1.081 . . . . 0.0 108.869 176.273 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . 0.543 HG23 ' N ' ' A' ' 395' ' ' ILE . 1.9 m -58.23 -49.52 81.48 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 CA-C-N 113.189 -1.823 . . . . 0.0 107.77 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.558 HG21 HG22 ' A' ' 425' ' ' ILE . 4.2 mp -58.26 -52.8 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 CA-C-O 117.97 -1.014 . . . . 0.0 113.462 -174.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . 0.622 ' HG3' ' CZ ' ' A' ' 429' ' ' TYR . 0.1 OUTLIER -63.91 -48.93 74.65 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 121.796 2.089 . . . . 0.0 112.024 -172.865 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -54.02 -45.26 72.36 Favored Glycine 0 N--CA 1.438 -1.181 0 C-N-CA 119.88 -1.153 . . . . 0.0 111.238 -178.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . 0.699 ' CD1' HD11 ' A' ' 410' ' ' LEU . 33.6 mt -71.04 -34.56 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -178.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . 0.571 HG22 ' O ' ' A' ' 396' ' ' LYS . 11.7 m -63.68 -39.68 86.25 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 C-N-CA 119.05 -1.06 . . . . 0.0 108.728 -173.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -67.4 -39.9 85.58 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 176.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -93.43 -50.73 5.3 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -170.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -108.87 -20.19 13.14 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.227 0.537 . . . . 0.0 110.461 -172.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 105.44 162.5 23.46 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.548 -0.751 . . . . 0.0 113.159 177.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . 0.63 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.5 m -52.98 -45.59 52.34 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.738 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -175.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . 0.473 ' HB3' HG23 ' A' ' 457' ' ' ILE . . . -64.93 -30.06 71.03 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 119.793 -0.763 . . . . 0.0 112.488 -177.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 406' ' ' THR . . . . . 0.697 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 86.2 m -77.45 -42.42 36.05 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 120.096 -0.642 . . . . 0.0 110.216 173.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.518 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.86 -37.23 76.04 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 122.252 1.025 . . . . 0.0 109.043 177.076 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 408' ' ' TYR . . . . . 0.63 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.31 -52.95 50.64 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 113.364 -1.744 . . . . 0.0 109.889 176.687 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 409' ' ' THR . . . . . 0.537 HG22 HD23 ' A' ' 410' ' ' LEU . 9.0 m -55.58 -47.17 76.88 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.395 -0.821 . . . . 0.0 112.557 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . 0.699 HD11 ' CD1' ' A' ' 398' ' ' ILE . 14.5 mt -72.4 -36.32 68.62 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.055 -175.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -60.0 -35.2 86.48 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 119.973 -1.108 . . . . 0.0 110.789 172.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -67.98 -46.55 71.05 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 115.812 -0.194 . . . . 0.0 111.399 178.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 413' ' ' MET . . . . . 0.891 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.4 OUTLIER -70.62 -48.95 52.49 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 118.834 -1.147 . . . . 0.0 111.821 179.691 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . 0.891 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 16.0 mt -68.38 -46.69 69.35 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -176.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.527 ' HB2' ' HE2' ' A' ' 388' ' ' MET . 14.6 t -92.9 -1.86 56.35 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.297 0.57 . . . . 0.0 110.063 -173.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . 0.444 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 93.1 -177.55 38.27 Favored Glycine 0 N--CA 1.434 -1.485 0 C-N-CA 120.395 -0.907 . . . . 0.0 110.916 -176.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -79.98 23.36 0.46 Allowed 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.126 0.488 . . . . 0.0 111.31 -172.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 418' ' ' ASN . . . . . 0.444 ' H ' ' C ' ' A' ' 416' ' ' GLY . 5.5 m-20 -71.61 76.0 0.81 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.612 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 419' ' ' TYR . . . . . 0.527 ' CD1' ' HB1' ' A' ' 453' ' ' ALA . 11.1 p90 -51.41 -38.55 54.07 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.366 176.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -55.29 -43.79 75.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.671 0.272 . . . . 0.0 110.919 178.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.47 -49.17 61.75 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.949 -177.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . 0.441 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.3 OUTLIER -66.84 -40.36 85.68 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.214 -176.954 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.732 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 79.2 p -66.98 -38.91 86.92 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.38 -39.5 91.62 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.255 176.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . 0.558 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -73.06 -50.82 29.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 121.223 -0.191 . . . . 0.0 111.032 -177.234 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . 0.539 ' O ' HD21 ' A' ' 430' ' ' LEU . 1.2 mm -74.96 -22.52 17.07 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.823 0 CA-C-O 120.886 0.374 . . . . 0.0 110.27 -172.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.732 ' HB2' ' O ' ' A' ' 423' ' ' SER . 0.8 OUTLIER -55.02 -30.13 58.88 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.217 0.532 . . . . 0.0 110.64 -179.008 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.74 -6.06 77.08 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.638 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.622 ' CZ ' ' HG3' ' A' ' 396' ' ' LYS . 22.9 m-85 -118.23 0.54 11.75 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 120.977 0.418 . . . . 0.0 110.665 -177.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . 0.539 HD21 ' O ' ' A' ' 426' ' ' ILE . 0.1 OUTLIER -65.71 128.2 93.63 Favored Pre-proline 0 N--CA 1.441 -0.907 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 179.032 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 431' ' ' PRO . . . . . 0.505 ' HD2' HD13 ' A' ' 430' ' ' LEU . 80.8 Cg_exo -23.87 -69.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.905 1 C-N-CA 125.514 4.143 . . . . 0.0 114.857 179.887 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . 0.506 ' O ' HG11 ' A' ' 435' ' ' VAL . . . -138.8 -166.9 10.78 Favored Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 174.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . 0.54 ' O ' HG13 ' A' ' 436' ' ' VAL . 50.3 tp60 -70.8 -26.88 63.52 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 118.241 1.021 . . . . 0.0 110.457 177.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -64.75 -39.51 93.75 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -177.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 435' ' ' VAL . . . . . 0.506 HG11 ' O ' ' A' ' 432' ' ' GLY . 7.5 p -68.72 -43.94 82.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-O 120.968 0.413 . . . . 0.0 110.501 -178.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . 0.54 HG13 ' O ' ' A' ' 433' ' ' GLN . 0.1 OUTLIER -67.15 -30.29 48.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.668 175.579 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 437' ' ' THR . . . . . 0.422 HG21 ' N ' ' A' ' 438' ' ' ALA . 0.9 OUTLIER -67.48 -51.91 45.6 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.936 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . 0.763 ' O ' ' HG2' ' A' ' 442' ' ' ARG . . . -57.0 -43.93 82.27 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.003 177.094 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 439' ' ' LEU . . . . . 0.619 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 2.1 tm? -64.69 -47.64 77.64 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 -176.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.86 -39.7 78.4 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.81 -1.086 . . . . 0.0 111.362 175.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 441' ' ' GLN . . . . . 0.581 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 9.2 mm-40 -55.59 -51.25 67.76 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 123.473 0.709 . . . . 0.0 110.83 175.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . 0.763 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -58.13 -33.81 69.55 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.798 173.174 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 443' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 57.1 mt -72.25 -36.6 69.1 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-O 120.865 0.364 . . . . 0.0 110.227 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -57.49 -37.58 73.18 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.607 0.717 . . . . 0.0 110.67 174.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -73.2 -26.77 61.29 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.238 177.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 446' ' ' GLU . . . . . 0.462 ' HB3' ' O ' ' A' ' 443' ' ' LEU . 7.4 pt-20 23.7 103.13 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 173.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 60.3 mt -62.21 -34.1 62.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.577 0.703 . . . . 0.0 110.13 176.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . 0.497 ' HB2' ' OG1' ' A' ' 451' ' ' THR . 17.8 m-20 -162.8 -159.43 0.56 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -84.45 -66.35 0.9 Allowed 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 171.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 450' ' ' GLN . . . . . 0.416 ' O ' ' HB3' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -70.91 -25.54 62.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.855 0.359 . . . . 0.0 111.895 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 451' ' ' THR . . . . . 0.497 ' OG1' ' HB2' ' A' ' 448' ' ' ASP . 12.4 m -67.4 -22.54 65.54 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 122.037 -0.414 . . . . 0.0 110.679 -178.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 66.4 mtm180 -54.99 -51.37 66.45 Favored 'General case' 0 C--O 1.216 -0.66 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 170.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 453' ' ' ALA . . . . . 0.527 ' HB1' ' CD1' ' A' ' 419' ' ' TYR . . . -53.41 -52.24 60.01 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 124.352 1.033 . . . . 0.0 112.293 173.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . 0.456 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 23.6 mm-40 -51.15 -32.44 23.11 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.255 0.55 . . . . 0.0 111.987 -178.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 28.7 p -119.69 14.36 12.6 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.972 -175.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . 0.513 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.8 OUTLIER -58.37 -47.57 83.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.383 -170.995 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . 0.509 ' CG1' ' HB3' ' A' ' 408' ' ' TYR . 1.9 mp -77.21 -31.42 18.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.08 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -56.47 -39.01 72.48 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 122.025 0.917 . . . . 0.0 108.689 170.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . 0.745 ' O ' HG23 ' A' ' 463' ' ' VAL . 50.3 m-70 -73.22 -28.07 61.97 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 114.179 -1.373 . . . . 0.0 110.381 -178.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . 0.727 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -74.46 -35.11 63.31 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.864 0.84 . . . . 0.0 108.886 178.391 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . 0.418 ' O ' ' HB2' ' A' ' 464' ' ' TYR . 23.6 m-80 -73.44 -37.67 65.77 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.92 0.866 . . . . 0.0 109.0 176.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 462' ' ' ALA . . . . . 0.631 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -56.61 -33.32 66.14 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.402 -1.272 . . . . 0.0 109.788 169.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.745 HG23 ' O ' ' A' ' 459' ' ' HIS . 63.2 t -62.19 -50.68 79.0 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.751 0 CA-C-N 114.555 -1.202 . . . . 0.0 107.804 175.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 464' ' ' TYR . . . . . 0.566 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 18.2 m-30 -53.27 -28.2 26.58 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 124.478 1.111 . . . . 0.0 110.38 178.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.63 -40.89 20.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.583 0.706 . . . . 0.0 109.676 -177.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.631 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.4 mt -56.61 -55.52 19.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.336 -1.302 . . . . 0.0 112.294 176.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.759 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -102.66 -10.01 19.59 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -171.985 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 93.57 32.31 7.76 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 119.242 -1.456 . . . . 0.0 114.237 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 469' ' ' LEU . . . . . 0.759 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.3 mt -88.67 165.64 14.63 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 117.862 0.831 . . . . 0.0 111.351 176.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 45.1 p30 -104.05 -178.77 3.75 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.559 170.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 471' ' ' ALA . . . . . 0.527 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -62.1 -21.58 65.1 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -177.229 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -88.17 5.33 41.93 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.418 -172.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 473' ' ' GLY . . . . . 0.453 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 74.92 15.38 81.01 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.346 -0.93 . . . . 0.0 111.047 -177.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -101.08 152.13 20.98 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 11.0 p -89.53 130.93 35.78 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.923 0.392 . . . . 0.0 110.978 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 476' ' ' ILE . . . . . . . . . . . . . 2.6 pp . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.309 -178.94 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 386' ' ' PHE . . . . . 0.503 ' CD1' HD21 ' B' ' 414' ' ' LEU . 3.0 t80 . . . . . 0 N--CA 1.451 -0.397 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 387' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -43.08 -75.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.786 2.99 . . . . 0.0 113.892 -175.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 388' ' ' MET . . . . . 0.531 ' HE2' ' HB2' ' B' ' 415' ' ' SER . 28.4 ttm 67.2 143.76 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.652 0 O-C-N 123.497 0.498 . . . . 0.0 110.155 -178.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 389' ' ' HIS . . . . . 0.622 ' H ' ' HB3' ' B' ' 393' ' ' ASN . 29.5 m170 -55.15 -79.15 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.542 0.687 . . . . 0.0 110.113 -174.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -153.27 19.33 0.56 Allowed 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 170.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 391' ' ' LEU . . . . . 0.485 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.5 pt? -173.86 -48.61 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.868 -170.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 392' ' ' GLY . . . . . 0.498 ' CA ' HD11 ' B' ' 395' ' ' ILE . . . -172.6 53.91 0.17 Allowed Glycine 0 CA--C 1.524 0.621 0 C-N-CA 118.796 -1.668 . . . . 0.0 115.215 -171.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 393' ' ' ASN . . . . . 0.622 ' HB3' ' H ' ' B' ' 389' ' ' HIS . 0.0 OUTLIER -57.29 -38.08 73.43 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 118.295 1.047 . . . . 0.0 108.865 176.228 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 394' ' ' VAL . . . . . 0.544 HG22 HD11 ' B' ' 398' ' ' ILE . 1.8 m -58.27 -49.39 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 CA-C-N 113.213 -1.812 . . . . 0.0 107.791 179.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 395' ' ' ILE . . . . . 0.556 HG21 HG22 ' B' ' 425' ' ' ILE . 4.2 mp -58.26 -52.91 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-O 117.849 -1.072 . . . . 0.0 113.441 -174.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 396' ' ' LYS . . . . . 0.619 ' HG3' ' CZ ' ' B' ' 429' ' ' TYR . 0.1 OUTLIER -63.96 -49.18 73.57 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 121.832 2.106 . . . . 0.0 111.93 -172.802 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.79 -45.15 70.22 Favored Glycine 0 N--CA 1.438 -1.193 0 C-N-CA 119.86 -1.162 . . . . 0.0 111.279 -178.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 398' ' ' ILE . . . . . 0.692 ' CD1' HD11 ' B' ' 410' ' ' LEU . 32.8 mt -71.07 -34.38 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -178.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 399' ' ' VAL . . . . . 0.576 HG22 ' O ' ' B' ' 396' ' ' LYS . 11.5 m -63.77 -39.93 87.18 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 C-N-CA 118.898 -1.121 . . . . 0.0 108.748 -173.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -67.34 -39.68 85.81 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 176.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 401' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -93.67 -50.69 5.27 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 -170.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 402' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -108.72 -20.31 13.12 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.191 0.519 . . . . 0.0 110.392 -173.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 105.29 162.65 23.62 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.663 -0.699 . . . . 0.0 113.25 177.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 404' ' ' VAL . . . . . 0.617 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.5 m -53.18 -45.36 54.48 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.792 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 -175.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 405' ' ' ALA . . . . . 0.472 ' HB3' HG23 ' B' ' 457' ' ' ILE . . . -65.21 -29.86 70.7 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 119.761 -0.775 . . . . 0.0 112.457 -177.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 406' ' ' THR . . . . . 0.697 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 85.6 m -77.46 -42.55 35.51 Favored 'General case' 0 C--O 1.222 -0.368 0 C-N-CA 120.191 -0.604 . . . . 0.0 110.238 173.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 407' ' ' ALA . . . . . 0.513 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.9 -37.11 75.86 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 122.128 0.966 . . . . 0.0 109.005 177.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 408' ' ' TYR . . . . . 0.617 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.44 -52.95 49.5 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 113.394 -1.73 . . . . 0.0 109.863 176.708 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 409' ' ' THR . . . . . 0.539 HG22 HD23 ' B' ' 410' ' ' LEU . 9.9 m -55.61 -47.08 77.13 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.51 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 410' ' ' LEU . . . . . 0.697 ' HG ' ' O ' ' B' ' 406' ' ' THR . 14.4 mt -72.42 -36.33 68.58 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.045 -175.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -59.84 -35.27 86.07 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 119.854 -1.165 . . . . 0.0 110.803 172.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 412' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -68.1 -46.48 70.85 Favored 'General case' 0 C--O 1.224 -0.289 0 CA-C-O 120.486 0.184 . . . . 0.0 111.414 178.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 413' ' ' MET . . . . . 0.882 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.4 OUTLIER -70.82 -48.25 55.08 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 118.847 -1.141 . . . . 0.0 112.038 179.662 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 414' ' ' LEU . . . . . 0.882 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 15.9 mt -68.92 -46.65 67.74 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -176.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 415' ' ' SER . . . . . 0.531 ' HB2' ' HE2' ' B' ' 388' ' ' MET . 13.9 t -93.09 -1.77 56.15 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.296 0.57 . . . . 0.0 110.091 -173.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 416' ' ' GLY . . . . . 0.435 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 93.07 -177.46 38.24 Favored Glycine 0 N--CA 1.435 -1.388 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -176.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -79.95 23.42 0.45 Allowed 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.169 0.509 . . . . 0.0 111.314 -172.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 418' ' ' ASN . . . . . 0.435 ' H ' ' C ' ' B' ' 416' ' ' GLY . 5.4 m-20 -71.6 75.87 0.81 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.567 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 419' ' ' TYR . . . . . 0.532 ' CD1' ' HB1' ' B' ' 453' ' ' ALA . 10.9 p90 -51.36 -38.52 53.66 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.387 176.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -55.23 -43.88 74.94 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.753 0.311 . . . . 0.0 110.966 177.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.56 -49.0 62.8 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.852 -177.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 422' ' ' VAL . . . . . 0.444 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.3 OUTLIER -66.8 -40.49 86.03 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.26 -177.069 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 423' ' ' SER . . . . . 0.764 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 79.5 p -66.95 -38.99 87.15 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.47 -39.16 91.28 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.186 176.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 425' ' ' ILE . . . . . 0.556 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -73.08 -51.37 26.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.593 0.196 . . . . 0.0 111.025 -177.445 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 426' ' ' ILE . . . . . 0.529 ' O ' HD21 ' B' ' 430' ' ' LEU . 1.1 mm -74.6 -22.51 17.56 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.808 0 CA-C-O 120.863 0.363 . . . . 0.0 110.242 -172.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 427' ' ' ARG . . . . . 0.764 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.8 OUTLIER -54.98 -30.34 58.95 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.242 0.544 . . . . 0.0 110.586 -178.893 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.57 -6.17 77.54 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.481 178.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 429' ' ' TYR . . . . . 0.619 ' CZ ' ' HG3' ' B' ' 396' ' ' LYS . 22.9 m-85 -118.17 0.75 11.83 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 120.996 0.427 . . . . 0.0 110.534 -177.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 430' ' ' LEU . . . . . 0.533 ' HA ' HG13 ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.72 128.18 93.62 Favored Pre-proline 0 N--CA 1.442 -0.861 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.929 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 431' ' ' PRO . . . . . 0.504 ' HD2' HD13 ' B' ' 430' ' ' LEU . 80.4 Cg_exo -23.67 -70.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 0.988 1 C-N-CA 125.478 4.119 . . . . 0.0 114.673 179.769 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 432' ' ' GLY . . . . . 0.498 ' O ' HG11 ' B' ' 435' ' ' VAL . . . -138.25 -166.38 10.65 Favored Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 175.11 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 433' ' ' GLN . . . . . 0.547 ' O ' HG13 ' B' ' 436' ' ' VAL . 50.1 tp60 -71.08 -26.85 63.24 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 118.352 1.076 . . . . 0.0 110.46 177.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -64.7 -39.7 94.1 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -177.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 435' ' ' VAL . . . . . 0.498 HG11 ' O ' ' B' ' 432' ' ' GLY . 7.6 p -68.66 -43.82 82.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 120.938 0.399 . . . . 0.0 110.543 -178.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 436' ' ' VAL . . . . . 0.547 HG13 ' O ' ' B' ' 433' ' ' GLN . 0.1 OUTLIER -67.48 -30.1 47.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.766 0.317 . . . . 0.0 110.56 175.669 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 437' ' ' THR . . . . . 0.428 HG21 ' N ' ' B' ' 438' ' ' ALA . 0.9 OUTLIER -67.47 -51.91 45.71 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 179.909 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 438' ' ' ALA . . . . . 0.758 ' O ' ' HG2' ' B' ' 442' ' ' ARG . . . -57.1 -43.96 82.73 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 124.089 0.868 . . . . 0.0 111.087 177.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 439' ' ' LEU . . . . . 0.623 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 2.1 tm? -64.77 -47.47 78.06 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -176.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.06 -39.52 78.7 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.293 175.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 441' ' ' GLN . . . . . 0.585 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 9.2 mm-40 -55.77 -51.31 67.87 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 123.447 0.699 . . . . 0.0 110.813 175.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 442' ' ' ARG . . . . . 0.758 ' HG2' ' O ' ' B' ' 438' ' ' ALA . 0.0 OUTLIER -58.08 -33.75 69.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.739 173.207 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 443' ' ' LEU . . . . . 0.623 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 56.6 mt -72.38 -36.2 68.65 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-O 120.927 0.394 . . . . 0.0 110.247 179.079 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -57.68 -37.76 74.0 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.642 174.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -72.99 -26.8 61.47 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.911 -1.04 . . . . 0.0 111.036 178.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 446' ' ' GLU . . . . . 0.456 ' HB3' ' O ' ' B' ' 443' ' ' LEU . 7.5 pt-20 23.79 103.31 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 174.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 60.7 mt -62.33 -34.17 62.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.556 0.693 . . . . 0.0 110.091 175.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 448' ' ' ASP . . . . . 0.491 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 15.9 m-20 -162.76 -159.31 0.55 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -84.5 -66.21 0.92 Allowed 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.588 -0.445 . . . . 0.0 109.852 171.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 450' ' ' GLN . . . . . 0.428 ' O ' ' HB3' ' B' ' 453' ' ' ALA . 0.0 OUTLIER -70.94 -25.67 62.84 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.828 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 451' ' ' THR . . . . . 0.491 ' OG1' ' HB2' ' B' ' 448' ' ' ASP . 12.2 m -67.3 -22.66 65.62 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.71 -178.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 452' ' ' ARG . . . . . . . . . . . . . 66.0 mtm180 -54.87 -51.54 65.6 Favored 'General case' 0 C--O 1.216 -0.687 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 170.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 453' ' ' ALA . . . . . 0.532 ' HB1' ' CD1' ' B' ' 419' ' ' TYR . . . -53.24 -51.94 60.58 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.338 173.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 454' ' ' GLU . . . . . 0.456 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 24.0 mm-40 -51.59 -32.19 27.72 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.128 -178.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 29.6 p -119.84 14.36 12.47 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.985 -175.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 456' ' ' PHE . . . . . 0.516 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 0.8 OUTLIER -58.26 -47.74 82.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.348 -170.98 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 457' ' ' ILE . . . . . 0.524 ' CG1' ' HB3' ' B' ' 408' ' ' TYR . 1.9 mp -77.04 -31.11 18.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.108 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -56.66 -39.16 73.25 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 170.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 459' ' ' HIS . . . . . 0.742 ' O ' HG23 ' B' ' 463' ' ' VAL . 49.5 m-70 -73.21 -27.99 61.92 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.126 -1.397 . . . . 0.0 110.4 -178.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 460' ' ' LEU . . . . . 0.722 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -74.54 -35.06 63.12 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.957 0.884 . . . . 0.0 108.975 178.163 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 461' ' ' ASN . . . . . 0.405 ' O ' ' HB2' ' B' ' 464' ' ' TYR . 23.7 m-80 -73.33 -37.63 66.05 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.886 0.85 . . . . 0.0 109.1 176.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 462' ' ' ALA . . . . . 0.641 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -56.73 -33.25 66.34 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.326 -1.306 . . . . 0.0 109.839 169.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 463' ' ' VAL . . . . . 0.742 HG23 ' O ' ' B' ' 459' ' ' HIS . 63.9 t -62.32 -50.79 78.5 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.799 0 CA-C-N 114.545 -1.207 . . . . 0.0 107.781 175.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 464' ' ' TYR . . . . . 0.56 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 18.1 m-30 -53.12 -28.18 24.36 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.53 178.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.66 -41.2 19.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.594 0.711 . . . . 0.0 109.587 -177.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 466' ' ' ILE . . . . . 0.641 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.5 mt -56.29 -55.66 17.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 114.396 -1.275 . . . . 0.0 112.399 176.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 467' ' ' LEU . . . . . 0.756 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -102.23 -10.39 19.61 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -172.248 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 468' ' ' GLY . . . . . . . . . . . . . . . 93.75 32.45 7.6 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 119.209 -1.472 . . . . 0.0 114.236 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 469' ' ' LEU . . . . . 0.756 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.3 mt -88.69 165.53 14.69 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 117.929 0.864 . . . . 0.0 111.243 176.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 45.6 p30 -103.9 -178.41 3.65 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.589 170.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 471' ' ' ALA . . . . . 0.522 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -62.66 -21.52 65.77 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -176.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -87.98 5.22 41.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.414 -172.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 473' ' ' GLY . . . . . 0.459 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 75.08 15.2 81.23 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.275 -0.964 . . . . 0.0 111.119 -177.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -101.07 151.97 21.17 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 10.3 p -89.48 131.1 35.69 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.05 0.452 . . . . 0.0 110.982 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 476' ' ' ILE . . . . . . . . . . . . . 2.6 pp . . . . . 0 C--N 1.327 -0.396 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.263 -178.828 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 386' ' ' PHE . . . . . 0.734 ' CE2' HG12 ' A' ' 394' ' ' VAL . 2.6 t80 . . . . . 0 CA--C 1.531 0.245 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -64.69 105.8 0.68 Allowed 'Trans proline' 0 N--CA 1.478 0.571 0 C-N-CA 123.788 2.992 . . . . 0.0 112.176 173.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 388' ' ' MET . . . . . 0.55 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 5.2 ttp -122.01 55.26 1.13 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.29 0.567 . . . . 0.0 111.289 -168.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 389' ' ' HIS . . . . . 0.564 ' CE1' ' HA ' ' A' ' 393' ' ' ASN . 39.2 m170 52.93 -98.9 0.08 Allowed 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.026 -172.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -148.55 17.12 1.02 Allowed 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 171.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.596 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.5 pt? -167.3 -62.54 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.84 -171.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . 0.596 ' N ' ' HG ' ' A' ' 391' ' ' LEU . . . -163.14 60.03 0.27 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 119.914 -1.136 . . . . 0.0 114.396 -172.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . 0.564 ' HA ' ' CE1' ' A' ' 389' ' ' HIS . 0.2 OUTLIER -57.48 -43.39 84.07 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.996 0.427 . . . . 0.0 109.861 174.192 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . 0.734 HG12 ' CE2' ' A' ' 386' ' ' PHE . 2.0 m -55.71 -45.91 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 -179.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.579 ' N ' HG23 ' A' ' 394' ' ' VAL . 3.7 mp -58.02 -52.72 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 CA-C-O 117.812 -1.09 . . . . 0.0 113.53 -174.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . 0.6 ' O ' HG22 ' A' ' 399' ' ' VAL . 0.0 OUTLIER -62.79 -49.62 74.25 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 121.952 2.16 . . . . 0.0 112.186 -174.756 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . 0.536 ' O ' ' HG3' ' A' ' 401' ' ' GLN . . . -53.1 -44.44 63.13 Favored Glycine 0 N--CA 1.433 -1.54 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.84 -176.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . 0.644 ' CD1' HD12 ' A' ' 410' ' ' LEU . 39.1 mt -71.52 -33.81 50.78 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -179.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . 0.6 HG22 ' O ' ' A' ' 396' ' ' LYS . 13.8 m -63.72 -39.88 86.99 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 C-N-CA 118.727 -1.189 . . . . 0.0 108.252 -174.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -63.58 -42.96 98.27 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 174.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . 0.536 ' HG3' ' O ' ' A' ' 397' ' ' GLY . 36.4 mt-30 -92.68 -48.17 6.72 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -169.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . 0.403 ' HB3' ' HB ' ' A' ' 406' ' ' THR . 2.8 mm-40 -114.38 -19.31 11.28 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.149 0.499 . . . . 0.0 111.494 -171.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 104.15 162.78 24.68 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.886 177.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . 0.635 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.7 m -53.72 -45.46 61.12 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.83 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -175.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . 0.473 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -64.87 -31.18 72.29 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 119.787 -0.765 . . . . 0.0 112.328 -176.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 406' ' ' THR . . . . . 0.678 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 85.5 m -76.75 -42.78 39.79 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.101 -0.639 . . . . 0.0 110.365 173.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.514 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.67 -36.4 74.12 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 122.016 0.912 . . . . 0.0 109.195 176.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 408' ' ' TYR . . . . . 0.635 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.83 -52.16 52.87 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 113.649 -1.614 . . . . 0.0 109.771 176.285 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 409' ' ' THR . . . . . 0.547 HG21 HD21 ' A' ' 410' ' ' LEU . 17.6 m -54.67 -47.62 73.38 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.562 178.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . 0.678 ' HG ' ' O ' ' A' ' 406' ' ' THR . 13.6 mt -72.84 -35.99 67.37 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.123 -174.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -59.41 -34.77 82.35 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 119.966 -1.111 . . . . 0.0 110.592 173.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 412' ' ' MET . . . . . 0.414 ' HB2' ' O ' ' A' ' 409' ' ' THR . 0.3 OUTLIER -65.91 -48.47 71.34 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 115.726 -0.237 . . . . 0.0 111.32 177.719 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 413' ' ' MET . . . . . 0.91 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.5 OUTLIER -71.64 -46.5 58.83 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 118.988 -1.085 . . . . 0.0 111.974 -179.508 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . 0.91 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 16.4 mt -68.69 -45.09 72.57 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -176.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.443 ' HB2' ' HE2' ' A' ' 388' ' ' MET . 33.9 t -86.57 -21.58 26.78 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.483 0.659 . . . . 0.0 110.176 -175.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . 0.455 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 107.55 -175.81 20.45 Favored Glycine 0 N--CA 1.429 -1.775 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -171.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -79.75 23.68 0.42 Allowed 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.598 0.713 . . . . 0.0 111.405 -172.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 418' ' ' ASN . . . . . 0.455 ' H ' ' C ' ' A' ' 416' ' ' GLY . 62.5 m-80 -71.83 74.77 0.87 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.687 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 419' ' ' TYR . . . . . 0.535 ' CD1' ' HB1' ' A' ' 453' ' ' ALA . 23.2 p90 -52.29 -37.32 55.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.764 174.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -53.82 -46.4 71.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.691 177.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . 0.41 ' O ' HD13 ' A' ' 425' ' ' ILE . 0.0 OUTLIER -68.96 -49.53 57.13 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.389 -177.837 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . 0.46 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -65.74 -39.09 83.83 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.144 -175.879 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.792 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 77.7 p -66.7 -39.24 88.0 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.793 -178.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -68.45 -38.63 86.99 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.136 176.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . 0.544 HG23 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.18 -52.27 25.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.456 0.17 . . . . 0.0 111.01 -177.259 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . 0.531 ' O ' HD22 ' A' ' 430' ' ' LEU . 1.1 mm -74.36 -22.75 17.96 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.897 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -173.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.792 ' HB2' ' O ' ' A' ' 423' ' ' SER . 1.1 tmt_? -54.64 -33.15 60.2 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.103 0.478 . . . . 0.0 110.699 -177.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -85.87 -10.8 74.98 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.148 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.489 ' HD1' ' CG2' ' A' ' 395' ' ' ILE . 9.7 m-30 -113.64 -0.14 14.42 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.421 0.629 . . . . 0.0 109.366 -174.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . 0.546 HD11 ' HD2' ' A' ' 431' ' ' PRO . 0.1 OUTLIER -66.02 129.5 94.26 Favored Pre-proline 0 N--CA 1.445 -0.718 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.291 178.267 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 431' ' ' PRO . . . . . 0.546 ' HD2' HD11 ' A' ' 430' ' ' LEU . 94.6 Cg_exo -23.72 -66.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.359 1.088 1 C-N-CA 125.768 4.312 . . . . 0.0 115.122 179.589 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . 0.49 ' O ' HG11 ' A' ' 435' ' ' VAL . . . -145.86 -166.41 11.95 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 177.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . 0.522 ' O ' HG12 ' A' ' 436' ' ' VAL . 17.0 tp60 -70.01 -27.43 64.67 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 117.904 0.852 . . . . 0.0 110.526 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -67.12 -40.97 86.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.995 -177.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 435' ' ' VAL . . . . . 0.49 HG11 ' O ' ' A' ' 432' ' ' GLY . 7.9 p -67.87 -43.43 86.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 121.004 0.431 . . . . 0.0 110.641 -177.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . 0.551 HG23 ' NE ' ' A' ' 427' ' ' ARG . 0.1 OUTLIER -66.38 -31.97 55.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.483 175.832 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.29 -52.45 40.4 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -178.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . 0.538 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -58.35 -38.7 77.73 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.225 177.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 439' ' ' LEU . . . . . 0.591 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 1.9 tm? -68.99 -48.53 62.87 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.89 -35.76 73.56 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.717 -1.128 . . . . 0.0 111.327 176.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 441' ' ' GLN . . . . . 0.436 ' O ' ' HG2' ' A' ' 445' ' ' GLN . 5.8 mm-40 -56.93 -51.35 69.5 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 123.484 0.714 . . . . 0.0 110.6 178.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 438' ' ' ALA . 0.1 OUTLIER -61.56 -33.4 73.8 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.514 174.795 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 443' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 56.6 mt -68.23 -38.52 81.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.136 0.493 . . . . 0.0 109.931 177.163 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -57.95 -36.11 72.07 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.63 174.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 445' ' ' GLN . . . . . 0.436 ' HG2' ' O ' ' A' ' 441' ' ' GLN . 29.1 mm-40 -72.96 -26.63 61.43 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.8 177.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 446' ' ' GLU . . . . . 0.402 ' HB3' ' O ' ' A' ' 443' ' ' LEU . 12.0 pt-20 32.44 104.33 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 172.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 47.0 mt -72.54 -34.67 48.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.464 0.65 . . . . 0.0 110.041 175.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . 0.401 ' HB2' ' CB ' ' A' ' 451' ' ' THR . 11.0 m-20 -165.84 -158.37 0.35 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 -177.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -88.12 -67.41 0.83 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 168.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.44 -25.84 66.93 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 451' ' ' THR . . . . . 0.488 ' HA ' ' HB2' ' A' ' 454' ' ' GLU . 9.9 m -71.35 -22.98 61.83 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.457 -176.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 71.3 mtt180 -54.87 -53.99 48.31 Favored 'General case' 0 C--O 1.217 -0.631 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 171.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 453' ' ' ALA . . . . . 0.535 ' HB1' ' CD1' ' A' ' 419' ' ' TYR . . . -56.33 -48.86 75.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.7 -1.136 . . . . 0.0 112.576 174.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . 0.488 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 31.4 mm-40 -52.22 -34.01 43.77 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.07 0.462 . . . . 0.0 111.758 -178.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 27.2 p -120.25 14.9 12.21 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.481 -176.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . 0.555 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.9 OUTLIER -56.07 -49.21 74.42 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.043 0.449 . . . . 0.0 111.484 -171.057 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . 0.524 ' CG1' ' HB3' ' A' ' 408' ' ' TYR . 1.9 mp -74.56 -32.04 28.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.063 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -58.16 -36.2 72.67 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.604 0.716 . . . . 0.0 109.518 171.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . 0.758 ' O ' HG21 ' A' ' 463' ' ' VAL . 87.3 m-70 -72.79 -29.15 63.04 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.048 177.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . 0.718 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -74.0 -34.92 64.35 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.887 0.851 . . . . 0.0 109.137 -179.916 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . 0.456 ' O ' ' HB2' ' A' ' 464' ' ' TYR . 24.3 m-80 -73.08 -38.07 66.54 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.911 0.863 . . . . 0.0 108.985 176.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 462' ' ' ALA . . . . . 0.616 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -57.07 -32.88 66.7 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.394 -1.275 . . . . 0.0 109.874 169.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.758 HG21 ' O ' ' A' ' 459' ' ' HIS . 60.2 t -62.63 -50.92 77.85 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.856 0 CA-C-N 114.699 -1.137 . . . . 0.0 107.958 175.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 464' ' ' TYR . . . . . 0.583 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 17.7 m-30 -52.07 -28.14 16.41 Favored 'General case' 0 N--CA 1.455 -0.182 0 O-C-N 124.353 1.033 . . . . 0.0 110.494 177.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.89 -39.08 20.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.787 0.803 . . . . 0.0 109.724 -178.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.616 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.6 mt -58.72 -55.85 20.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 114.357 -1.292 . . . . 0.0 112.189 176.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.747 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -101.16 -10.05 20.77 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -172.693 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . 0.527 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 93.77 30.84 8.62 Favored Glycine 0 CA--C 1.527 0.844 0 C-N-CA 119.646 -1.264 . . . . 0.0 114.169 179.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 469' ' ' LEU . . . . . 0.747 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.2 mt -88.69 159.5 17.79 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 117.847 0.823 . . . . 0.0 110.848 177.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . 0.483 HD21 HG23 ' A' ' 476' ' ' ILE . 13.9 p30 -105.32 -177.77 3.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.145 172.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -57.24 -26.18 60.34 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -174.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 -86.87 6.19 33.08 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 122.258 -0.277 . . . . 0.0 111.525 -171.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 473' ' ' GLY . . . . . 0.525 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 76.72 9.26 86.42 Favored Glycine 0 C--O 1.225 -0.447 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.204 -177.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -100.84 157.45 16.71 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 475' ' ' SER . . . . . 0.499 ' HA ' ' HA ' ' A' ' 469' ' ' LEU . 9.5 t -94.66 145.53 24.77 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.246 -0.582 . . . . 0.0 111.074 -178.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 476' ' ' ILE . . . . . 0.527 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.0 pp . . . . . 0 C--N 1.323 -0.57 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.035 178.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 386' ' ' PHE . . . . . 0.729 ' CE2' HG12 ' B' ' 394' ' ' VAL . 2.6 t80 . . . . . 0 CA--C 1.531 0.248 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 387' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -64.62 105.3 0.62 Allowed 'Trans proline' 0 N--CA 1.48 0.722 0 C-N-CA 123.801 3.001 . . . . 0.0 112.2 172.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 388' ' ' MET . . . . . 0.552 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 5.2 ttp -121.58 55.29 1.1 Allowed 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.428 0.632 . . . . 0.0 111.368 -168.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 389' ' ' HIS . . . . . 0.571 ' CE1' ' HA ' ' B' ' 393' ' ' ASN . 38.9 m170 52.78 -99.19 0.08 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.676 0.79 . . . . 0.0 109.908 -172.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -148.03 16.94 1.09 Allowed 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 171.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 391' ' ' LEU . . . . . 0.592 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.5 pt? -167.12 -62.58 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.92 -171.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 392' ' ' GLY . . . . . 0.592 ' N ' ' HG ' ' B' ' 391' ' ' LEU . . . -163.32 60.13 0.27 Allowed Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 119.861 -1.161 . . . . 0.0 114.343 -172.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 393' ' ' ASN . . . . . 0.571 ' HA ' ' CE1' ' B' ' 389' ' ' HIS . 0.2 OUTLIER -57.44 -43.47 83.95 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 174.257 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 394' ' ' VAL . . . . . 0.729 HG12 ' CE2' ' B' ' 386' ' ' PHE . 2.0 m -55.68 -45.95 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 -179.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 395' ' ' ILE . . . . . 0.586 ' N ' HG23 ' B' ' 394' ' ' VAL . 3.7 mp -58.07 -52.54 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-O 117.849 -1.072 . . . . 0.0 113.484 -174.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 396' ' ' LYS . . . . . 0.597 ' O ' HG22 ' B' ' 399' ' ' VAL . 0.0 OUTLIER -62.96 -49.74 73.54 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 121.986 2.175 . . . . 0.0 112.159 -174.84 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 397' ' ' GLY . . . . . 0.54 ' O ' ' HG3' ' B' ' 401' ' ' GLN . . . -52.95 -44.33 61.74 Favored Glycine 0 N--CA 1.435 -1.395 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.908 -176.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 398' ' ' ILE . . . . . 0.627 ' CD1' HD12 ' B' ' 410' ' ' LEU . 39.0 mt -71.66 -33.74 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 399' ' ' VAL . . . . . 0.597 HG22 ' O ' ' B' ' 396' ' ' LYS . 14.2 m -63.68 -39.67 86.21 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 C-N-CA 118.755 -1.178 . . . . 0.0 108.478 -174.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -64.03 -42.71 96.99 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 174.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 401' ' ' GLN . . . . . 0.54 ' HG3' ' O ' ' B' ' 397' ' ' GLY . 36.7 mt-30 -92.62 -48.22 6.71 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -169.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 402' ' ' GLU . . . . . 0.404 ' HB3' ' HB ' ' B' ' 406' ' ' THR . 2.9 mm-40 -114.29 -19.43 11.27 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.175 0.512 . . . . 0.0 111.539 -171.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 104.18 162.69 24.65 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.986 177.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 404' ' ' VAL . . . . . 0.625 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.6 m -53.63 -45.47 60.06 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.813 0 N-CA-C 114.463 1.282 . . . . 0.0 114.463 -175.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 405' ' ' ALA . . . . . 0.472 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -64.83 -31.32 72.5 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 119.81 -0.756 . . . . 0.0 112.312 -177.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 406' ' ' THR . . . . . 0.679 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 85.7 m -76.69 -42.98 39.58 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.169 -0.613 . . . . 0.0 110.187 173.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 407' ' ' ALA . . . . . 0.5 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.56 -36.41 73.88 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 122.158 0.98 . . . . 0.0 109.194 176.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 408' ' ' TYR . . . . . 0.625 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.88 -52.2 52.24 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 113.594 -1.639 . . . . 0.0 109.752 176.265 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 409' ' ' THR . . . . . 0.55 HG21 HD21 ' B' ' 410' ' ' LEU . 17.9 m -54.73 -47.57 73.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.545 179.021 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 410' ' ' LEU . . . . . 0.679 ' HG ' ' O ' ' B' ' 406' ' ' THR . 13.6 mt -72.85 -35.85 67.3 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.189 -174.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -59.42 -34.92 83.07 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 119.988 -1.101 . . . . 0.0 110.626 173.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 412' ' ' MET . . . . . 0.416 ' HB2' ' O ' ' B' ' 409' ' ' THR . 0.3 OUTLIER -65.78 -48.38 71.99 Favored 'General case' 0 C--O 1.223 -0.341 0 CA-C-N 115.629 -0.285 . . . . 0.0 111.411 177.715 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 413' ' ' MET . . . . . 0.91 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.5 OUTLIER -71.63 -46.38 59.28 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 119.058 -1.057 . . . . 0.0 111.994 -179.373 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 414' ' ' LEU . . . . . 0.91 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 16.5 mt -68.93 -45.16 71.53 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -176.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 415' ' ' SER . . . . . 0.456 ' HB2' ' HE2' ' B' ' 388' ' ' MET . 33.9 t -86.83 -21.34 26.48 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.634 0.731 . . . . 0.0 110.169 -175.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 416' ' ' GLY . . . . . 0.448 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 107.58 -175.86 20.46 Favored Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 -171.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -79.81 23.6 0.43 Allowed 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.486 0.66 . . . . 0.0 111.294 -172.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 418' ' ' ASN . . . . . 0.448 ' H ' ' C ' ' B' ' 416' ' ' GLY . 61.6 m-80 -71.81 74.75 0.86 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.696 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 419' ' ' TYR . . . . . 0.552 ' CD1' ' HB1' ' B' ' 453' ' ' ALA . 23.9 p90 -52.34 -37.29 55.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.748 174.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -53.7 -46.42 70.71 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.729 177.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 421' ' ' LEU . . . . . 0.416 ' O ' HD13 ' B' ' 425' ' ' ILE . 0.0 OUTLIER -69.02 -49.51 57.04 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.438 -177.806 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 422' ' ' VAL . . . . . 0.461 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.2 OUTLIER -65.9 -39.02 83.47 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.093 -175.852 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 423' ' ' SER . . . . . 0.812 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 78.1 p -66.73 -39.12 87.85 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.818 -178.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -68.62 -38.54 86.19 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.153 176.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 425' ' ' ILE . . . . . 0.54 HG23 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -72.21 -52.32 24.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 121.351 -0.14 . . . . 0.0 110.794 -177.282 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 426' ' ' ILE . . . . . 0.517 ' CD1' HG22 ' B' ' 395' ' ' ILE . 1.1 mm -74.29 -22.71 18.05 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.929 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -173.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 427' ' ' ARG . . . . . 0.812 ' HB2' ' O ' ' B' ' 423' ' ' SER . 1.2 tmt_? -54.58 -33.25 59.96 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.166 0.507 . . . . 0.0 110.69 -177.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -85.85 -10.71 75.22 Favored Glycine 0 N--CA 1.44 -1.043 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.222 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 429' ' ' TYR . . . . . 0.483 ' HD1' ' CG2' ' B' ' 395' ' ' ILE . 9.5 m-30 -113.97 0.23 14.31 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.468 0.652 . . . . 0.0 109.326 -174.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 430' ' ' LEU . . . . . 0.542 HD11 ' HD2' ' B' ' 431' ' ' PRO . 0.1 OUTLIER -66.36 129.4 94.17 Favored Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.302 178.211 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 431' ' ' PRO . . . . . 0.542 ' HD2' HD11 ' B' ' 430' ' ' LEU . 94.3 Cg_exo -23.98 -65.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.36 1.137 1 C-N-CA 125.707 4.271 . . . . 0.0 115.155 179.81 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 432' ' ' GLY . . . . . 0.495 ' O ' HG11 ' B' ' 435' ' ' VAL . . . -146.56 -166.28 12.11 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 176.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 433' ' ' GLN . . . . . 0.517 ' O ' HG12 ' B' ' 436' ' ' VAL . 15.9 tp60 -69.83 -27.33 64.77 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 117.869 0.834 . . . . 0.0 110.617 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -67.23 -41.02 86.38 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -177.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 435' ' ' VAL . . . . . 0.495 HG11 ' O ' ' B' ' 432' ' ' GLY . 8.0 p -67.81 -43.65 86.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-O 121.088 0.47 . . . . 0.0 110.683 -177.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 436' ' ' VAL . . . . . 0.545 HG23 ' NE ' ' B' ' 427' ' ' ARG . 0.1 OUTLIER -66.06 -32.23 57.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.444 175.653 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.12 -52.46 41.51 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -178.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 438' ' ' ALA . . . . . 0.539 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -58.33 -38.84 77.97 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.155 177.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 439' ' ' LEU . . . . . 0.592 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 2.0 tm? -68.88 -48.46 63.33 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.1 -35.6 73.69 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.279 176.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 441' ' ' GLN . . . . . 0.436 ' O ' ' HG2' ' B' ' 445' ' ' GLN . 5.7 mm-40 -56.85 -51.5 68.76 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 123.385 0.674 . . . . 0.0 110.556 178.185 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 442' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' B' ' 438' ' ' ALA . 0.1 OUTLIER -61.59 -33.21 73.49 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.58 174.956 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 443' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 56.6 mt -68.27 -38.83 82.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.127 0.489 . . . . 0.0 109.856 177.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -57.96 -35.56 71.34 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.628 174.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 445' ' ' GLN . . . . . 0.436 ' HG2' ' O ' ' B' ' 441' ' ' GLN . 29.3 mm-40 -73.26 -26.67 61.19 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.778 177.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 446' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 32.31 104.72 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 172.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 47.2 mt -72.82 -34.81 47.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.383 0.611 . . . . 0.0 109.975 175.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 448' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -165.87 -158.69 0.36 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -177.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -88.01 -67.27 0.84 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 169.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.53 -25.73 66.81 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 179.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 451' ' ' THR . . . . . 0.482 ' HA ' ' HB2' ' B' ' 454' ' ' GLU . 10.6 m -71.27 -23.11 61.91 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.421 -176.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 452' ' ' ARG . . . . . . . . . . . . . 70.9 mtt180 -54.67 -53.91 48.59 Favored 'General case' 0 C--O 1.217 -0.612 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 171.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 453' ' ' ALA . . . . . 0.552 ' HB1' ' CD1' ' B' ' 419' ' ' TYR . . . -56.48 -48.93 76.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.719 -1.128 . . . . 0.0 112.499 174.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 454' ' ' GLU . . . . . 0.482 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 31.9 mm-40 -52.23 -34.0 43.88 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.161 0.505 . . . . 0.0 111.626 -177.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 26.9 p -120.24 14.96 12.23 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.413 -176.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 456' ' ' PHE . . . . . 0.556 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 0.9 OUTLIER -56.13 -49.18 74.64 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.982 0.42 . . . . 0.0 111.495 -171.262 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 457' ' ' ILE . . . . . 0.539 ' CG1' ' HB3' ' B' ' 408' ' ' TYR . 1.9 mp -74.63 -31.96 28.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.0 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -58.26 -36.1 72.74 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.569 0.7 . . . . 0.0 109.418 171.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 459' ' ' HIS . . . . . 0.764 ' O ' HG21 ' B' ' 463' ' ' VAL . 87.4 m-70 -72.86 -29.18 62.99 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.175 177.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 460' ' ' LEU . . . . . 0.729 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -73.94 -34.95 64.51 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.901 0.857 . . . . 0.0 109.063 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 461' ' ' ASN . . . . . 0.426 ' O ' ' HB2' ' B' ' 464' ' ' TYR . 24.9 m-80 -73.3 -37.73 66.1 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.883 0.849 . . . . 0.0 109.075 176.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 462' ' ' ALA . . . . . 0.617 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -57.2 -32.99 67.05 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.832 169.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 463' ' ' VAL . . . . . 0.764 HG21 ' O ' ' B' ' 459' ' ' HIS . 60.9 t -62.41 -51.02 77.39 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.799 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 175.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 464' ' ' TYR . . . . . 0.576 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 17.7 m-30 -52.04 -28.06 15.91 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 124.405 1.066 . . . . 0.0 110.616 177.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.16 -38.85 20.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.698 0.761 . . . . 0.0 109.766 -177.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 466' ' ' ILE . . . . . 0.617 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.6 mt -58.85 -55.89 20.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 114.44 -1.255 . . . . 0.0 112.229 176.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 467' ' ' LEU . . . . . 0.747 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -100.95 -10.22 20.8 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 -172.772 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 468' ' ' GLY . . . . . 0.522 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 93.86 30.89 8.53 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 119.637 -1.268 . . . . 0.0 114.157 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 469' ' ' LEU . . . . . 0.747 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.2 mt -88.62 159.59 17.8 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 117.855 0.828 . . . . 0.0 110.846 177.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 470' ' ' ASN . . . . . 0.492 HD21 HG23 ' B' ' 476' ' ' ILE . 13.9 p30 -105.38 -178.05 3.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.107 172.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 471' ' ' ALA . . . . . . . . . . . . . . . -56.74 -26.58 57.58 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -174.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 -86.75 6.5 31.12 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 122.178 -0.326 . . . . 0.0 111.73 -171.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 473' ' ' GLY . . . . . 0.523 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 76.33 9.54 85.76 Favored Glycine 0 C--O 1.227 -0.319 0 C-N-CA 120.484 -0.865 . . . . 0.0 111.257 -177.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -100.94 157.65 16.58 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 176.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 475' ' ' SER . . . . . 0.504 ' HA ' ' HA ' ' B' ' 469' ' ' LEU . 9.9 t -95.05 145.3 25.06 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.074 -178.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 476' ' ' ILE . . . . . 0.522 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.0 pp . . . . . 0 C--N 1.322 -0.6 0 CA-C-O 121.618 0.723 . . . . 0.0 110.054 178.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 386' ' ' PHE . . . . . 0.524 ' CD1' HD22 ' A' ' 414' ' ' LEU . 1.3 t80 . . . . . 0 CA--C 1.538 0.5 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -42.98 -69.35 0.08 OUTLIER 'Trans proline' 0 N--CA 1.479 0.628 0 C-N-CA 124.265 3.31 . . . . 0.0 113.667 -176.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 388' ' ' MET . . . . . 0.542 ' SD ' ' HB2' ' A' ' 415' ' ' SER . 6.7 ttp 66.44 34.13 6.41 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 173.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 389' ' ' HIS . . . . . 0.46 ' CE1' ' HB2' ' A' ' 393' ' ' ASN . 36.6 m170 53.93 -95.17 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.327 0.584 . . . . 0.0 110.379 -177.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -149.63 18.87 0.92 Allowed 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 174.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.592 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.6 pt? -173.49 -54.96 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -169.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . 0.592 ' N ' ' HG ' ' A' ' 391' ' ' LEU . . . -167.57 47.08 0.24 Allowed Glycine 0 CA--C 1.525 0.669 0 C-N-CA 119.685 -1.245 . . . . 0.0 114.569 -169.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . 0.489 ' HB3' ' C ' ' A' ' 388' ' ' MET . 0.0 OUTLIER -54.95 -37.58 66.65 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 117.925 0.862 . . . . 0.0 109.495 175.87 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . 0.613 HG22 ' N ' ' A' ' 395' ' ' ILE . 1.5 m -57.45 -49.97 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 CA-C-N 113.824 -1.535 . . . . 0.0 107.603 178.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.613 ' N ' HG22 ' A' ' 394' ' ' VAL . 4.0 mp -57.96 -52.88 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 CA-C-O 118.013 -0.994 . . . . 0.0 113.544 -174.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . 0.634 ' HG3' ' CZ ' ' A' ' 429' ' ' TYR . 0.1 OUTLIER -64.7 -48.48 74.54 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 121.737 2.062 . . . . 0.0 111.664 -172.525 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.34 -45.49 65.26 Favored Glycine 0 N--CA 1.433 -1.517 0 C-N-CA 120.106 -1.045 . . . . 0.0 110.978 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . 0.675 ' CD1' HD13 ' A' ' 410' ' ' LEU . 35.4 mt -70.95 -33.86 53.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 -178.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 396' ' ' LYS . 11.4 m -63.44 -39.88 86.95 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.514 0 C-N-CA 118.73 -1.188 . . . . 0.0 108.539 -173.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -70.93 -37.09 72.88 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 176.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 4.2 mm100 -86.86 -48.26 8.34 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -171.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . 0.453 ' HG3' ' HE1' ' B' ' 413' ' ' MET . 3.0 mm-40 -119.43 -20.92 7.65 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.375 -171.027 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 107.48 161.95 21.47 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.879 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . 0.675 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.5 m -53.71 -41.79 48.79 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.784 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -175.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . 0.515 ' HB2' HG21 ' A' ' 457' ' ' ILE . . . -69.23 -29.33 67.25 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.916 -176.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 406' ' ' THR . . . . . 0.699 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 89.3 m -77.63 -42.79 33.6 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.206 -0.598 . . . . 0.0 110.137 172.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.484 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.42 -36.94 74.38 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 122.062 0.934 . . . . 0.0 109.355 176.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 408' ' ' TYR . . . . . 0.675 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.8 -52.13 53.22 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 113.619 -1.628 . . . . 0.0 109.767 176.372 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 409' ' ' THR . . . . . 0.534 HG21 HD23 ' A' ' 410' ' ' LEU . 17.7 m -55.53 -47.57 76.09 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.592 178.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . 0.699 ' HG ' ' O ' ' A' ' 406' ' ' THR . 15.0 mt -72.85 -35.11 67.17 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -174.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.66 -34.3 76.16 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.123 -1.037 . . . . 0.0 111.047 171.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -68.35 -49.51 59.78 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-O 120.527 0.203 . . . . 0.0 111.34 178.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 413' ' ' MET . . . . . 0.922 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.9 OUTLIER -71.18 -43.14 68.04 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 119.437 -0.905 . . . . 0.0 112.08 -177.474 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . 0.922 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 12.0 mt -73.99 -46.13 45.65 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 113.234 0.828 . . . . 0.0 113.234 -178.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.542 ' HB2' ' SD ' ' A' ' 388' ' ' MET . 3.7 t -100.1 17.55 20.85 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.361 0.6 . . . . 0.0 110.928 -170.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 78.87 178.31 50.45 Favored Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 120.285 -0.96 . . . . 0.0 111.768 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -81.72 21.17 0.85 Allowed 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.012 0.434 . . . . 0.0 111.642 -172.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 418' ' ' ASN . . . . . 0.435 ' HB3' ' HB3' ' A' ' 421' ' ' LEU . 6.3 m-20 -73.23 80.89 1.31 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.574 0.702 . . . . 0.0 111.021 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 419' ' ' TYR . . . . . 0.542 ' HB2' ' CE2' ' A' ' 456' ' ' PHE . 10.5 p90 -51.91 -38.24 55.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.761 176.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -55.58 -43.67 76.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.87 177.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . 0.435 ' HB3' ' HB3' ' A' ' 418' ' ' ASN . 0.0 OUTLIER -67.8 -48.54 66.01 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.264 -178.075 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . 0.469 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -65.89 -42.22 91.58 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 C-N-CA 120.421 -0.511 . . . . 0.0 111.189 -177.725 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.742 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 29.0 t -69.46 -34.99 75.2 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -178.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.54 -40.54 90.87 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.192 175.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . 0.566 HG23 HG22 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.81 -49.9 36.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-O 120.554 0.216 . . . . 0.0 110.763 -178.914 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 1.2 mm -74.31 -22.41 17.91 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.911 0 C-N-CA 123.055 0.542 . . . . 0.0 110.183 -172.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.742 ' HB2' ' O ' ' A' ' 423' ' ' SER . 0.3 OUTLIER -54.72 -28.82 50.83 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 123.031 0.533 . . . . 0.0 111.075 -178.718 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -90.15 -8.32 66.8 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.684 178.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.634 ' CZ ' ' HG3' ' A' ' 396' ' ' LYS . 21.5 m-85 -114.46 -2.86 13.1 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 121.667 0.746 . . . . 0.0 109.619 -178.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . 0.507 HD11 ' HD2' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -65.89 135.79 95.47 Favored Pre-proline 0 N--CA 1.437 -1.088 0 CA-C-N 114.339 -1.3 . . . . 0.0 108.657 178.325 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 431' ' ' PRO . . . . . 0.685 ' CD ' HG13 ' A' ' 435' ' ' VAL . 47.0 Cg_exo -36.42 -65.21 0.15 Allowed 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 124.614 3.543 . . . . 0.0 114.081 -172.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . 0.574 ' O ' HG12 ' A' ' 435' ' ' VAL . . . -141.94 -165.08 10.32 Favored Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 175.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . 0.551 ' O ' HG12 ' A' ' 436' ' ' VAL . 23.9 tp60 -70.26 -26.91 64.05 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 118.198 0.999 . . . . 0.0 110.331 177.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -66.29 -40.44 90.05 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -177.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 435' ' ' VAL . . . . . 0.685 HG13 ' CD ' ' A' ' 431' ' ' PRO . 7.0 p -68.14 -44.64 84.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-O 120.892 0.377 . . . . 0.0 110.785 -178.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . 0.551 HG12 ' O ' ' A' ' 433' ' ' GLN . 0.2 OUTLIER -65.43 -29.11 46.17 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 CA-C-O 121.057 0.456 . . . . 0.0 110.094 175.862 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 1.1 m -69.26 -52.92 22.87 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . 0.803 ' O ' ' HG2' ' A' ' 442' ' ' ARG . . . -58.77 -38.13 77.79 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.807 177.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 439' ' ' LEU . . . . . 0.568 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 2.2 tm? -69.91 -47.43 62.5 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.62 -39.67 77.44 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.38 174.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 441' ' ' GLN . . . . . 0.457 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 8.9 mm-40 -53.58 -49.54 67.53 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 123.788 0.835 . . . . 0.0 110.855 174.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . 0.803 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 0.7 OUTLIER -55.85 -39.43 71.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.607 172.034 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 443' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 37.1 mt -71.71 -35.56 70.25 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.025 0.44 . . . . 0.0 110.178 -178.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -58.05 -36.97 73.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.631 174.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -72.82 -28.03 62.31 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.616 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 446' ' ' GLU . . . . . 0.565 ' HB2' ' O ' ' A' ' 443' ' ' LEU . 31.6 tt0 29.75 96.49 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 172.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 42.1 mt -67.91 -35.31 71.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.202 0.525 . . . . 0.0 110.518 177.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . 0.592 ' O ' ' HG3' ' A' ' 452' ' ' ARG . 23.2 m-20 -166.15 -170.52 1.73 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 449' ' ' ASP . . . . . 0.433 ' CG ' ' H ' ' A' ' 450' ' ' GLN . 12.8 p-10 -76.7 -62.44 1.63 Allowed 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.176 -0.61 . . . . 0.0 109.405 173.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 450' ' ' GLN . . . . . 0.433 ' H ' ' CG ' ' A' ' 449' ' ' ASP . 0.0 OUTLIER -70.37 -26.03 63.54 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 178.007 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 451' ' ' THR . . . . . 0.486 ' HA ' ' HB2' ' A' ' 454' ' ' GLU . 17.7 m -71.71 -22.65 61.61 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 119.824 -0.75 . . . . 0.0 110.853 -175.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . 0.592 ' HG3' ' O ' ' A' ' 448' ' ' ASP . 13.3 mtp180 -53.64 -54.75 33.34 Favored 'General case' 0 C--O 1.218 -0.569 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 170.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 453' ' ' ALA . . . . . 0.49 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -57.34 -48.2 79.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.264 -1.335 . . . . 0.0 112.582 175.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . 0.486 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 20.8 mm-40 -51.83 -35.72 45.55 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.151 0.501 . . . . 0.0 111.752 -177.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 31.2 p -119.22 16.2 13.15 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.314 -176.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . 0.542 ' CE2' ' HB2' ' A' ' 419' ' ' TYR . 1.0 OUTLIER -57.05 -48.84 77.55 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.975 0.417 . . . . 0.0 111.819 -171.441 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . 0.546 ' CG1' ' HB3' ' A' ' 408' ' ' TYR . 2.0 mp -75.67 -33.02 25.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.934 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -58.4 -35.08 71.49 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.942 0.877 . . . . 0.0 109.268 172.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . 0.722 ' O ' HG23 ' A' ' 463' ' ' VAL . 59.4 m-70 -74.23 -28.87 61.44 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.539 -1.21 . . . . 0.0 110.732 177.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . 0.692 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.4 OUTLIER -73.64 -34.79 65.14 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.794 0.807 . . . . 0.0 108.914 178.869 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . 0.488 ' HA ' ' CD2' ' A' ' 464' ' ' TYR . 20.0 m-80 -73.21 -37.64 66.36 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.276 -0.874 . . . . 0.0 108.872 176.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 462' ' ' ALA . . . . . 0.611 ' O ' HD11 ' A' ' 466' ' ' ILE . . . -56.85 -34.92 68.26 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.443 -1.253 . . . . 0.0 109.812 169.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.722 HG23 ' O ' ' A' ' 459' ' ' HIS . 68.4 t -60.12 -51.22 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 175.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 464' ' ' TYR . . . . . 0.6 ' CE2' ' HA ' ' A' ' 471' ' ' ALA . 16.2 m-30 -53.52 -28.33 30.7 Favored 'General case' 0 N--CA 1.456 -0.159 0 O-C-N 124.233 0.958 . . . . 0.0 110.598 178.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.19 -39.6 20.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.787 0.803 . . . . 0.0 109.466 -177.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.611 HD11 ' O ' ' A' ' 462' ' ' ALA . 3.7 mt -57.62 -55.68 19.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 114.22 -1.354 . . . . 0.0 112.286 175.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.766 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -102.83 -10.64 18.92 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -172.343 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . 0.691 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 93.93 32.47 7.52 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 118.96 -1.59 . . . . 0.0 114.155 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 469' ' ' LEU . . . . . 0.766 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.7 mt -89.63 166.41 13.64 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 117.793 0.797 . . . . 0.0 111.489 176.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 40.4 p30 -106.06 -178.12 3.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.564 -0.743 . . . . 0.0 109.668 169.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 471' ' ' ALA . . . . . 0.6 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -70.71 -9.72 57.83 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -175.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -89.09 -0.63 57.6 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.931 0.396 . . . . 0.0 110.861 -177.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 473' ' ' GLY . . . . . 0.465 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 75.5 16.58 80.54 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -173.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -101.57 155.57 18.01 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.275 -0.462 . . . . 0.0 109.818 178.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 3.0 p -94.49 121.06 35.65 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.165 0.507 . . . . 0.0 110.768 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 476' ' ' ILE . . . . . 0.691 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.3 pp . . . . . 0 C--N 1.322 -0.626 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.072 -176.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 386' ' ' PHE . . . . . 0.528 ' CD1' HD22 ' B' ' 414' ' ' LEU . 1.2 t80 . . . . . 0 CA--C 1.537 0.458 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 387' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -43.12 -68.99 0.09 OUTLIER 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 124.049 3.166 . . . . 0.0 113.782 -176.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 388' ' ' MET . . . . . 0.54 ' SD ' ' HB2' ' B' ' 415' ' ' SER . 6.6 ttp 66.23 34.21 6.75 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 173.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 389' ' ' HIS . . . . . 0.464 ' CE1' ' HB2' ' B' ' 393' ' ' ASN . 36.6 m170 54.08 -94.62 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.363 0.602 . . . . 0.0 110.546 -177.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -150.29 19.22 0.85 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.144 -0.934 . . . . 0.0 108.657 174.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 391' ' ' LEU . . . . . 0.585 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.6 pt? -173.91 -55.01 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -169.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 392' ' ' GLY . . . . . 0.585 ' N ' ' HG ' ' B' ' 391' ' ' LEU . . . -167.57 47.11 0.24 Allowed Glycine 0 CA--C 1.523 0.566 0 C-N-CA 119.796 -1.192 . . . . 0.0 114.736 -169.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 393' ' ' ASN . . . . . 0.481 ' HB3' ' C ' ' B' ' 388' ' ' MET . 0.0 OUTLIER -54.92 -37.56 66.54 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 117.915 0.857 . . . . 0.0 109.461 175.94 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 394' ' ' VAL . . . . . 0.609 HG22 ' N ' ' B' ' 395' ' ' ILE . 1.5 m -57.5 -49.9 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 113.795 -1.548 . . . . 0.0 107.491 179.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 395' ' ' ILE . . . . . 0.609 ' N ' HG22 ' B' ' 394' ' ' VAL . 4.0 mp -58.14 -52.86 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-O 117.978 -1.01 . . . . 0.0 113.464 -174.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 396' ' ' LYS . . . . . 0.636 ' HG3' ' CZ ' ' B' ' 429' ' ' TYR . 0.1 OUTLIER -64.71 -48.5 74.42 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 121.788 2.086 . . . . 0.0 111.679 -172.476 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.24 -45.49 64.28 Favored Glycine 0 N--CA 1.435 -1.397 0 C-N-CA 120.01 -1.09 . . . . 0.0 110.935 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 398' ' ' ILE . . . . . 0.666 ' CD1' HD13 ' B' ' 410' ' ' LEU . 36.0 mt -71.05 -33.93 53.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 113.607 0.965 . . . . 0.0 113.607 -178.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 399' ' ' VAL . . . . . 0.579 HG23 ' O ' ' B' ' 396' ' ' LYS . 11.7 m -63.3 -39.86 86.86 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.54 0 C-N-CA 118.827 -1.149 . . . . 0.0 108.559 -174.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -70.95 -37.44 72.82 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 176.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 401' ' ' GLN . . . . . 0.402 HE21 ' HB3' ' B' ' 401' ' ' GLN . 3.9 mm100 -86.66 -47.8 8.85 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -171.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 402' ' ' GLU . . . . . 0.434 ' HG3' ' HE1' ' A' ' 413' ' ' MET . 3.0 mm-40 -119.71 -20.64 7.58 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.385 -171.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 107.2 161.98 21.74 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.863 178.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 404' ' ' VAL . . . . . 0.659 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.5 m -53.74 -41.8 49.09 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.862 0 N-CA-C 114.649 1.352 . . . . 0.0 114.649 -175.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 405' ' ' ALA . . . . . 0.504 ' HB2' HG21 ' B' ' 457' ' ' ILE . . . -69.2 -29.11 67.01 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 119.657 -0.817 . . . . 0.0 112.042 -176.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 406' ' ' THR . . . . . 0.696 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 91.6 m -77.74 -42.82 32.89 Favored 'General case' 0 C--O 1.22 -0.474 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.142 172.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 407' ' ' ALA . . . . . 0.481 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.54 -36.82 74.47 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 122.01 0.909 . . . . 0.0 109.375 176.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 408' ' ' TYR . . . . . 0.659 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.81 -52.33 51.57 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 113.581 -1.645 . . . . 0.0 109.777 176.185 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 409' ' ' THR . . . . . 0.53 HG21 HD23 ' B' ' 410' ' ' LEU . 17.7 m -55.27 -47.66 75.17 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.676 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 410' ' ' LEU . . . . . 0.696 ' HG ' ' O ' ' B' ' 406' ' ' THR . 14.9 mt -72.81 -35.16 67.27 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 -174.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.67 -34.25 75.99 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.136 -1.03 . . . . 0.0 111.035 171.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 412' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -68.41 -49.37 60.52 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.558 0.218 . . . . 0.0 111.369 178.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 413' ' ' MET . . . . . 0.937 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.9 OUTLIER -71.34 -43.1 67.64 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 119.355 -0.938 . . . . 0.0 112.099 -177.553 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 414' ' ' LEU . . . . . 0.937 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 12.0 mt -73.89 -46.15 46.31 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -178.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 415' ' ' SER . . . . . 0.54 ' HB2' ' SD ' ' B' ' 388' ' ' MET . 3.7 t -100.37 17.79 20.61 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.265 0.555 . . . . 0.0 110.897 -170.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 416' ' ' GLY . . . . . . . . . . . . . . . 78.82 178.22 50.26 Favored Glycine 0 N--CA 1.438 -1.189 0 C-N-CA 120.342 -0.932 . . . . 0.0 111.771 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 33.6 mm-40 -81.7 21.25 0.84 Allowed 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.074 0.464 . . . . 0.0 111.496 -172.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 418' ' ' ASN . . . . . 0.442 ' HB3' ' HB3' ' B' ' 421' ' ' LEU . 6.6 m-20 -73.26 80.82 1.33 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.541 0.686 . . . . 0.0 111.067 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 419' ' ' TYR . . . . . 0.537 ' HB2' ' CE2' ' B' ' 456' ' ' PHE . 10.4 p90 -52.02 -38.13 55.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.869 -1.059 . . . . 0.0 111.843 176.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -55.36 -43.81 75.4 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.646 0.26 . . . . 0.0 110.81 176.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 421' ' ' LEU . . . . . 0.442 ' HB3' ' HB3' ' B' ' 418' ' ' ASN . 0.0 OUTLIER -67.73 -48.51 66.25 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.24 -177.908 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 422' ' ' VAL . . . . . 0.47 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.2 OUTLIER -66.05 -42.06 90.8 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.149 -177.579 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 423' ' ' SER . . . . . 0.743 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 25.5 t -69.54 -35.0 75.03 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.52 -40.54 90.93 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.265 175.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 425' ' ' ILE . . . . . 0.56 HG23 HG22 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -72.76 -50.07 36.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 O-C-N 122.834 -0.216 . . . . 0.0 110.824 -179.074 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 426' ' ' ILE . . . . . 0.405 ' O ' ' N ' ' B' ' 430' ' ' LEU . 1.2 mm -74.41 -22.32 17.76 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.911 0 C-N-CA 122.956 0.502 . . . . 0.0 110.235 -172.014 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 427' ' ' ARG . . . . . 0.743 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.3 OUTLIER -54.7 -28.7 49.74 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 123.023 0.529 . . . . 0.0 111.186 -178.91 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -90.58 -7.77 66.49 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.489 178.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 429' ' ' TYR . . . . . 0.636 ' CZ ' ' HG3' ' B' ' 396' ' ' LYS . 21.6 m-85 -114.94 -2.49 12.85 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.74 0.781 . . . . 0.0 109.571 -178.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 430' ' ' LEU . . . . . 0.504 ' HA ' HG12 ' B' ' 404' ' ' VAL . 0.0 OUTLIER -65.91 135.76 95.44 Favored Pre-proline 0 N--CA 1.437 -1.088 0 CA-C-N 114.462 -1.244 . . . . 0.0 108.679 178.165 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 431' ' ' PRO . . . . . 0.689 ' CD ' HG13 ' B' ' 435' ' ' VAL . 46.5 Cg_exo -36.53 -65.08 0.15 Allowed 'Trans proline' 0 N--CA 1.473 0.322 0 C-N-CA 124.658 3.572 . . . . 0.0 114.09 -172.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 432' ' ' GLY . . . . . 0.575 ' O ' HG12 ' B' ' 435' ' ' VAL . . . -142.08 -165.12 10.36 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 175.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 433' ' ' GLN . . . . . 0.54 ' O ' HG12 ' B' ' 436' ' ' VAL . 24.5 tp60 -70.13 -26.89 64.16 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 118.195 0.998 . . . . 0.0 110.423 177.299 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -66.54 -40.01 88.87 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -177.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 435' ' ' VAL . . . . . 0.689 HG13 ' CD ' ' B' ' 431' ' ' PRO . 7.1 p -68.43 -44.63 83.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-O 120.962 0.41 . . . . 0.0 110.702 -178.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 436' ' ' VAL . . . . . 0.54 HG12 ' O ' ' B' ' 433' ' ' GLN . 0.1 OUTLIER -65.43 -29.34 46.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.112 175.826 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 1.1 m -69.19 -52.81 24.18 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 438' ' ' ALA . . . . . 0.811 ' O ' ' HG2' ' B' ' 442' ' ' ARG . . . -58.75 -38.43 78.4 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.744 177.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 439' ' ' LEU . . . . . 0.571 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 2.2 tm? -69.68 -47.34 63.58 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -178.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.69 -39.53 77.38 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.291 174.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 441' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 8.8 mm-40 -53.8 -49.54 68.1 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 123.733 0.813 . . . . 0.0 110.82 174.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 442' ' ' ARG . . . . . 0.811 ' HG2' ' O ' ' B' ' 438' ' ' ALA . 0.7 OUTLIER -55.82 -39.3 71.18 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.609 172.061 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 443' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 37.5 mt -71.68 -35.61 70.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.953 0.406 . . . . 0.0 110.19 -178.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -58.16 -37.05 73.93 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.521 174.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -72.74 -28.27 62.54 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.512 178.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 446' ' ' GLU . . . . . 0.565 ' HB2' ' O ' ' B' ' 443' ' ' LEU . 31.7 tt0 30.04 96.96 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 O-C-N 124.686 1.241 . . . . 0.0 114.339 172.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 42.7 mt -68.29 -35.27 70.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.112 0.482 . . . . 0.0 110.593 177.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 448' ' ' ASP . . . . . 0.585 ' O ' ' HG3' ' B' ' 452' ' ' ARG . 23.5 m-20 -165.89 -170.26 1.71 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 449' ' ' ASP . . . . . 0.437 ' CG ' ' H ' ' B' ' 450' ' ' GLN . 12.6 p-10 -76.73 -62.64 1.57 Allowed 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 173.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 450' ' ' GLN . . . . . 0.437 ' H ' ' CG ' ' B' ' 449' ' ' ASP . 0.0 OUTLIER -70.43 -25.91 63.43 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 178.157 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 451' ' ' THR . . . . . 0.479 ' HA ' ' HB2' ' B' ' 454' ' ' GLU . 18.6 m -71.71 -22.74 61.6 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.632 -175.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 452' ' ' ARG . . . . . 0.585 ' HG3' ' O ' ' B' ' 448' ' ' ASP . 13.6 mtp180 -53.54 -54.65 34.35 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 170.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 453' ' ' ALA . . . . . 0.487 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -57.51 -48.22 79.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.275 -1.33 . . . . 0.0 112.604 175.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 454' ' ' GLU . . . . . 0.479 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 20.9 mm-40 -51.67 -35.72 43.57 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.252 0.548 . . . . 0.0 111.736 -177.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 31.1 p -119.28 16.15 13.1 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.362 -176.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 456' ' ' PHE . . . . . 0.537 ' CE2' ' HB2' ' B' ' 419' ' ' TYR . 1.0 OUTLIER -57.13 -48.67 78.08 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.95 0.405 . . . . 0.0 111.766 -171.343 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 457' ' ' ILE . . . . . 0.556 ' CG1' ' HB3' ' B' ' 408' ' ' TYR . 2.0 mp -75.77 -33.23 25.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.864 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -58.35 -34.95 71.23 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.888 0.851 . . . . 0.0 109.293 172.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 459' ' ' HIS . . . . . 0.723 ' O ' HG23 ' B' ' 463' ' ' VAL . 60.1 m-70 -74.33 -28.78 61.31 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.777 177.053 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 460' ' ' LEU . . . . . 0.696 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.4 OUTLIER -73.63 -34.81 65.18 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.869 0.842 . . . . 0.0 108.872 178.94 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 461' ' ' ASN . . . . . 0.491 ' HA ' ' CD2' ' B' ' 464' ' ' TYR . 19.2 m-80 -73.26 -37.69 66.23 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.279 -0.873 . . . . 0.0 108.909 176.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 462' ' ' ALA . . . . . 0.606 ' O ' HD11 ' B' ' 466' ' ' ILE . . . -56.8 -34.9 68.12 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.812 169.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 463' ' ' VAL . . . . . 0.723 HG23 ' O ' ' B' ' 459' ' ' HIS . 68.6 t -60.12 -51.24 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 175.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 464' ' ' TYR . . . . . 0.606 ' CE2' ' HA ' ' B' ' 471' ' ' ALA . 16.4 m-30 -53.51 -28.16 29.58 Favored 'General case' 0 N--CA 1.457 -0.105 0 O-C-N 124.242 0.964 . . . . 0.0 110.551 178.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.29 -39.94 20.18 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.706 0.765 . . . . 0.0 109.411 -177.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 466' ' ' ILE . . . . . 0.606 HD11 ' O ' ' B' ' 462' ' ' ALA . 3.7 mt -57.4 -55.5 20.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 114.189 -1.369 . . . . 0.0 112.231 176.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 467' ' ' LEU . . . . . 0.769 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -103.05 -10.47 18.88 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -172.369 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 468' ' ' GLY . . . . . 0.696 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 93.82 32.52 7.53 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 118.996 -1.573 . . . . 0.0 114.133 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 469' ' ' LEU . . . . . 0.769 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.7 mt -89.63 166.26 13.73 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 117.832 0.816 . . . . 0.0 111.538 176.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 41.3 p30 -105.91 -178.19 3.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.72 169.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 471' ' ' ALA . . . . . 0.606 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -70.83 -9.55 57.77 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -175.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -89.27 -0.75 57.71 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.856 0.36 . . . . 0.0 110.908 -177.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 473' ' ' GLY . . . . . 0.449 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 75.74 16.53 80.59 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -173.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -101.45 155.71 17.9 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.23 -0.485 . . . . 0.0 109.861 178.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 2.7 p -94.93 120.92 35.95 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.193 0.52 . . . . 0.0 110.673 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 476' ' ' ILE . . . . . 0.696 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.3 pp . . . . . 0 C--N 1.322 -0.607 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.189 -176.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 386' ' ' PHE . . . . . 0.624 ' CE2' HG11 ' A' ' 394' ' ' VAL . 2.3 t80 . . . . . 0 CA--C 1.535 0.388 0 CA-C-O 120.491 0.186 . . . . 0.0 110.515 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 386' ' ' PHE . 40.6 Cg_endo -65.5 111.54 1.89 Allowed 'Trans proline' 0 N--CA 1.482 0.811 0 C-N-CA 123.873 3.049 . . . . 0.0 112.458 173.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 388' ' ' MET . . . . . 0.565 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 34.2 ttm -121.37 47.92 1.76 Allowed 'General case' 0 C--N 1.321 -0.634 0 O-C-N 121.984 -0.448 . . . . 0.0 111.536 -169.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 389' ' ' HIS . . . . . 0.629 ' CG ' ' HB2' ' A' ' 393' ' ' ASN . 38.0 m170 57.09 -90.17 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 121.484 0.659 . . . . 0.0 109.482 -170.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -160.49 17.36 0.13 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.293 175.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.55 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.3 pt? -167.42 -59.35 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.562 -0.744 . . . . 0.0 112.119 -171.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . 0.55 ' N ' ' HG ' ' A' ' 391' ' ' LEU . . . -167.07 53.33 0.24 Allowed Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.216 -0.993 . . . . 0.0 114.059 -172.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . 0.629 ' HB2' ' CG ' ' A' ' 389' ' ' HIS . 0.4 OUTLIER -56.35 -44.07 79.7 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 117.314 0.557 . . . . 0.0 110.262 176.811 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . 0.624 HG11 ' CE2' ' A' ' 386' ' ' PHE . 1.9 m -55.25 -45.13 77.5 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.777 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 -178.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.591 ' N ' HG23 ' A' ' 394' ' ' VAL . 3.7 mp -58.02 -52.74 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 CA-C-O 117.853 -1.07 . . . . 0.0 113.544 -175.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . 0.573 ' O ' HG21 ' A' ' 399' ' ' VAL . 0.0 OUTLIER -63.2 -48.86 76.52 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 122.044 2.202 . . . . 0.0 112.139 -174.13 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . 0.464 ' O ' ' HG3' ' A' ' 401' ' ' GLN . . . -53.02 -44.49 62.33 Favored Glycine 0 N--CA 1.435 -1.414 0 C-N-CA 119.989 -1.101 . . . . 0.0 110.983 -177.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . 0.637 ' CD1' HD12 ' A' ' 410' ' ' LEU . 34.6 mt -71.83 -34.01 50.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . 0.573 HG21 ' O ' ' A' ' 396' ' ' LYS . 11.8 m -64.18 -40.44 89.05 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 C-N-CA 118.742 -1.183 . . . . 0.0 108.402 -173.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -64.27 -41.47 96.91 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 175.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . 0.464 ' HG3' ' O ' ' A' ' 397' ' ' GLY . 34.9 mt-30 -92.94 -49.74 5.89 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -170.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -111.74 -20.22 12.17 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.026 0.441 . . . . 0.0 111.227 -171.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 104.75 162.18 24.06 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.944 178.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . 0.63 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.5 m -54.03 -45.85 65.23 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.784 0 N-CA-C 114.568 1.322 . . . . 0.0 114.568 -175.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . 0.472 ' HB1' HG21 ' A' ' 457' ' ' ILE . . . -63.46 -33.04 74.69 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 119.851 -0.74 . . . . 0.0 112.26 -177.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 406' ' ' THR . . . . . 0.704 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 93.0 m -76.04 -41.91 49.36 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.199 174.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.517 ' HB3' ' HA ' ' A' ' 395' ' ' ILE . . . -58.49 -36.97 74.59 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 122.139 0.971 . . . . 0.0 109.221 176.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 408' ' ' TYR . . . . . 0.63 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -66.46 -52.78 42.6 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 113.471 -1.695 . . . . 0.0 110.06 177.336 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 409' ' ' THR . . . . . 0.546 HG22 HD22 ' A' ' 410' ' ' LEU . 1.7 m -56.4 -45.68 80.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.395 178.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . 0.704 ' HG ' ' O ' ' A' ' 406' ' ' THR . 13.3 mt -71.54 -36.88 71.12 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -176.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.95 -35.14 81.93 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.054 -1.07 . . . . 0.0 110.727 172.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -67.2 -47.93 69.42 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 115.719 -0.241 . . . . 0.0 111.386 177.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 413' ' ' MET . . . . . 0.912 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.6 OUTLIER -70.94 -46.81 61.78 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 118.813 -1.155 . . . . 0.0 111.912 -179.772 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . 0.912 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 14.7 mt -68.02 -44.96 75.32 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -176.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.434 ' HB2' ' HE3' ' A' ' 388' ' ' MET . 33.8 t -88.99 -16.28 32.09 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.732 0.777 . . . . 0.0 110.267 -175.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . 0.428 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 102.02 -175.8 25.36 Favored Glycine 0 N--CA 1.431 -1.681 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -171.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -79.95 23.63 0.44 Allowed 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.278 0.561 . . . . 0.0 111.7 -171.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 418' ' ' ASN . . . . . 0.428 ' H ' ' C ' ' A' ' 416' ' ' GLY . 64.8 m-80 -72.33 77.17 1.01 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.007 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 419' ' ' TYR . . . . . 0.555 ' CD1' ' HB3' ' A' ' 453' ' ' ALA . 11.6 p90 -53.01 -38.78 62.61 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.517 176.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.51 -44.14 76.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.784 0.326 . . . . 0.0 110.938 178.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.07 -49.36 61.8 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.293 -178.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . 0.433 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -65.99 -39.53 84.81 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 C-N-CA 120.376 -0.529 . . . . 0.0 111.209 -176.759 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.766 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 78.2 p -68.21 -37.99 81.47 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 -178.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -69.06 -37.16 82.31 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.072 176.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . 0.519 HG23 HG22 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.88 -53.32 19.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.42 0.152 . . . . 0.0 111.052 -178.746 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . 0.536 ' O ' HD23 ' A' ' 430' ' ' LEU . 1.1 mm -73.53 -22.89 19.16 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.828 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -172.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.766 ' HB2' ' O ' ' A' ' 423' ' ' SER . 0.9 OUTLIER -54.61 -32.54 58.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.142 0.496 . . . . 0.0 110.432 -178.663 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.02 -7.37 77.64 Favored Glycine 0 N--CA 1.44 -1.074 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.387 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.489 ' HD1' ' CG2' ' A' ' 395' ' ' ILE . 14.4 m-85 -117.21 0.58 12.32 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.079 0.466 . . . . 0.0 109.945 -176.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . 0.536 HD23 ' O ' ' A' ' 426' ' ' ILE . 0.1 OUTLIER -65.98 129.27 94.24 Favored Pre-proline 0 N--CA 1.446 -0.665 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.251 178.812 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 431' ' ' PRO . . . . . 0.529 ' HD2' HD11 ' A' ' 430' ' ' LEU . 90.3 Cg_exo -24.61 -68.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.359 1.113 1 C-N-CA 125.424 4.083 . . . . 0.0 115.029 179.709 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . 0.557 ' O ' HG11 ' A' ' 435' ' ' VAL . . . -142.07 -170.42 12.54 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 177.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . 0.505 ' O ' HG11 ' A' ' 436' ' ' VAL . 41.4 tp60 -68.13 -26.35 65.75 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 118.006 0.903 . . . . 0.0 110.458 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -66.29 -41.26 90.04 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -178.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 435' ' ' VAL . . . . . 0.557 HG11 ' O ' ' A' ' 432' ' ' GLY . 8.0 p -68.65 -43.81 82.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-O 120.929 0.395 . . . . 0.0 110.508 -177.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . 0.505 HG11 ' O ' ' A' ' 433' ' ' GLN . 0.1 OUTLIER -65.84 -30.55 50.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.512 175.538 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 1.1 m -69.16 -52.18 30.72 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . 0.786 ' O ' ' HG2' ' A' ' 442' ' ' ARG . . . -58.61 -37.42 75.83 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.823 177.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 439' ' ' LEU . . . . . 0.543 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 2.0 tm? -70.35 -47.18 62.15 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.37 -38.85 74.85 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.368 174.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 441' ' ' GLN . . . . . 0.461 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 35.9 mm-40 -53.47 -50.05 66.15 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 123.486 0.714 . . . . 0.0 110.562 174.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . 0.786 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 0.8 OUTLIER -56.83 -40.57 76.28 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.752 172.344 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 443' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 40.9 mt -72.64 -26.11 61.53 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.35 0.595 . . . . 0.0 110.865 -178.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -70.22 -36.38 74.5 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.008 177.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 445' ' ' GLN . . . . . 0.473 ' HG3' ' N ' ' A' ' 446' ' ' GLU . 0.0 OUTLIER -75.22 -30.19 60.51 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.026 178.098 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 446' ' ' GLU . . . . . 0.511 ' HB3' ' O ' ' A' ' 443' ' ' LEU . 13.6 pt-20 27.52 97.31 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.171 0 O-C-N 125.396 1.685 . . . . 0.0 113.646 175.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 49.3 mt -59.25 -35.12 56.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.206 0.527 . . . . 0.0 110.989 -178.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . 0.463 ' HB2' ' OG1' ' A' ' 451' ' ' THR . 17.1 m-20 -163.33 -157.8 0.44 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 -178.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -87.13 -67.31 0.83 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 171.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.2 -25.43 66.92 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 176.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 451' ' ' THR . . . . . 0.499 ' HA ' ' HB2' ' A' ' 454' ' ' GLU . 10.5 m -71.31 -22.64 61.91 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 119.906 -0.717 . . . . 0.0 110.602 -174.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . 0.431 ' NH2' ' HB3' ' A' ' 443' ' ' LEU . 19.0 mtp180 -53.53 -54.26 39.77 Favored 'General case' 0 C--O 1.22 -0.495 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 171.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 453' ' ' ALA . . . . . 0.555 ' HB3' ' CD1' ' A' ' 419' ' ' TYR . . . -58.4 -49.4 77.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.525 -1.216 . . . . 0.0 112.808 174.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . 0.499 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 16.0 mm-40 -51.15 -35.47 36.01 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.1 0.476 . . . . 0.0 112.049 -177.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 28.2 p -119.98 16.16 12.51 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.191 -176.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . 0.576 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.9 OUTLIER -55.23 -48.62 73.66 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.99 0.424 . . . . 0.0 111.639 -172.351 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . 0.524 ' CG1' ' HB3' ' A' ' 408' ' ' TYR . 1.9 mp -76.96 -33.05 20.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.964 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -57.97 -34.88 70.42 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.786 0.803 . . . . 0.0 109.347 171.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . 0.723 ' O ' HG21 ' A' ' 463' ' ' VAL . 63.3 m-70 -74.37 -28.82 61.29 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.639 177.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . 0.718 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.4 OUTLIER -73.93 -34.6 64.4 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.981 0.896 . . . . 0.0 108.787 178.559 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . 0.431 ' O ' ' HB2' ' A' ' 464' ' ' TYR . 26.9 m-80 -73.02 -37.58 66.89 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.992 0.901 . . . . 0.0 108.925 176.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 462' ' ' ALA . . . . . 0.609 ' O ' HD13 ' A' ' 466' ' ' ILE . . . -56.49 -34.46 66.97 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.491 -1.232 . . . . 0.0 109.814 169.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.723 HG21 ' O ' ' A' ' 459' ' ' HIS . 68.0 t -61.64 -50.89 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 175.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 464' ' ' TYR . . . . . 0.58 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 17.0 m-30 -53.01 -26.85 16.75 Favored 'General case' 0 C--N 1.33 -0.255 0 O-C-N 124.317 1.011 . . . . 0.0 110.664 177.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.14 -39.7 17.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.576 0.703 . . . . 0.0 109.821 -178.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.609 HD13 ' O ' ' A' ' 462' ' ' ALA . 3.7 mt -57.75 -55.64 20.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 114.421 -1.263 . . . . 0.0 112.157 175.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.737 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -101.64 -11.04 19.5 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -173.345 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . 0.571 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 93.94 31.57 8.06 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 119.38 -1.391 . . . . 0.0 114.353 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 469' ' ' LEU . . . . . 0.737 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 2.5 mt -88.08 159.38 18.26 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 117.777 0.789 . . . . 0.0 110.625 176.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . 0.514 HD21 HG23 ' A' ' 476' ' ' ILE . 12.0 p30 -104.76 -179.18 3.87 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.278 172.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -56.3 -27.79 56.68 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -173.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 -86.66 5.33 36.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.674 0.273 . . . . 0.0 111.607 -171.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 473' ' ' GLY . . . . . 0.451 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 77.68 11.84 85.05 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.325 -0.94 . . . . 0.0 111.472 -178.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 474' ' ' GLN . . . . . 0.404 ' HB2' HD22 ' A' ' 470' ' ' ASN . 56.0 mt-30 -101.09 158.0 16.34 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 177.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 5.3 p -97.34 122.43 40.37 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.171 0.51 . . . . 0.0 112.074 -176.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 476' ' ' ILE . . . . . 0.571 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.5 pp . . . . . 0 C--N 1.324 -0.507 0 CA-C-O 121.574 0.702 . . . . 0.0 110.005 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 386' ' ' PHE . . . . . 0.618 ' CE2' HG11 ' B' ' 394' ' ' VAL . 2.3 t80 . . . . . 0 CA--C 1.534 0.36 0 CA-C-O 120.572 0.225 . . . . 0.0 110.428 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 387' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' B' ' 386' ' ' PHE . 42.6 Cg_endo -65.69 111.38 1.89 Allowed 'Trans proline' 0 N--CA 1.481 0.76 0 C-N-CA 123.929 3.086 . . . . 0.0 112.431 173.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 388' ' ' MET . . . . . 0.552 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 33.8 ttm -121.12 47.88 1.75 Allowed 'General case' 0 C--N 1.32 -0.716 0 O-C-N 122.094 -0.379 . . . . 0.0 111.645 -169.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 389' ' ' HIS . . . . . 0.627 ' CG ' ' HB2' ' B' ' 393' ' ' ASN . 38.4 m170 57.04 -90.21 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.443 0.64 . . . . 0.0 109.481 -171.016 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -160.29 17.0 0.14 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.986 -1.006 . . . . 0.0 108.348 174.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 391' ' ' LEU . . . . . 0.548 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.3 pt? -167.11 -59.55 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.074 -171.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 392' ' ' GLY . . . . . 0.548 ' N ' ' HG ' ' B' ' 391' ' ' LEU . . . -166.86 53.28 0.24 Allowed Glycine 0 C--N 1.335 0.523 0 C-N-CA 120.232 -0.985 . . . . 0.0 114.181 -172.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 393' ' ' ASN . . . . . 0.627 ' HB2' ' CG ' ' B' ' 389' ' ' HIS . 0.4 OUTLIER -56.2 -44.19 79.21 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 117.238 0.519 . . . . 0.0 110.258 176.789 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 394' ' ' VAL . . . . . 0.618 HG11 ' CE2' ' B' ' 386' ' ' PHE . 1.9 m -55.32 -45.06 77.73 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.756 0 N-CA-C 106.706 -1.591 . . . . 0.0 106.706 -178.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 395' ' ' ILE . . . . . 0.596 ' N ' HG23 ' B' ' 394' ' ' VAL . 3.7 mp -57.98 -52.69 55.14 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.526 0 CA-C-O 117.77 -1.11 . . . . 0.0 113.59 -176.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 396' ' ' LYS . . . . . 0.586 ' O ' HG21 ' B' ' 399' ' ' VAL . 0.0 OUTLIER -63.22 -49.24 74.96 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 122.055 2.207 . . . . 0.0 111.932 -174.126 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 397' ' ' GLY . . . . . 0.466 ' O ' ' HG3' ' B' ' 401' ' ' GLN . . . -52.72 -44.43 60.44 Favored Glycine 0 N--CA 1.436 -1.336 0 C-N-CA 119.986 -1.102 . . . . 0.0 111.009 -177.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 398' ' ' ILE . . . . . 0.632 ' CD1' HD12 ' B' ' 410' ' ' LEU . 33.5 mt -71.82 -33.88 49.67 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 399' ' ' VAL . . . . . 0.586 HG21 ' O ' ' B' ' 396' ' ' LYS . 11.9 m -64.38 -40.39 88.88 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 C-N-CA 118.793 -1.163 . . . . 0.0 108.429 -173.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -64.27 -41.65 96.81 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 174.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 401' ' ' GLN . . . . . 0.466 ' HG3' ' O ' ' B' ' 397' ' ' GLY . 35.2 mt-30 -92.86 -49.66 5.94 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -170.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 402' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -111.75 -20.19 12.17 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.018 0.437 . . . . 0.0 111.265 -171.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 104.89 162.33 23.95 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.953 177.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 404' ' ' VAL . . . . . 0.629 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.6 m -54.08 -45.88 65.89 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.769 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 -175.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 405' ' ' ALA . . . . . 0.48 ' HB1' HG21 ' B' ' 457' ' ' ILE . . . -63.49 -33.03 74.68 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 119.785 -0.766 . . . . 0.0 112.337 -177.012 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 406' ' ' THR . . . . . 0.689 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 93.5 m -75.95 -42.09 49.61 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.251 174.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 407' ' ' ALA . . . . . 0.503 ' HB3' ' HA ' ' B' ' 395' ' ' ILE . . . -58.45 -36.83 74.28 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 122.145 0.974 . . . . 0.0 109.263 176.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 408' ' ' TYR . . . . . 0.629 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -66.53 -52.75 42.46 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 113.541 -1.663 . . . . 0.0 110.027 177.344 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 409' ' ' THR . . . . . 0.54 HG22 HD22 ' B' ' 410' ' ' LEU . 1.8 m -56.31 -45.68 80.15 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.44 178.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 410' ' ' LEU . . . . . 0.689 ' HG ' ' O ' ' B' ' 406' ' ' THR . 13.4 mt -71.69 -36.91 70.73 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -176.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.85 -35.18 81.37 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.064 -1.065 . . . . 0.0 110.73 172.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 412' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -67.34 -47.95 68.94 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 115.693 -0.254 . . . . 0.0 111.301 178.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 413' ' ' MET . . . . . 0.913 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.6 OUTLIER -70.91 -46.9 61.69 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 118.811 -1.155 . . . . 0.0 111.881 -179.945 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 414' ' ' LEU . . . . . 0.913 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 14.9 mt -67.84 -44.97 75.97 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -175.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 415' ' ' SER . . . . . 0.445 ' HB2' ' HE3' ' B' ' 388' ' ' MET . 33.9 t -89.03 -16.46 31.57 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.555 0.693 . . . . 0.0 110.264 -175.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 416' ' ' GLY . . . . . 0.422 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 102.44 -175.92 24.98 Favored Glycine 0 N--CA 1.43 -1.758 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 -171.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -79.96 23.51 0.45 Allowed 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.362 0.601 . . . . 0.0 111.724 -171.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 418' ' ' ASN . . . . . 0.422 ' H ' ' C ' ' B' ' 416' ' ' GLY . 64.1 m-80 -72.23 77.17 0.98 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.946 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 419' ' ' TYR . . . . . 0.55 ' CD1' ' HB3' ' B' ' 453' ' ' ALA . 11.5 p90 -53.13 -38.77 62.96 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.399 176.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.47 -44.08 76.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.613 0.244 . . . . 0.0 110.972 178.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.32 -49.33 61.14 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.18 -178.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 422' ' ' VAL . . . . . 0.432 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.2 OUTLIER -65.92 -39.37 84.46 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.205 -176.643 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 423' ' ' SER . . . . . 0.789 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 78.4 p -68.5 -37.69 80.32 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.87 -178.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -69.32 -37.19 79.93 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.039 176.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 425' ' ' ILE . . . . . 0.539 HG23 HG22 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -72.65 -53.37 19.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 O-C-N 122.907 -0.173 . . . . 0.0 111.116 -178.828 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 426' ' ' ILE . . . . . 0.531 ' O ' HD23 ' B' ' 430' ' ' LEU . 1.1 mm -73.59 -22.77 19.03 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.768 0 CA-C-O 120.801 0.334 . . . . 0.0 110.176 -172.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 427' ' ' ARG . . . . . 0.789 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.9 OUTLIER -54.94 -32.21 61.14 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.236 0.541 . . . . 0.0 110.522 -178.63 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -86.98 -7.47 77.58 Favored Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.449 179.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 429' ' ' TYR . . . . . 0.502 ' HD1' ' CG2' ' B' ' 395' ' ' ILE . 14.7 m-85 -117.29 0.61 12.29 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.096 0.474 . . . . 0.0 109.856 -176.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 430' ' ' LEU . . . . . 0.54 ' HA ' HG13 ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.86 129.27 94.26 Favored Pre-proline 0 N--CA 1.445 -0.702 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.152 178.816 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 431' ' ' PRO . . . . . 0.52 ' HD2' HD11 ' B' ' 430' ' ' LEU . 87.0 Cg_exo -24.43 -69.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.358 1.068 1 C-N-CA 125.4 4.067 . . . . 0.0 114.879 179.532 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 432' ' ' GLY . . . . . 0.543 ' O ' HG11 ' B' ' 435' ' ' VAL . . . -141.12 -169.87 11.97 Favored Glycine 0 N--CA 1.44 -1.038 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 177.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 433' ' ' GLN . . . . . 0.497 ' O ' HG11 ' B' ' 436' ' ' VAL . 41.2 tp60 -68.39 -26.37 65.52 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 118.062 0.931 . . . . 0.0 110.574 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -66.17 -41.46 90.29 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -178.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 435' ' ' VAL . . . . . 0.543 HG11 ' O ' ' B' ' 432' ' ' GLY . 7.9 p -68.38 -43.97 83.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-O 121.071 0.463 . . . . 0.0 110.506 -177.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 436' ' ' VAL . . . . . 0.497 HG11 ' O ' ' B' ' 433' ' ' GLN . 0.1 OUTLIER -65.76 -30.56 50.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.452 175.65 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 1.1 m -69.08 -52.2 30.87 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -178.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 438' ' ' ALA . . . . . 0.8 ' O ' ' HG2' ' B' ' 442' ' ' ARG . . . -58.68 -37.32 75.79 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.81 177.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 439' ' ' LEU . . . . . 0.554 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 2.0 tm? -70.38 -47.19 62.07 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.37 -38.83 74.84 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.303 174.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 441' ' ' GLN . . . . . 0.458 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 35.2 mm-40 -53.46 -50.05 66.13 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 123.519 0.728 . . . . 0.0 110.604 174.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 442' ' ' ARG . . . . . 0.8 ' HG2' ' O ' ' B' ' 438' ' ' ALA . 0.8 OUTLIER -56.68 -40.81 76.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.751 172.215 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 443' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 40.6 mt -72.6 -26.14 61.58 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.273 0.558 . . . . 0.0 110.833 -178.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -70.06 -36.51 75.02 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.874 177.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 445' ' ' GLN . . . . . 0.466 ' HG3' ' N ' ' B' ' 446' ' ' GLU . 0.0 OUTLIER -74.94 -30.17 61.16 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.594 -1.185 . . . . 0.0 109.023 178.321 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 446' ' ' GLU . . . . . 0.529 ' HB3' ' O ' ' B' ' 443' ' ' LEU . 13.4 pt-20 27.48 96.9 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 O-C-N 125.42 1.7 . . . . 0.0 113.65 175.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 49.7 mt -59.09 -35.0 54.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.158 0.504 . . . . 0.0 110.95 -178.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 448' ' ' ASP . . . . . 0.459 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 16.3 m-20 -163.0 -156.92 0.41 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 -178.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -87.97 -67.21 0.84 Allowed 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 171.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.13 -25.45 66.98 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 176.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 451' ' ' THR . . . . . 0.497 ' HA ' ' HB2' ' B' ' 454' ' ' GLU . 10.5 m -71.37 -22.65 61.87 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 119.946 -0.701 . . . . 0.0 110.679 -174.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 452' ' ' ARG . . . . . 0.432 ' NH2' ' HB3' ' B' ' 443' ' ' LEU . 19.0 mtp180 -53.57 -54.27 39.88 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 171.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 453' ' ' ALA . . . . . 0.55 ' HB3' ' CD1' ' B' ' 419' ' ' TYR . . . -58.24 -49.49 76.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.507 -1.224 . . . . 0.0 112.707 174.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 454' ' ' GLU . . . . . 0.497 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 16.2 mm-40 -51.32 -35.15 36.6 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.22 0.533 . . . . 0.0 112.153 -176.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 28.8 p -120.26 16.19 12.28 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.143 -176.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 456' ' ' PHE . . . . . 0.58 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 1.0 OUTLIER -55.27 -48.73 73.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.957 0.408 . . . . 0.0 111.516 -172.331 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 457' ' ' ILE . . . . . 0.537 ' CG1' ' HB3' ' B' ' 408' ' ' TYR . 1.9 mp -76.46 -33.19 22.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.149 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -58.06 -34.91 70.62 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.821 0.82 . . . . 0.0 109.227 171.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 459' ' ' HIS . . . . . 0.718 ' O ' HG21 ' B' ' 463' ' ' VAL . 63.7 m-70 -74.37 -28.85 61.3 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.583 -1.189 . . . . 0.0 110.596 177.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 460' ' ' LEU . . . . . 0.722 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -73.8 -34.75 64.75 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.951 0.881 . . . . 0.0 108.808 178.407 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 461' ' ' ASN . . . . . 0.432 ' O ' ' HB2' ' B' ' 464' ' ' TYR . 26.4 m-80 -72.81 -37.6 67.48 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.34 -0.846 . . . . 0.0 108.965 176.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 462' ' ' ALA . . . . . 0.619 ' O ' HD13 ' B' ' 466' ' ' ILE . . . -56.51 -34.48 67.04 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.352 -1.295 . . . . 0.0 109.796 169.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 463' ' ' VAL . . . . . 0.722 ' HB ' ' O ' ' B' ' 460' ' ' LEU . 65.1 t -61.79 -50.63 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 175.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 464' ' ' TYR . . . . . 0.571 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 17.1 m-30 -53.12 -27.05 18.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.683 177.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.98 -39.69 17.79 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.775 0.798 . . . . 0.0 109.775 -178.073 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 466' ' ' ILE . . . . . 0.619 HD13 ' O ' ' B' ' 462' ' ' ALA . 3.6 mt -57.72 -55.4 21.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.204 175.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 467' ' ' LEU . . . . . 0.732 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -101.73 -11.12 19.37 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 -173.484 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 468' ' ' GLY . . . . . 0.58 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 93.97 31.43 8.13 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 119.241 -1.457 . . . . 0.0 114.35 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 469' ' ' LEU . . . . . 0.732 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 2.5 mt -88.19 159.39 18.18 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 117.818 0.809 . . . . 0.0 110.606 176.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 470' ' ' ASN . . . . . 0.488 HD21 HG23 ' B' ' 476' ' ' ILE . 12.1 p30 -104.82 -179.6 3.99 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.101 172.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 471' ' ' ALA . . . . . . . . . . . . . . . -55.7 -28.21 54.44 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -173.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -86.29 4.95 36.79 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 122.314 -0.241 . . . . 0.0 111.56 -171.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 473' ' ' GLY . . . . . 0.456 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 78.0 11.82 85.01 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.384 -0.913 . . . . 0.0 111.475 -178.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 474' ' ' GLN . . . . . 0.405 ' HB2' HD22 ' B' ' 470' ' ' ASN . 56.5 mt-30 -101.07 158.12 16.25 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 177.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 6.0 p -97.3 122.64 40.57 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.327 0.584 . . . . 0.0 112.114 -176.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 476' ' ' ILE . . . . . 0.58 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.5 pp . . . . . 0 C--N 1.326 -0.439 0 CA-C-O 121.579 0.704 . . . . 0.0 110.006 178.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 386' ' ' PHE . . . . . 0.791 ' CZ ' HG13 ' A' ' 394' ' ' VAL . 1.4 t80 . . . . . 0 N--CA 1.45 -0.427 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -47.6 -75.25 0.03 OUTLIER 'Trans proline' 0 N--CA 1.479 0.625 0 C-N-CA 124.463 3.442 . . . . 0.0 115.125 -174.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 388' ' ' MET . . . . . 0.56 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 28.5 mtt 73.63 146.69 0.08 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.759 0.824 . . . . 0.0 111.225 -171.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 389' ' ' HIS . . . . . 0.511 ' CG ' ' HB2' ' A' ' 393' ' ' ASN . 32.7 m170 -49.29 -65.28 0.59 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.587 0.708 . . . . 0.0 109.519 178.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . 0.424 ' H ' HD22 ' A' ' 391' ' ' LEU . 3.7 pt20 -168.29 26.65 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.518 -1.219 . . . . 0.0 108.153 173.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.637 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.1 pt? -178.04 -65.31 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -167.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . 0.637 ' N ' ' HG ' ' A' ' 391' ' ' LEU . . . -163.64 49.9 0.3 Allowed Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.955 -0.64 . . . . 0.0 113.154 -168.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . 0.56 ' HB3' ' HA ' ' A' ' 388' ' ' MET . 0.4 OUTLIER -56.31 -37.68 70.24 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 177.942 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . 0.791 HG13 ' CZ ' ' A' ' 386' ' ' PHE . 0.9 OUTLIER -56.25 -47.39 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 178.681 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.54 HG22 HG21 ' A' ' 425' ' ' ILE . 4.2 mp -57.66 -51.8 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.275 0 CA-C-O 118.108 -0.948 . . . . 0.0 112.967 -174.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . 0.663 ' HG3' ' CZ ' ' A' ' 429' ' ' TYR . 0.2 OUTLIER -62.52 -48.98 77.15 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 121.359 1.891 . . . . 0.0 111.415 -174.205 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -55.19 -45.38 82.67 Favored Glycine 0 N--CA 1.434 -1.486 0 C-N-CA 120.131 -1.033 . . . . 0.0 111.166 -179.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . 0.713 ' CD1' HD12 ' A' ' 410' ' ' LEU . 28.2 mt -70.46 -33.84 55.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -177.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . 0.548 HG21 ' O ' ' A' ' 396' ' ' LYS . 11.8 m -63.89 -39.59 85.97 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 C-N-CA 118.798 -1.161 . . . . 0.0 108.385 -174.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -69.92 -36.65 75.53 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 175.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -87.58 -48.19 8.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.089 0.471 . . . . 0.0 111.944 -171.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . 0.416 ' HB3' ' HB ' ' A' ' 406' ' ' THR . 1.9 mm-40 -121.41 -20.43 6.63 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.757 -170.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 107.4 162.38 21.62 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.046 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . 0.65 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.5 m -53.45 -41.82 46.52 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.723 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 -176.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . 0.513 ' HB2' HG22 ' A' ' 457' ' ' ILE . . . -69.04 -30.36 68.7 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.795 -176.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 406' ' ' THR . . . . . 0.704 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 90.5 m -77.29 -42.31 37.46 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.162 -0.615 . . . . 0.0 109.981 173.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.5 ' HB2' ' HA ' ' A' ' 395' ' ' ILE . . . -58.41 -36.98 74.42 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 122.123 0.963 . . . . 0.0 109.038 176.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 408' ' ' TYR . . . . . 0.65 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.7 -52.25 52.87 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 113.445 -1.707 . . . . 0.0 110.083 176.61 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 409' ' ' THR . . . . . 0.542 HG21 HD23 ' A' ' 410' ' ' LEU . 3.4 m -55.71 -46.56 77.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.674 178.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . 0.713 HD12 ' CD1' ' A' ' 398' ' ' ILE . 14.0 mt -72.22 -35.86 68.98 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.048 0.451 . . . . 0.0 110.358 -174.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -59.63 -34.86 83.7 Favored Glycine 0 N--CA 1.438 -1.205 0 C-N-CA 120.224 -0.989 . . . . 0.0 110.83 171.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -68.26 -43.72 77.18 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 178.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 413' ' ' MET . . . . . 0.736 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.0 OUTLIER -70.5 -57.65 4.55 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 118.822 -1.151 . . . . 0.0 111.549 179.607 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . 0.736 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 4.6 mt -67.35 -43.7 80.88 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -172.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.441 ' HB2' ' HE1' ' A' ' 388' ' ' MET . 5.2 t -95.45 18.14 13.23 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.482 0.658 . . . . 0.0 109.975 -174.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 73.17 -177.93 41.81 Favored Glycine 0 N--CA 1.437 -1.245 0 C-N-CA 120.357 -0.925 . . . . 0.0 111.675 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 33.9 mm-40 -80.69 23.13 0.54 Allowed 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.199 0.524 . . . . 0.0 111.616 -173.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 418' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -71.73 77.65 0.85 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.72 -179.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 419' ' ' TYR . . . . . 0.537 ' CD1' ' HB1' ' A' ' 453' ' ' ALA . 14.6 p90 -54.47 -37.85 65.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.549 177.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -54.97 -43.04 73.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.625 0.25 . . . . 0.0 110.644 177.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.42 -48.85 63.54 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.152 -178.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . 0.481 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.3 OUTLIER -66.32 -40.53 86.99 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 C-N-CA 120.235 -0.586 . . . . 0.0 111.239 -177.142 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.748 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 65.9 p -67.06 -38.29 85.52 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -178.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.29 -40.26 92.02 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.129 175.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . 0.54 HG21 HG22 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.61 -50.13 36.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 O-C-N 122.883 -0.187 . . . . 0.0 110.934 -176.996 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . 0.526 ' O ' HD23 ' A' ' 430' ' ' LEU . 1.2 mm -74.55 -22.62 17.66 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -172.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.748 ' HB2' ' O ' ' A' ' 423' ' ' SER . 0.9 OUTLIER -54.86 -30.2 57.17 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.088 0.47 . . . . 0.0 110.756 -178.581 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -86.81 -9.12 75.11 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.458 178.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.663 ' CZ ' ' HG3' ' A' ' 396' ' ' LYS . 23.0 m-85 -115.87 1.03 13.29 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-O 120.995 0.426 . . . . 0.0 110.478 -177.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . 0.544 ' HA ' HG12 ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.82 127.38 93.05 Favored Pre-proline 0 N--CA 1.439 -1.019 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 178.505 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 431' ' ' PRO . . . . . 0.52 ' HD2' HD11 ' A' ' 430' ' ' LEU . 84.6 Cg_exo -22.7 -74.88 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 1.012 1 C-N-CA 125.653 4.235 . . . . 0.0 114.72 -179.102 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . 0.489 ' O ' HG12 ' A' ' 435' ' ' VAL . . . -129.27 -166.53 11.93 Favored Glycine 0 N--CA 1.441 -0.99 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 172.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . 0.619 ' O ' HG12 ' A' ' 436' ' ' VAL . 21.6 tt0 -71.61 -26.64 62.67 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 118.838 1.319 . . . . 0.0 110.587 176.12 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -62.26 -38.34 88.92 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.833 -176.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 435' ' ' VAL . . . . . 0.489 HG12 ' O ' ' A' ' 432' ' ' GLY . 7.5 p -69.76 -43.34 80.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-O 120.839 0.352 . . . . 0.0 110.611 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . 0.619 HG12 ' O ' ' A' ' 433' ' ' GLN . 0.2 OUTLIER -66.42 -30.17 48.94 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-O 120.822 0.344 . . . . 0.0 110.299 175.028 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 437' ' ' THR . . . . . 0.401 HG21 ' N ' ' A' ' 438' ' ' ALA . 0.9 OUTLIER -69.37 -52.0 31.35 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -178.156 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . 0.71 ' O ' ' HG2' ' A' ' 442' ' ' ARG . . . -57.42 -43.04 83.48 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.99 176.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 439' ' ' LEU . . . . . 0.613 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 2.0 tm? -65.28 -47.35 76.97 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -176.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.99 -39.11 77.42 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.228 174.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 441' ' ' GLN . . . . . 0.556 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 8.7 mm-40 -56.85 -50.46 72.37 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 123.379 0.672 . . . . 0.0 110.631 176.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . 0.71 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -58.65 -33.78 70.46 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.924 172.601 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 443' ' ' LEU . . . . . 0.613 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 59.5 mt -72.21 -33.99 68.02 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.024 0.44 . . . . 0.0 110.163 178.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -57.69 -36.75 72.37 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.319 173.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -72.6 -27.13 61.98 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.963 177.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 446' ' ' GLU . . . . . 0.559 ' HB2' ' O ' ' A' ' 443' ' ' LEU . 38.2 tt0 29.53 96.88 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 170.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 50.3 mt -68.33 -35.46 71.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.062 0.458 . . . . 0.0 110.882 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . 0.537 ' O ' ' HG3' ' A' ' 452' ' ' ARG . 36.8 m-20 -165.83 -166.78 0.98 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 -178.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 449' ' ' ASP . . . . . 0.458 ' CG ' ' H ' ' A' ' 450' ' ' GLN . 11.3 p-10 -79.63 -63.81 1.33 Allowed 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.23 -0.588 . . . . 0.0 109.525 172.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 450' ' ' GLN . . . . . 0.458 ' H ' ' CG ' ' A' ' 449' ' ' ASP . 0.0 OUTLIER -69.58 -25.97 64.24 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 178.725 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 451' ' ' THR . . . . . 0.461 ' HA ' ' HB2' ' A' ' 454' ' ' GLU . 12.1 m -71.85 -22.43 61.54 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.692 -175.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . 0.537 ' HG3' ' O ' ' A' ' 448' ' ' ASP . 11.1 mtp180 -53.11 -54.51 34.53 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 170.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 453' ' ' ALA . . . . . 0.537 ' HB1' ' CD1' ' A' ' 419' ' ' TYR . . . -57.93 -50.42 73.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.363 -1.29 . . . . 0.0 112.595 175.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . 0.461 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 31.4 mm-40 -49.73 -38.26 32.71 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.386 0.612 . . . . 0.0 111.729 -176.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 32.0 p -117.45 16.03 14.69 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.246 -176.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . 0.568 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 1.1 t80 -55.71 -47.36 76.98 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.169 0.509 . . . . 0.0 111.479 -171.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . 0.513 HG22 ' HB2' ' A' ' 405' ' ' ALA . 2.0 mp -75.41 -32.1 24.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.909 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -58.38 -35.78 72.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.67 0.748 . . . . 0.0 109.361 171.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . 0.723 ' O ' HG21 ' A' ' 463' ' ' VAL . 82.8 m-70 -72.44 -29.2 63.48 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.711 -1.132 . . . . 0.0 110.198 178.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . 0.73 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -74.51 -34.57 63.07 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.913 0.863 . . . . 0.0 108.929 179.129 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . 0.44 ' HA ' ' CD2' ' A' ' 464' ' ' TYR . 22.0 m-80 -72.83 -37.81 67.33 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.232 176.037 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 462' ' ' ALA . . . . . 0.64 ' O ' HD11 ' A' ' 466' ' ' ILE . . . -56.62 -33.1 65.95 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.852 169.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.73 ' HB ' ' O ' ' A' ' 460' ' ' LEU . 63.4 t -62.42 -50.78 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 CA-C-N 114.49 -1.232 . . . . 0.0 107.831 175.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 464' ' ' TYR . . . . . 0.547 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 16.2 m-30 -53.92 -27.77 32.77 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.53 178.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.8 -38.91 20.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.868 0.842 . . . . 0.0 109.337 -177.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.64 HD11 ' O ' ' A' ' 462' ' ' ALA . 3.7 mt -57.91 -56.08 17.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 114.172 -1.377 . . . . 0.0 112.463 174.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.744 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -102.78 -10.62 18.97 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -171.512 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . 0.587 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 94.12 31.73 7.89 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 119.46 -1.353 . . . . 0.0 114.241 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 469' ' ' LEU . . . . . 0.744 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.1 mt -89.69 164.06 14.86 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 117.718 0.759 . . . . 0.0 111.13 176.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 37.6 p30 -105.61 -178.69 3.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.816 171.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 471' ' ' ALA . . . . . 0.517 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -69.98 -5.99 30.17 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -174.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -96.75 0.67 49.87 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.9 0.381 . . . . 0.0 110.885 -178.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 473' ' ' GLY . . . . . 0.426 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 79.31 12.47 83.86 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.443 -0.884 . . . . 0.0 111.2 -175.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -100.19 157.35 16.65 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 178.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 12.7 p -95.28 127.95 41.74 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.066 0.46 . . . . 0.0 111.333 -178.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 476' ' ' ILE . . . . . 0.587 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.9 pp . . . . . 0 C--N 1.325 -0.489 0 CA-C-O 121.788 0.804 . . . . 0.0 110.212 179.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 386' ' ' PHE . . . . . 0.793 ' CZ ' HG13 ' B' ' 394' ' ' VAL . 1.4 t80 . . . . . 0 N--CA 1.451 -0.414 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 387' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -47.38 -75.32 0.03 OUTLIER 'Trans proline' 0 N--CA 1.481 0.763 0 C-N-CA 124.44 3.427 . . . . 0.0 115.164 -174.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 388' ' ' MET . . . . . 0.569 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 28.4 mtt 73.69 146.6 0.08 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.698 0.799 . . . . 0.0 111.116 -171.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 389' ' ' HIS . . . . . 0.525 ' CG ' ' HB2' ' B' ' 393' ' ' ASN . 32.8 m170 -49.19 -64.99 0.64 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.606 0.717 . . . . 0.0 109.569 178.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 390' ' ' GLN . . . . . 0.431 ' H ' HD22 ' B' ' 391' ' ' LEU . 3.7 pt20 -168.74 26.61 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.509 -1.223 . . . . 0.0 108.245 173.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 391' ' ' LEU . . . . . 0.617 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.1 pt? -177.98 -65.44 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -167.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 392' ' ' GLY . . . . . 0.617 ' N ' ' HG ' ' B' ' 391' ' ' LEU . . . -163.66 50.1 0.3 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.082 -168.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 393' ' ' ASN . . . . . 0.569 ' HB3' ' HA ' ' B' ' 388' ' ' MET . 0.4 OUTLIER -56.38 -37.77 70.55 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.901 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 394' ' ' VAL . . . . . 0.793 HG13 ' CZ ' ' B' ' 386' ' ' PHE . 0.9 OUTLIER -56.22 -47.36 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 178.705 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 395' ' ' ILE . . . . . 0.548 HG22 HG21 ' B' ' 425' ' ' ILE . 4.3 mp -57.81 -51.67 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 CA-C-O 118.034 -0.984 . . . . 0.0 112.946 -174.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 396' ' ' LYS . . . . . 0.662 ' HG3' ' CZ ' ' B' ' 429' ' ' TYR . 0.2 OUTLIER -62.53 -48.8 77.93 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 121.482 1.946 . . . . 0.0 111.537 -174.219 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -55.24 -45.59 82.21 Favored Glycine 0 N--CA 1.434 -1.452 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.132 -179.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 398' ' ' ILE . . . . . 0.696 ' CD1' HD12 ' B' ' 410' ' ' LEU . 28.1 mt -70.34 -33.8 55.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -177.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 399' ' ' VAL . . . . . 0.543 HG21 ' O ' ' B' ' 396' ' ' LYS . 12.0 m -63.9 -39.47 85.56 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 C-N-CA 118.754 -1.178 . . . . 0.0 108.489 -174.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -70.12 -36.63 74.95 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 175.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 401' ' ' GLN . . . . . . . . . . . . . 3.0 mm100 -87.47 -48.11 8.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.966 0.412 . . . . 0.0 111.988 -171.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 402' ' ' GLU . . . . . 0.422 ' HB3' ' HB ' ' B' ' 406' ' ' THR . 2.0 mm-40 -121.27 -21.02 6.5 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.678 -170.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 108.33 162.77 20.83 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.905 -0.664 . . . . 0.0 113.096 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 404' ' ' VAL . . . . . 0.641 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.5 m -53.71 -41.56 47.87 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.751 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -176.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 405' ' ' ALA . . . . . 0.496 ' HB2' HG22 ' B' ' 457' ' ' ILE . . . -69.32 -30.36 68.39 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 119.649 -0.821 . . . . 0.0 111.725 -175.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 406' ' ' THR . . . . . 0.7 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 93.8 m -77.56 -42.39 35.49 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 174.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 407' ' ' ALA . . . . . 0.487 ' HB2' ' HA ' ' B' ' 395' ' ' ILE . . . -58.41 -37.12 74.69 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 122.104 0.954 . . . . 0.0 108.935 176.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 408' ' ' TYR . . . . . 0.641 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.51 -52.4 52.95 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 113.492 -1.686 . . . . 0.0 110.046 176.534 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 409' ' ' THR . . . . . 0.556 HG21 HD23 ' B' ' 410' ' ' LEU . 3.3 m -55.79 -46.64 77.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.582 178.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 410' ' ' LEU . . . . . 0.7 ' HG ' ' O ' ' B' ' 406' ' ' THR . 13.8 mt -72.05 -36.04 69.5 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.124 0.488 . . . . 0.0 110.314 -174.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -59.59 -34.86 83.54 Favored Glycine 0 N--CA 1.439 -1.142 0 C-N-CA 120.213 -0.994 . . . . 0.0 110.825 171.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 412' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -68.24 -43.78 77.14 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.517 0.191 . . . . 0.0 111.517 178.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 413' ' ' MET . . . . . 0.722 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.0 OUTLIER -70.52 -57.69 4.5 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 118.772 -1.171 . . . . 0.0 111.546 179.721 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 414' ' ' LEU . . . . . 0.722 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 4.7 mt -67.24 -43.74 81.18 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 -172.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 415' ' ' SER . . . . . 0.434 ' HB2' ' HE1' ' B' ' 388' ' ' MET . 5.3 t -95.28 18.03 13.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.421 0.629 . . . . 0.0 110.108 -174.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 416' ' ' GLY . . . . . 0.406 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 73.08 -178.29 40.96 Favored Glycine 0 N--CA 1.438 -1.186 0 C-N-CA 120.427 -0.892 . . . . 0.0 111.659 -178.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -80.46 23.22 0.51 Allowed 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.009 0.433 . . . . 0.0 111.493 -173.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 418' ' ' ASN . . . . . 0.406 ' H ' ' C ' ' B' ' 416' ' ' GLY . 4.4 m-20 -71.58 77.9 0.81 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.834 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 419' ' ' TYR . . . . . 0.542 ' CD1' ' HB1' ' B' ' 453' ' ' ALA . 14.5 p90 -54.88 -37.6 66.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.482 178.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -54.97 -43.12 73.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.723 0.297 . . . . 0.0 110.651 177.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.46 -48.79 63.6 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.148 -178.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 422' ' ' VAL . . . . . 0.478 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.3 OUTLIER -66.34 -40.66 87.28 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 C-N-CA 120.261 -0.576 . . . . 0.0 111.13 -177.17 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 423' ' ' SER . . . . . 0.74 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 69.4 p -67.03 -38.13 85.36 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.659 -0.416 . . . . 0.0 109.903 -178.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.42 -40.02 91.42 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.321 175.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 425' ' ' ILE . . . . . 0.548 HG21 HG22 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -72.68 -50.24 35.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.553 0.216 . . . . 0.0 110.887 -177.096 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 426' ' ' ILE . . . . . 0.523 ' O ' HD23 ' B' ' 430' ' ' LEU . 1.2 mm -74.55 -22.57 17.64 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.815 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -172.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 427' ' ' ARG . . . . . 0.74 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.9 OUTLIER -54.75 -30.61 56.85 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.139 0.495 . . . . 0.0 110.701 -178.563 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -86.57 -8.91 76.32 Favored Glycine 0 N--CA 1.443 -0.89 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.456 178.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 429' ' ' TYR . . . . . 0.662 ' CZ ' ' HG3' ' B' ' 396' ' ' LYS . 22.9 m-85 -116.28 0.98 13.02 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-O 121.089 0.471 . . . . 0.0 110.509 -177.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 430' ' ' LEU . . . . . 0.549 ' HA ' HG12 ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.68 127.4 93.02 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.394 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 431' ' ' PRO . . . . . 0.518 ' HD2' HD11 ' B' ' 430' ' ' LEU . 86.1 Cg_exo -22.73 -75.44 0.02 OUTLIER 'Trans proline' 0 C--N 1.358 1.06 1 C-N-CA 125.617 4.211 . . . . 0.0 114.699 -179.246 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 432' ' ' GLY . . . . . 0.494 ' O ' HG12 ' B' ' 435' ' ' VAL . . . -128.84 -166.69 12.01 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 173.015 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 433' ' ' GLN . . . . . 0.623 ' O ' HG12 ' B' ' 436' ' ' VAL . 21.9 tt0 -71.44 -26.43 62.73 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 118.854 1.327 . . . . 0.0 110.571 176.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -62.58 -38.09 88.73 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -176.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 435' ' ' VAL . . . . . 0.497 ' HA ' ' CG1' ' B' ' 463' ' ' VAL . 7.5 p -69.77 -43.53 79.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 120.784 0.326 . . . . 0.0 110.57 -179.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 436' ' ' VAL . . . . . 0.623 HG12 ' O ' ' B' ' 433' ' ' GLN . 0.2 OUTLIER -66.35 -30.12 48.84 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 CA-C-O 120.895 0.379 . . . . 0.0 110.366 175.058 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 437' ' ' THR . . . . . 0.401 HG21 ' N ' ' B' ' 438' ' ' ALA . 0.9 OUTLIER -69.27 -51.97 32.15 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 -178.248 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 438' ' ' ALA . . . . . 0.7 ' O ' ' HG2' ' B' ' 442' ' ' ARG . . . -57.5 -43.1 83.9 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.005 176.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 439' ' ' LEU . . . . . 0.623 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 2.0 tm? -65.22 -47.27 77.44 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -176.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.01 -39.01 77.25 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.235 174.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 441' ' ' GLN . . . . . 0.559 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 8.5 mm-40 -56.93 -50.43 72.6 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 123.368 0.667 . . . . 0.0 110.617 176.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 442' ' ' ARG . . . . . 0.7 ' HG2' ' O ' ' B' ' 438' ' ' ALA . 0.0 OUTLIER -58.76 -33.64 70.52 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.9 172.606 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 443' ' ' LEU . . . . . 0.623 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 58.8 mt -72.18 -33.93 68.05 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.037 0.446 . . . . 0.0 110.129 178.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -57.62 -36.82 72.29 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.56 172.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -72.62 -27.36 62.1 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.866 177.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 446' ' ' GLU . . . . . 0.553 ' HB2' ' O ' ' B' ' 443' ' ' LEU . 39.5 tt0 29.79 96.47 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 170.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 52.2 mt -68.28 -35.45 71.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.109 0.48 . . . . 0.0 110.798 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 448' ' ' ASP . . . . . 0.527 ' O ' ' HG3' ' B' ' 452' ' ' ARG . 37.2 m-20 -165.61 -166.57 0.98 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 -178.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 449' ' ' ASP . . . . . 0.454 ' CG ' ' H ' ' B' ' 450' ' ' GLN . 11.7 p-10 -80.1 -63.47 1.4 Allowed 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.472 172.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 450' ' ' GLN . . . . . 0.454 ' H ' ' CG ' ' B' ' 449' ' ' ASP . 0.0 OUTLIER -69.85 -25.96 63.99 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 178.646 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 451' ' ' THR . . . . . 0.452 ' HA ' ' HB2' ' B' ' 454' ' ' GLU . 14.1 m -71.78 -22.44 61.58 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.664 -175.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 452' ' ' ARG . . . . . 0.527 ' HG3' ' O ' ' B' ' 448' ' ' ASP . 11.2 mtp180 -53.11 -54.56 33.91 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 170.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 453' ' ' ALA . . . . . 0.542 ' HB1' ' CD1' ' B' ' 419' ' ' TYR . . . -57.97 -50.09 74.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.378 -1.283 . . . . 0.0 112.688 175.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 454' ' ' GLU . . . . . 0.452 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 30.5 mm-40 -50.03 -38.36 37.32 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.472 0.653 . . . . 0.0 111.535 -176.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 32.0 p -117.42 16.11 14.72 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.226 -176.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 456' ' ' PHE . . . . . 0.562 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 1.1 t80 -55.75 -47.27 77.28 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.188 0.518 . . . . 0.0 111.489 -171.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 457' ' ' ILE . . . . . 0.52 ' CG1' ' HB3' ' B' ' 408' ' ' TYR . 2.0 mp -75.66 -32.08 24.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.816 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -58.3 -35.94 72.59 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.733 0.778 . . . . 0.0 109.357 171.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 459' ' ' HIS . . . . . 0.71 ' O ' HG21 ' B' ' 463' ' ' VAL . 82.4 m-70 -72.42 -29.1 63.41 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.213 178.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 460' ' ' LEU . . . . . 0.733 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -74.55 -34.62 62.98 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.858 0.837 . . . . 0.0 108.911 179.16 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 461' ' ' ASN . . . . . 0.43 ' HA ' ' CD2' ' B' ' 464' ' ' TYR . 22.4 m-80 -72.89 -37.89 67.13 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.253 176.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 462' ' ' ALA . . . . . 0.642 ' O ' HD11 ' B' ' 466' ' ' ILE . . . -56.58 -33.17 65.91 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.529 -1.214 . . . . 0.0 109.802 169.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 463' ' ' VAL . . . . . 0.733 ' HB ' ' O ' ' B' ' 460' ' ' LEU . 64.6 t -62.33 -50.68 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 175.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 464' ' ' TYR . . . . . 0.541 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 16.1 m-30 -54.07 -27.51 33.04 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.623 178.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.82 -38.94 20.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.908 0.861 . . . . 0.0 109.413 -177.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 466' ' ' ILE . . . . . 0.642 HD11 ' O ' ' B' ' 462' ' ' ALA . 3.8 mt -58.12 -56.2 17.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 114.125 -1.398 . . . . 0.0 112.395 174.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 467' ' ' LEU . . . . . 0.75 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -102.8 -10.39 19.16 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -171.532 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 468' ' ' GLY . . . . . 0.587 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 94.0 31.64 7.99 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 119.344 -1.408 . . . . 0.0 114.205 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 469' ' ' LEU . . . . . 0.75 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.2 mt -89.77 164.03 14.83 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 117.788 0.794 . . . . 0.0 111.152 176.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 37.1 p30 -105.57 -178.44 3.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.746 171.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 471' ' ' ALA . . . . . 0.504 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -70.23 -5.65 29.09 Favored 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -174.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 472' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' B' ' 472' ' ' ARG . 21.3 mmt180 -97.08 1.13 49.66 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.019 0.438 . . . . 0.0 110.891 -178.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 473' ' ' GLY . . . . . 0.424 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 78.95 12.66 83.91 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.36 -0.924 . . . . 0.0 111.079 -175.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -100.39 157.47 16.6 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 9.6 p -95.12 127.88 41.52 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.252 0.549 . . . . 0.0 111.448 -178.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 476' ' ' ILE . . . . . 0.587 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.9 pp . . . . . 0 C--N 1.325 -0.474 0 CA-C-O 121.579 0.704 . . . . 0.0 110.205 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 386' ' ' PHE . . . . . 0.742 ' CZ ' HG11 ' A' ' 394' ' ' VAL . 2.0 t80 . . . . . 0 CA--C 1.53 0.175 0 CA-C-O 121.104 0.478 . . . . 0.0 110.789 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . 0.533 ' HG2' ' OD1' ' B' ' 393' ' ' ASN . 61.7 Cg_endo -72.12 110.02 2.84 Favored 'Trans proline' 0 N--CA 1.481 0.738 0 C-N-CA 124.183 3.255 . . . . 0.0 114.104 175.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 388' ' ' MET . . . . . 0.422 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 32.8 mtt -104.07 169.07 8.71 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 121.991 -0.443 . . . . 0.0 110.109 175.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -54.84 -62.6 1.55 Allowed 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 177.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -172.3 17.31 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.625 -1.171 . . . . 0.0 108.27 172.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.584 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 1.9 pt? -165.91 -66.15 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.24 -167.14 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . 0.584 ' N ' ' HG ' ' A' ' 391' ' ' LEU . . . -162.8 54.87 0.3 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.409 -0.9 . . . . 0.0 113.173 -173.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . 0.539 ' OD1' ' HG2' ' B' ' 387' ' ' PRO . 0.2 OUTLIER -54.31 -42.25 69.91 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.455 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . 0.742 HG11 ' CZ ' ' A' ' 386' ' ' PHE . 0.7 OUTLIER -57.03 -46.22 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -179.48 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.545 HG23 HG21 ' A' ' 425' ' ' ILE . 4.2 mp -57.55 -51.77 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.247 0 CA-C-O 118.009 -0.996 . . . . 0.0 112.887 -174.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . 0.654 ' HG3' ' CZ ' ' A' ' 429' ' ' TYR . 0.1 OUTLIER -62.22 -48.82 78.29 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 121.446 1.93 . . . . 0.0 111.698 -175.163 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -54.95 -45.56 80.5 Favored Glycine 0 N--CA 1.436 -1.341 0 C-N-CA 119.84 -1.171 . . . . 0.0 111.229 -178.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . 0.672 ' CD1' HD11 ' A' ' 410' ' ' LEU . 26.3 mt -70.88 -34.11 54.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -177.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . 0.525 HG21 ' O ' ' A' ' 396' ' ' LYS . 13.1 m -63.99 -39.38 85.24 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.499 0 C-N-CA 118.784 -1.166 . . . . 0.0 108.43 -174.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -71.0 -34.87 71.77 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 175.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -88.79 -48.0 7.81 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -172.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . 0.417 ' HB3' ' HB ' ' A' ' 406' ' ' THR . 1.3 mm-40 -121.2 -20.55 6.7 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.609 -170.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 107.27 162.28 21.72 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.702 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . 0.614 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.8 m -53.77 -46.18 62.5 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.739 0 N-CA-C 114.946 1.462 . . . . 0.0 114.946 -175.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . 0.467 ' HB1' HG21 ' A' ' 457' ' ' ILE . . . -64.0 -29.88 71.0 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 119.778 -0.769 . . . . 0.0 112.379 -177.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 406' ' ' THR . . . . . 0.722 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 93.2 m -77.51 -42.56 35.19 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.119 -0.632 . . . . 0.0 110.204 172.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.498 ' HB2' ' HA ' ' A' ' 395' ' ' ILE . . . -58.28 -37.22 74.56 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 122.232 1.015 . . . . 0.0 109.25 176.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 408' ' ' TYR . . . . . 0.614 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.67 -52.02 54.87 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 113.351 -1.75 . . . . 0.0 109.933 176.382 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 409' ' ' THR . . . . . 0.543 HG23 HD22 ' A' ' 410' ' ' LEU . 16.5 m -55.12 -47.11 75.47 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.479 179.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . 0.722 ' HG ' ' O ' ' A' ' 406' ' ' THR . 14.7 mt -72.69 -36.92 67.96 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.282 -174.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.74 -34.95 79.51 Favored Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.123 -1.036 . . . . 0.0 110.813 172.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 412' ' ' MET . . . . . 0.401 ' HB2' ' O ' ' A' ' 409' ' ' THR . 0.4 OUTLIER -66.61 -44.78 81.16 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 115.734 -0.233 . . . . 0.0 111.441 177.962 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 413' ' ' MET . . . . . 0.764 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.0 OUTLIER -70.82 -57.1 4.97 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 118.675 -1.21 . . . . 0.0 111.668 179.135 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . 0.764 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 6.8 mt -64.58 -43.18 94.68 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -171.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 32.8 t -86.03 -16.84 36.94 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.734 0.778 . . . . 0.0 109.816 -177.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . 0.44 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 100.79 -175.34 26.38 Favored Glycine 0 N--CA 1.429 -1.773 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -170.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 34.0 mm-40 -79.65 24.03 0.39 Allowed 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.207 0.527 . . . . 0.0 111.645 -171.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 418' ' ' ASN . . . . . 0.44 ' H ' ' C ' ' A' ' 416' ' ' GLY . 61.2 m-80 -71.4 75.96 0.76 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.146 -178.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 419' ' ' TYR . . . . . 0.51 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 7.4 p90 -50.39 -38.54 43.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.933 173.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -54.27 -46.78 72.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.886 178.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.16 -48.98 60.8 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.188 -176.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . 0.402 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -66.37 -40.02 85.62 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 C-N-CA 120.368 -0.533 . . . . 0.0 111.146 -175.509 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.696 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 78.2 p -67.31 -38.57 85.2 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.607 -0.437 . . . . 0.0 109.976 -178.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -69.56 -37.61 78.11 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.071 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . 0.545 HG21 HG23 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -73.34 -51.9 23.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.466 0.174 . . . . 0.0 111.113 -178.018 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . 0.407 HD11 HG21 ' A' ' 395' ' ' ILE . 1.2 mm -74.4 -23.35 18.19 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.829 0 CA-C-O 120.835 0.35 . . . . 0.0 110.241 -171.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.696 ' HB2' ' O ' ' A' ' 423' ' ' SER . 1.0 OUTLIER -54.62 -29.33 51.68 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.165 0.507 . . . . 0.0 110.602 179.773 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -86.35 -8.38 77.97 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.858 178.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.654 ' CZ ' ' HG3' ' A' ' 396' ' ' LYS . 24.2 m-85 -117.51 -1.09 11.75 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-O 121.465 0.65 . . . . 0.0 110.272 -178.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . 0.539 ' HA ' HG13 ' A' ' 404' ' ' VAL . 0.0 OUTLIER -65.99 132.78 94.71 Favored Pre-proline 0 N--CA 1.437 -1.118 0 CA-C-N 114.624 -1.171 . . . . 0.0 108.624 179.241 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 431' ' ' PRO . . . . . 0.713 ' CD ' HG11 ' A' ' 435' ' ' VAL . 42.4 Cg_exo -35.17 -72.36 0.05 OUTLIER 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 124.847 3.698 . . . . 0.0 113.984 -170.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . 0.531 ' O ' HG13 ' A' ' 435' ' ' VAL . . . -131.38 -162.49 10.57 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 175.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . 0.551 ' O ' HG11 ' A' ' 436' ' ' VAL . 22.3 tp60 -71.29 -27.6 63.53 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 118.088 0.944 . . . . 0.0 110.459 177.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -68.23 -37.92 81.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.164 -175.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 435' ' ' VAL . . . . . 0.713 HG11 ' CD ' ' A' ' 431' ' ' PRO . 6.7 p -68.45 -46.63 80.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-O 120.979 0.419 . . . . 0.0 110.438 -178.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . 0.551 HG11 ' O ' ' A' ' 433' ' ' GLN . 0.2 OUTLIER -63.47 -31.08 51.55 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.321 175.702 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 437' ' ' THR . . . . . 0.58 ' O ' ' HG3' ' A' ' 441' ' ' GLN . 1.0 OUTLIER -69.03 -52.94 23.46 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 -178.028 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . 0.516 ' HB3' HG12 ' A' ' 463' ' ' VAL . . . -59.43 -36.06 75.19 Favored 'General case' 0 N--CA 1.436 -1.15 0 O-C-N 124.01 0.819 . . . . 0.0 112.01 178.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 439' ' ' LEU . . . . . 0.571 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 1.9 tm? -70.24 -47.91 59.28 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.47 -36.43 75.97 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.18 176.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 441' ' ' GLN . . . . . 0.58 ' HG3' ' O ' ' A' ' 437' ' ' THR . 43.4 mt-30 -54.33 -51.47 64.61 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.106 178.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -62.47 -36.87 83.84 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.839 174.869 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 443' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 61.4 mt -66.57 -37.36 84.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.007 0.432 . . . . 0.0 110.195 179.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -57.68 -37.81 74.08 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.563 173.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -72.53 -27.48 62.26 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.533 178.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 446' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 443' ' ' LEU . 37.9 tt0 33.55 101.18 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 114.56 1.318 . . . . 0.0 114.56 170.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 54.6 mt -69.87 -35.26 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-O 121.054 0.454 . . . . 0.0 110.745 178.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . 0.494 ' HB2' ' OG1' ' A' ' 451' ' ' THR . 16.6 m-20 -168.35 -167.42 0.8 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -176.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -77.06 -69.98 0.49 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.039 0.447 . . . . 0.0 109.807 172.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.86 -25.06 66.23 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 178.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 451' ' ' THR . . . . . 0.494 ' OG1' ' HB2' ' A' ' 448' ' ' ASP . 11.7 m -70.89 -22.91 62.21 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 119.989 -0.685 . . . . 0.0 110.86 -174.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' A' ' 448' ' ' ASP . 11.6 mtp180 -53.61 -54.0 43.86 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 170.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 453' ' ' ALA . . . . . 0.51 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -58.88 -47.04 86.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.557 -1.201 . . . . 0.0 112.656 175.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . 0.468 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 23.6 mm-40 -52.41 -36.17 53.58 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.175 0.512 . . . . 0.0 111.462 -178.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 29.5 p -118.38 15.61 13.87 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.449 -176.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . 0.529 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.9 OUTLIER -56.83 -48.69 77.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.05 0.452 . . . . 0.0 111.54 -171.704 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . 0.543 ' CG1' ' HB3' ' A' ' 408' ' ' TYR . 1.9 mp -76.11 -32.0 22.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.8 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -57.46 -37.08 72.28 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.672 0.749 . . . . 0.0 109.325 171.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . 0.779 ' O ' HG23 ' A' ' 463' ' ' VAL . 79.3 m-70 -72.32 -29.14 63.56 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.365 178.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . 0.718 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -74.18 -35.38 63.97 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.954 0.883 . . . . 0.0 108.992 179.688 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . 0.49 ' O ' ' HB2' ' A' ' 464' ' ' TYR . 23.7 m-80 -73.13 -37.67 66.56 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.362 -0.835 . . . . 0.0 108.977 176.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 462' ' ' ALA . . . . . 0.618 ' O ' HD13 ' A' ' 466' ' ' ILE . . . -56.98 -33.58 67.23 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.586 -1.188 . . . . 0.0 109.931 169.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.779 HG23 ' O ' ' A' ' 459' ' ' HIS . 55.2 t -62.66 -50.29 80.36 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.893 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 175.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 464' ' ' TYR . . . . . 0.577 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 20.7 m-30 -52.89 -29.57 29.07 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.481 177.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.37 -38.71 19.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.75 0.786 . . . . 0.0 109.636 -176.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.618 HD13 ' O ' ' A' ' 462' ' ' ALA . 3.6 mt -56.8 -55.98 16.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 114.289 -1.323 . . . . 0.0 112.271 174.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.757 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -102.14 -10.07 19.96 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -171.94 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . 0.564 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 94.72 31.39 7.83 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 119.481 -1.342 . . . . 0.0 114.345 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 469' ' ' LEU . . . . . 0.757 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 4.2 mt -89.75 160.45 16.54 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 117.862 0.831 . . . . 0.0 110.889 174.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . 0.6 HD21 ' C ' ' A' ' 470' ' ' ASN . 0.2 OUTLIER -105.53 -178.24 3.6 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.4 170.948 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 471' ' ' ALA . . . . . 0.405 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -56.91 -27.9 61.33 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -174.132 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -85.08 8.46 17.91 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -171.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 74.01 9.08 79.63 Favored Glycine 0 CA--C 1.519 0.344 0 C-N-CA 120.313 -0.946 . . . . 0.0 111.642 -177.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -100.14 155.08 17.93 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 177.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 59.9 p -91.43 136.73 32.9 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.348 0.594 . . . . 0.0 110.837 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 476' ' ' ILE . . . . . 0.564 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.7 pp . . . . . 0 C--N 1.319 -0.743 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.468 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 386' ' ' PHE . . . . . 0.753 ' CZ ' HG11 ' B' ' 394' ' ' VAL . 2.0 t80 . . . . . 0 CA--C 1.53 0.21 0 CA-C-O 121.061 0.457 . . . . 0.0 110.846 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 387' ' ' PRO . . . . . 0.539 ' HG2' ' OD1' ' A' ' 393' ' ' ASN . 61.5 Cg_endo -72.23 110.23 2.91 Favored 'Trans proline' 0 N--CA 1.479 0.645 0 C-N-CA 124.166 3.244 . . . . 0.0 114.107 175.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 388' ' ' MET . . . . . 0.41 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 33.1 mtt -104.3 169.08 8.69 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 122.103 -0.373 . . . . 0.0 110.127 175.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 389' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -54.98 -62.45 1.65 Allowed 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 177.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -172.35 17.06 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.736 -1.12 . . . . 0.0 108.311 172.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 391' ' ' LEU . . . . . 0.581 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.0 pt? -165.82 -66.18 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.269 -167.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 392' ' ' GLY . . . . . 0.581 ' N ' ' HG ' ' B' ' 391' ' ' LEU . . . -162.83 54.96 0.3 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.432 -0.889 . . . . 0.0 113.169 -173.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 393' ' ' ASN . . . . . 0.533 ' OD1' ' HG2' ' A' ' 387' ' ' PRO . 0.2 OUTLIER -54.3 -42.37 70.0 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 178.41 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 394' ' ' VAL . . . . . 0.753 HG11 ' CZ ' ' B' ' 386' ' ' PHE . 0.7 OUTLIER -56.95 -46.15 83.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -179.388 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 395' ' ' ILE . . . . . 0.549 HG23 HG21 ' B' ' 425' ' ' ILE . 4.2 mp -57.59 -51.8 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-O 117.991 -1.004 . . . . 0.0 112.81 -174.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 396' ' ' LYS . . . . . 0.659 ' HG3' ' CZ ' ' B' ' 429' ' ' TYR . 0.1 OUTLIER -62.17 -49.03 77.45 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 121.487 1.949 . . . . 0.0 111.719 -175.142 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -54.77 -45.59 78.7 Favored Glycine 0 N--CA 1.437 -1.252 0 C-N-CA 119.84 -1.171 . . . . 0.0 111.209 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 398' ' ' ILE . . . . . 0.667 ' CD1' HD11 ' B' ' 410' ' ' LEU . 26.8 mt -70.94 -34.19 54.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 113.361 0.875 . . . . 0.0 113.361 -177.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 399' ' ' VAL . . . . . 0.532 HG21 ' O ' ' B' ' 396' ' ' LYS . 13.5 m -63.82 -39.44 85.43 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.481 0 C-N-CA 118.774 -1.17 . . . . 0.0 108.56 -174.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -70.98 -34.83 71.78 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 175.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 401' ' ' GLN . . . . . 0.413 HE21 ' HB3' ' B' ' 401' ' ' GLN . 4.2 mm100 -89.06 -47.61 7.99 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -172.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 402' ' ' GLU . . . . . 0.431 ' HB3' ' HB ' ' B' ' 406' ' ' THR . 1.3 mm-40 -121.64 -20.47 6.5 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.026 0.441 . . . . 0.0 111.489 -170.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 107.12 162.31 21.87 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.736 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 404' ' ' VAL . . . . . 0.61 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.8 m -53.72 -46.38 62.05 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.792 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -175.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 405' ' ' ALA . . . . . 0.485 ' HB1' HG21 ' B' ' 457' ' ' ILE . . . -63.87 -29.88 71.02 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 119.639 -0.825 . . . . 0.0 112.464 -177.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 406' ' ' THR . . . . . 0.72 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 89.1 m -77.38 -42.78 35.12 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.149 172.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 407' ' ' ALA . . . . . 0.488 ' HB2' ' HA ' ' B' ' 395' ' ' ILE . . . -58.17 -37.19 74.23 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 122.248 1.023 . . . . 0.0 109.317 176.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 408' ' ' TYR . . . . . 0.61 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.79 -51.97 54.69 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 113.279 -1.782 . . . . 0.0 109.86 176.48 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 409' ' ' THR . . . . . 0.541 HG23 HD22 ' B' ' 410' ' ' LEU . 16.6 m -55.23 -47.08 75.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.427 179.1 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 410' ' ' LEU . . . . . 0.72 ' HG ' ' O ' ' B' ' 406' ' ' THR . 14.7 mt -72.72 -36.82 67.87 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.312 -174.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.84 -34.89 79.97 Favored Glycine 0 N--CA 1.44 -1.074 0 C-N-CA 120.175 -1.012 . . . . 0.0 110.72 172.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 412' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -66.79 -44.52 81.09 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 115.839 -0.18 . . . . 0.0 111.458 177.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 413' ' ' MET . . . . . 0.767 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.0 OUTLIER -70.99 -56.9 5.18 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 118.66 -1.216 . . . . 0.0 111.701 179.035 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 414' ' ' LEU . . . . . 0.767 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 6.8 mt -64.71 -43.17 94.31 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -171.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 33.1 t -86.29 -16.45 37.5 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.76 0.791 . . . . 0.0 109.745 -176.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 416' ' ' GLY . . . . . 0.44 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 100.41 -175.54 26.99 Favored Glycine 0 N--CA 1.429 -1.831 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -171.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -79.48 24.13 0.37 Allowed 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.251 0.548 . . . . 0.0 111.742 -171.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 418' ' ' ASN . . . . . 0.44 ' H ' ' C ' ' B' ' 416' ' ' GLY . 62.5 m-80 -71.55 75.99 0.8 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.025 -179.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 419' ' ' TYR . . . . . 0.517 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 7.3 p90 -50.39 -38.49 42.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.936 173.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -54.37 -46.56 73.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.939 178.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.25 -49.03 59.96 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.249 -177.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 422' ' ' VAL . . . . . 0.406 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.2 OUTLIER -66.31 -40.08 85.86 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.212 -175.514 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 423' ' ' SER . . . . . 0.711 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 78.0 p -67.3 -38.56 85.18 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.921 -178.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -69.71 -37.45 76.5 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.11 177.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 425' ' ' ILE . . . . . 0.549 HG21 HG23 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -73.46 -52.03 23.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.488 0.185 . . . . 0.0 111.186 -178.259 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 426' ' ' ILE . . . . . 0.415 HD11 HG21 ' B' ' 395' ' ' ILE . 1.2 mm -74.13 -23.38 18.6 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.797 0 CA-C-O 120.82 0.343 . . . . 0.0 110.226 -171.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 427' ' ' ARG . . . . . 0.711 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.9 OUTLIER -54.68 -29.11 51.84 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.122 0.487 . . . . 0.0 110.666 179.913 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -86.55 -8.75 76.68 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.756 178.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 429' ' ' TYR . . . . . 0.659 ' CZ ' ' HG3' ' B' ' 396' ' ' LYS . 24.3 m-85 -117.1 -0.82 12.02 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 121.465 0.65 . . . . 0.0 110.156 -178.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 430' ' ' LEU . . . . . 0.534 ' HA ' HG13 ' B' ' 404' ' ' VAL . 0.0 OUTLIER -66.07 132.97 94.66 Favored Pre-proline 0 N--CA 1.438 -1.054 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.54 179.27 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 431' ' ' PRO . . . . . 0.709 ' CD ' HG11 ' B' ' 435' ' ' VAL . 42.6 Cg_exo -35.23 -71.73 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 124.76 3.64 . . . . 0.0 114.054 -170.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 432' ' ' GLY . . . . . 0.516 ' O ' HG13 ' B' ' 435' ' ' VAL . . . -131.99 -162.15 10.32 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 175.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 433' ' ' GLN . . . . . 0.554 ' O ' HG11 ' B' ' 436' ' ' VAL . 22.5 tp60 -71.58 -27.82 63.41 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 118.119 0.96 . . . . 0.0 110.447 177.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -68.06 -38.08 82.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.215 -0.448 . . . . 0.0 112.065 -175.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 435' ' ' VAL . . . . . 0.709 HG11 ' CD ' ' B' ' 431' ' ' PRO . 6.7 p -68.17 -46.73 80.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-O 121.068 0.461 . . . . 0.0 110.46 -178.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 436' ' ' VAL . . . . . 0.554 HG11 ' O ' ' B' ' 433' ' ' GLN . 0.2 OUTLIER -63.32 -31.44 52.81 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.191 175.759 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 437' ' ' THR . . . . . 0.584 ' O ' ' HG3' ' B' ' 441' ' ' GLN . 1.0 OUTLIER -68.87 -52.74 26.42 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -177.996 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 438' ' ' ALA . . . . . 0.516 ' HB3' HG12 ' B' ' 463' ' ' VAL . . . -59.51 -36.12 75.46 Favored 'General case' 0 N--CA 1.435 -1.193 0 O-C-N 124.132 0.895 . . . . 0.0 112.04 178.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 439' ' ' LEU . . . . . 0.578 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 1.9 tm? -70.22 -47.93 59.3 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.43 -36.32 75.69 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.154 175.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 441' ' ' GLN . . . . . 0.584 ' HG3' ' O ' ' B' ' 437' ' ' THR . 43.9 mt-30 -54.44 -51.66 64.26 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 123.755 0.822 . . . . 0.0 110.034 178.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 442' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' B' ' 438' ' ' ALA . 0.0 OUTLIER -62.4 -36.69 83.11 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.461 -0.791 . . . . 0.0 112.855 174.942 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 443' ' ' LEU . . . . . 0.578 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 61.2 mt -66.6 -37.33 84.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.17 0.51 . . . . 0.0 110.237 179.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -57.82 -37.69 74.24 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.675 173.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -72.58 -27.39 62.16 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.497 -1.229 . . . . 0.0 110.595 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 446' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' B' ' 443' ' ' LEU . 37.9 tt0 33.41 101.52 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 170.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 54.9 mt -70.35 -35.35 62.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.074 0.464 . . . . 0.0 110.616 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 448' ' ' ASP . . . . . 0.484 ' O ' ' HG3' ' B' ' 452' ' ' ARG . 17.6 m-20 -168.17 -167.27 0.8 Allowed 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 -176.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -77.2 -70.15 0.48 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 173.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.79 -25.08 66.3 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 178.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 451' ' ' THR . . . . . 0.48 ' OG1' ' HB2' ' B' ' 448' ' ' ASP . 13.1 m -70.95 -22.82 62.16 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.688 -174.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 452' ' ' ARG . . . . . 0.484 ' HG3' ' O ' ' B' ' 448' ' ' ASP . 11.7 mtp180 -53.7 -53.92 45.23 Favored 'General case' 0 C--O 1.219 -0.552 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 171.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 453' ' ' ALA . . . . . 0.517 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -58.8 -47.28 85.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.517 -1.22 . . . . 0.0 112.666 175.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 454' ' ' GLU . . . . . 0.465 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 22.7 mm-40 -52.39 -36.07 53.12 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.321 0.581 . . . . 0.0 111.488 -178.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 29.4 p -118.3 15.58 13.94 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.397 -176.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 456' ' ' PHE . . . . . 0.528 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 0.9 OUTLIER -56.88 -48.89 77.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.054 0.454 . . . . 0.0 111.474 -171.712 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 457' ' ' ILE . . . . . 0.551 ' CG1' ' HB3' ' B' ' 408' ' ' TYR . 1.9 mp -75.97 -31.9 22.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.875 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -57.6 -37.06 72.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.693 0.759 . . . . 0.0 109.355 171.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 459' ' ' HIS . . . . . 0.776 ' O ' HG23 ' B' ' 463' ' ' VAL . 79.0 m-70 -72.36 -28.97 63.37 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.385 178.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 460' ' ' LEU . . . . . 0.73 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.4 OUTLIER -74.25 -35.4 63.8 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.909 0.861 . . . . 0.0 108.974 179.655 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 461' ' ' ASN . . . . . 0.483 ' O ' ' HB2' ' B' ' 464' ' ' TYR . 23.2 m-80 -73.3 -37.36 66.22 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.864 0.84 . . . . 0.0 109.087 176.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 462' ' ' ALA . . . . . 0.62 ' O ' HD13 ' B' ' 466' ' ' ILE . . . -57.11 -33.65 67.56 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.493 -1.23 . . . . 0.0 109.891 169.098 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 463' ' ' VAL . . . . . 0.776 HG23 ' O ' ' B' ' 459' ' ' HIS . 55.9 t -62.53 -50.4 79.98 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.871 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 175.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 464' ' ' TYR . . . . . 0.582 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 20.7 m-30 -52.79 -29.45 27.5 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.481 177.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.41 -38.95 19.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.701 0.762 . . . . 0.0 109.601 -176.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 466' ' ' ILE . . . . . 0.62 HD13 ' O ' ' B' ' 462' ' ' ALA . 3.6 mt -56.72 -55.77 17.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 114.245 -1.343 . . . . 0.0 112.257 174.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 467' ' ' LEU . . . . . 0.745 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -102.3 -9.94 19.94 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -171.943 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 468' ' ' GLY . . . . . 0.567 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 94.53 31.58 7.8 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 119.519 -1.324 . . . . 0.0 114.456 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 469' ' ' LEU . . . . . 0.745 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 4.2 mt -89.89 160.67 16.33 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 117.674 0.737 . . . . 0.0 110.853 174.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 470' ' ' ASN . . . . . 0.598 HD21 ' C ' ' B' ' 470' ' ' ASN . 0.2 OUTLIER -105.64 -178.15 3.57 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.365 170.96 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 471' ' ' ALA . . . . . 0.407 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -57.05 -27.87 62.05 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -174.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -85.14 8.63 17.46 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.973 0.361 . . . . 0.0 111.973 -171.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 473' ' ' GLY . . . . . . . . . . . . . . . 74.02 8.96 79.51 Favored Glycine 0 C--O 1.228 -0.221 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.553 -177.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -100.16 154.88 18.08 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 177.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 475' ' ' SER . . . . . 0.407 ' HA ' ' HA ' ' B' ' 469' ' ' LEU . 61.1 p -91.12 136.69 32.91 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.329 0.585 . . . . 0.0 110.862 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 476' ' ' ILE . . . . . 0.567 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.7 pp . . . . . 0 C--N 1.318 -0.777 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.47 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 386' ' ' PHE . . . . . 0.64 ' CZ ' HG13 ' A' ' 394' ' ' VAL . 1.9 t80 . . . . . 0 CA--C 1.539 0.551 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -55.4 -72.76 0.03 OUTLIER 'Trans proline' 0 N--CA 1.486 1.068 0 C-N-CA 124.488 3.458 . . . . 0.0 114.465 178.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 388' ' ' MET . . . . . 0.517 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 10.4 ttp 69.17 59.6 0.33 Allowed 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 170.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 389' ' ' HIS . . . . . 0.543 ' ND1' ' HA ' ' A' ' 393' ' ' ASN . 17.1 m170 51.05 -138.56 1.04 Allowed 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -178.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . 0.411 ' NE2' HD23 ' A' ' 391' ' ' LEU . 5.9 pm0 -110.68 22.67 15.14 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 164.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.595 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.5 pt? -168.28 -61.71 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.542 -174.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . 0.595 ' N ' ' HG ' ' A' ' 391' ' ' LEU . . . -160.51 59.45 0.31 Allowed Glycine 0 C--N 1.337 0.589 0 C-N-CA 119.733 -1.222 . . . . 0.0 114.715 -171.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . 0.543 ' HA ' ' ND1' ' A' ' 389' ' ' HIS . 0.4 OUTLIER -62.4 -39.55 93.61 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 117.4 0.6 . . . . 0.0 109.568 175.714 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . 0.64 HG13 ' CZ ' ' A' ' 386' ' ' PHE . 0.6 OUTLIER -56.7 -46.02 82.91 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 179.21 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.604 HG22 ' CD1' ' A' ' 426' ' ' ILE . 4.0 mp -57.79 -52.71 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.323 0 CA-C-O 117.853 -1.07 . . . . 0.0 113.465 -174.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . 0.641 ' O ' HG21 ' A' ' 399' ' ' VAL . 0.0 OUTLIER -63.72 -49.76 71.8 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-N 121.972 2.169 . . . . 0.0 111.645 -175.77 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.62 -44.89 68.72 Favored Glycine 0 N--CA 1.428 -1.842 0 CA-C-N 114.473 -1.239 . . . . 0.0 110.818 -175.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . 0.689 ' CD1' HD11 ' A' ' 410' ' ' LEU . 34.8 mt -70.79 -33.05 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . 0.641 HG21 ' O ' ' A' ' 396' ' ' LYS . 16.7 m -62.9 -39.73 86.16 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 C-N-CA 118.688 -1.205 . . . . 0.0 108.43 -175.067 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -71.35 -35.03 71.0 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 175.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -88.52 -47.47 8.3 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -172.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . 0.436 ' HB3' ' HB ' ' A' ' 406' ' ' THR . 3.1 mm-40 -121.72 -21.03 6.26 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.539 -171.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 109.25 160.98 19.44 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.728 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . 0.658 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.1 m -53.71 -40.77 44.5 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.771 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -175.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . 0.487 ' HB2' HG22 ' A' ' 457' ' ' ILE . . . -68.48 -31.55 70.92 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 119.591 -0.844 . . . . 0.0 112.013 -177.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 406' ' ' THR . . . . . 0.696 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 92.3 m -77.08 -41.51 41.93 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.1 173.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.496 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.47 -37.26 75.12 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 122.059 0.933 . . . . 0.0 109.365 176.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 408' ' ' TYR . . . . . 0.658 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.6 -52.79 49.38 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 113.709 -1.587 . . . . 0.0 109.973 176.433 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 409' ' ' THR . . . . . 0.548 HG22 HD21 ' A' ' 410' ' ' LEU . 3.2 m -56.09 -46.8 78.93 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 179.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . 0.696 ' HG ' ' O ' ' A' ' 406' ' ' THR . 13.6 mt -72.36 -37.69 68.73 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -175.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.48 -37.03 87.31 Favored Glycine 0 N--CA 1.435 -1.4 0 C-N-CA 119.849 -1.167 . . . . 0.0 110.298 172.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 412' ' ' MET . . . . . 0.449 ' HE1' ' HA ' ' A' ' 417' ' ' GLN . 0.0 OUTLIER -64.27 -49.98 69.72 Favored 'General case' 0 C--O 1.223 -0.306 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 178.53 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 413' ' ' MET . . . . . 0.934 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 1.0 OUTLIER -71.27 -42.88 68.21 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 118.849 -1.14 . . . . 0.0 112.133 -176.146 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . 0.934 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 19.7 mt -69.61 -45.19 69.14 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -177.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.432 ' HB3' ' HE1' ' A' ' 388' ' ' MET . 54.6 p -85.91 -21.65 27.86 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.511 0.672 . . . . 0.0 110.482 -174.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . 0.412 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 108.64 178.65 21.71 Favored Glycine 0 N--CA 1.431 -1.682 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -168.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 417' ' ' GLN . . . . . 0.449 ' HA ' ' HE1' ' A' ' 412' ' ' MET . 1.7 mp0 -80.17 23.94 0.45 Allowed 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.037 0.446 . . . . 0.0 111.859 -173.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 418' ' ' ASN . . . . . 0.412 ' H ' ' C ' ' A' ' 416' ' ' GLY . 4.3 m-20 -71.35 78.25 0.74 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.677 0.751 . . . . 0.0 110.947 178.024 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 419' ' ' TYR . . . . . 0.556 ' CD1' ' HB3' ' A' ' 453' ' ' ALA . 17.1 p90 -51.86 -38.32 55.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.749 177.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -55.12 -45.41 75.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.746 178.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . 0.401 HD22 ' N ' ' A' ' 422' ' ' VAL . 0.0 OUTLIER -68.33 -48.58 64.48 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.11 -177.943 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . 0.466 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.1 OUTLIER -65.64 -41.78 91.33 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 C-N-CA 120.347 -0.541 . . . . 0.0 110.932 -176.291 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.777 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 29.6 t -69.35 -36.53 76.98 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.7 -178.145 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -69.34 -37.47 80.07 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.84 176.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . 0.573 HG23 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.41 -51.25 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-O 120.515 0.198 . . . . 0.0 110.621 -179.631 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . 0.604 ' CD1' HG22 ' A' ' 395' ' ' ILE . 1.1 mm -73.38 -22.9 19.37 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.952 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -173.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.777 ' HB2' ' O ' ' A' ' 423' ' ' SER . 1.1 tmm_? -54.38 -33.63 59.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.289 0.566 . . . . 0.0 110.893 -177.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -86.28 -10.94 73.33 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.404 -0.903 . . . . 0.0 110.853 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.49 ' HD1' ' CG2' ' A' ' 395' ' ' ILE . 5.4 m-30 -112.91 -1.8 14.47 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -174.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . 0.552 HD11 ' HD2' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -66.61 129.88 94.1 Favored Pre-proline 0 N--CA 1.443 -0.789 0 CA-C-N 114.201 -1.363 . . . . 0.0 108.947 177.203 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 431' ' ' PRO . . . . . 0.552 ' HD2' HD11 ' A' ' 430' ' ' LEU . 79.7 Cg_exo -24.09 -66.95 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.758 1 C-N-CA 125.536 4.157 . . . . 0.0 114.727 179.221 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . 0.52 ' O ' HG13 ' A' ' 435' ' ' VAL . . . -145.2 -168.17 12.75 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 176.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . 0.543 ' O ' HG12 ' A' ' 436' ' ' VAL . 40.1 tp60 -69.84 -26.26 64.13 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 117.888 0.844 . . . . 0.0 110.459 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -65.85 -40.8 92.07 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.887 -178.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 435' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 432' ' ' GLY . 7.4 p -68.84 -43.39 82.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-O 120.947 0.403 . . . . 0.0 110.755 -177.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . 0.543 HG12 ' O ' ' A' ' 433' ' ' GLN . 0.1 OUTLIER -65.25 -33.42 63.59 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.19 175.73 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 437' ' ' THR . . . . . 0.458 ' O ' ' HG3' ' A' ' 441' ' ' GLN . 1.0 OUTLIER -66.84 -52.86 38.67 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -177.727 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . 0.609 ' O ' ' HD2' ' A' ' 442' ' ' ARG . . . -58.58 -37.79 76.52 Favored 'General case' 0 N--CA 1.436 -1.162 0 O-C-N 123.788 0.68 . . . . 0.0 111.835 178.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 439' ' ' LEU . . . . . 0.603 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 2.1 tm? -67.64 -48.78 65.76 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 -179.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.28 -35.02 74.58 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.535 -1.212 . . . . 0.0 110.729 176.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 441' ' ' GLN . . . . . 0.543 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 13.3 mt-30 -53.32 -50.96 63.88 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.186 -178.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . 0.609 ' HD2' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -76.09 -23.38 54.96 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 175.118 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 443' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 47.3 mt -64.09 -35.47 80.87 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 174.072 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -56.89 -36.09 69.71 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.373 172.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -73.16 -27.63 61.77 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.872 178.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 446' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 443' ' ' LEU . 33.5 tt0 32.94 89.45 0.01 OUTLIER 'General case' 0 C--N 1.353 0.745 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 170.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 70.8 mt -59.31 -35.82 60.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 175.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . 0.489 ' HB2' ' OG1' ' A' ' 451' ' ' THR . 24.5 m-20 -166.49 175.34 8.16 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 178.104 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 449' ' ' ASP . . . . . 0.595 ' O ' ' HG2' ' A' ' 452' ' ' ARG . 13.0 m-20 -62.72 -60.03 4.07 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.312 -0.555 . . . . 0.0 109.715 174.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.93 -28.51 63.51 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 178.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 451' ' ' THR . . . . . 0.489 ' OG1' ' HB2' ' A' ' 448' ' ' ASP . 10.1 m -73.0 -23.54 60.65 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.326 -174.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . 0.595 ' HG2' ' O ' ' A' ' 449' ' ' ASP . 6.0 ptp180 -64.73 -41.52 95.9 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 174.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 453' ' ' ALA . . . . . 0.556 ' HB3' ' CD1' ' A' ' 419' ' ' TYR . . . -58.99 -49.19 78.82 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 123.843 0.714 . . . . 0.0 112.445 168.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . 0.466 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 33.5 mm-40 -53.97 -33.44 56.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.148 0.499 . . . . 0.0 111.738 -177.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 29.1 p -115.56 15.27 16.65 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.224 -178.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . 0.552 ' CZ ' ' HB2' ' A' ' 423' ' ' SER . 1.0 OUTLIER -56.78 -47.68 79.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.995 0.426 . . . . 0.0 111.775 -171.667 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . 0.52 ' CG1' ' HB3' ' A' ' 408' ' ' TYR . 1.9 mp -76.41 -33.41 23.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.153 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -57.84 -34.05 69.29 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.955 0.883 . . . . 0.0 108.963 171.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . 0.747 ' O ' HG23 ' A' ' 463' ' ' VAL . 45.0 m-70 -74.47 -29.31 61.4 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.197 -1.365 . . . . 0.0 110.947 177.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . 0.686 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -74.07 -34.78 64.13 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.342 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 24.2 m-80 -73.02 -37.59 66.88 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.047 176.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 462' ' ' ALA . . . . . 0.61 ' O ' HD13 ' A' ' 466' ' ' ILE . . . -55.86 -34.92 65.89 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.659 169.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.747 HG23 ' O ' ' A' ' 459' ' ' HIS . 73.3 t -61.69 -51.15 76.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-N 114.612 -1.176 . . . . 0.0 108.201 176.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 464' ' ' TYR . . . . . 0.567 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 15.9 m-30 -52.95 -28.16 22.35 Favored 'General case' 0 C--N 1.332 -0.188 0 O-C-N 124.295 0.997 . . . . 0.0 110.614 178.13 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.92 -39.53 19.68 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.76 0.79 . . . . 0.0 109.632 -177.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.61 HD13 ' O ' ' A' ' 462' ' ' ALA . 3.7 mt -57.95 -55.86 19.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 114.296 -1.32 . . . . 0.0 112.252 175.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.733 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -102.46 -10.88 19.01 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -172.274 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . 0.623 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 93.94 31.79 7.93 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 119.34 -1.41 . . . . 0.0 114.331 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 469' ' ' LEU . . . . . 0.733 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.1 mt -88.96 161.42 16.63 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 117.838 0.819 . . . . 0.0 110.922 175.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . 0.443 HD21 HG22 ' A' ' 476' ' ' ILE . 12.5 p30 -106.33 -176.84 3.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.075 170.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 471' ' ' ALA . . . . . 0.416 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -62.62 -19.55 63.89 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -173.227 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -87.77 2.26 51.72 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 122.113 -0.367 . . . . 0.0 111.809 -174.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 473' ' ' GLY . . . . . 0.479 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 76.77 11.58 85.26 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.21 -0.995 . . . . 0.0 111.003 -175.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -101.32 156.74 17.27 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 176.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 8.2 p -93.92 132.98 37.82 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.087 0.47 . . . . 0.0 111.587 -176.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 476' ' ' ILE . . . . . 0.623 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.5 pp . . . . . 0 C--N 1.328 -0.356 0 CA-C-O 121.479 0.657 . . . . 0.0 110.015 177.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 386' ' ' PHE . . . . . 0.639 ' CZ ' HG13 ' B' ' 394' ' ' VAL . 1.9 t80 . . . . . 0 CA--C 1.538 0.504 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 387' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -55.59 -72.61 0.03 OUTLIER 'Trans proline' 0 N--CA 1.486 1.078 0 C-N-CA 124.536 3.491 . . . . 0.0 114.456 178.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 388' ' ' MET . . . . . 0.516 ' SD ' HG12 ' B' ' 394' ' ' VAL . 10.4 ttp 69.34 59.49 0.32 Allowed 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 170.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 389' ' ' HIS . . . . . 0.55 ' ND1' ' HA ' ' B' ' 393' ' ' ASN . 17.7 m170 51.28 -138.36 1.07 Allowed 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -178.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 390' ' ' GLN . . . . . 0.425 ' H ' ' HB3' ' B' ' 389' ' ' HIS . 5.9 pm0 -110.99 22.81 14.89 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 164.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 391' ' ' LEU . . . . . 0.585 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.5 pt? -168.46 -61.73 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.553 -174.044 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 392' ' ' GLY . . . . . 0.585 ' N ' ' HG ' ' B' ' 391' ' ' LEU . . . -160.4 59.37 0.31 Allowed Glycine 0 C--N 1.338 0.644 0 C-N-CA 119.65 -1.262 . . . . 0.0 114.649 -171.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 393' ' ' ASN . . . . . 0.55 ' HA ' ' ND1' ' B' ' 389' ' ' HIS . 0.4 OUTLIER -62.23 -39.71 93.7 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 117.371 0.586 . . . . 0.0 109.535 175.798 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 394' ' ' VAL . . . . . 0.639 HG13 ' CZ ' ' B' ' 386' ' ' PHE . 0.6 OUTLIER -56.62 -46.09 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 179.346 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 395' ' ' ILE . . . . . 0.589 HG22 ' CD1' ' B' ' 426' ' ' ILE . 4.0 mp -57.86 -52.6 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.37 0 CA-C-O 117.794 -1.098 . . . . 0.0 113.45 -174.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 396' ' ' LYS . . . . . 0.643 ' O ' HG21 ' B' ' 399' ' ' VAL . 0.0 OUTLIER -63.58 -49.81 71.9 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-N 121.978 2.172 . . . . 0.0 111.706 -175.885 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.62 -44.86 68.73 Favored Glycine 0 N--CA 1.429 -1.819 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.825 -175.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 398' ' ' ILE . . . . . 0.699 ' CD1' HD11 ' B' ' 410' ' ' LEU . 35.1 mt -70.79 -33.11 51.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 399' ' ' VAL . . . . . 0.643 HG21 ' O ' ' B' ' 396' ' ' LYS . 16.7 m -62.93 -39.64 85.87 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 C-N-CA 118.678 -1.209 . . . . 0.0 108.362 -175.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -71.15 -35.55 71.72 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 175.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 401' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -88.37 -47.38 8.43 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -172.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 402' ' ' GLU . . . . . 0.445 ' HB3' ' HB ' ' B' ' 406' ' ' THR . 3.1 mm-40 -121.75 -21.09 6.23 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.573 -171.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 109.34 160.77 19.24 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.797 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 404' ' ' VAL . . . . . 0.648 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.1 m -53.62 -40.72 43.46 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.733 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -175.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 405' ' ' ALA . . . . . 0.5 ' HB2' HG22 ' B' ' 457' ' ' ILE . . . -68.39 -31.73 71.29 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 119.689 -0.804 . . . . 0.0 111.989 -177.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 406' ' ' THR . . . . . 0.694 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 94.8 m -77.15 -41.38 41.98 Favored 'General case' 0 C--O 1.222 -0.39 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.065 173.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 407' ' ' ALA . . . . . 0.492 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.53 -37.29 75.34 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 122.024 0.916 . . . . 0.0 109.249 176.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 408' ' ' TYR . . . . . 0.648 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.54 -52.7 50.59 Favored 'General case' 0 N--CA 1.433 -1.275 0 CA-C-N 113.612 -1.631 . . . . 0.0 110.032 176.376 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 409' ' ' THR . . . . . 0.554 HG22 HD21 ' B' ' 410' ' ' LEU . 3.3 m -56.05 -46.98 78.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.616 179.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 410' ' ' LEU . . . . . 0.699 HD11 ' CD1' ' B' ' 398' ' ' ILE . 13.6 mt -72.31 -37.74 68.86 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -175.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.5 -37.18 87.81 Favored Glycine 0 N--CA 1.436 -1.347 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 173.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 412' ' ' MET . . . . . 0.448 ' HE1' ' HA ' ' B' ' 417' ' ' GLN . 0.0 OUTLIER -64.0 -50.11 69.81 Favored 'General case' 0 C--O 1.223 -0.309 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 178.457 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 413' ' ' MET . . . . . 0.939 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 1.0 OUTLIER -71.18 -43.15 68.03 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 118.941 -1.104 . . . . 0.0 112.045 -176.22 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 414' ' ' LEU . . . . . 0.939 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 19.6 mt -69.49 -45.18 69.56 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -176.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 415' ' ' SER . . . . . 0.431 ' HB3' ' HE1' ' B' ' 388' ' ' MET . 54.7 p -85.95 -21.69 27.76 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.556 0.693 . . . . 0.0 110.462 -174.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 416' ' ' GLY . . . . . . . . . . . . . . . 108.75 178.54 21.64 Favored Glycine 0 N--CA 1.431 -1.687 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -168.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 417' ' ' GLN . . . . . 0.448 ' HA ' ' HE1' ' B' ' 412' ' ' MET . 1.7 mp0 -80.01 23.88 0.44 Allowed 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.038 0.447 . . . . 0.0 112.041 -173.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 418' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -71.44 78.41 0.77 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.699 0.762 . . . . 0.0 110.726 178.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 419' ' ' TYR . . . . . 0.56 ' CD1' ' HB3' ' B' ' 453' ' ' ALA . 17.1 p90 -51.89 -38.31 55.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.726 177.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -55.15 -45.32 75.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.858 178.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.4 -48.5 64.49 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.171 -178.031 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 422' ' ' VAL . . . . . 0.462 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.1 OUTLIER -65.7 -41.79 91.21 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.839 -176.291 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 423' ' ' SER . . . . . 0.769 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 28.5 t -69.39 -36.41 76.76 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.71 -178.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -69.41 -37.56 79.47 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.909 176.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 425' ' ' ILE . . . . . 0.582 HG23 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -72.36 -51.01 31.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.431 0.158 . . . . 0.0 110.623 -179.625 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 426' ' ' ILE . . . . . 0.589 ' CD1' HG22 ' B' ' 395' ' ' ILE . 1.1 mm -73.68 -22.86 18.95 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.899 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -173.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 427' ' ' ARG . . . . . 0.769 ' HB2' ' O ' ' B' ' 423' ' ' SER . 1.2 tmm_? -54.25 -33.73 59.14 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.284 0.564 . . . . 0.0 110.879 -177.053 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -86.33 -10.66 73.72 Favored Glycine 0 N--CA 1.441 -1.013 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 429' ' ' TYR . . . . . 0.492 ' HD1' ' CG2' ' B' ' 395' ' ' ILE . 5.6 m-30 -113.12 -1.92 14.28 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.884 0.85 . . . . 0.0 108.711 -174.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 430' ' ' LEU . . . . . 0.536 HD11 ' HD2' ' B' ' 431' ' ' PRO . 0.1 OUTLIER -66.38 130.03 94.18 Favored Pre-proline 0 N--CA 1.444 -0.757 0 CA-C-N 114.098 -1.41 . . . . 0.0 108.865 177.208 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 431' ' ' PRO . . . . . 0.536 ' HD2' HD11 ' B' ' 430' ' ' LEU . 80.2 Cg_exo -24.17 -66.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.759 1 C-N-CA 125.595 4.197 . . . . 0.0 114.697 178.984 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 432' ' ' GLY . . . . . 0.525 ' O ' HG13 ' B' ' 435' ' ' VAL . . . -145.4 -168.03 12.76 Favored Glycine 0 N--CA 1.441 -1.01 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 176.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 433' ' ' GLN . . . . . 0.532 ' O ' HG12 ' B' ' 436' ' ' VAL . 40.0 tp60 -69.79 -26.24 64.17 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 117.767 0.784 . . . . 0.0 110.465 179.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -65.95 -40.6 91.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.955 -178.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 435' ' ' VAL . . . . . 0.525 HG13 ' O ' ' B' ' 432' ' ' GLY . 7.5 p -68.95 -43.59 82.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-O 120.85 0.357 . . . . 0.0 110.732 -177.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 436' ' ' VAL . . . . . 0.532 HG12 ' O ' ' B' ' 433' ' ' GLN . 0.1 OUTLIER -65.12 -33.45 63.8 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.234 175.723 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 437' ' ' THR . . . . . 0.458 ' O ' ' HG3' ' B' ' 441' ' ' GLN . 1.0 OUTLIER -67.02 -52.62 40.26 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -177.73 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 438' ' ' ALA . . . . . 0.615 ' O ' ' HD2' ' B' ' 442' ' ' ARG . . . -58.6 -37.88 76.77 Favored 'General case' 0 N--CA 1.436 -1.151 0 O-C-N 123.809 0.693 . . . . 0.0 111.84 178.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 439' ' ' LEU . . . . . 0.598 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 2.1 tm? -67.44 -48.71 66.44 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -179.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.5 -34.78 74.57 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.498 -1.228 . . . . 0.0 110.773 176.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 441' ' ' GLN . . . . . 0.538 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 13.0 mt-30 -53.5 -50.67 64.9 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.175 -178.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 442' ' ' ARG . . . . . 0.615 ' HD2' ' O ' ' B' ' 438' ' ' ALA . 0.0 OUTLIER -76.33 -23.52 54.25 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 175.141 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 443' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 45.9 mt -63.79 -35.89 82.08 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 173.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -56.82 -35.76 69.17 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.378 172.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -73.21 -27.98 61.92 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.794 178.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 446' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 33.17 89.63 0.01 OUTLIER 'General case' 0 C--N 1.351 0.668 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 170.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 71.1 mt -59.51 -35.52 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 121.552 0.691 . . . . 0.0 109.18 175.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 448' ' ' ASP . . . . . 0.495 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 28.6 m-20 -166.72 175.65 7.71 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 177.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 449' ' ' ASP . . . . . 0.589 ' O ' ' HG2' ' B' ' 452' ' ' ARG . 13.6 m-20 -62.88 -60.08 3.97 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.394 -0.522 . . . . 0.0 109.61 174.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.9 -28.6 63.6 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 178.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 451' ' ' THR . . . . . 0.495 ' OG1' ' HB2' ' B' ' 448' ' ' ASP . 9.8 m -72.99 -23.38 60.64 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 119.621 -0.832 . . . . 0.0 111.39 -174.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 452' ' ' ARG . . . . . 0.589 ' HG2' ' O ' ' B' ' 449' ' ' ASP . 6.0 ptp180 -64.73 -41.62 95.81 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 174.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 453' ' ' ALA . . . . . 0.56 ' HB3' ' CD1' ' B' ' 419' ' ' TYR . . . -59.06 -49.17 78.92 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 123.751 0.657 . . . . 0.0 112.395 168.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 454' ' ' GLU . . . . . 0.464 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 33.5 mm-40 -53.77 -34.19 58.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.493 -177.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 30.0 p -115.04 15.36 17.19 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.255 -178.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 456' ' ' PHE . . . . . 0.56 ' CZ ' ' HB2' ' B' ' 423' ' ' SER . 1.0 OUTLIER -56.83 -47.64 79.86 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.833 -171.726 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 457' ' ' ILE . . . . . 0.534 ' CG1' ' HB3' ' B' ' 408' ' ' TYR . 1.9 mp -76.31 -33.47 23.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.224 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -57.83 -33.95 69.18 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 122.072 0.939 . . . . 0.0 108.999 171.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 459' ' ' HIS . . . . . 0.746 ' O ' HG23 ' B' ' 463' ' ' VAL . 44.4 m-70 -74.64 -29.25 61.2 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.136 -1.393 . . . . 0.0 110.964 177.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 460' ' ' LEU . . . . . 0.691 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -73.98 -34.64 64.29 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.882 0.849 . . . . 0.0 108.817 179.117 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 461' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 -73.13 -37.61 66.59 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.11 176.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 462' ' ' ALA . . . . . 0.622 ' O ' HD13 ' B' ' 466' ' ' ILE . . . -55.91 -34.98 66.07 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.351 -1.295 . . . . 0.0 109.62 169.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 463' ' ' VAL . . . . . 0.746 HG23 ' O ' ' B' ' 459' ' ' HIS . 72.6 t -61.68 -51.21 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-N 114.656 -1.157 . . . . 0.0 108.227 177.054 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 464' ' ' TYR . . . . . 0.561 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 15.8 m-30 -52.8 -28.41 22.41 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 124.347 1.03 . . . . 0.0 110.532 178.062 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.07 -38.9 20.22 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.765 0.793 . . . . 0.0 109.674 -177.155 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 466' ' ' ILE . . . . . 0.622 HD13 ' O ' ' B' ' 462' ' ' ALA . 3.7 mt -58.48 -55.85 20.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 114.419 -1.264 . . . . 0.0 112.181 175.134 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 467' ' ' LEU . . . . . 0.736 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -102.49 -10.72 19.12 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -172.235 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 468' ' ' GLY . . . . . 0.638 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 94.05 31.57 8.01 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 119.38 -1.391 . . . . 0.0 114.312 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 469' ' ' LEU . . . . . 0.736 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.1 mt -88.82 161.33 16.79 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 117.729 0.765 . . . . 0.0 110.883 175.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 470' ' ' ASN . . . . . 0.45 HD21 HG22 ' B' ' 476' ' ' ILE . 12.1 p30 -106.47 -177.06 3.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.014 170.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 471' ' ' ALA . . . . . 0.41 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -62.13 -19.66 63.26 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -173.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -88.0 2.48 51.67 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 122.06 -0.4 . . . . 0.0 111.775 -173.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 473' ' ' GLY . . . . . 0.483 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 76.52 11.67 84.99 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.33 -0.938 . . . . 0.0 111.035 -175.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -101.39 157.02 17.1 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 176.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 8.6 p -93.86 133.53 37.18 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.116 0.484 . . . . 0.0 111.387 -176.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 476' ' ' ILE . . . . . 0.638 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.5 pp . . . . . 0 C--N 1.328 -0.333 0 CA-C-O 121.431 0.634 . . . . 0.0 109.888 177.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 386' ' ' PHE . . . . . 0.71 ' CE2' HG11 ' A' ' 394' ' ' VAL . 0.8 OUTLIER . . . . . 0 N--CA 1.449 -0.495 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -60.16 102.94 0.19 Allowed 'Trans proline' 0 CA--C 1.531 0.362 0 C-N-CA 123.779 2.986 . . . . 0.0 113.516 177.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 388' ' ' MET . . . . . 0.641 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 47.2 mtt -105.98 163.88 12.4 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.27 176.443 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 389' ' ' HIS . . . . . 0.595 ' HD1' ' HE3' ' A' ' 396' ' ' LYS . 17.5 m170 -74.1 39.68 0.12 Allowed 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . 0.527 ' O ' ' HG2' ' A' ' 390' ' ' GLN . 9.8 tt0 71.53 16.64 5.86 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.099 0.559 . . . . 0.0 110.673 -171.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.534 HD21 ' H ' ' A' ' 392' ' ' GLY . 2.0 pt? -163.41 -59.5 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 177.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . 0.534 ' H ' HD21 ' A' ' 391' ' ' LEU . . . -171.99 67.98 0.12 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 119.714 -1.231 . . . . 0.0 113.988 -173.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . 0.641 ' HB3' ' HA ' ' A' ' 388' ' ' MET . 0.2 OUTLIER -62.22 -41.14 98.12 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 174.712 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . 0.71 HG11 ' CE2' ' A' ' 386' ' ' PHE . 0.9 OUTLIER -55.57 -47.26 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 178.95 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.545 ' N ' HG23 ' A' ' 394' ' ' VAL . 3.6 mp -57.07 -52.08 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 CA-C-O 117.762 -1.113 . . . . 0.0 113.64 -175.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . 0.629 ' O ' HG22 ' A' ' 399' ' ' VAL . 0.1 OUTLIER -60.62 -51.09 70.9 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 121.873 2.124 . . . . 0.0 112.821 -175.245 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.93 -42.72 70.76 Favored Glycine 0 N--CA 1.438 -1.18 0 C-N-CA 119.554 -1.308 . . . . 0.0 110.894 -174.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . 0.598 HD13 ' CD1' ' A' ' 410' ' ' LEU . 39.4 mt -71.78 -34.29 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 CA-C-N 114.009 -1.095 . . . . 0.0 113.641 -178.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . 0.629 HG22 ' O ' ' A' ' 396' ' ' LYS . 16.0 m -62.91 -39.56 85.53 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 C-N-CA 118.881 -1.128 . . . . 0.0 108.649 -174.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -69.96 -38.2 76.03 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 175.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . 0.448 HE21 ' HB3' ' A' ' 401' ' ' GLN . 2.5 mm100 -90.19 -48.81 6.93 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -170.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . 0.444 ' HB3' ' HB ' ' A' ' 406' ' ' THR . 1.3 mm-40 -116.12 -19.15 10.4 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.106 -170.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 104.51 161.0 24.14 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.579 178.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . 0.674 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.5 m -53.42 -45.26 57.29 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.967 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -176.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . 0.47 ' HB1' HG22 ' A' ' 457' ' ' ILE . . . -62.93 -31.23 72.27 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 119.995 -0.682 . . . . 0.0 112.606 -178.03 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 406' ' ' THR . . . . . 0.675 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 87.9 m -76.96 -43.14 36.3 Favored 'General case' 0 C--O 1.222 -0.364 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.201 173.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.482 ' HB3' ' HA ' ' A' ' 395' ' ' ILE . . . -58.69 -37.22 75.61 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 122.191 0.996 . . . . 0.0 109.297 176.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 408' ' ' TYR . . . . . 0.674 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -66.11 -51.91 53.55 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 113.414 -1.721 . . . . 0.0 109.659 176.568 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 409' ' ' THR . . . . . 0.575 HG23 HD23 ' A' ' 410' ' ' LEU . 13.3 m -54.44 -47.11 73.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.451 178.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . 0.675 ' HG ' ' O ' ' A' ' 406' ' ' THR . 14.4 mt -71.57 -37.47 71.06 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 120.944 0.402 . . . . 0.0 109.92 -175.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.33 -34.57 75.02 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.017 -1.087 . . . . 0.0 110.53 173.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 412' ' ' MET . . . . . 0.412 ' HB2' ' O ' ' A' ' 409' ' ' THR . 0.4 OUTLIER -67.28 -44.4 79.4 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 115.412 -0.394 . . . . 0.0 111.454 177.836 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 413' ' ' MET . . . . . 0.756 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.0 OUTLIER -70.85 -55.45 8.45 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 118.371 -1.332 . . . . 0.0 111.736 179.187 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . 0.756 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 3.9 mt -63.62 -44.51 93.71 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -171.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 46.8 t -86.42 -21.05 27.33 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.71 0.767 . . . . 0.0 109.906 -176.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . 0.452 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 107.37 -176.26 20.85 Favored Glycine 0 N--CA 1.431 -1.667 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -170.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -79.72 24.71 0.37 Allowed 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.4 0.619 . . . . 0.0 111.479 -172.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 418' ' ' ASN . . . . . 0.452 ' H ' ' C ' ' A' ' 416' ' ' GLY . 92.6 m-20 -70.83 75.28 0.62 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.856 -178.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 419' ' ' TYR . . . . . 0.518 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 12.1 p90 -50.56 -38.84 47.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.173 175.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -54.71 -47.82 73.24 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 123.292 0.37 . . . . 0.0 110.816 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.69 -49.12 64.36 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.419 -177.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . 0.416 ' HB ' ' CD1' ' A' ' 408' ' ' TYR . 0.2 OUTLIER -65.64 -39.5 85.16 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.552 -176.934 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.751 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 78.6 p -68.75 -36.32 78.22 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.564 -0.454 . . . . 0.0 109.868 -178.088 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -70.32 -38.75 71.05 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.946 175.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . 0.539 HG21 HG22 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -71.74 -51.68 30.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 O-C-N 122.852 -0.205 . . . . 0.0 110.857 -178.195 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . 0.541 ' O ' HD21 ' A' ' 430' ' ' LEU . 1.1 mm -74.05 -23.44 18.75 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.827 0 C-N-CA 122.407 0.283 . . . . 0.0 110.405 -173.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.751 ' HB2' ' O ' ' A' ' 423' ' ' SER . 1.0 OUTLIER -54.77 -31.84 59.21 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.034 0.445 . . . . 0.0 111.496 -177.536 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -85.16 -14.84 68.19 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.228 -0.987 . . . . 0.0 110.859 178.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.525 ' CE1' ' HD2' ' A' ' 396' ' ' LYS . 5.1 m-30 -111.0 0.2 16.9 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.689 0.757 . . . . 0.0 109.031 -171.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . 0.541 HD21 ' O ' ' A' ' 426' ' ' ILE . 0.1 OUTLIER -65.48 129.1 94.29 Favored Pre-proline 0 N--CA 1.442 -0.866 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.74 177.576 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 431' ' ' PRO . . . . . 0.515 ' HD2' HD13 ' A' ' 430' ' ' LEU . 81.3 Cg_exo -23.59 -71.19 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.941 1 C-N-CA 125.539 4.159 . . . . 0.0 114.76 179.841 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . 0.548 ' O ' HG11 ' A' ' 435' ' ' VAL . . . -138.22 -171.93 12.36 Favored Glycine 0 N--CA 1.441 -1.031 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 176.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . 0.517 ' O ' HG13 ' A' ' 436' ' ' VAL . 51.3 tp60 -67.46 -25.56 65.95 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 118.106 0.953 . . . . 0.0 110.13 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -63.84 -43.41 96.23 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 435' ' ' VAL . . . . . 0.548 HG11 ' O ' ' A' ' 432' ' ' GLY . 8.3 p -69.27 -41.93 81.26 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 CA-C-O 121.082 0.467 . . . . 0.0 110.641 -176.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . 0.517 HG13 ' O ' ' A' ' 433' ' ' GLN . 0.1 OUTLIER -67.14 -30.19 48.57 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.082 174.832 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 437' ' ' THR . . . . . 0.473 ' O ' ' HG2' ' A' ' 441' ' ' GLN . 1.1 m -66.71 -53.95 28.13 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . 0.538 ' HB1' HG11 ' A' ' 463' ' ' VAL . . . -59.46 -34.59 72.73 Favored 'General case' 0 N--CA 1.434 -1.237 0 O-C-N 124.116 0.885 . . . . 0.0 111.227 178.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 439' ' ' LEU . . . . . 0.935 HD21 ' NH2' ' A' ' 442' ' ' ARG . 0.3 OUTLIER -67.11 -50.74 60.46 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.223 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.46 -33.89 74.51 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.44 -1.254 . . . . 0.0 111.032 175.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 441' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 437' ' ' THR . 7.0 mm100 -55.01 -50.09 69.9 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.68 -175.02 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . 0.935 ' NH2' HD21 ' A' ' 439' ' ' LEU . 0.0 OUTLIER -78.08 -25.54 47.68 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 119.511 -0.875 . . . . 0.0 112.687 175.847 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 443' ' ' LEU . . . . . 0.767 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 67.3 mt -67.81 -26.62 66.16 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.7 178.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -64.82 -38.52 91.24 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.842 0.829 . . . . 0.0 109.976 173.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -77.24 -26.56 52.7 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.424 -1.262 . . . . 0.0 111.373 179.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 29.43 101.8 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 175.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 51.7 mt -60.07 -35.14 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 121.45 0.643 . . . . 0.0 110.434 -179.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . 0.459 ' HB2' ' OG1' ' A' ' 451' ' ' THR . 31.8 m-20 -164.77 -162.42 0.64 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -177.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -81.44 -72.05 0.45 Allowed 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 171.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.0 -25.14 67.99 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 178.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 451' ' ' THR . . . . . 0.482 ' HA ' ' HB2' ' A' ' 454' ' ' GLU . 8.9 m -71.03 -22.98 62.07 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.998 -174.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 452' ' ' ARG . 17.8 mtp180 -53.41 -54.16 40.88 Favored 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 171.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 453' ' ' ALA . . . . . 0.518 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -59.71 -49.61 77.05 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 114.395 -1.275 . . . . 0.0 113.095 175.183 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . 0.482 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 20.8 mm-40 -49.23 -38.34 26.24 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.341 0.591 . . . . 0.0 111.849 -176.298 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 26.1 p -120.11 16.55 12.42 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.818 -175.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . 0.483 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.8 OUTLIER -54.64 -46.8 74.0 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.688 -172.063 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . 0.516 ' CG1' ' HB3' ' A' ' 408' ' ' TYR . 1.9 mp -78.67 -35.22 18.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.64 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -57.23 -36.43 70.91 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 121.841 0.829 . . . . 0.0 109.192 172.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . 0.728 ' HB3' ' CZ ' ' A' ' 442' ' ' ARG . 78.9 m-70 -75.2 -30.43 60.63 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.528 177.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . 0.733 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.6 OUTLIER -67.49 -34.52 77.32 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 179.421 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . 0.46 ' O ' ' HB2' ' A' ' 464' ' ' TYR . 17.3 m-80 -72.95 -37.49 67.11 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.347 -1.297 . . . . 0.0 109.04 176.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 462' ' ' ALA . . . . . 0.619 ' O ' HD13 ' A' ' 466' ' ' ILE . . . -56.63 -32.19 65.08 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.146 169.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.733 ' HB ' ' O ' ' A' ' 460' ' ' LEU . 51.3 t -64.88 -49.91 77.65 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.798 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 176.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 464' ' ' TYR . . . . . 0.59 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 19.5 m-30 -51.48 -28.98 14.81 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 124.511 1.132 . . . . 0.0 110.454 176.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.84 -38.36 19.59 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.602 0.715 . . . . 0.0 109.7 -176.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.619 HD13 ' O ' ' A' ' 462' ' ' ALA . 3.7 mt -58.11 -55.48 21.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.149 174.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.732 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -101.35 -10.85 19.9 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 -172.317 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . 0.575 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 94.13 31.58 7.97 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 119.538 -1.315 . . . . 0.0 114.287 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 469' ' ' LEU . . . . . 0.732 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.1 mt -89.45 164.02 15.01 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 117.801 0.8 . . . . 0.0 110.911 175.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 43.0 p30 -105.0 -179.19 3.87 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.267 172.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 471' ' ' ALA . . . . . 0.437 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -59.62 -23.47 63.02 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -177.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -87.43 3.11 48.46 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.157 -173.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 473' ' ' GLY . . . . . 0.448 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 75.45 15.43 81.22 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.393 -0.908 . . . . 0.0 110.973 -176.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -100.95 150.17 23.15 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 178.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 4.4 p -89.61 117.07 28.22 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.286 0.565 . . . . 0.0 111.557 -178.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 476' ' ' ILE . . . . . 0.575 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.8 pp . . . . . 0 C--N 1.32 -0.692 0 CA-C-O 121.722 0.772 . . . . 0.0 110.231 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 386' ' ' PHE . . . . . 0.719 ' CE2' HG11 ' B' ' 394' ' ' VAL . 0.8 OUTLIER . . . . . 0 N--CA 1.448 -0.537 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 387' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -59.92 103.05 0.19 Allowed 'Trans proline' 0 N--CA 1.473 0.312 0 C-N-CA 123.787 2.992 . . . . 0.0 113.473 177.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 388' ' ' MET . . . . . 0.62 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 47.1 mtt -106.04 164.0 12.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.227 176.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 389' ' ' HIS . . . . . 0.599 ' HD1' ' HE3' ' B' ' 396' ' ' LYS . 17.3 m170 -74.17 39.86 0.12 Allowed 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 179.068 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 390' ' ' GLN . . . . . 0.522 ' O ' ' HG2' ' B' ' 390' ' ' GLN . 9.8 tt0 71.59 15.98 5.92 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.03 0.532 . . . . 0.0 110.65 -172.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 391' ' ' LEU . . . . . 0.526 HD21 ' H ' ' B' ' 392' ' ' GLY . 2.0 pt? -163.05 -59.5 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 177.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 392' ' ' GLY . . . . . 0.526 ' H ' HD21 ' B' ' 391' ' ' LEU . . . -171.91 68.0 0.13 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 119.729 -1.224 . . . . 0.0 114.028 -173.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 393' ' ' ASN . . . . . 0.62 ' HB3' ' HA ' ' B' ' 388' ' ' MET . 0.2 OUTLIER -62.11 -41.2 97.99 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 174.649 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 394' ' ' VAL . . . . . 0.719 HG11 ' CE2' ' B' ' 386' ' ' PHE . 0.9 OUTLIER -55.51 -47.38 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 178.867 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 395' ' ' ILE . . . . . 0.533 ' N ' HG23 ' B' ' 394' ' ' VAL . 3.6 mp -57.07 -52.01 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 CA-C-O 117.783 -1.103 . . . . 0.0 113.615 -175.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 396' ' ' LYS . . . . . 0.623 ' O ' HG22 ' B' ' 399' ' ' VAL . 0.1 OUTLIER -60.65 -51.06 70.98 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 122.049 2.204 . . . . 0.0 112.798 -175.197 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.84 -42.99 70.43 Favored Glycine 0 N--CA 1.438 -1.185 0 C-N-CA 119.595 -1.288 . . . . 0.0 110.927 -174.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 398' ' ' ILE . . . . . 0.599 HD13 ' CD1' ' B' ' 410' ' ' LEU . 39.1 mt -71.74 -34.19 51.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-N 114.074 -1.063 . . . . 0.0 113.668 -178.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 399' ' ' VAL . . . . . 0.623 HG22 ' O ' ' B' ' 396' ' ' LYS . 15.9 m -62.76 -39.72 85.9 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 C-N-CA 118.837 -1.145 . . . . 0.0 108.617 -174.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -70.07 -38.3 75.72 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 175.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 401' ' ' GLN . . . . . 0.436 HE21 ' HB3' ' B' ' 401' ' ' GLN . 2.4 mm100 -89.94 -48.79 6.99 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -170.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 402' ' ' GLU . . . . . 0.459 ' HB3' ' HB ' ' B' ' 406' ' ' THR . 1.3 mm-40 -116.23 -19.09 10.36 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.257 -170.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 104.73 160.86 23.92 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.622 178.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 404' ' ' VAL . . . . . 0.68 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.5 m -53.26 -45.17 55.22 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.954 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -176.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 405' ' ' ALA . . . . . 0.459 ' HB1' HG22 ' B' ' 457' ' ' ILE . . . -62.89 -31.36 72.39 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 119.994 -0.683 . . . . 0.0 112.655 -178.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 406' ' ' THR . . . . . 0.671 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 86.4 m -77.06 -42.83 36.78 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.232 173.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 407' ' ' ALA . . . . . 0.477 ' HB3' ' HA ' ' B' ' 395' ' ' ILE . . . -58.86 -37.12 75.8 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 122.227 1.013 . . . . 0.0 109.281 176.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 408' ' ' TYR . . . . . 0.68 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -66.28 -51.68 55.02 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 113.343 -1.753 . . . . 0.0 109.779 176.588 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 409' ' ' THR . . . . . 0.569 HG23 HD23 ' B' ' 410' ' ' LEU . 13.1 m -54.44 -47.26 73.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.377 178.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 410' ' ' LEU . . . . . 0.671 ' HG ' ' O ' ' B' ' 406' ' ' THR . 14.5 mt -71.59 -37.44 70.98 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 120.92 0.391 . . . . 0.0 109.989 -175.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.39 -34.54 75.35 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.031 -1.08 . . . . 0.0 110.499 173.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 412' ' ' MET . . . . . 0.42 ' HB2' ' O ' ' B' ' 409' ' ' THR . 0.4 OUTLIER -67.18 -44.46 79.65 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 115.434 -0.383 . . . . 0.0 111.535 177.771 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 413' ' ' MET . . . . . 0.753 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.0 OUTLIER -70.86 -55.34 8.7 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 118.316 -1.354 . . . . 0.0 111.714 179.187 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 414' ' ' LEU . . . . . 0.753 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 3.9 mt -63.79 -44.43 93.4 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -171.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 46.5 t -86.45 -20.89 27.46 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.749 0.785 . . . . 0.0 109.943 -176.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 416' ' ' GLY . . . . . 0.457 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 107.18 -176.24 20.97 Favored Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -170.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -79.72 24.82 0.37 Allowed 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.21 0.529 . . . . 0.0 111.461 -172.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 418' ' ' ASN . . . . . 0.457 ' H ' ' C ' ' B' ' 416' ' ' GLY . 92.6 m-20 -71.09 75.49 0.67 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.814 -178.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 419' ' ' TYR . . . . . 0.53 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 12.4 p90 -50.56 -38.82 47.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.195 175.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -54.77 -47.56 73.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.932 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.78 -49.22 63.59 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.45 -177.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 422' ' ' VAL . . . . . 0.42 ' HB ' ' CD1' ' B' ' 408' ' ' TYR . 0.2 OUTLIER -65.55 -39.5 85.26 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.494 -176.903 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 423' ' ' SER . . . . . 0.756 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 78.0 p -68.78 -36.38 78.23 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -178.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -70.43 -38.44 69.84 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.961 176.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 425' ' ' ILE . . . . . 0.526 HG21 HG22 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -71.94 -51.85 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-O 120.327 0.108 . . . . 0.0 110.799 -178.207 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 426' ' ' ILE . . . . . 0.536 ' O ' HD21 ' B' ' 430' ' ' LEU . 1.1 mm -73.95 -23.42 18.87 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.828 0 C-N-CA 122.37 0.268 . . . . 0.0 110.491 -173.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 427' ' ' ARG . . . . . 0.756 ' HB2' ' O ' ' B' ' 423' ' ' SER . 1.0 OUTLIER -54.75 -31.95 59.23 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.045 0.45 . . . . 0.0 111.449 -177.607 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -84.99 -15.11 67.98 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.15 -1.024 . . . . 0.0 110.817 178.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 429' ' ' TYR . . . . . 0.521 ' CE1' ' HD2' ' B' ' 396' ' ' LYS . 5.1 m-30 -110.62 -0.13 17.35 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -171.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 430' ' ' LEU . . . . . 0.538 ' HA ' HG11 ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.26 129.16 94.35 Favored Pre-proline 0 N--CA 1.441 -0.886 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.821 177.61 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 431' ' ' PRO . . . . . 0.509 ' HD2' HD13 ' B' ' 430' ' ' LEU . 78.8 Cg_exo -23.48 -70.94 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 1.003 1 C-N-CA 125.646 4.23 . . . . 0.0 114.814 179.844 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 432' ' ' GLY . . . . . 0.548 ' O ' HG11 ' B' ' 435' ' ' VAL . . . -138.82 -172.17 12.46 Favored Glycine 0 N--CA 1.441 -0.99 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 176.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 433' ' ' GLN . . . . . 0.509 ' O ' HG13 ' B' ' 436' ' ' VAL . 50.2 tp60 -67.11 -25.55 66.26 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 118.136 0.968 . . . . 0.0 110.291 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -63.99 -43.22 96.34 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 435' ' ' VAL . . . . . 0.548 HG11 ' O ' ' B' ' 432' ' ' GLY . 8.3 p -69.26 -41.87 81.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-O 120.947 0.403 . . . . 0.0 110.7 -176.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 436' ' ' VAL . . . . . 0.509 HG13 ' O ' ' B' ' 433' ' ' GLN . 0.1 OUTLIER -67.29 -30.19 48.35 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.049 174.937 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 437' ' ' THR . . . . . 0.452 ' O ' ' HG2' ' B' ' 441' ' ' GLN . 1.1 m -66.81 -53.86 28.51 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -179.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 438' ' ' ALA . . . . . 0.534 ' HB1' HG11 ' B' ' 463' ' ' VAL . . . -59.37 -34.65 72.66 Favored 'General case' 0 N--CA 1.434 -1.227 0 O-C-N 124.071 0.857 . . . . 0.0 111.261 178.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 439' ' ' LEU . . . . . 0.926 HD21 ' NH2' ' B' ' 442' ' ' ARG . 0.3 OUTLIER -67.12 -50.72 60.43 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.206 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.41 -33.98 74.61 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 114.463 -1.244 . . . . 0.0 111.037 175.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 441' ' ' GLN . . . . . 0.467 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 6.9 mm100 -54.97 -50.16 69.63 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.772 -175.007 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 442' ' ' ARG . . . . . 0.926 ' NH2' HD21 ' B' ' 439' ' ' LEU . 0.0 OUTLIER -77.97 -25.62 48.25 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 119.558 -0.857 . . . . 0.0 112.654 175.785 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 443' ' ' LEU . . . . . 0.762 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 67.3 mt -67.89 -26.4 65.99 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 120.383 -0.527 . . . . 0.0 109.593 178.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -65.06 -38.48 90.95 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.072 173.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -76.95 -27.09 54.7 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.339 -1.3 . . . . 0.0 111.33 179.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 446' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 30.08 101.95 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 175.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 52.0 mt -60.51 -34.88 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 121.359 0.599 . . . . 0.0 110.467 -179.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 448' ' ' ASP . . . . . 0.45 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 32.3 m-20 -164.91 -162.39 0.63 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -178.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -81.54 -71.76 0.46 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 171.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.27 -25.05 67.88 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 178.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 451' ' ' THR . . . . . 0.475 ' HA ' ' HB2' ' B' ' 454' ' ' GLU . 9.7 m -71.03 -23.17 62.1 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.046 -174.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 452' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' B' ' 452' ' ' ARG . 17.8 mtp180 -53.25 -54.28 38.51 Favored 'General case' 0 C--O 1.221 -0.401 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 171.336 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 453' ' ' ALA . . . . . 0.53 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -59.67 -49.33 78.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.393 -1.276 . . . . 0.0 113.11 175.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 454' ' ' GLU . . . . . 0.475 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 22.0 mm-40 -49.38 -38.34 28.27 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.299 0.571 . . . . 0.0 111.909 -176.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 25.6 p -120.24 16.57 12.32 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.818 -175.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 456' ' ' PHE . . . . . 0.472 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 0.8 OUTLIER -54.48 -46.9 73.49 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.656 -172.127 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 457' ' ' ILE . . . . . 0.52 ' CG1' ' HB3' ' B' ' 408' ' ' TYR . 1.9 mp -78.64 -35.42 18.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.565 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -57.03 -36.52 70.55 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.884 0.849 . . . . 0.0 109.278 172.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 459' ' ' HIS . . . . . 0.735 ' HB3' ' CZ ' ' B' ' 442' ' ' ARG . 78.7 m-70 -75.21 -30.37 60.59 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.515 177.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 460' ' ' LEU . . . . . 0.741 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.6 OUTLIER -67.47 -34.46 77.22 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.364 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 461' ' ' ASN . . . . . 0.453 ' O ' ' HB2' ' B' ' 464' ' ' TYR . 16.9 m-80 -73.03 -37.6 66.84 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.499 -1.228 . . . . 0.0 109.069 176.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 462' ' ' ALA . . . . . 0.608 ' O ' HD13 ' B' ' 466' ' ' ILE . . . -56.49 -32.42 65.01 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.628 -1.169 . . . . 0.0 109.957 169.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 463' ' ' VAL . . . . . 0.741 ' HB ' ' O ' ' B' ' 460' ' ' LEU . 50.9 t -64.8 -49.86 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 176.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 464' ' ' TYR . . . . . 0.576 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 19.6 m-30 -51.63 -28.58 14.79 Favored 'General case' 0 C--N 1.333 -0.13 0 O-C-N 124.442 1.089 . . . . 0.0 110.432 176.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.04 -38.57 19.02 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.662 0.744 . . . . 0.0 109.813 -176.492 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 466' ' ' ILE . . . . . 0.608 HD13 ' O ' ' B' ' 462' ' ' ALA . 3.7 mt -57.92 -55.31 22.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 114.374 -1.284 . . . . 0.0 112.215 174.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 467' ' ' LEU . . . . . 0.727 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -101.43 -10.94 19.75 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -172.383 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 468' ' ' GLY . . . . . 0.583 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 94.29 31.15 8.16 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 119.424 -1.369 . . . . 0.0 114.378 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 469' ' ' LEU . . . . . 0.727 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.0 mt -89.36 164.25 14.97 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 117.847 0.823 . . . . 0.0 110.921 175.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 42.6 p30 -105.12 -179.34 3.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.297 172.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 471' ' ' ALA . . . . . 0.433 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -59.01 -23.82 62.27 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -177.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -87.47 3.34 47.65 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.1 -173.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 473' ' ' GLY . . . . . 0.451 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 74.88 15.82 80.74 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.348 -0.929 . . . . 0.0 111.087 -176.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -100.98 150.23 23.1 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 178.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 4.6 p -89.76 117.07 28.33 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.067 0.46 . . . . 0.0 111.459 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 476' ' ' ILE . . . . . 0.583 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.8 pp . . . . . 0 C--N 1.321 -0.64 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.232 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 386' ' ' PHE . . . . . 0.684 ' CE2' HG13 ' A' ' 394' ' ' VAL . 2.1 t80 . . . . . 0 CA--C 1.538 0.501 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.08 -64.1 0.23 Allowed 'Trans proline' 0 N--CA 1.484 0.935 0 C-N-CA 124.361 3.374 . . . . 0.0 113.908 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 388' ' ' MET . . . . . 0.57 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 4.5 ttp 63.36 41.94 7.25 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 171.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 389' ' ' HIS . . . . . 0.615 ' CD2' ' HB2' ' A' ' 393' ' ' ASN . 33.0 m170 50.24 -107.34 0.27 Allowed 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 121.236 0.541 . . . . 0.0 109.757 -174.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -140.17 18.33 2.43 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 172.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.488 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.5 pt? -165.57 -54.54 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.709 -172.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . 0.488 ' N ' ' HG ' ' A' ' 391' ' ' LEU . . . -171.5 58.49 0.17 Allowed Glycine 0 C--N 1.335 0.491 0 C-N-CA 119.667 -1.254 . . . . 0.0 114.438 -174.04 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . 0.615 ' HB2' ' CD2' ' A' ' 389' ' ' HIS . 0.2 OUTLIER -59.5 -40.19 86.23 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 117.748 0.774 . . . . 0.0 109.746 174.695 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . 0.684 HG13 ' CE2' ' A' ' 386' ' ' PHE . 1.8 m -56.13 -47.46 80.53 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.598 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 178.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.601 ' N ' HG23 ' A' ' 394' ' ' VAL . 3.6 mp -57.56 -52.75 53.3 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.358 0 CA-C-O 117.86 -1.066 . . . . 0.0 113.662 -174.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . 0.616 ' O ' HG21 ' A' ' 399' ' ' VAL . 0.0 OUTLIER -63.25 -49.61 73.43 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 121.968 2.167 . . . . 0.0 112.054 -175.131 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -52.99 -44.47 62.03 Favored Glycine 0 N--CA 1.431 -1.658 0 CA-C-N 114.706 -1.133 . . . . 0.0 110.726 -176.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . 0.54 HD11 ' CD1' ' A' ' 410' ' ' LEU . 38.0 mt -71.51 -33.13 48.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . 0.616 HG21 ' O ' ' A' ' 396' ' ' LYS . 15.7 m -63.26 -39.85 86.81 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 C-N-CA 118.624 -1.23 . . . . 0.0 108.114 -175.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -69.63 -35.74 75.5 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 174.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . 0.447 HE21 ' HB3' ' A' ' 401' ' ' GLN . 5.5 mm100 -89.42 -48.06 7.59 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -172.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . 0.43 ' HB3' ' HB ' ' A' ' 406' ' ' THR . 2.4 mm-40 -120.85 -20.36 6.98 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.358 -170.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 106.74 161.74 22.14 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.607 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . 0.62 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.4 m -53.7 -45.66 61.09 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.87 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -175.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . 0.485 ' HB3' HG21 ' A' ' 457' ' ' ILE . . . -62.35 -32.62 73.43 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 119.92 -0.712 . . . . 0.0 112.527 -177.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 406' ' ' THR . . . . . 0.673 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 92.1 m -77.54 -41.26 39.68 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.534 174.148 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.49 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.7 -36.44 74.26 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 122.121 0.962 . . . . 0.0 109.081 175.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 408' ' ' TYR . . . . . 0.62 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -66.19 -52.19 50.49 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 113.569 -1.65 . . . . 0.0 109.841 175.961 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 409' ' ' THR . . . . . 0.564 HG23 HD22 ' A' ' 410' ' ' LEU . 18.0 m -54.69 -47.64 73.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.494 178.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . 0.673 ' HG ' ' O ' ' A' ' 406' ' ' THR . 14.5 mt -72.46 -36.46 68.5 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.895 -174.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.71 -34.56 77.61 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 119.901 -1.142 . . . . 0.0 110.457 173.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 412' ' ' MET . . . . . 0.436 ' HB2' ' O ' ' A' ' 409' ' ' THR . 0.5 OUTLIER -67.04 -48.94 66.79 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 115.712 -0.244 . . . . 0.0 111.441 177.595 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 413' ' ' MET . . . . . 0.931 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 1.0 OUTLIER -72.0 -43.51 64.97 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.096 -1.041 . . . . 0.0 112.15 -178.75 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . 0.931 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 14.5 mt -69.81 -45.7 67.32 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -176.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 33.0 t -87.45 -23.44 24.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.52 0.676 . . . . 0.0 110.139 -176.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . 0.444 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 108.92 -175.96 19.57 Favored Glycine 0 N--CA 1.429 -1.784 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -170.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 32.4 mm-40 -80.56 23.22 0.52 Allowed 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.312 0.577 . . . . 0.0 111.322 -171.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 418' ' ' ASN . . . . . 0.444 ' H ' ' C ' ' A' ' 416' ' ' GLY . 3.4 m-20 -72.24 75.48 0.98 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.685 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 419' ' ' TYR . . . . . 0.629 ' CD1' ' HB1' ' A' ' 453' ' ' ALA . 11.2 p90 -55.48 -38.11 68.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.163 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -54.73 -44.15 73.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.823 0.344 . . . . 0.0 110.913 178.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.9 -49.36 62.38 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.283 -177.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . 0.463 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.1 OUTLIER -64.84 -40.94 90.78 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.691 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.068 -177.659 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.777 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 16.0 t -69.46 -36.06 76.23 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 120.326 -0.55 . . . . 0.0 109.635 -176.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -70.4 -37.05 69.92 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.989 176.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . 0.558 HG23 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -71.6 -50.65 38.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.502 0.191 . . . . 0.0 110.558 -179.716 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . 0.548 ' CD1' HG22 ' A' ' 395' ' ' ILE . 1.2 mm -73.68 -23.72 19.46 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.979 0 CA-C-O 120.833 0.349 . . . . 0.0 110.2 -173.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.777 ' HB2' ' O ' ' A' ' 423' ' ' SER . 1.5 tmm_? -55.04 -32.35 61.8 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.26 0.552 . . . . 0.0 111.127 -177.247 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.68 -9.54 71.61 Favored Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 120.412 -0.899 . . . . 0.0 111.041 178.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.49 ' HD1' ' CG2' ' A' ' 395' ' ' ILE . 7.4 m-30 -114.0 -0.26 14.13 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -175.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . 0.544 HD12 ' HD2' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -66.34 129.04 94.16 Favored Pre-proline 0 N--CA 1.444 -0.773 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.784 177.92 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 431' ' ' PRO . . . . . 0.544 ' HD2' HD12 ' A' ' 430' ' ' LEU . 87.5 Cg_exo -23.45 -73.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.356 0.974 1 C-N-CA 125.62 4.213 . . . . 0.0 114.909 179.901 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . 0.534 ' O ' HG13 ' A' ' 435' ' ' VAL . . . -137.99 -170.02 11.76 Favored Glycine 0 N--CA 1.439 -1.105 0 N-CA-C 110.311 -1.115 . . . . 0.0 110.311 176.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . 0.481 ' O ' HG12 ' A' ' 436' ' ' VAL . 22.6 tp60 -65.89 -27.42 68.19 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 117.929 0.865 . . . . 0.0 110.315 -178.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -66.41 -40.59 89.69 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -177.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 435' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 432' ' ' GLY . 8.5 p -70.22 -43.48 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.09 0 CA-C-O 120.942 0.401 . . . . 0.0 110.655 -177.247 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . 0.481 HG12 ' O ' ' A' ' 433' ' ' GLN . 0.1 OUTLIER -66.29 -30.6 50.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.12 175.044 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 437' ' ' THR . . . . . 0.514 ' O ' ' HG2' ' A' ' 441' ' ' GLN . 1.0 OUTLIER -67.89 -53.19 28.48 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -179.212 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . 0.539 ' HB3' HG11 ' A' ' 463' ' ' VAL . . . -59.44 -35.17 73.52 Favored 'General case' 0 N--CA 1.437 -1.091 0 O-C-N 123.924 0.765 . . . . 0.0 111.349 178.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 439' ' ' LEU . . . . . 0.921 HD21 ' NH2' ' A' ' 442' ' ' ARG . 0.4 OUTLIER -67.14 -50.75 60.19 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 -179.257 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.44 -34.16 74.96 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.231 -1.349 . . . . 0.0 111.294 175.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 441' ' ' GLN . . . . . 0.514 ' HG2' ' O ' ' A' ' 437' ' ' THR . 7.4 mm100 -54.65 -49.65 70.06 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.047 -176.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . 0.921 ' NH2' HD21 ' A' ' 439' ' ' LEU . 0.0 OUTLIER -78.26 -25.65 46.87 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.484 -0.886 . . . . 0.0 112.648 175.72 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 443' ' ' LEU . . . . . 0.739 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 67.6 mt -67.51 -26.38 66.31 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.197 0.522 . . . . 0.0 109.618 178.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -64.6 -38.16 90.05 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.969 173.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -76.31 -26.66 56.04 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.43 -1.259 . . . . 0.0 111.102 178.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 28.53 99.05 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 O-C-N 124.702 1.251 . . . . 0.0 114.373 175.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 50.1 mt -59.0 -34.56 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 121.545 0.688 . . . . 0.0 110.579 -179.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -163.29 -161.2 0.66 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 -177.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -82.13 -70.83 0.52 Allowed 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 167.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 450' ' ' GLN . . . . . 0.4 ' O ' ' HG2' ' A' ' 454' ' ' GLU . 0.0 OUTLIER -64.7 -26.38 68.35 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -179.375 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 451' ' ' THR . . . . . 0.456 ' HA ' ' HB2' ' A' ' 454' ' ' GLU . 9.0 m -71.2 -23.18 61.98 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.982 -174.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . 0.419 ' NH2' ' HB3' ' A' ' 443' ' ' LEU . 19.3 mtp180 -53.19 -54.55 34.35 Favored 'General case' 0 C--O 1.222 -0.381 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 171.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 453' ' ' ALA . . . . . 0.629 ' HB1' ' CD1' ' A' ' 419' ' ' TYR . . . -60.34 -48.75 80.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.203 -1.362 . . . . 0.0 113.028 175.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . 0.456 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 78.6 mm-40 -49.1 -38.3 24.2 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.34 0.59 . . . . 0.0 111.723 -175.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 28.3 p -120.57 16.41 12.03 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.291 -176.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . 0.482 ' CZ ' ' HB2' ' A' ' 423' ' ' SER . 0.8 OUTLIER -53.66 -47.88 69.95 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.648 -172.042 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . 0.511 ' CG1' ' HB3' ' A' ' 408' ' ' TYR . 1.9 mp -77.59 -35.2 21.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.712 -179.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -56.93 -36.13 69.87 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 121.969 0.89 . . . . 0.0 109.055 172.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . 0.725 ' HB3' ' CZ ' ' A' ' 442' ' ' ARG . 81.3 m-70 -75.62 -30.4 59.51 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.405 -1.27 . . . . 0.0 110.743 177.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . 0.734 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.6 OUTLIER -67.84 -34.71 77.24 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.749 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . 0.469 ' O ' ' HB2' ' A' ' 464' ' ' TYR . 24.4 m-80 -72.95 -37.3 67.17 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.344 -1.298 . . . . 0.0 108.889 177.098 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 462' ' ' ALA . . . . . 0.569 ' O ' HD11 ' A' ' 466' ' ' ILE . . . -56.98 -32.49 66.13 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.429 -1.26 . . . . 0.0 110.238 168.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.734 ' HB ' ' O ' ' A' ' 460' ' ' LEU . 49.4 t -64.12 -49.77 79.92 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 176.061 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 464' ' ' TYR . . . . . 0.59 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 18.8 m-30 -51.99 -28.21 16.12 Favored 'General case' 0 C--N 1.333 -0.137 0 O-C-N 124.435 1.084 . . . . 0.0 110.403 176.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.94 -40.5 18.45 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.611 0.72 . . . . 0.0 109.616 -177.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.569 HD11 ' O ' ' A' ' 462' ' ' ALA . 3.7 mt -57.33 -54.76 26.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 114.481 -1.236 . . . . 0.0 112.174 176.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.741 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -101.49 -10.85 19.78 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -172.966 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . 0.599 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 94.07 31.18 8.23 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 119.586 -1.292 . . . . 0.0 114.425 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 469' ' ' LEU . . . . . 0.741 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.7 mt -89.08 165.43 14.52 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 117.79 0.795 . . . . 0.0 110.932 176.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 37.2 p30 -105.49 -177.82 3.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.9 171.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 471' ' ' ALA . . . . . 0.555 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -66.05 -15.5 63.11 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -176.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 -88.02 -1.84 58.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.709 0.29 . . . . 0.0 111.023 -175.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 473' ' ' GLY . . . . . 0.459 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 79.32 12.99 83.29 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.224 -0.989 . . . . 0.0 111.032 -175.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -101.17 151.82 21.38 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 176.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 27.5 t -89.73 134.96 33.9 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.155 0.502 . . . . 0.0 110.536 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 476' ' ' ILE . . . . . 0.599 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.6 pp . . . . . 0 C--N 1.318 -0.769 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.2 -176.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 386' ' ' PHE . . . . . 0.674 ' CE2' HG13 ' B' ' 394' ' ' VAL . 2.1 t80 . . . . . 0 CA--C 1.538 0.501 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 387' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -51.04 -64.05 0.23 Allowed 'Trans proline' 0 N--CA 1.482 0.836 0 C-N-CA 124.355 3.37 . . . . 0.0 114.014 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 388' ' ' MET . . . . . 0.57 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 4.5 ttp 63.39 41.83 7.29 Favored 'General case' 0 CA--C 1.549 0.941 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 171.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 389' ' ' HIS . . . . . 0.607 ' CD2' ' HB2' ' B' ' 393' ' ' ASN . 33.0 m170 50.39 -107.34 0.27 Allowed 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 121.113 0.482 . . . . 0.0 109.794 -174.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -140.25 18.49 2.42 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 172.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 391' ' ' LEU . . . . . 0.49 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.5 pt? -165.62 -54.69 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.668 -172.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 392' ' ' GLY . . . . . 0.49 ' N ' ' HG ' ' B' ' 391' ' ' LEU . . . -171.46 58.63 0.17 Allowed Glycine 0 CA--C 1.523 0.552 0 C-N-CA 119.755 -1.212 . . . . 0.0 114.452 -173.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 393' ' ' ASN . . . . . 0.607 ' HB2' ' CD2' ' B' ' 389' ' ' HIS . 0.2 OUTLIER -59.67 -40.18 86.94 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 117.658 0.729 . . . . 0.0 109.665 174.722 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 394' ' ' VAL . . . . . 0.674 HG13 ' CE2' ' B' ' 386' ' ' PHE . 1.8 m -56.15 -47.48 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 178.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 395' ' ' ILE . . . . . 0.598 ' N ' HG23 ' B' ' 394' ' ' VAL . 3.7 mp -57.68 -52.72 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 CA-C-O 117.846 -1.073 . . . . 0.0 113.738 -174.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 396' ' ' LYS . . . . . 0.617 ' O ' HG21 ' B' ' 399' ' ' VAL . 0.0 OUTLIER -63.07 -49.7 73.51 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 122.117 2.235 . . . . 0.0 111.967 -175.3 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -52.94 -44.53 61.78 Favored Glycine 0 N--CA 1.432 -1.621 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.696 -175.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 398' ' ' ILE . . . . . 0.552 HD11 ' CD1' ' B' ' 410' ' ' LEU . 38.8 mt -71.45 -33.28 49.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -179.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 399' ' ' VAL . . . . . 0.617 HG21 ' O ' ' B' ' 396' ' ' LYS . 15.6 m -63.35 -39.58 85.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 C-N-CA 118.583 -1.247 . . . . 0.0 108.111 -175.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -69.8 -35.83 75.17 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 174.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 401' ' ' GLN . . . . . . . . . . . . . 5.3 mm100 -89.21 -48.01 7.68 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -172.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 402' ' ' GLU . . . . . 0.441 ' HB3' ' HB ' ' B' ' 406' ' ' THR . 2.4 mm-40 -121.09 -20.31 6.85 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.46 -170.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 106.99 161.78 21.91 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.658 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 404' ' ' VAL . . . . . 0.61 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.4 m -53.67 -45.55 60.65 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -175.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 405' ' ' ALA . . . . . 0.474 ' HB3' HG21 ' B' ' 457' ' ' ILE . . . -62.58 -32.36 73.33 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 119.866 -0.734 . . . . 0.0 112.43 -177.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 406' ' ' THR . . . . . 0.67 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 93.7 m -77.72 -41.34 38.17 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.039 -0.664 . . . . 0.0 110.498 174.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 407' ' ' ALA . . . . . 0.483 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.69 -36.37 74.1 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 122.122 0.963 . . . . 0.0 109.135 175.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 408' ' ' TYR . . . . . 0.61 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -66.16 -52.18 50.69 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 113.581 -1.645 . . . . 0.0 109.866 175.905 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 409' ' ' THR . . . . . 0.565 HG23 HD22 ' B' ' 410' ' ' LEU . 17.9 m -54.74 -47.59 73.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.467 178.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 410' ' ' LEU . . . . . 0.67 ' HG ' ' O ' ' B' ' 406' ' ' THR . 14.6 mt -72.51 -36.48 68.37 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -174.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.57 -34.61 76.87 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 119.891 -1.147 . . . . 0.0 110.481 173.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 412' ' ' MET . . . . . 0.435 ' HB2' ' O ' ' B' ' 409' ' ' THR . 0.5 OUTLIER -67.03 -49.15 66.15 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 115.645 -0.277 . . . . 0.0 111.361 177.665 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 413' ' ' MET . . . . . 0.94 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 1.0 OUTLIER -71.84 -43.64 65.19 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.02 -1.072 . . . . 0.0 112.033 -178.63 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 414' ' ' LEU . . . . . 0.94 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 14.4 mt -69.63 -45.91 67.4 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -176.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 415' ' ' SER . . . . . 0.406 ' HB2' ' HE2' ' B' ' 388' ' ' MET . 33.4 t -87.27 -23.44 24.69 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.625 0.726 . . . . 0.0 110.12 -175.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 416' ' ' GLY . . . . . 0.438 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 109.0 -175.81 19.43 Favored Glycine 0 N--CA 1.43 -1.714 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -170.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 33.0 mm-40 -80.48 23.05 0.53 Allowed 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.205 0.526 . . . . 0.0 111.419 -172.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 418' ' ' ASN . . . . . 0.438 ' H ' ' C ' ' B' ' 416' ' ' GLY . 3.1 m-20 -72.19 75.54 0.97 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.684 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 419' ' ' TYR . . . . . 0.628 ' CD1' ' HB1' ' B' ' 453' ' ' ALA . 10.7 p90 -55.64 -38.04 69.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.204 -179.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -54.91 -43.96 73.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.845 0.355 . . . . 0.0 110.8 178.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.97 -49.34 62.24 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.328 -177.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 422' ' ' VAL . . . . . 0.46 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.1 OUTLIER -64.9 -40.97 90.85 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.105 -177.682 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 423' ' ' SER . . . . . 0.765 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 15.0 t -69.54 -35.84 75.83 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 120.297 -0.561 . . . . 0.0 109.569 -176.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -70.39 -37.19 70.04 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.964 176.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 425' ' ' ILE . . . . . 0.545 HG23 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -71.57 -50.57 38.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.655 0.264 . . . . 0.0 110.59 -179.728 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 426' ' ' ILE . . . . . 0.534 ' CD1' HG22 ' B' ' 395' ' ' ILE . 1.2 mm -73.81 -23.73 19.28 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.042 0 CA-C-O 120.887 0.375 . . . . 0.0 110.163 -173.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 427' ' ' ARG . . . . . 0.765 ' HB2' ' O ' ' B' ' 423' ' ' SER . 1.5 tmm_? -55.03 -32.52 61.92 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.28 0.562 . . . . 0.0 111.134 -177.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.5 -9.44 72.31 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.152 178.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 429' ' ' TYR . . . . . 0.483 ' HD1' ' CG2' ' B' ' 395' ' ' ILE . 7.5 m-30 -113.98 -0.52 14.06 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -175.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 430' ' ' LEU . . . . . 0.536 HD12 ' HD2' ' B' ' 431' ' ' PRO . 0.0 OUTLIER -66.13 129.26 94.21 Favored Pre-proline 0 N--CA 1.444 -0.772 0 CA-C-N 114.532 -1.213 . . . . 0.0 108.782 178.039 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 431' ' ' PRO . . . . . 0.536 ' HD2' HD12 ' B' ' 430' ' ' LEU . 84.3 Cg_exo -23.4 -74.1 0.02 OUTLIER 'Trans proline' 0 C--N 1.356 0.936 1 C-N-CA 125.698 4.265 . . . . 0.0 114.93 179.708 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 432' ' ' GLY . . . . . 0.527 ' O ' HG13 ' B' ' 435' ' ' VAL . . . -137.57 -170.26 11.84 Favored Glycine 0 N--CA 1.441 -0.978 0 N-CA-C 110.301 -1.119 . . . . 0.0 110.301 176.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 433' ' ' GLN . . . . . 0.472 ' O ' HG12 ' B' ' 436' ' ' VAL . 22.7 tp60 -65.77 -27.51 68.34 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 117.865 0.832 . . . . 0.0 110.266 -179.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -66.3 -40.94 90.32 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.209 -177.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 435' ' ' VAL . . . . . 0.527 HG13 ' O ' ' B' ' 432' ' ' GLY . 8.6 p -70.01 -43.32 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-O 120.94 0.4 . . . . 0.0 110.693 -177.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 436' ' ' VAL . . . . . 0.472 HG12 ' O ' ' B' ' 433' ' ' GLN . 0.1 OUTLIER -66.46 -30.53 50.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.049 175.139 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 437' ' ' THR . . . . . 0.499 ' O ' ' HG2' ' B' ' 441' ' ' GLN . 1.0 OUTLIER -67.89 -53.43 26.62 Favored 'General case' 0 C--O 1.204 -1.33 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -179.38 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 438' ' ' ALA . . . . . 0.536 ' HB3' HG11 ' B' ' 463' ' ' VAL . . . -59.27 -35.21 73.31 Favored 'General case' 0 N--CA 1.438 -1.049 0 O-C-N 123.869 0.731 . . . . 0.0 111.275 178.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 439' ' ' LEU . . . . . 0.906 HD21 ' NH2' ' B' ' 442' ' ' ARG . 0.4 OUTLIER -67.08 -50.8 60.45 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -179.286 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.45 -34.11 74.88 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 114.354 -1.294 . . . . 0.0 111.252 175.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 441' ' ' GLN . . . . . 0.499 ' HG2' ' O ' ' B' ' 437' ' ' THR . 7.5 mm100 -54.74 -50.01 69.44 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.917 -176.015 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 442' ' ' ARG . . . . . 0.906 ' NH2' HD21 ' B' ' 439' ' ' LEU . 0.0 OUTLIER -77.86 -25.64 48.78 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 119.502 -0.879 . . . . 0.0 112.709 175.752 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 443' ' ' LEU . . . . . 0.746 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 68.2 mt -67.68 -26.21 66.08 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -64.88 -37.92 89.25 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.95 173.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -76.45 -26.79 55.79 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.444 -1.253 . . . . 0.0 111.043 178.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 446' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 28.6 99.0 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 176.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 50.8 mt -58.96 -34.38 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-O 121.427 0.632 . . . . 0.0 110.601 -179.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 448' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -163.51 -160.89 0.62 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -177.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -82.74 -70.64 0.54 Allowed 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 168.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 450' ' ' GLN . . . . . 0.409 ' O ' ' HG2' ' B' ' 454' ' ' GLU . 0.0 OUTLIER -64.61 -26.31 68.34 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -179.502 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 451' ' ' THR . . . . . 0.445 ' HA ' ' HB2' ' B' ' 454' ' ' GLU . 9.1 m -71.35 -23.19 61.87 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.901 -174.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 452' ' ' ARG . . . . . 0.416 ' NH2' ' HB3' ' B' ' 443' ' ' LEU . 19.4 mtp180 -53.29 -54.45 36.15 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 171.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 453' ' ' ALA . . . . . 0.628 ' HB1' ' CD1' ' B' ' 419' ' ' TYR . . . -60.27 -48.74 80.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.36 -1.291 . . . . 0.0 113.032 175.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 454' ' ' GLU . . . . . 0.445 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 78.7 mm-40 -49.1 -38.57 25.16 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.158 0.504 . . . . 0.0 111.73 -175.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 28.4 p -120.58 16.49 12.03 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.163 -175.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 456' ' ' PHE . . . . . 0.48 ' CZ ' ' HB2' ' B' ' 423' ' ' SER . 0.9 OUTLIER -53.41 -48.12 68.98 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.6 -172.273 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 457' ' ' ILE . . . . . 0.527 ' CG1' ' HB3' ' B' ' 408' ' ' TYR . 1.9 mp -77.41 -35.2 21.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.77 -179.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -56.87 -36.12 69.69 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 122.059 0.933 . . . . 0.0 109.073 172.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 459' ' ' HIS . . . . . 0.735 ' HB3' ' CZ ' ' B' ' 442' ' ' ARG . 81.4 m-70 -75.59 -30.6 59.65 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.707 177.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 460' ' ' LEU . . . . . 0.738 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.6 OUTLIER -67.8 -34.62 77.12 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.843 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 461' ' ' ASN . . . . . 0.453 ' O ' ' HB2' ' B' ' 464' ' ' TYR . 25.2 m-80 -72.86 -37.51 67.35 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.394 -1.275 . . . . 0.0 109.007 176.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 462' ' ' ALA . . . . . 0.577 ' O ' HD11 ' B' ' 466' ' ' ILE . . . -56.77 -32.65 65.83 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.462 -1.245 . . . . 0.0 110.174 168.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 463' ' ' VAL . . . . . 0.738 ' HB ' ' O ' ' B' ' 460' ' ' LEU . 50.2 t -63.93 -49.7 80.63 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.817 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 176.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 464' ' ' TYR . . . . . 0.571 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 18.7 m-30 -52.13 -28.23 17.11 Favored 'General case' 0 C--N 1.332 -0.159 0 O-C-N 124.432 1.082 . . . . 0.0 110.404 176.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.05 -40.1 18.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.525 0.679 . . . . 0.0 109.653 -177.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 466' ' ' ILE . . . . . 0.577 HD11 ' O ' ' B' ' 462' ' ' ALA . 3.7 mt -57.49 -55.12 22.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 114.355 -1.293 . . . . 0.0 112.117 176.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 467' ' ' LEU . . . . . 0.743 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -101.36 -10.73 19.99 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -173.042 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 468' ' ' GLY . . . . . 0.583 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 94.01 31.28 8.2 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 119.412 -1.375 . . . . 0.0 114.343 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 469' ' ' LEU . . . . . 0.743 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.7 mt -89.26 165.08 14.65 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 117.899 0.85 . . . . 0.0 110.859 176.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 36.9 p30 -105.32 -177.75 3.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.817 171.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 471' ' ' ALA . . . . . 0.557 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -65.97 -15.66 63.2 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -176.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 -87.95 -1.74 58.18 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.081 -175.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 473' ' ' GLY . . . . . 0.444 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 79.01 13.06 83.46 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.333 -0.937 . . . . 0.0 110.963 -175.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -100.91 151.63 21.51 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 176.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 475' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' B' ' 469' ' ' LEU . 24.7 t -89.59 135.34 33.66 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.158 0.504 . . . . 0.0 110.299 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 476' ' ' ILE . . . . . 0.583 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.6 pp . . . . . 0 C--N 1.32 -0.711 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.18 -176.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 21.6 ptt180 . . . . . 0 N--CA 1.478 0.964 0 CA-C-O 120.927 0.394 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -129.16 -33.12 1.97 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.826 -178.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' HIS . . . . . 0.433 ' HB3' ' HB3' ' A' ' 388' ' ' MET . 13.7 p80 -164.03 158.1 19.12 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 121.133 0.492 . . . . 0.0 112.068 -177.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -138.07 -43.77 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.641 177.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 21.0 m -97.49 -55.95 2.67 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.794 0.33 . . . . 0.0 110.88 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' PHE . . . . . 0.816 ' CZ ' HG11 ' A' ' 394' ' ' VAL . 3.4 t80 -76.44 129.22 80.46 Favored Pre-proline 0 C--N 1.329 -0.32 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . 0.577 ' HG2' ' OD1' ' B' ' 393' ' ' ASN . 35.6 Cg_endo -66.88 64.14 0.59 Allowed 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 123.91 3.073 . . . . 0.0 113.562 176.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' MET . . . . . 0.774 ' SD ' HG13 ' A' ' 394' ' ' VAL . 5.2 tpp -68.15 164.79 19.59 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.868 176.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' HIS . . . . . 0.595 ' CE1' ' HA ' ' A' ' 393' ' ' ASN . 30.6 m170 -65.25 -160.77 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 172.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -71.34 1.48 6.15 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.196 170.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.56 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.1 pt? -155.23 -63.73 0.12 Allowed 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -177.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . 0.611 ' HA2' ' SD ' ' A' ' 388' ' ' MET . . . -158.98 74.93 0.21 Allowed Glycine 0 CA--C 1.523 0.583 0 C-N-CA 120.055 -1.069 . . . . 0.0 114.203 -172.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . 0.595 ' HA ' ' CE1' ' A' ' 389' ' ' HIS . 0.0 OUTLIER -65.76 -42.01 91.38 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 177.696 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . 0.816 HG11 ' CZ ' ' A' ' 386' ' ' PHE . 0.6 OUTLIER -57.3 -46.23 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 179.754 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.583 HG23 HG22 ' A' ' 425' ' ' ILE . 4.1 mp -57.43 -52.15 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 CA-C-O 117.743 -1.122 . . . . 0.0 113.301 -173.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . 0.628 ' O ' HG21 ' A' ' 399' ' ' VAL . 0.1 OUTLIER -62.14 -50.6 71.22 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-N 122.025 2.193 . . . . 0.0 112.198 -176.776 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.76 -44.65 70.14 Favored Glycine 0 N--CA 1.434 -1.463 0 C-N-CA 119.911 -1.138 . . . . 0.0 110.898 -175.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . 0.696 ' CD1' HD12 ' A' ' 410' ' ' LEU . 27.1 mt -71.22 -34.04 52.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . 0.628 HG21 ' O ' ' A' ' 396' ' ' LYS . 16.1 m -62.7 -40.0 86.86 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 C-N-CA 118.898 -1.121 . . . . 0.0 108.576 -174.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -71.25 -36.99 71.98 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 176.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . 0.42 HE21 ' HB3' ' A' ' 401' ' ' GLN . 4.1 mm100 -88.61 -46.79 8.77 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -171.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . 0.451 ' HB3' ' HB ' ' A' ' 406' ' ' THR . 2.5 mm-40 -120.35 -20.29 7.31 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.484 -171.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 106.58 162.04 22.34 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.922 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . 0.63 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.5 m -53.61 -45.25 59.53 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.81 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -175.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . 0.469 ' HB3' HG22 ' A' ' 457' ' ' ILE . . . -64.37 -30.82 71.86 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 119.784 -0.766 . . . . 0.0 112.489 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 406' ' ' THR . . . . . 0.704 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 85.2 m -76.96 -42.53 38.71 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.03 173.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.529 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.57 -36.96 74.78 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 122.141 0.972 . . . . 0.0 109.363 177.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 408' ' ' TYR . . . . . 0.63 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -66.2 -52.1 51.25 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 113.469 -1.696 . . . . 0.0 109.686 176.404 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 409' ' ' THR . . . . . 0.547 HG22 HD22 ' A' ' 410' ' ' LEU . 12.3 m -55.15 -47.46 75.08 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.541 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . 0.704 ' HG ' ' O ' ' A' ' 406' ' ' THR . 13.7 mt -72.25 -35.79 68.88 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.041 0.448 . . . . 0.0 109.983 -175.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.86 -34.72 79.37 Favored Glycine 0 N--CA 1.439 -1.13 0 C-N-CA 120.238 -0.982 . . . . 0.0 110.755 172.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 412' ' ' MET . . . . . 0.413 ' HE1' ' HA ' ' A' ' 417' ' ' GLN . 0.5 OUTLIER -69.8 -48.01 60.74 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-O 120.532 0.206 . . . . 0.0 111.362 178.33 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 413' ' ' MET . . . . . 0.93 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.5 OUTLIER -70.56 -42.0 71.69 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 119.082 -1.047 . . . . 0.0 112.256 -178.289 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . 0.93 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 19.4 mt -75.25 -46.45 33.63 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -177.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 25.2 t -86.44 -16.87 35.81 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.757 0.789 . . . . 0.0 109.763 -173.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . 0.464 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 106.4 -178.26 22.5 Favored Glycine 0 N--CA 1.43 -1.702 0 N-CA-C 109.934 -1.267 . . . . 0.0 109.934 -171.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 417' ' ' GLN . . . . . 0.413 ' HA ' ' HE1' ' A' ' 412' ' ' MET . 33.4 mm-40 -79.76 24.19 0.4 Allowed 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.262 0.554 . . . . 0.0 111.001 -174.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 418' ' ' ASN . . . . . 0.464 ' H ' ' C ' ' A' ' 416' ' ' GLY . 3.8 m-20 -70.99 75.55 0.65 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.864 -177.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 419' ' ' TYR . . . . . 0.577 ' CD1' ' HB3' ' A' ' 453' ' ' ALA . 2.3 p90 -49.11 -40.1 30.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.763 176.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -55.39 -45.85 76.61 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.926 0.393 . . . . 0.0 111.007 178.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.74 -48.75 62.96 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.254 -176.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . 0.438 ' HB ' ' CD1' ' A' ' 408' ' ' TYR . 0.1 OUTLIER -66.14 -41.36 89.26 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.515 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.126 -175.737 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.8 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 76.9 p -66.95 -39.45 87.29 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.906 -178.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.0 -38.91 93.08 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.442 -0.885 . . . . 0.0 111.883 176.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . 0.583 HG22 HG23 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.94 -52.9 20.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.308 0.099 . . . . 0.0 111.232 -176.956 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . 0.57 ' CD1' HG21 ' A' ' 395' ' ' ILE . 1.1 mm -74.18 -23.6 18.65 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.758 0 O-C-N 122.199 -0.313 . . . . 0.0 110.21 -171.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.8 ' HB2' ' O ' ' A' ' 423' ' ' SER . 2.3 tmm_? -55.4 -31.5 61.88 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.266 0.555 . . . . 0.0 111.022 -177.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -85.37 -12.3 73.33 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.168 178.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.516 ' HD1' ' CG2' ' A' ' 395' ' ' ILE . 7.5 m-30 -113.15 -0.08 14.77 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.588 0.709 . . . . 0.0 109.297 -173.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . 0.545 HD13 ' HD2' ' A' ' 431' ' ' PRO . 0.1 OUTLIER -65.97 129.69 94.3 Favored Pre-proline 0 N--CA 1.446 -0.631 0 CA-C-N 114.476 -1.238 . . . . 0.0 109.268 178.159 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . 0.545 ' HD2' HD13 ' A' ' 430' ' ' LEU . 95.4 Cg_exo -24.05 -60.46 0.05 OUTLIER 'Trans proline' 0 C--N 1.359 1.099 1 C-N-CA 125.709 4.273 . . . . 0.0 115.012 179.736 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . 0.549 ' O ' HG13 ' A' ' 435' ' ' VAL . . . -152.68 -170.6 19.26 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 177.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . 0.539 ' O ' HG12 ' A' ' 436' ' ' VAL . 17.2 tp60 -66.76 -26.63 67.07 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 118.026 0.913 . . . . 0.0 110.402 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -65.88 -43.27 88.81 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -177.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 435' ' ' VAL . . . . . 0.549 HG13 ' O ' ' A' ' 432' ' ' GLY . 7.5 p -67.32 -42.19 87.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-O 121.082 0.467 . . . . 0.0 110.409 -177.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . 0.539 HG12 ' O ' ' A' ' 433' ' ' GLN . 0.1 OUTLIER -68.08 -30.66 48.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.83 175.643 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 437' ' ' THR . . . . . 0.405 HG22 ' N ' ' A' ' 438' ' ' ALA . 0.9 OUTLIER -67.88 -51.84 43.37 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -179.871 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . 0.801 ' O ' ' HG2' ' A' ' 442' ' ' ARG . . . -58.02 -38.92 77.08 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.929 177.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 439' ' ' LEU . . . . . 0.541 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 1.9 tm? -69.94 -46.96 64.18 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.1 -39.17 74.51 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.109 174.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 441' ' ' GLN . . . . . 0.508 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 8.4 mm-40 -54.46 -49.65 69.57 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 123.776 0.83 . . . . 0.0 110.747 174.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . 0.801 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 0.9 OUTLIER -56.29 -39.92 73.47 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.729 172.294 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 443' ' ' LEU . . . . . 0.542 ' O ' ' HB2' ' A' ' 446' ' ' GLU . 46.9 mt -71.64 -33.02 68.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.268 0.556 . . . . 0.0 110.062 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -60.55 -37.77 82.31 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.502 174.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -73.02 -28.69 62.5 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.584 177.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 446' ' ' GLU . . . . . 0.542 ' HB2' ' O ' ' A' ' 443' ' ' LEU . 42.0 tt0 31.41 97.06 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.247 1.202 . . . . 0.0 114.247 172.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 49.3 mt -66.34 -36.05 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 121.294 0.569 . . . . 0.0 110.402 178.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . 0.61 ' O ' ' HG3' ' A' ' 452' ' ' ARG . 19.7 m-20 -166.05 -172.4 2.29 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 -179.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -77.58 -61.13 2.09 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.442 175.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.17 -26.1 64.68 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 176.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 451' ' ' THR . . . . . 0.505 ' OG1' ' HB2' ' A' ' 448' ' ' ASP . 18.3 m -71.73 -22.24 61.65 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.437 -175.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . 0.61 ' HG3' ' O ' ' A' ' 448' ' ' ASP . 13.5 mtp180 -52.97 -54.22 38.25 Favored 'General case' 0 C--O 1.218 -0.567 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 170.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 453' ' ' ALA . . . . . 0.577 ' HB3' ' CD1' ' A' ' 419' ' ' TYR . . . -56.99 -50.06 73.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.443 -1.253 . . . . 0.0 112.623 175.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . 0.456 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 40.7 mm-40 -51.41 -35.93 41.33 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.892 -177.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 28.3 p -118.48 16.07 13.79 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.283 -176.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . 0.568 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.9 OUTLIER -56.58 -47.73 78.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.06 0.457 . . . . 0.0 111.656 -171.33 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . 0.528 ' CG1' ' HB3' ' A' ' 408' ' ' TYR . 1.9 mp -77.32 -33.06 19.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.964 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -58.05 -35.18 70.97 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.889 0.852 . . . . 0.0 109.385 171.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . 0.722 ' O ' HG23 ' A' ' 463' ' ' VAL . 62.1 m-70 -73.81 -28.69 61.75 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.712 177.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . 0.725 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -73.85 -34.69 64.62 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.891 0.853 . . . . 0.0 108.968 178.869 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . 0.458 ' O ' ' HB2' ' A' ' 464' ' ' TYR . 22.4 m-80 -73.37 -37.3 66.06 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.922 0.868 . . . . 0.0 108.899 176.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 462' ' ' ALA . . . . . 0.642 ' O ' HD11 ' A' ' 466' ' ' ILE . . . -56.54 -34.2 66.84 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.848 169.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.725 ' HB ' ' O ' ' A' ' 460' ' ' LEU . 56.0 t -61.69 -50.16 81.37 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.796 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.051 175.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 464' ' ' TYR . . . . . 0.571 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 18.6 m-30 -53.1 -28.45 25.49 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.611 177.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.86 -40.35 22.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.842 0.829 . . . . 0.0 109.596 -178.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.642 HD11 ' O ' ' A' ' 462' ' ' ALA . 3.4 mt -58.02 -55.23 23.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 114.196 -1.366 . . . . 0.0 112.308 177.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.734 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -102.26 -10.04 19.89 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -172.89 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . 0.511 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 93.42 31.9 8.08 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 119.173 -1.489 . . . . 0.0 113.932 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 469' ' ' LEU . . . . . 0.734 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.2 mt -89.56 162.84 15.46 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 117.78 0.79 . . . . 0.0 110.732 175.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . 0.477 ' HB3' ' CG2' ' A' ' 476' ' ' ILE . 39.0 p30 -102.64 -179.65 4.03 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.902 171.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 471' ' ' ALA . . . . . 0.536 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -61.04 -22.01 64.16 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -175.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 472' ' ' ARG . . . . . 0.445 ' HA ' ' O ' ' A' ' 402' ' ' GLU . 17.4 mmt180 -88.61 6.79 36.56 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.507 -171.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . 0.431 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 74.34 13.08 81.78 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.455 -0.879 . . . . 0.0 111.114 -177.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -100.6 152.71 20.1 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 24.0 p -91.03 126.79 36.22 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.297 0.57 . . . . 0.0 110.573 176.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 476' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.7 pp -87.74 -3.18 9.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.701 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 477' ' ' ARG . . . . . 0.461 ' HD2' ' O ' ' A' ' 477' ' ' ARG . 1.3 ppt_? -123.79 166.1 16.17 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.158 177.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 83.2 mt -112.72 136.5 52.24 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 . . . . . 0 C--O 1.246 0.901 0 CA-C-O 118.653 -0.689 . . . . 0.0 110.357 179.501 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 381' ' ' ARG . . . . . . . . . . . . . 21.2 ptt180 . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 120.943 0.401 . . . . 0.0 110.39 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 382' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.63 -33.47 2.07 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.706 -178.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 383' ' ' HIS . . . . . 0.443 ' HB3' ' HB3' ' B' ' 388' ' ' MET . 13.7 p80 -163.66 158.36 20.36 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 121.179 0.514 . . . . 0.0 112.103 -177.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 384' ' ' GLY . . . . . . . . . . . . . . . -137.77 -44.26 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.6 177.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 385' ' ' THR . . . . . . . . . . . . . 23.1 m -97.0 -56.01 2.69 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.869 0.366 . . . . 0.0 110.907 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 386' ' ' PHE . . . . . 0.81 ' CZ ' HG11 ' B' ' 394' ' ' VAL . 3.5 t80 -76.57 129.13 80.42 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 387' ' ' PRO . . . . . 0.582 ' HG2' ' OD1' ' A' ' 393' ' ' ASN . 35.1 Cg_endo -66.83 63.89 0.58 Allowed 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.928 3.085 . . . . 0.0 113.628 177.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 388' ' ' MET . . . . . 0.766 ' SD ' HG13 ' B' ' 394' ' ' VAL . 5.2 tpp -68.05 164.53 19.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.888 176.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 389' ' ' HIS . . . . . 0.59 ' CE1' ' HA ' ' B' ' 393' ' ' ASN . 30.6 m170 -65.2 -160.49 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 172.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -71.59 1.43 6.62 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.241 170.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 391' ' ' LEU . . . . . 0.562 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.2 pt? -155.15 -64.14 0.12 Allowed 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -176.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 392' ' ' GLY . . . . . 0.612 ' HA2' ' SD ' ' B' ' 388' ' ' MET . . . -158.55 74.94 0.21 Allowed Glycine 0 CA--C 1.524 0.635 0 C-N-CA 119.988 -1.101 . . . . 0.0 114.243 -172.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 393' ' ' ASN . . . . . 0.59 ' HA ' ' CE1' ' B' ' 389' ' ' HIS . 0.0 OUTLIER -65.74 -42.03 91.49 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 177.697 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 394' ' ' VAL . . . . . 0.81 HG11 ' CZ ' ' B' ' 386' ' ' PHE . 0.6 OUTLIER -57.27 -46.18 85.06 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 179.72 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 395' ' ' ILE . . . . . 0.565 HG23 HG22 ' B' ' 425' ' ' ILE . 4.1 mp -57.53 -52.06 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.575 0 CA-C-O 117.792 -1.099 . . . . 0.0 113.381 -173.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 396' ' ' LYS . . . . . 0.628 ' O ' HG21 ' B' ' 399' ' ' VAL . 0.1 OUTLIER -62.19 -50.67 70.88 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 122.021 2.191 . . . . 0.0 112.178 -176.838 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.7 -44.62 69.47 Favored Glycine 0 N--CA 1.435 -1.421 0 C-N-CA 119.904 -1.141 . . . . 0.0 110.848 -175.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . 0.699 ' CD1' HD12 ' B' ' 410' ' ' LEU . 27.0 mt -71.25 -34.08 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -178.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 399' ' ' VAL . . . . . 0.628 HG21 ' O ' ' B' ' 396' ' ' LYS . 16.1 m -62.58 -40.07 86.93 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 C-N-CA 118.778 -1.169 . . . . 0.0 108.594 -174.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -71.28 -36.76 71.82 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 176.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 401' ' ' GLN . . . . . . . . . . . . . 4.2 mm100 -88.73 -46.72 8.77 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -171.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 402' ' ' GLU . . . . . 0.461 ' HB3' ' HB ' ' B' ' 406' ' ' THR . 2.4 mm-40 -120.52 -20.11 7.27 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.504 -171.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 106.49 162.08 22.42 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.834 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 404' ' ' VAL . . . . . 0.634 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.5 m -53.66 -45.35 60.28 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.802 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -175.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 405' ' ' ALA . . . . . 0.489 ' HB3' HG22 ' B' ' 457' ' ' ILE . . . -64.28 -30.89 71.92 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.425 -177.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 406' ' ' THR . . . . . 0.686 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 87.6 m -76.93 -42.61 38.69 Favored 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 120.099 -0.64 . . . . 0.0 109.986 173.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 407' ' ' ALA . . . . . 0.515 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.56 -37.06 74.93 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 122.171 0.986 . . . . 0.0 109.434 176.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 408' ' ' TYR . . . . . 0.634 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -66.04 -52.08 52.35 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 113.452 -1.704 . . . . 0.0 109.682 176.395 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 409' ' ' THR . . . . . 0.545 HG22 HD22 ' B' ' 410' ' ' LEU . 10.1 m -55.35 -47.4 75.78 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.69 -0.687 . . . . 0.0 112.571 178.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 410' ' ' LEU . . . . . 0.699 HD12 ' CD1' ' B' ' 398' ' ' ILE . 13.7 mt -72.14 -35.93 69.23 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 120.992 0.425 . . . . 0.0 109.925 -175.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.77 -34.75 78.85 Favored Glycine 0 N--CA 1.438 -1.192 0 C-N-CA 120.236 -0.983 . . . . 0.0 110.779 172.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 412' ' ' MET . . . . . 0.425 ' HE1' ' HA ' ' B' ' 417' ' ' GLN . 0.5 OUTLIER -69.85 -47.87 61.03 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-O 120.574 0.226 . . . . 0.0 111.346 178.381 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 413' ' ' MET . . . . . 0.927 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.5 OUTLIER -70.58 -42.11 71.49 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 119.035 -1.066 . . . . 0.0 112.211 -178.334 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 414' ' ' LEU . . . . . 0.927 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 19.4 mt -75.32 -46.34 33.96 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -176.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 24.8 t -86.34 -16.99 35.71 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.806 0.812 . . . . 0.0 109.717 -173.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 416' ' ' GLY . . . . . 0.47 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 106.33 -178.26 22.55 Favored Glycine 0 N--CA 1.431 -1.662 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 -171.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 417' ' ' GLN . . . . . 0.425 ' HA ' ' HE1' ' B' ' 412' ' ' MET . 33.0 mm-40 -79.72 24.44 0.38 Allowed 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.151 0.5 . . . . 0.0 110.94 -174.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 418' ' ' ASN . . . . . 0.47 ' H ' ' C ' ' B' ' 416' ' ' GLY . 3.9 m-20 -71.19 75.87 0.7 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.807 -177.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 419' ' ' TYR . . . . . 0.575 ' CD1' ' HB3' ' B' ' 453' ' ' ALA . 2.2 p90 -49.27 -40.06 33.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.801 -1.09 . . . . 0.0 111.789 176.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -55.33 -46.12 76.37 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.774 0.321 . . . . 0.0 110.963 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.66 -48.81 63.01 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.172 -176.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 422' ' ' VAL . . . . . 0.438 ' HB ' ' CD1' ' B' ' 408' ' ' TYR . 0.1 OUTLIER -66.03 -41.4 89.59 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 C-N-CA 120.371 -0.531 . . . . 0.0 111.076 -175.898 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 423' ' ' SER . . . . . 0.791 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 76.3 p -66.89 -39.33 87.44 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.883 -178.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.08 -38.98 92.8 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.922 176.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 425' ' ' ILE . . . . . 0.565 HG22 HG23 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -73.05 -52.79 20.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.318 0.104 . . . . 0.0 111.161 -176.869 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 426' ' ' ILE . . . . . 0.56 ' CD1' HG21 ' B' ' 395' ' ' ILE . 1.1 mm -74.23 -23.55 18.55 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.863 0 O-C-N 122.185 -0.322 . . . . 0.0 110.164 -171.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 427' ' ' ARG . . . . . 0.791 ' HB2' ' O ' ' B' ' 423' ' ' SER . 2.3 tmm_? -55.58 -31.36 62.13 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.221 0.534 . . . . 0.0 110.928 -177.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -85.38 -12.27 73.4 Favored Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.429 -0.891 . . . . 0.0 111.11 178.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 429' ' ' TYR . . . . . 0.512 ' HD1' ' CG2' ' B' ' 395' ' ' ILE . 7.3 m-30 -113.26 0.27 14.81 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.558 0.694 . . . . 0.0 109.227 -173.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 430' ' ' LEU . . . . . 0.534 ' HA ' HG13 ' B' ' 404' ' ' VAL . 0.1 OUTLIER -66.27 129.71 94.21 Favored Pre-proline 0 N--CA 1.445 -0.696 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.23 178.101 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 431' ' ' PRO . . . . . 0.531 ' HD2' HD13 ' B' ' 430' ' ' LEU . 95.0 Cg_exo -24.06 -60.35 0.05 OUTLIER 'Trans proline' 0 C--N 1.36 1.148 1 C-N-CA 125.602 4.201 . . . . 0.0 115.094 179.747 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 432' ' ' GLY . . . . . 0.571 ' O ' HG13 ' B' ' 435' ' ' VAL . . . -153.18 -171.5 20.53 Favored Glycine 0 N--CA 1.443 -0.887 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 177.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 433' ' ' GLN . . . . . 0.548 ' O ' HG12 ' B' ' 436' ' ' VAL . 16.3 tp60 -66.09 -26.89 67.68 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 118.088 0.944 . . . . 0.0 110.368 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -65.44 -43.42 90.51 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -178.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 435' ' ' VAL . . . . . 0.571 HG13 ' O ' ' B' ' 432' ' ' GLY . 7.6 p -67.32 -42.31 87.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 121.104 0.478 . . . . 0.0 110.423 -176.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 436' ' ' VAL . . . . . 0.548 HG12 ' O ' ' B' ' 433' ' ' GLN . 0.1 OUTLIER -68.02 -30.58 48.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.838 175.698 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 437' ' ' THR . . . . . 0.403 HG22 ' N ' ' B' ' 438' ' ' ALA . 1.0 OUTLIER -67.93 -51.9 42.4 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 438' ' ' ALA . . . . . 0.806 ' O ' ' HG2' ' B' ' 442' ' ' ARG . . . -58.11 -38.65 76.86 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.916 177.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 439' ' ' LEU . . . . . 0.551 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 1.9 tm? -70.27 -46.93 63.38 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.03 -39.23 74.41 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.127 174.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 441' ' ' GLN . . . . . 0.497 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 8.3 mm-40 -54.24 -49.89 68.44 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 123.888 0.875 . . . . 0.0 110.795 174.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 442' ' ' ARG . . . . . 0.806 ' HG2' ' O ' ' B' ' 438' ' ' ALA . 0.9 OUTLIER -56.17 -39.86 73.03 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.65 172.364 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 443' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 47.1 mt -71.74 -32.85 68.16 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.217 0.532 . . . . 0.0 110.119 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -60.76 -37.61 82.4 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.463 174.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -73.28 -28.42 62.1 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.554 177.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 446' ' ' GLU . . . . . 0.545 ' HB2' ' O ' ' B' ' 443' ' ' LEU . 41.3 tt0 31.26 97.02 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 172.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 49.9 mt -66.7 -35.83 75.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.37 0.605 . . . . 0.0 110.343 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 448' ' ' ASP . . . . . 0.617 ' O ' ' HG3' ' B' ' 452' ' ' ARG . 17.5 m-20 -166.12 -172.62 2.34 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -77.51 -61.15 2.08 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.432 175.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.05 -26.14 64.82 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 176.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 451' ' ' THR . . . . . 0.501 ' OG1' ' HB2' ' B' ' 448' ' ' ASP . 18.6 m -71.72 -22.1 61.68 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.538 -175.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 452' ' ' ARG . . . . . 0.617 ' HG3' ' O ' ' B' ' 448' ' ' ASP . 13.4 mtp180 -53.07 -54.1 40.54 Favored 'General case' 0 C--O 1.218 -0.553 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 170.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 453' ' ' ALA . . . . . 0.575 ' HB3' ' CD1' ' B' ' 419' ' ' TYR . . . -57.09 -50.11 73.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.381 -1.281 . . . . 0.0 112.585 175.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 454' ' ' GLU . . . . . 0.447 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 45.5 mm-40 -51.4 -36.0 41.6 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.803 -177.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 27.2 p -118.36 16.1 13.89 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.264 -176.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 456' ' ' PHE . . . . . 0.579 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 0.9 OUTLIER -56.65 -47.76 79.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.076 0.465 . . . . 0.0 111.612 -171.178 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 457' ' ' ILE . . . . . 0.538 ' CG1' ' HB3' ' B' ' 408' ' ' TYR . 1.9 mp -77.16 -33.14 19.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.979 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -58.05 -35.14 70.9 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.88 0.848 . . . . 0.0 109.393 172.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 459' ' ' HIS . . . . . 0.715 ' O ' HG23 ' B' ' 463' ' ' VAL . 62.0 m-70 -73.83 -28.77 61.77 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.731 177.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 460' ' ' LEU . . . . . 0.727 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -73.89 -34.64 64.5 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.906 0.86 . . . . 0.0 108.994 178.881 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 461' ' ' ASN . . . . . 0.448 ' O ' ' HB2' ' B' ' 464' ' ' TYR . 21.7 m-80 -73.25 -37.28 66.39 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.877 0.846 . . . . 0.0 108.869 176.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 462' ' ' ALA . . . . . 0.65 ' O ' HD11 ' B' ' 466' ' ' ILE . . . -56.61 -34.05 66.85 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.981 169.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 463' ' ' VAL . . . . . 0.727 ' HB ' ' O ' ' B' ' 460' ' ' LEU . 55.9 t -61.71 -50.07 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-N 114.642 -1.163 . . . . 0.0 107.999 175.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 464' ' ' TYR . . . . . 0.557 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 18.5 m-30 -53.1 -28.34 24.88 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 114.678 -1.147 . . . . 0.0 110.633 177.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.11 -40.24 22.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.906 0.86 . . . . 0.0 109.62 -178.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 466' ' ' ILE . . . . . 0.65 HD11 ' O ' ' B' ' 462' ' ' ALA . 3.4 mt -57.91 -55.35 22.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 114.209 -1.36 . . . . 0.0 112.235 176.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 467' ' ' LEU . . . . . 0.735 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -102.42 -10.0 19.79 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 114.474 1.286 . . . . 0.0 114.474 -172.821 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 468' ' ' GLY . . . . . 0.521 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 93.46 31.87 8.08 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 119.081 -1.533 . . . . 0.0 113.91 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 469' ' ' LEU . . . . . 0.735 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.2 mt -89.76 162.53 15.49 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 117.677 0.738 . . . . 0.0 110.795 175.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 470' ' ' ASN . . . . . 0.487 ' HB3' ' CG2' ' B' ' 476' ' ' ILE . 39.4 p30 -102.48 -179.54 4.01 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.889 171.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 471' ' ' ALA . . . . . 0.54 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -61.6 -21.64 64.52 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -175.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 472' ' ' ARG . . . . . 0.448 ' HA ' ' O ' ' B' ' 402' ' ' GLU . 17.2 mmt180 -88.67 6.74 37.01 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.431 -171.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 473' ' ' GLY . . . . . 0.429 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 74.5 12.8 82.21 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.145 -177.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -100.4 152.92 19.78 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 25.1 p -91.06 127.03 36.32 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.367 0.603 . . . . 0.0 110.522 176.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 476' ' ' ILE . . . . . 0.521 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.7 pp -88.09 -3.01 9.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 114.92 -1.037 . . . . 0.0 110.621 -179.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 477' ' ' ARG . . . . . 0.457 ' HD2' ' O ' ' B' ' 477' ' ' ARG . 1.3 ppt_? -123.97 166.23 16.06 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.176 177.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 478' ' ' LEU . . . . . . . . . . . . . 83.5 mt -112.86 135.95 53.05 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 479' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.345 -0.836 . . . . 0.0 110.068 178.948 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 . . . . . 0 N--CA 1.481 1.088 0 CA-C-O 120.823 0.344 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -114.61 -30.19 6.58 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -178.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' HIS . . . . . 0.418 ' HB2' ' O ' ' A' ' 386' ' ' PHE . 2.5 p80 -152.03 161.07 43.21 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 119.942 -0.703 . . . . 0.0 111.844 -171.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -110.77 -115.45 3.6 Favored Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 171.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 18.8 m -65.04 -37.08 86.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.195 0.521 . . . . 0.0 111.067 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' PHE . . . . . 0.652 ' CE2' HG13 ' A' ' 394' ' ' VAL . 1.4 t80 -79.9 129.72 69.55 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.012 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -49.27 -72.84 0.04 OUTLIER 'Trans proline' 0 N--CA 1.485 0.995 0 C-N-CA 124.309 3.339 . . . . 0.0 114.418 -178.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' MET . . . . . 0.559 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 38.9 ttm 74.36 49.36 0.11 Allowed 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 172.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' HIS . . . . . 0.684 ' CG ' ' HB2' ' A' ' 393' ' ' ASN . 40.7 m170 47.31 -99.44 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.25 0.62 . . . . 0.0 110.642 -175.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -146.36 15.71 1.3 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.469 -0.787 . . . . 0.0 108.884 174.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.465 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.4 pt? -169.15 -50.97 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -168.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . 0.465 ' N ' ' HG ' ' A' ' 391' ' ' LEU . . . -176.47 50.89 0.11 Allowed Glycine 0 C--N 1.335 0.495 0 C-N-CA 119.609 -1.282 . . . . 0.0 114.214 -172.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . 0.684 ' HB2' ' CG ' ' A' ' 389' ' ' HIS . 0.4 OUTLIER -54.21 -41.31 68.48 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 117.401 0.6 . . . . 0.0 109.679 176.761 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . 0.652 HG13 ' CE2' ' A' ' 386' ' ' PHE . 0.9 OUTLIER -56.85 -47.08 83.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 -179.249 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.534 HG21 HG22 ' A' ' 425' ' ' ILE . 4.3 mp -57.87 -52.22 60.66 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 CA-C-O 117.938 -1.03 . . . . 0.0 113.307 -175.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . 0.688 ' HG3' ' CZ ' ' A' ' 429' ' ' TYR . 0.1 OUTLIER -62.98 -49.88 72.95 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 121.692 2.042 . . . . 0.0 112.069 -174.165 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . 0.542 ' O ' ' HG3' ' A' ' 401' ' ' GLN . . . -54.32 -44.67 76.02 Favored Glycine 0 N--CA 1.435 -1.387 0 C-N-CA 120.099 -1.048 . . . . 0.0 111.035 -177.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . 0.594 ' CD1' HD12 ' A' ' 410' ' ' LEU . 45.4 mt -71.6 -34.37 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -177.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 396' ' ' LYS . 5.4 m -64.09 -39.99 87.46 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 C-N-CA 118.738 -1.185 . . . . 0.0 108.408 -174.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -64.74 -41.24 96.08 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 174.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . 0.542 ' HG3' ' O ' ' A' ' 397' ' ' GLY . 32.1 mt-30 -93.07 -48.39 6.52 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -169.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . 0.423 ' HG3' ' HE1' ' B' ' 413' ' ' MET . 3.0 mm-40 -113.42 -20.11 11.44 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.448 -171.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 104.77 163.21 24.15 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.125 -0.559 . . . . 0.0 113.137 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . 0.659 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.5 m -53.43 -45.21 57.37 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.752 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 -176.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . 0.485 ' HB2' HG22 ' A' ' 457' ' ' ILE . . . -66.41 -30.87 71.34 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.994 -175.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 406' ' ' THR . . . . . 0.701 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 92.4 m -77.23 -42.35 37.68 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.241 173.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.52 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.21 -37.71 75.37 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 122.049 0.928 . . . . 0.0 109.215 176.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 408' ' ' TYR . . . . . 0.659 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.64 -52.39 52.15 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 113.593 -1.64 . . . . 0.0 109.961 177.115 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 409' ' ' THR . . . . . 0.55 HG22 HD23 ' A' ' 410' ' ' LEU . 2.7 m -56.22 -46.23 79.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.505 178.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . 0.701 ' HG ' ' O ' ' A' ' 406' ' ' THR . 13.4 mt -72.03 -36.74 69.75 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 -175.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.6 -34.66 77.25 Favored Glycine 0 N--CA 1.44 -1.094 0 C-N-CA 120.085 -1.055 . . . . 0.0 110.708 172.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 412' ' ' MET . . . . . 0.41 ' HB2' ' O ' ' A' ' 409' ' ' THR . 0.4 OUTLIER -67.19 -48.21 68.6 Favored 'General case' 0 C--O 1.221 -0.438 0 C-N-CA 122.129 0.172 . . . . 0.0 111.403 177.672 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 413' ' ' MET . . . . . 0.941 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.7 OUTLIER -71.52 -47.73 53.4 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 118.848 -1.141 . . . . 0.0 112.103 -179.935 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . 0.941 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 23.3 mt -67.43 -44.24 79.24 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -175.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.438 ' HB2' ' HE1' ' A' ' 388' ' ' MET . 48.1 t -86.97 -23.76 24.96 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.503 0.668 . . . . 0.0 110.011 -177.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . 0.471 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 109.69 -175.62 18.84 Favored Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -170.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -79.65 24.3 0.38 Allowed 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.495 0.664 . . . . 0.0 111.291 -172.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 418' ' ' ASN . . . . . 0.471 ' H ' ' C ' ' A' ' 416' ' ' GLY . 79.6 m-20 -71.67 76.04 0.83 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.651 -178.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 419' ' ' TYR . . . . . 0.536 ' CD1' ' HB1' ' A' ' 453' ' ' ALA . 12.0 p90 -55.21 -39.0 69.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.537 178.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -55.71 -43.48 76.52 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.833 0.349 . . . . 0.0 111.166 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.22 -48.68 64.53 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.951 -177.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . 0.423 ' HB ' ' CD1' ' A' ' 408' ' ' TYR . 0.2 OUTLIER -66.36 -39.52 84.34 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.155 -177.277 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.74 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 68.4 p -66.84 -39.38 87.62 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.93 -39.2 89.41 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.199 176.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . 0.534 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.79 -51.75 25.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 121.176 -0.209 . . . . 0.0 111.114 -177.375 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . 0.519 ' O ' HD23 ' A' ' 430' ' ' LEU . 1.2 mm -74.27 -22.88 18.14 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.625 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -172.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.74 ' HB2' ' O ' ' A' ' 423' ' ' SER . 0.7 OUTLIER -54.86 -31.45 59.65 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.25 0.548 . . . . 0.0 110.149 -179.728 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -85.31 -5.16 85.57 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.667 178.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.688 ' CZ ' ' HG3' ' A' ' 396' ' ' LYS . 24.9 m-85 -119.76 0.69 10.95 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 121.08 0.467 . . . . 0.0 110.666 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . 0.522 HD11 ' HD2' ' A' ' 431' ' ' PRO . 0.1 OUTLIER -65.94 127.9 93.46 Favored Pre-proline 0 N--CA 1.438 -1.044 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.735 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . 0.522 ' HD2' HD11 ' A' ' 430' ' ' LEU . 80.9 Cg_exo -23.41 -70.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.892 1 C-N-CA 125.627 4.218 . . . . 0.0 115.082 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . 0.479 ' O ' HG13 ' A' ' 435' ' ' VAL . . . -138.17 -167.4 10.99 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 176.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . 0.503 ' O ' HG13 ' A' ' 436' ' ' VAL . 19.2 tp60 -69.41 -26.92 64.86 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 117.831 0.815 . . . . 0.0 110.165 179.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -68.24 -39.04 82.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.357 -176.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 435' ' ' VAL . . . . . 0.492 ' HA ' ' CG1' ' A' ' 463' ' ' VAL . 7.2 p -69.48 -44.01 80.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-O 120.972 0.415 . . . . 0.0 110.527 -177.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . 0.503 HG13 ' O ' ' A' ' 433' ' ' GLN . 0.2 OUTLIER -65.33 -31.36 53.52 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 174.825 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 1.1 m -67.22 -52.82 36.35 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -178.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . 0.572 ' O ' ' HD2' ' A' ' 442' ' ' ARG . . . -58.89 -39.16 80.62 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.12 177.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 439' ' ' LEU . . . . . 0.626 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 1.9 tm? -68.13 -48.52 65.17 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -178.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.21 -35.02 72.87 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.519 -1.219 . . . . 0.0 111.171 174.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 441' ' ' GLN . . . . . 0.468 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 3.7 mm-40 -55.13 -49.68 71.17 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.122 -177.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . 0.61 ' HG3' ' CG ' ' A' ' 459' ' ' HIS . 0.0 OUTLIER -75.8 -24.64 55.94 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 119.563 -0.855 . . . . 0.0 113.032 175.073 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 443' ' ' LEU . . . . . 0.626 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 70.1 mt -64.18 -35.29 80.3 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-N 118.453 0.569 . . . . 0.0 109.601 175.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -57.0 -37.96 72.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.524 173.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 -74.34 -26.75 60.34 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.312 177.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 27.59 98.86 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 176.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 49.2 mt -60.9 -35.13 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-O 121.266 0.555 . . . . 0.0 110.689 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . 0.462 ' HB2' ' OG1' ' A' ' 451' ' ' THR . 18.4 m-20 -163.66 -161.79 0.67 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 -177.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -82.38 -69.56 0.61 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 172.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -24.78 66.21 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 178.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 451' ' ' THR . . . . . 0.47 ' HA ' ' HB2' ' A' ' 454' ' ' GLU . 14.0 m -70.62 -22.55 62.51 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.788 -173.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . 0.426 HH11 ' HD2' ' A' ' 452' ' ' ARG . 18.3 mtp180 -54.1 -54.22 42.5 Favored 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 171.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 453' ' ' ALA . . . . . 0.536 ' HB1' ' CD1' ' A' ' 419' ' ' TYR . . . -59.13 -47.1 86.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.524 -1.216 . . . . 0.0 112.604 175.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . 0.47 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 12.0 mm-40 -51.58 -38.39 54.23 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.203 0.525 . . . . 0.0 111.478 -177.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 28.1 p -116.36 15.44 15.78 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.422 -175.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . 0.49 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.7 OUTLIER -56.74 -48.99 76.54 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 120.951 0.405 . . . . 0.0 111.777 -171.472 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . 0.519 ' CG1' ' HB3' ' A' ' 408' ' ' TYR . 1.9 mp -75.45 -32.93 26.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 120.841 0.353 . . . . 0.0 110.713 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -57.63 -35.51 70.58 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.694 0.759 . . . . 0.0 109.586 171.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . 0.75 ' O ' HG21 ' A' ' 463' ' ' VAL . 71.3 m-70 -71.74 -29.57 64.67 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.755 -1.112 . . . . 0.0 110.613 176.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . 0.699 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -74.08 -34.81 64.14 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.912 0.863 . . . . 0.0 108.787 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -72.84 -38.17 67.19 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.311 175.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 462' ' ' ALA . . . . . 0.633 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -55.82 -32.93 64.0 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.807 169.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.75 HG21 ' O ' ' A' ' 459' ' ' HIS . 61.6 t -63.89 -50.57 76.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 CA-C-N 114.474 -1.239 . . . . 0.0 107.901 177.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 464' ' ' TYR . . . . . 0.553 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 15.3 m-30 -53.89 -27.16 28.69 Favored 'General case' 0 C--N 1.332 -0.169 0 O-C-N 124.259 0.974 . . . . 0.0 110.324 178.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.68 -40.95 18.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.689 0.757 . . . . 0.0 109.38 -177.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.633 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.7 mt -56.22 -55.82 16.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 114.295 -1.32 . . . . 0.0 112.289 175.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.735 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -103.41 -10.82 18.3 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -171.752 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . 0.547 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 93.73 31.74 8.05 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 119.43 -1.367 . . . . 0.0 114.351 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 469' ' ' LEU . . . . . 0.735 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 2.6 mt -88.91 162.3 16.19 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 117.983 0.892 . . . . 0.0 111.435 177.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 39.5 p30 -105.29 -174.45 2.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.349 173.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -67.02 -17.49 64.94 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -175.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -88.48 -0.43 57.2 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 122.101 -0.375 . . . . 0.0 111.321 -175.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 75.85 17.08 80.25 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -173.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -101.55 151.6 21.78 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 177.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 5.6 p -90.61 127.76 36.38 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.95 0.405 . . . . 0.0 111.169 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 476' ' ' ILE . . . . . 0.547 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.5 pp -98.23 10.0 6.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.806 0.812 . . . . 0.0 110.282 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 28.6 mmm180 -77.37 -172.3 2.43 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.959 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 6.1 mp -80.0 -43.26 22.3 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 . . . . . 0 C--O 1.247 0.94 0 CA-C-O 118.399 -0.81 . . . . 0.0 109.961 179.309 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 381' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 . . . . . 0 N--CA 1.48 1.031 0 CA-C-O 120.756 0.312 . . . . 0.0 110.254 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 382' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -114.61 -30.18 6.58 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -178.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 383' ' ' HIS . . . . . 0.411 ' HB2' ' O ' ' B' ' 386' ' ' PHE . 2.4 p80 -152.23 160.81 43.3 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 119.931 -0.708 . . . . 0.0 111.992 -171.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 384' ' ' GLY . . . . . . . . . . . . . . . -110.74 -116.26 3.67 Favored Glycine 0 N--CA 1.44 -1.098 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.269 171.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 385' ' ' THR . . . . . . . . . . . . . 19.3 m -64.37 -36.92 85.72 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.167 0.508 . . . . 0.0 111.154 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 386' ' ' PHE . . . . . 0.656 ' CE2' HG13 ' B' ' 394' ' ' VAL . 1.4 t80 -79.96 130.01 68.31 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.012 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 387' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -49.32 -72.67 0.04 OUTLIER 'Trans proline' 0 N--CA 1.487 1.13 0 C-N-CA 124.492 3.461 . . . . 0.0 114.375 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 388' ' ' MET . . . . . 0.557 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 38.9 ttm 73.98 49.54 0.12 Allowed 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 112.754 0.649 . . . . 0.0 112.754 172.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 389' ' ' HIS . . . . . 0.697 ' CG ' ' HB2' ' B' ' 393' ' ' ASN . 40.7 m170 47.32 -99.84 0.05 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.22 0.608 . . . . 0.0 110.499 -175.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -145.99 15.49 1.36 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.823 174.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 391' ' ' LEU . . . . . 0.459 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.4 pt? -169.15 -50.89 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -168.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 392' ' ' GLY . . . . . 0.459 ' N ' ' HG ' ' B' ' 391' ' ' LEU . . . -176.51 51.14 0.11 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 119.599 -1.286 . . . . 0.0 114.25 -172.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 393' ' ' ASN . . . . . 0.697 ' HB2' ' CG ' ' B' ' 389' ' ' HIS . 0.4 OUTLIER -54.47 -41.19 69.21 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 117.359 0.579 . . . . 0.0 109.705 176.914 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 394' ' ' VAL . . . . . 0.656 HG13 ' CE2' ' B' ' 386' ' ' PHE . 0.9 OUTLIER -56.86 -47.2 83.41 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 -179.29 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 395' ' ' ILE . . . . . 0.54 HG21 HG22 ' B' ' 425' ' ' ILE . 4.3 mp -57.86 -52.15 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 CA-C-O 117.824 -1.084 . . . . 0.0 113.31 -175.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 396' ' ' LYS . . . . . 0.684 ' HG3' ' CZ ' ' B' ' 429' ' ' TYR . 0.1 OUTLIER -62.95 -49.8 73.31 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 121.714 2.052 . . . . 0.0 112.12 -174.201 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 397' ' ' GLY . . . . . 0.541 ' O ' ' HG3' ' B' ' 401' ' ' GLN . . . -54.51 -44.47 77.96 Favored Glycine 0 N--CA 1.436 -1.355 0 C-N-CA 120.05 -1.071 . . . . 0.0 110.986 -177.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . 0.611 ' CD1' HD12 ' B' ' 410' ' ' LEU . 46.2 mt -71.71 -34.27 51.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -177.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 399' ' ' VAL . . . . . 0.488 HG23 ' O ' ' B' ' 396' ' ' LYS . 5.5 m -64.21 -39.82 86.85 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.501 0 C-N-CA 118.836 -1.145 . . . . 0.0 108.457 -174.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -64.96 -41.11 95.75 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 174.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 401' ' ' GLN . . . . . 0.541 ' HG3' ' O ' ' B' ' 397' ' ' GLY . 32.3 mt-30 -93.13 -48.29 6.55 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -169.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 402' ' ' GLU . . . . . 0.427 ' HG3' ' HE1' ' A' ' 413' ' ' MET . 3.0 mm-40 -113.61 -19.99 11.39 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.44 -171.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 104.58 162.83 24.3 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.061 -0.59 . . . . 0.0 113.224 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 404' ' ' VAL . . . . . 0.659 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.4 m -53.21 -45.32 54.73 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.766 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -176.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 405' ' ' ALA . . . . . 0.485 ' HB2' HG22 ' B' ' 457' ' ' ILE . . . -66.23 -30.71 71.22 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 119.711 -0.795 . . . . 0.0 112.062 -175.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 406' ' ' THR . . . . . 0.691 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 88.2 m -77.26 -42.51 36.84 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.303 173.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 407' ' ' ALA . . . . . 0.518 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.09 -37.75 75.1 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 122.093 0.949 . . . . 0.0 109.2 176.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 408' ' ' TYR . . . . . 0.659 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.51 -52.58 51.69 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 113.631 -1.622 . . . . 0.0 109.975 177.028 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 409' ' ' THR . . . . . 0.566 HG22 HD23 ' B' ' 410' ' ' LEU . 2.7 m -56.17 -46.17 79.44 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.569 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 410' ' ' LEU . . . . . 0.691 ' HG ' ' O ' ' B' ' 406' ' ' THR . 13.2 mt -71.95 -36.74 69.98 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.808 0.337 . . . . 0.0 110.2 -175.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.51 -34.8 77.21 Favored Glycine 0 N--CA 1.439 -1.109 0 C-N-CA 120.04 -1.076 . . . . 0.0 110.729 172.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 412' ' ' MET . . . . . 0.411 ' HB2' ' O ' ' B' ' 409' ' ' THR . 0.4 OUTLIER -67.11 -48.14 69.01 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 115.808 -0.196 . . . . 0.0 111.423 177.76 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 413' ' ' MET . . . . . 0.929 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.7 OUTLIER -71.38 -48.1 52.11 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 118.884 -1.126 . . . . 0.0 112.119 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 414' ' ' LEU . . . . . 0.929 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 23.4 mt -67.2 -44.24 80.11 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -175.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 415' ' ' SER . . . . . 0.426 ' HB2' ' HE1' ' B' ' 388' ' ' MET . 48.1 t -86.81 -24.11 25.12 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.592 0.711 . . . . 0.0 109.907 -177.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 416' ' ' GLY . . . . . 0.471 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 109.98 -175.52 18.58 Favored Glycine 0 N--CA 1.43 -1.715 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -170.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -79.71 24.47 0.38 Allowed 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.61 0.719 . . . . 0.0 111.326 -172.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 418' ' ' ASN . . . . . 0.471 ' H ' ' C ' ' B' ' 416' ' ' GLY . 79.9 m-20 -71.75 75.71 0.85 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.785 -178.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 419' ' ' TYR . . . . . 0.529 ' CD1' ' HB1' ' B' ' 453' ' ' ALA . 11.8 p90 -54.89 -38.9 68.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.598 178.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -55.73 -43.57 76.69 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.739 0.304 . . . . 0.0 111.061 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.15 -48.63 64.84 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.013 -177.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 422' ' ' VAL . . . . . 0.424 ' HB ' ' CD1' ' B' ' 408' ' ' TYR . 0.2 OUTLIER -66.41 -39.44 84.07 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.212 -177.365 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 423' ' ' SER . . . . . 0.76 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 67.3 p -66.97 -39.33 87.18 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.98 -39.11 89.24 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.161 176.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 425' ' ' ILE . . . . . 0.54 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -72.79 -51.7 26.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 116.622 0.211 . . . . 0.0 111.121 -177.334 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 426' ' ' ILE . . . . . 0.511 ' O ' HD23 ' B' ' 430' ' ' LEU . 1.2 mm -74.3 -23.06 18.17 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.708 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -172.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 427' ' ' ARG . . . . . 0.76 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.7 OUTLIER -54.75 -31.34 58.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.344 0.592 . . . . 0.0 110.305 -179.769 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -85.5 -4.74 85.47 Favored Glycine 0 N--CA 1.446 -0.7 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.65 178.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 429' ' ' TYR . . . . . 0.684 ' CZ ' ' HG3' ' B' ' 396' ' ' LYS . 24.9 m-85 -120.13 0.52 10.72 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 121.105 0.479 . . . . 0.0 110.693 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 430' ' ' LEU . . . . . 0.515 HD11 ' HD2' ' B' ' 431' ' ' PRO . 0.1 OUTLIER -65.77 127.87 93.4 Favored Pre-proline 0 N--CA 1.44 -0.972 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.634 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 431' ' ' PRO . . . . . 0.515 ' HD2' HD11 ' B' ' 430' ' ' LEU . 84.1 Cg_exo -23.47 -70.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.832 1 C-N-CA 125.665 4.243 . . . . 0.0 115.011 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 432' ' ' GLY . . . . . 0.485 ' O ' HG13 ' B' ' 435' ' ' VAL . . . -138.12 -167.54 11.04 Favored Glycine 0 N--CA 1.442 -0.921 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 176.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 433' ' ' GLN . . . . . 0.499 ' O ' HG13 ' B' ' 436' ' ' VAL . 19.1 tp60 -69.5 -26.82 64.73 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 117.791 0.796 . . . . 0.0 110.074 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -68.07 -39.51 82.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.227 -176.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 435' ' ' VAL . . . . . 0.497 ' HA ' ' CG1' ' B' ' 463' ' ' VAL . 7.3 p -69.05 -44.03 81.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-O 120.968 0.413 . . . . 0.0 110.649 -177.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 436' ' ' VAL . . . . . 0.499 HG13 ' O ' ' B' ' 433' ' ' GLN . 0.2 OUTLIER -65.26 -31.22 52.93 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 CA-C-O 121.08 0.467 . . . . 0.0 109.883 174.795 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 1.1 m -67.28 -52.8 36.21 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 -178.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 438' ' ' ALA . . . . . 0.576 ' O ' ' HD2' ' B' ' 442' ' ' ARG . . . -58.94 -39.19 80.86 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 115.351 -0.841 . . . . 0.0 112.113 177.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 439' ' ' LEU . . . . . 0.618 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 1.9 tm? -68.15 -48.48 65.22 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -178.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.26 -34.99 72.9 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.485 -1.234 . . . . 0.0 111.097 174.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 441' ' ' GLN . . . . . 0.472 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 3.6 mm-40 -54.98 -50.02 70.01 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.017 -177.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 442' ' ' ARG . . . . . 0.613 ' HG3' ' CG ' ' B' ' 459' ' ' HIS . 0.0 OUTLIER -75.67 -24.34 56.32 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 119.547 -0.861 . . . . 0.0 113.095 175.261 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 443' ' ' LEU . . . . . 0.618 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 70.2 mt -64.47 -35.2 80.18 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 175.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -56.99 -38.2 72.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.451 173.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -74.22 -26.85 60.49 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.318 177.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 446' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 27.91 98.94 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.625 1.17 . . . . 0.0 114.147 176.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 49.0 mt -61.13 -35.13 63.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-O 121.151 0.5 . . . . 0.0 110.74 -178.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 448' ' ' ASP . . . . . 0.47 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 19.8 m-20 -163.79 -162.14 0.69 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 -177.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -81.85 -69.67 0.6 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 172.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.76 -24.72 66.24 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 178.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 451' ' ' THR . . . . . 0.471 ' HA ' ' HB2' ' B' ' 454' ' ' GLU . 12.4 m -70.62 -22.53 62.52 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.765 -173.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 452' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' B' ' 452' ' ' ARG . 18.2 mtp180 -54.2 -54.12 44.25 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 171.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 453' ' ' ALA . . . . . 0.529 ' HB1' ' CD1' ' B' ' 419' ' ' TYR . . . -58.94 -47.35 85.41 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.514 -1.221 . . . . 0.0 112.613 174.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 454' ' ' GLU . . . . . 0.471 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 10.5 mm-40 -51.83 -37.38 51.59 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.284 0.564 . . . . 0.0 111.603 -177.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 28.2 p -117.08 15.34 15.04 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.468 -176.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 456' ' ' PHE . . . . . 0.497 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 0.7 OUTLIER -56.57 -49.1 75.85 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.906 0.384 . . . . 0.0 111.879 -171.522 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 457' ' ' ILE . . . . . 0.531 ' CG1' ' HB3' ' B' ' 408' ' ' TYR . 1.9 mp -75.25 -33.08 27.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 120.809 0.337 . . . . 0.0 110.855 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -57.44 -35.63 70.35 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.814 0.816 . . . . 0.0 109.482 171.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 459' ' ' HIS . . . . . 0.743 ' O ' HG21 ' B' ' 463' ' ' VAL . 70.8 m-70 -71.89 -29.4 64.31 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.629 176.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 460' ' ' LEU . . . . . 0.705 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -74.14 -34.74 63.98 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.88 0.848 . . . . 0.0 108.882 179.811 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 461' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -72.82 -38.25 67.21 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.288 175.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 462' ' ' ALA . . . . . 0.646 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -55.72 -32.87 63.72 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.692 169.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 463' ' ' VAL . . . . . 0.743 HG21 ' O ' ' B' ' 459' ' ' HIS . 60.1 t -64.07 -50.6 76.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 CA-C-N 114.433 -1.258 . . . . 0.0 107.961 177.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 464' ' ' TYR . . . . . 0.547 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 15.3 m-30 -53.72 -27.48 28.54 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.327 178.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.62 -40.52 18.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.622 0.725 . . . . 0.0 109.43 -177.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 466' ' ' ILE . . . . . 0.646 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.6 mt -56.42 -55.92 16.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 114.295 -1.321 . . . . 0.0 112.268 175.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 467' ' ' LEU . . . . . 0.748 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -103.36 -10.74 18.4 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -171.884 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 468' ' ' GLY . . . . . 0.571 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 93.84 31.69 8.03 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 119.453 -1.356 . . . . 0.0 114.281 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 469' ' ' LEU . . . . . 0.748 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 2.6 mt -88.91 162.26 16.21 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 117.969 0.885 . . . . 0.0 111.29 177.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 39.7 p30 -105.27 -173.96 2.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.367 173.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 471' ' ' ALA . . . . . . . . . . . . . . . -67.69 -17.06 64.45 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -175.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -88.59 -0.81 57.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.751 0.31 . . . . 0.0 111.136 -176.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 473' ' ' GLY . . . . . . . . . . . . . . . 76.19 16.88 80.38 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 -173.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -101.4 151.96 21.3 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 177.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 5.4 p -90.78 128.21 36.61 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.88 0.372 . . . . 0.0 111.184 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 476' ' ' ILE . . . . . 0.571 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.5 pp -98.26 9.45 7.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.672 0.748 . . . . 0.0 110.266 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 477' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 -77.04 -172.63 2.43 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.801 -1.09 . . . . 0.0 111.104 -178.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 478' ' ' LEU . . . . . 0.405 ' N ' HD11 ' B' ' 478' ' ' LEU . 6.0 mp -79.68 -43.08 23.4 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.187 0.518 . . . . 0.0 109.842 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 479' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 . . . . . 0 C--O 1.245 0.835 0 CA-C-O 118.519 -0.753 . . . . 0.0 110.016 179.361 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 . . . . . 0 N--CA 1.478 0.952 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -116.26 -34.27 4.71 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -175.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' HIS . . . . . 0.51 ' HB2' ' O ' ' A' ' 386' ' ' PHE . 3.6 p80 -143.19 154.31 43.73 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.223 -0.591 . . . . 0.0 111.326 -170.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -103.38 -108.79 3.3 Favored Glycine 0 N--CA 1.438 -1.183 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 170.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 47.2 m -75.0 -30.95 61.3 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.873 0.368 . . . . 0.0 111.113 177.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' PHE . . . . . 0.669 ' CE2' HG13 ' A' ' 394' ' ' VAL . 2.6 t80 -75.68 125.06 88.92 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.082 0.468 . . . . 0.0 110.616 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . 0.588 ' HG2' ' OD1' ' B' ' 393' ' ' ASN . 60.9 Cg_endo -72.0 111.27 3.13 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 124.105 3.203 . . . . 0.0 113.701 175.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' MET . . . . . 0.465 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 40.0 mtt -103.28 172.7 6.67 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 176.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -57.28 -61.76 2.24 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 175.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -175.49 19.66 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.5 -1.227 . . . . 0.0 108.448 173.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.464 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.1 pt? -169.76 -54.8 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.616 -167.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . 0.464 ' N ' ' HG ' ' A' ' 391' ' ' LEU . . . -174.88 54.77 0.13 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 119.93 -1.129 . . . . 0.0 113.703 -174.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . 0.58 ' OD1' ' HG2' ' B' ' 387' ' ' PRO . 0.2 OUTLIER -54.25 -41.9 69.29 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 177.707 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . 0.669 HG13 ' CE2' ' A' ' 386' ' ' PHE . 2.0 m -56.35 -47.05 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.597 ' N ' HG23 ' A' ' 394' ' ' VAL . 3.9 mp -57.47 -52.12 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 CA-C-O 118.04 -0.981 . . . . 0.0 113.254 -175.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . 0.666 ' HG3' ' CZ ' ' A' ' 429' ' ' TYR . 0.1 OUTLIER -61.49 -49.3 77.33 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-N 121.52 1.964 . . . . 0.0 111.857 -173.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -54.26 -45.14 75.07 Favored Glycine 0 N--CA 1.437 -1.279 0 C-N-CA 119.756 -1.212 . . . . 0.0 111.142 -178.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . 0.619 ' CD1' HD11 ' A' ' 410' ' ' LEU . 39.2 mt -70.94 -34.08 54.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -177.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 396' ' ' LYS . 10.6 m -63.5 -39.61 85.96 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 C-N-CA 118.573 -1.251 . . . . 0.0 108.24 -175.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -70.91 -33.99 71.09 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 175.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . 0.442 HE21 ' HB3' ' A' ' 401' ' ' GLN . 3.2 mm100 -90.14 -47.27 7.91 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -172.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . 0.433 ' HG3' ' HE2' ' B' ' 413' ' ' MET . 2.9 mm-40 -121.61 -20.97 6.34 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.576 -170.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 107.21 162.73 21.86 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.823 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . 0.651 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.6 m -53.52 -46.45 59.87 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.771 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -175.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . 0.485 ' HB3' HG21 ' A' ' 457' ' ' ILE . . . -64.25 -30.39 71.45 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 119.891 -0.724 . . . . 0.0 112.452 -176.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 406' ' ' THR . . . . . 0.709 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 91.9 m -77.5 -42.96 33.76 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.223 173.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.496 ' HB2' ' HA ' ' A' ' 395' ' ' ILE . . . -58.46 -37.37 75.33 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 122.117 0.96 . . . . 0.0 109.265 176.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 408' ' ' TYR . . . . . 0.651 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.58 -51.69 57.85 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 113.402 -1.726 . . . . 0.0 109.746 176.687 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 409' ' ' THR . . . . . 0.544 HG21 HD21 ' A' ' 410' ' ' LEU . 14.1 m -55.34 -47.03 76.32 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.588 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . 0.709 ' HG ' ' O ' ' A' ' 406' ' ' THR . 14.8 mt -72.19 -37.12 69.36 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 120.826 0.346 . . . . 0.0 110.164 -174.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.68 -34.46 76.98 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.57 173.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 412' ' ' MET . . . . . 0.426 ' HB2' ' O ' ' A' ' 409' ' ' THR . 0.2 OUTLIER -65.86 -44.03 86.65 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 115.685 -0.258 . . . . 0.0 111.589 177.915 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 413' ' ' MET . . . . . 0.751 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.0 OUTLIER -71.13 -56.49 6.0 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 118.431 -1.308 . . . . 0.0 111.558 177.884 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . 0.751 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 6.8 mt -62.46 -43.52 98.62 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -171.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 37.8 t -85.16 -21.14 29.33 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.701 0.762 . . . . 0.0 109.562 -178.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . 0.469 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 103.69 -173.42 21.85 Favored Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -169.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -79.7 24.43 0.38 Allowed 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.563 0.696 . . . . 0.0 111.206 -171.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 418' ' ' ASN . . . . . 0.469 ' H ' ' C ' ' A' ' 416' ' ' GLY . 89.2 m-20 -71.17 73.4 0.65 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.493 179.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 419' ' ' TYR . . . . . 0.532 ' CD1' ' HB1' ' A' ' 453' ' ' ALA . 29.9 p90 -56.74 -36.58 69.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.002 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -54.72 -42.69 71.86 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.908 178.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.16 -49.14 62.92 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.136 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . 0.49 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.5 OUTLIER -66.17 -38.8 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.244 -176.487 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.717 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 57.6 p -67.3 -38.66 85.35 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.072 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -70.07 -37.5 73.17 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.96 176.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . 0.538 HG22 HG22 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.66 -52.51 22.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 121.305 -0.158 . . . . 0.0 111.097 -178.308 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . 0.513 ' O ' HD23 ' A' ' 430' ' ' LEU . 1.2 mm -73.49 -22.71 19.14 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.699 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -172.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.717 ' HB2' ' O ' ' A' ' 423' ' ' SER . 0.7 OUTLIER -54.04 -32.77 55.48 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.271 0.558 . . . . 0.0 110.119 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -84.74 -6.28 85.6 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.598 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.666 ' CZ ' ' HG3' ' A' ' 396' ' ' LYS . 23.9 m-85 -118.64 0.6 11.54 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 121.105 0.479 . . . . 0.0 110.56 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . 0.531 HD12 ' HD2' ' A' ' 431' ' ' PRO . 0.1 OUTLIER -66.33 127.79 93.48 Favored Pre-proline 0 N--CA 1.437 -1.075 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.348 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . 0.531 ' HD2' HD12 ' A' ' 430' ' ' LEU . 83.6 Cg_exo -23.55 -65.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.354 0.836 1 C-N-CA 125.655 4.237 . . . . 0.0 114.983 179.9 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . 0.522 ' O ' HG13 ' A' ' 435' ' ' VAL . . . -143.22 -169.2 12.37 Favored Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 175.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . 0.54 ' O ' HG11 ' A' ' 436' ' ' VAL . 45.1 tp60 -69.93 -26.66 64.24 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 118.19 0.995 . . . . 0.0 110.111 177.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -62.93 -42.47 99.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.268 -0.424 . . . . 0.0 112.035 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 435' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 432' ' ' GLY . 7.5 p -68.8 -43.17 82.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-O 120.947 0.403 . . . . 0.0 110.766 -177.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . 0.54 HG11 ' O ' ' A' ' 433' ' ' GLN . 0.1 OUTLIER -66.22 -31.74 55.01 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.241 175.712 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.56 -52.39 46.13 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -178.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . 0.602 ' O ' ' HD2' ' A' ' 442' ' ' ARG . . . -57.85 -40.09 79.27 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.997 177.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 439' ' ' LEU . . . . . 0.598 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 2.0 tm? -68.03 -48.54 65.37 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -178.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.13 -35.16 72.98 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.1 175.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 441' ' ' GLN . . . . . 0.484 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 3.3 mm-40 -54.87 -49.53 70.94 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.126 -178.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . 0.606 ' HG3' ' CG ' ' A' ' 459' ' ' HIS . 0.0 OUTLIER -76.43 -24.0 53.96 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 119.736 -0.785 . . . . 0.0 113.058 174.899 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 443' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 69.4 mt -64.23 -35.81 82.04 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 118.404 0.547 . . . . 0.0 109.53 174.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -57.46 -37.53 73.02 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.537 173.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -73.73 -27.12 61.03 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.113 177.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 26.68 100.57 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.878 1.271 . . . . 0.0 114.387 176.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 51.8 mt -63.47 -34.94 70.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.046 -178.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . 0.449 ' HB2' ' OG1' ' A' ' 451' ' ' THR . 33.5 m-20 -164.21 -162.04 0.65 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -178.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -79.55 -71.01 0.47 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 172.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -24.82 66.13 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 178.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 451' ' ' THR . . . . . 0.452 ' HA ' ' HB2' ' A' ' 454' ' ' GLU . 15.8 m -70.49 -22.18 62.68 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.104 -0.638 . . . . 0.0 110.836 -173.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 452' ' ' ARG . 20.9 mtp180 -53.43 -53.83 45.6 Favored 'General case' 0 C--O 1.221 -0.406 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 171.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 453' ' ' ALA . . . . . 0.532 ' HB1' ' CD1' ' A' ' 419' ' ' TYR . . . -59.8 -47.83 84.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.388 -1.278 . . . . 0.0 112.58 175.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . 0.452 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 77.4 mm-40 -50.4 -37.19 36.36 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.181 0.515 . . . . 0.0 111.774 -177.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 29.9 p -117.98 15.22 14.23 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.374 -176.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . 0.54 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.8 OUTLIER -56.9 -47.67 79.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.09 0.471 . . . . 0.0 111.718 -171.747 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . 0.516 ' CG1' ' HB3' ' A' ' 408' ' ' TYR . 1.9 mp -76.78 -33.04 20.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.053 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -57.7 -34.49 69.49 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.783 0.802 . . . . 0.0 109.28 171.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . 0.734 ' O ' HG21 ' A' ' 463' ' ' VAL . 59.9 m-70 -73.18 -29.33 62.76 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.828 177.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . 0.695 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.4 OUTLIER -74.16 -34.68 63.91 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.993 0.902 . . . . 0.0 108.753 179.286 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -72.78 -37.89 67.47 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.257 175.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 462' ' ' ALA . . . . . 0.637 ' O ' HD11 ' A' ' 466' ' ' ILE . . . -55.73 -33.23 64.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.674 169.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.734 HG21 ' O ' ' A' ' 459' ' ' HIS . 77.8 t -64.48 -50.75 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 CA-C-N 114.603 -1.181 . . . . 0.0 107.906 177.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 464' ' ' TYR . . . . . 0.541 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 17.3 m-30 -53.34 -25.8 16.49 Favored 'General case' 0 C--N 1.333 -0.143 0 O-C-N 124.313 1.008 . . . . 0.0 110.605 178.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.39 -40.93 15.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.6 0.714 . . . . 0.0 109.437 -178.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.637 HD11 ' O ' ' A' ' 462' ' ' ALA . 3.4 mt -55.94 -55.22 19.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 114.272 -1.331 . . . . 0.0 112.199 175.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.744 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -103.93 -11.01 17.72 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -172.748 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . 0.605 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 93.64 31.82 8.03 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 119.328 -1.415 . . . . 0.0 114.374 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 469' ' ' LEU . . . . . 0.744 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 2.9 mt -89.14 161.84 16.27 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 117.886 0.843 . . . . 0.0 111.361 177.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 38.1 p30 -104.97 -177.01 3.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.569 173.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -60.36 -22.53 63.39 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -176.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -87.89 0.28 56.05 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 122.32 -0.238 . . . . 0.0 111.551 -172.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . 0.447 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 77.71 12.31 84.6 Favored Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 110.724 -0.951 . . . . 0.0 110.724 -174.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -101.18 152.48 20.59 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 11.5 p -89.28 129.45 35.83 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.279 0.561 . . . . 0.0 111.118 -178.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 476' ' ' ILE . . . . . 0.605 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.8 pp -94.72 -2.07 10.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.636 0.731 . . . . 0.0 109.953 177.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 23.3 mmt180 -74.86 91.63 2.47 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.562 -1.199 . . . . 0.0 109.494 173.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 88.7 mt -82.82 52.21 2.08 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.384 0.611 . . . . 0.0 110.568 -178.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 . . . . . 0 C--O 1.249 1.057 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.733 -179.353 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 381' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 . . . . . 0 N--CA 1.479 1.016 0 CA-C-O 120.875 0.369 . . . . 0.0 110.046 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 382' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -116.02 -34.72 4.64 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.154 -0.476 . . . . 0.0 112.226 -175.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 383' ' ' HIS . . . . . 0.514 ' HB2' ' O ' ' B' ' 386' ' ' PHE . 3.5 p80 -142.66 154.88 44.76 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.224 -0.59 . . . . 0.0 111.29 -170.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 384' ' ' GLY . . . . . . . . . . . . . . . -103.95 -108.32 3.27 Favored Glycine 0 N--CA 1.438 -1.176 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 170.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 385' ' ' THR . . . . . . . . . . . . . 56.1 m -75.49 -30.55 59.89 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.934 0.397 . . . . 0.0 111.296 177.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 386' ' ' PHE . . . . . 0.665 ' CE2' HG13 ' B' ' 394' ' ' VAL . 2.6 t80 -75.99 124.98 88.62 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 120.991 0.424 . . . . 0.0 110.599 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 387' ' ' PRO . . . . . 0.58 ' HG2' ' OD1' ' A' ' 393' ' ' ASN . 60.8 Cg_endo -71.97 111.21 3.11 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 124.059 3.172 . . . . 0.0 113.767 175.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 388' ' ' MET . . . . . 0.46 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 39.9 mtt -103.26 172.62 6.71 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 122.012 -0.43 . . . . 0.0 110.1 177.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 389' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -57.4 -61.49 2.45 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 175.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -175.89 19.84 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.647 -1.16 . . . . 0.0 108.311 173.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 391' ' ' LEU . . . . . 0.458 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.1 pt? -169.91 -54.86 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.562 -167.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 392' ' ' GLY . . . . . 0.458 ' N ' ' HG ' ' B' ' 391' ' ' LEU . . . -174.8 54.9 0.13 Allowed Glycine 0 C--N 1.333 0.408 0 C-N-CA 119.911 -1.138 . . . . 0.0 113.67 -174.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 393' ' ' ASN . . . . . 0.588 ' OD1' ' HG2' ' A' ' 387' ' ' PRO . 0.2 OUTLIER -54.33 -41.89 69.56 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 177.728 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 394' ' ' VAL . . . . . 0.665 HG13 ' CE2' ' B' ' 386' ' ' PHE . 2.0 m -56.34 -47.1 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 -179.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 395' ' ' ILE . . . . . 0.606 ' N ' HG23 ' B' ' 394' ' ' VAL . 3.9 mp -57.44 -52.24 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 CA-C-O 117.935 -1.031 . . . . 0.0 113.246 -175.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 396' ' ' LYS . . . . . 0.666 ' HG3' ' CZ ' ' B' ' 429' ' ' TYR . 0.1 OUTLIER -61.42 -49.18 77.92 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 121.488 1.949 . . . . 0.0 111.818 -173.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -54.39 -45.18 76.23 Favored Glycine 0 N--CA 1.436 -1.31 0 C-N-CA 119.747 -1.216 . . . . 0.0 111.073 -178.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . 0.619 ' CD1' HD11 ' B' ' 410' ' ' LEU . 39.2 mt -70.96 -34.1 54.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -176.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 399' ' ' VAL . . . . . 0.496 HG22 ' O ' ' B' ' 396' ' ' LYS . 10.6 m -63.47 -39.73 86.42 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 C-N-CA 118.514 -1.274 . . . . 0.0 108.265 -175.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -70.83 -34.12 71.38 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 175.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 401' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -89.84 -47.48 7.86 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -172.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 402' ' ' GLU . . . . . 0.454 ' HG3' ' HE2' ' A' ' 413' ' ' MET . 2.9 mm-40 -121.4 -21.08 6.41 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.653 -170.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 107.42 162.5 21.62 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.843 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 404' ' ' VAL . . . . . 0.667 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.5 m -53.41 -46.44 58.55 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.71 0 N-CA-C 114.506 1.298 . . . . 0.0 114.506 -175.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 405' ' ' ALA . . . . . 0.472 ' HB3' HG21 ' B' ' 457' ' ' ILE . . . -64.11 -30.5 71.57 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 119.861 -0.736 . . . . 0.0 112.427 -177.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 406' ' ' THR . . . . . 0.707 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 89.0 m -77.36 -43.1 34.06 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 121.749 -0.595 . . . . 0.0 110.282 173.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 407' ' ' ALA . . . . . 0.48 ' HB2' ' HA ' ' B' ' 395' ' ' ILE . . . -58.38 -37.35 75.09 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 122.175 0.988 . . . . 0.0 109.252 176.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 408' ' ' TYR . . . . . 0.667 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.59 -51.67 57.93 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 113.414 -1.721 . . . . 0.0 109.816 176.714 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 409' ' ' THR . . . . . 0.546 HG21 HD21 ' B' ' 410' ' ' LEU . 15.7 m -55.3 -47.1 76.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.568 178.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 410' ' ' LEU . . . . . 0.707 ' HG ' ' O ' ' B' ' 406' ' ' THR . 14.8 mt -72.29 -37.1 69.09 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.093 -174.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.6 -34.42 76.26 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 119.915 -1.136 . . . . 0.0 110.481 173.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 412' ' ' MET . . . . . 0.433 ' HB2' ' O ' ' B' ' 409' ' ' THR . 0.3 OUTLIER -65.92 -44.2 85.87 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 115.667 -0.266 . . . . 0.0 111.597 177.932 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 413' ' ' MET . . . . . 0.739 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.0 OUTLIER -70.97 -56.58 5.89 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 118.414 -1.315 . . . . 0.0 111.47 177.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 414' ' ' LEU . . . . . 0.739 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 6.8 mt -62.45 -43.48 98.72 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 114.19 1.181 . . . . 0.0 114.19 -171.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 37.2 t -85.2 -20.98 29.35 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.797 0.808 . . . . 0.0 109.525 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 416' ' ' GLY . . . . . 0.472 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 103.5 -173.15 21.8 Favored Glycine 0 N--CA 1.428 -1.852 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -169.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -79.9 24.52 0.4 Allowed 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.617 0.722 . . . . 0.0 111.336 -171.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 418' ' ' ASN . . . . . 0.472 ' H ' ' C ' ' B' ' 416' ' ' GLY . 89.6 m-20 -71.25 73.38 0.67 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.344 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 419' ' ' TYR . . . . . 0.531 ' CD1' ' HB1' ' B' ' 453' ' ' ALA . 29.6 p90 -56.68 -36.63 69.81 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.944 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -54.67 -42.59 71.54 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.864 178.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.26 -49.14 62.62 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.123 -178.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 422' ' ' VAL . . . . . 0.476 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.5 OUTLIER -66.23 -38.75 82.59 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.238 -176.422 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 423' ' ' SER . . . . . 0.724 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 59.9 p -67.31 -38.82 85.56 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.124 -178.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -70.01 -37.12 73.54 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.056 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 425' ' ' ILE . . . . . 0.539 HG22 HG22 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -72.82 -52.97 20.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 120.424 0.154 . . . . 0.0 110.996 -178.501 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 426' ' ' ILE . . . . . 0.5 ' O ' HD23 ' B' ' 430' ' ' LEU . 1.2 mm -73.24 -22.82 19.53 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.722 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -172.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 427' ' ' ARG . . . . . 0.724 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.7 OUTLIER -53.92 -32.79 54.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.341 0.591 . . . . 0.0 110.098 -179.827 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -85.03 -5.67 85.75 Favored Glycine 0 N--CA 1.443 -0.839 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.599 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 429' ' ' TYR . . . . . 0.666 ' CZ ' ' HG3' ' B' ' 396' ' ' LYS . 23.8 m-85 -119.15 0.56 11.25 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-O 121.017 0.436 . . . . 0.0 110.454 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 430' ' ' LEU . . . . . 0.524 HD12 ' HD2' ' B' ' 431' ' ' PRO . 0.1 OUTLIER -66.34 127.66 93.41 Favored Pre-proline 0 N--CA 1.439 -1.004 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.402 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 431' ' ' PRO . . . . . 0.524 ' HD2' HD12 ' B' ' 430' ' ' LEU . 84.0 Cg_exo -23.45 -65.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.874 1 C-N-CA 125.728 4.285 . . . . 0.0 115.059 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 432' ' ' GLY . . . . . 0.525 ' O ' HG13 ' B' ' 435' ' ' VAL . . . -143.23 -169.15 12.35 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 175.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 433' ' ' GLN . . . . . 0.536 ' O ' HG11 ' B' ' 436' ' ' VAL . 46.0 tp60 -70.2 -26.54 63.93 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 118.186 0.993 . . . . 0.0 109.893 177.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -62.99 -42.41 99.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.979 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 435' ' ' VAL . . . . . 0.525 HG13 ' O ' ' B' ' 432' ' ' GLY . 7.3 p -69.03 -42.97 82.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 120.933 0.396 . . . . 0.0 110.742 -177.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 436' ' ' VAL . . . . . 0.536 HG11 ' O ' ' B' ' 433' ' ' GLN . 0.1 OUTLIER -66.38 -31.7 54.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.251 175.628 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.57 -52.39 46.0 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 -178.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 438' ' ' ALA . . . . . 0.609 ' O ' ' HD2' ' B' ' 442' ' ' ARG . . . -57.88 -40.03 79.27 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.015 177.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 439' ' ' LEU . . . . . 0.603 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 1.9 tm? -68.26 -48.39 65.19 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -178.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.17 -35.16 73.06 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.515 -1.22 . . . . 0.0 111.061 175.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 441' ' ' GLN . . . . . 0.486 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 3.4 mm-40 -54.7 -49.84 69.72 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.178 -178.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 442' ' ' ARG . . . . . 0.609 ' HD2' ' O ' ' B' ' 438' ' ' ALA . 0.0 OUTLIER -76.17 -23.96 54.75 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 119.663 -0.815 . . . . 0.0 113.092 174.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 443' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 69.4 mt -64.24 -35.78 81.94 Favored 'General case' 0 CA--C 1.519 -0.218 0 O-C-N 121.773 -0.579 . . . . 0.0 109.53 174.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -57.35 -37.64 72.89 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.533 173.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -73.67 -27.42 61.23 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.044 178.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 446' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 26.87 100.59 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 114.422 1.268 . . . . 0.0 114.422 176.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 52.9 mt -63.54 -34.93 70.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.97 -178.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 448' ' ' ASP . . . . . 0.471 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 30.6 m-20 -164.08 -161.95 0.65 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -178.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -79.55 -71.21 0.46 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 171.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.71 -24.97 66.31 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 178.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 451' ' ' THR . . . . . 0.471 ' OG1' ' HB2' ' B' ' 448' ' ' ASP . 13.4 m -70.53 -22.24 62.64 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.775 -173.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 452' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' B' ' 452' ' ' ARG . 20.9 mtp180 -53.39 -53.71 47.22 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 107.481 -1.304 . . . . 0.0 107.481 170.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 453' ' ' ALA . . . . . 0.531 ' HB1' ' CD1' ' B' ' 419' ' ' TYR . . . -59.96 -47.6 85.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.415 -1.266 . . . . 0.0 112.525 175.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 454' ' ' GLU . . . . . 0.445 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 77.5 mm-40 -50.53 -37.65 40.35 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.245 0.545 . . . . 0.0 111.685 -177.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 31.2 p -117.64 15.22 14.54 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.325 -175.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 456' ' ' PHE . . . . . 0.546 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 0.8 OUTLIER -56.91 -47.53 80.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.082 0.468 . . . . 0.0 111.72 -171.82 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 457' ' ' ILE . . . . . 0.526 ' CG1' ' HB3' ' B' ' 408' ' ' TYR . 1.9 mp -77.16 -32.87 19.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.851 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -57.89 -34.28 69.64 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.811 0.815 . . . . 0.0 109.375 170.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 459' ' ' HIS . . . . . 0.726 ' O ' HG21 ' B' ' 463' ' ' VAL . 60.3 m-70 -73.1 -29.58 63.03 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.743 177.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 460' ' ' LEU . . . . . 0.697 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.4 OUTLIER -74.13 -34.67 63.97 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.887 0.851 . . . . 0.0 108.794 179.456 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 461' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -72.85 -37.72 67.3 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.258 175.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 462' ' ' ALA . . . . . 0.644 ' O ' HD11 ' B' ' 466' ' ' ILE . . . -55.9 -33.22 64.45 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.584 -1.189 . . . . 0.0 109.722 169.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 463' ' ' VAL . . . . . 0.726 HG21 ' O ' ' B' ' 459' ' ' HIS . 77.5 t -64.48 -50.77 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 CA-C-N 114.54 -1.209 . . . . 0.0 107.835 177.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 464' ' ' TYR . . . . . 0.538 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 17.3 m-30 -53.08 -26.4 16.04 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 124.339 1.024 . . . . 0.0 110.471 178.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.79 -40.89 16.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.619 0.724 . . . . 0.0 109.526 -177.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 466' ' ' ILE . . . . . 0.644 HD11 ' O ' ' B' ' 462' ' ' ALA . 3.4 mt -56.21 -55.11 20.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 114.339 -1.301 . . . . 0.0 112.117 175.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 467' ' ' LEU . . . . . 0.756 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -103.83 -11.07 17.76 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -172.667 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 468' ' ' GLY . . . . . 0.595 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 93.73 31.87 7.97 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 119.441 -1.362 . . . . 0.0 114.398 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 469' ' ' LEU . . . . . 0.756 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 2.8 mt -89.04 162.06 16.22 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 117.866 0.833 . . . . 0.0 111.417 177.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 38.3 p30 -105.17 -177.0 3.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.692 173.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 471' ' ' ALA . . . . . . . . . . . . . . . -60.3 -22.88 63.68 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -176.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -87.79 0.73 55.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.617 -172.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 473' ' ' GLY . . . . . 0.451 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 77.59 12.05 84.88 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.197 -1.001 . . . . 0.0 110.751 -175.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -101.09 152.7 20.3 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 11.0 p -89.69 129.22 36.15 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.18 0.514 . . . . 0.0 111.134 -178.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 476' ' ' ILE . . . . . 0.595 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.8 pp -94.5 -1.92 10.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.678 0.751 . . . . 0.0 109.889 177.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 477' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -74.91 91.81 2.5 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.432 173.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 478' ' ' LEU . . . . . . . . . . . . . 88.7 mt -82.99 52.26 2.13 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.315 0.579 . . . . 0.0 110.588 -178.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 479' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.376 -0.821 . . . . 0.0 109.707 -179.163 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 . . . . . 0 N--CA 1.479 1.015 0 CA-C-O 121.05 0.452 . . . . 0.0 110.661 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -116.28 -27.05 6.96 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.742 178.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -160.8 161.67 32.09 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.254 -0.578 . . . . 0.0 111.758 -173.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -106.74 -78.91 1.18 Allowed Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 168.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' THR . . . . . 0.429 ' O ' ' HB3' ' A' ' 386' ' ' PHE . 5.8 m -97.06 168.21 10.59 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 166.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' PHE . . . . . 0.55 ' CE2' HG13 ' A' ' 394' ' ' VAL . 1.1 t80 73.11 113.04 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.682 0 C-N-CA 122.681 0.393 . . . . 0.0 110.062 -177.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -42.14 -70.73 0.06 OUTLIER 'Trans proline' 0 N--CA 1.484 0.947 0 C-N-CA 124.48 3.453 . . . . 0.0 114.088 -175.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' MET . . . . . 0.583 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 36.4 ttm 77.67 29.65 0.51 Allowed 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 173.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' HIS . . . . . 0.656 ' CG ' ' HB2' ' A' ' 393' ' ' ASN . 42.4 m170 61.35 -82.91 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.291 0.636 . . . . 0.0 110.633 -176.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -167.92 14.47 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.246 -0.888 . . . . 0.0 108.702 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.481 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.5 pt? -169.53 -48.23 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -168.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . 0.499 ' CA ' HD12 ' A' ' 395' ' ' ILE . . . 178.78 48.36 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 119.309 -1.424 . . . . 0.0 114.531 -172.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . 0.656 ' HB2' ' CG ' ' A' ' 389' ' ' HIS . 0.3 OUTLIER -54.14 -39.79 66.83 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 117.58 0.69 . . . . 0.0 109.405 174.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . 0.618 HG22 ' N ' ' A' ' 395' ' ' ILE . 1.8 m -56.23 -49.18 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.618 ' N ' HG22 ' A' ' 394' ' ' VAL . 3.7 mp -56.75 -53.41 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -174.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . 0.729 ' HG3' ' CE1' ' A' ' 429' ' ' TYR . 0.1 OUTLIER -66.25 -47.21 74.47 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 121.349 1.886 . . . . 0.0 112.06 -172.133 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -52.81 -45.16 61.15 Favored Glycine 0 N--CA 1.434 -1.452 0 C-N-CA 120.132 -1.032 . . . . 0.0 110.882 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . 0.711 ' CD1' HD11 ' A' ' 410' ' ' LEU . 31.2 mt -70.75 -33.87 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . 0.613 HG21 ' O ' ' A' ' 396' ' ' LYS . 11.3 m -62.6 -39.58 85.14 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 C-N-CA 118.821 -1.152 . . . . 0.0 108.103 -174.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -70.93 -34.78 71.83 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 175.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . 0.461 HE21 ' HB3' ' A' ' 401' ' ' GLN . 5.5 mm100 -89.17 -47.71 7.89 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -173.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . 0.439 ' HB3' ' HB ' ' A' ' 406' ' ' THR . 3.0 mm-40 -119.75 -20.94 7.44 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.462 -170.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 107.48 162.77 21.61 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.519 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . 0.599 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.7 m -54.12 -45.73 66.28 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.731 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -175.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . 0.488 ' HB1' HG22 ' A' ' 457' ' ' ILE . . . -64.12 -29.61 70.73 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 119.84 -0.744 . . . . 0.0 112.209 -177.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 406' ' ' THR . . . . . 0.695 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 85.7 m -77.59 -43.21 32.42 Favored 'General case' 0 C--O 1.219 -0.54 0 O-C-N 121.888 -0.507 . . . . 0.0 110.227 173.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.489 ' HB2' ' HA ' ' A' ' 395' ' ' ILE . . . -58.18 -36.09 72.55 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 122.106 0.955 . . . . 0.0 109.14 176.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 408' ' ' TYR . . . . . 0.599 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -66.34 -52.65 44.89 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 113.446 -1.707 . . . . 0.0 109.749 175.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 409' ' ' THR . . . . . 0.526 HG21 HD23 ' A' ' 410' ' ' LEU . 17.3 m -55.48 -47.4 76.21 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.673 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . 0.711 HD11 ' CD1' ' A' ' 398' ' ' ILE . 15.0 mt -72.42 -36.68 68.67 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -174.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.73 -35.31 81.11 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.066 -1.064 . . . . 0.0 110.783 172.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -68.64 -48.32 64.33 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 120.644 0.259 . . . . 0.0 111.265 178.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 413' ' ' MET . . . . . 0.961 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 1.2 ppp? -71.02 -43.27 68.27 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 118.888 -1.125 . . . . 0.0 112.155 -177.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . 0.961 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 12.1 mt -71.31 -45.85 62.08 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -177.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 44.5 t -84.98 -24.3 28.33 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.787 0.803 . . . . 0.0 110.277 -175.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . 0.445 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 110.74 -175.69 18.19 Favored Glycine 0 N--CA 1.428 -1.89 0 N-CA-C 109.824 -1.311 . . . . 0.0 109.824 -171.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -80.84 24.24 0.5 Allowed 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 121.407 0.622 . . . . 0.0 111.193 -172.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 418' ' ' ASN . . . . . 0.445 ' H ' ' C ' ' A' ' 416' ' ' GLY . 84.5 m-20 -71.74 76.64 0.85 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.701 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 419' ' ' TYR . . . . . 0.562 ' CD1' ' HB3' ' A' ' 453' ' ' ALA . 17.1 p90 -54.36 -38.84 66.56 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.656 177.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -55.63 -44.07 76.78 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.634 0.254 . . . . 0.0 111.138 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.78 -48.64 65.76 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.055 -177.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . 0.424 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -66.07 -39.42 84.42 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.158 -177.519 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.721 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 64.0 p -67.49 -39.81 85.21 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.024 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -66.26 -39.9 94.56 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.739 -0.743 . . . . 0.0 111.954 175.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . 0.562 HG21 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.72 -51.91 25.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 121.236 -0.185 . . . . 0.0 111.291 -177.094 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . 0.439 HD11 HG22 ' A' ' 395' ' ' ILE . 1.2 mm -73.77 -23.01 18.88 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.885 0 CA-C-O 120.76 0.314 . . . . 0.0 110.176 -171.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.721 ' HB2' ' O ' ' A' ' 423' ' ' SER . 0.8 OUTLIER -54.77 -29.14 53.27 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.981 0.419 . . . . 0.0 110.975 -178.009 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.73 -11.45 68.24 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.641 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.729 ' CE1' ' HG3' ' A' ' 396' ' ' LYS . 15.0 m-85 -113.99 -1.41 13.8 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 121.709 0.766 . . . . 0.0 109.241 -176.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . 0.541 ' HA ' HG13 ' A' ' 404' ' ' VAL . 0.0 OUTLIER -65.94 135.12 95.2 Favored Pre-proline 0 N--CA 1.438 -1.039 0 CA-C-N 114.05 -1.432 . . . . 0.0 108.665 177.694 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . 0.683 ' CD ' HG11 ' A' ' 435' ' ' VAL . 43.0 Cg_exo -36.25 -65.71 0.13 Allowed 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 124.804 3.669 . . . . 0.0 114.34 -171.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . 0.559 ' O ' HG13 ' A' ' 435' ' ' VAL . . . -141.85 -163.18 9.5 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 176.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . 0.532 ' O ' HG12 ' A' ' 436' ' ' VAL . 21.7 tp60 -70.73 -27.64 64.12 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 118.103 0.952 . . . . 0.0 110.411 177.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -67.47 -38.89 85.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.031 -176.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 435' ' ' VAL . . . . . 0.683 HG11 ' CD ' ' A' ' 431' ' ' PRO . 7.6 p -68.48 -44.9 82.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.974 0.416 . . . . 0.0 110.602 -178.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . 0.532 HG12 ' O ' ' A' ' 433' ' ' GLN . 0.2 OUTLIER -65.41 -29.35 46.9 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.334 175.965 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 437' ' ' THR . . . . . 0.409 HG23 ' N ' ' A' ' 438' ' ' ALA . 0.9 OUTLIER -70.71 -51.98 23.97 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -179.342 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . 0.804 ' O ' ' HG2' ' A' ' 442' ' ' ARG . . . -58.14 -38.69 77.04 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.692 177.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 439' ' ' LEU . . . . . 0.546 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 2.1 tm? -70.15 -47.21 62.61 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -178.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.53 -39.33 76.35 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.406 174.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 441' ' ' GLN . . . . . 0.484 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 9.5 mm-40 -53.54 -49.7 67.08 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 123.958 0.903 . . . . 0.0 110.663 174.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . 0.804 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 0.6 OUTLIER -56.09 -40.17 73.24 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.762 172.226 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 443' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 31.9 mt -72.21 -32.07 66.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.023 0.44 . . . . 0.0 110.467 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -58.69 -38.2 77.73 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.458 173.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 -74.01 -27.53 61.01 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.219 177.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 446' ' ' GLU . . . . . 0.443 ' HB3' ' O ' ' A' ' 443' ' ' LEU . 10.3 pt-20 19.29 101.01 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 178.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 45.0 mt -61.03 -33.88 57.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.382 0.61 . . . . 0.0 110.438 177.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . 0.401 ' HB2' ' CB ' ' A' ' 451' ' ' THR . 10.8 m-20 -162.92 -156.14 0.38 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -178.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -89.74 -63.97 1.21 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 169.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.07 -25.86 64.66 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 178.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 451' ' ' THR . . . . . 0.456 ' HA ' ' HB2' ' A' ' 454' ' ' GLU . 13.5 m -71.28 -22.57 61.94 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.572 -176.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -54.24 -53.77 49.13 Favored 'General case' 0 C--O 1.22 -0.498 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 171.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 453' ' ' ALA . . . . . 0.562 ' HB3' ' CD1' ' A' ' 419' ' ' TYR . . . -57.43 -48.53 78.9 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 114.624 -1.171 . . . . 0.0 112.396 175.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . 0.456 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 14.7 mm-40 -51.1 -35.11 33.5 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.357 0.599 . . . . 0.0 111.559 -178.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 33.5 p -119.22 16.15 13.15 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.493 -176.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . 0.539 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.9 OUTLIER -57.77 -48.35 79.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.914 0.387 . . . . 0.0 111.693 -171.282 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . 0.537 ' CG1' ' HB3' ' A' ' 408' ' ' TYR . 2.0 mp -76.14 -32.63 23.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 120.8 0.333 . . . . 0.0 110.933 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -57.62 -35.05 69.95 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.978 0.894 . . . . 0.0 109.195 171.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . 0.734 ' O ' HG21 ' A' ' 463' ' ' VAL . 59.8 m-70 -74.84 -28.99 60.91 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.542 -1.208 . . . . 0.0 110.946 177.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . 0.704 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.4 OUTLIER -73.88 -34.94 64.63 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.97 0.89 . . . . 0.0 108.89 179.049 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . 0.434 ' O ' ' HB2' ' A' ' 464' ' ' TYR . 22.1 m-80 -73.34 -37.34 66.14 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.862 0.839 . . . . 0.0 108.78 177.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 462' ' ' ALA . . . . . 0.601 ' O ' HD13 ' A' ' 466' ' ' ILE . . . -56.46 -35.34 67.8 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.377 -1.283 . . . . 0.0 109.656 169.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.734 HG21 ' O ' ' A' ' 459' ' ' HIS . 68.2 t -60.93 -51.6 71.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 175.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 464' ' ' TYR . . . . . 0.607 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 19.9 m-30 -52.01 -28.34 16.68 Favored 'General case' 0 C--N 1.333 -0.125 0 O-C-N 124.363 1.039 . . . . 0.0 110.765 177.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.5 -40.6 17.45 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.5 0.667 . . . . 0.0 109.67 -177.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.601 HD13 ' O ' ' A' ' 462' ' ' ALA . 3.7 mt -56.27 -55.43 18.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 114.395 -1.275 . . . . 0.0 112.198 176.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.771 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -101.9 -10.61 19.68 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 -172.667 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . 0.61 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 93.7 31.97 7.92 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 119.337 -1.411 . . . . 0.0 114.23 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 469' ' ' LEU . . . . . 0.771 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.7 mt -88.98 161.84 16.39 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 117.808 0.804 . . . . 0.0 111.146 176.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 37.9 p30 -104.55 -176.9 3.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.956 172.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 471' ' ' ALA . . . . . 0.439 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -62.28 -20.48 64.34 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -176.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -87.21 -1.8 58.16 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.655 0.265 . . . . 0.0 111.648 -173.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 79.11 14.21 82.09 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.008 -1.092 . . . . 0.0 110.66 -174.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -100.85 148.86 24.47 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 177.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 3.9 p -88.05 126.73 35.25 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.995 0.426 . . . . 0.0 111.168 -178.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 476' ' ' ILE . . . . . 0.61 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.8 pp -98.99 3.75 10.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.523 0.678 . . . . 0.0 110.307 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 -59.6 119.22 7.16 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.623 -1.171 . . . . 0.0 112.088 -177.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -78.23 -12.42 60.0 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.362 0.601 . . . . 0.0 109.632 173.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 . . . . . 0 C--O 1.247 0.922 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.639 179.765 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 381' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 . . . . . 0 N--CA 1.48 1.038 0 CA-C-O 121.238 0.542 . . . . 0.0 110.74 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 382' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -116.33 -26.86 7.0 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.836 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 383' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -160.8 161.87 32.16 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.71 -173.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 384' ' ' GLY . . . . . . . . . . . . . . . -106.98 -78.82 1.17 Allowed Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 168.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 385' ' ' THR . . . . . 0.435 ' O ' ' HB3' ' B' ' 386' ' ' PHE . 5.7 m -97.45 168.02 10.64 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 166.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 386' ' ' PHE . . . . . 0.545 ' CE2' HG13 ' B' ' 394' ' ' VAL . 1.2 t80 73.2 113.03 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.661 0 C-N-CA 122.719 0.408 . . . . 0.0 110.035 -177.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 387' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -42.01 -71.45 0.06 OUTLIER 'Trans proline' 0 N--CA 1.482 0.851 0 C-N-CA 124.528 3.486 . . . . 0.0 113.967 -176.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 388' ' ' MET . . . . . 0.559 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 36.1 ttm 78.21 29.18 0.47 Allowed 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 173.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 389' ' ' HIS . . . . . 0.648 ' CG ' ' HB2' ' B' ' 393' ' ' ASN . 42.6 m170 61.87 -83.05 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.384 0.674 . . . . 0.0 110.554 -176.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -167.68 14.22 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.731 177.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 391' ' ' LEU . . . . . 0.468 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.5 pt? -169.5 -48.29 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -167.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 392' ' ' GLY . . . . . 0.502 ' CA ' HD12 ' B' ' 395' ' ' ILE . . . 178.61 48.49 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 119.31 -1.424 . . . . 0.0 114.527 -172.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 393' ' ' ASN . . . . . 0.648 ' HB2' ' CG ' ' B' ' 389' ' ' HIS . 0.2 OUTLIER -54.27 -39.61 67.05 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 117.531 0.665 . . . . 0.0 109.355 174.905 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 394' ' ' VAL . . . . . 0.622 HG22 ' N ' ' B' ' 395' ' ' ILE . 1.8 m -56.25 -49.17 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 395' ' ' ILE . . . . . 0.622 ' N ' HG22 ' B' ' 394' ' ' VAL . 3.7 mp -56.8 -53.39 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 CA-C-O 118.255 -0.879 . . . . 0.0 113.323 -174.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 396' ' ' LYS . . . . . 0.723 ' HG3' ' CE1' ' B' ' 429' ' ' TYR . 0.1 OUTLIER -66.27 -47.0 75.09 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 121.42 1.918 . . . . 0.0 112.054 -172.042 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 397' ' ' GLY . . . . . 0.419 ' HA2' HG21 ' A' ' 385' ' ' THR . . . -53.0 -45.19 62.19 Favored Glycine 0 N--CA 1.432 -1.571 0 C-N-CA 120.099 -1.048 . . . . 0.0 110.893 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . 0.704 ' CD1' HD11 ' B' ' 410' ' ' LEU . 31.1 mt -70.67 -33.88 54.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 399' ' ' VAL . . . . . 0.614 HG21 ' O ' ' B' ' 396' ' ' LYS . 11.2 m -62.59 -39.52 84.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 C-N-CA 118.664 -1.214 . . . . 0.0 108.07 -174.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -70.93 -34.8 71.85 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 175.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 401' ' ' GLN . . . . . 0.41 HE21 ' HB3' ' B' ' 401' ' ' GLN . 5.7 mm100 -89.11 -47.71 7.9 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -173.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 402' ' ' GLU . . . . . 0.445 ' HB3' ' HB ' ' B' ' 406' ' ' THR . 3.1 mm-40 -119.85 -20.89 7.4 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.558 -170.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 107.44 162.55 21.61 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.52 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 404' ' ' VAL . . . . . 0.587 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.6 m -53.95 -45.78 64.19 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.754 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -175.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 405' ' ' ALA . . . . . 0.488 ' HB1' HG22 ' B' ' 457' ' ' ILE . . . -64.02 -29.81 70.93 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 119.741 -0.784 . . . . 0.0 112.187 -177.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 406' ' ' THR . . . . . 0.686 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 90.1 m -77.34 -43.14 33.98 Favored 'General case' 0 C--O 1.22 -0.499 0 O-C-N 121.867 -0.521 . . . . 0.0 110.343 172.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 407' ' ' ALA . . . . . 0.493 ' HB2' ' HA ' ' B' ' 395' ' ' ILE . . . -58.16 -36.0 72.37 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 122.162 0.982 . . . . 0.0 109.254 176.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 408' ' ' TYR . . . . . 0.587 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -66.33 -52.74 44.09 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 113.411 -1.722 . . . . 0.0 109.711 176.003 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 409' ' ' THR . . . . . 0.521 HG21 HD23 ' B' ' 410' ' ' LEU . 17.1 m -55.41 -47.37 76.04 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.675 179.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 410' ' ' LEU . . . . . 0.704 HD11 ' CD1' ' B' ' 398' ' ' ILE . 15.1 mt -72.5 -36.46 68.39 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -174.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.91 -35.21 81.94 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.058 -1.068 . . . . 0.0 110.769 172.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 412' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -68.6 -48.41 64.21 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-O 120.514 0.197 . . . . 0.0 111.34 178.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 413' ' ' MET . . . . . 0.953 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 1.2 ppp? -71.07 -43.17 68.33 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 118.954 -1.098 . . . . 0.0 112.116 -177.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 414' ' ' LEU . . . . . 0.953 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 11.9 mt -71.21 -46.31 61.45 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -177.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 43.9 t -84.76 -24.4 28.82 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.649 0.738 . . . . 0.0 110.289 -174.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 416' ' ' GLY . . . . . 0.454 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 111.08 -175.83 18.07 Favored Glycine 0 N--CA 1.426 -2.009 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -171.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -80.54 24.05 0.48 Allowed 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.482 0.658 . . . . 0.0 111.255 -172.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 418' ' ' ASN . . . . . 0.454 ' H ' ' C ' ' B' ' 416' ' ' GLY . 84.9 m-20 -71.55 76.77 0.8 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.74 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 419' ' ' TYR . . . . . 0.573 ' CD1' ' HB3' ' B' ' 453' ' ' ALA . 16.8 p90 -54.4 -39.01 66.84 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.653 177.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -55.73 -43.85 76.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.788 0.328 . . . . 0.0 111.168 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.81 -48.69 65.55 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.033 -178.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 422' ' ' VAL . . . . . 0.425 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.2 OUTLIER -66.23 -39.44 84.3 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.398 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.089 -177.396 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 423' ' ' SER . . . . . 0.738 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 64.4 p -67.32 -39.88 85.92 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.924 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -66.38 -39.71 94.29 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.107 175.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 425' ' ' ILE . . . . . 0.563 HG21 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -72.79 -51.84 25.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 121.219 -0.192 . . . . 0.0 111.329 -177.218 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 426' ' ' ILE . . . . . 0.425 HD11 HG22 ' B' ' 395' ' ' ILE . 1.2 mm -73.87 -23.04 18.76 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.896 0 O-C-N 122.194 -0.316 . . . . 0.0 110.227 -171.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 427' ' ' ARG . . . . . 0.738 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.8 OUTLIER -54.7 -29.32 52.74 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.074 0.464 . . . . 0.0 111.007 -178.106 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.51 -11.4 68.86 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.638 -0.791 . . . . 0.0 111.637 178.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 429' ' ' TYR . . . . . 0.723 ' CE1' ' HG3' ' B' ' 396' ' ' LYS . 14.9 m-85 -114.13 -1.17 13.76 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-O 121.766 0.793 . . . . 0.0 109.256 -176.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 430' ' ' LEU . . . . . 0.542 ' HA ' HG13 ' B' ' 404' ' ' VAL . 0.0 OUTLIER -66.02 135.13 95.11 Favored Pre-proline 0 N--CA 1.438 -1.031 0 CA-C-N 114.017 -1.447 . . . . 0.0 108.649 177.582 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 431' ' ' PRO . . . . . 0.69 ' CD ' HG11 ' B' ' 435' ' ' VAL . 43.9 Cg_exo -36.21 -65.99 0.13 Allowed 'Trans proline' 0 N--CA 1.474 0.365 0 C-N-CA 124.888 3.725 . . . . 0.0 114.226 -171.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 432' ' ' GLY . . . . . 0.564 ' O ' HG13 ' B' ' 435' ' ' VAL . . . -141.63 -163.36 9.56 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 176.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 433' ' ' GLN . . . . . 0.527 ' O ' HG12 ' B' ' 436' ' ' VAL . 21.3 tp60 -70.54 -27.6 64.28 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 118.079 0.94 . . . . 0.0 110.322 177.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -67.52 -38.94 85.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.995 -176.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 435' ' ' VAL . . . . . 0.69 HG11 ' CD ' ' B' ' 431' ' ' PRO . 7.7 p -68.59 -44.85 82.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-O 120.958 0.409 . . . . 0.0 110.623 -178.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 436' ' ' VAL . . . . . 0.527 HG12 ' O ' ' B' ' 433' ' ' GLN . 0.2 OUTLIER -65.19 -29.69 48.06 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.39 175.83 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 437' ' ' THR . . . . . 0.407 HG23 ' N ' ' B' ' 438' ' ' ALA . 0.9 OUTLIER -70.37 -51.99 25.76 Favored 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -179.202 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 438' ' ' ALA . . . . . 0.813 ' O ' ' HG2' ' B' ' 442' ' ' ARG . . . -58.15 -38.73 77.18 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.707 177.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 439' ' ' LEU . . . . . 0.554 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 2.1 tm? -70.23 -47.09 62.92 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -178.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.67 -39.16 76.45 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.34 174.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 441' ' ' GLN . . . . . 0.482 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 9.2 mm-40 -53.76 -49.62 67.8 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 123.826 0.85 . . . . 0.0 110.624 174.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 442' ' ' ARG . . . . . 0.813 ' HG2' ' O ' ' B' ' 438' ' ' ALA . 0.7 OUTLIER -56.15 -40.24 73.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.684 172.228 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 443' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 32.5 mt -72.16 -32.03 66.5 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.995 0.426 . . . . 0.0 110.34 -178.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -58.81 -38.06 77.77 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.682 0.753 . . . . 0.0 110.464 173.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -74.03 -27.54 60.99 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.275 177.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 446' ' ' GLU . . . . . 0.441 ' HB3' ' O ' ' B' ' 443' ' ' LEU . 10.8 pt-20 19.3 100.29 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 178.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 45.2 mt -60.61 -34.03 56.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.382 0.611 . . . . 0.0 110.426 177.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 448' ' ' ASP . . . . . 0.404 ' HB2' ' CB ' ' B' ' 451' ' ' THR . 11.4 m-20 -162.61 -156.31 0.4 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -178.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -89.66 -63.97 1.21 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 169.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.87 -25.94 64.88 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 178.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 451' ' ' THR . . . . . 0.455 ' HA ' ' HB2' ' B' ' 454' ' ' GLU . 12.1 m -71.29 -22.57 61.93 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.602 -176.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 452' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -54.37 -53.65 51.11 Favored 'General case' 0 C--O 1.219 -0.533 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 171.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 453' ' ' ALA . . . . . 0.573 ' HB3' ' CD1' ' B' ' 419' ' ' TYR . . . -57.71 -48.04 80.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 114.609 -1.178 . . . . 0.0 112.53 175.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 454' ' ' GLU . . . . . 0.455 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 11.4 mm-40 -51.53 -34.82 37.98 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.161 0.505 . . . . 0.0 111.578 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 32.4 p -119.63 16.04 12.8 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.424 -176.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 456' ' ' PHE . . . . . 0.544 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 0.9 OUTLIER -57.46 -48.68 78.54 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.664 -171.304 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 457' ' ' ILE . . . . . 0.546 ' CG1' ' HB3' ' B' ' 408' ' ' TYR . 2.0 mp -75.68 -32.83 25.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.986 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -57.39 -35.29 69.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.959 0.885 . . . . 0.0 109.139 171.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 459' ' ' HIS . . . . . 0.732 ' O ' HG21 ' B' ' 463' ' ' VAL . 60.8 m-70 -74.73 -28.91 60.98 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.44 -1.254 . . . . 0.0 110.998 177.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 460' ' ' LEU . . . . . 0.714 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.4 OUTLIER -73.91 -35.04 64.61 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.9 0.857 . . . . 0.0 108.938 178.944 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 461' ' ' ASN . . . . . 0.418 ' O ' ' HB2' ' B' ' 464' ' ' TYR . 23.5 m-80 -73.24 -37.42 66.37 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.743 177.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 462' ' ' ALA . . . . . 0.612 ' O ' HD13 ' B' ' 466' ' ' ILE . . . -56.39 -35.34 67.64 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.711 169.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 463' ' ' VAL . . . . . 0.732 HG21 ' O ' ' B' ' 459' ' ' HIS . 68.3 t -61.01 -51.59 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 175.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 464' ' ' TYR . . . . . 0.592 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 19.9 m-30 -52.0 -28.39 16.8 Favored 'General case' 0 N--CA 1.457 -0.11 0 O-C-N 124.4 1.063 . . . . 0.0 110.764 178.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.41 -40.53 17.69 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.633 0.73 . . . . 0.0 109.736 -177.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 466' ' ' ILE . . . . . 0.612 HD13 ' O ' ' B' ' 462' ' ' ALA . 3.7 mt -56.04 -55.83 16.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 114.402 -1.272 . . . . 0.0 112.184 176.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 467' ' ' LEU . . . . . 0.771 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -101.83 -10.44 19.88 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -172.468 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 468' ' ' GLY . . . . . 0.611 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 93.75 32.03 7.86 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 119.352 -1.404 . . . . 0.0 114.164 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 469' ' ' LEU . . . . . 0.771 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.7 mt -89.05 161.81 16.35 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 117.81 0.805 . . . . 0.0 111.149 176.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 37.9 p30 -104.59 -176.93 3.22 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.901 172.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 471' ' ' ALA . . . . . 0.439 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -62.22 -20.74 64.52 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -175.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -87.11 -1.68 58.07 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.655 0.264 . . . . 0.0 111.647 -173.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 473' ' ' GLY . . . . . . . . . . . . . . . 78.7 14.62 81.87 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 119.986 -1.102 . . . . 0.0 110.61 -174.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -101.11 149.01 24.4 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 177.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 4.2 p -87.86 127.5 35.34 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.05 0.452 . . . . 0.0 111.006 -178.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 476' ' ' ILE . . . . . 0.611 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.9 pp -99.68 4.19 10.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.625 0.726 . . . . 0.0 110.225 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 477' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 -59.79 119.86 8.45 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.944 -177.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 478' ' ' LEU . . . . . 0.409 ' H ' HD21 ' B' ' 478' ' ' LEU . 2.6 pt? -78.99 -12.59 60.04 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.428 0.632 . . . . 0.0 109.646 173.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 479' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 . . . . . 0 C--O 1.247 0.956 0 CA-C-O 118.283 -0.865 . . . . 0.0 109.45 179.74 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 . . . . . 0 N--CA 1.481 1.09 0 CA-C-O 121.157 0.503 . . . . 0.0 110.657 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' THR . . . . . 0.406 HG22 ' H ' ' A' ' 383' ' ' HIS . 0.1 OUTLIER -142.68 -66.12 0.39 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.882 -179.729 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' HIS . . . . . 0.406 ' H ' HG22 ' A' ' 382' ' ' THR . 9.5 p80 -121.41 170.75 9.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.411 0.624 . . . . 0.0 112.671 -169.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -119.19 -110.62 2.38 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 114.999 -1.001 . . . . 0.0 111.53 174.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 21.0 m -68.48 -41.75 79.68 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.943 0.401 . . . . 0.0 110.832 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' PHE . . . . . 0.626 ' CD1' HD23 ' A' ' 414' ' ' LEU . 4.7 t80 -70.46 125.82 92.11 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.217 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -47.11 -67.72 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.848 3.032 . . . . 0.0 114.5 -174.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' MET . . . . . 0.48 ' HE2' ' CB ' ' A' ' 415' ' ' SER . 34.5 ttm 66.27 160.81 0.14 Allowed 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.792 0.33 . . . . 0.0 111.235 176.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' HIS . . . . . 0.593 ' CE1' ' HA ' ' A' ' 393' ' ' ASN . 34.4 m170 -72.73 -155.68 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 108.353 -0.981 . . . . 0.0 108.353 173.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 5.7 pm0 -77.84 8.77 4.16 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.395 172.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.483 HD22 ' H ' ' A' ' 392' ' ' GLY . 2.1 pt? -159.79 -51.84 0.06 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -176.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . 0.483 ' H ' HD22 ' A' ' 391' ' ' LEU . . . -171.05 72.82 0.11 Allowed Glycine 0 CA--C 1.526 0.766 0 C-N-CA 119.438 -1.363 . . . . 0.0 114.762 -173.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . 0.593 ' HA ' ' CE1' ' A' ' 389' ' ' HIS . 0.0 OUTLIER -66.4 -36.95 84.14 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 175.832 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . 0.574 HG23 ' N ' ' A' ' 395' ' ' ILE . 1.0 OUTLIER -57.07 -49.09 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 CA-C-N 113.032 -1.894 . . . . 0.0 107.248 178.193 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.574 ' N ' HG23 ' A' ' 394' ' ' VAL . 3.7 mp -58.48 -52.61 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 CA-C-O 117.663 -1.161 . . . . 0.0 113.671 -174.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . 0.621 ' O ' HG23 ' A' ' 399' ' ' VAL . 0.0 OUTLIER -61.88 -50.02 73.89 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 122.221 2.282 . . . . 0.0 112.143 -174.56 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . 0.442 ' O ' ' HG3' ' A' ' 401' ' ' GLN . . . -53.29 -44.68 65.24 Favored Glycine 0 N--CA 1.432 -1.571 0 CA-C-N 114.713 -1.13 . . . . 0.0 111.045 -176.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . 0.514 HD13 ' CD1' ' A' ' 410' ' ' LEU . 37.8 mt -71.34 -34.23 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -178.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 396' ' ' LYS . 16.3 m -63.24 -40.33 88.62 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 C-N-CA 118.92 -1.112 . . . . 0.0 108.49 -173.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -64.3 -43.85 93.44 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 175.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . 0.529 ' NE2' ' HA ' ' B' ' 414' ' ' LEU . 14.5 mt-30 -92.9 -48.38 6.56 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -167.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . 0.406 ' HB3' ' HB ' ' A' ' 406' ' ' THR . 1.2 tm-20 -111.52 -19.13 12.66 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.193 0.52 . . . . 0.0 110.82 -173.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 104.51 161.33 24.18 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.846 177.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . 0.645 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.2 m -53.94 -45.13 63.51 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.866 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -175.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . 0.483 ' HB2' HG21 ' A' ' 457' ' ' ILE . . . -63.58 -31.65 72.87 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 119.956 -0.697 . . . . 0.0 112.517 -177.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 406' ' ' THR . . . . . 0.686 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 88.0 m -77.08 -41.48 42.06 Favored 'General case' 0 C--O 1.222 -0.35 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.46 173.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.505 ' HB2' ' HA ' ' A' ' 395' ' ' ILE . . . -58.84 -36.6 74.82 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 122.1 0.953 . . . . 0.0 109.354 175.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 408' ' ' TYR . . . . . 0.645 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -67.18 -51.47 53.23 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 113.525 -1.671 . . . . 0.0 109.729 177.009 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 409' ' ' THR . . . . . 0.571 HG23 HD22 ' A' ' 410' ' ' LEU . 17.1 m -54.55 -47.76 72.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.591 -0.732 . . . . 0.0 112.508 177.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . 0.686 ' HG ' ' O ' ' A' ' 406' ' ' THR . 14.5 mt -72.55 -34.4 67.5 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -175.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.59 -34.01 74.46 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.286 -0.959 . . . . 0.0 110.865 170.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 412' ' ' MET . . . . . 0.402 ' HB2' ' O ' ' A' ' 409' ' ' THR . 0.4 OUTLIER -67.89 -48.09 67.0 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 122.547 -0.384 . . . . 0.0 111.17 177.148 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 413' ' ' MET . . . . . 0.918 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.7 OUTLIER -72.32 -48.21 43.89 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 119.176 -1.01 . . . . 0.0 112.569 -179.778 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . 0.918 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 15.4 mt -69.18 -46.95 66.23 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -174.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.48 ' CB ' ' HE2' ' A' ' 388' ' ' MET . 0.0 OUTLIER -97.08 9.62 41.59 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.432 0.634 . . . . 0.0 110.746 -173.541 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . 0.442 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 85.32 -178.46 50.57 Favored Glycine 0 N--CA 1.435 -1.375 0 CA-C-N 115.437 -0.802 . . . . 0.0 111.554 -178.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -79.94 22.66 0.49 Allowed 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.285 0.564 . . . . 0.0 111.108 -173.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 418' ' ' ASN . . . . . 0.442 ' H ' ' C ' ' A' ' 416' ' ' GLY . 3.5 m-20 -71.94 75.1 0.9 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.083 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 419' ' ' TYR . . . . . 0.57 ' CD1' ' HB3' ' A' ' 453' ' ' ALA . 28.3 p90 -56.6 -36.96 70.0 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.456 177.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -54.81 -42.03 71.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.461 175.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . 0.424 ' O ' HD11 ' A' ' 425' ' ' ILE . 0.0 OUTLIER -68.62 -51.89 37.32 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.624 -179.068 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . 0.516 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -62.77 -37.1 78.24 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.582 -174.705 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.763 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 58.4 p -69.27 -34.07 74.19 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -68.69 -42.18 80.86 Favored Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.3 174.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . 0.562 HG22 HG23 ' A' ' 395' ' ' ILE . 2.6 mp -72.55 -50.98 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 116.921 0.361 . . . . 0.0 111.514 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . 0.5 ' CD1' HG21 ' A' ' 395' ' ' ILE . 1.2 mm -75.19 -23.69 17.26 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.911 0 O-C-N 122.085 -0.384 . . . . 0.0 110.926 -171.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.763 ' HB2' ' O ' ' A' ' 423' ' ' SER . 1.0 OUTLIER -54.3 -33.3 58.44 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.196 0.522 . . . . 0.0 111.009 -177.199 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -84.65 -13.79 71.99 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.316 -0.945 . . . . 0.0 111.021 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.507 ' HD1' ' CG2' ' A' ' 395' ' ' ILE . 7.3 m-30 -110.83 -2.05 16.29 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.913 0.863 . . . . 0.0 108.758 -174.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . 0.533 ' HA ' HG13 ' A' ' 404' ' ' VAL . 0.0 OUTLIER -66.3 138.96 96.12 Favored Pre-proline 0 N--CA 1.441 -0.902 0 CA-C-N 113.972 -1.467 . . . . 0.0 109.027 176.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . 0.68 ' CD ' HG11 ' A' ' 435' ' ' VAL . 71.0 Cg_exo -37.81 -65.3 0.16 Allowed 'Trans proline' 0 N--CA 1.473 0.312 0 C-N-CA 124.499 3.466 . . . . 0.0 113.874 -173.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . 0.563 ' O ' HG13 ' A' ' 435' ' ' VAL . . . -143.86 -163.24 9.8 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 176.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . 0.573 ' O ' HG12 ' A' ' 436' ' ' VAL . 43.8 tp60 -71.87 -26.67 62.44 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 118.328 1.064 . . . . 0.0 110.882 177.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -66.29 -40.7 90.22 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -177.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 435' ' ' VAL . . . . . 0.68 HG11 ' CD ' ' A' ' 431' ' ' PRO . 7.5 p -67.08 -44.13 88.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-O 120.962 0.411 . . . . 0.0 110.783 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . 0.573 HG12 ' O ' ' A' ' 433' ' ' GLN . 0.1 OUTLIER -65.98 -31.55 54.19 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.179 176.383 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.2 -52.98 34.58 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -178.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . 0.507 ' HB2' HG12 ' A' ' 463' ' ' VAL . . . -58.56 -40.06 82.02 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.23 177.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 439' ' ' LEU . . . . . 0.592 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 1.9 tm? -68.13 -48.1 66.3 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -178.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.9 -38.44 78.91 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.457 176.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 441' ' ' GLN . . . . . 0.411 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 6.0 mm-40 -53.69 -52.09 61.14 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 123.629 0.771 . . . . 0.0 110.56 177.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . 0.536 ' NH1' ' HB3' ' A' ' 462' ' ' ALA . 0.1 OUTLIER -60.95 -34.9 75.45 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.734 174.848 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 443' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 64.1 mt -68.32 -36.55 79.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.744 178.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -56.57 -37.12 70.13 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.527 0.679 . . . . 0.0 110.284 174.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -74.12 -26.75 60.52 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.577 177.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 446' ' ' GLU . . . . . 0.427 ' HB3' ' O ' ' A' ' 443' ' ' LEU . 10.1 pt-20 19.26 103.36 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 176.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 43.0 mt -60.95 -34.9 61.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.852 178.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . 0.451 ' HB2' ' OG1' ' A' ' 451' ' ' THR . 22.1 m-20 -162.43 -158.8 0.53 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -178.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 449' ' ' ASP . . . . . 0.513 ' HA ' ' CZ ' ' A' ' 452' ' ' ARG . 9.6 m-20 -86.29 -67.2 0.83 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 170.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.94 -25.57 67.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.167 178.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 451' ' ' THR . . . . . 0.491 ' HA ' ' HB2' ' A' ' 454' ' ' GLU . 14.3 m -71.47 -22.6 61.8 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.633 -176.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . 0.513 ' CZ ' ' HA ' ' A' ' 449' ' ' ASP . 48.8 mtt85 -54.65 -53.92 48.4 Favored 'General case' 0 C--O 1.219 -0.535 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 171.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 453' ' ' ALA . . . . . 0.57 ' HB3' ' CD1' ' A' ' 419' ' ' TYR . . . -56.69 -47.91 78.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.706 -1.134 . . . . 0.0 112.404 174.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . 0.491 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 13.3 mm-40 -52.36 -33.09 41.54 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.14 0.495 . . . . 0.0 111.742 -178.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 28.6 p -120.04 13.17 12.11 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.551 -176.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . 0.522 ' CE2' ' HB2' ' A' ' 419' ' ' TYR . 0.6 OUTLIER -56.71 -49.03 76.39 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.003 0.43 . . . . 0.0 111.493 -171.525 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . 0.517 HG13 ' HB3' ' A' ' 408' ' ' TYR . 1.9 mp -75.98 -32.02 22.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.067 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -57.88 -35.45 71.0 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.722 0.772 . . . . 0.0 108.939 171.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . 0.777 ' O ' HG22 ' A' ' 463' ' ' VAL . 74.2 m-70 -74.44 -29.3 61.42 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.294 178.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . 0.715 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -74.1 -35.36 64.17 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.864 0.84 . . . . 0.0 109.241 179.78 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . 0.485 ' O ' ' HB2' ' A' ' 464' ' ' TYR . 23.1 m-80 -73.65 -37.25 65.37 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 121.935 0.874 . . . . 0.0 108.922 177.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 462' ' ' ALA . . . . . 0.587 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -57.26 -34.8 69.0 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.803 169.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.777 HG22 ' O ' ' A' ' 459' ' ' HIS . 63.7 t -60.46 -50.82 78.85 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.851 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 175.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 464' ' ' TYR . . . . . 0.608 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 19.3 m-30 -52.77 -28.25 21.56 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.552 177.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.53 -41.77 19.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.721 0.772 . . . . 0.0 109.457 -178.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.587 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.8 mt -57.24 -55.85 18.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 114.269 -1.332 . . . . 0.0 112.076 177.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.753 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -101.07 -10.12 20.78 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -172.999 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . 0.586 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 94.14 31.59 7.96 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 119.354 -1.403 . . . . 0.0 114.31 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 469' ' ' LEU . . . . . 0.753 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.9 mt -88.58 163.77 15.7 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 117.831 0.815 . . . . 0.0 111.09 176.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 37.4 p30 -105.34 -179.27 3.89 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.521 174.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -60.17 -23.25 63.8 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -177.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -87.24 2.34 50.37 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.325 -172.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . 0.472 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 77.8 10.61 86.11 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.501 -0.857 . . . . 0.0 111.3 -177.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -101.23 157.98 16.38 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 176.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 475' ' ' SER . . . . . 0.523 ' OG ' ' HG2' ' A' ' 477' ' ' ARG . 16.3 t -94.01 144.3 25.59 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.314 -0.555 . . . . 0.0 110.755 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 476' ' ' ILE . . . . . 0.586 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.5 pp -108.44 12.32 8.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.513 -178.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 477' ' ' ARG . . . . . 0.523 ' HG2' ' OG ' ' A' ' 475' ' ' SER . 29.9 mmm180 -54.4 111.27 0.75 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.48 -1.236 . . . . 0.0 111.084 177.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 62.18 34.8 15.95 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.129 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 . . . . . 0 C--O 1.25 1.083 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.471 177.77 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 381' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 . . . . . 0 N--CA 1.481 1.099 0 CA-C-O 121.195 0.521 . . . . 0.0 110.53 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 382' ' ' THR . . . . . 0.408 HG22 ' H ' ' B' ' 383' ' ' HIS . 0.1 OUTLIER -142.5 -66.42 0.39 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.978 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 383' ' ' HIS . . . . . 0.408 ' H ' HG22 ' B' ' 382' ' ' THR . 9.4 p80 -120.85 170.99 8.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.516 0.674 . . . . 0.0 112.75 -169.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 384' ' ' GLY . . . . . . . . . . . . . . . -119.35 -110.33 2.35 Favored Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.408 173.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 385' ' ' THR . . . . . . . . . . . . . 19.4 m -68.48 -41.66 79.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.002 0.43 . . . . 0.0 110.931 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 386' ' ' PHE . . . . . 0.633 ' CD1' HD23 ' B' ' 414' ' ' LEU . 4.6 t80 -70.63 125.93 92.11 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.174 178.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 387' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -47.22 -67.75 0.11 Allowed 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 123.788 2.992 . . . . 0.0 114.388 -174.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 388' ' ' MET . . . . . 0.493 ' HE2' ' CB ' ' B' ' 415' ' ' SER . 34.6 ttm 66.2 161.01 0.14 Allowed 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.683 0.278 . . . . 0.0 111.247 177.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 389' ' ' HIS . . . . . 0.582 ' CE1' ' HA ' ' B' ' 393' ' ' ASN . 34.5 m170 -72.91 -155.14 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 173.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 5.7 pm0 -77.92 8.8 4.19 Favored 'General case' 0 C--N 1.317 -0.837 0 O-C-N 121.914 -0.491 . . . . 0.0 110.428 171.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 391' ' ' LEU . . . . . 0.477 HD22 ' H ' ' B' ' 392' ' ' GLY . 2.1 pt? -160.06 -51.69 0.05 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -176.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 392' ' ' GLY . . . . . 0.477 ' H ' HD22 ' B' ' 391' ' ' LEU . . . -170.92 72.83 0.11 Allowed Glycine 0 C--N 1.338 0.689 0 C-N-CA 119.513 -1.327 . . . . 0.0 114.746 -173.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 393' ' ' ASN . . . . . 0.582 ' HA ' ' CE1' ' B' ' 389' ' ' HIS . 0.0 OUTLIER -66.28 -37.02 84.46 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 175.711 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 394' ' ' VAL . . . . . 0.557 HG23 ' N ' ' B' ' 395' ' ' ILE . 1.0 OUTLIER -57.04 -49.09 80.55 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 CA-C-N 113.039 -1.892 . . . . 0.0 107.216 178.352 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 395' ' ' ILE . . . . . 0.557 ' N ' HG23 ' B' ' 394' ' ' VAL . 3.7 mp -58.42 -52.6 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.559 0 CA-C-O 117.681 -1.152 . . . . 0.0 113.63 -174.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 396' ' ' LYS . . . . . 0.615 ' O ' HG23 ' B' ' 399' ' ' VAL . 0.0 OUTLIER -62.02 -49.75 74.78 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 122.18 2.264 . . . . 0.0 112.139 -174.4 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 397' ' ' GLY . . . . . 0.445 ' O ' ' HG3' ' B' ' 401' ' ' GLN . . . -53.51 -44.79 67.59 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 114.704 -1.135 . . . . 0.0 110.904 -176.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . 0.511 HD11 HG22 ' B' ' 394' ' ' VAL . 38.1 mt -71.24 -34.2 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -178.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 399' ' ' VAL . . . . . 0.615 HG23 ' O ' ' B' ' 396' ' ' LYS . 16.4 m -63.32 -40.19 88.09 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 C-N-CA 118.949 -1.1 . . . . 0.0 108.573 -173.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -64.35 -44.03 92.75 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 174.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 401' ' ' GLN . . . . . 0.53 ' NE2' ' HA ' ' A' ' 414' ' ' LEU . 14.5 mt-30 -92.78 -48.45 6.56 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -167.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 402' ' ' GLU . . . . . 0.4 ' HB3' ' HB ' ' B' ' 406' ' ' THR . 1.2 tm-20 -111.36 -19.28 12.67 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.19 0.519 . . . . 0.0 110.842 -173.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 104.62 161.31 24.08 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.89 177.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 404' ' ' VAL . . . . . 0.648 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.2 m -54.0 -45.13 64.3 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.812 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -175.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 405' ' ' ALA . . . . . 0.487 ' HB2' HG21 ' B' ' 457' ' ' ILE . . . -63.63 -31.46 72.64 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 119.954 -0.698 . . . . 0.0 112.522 -177.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 406' ' ' THR . . . . . 0.683 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 89.6 m -77.14 -41.7 40.76 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.146 -0.622 . . . . 0.0 110.402 173.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 407' ' ' ALA . . . . . 0.493 ' HB2' ' HA ' ' B' ' 395' ' ' ILE . . . -58.7 -36.68 74.63 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 122.154 0.978 . . . . 0.0 109.319 175.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 408' ' ' TYR . . . . . 0.648 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -67.27 -51.39 53.42 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 113.512 -1.677 . . . . 0.0 109.693 177.151 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 409' ' ' THR . . . . . 0.556 HG23 HD22 ' B' ' 410' ' ' LEU . 17.6 m -54.49 -47.88 72.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.478 177.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 410' ' ' LEU . . . . . 0.683 ' HG ' ' O ' ' B' ' 406' ' ' THR . 14.5 mt -72.46 -34.41 67.72 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -175.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.48 -33.94 73.54 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 120.311 -0.947 . . . . 0.0 110.954 170.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 412' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -68.04 -48.09 66.61 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 122.406 -0.467 . . . . 0.0 111.21 177.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 413' ' ' MET . . . . . 0.909 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.7 OUTLIER -72.18 -47.98 46.67 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 119.201 -0.999 . . . . 0.0 112.627 -179.779 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 414' ' ' LEU . . . . . 0.909 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 15.7 mt -69.62 -46.65 65.74 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -174.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 415' ' ' SER . . . . . 0.493 ' CB ' ' HE2' ' B' ' 388' ' ' MET . 0.0 OUTLIER -97.19 9.36 42.41 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.434 0.635 . . . . 0.0 110.769 -173.624 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 416' ' ' GLY . . . . . 0.437 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 85.56 -178.38 50.22 Favored Glycine 0 N--CA 1.435 -1.378 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.64 -178.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -80.08 22.51 0.51 Allowed 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.227 0.537 . . . . 0.0 111.08 -173.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 418' ' ' ASN . . . . . 0.437 ' H ' ' C ' ' B' ' 416' ' ' GLY . 3.5 m-20 -71.76 75.06 0.85 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.108 179.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 419' ' ' TYR . . . . . 0.569 ' CD1' ' HB3' ' B' ' 453' ' ' ALA . 29.0 p90 -56.59 -36.9 69.91 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.484 177.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -54.91 -41.91 71.55 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.505 175.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 421' ' ' LEU . . . . . 0.424 ' O ' HD11 ' B' ' 425' ' ' ILE . 0.0 OUTLIER -68.75 -51.86 36.66 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.71 -179.201 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 422' ' ' VAL . . . . . 0.504 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.2 OUTLIER -62.72 -37.22 78.48 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.57 -174.776 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 423' ' ' SER . . . . . 0.77 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 57.1 p -69.03 -34.55 75.4 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -68.3 -42.18 83.61 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.347 175.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 425' ' ' ILE . . . . . 0.552 HG22 HG23 ' B' ' 395' ' ' ILE . 2.6 mp -72.43 -51.1 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-N 116.723 0.261 . . . . 0.0 111.566 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 426' ' ' ILE . . . . . 0.513 ' CD1' HG21 ' B' ' 395' ' ' ILE . 1.2 mm -75.31 -23.51 17.03 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.925 0 O-C-N 121.978 -0.451 . . . . 0.0 110.95 -171.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 427' ' ' ARG . . . . . 0.77 ' HB2' ' O ' ' B' ' 423' ' ' SER . 1.0 OUTLIER -54.42 -33.21 58.99 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.192 0.52 . . . . 0.0 111.008 -177.194 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -84.88 -13.33 72.38 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.417 -0.897 . . . . 0.0 111.032 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 429' ' ' TYR . . . . . 0.5 ' HD1' ' CG2' ' B' ' 395' ' ' ILE . 7.4 m-30 -111.24 -2.13 15.85 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -174.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 430' ' ' LEU . . . . . 0.539 ' HA ' HG13 ' B' ' 404' ' ' VAL . 0.0 OUTLIER -66.46 138.65 95.8 Favored Pre-proline 0 N--CA 1.441 -0.904 0 CA-C-N 114.001 -1.454 . . . . 0.0 109.08 176.946 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 431' ' ' PRO . . . . . 0.684 ' CD ' HG11 ' B' ' 435' ' ' VAL . 70.0 Cg_exo -37.69 -64.6 0.18 Allowed 'Trans proline' 0 CA--C 1.533 0.426 0 C-N-CA 124.548 3.499 . . . . 0.0 114.045 -173.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 432' ' ' GLY . . . . . 0.574 ' O ' HG13 ' B' ' 435' ' ' VAL . . . -144.7 -163.92 10.29 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 176.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 433' ' ' GLN . . . . . 0.559 ' O ' HG12 ' B' ' 436' ' ' VAL . 43.0 tp60 -71.58 -26.79 62.76 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 118.34 1.07 . . . . 0.0 110.762 178.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -66.09 -40.6 90.92 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 435' ' ' VAL . . . . . 0.684 HG11 ' CD ' ' B' ' 431' ' ' PRO . 7.5 p -67.33 -44.03 87.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-O 120.981 0.42 . . . . 0.0 110.788 -178.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 436' ' ' VAL . . . . . 0.559 HG12 ' O ' ' B' ' 433' ' ' GLN . 0.1 OUTLIER -65.91 -31.55 54.23 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.103 176.485 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.36 -52.91 34.34 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -178.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 438' ' ' ALA . . . . . 0.514 ' HB2' HG12 ' B' ' 463' ' ' VAL . . . -58.52 -39.94 81.52 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.157 177.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 439' ' ' LEU . . . . . 0.585 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 1.9 tm? -68.14 -48.13 66.2 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -178.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.94 -38.28 78.64 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.665 -1.152 . . . . 0.0 111.507 176.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 441' ' ' GLN . . . . . 0.405 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 6.0 mm-40 -53.87 -52.0 61.86 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 123.496 0.718 . . . . 0.0 110.499 177.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 442' ' ' ARG . . . . . 0.542 ' NH1' ' HB3' ' B' ' 462' ' ' ALA . 0.1 OUTLIER -60.96 -35.07 75.82 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.652 174.984 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 443' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 64.9 mt -68.24 -36.47 79.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.803 178.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -56.64 -37.3 70.57 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.511 0.672 . . . . 0.0 110.346 174.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -74.03 -26.87 60.66 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.467 177.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 446' ' ' GLU . . . . . 0.437 ' HB3' ' O ' ' B' ' 443' ' ' LEU . 10.3 pt-20 19.72 103.26 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 176.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 43.3 mt -60.88 -34.68 60.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.927 178.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 448' ' ' ASP . . . . . 0.452 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 21.1 m-20 -162.57 -158.56 0.51 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -178.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 449' ' ' ASP . . . . . 0.506 ' HA ' ' CZ ' ' B' ' 452' ' ' ARG . 11.0 m-20 -86.59 -67.05 0.84 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 170.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.87 -25.68 67.29 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 178.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 451' ' ' THR . . . . . 0.496 ' HA ' ' HB2' ' B' ' 454' ' ' GLU . 14.1 m -71.34 -22.66 61.88 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.615 -176.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 452' ' ' ARG . . . . . 0.506 ' CZ ' ' HA ' ' B' ' 449' ' ' ASP . 48.7 mtt180 -54.65 -53.79 50.19 Favored 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 171.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 453' ' ' ALA . . . . . 0.569 ' HB3' ' CD1' ' B' ' 419' ' ' TYR . . . -56.75 -47.98 78.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.689 -1.141 . . . . 0.0 112.415 174.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 454' ' ' GLU . . . . . 0.496 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 14.4 mm-40 -52.36 -32.92 40.67 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.028 0.442 . . . . 0.0 111.828 -178.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 27.8 p -120.23 13.38 11.98 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.58 -176.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 456' ' ' PHE . . . . . 0.533 ' CE2' ' HB2' ' B' ' 419' ' ' TYR . 0.7 OUTLIER -56.86 -48.91 77.01 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.09 0.471 . . . . 0.0 111.496 -171.479 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 457' ' ' ILE . . . . . 0.526 HG13 ' HB3' ' B' ' 408' ' ' TYR . 1.9 mp -76.19 -32.08 22.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.968 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -57.81 -35.51 70.96 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.696 0.76 . . . . 0.0 109.025 171.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 459' ' ' HIS . . . . . 0.782 ' O ' HG22 ' B' ' 463' ' ' VAL . 73.4 m-70 -74.39 -29.16 61.42 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.312 178.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 460' ' ' LEU . . . . . 0.72 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -74.05 -35.42 64.3 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.907 0.861 . . . . 0.0 109.198 179.679 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 461' ' ' ASN . . . . . 0.467 ' O ' ' HB2' ' B' ' 464' ' ' TYR . 22.4 m-80 -73.65 -37.3 65.35 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.911 0.862 . . . . 0.0 108.857 177.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 462' ' ' ALA . . . . . 0.589 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -57.25 -34.61 68.79 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.383 -1.28 . . . . 0.0 109.84 169.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 463' ' ' VAL . . . . . 0.782 HG22 ' O ' ' B' ' 459' ' ' HIS . 64.6 t -60.57 -50.9 78.53 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.778 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 464' ' ' TYR . . . . . 0.6 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 19.2 m-30 -52.83 -28.12 21.34 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.492 177.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.62 -41.94 18.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.593 0.711 . . . . 0.0 109.382 -178.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 466' ' ' ILE . . . . . 0.589 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.8 mt -57.06 -55.93 17.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 114.405 -1.27 . . . . 0.0 112.154 177.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 467' ' ' LEU . . . . . 0.745 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -100.75 -10.26 20.97 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -173.009 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 468' ' ' GLY . . . . . 0.595 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 94.18 31.57 7.96 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 119.222 -1.466 . . . . 0.0 114.396 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 469' ' ' LEU . . . . . 0.745 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.9 mt -88.5 163.83 15.73 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 117.954 0.877 . . . . 0.0 111.046 176.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 37.4 p30 -105.32 -179.41 3.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.553 174.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 471' ' ' ALA . . . . . . . . . . . . . . . -60.1 -22.84 63.28 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -87.49 2.06 51.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.251 -172.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 473' ' ' GLY . . . . . 0.478 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 78.16 10.47 86.19 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.37 -0.919 . . . . 0.0 111.214 -177.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -101.19 157.87 16.45 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 176.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 475' ' ' SER . . . . . 0.528 ' OG ' ' HG2' ' B' ' 477' ' ' ARG . 16.7 t -93.87 143.83 25.98 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.757 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 476' ' ' ILE . . . . . 0.595 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.5 pp -108.18 12.57 8.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.498 0.666 . . . . 0.0 110.508 -178.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 477' ' ' ARG . . . . . 0.528 ' HG2' ' OG ' ' B' ' 475' ' ' SER . 29.9 mmm180 -54.4 111.63 0.83 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.39 -1.277 . . . . 0.0 111.056 177.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 478' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 61.67 34.75 17.38 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.135 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 479' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 . . . . . 0 C--O 1.249 1.052 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.433 177.778 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 . . . . . 0 N--CA 1.479 1.003 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 1.5 t -115.02 -22.04 9.74 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -175.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' HIS . . . . . 0.506 ' HB2' ' O ' ' A' ' 386' ' ' PHE . 1.7 p80 -161.98 160.12 27.33 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.927 -173.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -113.02 -99.8 2.42 Favored Glycine 0 N--CA 1.443 -0.88 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.965 170.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 35.5 m -74.96 -42.53 57.46 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.816 0.341 . . . . 0.0 110.841 177.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' PHE . . . . . 0.506 ' O ' ' HB2' ' A' ' 383' ' ' HIS . 5.0 t80 -68.15 122.62 84.79 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.023 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . 0.536 ' HG2' ' OD1' ' B' ' 393' ' ' ASN . 1.2 Cg_endo -45.09 -65.21 0.2 Allowed 'Trans proline' 0 CA--C 1.533 0.438 0 C-N-CA 123.667 2.911 . . . . 0.0 114.088 -177.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' MET . . . . . 0.719 ' SD ' HG12 ' A' ' 394' ' ' VAL . 18.2 tpp 67.21 160.69 0.16 Allowed 'General case' 0 N--CA 1.472 0.655 0 O-C-N 123.06 0.225 . . . . 0.0 110.814 178.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' HIS . . . . . 0.566 ' CG ' ' HB2' ' A' ' 393' ' ' ASN . 32.3 m170 -70.69 -161.19 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 171.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -72.76 6.99 2.16 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.288 172.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.557 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.1 pt? -161.01 -64.08 0.06 Allowed 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -175.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . 0.557 ' N ' ' HG ' ' A' ' 391' ' ' LEU . . . -158.36 59.95 0.33 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 119.759 -1.21 . . . . 0.0 114.175 -170.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . 0.566 ' HB2' ' CG ' ' A' ' 389' ' ' HIS . 0.2 OUTLIER -55.11 -44.06 74.63 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.344 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . 0.719 HG12 ' SD ' ' A' ' 388' ' ' MET . 1.1 m -59.08 -44.79 92.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-N 114.32 -1.309 . . . . 0.0 108.247 -177.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.566 HG22 HG23 ' A' ' 425' ' ' ILE . 4.2 mp -57.76 -52.05 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 CA-C-O 117.855 -1.069 . . . . 0.0 113.024 -175.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . 0.625 ' HG3' ' CZ ' ' A' ' 429' ' ' TYR . 0.1 OUTLIER -62.95 -49.2 75.7 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 121.681 2.037 . . . . 0.0 111.662 -175.766 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -54.69 -45.84 77.01 Favored Glycine 0 N--CA 1.432 -1.589 0 C-N-CA 120.072 -1.061 . . . . 0.0 111.31 -178.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . 0.685 ' CD1' HD13 ' A' ' 410' ' ' LEU . 26.9 mt -71.38 -33.86 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -177.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . 0.49 HG21 ' O ' ' A' ' 396' ' ' LYS . 7.9 m -63.68 -39.58 85.89 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 C-N-CA 118.79 -1.164 . . . . 0.0 108.396 -174.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -69.33 -38.53 78.21 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 175.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -86.17 -48.8 8.25 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -170.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . 0.451 ' HA ' ' NH1' ' A' ' 472' ' ' ARG . 10.2 tp10 -120.97 -21.04 6.66 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.868 0.366 . . . . 0.0 111.22 -171.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 109.7 163.64 19.63 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.985 178.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . 0.622 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.7 m -53.41 -45.56 57.53 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -175.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . 0.5 ' HB3' HG21 ' A' ' 457' ' ' ILE . . . -64.81 -31.02 72.06 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.702 -0.799 . . . . 0.0 112.288 -176.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 406' ' ' THR . . . . . 0.725 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 92.8 m -77.79 -41.35 37.63 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.297 173.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.531 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.86 -37.02 75.58 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 122.233 1.015 . . . . 0.0 109.06 176.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 408' ' ' TYR . . . . . 0.622 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.25 -52.47 54.21 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 113.27 -1.786 . . . . 0.0 109.924 175.761 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 409' ' ' THR . . . . . 0.545 HG23 HD22 ' A' ' 410' ' ' LEU . 18.6 m -55.35 -47.83 75.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.508 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . 0.725 ' HG ' ' O ' ' A' ' 406' ' ' THR . 14.3 mt -73.34 -36.86 66.22 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.16 -174.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -59.53 -35.16 84.51 Favored Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.053 -1.07 . . . . 0.0 110.606 172.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 412' ' ' MET . . . . . 0.449 ' HE2' ' HA ' ' A' ' 417' ' ' GLN . 0.0 OUTLIER -66.71 -49.93 64.46 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 120.605 0.24 . . . . 0.0 111.444 178.087 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 413' ' ' MET . . . . . 0.911 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.6 OUTLIER -71.44 -45.0 63.76 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 119.128 -1.029 . . . . 0.0 112.446 -176.069 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . 0.911 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 18.3 mt -72.52 -45.39 59.57 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -176.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 32.8 t -84.81 -19.1 33.03 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.795 0.807 . . . . 0.0 109.618 -173.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . 0.495 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 106.98 179.61 22.61 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -172.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 417' ' ' GLN . . . . . 0.449 ' HA ' ' HE2' ' A' ' 412' ' ' MET . 1.7 mp0 -79.1 25.43 0.29 Allowed 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 121.557 0.694 . . . . 0.0 111.027 -173.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 418' ' ' ASN . . . . . 0.495 ' H ' ' C ' ' A' ' 416' ' ' GLY . 84.1 m-20 -70.55 73.21 0.53 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.11 178.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 419' ' ' TYR . . . . . 0.533 ' CD1' ' HB1' ' A' ' 453' ' ' ALA . 5.7 p90 -51.34 -37.75 49.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.928 175.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -54.23 -45.81 72.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.119 176.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.25 -48.78 60.88 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.215 -177.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . 0.447 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -66.57 -40.61 86.73 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 C-N-CA 120.289 -0.565 . . . . 0.0 111.115 -175.465 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.72 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 79.1 p -67.53 -38.95 85.0 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.921 -178.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -69.34 -36.47 78.47 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.092 176.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . 0.566 HG23 HG22 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -73.53 -51.61 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 O-C-N 122.904 -0.174 . . . . 0.0 111.09 -178.605 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . 0.425 ' O ' HD23 ' A' ' 430' ' ' LEU . 1.1 mm -74.63 -22.89 17.64 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.819 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -172.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.72 ' HB2' ' O ' ' A' ' 423' ' ' SER . 0.8 OUTLIER -55.07 -29.78 58.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.302 0.572 . . . . 0.0 110.463 -178.867 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -88.09 -4.38 78.21 Favored Glycine 0 N--CA 1.443 -0.839 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.702 178.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.625 ' CZ ' ' HG3' ' A' ' 396' ' ' LYS . 23.5 m-85 -119.18 -1.31 10.89 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 121.011 0.434 . . . . 0.0 110.314 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . 0.549 HD11 ' HD2' ' A' ' 431' ' ' PRO . 0.1 OUTLIER -66.07 128.89 94.12 Favored Pre-proline 0 N--CA 1.44 -0.935 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.62 179.485 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . 0.549 ' HD2' HD11 ' A' ' 430' ' ' LEU . 99.9 Cg_exo -23.67 -68.31 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.736 1 C-N-CA 125.4 4.067 . . . . 0.0 114.62 179.5 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . 0.52 ' O ' HG11 ' A' ' 435' ' ' VAL . . . -144.54 -165.76 11.2 Favored Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 175.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . 0.547 ' O ' HG11 ' A' ' 436' ' ' VAL . 44.1 tp60 -70.11 -25.81 63.67 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 118.003 0.901 . . . . 0.0 110.568 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -66.84 -40.34 87.91 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -178.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 435' ' ' VAL . . . . . 0.52 HG11 ' O ' ' A' ' 432' ' ' GLY . 7.5 p -68.63 -44.62 82.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 120.901 0.382 . . . . 0.0 110.406 -177.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . 0.547 HG11 ' O ' ' A' ' 433' ' ' GLN . 0.1 OUTLIER -64.4 -30.86 51.33 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 CA-C-O 120.834 0.349 . . . . 0.0 110.643 175.218 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 1.1 m -69.32 -52.03 31.29 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -178.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . 0.78 ' O ' ' HG2' ' A' ' 442' ' ' ARG . . . -58.84 -37.21 75.96 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.551 177.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 439' ' ' LEU . . . . . 0.542 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 2.1 tm? -70.76 -47.8 57.73 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.97 -39.01 73.81 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.339 174.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 441' ' ' GLN . . . . . 0.447 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 37.1 mm-40 -53.2 -50.08 65.42 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 123.586 0.754 . . . . 0.0 110.705 173.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . 0.78 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 0.9 OUTLIER -56.23 -39.63 72.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.78 173.04 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 443' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 43.2 mt -71.89 -36.91 70.17 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.95 0.405 . . . . 0.0 110.28 -178.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -57.86 -37.51 74.05 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.614 173.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -73.16 -26.67 61.28 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.942 178.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 446' ' ' GLU . . . . . 0.411 ' HB3' ' O ' ' A' ' 443' ' ' LEU . 8.9 pt-20 29.3 104.53 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 172.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 447' ' ' ILE . . . . . 0.5 ' HB ' ' HB ' ' A' ' 451' ' ' THR . 64.7 mt -66.08 -32.21 57.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.877 0.846 . . . . 0.0 109.46 171.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -167.34 -153.87 0.15 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -177.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 449' ' ' ASP . . . . . 0.439 ' O ' ' HG3' ' A' ' 452' ' ' ARG . 4.0 m-20 -90.6 -61.62 1.64 Allowed 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 165.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 450' ' ' GLN . . . . . 0.468 ' O ' ' HB3' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -72.59 -26.05 61.56 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.447 -176.794 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 451' ' ' THR . . . . . 0.5 ' HB ' ' HB ' ' A' ' 447' ' ' ILE . 4.0 m -72.8 -21.15 61.03 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.992 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' A' ' 449' ' ' ASP . 18.4 mtm180 -55.91 -47.44 77.46 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 107.138 -1.431 . . . . 0.0 107.138 170.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 453' ' ' ALA . . . . . 0.533 ' HB1' ' CD1' ' A' ' 419' ' ' TYR . . . -57.59 -49.29 76.88 Favored 'General case' 0 N--CA 1.462 0.163 0 O-C-N 124.142 0.901 . . . . 0.0 111.921 171.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . 0.498 ' CG ' ' HA ' ' A' ' 451' ' ' THR . 37.1 mt-10 -46.31 -38.84 9.22 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.471 0.653 . . . . 0.0 111.693 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 30.1 p -121.16 15.74 11.49 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.139 -173.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . 0.581 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.8 OUTLIER -55.45 -47.53 75.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.246 0.546 . . . . 0.0 111.349 -171.442 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . 0.557 ' CG1' ' HB3' ' A' ' 408' ' ' TYR . 2.0 mp -77.08 -34.45 21.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.439 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -57.33 -35.89 70.46 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.948 0.88 . . . . 0.0 109.21 171.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . 0.736 ' O ' HG22 ' A' ' 463' ' ' VAL . 55.5 m-70 -72.78 -29.21 63.1 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.841 176.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . 0.71 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -74.1 -34.16 63.86 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 122.114 0.959 . . . . 0.0 108.683 179.044 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . 0.45 ' O ' ' HB2' ' A' ' 464' ' ' TYR . 1.3 m-80 -73.27 -38.07 66.07 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.2 -0.909 . . . . 0.0 108.909 176.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 462' ' ' ALA . . . . . 0.622 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -56.24 -35.0 66.9 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.659 169.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.736 HG22 ' O ' ' A' ' 459' ' ' HIS . 61.9 t -61.01 -50.95 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 175.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 464' ' ' TYR . . . . . 0.577 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 19.4 m-30 -52.95 -29.13 27.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.612 178.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.82 -40.18 19.03 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.667 0.746 . . . . 0.0 109.347 -176.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.622 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.7 mt -55.95 -55.55 17.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 114.288 -1.324 . . . . 0.0 112.198 175.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.746 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -102.9 -9.87 19.52 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 -172.748 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . 0.523 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 93.38 31.8 8.16 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 119.308 -1.425 . . . . 0.0 114.07 179.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 469' ' ' LEU . . . . . 0.746 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 2.8 mt -89.65 162.77 15.44 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 117.732 0.766 . . . . 0.0 111.272 176.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . 0.413 ' HB3' ' CG2' ' A' ' 476' ' ' ILE . 37.8 p30 -105.07 -177.68 3.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.142 171.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 471' ' ' ALA . . . . . 0.494 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -60.44 -23.51 64.48 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -176.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 472' ' ' ARG . . . . . 0.451 ' NH1' ' HA ' ' A' ' 402' ' ' GLU . 28.5 mmt180 -87.27 1.09 54.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.38 -170.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . 0.453 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 79.29 11.27 85.16 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.376 -0.916 . . . . 0.0 111.348 -177.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -101.02 150.82 22.5 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 177.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 475' ' ' SER . . . . . 0.524 ' OG ' ' HG2' ' A' ' 479' ' ' GLU . 11.0 p -88.76 127.81 35.61 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.183 0.516 . . . . 0.0 110.842 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 476' ' ' ILE . . . . . 0.523 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.7 pp -91.17 -17.71 7.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.444 -176.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 477' ' ' ARG . . . . . 0.474 ' N ' HD12 ' A' ' 476' ' ' ILE . 0.4 OUTLIER -95.48 -166.01 1.38 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.997 179.87 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 39.4 tp -53.19 123.57 12.17 Favored 'General case' 0 C--N 1.328 -0.357 0 O-C-N 123.23 0.332 . . . . 0.0 110.289 177.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 479' ' ' GLU . . . . . 0.524 ' HG2' ' OG ' ' A' ' 475' ' ' SER . 33.4 mt-10 . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.504 -0.76 . . . . 0.0 110.994 -177.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 381' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 382' ' ' THR . . . . . . . . . . . . . 1.6 t -114.74 -22.07 9.88 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -175.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 383' ' ' HIS . . . . . 0.506 ' HB2' ' O ' ' B' ' 386' ' ' PHE . 1.8 p80 -161.86 160.04 27.57 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.941 -173.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 384' ' ' GLY . . . . . . . . . . . . . . . -112.9 -99.25 2.4 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 170.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 385' ' ' THR . . . . . . . . . . . . . 34.1 m -75.83 -41.88 51.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.938 0.369 . . . . 0.0 110.854 177.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 386' ' ' PHE . . . . . 0.506 ' O ' ' HB2' ' B' ' 383' ' ' HIS . 5.1 t80 -68.57 122.56 85.08 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 387' ' ' PRO . . . . . 0.54 ' HG2' ' OD1' ' A' ' 393' ' ' ASN . 1.2 Cg_endo -44.96 -65.44 0.19 Allowed 'Trans proline' 0 CA--C 1.532 0.415 0 C-N-CA 123.55 2.833 . . . . 0.0 114.111 -177.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 388' ' ' MET . . . . . 0.717 ' SD ' HG12 ' B' ' 394' ' ' VAL . 18.3 tpp 67.61 160.99 0.17 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.549 0.214 . . . . 0.0 110.779 178.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 389' ' ' HIS . . . . . 0.57 ' CG ' ' HB2' ' B' ' 393' ' ' ASN . 32.5 m170 -70.91 -160.84 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 171.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -73.07 7.22 2.21 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.368 172.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 391' ' ' LEU . . . . . 0.563 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.1 pt? -161.14 -64.14 0.06 Allowed 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 392' ' ' GLY . . . . . 0.563 ' N ' ' HG ' ' B' ' 391' ' ' LEU . . . -158.3 59.88 0.33 Allowed Glycine 0 C--N 1.334 0.431 0 C-N-CA 119.81 -1.186 . . . . 0.0 114.175 -170.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 393' ' ' ASN . . . . . 0.57 ' HB2' ' CG ' ' B' ' 389' ' ' HIS . 0.2 OUTLIER -54.98 -44.0 74.03 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-O 121.091 0.472 . . . . 0.0 109.851 178.304 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 394' ' ' VAL . . . . . 0.717 HG12 ' SD ' ' B' ' 388' ' ' MET . 1.1 m -59.2 -44.63 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 114.23 -1.35 . . . . 0.0 108.24 -177.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 395' ' ' ILE . . . . . 0.571 HG22 HG23 ' B' ' 425' ' ' ILE . 4.2 mp -57.77 -52.13 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-O 117.934 -1.032 . . . . 0.0 113.015 -175.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 396' ' ' LYS . . . . . 0.621 ' HG3' ' CZ ' ' B' ' 429' ' ' TYR . 0.1 OUTLIER -62.91 -49.21 75.7 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 121.661 2.028 . . . . 0.0 111.615 -175.683 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -54.62 -45.91 76.19 Favored Glycine 0 N--CA 1.433 -1.534 0 C-N-CA 120.029 -1.081 . . . . 0.0 111.295 -178.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . 0.671 ' CD1' HD13 ' B' ' 410' ' ' LEU . 26.8 mt -71.24 -34.01 52.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 113.531 0.938 . . . . 0.0 113.531 -177.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 399' ' ' VAL . . . . . 0.491 HG21 ' O ' ' B' ' 396' ' ' LYS . 8.0 m -63.67 -39.7 86.32 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.519 0 C-N-CA 118.837 -1.145 . . . . 0.0 108.346 -174.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -69.15 -38.54 78.84 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 175.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 401' ' ' GLN . . . . . . . . . . . . . 4.3 mm100 -86.2 -49.07 8.0 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -170.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 402' ' ' GLU . . . . . 0.456 ' HA ' ' NH1' ' B' ' 472' ' ' ARG . 9.4 tp10 -120.67 -21.0 6.86 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 120.88 0.372 . . . . 0.0 111.324 -170.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 109.72 163.57 19.6 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.956 178.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 404' ' ' VAL . . . . . 0.614 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.7 m -53.3 -45.69 56.26 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.705 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -175.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 405' ' ' ALA . . . . . 0.513 ' HB3' HG21 ' B' ' 457' ' ' ILE . . . -64.85 -30.88 71.91 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 119.725 -0.79 . . . . 0.0 112.319 -176.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 406' ' ' THR . . . . . 0.721 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 92.5 m -77.86 -41.4 36.98 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 119.961 -0.696 . . . . 0.0 110.231 173.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 407' ' ' ALA . . . . . 0.522 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.95 -36.98 75.7 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 122.241 1.019 . . . . 0.0 109.014 176.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 408' ' ' TYR . . . . . 0.614 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.23 -52.44 54.56 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 113.283 -1.78 . . . . 0.0 109.941 175.82 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 409' ' ' THR . . . . . 0.541 HG23 HD22 ' B' ' 410' ' ' LEU . 17.5 m -55.43 -47.72 75.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.572 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 410' ' ' LEU . . . . . 0.721 ' HG ' ' O ' ' B' ' 406' ' ' THR . 14.4 mt -73.34 -37.11 66.21 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.06 -174.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -59.27 -35.32 84.14 Favored Glycine 0 N--CA 1.438 -1.224 0 C-N-CA 120.14 -1.028 . . . . 0.0 110.666 172.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 412' ' ' MET . . . . . 0.462 ' HE2' ' HA ' ' B' ' 417' ' ' GLN . 0.0 OUTLIER -66.51 -49.87 65.09 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-O 120.6 0.238 . . . . 0.0 111.572 177.97 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 413' ' ' MET . . . . . 0.925 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.7 OUTLIER -71.58 -45.21 62.87 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 119.064 -1.054 . . . . 0.0 112.356 -176.196 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 414' ' ' LEU . . . . . 0.925 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 17.9 mt -72.22 -45.64 59.45 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 113.95 1.092 . . . . 0.0 113.95 -176.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 32.8 t -84.89 -18.57 34.34 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.646 0.736 . . . . 0.0 109.599 -173.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 416' ' ' GLY . . . . . 0.492 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 106.61 179.67 22.89 Favored Glycine 0 N--CA 1.429 -1.774 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 -173.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 417' ' ' GLN . . . . . 0.462 ' HA ' ' HE2' ' B' ' 412' ' ' MET . 1.7 mp0 -79.13 25.38 0.29 Allowed 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.532 0.682 . . . . 0.0 111.015 -174.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 418' ' ' ASN . . . . . 0.492 ' H ' ' C ' ' B' ' 416' ' ' GLY . 83.8 m-20 -70.6 73.27 0.54 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.166 177.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 419' ' ' TYR . . . . . 0.54 ' CD1' ' HB1' ' B' ' 453' ' ' ALA . 5.4 p90 -51.38 -37.77 49.86 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.897 175.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -54.25 -45.82 72.47 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.064 176.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.17 -48.84 61.17 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.224 -177.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 422' ' ' VAL . . . . . 0.442 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.2 OUTLIER -66.44 -40.69 87.18 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.096 -175.464 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 423' ' ' SER . . . . . 0.74 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 80.0 p -67.48 -39.29 85.26 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.825 -178.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -68.93 -36.63 82.07 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.067 177.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 425' ' ' ILE . . . . . 0.571 HG23 HG22 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -73.45 -51.7 24.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 121.401 -0.12 . . . . 0.0 111.035 -178.593 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 426' ' ' ILE . . . . . 0.422 ' O ' HD23 ' B' ' 430' ' ' LEU . 1.1 mm -74.76 -22.92 17.48 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.853 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 -172.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 427' ' ' ARG . . . . . 0.74 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.8 OUTLIER -54.97 -29.91 57.91 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.339 0.59 . . . . 0.0 110.407 -179.065 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.49 -5.14 79.42 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.79 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 429' ' ' TYR . . . . . 0.621 ' CZ ' ' HG3' ' B' ' 396' ' ' LYS . 23.5 m-85 -118.88 -1.49 11.01 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.118 0.485 . . . . 0.0 110.44 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 430' ' ' LEU . . . . . 0.529 HD11 ' HD2' ' B' ' 431' ' ' PRO . 0.1 OUTLIER -65.85 128.79 94.07 Favored Pre-proline 0 N--CA 1.44 -0.945 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.641 179.589 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 431' ' ' PRO . . . . . 0.529 ' HD2' HD11 ' B' ' 430' ' ' LEU . 99.6 Cg_exo -23.57 -68.37 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.749 1 C-N-CA 125.484 4.123 . . . . 0.0 114.633 179.599 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 432' ' ' GLY . . . . . 0.496 ' O ' HG11 ' B' ' 435' ' ' VAL . . . -144.13 -165.5 10.97 Favored Glycine 0 N--CA 1.444 -0.83 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 175.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 433' ' ' GLN . . . . . 0.538 ' O ' HG11 ' B' ' 436' ' ' VAL . 43.9 tp60 -70.28 -25.73 63.48 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 118.024 0.912 . . . . 0.0 110.734 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -67.2 -40.09 86.44 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -177.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 435' ' ' VAL . . . . . 0.496 HG11 ' O ' ' B' ' 432' ' ' GLY . 7.4 p -68.87 -44.58 81.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 120.937 0.399 . . . . 0.0 110.39 -177.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 436' ' ' VAL . . . . . 0.538 HG11 ' O ' ' B' ' 433' ' ' GLN . 0.1 OUTLIER -64.39 -31.05 51.92 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.499 175.077 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 1.1 m -69.19 -52.04 31.95 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 438' ' ' ALA . . . . . 0.803 ' O ' ' HG2' ' B' ' 442' ' ' ARG . . . -58.94 -37.28 76.36 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.663 177.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 439' ' ' LEU . . . . . 0.544 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 2.1 tm? -70.75 -47.69 58.35 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -179.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.9 -39.25 74.08 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.326 174.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 441' ' ' GLN . . . . . 0.447 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 36.7 mm-40 -53.12 -50.04 65.31 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 123.576 0.75 . . . . 0.0 110.644 173.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 442' ' ' ARG . . . . . 0.803 ' HG2' ' O ' ' B' ' 438' ' ' ALA . 0.9 OUTLIER -56.25 -39.66 72.93 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.824 173.066 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 443' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 42.4 mt -71.96 -36.73 69.93 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.99 0.424 . . . . 0.0 110.31 -178.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -57.97 -37.5 74.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.609 173.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -73.22 -26.42 61.14 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.986 178.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 446' ' ' GLU . . . . . 0.403 ' HB3' ' O ' ' B' ' 443' ' ' LEU . 8.8 pt-20 29.4 104.28 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 172.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 447' ' ' ILE . . . . . 0.515 ' HB ' ' HB ' ' B' ' 451' ' ' THR . 64.4 mt -66.07 -32.39 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 121.911 0.862 . . . . 0.0 109.443 171.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 448' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -167.04 -153.63 0.15 Allowed 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 -177.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 449' ' ' ASP . . . . . 0.44 ' O ' ' HG3' ' B' ' 452' ' ' ARG . 4.9 m-20 -90.87 -61.64 1.63 Allowed 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 165.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 450' ' ' GLN . . . . . 0.471 ' O ' ' HB3' ' B' ' 453' ' ' ALA . 0.0 OUTLIER -72.55 -26.01 61.58 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.432 -176.908 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 451' ' ' THR . . . . . 0.515 ' HB ' ' HB ' ' B' ' 447' ' ' ILE . 4.1 m -72.77 -21.07 61.06 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.063 -0.655 . . . . 0.0 111.035 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 452' ' ' ARG . . . . . 0.44 ' HG3' ' O ' ' B' ' 449' ' ' ASP . 18.6 mtm180 -56.08 -47.48 77.92 Favored 'General case' 0 C--O 1.215 -0.76 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 170.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 453' ' ' ALA . . . . . 0.54 ' HB1' ' CD1' ' B' ' 419' ' ' TYR . . . -57.51 -49.2 77.09 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.994 171.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 454' ' ' GLU . . . . . 0.502 ' CG ' ' HA ' ' B' ' 451' ' ' THR . 37.2 mt-10 -46.39 -38.91 9.56 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.571 0.7 . . . . 0.0 111.677 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 31.1 p -121.05 15.82 11.59 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.257 -173.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 456' ' ' PHE . . . . . 0.567 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 0.8 OUTLIER -55.59 -47.73 75.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.209 0.528 . . . . 0.0 111.28 -171.524 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 457' ' ' ILE . . . . . 0.563 ' CG1' ' HB3' ' B' ' 408' ' ' TYR . 2.0 mp -76.8 -34.64 23.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.387 -179.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -57.33 -35.82 70.36 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 122.022 0.915 . . . . 0.0 109.291 172.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 459' ' ' HIS . . . . . 0.729 ' O ' HG22 ' B' ' 463' ' ' VAL . 55.4 m-70 -72.82 -29.04 62.93 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.208 -1.36 . . . . 0.0 110.915 176.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 460' ' ' LEU . . . . . 0.711 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -74.24 -34.17 63.56 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.107 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 461' ' ' ASN . . . . . 0.43 ' O ' ' HB2' ' B' ' 464' ' ' TYR . 1.3 m-80 -73.17 -38.29 66.25 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.216 -0.902 . . . . 0.0 108.924 176.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 462' ' ' ALA . . . . . 0.624 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -56.16 -34.83 66.53 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.668 169.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 463' ' ' VAL . . . . . 0.729 HG22 ' O ' ' B' ' 459' ' ' HIS . 62.7 t -61.04 -51.09 77.18 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 175.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 464' ' ' TYR . . . . . 0.562 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 19.4 m-30 -52.87 -29.09 26.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.642 178.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.13 -39.59 19.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.716 0.769 . . . . 0.0 109.501 -176.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 466' ' ' ILE . . . . . 0.624 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.7 mt -56.2 -55.83 16.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 114.344 -1.298 . . . . 0.0 112.115 174.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 467' ' ' LEU . . . . . 0.756 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -102.73 -9.97 19.57 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -172.513 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 468' ' ' GLY . . . . . 0.519 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 93.41 31.92 8.07 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 119.346 -1.407 . . . . 0.0 114.182 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 469' ' ' LEU . . . . . 0.756 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 2.8 mt -89.73 162.81 15.37 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 117.646 0.723 . . . . 0.0 111.062 176.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 470' ' ' ASN . . . . . 0.417 ' HB3' ' CG2' ' B' ' 476' ' ' ILE . 37.4 p30 -105.14 -177.82 3.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.23 171.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 471' ' ' ALA . . . . . 0.483 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -60.25 -23.51 64.16 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -176.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 472' ' ' ARG . . . . . 0.456 ' NH1' ' HA ' ' B' ' 402' ' ' GLU . 28.7 mmt180 -87.48 1.52 53.25 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.407 -170.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 473' ' ' GLY . . . . . 0.447 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 78.76 11.39 85.29 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.564 -0.827 . . . . 0.0 111.37 -177.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -100.94 150.66 22.64 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 177.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 475' ' ' SER . . . . . 0.544 ' OG ' ' HG2' ' B' ' 479' ' ' GLU . 11.9 p -88.35 127.81 35.49 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.207 0.527 . . . . 0.0 110.926 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 476' ' ' ILE . . . . . 0.519 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.7 pp -91.16 -17.62 7.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.485 -176.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 477' ' ' ARG . . . . . 0.462 ' N ' HD12 ' B' ' 476' ' ' ILE . 0.4 OUTLIER -95.31 -165.72 1.34 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.988 179.87 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 478' ' ' LEU . . . . . . . . . . . . . 39.8 tp -53.16 124.22 13.89 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.234 0.334 . . . . 0.0 110.153 177.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 479' ' ' GLU . . . . . 0.544 ' HG2' ' OG ' ' B' ' 475' ' ' SER . 31.9 mt-10 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.413 -0.803 . . . . 0.0 110.785 -177.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 . . . . . 0 N--CA 1.48 1.048 0 CA-C-O 120.751 0.31 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.01 -24.49 14.6 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.269 177.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' HIS . . . . . 0.514 ' HB2' ' O ' ' A' ' 386' ' ' PHE . 17.5 p80 -167.75 159.54 11.85 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.928 -175.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -109.15 -110.8 3.38 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.354 172.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 14.2 m -64.63 -36.43 84.24 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.265 0.555 . . . . 0.0 111.462 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' PHE . . . . . 0.782 ' CZ ' HG12 ' A' ' 394' ' ' VAL . 1.6 t80 -81.78 128.37 69.14 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.494 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -53.55 -51.59 10.54 Favored 'Trans proline' 0 N--CA 1.489 1.214 1 C-N-CA 125.403 4.069 . . . . 0.0 115.952 -176.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' MET . . . . . 0.731 ' SD ' HG11 ' A' ' 394' ' ' VAL . 53.8 tpp 74.29 15.63 3.53 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 165.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' HIS . . . . . 0.789 ' CG ' ' HB2' ' A' ' 393' ' ' ASN . 15.6 m170 64.17 7.1 3.26 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.264 -0.897 . . . . 0.0 110.249 -175.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 66.29 25.09 10.54 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.498 -170.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.467 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.6 pt? -164.51 -53.4 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 170.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . 0.547 ' HA2' ' SD ' ' A' ' 388' ' ' MET . . . -175.39 49.38 0.13 Allowed Glycine 0 CA--C 1.525 0.659 0 C-N-CA 119.796 -1.192 . . . . 0.0 114.521 -176.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . 0.789 ' HB2' ' CG ' ' A' ' 389' ' ' HIS . 0.5 OUTLIER -54.49 -43.31 71.67 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 117.302 0.551 . . . . 0.0 109.81 177.886 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . 0.782 HG12 ' CZ ' ' A' ' 386' ' ' PHE . 0.7 OUTLIER -57.64 -46.12 86.51 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 -177.649 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.595 HG23 HG22 ' A' ' 425' ' ' ILE . 4.1 mp -57.36 -52.3 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-O 118.023 -0.989 . . . . 0.0 113.139 -174.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . 0.615 ' HG3' ' CZ ' ' A' ' 429' ' ' TYR . 0.0 OUTLIER -63.55 -50.23 70.32 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 121.664 2.029 . . . . 0.0 112.335 -175.738 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . 0.573 ' O ' ' HG3' ' A' ' 401' ' ' GLN . . . -54.47 -44.89 77.59 Favored Glycine 0 N--CA 1.435 -1.393 0 C-N-CA 120.04 -1.076 . . . . 0.0 111.025 -177.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . 0.663 ' CD1' HD12 ' A' ' 410' ' ' LEU . 31.2 mt -71.28 -34.47 54.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -178.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 396' ' ' LYS . 9.9 m -63.66 -39.92 87.14 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 C-N-CA 118.973 -1.091 . . . . 0.0 108.594 -173.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -66.67 -40.99 88.85 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 175.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . 0.573 ' HG3' ' O ' ' A' ' 397' ' ' GLY . 36.2 mt-30 -91.84 -47.13 7.49 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -169.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . 0.408 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 3.0 mm-40 -115.15 -20.35 10.45 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.983 0.421 . . . . 0.0 111.377 -173.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 106.14 162.84 22.86 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.874 -0.679 . . . . 0.0 113.027 177.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . 0.679 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.2 m -53.61 -42.89 52.34 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.851 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -175.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . 0.503 ' HB3' HG22 ' A' ' 457' ' ' ILE . . . -69.17 -28.57 66.52 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 119.602 -0.839 . . . . 0.0 112.139 -176.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 406' ' ' THR . . . . . 0.698 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 89.9 m -77.55 -43.1 33.0 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.139 -0.624 . . . . 0.0 109.972 172.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.531 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.3 -37.64 75.47 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 122.125 0.964 . . . . 0.0 109.285 176.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 408' ' ' TYR . . . . . 0.679 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.6 -52.14 54.38 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 113.606 -1.634 . . . . 0.0 109.734 177.155 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 409' ' ' THR . . . . . 0.546 HG22 HD22 ' A' ' 410' ' ' LEU . 13.0 m -55.51 -47.36 76.34 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.743 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . 0.698 ' HG ' ' O ' ' A' ' 406' ' ' THR . 13.8 mt -72.28 -35.71 68.8 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.197 -175.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.92 -35.09 81.48 Favored Glycine 0 N--CA 1.439 -1.142 0 C-N-CA 120.182 -1.009 . . . . 0.0 110.7 172.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -67.55 -47.62 69.31 Favored 'General case' 0 C--O 1.223 -0.309 0 N-CA-C 111.528 0.195 . . . . 0.0 111.528 178.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 413' ' ' MET . . . . . 0.913 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.3 OUTLIER -70.78 -48.26 55.23 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 119.06 -1.056 . . . . 0.0 112.106 -179.461 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . 0.913 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 18.6 mt -69.47 -44.23 71.61 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -175.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.463 ' HB2' ' HE1' ' A' ' 388' ' ' MET . 33.7 t -86.62 -24.04 25.49 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.526 0.679 . . . . 0.0 110.147 -175.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . 0.43 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 112.55 -176.79 18.03 Favored Glycine 0 N--CA 1.429 -1.832 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 -173.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -81.02 22.29 0.64 Allowed 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.367 0.604 . . . . 0.0 111.285 -172.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 418' ' ' ASN . . . . . 0.43 ' H ' ' C ' ' A' ' 416' ' ' GLY . 11.4 m120 -73.04 74.91 1.21 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.984 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 419' ' ' TYR . . . . . 0.601 ' HB2' ' CE2' ' A' ' 456' ' ' PHE . 27.0 p90 -54.2 -37.57 64.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.324 178.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -54.47 -46.27 73.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.908 0.385 . . . . 0.0 110.987 177.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . 0.458 ' O ' HD11 ' A' ' 425' ' ' ILE . 0.0 OUTLIER -68.51 -47.86 65.87 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.085 -177.291 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . 0.462 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -65.33 -38.35 82.34 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 C-N-CA 120.343 -0.543 . . . . 0.0 111.198 -178.451 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.745 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 61.1 p -68.1 -37.46 81.21 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -179.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.51 -39.35 91.12 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.237 175.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . 0.595 HG22 HG23 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.78 -52.53 22.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 O-C-N 122.789 -0.242 . . . . 0.0 111.011 -178.376 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . 0.527 ' O ' HD21 ' A' ' 430' ' ' LEU . 1.2 mm -72.14 -21.76 20.7 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.715 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -172.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.745 ' HB2' ' O ' ' A' ' 423' ' ' SER . 0.7 OUTLIER -54.25 -31.46 53.55 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.52 -179.206 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -84.39 -12.2 76.31 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.463 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.615 ' CZ ' ' HG3' ' A' ' 396' ' ' LYS . 23.3 m-85 -114.69 1.9 14.32 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-O 121.15 0.5 . . . . 0.0 110.45 -176.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . 0.531 ' HA ' HG12 ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.85 128.11 93.58 Favored Pre-proline 0 N--CA 1.439 -1.008 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.759 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . 0.509 ' HD2' HD11 ' A' ' 430' ' ' LEU . 59.1 Cg_exo -22.39 -72.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.355 0.906 1 C-N-CA 125.56 4.173 . . . . 0.0 114.855 179.784 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . 0.411 ' O ' HG13 ' A' ' 435' ' ' VAL . . . -132.27 -165.44 11.29 Favored Glycine 0 N--CA 1.439 -1.125 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 175.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . 0.609 ' O ' HG11 ' A' ' 436' ' ' VAL . 1.0 OUTLIER -71.21 -28.1 63.97 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 117.575 0.687 . . . . 0.0 110.631 177.513 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -70.24 -36.62 74.61 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -174.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 435' ' ' VAL . . . . . 0.472 ' HA ' ' CG1' ' A' ' 463' ' ' VAL . 7.5 p -67.24 -41.46 86.73 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-O 121.056 0.455 . . . . 0.0 110.388 -177.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . 0.609 HG11 ' O ' ' A' ' 433' ' ' GLN . 0.2 OUTLIER -64.63 -34.78 72.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.177 175.682 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 437' ' ' THR . . . . . 0.418 HG23 ' N ' ' A' ' 438' ' ' ALA . 0.8 OUTLIER -70.85 -48.53 53.39 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -174.135 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . 0.746 ' O ' ' HG2' ' A' ' 442' ' ' ARG . . . -56.15 -37.24 69.26 Favored 'General case' 0 N--CA 1.432 -1.356 0 O-C-N 123.713 0.633 . . . . 0.0 110.498 175.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 439' ' ' LEU . . . . . 0.547 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 2.1 tm? -67.66 -46.97 70.86 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -178.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . 0.478 ' NE2' HD13 ' A' ' 443' ' ' LEU . 0.4 OUTLIER -62.08 -33.92 75.32 Favored 'General case' 0 CA--C 1.49 -1.353 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.803 176.192 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 441' ' ' GLN . . . . . 0.558 ' O ' ' HG2' ' A' ' 445' ' ' GLN . 8.9 mm-40 -58.26 -49.2 77.96 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.199 175.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . 0.746 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -57.31 -39.79 76.55 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.852 171.208 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 443' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 33.6 mt -72.38 -34.45 67.95 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.201 0.524 . . . . 0.0 109.932 -178.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -57.94 -36.95 73.25 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.793 173.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 445' ' ' GLN . . . . . 0.558 ' HG2' ' O ' ' A' ' 441' ' ' GLN . 30.6 mm-40 -72.26 -27.52 62.54 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.195 178.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 446' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 443' ' ' LEU . 36.7 tt0 35.44 98.09 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 169.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 447' ' ' ILE . . . . . 0.527 ' HB ' ' HB ' ' A' ' 451' ' ' THR . 54.2 mt -73.41 -32.68 37.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.447 0.642 . . . . 0.0 110.447 176.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -170.21 -158.17 0.16 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -87.78 -58.81 2.44 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 166.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 450' ' ' GLN . . . . . 0.45 ' C ' HE21 ' A' ' 450' ' ' GLN . 0.0 OUTLIER -66.88 -33.34 75.38 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.592 -177.523 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 451' ' ' THR . . . . . 0.527 ' HB ' ' HB ' ' A' ' 447' ' ' ILE . 4.8 m -72.05 -23.36 61.36 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.653 -174.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 13.1 mtp180 -55.13 -54.18 46.55 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 172.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 453' ' ' ALA . . . . . 0.515 ' HB1' ' CD1' ' A' ' 419' ' ' TYR . . . -58.57 -48.52 80.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.616 -1.175 . . . . 0.0 112.561 175.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . 0.48 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 27.2 mm-40 -51.2 -37.2 45.32 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.289 0.566 . . . . 0.0 111.597 -178.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 27.6 p -117.9 16.92 14.29 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.352 -176.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . 0.601 ' CE2' ' HB2' ' A' ' 419' ' ' TYR . 1.1 t80 -58.04 -47.15 84.0 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.006 0.432 . . . . 0.0 111.6 -171.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . 0.514 ' CG1' ' HB3' ' A' ' 408' ' ' TYR . 2.0 mp -76.83 -32.43 20.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.044 0.45 . . . . 0.0 110.611 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -57.83 -34.29 69.54 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.717 0.77 . . . . 0.0 109.268 170.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . 0.686 ' O ' HG22 ' A' ' 463' ' ' VAL . 57.9 m-70 -76.08 -28.04 57.44 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.635 178.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . 0.71 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -74.09 -34.63 64.05 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.822 0.82 . . . . 0.0 108.82 178.196 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . 0.546 ' HA ' ' CD2' ' A' ' 464' ' ' TYR . 21.4 m-80 -72.63 -37.74 67.95 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.309 -0.86 . . . . 0.0 108.975 176.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 462' ' ' ALA . . . . . 0.632 ' O ' HD13 ' A' ' 466' ' ' ILE . . . -56.21 -34.4 66.24 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.442 -1.254 . . . . 0.0 109.729 169.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.71 ' HB ' ' O ' ' A' ' 460' ' ' LEU . 64.5 t -61.53 -51.58 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 114.811 -1.086 . . . . 0.0 108.085 176.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 464' ' ' TYR . . . . . 0.734 ' CE2' ' HA ' ' A' ' 471' ' ' ALA . 15.4 m-30 -52.62 -27.37 16.76 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.685 178.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.34 -39.11 21.16 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.593 0.711 . . . . 0.0 109.557 -178.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.632 HD13 ' O ' ' A' ' 462' ' ' ALA . 3.7 mt -60.17 -55.54 23.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 114.23 -1.35 . . . . 0.0 112.268 176.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.716 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -100.36 -10.69 20.96 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -173.469 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . 0.596 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 93.15 31.18 8.65 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 119.556 -1.307 . . . . 0.0 114.165 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 469' ' ' LEU . . . . . 0.716 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.0 mt -89.98 166.56 13.39 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.24 1.02 . . . . 0.0 111.767 178.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 35.1 p30 -106.07 177.57 4.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.271 169.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 471' ' ' ALA . . . . . 0.734 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -71.09 -6.92 42.87 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -173.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -92.2 -0.33 57.42 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.022 0.439 . . . . 0.0 110.6 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 77.47 12.79 84.2 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.571 -0.824 . . . . 0.0 111.085 -175.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -100.91 157.9 16.39 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 175.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 475' ' ' SER . . . . . 0.44 ' HA ' HD21 ' A' ' 469' ' ' LEU . 0.6 OUTLIER -93.45 120.06 33.28 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.538 0.685 . . . . 0.0 112.633 -177.03 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 476' ' ' ILE . . . . . 0.615 HD12 ' N ' ' A' ' 477' ' ' ARG . 2.2 pp -89.4 179.69 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 162.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 477' ' ' ARG . . . . . 0.687 ' HD3' ' N ' ' A' ' 477' ' ' ARG . 0.1 OUTLIER -119.43 104.24 10.16 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 118.385 -1.326 . . . . 0.0 111.442 -171.873 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -71.65 176.25 4.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.569 -1.196 . . . . 0.0 111.292 -177.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.445 -0.788 . . . . 0.0 110.486 179.778 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 381' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 . . . . . 0 N--CA 1.479 0.98 0 CA-C-O 120.891 0.377 . . . . 0.0 110.471 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 382' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.8 -24.49 14.66 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.297 177.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 383' ' ' HIS . . . . . 0.519 ' HB2' ' O ' ' B' ' 386' ' ' PHE . 17.5 p80 -167.86 159.3 11.43 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.506 -0.477 . . . . 0.0 111.92 -175.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 384' ' ' GLY . . . . . . . . . . . . . . . -109.06 -110.91 3.4 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.378 172.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 385' ' ' THR . . . . . . . . . . . . . 14.1 m -64.5 -36.21 83.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.061 0.458 . . . . 0.0 111.58 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 386' ' ' PHE . . . . . 0.786 ' CZ ' HG12 ' B' ' 394' ' ' VAL . 1.6 t80 -82.08 128.52 67.71 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.577 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 387' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -53.68 -51.54 10.59 Favored 'Trans proline' 0 N--CA 1.49 1.294 1 C-N-CA 125.48 4.12 . . . . 0.0 115.895 -176.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 388' ' ' MET . . . . . 0.723 ' SD ' HG11 ' B' ' 394' ' ' VAL . 53.8 tpp 74.18 15.7 3.6 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 165.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 389' ' ' HIS . . . . . 0.785 ' CG ' ' HB2' ' B' ' 393' ' ' ASN . 16.1 m170 64.03 7.29 3.28 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.203 -0.936 . . . . 0.0 110.257 -175.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 390' ' ' GLN . . . . . 0.4 ' HB2' ' O ' ' B' ' 389' ' ' HIS . 29.3 mt-30 66.31 24.73 10.56 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.527 -170.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 391' ' ' LEU . . . . . 0.461 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.6 pt? -164.32 -53.23 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 171.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 392' ' ' GLY . . . . . 0.546 ' HA2' ' SD ' ' B' ' 388' ' ' MET . . . -175.64 49.51 0.12 Allowed Glycine 0 CA--C 1.524 0.641 0 C-N-CA 119.756 -1.212 . . . . 0.0 114.464 -176.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 393' ' ' ASN . . . . . 0.785 ' HB2' ' CG ' ' B' ' 389' ' ' HIS . 0.5 OUTLIER -54.61 -43.28 72.08 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 117.348 0.574 . . . . 0.0 109.862 177.837 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 394' ' ' VAL . . . . . 0.786 HG12 ' CZ ' ' B' ' 386' ' ' PHE . 0.7 OUTLIER -57.6 -46.13 86.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -177.818 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 395' ' ' ILE . . . . . 0.605 HG23 HG22 ' B' ' 425' ' ' ILE . 4.1 mp -57.42 -52.26 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-O 117.979 -1.01 . . . . 0.0 113.186 -174.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 396' ' ' LYS . . . . . 0.622 ' HG3' ' CZ ' ' B' ' 429' ' ' TYR . 0.0 OUTLIER -63.58 -50.22 70.32 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 121.661 2.028 . . . . 0.0 112.302 -175.684 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 397' ' ' GLY . . . . . 0.583 ' O ' ' HG3' ' B' ' 401' ' ' GLN . . . -54.39 -44.86 76.74 Favored Glycine 0 N--CA 1.434 -1.449 0 C-N-CA 120.03 -1.081 . . . . 0.0 111.089 -177.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . 0.66 ' CD1' HD12 ' B' ' 410' ' ' LEU . 31.2 mt -71.33 -34.54 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -178.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 399' ' ' VAL . . . . . 0.545 HG23 ' O ' ' B' ' 396' ' ' LYS . 10.0 m -63.66 -39.94 87.2 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.519 0 C-N-CA 118.971 -1.092 . . . . 0.0 108.577 -173.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -66.41 -41.24 89.55 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 175.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 401' ' ' GLN . . . . . 0.583 ' HG3' ' O ' ' B' ' 397' ' ' GLY . 36.4 mt-30 -91.89 -47.19 7.45 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -168.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 402' ' ' GLU . . . . . 0.409 ' HB3' ' HB ' ' B' ' 406' ' ' THR . 2.9 mm-40 -115.01 -20.56 10.45 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.987 0.422 . . . . 0.0 111.276 -172.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 106.19 162.95 22.82 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.099 177.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 404' ' ' VAL . . . . . 0.671 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.3 m -53.53 -42.89 51.63 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.858 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -175.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 405' ' ' ALA . . . . . 0.488 ' HB3' HG22 ' B' ' 457' ' ' ILE . . . -69.24 -28.64 66.52 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 119.545 -0.862 . . . . 0.0 112.165 -176.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 406' ' ' THR . . . . . 0.696 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 85.9 m -77.4 -43.14 33.69 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.159 -0.616 . . . . 0.0 109.94 172.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 407' ' ' ALA . . . . . 0.518 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.28 -37.54 75.22 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 122.118 0.961 . . . . 0.0 109.351 176.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 408' ' ' TYR . . . . . 0.671 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.69 -52.04 54.65 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 113.568 -1.651 . . . . 0.0 109.8 177.072 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 409' ' ' THR . . . . . 0.54 HG22 HD22 ' B' ' 410' ' ' LEU . 14.8 m -55.46 -47.53 75.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.678 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 410' ' ' LEU . . . . . 0.696 ' HG ' ' O ' ' B' ' 406' ' ' THR . 13.8 mt -72.14 -35.79 69.18 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 120.838 0.351 . . . . 0.0 110.271 -175.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.94 -35.06 81.48 Favored Glycine 0 N--CA 1.439 -1.144 0 C-N-CA 120.229 -0.986 . . . . 0.0 110.71 172.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 412' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -67.46 -47.75 69.2 Favored 'General case' 0 C--O 1.224 -0.267 0 N-CA-C 111.556 0.206 . . . . 0.0 111.556 178.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 413' ' ' MET . . . . . 0.927 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.3 OUTLIER -70.67 -48.26 55.73 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 118.96 -1.096 . . . . 0.0 112.139 -179.367 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 414' ' ' LEU . . . . . 0.927 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 18.7 mt -69.53 -44.3 71.27 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -175.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 415' ' ' SER . . . . . 0.454 ' HB2' ' HE1' ' B' ' 388' ' ' MET . 33.5 t -86.55 -23.98 25.63 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.509 0.671 . . . . 0.0 110.158 -175.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 416' ' ' GLY . . . . . 0.422 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 112.44 -177.06 18.29 Favored Glycine 0 N--CA 1.428 -1.843 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 -173.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -80.93 22.67 0.6 Allowed 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.219 0.533 . . . . 0.0 111.214 -172.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 418' ' ' ASN . . . . . 0.425 ' O ' HD21 ' B' ' 421' ' ' LEU . 11.3 m120 -73.09 75.36 1.24 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.884 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 419' ' ' TYR . . . . . 0.613 ' HB2' ' CE2' ' B' ' 456' ' ' PHE . 26.8 p90 -54.86 -37.42 66.22 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.207 178.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -54.56 -46.31 73.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.961 0.41 . . . . 0.0 110.889 177.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 421' ' ' LEU . . . . . 0.461 ' O ' HD11 ' B' ' 425' ' ' ILE . 0.0 OUTLIER -68.42 -47.83 66.23 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.136 -177.158 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 422' ' ' VAL . . . . . 0.465 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.2 OUTLIER -65.18 -38.56 82.96 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.218 -178.524 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 423' ' ' SER . . . . . 0.753 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 62.3 p -68.05 -37.37 81.24 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.21 -39.76 92.34 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.307 175.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 425' ' ' ILE . . . . . 0.605 HG22 HG23 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -72.55 -52.58 22.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 O-C-N 122.785 -0.244 . . . . 0.0 111.003 -178.081 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 426' ' ' ILE . . . . . 0.519 ' O ' HD21 ' B' ' 430' ' ' LEU . 1.2 mm -72.21 -21.67 20.56 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.821 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -172.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 427' ' ' ARG . . . . . 0.753 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.7 OUTLIER -54.31 -31.33 53.89 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.216 0.531 . . . . 0.0 110.479 -179.265 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -84.25 -12.39 76.27 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.404 178.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 429' ' ' TYR . . . . . 0.622 ' CZ ' ' HG3' ' B' ' 396' ' ' LYS . 23.2 m-85 -114.77 1.87 14.25 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 121.064 0.459 . . . . 0.0 110.372 -176.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 430' ' ' LEU . . . . . 0.534 ' HA ' HG12 ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.77 128.32 93.72 Favored Pre-proline 0 N--CA 1.438 -1.042 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.681 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 431' ' ' PRO . . . . . 0.513 ' HD2' HD11 ' B' ' 430' ' ' LEU . 56.8 Cg_exo -22.48 -73.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.355 0.883 1 C-N-CA 125.702 4.268 . . . . 0.0 114.606 179.563 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 432' ' ' GLY . . . . . 0.444 ' H ' ' HB2' ' B' ' 431' ' ' PRO . . . -132.34 -165.74 11.36 Favored Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 175.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 433' ' ' GLN . . . . . 0.612 ' O ' HG11 ' B' ' 436' ' ' VAL . 1.0 OUTLIER -70.94 -27.96 64.14 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 117.506 0.653 . . . . 0.0 110.643 177.85 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -70.39 -36.43 74.08 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -174.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 435' ' ' VAL . . . . . 0.47 ' HA ' ' CG1' ' B' ' 463' ' ' VAL . 7.5 p -67.36 -41.52 86.45 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 CA-C-O 121.102 0.477 . . . . 0.0 110.346 -177.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 436' ' ' VAL . . . . . 0.612 HG11 ' O ' ' B' ' 433' ' ' GLN . 0.2 OUTLIER -64.67 -34.77 72.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.214 175.64 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 437' ' ' THR . . . . . 0.416 HG23 ' N ' ' B' ' 438' ' ' ALA . 0.8 OUTLIER -70.87 -48.51 53.42 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 -174.211 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 438' ' ' ALA . . . . . 0.739 ' O ' ' HG2' ' B' ' 442' ' ' ARG . . . -56.21 -37.17 69.3 Favored 'General case' 0 N--CA 1.433 -1.32 0 O-C-N 123.631 0.582 . . . . 0.0 110.382 175.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 439' ' ' LEU . . . . . 0.556 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 2.1 tm? -67.72 -47.0 70.57 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 440' ' ' GLN . . . . . 0.487 ' NE2' HD13 ' B' ' 443' ' ' LEU . 0.3 OUTLIER -62.15 -33.89 75.35 Favored 'General case' 0 CA--C 1.489 -1.378 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.828 176.178 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 441' ' ' GLN . . . . . 0.558 ' O ' ' HG2' ' B' ' 445' ' ' GLN . 9.0 mm-40 -58.3 -49.19 78.05 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.258 175.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 442' ' ' ARG . . . . . 0.739 ' HG2' ' O ' ' B' ' 438' ' ' ALA . 0.0 OUTLIER -57.24 -39.93 76.53 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.913 171.067 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 443' ' ' LEU . . . . . 0.556 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 33.3 mt -72.26 -34.34 68.16 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.376 0.608 . . . . 0.0 109.918 -178.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -58.02 -36.96 73.44 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.838 173.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 445' ' ' GLN . . . . . 0.558 ' HG2' ' O ' ' B' ' 441' ' ' GLN . 30.6 mm-40 -72.13 -27.66 62.77 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.161 178.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 446' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' B' ' 443' ' ' LEU . 38.0 tt0 35.6 98.07 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 170.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 447' ' ' ILE . . . . . 0.517 ' HB ' ' HB ' ' B' ' 451' ' ' THR . 54.4 mt -73.41 -32.71 37.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.629 0.728 . . . . 0.0 110.48 176.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 448' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -170.16 -158.42 0.17 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -87.55 -58.92 2.4 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 166.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 450' ' ' GLN . . . . . 0.461 ' C ' HE21 ' B' ' 450' ' ' GLN . 0.0 OUTLIER -66.66 -33.41 75.6 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 115.272 -0.877 . . . . 0.0 112.609 -177.562 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 451' ' ' THR . . . . . 0.517 ' HB ' ' HB ' ' B' ' 447' ' ' ILE . 4.7 m -72.0 -23.26 61.38 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.671 -174.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 452' ' ' ARG . . . . . . . . . . . . . 13.1 mtp180 -55.25 -54.13 47.38 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 172.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 453' ' ' ALA . . . . . 0.506 ' HB1' ' CD1' ' B' ' 419' ' ' TYR . . . -58.51 -48.36 81.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.689 -1.142 . . . . 0.0 112.622 175.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 454' ' ' GLU . . . . . 0.479 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 26.2 mm-40 -51.61 -37.3 49.39 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.399 0.619 . . . . 0.0 111.366 -178.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 29.1 p -117.71 16.82 14.45 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.471 -176.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 456' ' ' PHE . . . . . 0.613 ' CE2' ' HB2' ' B' ' 419' ' ' TYR . 1.1 t80 -58.01 -47.17 83.87 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.035 0.445 . . . . 0.0 111.571 -171.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 457' ' ' ILE . . . . . 0.512 ' CG1' ' HB3' ' B' ' 408' ' ' TYR . 2.0 mp -76.92 -32.31 19.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.622 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -57.93 -34.29 69.71 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.702 0.763 . . . . 0.0 109.214 170.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 459' ' ' HIS . . . . . 0.686 ' O ' HG22 ' B' ' 463' ' ' VAL . 58.4 m-70 -75.97 -28.14 57.76 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.634 178.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 460' ' ' LEU . . . . . 0.715 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.4 OUTLIER -74.06 -34.66 64.11 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.903 0.859 . . . . 0.0 108.82 178.262 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 461' ' ' ASN . . . . . 0.545 ' HA ' ' CD2' ' B' ' 464' ' ' TYR . 22.1 m-80 -72.59 -37.8 68.04 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.965 176.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 462' ' ' ALA . . . . . 0.638 ' O ' HD13 ' B' ' 466' ' ' ILE . . . -56.37 -34.25 66.48 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.688 169.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 463' ' ' VAL . . . . . 0.715 ' HB ' ' O ' ' B' ' 460' ' ' LEU . 65.3 t -61.49 -51.49 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 176.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 464' ' ' TYR . . . . . 0.739 ' CE2' ' HA ' ' B' ' 471' ' ' ALA . 15.5 m-30 -52.76 -27.24 16.97 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 124.354 1.034 . . . . 0.0 110.745 178.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.53 -39.11 20.85 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.703 0.763 . . . . 0.0 109.486 -178.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 466' ' ' ILE . . . . . 0.638 HD13 ' O ' ' B' ' 462' ' ' ALA . 3.6 mt -59.76 -55.92 20.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 114.219 -1.355 . . . . 0.0 112.224 176.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 467' ' ' LEU . . . . . 0.722 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -100.21 -10.62 21.18 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -173.235 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 468' ' ' GLY . . . . . 0.602 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 93.25 31.06 8.67 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 119.604 -1.284 . . . . 0.0 114.122 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 469' ' ' LEU . . . . . 0.722 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 2.9 mt -90.05 166.51 13.39 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.343 1.072 . . . . 0.0 111.723 178.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 34.6 p30 -106.11 177.94 4.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.366 169.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 471' ' ' ALA . . . . . 0.739 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -71.16 -7.08 44.26 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -173.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -92.05 -0.44 57.46 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.022 0.439 . . . . 0.0 110.674 -177.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 473' ' ' GLY . . . . . . . . . . . . . . . 77.45 13.06 83.94 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.136 -175.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -101.25 157.99 16.37 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 175.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 475' ' ' SER . . . . . 0.431 ' HA ' HD21 ' B' ' 469' ' ' LEU . 0.5 OUTLIER -93.61 120.2 33.58 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.729 0.776 . . . . 0.0 112.644 -177.081 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 476' ' ' ILE . . . . . 0.611 HD12 ' N ' ' B' ' 477' ' ' ARG . 2.2 pp -89.27 179.97 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 N-CA-C 105.426 -2.065 . . . . 0.0 105.426 162.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 477' ' ' ARG . . . . . 0.697 ' HD3' ' N ' ' B' ' 477' ' ' ARG . 0.1 OUTLIER -119.6 103.92 9.83 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 118.427 -1.309 . . . . 0.0 111.485 -172.009 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 478' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -71.53 175.91 5.16 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.322 -177.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 479' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 . . . . . 0 C--O 1.253 1.249 0 CA-C-O 118.583 -0.722 . . . . 0.0 110.509 179.781 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' ARG . . . . . 0.482 ' HD2' ' OD1' ' A' ' 418' ' ' ASN . 19.1 ptp180 . . . . . 0 N--CA 1.48 1.031 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' THR . . . . . 0.598 ' O ' ' HB3' ' A' ' 415' ' ' SER . 0.1 OUTLIER -131.4 -39.67 1.14 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 -175.369 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -153.41 159.47 42.39 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 119.515 -0.874 . . . . 0.0 112.867 -171.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -115.15 -112.19 2.87 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.048 171.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 11.3 m -58.95 -44.12 91.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.805 0.335 . . . . 0.0 111.72 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' PHE . . . . . 0.581 ' CD1' HD23 ' A' ' 414' ' ' LEU . 3.6 t80 -73.19 121.04 84.1 Favored Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 386' ' ' PHE . 6.5 Cg_endo -46.47 -71.55 0.05 OUTLIER 'Trans proline' 0 N--CA 1.475 0.44 0 C-N-CA 124.163 3.242 . . . . 0.0 114.412 -175.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' MET . . . . . 0.556 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 30.7 ttm 70.38 143.96 0.05 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 122.356 0.262 . . . . 0.0 110.717 178.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' HIS . . . . . 0.589 ' CD2' ' HB2' ' A' ' 393' ' ' ASN . 32.6 m170 -48.49 -76.17 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 121.42 0.629 . . . . 0.0 110.382 -176.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -166.66 19.49 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 173.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.512 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.6 pt? -168.67 -51.83 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.505 -171.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . 0.512 ' N ' ' HG ' ' A' ' 391' ' ' LEU . . . -176.22 60.84 0.1 Allowed Glycine 0 C--N 1.336 0.571 0 C-N-CA 119.751 -1.214 . . . . 0.0 114.028 -176.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . 0.589 ' HB2' ' CD2' ' A' ' 389' ' ' HIS . 0.2 OUTLIER -58.39 -42.08 86.31 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 174.115 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . 0.607 HG23 ' N ' ' A' ' 395' ' ' ILE . 1.7 m -55.24 -47.06 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 -179.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.607 ' N ' HG23 ' A' ' 394' ' ' VAL . 3.6 mp -57.7 -52.65 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 CA-C-O 117.8 -1.095 . . . . 0.0 113.729 -175.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . 0.63 ' O ' HG23 ' A' ' 399' ' ' VAL . 0.0 OUTLIER -62.75 -50.15 72.22 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 122.022 2.192 . . . . 0.0 112.298 -173.525 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . 0.492 ' O ' ' HG3' ' A' ' 401' ' ' GLN . . . -53.86 -42.09 68.64 Favored Glycine 0 N--CA 1.436 -1.344 0 C-N-CA 119.895 -1.145 . . . . 0.0 110.804 -175.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . 0.666 ' CD1' HD13 ' A' ' 410' ' ' LEU . 36.1 mt -71.64 -34.43 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 CA-C-N 114.263 -0.969 . . . . 0.0 113.517 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 396' ' ' LYS . 15.6 m -63.57 -39.94 87.22 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 C-N-CA 118.925 -1.11 . . . . 0.0 108.631 -173.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -68.29 -38.79 82.01 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 176.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . 0.492 ' HG3' ' O ' ' A' ' 397' ' ' GLY . 33.1 mt-30 -93.05 -48.46 6.49 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -171.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . 0.442 ' HG3' ' HE2' ' B' ' 413' ' ' MET . 3.0 mm-40 -113.14 -20.15 11.57 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.2 -172.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 105.48 161.51 23.29 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.849 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . 0.638 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.5 m -53.78 -45.23 61.62 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.78 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 -176.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . 0.469 ' HB1' HG21 ' A' ' 457' ' ' ILE . . . -64.03 -31.16 72.25 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.005 -0.678 . . . . 0.0 112.481 -177.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 406' ' ' THR . . . . . 0.689 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 87.1 m -77.38 -42.43 36.46 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.476 -0.489 . . . . 0.0 110.244 173.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.506 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.4 -36.85 74.19 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 122.245 1.022 . . . . 0.0 109.311 176.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 408' ' ' TYR . . . . . 0.638 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -66.33 -51.92 52.37 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 113.436 -1.711 . . . . 0.0 109.991 176.337 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 409' ' ' THR . . . . . 0.52 HG23 HD23 ' A' ' 410' ' ' LEU . 16.5 m -55.68 -46.91 77.5 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.58 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . 0.689 ' HG ' ' O ' ' A' ' 406' ' ' THR . 14.1 mt -72.36 -34.95 68.37 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -175.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -59.35 -34.22 79.5 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.383 -0.913 . . . . 0.0 110.994 170.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 412' ' ' MET . . . . . 0.42 ' HB2' ' O ' ' A' ' 409' ' ' THR . 0.6 OUTLIER -66.71 -48.25 69.8 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 122.611 -0.346 . . . . 0.0 111.119 177.035 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 413' ' ' MET . . . . . 0.894 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.5 OUTLIER -71.53 -51.45 23.5 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 119.363 -0.935 . . . . 0.0 112.656 -179.357 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . 0.894 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 12.5 mt -67.55 -46.47 72.67 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -174.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.598 ' HB3' ' O ' ' A' ' 382' ' ' THR . 0.1 OUTLIER -97.58 10.98 38.46 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.364 0.602 . . . . 0.0 111.086 -172.66 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . 0.457 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 84.08 179.82 51.84 Favored Glycine 0 N--CA 1.438 -1.187 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.68 -179.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -79.83 23.06 0.46 Allowed 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.364 0.602 . . . . 0.0 110.789 -173.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 418' ' ' ASN . . . . . 0.482 ' OD1' ' HD2' ' A' ' 381' ' ' ARG . 64.0 m-80 -72.33 77.36 1.01 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.782 -178.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 419' ' ' TYR . . . . . 0.545 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 7.1 p90 -49.83 -38.23 33.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.977 174.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -54.33 -47.72 72.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.749 177.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -48.65 66.02 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.044 -176.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . 0.455 ' HB ' ' CD1' ' A' ' 408' ' ' TYR . 0.2 OUTLIER -66.01 -40.49 87.45 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.572 0 C-N-CA 120.281 -0.567 . . . . 0.0 111.355 -176.918 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.805 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 80.6 p -69.24 -37.88 78.22 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -178.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.56 -38.96 90.91 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.761 176.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . 0.534 HG23 HG23 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.91 -52.56 21.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.028 -0.086 . . . . 0.0 111.182 -178.279 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . 0.524 ' O ' HD23 ' A' ' 430' ' ' LEU . 1.1 mm -74.69 -23.59 17.91 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.896 0 O-C-N 121.968 -0.457 . . . . 0.0 110.374 -171.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.805 ' HB2' ' O ' ' A' ' 423' ' ' SER . 1.3 tmm_? -55.44 -30.86 61.3 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.325 0.583 . . . . 0.0 111.007 -177.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -86.58 -12.11 70.1 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.203 178.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.474 ' HD1' ' CG2' ' A' ' 395' ' ' ILE . 7.7 m-30 -112.68 -0.5 15.05 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.615 0.722 . . . . 0.0 109.07 -174.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . 0.55 HD11 ' HD2' ' A' ' 431' ' ' PRO . 0.1 OUTLIER -66.07 129.75 94.27 Favored Pre-proline 0 N--CA 1.444 -0.754 0 CA-C-N 114.549 -1.205 . . . . 0.0 108.953 177.508 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . 0.55 ' HD2' HD11 ' A' ' 430' ' ' LEU . 81.4 Cg_exo -23.91 -68.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.915 1 C-N-CA 125.489 4.126 . . . . 0.0 114.852 179.117 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . 0.5 ' O ' HG13 ' A' ' 435' ' ' VAL . . . -141.51 -167.81 11.32 Favored Glycine 0 N--CA 1.442 -0.91 0 N-CA-C 110.089 -1.205 . . . . 0.0 110.089 176.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . 0.551 ' O ' HG12 ' A' ' 436' ' ' VAL . 43.6 tp60 -70.4 -26.96 63.93 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 118.083 0.941 . . . . 0.0 110.449 178.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -64.3 -41.98 96.59 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 435' ' ' VAL . . . . . 0.5 HG13 ' O ' ' A' ' 432' ' ' GLY . 7.4 p -67.67 -42.81 86.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 121.018 0.437 . . . . 0.0 110.66 -177.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . 0.551 HG12 ' O ' ' A' ' 433' ' ' GLN . 0.1 OUTLIER -67.26 -31.61 53.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.402 175.735 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.61 -52.76 41.71 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -178.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . 0.559 ' O ' ' HD2' ' A' ' 442' ' ' ARG . . . -58.63 -39.82 81.63 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.936 177.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 439' ' ' LEU . . . . . 0.642 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 1.8 tm? -68.0 -48.39 65.87 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -177.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -60.54 -33.73 73.09 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.074 175.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 441' ' ' GLN . . . . . 0.487 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 3.5 mm-40 -54.83 -50.29 68.96 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.863 -178.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . 0.608 ' HG3' ' CG ' ' A' ' 459' ' ' HIS . 0.0 OUTLIER -77.76 -24.12 49.05 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 174.271 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 443' ' ' LEU . . . . . 0.642 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 56.5 mt -64.04 -27.17 68.93 Favored 'General case' 0 CA--C 1.516 -0.356 0 O-C-N 121.496 -0.753 . . . . 0.0 109.985 173.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -66.5 -37.12 84.37 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.85 178.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 445' ' ' GLN . . . . . 0.478 ' HG3' ' N ' ' A' ' 446' ' ' GLU . 0.0 OUTLIER -80.25 -30.39 38.47 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.479 -179.923 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 446' ' ' GLU . . . . . 0.478 ' N ' ' HG3' ' A' ' 445' ' ' GLN . 8.6 pt-20 15.21 105.03 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.248 0 O-C-N 125.617 1.823 . . . . 0.0 113.841 -177.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 43.6 mt -51.26 -34.44 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.369 -177.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . 0.505 ' HB2' ' OG1' ' A' ' 451' ' ' THR . 13.3 m-20 -160.88 -174.59 4.48 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 449' ' ' ASP . . . . . 0.472 ' O ' ' HB3' ' A' ' 452' ' ' ARG . 25.8 t0 -72.41 -62.49 1.42 Allowed 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 174.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.22 -27.13 64.23 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 176.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 451' ' ' THR . . . . . 0.505 ' OG1' ' HB2' ' A' ' 448' ' ' ASP . 16.0 m -72.12 -23.06 61.26 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.004 -176.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . 0.472 ' HB3' ' O ' ' A' ' 449' ' ' ASP . 43.9 ttt180 -55.96 -52.26 64.79 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 172.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 453' ' ' ALA . . . . . 0.545 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -59.77 -47.21 86.6 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.707 170.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . 0.482 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 14.1 mm-40 -51.73 -36.45 47.11 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.137 0.494 . . . . 0.0 111.917 -175.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 24.9 p -115.46 13.98 16.58 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.271 -176.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . 0.572 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 1.2 t80 -55.06 -46.4 75.39 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.945 0.402 . . . . 0.0 111.746 -172.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . 0.504 ' CG1' ' HB3' ' A' ' 408' ' ' TYR . 1.9 mp -78.19 -33.36 17.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.784 0.326 . . . . 0.0 111.239 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -58.09 -32.71 68.34 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.805 0.812 . . . . 0.0 109.117 171.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . 0.746 ' O ' HG22 ' A' ' 463' ' ' VAL . 56.9 m-70 -74.17 -30.04 62.06 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.8 177.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . 0.696 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -73.99 -34.88 64.35 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.995 0.902 . . . . 0.0 108.988 179.518 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -73.08 -37.02 66.93 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.126 176.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 462' ' ' ALA . . . . . 0.619 ' O ' HD11 ' A' ' 466' ' ' ILE . . . -56.02 -34.25 65.66 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.385 -1.279 . . . . 0.0 109.9 169.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.746 HG22 ' O ' ' A' ' 459' ' ' HIS . 66.1 t -63.57 -50.83 76.57 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 CA-C-N 114.421 -1.263 . . . . 0.0 108.114 177.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 464' ' ' TYR . . . . . 0.564 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 16.9 m-30 -52.4 -29.15 22.73 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 124.348 1.03 . . . . 0.0 110.257 177.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.82 -40.69 22.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.745 0.784 . . . . 0.0 109.498 -177.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.619 HD11 ' O ' ' A' ' 462' ' ' ALA . 3.6 mt -57.84 -56.17 17.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 114.304 -1.316 . . . . 0.0 112.269 176.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.741 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -100.82 -11.23 20.01 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -172.051 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . 0.528 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 94.09 31.6 7.98 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 119.366 -1.397 . . . . 0.0 114.321 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 469' ' ' LEU . . . . . 0.741 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.3 mt -88.47 163.02 16.15 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 117.915 0.857 . . . . 0.0 110.92 177.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 37.9 p30 -105.17 -178.04 3.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.065 172.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -66.05 -14.65 62.07 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -176.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -88.53 -1.6 58.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.675 0.274 . . . . 0.0 111.148 -175.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . 0.482 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 79.04 10.66 85.95 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -175.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -101.43 156.22 17.59 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 176.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 32.1 t -93.25 137.52 32.49 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.248 0.547 . . . . 0.0 111.287 -176.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 476' ' ' ILE . . . . . 0.703 ' O ' ' HD2' ' A' ' 477' ' ' ARG . 2.4 pp -115.61 -19.8 6.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.878 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 477' ' ' ARG . . . . . 0.703 ' HD2' ' O ' ' A' ' 476' ' ' ILE . 0.1 OUTLIER 22.11 63.39 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 174.313 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . 0.417 ' H ' HD11 ' A' ' 476' ' ' ILE . 95.4 mt 59.1 83.54 0.13 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.151 -177.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.731 -0.652 . . . . 0.0 110.544 179.735 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 381' ' ' ARG . . . . . 0.469 ' HD2' ' OD1' ' B' ' 418' ' ' ASN . 19.0 ptp180 . . . . . 0 N--CA 1.48 1.058 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 382' ' ' THR . . . . . 0.589 ' O ' ' HB3' ' B' ' 415' ' ' SER . 0.1 OUTLIER -130.95 -39.31 1.21 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -175.22 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 383' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -153.59 159.29 42.11 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 119.428 -0.909 . . . . 0.0 112.85 -171.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 384' ' ' GLY . . . . . . . . . . . . . . . -114.98 -111.95 2.88 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.103 171.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 385' ' ' THR . . . . . . . . . . . . . 14.1 m -59.7 -43.33 94.12 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.856 0.36 . . . . 0.0 111.684 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 386' ' ' PHE . . . . . 0.582 ' CD1' HD23 ' B' ' 414' ' ' LEU . 3.5 t80 -73.59 121.16 84.47 Favored Pre-proline 0 C--N 1.329 -0.322 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 387' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' B' ' 386' ' ' PHE . 6.7 Cg_endo -46.56 -71.56 0.05 OUTLIER 'Trans proline' 0 N--CA 1.476 0.479 0 C-N-CA 124.17 3.247 . . . . 0.0 114.433 -175.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 388' ' ' MET . . . . . 0.544 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 30.8 ttm 70.39 143.57 0.05 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 122.412 0.285 . . . . 0.0 110.896 178.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 389' ' ' HIS . . . . . 0.584 ' CD2' ' HB2' ' B' ' 393' ' ' ASN . 32.6 m170 -48.14 -75.93 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.1 0 CA-C-O 121.304 0.574 . . . . 0.0 110.417 -176.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -166.92 19.31 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 173.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 391' ' ' LEU . . . . . 0.513 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.6 pt? -168.76 -51.49 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.497 -171.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 392' ' ' GLY . . . . . 0.513 ' N ' ' HG ' ' B' ' 391' ' ' LEU . . . -176.44 60.85 0.1 Allowed Glycine 0 CA--C 1.522 0.522 0 C-N-CA 119.794 -1.193 . . . . 0.0 114.151 -176.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 393' ' ' ASN . . . . . 0.584 ' HB2' ' CD2' ' B' ' 389' ' ' HIS . 0.2 OUTLIER -58.47 -42.07 86.68 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 174.095 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 394' ' ' VAL . . . . . 0.609 HG23 ' N ' ' B' ' 395' ' ' ILE . 1.7 m -55.18 -47.12 77.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 395' ' ' ILE . . . . . 0.609 ' N ' HG23 ' B' ' 394' ' ' VAL . 3.6 mp -57.64 -52.65 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 117.779 -1.105 . . . . 0.0 113.751 -175.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 396' ' ' LYS . . . . . 0.635 ' O ' HG23 ' B' ' 399' ' ' VAL . 0.0 OUTLIER -62.71 -50.18 72.14 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 122.043 2.201 . . . . 0.0 112.347 -173.667 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 397' ' ' GLY . . . . . 0.507 ' O ' ' HG3' ' B' ' 401' ' ' GLN . . . -54.06 -41.86 70.02 Favored Glycine 0 N--CA 1.436 -1.345 0 C-N-CA 119.799 -1.191 . . . . 0.0 110.838 -175.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . 0.668 ' CD1' HD13 ' B' ' 410' ' ' LEU . 35.9 mt -71.62 -34.56 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 399' ' ' VAL . . . . . 0.635 HG23 ' O ' ' B' ' 396' ' ' LYS . 15.6 m -63.38 -40.1 87.76 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 C-N-CA 118.94 -1.104 . . . . 0.0 108.68 -174.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -68.53 -38.5 80.9 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 176.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 401' ' ' GLN . . . . . 0.507 ' HG3' ' O ' ' B' ' 397' ' ' GLY . 32.9 mt-30 -92.86 -48.39 6.57 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -171.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 402' ' ' GLU . . . . . 0.451 ' HG3' ' HE2' ' A' ' 413' ' ' MET . 3.1 mm-40 -113.43 -19.89 11.52 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.154 -172.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 105.12 161.42 23.62 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.947 178.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 404' ' ' VAL . . . . . 0.628 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.4 m -53.69 -45.37 60.66 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 N-CA-C 114.409 1.262 . . . . 0.0 114.409 -176.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 405' ' ' ALA . . . . . 0.459 ' HB1' HG21 ' B' ' 457' ' ' ILE . . . -63.97 -31.23 72.35 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 119.954 -0.698 . . . . 0.0 112.504 -177.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 406' ' ' THR . . . . . 0.681 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 89.9 m -77.12 -42.36 38.29 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.298 173.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 407' ' ' ALA . . . . . 0.502 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.48 -36.79 74.27 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 122.203 1.001 . . . . 0.0 109.282 176.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 408' ' ' TYR . . . . . 0.628 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -66.46 -51.87 52.28 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 113.43 -1.714 . . . . 0.0 109.937 176.449 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 409' ' ' THR . . . . . 0.541 HG23 HD23 ' B' ' 410' ' ' LEU . 16.6 m -55.45 -47.07 76.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.591 178.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 410' ' ' LEU . . . . . 0.681 ' HG ' ' O ' ' B' ' 406' ' ' THR . 14.1 mt -72.42 -34.78 68.08 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -175.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -59.41 -34.14 79.39 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.308 -0.948 . . . . 0.0 110.998 170.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 412' ' ' MET . . . . . 0.423 ' HB2' ' O ' ' B' ' 409' ' ' THR . 0.6 OUTLIER -66.88 -48.15 69.64 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 122.612 -0.346 . . . . 0.0 111.072 177.163 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 413' ' ' MET . . . . . 0.912 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.5 OUTLIER -71.59 -51.69 22.01 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 119.336 -0.946 . . . . 0.0 112.678 -179.456 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 414' ' ' LEU . . . . . 0.912 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 12.4 mt -67.21 -46.5 73.67 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -174.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 415' ' ' SER . . . . . 0.589 ' HB3' ' O ' ' B' ' 382' ' ' THR . 0.1 OUTLIER -97.44 10.61 39.27 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.368 0.604 . . . . 0.0 110.975 -172.556 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 416' ' ' GLY . . . . . 0.468 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 84.16 179.39 51.73 Favored Glycine 0 N--CA 1.438 -1.202 0 C-N-CA 120.638 -0.791 . . . . 0.0 111.609 -178.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -79.5 23.23 0.41 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.564 0.697 . . . . 0.0 110.843 -173.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 418' ' ' ASN . . . . . 0.469 ' OD1' ' HD2' ' B' ' 381' ' ' ARG . 64.8 m-80 -72.51 77.49 1.06 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.763 -178.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 419' ' ' TYR . . . . . 0.553 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 6.9 p90 -50.0 -38.29 36.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.975 174.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -54.28 -47.64 72.12 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.807 177.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.7 -48.76 65.63 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.963 -176.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 422' ' ' VAL . . . . . 0.454 ' HB ' ' CD1' ' B' ' 408' ' ' TYR . 0.2 OUTLIER -66.01 -40.47 87.38 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.499 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.216 -176.757 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 423' ' ' SER . . . . . 0.8 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 80.3 p -69.15 -37.76 78.43 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -178.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -68.0 -38.61 88.8 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.636 176.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 425' ' ' ILE . . . . . 0.552 HG23 HG23 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -72.95 -52.91 20.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 O-C-N 123.062 -0.081 . . . . 0.0 111.088 -178.289 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 426' ' ' ILE . . . . . 0.519 ' CD1' HG21 ' B' ' 395' ' ' ILE . 1.1 mm -74.34 -23.77 18.53 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.89 0 O-C-N 122.182 -0.324 . . . . 0.0 110.376 -171.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 427' ' ' ARG . . . . . 0.8 ' HB2' ' O ' ' B' ' 423' ' ' SER . 1.3 tmm_? -55.33 -30.76 60.88 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.241 0.544 . . . . 0.0 111.024 -177.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -86.87 -11.8 69.8 Favored Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 120.445 -0.883 . . . . 0.0 111.224 178.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 429' ' ' TYR . . . . . 0.468 ' HD1' ' CG2' ' B' ' 395' ' ' ILE . 7.9 m-30 -112.94 -0.39 14.84 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -174.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 430' ' ' LEU . . . . . 0.541 HD11 ' HD2' ' B' ' 431' ' ' PRO . 0.1 OUTLIER -66.12 129.72 94.25 Favored Pre-proline 0 N--CA 1.442 -0.837 0 CA-C-N 114.477 -1.238 . . . . 0.0 108.938 177.426 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 431' ' ' PRO . . . . . 0.541 ' HD2' HD11 ' B' ' 430' ' ' LEU . 81.0 Cg_exo -24.05 -69.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.357 1.001 1 C-N-CA 125.399 4.066 . . . . 0.0 114.796 179.224 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 432' ' ' GLY . . . . . 0.51 ' O ' HG13 ' B' ' 435' ' ' VAL . . . -141.28 -168.03 11.34 Favored Glycine 0 N--CA 1.443 -0.886 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 177.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 433' ' ' GLN . . . . . 0.555 ' O ' HG12 ' B' ' 436' ' ' VAL . 43.8 tp60 -70.23 -26.93 64.08 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 118.173 0.986 . . . . 0.0 110.411 178.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -63.99 -42.18 97.28 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.964 -178.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 435' ' ' VAL . . . . . 0.51 HG13 ' O ' ' B' ' 432' ' ' GLY . 7.3 p -67.76 -42.77 86.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 120.977 0.417 . . . . 0.0 110.649 -177.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 436' ' ' VAL . . . . . 0.555 HG12 ' O ' ' B' ' 433' ' ' GLN . 0.1 OUTLIER -67.31 -31.57 53.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.323 175.732 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.58 -52.74 42.11 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -178.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 438' ' ' ALA . . . . . 0.56 ' O ' ' HD2' ' B' ' 442' ' ' ARG . . . -58.68 -39.74 81.57 Favored 'General case' 0 N--CA 1.436 -1.128 0 O-C-N 124.042 0.838 . . . . 0.0 111.97 177.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 439' ' ' LEU . . . . . 0.655 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 1.8 tm? -68.03 -48.41 65.73 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -178.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 440' ' ' GLN . . . . . 0.402 ' O ' ' HG3' ' B' ' 440' ' ' GLN . 0.3 OUTLIER -60.45 -33.7 72.94 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.143 175.256 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 441' ' ' GLN . . . . . 0.481 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 3.4 mm-40 -55.0 -50.25 69.47 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.742 -178.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 442' ' ' ARG . . . . . 0.603 ' HG3' ' CG ' ' B' ' 459' ' ' HIS . 0.0 OUTLIER -77.74 -24.0 49.19 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 174.388 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 443' ' ' LEU . . . . . 0.655 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 55.8 mt -64.31 -26.91 68.69 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 118.755 0.707 . . . . 0.0 109.966 173.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -66.71 -37.03 83.89 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.78 178.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 445' ' ' GLN . . . . . 0.472 ' HG3' ' N ' ' B' ' 446' ' ' GLU . 0.0 OUTLIER -80.33 -30.42 38.12 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.584 179.874 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 446' ' ' GLU . . . . . 0.472 ' N ' ' HG3' ' B' ' 445' ' ' GLN . 8.7 pt-20 15.2 105.14 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 O-C-N 125.517 1.761 . . . . 0.0 113.816 -177.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 43.7 mt -51.28 -34.23 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.362 -177.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 448' ' ' ASP . . . . . 0.507 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 13.0 m-20 -161.04 -174.45 4.38 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 449' ' ' ASP . . . . . 0.477 ' O ' ' HB3' ' B' ' 452' ' ' ARG . 27.9 t0 -72.26 -62.69 1.34 Allowed 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 174.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.03 -27.26 64.52 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 176.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 451' ' ' THR . . . . . 0.507 ' OG1' ' HB2' ' B' ' 448' ' ' ASP . 14.6 m -72.07 -23.02 61.29 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 119.749 -0.78 . . . . 0.0 109.946 -176.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 452' ' ' ARG . . . . . 0.477 ' HB3' ' O ' ' B' ' 449' ' ' ASP . 43.5 ttt180 -56.0 -52.15 65.22 Favored 'General case' 0 N--CA 1.415 -2.176 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 172.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 453' ' ' ALA . . . . . 0.553 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -60.05 -46.9 87.99 Favored 'General case' 0 CA--C 1.527 0.081 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 171.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 454' ' ' GLU . . . . . 0.481 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 13.5 mm-40 -51.95 -36.25 48.73 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.157 0.503 . . . . 0.0 111.837 -176.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 24.9 p -115.61 14.18 16.45 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.368 -176.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 456' ' ' PHE . . . . . 0.581 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 1.2 t80 -55.32 -46.29 76.32 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.944 0.402 . . . . 0.0 111.745 -172.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 457' ' ' ILE . . . . . 0.516 ' CG1' ' HB3' ' B' ' 408' ' ' TYR . 1.9 mp -78.16 -33.39 17.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 120.687 0.279 . . . . 0.0 111.273 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -58.06 -32.92 68.49 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.993 0.902 . . . . 0.0 109.078 171.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 459' ' ' HIS . . . . . 0.739 ' O ' HG22 ' B' ' 463' ' ' VAL . 56.4 m-70 -73.98 -29.97 62.25 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.79 177.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 460' ' ' LEU . . . . . 0.699 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -74.16 -34.71 63.91 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.814 0.816 . . . . 0.0 108.923 179.649 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 461' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -73.07 -37.34 66.83 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.016 176.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 462' ' ' ALA . . . . . 0.629 ' O ' HD11 ' B' ' 466' ' ' ILE . . . -55.99 -34.04 65.4 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.758 169.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 463' ' ' VAL . . . . . 0.739 HG22 ' O ' ' B' ' 459' ' ' HIS . 68.4 t -63.49 -51.09 74.95 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-N 114.548 -1.205 . . . . 0.0 108.152 177.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 464' ' ' TYR . . . . . 0.553 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 16.9 m-30 -52.3 -29.15 21.97 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 124.347 1.029 . . . . 0.0 110.311 177.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.68 -40.98 22.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.614 0.721 . . . . 0.0 109.475 -177.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 466' ' ' ILE . . . . . 0.629 HD11 ' O ' ' B' ' 462' ' ' ALA . 3.7 mt -57.42 -56.32 15.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 114.277 -1.329 . . . . 0.0 112.251 176.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 467' ' ' LEU . . . . . 0.743 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -100.78 -11.36 19.95 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 114.66 1.355 . . . . 0.0 114.66 -171.971 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 468' ' ' GLY . . . . . 0.549 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 94.24 31.56 7.93 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 119.368 -1.396 . . . . 0.0 114.32 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 469' ' ' LEU . . . . . 0.743 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.3 mt -88.6 162.93 16.09 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 117.873 0.836 . . . . 0.0 110.879 177.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 37.8 p30 -105.0 -177.95 3.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.109 172.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 471' ' ' ALA . . . . . . . . . . . . . . . -66.41 -14.46 62.19 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -176.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -88.43 -1.71 58.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.624 0.249 . . . . 0.0 111.166 -176.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 473' ' ' GLY . . . . . 0.479 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 78.99 10.82 85.83 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -175.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -101.51 156.46 17.46 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 176.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 34.8 t -93.36 137.56 32.55 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.348 0.594 . . . . 0.0 111.264 -176.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 476' ' ' ILE . . . . . 0.707 ' O ' ' HD2' ' B' ' 477' ' ' ARG . 2.4 pp -115.64 -19.63 6.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.865 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 477' ' ' ARG . . . . . 0.707 ' HD2' ' O ' ' B' ' 476' ' ' ILE . 0.1 OUTLIER 21.98 62.82 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 115.076 1.509 . . . . 0.0 115.076 174.295 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 478' ' ' LEU . . . . . 0.422 ' H ' HD11 ' B' ' 476' ' ' ILE . 96.4 mt 59.77 83.82 0.13 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.972 -177.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 479' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.659 -0.686 . . . . 0.0 110.629 179.89 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -53.9 -44.52 70.6 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -139.97 119.59 13.22 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 120.898 0.38 . . . . 0.0 111.806 175.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 162.82 85.12 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 -178.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 24.2 m 73.8 123.12 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 122.963 0.505 . . . . 0.0 110.414 -175.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' PHE . . . . . 0.536 ' CD1' HD21 ' A' ' 414' ' ' LEU . 2.1 t80 69.64 111.53 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.542 -171.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 386' ' ' PHE . 1.5 Cg_endo -39.85 -62.84 0.33 Allowed 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 124.404 3.403 . . . . 0.0 113.764 -174.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' MET . . . . . 0.478 ' C ' ' HB3' ' A' ' 393' ' ' ASN . 6.3 ttp 59.04 38.34 24.11 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 174.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' HIS . . . . . 0.583 ' N ' ' HB3' ' A' ' 393' ' ' ASN . 31.3 m170 51.8 -97.22 0.05 Allowed 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.41 0.624 . . . . 0.0 110.064 -176.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -151.57 23.89 0.7 Allowed 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.186 171.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.45 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.4 pt? -175.77 -47.87 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.221 -172.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . 0.504 ' CA ' HD13 ' A' ' 395' ' ' ILE . . . -173.22 56.37 0.15 Allowed Glycine 0 CA--C 1.524 0.645 0 C-N-CA 119.443 -1.361 . . . . 0.0 114.796 -172.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . 0.583 ' HB3' ' N ' ' A' ' 389' ' ' HIS . 0.0 OUTLIER -61.72 -37.64 84.93 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-N 117.65 0.725 . . . . 0.0 109.061 174.18 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . 0.618 HG23 ' N ' ' A' ' 395' ' ' ILE . 1.0 OUTLIER -57.2 -49.4 79.89 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 CA-C-N 113.674 -1.603 . . . . 0.0 107.047 179.015 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.618 ' N ' HG23 ' A' ' 394' ' ' VAL . 3.6 mp -57.69 -52.82 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 CA-C-O 117.745 -1.121 . . . . 0.0 113.605 -174.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . 0.64 ' O ' HG22 ' A' ' 399' ' ' VAL . 0.0 OUTLIER -62.54 -49.51 75.02 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 122.017 2.189 . . . . 0.0 112.199 -174.715 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.16 -44.48 63.76 Favored Glycine 0 N--CA 1.435 -1.391 0 C-N-CA 119.98 -1.105 . . . . 0.0 110.98 -176.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . 0.673 ' CD1' HD12 ' A' ' 410' ' ' LEU . 28.5 mt -71.09 -33.94 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . 0.64 HG22 ' O ' ' A' ' 396' ' ' LYS . 17.3 m -63.29 -39.81 86.67 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 C-N-CA 118.751 -1.18 . . . . 0.0 108.436 -174.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -70.62 -37.7 73.84 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 175.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . 0.408 HE21 ' HB3' ' A' ' 401' ' ' GLN . 3.3 mm100 -88.15 -48.86 7.39 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -171.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . 0.414 ' HB3' ' HB ' ' A' ' 406' ' ' THR . 1.3 tm-20 -117.93 -19.94 8.98 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.065 0.46 . . . . 0.0 111.213 -170.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 106.45 160.67 22.25 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.673 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . 0.625 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.2 m -54.16 -45.5 66.51 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.862 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -175.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . 0.48 ' HB2' HG23 ' A' ' 457' ' ' ILE . . . -63.15 -31.26 72.36 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 119.794 -0.762 . . . . 0.0 112.403 -177.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 406' ' ' THR . . . . . 0.706 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 92.5 m -76.92 -42.03 41.1 Favored 'General case' 0 C--O 1.221 -0.412 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.164 173.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.472 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.8 -36.79 75.04 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 122.183 0.992 . . . . 0.0 109.301 176.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 408' ' ' TYR . . . . . 0.625 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -66.41 -51.73 53.92 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 113.492 -1.685 . . . . 0.0 109.571 176.762 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 409' ' ' THR . . . . . 0.521 HG22 HD22 ' A' ' 410' ' ' LEU . 17.5 m -55.11 -47.37 75.09 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.436 178.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . 0.706 ' HG ' ' O ' ' A' ' 406' ' ' THR . 15.0 mt -72.59 -35.73 67.99 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -174.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.44 -34.63 76.06 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.15 -1.024 . . . . 0.0 110.893 172.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -69.58 -47.22 64.33 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 413' ' ' MET . . . . . 0.917 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.8 OUTLIER -71.52 -44.84 63.9 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 118.914 -1.114 . . . . 0.0 111.879 -179.425 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . 0.917 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 11.7 mt -70.03 -46.37 65.21 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -177.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.45 ' HB2' ' SD ' ' A' ' 388' ' ' MET . 8.4 t -99.86 16.56 23.37 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.319 0.58 . . . . 0.0 110.349 -172.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . 0.434 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 75.85 -176.66 50.81 Favored Glycine 0 N--CA 1.437 -1.266 0 C-N-CA 120.354 -0.927 . . . . 0.0 111.721 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -80.56 23.12 0.53 Allowed 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.272 0.558 . . . . 0.0 111.402 -172.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 418' ' ' ASN . . . . . 0.434 ' H ' ' C ' ' A' ' 416' ' ' GLY . 4.3 m-20 -71.58 76.98 0.81 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.514 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 419' ' ' TYR . . . . . 0.499 ' CD1' ' HB3' ' A' ' 453' ' ' ALA . 21.4 p90 -56.17 -38.04 70.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.518 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -55.71 -42.57 75.45 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.723 0.297 . . . . 0.0 111.081 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.1 -49.05 63.63 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.287 -178.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . 0.47 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -65.7 -39.51 85.11 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.259 -177.878 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.788 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 61.8 p -67.73 -37.75 82.61 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 -178.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -68.09 -39.25 88.75 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.129 175.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . 0.553 HG22 HG23 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.23 -52.4 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-O 120.352 0.12 . . . . 0.0 111.035 -177.908 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . 0.546 ' CD1' HG21 ' A' ' 395' ' ' ILE . 1.2 mm -74.75 -23.37 17.7 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.91 0 O-C-N 122.135 -0.353 . . . . 0.0 110.555 -172.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.788 ' HB2' ' O ' ' A' ' 423' ' ' SER . 1.5 tmt_? -54.57 -31.8 57.37 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.224 0.535 . . . . 0.0 111.13 -177.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.37 -12.1 67.99 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.217 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.495 ' HD1' ' CG2' ' A' ' 395' ' ' ILE . 6.1 m-30 -112.0 -1.97 15.23 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -173.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . 0.542 ' HA ' HG13 ' A' ' 404' ' ' VAL . 0.0 OUTLIER -66.05 139.97 96.83 Favored Pre-proline 0 N--CA 1.443 -0.815 0 CA-C-N 114.136 -1.393 . . . . 0.0 109.206 177.349 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . 0.701 ' CD ' HG12 ' A' ' 435' ' ' VAL . 77.4 Cg_exo -37.99 -75.45 0.04 OUTLIER 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 124.606 3.537 . . . . 0.0 113.92 -173.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . 0.484 ' O ' HG11 ' A' ' 435' ' ' VAL . . . -130.06 -161.63 10.51 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 176.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . 0.547 ' O ' HG11 ' A' ' 436' ' ' VAL . 19.0 tp60 -71.47 -28.78 64.18 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 118.038 0.919 . . . . 0.0 110.569 176.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -67.03 -39.19 86.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 0.0 112.123 -175.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 435' ' ' VAL . . . . . 0.701 HG12 ' CD ' ' A' ' 431' ' ' PRO . 6.8 p -66.55 -45.08 89.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.173 0.511 . . . . 0.0 110.736 -177.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . 0.547 HG11 ' O ' ' A' ' 433' ' ' GLN . 0.2 OUTLIER -66.28 -31.91 55.73 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.105 177.014 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -68.01 -52.26 37.63 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -177.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . 0.684 ' O ' ' HD2' ' A' ' 442' ' ' ARG . . . -57.58 -40.56 79.29 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.179 177.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 439' ' ' LEU . . . . . 0.597 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 1.9 tm? -68.12 -48.13 66.26 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -178.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.86 -34.99 73.85 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.085 175.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 441' ' ' GLN . . . . . 0.508 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 4.4 mm-40 -53.62 -49.6 67.49 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.001 -178.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . 0.684 ' HD2' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -76.89 -25.28 52.84 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 119.133 -1.027 . . . . 0.0 113.368 174.346 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 443' ' ' LEU . . . . . 0.597 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 66.8 mt -65.59 -27.75 68.64 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 118.653 0.66 . . . . 0.0 109.771 175.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -61.29 -38.37 86.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.937 176.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -78.49 -27.63 46.25 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.319 -1.31 . . . . 0.0 111.149 178.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 25.36 101.58 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 41.5 mt -58.61 -33.59 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 121.353 0.597 . . . . 0.0 111.322 -178.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . 0.441 ' HB2' ' OG1' ' A' ' 451' ' ' THR . 8.4 m-20 -162.46 -159.81 0.61 Allowed 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 -178.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 449' ' ' ASP . . . . . 0.476 ' CG ' ' H ' ' A' ' 450' ' ' GLN . 12.3 p-10 -85.39 -64.88 1.08 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 168.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 450' ' ' GLN . . . . . 0.476 ' H ' ' CG ' ' A' ' 449' ' ' ASP . 0.0 OUTLIER -68.24 -26.11 65.53 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 179.012 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 451' ' ' THR . . . . . 0.478 ' HA ' ' HB2' ' A' ' 454' ' ' GLU . 10.4 m -71.44 -23.13 61.79 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 119.859 -0.736 . . . . 0.0 110.732 -175.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 452' ' ' ARG . 14.7 mtp180 -54.02 -53.95 45.91 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 171.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 453' ' ' ALA . . . . . 0.499 ' HB3' ' CD1' ' A' ' 419' ' ' TYR . . . -58.73 -49.08 78.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.354 -1.293 . . . . 0.0 112.53 174.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . 0.478 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 69.0 mm-40 -49.69 -37.15 27.67 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.283 0.563 . . . . 0.0 111.601 -177.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 32.0 p -118.03 15.06 14.18 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.45 -175.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . 0.527 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.8 OUTLIER -57.44 -47.47 81.73 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.089 0.471 . . . . 0.0 111.643 -171.28 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . 0.504 ' CG1' ' HB3' ' A' ' 408' ' ' TYR . 1.9 mp -76.92 -32.54 19.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.831 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -57.96 -34.41 69.9 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.905 0.86 . . . . 0.0 109.143 171.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . 0.767 ' O ' HG23 ' A' ' 463' ' ' VAL . 63.2 m-70 -74.68 -29.45 61.23 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.725 177.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . 0.705 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -73.47 -34.61 65.44 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.793 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . 0.449 ' O ' ' HB2' ' A' ' 464' ' ' TYR . 25.1 m-80 -73.11 -37.2 66.78 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.207 176.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 462' ' ' ALA . . . . . 0.594 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -55.75 -36.46 67.31 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.449 169.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 459' ' ' HIS . 75.5 t -61.9 -51.16 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 CA-C-N 114.274 -1.33 . . . . 0.0 108.098 176.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 464' ' ' TYR . . . . . 0.586 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 18.5 m-30 -51.28 -29.03 13.43 Favored 'General case' 0 N--CA 1.455 -0.195 0 O-C-N 124.551 1.157 . . . . 0.0 110.758 177.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.0 -39.78 19.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.657 0.742 . . . . 0.0 109.76 -176.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.594 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.6 mt -57.89 -55.84 19.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 114.481 -1.236 . . . . 0.0 112.113 176.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.764 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -100.22 -10.51 21.29 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 -172.667 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . 0.657 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 94.24 32.06 7.64 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 119.238 -1.458 . . . . 0.0 114.259 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 469' ' ' LEU . . . . . 0.764 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 4.3 mt -89.2 158.85 17.73 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 117.827 0.814 . . . . 0.0 110.828 174.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . 0.464 HD21 HG23 ' A' ' 476' ' ' ILE . 10.8 p30 -105.8 -178.04 3.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.983 171.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -55.35 -27.42 47.12 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -173.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -85.82 7.32 24.33 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.767 0.318 . . . . 0.0 111.406 -170.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . 0.437 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 74.63 10.19 82.77 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.227 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -100.39 154.19 18.71 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 177.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 5.6 p -89.77 130.99 35.95 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.218 0.532 . . . . 0.0 111.221 -178.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 476' ' ' ILE . . . . . 0.657 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.8 pp -92.64 -4.67 10.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.564 0.697 . . . . 0.0 109.686 177.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 23.7 mmm180 -68.64 -43.83 75.46 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.066 175.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -149.24 150.7 33.01 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.693 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 . . . . . 0 C--O 1.247 0.94 0 CA-C-O 118.662 -0.685 . . . . 0.0 110.332 -179.557 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 381' ' ' ARG . . . . . . . . . . . . . 19.7 ptp180 . . . . . 0 N--CA 1.477 0.907 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 382' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -54.06 -44.4 71.08 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 383' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -140.22 119.66 13.09 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 120.94 0.4 . . . . 0.0 111.768 175.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 384' ' ' GLY . . . . . . . . . . . . . . . 162.78 85.05 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 111.43 -0.668 . . . . 0.0 111.43 -178.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 385' ' ' THR . . . . . . . . . . . . . 25.1 m 73.91 123.15 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 122.973 0.509 . . . . 0.0 110.386 -175.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 386' ' ' PHE . . . . . 0.541 ' CD1' HD21 ' B' ' 414' ' ' LEU . 2.1 t80 69.66 111.85 0.03 OUTLIER Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.534 -171.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 387' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -39.86 -62.98 0.31 Allowed 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 124.427 3.418 . . . . 0.0 113.872 -175.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 388' ' ' MET . . . . . 0.481 ' C ' ' HB3' ' B' ' 393' ' ' ASN . 6.3 ttp 59.0 38.52 24.17 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 174.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 389' ' ' HIS . . . . . 0.592 ' N ' ' HB3' ' B' ' 393' ' ' ASN . 31.3 m170 51.71 -97.01 0.05 Allowed 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 121.426 0.631 . . . . 0.0 110.268 -176.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -151.8 23.96 0.67 Allowed 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 171.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 391' ' ' LEU . . . . . 0.455 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.4 pt? -175.75 -47.78 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.357 -172.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 392' ' ' GLY . . . . . 0.504 ' CA ' HD13 ' B' ' 395' ' ' ILE . . . -173.2 56.48 0.15 Allowed Glycine 0 CA--C 1.525 0.685 0 C-N-CA 119.477 -1.344 . . . . 0.0 114.778 -172.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 393' ' ' ASN . . . . . 0.592 ' HB3' ' N ' ' B' ' 389' ' ' HIS . 0.0 OUTLIER -61.8 -37.62 85.06 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-N 117.649 0.725 . . . . 0.0 109.046 174.216 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 394' ' ' VAL . . . . . 0.594 HG23 ' N ' ' B' ' 395' ' ' ILE . 1.0 OUTLIER -57.18 -49.4 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 CA-C-N 113.642 -1.617 . . . . 0.0 107.094 179.02 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 395' ' ' ILE . . . . . 0.594 ' N ' HG23 ' B' ' 394' ' ' VAL . 3.6 mp -57.68 -52.72 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.315 0 CA-C-O 117.842 -1.075 . . . . 0.0 113.625 -174.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 396' ' ' LYS . . . . . 0.644 ' O ' HG22 ' B' ' 399' ' ' VAL . 0.0 OUTLIER -62.57 -49.74 74.07 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 121.991 2.178 . . . . 0.0 112.032 -174.666 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.06 -44.58 62.8 Favored Glycine 0 N--CA 1.435 -1.405 0 C-N-CA 119.979 -1.105 . . . . 0.0 110.933 -176.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . 0.663 ' CD1' HD12 ' B' ' 410' ' ' LEU . 28.5 mt -71.0 -33.84 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -179.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 399' ' ' VAL . . . . . 0.644 HG22 ' O ' ' B' ' 396' ' ' LYS . 17.2 m -63.42 -39.72 86.37 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 C-N-CA 118.753 -1.179 . . . . 0.0 108.483 -174.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -70.51 -37.98 74.24 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 175.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 401' ' ' GLN . . . . . 0.461 HE21 ' HB3' ' B' ' 401' ' ' GLN . 3.3 mm100 -88.09 -48.61 7.61 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -171.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 402' ' ' GLU . . . . . 0.406 ' HB3' ' HB ' ' B' ' 406' ' ' THR . 1.2 tm-20 -118.14 -19.89 8.86 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.216 -170.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 106.26 160.73 22.44 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.549 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 404' ' ' VAL . . . . . 0.631 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.2 m -54.19 -45.41 66.77 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.886 0 N-CA-C 114.568 1.322 . . . . 0.0 114.568 -175.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 405' ' ' ALA . . . . . 0.483 ' HB2' HG23 ' B' ' 457' ' ' ILE . . . -63.2 -31.18 72.26 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 119.819 -0.753 . . . . 0.0 112.43 -177.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 406' ' ' THR . . . . . 0.703 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 92.0 m -76.78 -42.17 41.85 Favored 'General case' 0 C--O 1.221 -0.4 0 O-C-N 121.682 -0.636 . . . . 0.0 110.226 173.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 407' ' ' ALA . . . . . 0.472 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.89 -36.68 75.06 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 122.204 1.002 . . . . 0.0 109.306 176.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 408' ' ' TYR . . . . . 0.631 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -66.5 -51.69 54.01 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 113.474 -1.694 . . . . 0.0 109.576 176.772 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 409' ' ' THR . . . . . 0.516 HG22 HD22 ' B' ' 410' ' ' LEU . 17.3 m -55.18 -47.29 75.42 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.447 178.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 410' ' ' LEU . . . . . 0.703 ' HG ' ' O ' ' B' ' 406' ' ' THR . 15.2 mt -72.65 -35.75 67.83 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -174.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.4 -34.72 76.13 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.196 -1.002 . . . . 0.0 110.951 172.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 412' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -69.56 -47.03 65.01 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-O 120.64 0.257 . . . . 0.0 111.612 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 413' ' ' MET . . . . . 0.93 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.9 OUTLIER -71.43 -45.27 63.1 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 118.848 -1.141 . . . . 0.0 111.792 -179.459 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 414' ' ' LEU . . . . . 0.93 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 11.7 mt -69.87 -46.39 65.6 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -177.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 415' ' ' SER . . . . . 0.453 ' HB2' ' SD ' ' B' ' 388' ' ' MET . 8.4 t -99.74 16.58 23.12 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.388 0.613 . . . . 0.0 110.515 -172.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 416' ' ' GLY . . . . . 0.421 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 75.84 -176.66 50.81 Favored Glycine 0 N--CA 1.436 -1.361 0 C-N-CA 120.359 -0.924 . . . . 0.0 111.699 -179.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -80.66 23.11 0.54 Allowed 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.222 0.534 . . . . 0.0 111.397 -172.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 418' ' ' ASN . . . . . 0.421 ' H ' ' C ' ' B' ' 416' ' ' GLY . 4.6 m-20 -71.59 76.74 0.81 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.47 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 419' ' ' TYR . . . . . 0.492 ' CD1' ' HB3' ' B' ' 453' ' ' ALA . 21.1 p90 -55.65 -38.15 69.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.66 178.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -55.54 -42.91 75.27 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.952 178.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.73 -49.06 64.57 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.354 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 422' ' ' VAL . . . . . 0.469 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.2 OUTLIER -65.78 -39.29 84.37 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.364 -177.872 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 423' ' ' SER . . . . . 0.8 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 61.6 p -67.98 -37.88 82.03 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -178.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.86 -39.14 89.7 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.241 175.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 425' ' ' ILE . . . . . 0.539 HG22 HG23 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -72.35 -52.3 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 120.367 0.127 . . . . 0.0 111.145 -178.037 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 426' ' ' ILE . . . . . 0.548 ' CD1' HG21 ' B' ' 395' ' ' ILE . 1.2 mm -74.79 -23.42 17.68 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.969 0 O-C-N 122.095 -0.378 . . . . 0.0 110.594 -172.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 427' ' ' ARG . . . . . 0.8 ' HB2' ' O ' ' B' ' 423' ' ' SER . 1.5 tmt_? -54.59 -31.63 57.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.176 0.512 . . . . 0.0 111.134 -177.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.58 -12.19 67.36 Favored Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.501 -0.857 . . . . 0.0 111.141 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 429' ' ' TYR . . . . . 0.479 ' HD1' ' CG2' ' B' ' 395' ' ' ILE . 6.1 m-30 -111.77 -2.12 15.39 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.869 0.842 . . . . 0.0 108.797 -174.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 430' ' ' LEU . . . . . 0.546 ' HA ' HG13 ' B' ' 404' ' ' VAL . 0.0 OUTLIER -66.18 139.94 96.68 Favored Pre-proline 0 N--CA 1.442 -0.865 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.407 177.555 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 431' ' ' PRO . . . . . 0.694 ' CD ' HG12 ' B' ' 435' ' ' VAL . 77.2 Cg_exo -38.19 -75.03 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 124.633 3.555 . . . . 0.0 113.985 -173.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 432' ' ' GLY . . . . . 0.487 ' O ' HG11 ' B' ' 435' ' ' VAL . . . -130.1 -161.65 10.51 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 176.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 433' ' ' GLN . . . . . 0.551 ' O ' HG11 ' B' ' 436' ' ' VAL . 19.8 tp60 -71.38 -29.15 64.6 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 118.058 0.929 . . . . 0.0 110.506 176.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -66.74 -39.3 87.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.215 -0.448 . . . . 0.0 112.093 -175.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 435' ' ' VAL . . . . . 0.694 HG12 ' CD ' ' B' ' 431' ' ' PRO . 6.8 p -66.44 -45.21 89.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.117 0.484 . . . . 0.0 110.69 -177.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 436' ' ' VAL . . . . . 0.551 HG11 ' O ' ' B' ' 433' ' ' GLN . 0.2 OUTLIER -66.26 -31.75 55.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.091 177.124 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -68.16 -52.27 36.51 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -177.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 438' ' ' ALA . . . . . 0.685 ' O ' ' HD2' ' B' ' 442' ' ' ARG . . . -57.63 -40.51 79.36 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.139 177.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 439' ' ' LEU . . . . . 0.598 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 1.9 tm? -67.99 -48.22 66.38 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -178.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.97 -34.76 73.71 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.093 175.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 441' ' ' GLN . . . . . 0.509 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 4.5 mm-40 -53.75 -49.66 67.7 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.967 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 442' ' ' ARG . . . . . 0.685 ' HD2' ' O ' ' B' ' 438' ' ' ALA . 0.0 OUTLIER -76.76 -25.45 53.42 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 119.221 -0.992 . . . . 0.0 113.308 174.441 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 443' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 67.4 mt -65.62 -27.41 68.37 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 118.656 0.662 . . . . 0.0 109.806 175.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -61.7 -38.02 86.33 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.954 176.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 34.5 mm-40 -78.74 -27.39 44.78 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.266 -1.334 . . . . 0.0 111.232 178.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 446' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 24.9 101.35 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 41.6 mt -58.09 -33.91 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 121.35 0.595 . . . . 0.0 111.292 -178.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 448' ' ' ASP . . . . . 0.448 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 8.1 m-20 -162.14 -159.62 0.61 Allowed 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -178.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 449' ' ' ASP . . . . . 0.481 ' CG ' ' H ' ' B' ' 450' ' ' GLN . 12.1 p-10 -85.4 -64.87 1.08 Allowed 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 168.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 450' ' ' GLN . . . . . 0.481 ' H ' ' CG ' ' B' ' 449' ' ' ASP . 0.0 OUTLIER -68.41 -26.05 65.35 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 179.128 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 451' ' ' THR . . . . . 0.465 ' HA ' ' HB2' ' B' ' 454' ' ' GLU . 10.0 m -71.58 -23.09 61.67 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.75 -175.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 452' ' ' ARG . . . . . . . . . . . . . 14.5 mtp180 -53.97 -54.0 45.02 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 171.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 453' ' ' ALA . . . . . 0.492 ' HB3' ' CD1' ' B' ' 419' ' ' TYR . . . -58.68 -49.09 78.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.361 -1.291 . . . . 0.0 112.596 174.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 454' ' ' GLU . . . . . 0.465 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 71.1 mm-40 -49.8 -36.93 28.14 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.218 0.533 . . . . 0.0 111.616 -177.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 32.3 p -118.15 15.0 14.08 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.448 -175.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 456' ' ' PHE . . . . . 0.532 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 0.8 OUTLIER -57.53 -47.27 82.44 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.136 0.493 . . . . 0.0 111.66 -171.266 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 457' ' ' ILE . . . . . 0.518 ' CG1' ' HB3' ' B' ' 408' ' ' TYR . 1.9 mp -77.15 -32.4 19.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.029 0.442 . . . . 0.0 110.853 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -57.87 -34.62 69.96 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.779 0.799 . . . . 0.0 109.113 171.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 459' ' ' HIS . . . . . 0.765 ' O ' HG23 ' B' ' 463' ' ' VAL . 64.1 m-70 -74.65 -29.47 61.27 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.55 -1.204 . . . . 0.0 110.748 177.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 460' ' ' LEU . . . . . 0.717 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -73.33 -34.52 65.72 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.91 0.862 . . . . 0.0 108.758 178.59 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 461' ' ' ASN . . . . . 0.447 ' O ' ' HB2' ' B' ' 464' ' ' TYR . 23.5 m-80 -73.26 -37.26 66.36 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.15 176.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 462' ' ' ALA . . . . . 0.597 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -55.66 -36.33 66.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.636 -1.165 . . . . 0.0 109.495 169.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 463' ' ' VAL . . . . . 0.765 HG23 ' O ' ' B' ' 459' ' ' HIS . 75.6 t -62.07 -51.09 76.64 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-N 114.293 -1.321 . . . . 0.0 107.983 176.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 464' ' ' TYR . . . . . 0.593 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 18.6 m-30 -51.47 -28.97 14.75 Favored 'General case' 0 C--N 1.332 -0.167 0 O-C-N 124.496 1.123 . . . . 0.0 110.644 177.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.94 -39.97 19.11 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.719 0.771 . . . . 0.0 109.712 -176.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 466' ' ' ILE . . . . . 0.597 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.6 mt -57.75 -55.7 19.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 114.35 -1.295 . . . . 0.0 112.249 176.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 467' ' ' LEU . . . . . 0.758 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -100.25 -10.58 21.18 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -172.833 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 468' ' ' GLY . . . . . 0.661 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 94.21 32.12 7.62 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 119.308 -1.425 . . . . 0.0 114.313 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 469' ' ' LEU . . . . . 0.758 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 4.3 mt -89.05 159.05 17.76 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 117.814 0.807 . . . . 0.0 110.742 174.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 470' ' ' ASN . . . . . 0.457 HD21 HG23 ' B' ' 476' ' ' ILE . 10.6 p30 -105.88 -178.11 3.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.001 170.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 471' ' ' ALA . . . . . . . . . . . . . . . -55.36 -27.47 47.56 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -173.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -85.67 7.18 24.38 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 122.159 -0.338 . . . . 0.0 111.438 -171.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 473' ' ' GLY . . . . . 0.441 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 74.87 9.96 83.51 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.322 -0.942 . . . . 0.0 111.306 -178.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -100.54 154.41 18.58 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 177.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 6.4 p -89.69 131.06 35.86 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.27 0.557 . . . . 0.0 111.291 -178.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 476' ' ' ILE . . . . . 0.661 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.8 pp -92.62 -4.97 10.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.539 0.685 . . . . 0.0 109.75 177.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 477' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 -68.29 -43.92 76.64 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.06 175.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 478' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -149.28 150.25 32.25 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.743 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 479' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 . . . . . 0 C--O 1.246 0.898 0 CA-C-O 118.587 -0.72 . . . . 0.0 110.342 -179.259 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 . . . . . 0 N--CA 1.479 0.982 0 CA-C-O 120.962 0.41 . . . . 0.0 110.559 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.13 -27.94 6.74 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.914 -0.584 . . . . 0.0 112.16 -176.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' HIS . . . . . 0.446 ' HB2' ' O ' ' A' ' 386' ' ' PHE . 15.1 p80 -159.17 157.94 31.82 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.089 -0.644 . . . . 0.0 111.757 -173.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -103.92 -115.87 4.13 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.099 171.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 34.3 m -66.51 -31.16 71.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.941 0.401 . . . . 0.0 111.51 -178.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' PHE . . . . . 0.686 ' CE2' HG12 ' A' ' 394' ' ' VAL . 1.4 t80 -80.7 120.61 79.56 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.302 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 386' ' ' PHE . 10.0 Cg_endo -48.17 -69.77 0.07 OUTLIER 'Trans proline' 0 N--CA 1.483 0.873 0 C-N-CA 124.722 3.615 . . . . 0.0 115.907 -173.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' MET . . . . . 0.523 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 32.6 mtt 72.73 156.24 0.17 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.379 0.671 . . . . 0.0 111.216 -172.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' HIS . . . . . 0.535 ' CG ' ' HB2' ' A' ' 393' ' ' ASN . 32.7 m170 -54.33 -59.67 4.37 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 175.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -177.55 19.96 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.786 -1.097 . . . . 0.0 108.687 175.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.565 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.3 pt? -170.11 -58.53 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.38 -167.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . 0.565 ' N ' ' HG ' ' A' ' 391' ' ' LEU . . . -172.73 51.31 0.17 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.372 -0.918 . . . . 0.0 113.181 -172.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . 0.535 ' HB2' ' CG ' ' A' ' 389' ' ' HIS . 0.6 OUTLIER -57.01 -38.56 73.27 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.138 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . 0.686 HG12 ' CE2' ' A' ' 386' ' ' PHE . 0.9 OUTLIER -55.88 -46.44 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 179.771 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.532 HG22 HG23 ' A' ' 425' ' ' ILE . 4.2 mp -57.82 -51.98 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 CA-C-O 117.902 -1.046 . . . . 0.0 113.047 -175.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . 0.687 ' HG3' ' CZ ' ' A' ' 429' ' ' TYR . 0.2 OUTLIER -62.49 -49.19 76.37 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 121.563 1.983 . . . . 0.0 111.816 -173.689 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -54.48 -44.87 77.71 Favored Glycine 0 N--CA 1.434 -1.471 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.0 -178.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . 0.58 HD13 ' CD1' ' A' ' 410' ' ' LEU . 45.0 mt -70.9 -33.87 53.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -177.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . 0.521 HG22 ' O ' ' A' ' 396' ' ' LYS . 10.9 m -64.23 -39.42 85.45 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 C-N-CA 118.667 -1.213 . . . . 0.0 108.324 -175.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -70.37 -35.29 73.44 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 175.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . 0.427 HE21 ' HB3' ' A' ' 401' ' ' GLN . 2.7 mm100 -89.42 -47.95 7.66 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -172.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . 0.441 ' HG3' ' HE1' ' B' ' 413' ' ' MET . 3.1 mm-40 -121.0 -21.23 6.58 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.795 -170.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 108.03 162.23 20.99 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.952 -0.642 . . . . 0.0 113.046 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . 0.683 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.5 m -53.75 -42.51 52.21 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.772 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -175.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . 0.508 ' HB1' HG21 ' A' ' 457' ' ' ILE . . . -68.86 -29.86 68.26 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 119.708 -0.797 . . . . 0.0 112.073 -175.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 406' ' ' THR . . . . . 0.688 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 90.6 m -77.76 -42.5 33.87 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.074 173.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.502 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.35 -37.91 76.14 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 122.084 0.945 . . . . 0.0 109.229 176.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 408' ' ' TYR . . . . . 0.683 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.4 -51.79 57.91 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 113.517 -1.674 . . . . 0.0 109.851 176.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 409' ' ' THR . . . . . 0.581 HG22 HD22 ' A' ' 410' ' ' LEU . 12.0 m -54.96 -47.08 75.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.586 178.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . 0.688 ' HG ' ' O ' ' A' ' 406' ' ' THR . 14.5 mt -72.24 -36.67 69.15 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.893 0.377 . . . . 0.0 110.213 -174.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.82 -34.94 80.06 Favored Glycine 0 N--CA 1.438 -1.182 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 172.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 412' ' ' MET . . . . . 0.461 ' HB2' ' O ' ' A' ' 409' ' ' THR . 0.6 OUTLIER -66.06 -46.58 77.25 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 115.61 -0.295 . . . . 0.0 111.5 177.252 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 413' ' ' MET . . . . . 0.78 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.0 OUTLIER -70.33 -55.22 9.69 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 118.788 -1.165 . . . . 0.0 111.94 -179.814 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . 0.78 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 6.9 mt -64.76 -43.71 92.43 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -172.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.424 ' HB2' ' HE2' ' A' ' 388' ' ' MET . 40.8 t -86.05 -20.43 28.8 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.677 0.751 . . . . 0.0 110.032 -177.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . 0.425 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 104.03 -175.65 23.2 Favored Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 -171.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 34.5 mm-40 -79.85 24.2 0.41 Allowed 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.186 0.517 . . . . 0.0 111.748 -171.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 418' ' ' ASN . . . . . 0.425 ' H ' ' C ' ' A' ' 416' ' ' GLY . 60.4 m-80 -71.09 75.04 0.67 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.393 178.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 419' ' ' TYR . . . . . 0.491 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 14.0 p90 -52.22 -37.07 53.97 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.947 175.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . 0.406 ' HG3' ' H ' ' A' ' 421' ' ' LEU . 2.5 pt20 -53.7 -47.18 70.76 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.95 176.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . 0.406 ' H ' ' HG3' ' A' ' 420' ' ' GLN . 0.0 OUTLIER -68.09 -48.58 65.13 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.192 -177.005 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . 0.457 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.3 OUTLIER -66.48 -40.35 86.26 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.345 -176.584 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.761 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 77.2 p -67.33 -37.08 82.73 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 -179.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -68.51 -38.67 86.81 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.249 175.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . 0.532 HG23 HG22 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -73.44 -51.92 23.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.461 0.172 . . . . 0.0 111.235 -178.452 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . 0.41 HD12 HG23 ' A' ' 395' ' ' ILE . 1.2 mm -74.53 -22.45 17.64 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.845 0 C-N-CA 122.614 0.366 . . . . 0.0 110.092 -171.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.761 ' HB2' ' O ' ' A' ' 423' ' ' SER . 0.5 OUTLIER -54.2 -30.78 51.01 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.227 0.537 . . . . 0.0 110.26 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.92 -4.89 78.19 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.808 179.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.687 ' CZ ' ' HG3' ' A' ' 396' ' ' LYS . 23.7 m-85 -119.09 -2.12 10.81 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 121.573 0.701 . . . . 0.0 110.081 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . 0.51 HD12 ' HD2' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -66.29 135.17 94.81 Favored Pre-proline 0 N--CA 1.439 -0.989 0 CA-C-N 114.664 -1.153 . . . . 0.0 108.881 178.84 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . 0.691 ' CD ' HG12 ' A' ' 435' ' ' VAL . 50.6 Cg_exo -36.69 -64.42 0.18 Allowed 'Trans proline' 0 CA--C 1.533 0.442 0 C-N-CA 124.723 3.615 . . . . 0.0 114.247 -172.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . 0.585 ' O ' HG11 ' A' ' 435' ' ' VAL . . . -144.17 -164.96 10.72 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 176.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . 0.522 ' O ' HG13 ' A' ' 436' ' ' VAL . 18.4 tp60 -70.47 -26.93 63.85 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 118.197 0.999 . . . . 0.0 110.347 178.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -67.46 -39.49 85.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.312 -0.404 . . . . 0.0 112.045 -177.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 435' ' ' VAL . . . . . 0.691 HG12 ' CD ' ' A' ' 431' ' ' PRO . 7.0 p -67.96 -44.99 84.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-O 120.953 0.406 . . . . 0.0 110.576 -178.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . 0.535 HG21 ' NE ' ' A' ' 427' ' ' ARG . 0.1 OUTLIER -66.06 -29.31 46.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.343 176.167 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 437' ' ' THR . . . . . 0.422 HG23 ' N ' ' A' ' 438' ' ' ALA . 1.0 OUTLIER -69.35 -52.55 26.13 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.635 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . 0.811 ' O ' ' HG2' ' A' ' 442' ' ' ARG . . . -58.03 -37.99 75.39 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.57 177.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 439' ' ' LEU . . . . . 0.572 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 2.1 tm? -70.16 -47.17 62.78 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -178.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.1 -40.3 76.75 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.21 174.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 441' ' ' GLN . . . . . 0.496 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 11.0 mm-40 -53.51 -49.89 66.58 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 123.751 0.82 . . . . 0.0 110.852 173.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . 0.811 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 1.6 mmp_? -55.89 -39.75 72.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.816 171.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 443' ' ' LEU . . . . . 0.572 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 39.2 mt -72.09 -31.15 65.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.788 0.328 . . . . 0.0 110.862 -178.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -57.25 -38.29 73.6 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.773 0.796 . . . . 0.0 110.081 171.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -76.44 -25.91 54.89 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.528 -1.214 . . . . 0.0 111.96 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 446' ' ' GLU . . . . . 0.472 ' O ' ' HG3' ' A' ' 446' ' ' GLU . 14.5 pt-20 1.92 105.43 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 125.35 1.46 . . . . 0.0 114.393 -178.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 38.4 mt -58.01 -35.54 52.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.877 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . 0.485 ' HB2' ' OG1' ' A' ' 451' ' ' THR . 26.1 m-20 -164.07 -176.55 4.56 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -178.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -66.36 -67.11 0.47 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 173.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.03 -26.88 64.25 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 451' ' ' THR . . . . . 0.485 ' OG1' ' HB2' ' A' ' 448' ' ' ASP . 10.7 m -72.43 -23.81 61.13 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.046 -0.661 . . . . 0.0 110.256 -177.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 19.7 ttm180 -54.62 -53.06 59.71 Favored 'General case' 0 N--CA 1.413 -2.324 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 171.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 453' ' ' ALA . . . . . 0.491 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -58.37 -47.27 84.38 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.673 172.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . 0.459 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 16.5 mm-40 -52.31 -38.5 58.64 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.26 0.552 . . . . 0.0 111.369 -176.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 27.3 p -112.26 12.48 20.31 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.362 -176.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . 0.525 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 1.0 OUTLIER -55.5 -46.93 76.9 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.037 0.446 . . . . 0.0 111.599 -173.052 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . 0.531 ' CG1' ' HB3' ' A' ' 408' ' ' TYR . 2.0 mp -77.77 -34.37 19.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.022 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -57.83 -34.57 69.82 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.946 0.879 . . . . 0.0 109.203 171.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . 0.73 ' O ' HG22 ' A' ' 463' ' ' VAL . 51.3 m-70 -74.0 -28.99 61.73 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.92 176.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . 0.706 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -73.69 -34.54 64.9 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.939 0.875 . . . . 0.0 108.717 179.016 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . 0.429 ' HA ' ' CD2' ' A' ' 464' ' ' TYR . 23.5 m-80 -73.19 -38.33 66.18 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.004 176.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 462' ' ' ALA . . . . . 0.635 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -56.45 -34.91 67.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.723 169.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.73 HG22 ' O ' ' A' ' 459' ' ' HIS . 61.5 t -59.96 -50.97 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 114.611 -1.177 . . . . 0.0 107.845 175.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 464' ' ' TYR . . . . . 0.587 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 17.2 m-30 -53.69 -28.26 32.68 Favored 'General case' 0 C--N 1.333 -0.14 0 O-C-N 124.395 1.06 . . . . 0.0 110.743 178.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.99 -41.34 20.87 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.691 0.758 . . . . 0.0 109.636 -178.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.635 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.5 mt -56.11 -55.35 18.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 114.266 -1.334 . . . . 0.0 112.345 176.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.767 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -102.16 -10.42 19.64 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -173.064 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . 0.561 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 93.86 31.4 8.19 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 119.396 -1.383 . . . . 0.0 114.348 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 469' ' ' LEU . . . . . 0.767 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 4.4 mt -88.59 164.55 15.33 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 118.01 0.905 . . . . 0.0 111.408 177.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 38.5 p30 -105.24 -176.83 3.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.827 170.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 471' ' ' ALA . . . . . 0.491 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -68.17 -13.67 62.4 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -176.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -89.02 -1.19 57.99 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 122.23 -0.294 . . . . 0.0 111.347 -175.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 78.47 12.58 84.12 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.334 -0.936 . . . . 0.0 110.898 -174.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -100.58 151.27 21.79 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 177.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 475' ' ' SER . . . . . 0.5 ' OG ' ' HG3' ' A' ' 477' ' ' ARG . 31.7 t -92.26 136.69 32.98 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.241 0.543 . . . . 0.0 111.023 -177.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 476' ' ' ILE . . . . . 0.686 ' C ' ' HD2' ' A' ' 477' ' ' ARG . 2.3 pp -115.48 -29.67 2.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.087 -178.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 477' ' ' ARG . . . . . 0.686 ' HD2' ' C ' ' A' ' 476' ' ' ILE . 0.2 OUTLIER 17.46 69.88 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 O-C-N 125.164 1.54 . . . . 0.0 114.998 178.258 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 95.9 mt -89.25 40.32 0.98 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.101 -177.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.764 -0.636 . . . . 0.0 109.835 178.653 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 381' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 . . . . . 0 N--CA 1.48 1.051 0 CA-C-O 120.915 0.388 . . . . 0.0 110.414 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 382' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.09 -27.95 6.75 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.21 -176.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 383' ' ' HIS . . . . . 0.447 ' HB2' ' O ' ' B' ' 386' ' ' PHE . 15.4 p80 -159.13 157.76 31.55 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.161 -0.616 . . . . 0.0 111.693 -173.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 384' ' ' GLY . . . . . . . . . . . . . . . -103.79 -115.68 4.11 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.472 -0.87 . . . . 0.0 111.116 171.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 385' ' ' THR . . . . . . . . . . . . . 33.8 m -66.69 -30.81 71.14 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.919 0.39 . . . . 0.0 111.593 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 386' ' ' PHE . . . . . 0.691 ' CE2' HG12 ' B' ' 394' ' ' VAL . 1.4 t80 -81.1 120.72 79.39 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.102 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 387' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -48.19 -69.9 0.07 OUTLIER 'Trans proline' 0 N--CA 1.484 0.921 0 C-N-CA 124.703 3.602 . . . . 0.0 115.872 -173.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 388' ' ' MET . . . . . 0.538 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 32.5 mtt 72.94 156.56 0.17 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.222 0.609 . . . . 0.0 111.162 -172.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 389' ' ' HIS . . . . . 0.547 ' CG ' ' HB2' ' B' ' 393' ' ' ASN . 32.7 m170 -54.58 -59.9 4.08 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 175.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -177.23 19.77 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.649 175.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 391' ' ' LEU . . . . . 0.557 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.3 pt? -169.97 -58.37 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.451 -167.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 392' ' ' GLY . . . . . 0.557 ' N ' ' HG ' ' B' ' 391' ' ' LEU . . . -172.81 51.51 0.17 Allowed Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.302 -0.951 . . . . 0.0 113.026 -172.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 393' ' ' ASN . . . . . 0.547 ' HB2' ' CG ' ' B' ' 389' ' ' HIS . 0.6 OUTLIER -57.01 -38.54 73.24 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.967 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 394' ' ' VAL . . . . . 0.691 HG12 ' CE2' ' B' ' 386' ' ' PHE . 0.9 OUTLIER -56.07 -46.45 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 395' ' ' ILE . . . . . 0.536 HG22 HG23 ' B' ' 425' ' ' ILE . 4.2 mp -57.63 -52.09 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 CA-C-O 117.973 -1.013 . . . . 0.0 113.04 -175.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 396' ' ' LYS . . . . . 0.692 ' HG3' ' CZ ' ' B' ' 429' ' ' TYR . 0.2 OUTLIER -62.49 -49.27 76.06 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 121.482 1.947 . . . . 0.0 111.8 -173.777 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -54.35 -44.89 76.35 Favored Glycine 0 N--CA 1.434 -1.487 0 C-N-CA 120.103 -1.046 . . . . 0.0 111.02 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . 0.573 HD13 ' CD1' ' B' ' 410' ' ' LEU . 45.0 mt -70.94 -33.81 53.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -177.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 399' ' ' VAL . . . . . 0.53 HG22 ' O ' ' B' ' 396' ' ' LYS . 10.8 m -64.22 -39.51 85.75 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 C-N-CA 118.592 -1.243 . . . . 0.0 108.346 -175.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -70.39 -35.26 73.36 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 175.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 401' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -89.43 -47.81 7.75 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -172.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 402' ' ' GLU . . . . . 0.428 ' HG3' ' HE1' ' A' ' 413' ' ' MET . 3.0 mm-40 -121.09 -21.3 6.5 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.771 -170.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 108.02 162.25 21.0 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.954 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 404' ' ' VAL . . . . . 0.683 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.5 m -53.83 -42.56 53.21 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.809 0 N-CA-C 114.698 1.369 . . . . 0.0 114.698 -175.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 405' ' ' ALA . . . . . 0.507 ' HB1' HG21 ' B' ' 457' ' ' ILE . . . -68.82 -29.9 68.34 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 119.77 -0.772 . . . . 0.0 111.991 -175.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 406' ' ' THR . . . . . 0.684 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 92.5 m -77.59 -42.53 34.82 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.161 173.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 407' ' ' ALA . . . . . 0.486 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.3 -37.76 75.7 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 122.182 0.992 . . . . 0.0 109.295 176.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 408' ' ' TYR . . . . . 0.683 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.56 -51.86 56.65 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 113.494 -1.685 . . . . 0.0 109.747 177.12 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 409' ' ' THR . . . . . 0.579 HG22 HD22 ' B' ' 410' ' ' LEU . 10.2 m -54.84 -47.13 74.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.636 178.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 410' ' ' LEU . . . . . 0.684 ' HG ' ' O ' ' B' ' 406' ' ' THR . 14.3 mt -72.05 -36.91 69.73 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.972 0.415 . . . . 0.0 110.263 -174.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.63 -34.87 78.37 Favored Glycine 0 N--CA 1.439 -1.135 0 C-N-CA 120.036 -1.078 . . . . 0.0 110.52 172.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 412' ' ' MET . . . . . 0.464 ' HB2' ' O ' ' B' ' 409' ' ' THR . 0.5 OUTLIER -66.26 -46.47 76.97 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 115.64 -0.28 . . . . 0.0 111.39 177.287 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 413' ' ' MET . . . . . 0.778 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.0 OUTLIER -70.34 -55.02 10.15 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 118.709 -1.197 . . . . 0.0 111.987 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 414' ' ' LEU . . . . . 0.778 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 6.9 mt -64.97 -43.7 91.76 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -172.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 415' ' ' SER . . . . . 0.421 ' HB2' ' HE2' ' B' ' 388' ' ' MET . 43.0 t -86.02 -20.48 28.78 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.79 0.805 . . . . 0.0 109.991 -177.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 416' ' ' GLY . . . . . 0.427 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 104.06 -175.91 23.34 Favored Glycine 0 N--CA 1.43 -1.758 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -171.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 35.4 mm-40 -79.85 24.45 0.39 Allowed 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.22 0.533 . . . . 0.0 111.808 -171.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 418' ' ' ASN . . . . . 0.427 ' H ' ' C ' ' B' ' 416' ' ' GLY . 62.1 m-80 -71.28 74.89 0.72 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.456 178.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 419' ' ' TYR . . . . . 0.487 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 14.4 p90 -52.09 -37.04 52.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.997 175.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -53.67 -47.39 70.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.904 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.98 -48.62 65.3 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.136 -177.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 422' ' ' VAL . . . . . 0.457 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.3 OUTLIER -66.51 -40.26 86.0 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.436 -176.476 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 423' ' ' SER . . . . . 0.763 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 77.7 p -67.39 -36.97 82.39 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 -179.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -68.58 -38.6 86.44 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.292 175.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 425' ' ' ILE . . . . . 0.536 HG23 HG22 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -73.37 -51.72 24.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 O-C-N 122.975 -0.132 . . . . 0.0 111.204 -178.318 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 426' ' ' ILE . . . . . 0.402 HD12 HG23 ' B' ' 395' ' ' ILE . 1.2 mm -74.87 -22.42 17.17 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.873 0 C-N-CA 122.627 0.371 . . . . 0.0 110.019 -171.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 427' ' ' ARG . . . . . 0.763 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.5 OUTLIER -54.26 -30.44 50.47 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.275 0.56 . . . . 0.0 110.294 179.85 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.88 -5.4 77.6 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.809 178.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 429' ' ' TYR . . . . . 0.692 ' CZ ' ' HG3' ' B' ' 396' ' ' LYS . 23.7 m-85 -118.9 -1.72 10.97 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 121.415 0.626 . . . . 0.0 110.152 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 430' ' ' LEU . . . . . 0.497 HD12 ' HD2' ' B' ' 431' ' ' PRO . 0.0 OUTLIER -66.42 135.38 94.72 Favored Pre-proline 0 N--CA 1.439 -0.992 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.855 178.777 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 431' ' ' PRO . . . . . 0.692 ' CD ' HG12 ' B' ' 435' ' ' VAL . 52.5 Cg_exo -36.89 -64.51 0.18 Allowed 'Trans proline' 0 CA--C 1.532 0.391 0 C-N-CA 124.716 3.611 . . . . 0.0 114.209 -172.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 432' ' ' GLY . . . . . 0.567 ' O ' HG11 ' B' ' 435' ' ' VAL . . . -144.09 -164.48 10.45 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 176.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 433' ' ' GLN . . . . . 0.518 ' O ' HG13 ' B' ' 436' ' ' VAL . 17.5 tp60 -70.67 -26.99 63.69 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 118.198 0.999 . . . . 0.0 110.369 178.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -67.64 -39.3 84.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.304 -0.407 . . . . 0.0 112.076 -177.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 435' ' ' VAL . . . . . 0.692 HG12 ' CD ' ' B' ' 431' ' ' PRO . 7.2 p -68.02 -45.08 84.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-O 120.962 0.411 . . . . 0.0 110.562 -178.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 436' ' ' VAL . . . . . 0.539 HG21 ' NE ' ' B' ' 427' ' ' ARG . 0.1 OUTLIER -66.01 -29.15 45.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.465 176.175 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 437' ' ' THR . . . . . 0.417 HG23 ' N ' ' B' ' 438' ' ' ALA . 1.0 OUTLIER -69.53 -52.54 25.44 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.575 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 438' ' ' ALA . . . . . 0.818 ' O ' ' HG2' ' B' ' 442' ' ' ARG . . . -57.94 -37.95 75.04 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.618 177.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 439' ' ' LEU . . . . . 0.587 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 2.1 tm? -70.18 -47.23 62.48 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -178.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.99 -40.37 76.45 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.2 174.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 441' ' ' GLN . . . . . 0.491 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 10.8 mm-40 -53.53 -49.9 66.62 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 123.827 0.851 . . . . 0.0 110.747 174.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 442' ' ' ARG . . . . . 0.818 ' HG2' ' O ' ' B' ' 438' ' ' ALA . 1.5 mmp_? -55.99 -39.66 72.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.754 171.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 443' ' ' LEU . . . . . 0.587 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 39.3 mt -72.08 -31.04 65.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.795 0.331 . . . . 0.0 110.816 -178.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -57.32 -38.43 74.05 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.769 0.795 . . . . 0.0 110.028 171.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -76.49 -25.91 54.75 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.457 -1.247 . . . . 0.0 111.842 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 446' ' ' GLU . . . . . 0.478 ' O ' ' HG3' ' B' ' 446' ' ' GLU . 14.4 pt-20 2.21 105.73 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 125.292 1.437 . . . . 0.0 114.377 -178.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 39.4 mt -58.59 -35.18 53.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.028 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 448' ' ' ASP . . . . . 0.479 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 23.6 m-20 -164.23 -176.52 4.48 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 -178.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -66.72 -66.84 0.5 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 173.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.14 -26.75 64.09 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 179.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 451' ' ' THR . . . . . 0.479 ' OG1' ' HB2' ' B' ' 448' ' ' ASP . 11.3 m -72.42 -23.73 61.12 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.244 -177.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 452' ' ' ARG . . . . . . . . . . . . . 19.6 ttm180 -54.61 -53.17 58.15 Favored 'General case' 0 N--CA 1.412 -2.37 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 171.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 453' ' ' ALA . . . . . 0.487 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -58.47 -47.15 84.98 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.703 172.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 454' ' ' GLU . . . . . 0.46 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 21.9 mm-40 -52.24 -38.69 58.82 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.305 0.574 . . . . 0.0 111.313 -176.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 25.8 p -112.12 12.46 20.52 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.272 -176.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 456' ' ' PHE . . . . . 0.523 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 1.0 OUTLIER -55.57 -46.91 77.13 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.044 0.45 . . . . 0.0 111.615 -172.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 457' ' ' ILE . . . . . 0.543 ' CG1' ' HB3' ' B' ' 408' ' ' TYR . 2.0 mp -77.85 -34.25 19.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.097 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -58.0 -34.39 69.95 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.969 0.89 . . . . 0.0 109.265 171.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 459' ' ' HIS . . . . . 0.725 ' O ' HG22 ' B' ' 463' ' ' VAL . 52.2 m-70 -73.87 -29.24 61.98 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.943 176.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 460' ' ' LEU . . . . . 0.704 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -73.62 -34.58 65.09 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.934 0.873 . . . . 0.0 108.775 179.192 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 461' ' ' ASN . . . . . 0.438 ' HA ' ' CD2' ' B' ' 464' ' ' TYR . 22.4 m-80 -73.2 -38.09 66.24 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.142 176.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 462' ' ' ALA . . . . . 0.617 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -56.6 -35.08 67.83 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.72 169.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 463' ' ' VAL . . . . . 0.725 HG22 ' O ' ' B' ' 459' ' ' HIS . 61.0 t -59.79 -51.11 76.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 175.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 464' ' ' TYR . . . . . 0.574 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 17.4 m-30 -53.48 -28.66 31.98 Favored 'General case' 0 C--O 1.225 -0.2 0 O-C-N 124.322 1.014 . . . . 0.0 110.648 178.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.72 -41.17 21.66 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.572 0.701 . . . . 0.0 109.701 -178.029 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 466' ' ' ILE . . . . . 0.617 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.5 mt -56.2 -55.66 17.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 114.409 -1.269 . . . . 0.0 112.21 176.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 467' ' ' LEU . . . . . 0.775 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -101.88 -10.6 19.71 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -172.941 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 468' ' ' GLY . . . . . 0.561 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 93.99 31.54 8.05 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 119.419 -1.372 . . . . 0.0 114.29 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 469' ' ' LEU . . . . . 0.775 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 4.4 mt -88.62 164.54 15.31 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 118.059 0.929 . . . . 0.0 111.39 177.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 38.2 p30 -105.22 -176.64 3.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.869 170.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 471' ' ' ALA . . . . . 0.495 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -68.47 -13.64 62.45 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -175.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -88.94 -1.58 58.17 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.705 0.288 . . . . 0.0 111.325 -175.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 473' ' ' GLY . . . . . . . . . . . . . . . 78.86 12.63 83.97 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.263 -0.97 . . . . 0.0 110.884 -174.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -100.59 151.61 21.4 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 475' ' ' SER . . . . . 0.524 ' OG ' ' HG3' ' B' ' 477' ' ' ARG . 32.1 t -92.56 136.55 33.12 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.239 0.542 . . . . 0.0 111.023 -177.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 476' ' ' ILE . . . . . 0.689 ' C ' ' HD2' ' B' ' 477' ' ' ARG . 2.3 pp -115.41 -29.88 2.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.115 -178.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 477' ' ' ARG . . . . . 0.689 ' HD2' ' C ' ' B' ' 476' ' ' ILE . 0.2 OUTLIER 17.59 69.45 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 178.288 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 478' ' ' LEU . . . . . . . . . . . . . 95.8 mt -89.03 40.36 0.98 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.058 -177.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 479' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.635 -0.698 . . . . 0.0 109.883 178.634 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 . . . . . 0 N--CA 1.48 1.034 0 CA-C-O 120.681 0.277 . . . . 0.0 110.304 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 382' ' ' THR . . . . . 0.614 ' OG1' ' HA ' ' A' ' 391' ' ' LEU . 2.4 t -109.67 -20.79 12.7 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.768 178.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -159.83 171.47 19.4 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.504 -174.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -118.31 -113.42 2.58 Favored Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.374 172.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 25.4 m -69.42 -41.47 76.3 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.654 0.264 . . . . 0.0 111.456 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 386' ' ' PHE . . . . . 0.56 ' CD1' HD23 ' A' ' 414' ' ' LEU . 3.4 t80 -65.68 125.77 90.39 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.247 179.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -47.06 -70.87 0.06 OUTLIER 'Trans proline' 0 CA--C 1.532 0.407 0 C-N-CA 123.961 3.107 . . . . 0.0 114.091 -174.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 388' ' ' MET . . . . . 0.458 ' HE3' ' HB2' ' A' ' 415' ' ' SER . 40.7 ttm 71.98 155.77 0.16 Allowed 'General case' 0 CA--C 1.547 0.841 0 CA-C-O 121.237 0.542 . . . . 0.0 111.893 175.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 389' ' ' HIS . . . . . 0.591 ' O ' ' HG2' ' A' ' 390' ' ' GLN . 2.7 m170 -76.6 27.72 0.13 Allowed 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.711 0.804 . . . . 0.0 112.917 -171.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . 0.591 ' HG2' ' O ' ' A' ' 389' ' ' HIS . 2.3 pt20 71.2 4.22 4.98 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.562 0.745 . . . . 0.0 109.902 -167.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.614 ' HA ' ' OG1' ' A' ' 382' ' ' THR . 2.1 pt? -164.57 -43.59 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . 0.491 ' CA ' HD12 ' A' ' 395' ' ' ILE . . . -175.89 55.42 0.12 Allowed Glycine 0 C--O 1.223 -0.56 0 C-N-CA 118.088 -2.006 . . . . 0.0 115.88 -176.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . 0.567 ' HB3' ' N ' ' A' ' 389' ' ' HIS . 0.0 OUTLIER -60.89 -36.44 79.23 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 118.095 0.948 . . . . 0.0 108.644 176.294 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . 0.591 HG22 ' N ' ' A' ' 395' ' ' ILE . 1.5 m -58.54 -50.23 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 CA-C-N 113.289 -1.778 . . . . 0.0 107.834 178.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.591 ' N ' HG22 ' A' ' 394' ' ' VAL . 4.0 mp -57.98 -52.5 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 CA-C-O 117.985 -1.007 . . . . 0.0 113.614 -174.018 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . 0.597 ' HG3' ' CZ ' ' A' ' 429' ' ' TYR . 0.0 OUTLIER -64.06 -48.2 77.16 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 121.736 2.062 . . . . 0.0 111.493 -173.82 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -54.0 -45.33 71.94 Favored Glycine 0 N--CA 1.431 -1.636 0 C-N-CA 119.846 -1.169 . . . . 0.0 111.044 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . 0.669 ' CD1' HD12 ' A' ' 410' ' ' LEU . 33.2 mt -70.87 -33.87 53.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -178.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 396' ' ' LYS . 15.3 m -63.75 -39.43 85.34 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 C-N-CA 118.685 -1.206 . . . . 0.0 108.41 -174.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -71.11 -35.24 71.71 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 175.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 -88.69 -48.07 7.8 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -172.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -121.22 -21.36 6.42 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.601 -169.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 108.41 162.61 20.72 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.953 -0.642 . . . . 0.0 113.128 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . 0.68 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.5 m -53.67 -41.86 48.74 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.794 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -176.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . 0.494 ' HB1' HG21 ' A' ' 457' ' ' ILE . . . -68.88 -30.96 69.58 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 119.566 -0.854 . . . . 0.0 111.773 -176.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 406' ' ' THR . . . . . 0.709 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 89.0 m -77.38 -42.56 35.96 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.174 -0.611 . . . . 0.0 110.3 173.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.493 ' HB3' ' HA ' ' A' ' 395' ' ' ILE . . . -58.26 -37.22 74.53 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 122.054 0.931 . . . . 0.0 109.263 176.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 408' ' ' TYR . . . . . 0.68 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.77 -52.12 53.51 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 113.558 -1.655 . . . . 0.0 109.761 176.387 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 409' ' ' THR . . . . . 0.542 HG21 HD23 ' A' ' 410' ' ' LEU . 16.0 m -55.32 -47.37 75.74 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.635 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . 0.709 ' HG ' ' O ' ' A' ' 406' ' ' THR . 14.9 mt -72.65 -36.87 68.08 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -174.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.66 -34.96 78.96 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 119.83 -1.176 . . . . 0.0 110.641 173.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 412' ' ' MET . . . . . 0.405 ' HB2' ' O ' ' A' ' 409' ' ' THR . 0.3 OUTLIER -66.83 -48.67 68.2 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-O 120.597 0.236 . . . . 0.0 111.475 178.033 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 413' ' ' MET . . . . . 0.933 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.8 OUTLIER -71.35 -44.26 65.38 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 119.022 -1.071 . . . . 0.0 112.037 -178.552 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . 0.933 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 17.6 mt -69.02 -45.22 71.04 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -176.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.458 ' HB2' ' HE3' ' A' ' 388' ' ' MET . 45.5 t -86.45 -24.63 25.57 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.819 0.818 . . . . 0.0 110.099 -176.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . 0.433 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 108.93 -174.82 18.81 Favored Glycine 0 N--CA 1.429 -1.779 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -170.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -80.54 23.54 0.51 Allowed 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.244 0.545 . . . . 0.0 111.587 -171.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 418' ' ' ASN . . . . . 0.433 ' H ' ' C ' ' A' ' 416' ' ' GLY . 4.7 m-20 -72.0 75.28 0.92 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.064 179.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 419' ' ' TYR . . . . . 0.511 ' CD1' ' HB1' ' A' ' 453' ' ' ALA . 9.4 p90 -51.1 -39.03 55.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.493 176.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -55.32 -43.99 75.42 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.672 0.272 . . . . 0.0 110.99 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.37 -48.98 63.33 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.073 -178.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . 0.424 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -66.49 -40.67 87.06 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.522 0 C-N-CA 120.409 -0.517 . . . . 0.0 111.299 -177.021 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.783 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 77.6 p -68.09 -36.66 80.16 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -178.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -69.67 -37.95 77.25 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.253 175.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . 0.554 HG21 HG23 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -73.14 -51.92 24.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 O-C-N 122.82 -0.224 . . . . 0.0 111.048 -178.638 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . 0.514 ' O ' HD23 ' A' ' 430' ' ' LEU . 1.2 mm -74.09 -22.68 18.31 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.756 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -172.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.783 ' HB2' ' O ' ' A' ' 423' ' ' SER . 0.8 OUTLIER -54.61 -29.71 52.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.157 0.503 . . . . 0.0 110.484 -179.263 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -88.94 -6.57 71.89 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.693 178.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.597 ' CZ ' ' HG3' ' A' ' 396' ' ' LYS . 22.4 m-85 -117.27 -0.09 12.12 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.095 0.474 . . . . 0.0 110.221 -178.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . 0.538 HD12 ' HD2' ' A' ' 431' ' ' PRO . 0.1 OUTLIER -66.15 129.13 94.19 Favored Pre-proline 0 N--CA 1.441 -0.876 0 CA-C-N 115.353 -0.84 . . . . 0.0 108.857 177.584 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . 0.55 ' HG3' ' O ' ' A' ' 473' ' ' GLY . 73.4 Cg_exo -25.46 -69.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.757 1 C-N-CA 125.318 4.012 . . . . 0.0 114.911 179.68 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . 0.524 ' O ' HG11 ' A' ' 435' ' ' VAL . . . -144.07 -165.8 11.09 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 110.061 -1.215 . . . . 0.0 110.061 177.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . 0.496 ' O ' HG11 ' A' ' 436' ' ' VAL . 15.8 tp60 -69.62 -27.58 65.19 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 118.127 0.964 . . . . 0.0 110.449 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -67.32 -39.78 85.91 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -176.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 435' ' ' VAL . . . . . 0.524 HG11 ' O ' ' A' ' 432' ' ' GLY . 8.8 p -68.49 -44.26 83.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-O 121.107 0.479 . . . . 0.0 110.48 -177.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . 0.501 HG21 ' NE ' ' A' ' 427' ' ' ARG . 0.1 OUTLIER -66.95 -31.46 53.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.399 175.305 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.23 -52.45 40.81 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -178.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . 0.625 ' O ' ' HD2' ' A' ' 442' ' ' ARG . . . -57.74 -40.05 78.74 Favored 'General case' 0 N--CA 1.439 -1.023 0 O-C-N 123.883 0.739 . . . . 0.0 111.992 177.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 439' ' ' LEU . . . . . 0.578 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 2.0 tm? -68.3 -48.74 64.13 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -178.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.27 -34.97 72.9 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.442 -1.254 . . . . 0.0 111.135 175.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 441' ' ' GLN . . . . . 0.513 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 3.8 mm-40 -53.39 -49.88 66.31 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.106 -178.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . 0.685 ' HG3' ' CG ' ' A' ' 459' ' ' HIS . 0.0 OUTLIER -76.18 -25.03 54.78 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 119.361 -0.936 . . . . 0.0 113.248 174.898 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 443' ' ' LEU . . . . . 0.578 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 56.2 mt -65.3 -33.72 76.65 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.421 0.629 . . . . 0.0 109.718 175.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -70.57 -33.88 71.6 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.114 -178.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 445' ' ' GLN . . . . . 0.42 ' HG3' ' N ' ' A' ' 446' ' ' GLU . 0.0 OUTLIER -75.29 -31.15 60.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 114.673 -1.149 . . . . 0.0 108.321 178.43 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 446' ' ' GLU . . . . . 0.42 ' N ' ' HG3' ' A' ' 445' ' ' GLN . 34.9 tt0 48.09 98.47 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 114.812 -1.085 . . . . 0.0 113.2 171.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 60.9 mt -65.82 -35.67 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 121.667 0.746 . . . . 0.0 109.785 176.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . 0.516 ' HB2' ' OG1' ' A' ' 451' ' ' THR . 18.7 m-20 -169.83 -175.94 2.22 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 -177.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -72.16 -67.83 0.51 Allowed 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.6 174.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.46 -25.46 66.73 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 178.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 451' ' ' THR . . . . . 0.516 ' OG1' ' HB2' ' A' ' 448' ' ' ASP . 15.3 m -71.13 -23.02 62.0 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.702 -173.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . 0.505 ' HG3' ' O ' ' A' ' 448' ' ' ASP . 55.7 mtm180 -55.06 -54.15 46.75 Favored 'General case' 0 C--O 1.218 -0.553 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 170.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 453' ' ' ALA . . . . . 0.511 ' HB1' ' CD1' ' A' ' 419' ' ' TYR . . . -56.99 -48.03 79.42 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 124.278 0.986 . . . . 0.0 112.571 174.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . 0.451 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 63.9 mm-40 -51.34 -37.49 48.1 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.312 0.577 . . . . 0.0 111.693 -177.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 24.6 p -119.13 16.28 13.23 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.187 -175.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . 0.493 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.9 OUTLIER -55.19 -47.33 75.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.12 0.486 . . . . 0.0 111.728 -171.58 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . 0.522 ' CG1' ' HB3' ' A' ' 408' ' ' TYR . 1.9 mp -77.11 -34.43 21.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.257 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -57.54 -34.09 68.78 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.891 0.853 . . . . 0.0 109.288 171.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . 0.754 ' O ' HG22 ' A' ' 463' ' ' VAL . 52.8 m-70 -73.76 -29.33 62.15 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.357 -1.292 . . . . 0.0 110.926 176.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . 0.703 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -73.59 -33.96 64.86 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.863 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -73.05 -38.12 66.61 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.345 175.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 462' ' ' ALA . . . . . 0.616 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -55.82 -34.0 64.98 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.691 169.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.754 HG22 ' O ' ' A' ' 459' ' ' HIS . 62.6 t -62.8 -50.22 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 CA-C-N 114.363 -1.289 . . . . 0.0 107.996 177.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 464' ' ' TYR . . . . . 0.539 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 14.8 m-30 -53.8 -27.67 30.65 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.66 178.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.31 -40.83 20.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.635 0.731 . . . . 0.0 109.476 -178.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.616 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.6 mt -57.3 -55.63 19.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 114.174 -1.375 . . . . 0.0 112.196 176.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.757 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -102.51 -10.65 19.16 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -172.517 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 93.9 32.22 7.68 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 119.114 -1.517 . . . . 0.0 114.201 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 469' ' ' LEU . . . . . 0.757 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.5 mt -88.45 162.2 16.61 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 117.889 0.844 . . . . 0.0 111.378 176.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 37.7 p30 -100.72 -177.76 3.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.651 170.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 471' ' ' ALA . . . . . 0.483 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -69.43 -12.4 61.62 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.557 0.576 . . . . 0.0 112.557 -176.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -89.12 2.03 54.74 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.79 0.329 . . . . 0.0 111.219 -175.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . 0.55 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 76.42 12.6 84.15 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -175.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -101.67 150.43 23.12 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 177.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 30.7 t -86.59 138.15 31.93 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.025 -0.67 . . . . 0.0 109.819 175.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 476' ' ' ILE . . . . . 0.66 HD12 ' N ' ' A' ' 477' ' ' ARG . 2.4 pp -103.84 -14.51 8.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.849 178.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 477' ' ' ARG . . . . . 0.66 ' N ' HD12 ' A' ' 476' ' ' ILE . 0.0 OUTLIER 59.23 -81.65 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 114.48 -1.236 . . . . 0.0 111.544 178.187 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 45.7 tp -143.36 83.66 1.79 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 177.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 . . . . . 0 C--O 1.253 1.24 0 CA-C-O 118.608 -0.711 . . . . 0.0 110.371 -177.397 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 381' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 . . . . . 0 N--CA 1.482 1.129 0 N-CA-C 110.197 -0.298 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 382' ' ' THR . . . . . 0.615 ' OG1' ' HA ' ' B' ' 391' ' ' LEU . 2.1 t -110.24 -20.77 12.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.662 178.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 383' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -159.77 171.58 19.25 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.571 -175.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 384' ' ' GLY . . . . . . . . . . . . . . . -118.37 -113.32 2.57 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.406 172.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 385' ' ' THR . . . . . . . . . . . . . 24.7 m -69.51 -41.48 75.97 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.816 0.341 . . . . 0.0 111.516 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 386' ' ' PHE . . . . . 0.561 ' CD1' HD23 ' B' ' 414' ' ' LEU . 3.3 t80 -65.73 125.7 90.3 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.273 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 387' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -46.98 -70.88 0.06 OUTLIER 'Trans proline' 0 N--CA 1.475 0.424 0 C-N-CA 123.914 3.076 . . . . 0.0 114.101 -174.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 388' ' ' MET . . . . . 0.463 ' HE3' ' HB2' ' B' ' 415' ' ' SER . 40.6 ttm 71.95 155.53 0.15 Allowed 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.265 0.555 . . . . 0.0 111.852 175.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 389' ' ' HIS . . . . . 0.589 ' O ' ' HG2' ' B' ' 390' ' ' GLN . 2.6 m170 -76.37 27.83 0.12 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.674 0.79 . . . . 0.0 112.941 -171.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 390' ' ' GLN . . . . . 0.589 ' HG2' ' O ' ' B' ' 389' ' ' HIS . 2.4 pt20 71.31 3.88 4.84 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.509 0.724 . . . . 0.0 109.884 -168.072 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 391' ' ' LEU . . . . . 0.615 ' HA ' ' OG1' ' B' ' 382' ' ' THR . 2.1 pt? -164.31 -43.55 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 392' ' ' GLY . . . . . 0.499 ' CA ' HD12 ' B' ' 395' ' ' ILE . . . -175.81 55.39 0.12 Allowed Glycine 0 C--N 1.336 0.576 0 C-N-CA 118.037 -2.03 . . . . 0.0 115.792 -176.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 393' ' ' ASN . . . . . 0.564 ' HB3' ' N ' ' B' ' 389' ' ' HIS . 0.0 OUTLIER -60.81 -36.6 79.47 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 118.217 1.008 . . . . 0.0 108.586 176.307 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 394' ' ' VAL . . . . . 0.598 HG22 ' N ' ' B' ' 395' ' ' ILE . 1.5 m -58.36 -50.16 79.56 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 CA-C-N 113.306 -1.77 . . . . 0.0 107.904 178.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 395' ' ' ILE . . . . . 0.598 ' N ' HG22 ' B' ' 394' ' ' VAL . 4.0 mp -58.07 -52.58 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 CA-C-O 118.005 -0.998 . . . . 0.0 113.568 -173.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 396' ' ' LYS . . . . . 0.597 ' HG3' ' CZ ' ' B' ' 429' ' ' TYR . 0.0 OUTLIER -63.96 -48.35 76.81 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 121.65 2.023 . . . . 0.0 111.464 -173.8 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.75 -45.31 69.49 Favored Glycine 0 N--CA 1.432 -1.583 0 C-N-CA 119.9 -1.143 . . . . 0.0 110.961 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . 0.668 ' CD1' HD12 ' B' ' 410' ' ' LEU . 33.4 mt -70.93 -33.98 54.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -178.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 399' ' ' VAL . . . . . 0.563 HG23 ' O ' ' B' ' 396' ' ' LYS . 15.3 m -63.73 -39.48 85.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 C-N-CA 118.796 -1.161 . . . . 0.0 108.475 -174.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -70.82 -35.59 72.55 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 175.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 401' ' ' GLN . . . . . 0.412 HE21 ' HB3' ' B' ' 401' ' ' GLN . 3.7 mm100 -88.7 -48.1 7.77 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -172.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 402' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -121.02 -21.48 6.48 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.727 -170.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 108.82 162.89 20.4 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.085 -0.579 . . . . 0.0 113.006 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 404' ' ' VAL . . . . . 0.676 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.5 m -53.76 -41.85 49.55 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.719 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 -176.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 405' ' ' ALA . . . . . 0.517 ' HB1' HG21 ' B' ' 457' ' ' ILE . . . -68.9 -30.7 69.24 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 119.797 -0.761 . . . . 0.0 111.855 -176.038 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 406' ' ' THR . . . . . 0.71 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 90.7 m -77.81 -42.78 32.61 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.068 174.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 407' ' ' ALA . . . . . 0.479 ' HB3' ' HA ' ' B' ' 395' ' ' ILE . . . -58.33 -37.13 74.5 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 122.078 0.942 . . . . 0.0 109.18 176.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 408' ' ' TYR . . . . . 0.676 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -66.0 -52.08 52.52 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 113.595 -1.639 . . . . 0.0 109.725 176.43 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 409' ' ' THR . . . . . 0.541 HG21 HD23 ' B' ' 410' ' ' LEU . 15.9 m -55.33 -47.31 75.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.675 179.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 410' ' ' LEU . . . . . 0.71 ' HG ' ' O ' ' B' ' 406' ' ' THR . 15.0 mt -72.71 -36.82 67.89 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -174.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.67 -34.81 78.43 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 119.868 -1.158 . . . . 0.0 110.629 173.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 412' ' ' MET . . . . . 0.401 ' HB2' ' O ' ' B' ' 409' ' ' THR . 0.3 OUTLIER -67.05 -48.52 68.04 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-O 120.634 0.254 . . . . 0.0 111.387 178.19 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 413' ' ' MET . . . . . 0.925 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.8 OUTLIER -71.47 -44.29 65.02 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 119.009 -1.076 . . . . 0.0 112.16 -178.706 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 414' ' ' LEU . . . . . 0.925 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 17.7 mt -68.93 -45.5 70.65 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -176.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 415' ' ' SER . . . . . 0.463 ' HB2' ' HE3' ' B' ' 388' ' ' MET . 47.0 t -86.05 -24.88 26.18 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.641 0.734 . . . . 0.0 110.004 -176.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 416' ' ' GLY . . . . . 0.421 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 109.17 -174.57 18.37 Favored Glycine 0 N--CA 1.43 -1.734 0 N-CA-C 109.731 -1.347 . . . . 0.0 109.731 -170.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -80.83 23.31 0.55 Allowed 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.287 0.565 . . . . 0.0 111.535 -171.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 418' ' ' ASN . . . . . 0.421 ' H ' ' C ' ' B' ' 416' ' ' GLY . 4.7 m-20 -71.94 75.13 0.9 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.102 179.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 419' ' ' TYR . . . . . 0.517 ' CD1' ' HB1' ' B' ' 453' ' ' ALA . 9.1 p90 -51.04 -38.94 54.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.572 176.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -55.37 -43.95 75.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.737 0.304 . . . . 0.0 111.092 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.29 -48.98 63.53 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.11 -178.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 422' ' ' VAL . . . . . 0.424 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.2 OUTLIER -66.46 -40.84 87.51 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.278 -176.959 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 423' ' ' SER . . . . . 0.782 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 77.3 p -67.97 -36.63 80.37 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -178.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -69.62 -38.22 77.97 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.225 176.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 425' ' ' ILE . . . . . 0.558 HG21 HG23 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -73.02 -51.8 24.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 O-C-N 122.865 -0.197 . . . . 0.0 111.083 -178.52 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 426' ' ' ILE . . . . . 0.503 ' O ' HD23 ' B' ' 430' ' ' LEU . 1.2 mm -74.08 -22.64 18.32 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.796 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -172.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 427' ' ' ARG . . . . . 0.782 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.8 OUTLIER -54.58 -29.85 52.62 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.21 0.529 . . . . 0.0 110.561 -179.251 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -88.58 -7.25 72.22 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.729 178.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 429' ' ' TYR . . . . . 0.597 ' CZ ' ' HG3' ' B' ' 396' ' ' LYS . 22.3 m-85 -116.63 -0.26 12.44 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 121.271 0.557 . . . . 0.0 110.295 -178.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 430' ' ' LEU . . . . . 0.517 HD12 ' HD2' ' B' ' 431' ' ' PRO . 0.1 OUTLIER -66.08 129.04 94.19 Favored Pre-proline 0 N--CA 1.442 -0.842 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.867 177.807 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 431' ' ' PRO . . . . . 0.559 ' HG3' ' O ' ' B' ' 473' ' ' GLY . 75.1 Cg_exo -25.33 -68.86 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 125.283 3.989 . . . . 0.0 114.919 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 432' ' ' GLY . . . . . 0.528 ' O ' HG11 ' B' ' 435' ' ' VAL . . . -144.52 -165.82 11.22 Favored Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 177.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 433' ' ' GLN . . . . . 0.5 ' O ' HG11 ' B' ' 436' ' ' VAL . 15.5 tp60 -69.39 -27.74 65.56 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 118.156 0.978 . . . . 0.0 110.507 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -67.07 -39.89 86.95 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -176.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 435' ' ' VAL . . . . . 0.528 HG11 ' O ' ' B' ' 432' ' ' GLY . 8.8 p -68.66 -44.01 82.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-O 121.013 0.435 . . . . 0.0 110.558 -177.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 436' ' ' VAL . . . . . 0.5 HG11 ' O ' ' B' ' 433' ' ' GLN . 0.1 OUTLIER -66.99 -31.4 53.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.431 175.075 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.23 -52.52 40.05 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -178.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 438' ' ' ALA . . . . . 0.633 ' O ' ' HD2' ' B' ' 442' ' ' ARG . . . -57.9 -39.93 79.1 Favored 'General case' 0 N--CA 1.439 -1.01 0 O-C-N 123.902 0.751 . . . . 0.0 111.969 177.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 439' ' ' LEU . . . . . 0.593 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 2.0 tm? -68.36 -48.73 64.03 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -178.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.22 -35.02 72.89 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.484 -1.234 . . . . 0.0 111.202 175.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 441' ' ' GLN . . . . . 0.507 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 3.8 mm-40 -53.34 -50.04 65.84 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.052 -178.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 442' ' ' ARG . . . . . 0.7 ' HG3' ' CG ' ' B' ' 459' ' ' HIS . 0.0 OUTLIER -75.95 -25.11 55.62 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 119.377 -0.929 . . . . 0.0 113.198 174.892 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 443' ' ' LEU . . . . . 0.593 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 56.5 mt -65.3 -33.84 76.94 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.289 0.566 . . . . 0.0 109.558 175.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -70.37 -34.2 72.32 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.942 -178.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 445' ' ' GLN . . . . . 0.414 ' HG3' ' N ' ' B' ' 446' ' ' GLU . 0.0 OUTLIER -75.1 -31.07 61.06 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.294 178.699 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 446' ' ' GLU . . . . . 0.414 ' N ' ' HG3' ' B' ' 445' ' ' GLN . 34.6 tt0 48.09 98.69 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 114.818 -1.083 . . . . 0.0 113.143 171.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 61.1 mt -65.97 -35.79 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 121.712 0.768 . . . . 0.0 109.811 176.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 448' ' ' ASP . . . . . 0.513 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 17.1 m-20 -169.66 -176.02 2.3 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 -177.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -71.76 -67.77 0.51 Allowed 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.535 173.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.87 -25.34 66.36 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 451' ' ' THR . . . . . 0.513 ' OG1' ' HB2' ' B' ' 448' ' ' ASP . 15.9 m -71.1 -22.92 62.03 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.756 -173.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 452' ' ' ARG . . . . . 0.513 ' HG3' ' O ' ' B' ' 448' ' ' ASP . 55.9 mtm180 -55.21 -54.14 47.16 Favored 'General case' 0 C--O 1.219 -0.525 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 170.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 453' ' ' ALA . . . . . 0.517 ' HB1' ' CD1' ' B' ' 419' ' ' TYR . . . -56.93 -48.14 78.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.576 173.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 454' ' ' GLU . . . . . 0.454 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 65.1 mm-40 -51.18 -37.84 48.85 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.263 0.554 . . . . 0.0 111.572 -177.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 25.2 p -118.81 16.24 13.51 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.335 -175.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 456' ' ' PHE . . . . . 0.498 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 0.9 OUTLIER -55.15 -47.08 75.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.142 0.496 . . . . 0.0 111.747 -171.708 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 457' ' ' ILE . . . . . 0.534 ' CG1' ' HB3' ' B' ' 408' ' ' TYR . 1.9 mp -77.33 -34.3 20.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.198 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -57.68 -34.19 69.15 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.88 0.847 . . . . 0.0 109.234 172.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 459' ' ' HIS . . . . . 0.75 ' O ' HG22 ' B' ' 463' ' ' VAL . 51.5 m-70 -73.61 -29.25 62.27 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.981 176.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 460' ' ' LEU . . . . . 0.699 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -73.64 -33.96 64.75 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.765 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 461' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -72.94 -38.43 66.79 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.195 175.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 462' ' ' ALA . . . . . 0.624 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -55.78 -33.8 64.69 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.76 169.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 463' ' ' VAL . . . . . 0.75 HG22 ' O ' ' B' ' 459' ' ' HIS . 62.9 t -62.91 -50.15 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.008 177.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 464' ' ' TYR . . . . . 0.53 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 15.0 m-30 -53.79 -27.82 31.43 Favored 'General case' 0 C--N 1.332 -0.193 0 O-C-N 124.237 0.961 . . . . 0.0 110.599 178.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.27 -40.86 20.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.693 0.758 . . . . 0.0 109.359 -177.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 466' ' ' ILE . . . . . 0.624 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.6 mt -57.23 -55.6 19.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 114.305 -1.316 . . . . 0.0 112.19 176.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 467' ' ' LEU . . . . . 0.756 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -102.69 -10.63 19.04 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -172.389 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 468' ' ' GLY . . . . . . . . . . . . . . . 93.92 32.24 7.66 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 119.013 -1.565 . . . . 0.0 114.304 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 469' ' ' LEU . . . . . 0.756 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.5 mt -88.58 162.27 16.47 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 117.915 0.857 . . . . 0.0 111.249 177.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 37.6 p30 -100.86 -177.75 3.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.587 170.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 471' ' ' ALA . . . . . 0.485 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -69.81 -11.5 60.9 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -176.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -89.34 1.95 55.07 Favored 'General case' 0 C--N 1.32 -0.682 0 O-C-N 122.262 -0.273 . . . . 0.0 111.213 -176.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 473' ' ' GLY . . . . . 0.559 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 76.43 12.48 84.26 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 -175.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -101.61 150.56 22.97 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 32.3 t -86.81 137.7 32.2 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.147 -0.621 . . . . 0.0 109.893 175.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 476' ' ' ILE . . . . . 0.654 HD12 ' N ' ' B' ' 477' ' ' ARG . 2.4 pp -103.52 -14.51 8.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.923 179.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 477' ' ' ARG . . . . . 0.654 ' N ' HD12 ' B' ' 476' ' ' ILE . 0.0 OUTLIER 59.32 -81.88 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 114.494 -1.23 . . . . 0.0 111.477 178.088 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 478' ' ' LEU . . . . . . . . . . . . . 45.5 tp -143.2 83.34 1.78 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 479' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 . . . . . 0 C--O 1.246 0.88 0 CA-C-O 118.478 -0.772 . . . . 0.0 110.31 -177.646 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 . . . . . 0 N--CA 1.481 1.121 0 CA-C-O 121.18 0.514 . . . . 0.0 111.348 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 1.2 t -77.58 -46.41 22.29 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.536 176.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -86.18 56.27 3.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.296 0.57 . . . . 0.0 110.871 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -99.07 88.75 0.85 Allowed Glycine 0 N--CA 1.442 -0.961 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.762 -178.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 24.4 m 71.57 -60.34 0.52 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.058 0.543 . . . . 0.0 110.971 -178.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 386' ' ' PHE . . . . . 0.496 ' CD1' HD21 ' A' ' 414' ' ' LEU . 2.9 t80 -75.95 126.34 87.04 Favored Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 172.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -43.01 -75.36 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.821 3.014 . . . . 0.0 113.892 -175.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 388' ' ' MET . . . . . 0.527 ' HE2' ' HB2' ' A' ' 415' ' ' SER . 28.5 ttm 67.22 143.43 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.607 0 O-C-N 123.397 0.435 . . . . 0.0 110.305 -178.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 389' ' ' HIS . . . . . 0.619 ' H ' ' HB3' ' A' ' 393' ' ' ASN . 29.3 m170 -54.85 -79.24 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.694 0.759 . . . . 0.0 110.076 -174.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -153.46 19.35 0.55 Allowed 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 170.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.487 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.6 pt? -173.9 -48.54 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.837 -170.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . 0.494 ' CA ' HD11 ' A' ' 395' ' ' ILE . . . -172.48 53.88 0.17 Allowed Glycine 0 C--O 1.223 -0.593 0 C-N-CA 118.81 -1.662 . . . . 0.0 115.305 -171.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . 0.619 ' HB3' ' H ' ' A' ' 389' ' ' HIS . 0.0 OUTLIER -57.34 -38.06 73.51 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 118.361 1.081 . . . . 0.0 108.869 176.273 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . 0.543 HG23 ' N ' ' A' ' 395' ' ' ILE . 1.9 m -58.23 -49.52 81.48 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 CA-C-N 113.189 -1.823 . . . . 0.0 107.77 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.558 HG21 HG22 ' A' ' 425' ' ' ILE . 4.2 mp -58.26 -52.8 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 CA-C-O 117.97 -1.014 . . . . 0.0 113.462 -174.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . 0.622 ' HG3' ' CZ ' ' A' ' 429' ' ' TYR . 0.1 OUTLIER -63.91 -48.93 74.65 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 121.796 2.089 . . . . 0.0 112.024 -172.865 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -54.02 -45.26 72.36 Favored Glycine 0 N--CA 1.438 -1.181 0 C-N-CA 119.88 -1.153 . . . . 0.0 111.238 -178.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . 0.699 ' CD1' HD11 ' A' ' 410' ' ' LEU . 33.6 mt -71.04 -34.56 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -178.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . 0.571 HG22 ' O ' ' A' ' 396' ' ' LYS . 11.7 m -63.68 -39.68 86.25 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 C-N-CA 119.05 -1.06 . . . . 0.0 108.728 -173.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -67.4 -39.9 85.58 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 176.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -93.43 -50.73 5.3 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -170.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -108.87 -20.19 13.14 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.227 0.537 . . . . 0.0 110.461 -172.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 105.44 162.5 23.46 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.548 -0.751 . . . . 0.0 113.159 177.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . 0.63 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.5 m -52.98 -45.59 52.34 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.738 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -175.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . 0.473 ' HB3' HG23 ' A' ' 457' ' ' ILE . . . -64.93 -30.06 71.03 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 119.793 -0.763 . . . . 0.0 112.488 -177.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 406' ' ' THR . . . . . 0.697 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 86.2 m -77.45 -42.42 36.05 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 120.096 -0.642 . . . . 0.0 110.216 173.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.518 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.86 -37.23 76.04 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 122.252 1.025 . . . . 0.0 109.043 177.076 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 408' ' ' TYR . . . . . 0.63 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.31 -52.95 50.64 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 113.364 -1.744 . . . . 0.0 109.889 176.687 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 409' ' ' THR . . . . . 0.537 HG22 HD23 ' A' ' 410' ' ' LEU . 9.0 m -55.58 -47.17 76.88 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.395 -0.821 . . . . 0.0 112.557 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . 0.699 HD11 ' CD1' ' A' ' 398' ' ' ILE . 14.5 mt -72.4 -36.32 68.62 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.055 -175.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -60.0 -35.2 86.48 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 119.973 -1.108 . . . . 0.0 110.789 172.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -67.98 -46.55 71.05 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 115.812 -0.194 . . . . 0.0 111.399 178.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 413' ' ' MET . . . . . 0.891 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.4 OUTLIER -70.62 -48.95 52.49 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 118.834 -1.147 . . . . 0.0 111.821 179.691 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . 0.891 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 16.0 mt -68.38 -46.69 69.35 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -176.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.527 ' HB2' ' HE2' ' A' ' 388' ' ' MET . 14.6 t -92.9 -1.86 56.35 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.297 0.57 . . . . 0.0 110.063 -173.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . 0.444 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 93.1 -177.55 38.27 Favored Glycine 0 N--CA 1.434 -1.485 0 C-N-CA 120.395 -0.907 . . . . 0.0 110.916 -176.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -79.98 23.36 0.46 Allowed 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.126 0.488 . . . . 0.0 111.31 -172.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 418' ' ' ASN . . . . . 0.444 ' H ' ' C ' ' A' ' 416' ' ' GLY . 5.5 m-20 -71.61 76.0 0.81 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.612 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 419' ' ' TYR . . . . . 0.527 ' CD1' ' HB1' ' A' ' 453' ' ' ALA . 11.1 p90 -51.41 -38.55 54.07 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.366 176.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -55.29 -43.79 75.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.671 0.272 . . . . 0.0 110.919 178.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.47 -49.17 61.75 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.949 -177.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . 0.441 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.3 OUTLIER -66.84 -40.36 85.68 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.214 -176.954 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.732 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 79.2 p -66.98 -38.91 86.92 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.38 -39.5 91.62 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.255 176.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . 0.558 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -73.06 -50.82 29.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 121.223 -0.191 . . . . 0.0 111.032 -177.234 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . 0.539 ' O ' HD21 ' A' ' 430' ' ' LEU . 1.2 mm -74.96 -22.52 17.07 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.823 0 CA-C-O 120.886 0.374 . . . . 0.0 110.27 -172.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.732 ' HB2' ' O ' ' A' ' 423' ' ' SER . 0.8 OUTLIER -55.02 -30.13 58.88 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.217 0.532 . . . . 0.0 110.64 -179.008 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.74 -6.06 77.08 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.638 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.622 ' CZ ' ' HG3' ' A' ' 396' ' ' LYS . 22.9 m-85 -118.23 0.54 11.75 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 120.977 0.418 . . . . 0.0 110.665 -177.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . 0.539 HD21 ' O ' ' A' ' 426' ' ' ILE . 0.1 OUTLIER -65.71 128.2 93.63 Favored Pre-proline 0 N--CA 1.441 -0.907 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 179.032 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . 0.505 ' HD2' HD13 ' A' ' 430' ' ' LEU . 80.8 Cg_exo -23.87 -69.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.905 1 C-N-CA 125.514 4.143 . . . . 0.0 114.857 179.887 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . 0.506 ' O ' HG11 ' A' ' 435' ' ' VAL . . . -138.8 -166.9 10.78 Favored Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 174.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . 0.54 ' O ' HG13 ' A' ' 436' ' ' VAL . 50.3 tp60 -70.8 -26.88 63.52 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 118.241 1.021 . . . . 0.0 110.457 177.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -64.75 -39.51 93.75 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -177.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 435' ' ' VAL . . . . . 0.506 HG11 ' O ' ' A' ' 432' ' ' GLY . 7.5 p -68.72 -43.94 82.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-O 120.968 0.413 . . . . 0.0 110.501 -178.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . 0.54 HG13 ' O ' ' A' ' 433' ' ' GLN . 0.1 OUTLIER -67.15 -30.29 48.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.668 175.579 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 437' ' ' THR . . . . . 0.422 HG21 ' N ' ' A' ' 438' ' ' ALA . 0.9 OUTLIER -67.48 -51.91 45.6 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.936 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . 0.763 ' O ' ' HG2' ' A' ' 442' ' ' ARG . . . -57.0 -43.93 82.27 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.003 177.094 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 439' ' ' LEU . . . . . 0.619 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 2.1 tm? -64.69 -47.64 77.64 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 -176.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.86 -39.7 78.4 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.81 -1.086 . . . . 0.0 111.362 175.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 441' ' ' GLN . . . . . 0.581 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 9.2 mm-40 -55.59 -51.25 67.76 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 123.473 0.709 . . . . 0.0 110.83 175.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . 0.763 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -58.13 -33.81 69.55 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.798 173.174 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 443' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 57.1 mt -72.25 -36.6 69.1 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-O 120.865 0.364 . . . . 0.0 110.227 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -57.49 -37.58 73.18 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.607 0.717 . . . . 0.0 110.67 174.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -73.2 -26.77 61.29 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.238 177.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 446' ' ' GLU . . . . . 0.462 ' HB3' ' O ' ' A' ' 443' ' ' LEU . 7.4 pt-20 23.7 103.13 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 173.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 60.3 mt -62.21 -34.1 62.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.577 0.703 . . . . 0.0 110.13 176.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . 0.497 ' HB2' ' OG1' ' A' ' 451' ' ' THR . 17.8 m-20 -162.8 -159.43 0.56 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -84.45 -66.35 0.9 Allowed 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 171.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 450' ' ' GLN . . . . . 0.416 ' O ' ' HB3' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -70.91 -25.54 62.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.855 0.359 . . . . 0.0 111.895 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 451' ' ' THR . . . . . 0.497 ' OG1' ' HB2' ' A' ' 448' ' ' ASP . 12.4 m -67.4 -22.54 65.54 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 122.037 -0.414 . . . . 0.0 110.679 -178.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 66.4 mtm180 -54.99 -51.37 66.45 Favored 'General case' 0 C--O 1.216 -0.66 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 170.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 453' ' ' ALA . . . . . 0.527 ' HB1' ' CD1' ' A' ' 419' ' ' TYR . . . -53.41 -52.24 60.01 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 124.352 1.033 . . . . 0.0 112.293 173.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . 0.456 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 23.6 mm-40 -51.15 -32.44 23.11 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.255 0.55 . . . . 0.0 111.987 -178.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 28.7 p -119.69 14.36 12.6 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.972 -175.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . 0.513 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.8 OUTLIER -58.37 -47.57 83.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.383 -170.995 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . 0.509 ' CG1' ' HB3' ' A' ' 408' ' ' TYR . 1.9 mp -77.21 -31.42 18.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.08 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -56.47 -39.01 72.48 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 122.025 0.917 . . . . 0.0 108.689 170.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . 0.745 ' O ' HG23 ' A' ' 463' ' ' VAL . 50.3 m-70 -73.22 -28.07 61.97 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 114.179 -1.373 . . . . 0.0 110.381 -178.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . 0.727 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -74.46 -35.11 63.31 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.864 0.84 . . . . 0.0 108.886 178.391 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . 0.418 ' O ' ' HB2' ' A' ' 464' ' ' TYR . 23.6 m-80 -73.44 -37.67 65.77 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.92 0.866 . . . . 0.0 109.0 176.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 462' ' ' ALA . . . . . 0.631 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -56.61 -33.32 66.14 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.402 -1.272 . . . . 0.0 109.788 169.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.745 HG23 ' O ' ' A' ' 459' ' ' HIS . 63.2 t -62.19 -50.68 79.0 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.751 0 CA-C-N 114.555 -1.202 . . . . 0.0 107.804 175.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 464' ' ' TYR . . . . . 0.566 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 18.2 m-30 -53.27 -28.2 26.58 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 124.478 1.111 . . . . 0.0 110.38 178.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.63 -40.89 20.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.583 0.706 . . . . 0.0 109.676 -177.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.631 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.4 mt -56.61 -55.52 19.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.336 -1.302 . . . . 0.0 112.294 176.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.759 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -102.66 -10.01 19.59 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -171.985 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 93.57 32.31 7.76 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 119.242 -1.456 . . . . 0.0 114.237 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 469' ' ' LEU . . . . . 0.759 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.3 mt -88.67 165.64 14.63 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 117.862 0.831 . . . . 0.0 111.351 176.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 45.1 p30 -104.05 -178.77 3.75 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.559 170.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 471' ' ' ALA . . . . . 0.527 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -62.1 -21.58 65.1 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -177.229 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -88.17 5.33 41.93 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.418 -172.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . 0.453 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 74.92 15.38 81.01 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.346 -0.93 . . . . 0.0 111.047 -177.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -101.08 152.13 20.98 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 11.0 p -89.53 130.93 35.78 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.923 0.392 . . . . 0.0 110.978 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 476' ' ' ILE . . . . . 0.76 HD11 ' N ' ' A' ' 477' ' ' ARG . 2.6 pp -112.16 -27.47 2.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.309 -178.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 477' ' ' ARG . . . . . 0.76 ' N ' HD11 ' A' ' 476' ' ' ILE . 0.0 OUTLIER 61.0 -76.75 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.966 0.907 . . . . 0.0 111.853 -179.69 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -102.56 110.15 22.0 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.769 -0.634 . . . . 0.0 110.354 -179.994 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 381' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 . . . . . 0 N--CA 1.482 1.148 0 CA-C-O 121.163 0.506 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 382' ' ' THR . . . . . . . . . . . . . 1.2 t -77.34 -46.13 23.88 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.581 176.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 383' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -86.49 56.07 3.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.361 0.6 . . . . 0.0 110.791 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 384' ' ' GLY . . . . . . . . . . . . . . . -99.1 89.09 0.87 Allowed Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.789 -178.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 385' ' ' THR . . . . . . . . . . . . . 23.9 m 71.38 -60.48 0.51 Allowed 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.004 0.522 . . . . 0.0 110.923 -178.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 386' ' ' PHE . . . . . 0.503 ' CD1' HD21 ' B' ' 414' ' ' LEU . 3.0 t80 -76.01 126.4 86.89 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 172.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 387' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -43.08 -75.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.786 2.99 . . . . 0.0 113.892 -175.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 388' ' ' MET . . . . . 0.531 ' HE2' ' HB2' ' B' ' 415' ' ' SER . 28.4 ttm 67.2 143.76 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.652 0 O-C-N 123.497 0.498 . . . . 0.0 110.155 -178.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 389' ' ' HIS . . . . . 0.622 ' H ' ' HB3' ' B' ' 393' ' ' ASN . 29.5 m170 -55.15 -79.15 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.542 0.687 . . . . 0.0 110.113 -174.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -153.27 19.33 0.56 Allowed 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 170.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 391' ' ' LEU . . . . . 0.485 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.5 pt? -173.86 -48.61 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.868 -170.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 392' ' ' GLY . . . . . 0.498 ' CA ' HD11 ' B' ' 395' ' ' ILE . . . -172.6 53.91 0.17 Allowed Glycine 0 CA--C 1.524 0.621 0 C-N-CA 118.796 -1.668 . . . . 0.0 115.215 -171.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 393' ' ' ASN . . . . . 0.622 ' HB3' ' H ' ' B' ' 389' ' ' HIS . 0.0 OUTLIER -57.29 -38.08 73.43 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 118.295 1.047 . . . . 0.0 108.865 176.228 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 394' ' ' VAL . . . . . 0.544 HG22 HD11 ' B' ' 398' ' ' ILE . 1.8 m -58.27 -49.39 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 CA-C-N 113.213 -1.812 . . . . 0.0 107.791 179.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 395' ' ' ILE . . . . . 0.556 HG21 HG22 ' B' ' 425' ' ' ILE . 4.2 mp -58.26 -52.91 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-O 117.849 -1.072 . . . . 0.0 113.441 -174.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 396' ' ' LYS . . . . . 0.619 ' HG3' ' CZ ' ' B' ' 429' ' ' TYR . 0.1 OUTLIER -63.96 -49.18 73.57 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 121.832 2.106 . . . . 0.0 111.93 -172.802 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.79 -45.15 70.22 Favored Glycine 0 N--CA 1.438 -1.193 0 C-N-CA 119.86 -1.162 . . . . 0.0 111.279 -178.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . 0.692 ' CD1' HD11 ' B' ' 410' ' ' LEU . 32.8 mt -71.07 -34.38 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -178.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 399' ' ' VAL . . . . . 0.576 HG22 ' O ' ' B' ' 396' ' ' LYS . 11.5 m -63.77 -39.93 87.18 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 C-N-CA 118.898 -1.121 . . . . 0.0 108.748 -173.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -67.34 -39.68 85.81 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 176.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 401' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -93.67 -50.69 5.27 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 -170.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 402' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -108.72 -20.31 13.12 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.191 0.519 . . . . 0.0 110.392 -173.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 105.29 162.65 23.62 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.663 -0.699 . . . . 0.0 113.25 177.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 404' ' ' VAL . . . . . 0.617 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.5 m -53.18 -45.36 54.48 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.792 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 -175.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 405' ' ' ALA . . . . . 0.472 ' HB3' HG23 ' B' ' 457' ' ' ILE . . . -65.21 -29.86 70.7 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 119.761 -0.775 . . . . 0.0 112.457 -177.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 406' ' ' THR . . . . . 0.697 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 85.6 m -77.46 -42.55 35.51 Favored 'General case' 0 C--O 1.222 -0.368 0 C-N-CA 120.191 -0.604 . . . . 0.0 110.238 173.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 407' ' ' ALA . . . . . 0.513 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.9 -37.11 75.86 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 122.128 0.966 . . . . 0.0 109.005 177.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 408' ' ' TYR . . . . . 0.617 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.44 -52.95 49.5 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 113.394 -1.73 . . . . 0.0 109.863 176.708 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 409' ' ' THR . . . . . 0.539 HG22 HD23 ' B' ' 410' ' ' LEU . 9.9 m -55.61 -47.08 77.13 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.51 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 410' ' ' LEU . . . . . 0.697 ' HG ' ' O ' ' B' ' 406' ' ' THR . 14.4 mt -72.42 -36.33 68.58 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.045 -175.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -59.84 -35.27 86.07 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 119.854 -1.165 . . . . 0.0 110.803 172.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 412' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -68.1 -46.48 70.85 Favored 'General case' 0 C--O 1.224 -0.289 0 CA-C-O 120.486 0.184 . . . . 0.0 111.414 178.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 413' ' ' MET . . . . . 0.882 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.4 OUTLIER -70.82 -48.25 55.08 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 118.847 -1.141 . . . . 0.0 112.038 179.662 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 414' ' ' LEU . . . . . 0.882 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 15.9 mt -68.92 -46.65 67.74 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -176.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 415' ' ' SER . . . . . 0.531 ' HB2' ' HE2' ' B' ' 388' ' ' MET . 13.9 t -93.09 -1.77 56.15 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.296 0.57 . . . . 0.0 110.091 -173.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 416' ' ' GLY . . . . . 0.435 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 93.07 -177.46 38.24 Favored Glycine 0 N--CA 1.435 -1.388 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -176.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -79.95 23.42 0.45 Allowed 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.169 0.509 . . . . 0.0 111.314 -172.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 418' ' ' ASN . . . . . 0.435 ' H ' ' C ' ' B' ' 416' ' ' GLY . 5.4 m-20 -71.6 75.87 0.81 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.567 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 419' ' ' TYR . . . . . 0.532 ' CD1' ' HB1' ' B' ' 453' ' ' ALA . 10.9 p90 -51.36 -38.52 53.66 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.387 176.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -55.23 -43.88 74.94 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.753 0.311 . . . . 0.0 110.966 177.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.56 -49.0 62.8 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.852 -177.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 422' ' ' VAL . . . . . 0.444 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.3 OUTLIER -66.8 -40.49 86.03 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.26 -177.069 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 423' ' ' SER . . . . . 0.764 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 79.5 p -66.95 -38.99 87.15 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.47 -39.16 91.28 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.186 176.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 425' ' ' ILE . . . . . 0.556 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -73.08 -51.37 26.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.593 0.196 . . . . 0.0 111.025 -177.445 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 426' ' ' ILE . . . . . 0.529 ' O ' HD21 ' B' ' 430' ' ' LEU . 1.1 mm -74.6 -22.51 17.56 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.808 0 CA-C-O 120.863 0.363 . . . . 0.0 110.242 -172.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 427' ' ' ARG . . . . . 0.764 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.8 OUTLIER -54.98 -30.34 58.95 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.242 0.544 . . . . 0.0 110.586 -178.893 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.57 -6.17 77.54 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.481 178.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 429' ' ' TYR . . . . . 0.619 ' CZ ' ' HG3' ' B' ' 396' ' ' LYS . 22.9 m-85 -118.17 0.75 11.83 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 120.996 0.427 . . . . 0.0 110.534 -177.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 430' ' ' LEU . . . . . 0.533 ' HA ' HG13 ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.72 128.18 93.62 Favored Pre-proline 0 N--CA 1.442 -0.861 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.929 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 431' ' ' PRO . . . . . 0.504 ' HD2' HD13 ' B' ' 430' ' ' LEU . 80.4 Cg_exo -23.67 -70.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 0.988 1 C-N-CA 125.478 4.119 . . . . 0.0 114.673 179.769 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 432' ' ' GLY . . . . . 0.498 ' O ' HG11 ' B' ' 435' ' ' VAL . . . -138.25 -166.38 10.65 Favored Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 175.11 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 433' ' ' GLN . . . . . 0.547 ' O ' HG13 ' B' ' 436' ' ' VAL . 50.1 tp60 -71.08 -26.85 63.24 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 118.352 1.076 . . . . 0.0 110.46 177.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -64.7 -39.7 94.1 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -177.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 435' ' ' VAL . . . . . 0.498 HG11 ' O ' ' B' ' 432' ' ' GLY . 7.6 p -68.66 -43.82 82.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 120.938 0.399 . . . . 0.0 110.543 -178.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 436' ' ' VAL . . . . . 0.547 HG13 ' O ' ' B' ' 433' ' ' GLN . 0.1 OUTLIER -67.48 -30.1 47.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.766 0.317 . . . . 0.0 110.56 175.669 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 437' ' ' THR . . . . . 0.428 HG21 ' N ' ' B' ' 438' ' ' ALA . 0.9 OUTLIER -67.47 -51.91 45.71 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 179.909 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 438' ' ' ALA . . . . . 0.758 ' O ' ' HG2' ' B' ' 442' ' ' ARG . . . -57.1 -43.96 82.73 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 124.089 0.868 . . . . 0.0 111.087 177.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 439' ' ' LEU . . . . . 0.623 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 2.1 tm? -64.77 -47.47 78.06 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -176.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.06 -39.52 78.7 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.293 175.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 441' ' ' GLN . . . . . 0.585 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 9.2 mm-40 -55.77 -51.31 67.87 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 123.447 0.699 . . . . 0.0 110.813 175.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 442' ' ' ARG . . . . . 0.758 ' HG2' ' O ' ' B' ' 438' ' ' ALA . 0.0 OUTLIER -58.08 -33.75 69.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.739 173.207 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 443' ' ' LEU . . . . . 0.623 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 56.6 mt -72.38 -36.2 68.65 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-O 120.927 0.394 . . . . 0.0 110.247 179.079 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -57.68 -37.76 74.0 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.642 174.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -72.99 -26.8 61.47 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.911 -1.04 . . . . 0.0 111.036 178.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 446' ' ' GLU . . . . . 0.456 ' HB3' ' O ' ' B' ' 443' ' ' LEU . 7.5 pt-20 23.79 103.31 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 174.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 60.7 mt -62.33 -34.17 62.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.556 0.693 . . . . 0.0 110.091 175.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 448' ' ' ASP . . . . . 0.491 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 15.9 m-20 -162.76 -159.31 0.55 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -84.5 -66.21 0.92 Allowed 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.588 -0.445 . . . . 0.0 109.852 171.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 450' ' ' GLN . . . . . 0.428 ' O ' ' HB3' ' B' ' 453' ' ' ALA . 0.0 OUTLIER -70.94 -25.67 62.84 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.828 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 451' ' ' THR . . . . . 0.491 ' OG1' ' HB2' ' B' ' 448' ' ' ASP . 12.2 m -67.3 -22.66 65.62 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.71 -178.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 452' ' ' ARG . . . . . . . . . . . . . 66.0 mtm180 -54.87 -51.54 65.6 Favored 'General case' 0 C--O 1.216 -0.687 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 170.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 453' ' ' ALA . . . . . 0.532 ' HB1' ' CD1' ' B' ' 419' ' ' TYR . . . -53.24 -51.94 60.58 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.338 173.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 454' ' ' GLU . . . . . 0.456 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 24.0 mm-40 -51.59 -32.19 27.72 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.128 -178.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 29.6 p -119.84 14.36 12.47 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.985 -175.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 456' ' ' PHE . . . . . 0.516 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 0.8 OUTLIER -58.26 -47.74 82.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.348 -170.98 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 457' ' ' ILE . . . . . 0.524 ' CG1' ' HB3' ' B' ' 408' ' ' TYR . 1.9 mp -77.04 -31.11 18.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.108 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -56.66 -39.16 73.25 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 170.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 459' ' ' HIS . . . . . 0.742 ' O ' HG23 ' B' ' 463' ' ' VAL . 49.5 m-70 -73.21 -27.99 61.92 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.126 -1.397 . . . . 0.0 110.4 -178.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 460' ' ' LEU . . . . . 0.722 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -74.54 -35.06 63.12 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.957 0.884 . . . . 0.0 108.975 178.163 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 461' ' ' ASN . . . . . 0.405 ' O ' ' HB2' ' B' ' 464' ' ' TYR . 23.7 m-80 -73.33 -37.63 66.05 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.886 0.85 . . . . 0.0 109.1 176.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 462' ' ' ALA . . . . . 0.641 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -56.73 -33.25 66.34 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.326 -1.306 . . . . 0.0 109.839 169.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 463' ' ' VAL . . . . . 0.742 HG23 ' O ' ' B' ' 459' ' ' HIS . 63.9 t -62.32 -50.79 78.5 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.799 0 CA-C-N 114.545 -1.207 . . . . 0.0 107.781 175.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 464' ' ' TYR . . . . . 0.56 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 18.1 m-30 -53.12 -28.18 24.36 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.53 178.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.66 -41.2 19.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.594 0.711 . . . . 0.0 109.587 -177.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 466' ' ' ILE . . . . . 0.641 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.5 mt -56.29 -55.66 17.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 114.396 -1.275 . . . . 0.0 112.399 176.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 467' ' ' LEU . . . . . 0.756 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -102.23 -10.39 19.61 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -172.248 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 468' ' ' GLY . . . . . . . . . . . . . . . 93.75 32.45 7.6 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 119.209 -1.472 . . . . 0.0 114.236 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 469' ' ' LEU . . . . . 0.756 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.3 mt -88.69 165.53 14.69 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 117.929 0.864 . . . . 0.0 111.243 176.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 45.6 p30 -103.9 -178.41 3.65 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.589 170.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 471' ' ' ALA . . . . . 0.522 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -62.66 -21.52 65.77 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -176.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -87.98 5.22 41.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.414 -172.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 473' ' ' GLY . . . . . 0.459 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 75.08 15.2 81.23 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.275 -0.964 . . . . 0.0 111.119 -177.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -101.07 151.97 21.17 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 10.3 p -89.48 131.1 35.69 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.05 0.452 . . . . 0.0 110.982 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 476' ' ' ILE . . . . . 0.764 HD11 ' N ' ' B' ' 477' ' ' ARG . 2.6 pp -112.45 -27.2 2.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.263 -178.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 477' ' ' ARG . . . . . 0.764 ' N ' HD11 ' B' ' 476' ' ' ILE . 0.0 OUTLIER 60.8 -76.6 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.011 0.925 . . . . 0.0 111.829 -179.768 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 478' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -102.98 109.97 21.71 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 479' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.78 -0.628 . . . . 0.0 110.096 179.613 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 381' ' ' ARG . . . . . 0.457 ' HD2' ' OD1' ' A' ' 418' ' ' ASN . 19.9 ptp180 . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -151.1 -59.77 0.17 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.322 177.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 383' ' ' HIS . . . . . 0.698 ' HB2' ' O ' ' A' ' 386' ' ' PHE . 5.4 p80 -124.82 138.55 54.26 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.372 -0.531 . . . . 0.0 112.215 -170.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -114.68 -68.01 0.46 Allowed Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.015 176.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 7.3 m -97.41 -34.47 11.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.004 0.431 . . . . 0.0 110.873 178.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 386' ' ' PHE . . . . . 0.734 ' CE2' HG12 ' A' ' 394' ' ' VAL . 2.6 t80 -92.48 123.68 61.38 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.414 -177.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -64.69 105.8 0.68 Allowed 'Trans proline' 0 N--CA 1.478 0.571 0 C-N-CA 123.788 2.992 . . . . 0.0 112.176 173.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 388' ' ' MET . . . . . 0.55 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 5.2 ttp -122.01 55.26 1.13 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.29 0.567 . . . . 0.0 111.289 -168.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 389' ' ' HIS . . . . . 0.564 ' CE1' ' HA ' ' A' ' 393' ' ' ASN . 39.2 m170 52.93 -98.9 0.08 Allowed 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.026 -172.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -148.55 17.12 1.02 Allowed 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 171.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.596 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.5 pt? -167.3 -62.54 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.84 -171.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . 0.596 ' N ' ' HG ' ' A' ' 391' ' ' LEU . . . -163.14 60.03 0.27 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 119.914 -1.136 . . . . 0.0 114.396 -172.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . 0.564 ' HA ' ' CE1' ' A' ' 389' ' ' HIS . 0.2 OUTLIER -57.48 -43.39 84.07 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.996 0.427 . . . . 0.0 109.861 174.192 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . 0.734 HG12 ' CE2' ' A' ' 386' ' ' PHE . 2.0 m -55.71 -45.91 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 -179.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.579 ' N ' HG23 ' A' ' 394' ' ' VAL . 3.7 mp -58.02 -52.72 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 CA-C-O 117.812 -1.09 . . . . 0.0 113.53 -174.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . 0.6 ' O ' HG22 ' A' ' 399' ' ' VAL . 0.0 OUTLIER -62.79 -49.62 74.25 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 121.952 2.16 . . . . 0.0 112.186 -174.756 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . 0.536 ' O ' ' HG3' ' A' ' 401' ' ' GLN . . . -53.1 -44.44 63.13 Favored Glycine 0 N--CA 1.433 -1.54 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.84 -176.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . 0.644 ' CD1' HD12 ' A' ' 410' ' ' LEU . 39.1 mt -71.52 -33.81 50.78 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -179.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . 0.6 HG22 ' O ' ' A' ' 396' ' ' LYS . 13.8 m -63.72 -39.88 86.99 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 C-N-CA 118.727 -1.189 . . . . 0.0 108.252 -174.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -63.58 -42.96 98.27 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 174.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . 0.536 ' HG3' ' O ' ' A' ' 397' ' ' GLY . 36.4 mt-30 -92.68 -48.17 6.72 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -169.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . 0.403 ' HB3' ' HB ' ' A' ' 406' ' ' THR . 2.8 mm-40 -114.38 -19.31 11.28 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.149 0.499 . . . . 0.0 111.494 -171.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 104.15 162.78 24.68 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.886 177.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . 0.635 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.7 m -53.72 -45.46 61.12 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.83 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -175.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . 0.473 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -64.87 -31.18 72.29 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 119.787 -0.765 . . . . 0.0 112.328 -176.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 406' ' ' THR . . . . . 0.678 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 85.5 m -76.75 -42.78 39.79 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.101 -0.639 . . . . 0.0 110.365 173.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.514 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.67 -36.4 74.12 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 122.016 0.912 . . . . 0.0 109.195 176.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 408' ' ' TYR . . . . . 0.635 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.83 -52.16 52.87 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 113.649 -1.614 . . . . 0.0 109.771 176.285 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 409' ' ' THR . . . . . 0.547 HG21 HD21 ' A' ' 410' ' ' LEU . 17.6 m -54.67 -47.62 73.38 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.562 178.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . 0.678 ' HG ' ' O ' ' A' ' 406' ' ' THR . 13.6 mt -72.84 -35.99 67.37 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.123 -174.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -59.41 -34.77 82.35 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 119.966 -1.111 . . . . 0.0 110.592 173.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 412' ' ' MET . . . . . 0.414 ' HB2' ' O ' ' A' ' 409' ' ' THR . 0.3 OUTLIER -65.91 -48.47 71.34 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 115.726 -0.237 . . . . 0.0 111.32 177.719 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 413' ' ' MET . . . . . 0.91 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.5 OUTLIER -71.64 -46.5 58.83 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 118.988 -1.085 . . . . 0.0 111.974 -179.508 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . 0.91 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 16.4 mt -68.69 -45.09 72.57 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -176.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.443 ' HB2' ' HE2' ' A' ' 388' ' ' MET . 33.9 t -86.57 -21.58 26.78 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.483 0.659 . . . . 0.0 110.176 -175.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . 0.455 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 107.55 -175.81 20.45 Favored Glycine 0 N--CA 1.429 -1.775 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -171.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -79.75 23.68 0.42 Allowed 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.598 0.713 . . . . 0.0 111.405 -172.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 418' ' ' ASN . . . . . 0.457 ' OD1' ' HD2' ' A' ' 381' ' ' ARG . 62.5 m-80 -71.83 74.77 0.87 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.687 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 419' ' ' TYR . . . . . 0.535 ' CD1' ' HB1' ' A' ' 453' ' ' ALA . 23.2 p90 -52.29 -37.32 55.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.764 174.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -53.82 -46.4 71.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.691 177.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . 0.41 ' O ' HD13 ' A' ' 425' ' ' ILE . 0.0 OUTLIER -68.96 -49.53 57.13 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.389 -177.837 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . 0.46 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -65.74 -39.09 83.83 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.144 -175.879 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.792 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 77.7 p -66.7 -39.24 88.0 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.793 -178.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -68.45 -38.63 86.99 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.136 176.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . 0.544 HG23 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.18 -52.27 25.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.456 0.17 . . . . 0.0 111.01 -177.259 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . 0.531 ' O ' HD22 ' A' ' 430' ' ' LEU . 1.1 mm -74.36 -22.75 17.96 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.897 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -173.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.792 ' HB2' ' O ' ' A' ' 423' ' ' SER . 1.1 tmt_? -54.64 -33.15 60.2 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.103 0.478 . . . . 0.0 110.699 -177.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -85.87 -10.8 74.98 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.148 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.489 ' HD1' ' CG2' ' A' ' 395' ' ' ILE . 9.7 m-30 -113.64 -0.14 14.42 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.421 0.629 . . . . 0.0 109.366 -174.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . 0.546 HD11 ' HD2' ' A' ' 431' ' ' PRO . 0.1 OUTLIER -66.02 129.5 94.26 Favored Pre-proline 0 N--CA 1.445 -0.718 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.291 178.267 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . 0.546 ' HD2' HD11 ' A' ' 430' ' ' LEU . 94.6 Cg_exo -23.72 -66.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.359 1.088 1 C-N-CA 125.768 4.312 . . . . 0.0 115.122 179.589 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . 0.49 ' O ' HG11 ' A' ' 435' ' ' VAL . . . -145.86 -166.41 11.95 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 177.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . 0.522 ' O ' HG12 ' A' ' 436' ' ' VAL . 17.0 tp60 -70.01 -27.43 64.67 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 117.904 0.852 . . . . 0.0 110.526 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -67.12 -40.97 86.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.995 -177.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 435' ' ' VAL . . . . . 0.49 HG11 ' O ' ' A' ' 432' ' ' GLY . 7.9 p -67.87 -43.43 86.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 121.004 0.431 . . . . 0.0 110.641 -177.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . 0.551 HG23 ' NE ' ' A' ' 427' ' ' ARG . 0.1 OUTLIER -66.38 -31.97 55.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.483 175.832 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.29 -52.45 40.4 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -178.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . 0.538 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -58.35 -38.7 77.73 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.225 177.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 439' ' ' LEU . . . . . 0.591 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 1.9 tm? -68.99 -48.53 62.87 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.89 -35.76 73.56 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.717 -1.128 . . . . 0.0 111.327 176.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 441' ' ' GLN . . . . . 0.436 ' O ' ' HG2' ' A' ' 445' ' ' GLN . 5.8 mm-40 -56.93 -51.35 69.5 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 123.484 0.714 . . . . 0.0 110.6 178.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 438' ' ' ALA . 0.1 OUTLIER -61.56 -33.4 73.8 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.514 174.795 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 443' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 56.6 mt -68.23 -38.52 81.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.136 0.493 . . . . 0.0 109.931 177.163 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -57.95 -36.11 72.07 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.63 174.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 445' ' ' GLN . . . . . 0.436 ' HG2' ' O ' ' A' ' 441' ' ' GLN . 29.1 mm-40 -72.96 -26.63 61.43 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.8 177.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 446' ' ' GLU . . . . . 0.402 ' HB3' ' O ' ' A' ' 443' ' ' LEU . 12.0 pt-20 32.44 104.33 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 172.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 47.0 mt -72.54 -34.67 48.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.464 0.65 . . . . 0.0 110.041 175.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . 0.401 ' HB2' ' CB ' ' A' ' 451' ' ' THR . 11.0 m-20 -165.84 -158.37 0.35 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 -177.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -88.12 -67.41 0.83 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 168.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.44 -25.84 66.93 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 451' ' ' THR . . . . . 0.488 ' HA ' ' HB2' ' A' ' 454' ' ' GLU . 9.9 m -71.35 -22.98 61.83 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.457 -176.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 71.3 mtt180 -54.87 -53.99 48.31 Favored 'General case' 0 C--O 1.217 -0.631 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 171.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 453' ' ' ALA . . . . . 0.535 ' HB1' ' CD1' ' A' ' 419' ' ' TYR . . . -56.33 -48.86 75.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.7 -1.136 . . . . 0.0 112.576 174.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . 0.488 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 31.4 mm-40 -52.22 -34.01 43.77 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.07 0.462 . . . . 0.0 111.758 -178.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 27.2 p -120.25 14.9 12.21 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.481 -176.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . 0.555 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.9 OUTLIER -56.07 -49.21 74.42 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.043 0.449 . . . . 0.0 111.484 -171.057 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . 0.524 ' CG1' ' HB3' ' A' ' 408' ' ' TYR . 1.9 mp -74.56 -32.04 28.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.063 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -58.16 -36.2 72.67 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.604 0.716 . . . . 0.0 109.518 171.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . 0.758 ' O ' HG21 ' A' ' 463' ' ' VAL . 87.3 m-70 -72.79 -29.15 63.04 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.048 177.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . 0.718 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -74.0 -34.92 64.35 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.887 0.851 . . . . 0.0 109.137 -179.916 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . 0.456 ' O ' ' HB2' ' A' ' 464' ' ' TYR . 24.3 m-80 -73.08 -38.07 66.54 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.911 0.863 . . . . 0.0 108.985 176.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 462' ' ' ALA . . . . . 0.616 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -57.07 -32.88 66.7 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.394 -1.275 . . . . 0.0 109.874 169.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.758 HG21 ' O ' ' A' ' 459' ' ' HIS . 60.2 t -62.63 -50.92 77.85 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.856 0 CA-C-N 114.699 -1.137 . . . . 0.0 107.958 175.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 464' ' ' TYR . . . . . 0.583 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 17.7 m-30 -52.07 -28.14 16.41 Favored 'General case' 0 N--CA 1.455 -0.182 0 O-C-N 124.353 1.033 . . . . 0.0 110.494 177.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.89 -39.08 20.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.787 0.803 . . . . 0.0 109.724 -178.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.616 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.6 mt -58.72 -55.85 20.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 114.357 -1.292 . . . . 0.0 112.189 176.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.747 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -101.16 -10.05 20.77 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -172.693 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . 0.527 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 93.77 30.84 8.62 Favored Glycine 0 CA--C 1.527 0.844 0 C-N-CA 119.646 -1.264 . . . . 0.0 114.169 179.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 469' ' ' LEU . . . . . 0.747 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.2 mt -88.69 159.5 17.79 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 117.847 0.823 . . . . 0.0 110.848 177.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . 0.483 HD21 HG23 ' A' ' 476' ' ' ILE . 13.9 p30 -105.32 -177.77 3.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.145 172.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -57.24 -26.18 60.34 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -174.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 -86.87 6.19 33.08 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 122.258 -0.277 . . . . 0.0 111.525 -171.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . 0.525 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 76.72 9.26 86.42 Favored Glycine 0 C--O 1.225 -0.447 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.204 -177.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -100.84 157.45 16.71 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 475' ' ' SER . . . . . 0.499 ' HA ' ' HA ' ' A' ' 469' ' ' LEU . 9.5 t -94.66 145.53 24.77 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.246 -0.582 . . . . 0.0 111.074 -178.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 476' ' ' ILE . . . . . 0.527 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.0 pp -104.8 12.71 7.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.035 178.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 477' ' ' ARG . . . . . 0.466 ' HG2' ' OG ' ' A' ' 475' ' ' SER . 29.4 mmt180 -62.75 120.48 11.34 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.684 176.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 71.8 mt -115.22 44.09 1.89 Allowed 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 . . . . . 0 C--O 1.247 0.967 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.08 -175.582 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 381' ' ' ARG . . . . . 0.463 ' HD2' ' OD1' ' B' ' 418' ' ' ASN . 20.0 ptp180 . . . . . 0 N--CA 1.479 0.976 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 382' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.99 -59.6 0.17 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.372 177.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 383' ' ' HIS . . . . . 0.695 ' HB2' ' O ' ' B' ' 386' ' ' PHE . 5.4 p80 -125.16 138.99 54.14 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.362 -0.535 . . . . 0.0 112.111 -170.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 384' ' ' GLY . . . . . . . . . . . . . . . -115.13 -68.0 0.44 Allowed Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.922 176.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 385' ' ' THR . . . . . . . . . . . . . 7.3 m -97.16 -35.02 10.91 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.018 0.437 . . . . 0.0 110.732 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 386' ' ' PHE . . . . . 0.729 ' CE2' HG12 ' B' ' 394' ' ' VAL . 2.6 t80 -92.22 123.5 62.34 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.221 -177.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 387' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -64.62 105.3 0.62 Allowed 'Trans proline' 0 N--CA 1.48 0.722 0 C-N-CA 123.801 3.001 . . . . 0.0 112.2 172.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 388' ' ' MET . . . . . 0.552 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 5.2 ttp -121.58 55.29 1.1 Allowed 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.428 0.632 . . . . 0.0 111.368 -168.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 389' ' ' HIS . . . . . 0.571 ' CE1' ' HA ' ' B' ' 393' ' ' ASN . 38.9 m170 52.78 -99.19 0.08 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.676 0.79 . . . . 0.0 109.908 -172.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -148.03 16.94 1.09 Allowed 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 171.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 391' ' ' LEU . . . . . 0.592 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.5 pt? -167.12 -62.58 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.92 -171.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 392' ' ' GLY . . . . . 0.592 ' N ' ' HG ' ' B' ' 391' ' ' LEU . . . -163.32 60.13 0.27 Allowed Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 119.861 -1.161 . . . . 0.0 114.343 -172.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 393' ' ' ASN . . . . . 0.571 ' HA ' ' CE1' ' B' ' 389' ' ' HIS . 0.2 OUTLIER -57.44 -43.47 83.95 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 174.257 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 394' ' ' VAL . . . . . 0.729 HG12 ' CE2' ' B' ' 386' ' ' PHE . 2.0 m -55.68 -45.95 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 -179.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 395' ' ' ILE . . . . . 0.586 ' N ' HG23 ' B' ' 394' ' ' VAL . 3.7 mp -58.07 -52.54 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-O 117.849 -1.072 . . . . 0.0 113.484 -174.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 396' ' ' LYS . . . . . 0.597 ' O ' HG22 ' B' ' 399' ' ' VAL . 0.0 OUTLIER -62.96 -49.74 73.54 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 121.986 2.175 . . . . 0.0 112.159 -174.84 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 397' ' ' GLY . . . . . 0.54 ' O ' ' HG3' ' B' ' 401' ' ' GLN . . . -52.95 -44.33 61.74 Favored Glycine 0 N--CA 1.435 -1.395 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.908 -176.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . 0.627 ' CD1' HD12 ' B' ' 410' ' ' LEU . 39.0 mt -71.66 -33.74 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 399' ' ' VAL . . . . . 0.597 HG22 ' O ' ' B' ' 396' ' ' LYS . 14.2 m -63.68 -39.67 86.21 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 C-N-CA 118.755 -1.178 . . . . 0.0 108.478 -174.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -64.03 -42.71 96.99 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 174.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 401' ' ' GLN . . . . . 0.54 ' HG3' ' O ' ' B' ' 397' ' ' GLY . 36.7 mt-30 -92.62 -48.22 6.71 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -169.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 402' ' ' GLU . . . . . 0.404 ' HB3' ' HB ' ' B' ' 406' ' ' THR . 2.9 mm-40 -114.29 -19.43 11.27 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.175 0.512 . . . . 0.0 111.539 -171.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 104.18 162.69 24.65 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.986 177.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 404' ' ' VAL . . . . . 0.625 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.6 m -53.63 -45.47 60.06 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.813 0 N-CA-C 114.463 1.282 . . . . 0.0 114.463 -175.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 405' ' ' ALA . . . . . 0.472 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -64.83 -31.32 72.5 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 119.81 -0.756 . . . . 0.0 112.312 -177.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 406' ' ' THR . . . . . 0.679 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 85.7 m -76.69 -42.98 39.58 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.169 -0.613 . . . . 0.0 110.187 173.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 407' ' ' ALA . . . . . 0.5 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.56 -36.41 73.88 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 122.158 0.98 . . . . 0.0 109.194 176.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 408' ' ' TYR . . . . . 0.625 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.88 -52.2 52.24 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 113.594 -1.639 . . . . 0.0 109.752 176.265 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 409' ' ' THR . . . . . 0.55 HG21 HD21 ' B' ' 410' ' ' LEU . 17.9 m -54.73 -47.57 73.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.545 179.021 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 410' ' ' LEU . . . . . 0.679 ' HG ' ' O ' ' B' ' 406' ' ' THR . 13.6 mt -72.85 -35.85 67.3 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.189 -174.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -59.42 -34.92 83.07 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 119.988 -1.101 . . . . 0.0 110.626 173.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 412' ' ' MET . . . . . 0.416 ' HB2' ' O ' ' B' ' 409' ' ' THR . 0.3 OUTLIER -65.78 -48.38 71.99 Favored 'General case' 0 C--O 1.223 -0.341 0 CA-C-N 115.629 -0.285 . . . . 0.0 111.411 177.715 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 413' ' ' MET . . . . . 0.91 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.5 OUTLIER -71.63 -46.38 59.28 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 119.058 -1.057 . . . . 0.0 111.994 -179.373 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 414' ' ' LEU . . . . . 0.91 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 16.5 mt -68.93 -45.16 71.53 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -176.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 415' ' ' SER . . . . . 0.456 ' HB2' ' HE2' ' B' ' 388' ' ' MET . 33.9 t -86.83 -21.34 26.48 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.634 0.731 . . . . 0.0 110.169 -175.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 416' ' ' GLY . . . . . 0.448 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 107.58 -175.86 20.46 Favored Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 -171.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -79.81 23.6 0.43 Allowed 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.486 0.66 . . . . 0.0 111.294 -172.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 418' ' ' ASN . . . . . 0.463 ' OD1' ' HD2' ' B' ' 381' ' ' ARG . 61.6 m-80 -71.81 74.75 0.86 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.696 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 419' ' ' TYR . . . . . 0.552 ' CD1' ' HB1' ' B' ' 453' ' ' ALA . 23.9 p90 -52.34 -37.29 55.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.748 174.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -53.7 -46.42 70.71 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.729 177.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 421' ' ' LEU . . . . . 0.416 ' O ' HD13 ' B' ' 425' ' ' ILE . 0.0 OUTLIER -69.02 -49.51 57.04 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.438 -177.806 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 422' ' ' VAL . . . . . 0.461 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.2 OUTLIER -65.9 -39.02 83.47 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.093 -175.852 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 423' ' ' SER . . . . . 0.812 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 78.1 p -66.73 -39.12 87.85 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.818 -178.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -68.62 -38.54 86.19 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.153 176.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 425' ' ' ILE . . . . . 0.54 HG23 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -72.21 -52.32 24.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 121.351 -0.14 . . . . 0.0 110.794 -177.282 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 426' ' ' ILE . . . . . 0.517 ' CD1' HG22 ' B' ' 395' ' ' ILE . 1.1 mm -74.29 -22.71 18.05 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.929 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -173.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 427' ' ' ARG . . . . . 0.812 ' HB2' ' O ' ' B' ' 423' ' ' SER . 1.2 tmt_? -54.58 -33.25 59.96 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.166 0.507 . . . . 0.0 110.69 -177.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -85.85 -10.71 75.22 Favored Glycine 0 N--CA 1.44 -1.043 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.222 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 429' ' ' TYR . . . . . 0.483 ' HD1' ' CG2' ' B' ' 395' ' ' ILE . 9.5 m-30 -113.97 0.23 14.31 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.468 0.652 . . . . 0.0 109.326 -174.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 430' ' ' LEU . . . . . 0.542 HD11 ' HD2' ' B' ' 431' ' ' PRO . 0.1 OUTLIER -66.36 129.4 94.17 Favored Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.302 178.211 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 431' ' ' PRO . . . . . 0.542 ' HD2' HD11 ' B' ' 430' ' ' LEU . 94.3 Cg_exo -23.98 -65.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.36 1.137 1 C-N-CA 125.707 4.271 . . . . 0.0 115.155 179.81 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 432' ' ' GLY . . . . . 0.495 ' O ' HG11 ' B' ' 435' ' ' VAL . . . -146.56 -166.28 12.11 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 176.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 433' ' ' GLN . . . . . 0.517 ' O ' HG12 ' B' ' 436' ' ' VAL . 15.9 tp60 -69.83 -27.33 64.77 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 117.869 0.834 . . . . 0.0 110.617 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -67.23 -41.02 86.38 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -177.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 435' ' ' VAL . . . . . 0.495 HG11 ' O ' ' B' ' 432' ' ' GLY . 8.0 p -67.81 -43.65 86.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-O 121.088 0.47 . . . . 0.0 110.683 -177.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 436' ' ' VAL . . . . . 0.545 HG23 ' NE ' ' B' ' 427' ' ' ARG . 0.1 OUTLIER -66.06 -32.23 57.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.444 175.653 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.12 -52.46 41.51 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -178.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 438' ' ' ALA . . . . . 0.539 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -58.33 -38.84 77.97 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.155 177.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 439' ' ' LEU . . . . . 0.592 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 2.0 tm? -68.88 -48.46 63.33 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.1 -35.6 73.69 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.279 176.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 441' ' ' GLN . . . . . 0.436 ' O ' ' HG2' ' B' ' 445' ' ' GLN . 5.7 mm-40 -56.85 -51.5 68.76 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 123.385 0.674 . . . . 0.0 110.556 178.185 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 442' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' B' ' 438' ' ' ALA . 0.1 OUTLIER -61.59 -33.21 73.49 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.58 174.956 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 443' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 56.6 mt -68.27 -38.83 82.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.127 0.489 . . . . 0.0 109.856 177.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -57.96 -35.56 71.34 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.628 174.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 445' ' ' GLN . . . . . 0.436 ' HG2' ' O ' ' B' ' 441' ' ' GLN . 29.3 mm-40 -73.26 -26.67 61.19 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.778 177.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 446' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 32.31 104.72 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 172.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 47.2 mt -72.82 -34.81 47.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.383 0.611 . . . . 0.0 109.975 175.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 448' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -165.87 -158.69 0.36 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -177.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -88.01 -67.27 0.84 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 169.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.53 -25.73 66.81 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 179.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 451' ' ' THR . . . . . 0.482 ' HA ' ' HB2' ' B' ' 454' ' ' GLU . 10.6 m -71.27 -23.11 61.91 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.421 -176.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 452' ' ' ARG . . . . . . . . . . . . . 70.9 mtt180 -54.67 -53.91 48.59 Favored 'General case' 0 C--O 1.217 -0.612 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 171.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 453' ' ' ALA . . . . . 0.552 ' HB1' ' CD1' ' B' ' 419' ' ' TYR . . . -56.48 -48.93 76.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.719 -1.128 . . . . 0.0 112.499 174.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 454' ' ' GLU . . . . . 0.482 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 31.9 mm-40 -52.23 -34.0 43.88 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.161 0.505 . . . . 0.0 111.626 -177.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 26.9 p -120.24 14.96 12.23 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.413 -176.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 456' ' ' PHE . . . . . 0.556 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 0.9 OUTLIER -56.13 -49.18 74.64 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.982 0.42 . . . . 0.0 111.495 -171.262 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 457' ' ' ILE . . . . . 0.539 ' CG1' ' HB3' ' B' ' 408' ' ' TYR . 1.9 mp -74.63 -31.96 28.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.0 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -58.26 -36.1 72.74 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.569 0.7 . . . . 0.0 109.418 171.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 459' ' ' HIS . . . . . 0.764 ' O ' HG21 ' B' ' 463' ' ' VAL . 87.4 m-70 -72.86 -29.18 62.99 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.175 177.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 460' ' ' LEU . . . . . 0.729 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -73.94 -34.95 64.51 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.901 0.857 . . . . 0.0 109.063 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 461' ' ' ASN . . . . . 0.426 ' O ' ' HB2' ' B' ' 464' ' ' TYR . 24.9 m-80 -73.3 -37.73 66.1 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.883 0.849 . . . . 0.0 109.075 176.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 462' ' ' ALA . . . . . 0.617 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -57.2 -32.99 67.05 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.832 169.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 463' ' ' VAL . . . . . 0.764 HG21 ' O ' ' B' ' 459' ' ' HIS . 60.9 t -62.41 -51.02 77.39 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.799 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 175.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 464' ' ' TYR . . . . . 0.576 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 17.7 m-30 -52.04 -28.06 15.91 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 124.405 1.066 . . . . 0.0 110.616 177.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.16 -38.85 20.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.698 0.761 . . . . 0.0 109.766 -177.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 466' ' ' ILE . . . . . 0.617 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.6 mt -58.85 -55.89 20.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 114.44 -1.255 . . . . 0.0 112.229 176.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 467' ' ' LEU . . . . . 0.747 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -100.95 -10.22 20.8 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 -172.772 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 468' ' ' GLY . . . . . 0.522 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 93.86 30.89 8.53 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 119.637 -1.268 . . . . 0.0 114.157 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 469' ' ' LEU . . . . . 0.747 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.2 mt -88.62 159.59 17.8 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 117.855 0.828 . . . . 0.0 110.846 177.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 470' ' ' ASN . . . . . 0.492 HD21 HG23 ' B' ' 476' ' ' ILE . 13.9 p30 -105.38 -178.05 3.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.107 172.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 471' ' ' ALA . . . . . . . . . . . . . . . -56.74 -26.58 57.58 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -174.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 -86.75 6.5 31.12 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 122.178 -0.326 . . . . 0.0 111.73 -171.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 473' ' ' GLY . . . . . 0.523 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 76.33 9.54 85.76 Favored Glycine 0 C--O 1.227 -0.319 0 C-N-CA 120.484 -0.865 . . . . 0.0 111.257 -177.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -100.94 157.65 16.58 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 176.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 475' ' ' SER . . . . . 0.504 ' HA ' ' HA ' ' B' ' 469' ' ' LEU . 9.9 t -95.05 145.3 25.06 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.074 -178.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 476' ' ' ILE . . . . . 0.522 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.0 pp -104.66 12.62 7.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.618 0.723 . . . . 0.0 110.054 178.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 477' ' ' ARG . . . . . 0.469 ' HG2' ' OG ' ' B' ' 475' ' ' SER . 29.6 mmt180 -62.89 120.2 10.86 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.758 176.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 478' ' ' LEU . . . . . . . . . . . . . 70.8 mt -115.04 44.14 1.85 Allowed 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 479' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 . . . . . 0 C--O 1.247 0.963 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.372 -175.617 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 . . . . . 0 N--CA 1.479 1.019 0 N-CA-C 111.205 0.076 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -175.02 -53.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.644 0.259 . . . . 0.0 111.207 -178.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -129.99 141.99 50.68 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.702 0.287 . . . . 0.0 110.784 176.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 179.07 82.75 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.671 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 3.5 m 72.24 -58.17 0.6 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.171 0.588 . . . . 0.0 110.733 -176.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 386' ' ' PHE . . . . . 0.524 ' CD1' HD22 ' A' ' 414' ' ' LEU . 1.3 t80 -83.13 126.29 72.61 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.359 177.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -42.98 -69.35 0.08 OUTLIER 'Trans proline' 0 N--CA 1.479 0.628 0 C-N-CA 124.265 3.31 . . . . 0.0 113.667 -176.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 388' ' ' MET . . . . . 0.542 ' SD ' ' HB2' ' A' ' 415' ' ' SER . 6.7 ttp 66.44 34.13 6.41 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 173.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 389' ' ' HIS . . . . . 0.46 ' CE1' ' HB2' ' A' ' 393' ' ' ASN . 36.6 m170 53.93 -95.17 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.327 0.584 . . . . 0.0 110.379 -177.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -149.63 18.87 0.92 Allowed 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 174.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.592 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.6 pt? -173.49 -54.96 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -169.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . 0.592 ' N ' ' HG ' ' A' ' 391' ' ' LEU . . . -167.57 47.08 0.24 Allowed Glycine 0 CA--C 1.525 0.669 0 C-N-CA 119.685 -1.245 . . . . 0.0 114.569 -169.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . 0.489 ' HB3' ' C ' ' A' ' 388' ' ' MET . 0.0 OUTLIER -54.95 -37.58 66.65 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 117.925 0.862 . . . . 0.0 109.495 175.87 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . 0.613 HG22 ' N ' ' A' ' 395' ' ' ILE . 1.5 m -57.45 -49.97 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 CA-C-N 113.824 -1.535 . . . . 0.0 107.603 178.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.613 ' N ' HG22 ' A' ' 394' ' ' VAL . 4.0 mp -57.96 -52.88 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 CA-C-O 118.013 -0.994 . . . . 0.0 113.544 -174.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . 0.634 ' HG3' ' CZ ' ' A' ' 429' ' ' TYR . 0.1 OUTLIER -64.7 -48.48 74.54 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 121.737 2.062 . . . . 0.0 111.664 -172.525 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.34 -45.49 65.26 Favored Glycine 0 N--CA 1.433 -1.517 0 C-N-CA 120.106 -1.045 . . . . 0.0 110.978 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . 0.675 ' CD1' HD13 ' A' ' 410' ' ' LEU . 35.4 mt -70.95 -33.86 53.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 -178.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 396' ' ' LYS . 11.4 m -63.44 -39.88 86.95 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.514 0 C-N-CA 118.73 -1.188 . . . . 0.0 108.539 -173.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -70.93 -37.09 72.88 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 176.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 4.2 mm100 -86.86 -48.26 8.34 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -171.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . 0.453 ' HG3' ' HE1' ' B' ' 413' ' ' MET . 3.0 mm-40 -119.43 -20.92 7.65 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.375 -171.027 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 107.48 161.95 21.47 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.879 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . 0.675 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.5 m -53.71 -41.79 48.79 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.784 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -175.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . 0.515 ' HB2' HG21 ' A' ' 457' ' ' ILE . . . -69.23 -29.33 67.25 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.916 -176.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 406' ' ' THR . . . . . 0.699 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 89.3 m -77.63 -42.79 33.6 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.206 -0.598 . . . . 0.0 110.137 172.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.484 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.42 -36.94 74.38 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 122.062 0.934 . . . . 0.0 109.355 176.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 408' ' ' TYR . . . . . 0.675 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.8 -52.13 53.22 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 113.619 -1.628 . . . . 0.0 109.767 176.372 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 409' ' ' THR . . . . . 0.534 HG21 HD23 ' A' ' 410' ' ' LEU . 17.7 m -55.53 -47.57 76.09 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.592 178.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . 0.699 ' HG ' ' O ' ' A' ' 406' ' ' THR . 15.0 mt -72.85 -35.11 67.17 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -174.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.66 -34.3 76.16 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.123 -1.037 . . . . 0.0 111.047 171.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -68.35 -49.51 59.78 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-O 120.527 0.203 . . . . 0.0 111.34 178.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 413' ' ' MET . . . . . 0.922 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.9 OUTLIER -71.18 -43.14 68.04 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 119.437 -0.905 . . . . 0.0 112.08 -177.474 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . 0.922 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 12.0 mt -73.99 -46.13 45.65 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 113.234 0.828 . . . . 0.0 113.234 -178.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.542 ' HB2' ' SD ' ' A' ' 388' ' ' MET . 3.7 t -100.1 17.55 20.85 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.361 0.6 . . . . 0.0 110.928 -170.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 78.87 178.31 50.45 Favored Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 120.285 -0.96 . . . . 0.0 111.768 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -81.72 21.17 0.85 Allowed 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.012 0.434 . . . . 0.0 111.642 -172.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 418' ' ' ASN . . . . . 0.435 ' HB3' ' HB3' ' A' ' 421' ' ' LEU . 6.3 m-20 -73.23 80.89 1.31 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.574 0.702 . . . . 0.0 111.021 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 419' ' ' TYR . . . . . 0.542 ' HB2' ' CE2' ' A' ' 456' ' ' PHE . 10.5 p90 -51.91 -38.24 55.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.761 176.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -55.58 -43.67 76.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.87 177.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . 0.435 ' HB3' ' HB3' ' A' ' 418' ' ' ASN . 0.0 OUTLIER -67.8 -48.54 66.01 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.264 -178.075 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . 0.469 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -65.89 -42.22 91.58 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 C-N-CA 120.421 -0.511 . . . . 0.0 111.189 -177.725 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.742 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 29.0 t -69.46 -34.99 75.2 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -178.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.54 -40.54 90.87 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.192 175.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . 0.566 HG23 HG22 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.81 -49.9 36.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-O 120.554 0.216 . . . . 0.0 110.763 -178.914 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 1.2 mm -74.31 -22.41 17.91 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.911 0 C-N-CA 123.055 0.542 . . . . 0.0 110.183 -172.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.742 ' HB2' ' O ' ' A' ' 423' ' ' SER . 0.3 OUTLIER -54.72 -28.82 50.83 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 123.031 0.533 . . . . 0.0 111.075 -178.718 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -90.15 -8.32 66.8 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.684 178.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.634 ' CZ ' ' HG3' ' A' ' 396' ' ' LYS . 21.5 m-85 -114.46 -2.86 13.1 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 121.667 0.746 . . . . 0.0 109.619 -178.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . 0.507 HD11 ' HD2' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -65.89 135.79 95.47 Favored Pre-proline 0 N--CA 1.437 -1.088 0 CA-C-N 114.339 -1.3 . . . . 0.0 108.657 178.325 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . 0.685 ' CD ' HG13 ' A' ' 435' ' ' VAL . 47.0 Cg_exo -36.42 -65.21 0.15 Allowed 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 124.614 3.543 . . . . 0.0 114.081 -172.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . 0.574 ' O ' HG12 ' A' ' 435' ' ' VAL . . . -141.94 -165.08 10.32 Favored Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 175.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . 0.551 ' O ' HG12 ' A' ' 436' ' ' VAL . 23.9 tp60 -70.26 -26.91 64.05 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 118.198 0.999 . . . . 0.0 110.331 177.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -66.29 -40.44 90.05 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -177.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 435' ' ' VAL . . . . . 0.685 HG13 ' CD ' ' A' ' 431' ' ' PRO . 7.0 p -68.14 -44.64 84.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-O 120.892 0.377 . . . . 0.0 110.785 -178.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . 0.551 HG12 ' O ' ' A' ' 433' ' ' GLN . 0.2 OUTLIER -65.43 -29.11 46.17 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 CA-C-O 121.057 0.456 . . . . 0.0 110.094 175.862 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 1.1 m -69.26 -52.92 22.87 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . 0.803 ' O ' ' HG2' ' A' ' 442' ' ' ARG . . . -58.77 -38.13 77.79 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.807 177.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 439' ' ' LEU . . . . . 0.568 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 2.2 tm? -69.91 -47.43 62.5 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.62 -39.67 77.44 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.38 174.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 441' ' ' GLN . . . . . 0.457 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 8.9 mm-40 -53.58 -49.54 67.53 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 123.788 0.835 . . . . 0.0 110.855 174.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . 0.803 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 0.7 OUTLIER -55.85 -39.43 71.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.607 172.034 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 443' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 37.1 mt -71.71 -35.56 70.25 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.025 0.44 . . . . 0.0 110.178 -178.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -58.05 -36.97 73.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.631 174.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -72.82 -28.03 62.31 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.616 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 446' ' ' GLU . . . . . 0.565 ' HB2' ' O ' ' A' ' 443' ' ' LEU . 31.6 tt0 29.75 96.49 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 172.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 42.1 mt -67.91 -35.31 71.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.202 0.525 . . . . 0.0 110.518 177.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . 0.592 ' O ' ' HG3' ' A' ' 452' ' ' ARG . 23.2 m-20 -166.15 -170.52 1.73 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 449' ' ' ASP . . . . . 0.433 ' CG ' ' H ' ' A' ' 450' ' ' GLN . 12.8 p-10 -76.7 -62.44 1.63 Allowed 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.176 -0.61 . . . . 0.0 109.405 173.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 450' ' ' GLN . . . . . 0.433 ' H ' ' CG ' ' A' ' 449' ' ' ASP . 0.0 OUTLIER -70.37 -26.03 63.54 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 178.007 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 451' ' ' THR . . . . . 0.486 ' HA ' ' HB2' ' A' ' 454' ' ' GLU . 17.7 m -71.71 -22.65 61.61 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 119.824 -0.75 . . . . 0.0 110.853 -175.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . 0.592 ' HG3' ' O ' ' A' ' 448' ' ' ASP . 13.3 mtp180 -53.64 -54.75 33.34 Favored 'General case' 0 C--O 1.218 -0.569 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 170.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 453' ' ' ALA . . . . . 0.49 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -57.34 -48.2 79.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.264 -1.335 . . . . 0.0 112.582 175.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . 0.486 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 20.8 mm-40 -51.83 -35.72 45.55 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.151 0.501 . . . . 0.0 111.752 -177.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 31.2 p -119.22 16.2 13.15 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.314 -176.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . 0.542 ' CE2' ' HB2' ' A' ' 419' ' ' TYR . 1.0 OUTLIER -57.05 -48.84 77.55 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.975 0.417 . . . . 0.0 111.819 -171.441 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . 0.546 ' CG1' ' HB3' ' A' ' 408' ' ' TYR . 2.0 mp -75.67 -33.02 25.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.934 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -58.4 -35.08 71.49 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.942 0.877 . . . . 0.0 109.268 172.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . 0.722 ' O ' HG23 ' A' ' 463' ' ' VAL . 59.4 m-70 -74.23 -28.87 61.44 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.539 -1.21 . . . . 0.0 110.732 177.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . 0.692 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.4 OUTLIER -73.64 -34.79 65.14 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.794 0.807 . . . . 0.0 108.914 178.869 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . 0.488 ' HA ' ' CD2' ' A' ' 464' ' ' TYR . 20.0 m-80 -73.21 -37.64 66.36 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.276 -0.874 . . . . 0.0 108.872 176.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 462' ' ' ALA . . . . . 0.611 ' O ' HD11 ' A' ' 466' ' ' ILE . . . -56.85 -34.92 68.26 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.443 -1.253 . . . . 0.0 109.812 169.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.722 HG23 ' O ' ' A' ' 459' ' ' HIS . 68.4 t -60.12 -51.22 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 175.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 464' ' ' TYR . . . . . 0.6 ' CE2' ' HA ' ' A' ' 471' ' ' ALA . 16.2 m-30 -53.52 -28.33 30.7 Favored 'General case' 0 N--CA 1.456 -0.159 0 O-C-N 124.233 0.958 . . . . 0.0 110.598 178.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.19 -39.6 20.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.787 0.803 . . . . 0.0 109.466 -177.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.611 HD11 ' O ' ' A' ' 462' ' ' ALA . 3.7 mt -57.62 -55.68 19.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 114.22 -1.354 . . . . 0.0 112.286 175.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.766 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -102.83 -10.64 18.92 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -172.343 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . 0.691 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 93.93 32.47 7.52 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 118.96 -1.59 . . . . 0.0 114.155 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 469' ' ' LEU . . . . . 0.766 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.7 mt -89.63 166.41 13.64 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 117.793 0.797 . . . . 0.0 111.489 176.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 40.4 p30 -106.06 -178.12 3.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.564 -0.743 . . . . 0.0 109.668 169.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 471' ' ' ALA . . . . . 0.6 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -70.71 -9.72 57.83 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -175.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -89.09 -0.63 57.6 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.931 0.396 . . . . 0.0 110.861 -177.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . 0.465 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 75.5 16.58 80.54 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -173.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -101.57 155.57 18.01 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.275 -0.462 . . . . 0.0 109.818 178.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 3.0 p -94.49 121.06 35.65 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.165 0.507 . . . . 0.0 110.768 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 476' ' ' ILE . . . . . 0.691 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.3 pp -87.08 -51.15 13.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.072 -176.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 477' ' ' ARG . . . . . 0.597 ' N ' HD11 ' A' ' 476' ' ' ILE . 1.0 OUTLIER 46.44 65.12 1.27 Allowed 'General case' 0 C--N 1.329 -0.301 0 O-C-N 123.84 0.713 . . . . 0.0 110.777 178.203 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 90.8 mt 59.69 73.1 0.49 Allowed 'General case' 0 C--N 1.332 -0.152 0 O-C-N 123.653 0.596 . . . . 0.0 110.239 -172.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 479' ' ' GLU . . . . . 0.434 ' HB2' ' HB ' ' A' ' 476' ' ' ILE . 27.1 tt0 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.496 -0.764 . . . . 0.0 110.61 -177.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 381' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 . . . . . 0 N--CA 1.479 1.017 0 N-CA-C 111.307 0.114 . . . . 0.0 111.307 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 382' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -174.66 -53.26 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.573 0.225 . . . . 0.0 111.134 -178.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 383' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -129.98 141.88 50.7 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.675 0.274 . . . . 0.0 110.797 176.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 384' ' ' GLY . . . . . . . . . . . . . . . 179.0 82.43 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.726 -178.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 385' ' ' THR . . . . . . . . . . . . . 3.5 m 72.32 -58.25 0.6 Allowed 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.255 0.622 . . . . 0.0 110.598 -176.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 386' ' ' PHE . . . . . 0.528 ' CD1' HD22 ' B' ' 414' ' ' LEU . 1.2 t80 -83.22 126.18 72.66 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.36 177.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 387' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -43.12 -68.99 0.09 OUTLIER 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 124.049 3.166 . . . . 0.0 113.782 -176.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 388' ' ' MET . . . . . 0.54 ' SD ' ' HB2' ' B' ' 415' ' ' SER . 6.6 ttp 66.23 34.21 6.75 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 173.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 389' ' ' HIS . . . . . 0.464 ' CE1' ' HB2' ' B' ' 393' ' ' ASN . 36.6 m170 54.08 -94.62 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.363 0.602 . . . . 0.0 110.546 -177.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -150.29 19.22 0.85 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.144 -0.934 . . . . 0.0 108.657 174.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 391' ' ' LEU . . . . . 0.585 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.6 pt? -173.91 -55.01 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -169.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 392' ' ' GLY . . . . . 0.585 ' N ' ' HG ' ' B' ' 391' ' ' LEU . . . -167.57 47.11 0.24 Allowed Glycine 0 CA--C 1.523 0.566 0 C-N-CA 119.796 -1.192 . . . . 0.0 114.736 -169.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 393' ' ' ASN . . . . . 0.481 ' HB3' ' C ' ' B' ' 388' ' ' MET . 0.0 OUTLIER -54.92 -37.56 66.54 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 117.915 0.857 . . . . 0.0 109.461 175.94 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 394' ' ' VAL . . . . . 0.609 HG22 ' N ' ' B' ' 395' ' ' ILE . 1.5 m -57.5 -49.9 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 113.795 -1.548 . . . . 0.0 107.491 179.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 395' ' ' ILE . . . . . 0.609 ' N ' HG22 ' B' ' 394' ' ' VAL . 4.0 mp -58.14 -52.86 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-O 117.978 -1.01 . . . . 0.0 113.464 -174.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 396' ' ' LYS . . . . . 0.636 ' HG3' ' CZ ' ' B' ' 429' ' ' TYR . 0.1 OUTLIER -64.71 -48.5 74.42 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 121.788 2.086 . . . . 0.0 111.679 -172.476 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.24 -45.49 64.28 Favored Glycine 0 N--CA 1.435 -1.397 0 C-N-CA 120.01 -1.09 . . . . 0.0 110.935 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . 0.666 ' CD1' HD13 ' B' ' 410' ' ' LEU . 36.0 mt -71.05 -33.93 53.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 113.607 0.965 . . . . 0.0 113.607 -178.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 399' ' ' VAL . . . . . 0.579 HG23 ' O ' ' B' ' 396' ' ' LYS . 11.7 m -63.3 -39.86 86.86 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.54 0 C-N-CA 118.827 -1.149 . . . . 0.0 108.559 -174.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -70.95 -37.44 72.82 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 176.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 401' ' ' GLN . . . . . 0.402 HE21 ' HB3' ' B' ' 401' ' ' GLN . 3.9 mm100 -86.66 -47.8 8.85 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -171.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 402' ' ' GLU . . . . . 0.434 ' HG3' ' HE1' ' A' ' 413' ' ' MET . 3.0 mm-40 -119.71 -20.64 7.58 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.385 -171.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 107.2 161.98 21.74 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.863 178.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 404' ' ' VAL . . . . . 0.659 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.5 m -53.74 -41.8 49.09 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.862 0 N-CA-C 114.649 1.352 . . . . 0.0 114.649 -175.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 405' ' ' ALA . . . . . 0.504 ' HB2' HG21 ' B' ' 457' ' ' ILE . . . -69.2 -29.11 67.01 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 119.657 -0.817 . . . . 0.0 112.042 -176.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 406' ' ' THR . . . . . 0.696 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 91.6 m -77.74 -42.82 32.89 Favored 'General case' 0 C--O 1.22 -0.474 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.142 172.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 407' ' ' ALA . . . . . 0.481 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.54 -36.82 74.47 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 122.01 0.909 . . . . 0.0 109.375 176.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 408' ' ' TYR . . . . . 0.659 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.81 -52.33 51.57 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 113.581 -1.645 . . . . 0.0 109.777 176.185 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 409' ' ' THR . . . . . 0.53 HG21 HD23 ' B' ' 410' ' ' LEU . 17.7 m -55.27 -47.66 75.17 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.676 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 410' ' ' LEU . . . . . 0.696 ' HG ' ' O ' ' B' ' 406' ' ' THR . 14.9 mt -72.81 -35.16 67.27 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 -174.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.67 -34.25 75.99 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.136 -1.03 . . . . 0.0 111.035 171.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 412' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -68.41 -49.37 60.52 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.558 0.218 . . . . 0.0 111.369 178.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 413' ' ' MET . . . . . 0.937 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.9 OUTLIER -71.34 -43.1 67.64 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 119.355 -0.938 . . . . 0.0 112.099 -177.553 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 414' ' ' LEU . . . . . 0.937 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 12.0 mt -73.89 -46.15 46.31 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -178.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 415' ' ' SER . . . . . 0.54 ' HB2' ' SD ' ' B' ' 388' ' ' MET . 3.7 t -100.37 17.79 20.61 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.265 0.555 . . . . 0.0 110.897 -170.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 416' ' ' GLY . . . . . . . . . . . . . . . 78.82 178.22 50.26 Favored Glycine 0 N--CA 1.438 -1.189 0 C-N-CA 120.342 -0.932 . . . . 0.0 111.771 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 33.6 mm-40 -81.7 21.25 0.84 Allowed 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.074 0.464 . . . . 0.0 111.496 -172.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 418' ' ' ASN . . . . . 0.442 ' HB3' ' HB3' ' B' ' 421' ' ' LEU . 6.6 m-20 -73.26 80.82 1.33 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.541 0.686 . . . . 0.0 111.067 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 419' ' ' TYR . . . . . 0.537 ' HB2' ' CE2' ' B' ' 456' ' ' PHE . 10.4 p90 -52.02 -38.13 55.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.869 -1.059 . . . . 0.0 111.843 176.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -55.36 -43.81 75.4 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.646 0.26 . . . . 0.0 110.81 176.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 421' ' ' LEU . . . . . 0.442 ' HB3' ' HB3' ' B' ' 418' ' ' ASN . 0.0 OUTLIER -67.73 -48.51 66.25 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.24 -177.908 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 422' ' ' VAL . . . . . 0.47 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.2 OUTLIER -66.05 -42.06 90.8 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.149 -177.579 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 423' ' ' SER . . . . . 0.743 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 25.5 t -69.54 -35.0 75.03 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.52 -40.54 90.93 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.265 175.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 425' ' ' ILE . . . . . 0.56 HG23 HG22 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -72.76 -50.07 36.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 O-C-N 122.834 -0.216 . . . . 0.0 110.824 -179.074 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 426' ' ' ILE . . . . . 0.405 ' O ' ' N ' ' B' ' 430' ' ' LEU . 1.2 mm -74.41 -22.32 17.76 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.911 0 C-N-CA 122.956 0.502 . . . . 0.0 110.235 -172.014 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 427' ' ' ARG . . . . . 0.743 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.3 OUTLIER -54.7 -28.7 49.74 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 123.023 0.529 . . . . 0.0 111.186 -178.91 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -90.58 -7.77 66.49 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.489 178.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 429' ' ' TYR . . . . . 0.636 ' CZ ' ' HG3' ' B' ' 396' ' ' LYS . 21.6 m-85 -114.94 -2.49 12.85 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.74 0.781 . . . . 0.0 109.571 -178.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 430' ' ' LEU . . . . . 0.504 ' HA ' HG12 ' B' ' 404' ' ' VAL . 0.0 OUTLIER -65.91 135.76 95.44 Favored Pre-proline 0 N--CA 1.437 -1.088 0 CA-C-N 114.462 -1.244 . . . . 0.0 108.679 178.165 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 431' ' ' PRO . . . . . 0.689 ' CD ' HG13 ' B' ' 435' ' ' VAL . 46.5 Cg_exo -36.53 -65.08 0.15 Allowed 'Trans proline' 0 N--CA 1.473 0.322 0 C-N-CA 124.658 3.572 . . . . 0.0 114.09 -172.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 432' ' ' GLY . . . . . 0.575 ' O ' HG12 ' B' ' 435' ' ' VAL . . . -142.08 -165.12 10.36 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 175.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 433' ' ' GLN . . . . . 0.54 ' O ' HG12 ' B' ' 436' ' ' VAL . 24.5 tp60 -70.13 -26.89 64.16 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 118.195 0.998 . . . . 0.0 110.423 177.299 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -66.54 -40.01 88.87 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -177.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 435' ' ' VAL . . . . . 0.689 HG13 ' CD ' ' B' ' 431' ' ' PRO . 7.1 p -68.43 -44.63 83.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-O 120.962 0.41 . . . . 0.0 110.702 -178.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 436' ' ' VAL . . . . . 0.54 HG12 ' O ' ' B' ' 433' ' ' GLN . 0.1 OUTLIER -65.43 -29.34 46.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.112 175.826 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 1.1 m -69.19 -52.81 24.18 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 438' ' ' ALA . . . . . 0.811 ' O ' ' HG2' ' B' ' 442' ' ' ARG . . . -58.75 -38.43 78.4 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.744 177.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 439' ' ' LEU . . . . . 0.571 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 2.2 tm? -69.68 -47.34 63.58 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -178.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.69 -39.53 77.38 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.291 174.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 441' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 8.8 mm-40 -53.8 -49.54 68.1 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 123.733 0.813 . . . . 0.0 110.82 174.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 442' ' ' ARG . . . . . 0.811 ' HG2' ' O ' ' B' ' 438' ' ' ALA . 0.7 OUTLIER -55.82 -39.3 71.18 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.609 172.061 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 443' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 37.5 mt -71.68 -35.61 70.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.953 0.406 . . . . 0.0 110.19 -178.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -58.16 -37.05 73.93 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.521 174.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -72.74 -28.27 62.54 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.512 178.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 446' ' ' GLU . . . . . 0.565 ' HB2' ' O ' ' B' ' 443' ' ' LEU . 31.7 tt0 30.04 96.96 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 O-C-N 124.686 1.241 . . . . 0.0 114.339 172.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 42.7 mt -68.29 -35.27 70.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.112 0.482 . . . . 0.0 110.593 177.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 448' ' ' ASP . . . . . 0.585 ' O ' ' HG3' ' B' ' 452' ' ' ARG . 23.5 m-20 -165.89 -170.26 1.71 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 449' ' ' ASP . . . . . 0.437 ' CG ' ' H ' ' B' ' 450' ' ' GLN . 12.6 p-10 -76.73 -62.64 1.57 Allowed 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 173.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 450' ' ' GLN . . . . . 0.437 ' H ' ' CG ' ' B' ' 449' ' ' ASP . 0.0 OUTLIER -70.43 -25.91 63.43 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 178.157 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 451' ' ' THR . . . . . 0.479 ' HA ' ' HB2' ' B' ' 454' ' ' GLU . 18.6 m -71.71 -22.74 61.6 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.632 -175.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 452' ' ' ARG . . . . . 0.585 ' HG3' ' O ' ' B' ' 448' ' ' ASP . 13.6 mtp180 -53.54 -54.65 34.35 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 170.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 453' ' ' ALA . . . . . 0.487 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -57.51 -48.22 79.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.275 -1.33 . . . . 0.0 112.604 175.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 454' ' ' GLU . . . . . 0.479 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 20.9 mm-40 -51.67 -35.72 43.57 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.252 0.548 . . . . 0.0 111.736 -177.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 31.1 p -119.28 16.15 13.1 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.362 -176.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 456' ' ' PHE . . . . . 0.537 ' CE2' ' HB2' ' B' ' 419' ' ' TYR . 1.0 OUTLIER -57.13 -48.67 78.08 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.95 0.405 . . . . 0.0 111.766 -171.343 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 457' ' ' ILE . . . . . 0.556 ' CG1' ' HB3' ' B' ' 408' ' ' TYR . 2.0 mp -75.77 -33.23 25.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.864 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -58.35 -34.95 71.23 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.888 0.851 . . . . 0.0 109.293 172.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 459' ' ' HIS . . . . . 0.723 ' O ' HG23 ' B' ' 463' ' ' VAL . 60.1 m-70 -74.33 -28.78 61.31 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.777 177.053 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 460' ' ' LEU . . . . . 0.696 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.4 OUTLIER -73.63 -34.81 65.18 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.869 0.842 . . . . 0.0 108.872 178.94 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 461' ' ' ASN . . . . . 0.491 ' HA ' ' CD2' ' B' ' 464' ' ' TYR . 19.2 m-80 -73.26 -37.69 66.23 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.279 -0.873 . . . . 0.0 108.909 176.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 462' ' ' ALA . . . . . 0.606 ' O ' HD11 ' B' ' 466' ' ' ILE . . . -56.8 -34.9 68.12 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.812 169.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 463' ' ' VAL . . . . . 0.723 HG23 ' O ' ' B' ' 459' ' ' HIS . 68.6 t -60.12 -51.24 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 175.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 464' ' ' TYR . . . . . 0.606 ' CE2' ' HA ' ' B' ' 471' ' ' ALA . 16.4 m-30 -53.51 -28.16 29.58 Favored 'General case' 0 N--CA 1.457 -0.105 0 O-C-N 124.242 0.964 . . . . 0.0 110.551 178.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.29 -39.94 20.18 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.706 0.765 . . . . 0.0 109.411 -177.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 466' ' ' ILE . . . . . 0.606 HD11 ' O ' ' B' ' 462' ' ' ALA . 3.7 mt -57.4 -55.5 20.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 114.189 -1.369 . . . . 0.0 112.231 176.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 467' ' ' LEU . . . . . 0.769 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -103.05 -10.47 18.88 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -172.369 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 468' ' ' GLY . . . . . 0.696 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 93.82 32.52 7.53 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 118.996 -1.573 . . . . 0.0 114.133 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 469' ' ' LEU . . . . . 0.769 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.7 mt -89.63 166.26 13.73 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 117.832 0.816 . . . . 0.0 111.538 176.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 41.3 p30 -105.91 -178.19 3.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.72 169.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 471' ' ' ALA . . . . . 0.606 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -70.83 -9.55 57.77 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -175.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -89.27 -0.75 57.71 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.856 0.36 . . . . 0.0 110.908 -177.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 473' ' ' GLY . . . . . 0.449 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 75.74 16.53 80.59 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -173.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -101.45 155.71 17.9 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.23 -0.485 . . . . 0.0 109.861 178.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 2.7 p -94.93 120.92 35.95 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.193 0.52 . . . . 0.0 110.673 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 476' ' ' ILE . . . . . 0.696 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.3 pp -86.87 -50.8 13.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.189 -176.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 477' ' ' ARG . . . . . 0.602 ' N ' HD11 ' B' ' 476' ' ' ILE . 1.1 mmt85 46.15 65.08 1.26 Allowed 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.936 0.773 . . . . 0.0 110.713 178.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 478' ' ' LEU . . . . . . . . . . . . . 91.0 mt 60.13 72.5 0.52 Allowed 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.274 -173.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 479' ' ' GLU . . . . . 0.422 ' HB2' ' HB ' ' B' ' 476' ' ' ILE . 25.9 tt0 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.48 -0.772 . . . . 0.0 110.619 -177.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 381' ' ' ARG . . . . . 0.526 ' HD2' ' OD1' ' A' ' 418' ' ' ASN . 13.9 ptp180 . . . . . 0 N--CA 1.479 1.021 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.61 -39.13 0.35 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -176.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 383' ' ' HIS . . . . . 0.551 ' HB2' ' O ' ' A' ' 386' ' ' PHE . 24.2 p80 -165.08 152.37 10.97 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.228 -0.589 . . . . 0.0 112.237 -173.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -118.85 -86.6 1.07 Allowed Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.682 174.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 5.3 m -68.73 -41.25 79.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.062 0.458 . . . . 0.0 111.488 -179.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 386' ' ' PHE . . . . . 0.624 ' CE2' HG11 ' A' ' 394' ' ' VAL . 2.3 t80 -88.8 123.67 67.18 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.515 -176.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 386' ' ' PHE . 40.6 Cg_endo -65.5 111.54 1.89 Allowed 'Trans proline' 0 N--CA 1.482 0.811 0 C-N-CA 123.873 3.049 . . . . 0.0 112.458 173.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 388' ' ' MET . . . . . 0.565 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 34.2 ttm -121.37 47.92 1.76 Allowed 'General case' 0 C--N 1.321 -0.634 0 O-C-N 121.984 -0.448 . . . . 0.0 111.536 -169.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 389' ' ' HIS . . . . . 0.629 ' CG ' ' HB2' ' A' ' 393' ' ' ASN . 38.0 m170 57.09 -90.17 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 121.484 0.659 . . . . 0.0 109.482 -170.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -160.49 17.36 0.13 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.293 175.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.55 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.3 pt? -167.42 -59.35 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.562 -0.744 . . . . 0.0 112.119 -171.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . 0.55 ' N ' ' HG ' ' A' ' 391' ' ' LEU . . . -167.07 53.33 0.24 Allowed Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.216 -0.993 . . . . 0.0 114.059 -172.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . 0.629 ' HB2' ' CG ' ' A' ' 389' ' ' HIS . 0.4 OUTLIER -56.35 -44.07 79.7 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 117.314 0.557 . . . . 0.0 110.262 176.811 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . 0.624 HG11 ' CE2' ' A' ' 386' ' ' PHE . 1.9 m -55.25 -45.13 77.5 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.777 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 -178.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.591 ' N ' HG23 ' A' ' 394' ' ' VAL . 3.7 mp -58.02 -52.74 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 CA-C-O 117.853 -1.07 . . . . 0.0 113.544 -175.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . 0.573 ' O ' HG21 ' A' ' 399' ' ' VAL . 0.0 OUTLIER -63.2 -48.86 76.52 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 122.044 2.202 . . . . 0.0 112.139 -174.13 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . 0.464 ' O ' ' HG3' ' A' ' 401' ' ' GLN . . . -53.02 -44.49 62.33 Favored Glycine 0 N--CA 1.435 -1.414 0 C-N-CA 119.989 -1.101 . . . . 0.0 110.983 -177.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . 0.637 ' CD1' HD12 ' A' ' 410' ' ' LEU . 34.6 mt -71.83 -34.01 50.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . 0.573 HG21 ' O ' ' A' ' 396' ' ' LYS . 11.8 m -64.18 -40.44 89.05 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 C-N-CA 118.742 -1.183 . . . . 0.0 108.402 -173.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -64.27 -41.47 96.91 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 175.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . 0.464 ' HG3' ' O ' ' A' ' 397' ' ' GLY . 34.9 mt-30 -92.94 -49.74 5.89 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -170.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -111.74 -20.22 12.17 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.026 0.441 . . . . 0.0 111.227 -171.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 104.75 162.18 24.06 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.944 178.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . 0.63 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.5 m -54.03 -45.85 65.23 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.784 0 N-CA-C 114.568 1.322 . . . . 0.0 114.568 -175.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . 0.472 ' HB1' HG21 ' A' ' 457' ' ' ILE . . . -63.46 -33.04 74.69 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 119.851 -0.74 . . . . 0.0 112.26 -177.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 406' ' ' THR . . . . . 0.704 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 93.0 m -76.04 -41.91 49.36 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.199 174.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.517 ' HB3' ' HA ' ' A' ' 395' ' ' ILE . . . -58.49 -36.97 74.59 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 122.139 0.971 . . . . 0.0 109.221 176.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 408' ' ' TYR . . . . . 0.63 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -66.46 -52.78 42.6 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 113.471 -1.695 . . . . 0.0 110.06 177.336 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 409' ' ' THR . . . . . 0.546 HG22 HD22 ' A' ' 410' ' ' LEU . 1.7 m -56.4 -45.68 80.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.395 178.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . 0.704 ' HG ' ' O ' ' A' ' 406' ' ' THR . 13.3 mt -71.54 -36.88 71.12 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -176.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.95 -35.14 81.93 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.054 -1.07 . . . . 0.0 110.727 172.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -67.2 -47.93 69.42 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 115.719 -0.241 . . . . 0.0 111.386 177.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 413' ' ' MET . . . . . 0.912 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.6 OUTLIER -70.94 -46.81 61.78 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 118.813 -1.155 . . . . 0.0 111.912 -179.772 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . 0.912 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 14.7 mt -68.02 -44.96 75.32 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -176.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.434 ' HB2' ' HE3' ' A' ' 388' ' ' MET . 33.8 t -88.99 -16.28 32.09 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.732 0.777 . . . . 0.0 110.267 -175.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . 0.428 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 102.02 -175.8 25.36 Favored Glycine 0 N--CA 1.431 -1.681 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -171.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -79.95 23.63 0.44 Allowed 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.278 0.561 . . . . 0.0 111.7 -171.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 418' ' ' ASN . . . . . 0.526 ' OD1' ' HD2' ' A' ' 381' ' ' ARG . 64.8 m-80 -72.33 77.17 1.01 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.007 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 419' ' ' TYR . . . . . 0.555 ' CD1' ' HB3' ' A' ' 453' ' ' ALA . 11.6 p90 -53.01 -38.78 62.61 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.517 176.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.51 -44.14 76.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.784 0.326 . . . . 0.0 110.938 178.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.07 -49.36 61.8 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.293 -178.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . 0.433 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -65.99 -39.53 84.81 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 C-N-CA 120.376 -0.529 . . . . 0.0 111.209 -176.759 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.766 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 78.2 p -68.21 -37.99 81.47 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 -178.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -69.06 -37.16 82.31 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.072 176.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . 0.519 HG23 HG22 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.88 -53.32 19.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.42 0.152 . . . . 0.0 111.052 -178.746 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . 0.536 ' O ' HD23 ' A' ' 430' ' ' LEU . 1.1 mm -73.53 -22.89 19.16 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.828 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -172.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.766 ' HB2' ' O ' ' A' ' 423' ' ' SER . 0.9 OUTLIER -54.61 -32.54 58.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.142 0.496 . . . . 0.0 110.432 -178.663 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.02 -7.37 77.64 Favored Glycine 0 N--CA 1.44 -1.074 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.387 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.489 ' HD1' ' CG2' ' A' ' 395' ' ' ILE . 14.4 m-85 -117.21 0.58 12.32 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.079 0.466 . . . . 0.0 109.945 -176.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . 0.536 HD23 ' O ' ' A' ' 426' ' ' ILE . 0.1 OUTLIER -65.98 129.27 94.24 Favored Pre-proline 0 N--CA 1.446 -0.665 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.251 178.812 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . 0.529 ' HD2' HD11 ' A' ' 430' ' ' LEU . 90.3 Cg_exo -24.61 -68.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.359 1.113 1 C-N-CA 125.424 4.083 . . . . 0.0 115.029 179.709 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . 0.557 ' O ' HG11 ' A' ' 435' ' ' VAL . . . -142.07 -170.42 12.54 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 177.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . 0.505 ' O ' HG11 ' A' ' 436' ' ' VAL . 41.4 tp60 -68.13 -26.35 65.75 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 118.006 0.903 . . . . 0.0 110.458 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -66.29 -41.26 90.04 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -178.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 435' ' ' VAL . . . . . 0.557 HG11 ' O ' ' A' ' 432' ' ' GLY . 8.0 p -68.65 -43.81 82.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-O 120.929 0.395 . . . . 0.0 110.508 -177.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . 0.505 HG11 ' O ' ' A' ' 433' ' ' GLN . 0.1 OUTLIER -65.84 -30.55 50.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.512 175.538 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 1.1 m -69.16 -52.18 30.72 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . 0.786 ' O ' ' HG2' ' A' ' 442' ' ' ARG . . . -58.61 -37.42 75.83 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.823 177.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 439' ' ' LEU . . . . . 0.543 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 2.0 tm? -70.35 -47.18 62.15 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.37 -38.85 74.85 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.368 174.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 441' ' ' GLN . . . . . 0.461 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 35.9 mm-40 -53.47 -50.05 66.15 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 123.486 0.714 . . . . 0.0 110.562 174.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . 0.786 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 0.8 OUTLIER -56.83 -40.57 76.28 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.752 172.344 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 443' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 40.9 mt -72.64 -26.11 61.53 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.35 0.595 . . . . 0.0 110.865 -178.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -70.22 -36.38 74.5 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.008 177.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 445' ' ' GLN . . . . . 0.473 ' HG3' ' N ' ' A' ' 446' ' ' GLU . 0.0 OUTLIER -75.22 -30.19 60.51 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.026 178.098 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 446' ' ' GLU . . . . . 0.511 ' HB3' ' O ' ' A' ' 443' ' ' LEU . 13.6 pt-20 27.52 97.31 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.171 0 O-C-N 125.396 1.685 . . . . 0.0 113.646 175.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 49.3 mt -59.25 -35.12 56.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.206 0.527 . . . . 0.0 110.989 -178.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . 0.463 ' HB2' ' OG1' ' A' ' 451' ' ' THR . 17.1 m-20 -163.33 -157.8 0.44 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 -178.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -87.13 -67.31 0.83 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 171.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.2 -25.43 66.92 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 176.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 451' ' ' THR . . . . . 0.499 ' HA ' ' HB2' ' A' ' 454' ' ' GLU . 10.5 m -71.31 -22.64 61.91 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 119.906 -0.717 . . . . 0.0 110.602 -174.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . 0.431 ' NH2' ' HB3' ' A' ' 443' ' ' LEU . 19.0 mtp180 -53.53 -54.26 39.77 Favored 'General case' 0 C--O 1.22 -0.495 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 171.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 453' ' ' ALA . . . . . 0.555 ' HB3' ' CD1' ' A' ' 419' ' ' TYR . . . -58.4 -49.4 77.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.525 -1.216 . . . . 0.0 112.808 174.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . 0.499 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 16.0 mm-40 -51.15 -35.47 36.01 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.1 0.476 . . . . 0.0 112.049 -177.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 28.2 p -119.98 16.16 12.51 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.191 -176.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . 0.576 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.9 OUTLIER -55.23 -48.62 73.66 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.99 0.424 . . . . 0.0 111.639 -172.351 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . 0.524 ' CG1' ' HB3' ' A' ' 408' ' ' TYR . 1.9 mp -76.96 -33.05 20.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.964 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -57.97 -34.88 70.42 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.786 0.803 . . . . 0.0 109.347 171.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . 0.723 ' O ' HG21 ' A' ' 463' ' ' VAL . 63.3 m-70 -74.37 -28.82 61.29 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.639 177.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . 0.718 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.4 OUTLIER -73.93 -34.6 64.4 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.981 0.896 . . . . 0.0 108.787 178.559 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . 0.431 ' O ' ' HB2' ' A' ' 464' ' ' TYR . 26.9 m-80 -73.02 -37.58 66.89 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.992 0.901 . . . . 0.0 108.925 176.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 462' ' ' ALA . . . . . 0.609 ' O ' HD13 ' A' ' 466' ' ' ILE . . . -56.49 -34.46 66.97 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.491 -1.232 . . . . 0.0 109.814 169.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.723 HG21 ' O ' ' A' ' 459' ' ' HIS . 68.0 t -61.64 -50.89 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 175.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 464' ' ' TYR . . . . . 0.58 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 17.0 m-30 -53.01 -26.85 16.75 Favored 'General case' 0 C--N 1.33 -0.255 0 O-C-N 124.317 1.011 . . . . 0.0 110.664 177.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.14 -39.7 17.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.576 0.703 . . . . 0.0 109.821 -178.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.609 HD13 ' O ' ' A' ' 462' ' ' ALA . 3.7 mt -57.75 -55.64 20.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 114.421 -1.263 . . . . 0.0 112.157 175.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.737 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -101.64 -11.04 19.5 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -173.345 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . 0.571 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 93.94 31.57 8.06 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 119.38 -1.391 . . . . 0.0 114.353 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 469' ' ' LEU . . . . . 0.737 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 2.5 mt -88.08 159.38 18.26 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 117.777 0.789 . . . . 0.0 110.625 176.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . 0.514 HD21 HG23 ' A' ' 476' ' ' ILE . 12.0 p30 -104.76 -179.18 3.87 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.278 172.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -56.3 -27.79 56.68 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -173.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 -86.66 5.33 36.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.674 0.273 . . . . 0.0 111.607 -171.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . 0.451 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 77.68 11.84 85.05 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.325 -0.94 . . . . 0.0 111.472 -178.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 474' ' ' GLN . . . . . 0.404 ' HB2' HD22 ' A' ' 470' ' ' ASN . 56.0 mt-30 -101.09 158.0 16.34 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 177.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 5.3 p -97.34 122.43 40.37 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.171 0.51 . . . . 0.0 112.074 -176.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 476' ' ' ILE . . . . . 0.571 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.5 pp -85.8 -7.98 11.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.574 0.702 . . . . 0.0 110.005 178.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 30.2 mmm180 -70.24 -24.86 63.15 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.838 -1.073 . . . . 0.0 109.955 174.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 85.3 mt -108.79 -51.8 2.84 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.629 -177.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.666 -0.683 . . . . 0.0 110.741 -179.145 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 381' ' ' ARG . . . . . 0.545 ' HD2' ' OD1' ' B' ' 418' ' ' ASN . 13.5 ptp180 . . . . . 0 N--CA 1.478 0.929 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 382' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.86 -39.12 0.38 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -176.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 383' ' ' HIS . . . . . 0.547 ' HB2' ' O ' ' B' ' 386' ' ' PHE . 24.4 p80 -164.88 152.77 11.69 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.163 -0.615 . . . . 0.0 112.223 -173.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 384' ' ' GLY . . . . . . . . . . . . . . . -119.18 -86.97 1.07 Allowed Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.603 173.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 385' ' ' THR . . . . . . . . . . . . . 5.6 m -68.35 -41.36 80.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.898 0.38 . . . . 0.0 111.431 -178.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 386' ' ' PHE . . . . . 0.618 ' CE2' HG11 ' B' ' 394' ' ' VAL . 2.3 t80 -88.79 123.66 67.23 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.428 -176.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 387' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' B' ' 386' ' ' PHE . 42.6 Cg_endo -65.69 111.38 1.89 Allowed 'Trans proline' 0 N--CA 1.481 0.76 0 C-N-CA 123.929 3.086 . . . . 0.0 112.431 173.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 388' ' ' MET . . . . . 0.552 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 33.8 ttm -121.12 47.88 1.75 Allowed 'General case' 0 C--N 1.32 -0.716 0 O-C-N 122.094 -0.379 . . . . 0.0 111.645 -169.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 389' ' ' HIS . . . . . 0.627 ' CG ' ' HB2' ' B' ' 393' ' ' ASN . 38.4 m170 57.04 -90.21 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.443 0.64 . . . . 0.0 109.481 -171.016 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -160.29 17.0 0.14 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.986 -1.006 . . . . 0.0 108.348 174.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 391' ' ' LEU . . . . . 0.548 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.3 pt? -167.11 -59.55 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.074 -171.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 392' ' ' GLY . . . . . 0.548 ' N ' ' HG ' ' B' ' 391' ' ' LEU . . . -166.86 53.28 0.24 Allowed Glycine 0 C--N 1.335 0.523 0 C-N-CA 120.232 -0.985 . . . . 0.0 114.181 -172.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 393' ' ' ASN . . . . . 0.627 ' HB2' ' CG ' ' B' ' 389' ' ' HIS . 0.4 OUTLIER -56.2 -44.19 79.21 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 117.238 0.519 . . . . 0.0 110.258 176.789 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 394' ' ' VAL . . . . . 0.618 HG11 ' CE2' ' B' ' 386' ' ' PHE . 1.9 m -55.32 -45.06 77.73 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.756 0 N-CA-C 106.706 -1.591 . . . . 0.0 106.706 -178.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 395' ' ' ILE . . . . . 0.596 ' N ' HG23 ' B' ' 394' ' ' VAL . 3.7 mp -57.98 -52.69 55.14 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.526 0 CA-C-O 117.77 -1.11 . . . . 0.0 113.59 -176.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 396' ' ' LYS . . . . . 0.586 ' O ' HG21 ' B' ' 399' ' ' VAL . 0.0 OUTLIER -63.22 -49.24 74.96 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 122.055 2.207 . . . . 0.0 111.932 -174.126 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 397' ' ' GLY . . . . . 0.466 ' O ' ' HG3' ' B' ' 401' ' ' GLN . . . -52.72 -44.43 60.44 Favored Glycine 0 N--CA 1.436 -1.336 0 C-N-CA 119.986 -1.102 . . . . 0.0 111.009 -177.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . 0.632 ' CD1' HD12 ' B' ' 410' ' ' LEU . 33.5 mt -71.82 -33.88 49.67 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 399' ' ' VAL . . . . . 0.586 HG21 ' O ' ' B' ' 396' ' ' LYS . 11.9 m -64.38 -40.39 88.88 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 C-N-CA 118.793 -1.163 . . . . 0.0 108.429 -173.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -64.27 -41.65 96.81 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 174.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 401' ' ' GLN . . . . . 0.466 ' HG3' ' O ' ' B' ' 397' ' ' GLY . 35.2 mt-30 -92.86 -49.66 5.94 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -170.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 402' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -111.75 -20.19 12.17 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.018 0.437 . . . . 0.0 111.265 -171.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 104.89 162.33 23.95 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.953 177.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 404' ' ' VAL . . . . . 0.629 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.6 m -54.08 -45.88 65.89 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.769 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 -175.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 405' ' ' ALA . . . . . 0.48 ' HB1' HG21 ' B' ' 457' ' ' ILE . . . -63.49 -33.03 74.68 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 119.785 -0.766 . . . . 0.0 112.337 -177.012 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 406' ' ' THR . . . . . 0.689 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 93.5 m -75.95 -42.09 49.61 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.251 174.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 407' ' ' ALA . . . . . 0.503 ' HB3' ' HA ' ' B' ' 395' ' ' ILE . . . -58.45 -36.83 74.28 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 122.145 0.974 . . . . 0.0 109.263 176.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 408' ' ' TYR . . . . . 0.629 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -66.53 -52.75 42.46 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 113.541 -1.663 . . . . 0.0 110.027 177.344 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 409' ' ' THR . . . . . 0.54 HG22 HD22 ' B' ' 410' ' ' LEU . 1.8 m -56.31 -45.68 80.15 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.44 178.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 410' ' ' LEU . . . . . 0.689 ' HG ' ' O ' ' B' ' 406' ' ' THR . 13.4 mt -71.69 -36.91 70.73 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -176.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.85 -35.18 81.37 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.064 -1.065 . . . . 0.0 110.73 172.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 412' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -67.34 -47.95 68.94 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 115.693 -0.254 . . . . 0.0 111.301 178.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 413' ' ' MET . . . . . 0.913 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.6 OUTLIER -70.91 -46.9 61.69 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 118.811 -1.155 . . . . 0.0 111.881 -179.945 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 414' ' ' LEU . . . . . 0.913 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 14.9 mt -67.84 -44.97 75.97 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -175.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 415' ' ' SER . . . . . 0.445 ' HB2' ' HE3' ' B' ' 388' ' ' MET . 33.9 t -89.03 -16.46 31.57 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.555 0.693 . . . . 0.0 110.264 -175.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 416' ' ' GLY . . . . . 0.422 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 102.44 -175.92 24.98 Favored Glycine 0 N--CA 1.43 -1.758 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 -171.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -79.96 23.51 0.45 Allowed 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.362 0.601 . . . . 0.0 111.724 -171.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 418' ' ' ASN . . . . . 0.545 ' OD1' ' HD2' ' B' ' 381' ' ' ARG . 64.1 m-80 -72.23 77.17 0.98 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.946 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 419' ' ' TYR . . . . . 0.55 ' CD1' ' HB3' ' B' ' 453' ' ' ALA . 11.5 p90 -53.13 -38.77 62.96 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.399 176.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.47 -44.08 76.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.613 0.244 . . . . 0.0 110.972 178.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.32 -49.33 61.14 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.18 -178.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 422' ' ' VAL . . . . . 0.432 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.2 OUTLIER -65.92 -39.37 84.46 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.205 -176.643 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 423' ' ' SER . . . . . 0.789 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 78.4 p -68.5 -37.69 80.32 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.87 -178.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -69.32 -37.19 79.93 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.039 176.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 425' ' ' ILE . . . . . 0.539 HG23 HG22 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -72.65 -53.37 19.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 O-C-N 122.907 -0.173 . . . . 0.0 111.116 -178.828 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 426' ' ' ILE . . . . . 0.531 ' O ' HD23 ' B' ' 430' ' ' LEU . 1.1 mm -73.59 -22.77 19.03 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.768 0 CA-C-O 120.801 0.334 . . . . 0.0 110.176 -172.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 427' ' ' ARG . . . . . 0.789 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.9 OUTLIER -54.94 -32.21 61.14 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.236 0.541 . . . . 0.0 110.522 -178.63 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -86.98 -7.47 77.58 Favored Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.449 179.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 429' ' ' TYR . . . . . 0.502 ' HD1' ' CG2' ' B' ' 395' ' ' ILE . 14.7 m-85 -117.29 0.61 12.29 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.096 0.474 . . . . 0.0 109.856 -176.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 430' ' ' LEU . . . . . 0.54 ' HA ' HG13 ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.86 129.27 94.26 Favored Pre-proline 0 N--CA 1.445 -0.702 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.152 178.816 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 431' ' ' PRO . . . . . 0.52 ' HD2' HD11 ' B' ' 430' ' ' LEU . 87.0 Cg_exo -24.43 -69.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.358 1.068 1 C-N-CA 125.4 4.067 . . . . 0.0 114.879 179.532 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 432' ' ' GLY . . . . . 0.543 ' O ' HG11 ' B' ' 435' ' ' VAL . . . -141.12 -169.87 11.97 Favored Glycine 0 N--CA 1.44 -1.038 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 177.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 433' ' ' GLN . . . . . 0.497 ' O ' HG11 ' B' ' 436' ' ' VAL . 41.2 tp60 -68.39 -26.37 65.52 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 118.062 0.931 . . . . 0.0 110.574 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -66.17 -41.46 90.29 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -178.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 435' ' ' VAL . . . . . 0.543 HG11 ' O ' ' B' ' 432' ' ' GLY . 7.9 p -68.38 -43.97 83.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-O 121.071 0.463 . . . . 0.0 110.506 -177.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 436' ' ' VAL . . . . . 0.497 HG11 ' O ' ' B' ' 433' ' ' GLN . 0.1 OUTLIER -65.76 -30.56 50.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.452 175.65 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 1.1 m -69.08 -52.2 30.87 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -178.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 438' ' ' ALA . . . . . 0.8 ' O ' ' HG2' ' B' ' 442' ' ' ARG . . . -58.68 -37.32 75.79 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.81 177.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 439' ' ' LEU . . . . . 0.554 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 2.0 tm? -70.38 -47.19 62.07 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.37 -38.83 74.84 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.303 174.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 441' ' ' GLN . . . . . 0.458 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 35.2 mm-40 -53.46 -50.05 66.13 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 123.519 0.728 . . . . 0.0 110.604 174.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 442' ' ' ARG . . . . . 0.8 ' HG2' ' O ' ' B' ' 438' ' ' ALA . 0.8 OUTLIER -56.68 -40.81 76.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.751 172.215 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 443' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 40.6 mt -72.6 -26.14 61.58 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.273 0.558 . . . . 0.0 110.833 -178.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -70.06 -36.51 75.02 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.874 177.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 445' ' ' GLN . . . . . 0.466 ' HG3' ' N ' ' B' ' 446' ' ' GLU . 0.0 OUTLIER -74.94 -30.17 61.16 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.594 -1.185 . . . . 0.0 109.023 178.321 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 446' ' ' GLU . . . . . 0.529 ' HB3' ' O ' ' B' ' 443' ' ' LEU . 13.4 pt-20 27.48 96.9 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 O-C-N 125.42 1.7 . . . . 0.0 113.65 175.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 49.7 mt -59.09 -35.0 54.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.158 0.504 . . . . 0.0 110.95 -178.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 448' ' ' ASP . . . . . 0.459 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 16.3 m-20 -163.0 -156.92 0.41 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 -178.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -87.97 -67.21 0.84 Allowed 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 171.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.13 -25.45 66.98 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 176.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 451' ' ' THR . . . . . 0.497 ' HA ' ' HB2' ' B' ' 454' ' ' GLU . 10.5 m -71.37 -22.65 61.87 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 119.946 -0.701 . . . . 0.0 110.679 -174.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 452' ' ' ARG . . . . . 0.432 ' NH2' ' HB3' ' B' ' 443' ' ' LEU . 19.0 mtp180 -53.57 -54.27 39.88 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 171.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 453' ' ' ALA . . . . . 0.55 ' HB3' ' CD1' ' B' ' 419' ' ' TYR . . . -58.24 -49.49 76.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.507 -1.224 . . . . 0.0 112.707 174.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 454' ' ' GLU . . . . . 0.497 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 16.2 mm-40 -51.32 -35.15 36.6 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.22 0.533 . . . . 0.0 112.153 -176.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 28.8 p -120.26 16.19 12.28 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.143 -176.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 456' ' ' PHE . . . . . 0.58 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 1.0 OUTLIER -55.27 -48.73 73.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.957 0.408 . . . . 0.0 111.516 -172.331 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 457' ' ' ILE . . . . . 0.537 ' CG1' ' HB3' ' B' ' 408' ' ' TYR . 1.9 mp -76.46 -33.19 22.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.149 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -58.06 -34.91 70.62 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.821 0.82 . . . . 0.0 109.227 171.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 459' ' ' HIS . . . . . 0.718 ' O ' HG21 ' B' ' 463' ' ' VAL . 63.7 m-70 -74.37 -28.85 61.3 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.583 -1.189 . . . . 0.0 110.596 177.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 460' ' ' LEU . . . . . 0.722 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -73.8 -34.75 64.75 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.951 0.881 . . . . 0.0 108.808 178.407 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 461' ' ' ASN . . . . . 0.432 ' O ' ' HB2' ' B' ' 464' ' ' TYR . 26.4 m-80 -72.81 -37.6 67.48 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.34 -0.846 . . . . 0.0 108.965 176.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 462' ' ' ALA . . . . . 0.619 ' O ' HD13 ' B' ' 466' ' ' ILE . . . -56.51 -34.48 67.04 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.352 -1.295 . . . . 0.0 109.796 169.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 463' ' ' VAL . . . . . 0.722 ' HB ' ' O ' ' B' ' 460' ' ' LEU . 65.1 t -61.79 -50.63 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 175.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 464' ' ' TYR . . . . . 0.571 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 17.1 m-30 -53.12 -27.05 18.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.683 177.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.98 -39.69 17.79 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.775 0.798 . . . . 0.0 109.775 -178.073 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 466' ' ' ILE . . . . . 0.619 HD13 ' O ' ' B' ' 462' ' ' ALA . 3.6 mt -57.72 -55.4 21.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.204 175.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 467' ' ' LEU . . . . . 0.732 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -101.73 -11.12 19.37 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 -173.484 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 468' ' ' GLY . . . . . 0.58 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 93.97 31.43 8.13 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 119.241 -1.457 . . . . 0.0 114.35 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 469' ' ' LEU . . . . . 0.732 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 2.5 mt -88.19 159.39 18.18 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 117.818 0.809 . . . . 0.0 110.606 176.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 470' ' ' ASN . . . . . 0.488 HD21 HG23 ' B' ' 476' ' ' ILE . 12.1 p30 -104.82 -179.6 3.99 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.101 172.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 471' ' ' ALA . . . . . . . . . . . . . . . -55.7 -28.21 54.44 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -173.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -86.29 4.95 36.79 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 122.314 -0.241 . . . . 0.0 111.56 -171.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 473' ' ' GLY . . . . . 0.456 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 78.0 11.82 85.01 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.384 -0.913 . . . . 0.0 111.475 -178.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 474' ' ' GLN . . . . . 0.405 ' HB2' HD22 ' B' ' 470' ' ' ASN . 56.5 mt-30 -101.07 158.12 16.25 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 177.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 6.0 p -97.3 122.64 40.57 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.327 0.584 . . . . 0.0 112.114 -176.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 476' ' ' ILE . . . . . 0.58 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.5 pp -85.9 -7.87 11.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.579 0.704 . . . . 0.0 110.006 178.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 477' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -70.46 -25.08 63.01 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.787 174.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 478' ' ' LEU . . . . . . . . . . . . . 85.4 mt -108.49 -51.34 2.9 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.75 -177.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 479' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.669 -0.681 . . . . 0.0 110.79 -179.226 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 381' ' ' ARG . . . . . 0.421 ' HG3' ' N ' ' A' ' 382' ' ' THR . 18.9 ptt180 . . . . . 0 N--CA 1.475 0.817 0 CA-C-O 120.51 0.195 . . . . 0.0 110.777 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 382' ' ' THR . . . . . 0.421 ' N ' ' HG3' ' A' ' 381' ' ' ARG . 0.1 OUTLIER 173.7 -46.0 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 123.01 0.524 . . . . 0.0 109.74 -176.211 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -132.39 131.38 41.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.529 177.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -145.35 -135.76 2.89 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 177.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 25.6 m -69.05 -32.15 71.44 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 171.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 386' ' ' PHE . . . . . 0.791 ' CZ ' HG13 ' A' ' 394' ' ' VAL . 1.4 t80 -91.75 122.53 65.37 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.252 -0.886 . . . . 0.0 108.694 172.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -47.6 -75.25 0.03 OUTLIER 'Trans proline' 0 N--CA 1.479 0.625 0 C-N-CA 124.463 3.442 . . . . 0.0 115.125 -174.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 388' ' ' MET . . . . . 0.56 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 28.5 mtt 73.63 146.69 0.08 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.759 0.824 . . . . 0.0 111.225 -171.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 389' ' ' HIS . . . . . 0.511 ' CG ' ' HB2' ' A' ' 393' ' ' ASN . 32.7 m170 -49.29 -65.28 0.59 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.587 0.708 . . . . 0.0 109.519 178.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . 0.424 ' H ' HD22 ' A' ' 391' ' ' LEU . 3.7 pt20 -168.29 26.65 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.518 -1.219 . . . . 0.0 108.153 173.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.637 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.1 pt? -178.04 -65.31 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -167.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . 0.637 ' N ' ' HG ' ' A' ' 391' ' ' LEU . . . -163.64 49.9 0.3 Allowed Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.955 -0.64 . . . . 0.0 113.154 -168.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . 0.56 ' HB3' ' HA ' ' A' ' 388' ' ' MET . 0.4 OUTLIER -56.31 -37.68 70.24 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 177.942 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . 0.791 HG13 ' CZ ' ' A' ' 386' ' ' PHE . 0.9 OUTLIER -56.25 -47.39 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 178.681 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.54 HG22 HG21 ' A' ' 425' ' ' ILE . 4.2 mp -57.66 -51.8 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.275 0 CA-C-O 118.108 -0.948 . . . . 0.0 112.967 -174.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . 0.663 ' HG3' ' CZ ' ' A' ' 429' ' ' TYR . 0.2 OUTLIER -62.52 -48.98 77.15 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 121.359 1.891 . . . . 0.0 111.415 -174.205 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -55.19 -45.38 82.67 Favored Glycine 0 N--CA 1.434 -1.486 0 C-N-CA 120.131 -1.033 . . . . 0.0 111.166 -179.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . 0.713 ' CD1' HD12 ' A' ' 410' ' ' LEU . 28.2 mt -70.46 -33.84 55.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -177.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . 0.548 HG21 ' O ' ' A' ' 396' ' ' LYS . 11.8 m -63.89 -39.59 85.97 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 C-N-CA 118.798 -1.161 . . . . 0.0 108.385 -174.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -69.92 -36.65 75.53 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 175.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -87.58 -48.19 8.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.089 0.471 . . . . 0.0 111.944 -171.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . 0.416 ' HB3' ' HB ' ' A' ' 406' ' ' THR . 1.9 mm-40 -121.41 -20.43 6.63 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.757 -170.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 107.4 162.38 21.62 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.046 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . 0.65 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.5 m -53.45 -41.82 46.52 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.723 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 -176.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . 0.513 ' HB2' HG22 ' A' ' 457' ' ' ILE . . . -69.04 -30.36 68.7 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.795 -176.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 406' ' ' THR . . . . . 0.704 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 90.5 m -77.29 -42.31 37.46 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.162 -0.615 . . . . 0.0 109.981 173.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.5 ' HB2' ' HA ' ' A' ' 395' ' ' ILE . . . -58.41 -36.98 74.42 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 122.123 0.963 . . . . 0.0 109.038 176.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 408' ' ' TYR . . . . . 0.65 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.7 -52.25 52.87 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 113.445 -1.707 . . . . 0.0 110.083 176.61 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 409' ' ' THR . . . . . 0.542 HG21 HD23 ' A' ' 410' ' ' LEU . 3.4 m -55.71 -46.56 77.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.674 178.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . 0.713 HD12 ' CD1' ' A' ' 398' ' ' ILE . 14.0 mt -72.22 -35.86 68.98 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.048 0.451 . . . . 0.0 110.358 -174.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -59.63 -34.86 83.7 Favored Glycine 0 N--CA 1.438 -1.205 0 C-N-CA 120.224 -0.989 . . . . 0.0 110.83 171.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -68.26 -43.72 77.18 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 178.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 413' ' ' MET . . . . . 0.736 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.0 OUTLIER -70.5 -57.65 4.55 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 118.822 -1.151 . . . . 0.0 111.549 179.607 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . 0.736 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 4.6 mt -67.35 -43.7 80.88 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -172.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.441 ' HB2' ' HE1' ' A' ' 388' ' ' MET . 5.2 t -95.45 18.14 13.23 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.482 0.658 . . . . 0.0 109.975 -174.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 73.17 -177.93 41.81 Favored Glycine 0 N--CA 1.437 -1.245 0 C-N-CA 120.357 -0.925 . . . . 0.0 111.675 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 33.9 mm-40 -80.69 23.13 0.54 Allowed 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.199 0.524 . . . . 0.0 111.616 -173.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 418' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -71.73 77.65 0.85 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.72 -179.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 419' ' ' TYR . . . . . 0.537 ' CD1' ' HB1' ' A' ' 453' ' ' ALA . 14.6 p90 -54.47 -37.85 65.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.549 177.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -54.97 -43.04 73.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.625 0.25 . . . . 0.0 110.644 177.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.42 -48.85 63.54 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.152 -178.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . 0.481 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.3 OUTLIER -66.32 -40.53 86.99 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 C-N-CA 120.235 -0.586 . . . . 0.0 111.239 -177.142 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.748 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 65.9 p -67.06 -38.29 85.52 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -178.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.29 -40.26 92.02 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.129 175.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . 0.54 HG21 HG22 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.61 -50.13 36.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 O-C-N 122.883 -0.187 . . . . 0.0 110.934 -176.996 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . 0.526 ' O ' HD23 ' A' ' 430' ' ' LEU . 1.2 mm -74.55 -22.62 17.66 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -172.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.748 ' HB2' ' O ' ' A' ' 423' ' ' SER . 0.9 OUTLIER -54.86 -30.2 57.17 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.088 0.47 . . . . 0.0 110.756 -178.581 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -86.81 -9.12 75.11 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.458 178.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.663 ' CZ ' ' HG3' ' A' ' 396' ' ' LYS . 23.0 m-85 -115.87 1.03 13.29 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-O 120.995 0.426 . . . . 0.0 110.478 -177.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . 0.544 ' HA ' HG12 ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.82 127.38 93.05 Favored Pre-proline 0 N--CA 1.439 -1.019 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 178.505 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . 0.52 ' HD2' HD11 ' A' ' 430' ' ' LEU . 84.6 Cg_exo -22.7 -74.88 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 1.012 1 C-N-CA 125.653 4.235 . . . . 0.0 114.72 -179.102 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . 0.489 ' O ' HG12 ' A' ' 435' ' ' VAL . . . -129.27 -166.53 11.93 Favored Glycine 0 N--CA 1.441 -0.99 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 172.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . 0.619 ' O ' HG12 ' A' ' 436' ' ' VAL . 21.6 tt0 -71.61 -26.64 62.67 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 118.838 1.319 . . . . 0.0 110.587 176.12 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -62.26 -38.34 88.92 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.833 -176.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 435' ' ' VAL . . . . . 0.489 HG12 ' O ' ' A' ' 432' ' ' GLY . 7.5 p -69.76 -43.34 80.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-O 120.839 0.352 . . . . 0.0 110.611 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . 0.619 HG12 ' O ' ' A' ' 433' ' ' GLN . 0.2 OUTLIER -66.42 -30.17 48.94 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-O 120.822 0.344 . . . . 0.0 110.299 175.028 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 437' ' ' THR . . . . . 0.401 HG21 ' N ' ' A' ' 438' ' ' ALA . 0.9 OUTLIER -69.37 -52.0 31.35 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -178.156 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . 0.71 ' O ' ' HG2' ' A' ' 442' ' ' ARG . . . -57.42 -43.04 83.48 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.99 176.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 439' ' ' LEU . . . . . 0.613 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 2.0 tm? -65.28 -47.35 76.97 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -176.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.99 -39.11 77.42 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.228 174.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 441' ' ' GLN . . . . . 0.556 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 8.7 mm-40 -56.85 -50.46 72.37 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 123.379 0.672 . . . . 0.0 110.631 176.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . 0.71 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -58.65 -33.78 70.46 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.924 172.601 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 443' ' ' LEU . . . . . 0.613 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 59.5 mt -72.21 -33.99 68.02 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.024 0.44 . . . . 0.0 110.163 178.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -57.69 -36.75 72.37 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.319 173.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -72.6 -27.13 61.98 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.963 177.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 446' ' ' GLU . . . . . 0.559 ' HB2' ' O ' ' A' ' 443' ' ' LEU . 38.2 tt0 29.53 96.88 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 170.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 50.3 mt -68.33 -35.46 71.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.062 0.458 . . . . 0.0 110.882 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . 0.537 ' O ' ' HG3' ' A' ' 452' ' ' ARG . 36.8 m-20 -165.83 -166.78 0.98 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 -178.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 449' ' ' ASP . . . . . 0.458 ' CG ' ' H ' ' A' ' 450' ' ' GLN . 11.3 p-10 -79.63 -63.81 1.33 Allowed 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.23 -0.588 . . . . 0.0 109.525 172.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 450' ' ' GLN . . . . . 0.458 ' H ' ' CG ' ' A' ' 449' ' ' ASP . 0.0 OUTLIER -69.58 -25.97 64.24 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 178.725 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 451' ' ' THR . . . . . 0.461 ' HA ' ' HB2' ' A' ' 454' ' ' GLU . 12.1 m -71.85 -22.43 61.54 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.692 -175.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . 0.537 ' HG3' ' O ' ' A' ' 448' ' ' ASP . 11.1 mtp180 -53.11 -54.51 34.53 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 170.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 453' ' ' ALA . . . . . 0.537 ' HB1' ' CD1' ' A' ' 419' ' ' TYR . . . -57.93 -50.42 73.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.363 -1.29 . . . . 0.0 112.595 175.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . 0.461 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 31.4 mm-40 -49.73 -38.26 32.71 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.386 0.612 . . . . 0.0 111.729 -176.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 32.0 p -117.45 16.03 14.69 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.246 -176.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . 0.568 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 1.1 t80 -55.71 -47.36 76.98 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.169 0.509 . . . . 0.0 111.479 -171.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . 0.513 HG22 ' HB2' ' A' ' 405' ' ' ALA . 2.0 mp -75.41 -32.1 24.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.909 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -58.38 -35.78 72.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.67 0.748 . . . . 0.0 109.361 171.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . 0.723 ' O ' HG21 ' A' ' 463' ' ' VAL . 82.8 m-70 -72.44 -29.2 63.48 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.711 -1.132 . . . . 0.0 110.198 178.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . 0.73 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -74.51 -34.57 63.07 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.913 0.863 . . . . 0.0 108.929 179.129 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . 0.44 ' HA ' ' CD2' ' A' ' 464' ' ' TYR . 22.0 m-80 -72.83 -37.81 67.33 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.232 176.037 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 462' ' ' ALA . . . . . 0.64 ' O ' HD11 ' A' ' 466' ' ' ILE . . . -56.62 -33.1 65.95 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.852 169.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.73 ' HB ' ' O ' ' A' ' 460' ' ' LEU . 63.4 t -62.42 -50.78 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 CA-C-N 114.49 -1.232 . . . . 0.0 107.831 175.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 464' ' ' TYR . . . . . 0.547 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 16.2 m-30 -53.92 -27.77 32.77 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.53 178.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.8 -38.91 20.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.868 0.842 . . . . 0.0 109.337 -177.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.64 HD11 ' O ' ' A' ' 462' ' ' ALA . 3.7 mt -57.91 -56.08 17.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 114.172 -1.377 . . . . 0.0 112.463 174.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.744 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -102.78 -10.62 18.97 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -171.512 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . 0.587 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 94.12 31.73 7.89 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 119.46 -1.353 . . . . 0.0 114.241 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 469' ' ' LEU . . . . . 0.744 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.1 mt -89.69 164.06 14.86 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 117.718 0.759 . . . . 0.0 111.13 176.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 37.6 p30 -105.61 -178.69 3.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.816 171.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 471' ' ' ALA . . . . . 0.517 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -69.98 -5.99 30.17 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -174.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -96.75 0.67 49.87 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.9 0.381 . . . . 0.0 110.885 -178.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . 0.426 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 79.31 12.47 83.86 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.443 -0.884 . . . . 0.0 111.2 -175.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -100.19 157.35 16.65 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 178.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 12.7 p -95.28 127.95 41.74 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.066 0.46 . . . . 0.0 111.333 -178.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 476' ' ' ILE . . . . . 0.587 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.9 pp -98.71 5.69 9.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.788 0.804 . . . . 0.0 110.212 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -66.36 -30.8 71.27 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.443 -1.253 . . . . 0.0 110.515 176.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 84.3 mt 54.85 62.06 2.69 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.54 0.686 . . . . 0.0 110.688 177.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 . . . . . 0 C--O 1.25 1.093 0 CA-C-N 115.087 -0.961 . . . . 0.0 109.946 -179.766 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 381' ' ' ARG . . . . . 0.422 ' HG3' ' N ' ' B' ' 382' ' ' THR . 18.9 ptt180 . . . . . 0 N--CA 1.477 0.921 0 CA-C-O 120.476 0.179 . . . . 0.0 110.774 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 382' ' ' THR . . . . . 0.422 ' N ' ' HG3' ' B' ' 381' ' ' ARG . 0.1 OUTLIER 173.87 -45.97 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 123.04 0.536 . . . . 0.0 109.711 -176.116 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 383' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -132.49 131.43 41.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.589 177.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 384' ' ' GLY . . . . . . . . . . . . . . . -145.15 -136.15 2.96 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 177.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 385' ' ' THR . . . . . . . . . . . . . 26.0 m -68.8 -32.38 72.05 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 171.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 386' ' ' PHE . . . . . 0.793 ' CZ ' HG13 ' B' ' 394' ' ' VAL . 1.4 t80 -91.61 122.41 65.77 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 172.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 387' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -47.38 -75.32 0.03 OUTLIER 'Trans proline' 0 N--CA 1.481 0.763 0 C-N-CA 124.44 3.427 . . . . 0.0 115.164 -174.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 388' ' ' MET . . . . . 0.569 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 28.4 mtt 73.69 146.6 0.08 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.698 0.799 . . . . 0.0 111.116 -171.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 389' ' ' HIS . . . . . 0.525 ' CG ' ' HB2' ' B' ' 393' ' ' ASN . 32.8 m170 -49.19 -64.99 0.64 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.606 0.717 . . . . 0.0 109.569 178.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 390' ' ' GLN . . . . . 0.431 ' H ' HD22 ' B' ' 391' ' ' LEU . 3.7 pt20 -168.74 26.61 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.509 -1.223 . . . . 0.0 108.245 173.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 391' ' ' LEU . . . . . 0.617 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.1 pt? -177.98 -65.44 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -167.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 392' ' ' GLY . . . . . 0.617 ' N ' ' HG ' ' B' ' 391' ' ' LEU . . . -163.66 50.1 0.3 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.082 -168.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 393' ' ' ASN . . . . . 0.569 ' HB3' ' HA ' ' B' ' 388' ' ' MET . 0.4 OUTLIER -56.38 -37.77 70.55 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.901 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 394' ' ' VAL . . . . . 0.793 HG13 ' CZ ' ' B' ' 386' ' ' PHE . 0.9 OUTLIER -56.22 -47.36 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 178.705 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 395' ' ' ILE . . . . . 0.548 HG22 HG21 ' B' ' 425' ' ' ILE . 4.3 mp -57.81 -51.67 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 CA-C-O 118.034 -0.984 . . . . 0.0 112.946 -174.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 396' ' ' LYS . . . . . 0.662 ' HG3' ' CZ ' ' B' ' 429' ' ' TYR . 0.2 OUTLIER -62.53 -48.8 77.93 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 121.482 1.946 . . . . 0.0 111.537 -174.219 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -55.24 -45.59 82.21 Favored Glycine 0 N--CA 1.434 -1.452 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.132 -179.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . 0.696 ' CD1' HD12 ' B' ' 410' ' ' LEU . 28.1 mt -70.34 -33.8 55.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -177.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 399' ' ' VAL . . . . . 0.543 HG21 ' O ' ' B' ' 396' ' ' LYS . 12.0 m -63.9 -39.47 85.56 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 C-N-CA 118.754 -1.178 . . . . 0.0 108.489 -174.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -70.12 -36.63 74.95 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 175.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 401' ' ' GLN . . . . . . . . . . . . . 3.0 mm100 -87.47 -48.11 8.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.966 0.412 . . . . 0.0 111.988 -171.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 402' ' ' GLU . . . . . 0.422 ' HB3' ' HB ' ' B' ' 406' ' ' THR . 2.0 mm-40 -121.27 -21.02 6.5 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.678 -170.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 108.33 162.77 20.83 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.905 -0.664 . . . . 0.0 113.096 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 404' ' ' VAL . . . . . 0.641 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.5 m -53.71 -41.56 47.87 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.751 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -176.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 405' ' ' ALA . . . . . 0.496 ' HB2' HG22 ' B' ' 457' ' ' ILE . . . -69.32 -30.36 68.39 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 119.649 -0.821 . . . . 0.0 111.725 -175.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 406' ' ' THR . . . . . 0.7 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 93.8 m -77.56 -42.39 35.49 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 174.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 407' ' ' ALA . . . . . 0.487 ' HB2' ' HA ' ' B' ' 395' ' ' ILE . . . -58.41 -37.12 74.69 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 122.104 0.954 . . . . 0.0 108.935 176.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 408' ' ' TYR . . . . . 0.641 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.51 -52.4 52.95 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 113.492 -1.686 . . . . 0.0 110.046 176.534 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 409' ' ' THR . . . . . 0.556 HG21 HD23 ' B' ' 410' ' ' LEU . 3.3 m -55.79 -46.64 77.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.582 178.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 410' ' ' LEU . . . . . 0.7 ' HG ' ' O ' ' B' ' 406' ' ' THR . 13.8 mt -72.05 -36.04 69.5 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.124 0.488 . . . . 0.0 110.314 -174.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -59.59 -34.86 83.54 Favored Glycine 0 N--CA 1.439 -1.142 0 C-N-CA 120.213 -0.994 . . . . 0.0 110.825 171.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 412' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -68.24 -43.78 77.14 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.517 0.191 . . . . 0.0 111.517 178.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 413' ' ' MET . . . . . 0.722 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.0 OUTLIER -70.52 -57.69 4.5 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 118.772 -1.171 . . . . 0.0 111.546 179.721 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 414' ' ' LEU . . . . . 0.722 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 4.7 mt -67.24 -43.74 81.18 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 -172.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 415' ' ' SER . . . . . 0.434 ' HB2' ' HE1' ' B' ' 388' ' ' MET . 5.3 t -95.28 18.03 13.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.421 0.629 . . . . 0.0 110.108 -174.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 416' ' ' GLY . . . . . 0.406 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 73.08 -178.29 40.96 Favored Glycine 0 N--CA 1.438 -1.186 0 C-N-CA 120.427 -0.892 . . . . 0.0 111.659 -178.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -80.46 23.22 0.51 Allowed 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.009 0.433 . . . . 0.0 111.493 -173.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 418' ' ' ASN . . . . . 0.406 ' H ' ' C ' ' B' ' 416' ' ' GLY . 4.4 m-20 -71.58 77.9 0.81 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.834 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 419' ' ' TYR . . . . . 0.542 ' CD1' ' HB1' ' B' ' 453' ' ' ALA . 14.5 p90 -54.88 -37.6 66.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.482 178.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -54.97 -43.12 73.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.723 0.297 . . . . 0.0 110.651 177.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.46 -48.79 63.6 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.148 -178.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 422' ' ' VAL . . . . . 0.478 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.3 OUTLIER -66.34 -40.66 87.28 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 C-N-CA 120.261 -0.576 . . . . 0.0 111.13 -177.17 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 423' ' ' SER . . . . . 0.74 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 69.4 p -67.03 -38.13 85.36 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.659 -0.416 . . . . 0.0 109.903 -178.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.42 -40.02 91.42 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.321 175.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 425' ' ' ILE . . . . . 0.548 HG21 HG22 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -72.68 -50.24 35.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.553 0.216 . . . . 0.0 110.887 -177.096 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 426' ' ' ILE . . . . . 0.523 ' O ' HD23 ' B' ' 430' ' ' LEU . 1.2 mm -74.55 -22.57 17.64 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.815 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -172.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 427' ' ' ARG . . . . . 0.74 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.9 OUTLIER -54.75 -30.61 56.85 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.139 0.495 . . . . 0.0 110.701 -178.563 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -86.57 -8.91 76.32 Favored Glycine 0 N--CA 1.443 -0.89 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.456 178.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 429' ' ' TYR . . . . . 0.662 ' CZ ' ' HG3' ' B' ' 396' ' ' LYS . 22.9 m-85 -116.28 0.98 13.02 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-O 121.089 0.471 . . . . 0.0 110.509 -177.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 430' ' ' LEU . . . . . 0.549 ' HA ' HG12 ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.68 127.4 93.02 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.394 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 431' ' ' PRO . . . . . 0.518 ' HD2' HD11 ' B' ' 430' ' ' LEU . 86.1 Cg_exo -22.73 -75.44 0.02 OUTLIER 'Trans proline' 0 C--N 1.358 1.06 1 C-N-CA 125.617 4.211 . . . . 0.0 114.699 -179.246 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 432' ' ' GLY . . . . . 0.494 ' O ' HG12 ' B' ' 435' ' ' VAL . . . -128.84 -166.69 12.01 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 173.015 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 433' ' ' GLN . . . . . 0.623 ' O ' HG12 ' B' ' 436' ' ' VAL . 21.9 tt0 -71.44 -26.43 62.73 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 118.854 1.327 . . . . 0.0 110.571 176.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -62.58 -38.09 88.73 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -176.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 435' ' ' VAL . . . . . 0.497 ' HA ' ' CG1' ' B' ' 463' ' ' VAL . 7.5 p -69.77 -43.53 79.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 120.784 0.326 . . . . 0.0 110.57 -179.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 436' ' ' VAL . . . . . 0.623 HG12 ' O ' ' B' ' 433' ' ' GLN . 0.2 OUTLIER -66.35 -30.12 48.84 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 CA-C-O 120.895 0.379 . . . . 0.0 110.366 175.058 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 437' ' ' THR . . . . . 0.401 HG21 ' N ' ' B' ' 438' ' ' ALA . 0.9 OUTLIER -69.27 -51.97 32.15 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 -178.248 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 438' ' ' ALA . . . . . 0.7 ' O ' ' HG2' ' B' ' 442' ' ' ARG . . . -57.5 -43.1 83.9 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.005 176.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 439' ' ' LEU . . . . . 0.623 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 2.0 tm? -65.22 -47.27 77.44 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -176.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.01 -39.01 77.25 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.235 174.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 441' ' ' GLN . . . . . 0.559 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 8.5 mm-40 -56.93 -50.43 72.6 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 123.368 0.667 . . . . 0.0 110.617 176.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 442' ' ' ARG . . . . . 0.7 ' HG2' ' O ' ' B' ' 438' ' ' ALA . 0.0 OUTLIER -58.76 -33.64 70.52 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.9 172.606 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 443' ' ' LEU . . . . . 0.623 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 58.8 mt -72.18 -33.93 68.05 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.037 0.446 . . . . 0.0 110.129 178.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -57.62 -36.82 72.29 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.56 172.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -72.62 -27.36 62.1 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.866 177.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 446' ' ' GLU . . . . . 0.553 ' HB2' ' O ' ' B' ' 443' ' ' LEU . 39.5 tt0 29.79 96.47 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 170.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 52.2 mt -68.28 -35.45 71.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.109 0.48 . . . . 0.0 110.798 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 448' ' ' ASP . . . . . 0.527 ' O ' ' HG3' ' B' ' 452' ' ' ARG . 37.2 m-20 -165.61 -166.57 0.98 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 -178.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 449' ' ' ASP . . . . . 0.454 ' CG ' ' H ' ' B' ' 450' ' ' GLN . 11.7 p-10 -80.1 -63.47 1.4 Allowed 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.472 172.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 450' ' ' GLN . . . . . 0.454 ' H ' ' CG ' ' B' ' 449' ' ' ASP . 0.0 OUTLIER -69.85 -25.96 63.99 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 178.646 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 451' ' ' THR . . . . . 0.452 ' HA ' ' HB2' ' B' ' 454' ' ' GLU . 14.1 m -71.78 -22.44 61.58 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.664 -175.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 452' ' ' ARG . . . . . 0.527 ' HG3' ' O ' ' B' ' 448' ' ' ASP . 11.2 mtp180 -53.11 -54.56 33.91 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 170.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 453' ' ' ALA . . . . . 0.542 ' HB1' ' CD1' ' B' ' 419' ' ' TYR . . . -57.97 -50.09 74.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.378 -1.283 . . . . 0.0 112.688 175.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 454' ' ' GLU . . . . . 0.452 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 30.5 mm-40 -50.03 -38.36 37.32 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.472 0.653 . . . . 0.0 111.535 -176.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 32.0 p -117.42 16.11 14.72 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.226 -176.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 456' ' ' PHE . . . . . 0.562 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 1.1 t80 -55.75 -47.27 77.28 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.188 0.518 . . . . 0.0 111.489 -171.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 457' ' ' ILE . . . . . 0.52 ' CG1' ' HB3' ' B' ' 408' ' ' TYR . 2.0 mp -75.66 -32.08 24.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.816 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -58.3 -35.94 72.59 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.733 0.778 . . . . 0.0 109.357 171.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 459' ' ' HIS . . . . . 0.71 ' O ' HG21 ' B' ' 463' ' ' VAL . 82.4 m-70 -72.42 -29.1 63.41 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.213 178.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 460' ' ' LEU . . . . . 0.733 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -74.55 -34.62 62.98 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.858 0.837 . . . . 0.0 108.911 179.16 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 461' ' ' ASN . . . . . 0.43 ' HA ' ' CD2' ' B' ' 464' ' ' TYR . 22.4 m-80 -72.89 -37.89 67.13 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.253 176.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 462' ' ' ALA . . . . . 0.642 ' O ' HD11 ' B' ' 466' ' ' ILE . . . -56.58 -33.17 65.91 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.529 -1.214 . . . . 0.0 109.802 169.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 463' ' ' VAL . . . . . 0.733 ' HB ' ' O ' ' B' ' 460' ' ' LEU . 64.6 t -62.33 -50.68 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 175.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 464' ' ' TYR . . . . . 0.541 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 16.1 m-30 -54.07 -27.51 33.04 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.623 178.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.82 -38.94 20.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.908 0.861 . . . . 0.0 109.413 -177.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 466' ' ' ILE . . . . . 0.642 HD11 ' O ' ' B' ' 462' ' ' ALA . 3.8 mt -58.12 -56.2 17.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 114.125 -1.398 . . . . 0.0 112.395 174.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 467' ' ' LEU . . . . . 0.75 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -102.8 -10.39 19.16 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -171.532 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 468' ' ' GLY . . . . . 0.587 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 94.0 31.64 7.99 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 119.344 -1.408 . . . . 0.0 114.205 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 469' ' ' LEU . . . . . 0.75 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.2 mt -89.77 164.03 14.83 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 117.788 0.794 . . . . 0.0 111.152 176.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 37.1 p30 -105.57 -178.44 3.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.746 171.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 471' ' ' ALA . . . . . 0.504 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -70.23 -5.65 29.09 Favored 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -174.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 472' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' B' ' 472' ' ' ARG . 21.3 mmt180 -97.08 1.13 49.66 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.019 0.438 . . . . 0.0 110.891 -178.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 473' ' ' GLY . . . . . 0.424 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 78.95 12.66 83.91 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.36 -0.924 . . . . 0.0 111.079 -175.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -100.39 157.47 16.6 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 9.6 p -95.12 127.88 41.52 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.252 0.549 . . . . 0.0 111.448 -178.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 476' ' ' ILE . . . . . 0.587 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.9 pp -98.76 5.62 9.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.579 0.704 . . . . 0.0 110.205 179.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 477' ' ' ARG . . . . . . . . . . . . . 27.5 mmm180 -66.08 -31.29 72.07 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.508 176.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 478' ' ' LEU . . . . . . . . . . . . . 84.1 mt 55.43 61.83 2.71 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.476 0.655 . . . . 0.0 110.647 177.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 479' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 . . . . . 0 C--O 1.25 1.097 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.094 -179.493 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 381' ' ' ARG . . . . . 0.432 ' HD2' ' OD1' ' A' ' 418' ' ' ASN . 10.4 ptp180 . . . . . 0 N--CA 1.479 1.022 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.89 -31.2 1.17 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -176.366 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 383' ' ' HIS . . . . . 0.481 ' HB2' ' O ' ' A' ' 386' ' ' PHE . 1.3 p80 -150.76 160.93 43.53 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.022 -0.671 . . . . 0.0 112.028 -169.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -106.66 -109.71 3.41 Favored Glycine 0 N--CA 1.44 -1.059 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 168.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 39.1 m -74.04 -31.59 62.95 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.931 0.396 . . . . 0.0 111.175 177.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 386' ' ' PHE . . . . . 0.742 ' CZ ' HG11 ' A' ' 394' ' ' VAL . 2.0 t80 -74.74 126.49 88.44 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 121.104 0.478 . . . . 0.0 110.789 -178.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . 0.533 ' HG2' ' OD1' ' B' ' 393' ' ' ASN . 61.7 Cg_endo -72.12 110.02 2.84 Favored 'Trans proline' 0 N--CA 1.481 0.738 0 C-N-CA 124.183 3.255 . . . . 0.0 114.104 175.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 388' ' ' MET . . . . . 0.422 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 32.8 mtt -104.07 169.07 8.71 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 121.991 -0.443 . . . . 0.0 110.109 175.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -54.84 -62.6 1.55 Allowed 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 177.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -172.3 17.31 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.625 -1.171 . . . . 0.0 108.27 172.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.584 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 1.9 pt? -165.91 -66.15 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.24 -167.14 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . 0.584 ' N ' ' HG ' ' A' ' 391' ' ' LEU . . . -162.8 54.87 0.3 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.409 -0.9 . . . . 0.0 113.173 -173.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . 0.539 ' OD1' ' HG2' ' B' ' 387' ' ' PRO . 0.2 OUTLIER -54.31 -42.25 69.91 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.455 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . 0.742 HG11 ' CZ ' ' A' ' 386' ' ' PHE . 0.7 OUTLIER -57.03 -46.22 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -179.48 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.545 HG23 HG21 ' A' ' 425' ' ' ILE . 4.2 mp -57.55 -51.77 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.247 0 CA-C-O 118.009 -0.996 . . . . 0.0 112.887 -174.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . 0.654 ' HG3' ' CZ ' ' A' ' 429' ' ' TYR . 0.1 OUTLIER -62.22 -48.82 78.29 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 121.446 1.93 . . . . 0.0 111.698 -175.163 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -54.95 -45.56 80.5 Favored Glycine 0 N--CA 1.436 -1.341 0 C-N-CA 119.84 -1.171 . . . . 0.0 111.229 -178.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . 0.672 ' CD1' HD11 ' A' ' 410' ' ' LEU . 26.3 mt -70.88 -34.11 54.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -177.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . 0.525 HG21 ' O ' ' A' ' 396' ' ' LYS . 13.1 m -63.99 -39.38 85.24 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.499 0 C-N-CA 118.784 -1.166 . . . . 0.0 108.43 -174.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -71.0 -34.87 71.77 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 175.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -88.79 -48.0 7.81 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -172.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . 0.417 ' HB3' ' HB ' ' A' ' 406' ' ' THR . 1.3 mm-40 -121.2 -20.55 6.7 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.609 -170.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 107.27 162.28 21.72 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.702 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . 0.614 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.8 m -53.77 -46.18 62.5 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.739 0 N-CA-C 114.946 1.462 . . . . 0.0 114.946 -175.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . 0.467 ' HB1' HG21 ' A' ' 457' ' ' ILE . . . -64.0 -29.88 71.0 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 119.778 -0.769 . . . . 0.0 112.379 -177.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 406' ' ' THR . . . . . 0.722 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 93.2 m -77.51 -42.56 35.19 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.119 -0.632 . . . . 0.0 110.204 172.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.498 ' HB2' ' HA ' ' A' ' 395' ' ' ILE . . . -58.28 -37.22 74.56 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 122.232 1.015 . . . . 0.0 109.25 176.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 408' ' ' TYR . . . . . 0.614 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.67 -52.02 54.87 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 113.351 -1.75 . . . . 0.0 109.933 176.382 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 409' ' ' THR . . . . . 0.543 HG23 HD22 ' A' ' 410' ' ' LEU . 16.5 m -55.12 -47.11 75.47 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.479 179.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . 0.722 ' HG ' ' O ' ' A' ' 406' ' ' THR . 14.7 mt -72.69 -36.92 67.96 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.282 -174.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.74 -34.95 79.51 Favored Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.123 -1.036 . . . . 0.0 110.813 172.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 412' ' ' MET . . . . . 0.401 ' HB2' ' O ' ' A' ' 409' ' ' THR . 0.4 OUTLIER -66.61 -44.78 81.16 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 115.734 -0.233 . . . . 0.0 111.441 177.962 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 413' ' ' MET . . . . . 0.764 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.0 OUTLIER -70.82 -57.1 4.97 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 118.675 -1.21 . . . . 0.0 111.668 179.135 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . 0.764 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 6.8 mt -64.58 -43.18 94.68 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -171.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 32.8 t -86.03 -16.84 36.94 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.734 0.778 . . . . 0.0 109.816 -177.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . 0.44 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 100.79 -175.34 26.38 Favored Glycine 0 N--CA 1.429 -1.773 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -170.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 34.0 mm-40 -79.65 24.03 0.39 Allowed 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.207 0.527 . . . . 0.0 111.645 -171.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 418' ' ' ASN . . . . . 0.44 ' H ' ' C ' ' A' ' 416' ' ' GLY . 61.2 m-80 -71.4 75.96 0.76 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.146 -178.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 419' ' ' TYR . . . . . 0.51 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 7.4 p90 -50.39 -38.54 43.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.933 173.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -54.27 -46.78 72.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.886 178.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.16 -48.98 60.8 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.188 -176.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . 0.402 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -66.37 -40.02 85.62 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 C-N-CA 120.368 -0.533 . . . . 0.0 111.146 -175.509 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.696 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 78.2 p -67.31 -38.57 85.2 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.607 -0.437 . . . . 0.0 109.976 -178.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -69.56 -37.61 78.11 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.071 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . 0.545 HG21 HG23 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -73.34 -51.9 23.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.466 0.174 . . . . 0.0 111.113 -178.018 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . 0.407 HD11 HG21 ' A' ' 395' ' ' ILE . 1.2 mm -74.4 -23.35 18.19 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.829 0 CA-C-O 120.835 0.35 . . . . 0.0 110.241 -171.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.696 ' HB2' ' O ' ' A' ' 423' ' ' SER . 1.0 OUTLIER -54.62 -29.33 51.68 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.165 0.507 . . . . 0.0 110.602 179.773 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -86.35 -8.38 77.97 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.858 178.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.654 ' CZ ' ' HG3' ' A' ' 396' ' ' LYS . 24.2 m-85 -117.51 -1.09 11.75 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-O 121.465 0.65 . . . . 0.0 110.272 -178.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . 0.539 ' HA ' HG13 ' A' ' 404' ' ' VAL . 0.0 OUTLIER -65.99 132.78 94.71 Favored Pre-proline 0 N--CA 1.437 -1.118 0 CA-C-N 114.624 -1.171 . . . . 0.0 108.624 179.241 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . 0.713 ' CD ' HG11 ' A' ' 435' ' ' VAL . 42.4 Cg_exo -35.17 -72.36 0.05 OUTLIER 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 124.847 3.698 . . . . 0.0 113.984 -170.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . 0.531 ' O ' HG13 ' A' ' 435' ' ' VAL . . . -131.38 -162.49 10.57 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 175.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . 0.551 ' O ' HG11 ' A' ' 436' ' ' VAL . 22.3 tp60 -71.29 -27.6 63.53 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 118.088 0.944 . . . . 0.0 110.459 177.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -68.23 -37.92 81.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.164 -175.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 435' ' ' VAL . . . . . 0.713 HG11 ' CD ' ' A' ' 431' ' ' PRO . 6.7 p -68.45 -46.63 80.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-O 120.979 0.419 . . . . 0.0 110.438 -178.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . 0.551 HG11 ' O ' ' A' ' 433' ' ' GLN . 0.2 OUTLIER -63.47 -31.08 51.55 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.321 175.702 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 437' ' ' THR . . . . . 0.58 ' O ' ' HG3' ' A' ' 441' ' ' GLN . 1.0 OUTLIER -69.03 -52.94 23.46 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 -178.028 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . 0.516 ' HB3' HG12 ' A' ' 463' ' ' VAL . . . -59.43 -36.06 75.19 Favored 'General case' 0 N--CA 1.436 -1.15 0 O-C-N 124.01 0.819 . . . . 0.0 112.01 178.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 439' ' ' LEU . . . . . 0.571 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 1.9 tm? -70.24 -47.91 59.28 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.47 -36.43 75.97 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.18 176.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 441' ' ' GLN . . . . . 0.58 ' HG3' ' O ' ' A' ' 437' ' ' THR . 43.4 mt-30 -54.33 -51.47 64.61 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.106 178.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -62.47 -36.87 83.84 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.839 174.869 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 443' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 61.4 mt -66.57 -37.36 84.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.007 0.432 . . . . 0.0 110.195 179.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -57.68 -37.81 74.08 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.563 173.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -72.53 -27.48 62.26 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.533 178.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 446' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 443' ' ' LEU . 37.9 tt0 33.55 101.18 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 114.56 1.318 . . . . 0.0 114.56 170.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 54.6 mt -69.87 -35.26 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-O 121.054 0.454 . . . . 0.0 110.745 178.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . 0.494 ' HB2' ' OG1' ' A' ' 451' ' ' THR . 16.6 m-20 -168.35 -167.42 0.8 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -176.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -77.06 -69.98 0.49 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.039 0.447 . . . . 0.0 109.807 172.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.86 -25.06 66.23 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 178.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 451' ' ' THR . . . . . 0.494 ' OG1' ' HB2' ' A' ' 448' ' ' ASP . 11.7 m -70.89 -22.91 62.21 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 119.989 -0.685 . . . . 0.0 110.86 -174.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' A' ' 448' ' ' ASP . 11.6 mtp180 -53.61 -54.0 43.86 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 170.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 453' ' ' ALA . . . . . 0.51 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -58.88 -47.04 86.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.557 -1.201 . . . . 0.0 112.656 175.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . 0.468 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 23.6 mm-40 -52.41 -36.17 53.58 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.175 0.512 . . . . 0.0 111.462 -178.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 29.5 p -118.38 15.61 13.87 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.449 -176.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . 0.529 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.9 OUTLIER -56.83 -48.69 77.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.05 0.452 . . . . 0.0 111.54 -171.704 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . 0.543 ' CG1' ' HB3' ' A' ' 408' ' ' TYR . 1.9 mp -76.11 -32.0 22.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.8 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -57.46 -37.08 72.28 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.672 0.749 . . . . 0.0 109.325 171.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . 0.779 ' O ' HG23 ' A' ' 463' ' ' VAL . 79.3 m-70 -72.32 -29.14 63.56 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.365 178.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . 0.718 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -74.18 -35.38 63.97 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.954 0.883 . . . . 0.0 108.992 179.688 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . 0.49 ' O ' ' HB2' ' A' ' 464' ' ' TYR . 23.7 m-80 -73.13 -37.67 66.56 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.362 -0.835 . . . . 0.0 108.977 176.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 462' ' ' ALA . . . . . 0.618 ' O ' HD13 ' A' ' 466' ' ' ILE . . . -56.98 -33.58 67.23 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.586 -1.188 . . . . 0.0 109.931 169.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.779 HG23 ' O ' ' A' ' 459' ' ' HIS . 55.2 t -62.66 -50.29 80.36 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.893 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 175.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 464' ' ' TYR . . . . . 0.577 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 20.7 m-30 -52.89 -29.57 29.07 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.481 177.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.37 -38.71 19.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.75 0.786 . . . . 0.0 109.636 -176.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.618 HD13 ' O ' ' A' ' 462' ' ' ALA . 3.6 mt -56.8 -55.98 16.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 114.289 -1.323 . . . . 0.0 112.271 174.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.757 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -102.14 -10.07 19.96 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -171.94 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . 0.564 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 94.72 31.39 7.83 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 119.481 -1.342 . . . . 0.0 114.345 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 469' ' ' LEU . . . . . 0.757 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 4.2 mt -89.75 160.45 16.54 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 117.862 0.831 . . . . 0.0 110.889 174.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . 0.6 HD21 ' C ' ' A' ' 470' ' ' ASN . 0.2 OUTLIER -105.53 -178.24 3.6 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.4 170.948 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 471' ' ' ALA . . . . . 0.405 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -56.91 -27.9 61.33 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -174.132 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -85.08 8.46 17.91 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -171.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 74.01 9.08 79.63 Favored Glycine 0 CA--C 1.519 0.344 0 C-N-CA 120.313 -0.946 . . . . 0.0 111.642 -177.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -100.14 155.08 17.93 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 177.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 59.9 p -91.43 136.73 32.9 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.348 0.594 . . . . 0.0 110.837 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 476' ' ' ILE . . . . . 0.564 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.7 pp -94.45 -19.41 6.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.468 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 477' ' ' ARG . . . . . 0.529 ' O ' ' HD3' ' A' ' 477' ' ' ARG . 0.0 OUTLIER -96.07 162.1 13.69 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.857 174.015 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 97.9 mt -126.28 143.08 51.28 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.968 0.413 . . . . 0.0 110.665 -177.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.407 -0.806 . . . . 0.0 109.67 176.543 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 381' ' ' ARG . . . . . 0.422 ' HD2' ' OD1' ' B' ' 418' ' ' ASN . 10.4 ptp180 . . . . . 0 N--CA 1.48 1.056 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 382' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.43 -31.05 1.1 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -176.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 383' ' ' HIS . . . . . 0.473 ' HB2' ' O ' ' B' ' 386' ' ' PHE . 1.3 p80 -151.08 161.06 43.45 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 119.935 -0.706 . . . . 0.0 112.003 -169.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 384' ' ' GLY . . . . . . . . . . . . . . . -106.82 -110.04 3.44 Favored Glycine 0 N--CA 1.439 -1.128 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 168.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 385' ' ' THR . . . . . . . . . . . . . 34.8 m -73.44 -32.53 64.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.907 0.384 . . . . 0.0 111.083 177.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 386' ' ' PHE . . . . . 0.753 ' CZ ' HG11 ' B' ' 394' ' ' VAL . 2.0 t80 -74.0 126.62 89.17 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 121.061 0.457 . . . . 0.0 110.846 -178.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 387' ' ' PRO . . . . . 0.539 ' HG2' ' OD1' ' A' ' 393' ' ' ASN . 61.5 Cg_endo -72.23 110.23 2.91 Favored 'Trans proline' 0 N--CA 1.479 0.645 0 C-N-CA 124.166 3.244 . . . . 0.0 114.107 175.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 388' ' ' MET . . . . . 0.41 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 33.1 mtt -104.3 169.08 8.69 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 122.103 -0.373 . . . . 0.0 110.127 175.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 389' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -54.98 -62.45 1.65 Allowed 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 177.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -172.35 17.06 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.736 -1.12 . . . . 0.0 108.311 172.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 391' ' ' LEU . . . . . 0.581 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.0 pt? -165.82 -66.18 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.269 -167.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 392' ' ' GLY . . . . . 0.581 ' N ' ' HG ' ' B' ' 391' ' ' LEU . . . -162.83 54.96 0.3 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.432 -0.889 . . . . 0.0 113.169 -173.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 393' ' ' ASN . . . . . 0.533 ' OD1' ' HG2' ' A' ' 387' ' ' PRO . 0.2 OUTLIER -54.3 -42.37 70.0 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 178.41 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 394' ' ' VAL . . . . . 0.753 HG11 ' CZ ' ' B' ' 386' ' ' PHE . 0.7 OUTLIER -56.95 -46.15 83.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -179.388 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 395' ' ' ILE . . . . . 0.549 HG23 HG21 ' B' ' 425' ' ' ILE . 4.2 mp -57.59 -51.8 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-O 117.991 -1.004 . . . . 0.0 112.81 -174.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 396' ' ' LYS . . . . . 0.659 ' HG3' ' CZ ' ' B' ' 429' ' ' TYR . 0.1 OUTLIER -62.17 -49.03 77.45 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 121.487 1.949 . . . . 0.0 111.719 -175.142 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -54.77 -45.59 78.7 Favored Glycine 0 N--CA 1.437 -1.252 0 C-N-CA 119.84 -1.171 . . . . 0.0 111.209 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . 0.667 ' CD1' HD11 ' B' ' 410' ' ' LEU . 26.8 mt -70.94 -34.19 54.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 113.361 0.875 . . . . 0.0 113.361 -177.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 399' ' ' VAL . . . . . 0.532 HG21 ' O ' ' B' ' 396' ' ' LYS . 13.5 m -63.82 -39.44 85.43 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.481 0 C-N-CA 118.774 -1.17 . . . . 0.0 108.56 -174.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -70.98 -34.83 71.78 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 175.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 401' ' ' GLN . . . . . 0.413 HE21 ' HB3' ' B' ' 401' ' ' GLN . 4.2 mm100 -89.06 -47.61 7.99 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -172.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 402' ' ' GLU . . . . . 0.431 ' HB3' ' HB ' ' B' ' 406' ' ' THR . 1.3 mm-40 -121.64 -20.47 6.5 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.026 0.441 . . . . 0.0 111.489 -170.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 107.12 162.31 21.87 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.736 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 404' ' ' VAL . . . . . 0.61 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.8 m -53.72 -46.38 62.05 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.792 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -175.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 405' ' ' ALA . . . . . 0.485 ' HB1' HG21 ' B' ' 457' ' ' ILE . . . -63.87 -29.88 71.02 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 119.639 -0.825 . . . . 0.0 112.464 -177.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 406' ' ' THR . . . . . 0.72 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 89.1 m -77.38 -42.78 35.12 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.149 172.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 407' ' ' ALA . . . . . 0.488 ' HB2' ' HA ' ' B' ' 395' ' ' ILE . . . -58.17 -37.19 74.23 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 122.248 1.023 . . . . 0.0 109.317 176.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 408' ' ' TYR . . . . . 0.61 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.79 -51.97 54.69 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 113.279 -1.782 . . . . 0.0 109.86 176.48 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 409' ' ' THR . . . . . 0.541 HG23 HD22 ' B' ' 410' ' ' LEU . 16.6 m -55.23 -47.08 75.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.427 179.1 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 410' ' ' LEU . . . . . 0.72 ' HG ' ' O ' ' B' ' 406' ' ' THR . 14.7 mt -72.72 -36.82 67.87 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.312 -174.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.84 -34.89 79.97 Favored Glycine 0 N--CA 1.44 -1.074 0 C-N-CA 120.175 -1.012 . . . . 0.0 110.72 172.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 412' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -66.79 -44.52 81.09 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 115.839 -0.18 . . . . 0.0 111.458 177.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 413' ' ' MET . . . . . 0.767 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.0 OUTLIER -70.99 -56.9 5.18 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 118.66 -1.216 . . . . 0.0 111.701 179.035 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 414' ' ' LEU . . . . . 0.767 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 6.8 mt -64.71 -43.17 94.31 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -171.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 33.1 t -86.29 -16.45 37.5 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.76 0.791 . . . . 0.0 109.745 -176.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 416' ' ' GLY . . . . . 0.44 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 100.41 -175.54 26.99 Favored Glycine 0 N--CA 1.429 -1.831 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -171.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -79.48 24.13 0.37 Allowed 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.251 0.548 . . . . 0.0 111.742 -171.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 418' ' ' ASN . . . . . 0.44 ' H ' ' C ' ' B' ' 416' ' ' GLY . 62.5 m-80 -71.55 75.99 0.8 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.025 -179.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 419' ' ' TYR . . . . . 0.517 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 7.3 p90 -50.39 -38.49 42.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.936 173.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -54.37 -46.56 73.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.939 178.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.25 -49.03 59.96 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.249 -177.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 422' ' ' VAL . . . . . 0.406 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.2 OUTLIER -66.31 -40.08 85.86 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.212 -175.514 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 423' ' ' SER . . . . . 0.711 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 78.0 p -67.3 -38.56 85.18 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.921 -178.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -69.71 -37.45 76.5 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.11 177.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 425' ' ' ILE . . . . . 0.549 HG21 HG23 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -73.46 -52.03 23.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.488 0.185 . . . . 0.0 111.186 -178.259 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 426' ' ' ILE . . . . . 0.415 HD11 HG21 ' B' ' 395' ' ' ILE . 1.2 mm -74.13 -23.38 18.6 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.797 0 CA-C-O 120.82 0.343 . . . . 0.0 110.226 -171.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 427' ' ' ARG . . . . . 0.711 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.9 OUTLIER -54.68 -29.11 51.84 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.122 0.487 . . . . 0.0 110.666 179.913 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -86.55 -8.75 76.68 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.756 178.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 429' ' ' TYR . . . . . 0.659 ' CZ ' ' HG3' ' B' ' 396' ' ' LYS . 24.3 m-85 -117.1 -0.82 12.02 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 121.465 0.65 . . . . 0.0 110.156 -178.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 430' ' ' LEU . . . . . 0.534 ' HA ' HG13 ' B' ' 404' ' ' VAL . 0.0 OUTLIER -66.07 132.97 94.66 Favored Pre-proline 0 N--CA 1.438 -1.054 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.54 179.27 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 431' ' ' PRO . . . . . 0.709 ' CD ' HG11 ' B' ' 435' ' ' VAL . 42.6 Cg_exo -35.23 -71.73 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 124.76 3.64 . . . . 0.0 114.054 -170.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 432' ' ' GLY . . . . . 0.516 ' O ' HG13 ' B' ' 435' ' ' VAL . . . -131.99 -162.15 10.32 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 175.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 433' ' ' GLN . . . . . 0.554 ' O ' HG11 ' B' ' 436' ' ' VAL . 22.5 tp60 -71.58 -27.82 63.41 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 118.119 0.96 . . . . 0.0 110.447 177.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -68.06 -38.08 82.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.215 -0.448 . . . . 0.0 112.065 -175.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 435' ' ' VAL . . . . . 0.709 HG11 ' CD ' ' B' ' 431' ' ' PRO . 6.7 p -68.17 -46.73 80.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-O 121.068 0.461 . . . . 0.0 110.46 -178.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 436' ' ' VAL . . . . . 0.554 HG11 ' O ' ' B' ' 433' ' ' GLN . 0.2 OUTLIER -63.32 -31.44 52.81 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.191 175.759 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 437' ' ' THR . . . . . 0.584 ' O ' ' HG3' ' B' ' 441' ' ' GLN . 1.0 OUTLIER -68.87 -52.74 26.42 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -177.996 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 438' ' ' ALA . . . . . 0.516 ' HB3' HG12 ' B' ' 463' ' ' VAL . . . -59.51 -36.12 75.46 Favored 'General case' 0 N--CA 1.435 -1.193 0 O-C-N 124.132 0.895 . . . . 0.0 112.04 178.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 439' ' ' LEU . . . . . 0.578 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 1.9 tm? -70.22 -47.93 59.3 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.43 -36.32 75.69 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.154 175.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 441' ' ' GLN . . . . . 0.584 ' HG3' ' O ' ' B' ' 437' ' ' THR . 43.9 mt-30 -54.44 -51.66 64.26 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 123.755 0.822 . . . . 0.0 110.034 178.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 442' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' B' ' 438' ' ' ALA . 0.0 OUTLIER -62.4 -36.69 83.11 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.461 -0.791 . . . . 0.0 112.855 174.942 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 443' ' ' LEU . . . . . 0.578 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 61.2 mt -66.6 -37.33 84.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.17 0.51 . . . . 0.0 110.237 179.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -57.82 -37.69 74.24 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.675 173.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -72.58 -27.39 62.16 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.497 -1.229 . . . . 0.0 110.595 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 446' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' B' ' 443' ' ' LEU . 37.9 tt0 33.41 101.52 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 170.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 54.9 mt -70.35 -35.35 62.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.074 0.464 . . . . 0.0 110.616 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 448' ' ' ASP . . . . . 0.484 ' O ' ' HG3' ' B' ' 452' ' ' ARG . 17.6 m-20 -168.17 -167.27 0.8 Allowed 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 -176.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -77.2 -70.15 0.48 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 173.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.79 -25.08 66.3 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 178.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 451' ' ' THR . . . . . 0.48 ' OG1' ' HB2' ' B' ' 448' ' ' ASP . 13.1 m -70.95 -22.82 62.16 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.688 -174.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 452' ' ' ARG . . . . . 0.484 ' HG3' ' O ' ' B' ' 448' ' ' ASP . 11.7 mtp180 -53.7 -53.92 45.23 Favored 'General case' 0 C--O 1.219 -0.552 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 171.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 453' ' ' ALA . . . . . 0.517 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -58.8 -47.28 85.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.517 -1.22 . . . . 0.0 112.666 175.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 454' ' ' GLU . . . . . 0.465 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 22.7 mm-40 -52.39 -36.07 53.12 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.321 0.581 . . . . 0.0 111.488 -178.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 29.4 p -118.3 15.58 13.94 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.397 -176.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 456' ' ' PHE . . . . . 0.528 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 0.9 OUTLIER -56.88 -48.89 77.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.054 0.454 . . . . 0.0 111.474 -171.712 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 457' ' ' ILE . . . . . 0.551 ' CG1' ' HB3' ' B' ' 408' ' ' TYR . 1.9 mp -75.97 -31.9 22.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.875 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -57.6 -37.06 72.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.693 0.759 . . . . 0.0 109.355 171.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 459' ' ' HIS . . . . . 0.776 ' O ' HG23 ' B' ' 463' ' ' VAL . 79.0 m-70 -72.36 -28.97 63.37 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.385 178.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 460' ' ' LEU . . . . . 0.73 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.4 OUTLIER -74.25 -35.4 63.8 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.909 0.861 . . . . 0.0 108.974 179.655 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 461' ' ' ASN . . . . . 0.483 ' O ' ' HB2' ' B' ' 464' ' ' TYR . 23.2 m-80 -73.3 -37.36 66.22 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.864 0.84 . . . . 0.0 109.087 176.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 462' ' ' ALA . . . . . 0.62 ' O ' HD13 ' B' ' 466' ' ' ILE . . . -57.11 -33.65 67.56 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.493 -1.23 . . . . 0.0 109.891 169.098 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 463' ' ' VAL . . . . . 0.776 HG23 ' O ' ' B' ' 459' ' ' HIS . 55.9 t -62.53 -50.4 79.98 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.871 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 175.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 464' ' ' TYR . . . . . 0.582 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 20.7 m-30 -52.79 -29.45 27.5 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.481 177.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.41 -38.95 19.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.701 0.762 . . . . 0.0 109.601 -176.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 466' ' ' ILE . . . . . 0.62 HD13 ' O ' ' B' ' 462' ' ' ALA . 3.6 mt -56.72 -55.77 17.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 114.245 -1.343 . . . . 0.0 112.257 174.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 467' ' ' LEU . . . . . 0.745 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -102.3 -9.94 19.94 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -171.943 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 468' ' ' GLY . . . . . 0.567 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 94.53 31.58 7.8 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 119.519 -1.324 . . . . 0.0 114.456 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 469' ' ' LEU . . . . . 0.745 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 4.2 mt -89.89 160.67 16.33 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 117.674 0.737 . . . . 0.0 110.853 174.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 470' ' ' ASN . . . . . 0.598 HD21 ' C ' ' B' ' 470' ' ' ASN . 0.2 OUTLIER -105.64 -178.15 3.57 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.365 170.96 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 471' ' ' ALA . . . . . 0.407 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -57.05 -27.87 62.05 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -174.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -85.14 8.63 17.46 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.973 0.361 . . . . 0.0 111.973 -171.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 473' ' ' GLY . . . . . . . . . . . . . . . 74.02 8.96 79.51 Favored Glycine 0 C--O 1.228 -0.221 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.553 -177.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -100.16 154.88 18.08 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 177.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 475' ' ' SER . . . . . 0.407 ' HA ' ' HA ' ' B' ' 469' ' ' LEU . 61.1 p -91.12 136.69 32.91 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.329 0.585 . . . . 0.0 110.862 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 476' ' ' ILE . . . . . 0.567 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.7 pp -94.27 -19.85 6.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.47 179.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 477' ' ' ARG . . . . . 0.542 ' O ' ' HD3' ' B' ' 477' ' ' ARG . 0.0 OUTLIER -95.68 162.27 13.68 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.713 174.188 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 478' ' ' LEU . . . . . . . . . . . . . 98.1 mt -126.33 143.52 51.13 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.843 0.354 . . . . 0.0 110.664 -177.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 479' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.4 -0.809 . . . . 0.0 109.637 176.666 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 . . . . . 0 N--CA 1.479 0.996 0 CA-C-O 121.018 0.437 . . . . 0.0 110.686 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 382' ' ' THR . . . . . 0.533 ' OG1' ' HA ' ' A' ' 391' ' ' LEU . 0.0 OUTLIER -97.44 -29.58 13.41 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.481 174.302 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 383' ' ' HIS . . . . . 0.459 ' HB2' ' O ' ' A' ' 386' ' ' PHE . 19.0 p80 -159.28 159.37 33.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.924 0.392 . . . . 0.0 111.323 -176.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -114.84 -117.76 3.21 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.38 174.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 31.2 m -58.78 -35.13 72.3 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 121.167 0.508 . . . . 0.0 111.196 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 386' ' ' PHE . . . . . 0.64 ' CZ ' HG13 ' A' ' 394' ' ' VAL . 1.9 t80 -82.16 128.31 68.28 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 176.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -55.4 -72.76 0.03 OUTLIER 'Trans proline' 0 N--CA 1.486 1.068 0 C-N-CA 124.488 3.458 . . . . 0.0 114.465 178.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 388' ' ' MET . . . . . 0.517 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 10.4 ttp 69.17 59.6 0.33 Allowed 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 170.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 389' ' ' HIS . . . . . 0.543 ' ND1' ' HA ' ' A' ' 393' ' ' ASN . 17.1 m170 51.05 -138.56 1.04 Allowed 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -178.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . 0.411 ' NE2' HD23 ' A' ' 391' ' ' LEU . 5.9 pm0 -110.68 22.67 15.14 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 164.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.595 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.5 pt? -168.28 -61.71 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.542 -174.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . 0.595 ' N ' ' HG ' ' A' ' 391' ' ' LEU . . . -160.51 59.45 0.31 Allowed Glycine 0 C--N 1.337 0.589 0 C-N-CA 119.733 -1.222 . . . . 0.0 114.715 -171.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . 0.543 ' HA ' ' ND1' ' A' ' 389' ' ' HIS . 0.4 OUTLIER -62.4 -39.55 93.61 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 117.4 0.6 . . . . 0.0 109.568 175.714 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . 0.64 HG13 ' CZ ' ' A' ' 386' ' ' PHE . 0.6 OUTLIER -56.7 -46.02 82.91 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 179.21 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.604 HG22 ' CD1' ' A' ' 426' ' ' ILE . 4.0 mp -57.79 -52.71 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.323 0 CA-C-O 117.853 -1.07 . . . . 0.0 113.465 -174.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . 0.641 ' O ' HG21 ' A' ' 399' ' ' VAL . 0.0 OUTLIER -63.72 -49.76 71.8 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-N 121.972 2.169 . . . . 0.0 111.645 -175.77 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.62 -44.89 68.72 Favored Glycine 0 N--CA 1.428 -1.842 0 CA-C-N 114.473 -1.239 . . . . 0.0 110.818 -175.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . 0.689 ' CD1' HD11 ' A' ' 410' ' ' LEU . 34.8 mt -70.79 -33.05 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . 0.641 HG21 ' O ' ' A' ' 396' ' ' LYS . 16.7 m -62.9 -39.73 86.16 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 C-N-CA 118.688 -1.205 . . . . 0.0 108.43 -175.067 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -71.35 -35.03 71.0 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 175.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -88.52 -47.47 8.3 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -172.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . 0.436 ' HB3' ' HB ' ' A' ' 406' ' ' THR . 3.1 mm-40 -121.72 -21.03 6.26 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.539 -171.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 109.25 160.98 19.44 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.728 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . 0.658 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.1 m -53.71 -40.77 44.5 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.771 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -175.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . 0.487 ' HB2' HG22 ' A' ' 457' ' ' ILE . . . -68.48 -31.55 70.92 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 119.591 -0.844 . . . . 0.0 112.013 -177.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 406' ' ' THR . . . . . 0.696 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 92.3 m -77.08 -41.51 41.93 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.1 173.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.496 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.47 -37.26 75.12 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 122.059 0.933 . . . . 0.0 109.365 176.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 408' ' ' TYR . . . . . 0.658 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.6 -52.79 49.38 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 113.709 -1.587 . . . . 0.0 109.973 176.433 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 409' ' ' THR . . . . . 0.548 HG22 HD21 ' A' ' 410' ' ' LEU . 3.2 m -56.09 -46.8 78.93 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 179.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . 0.696 ' HG ' ' O ' ' A' ' 406' ' ' THR . 13.6 mt -72.36 -37.69 68.73 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -175.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.48 -37.03 87.31 Favored Glycine 0 N--CA 1.435 -1.4 0 C-N-CA 119.849 -1.167 . . . . 0.0 110.298 172.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 412' ' ' MET . . . . . 0.449 ' HE1' ' HA ' ' A' ' 417' ' ' GLN . 0.0 OUTLIER -64.27 -49.98 69.72 Favored 'General case' 0 C--O 1.223 -0.306 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 178.53 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 413' ' ' MET . . . . . 0.934 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 1.0 OUTLIER -71.27 -42.88 68.21 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 118.849 -1.14 . . . . 0.0 112.133 -176.146 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . 0.934 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 19.7 mt -69.61 -45.19 69.14 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -177.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.432 ' HB3' ' HE1' ' A' ' 388' ' ' MET . 54.6 p -85.91 -21.65 27.86 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.511 0.672 . . . . 0.0 110.482 -174.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . 0.412 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 108.64 178.65 21.71 Favored Glycine 0 N--CA 1.431 -1.682 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -168.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 417' ' ' GLN . . . . . 0.449 ' HA ' ' HE1' ' A' ' 412' ' ' MET . 1.7 mp0 -80.17 23.94 0.45 Allowed 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.037 0.446 . . . . 0.0 111.859 -173.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 418' ' ' ASN . . . . . 0.412 ' H ' ' C ' ' A' ' 416' ' ' GLY . 4.3 m-20 -71.35 78.25 0.74 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.677 0.751 . . . . 0.0 110.947 178.024 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 419' ' ' TYR . . . . . 0.556 ' CD1' ' HB3' ' A' ' 453' ' ' ALA . 17.1 p90 -51.86 -38.32 55.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.749 177.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -55.12 -45.41 75.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.746 178.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . 0.401 HD22 ' N ' ' A' ' 422' ' ' VAL . 0.0 OUTLIER -68.33 -48.58 64.48 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.11 -177.943 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . 0.466 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.1 OUTLIER -65.64 -41.78 91.33 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 C-N-CA 120.347 -0.541 . . . . 0.0 110.932 -176.291 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.777 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 29.6 t -69.35 -36.53 76.98 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.7 -178.145 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -69.34 -37.47 80.07 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.84 176.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . 0.573 HG23 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.41 -51.25 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-O 120.515 0.198 . . . . 0.0 110.621 -179.631 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . 0.604 ' CD1' HG22 ' A' ' 395' ' ' ILE . 1.1 mm -73.38 -22.9 19.37 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.952 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -173.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.777 ' HB2' ' O ' ' A' ' 423' ' ' SER . 1.1 tmm_? -54.38 -33.63 59.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.289 0.566 . . . . 0.0 110.893 -177.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -86.28 -10.94 73.33 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.404 -0.903 . . . . 0.0 110.853 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.49 ' HD1' ' CG2' ' A' ' 395' ' ' ILE . 5.4 m-30 -112.91 -1.8 14.47 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -174.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . 0.552 HD11 ' HD2' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -66.61 129.88 94.1 Favored Pre-proline 0 N--CA 1.443 -0.789 0 CA-C-N 114.201 -1.363 . . . . 0.0 108.947 177.203 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . 0.552 ' HD2' HD11 ' A' ' 430' ' ' LEU . 79.7 Cg_exo -24.09 -66.95 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.758 1 C-N-CA 125.536 4.157 . . . . 0.0 114.727 179.221 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . 0.52 ' O ' HG13 ' A' ' 435' ' ' VAL . . . -145.2 -168.17 12.75 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 176.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . 0.543 ' O ' HG12 ' A' ' 436' ' ' VAL . 40.1 tp60 -69.84 -26.26 64.13 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 117.888 0.844 . . . . 0.0 110.459 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -65.85 -40.8 92.07 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.887 -178.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 435' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 432' ' ' GLY . 7.4 p -68.84 -43.39 82.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-O 120.947 0.403 . . . . 0.0 110.755 -177.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . 0.543 HG12 ' O ' ' A' ' 433' ' ' GLN . 0.1 OUTLIER -65.25 -33.42 63.59 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.19 175.73 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 437' ' ' THR . . . . . 0.458 ' O ' ' HG3' ' A' ' 441' ' ' GLN . 1.0 OUTLIER -66.84 -52.86 38.67 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -177.727 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . 0.609 ' O ' ' HD2' ' A' ' 442' ' ' ARG . . . -58.58 -37.79 76.52 Favored 'General case' 0 N--CA 1.436 -1.162 0 O-C-N 123.788 0.68 . . . . 0.0 111.835 178.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 439' ' ' LEU . . . . . 0.603 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 2.1 tm? -67.64 -48.78 65.76 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 -179.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.28 -35.02 74.58 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.535 -1.212 . . . . 0.0 110.729 176.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 441' ' ' GLN . . . . . 0.543 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 13.3 mt-30 -53.32 -50.96 63.88 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.186 -178.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . 0.609 ' HD2' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -76.09 -23.38 54.96 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 175.118 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 443' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 47.3 mt -64.09 -35.47 80.87 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 174.072 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -56.89 -36.09 69.71 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.373 172.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -73.16 -27.63 61.77 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.872 178.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 446' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 443' ' ' LEU . 33.5 tt0 32.94 89.45 0.01 OUTLIER 'General case' 0 C--N 1.353 0.745 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 170.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 70.8 mt -59.31 -35.82 60.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 175.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . 0.489 ' HB2' ' OG1' ' A' ' 451' ' ' THR . 24.5 m-20 -166.49 175.34 8.16 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 178.104 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 449' ' ' ASP . . . . . 0.595 ' O ' ' HG2' ' A' ' 452' ' ' ARG . 13.0 m-20 -62.72 -60.03 4.07 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.312 -0.555 . . . . 0.0 109.715 174.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.93 -28.51 63.51 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 178.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 451' ' ' THR . . . . . 0.489 ' OG1' ' HB2' ' A' ' 448' ' ' ASP . 10.1 m -73.0 -23.54 60.65 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.326 -174.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . 0.595 ' HG2' ' O ' ' A' ' 449' ' ' ASP . 6.0 ptp180 -64.73 -41.52 95.9 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 174.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 453' ' ' ALA . . . . . 0.556 ' HB3' ' CD1' ' A' ' 419' ' ' TYR . . . -58.99 -49.19 78.82 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 123.843 0.714 . . . . 0.0 112.445 168.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . 0.466 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 33.5 mm-40 -53.97 -33.44 56.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.148 0.499 . . . . 0.0 111.738 -177.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 29.1 p -115.56 15.27 16.65 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.224 -178.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . 0.552 ' CZ ' ' HB2' ' A' ' 423' ' ' SER . 1.0 OUTLIER -56.78 -47.68 79.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.995 0.426 . . . . 0.0 111.775 -171.667 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . 0.52 ' CG1' ' HB3' ' A' ' 408' ' ' TYR . 1.9 mp -76.41 -33.41 23.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.153 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -57.84 -34.05 69.29 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.955 0.883 . . . . 0.0 108.963 171.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . 0.747 ' O ' HG23 ' A' ' 463' ' ' VAL . 45.0 m-70 -74.47 -29.31 61.4 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.197 -1.365 . . . . 0.0 110.947 177.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . 0.686 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -74.07 -34.78 64.13 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.342 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 24.2 m-80 -73.02 -37.59 66.88 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.047 176.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 462' ' ' ALA . . . . . 0.61 ' O ' HD13 ' A' ' 466' ' ' ILE . . . -55.86 -34.92 65.89 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.659 169.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.747 HG23 ' O ' ' A' ' 459' ' ' HIS . 73.3 t -61.69 -51.15 76.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-N 114.612 -1.176 . . . . 0.0 108.201 176.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 464' ' ' TYR . . . . . 0.567 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 15.9 m-30 -52.95 -28.16 22.35 Favored 'General case' 0 C--N 1.332 -0.188 0 O-C-N 124.295 0.997 . . . . 0.0 110.614 178.13 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.92 -39.53 19.68 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.76 0.79 . . . . 0.0 109.632 -177.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.61 HD13 ' O ' ' A' ' 462' ' ' ALA . 3.7 mt -57.95 -55.86 19.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 114.296 -1.32 . . . . 0.0 112.252 175.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.733 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -102.46 -10.88 19.01 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -172.274 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . 0.623 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 93.94 31.79 7.93 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 119.34 -1.41 . . . . 0.0 114.331 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 469' ' ' LEU . . . . . 0.733 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.1 mt -88.96 161.42 16.63 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 117.838 0.819 . . . . 0.0 110.922 175.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . 0.443 HD21 HG22 ' A' ' 476' ' ' ILE . 12.5 p30 -106.33 -176.84 3.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.075 170.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 471' ' ' ALA . . . . . 0.416 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -62.62 -19.55 63.89 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -173.227 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -87.77 2.26 51.72 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 122.113 -0.367 . . . . 0.0 111.809 -174.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . 0.479 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 76.77 11.58 85.26 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.21 -0.995 . . . . 0.0 111.003 -175.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -101.32 156.74 17.27 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 176.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 8.2 p -93.92 132.98 37.82 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.087 0.47 . . . . 0.0 111.587 -176.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 476' ' ' ILE . . . . . 0.623 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.5 pp -96.87 -3.78 10.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.479 0.657 . . . . 0.0 110.015 177.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 28.1 mmm180 -71.01 -39.08 72.6 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.045 176.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 86.9 mt 55.88 62.62 2.32 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.5 0.667 . . . . 0.0 110.523 179.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 . . . . . 0 C--O 1.246 0.911 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.027 -179.986 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 381' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 . . . . . 0 N--CA 1.478 0.949 0 CA-C-O 120.965 0.412 . . . . 0.0 110.842 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 382' ' ' THR . . . . . 0.539 ' OG1' ' HA ' ' B' ' 391' ' ' LEU . 0.0 OUTLIER -97.39 -29.47 13.49 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.42 174.652 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 383' ' ' HIS . . . . . 0.462 ' HB2' ' O ' ' B' ' 386' ' ' PHE . 19.0 p80 -159.5 159.29 33.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.052 0.453 . . . . 0.0 111.29 -176.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 384' ' ' GLY . . . . . . . . . . . . . . . -114.78 -118.02 3.24 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 174.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 385' ' ' THR . . . . . . . . . . . . . 30.0 m -58.45 -35.14 71.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.219 0.533 . . . . 0.0 111.304 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 386' ' ' PHE . . . . . 0.639 ' CZ ' HG13 ' B' ' 394' ' ' VAL . 1.9 t80 -82.19 128.22 68.53 Favored Pre-proline 0 C--N 1.324 -0.534 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 176.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 387' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -55.59 -72.61 0.03 OUTLIER 'Trans proline' 0 N--CA 1.486 1.078 0 C-N-CA 124.536 3.491 . . . . 0.0 114.456 178.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 388' ' ' MET . . . . . 0.516 ' SD ' HG12 ' B' ' 394' ' ' VAL . 10.4 ttp 69.34 59.49 0.32 Allowed 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 170.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 389' ' ' HIS . . . . . 0.55 ' ND1' ' HA ' ' B' ' 393' ' ' ASN . 17.7 m170 51.28 -138.36 1.07 Allowed 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -178.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 390' ' ' GLN . . . . . 0.425 ' H ' ' HB3' ' B' ' 389' ' ' HIS . 5.9 pm0 -110.99 22.81 14.89 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 164.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 391' ' ' LEU . . . . . 0.585 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.5 pt? -168.46 -61.73 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.553 -174.044 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 392' ' ' GLY . . . . . 0.585 ' N ' ' HG ' ' B' ' 391' ' ' LEU . . . -160.4 59.37 0.31 Allowed Glycine 0 C--N 1.338 0.644 0 C-N-CA 119.65 -1.262 . . . . 0.0 114.649 -171.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 393' ' ' ASN . . . . . 0.55 ' HA ' ' ND1' ' B' ' 389' ' ' HIS . 0.4 OUTLIER -62.23 -39.71 93.7 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 117.371 0.586 . . . . 0.0 109.535 175.798 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 394' ' ' VAL . . . . . 0.639 HG13 ' CZ ' ' B' ' 386' ' ' PHE . 0.6 OUTLIER -56.62 -46.09 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 179.346 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 395' ' ' ILE . . . . . 0.589 HG22 ' CD1' ' B' ' 426' ' ' ILE . 4.0 mp -57.86 -52.6 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.37 0 CA-C-O 117.794 -1.098 . . . . 0.0 113.45 -174.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 396' ' ' LYS . . . . . 0.643 ' O ' HG21 ' B' ' 399' ' ' VAL . 0.0 OUTLIER -63.58 -49.81 71.9 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-N 121.978 2.172 . . . . 0.0 111.706 -175.885 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.62 -44.86 68.73 Favored Glycine 0 N--CA 1.429 -1.819 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.825 -175.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . 0.699 ' CD1' HD11 ' B' ' 410' ' ' LEU . 35.1 mt -70.79 -33.11 51.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 399' ' ' VAL . . . . . 0.643 HG21 ' O ' ' B' ' 396' ' ' LYS . 16.7 m -62.93 -39.64 85.87 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 C-N-CA 118.678 -1.209 . . . . 0.0 108.362 -175.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -71.15 -35.55 71.72 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 175.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 401' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -88.37 -47.38 8.43 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -172.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 402' ' ' GLU . . . . . 0.445 ' HB3' ' HB ' ' B' ' 406' ' ' THR . 3.1 mm-40 -121.75 -21.09 6.23 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.573 -171.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 109.34 160.77 19.24 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.797 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 404' ' ' VAL . . . . . 0.648 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.1 m -53.62 -40.72 43.46 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.733 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -175.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 405' ' ' ALA . . . . . 0.5 ' HB2' HG22 ' B' ' 457' ' ' ILE . . . -68.39 -31.73 71.29 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 119.689 -0.804 . . . . 0.0 111.989 -177.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 406' ' ' THR . . . . . 0.694 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 94.8 m -77.15 -41.38 41.98 Favored 'General case' 0 C--O 1.222 -0.39 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.065 173.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 407' ' ' ALA . . . . . 0.492 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.53 -37.29 75.34 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 122.024 0.916 . . . . 0.0 109.249 176.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 408' ' ' TYR . . . . . 0.648 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.54 -52.7 50.59 Favored 'General case' 0 N--CA 1.433 -1.275 0 CA-C-N 113.612 -1.631 . . . . 0.0 110.032 176.376 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 409' ' ' THR . . . . . 0.554 HG22 HD21 ' B' ' 410' ' ' LEU . 3.3 m -56.05 -46.98 78.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.616 179.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 410' ' ' LEU . . . . . 0.699 HD11 ' CD1' ' B' ' 398' ' ' ILE . 13.6 mt -72.31 -37.74 68.86 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -175.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.5 -37.18 87.81 Favored Glycine 0 N--CA 1.436 -1.347 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 173.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 412' ' ' MET . . . . . 0.448 ' HE1' ' HA ' ' B' ' 417' ' ' GLN . 0.0 OUTLIER -64.0 -50.11 69.81 Favored 'General case' 0 C--O 1.223 -0.309 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 178.457 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 413' ' ' MET . . . . . 0.939 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 1.0 OUTLIER -71.18 -43.15 68.03 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 118.941 -1.104 . . . . 0.0 112.045 -176.22 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 414' ' ' LEU . . . . . 0.939 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 19.6 mt -69.49 -45.18 69.56 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -176.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 415' ' ' SER . . . . . 0.431 ' HB3' ' HE1' ' B' ' 388' ' ' MET . 54.7 p -85.95 -21.69 27.76 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.556 0.693 . . . . 0.0 110.462 -174.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 416' ' ' GLY . . . . . . . . . . . . . . . 108.75 178.54 21.64 Favored Glycine 0 N--CA 1.431 -1.687 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -168.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 417' ' ' GLN . . . . . 0.448 ' HA ' ' HE1' ' B' ' 412' ' ' MET . 1.7 mp0 -80.01 23.88 0.44 Allowed 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.038 0.447 . . . . 0.0 112.041 -173.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 418' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -71.44 78.41 0.77 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.699 0.762 . . . . 0.0 110.726 178.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 419' ' ' TYR . . . . . 0.56 ' CD1' ' HB3' ' B' ' 453' ' ' ALA . 17.1 p90 -51.89 -38.31 55.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.726 177.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -55.15 -45.32 75.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.858 178.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.4 -48.5 64.49 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.171 -178.031 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 422' ' ' VAL . . . . . 0.462 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.1 OUTLIER -65.7 -41.79 91.21 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.839 -176.291 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 423' ' ' SER . . . . . 0.769 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 28.5 t -69.39 -36.41 76.76 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.71 -178.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -69.41 -37.56 79.47 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.909 176.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 425' ' ' ILE . . . . . 0.582 HG23 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -72.36 -51.01 31.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.431 0.158 . . . . 0.0 110.623 -179.625 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 426' ' ' ILE . . . . . 0.589 ' CD1' HG22 ' B' ' 395' ' ' ILE . 1.1 mm -73.68 -22.86 18.95 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.899 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -173.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 427' ' ' ARG . . . . . 0.769 ' HB2' ' O ' ' B' ' 423' ' ' SER . 1.2 tmm_? -54.25 -33.73 59.14 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.284 0.564 . . . . 0.0 110.879 -177.053 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -86.33 -10.66 73.72 Favored Glycine 0 N--CA 1.441 -1.013 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 429' ' ' TYR . . . . . 0.492 ' HD1' ' CG2' ' B' ' 395' ' ' ILE . 5.6 m-30 -113.12 -1.92 14.28 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.884 0.85 . . . . 0.0 108.711 -174.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 430' ' ' LEU . . . . . 0.536 HD11 ' HD2' ' B' ' 431' ' ' PRO . 0.1 OUTLIER -66.38 130.03 94.18 Favored Pre-proline 0 N--CA 1.444 -0.757 0 CA-C-N 114.098 -1.41 . . . . 0.0 108.865 177.208 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 431' ' ' PRO . . . . . 0.536 ' HD2' HD11 ' B' ' 430' ' ' LEU . 80.2 Cg_exo -24.17 -66.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.759 1 C-N-CA 125.595 4.197 . . . . 0.0 114.697 178.984 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 432' ' ' GLY . . . . . 0.525 ' O ' HG13 ' B' ' 435' ' ' VAL . . . -145.4 -168.03 12.76 Favored Glycine 0 N--CA 1.441 -1.01 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 176.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 433' ' ' GLN . . . . . 0.532 ' O ' HG12 ' B' ' 436' ' ' VAL . 40.0 tp60 -69.79 -26.24 64.17 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 117.767 0.784 . . . . 0.0 110.465 179.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -65.95 -40.6 91.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.955 -178.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 435' ' ' VAL . . . . . 0.525 HG13 ' O ' ' B' ' 432' ' ' GLY . 7.5 p -68.95 -43.59 82.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-O 120.85 0.357 . . . . 0.0 110.732 -177.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 436' ' ' VAL . . . . . 0.532 HG12 ' O ' ' B' ' 433' ' ' GLN . 0.1 OUTLIER -65.12 -33.45 63.8 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.234 175.723 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 437' ' ' THR . . . . . 0.458 ' O ' ' HG3' ' B' ' 441' ' ' GLN . 1.0 OUTLIER -67.02 -52.62 40.26 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -177.73 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 438' ' ' ALA . . . . . 0.615 ' O ' ' HD2' ' B' ' 442' ' ' ARG . . . -58.6 -37.88 76.77 Favored 'General case' 0 N--CA 1.436 -1.151 0 O-C-N 123.809 0.693 . . . . 0.0 111.84 178.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 439' ' ' LEU . . . . . 0.598 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 2.1 tm? -67.44 -48.71 66.44 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -179.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.5 -34.78 74.57 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.498 -1.228 . . . . 0.0 110.773 176.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 441' ' ' GLN . . . . . 0.538 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 13.0 mt-30 -53.5 -50.67 64.9 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.175 -178.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 442' ' ' ARG . . . . . 0.615 ' HD2' ' O ' ' B' ' 438' ' ' ALA . 0.0 OUTLIER -76.33 -23.52 54.25 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 175.141 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 443' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 45.9 mt -63.79 -35.89 82.08 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 173.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -56.82 -35.76 69.17 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.378 172.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -73.21 -27.98 61.92 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.794 178.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 446' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 33.17 89.63 0.01 OUTLIER 'General case' 0 C--N 1.351 0.668 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 170.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 71.1 mt -59.51 -35.52 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 121.552 0.691 . . . . 0.0 109.18 175.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 448' ' ' ASP . . . . . 0.495 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 28.6 m-20 -166.72 175.65 7.71 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 177.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 449' ' ' ASP . . . . . 0.589 ' O ' ' HG2' ' B' ' 452' ' ' ARG . 13.6 m-20 -62.88 -60.08 3.97 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.394 -0.522 . . . . 0.0 109.61 174.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.9 -28.6 63.6 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 178.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 451' ' ' THR . . . . . 0.495 ' OG1' ' HB2' ' B' ' 448' ' ' ASP . 9.8 m -72.99 -23.38 60.64 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 119.621 -0.832 . . . . 0.0 111.39 -174.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 452' ' ' ARG . . . . . 0.589 ' HG2' ' O ' ' B' ' 449' ' ' ASP . 6.0 ptp180 -64.73 -41.62 95.81 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 174.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 453' ' ' ALA . . . . . 0.56 ' HB3' ' CD1' ' B' ' 419' ' ' TYR . . . -59.06 -49.17 78.92 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 123.751 0.657 . . . . 0.0 112.395 168.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 454' ' ' GLU . . . . . 0.464 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 33.5 mm-40 -53.77 -34.19 58.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.493 -177.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 30.0 p -115.04 15.36 17.19 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.255 -178.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 456' ' ' PHE . . . . . 0.56 ' CZ ' ' HB2' ' B' ' 423' ' ' SER . 1.0 OUTLIER -56.83 -47.64 79.86 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.833 -171.726 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 457' ' ' ILE . . . . . 0.534 ' CG1' ' HB3' ' B' ' 408' ' ' TYR . 1.9 mp -76.31 -33.47 23.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.224 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -57.83 -33.95 69.18 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 122.072 0.939 . . . . 0.0 108.999 171.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 459' ' ' HIS . . . . . 0.746 ' O ' HG23 ' B' ' 463' ' ' VAL . 44.4 m-70 -74.64 -29.25 61.2 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.136 -1.393 . . . . 0.0 110.964 177.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 460' ' ' LEU . . . . . 0.691 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -73.98 -34.64 64.29 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.882 0.849 . . . . 0.0 108.817 179.117 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 461' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 -73.13 -37.61 66.59 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.11 176.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 462' ' ' ALA . . . . . 0.622 ' O ' HD13 ' B' ' 466' ' ' ILE . . . -55.91 -34.98 66.07 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.351 -1.295 . . . . 0.0 109.62 169.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 463' ' ' VAL . . . . . 0.746 HG23 ' O ' ' B' ' 459' ' ' HIS . 72.6 t -61.68 -51.21 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-N 114.656 -1.157 . . . . 0.0 108.227 177.054 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 464' ' ' TYR . . . . . 0.561 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 15.8 m-30 -52.8 -28.41 22.41 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 124.347 1.03 . . . . 0.0 110.532 178.062 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.07 -38.9 20.22 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.765 0.793 . . . . 0.0 109.674 -177.155 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 466' ' ' ILE . . . . . 0.622 HD13 ' O ' ' B' ' 462' ' ' ALA . 3.7 mt -58.48 -55.85 20.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 114.419 -1.264 . . . . 0.0 112.181 175.134 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 467' ' ' LEU . . . . . 0.736 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -102.49 -10.72 19.12 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -172.235 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 468' ' ' GLY . . . . . 0.638 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 94.05 31.57 8.01 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 119.38 -1.391 . . . . 0.0 114.312 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 469' ' ' LEU . . . . . 0.736 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.1 mt -88.82 161.33 16.79 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 117.729 0.765 . . . . 0.0 110.883 175.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 470' ' ' ASN . . . . . 0.45 HD21 HG22 ' B' ' 476' ' ' ILE . 12.1 p30 -106.47 -177.06 3.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.014 170.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 471' ' ' ALA . . . . . 0.41 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -62.13 -19.66 63.26 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -173.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -88.0 2.48 51.67 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 122.06 -0.4 . . . . 0.0 111.775 -173.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 473' ' ' GLY . . . . . 0.483 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 76.52 11.67 84.99 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.33 -0.938 . . . . 0.0 111.035 -175.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -101.39 157.02 17.1 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 176.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 8.6 p -93.86 133.53 37.18 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.116 0.484 . . . . 0.0 111.387 -176.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 476' ' ' ILE . . . . . 0.638 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.5 pp -97.32 -3.92 9.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.431 0.634 . . . . 0.0 109.888 177.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 477' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -71.17 -38.81 72.14 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.056 176.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 478' ' ' LEU . . . . . . . . . . . . . 86.5 mt 55.83 62.62 2.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.449 0.642 . . . . 0.0 110.633 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 479' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 . . . . . 0 C--O 1.247 0.947 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.053 -179.86 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 . . . . . 0 N--CA 1.478 0.955 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 1.3 t -111.21 -43.22 3.76 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.637 172.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 29.4 m-70 -85.67 74.99 10.16 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.931 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -72.73 -77.67 0.56 Allowed Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 119.966 -1.111 . . . . 0.0 111.054 176.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 385' ' ' THR . . . . . 0.463 HG21 ' O ' ' A' ' 385' ' ' THR . 23.8 m -139.96 22.07 2.45 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 122.573 1.178 . . . . 0.0 108.871 172.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 386' ' ' PHE . . . . . 0.71 ' CE2' HG11 ' A' ' 394' ' ' VAL . 0.8 OUTLIER -139.45 123.78 11.19 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 114.746 -1.115 . . . . 0.0 108.842 -178.319 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -60.16 102.94 0.19 Allowed 'Trans proline' 0 CA--C 1.531 0.362 0 C-N-CA 123.779 2.986 . . . . 0.0 113.516 177.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 388' ' ' MET . . . . . 0.641 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 47.2 mtt -105.98 163.88 12.4 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.27 176.443 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 389' ' ' HIS . . . . . 0.595 ' HD1' ' HE3' ' A' ' 396' ' ' LYS . 17.5 m170 -74.1 39.68 0.12 Allowed 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . 0.527 ' O ' ' HG2' ' A' ' 390' ' ' GLN . 9.8 tt0 71.53 16.64 5.86 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.099 0.559 . . . . 0.0 110.673 -171.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.534 HD21 ' H ' ' A' ' 392' ' ' GLY . 2.0 pt? -163.41 -59.5 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 177.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . 0.534 ' H ' HD21 ' A' ' 391' ' ' LEU . . . -171.99 67.98 0.12 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 119.714 -1.231 . . . . 0.0 113.988 -173.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . 0.641 ' HB3' ' HA ' ' A' ' 388' ' ' MET . 0.2 OUTLIER -62.22 -41.14 98.12 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 174.712 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . 0.71 HG11 ' CE2' ' A' ' 386' ' ' PHE . 0.9 OUTLIER -55.57 -47.26 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 178.95 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.545 ' N ' HG23 ' A' ' 394' ' ' VAL . 3.6 mp -57.07 -52.08 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 CA-C-O 117.762 -1.113 . . . . 0.0 113.64 -175.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . 0.629 ' O ' HG22 ' A' ' 399' ' ' VAL . 0.1 OUTLIER -60.62 -51.09 70.9 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 121.873 2.124 . . . . 0.0 112.821 -175.245 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.93 -42.72 70.76 Favored Glycine 0 N--CA 1.438 -1.18 0 C-N-CA 119.554 -1.308 . . . . 0.0 110.894 -174.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . 0.598 HD13 ' CD1' ' A' ' 410' ' ' LEU . 39.4 mt -71.78 -34.29 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 CA-C-N 114.009 -1.095 . . . . 0.0 113.641 -178.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . 0.629 HG22 ' O ' ' A' ' 396' ' ' LYS . 16.0 m -62.91 -39.56 85.53 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 C-N-CA 118.881 -1.128 . . . . 0.0 108.649 -174.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -69.96 -38.2 76.03 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 175.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . 0.448 HE21 ' HB3' ' A' ' 401' ' ' GLN . 2.5 mm100 -90.19 -48.81 6.93 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -170.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . 0.444 ' HB3' ' HB ' ' A' ' 406' ' ' THR . 1.3 mm-40 -116.12 -19.15 10.4 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.106 -170.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 104.51 161.0 24.14 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.579 178.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . 0.674 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.5 m -53.42 -45.26 57.29 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.967 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -176.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . 0.47 ' HB1' HG22 ' A' ' 457' ' ' ILE . . . -62.93 -31.23 72.27 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 119.995 -0.682 . . . . 0.0 112.606 -178.03 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 406' ' ' THR . . . . . 0.675 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 87.9 m -76.96 -43.14 36.3 Favored 'General case' 0 C--O 1.222 -0.364 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.201 173.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.482 ' HB3' ' HA ' ' A' ' 395' ' ' ILE . . . -58.69 -37.22 75.61 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 122.191 0.996 . . . . 0.0 109.297 176.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 408' ' ' TYR . . . . . 0.674 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -66.11 -51.91 53.55 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 113.414 -1.721 . . . . 0.0 109.659 176.568 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 409' ' ' THR . . . . . 0.575 HG23 HD23 ' A' ' 410' ' ' LEU . 13.3 m -54.44 -47.11 73.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.451 178.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . 0.675 ' HG ' ' O ' ' A' ' 406' ' ' THR . 14.4 mt -71.57 -37.47 71.06 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 120.944 0.402 . . . . 0.0 109.92 -175.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.33 -34.57 75.02 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.017 -1.087 . . . . 0.0 110.53 173.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 412' ' ' MET . . . . . 0.412 ' HB2' ' O ' ' A' ' 409' ' ' THR . 0.4 OUTLIER -67.28 -44.4 79.4 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 115.412 -0.394 . . . . 0.0 111.454 177.836 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 413' ' ' MET . . . . . 0.756 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.0 OUTLIER -70.85 -55.45 8.45 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 118.371 -1.332 . . . . 0.0 111.736 179.187 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . 0.756 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 3.9 mt -63.62 -44.51 93.71 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -171.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 46.8 t -86.42 -21.05 27.33 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.71 0.767 . . . . 0.0 109.906 -176.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . 0.452 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 107.37 -176.26 20.85 Favored Glycine 0 N--CA 1.431 -1.667 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -170.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -79.72 24.71 0.37 Allowed 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.4 0.619 . . . . 0.0 111.479 -172.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 418' ' ' ASN . . . . . 0.452 ' H ' ' C ' ' A' ' 416' ' ' GLY . 92.6 m-20 -70.83 75.28 0.62 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.856 -178.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 419' ' ' TYR . . . . . 0.518 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 12.1 p90 -50.56 -38.84 47.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.173 175.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -54.71 -47.82 73.24 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 123.292 0.37 . . . . 0.0 110.816 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.69 -49.12 64.36 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.419 -177.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . 0.416 ' HB ' ' CD1' ' A' ' 408' ' ' TYR . 0.2 OUTLIER -65.64 -39.5 85.16 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.552 -176.934 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.751 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 78.6 p -68.75 -36.32 78.22 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.564 -0.454 . . . . 0.0 109.868 -178.088 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -70.32 -38.75 71.05 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.946 175.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . 0.539 HG21 HG22 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -71.74 -51.68 30.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 O-C-N 122.852 -0.205 . . . . 0.0 110.857 -178.195 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . 0.541 ' O ' HD21 ' A' ' 430' ' ' LEU . 1.1 mm -74.05 -23.44 18.75 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.827 0 C-N-CA 122.407 0.283 . . . . 0.0 110.405 -173.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.751 ' HB2' ' O ' ' A' ' 423' ' ' SER . 1.0 OUTLIER -54.77 -31.84 59.21 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.034 0.445 . . . . 0.0 111.496 -177.536 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -85.16 -14.84 68.19 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.228 -0.987 . . . . 0.0 110.859 178.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.525 ' CE1' ' HD2' ' A' ' 396' ' ' LYS . 5.1 m-30 -111.0 0.2 16.9 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.689 0.757 . . . . 0.0 109.031 -171.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . 0.541 HD21 ' O ' ' A' ' 426' ' ' ILE . 0.1 OUTLIER -65.48 129.1 94.29 Favored Pre-proline 0 N--CA 1.442 -0.866 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.74 177.576 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . 0.515 ' HD2' HD13 ' A' ' 430' ' ' LEU . 81.3 Cg_exo -23.59 -71.19 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.941 1 C-N-CA 125.539 4.159 . . . . 0.0 114.76 179.841 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . 0.548 ' O ' HG11 ' A' ' 435' ' ' VAL . . . -138.22 -171.93 12.36 Favored Glycine 0 N--CA 1.441 -1.031 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 176.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . 0.517 ' O ' HG13 ' A' ' 436' ' ' VAL . 51.3 tp60 -67.46 -25.56 65.95 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 118.106 0.953 . . . . 0.0 110.13 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -63.84 -43.41 96.23 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 435' ' ' VAL . . . . . 0.548 HG11 ' O ' ' A' ' 432' ' ' GLY . 8.3 p -69.27 -41.93 81.26 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 CA-C-O 121.082 0.467 . . . . 0.0 110.641 -176.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . 0.517 HG13 ' O ' ' A' ' 433' ' ' GLN . 0.1 OUTLIER -67.14 -30.19 48.57 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.082 174.832 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 437' ' ' THR . . . . . 0.473 ' O ' ' HG2' ' A' ' 441' ' ' GLN . 1.1 m -66.71 -53.95 28.13 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . 0.538 ' HB1' HG11 ' A' ' 463' ' ' VAL . . . -59.46 -34.59 72.73 Favored 'General case' 0 N--CA 1.434 -1.237 0 O-C-N 124.116 0.885 . . . . 0.0 111.227 178.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 439' ' ' LEU . . . . . 0.935 HD21 ' NH2' ' A' ' 442' ' ' ARG . 0.3 OUTLIER -67.11 -50.74 60.46 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.223 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.46 -33.89 74.51 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.44 -1.254 . . . . 0.0 111.032 175.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 441' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 437' ' ' THR . 7.0 mm100 -55.01 -50.09 69.9 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.68 -175.02 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . 0.935 ' NH2' HD21 ' A' ' 439' ' ' LEU . 0.0 OUTLIER -78.08 -25.54 47.68 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 119.511 -0.875 . . . . 0.0 112.687 175.847 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 443' ' ' LEU . . . . . 0.767 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 67.3 mt -67.81 -26.62 66.16 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.7 178.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -64.82 -38.52 91.24 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.842 0.829 . . . . 0.0 109.976 173.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -77.24 -26.56 52.7 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.424 -1.262 . . . . 0.0 111.373 179.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 29.43 101.8 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 175.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 51.7 mt -60.07 -35.14 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 121.45 0.643 . . . . 0.0 110.434 -179.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . 0.459 ' HB2' ' OG1' ' A' ' 451' ' ' THR . 31.8 m-20 -164.77 -162.42 0.64 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -177.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -81.44 -72.05 0.45 Allowed 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 171.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.0 -25.14 67.99 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 178.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 451' ' ' THR . . . . . 0.482 ' HA ' ' HB2' ' A' ' 454' ' ' GLU . 8.9 m -71.03 -22.98 62.07 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.998 -174.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 452' ' ' ARG . 17.8 mtp180 -53.41 -54.16 40.88 Favored 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 171.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 453' ' ' ALA . . . . . 0.518 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -59.71 -49.61 77.05 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 114.395 -1.275 . . . . 0.0 113.095 175.183 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . 0.482 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 20.8 mm-40 -49.23 -38.34 26.24 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.341 0.591 . . . . 0.0 111.849 -176.298 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 26.1 p -120.11 16.55 12.42 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.818 -175.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . 0.483 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.8 OUTLIER -54.64 -46.8 74.0 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.688 -172.063 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . 0.516 ' CG1' ' HB3' ' A' ' 408' ' ' TYR . 1.9 mp -78.67 -35.22 18.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.64 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -57.23 -36.43 70.91 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 121.841 0.829 . . . . 0.0 109.192 172.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . 0.728 ' HB3' ' CZ ' ' A' ' 442' ' ' ARG . 78.9 m-70 -75.2 -30.43 60.63 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.528 177.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . 0.733 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.6 OUTLIER -67.49 -34.52 77.32 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 179.421 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . 0.46 ' O ' ' HB2' ' A' ' 464' ' ' TYR . 17.3 m-80 -72.95 -37.49 67.11 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.347 -1.297 . . . . 0.0 109.04 176.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 462' ' ' ALA . . . . . 0.619 ' O ' HD13 ' A' ' 466' ' ' ILE . . . -56.63 -32.19 65.08 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.146 169.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.733 ' HB ' ' O ' ' A' ' 460' ' ' LEU . 51.3 t -64.88 -49.91 77.65 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.798 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 176.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 464' ' ' TYR . . . . . 0.59 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 19.5 m-30 -51.48 -28.98 14.81 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 124.511 1.132 . . . . 0.0 110.454 176.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.84 -38.36 19.59 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.602 0.715 . . . . 0.0 109.7 -176.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.619 HD13 ' O ' ' A' ' 462' ' ' ALA . 3.7 mt -58.11 -55.48 21.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.149 174.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.732 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -101.35 -10.85 19.9 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 -172.317 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . 0.575 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 94.13 31.58 7.97 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 119.538 -1.315 . . . . 0.0 114.287 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 469' ' ' LEU . . . . . 0.732 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.1 mt -89.45 164.02 15.01 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 117.801 0.8 . . . . 0.0 110.911 175.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 43.0 p30 -105.0 -179.19 3.87 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.267 172.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 471' ' ' ALA . . . . . 0.437 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -59.62 -23.47 63.02 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -177.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -87.43 3.11 48.46 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.157 -173.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . 0.448 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 75.45 15.43 81.22 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.393 -0.908 . . . . 0.0 110.973 -176.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -100.95 150.17 23.15 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 178.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 4.4 p -89.61 117.07 28.22 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.286 0.565 . . . . 0.0 111.557 -178.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 476' ' ' ILE . . . . . 0.575 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.8 pp -85.92 1.63 5.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.722 0.772 . . . . 0.0 110.231 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 -62.39 -34.48 76.8 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.243 173.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . 0.427 HD23 ' N ' ' A' ' 478' ' ' LEU . 1.8 pt? -141.62 114.3 8.42 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.041 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.286 -0.864 . . . . 0.0 109.802 179.672 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 381' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 . . . . . 0 N--CA 1.48 1.05 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 382' ' ' THR . . . . . . . . . . . . . 1.3 t -111.37 -43.17 3.74 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.685 172.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 383' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -85.66 75.0 10.17 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.828 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 384' ' ' GLY . . . . . . . . . . . . . . . -72.74 -77.63 0.57 Allowed Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.004 -1.093 . . . . 0.0 111.115 176.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 385' ' ' THR . . . . . 0.47 HG21 ' O ' ' B' ' 385' ' ' THR . 24.6 m -140.39 22.61 2.36 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 122.575 1.179 . . . . 0.0 108.874 172.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 386' ' ' PHE . . . . . 0.719 ' CE2' HG11 ' B' ' 394' ' ' VAL . 0.8 OUTLIER -140.1 123.45 10.41 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.773 -178.227 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 387' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -59.92 103.05 0.19 Allowed 'Trans proline' 0 N--CA 1.473 0.312 0 C-N-CA 123.787 2.992 . . . . 0.0 113.473 177.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 388' ' ' MET . . . . . 0.62 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 47.1 mtt -106.04 164.0 12.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.227 176.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 389' ' ' HIS . . . . . 0.599 ' HD1' ' HE3' ' B' ' 396' ' ' LYS . 17.3 m170 -74.17 39.86 0.12 Allowed 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 179.068 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 390' ' ' GLN . . . . . 0.522 ' O ' ' HG2' ' B' ' 390' ' ' GLN . 9.8 tt0 71.59 15.98 5.92 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.03 0.532 . . . . 0.0 110.65 -172.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 391' ' ' LEU . . . . . 0.526 HD21 ' H ' ' B' ' 392' ' ' GLY . 2.0 pt? -163.05 -59.5 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 177.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 392' ' ' GLY . . . . . 0.526 ' H ' HD21 ' B' ' 391' ' ' LEU . . . -171.91 68.0 0.13 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 119.729 -1.224 . . . . 0.0 114.028 -173.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 393' ' ' ASN . . . . . 0.62 ' HB3' ' HA ' ' B' ' 388' ' ' MET . 0.2 OUTLIER -62.11 -41.2 97.99 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 174.649 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 394' ' ' VAL . . . . . 0.719 HG11 ' CE2' ' B' ' 386' ' ' PHE . 0.9 OUTLIER -55.51 -47.38 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 178.867 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 395' ' ' ILE . . . . . 0.533 ' N ' HG23 ' B' ' 394' ' ' VAL . 3.6 mp -57.07 -52.01 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 CA-C-O 117.783 -1.103 . . . . 0.0 113.615 -175.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 396' ' ' LYS . . . . . 0.623 ' O ' HG22 ' B' ' 399' ' ' VAL . 0.1 OUTLIER -60.65 -51.06 70.98 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 122.049 2.204 . . . . 0.0 112.798 -175.197 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.84 -42.99 70.43 Favored Glycine 0 N--CA 1.438 -1.185 0 C-N-CA 119.595 -1.288 . . . . 0.0 110.927 -174.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . 0.599 HD13 ' CD1' ' B' ' 410' ' ' LEU . 39.1 mt -71.74 -34.19 51.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-N 114.074 -1.063 . . . . 0.0 113.668 -178.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 399' ' ' VAL . . . . . 0.623 HG22 ' O ' ' B' ' 396' ' ' LYS . 15.9 m -62.76 -39.72 85.9 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 C-N-CA 118.837 -1.145 . . . . 0.0 108.617 -174.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -70.07 -38.3 75.72 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 175.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 401' ' ' GLN . . . . . 0.436 HE21 ' HB3' ' B' ' 401' ' ' GLN . 2.4 mm100 -89.94 -48.79 6.99 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -170.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 402' ' ' GLU . . . . . 0.459 ' HB3' ' HB ' ' B' ' 406' ' ' THR . 1.3 mm-40 -116.23 -19.09 10.36 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.257 -170.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 104.73 160.86 23.92 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.622 178.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 404' ' ' VAL . . . . . 0.68 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.5 m -53.26 -45.17 55.22 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.954 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -176.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 405' ' ' ALA . . . . . 0.459 ' HB1' HG22 ' B' ' 457' ' ' ILE . . . -62.89 -31.36 72.39 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 119.994 -0.683 . . . . 0.0 112.655 -178.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 406' ' ' THR . . . . . 0.671 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 86.4 m -77.06 -42.83 36.78 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.232 173.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 407' ' ' ALA . . . . . 0.477 ' HB3' ' HA ' ' B' ' 395' ' ' ILE . . . -58.86 -37.12 75.8 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 122.227 1.013 . . . . 0.0 109.281 176.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 408' ' ' TYR . . . . . 0.68 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -66.28 -51.68 55.02 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 113.343 -1.753 . . . . 0.0 109.779 176.588 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 409' ' ' THR . . . . . 0.569 HG23 HD23 ' B' ' 410' ' ' LEU . 13.1 m -54.44 -47.26 73.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.377 178.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 410' ' ' LEU . . . . . 0.671 ' HG ' ' O ' ' B' ' 406' ' ' THR . 14.5 mt -71.59 -37.44 70.98 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 120.92 0.391 . . . . 0.0 109.989 -175.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.39 -34.54 75.35 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.031 -1.08 . . . . 0.0 110.499 173.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 412' ' ' MET . . . . . 0.42 ' HB2' ' O ' ' B' ' 409' ' ' THR . 0.4 OUTLIER -67.18 -44.46 79.65 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 115.434 -0.383 . . . . 0.0 111.535 177.771 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 413' ' ' MET . . . . . 0.753 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.0 OUTLIER -70.86 -55.34 8.7 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 118.316 -1.354 . . . . 0.0 111.714 179.187 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 414' ' ' LEU . . . . . 0.753 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 3.9 mt -63.79 -44.43 93.4 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -171.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 46.5 t -86.45 -20.89 27.46 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.749 0.785 . . . . 0.0 109.943 -176.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 416' ' ' GLY . . . . . 0.457 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 107.18 -176.24 20.97 Favored Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -170.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -79.72 24.82 0.37 Allowed 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.21 0.529 . . . . 0.0 111.461 -172.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 418' ' ' ASN . . . . . 0.457 ' H ' ' C ' ' B' ' 416' ' ' GLY . 92.6 m-20 -71.09 75.49 0.67 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.814 -178.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 419' ' ' TYR . . . . . 0.53 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 12.4 p90 -50.56 -38.82 47.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.195 175.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -54.77 -47.56 73.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.932 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.78 -49.22 63.59 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.45 -177.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 422' ' ' VAL . . . . . 0.42 ' HB ' ' CD1' ' B' ' 408' ' ' TYR . 0.2 OUTLIER -65.55 -39.5 85.26 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.494 -176.903 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 423' ' ' SER . . . . . 0.756 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 78.0 p -68.78 -36.38 78.23 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -178.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -70.43 -38.44 69.84 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.961 176.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 425' ' ' ILE . . . . . 0.526 HG21 HG22 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -71.94 -51.85 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-O 120.327 0.108 . . . . 0.0 110.799 -178.207 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 426' ' ' ILE . . . . . 0.536 ' O ' HD21 ' B' ' 430' ' ' LEU . 1.1 mm -73.95 -23.42 18.87 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.828 0 C-N-CA 122.37 0.268 . . . . 0.0 110.491 -173.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 427' ' ' ARG . . . . . 0.756 ' HB2' ' O ' ' B' ' 423' ' ' SER . 1.0 OUTLIER -54.75 -31.95 59.23 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.045 0.45 . . . . 0.0 111.449 -177.607 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -84.99 -15.11 67.98 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.15 -1.024 . . . . 0.0 110.817 178.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 429' ' ' TYR . . . . . 0.521 ' CE1' ' HD2' ' B' ' 396' ' ' LYS . 5.1 m-30 -110.62 -0.13 17.35 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -171.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 430' ' ' LEU . . . . . 0.538 ' HA ' HG11 ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.26 129.16 94.35 Favored Pre-proline 0 N--CA 1.441 -0.886 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.821 177.61 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 431' ' ' PRO . . . . . 0.509 ' HD2' HD13 ' B' ' 430' ' ' LEU . 78.8 Cg_exo -23.48 -70.94 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 1.003 1 C-N-CA 125.646 4.23 . . . . 0.0 114.814 179.844 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 432' ' ' GLY . . . . . 0.548 ' O ' HG11 ' B' ' 435' ' ' VAL . . . -138.82 -172.17 12.46 Favored Glycine 0 N--CA 1.441 -0.99 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 176.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 433' ' ' GLN . . . . . 0.509 ' O ' HG13 ' B' ' 436' ' ' VAL . 50.2 tp60 -67.11 -25.55 66.26 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 118.136 0.968 . . . . 0.0 110.291 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -63.99 -43.22 96.34 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 435' ' ' VAL . . . . . 0.548 HG11 ' O ' ' B' ' 432' ' ' GLY . 8.3 p -69.26 -41.87 81.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-O 120.947 0.403 . . . . 0.0 110.7 -176.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 436' ' ' VAL . . . . . 0.509 HG13 ' O ' ' B' ' 433' ' ' GLN . 0.1 OUTLIER -67.29 -30.19 48.35 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.049 174.937 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 437' ' ' THR . . . . . 0.452 ' O ' ' HG2' ' B' ' 441' ' ' GLN . 1.1 m -66.81 -53.86 28.51 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -179.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 438' ' ' ALA . . . . . 0.534 ' HB1' HG11 ' B' ' 463' ' ' VAL . . . -59.37 -34.65 72.66 Favored 'General case' 0 N--CA 1.434 -1.227 0 O-C-N 124.071 0.857 . . . . 0.0 111.261 178.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 439' ' ' LEU . . . . . 0.926 HD21 ' NH2' ' B' ' 442' ' ' ARG . 0.3 OUTLIER -67.12 -50.72 60.43 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.206 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.41 -33.98 74.61 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 114.463 -1.244 . . . . 0.0 111.037 175.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 441' ' ' GLN . . . . . 0.467 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 6.9 mm100 -54.97 -50.16 69.63 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.772 -175.007 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 442' ' ' ARG . . . . . 0.926 ' NH2' HD21 ' B' ' 439' ' ' LEU . 0.0 OUTLIER -77.97 -25.62 48.25 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 119.558 -0.857 . . . . 0.0 112.654 175.785 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 443' ' ' LEU . . . . . 0.762 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 67.3 mt -67.89 -26.4 65.99 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 120.383 -0.527 . . . . 0.0 109.593 178.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -65.06 -38.48 90.95 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.072 173.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -76.95 -27.09 54.7 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.339 -1.3 . . . . 0.0 111.33 179.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 446' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 30.08 101.95 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 175.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 52.0 mt -60.51 -34.88 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 121.359 0.599 . . . . 0.0 110.467 -179.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 448' ' ' ASP . . . . . 0.45 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 32.3 m-20 -164.91 -162.39 0.63 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -178.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -81.54 -71.76 0.46 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 171.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.27 -25.05 67.88 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 178.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 451' ' ' THR . . . . . 0.475 ' HA ' ' HB2' ' B' ' 454' ' ' GLU . 9.7 m -71.03 -23.17 62.1 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.046 -174.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 452' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' B' ' 452' ' ' ARG . 17.8 mtp180 -53.25 -54.28 38.51 Favored 'General case' 0 C--O 1.221 -0.401 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 171.336 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 453' ' ' ALA . . . . . 0.53 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -59.67 -49.33 78.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.393 -1.276 . . . . 0.0 113.11 175.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 454' ' ' GLU . . . . . 0.475 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 22.0 mm-40 -49.38 -38.34 28.27 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.299 0.571 . . . . 0.0 111.909 -176.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 25.6 p -120.24 16.57 12.32 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.818 -175.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 456' ' ' PHE . . . . . 0.472 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 0.8 OUTLIER -54.48 -46.9 73.49 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.656 -172.127 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 457' ' ' ILE . . . . . 0.52 ' CG1' ' HB3' ' B' ' 408' ' ' TYR . 1.9 mp -78.64 -35.42 18.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.565 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -57.03 -36.52 70.55 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.884 0.849 . . . . 0.0 109.278 172.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 459' ' ' HIS . . . . . 0.735 ' HB3' ' CZ ' ' B' ' 442' ' ' ARG . 78.7 m-70 -75.21 -30.37 60.59 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.515 177.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 460' ' ' LEU . . . . . 0.741 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.6 OUTLIER -67.47 -34.46 77.22 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.364 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 461' ' ' ASN . . . . . 0.453 ' O ' ' HB2' ' B' ' 464' ' ' TYR . 16.9 m-80 -73.03 -37.6 66.84 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.499 -1.228 . . . . 0.0 109.069 176.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 462' ' ' ALA . . . . . 0.608 ' O ' HD13 ' B' ' 466' ' ' ILE . . . -56.49 -32.42 65.01 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.628 -1.169 . . . . 0.0 109.957 169.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 463' ' ' VAL . . . . . 0.741 ' HB ' ' O ' ' B' ' 460' ' ' LEU . 50.9 t -64.8 -49.86 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 176.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 464' ' ' TYR . . . . . 0.576 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 19.6 m-30 -51.63 -28.58 14.79 Favored 'General case' 0 C--N 1.333 -0.13 0 O-C-N 124.442 1.089 . . . . 0.0 110.432 176.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.04 -38.57 19.02 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.662 0.744 . . . . 0.0 109.813 -176.492 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 466' ' ' ILE . . . . . 0.608 HD13 ' O ' ' B' ' 462' ' ' ALA . 3.7 mt -57.92 -55.31 22.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 114.374 -1.284 . . . . 0.0 112.215 174.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 467' ' ' LEU . . . . . 0.727 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -101.43 -10.94 19.75 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -172.383 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 468' ' ' GLY . . . . . 0.583 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 94.29 31.15 8.16 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 119.424 -1.369 . . . . 0.0 114.378 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 469' ' ' LEU . . . . . 0.727 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.0 mt -89.36 164.25 14.97 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 117.847 0.823 . . . . 0.0 110.921 175.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 42.6 p30 -105.12 -179.34 3.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.297 172.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 471' ' ' ALA . . . . . 0.433 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -59.01 -23.82 62.27 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -177.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -87.47 3.34 47.65 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.1 -173.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 473' ' ' GLY . . . . . 0.451 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 74.88 15.82 80.74 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.348 -0.929 . . . . 0.0 111.087 -176.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -100.98 150.23 23.1 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 178.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 4.6 p -89.76 117.07 28.33 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.067 0.46 . . . . 0.0 111.459 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 476' ' ' ILE . . . . . 0.583 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.8 pp -85.76 1.1 5.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.232 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 477' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -61.94 -34.49 76.19 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.155 173.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 478' ' ' LEU . . . . . 0.411 HD23 ' N ' ' B' ' 478' ' ' LEU . 1.8 pt? -141.88 114.22 8.26 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.188 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 479' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.488 -0.767 . . . . 0.0 109.863 179.908 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 381' ' ' ARG . . . . . 0.409 ' HG3' ' H ' ' A' ' 382' ' ' THR . 23.2 ptt180 . . . . . 0 N--CA 1.483 1.193 0 N-CA-C 111.371 0.137 . . . . 0.0 111.371 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 382' ' ' THR . . . . . 0.493 ' O ' ' HE3' ' A' ' 388' ' ' MET . 0.0 OUTLIER -176.25 -47.34 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -176.772 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 383' ' ' HIS . . . . . 0.47 ' HB2' ' O ' ' A' ' 386' ' ' PHE . 14.1 p80 -155.04 157.21 37.24 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.379 -0.529 . . . . 0.0 111.858 -173.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -121.31 -80.89 0.59 Allowed Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.563 174.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 21.5 m -76.48 -57.9 3.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.792 0.329 . . . . 0.0 111.224 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 386' ' ' PHE . . . . . 0.684 ' CE2' HG13 ' A' ' 394' ' ' VAL . 2.1 t80 -69.94 129.01 91.35 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.08 -64.1 0.23 Allowed 'Trans proline' 0 N--CA 1.484 0.935 0 C-N-CA 124.361 3.374 . . . . 0.0 113.908 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 388' ' ' MET . . . . . 0.57 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 4.5 ttp 63.36 41.94 7.25 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 171.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 389' ' ' HIS . . . . . 0.615 ' CD2' ' HB2' ' A' ' 393' ' ' ASN . 33.0 m170 50.24 -107.34 0.27 Allowed 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 121.236 0.541 . . . . 0.0 109.757 -174.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -140.17 18.33 2.43 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 172.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.488 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.5 pt? -165.57 -54.54 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.709 -172.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . 0.488 ' N ' ' HG ' ' A' ' 391' ' ' LEU . . . -171.5 58.49 0.17 Allowed Glycine 0 C--N 1.335 0.491 0 C-N-CA 119.667 -1.254 . . . . 0.0 114.438 -174.04 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . 0.615 ' HB2' ' CD2' ' A' ' 389' ' ' HIS . 0.2 OUTLIER -59.5 -40.19 86.23 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 117.748 0.774 . . . . 0.0 109.746 174.695 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . 0.684 HG13 ' CE2' ' A' ' 386' ' ' PHE . 1.8 m -56.13 -47.46 80.53 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.598 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 178.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.601 ' N ' HG23 ' A' ' 394' ' ' VAL . 3.6 mp -57.56 -52.75 53.3 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.358 0 CA-C-O 117.86 -1.066 . . . . 0.0 113.662 -174.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . 0.616 ' O ' HG21 ' A' ' 399' ' ' VAL . 0.0 OUTLIER -63.25 -49.61 73.43 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 121.968 2.167 . . . . 0.0 112.054 -175.131 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -52.99 -44.47 62.03 Favored Glycine 0 N--CA 1.431 -1.658 0 CA-C-N 114.706 -1.133 . . . . 0.0 110.726 -176.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . 0.54 HD11 ' CD1' ' A' ' 410' ' ' LEU . 38.0 mt -71.51 -33.13 48.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . 0.616 HG21 ' O ' ' A' ' 396' ' ' LYS . 15.7 m -63.26 -39.85 86.81 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 C-N-CA 118.624 -1.23 . . . . 0.0 108.114 -175.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -69.63 -35.74 75.5 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 174.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . 0.447 HE21 ' HB3' ' A' ' 401' ' ' GLN . 5.5 mm100 -89.42 -48.06 7.59 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -172.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . 0.43 ' HB3' ' HB ' ' A' ' 406' ' ' THR . 2.4 mm-40 -120.85 -20.36 6.98 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.358 -170.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 106.74 161.74 22.14 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.607 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . 0.62 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.4 m -53.7 -45.66 61.09 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.87 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -175.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . 0.485 ' HB3' HG21 ' A' ' 457' ' ' ILE . . . -62.35 -32.62 73.43 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 119.92 -0.712 . . . . 0.0 112.527 -177.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 406' ' ' THR . . . . . 0.673 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 92.1 m -77.54 -41.26 39.68 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.534 174.148 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.49 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.7 -36.44 74.26 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 122.121 0.962 . . . . 0.0 109.081 175.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 408' ' ' TYR . . . . . 0.62 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -66.19 -52.19 50.49 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 113.569 -1.65 . . . . 0.0 109.841 175.961 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 409' ' ' THR . . . . . 0.564 HG23 HD22 ' A' ' 410' ' ' LEU . 18.0 m -54.69 -47.64 73.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.494 178.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . 0.673 ' HG ' ' O ' ' A' ' 406' ' ' THR . 14.5 mt -72.46 -36.46 68.5 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.895 -174.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.71 -34.56 77.61 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 119.901 -1.142 . . . . 0.0 110.457 173.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 412' ' ' MET . . . . . 0.436 ' HB2' ' O ' ' A' ' 409' ' ' THR . 0.5 OUTLIER -67.04 -48.94 66.79 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 115.712 -0.244 . . . . 0.0 111.441 177.595 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 413' ' ' MET . . . . . 0.931 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 1.0 OUTLIER -72.0 -43.51 64.97 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.096 -1.041 . . . . 0.0 112.15 -178.75 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . 0.931 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 14.5 mt -69.81 -45.7 67.32 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -176.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 33.0 t -87.45 -23.44 24.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.52 0.676 . . . . 0.0 110.139 -176.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . 0.444 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 108.92 -175.96 19.57 Favored Glycine 0 N--CA 1.429 -1.784 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -170.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 32.4 mm-40 -80.56 23.22 0.52 Allowed 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.312 0.577 . . . . 0.0 111.322 -171.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 418' ' ' ASN . . . . . 0.444 ' H ' ' C ' ' A' ' 416' ' ' GLY . 3.4 m-20 -72.24 75.48 0.98 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.685 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 419' ' ' TYR . . . . . 0.629 ' CD1' ' HB1' ' A' ' 453' ' ' ALA . 11.2 p90 -55.48 -38.11 68.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.163 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -54.73 -44.15 73.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.823 0.344 . . . . 0.0 110.913 178.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.9 -49.36 62.38 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.283 -177.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . 0.463 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.1 OUTLIER -64.84 -40.94 90.78 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.691 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.068 -177.659 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.777 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 16.0 t -69.46 -36.06 76.23 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 120.326 -0.55 . . . . 0.0 109.635 -176.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -70.4 -37.05 69.92 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.989 176.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . 0.558 HG23 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -71.6 -50.65 38.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.502 0.191 . . . . 0.0 110.558 -179.716 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . 0.548 ' CD1' HG22 ' A' ' 395' ' ' ILE . 1.2 mm -73.68 -23.72 19.46 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.979 0 CA-C-O 120.833 0.349 . . . . 0.0 110.2 -173.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.777 ' HB2' ' O ' ' A' ' 423' ' ' SER . 1.5 tmm_? -55.04 -32.35 61.8 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.26 0.552 . . . . 0.0 111.127 -177.247 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.68 -9.54 71.61 Favored Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 120.412 -0.899 . . . . 0.0 111.041 178.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.49 ' HD1' ' CG2' ' A' ' 395' ' ' ILE . 7.4 m-30 -114.0 -0.26 14.13 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -175.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . 0.544 HD12 ' HD2' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -66.34 129.04 94.16 Favored Pre-proline 0 N--CA 1.444 -0.773 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.784 177.92 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . 0.544 ' HD2' HD12 ' A' ' 430' ' ' LEU . 87.5 Cg_exo -23.45 -73.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.356 0.974 1 C-N-CA 125.62 4.213 . . . . 0.0 114.909 179.901 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . 0.534 ' O ' HG13 ' A' ' 435' ' ' VAL . . . -137.99 -170.02 11.76 Favored Glycine 0 N--CA 1.439 -1.105 0 N-CA-C 110.311 -1.115 . . . . 0.0 110.311 176.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . 0.481 ' O ' HG12 ' A' ' 436' ' ' VAL . 22.6 tp60 -65.89 -27.42 68.19 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 117.929 0.865 . . . . 0.0 110.315 -178.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -66.41 -40.59 89.69 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -177.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 435' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 432' ' ' GLY . 8.5 p -70.22 -43.48 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.09 0 CA-C-O 120.942 0.401 . . . . 0.0 110.655 -177.247 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . 0.481 HG12 ' O ' ' A' ' 433' ' ' GLN . 0.1 OUTLIER -66.29 -30.6 50.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.12 175.044 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 437' ' ' THR . . . . . 0.514 ' O ' ' HG2' ' A' ' 441' ' ' GLN . 1.0 OUTLIER -67.89 -53.19 28.48 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -179.212 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . 0.539 ' HB3' HG11 ' A' ' 463' ' ' VAL . . . -59.44 -35.17 73.52 Favored 'General case' 0 N--CA 1.437 -1.091 0 O-C-N 123.924 0.765 . . . . 0.0 111.349 178.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 439' ' ' LEU . . . . . 0.921 HD21 ' NH2' ' A' ' 442' ' ' ARG . 0.4 OUTLIER -67.14 -50.75 60.19 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 -179.257 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.44 -34.16 74.96 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.231 -1.349 . . . . 0.0 111.294 175.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 441' ' ' GLN . . . . . 0.514 ' HG2' ' O ' ' A' ' 437' ' ' THR . 7.4 mm100 -54.65 -49.65 70.06 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.047 -176.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . 0.921 ' NH2' HD21 ' A' ' 439' ' ' LEU . 0.0 OUTLIER -78.26 -25.65 46.87 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.484 -0.886 . . . . 0.0 112.648 175.72 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 443' ' ' LEU . . . . . 0.739 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 67.6 mt -67.51 -26.38 66.31 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.197 0.522 . . . . 0.0 109.618 178.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -64.6 -38.16 90.05 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.969 173.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -76.31 -26.66 56.04 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.43 -1.259 . . . . 0.0 111.102 178.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 28.53 99.05 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 O-C-N 124.702 1.251 . . . . 0.0 114.373 175.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 50.1 mt -59.0 -34.56 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 121.545 0.688 . . . . 0.0 110.579 -179.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -163.29 -161.2 0.66 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 -177.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -82.13 -70.83 0.52 Allowed 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 167.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 450' ' ' GLN . . . . . 0.4 ' O ' ' HG2' ' A' ' 454' ' ' GLU . 0.0 OUTLIER -64.7 -26.38 68.35 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -179.375 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 451' ' ' THR . . . . . 0.456 ' HA ' ' HB2' ' A' ' 454' ' ' GLU . 9.0 m -71.2 -23.18 61.98 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.982 -174.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . 0.419 ' NH2' ' HB3' ' A' ' 443' ' ' LEU . 19.3 mtp180 -53.19 -54.55 34.35 Favored 'General case' 0 C--O 1.222 -0.381 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 171.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 453' ' ' ALA . . . . . 0.629 ' HB1' ' CD1' ' A' ' 419' ' ' TYR . . . -60.34 -48.75 80.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.203 -1.362 . . . . 0.0 113.028 175.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . 0.456 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 78.6 mm-40 -49.1 -38.3 24.2 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.34 0.59 . . . . 0.0 111.723 -175.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 28.3 p -120.57 16.41 12.03 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.291 -176.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . 0.482 ' CZ ' ' HB2' ' A' ' 423' ' ' SER . 0.8 OUTLIER -53.66 -47.88 69.95 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.648 -172.042 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . 0.511 ' CG1' ' HB3' ' A' ' 408' ' ' TYR . 1.9 mp -77.59 -35.2 21.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.712 -179.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -56.93 -36.13 69.87 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 121.969 0.89 . . . . 0.0 109.055 172.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . 0.725 ' HB3' ' CZ ' ' A' ' 442' ' ' ARG . 81.3 m-70 -75.62 -30.4 59.51 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.405 -1.27 . . . . 0.0 110.743 177.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . 0.734 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.6 OUTLIER -67.84 -34.71 77.24 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.749 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . 0.469 ' O ' ' HB2' ' A' ' 464' ' ' TYR . 24.4 m-80 -72.95 -37.3 67.17 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.344 -1.298 . . . . 0.0 108.889 177.098 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 462' ' ' ALA . . . . . 0.569 ' O ' HD11 ' A' ' 466' ' ' ILE . . . -56.98 -32.49 66.13 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.429 -1.26 . . . . 0.0 110.238 168.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.734 ' HB ' ' O ' ' A' ' 460' ' ' LEU . 49.4 t -64.12 -49.77 79.92 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 176.061 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 464' ' ' TYR . . . . . 0.59 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 18.8 m-30 -51.99 -28.21 16.12 Favored 'General case' 0 C--N 1.333 -0.137 0 O-C-N 124.435 1.084 . . . . 0.0 110.403 176.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.94 -40.5 18.45 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.611 0.72 . . . . 0.0 109.616 -177.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.569 HD11 ' O ' ' A' ' 462' ' ' ALA . 3.7 mt -57.33 -54.76 26.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 114.481 -1.236 . . . . 0.0 112.174 176.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.741 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -101.49 -10.85 19.78 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -172.966 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . 0.599 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 94.07 31.18 8.23 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 119.586 -1.292 . . . . 0.0 114.425 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 469' ' ' LEU . . . . . 0.741 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.7 mt -89.08 165.43 14.52 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 117.79 0.795 . . . . 0.0 110.932 176.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 37.2 p30 -105.49 -177.82 3.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.9 171.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 471' ' ' ALA . . . . . 0.555 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -66.05 -15.5 63.11 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -176.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 -88.02 -1.84 58.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.709 0.29 . . . . 0.0 111.023 -175.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . 0.459 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 79.32 12.99 83.29 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.224 -0.989 . . . . 0.0 111.032 -175.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -101.17 151.82 21.38 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 176.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 27.5 t -89.73 134.96 33.9 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.155 0.502 . . . . 0.0 110.536 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 476' ' ' ILE . . . . . 0.599 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.6 pp -105.69 -41.89 6.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.2 -176.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 477' ' ' ARG . . . . . 0.581 ' N ' HD11 ' A' ' 476' ' ' ILE . 22.3 mmm180 41.87 57.2 3.23 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 123.756 0.66 . . . . 0.0 111.422 178.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -163.37 126.82 2.75 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -175.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.877 -0.583 . . . . 0.0 109.78 178.998 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 381' ' ' ARG . . . . . 0.401 ' HG3' ' N ' ' B' ' 382' ' ' THR . 23.7 ptt180 . . . . . 0 N--CA 1.483 1.178 0 CA-C-O 120.361 0.124 . . . . 0.0 111.262 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 382' ' ' THR . . . . . 0.488 ' O ' ' HE3' ' B' ' 388' ' ' MET . 0.0 OUTLIER -176.41 -47.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -176.964 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 383' ' ' HIS . . . . . 0.471 ' HB2' ' O ' ' B' ' 386' ' ' PHE . 14.3 p80 -155.32 157.14 36.71 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.9 -173.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 384' ' ' GLY . . . . . . . . . . . . . . . -121.16 -80.85 0.6 Allowed Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.585 174.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 385' ' ' THR . . . . . . . . . . . . . 19.7 m -76.34 -57.94 3.57 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.618 0.247 . . . . 0.0 111.159 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 386' ' ' PHE . . . . . 0.674 ' CE2' HG13 ' B' ' 394' ' ' VAL . 2.1 t80 -70.1 129.03 91.12 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 387' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -51.04 -64.05 0.23 Allowed 'Trans proline' 0 N--CA 1.482 0.836 0 C-N-CA 124.355 3.37 . . . . 0.0 114.014 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 388' ' ' MET . . . . . 0.57 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 4.5 ttp 63.39 41.83 7.29 Favored 'General case' 0 CA--C 1.549 0.941 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 171.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 389' ' ' HIS . . . . . 0.607 ' CD2' ' HB2' ' B' ' 393' ' ' ASN . 33.0 m170 50.39 -107.34 0.27 Allowed 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 121.113 0.482 . . . . 0.0 109.794 -174.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -140.25 18.49 2.42 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 172.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 391' ' ' LEU . . . . . 0.49 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.5 pt? -165.62 -54.69 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.668 -172.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 392' ' ' GLY . . . . . 0.49 ' N ' ' HG ' ' B' ' 391' ' ' LEU . . . -171.46 58.63 0.17 Allowed Glycine 0 CA--C 1.523 0.552 0 C-N-CA 119.755 -1.212 . . . . 0.0 114.452 -173.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 393' ' ' ASN . . . . . 0.607 ' HB2' ' CD2' ' B' ' 389' ' ' HIS . 0.2 OUTLIER -59.67 -40.18 86.94 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 117.658 0.729 . . . . 0.0 109.665 174.722 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 394' ' ' VAL . . . . . 0.674 HG13 ' CE2' ' B' ' 386' ' ' PHE . 1.8 m -56.15 -47.48 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 178.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 395' ' ' ILE . . . . . 0.598 ' N ' HG23 ' B' ' 394' ' ' VAL . 3.7 mp -57.68 -52.72 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 CA-C-O 117.846 -1.073 . . . . 0.0 113.738 -174.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 396' ' ' LYS . . . . . 0.617 ' O ' HG21 ' B' ' 399' ' ' VAL . 0.0 OUTLIER -63.07 -49.7 73.51 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 122.117 2.235 . . . . 0.0 111.967 -175.3 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -52.94 -44.53 61.78 Favored Glycine 0 N--CA 1.432 -1.621 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.696 -175.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . 0.552 HD11 ' CD1' ' B' ' 410' ' ' LEU . 38.8 mt -71.45 -33.28 49.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -179.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 399' ' ' VAL . . . . . 0.617 HG21 ' O ' ' B' ' 396' ' ' LYS . 15.6 m -63.35 -39.58 85.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 C-N-CA 118.583 -1.247 . . . . 0.0 108.111 -175.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -69.8 -35.83 75.17 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 174.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 401' ' ' GLN . . . . . . . . . . . . . 5.3 mm100 -89.21 -48.01 7.68 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -172.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 402' ' ' GLU . . . . . 0.441 ' HB3' ' HB ' ' B' ' 406' ' ' THR . 2.4 mm-40 -121.09 -20.31 6.85 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.46 -170.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 106.99 161.78 21.91 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.658 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 404' ' ' VAL . . . . . 0.61 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.4 m -53.67 -45.55 60.65 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -175.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 405' ' ' ALA . . . . . 0.474 ' HB3' HG21 ' B' ' 457' ' ' ILE . . . -62.58 -32.36 73.33 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 119.866 -0.734 . . . . 0.0 112.43 -177.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 406' ' ' THR . . . . . 0.67 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 93.7 m -77.72 -41.34 38.17 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.039 -0.664 . . . . 0.0 110.498 174.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 407' ' ' ALA . . . . . 0.483 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.69 -36.37 74.1 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 122.122 0.963 . . . . 0.0 109.135 175.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 408' ' ' TYR . . . . . 0.61 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -66.16 -52.18 50.69 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 113.581 -1.645 . . . . 0.0 109.866 175.905 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 409' ' ' THR . . . . . 0.565 HG23 HD22 ' B' ' 410' ' ' LEU . 17.9 m -54.74 -47.59 73.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.467 178.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 410' ' ' LEU . . . . . 0.67 ' HG ' ' O ' ' B' ' 406' ' ' THR . 14.6 mt -72.51 -36.48 68.37 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -174.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.57 -34.61 76.87 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 119.891 -1.147 . . . . 0.0 110.481 173.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 412' ' ' MET . . . . . 0.435 ' HB2' ' O ' ' B' ' 409' ' ' THR . 0.5 OUTLIER -67.03 -49.15 66.15 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 115.645 -0.277 . . . . 0.0 111.361 177.665 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 413' ' ' MET . . . . . 0.94 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 1.0 OUTLIER -71.84 -43.64 65.19 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.02 -1.072 . . . . 0.0 112.033 -178.63 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 414' ' ' LEU . . . . . 0.94 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 14.4 mt -69.63 -45.91 67.4 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -176.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 415' ' ' SER . . . . . 0.406 ' HB2' ' HE2' ' B' ' 388' ' ' MET . 33.4 t -87.27 -23.44 24.69 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.625 0.726 . . . . 0.0 110.12 -175.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 416' ' ' GLY . . . . . 0.438 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 109.0 -175.81 19.43 Favored Glycine 0 N--CA 1.43 -1.714 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -170.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 33.0 mm-40 -80.48 23.05 0.53 Allowed 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.205 0.526 . . . . 0.0 111.419 -172.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 418' ' ' ASN . . . . . 0.438 ' H ' ' C ' ' B' ' 416' ' ' GLY . 3.1 m-20 -72.19 75.54 0.97 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.684 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 419' ' ' TYR . . . . . 0.628 ' CD1' ' HB1' ' B' ' 453' ' ' ALA . 10.7 p90 -55.64 -38.04 69.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.204 -179.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -54.91 -43.96 73.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.845 0.355 . . . . 0.0 110.8 178.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.97 -49.34 62.24 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.328 -177.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 422' ' ' VAL . . . . . 0.46 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.1 OUTLIER -64.9 -40.97 90.85 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.105 -177.682 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 423' ' ' SER . . . . . 0.765 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 15.0 t -69.54 -35.84 75.83 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 120.297 -0.561 . . . . 0.0 109.569 -176.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -70.39 -37.19 70.04 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.964 176.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 425' ' ' ILE . . . . . 0.545 HG23 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -71.57 -50.57 38.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.655 0.264 . . . . 0.0 110.59 -179.728 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 426' ' ' ILE . . . . . 0.534 ' CD1' HG22 ' B' ' 395' ' ' ILE . 1.2 mm -73.81 -23.73 19.28 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.042 0 CA-C-O 120.887 0.375 . . . . 0.0 110.163 -173.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 427' ' ' ARG . . . . . 0.765 ' HB2' ' O ' ' B' ' 423' ' ' SER . 1.5 tmm_? -55.03 -32.52 61.92 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.28 0.562 . . . . 0.0 111.134 -177.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.5 -9.44 72.31 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.152 178.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 429' ' ' TYR . . . . . 0.483 ' HD1' ' CG2' ' B' ' 395' ' ' ILE . 7.5 m-30 -113.98 -0.52 14.06 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -175.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 430' ' ' LEU . . . . . 0.536 HD12 ' HD2' ' B' ' 431' ' ' PRO . 0.0 OUTLIER -66.13 129.26 94.21 Favored Pre-proline 0 N--CA 1.444 -0.772 0 CA-C-N 114.532 -1.213 . . . . 0.0 108.782 178.039 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 431' ' ' PRO . . . . . 0.536 ' HD2' HD12 ' B' ' 430' ' ' LEU . 84.3 Cg_exo -23.4 -74.1 0.02 OUTLIER 'Trans proline' 0 C--N 1.356 0.936 1 C-N-CA 125.698 4.265 . . . . 0.0 114.93 179.708 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 432' ' ' GLY . . . . . 0.527 ' O ' HG13 ' B' ' 435' ' ' VAL . . . -137.57 -170.26 11.84 Favored Glycine 0 N--CA 1.441 -0.978 0 N-CA-C 110.301 -1.119 . . . . 0.0 110.301 176.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 433' ' ' GLN . . . . . 0.472 ' O ' HG12 ' B' ' 436' ' ' VAL . 22.7 tp60 -65.77 -27.51 68.34 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 117.865 0.832 . . . . 0.0 110.266 -179.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -66.3 -40.94 90.32 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.209 -177.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 435' ' ' VAL . . . . . 0.527 HG13 ' O ' ' B' ' 432' ' ' GLY . 8.6 p -70.01 -43.32 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-O 120.94 0.4 . . . . 0.0 110.693 -177.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 436' ' ' VAL . . . . . 0.472 HG12 ' O ' ' B' ' 433' ' ' GLN . 0.1 OUTLIER -66.46 -30.53 50.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.049 175.139 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 437' ' ' THR . . . . . 0.499 ' O ' ' HG2' ' B' ' 441' ' ' GLN . 1.0 OUTLIER -67.89 -53.43 26.62 Favored 'General case' 0 C--O 1.204 -1.33 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -179.38 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 438' ' ' ALA . . . . . 0.536 ' HB3' HG11 ' B' ' 463' ' ' VAL . . . -59.27 -35.21 73.31 Favored 'General case' 0 N--CA 1.438 -1.049 0 O-C-N 123.869 0.731 . . . . 0.0 111.275 178.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 439' ' ' LEU . . . . . 0.906 HD21 ' NH2' ' B' ' 442' ' ' ARG . 0.4 OUTLIER -67.08 -50.8 60.45 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -179.286 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.45 -34.11 74.88 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 114.354 -1.294 . . . . 0.0 111.252 175.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 441' ' ' GLN . . . . . 0.499 ' HG2' ' O ' ' B' ' 437' ' ' THR . 7.5 mm100 -54.74 -50.01 69.44 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.917 -176.015 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 442' ' ' ARG . . . . . 0.906 ' NH2' HD21 ' B' ' 439' ' ' LEU . 0.0 OUTLIER -77.86 -25.64 48.78 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 119.502 -0.879 . . . . 0.0 112.709 175.752 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 443' ' ' LEU . . . . . 0.746 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 68.2 mt -67.68 -26.21 66.08 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -64.88 -37.92 89.25 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.95 173.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -76.45 -26.79 55.79 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.444 -1.253 . . . . 0.0 111.043 178.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 446' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 28.6 99.0 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 176.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 50.8 mt -58.96 -34.38 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-O 121.427 0.632 . . . . 0.0 110.601 -179.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 448' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -163.51 -160.89 0.62 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -177.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -82.74 -70.64 0.54 Allowed 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 168.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 450' ' ' GLN . . . . . 0.409 ' O ' ' HG2' ' B' ' 454' ' ' GLU . 0.0 OUTLIER -64.61 -26.31 68.34 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -179.502 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 451' ' ' THR . . . . . 0.445 ' HA ' ' HB2' ' B' ' 454' ' ' GLU . 9.1 m -71.35 -23.19 61.87 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.901 -174.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 452' ' ' ARG . . . . . 0.416 ' NH2' ' HB3' ' B' ' 443' ' ' LEU . 19.4 mtp180 -53.29 -54.45 36.15 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 171.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 453' ' ' ALA . . . . . 0.628 ' HB1' ' CD1' ' B' ' 419' ' ' TYR . . . -60.27 -48.74 80.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.36 -1.291 . . . . 0.0 113.032 175.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 454' ' ' GLU . . . . . 0.445 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 78.7 mm-40 -49.1 -38.57 25.16 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.158 0.504 . . . . 0.0 111.73 -175.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 28.4 p -120.58 16.49 12.03 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.163 -175.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 456' ' ' PHE . . . . . 0.48 ' CZ ' ' HB2' ' B' ' 423' ' ' SER . 0.9 OUTLIER -53.41 -48.12 68.98 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.6 -172.273 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 457' ' ' ILE . . . . . 0.527 ' CG1' ' HB3' ' B' ' 408' ' ' TYR . 1.9 mp -77.41 -35.2 21.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.77 -179.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -56.87 -36.12 69.69 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 122.059 0.933 . . . . 0.0 109.073 172.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 459' ' ' HIS . . . . . 0.735 ' HB3' ' CZ ' ' B' ' 442' ' ' ARG . 81.4 m-70 -75.59 -30.6 59.65 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.707 177.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 460' ' ' LEU . . . . . 0.738 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.6 OUTLIER -67.8 -34.62 77.12 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.843 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 461' ' ' ASN . . . . . 0.453 ' O ' ' HB2' ' B' ' 464' ' ' TYR . 25.2 m-80 -72.86 -37.51 67.35 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.394 -1.275 . . . . 0.0 109.007 176.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 462' ' ' ALA . . . . . 0.577 ' O ' HD11 ' B' ' 466' ' ' ILE . . . -56.77 -32.65 65.83 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.462 -1.245 . . . . 0.0 110.174 168.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 463' ' ' VAL . . . . . 0.738 ' HB ' ' O ' ' B' ' 460' ' ' LEU . 50.2 t -63.93 -49.7 80.63 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.817 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 176.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 464' ' ' TYR . . . . . 0.571 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 18.7 m-30 -52.13 -28.23 17.11 Favored 'General case' 0 C--N 1.332 -0.159 0 O-C-N 124.432 1.082 . . . . 0.0 110.404 176.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.05 -40.1 18.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.525 0.679 . . . . 0.0 109.653 -177.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 466' ' ' ILE . . . . . 0.577 HD11 ' O ' ' B' ' 462' ' ' ALA . 3.7 mt -57.49 -55.12 22.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 114.355 -1.293 . . . . 0.0 112.117 176.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 467' ' ' LEU . . . . . 0.743 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -101.36 -10.73 19.99 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -173.042 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 468' ' ' GLY . . . . . 0.583 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 94.01 31.28 8.2 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 119.412 -1.375 . . . . 0.0 114.343 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 469' ' ' LEU . . . . . 0.743 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.7 mt -89.26 165.08 14.65 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 117.899 0.85 . . . . 0.0 110.859 176.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 36.9 p30 -105.32 -177.75 3.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.817 171.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 471' ' ' ALA . . . . . 0.557 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -65.97 -15.66 63.2 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -176.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 -87.95 -1.74 58.18 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.081 -175.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 473' ' ' GLY . . . . . 0.444 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 79.01 13.06 83.46 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.333 -0.937 . . . . 0.0 110.963 -175.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -100.91 151.63 21.51 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 176.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 475' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' B' ' 469' ' ' LEU . 24.7 t -89.59 135.34 33.66 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.158 0.504 . . . . 0.0 110.299 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 476' ' ' ILE . . . . . 0.583 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.6 pp -105.92 -42.12 6.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.18 -176.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 477' ' ' ARG . . . . . 0.577 ' N ' HD11 ' B' ' 476' ' ' ILE . 22.1 mmm180 41.92 56.88 3.35 Favored 'General case' 0 N--CA 1.466 0.325 0 O-C-N 123.844 0.715 . . . . 0.0 111.639 178.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 478' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -163.14 126.32 2.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.375 -175.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 479' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.643 -0.694 . . . . 0.0 109.755 179.205 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 386' ' ' PHE . . . . . 0.793 ' CZ ' HG12 ' A' ' 394' ' ' VAL . 3.4 t80 . . . . . 0 CA--C 1.531 0.239 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 387' ' ' PRO . . . . . 0.586 ' HG2' ' OD1' ' B' ' 393' ' ' ASN . 35.6 Cg_endo -66.88 64.14 0.59 Allowed 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 123.91 3.073 . . . . 0.0 113.562 176.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.806 ' SD ' HG13 ' A' ' 394' ' ' VAL . 5.2 tpp -68.15 164.79 19.59 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.868 176.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 389' ' ' HIS . . . . . 0.616 ' CE1' ' HA ' ' A' ' 393' ' ' ASN . 30.6 m170 -65.25 -160.77 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 172.155 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -71.34 1.48 6.15 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.196 170.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.586 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.1 pt? -155.23 -63.73 0.12 Allowed 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -177.016 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 392' ' ' GLY . . . . . 0.718 ' HA3' HD13 ' A' ' 395' ' ' ILE . . . -158.98 74.93 0.21 Allowed Glycine 0 CA--C 1.523 0.583 0 C-N-CA 120.055 -1.069 . . . . 0.0 114.203 -172.38 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 393' ' ' ASN . . . . . 0.616 ' HA ' ' CE1' ' A' ' 389' ' ' HIS . 0.0 OUTLIER -65.76 -42.01 91.38 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 177.696 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 394' ' ' VAL . . . . . 0.806 HG13 ' SD ' ' A' ' 388' ' ' MET . 0.6 OUTLIER -57.3 -46.23 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 179.754 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 395' ' ' ILE . . . . . 0.718 HD13 ' HA3' ' A' ' 392' ' ' GLY . 4.1 mp -57.43 -52.15 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 CA-C-O 117.743 -1.122 . . . . 0.0 113.301 -173.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 396' ' ' LYS . . . . . 0.594 ' O ' HG22 ' A' ' 399' ' ' VAL . 0.1 OUTLIER -62.14 -50.6 71.22 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-N 122.025 2.193 . . . . 0.0 112.198 -176.776 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.76 -44.65 70.14 Favored Glycine 0 N--CA 1.434 -1.463 0 C-N-CA 119.911 -1.138 . . . . 0.0 110.898 -175.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 398' ' ' ILE . . . . . 0.765 HG12 HD21 ' B' ' 414' ' ' LEU . 27.1 mt -71.22 -34.04 52.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 399' ' ' VAL . . . . . 0.594 HG22 ' O ' ' A' ' 396' ' ' LYS . 16.1 m -62.7 -40.0 86.86 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 C-N-CA 118.898 -1.121 . . . . 0.0 108.576 -174.175 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -71.25 -36.99 71.98 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 176.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 34.3 mm-40 -88.61 -46.79 8.77 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -171.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 402' ' ' GLU . . . . . 0.583 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 2.5 mm-40 -120.35 -20.29 7.31 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.484 -171.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 106.58 162.04 22.34 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.922 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 404' ' ' VAL . . . . . 0.679 HG11 ' HA ' ' A' ' 430' ' ' LEU . 1.5 m -53.61 -45.25 59.53 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.81 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -175.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 405' ' ' ALA . . . . . 0.565 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -64.37 -30.82 71.86 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 119.784 -0.766 . . . . 0.0 112.489 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.716 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 85.2 m -76.96 -42.53 38.71 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.03 173.183 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.483 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.57 -36.96 74.78 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 122.141 0.972 . . . . 0.0 109.363 177.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 408' ' ' TYR . . . . . 0.624 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -66.2 -52.1 51.25 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 113.469 -1.696 . . . . 0.0 109.686 176.404 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 409' ' ' THR . . . . . 0.664 HG22 HD23 ' A' ' 410' ' ' LEU . 12.3 m -55.15 -47.46 75.08 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.541 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 410' ' ' LEU . . . . . 0.739 HD12 ' CD1' ' A' ' 398' ' ' ILE . 13.7 mt -72.25 -35.79 68.88 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.041 0.448 . . . . 0.0 109.983 -175.406 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.86 -34.72 79.37 Favored Glycine 0 N--CA 1.439 -1.13 0 C-N-CA 120.238 -0.982 . . . . 0.0 110.755 172.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -69.8 -48.01 60.74 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-O 120.532 0.206 . . . . 0.0 111.362 178.33 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 413' ' ' MET . . . . . 0.936 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.5 OUTLIER -70.56 -42.0 71.69 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 119.082 -1.047 . . . . 0.0 112.256 -178.289 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 414' ' ' LEU . . . . . 0.936 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 19.4 mt -75.25 -46.45 33.63 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -177.03 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 25.2 t -86.44 -16.87 35.81 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.757 0.789 . . . . 0.0 109.763 -173.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 416' ' ' GLY . . . . . 0.438 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 106.4 -178.26 22.5 Favored Glycine 0 N--CA 1.43 -1.702 0 N-CA-C 109.934 -1.267 . . . . 0.0 109.934 -171.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -79.76 24.19 0.4 Allowed 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.262 0.554 . . . . 0.0 111.001 -174.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 418' ' ' ASN . . . . . 0.438 ' H ' ' C ' ' A' ' 416' ' ' GLY . 3.8 m-20 -70.99 75.55 0.65 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.864 -177.259 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 419' ' ' TYR . . . . . 0.581 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 2.3 p90 -49.11 -40.1 30.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.763 176.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -55.39 -45.85 76.61 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.926 0.393 . . . . 0.0 111.007 178.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.74 -48.75 62.96 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.254 -176.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 422' ' ' VAL . . . . . 0.444 ' HB ' ' CD1' ' A' ' 408' ' ' TYR . 0.1 OUTLIER -66.14 -41.36 89.26 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.515 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.126 -175.737 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.815 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 76.9 p -66.95 -39.45 87.29 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.906 -178.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.0 -38.91 93.08 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.442 -0.885 . . . . 0.0 111.883 176.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 425' ' ' ILE . . . . . 0.601 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.94 -52.9 20.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.308 0.099 . . . . 0.0 111.232 -176.956 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 426' ' ' ILE . . . . . 0.7 HG22 HD22 ' A' ' 430' ' ' LEU . 1.1 mm -74.18 -23.6 18.65 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.758 0 O-C-N 122.199 -0.313 . . . . 0.0 110.21 -171.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.815 ' HB2' ' O ' ' A' ' 423' ' ' SER . 2.3 tmm_? -55.4 -31.5 61.88 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.266 0.555 . . . . 0.0 111.022 -177.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -85.37 -12.3 73.33 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.168 178.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.63 ' HD1' HG22 ' A' ' 395' ' ' ILE . 7.5 m-30 -113.15 -0.08 14.77 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.588 0.709 . . . . 0.0 109.297 -173.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.746 HD23 ' HA ' ' A' ' 427' ' ' ARG . 0.1 OUTLIER -65.97 129.69 94.3 Favored Pre-proline 0 N--CA 1.446 -0.631 0 CA-C-N 114.476 -1.238 . . . . 0.0 109.268 178.159 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 431' ' ' PRO . . . . . 0.544 ' HD2' HD12 ' A' ' 430' ' ' LEU . 95.4 Cg_exo -24.05 -60.46 0.05 OUTLIER 'Trans proline' 0 C--N 1.359 1.099 1 C-N-CA 125.709 4.273 . . . . 0.0 115.012 179.736 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 432' ' ' GLY . . . . . 0.566 ' H ' HG12 ' A' ' 435' ' ' VAL . . . -152.68 -170.6 19.26 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 177.377 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 433' ' ' GLN . . . . . 0.493 ' O ' HG13 ' A' ' 436' ' ' VAL . 17.2 tp60 -66.76 -26.63 67.07 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 118.026 0.913 . . . . 0.0 110.402 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -65.88 -43.27 88.81 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -177.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 435' ' ' VAL . . . . . 0.726 HG23 HG11 ' A' ' 463' ' ' VAL . 7.5 p -67.32 -42.19 87.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-O 121.082 0.467 . . . . 0.0 110.409 -177.005 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.515 HG12 ' O ' ' A' ' 432' ' ' GLY . 0.1 OUTLIER -68.08 -30.66 48.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.83 175.643 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.88 -51.84 43.37 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 438' ' ' ALA . . . . . 0.867 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -58.02 -38.92 77.08 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.929 177.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 439' ' ' LEU . . . . . 0.551 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 1.9 tm? -69.94 -46.96 64.18 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -57.1 -39.17 74.51 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.109 174.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 441' ' ' GLN . . . . . 0.536 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 8.4 mm-40 -54.46 -49.65 69.57 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 123.776 0.83 . . . . 0.0 110.747 174.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 442' ' ' ARG . . . . . 0.818 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 0.9 OUTLIER -56.29 -39.92 73.47 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.729 172.294 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 443' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 46.9 mt -71.64 -33.02 68.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.268 0.556 . . . . 0.0 110.062 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -60.55 -37.77 82.31 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.502 174.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -73.02 -28.69 62.5 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.584 177.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 446' ' ' GLU . . . . . 0.551 ' HB2' ' O ' ' A' ' 443' ' ' LEU . 42.0 tt0 31.41 97.06 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.247 1.202 . . . . 0.0 114.247 172.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 49.3 mt -66.34 -36.05 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 121.294 0.569 . . . . 0.0 110.402 178.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 448' ' ' ASP . . . . . 0.642 ' O ' ' HG3' ' A' ' 452' ' ' ARG . 19.7 m-20 -166.05 -172.4 2.29 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 -179.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -77.58 -61.13 2.09 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.442 175.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -69.17 -26.1 64.68 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 176.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 451' ' ' THR . . . . . 0.509 ' OG1' ' HB2' ' A' ' 448' ' ' ASP . 18.3 m -71.73 -22.24 61.65 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.437 -175.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 452' ' ' ARG . . . . . 0.642 ' HG3' ' O ' ' A' ' 448' ' ' ASP . 13.5 mtp180 -52.97 -54.22 38.25 Favored 'General case' 0 C--O 1.218 -0.567 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 170.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 453' ' ' ALA . . . . . 0.581 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -56.99 -50.06 73.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.443 -1.253 . . . . 0.0 112.623 175.521 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 454' ' ' GLU . . . . . 0.43 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 40.7 mm-40 -51.41 -35.93 41.33 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.892 -177.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 28.3 p -118.48 16.07 13.79 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.283 -176.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 456' ' ' PHE . . . . . 0.593 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.9 OUTLIER -56.58 -47.73 78.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.06 0.457 . . . . 0.0 111.656 -171.33 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 457' ' ' ILE . . . . . 0.565 HG23 ' HB1' ' A' ' 405' ' ' ALA . 1.9 mp -77.32 -33.06 19.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.964 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -58.05 -35.18 70.97 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.889 0.852 . . . . 0.0 109.385 171.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 459' ' ' HIS . . . . . 0.713 ' O ' HG23 ' A' ' 463' ' ' VAL . 62.1 m-70 -73.81 -28.69 61.75 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.712 177.255 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 460' ' ' LEU . . . . . 0.735 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -73.85 -34.69 64.62 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.891 0.853 . . . . 0.0 108.968 178.869 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 461' ' ' ASN . . . . . 0.458 ' O ' ' HB2' ' A' ' 464' ' ' TYR . 22.4 m-80 -73.37 -37.3 66.06 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.922 0.868 . . . . 0.0 108.899 176.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 462' ' ' ALA . . . . . 0.635 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -56.54 -34.2 66.84 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.848 169.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.867 HG13 ' HB3' ' A' ' 438' ' ' ALA . 56.0 t -61.69 -50.16 81.37 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.796 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.051 175.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 464' ' ' TYR . . . . . 0.578 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 18.6 m-30 -53.1 -28.45 25.49 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.611 177.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.86 -40.35 22.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.842 0.829 . . . . 0.0 109.596 -178.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.635 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.4 mt -58.02 -55.23 23.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 114.196 -1.366 . . . . 0.0 112.308 177.024 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 0.755 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -102.26 -10.04 19.89 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -172.89 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 468' ' ' GLY . . . . . 0.515 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 93.42 31.9 8.08 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 119.173 -1.489 . . . . 0.0 113.932 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 469' ' ' LEU . . . . . 0.755 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.2 mt -89.56 162.84 15.46 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 117.78 0.79 . . . . 0.0 110.732 175.365 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 470' ' ' ASN . . . . . 0.479 ' HB3' ' CG2' ' A' ' 476' ' ' ILE . 39.0 p30 -102.64 -179.65 4.03 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.902 171.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 471' ' ' ALA . . . . . 0.566 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -61.04 -22.01 64.16 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -175.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 472' ' ' ARG . . . . . 0.459 ' HA ' ' O ' ' A' ' 402' ' ' GLU . 17.4 mmt180 -88.61 6.79 36.56 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.507 -171.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 473' ' ' GLY . . . . . 0.434 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 74.34 13.08 81.78 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.455 -0.879 . . . . 0.0 111.114 -177.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -100.6 152.71 20.1 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 24.0 p -91.03 126.79 36.22 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.297 0.57 . . . . 0.0 110.573 176.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 476' ' ' ILE . . . . . 0.515 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.7 pp . . . . . 0 C--N 1.315 -0.933 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.701 -179.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 386' ' ' PHE . . . . . 0.791 ' CZ ' HG12 ' B' ' 394' ' ' VAL . 3.5 t80 . . . . . 0 CA--C 1.53 0.184 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 387' ' ' PRO . . . . . 0.592 ' HG2' ' OD1' ' A' ' 393' ' ' ASN . 35.1 Cg_endo -66.83 63.89 0.58 Allowed 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.928 3.085 . . . . 0.0 113.628 177.121 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 388' ' ' MET . . . . . 0.815 ' SD ' HG13 ' B' ' 394' ' ' VAL . 5.2 tpp -68.05 164.53 19.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.888 176.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 389' ' ' HIS . . . . . 0.61 ' CE1' ' HA ' ' B' ' 393' ' ' ASN . 30.6 m170 -65.2 -160.49 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 172.278 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 28.9 pt20 -71.59 1.43 6.62 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.241 170.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 391' ' ' LEU . . . . . 0.588 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.2 pt? -155.15 -64.14 0.12 Allowed 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -176.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 392' ' ' GLY . . . . . 0.715 ' HA3' HD13 ' B' ' 395' ' ' ILE . . . -158.55 74.94 0.21 Allowed Glycine 0 CA--C 1.524 0.635 0 C-N-CA 119.988 -1.101 . . . . 0.0 114.243 -172.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 393' ' ' ASN . . . . . 0.61 ' HA ' ' CE1' ' B' ' 389' ' ' HIS . 0.0 OUTLIER -65.74 -42.03 91.49 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 177.697 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 394' ' ' VAL . . . . . 0.815 HG13 ' SD ' ' B' ' 388' ' ' MET . 0.6 OUTLIER -57.27 -46.18 85.06 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 179.72 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 395' ' ' ILE . . . . . 0.715 HD13 ' HA3' ' B' ' 392' ' ' GLY . 4.1 mp -57.53 -52.06 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.575 0 CA-C-O 117.792 -1.099 . . . . 0.0 113.381 -173.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 396' ' ' LYS . . . . . 0.593 ' O ' HG22 ' B' ' 399' ' ' VAL . 0.1 OUTLIER -62.19 -50.67 70.88 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 122.021 2.191 . . . . 0.0 112.178 -176.838 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.7 -44.62 69.47 Favored Glycine 0 N--CA 1.435 -1.421 0 C-N-CA 119.904 -1.141 . . . . 0.0 110.848 -175.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 398' ' ' ILE . . . . . 0.763 HG12 HD21 ' A' ' 414' ' ' LEU . 27.0 mt -71.25 -34.08 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -178.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 399' ' ' VAL . . . . . 0.593 HG22 ' O ' ' B' ' 396' ' ' LYS . 16.1 m -62.58 -40.07 86.93 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 C-N-CA 118.778 -1.169 . . . . 0.0 108.594 -174.205 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -71.28 -36.76 71.82 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 176.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 401' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -88.73 -46.72 8.77 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -171.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 402' ' ' GLU . . . . . 0.57 ' HG3' ' HE3' ' A' ' 413' ' ' MET . 2.4 mm-40 -120.52 -20.11 7.27 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.504 -171.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 106.49 162.08 22.42 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.834 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 404' ' ' VAL . . . . . 0.669 HG11 ' HA ' ' B' ' 430' ' ' LEU . 1.5 m -53.66 -45.35 60.28 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.802 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -175.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 405' ' ' ALA . . . . . 0.565 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -64.28 -30.89 71.92 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.425 -177.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 406' ' ' THR . . . . . 0.694 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 87.6 m -76.93 -42.61 38.69 Favored 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 120.099 -0.64 . . . . 0.0 109.986 173.235 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 407' ' ' ALA . . . . . 0.468 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.56 -37.06 74.93 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 122.171 0.986 . . . . 0.0 109.434 176.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 408' ' ' TYR . . . . . 0.619 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -66.04 -52.08 52.35 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 113.452 -1.704 . . . . 0.0 109.682 176.395 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 409' ' ' THR . . . . . 0.659 HG22 HD23 ' B' ' 410' ' ' LEU . 10.1 m -55.35 -47.4 75.78 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.69 -0.687 . . . . 0.0 112.571 178.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 410' ' ' LEU . . . . . 0.751 HD12 HD13 ' B' ' 398' ' ' ILE . 13.7 mt -72.14 -35.93 69.23 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 120.992 0.425 . . . . 0.0 109.925 -175.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.77 -34.75 78.85 Favored Glycine 0 N--CA 1.438 -1.192 0 C-N-CA 120.236 -0.983 . . . . 0.0 110.779 172.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 412' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -69.85 -47.87 61.03 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-O 120.574 0.226 . . . . 0.0 111.346 178.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 413' ' ' MET . . . . . 0.932 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.5 OUTLIER -70.58 -42.11 71.49 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 119.035 -1.066 . . . . 0.0 112.211 -178.334 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 414' ' ' LEU . . . . . 0.932 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 19.4 mt -75.32 -46.34 33.96 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -176.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 415' ' ' SER . . . . . 0.432 ' HB2' ' HE1' ' B' ' 388' ' ' MET . 24.8 t -86.34 -16.99 35.71 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.806 0.812 . . . . 0.0 109.717 -173.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 416' ' ' GLY . . . . . 0.443 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 106.33 -178.26 22.55 Favored Glycine 0 N--CA 1.431 -1.662 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 -171.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 33.0 mm-40 -79.72 24.44 0.38 Allowed 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.151 0.5 . . . . 0.0 110.94 -174.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 418' ' ' ASN . . . . . 0.443 ' H ' ' C ' ' B' ' 416' ' ' GLY . 3.9 m-20 -71.19 75.87 0.7 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.807 -177.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 419' ' ' TYR . . . . . 0.585 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 2.2 p90 -49.27 -40.06 33.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.801 -1.09 . . . . 0.0 111.789 176.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -55.33 -46.12 76.37 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.774 0.321 . . . . 0.0 110.963 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.66 -48.81 63.01 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.172 -176.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 422' ' ' VAL . . . . . 0.445 ' HB ' ' CD1' ' B' ' 408' ' ' TYR . 0.1 OUTLIER -66.03 -41.4 89.59 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 C-N-CA 120.371 -0.531 . . . . 0.0 111.076 -175.898 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 423' ' ' SER . . . . . 0.806 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 76.3 p -66.89 -39.33 87.44 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.883 -178.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.08 -38.98 92.8 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.922 176.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 425' ' ' ILE . . . . . 0.616 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -73.05 -52.79 20.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.318 0.104 . . . . 0.0 111.161 -176.869 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 426' ' ' ILE . . . . . 0.691 HG22 HD22 ' B' ' 430' ' ' LEU . 1.1 mm -74.23 -23.55 18.55 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.863 0 O-C-N 122.185 -0.322 . . . . 0.0 110.164 -171.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 427' ' ' ARG . . . . . 0.806 ' HB2' ' O ' ' B' ' 423' ' ' SER . 2.3 tmm_? -55.58 -31.36 62.13 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.221 0.534 . . . . 0.0 110.928 -177.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -85.38 -12.27 73.4 Favored Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.429 -0.891 . . . . 0.0 111.11 178.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 429' ' ' TYR . . . . . 0.629 ' HD1' HG22 ' B' ' 395' ' ' ILE . 7.3 m-30 -113.26 0.27 14.81 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.558 0.694 . . . . 0.0 109.227 -173.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 430' ' ' LEU . . . . . 0.749 HD23 ' HA ' ' B' ' 427' ' ' ARG . 0.1 OUTLIER -66.27 129.71 94.21 Favored Pre-proline 0 N--CA 1.445 -0.696 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.23 178.101 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 431' ' ' PRO . . . . . 0.533 ' HD2' HD12 ' B' ' 430' ' ' LEU . 95.0 Cg_exo -24.06 -60.35 0.05 OUTLIER 'Trans proline' 0 C--N 1.36 1.148 1 C-N-CA 125.602 4.201 . . . . 0.0 115.094 179.747 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 432' ' ' GLY . . . . . 0.576 ' H ' HG12 ' B' ' 435' ' ' VAL . . . -153.18 -171.5 20.53 Favored Glycine 0 N--CA 1.443 -0.887 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 177.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 433' ' ' GLN . . . . . 0.505 ' O ' HG13 ' B' ' 436' ' ' VAL . 16.3 tp60 -66.09 -26.89 67.68 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 118.088 0.944 . . . . 0.0 110.368 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -65.44 -43.42 90.51 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -178.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 435' ' ' VAL . . . . . 0.716 HG23 HG11 ' B' ' 463' ' ' VAL . 7.6 p -67.32 -42.31 87.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 121.104 0.478 . . . . 0.0 110.423 -176.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 436' ' ' VAL . . . . . 0.505 HG13 ' O ' ' B' ' 433' ' ' GLN . 0.1 OUTLIER -68.02 -30.58 48.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.838 175.698 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.93 -51.9 42.4 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 438' ' ' ALA . . . . . 0.854 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -58.11 -38.65 76.86 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.916 177.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 439' ' ' LEU . . . . . 0.562 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 1.9 tm? -70.27 -46.93 63.38 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -57.03 -39.23 74.41 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.127 174.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 441' ' ' GLN . . . . . 0.531 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 8.3 mm-40 -54.24 -49.89 68.44 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 123.888 0.875 . . . . 0.0 110.795 174.154 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 442' ' ' ARG . . . . . 0.827 ' HG2' ' O ' ' B' ' 438' ' ' ALA . 0.9 OUTLIER -56.17 -39.86 73.03 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.65 172.364 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 443' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 47.1 mt -71.74 -32.85 68.16 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.217 0.532 . . . . 0.0 110.119 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -60.76 -37.61 82.4 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.463 174.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -73.28 -28.42 62.1 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.554 177.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 446' ' ' GLU . . . . . 0.552 ' HB2' ' O ' ' B' ' 443' ' ' LEU . 41.3 tt0 31.26 97.02 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 172.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 49.9 mt -66.7 -35.83 75.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.37 0.605 . . . . 0.0 110.343 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 448' ' ' ASP . . . . . 0.646 ' O ' ' HG3' ' B' ' 452' ' ' ARG . 17.5 m-20 -166.12 -172.62 2.34 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -77.51 -61.15 2.08 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.432 175.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -69.05 -26.14 64.82 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 176.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 451' ' ' THR . . . . . 0.506 ' OG1' ' HB2' ' B' ' 448' ' ' ASP . 18.6 m -71.72 -22.1 61.68 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.538 -175.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 452' ' ' ARG . . . . . 0.646 ' HG3' ' O ' ' B' ' 448' ' ' ASP . 13.4 mtp180 -53.07 -54.1 40.54 Favored 'General case' 0 C--O 1.218 -0.553 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 170.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 453' ' ' ALA . . . . . 0.585 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -57.09 -50.11 73.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.381 -1.281 . . . . 0.0 112.585 175.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 454' ' ' GLU . . . . . 0.425 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 45.5 mm-40 -51.4 -36.0 41.6 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.803 -177.508 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 27.2 p -118.36 16.1 13.89 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.264 -176.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 456' ' ' PHE . . . . . 0.602 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 0.9 OUTLIER -56.65 -47.76 79.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.076 0.465 . . . . 0.0 111.612 -171.178 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 457' ' ' ILE . . . . . 0.565 HG23 ' HB1' ' B' ' 405' ' ' ALA . 1.9 mp -77.16 -33.14 19.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.979 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -58.05 -35.14 70.9 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.88 0.848 . . . . 0.0 109.393 172.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 459' ' ' HIS . . . . . 0.714 ' O ' HG23 ' B' ' 463' ' ' VAL . 62.0 m-70 -73.83 -28.77 61.77 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.731 177.244 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 460' ' ' LEU . . . . . 0.738 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -73.89 -34.64 64.5 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.906 0.86 . . . . 0.0 108.994 178.881 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 461' ' ' ASN . . . . . 0.453 ' O ' ' HB2' ' B' ' 464' ' ' TYR . 21.7 m-80 -73.25 -37.28 66.39 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.877 0.846 . . . . 0.0 108.869 176.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 462' ' ' ALA . . . . . 0.643 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -56.61 -34.05 66.85 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.981 169.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 463' ' ' VAL . . . . . 0.854 HG13 ' HB3' ' B' ' 438' ' ' ALA . 55.9 t -61.71 -50.07 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-N 114.642 -1.163 . . . . 0.0 107.999 175.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 464' ' ' TYR . . . . . 0.568 ' CE2' ' HA ' ' B' ' 471' ' ' ALA . 18.5 m-30 -53.1 -28.34 24.88 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 114.678 -1.147 . . . . 0.0 110.633 177.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.11 -40.24 22.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.906 0.86 . . . . 0.0 109.62 -178.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 466' ' ' ILE . . . . . 0.643 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.4 mt -57.91 -55.35 22.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 114.209 -1.36 . . . . 0.0 112.235 176.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 467' ' ' LEU . . . . . 0.761 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -102.42 -10.0 19.79 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 114.474 1.286 . . . . 0.0 114.474 -172.821 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 468' ' ' GLY . . . . . 0.518 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 93.46 31.87 8.08 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 119.081 -1.533 . . . . 0.0 113.91 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 469' ' ' LEU . . . . . 0.761 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.2 mt -89.76 162.53 15.49 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 117.677 0.738 . . . . 0.0 110.795 175.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 470' ' ' ASN . . . . . 0.492 ' HB3' ' CG2' ' B' ' 476' ' ' ILE . 39.4 p30 -102.48 -179.54 4.01 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.889 171.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 471' ' ' ALA . . . . . 0.568 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -61.6 -21.64 64.52 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -175.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 472' ' ' ARG . . . . . 0.463 ' HA ' ' O ' ' B' ' 402' ' ' GLU . 17.2 mmt180 -88.67 6.74 37.01 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.431 -171.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 473' ' ' GLY . . . . . 0.431 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 74.5 12.8 82.21 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.145 -177.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -100.4 152.92 19.78 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 25.1 p -91.06 127.03 36.32 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.367 0.603 . . . . 0.0 110.522 176.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 476' ' ' ILE . . . . . 0.518 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.7 pp . . . . . 0 C--N 1.315 -0.894 0 CA-C-N 114.92 -1.037 . . . . 0.0 110.621 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 386' ' ' PHE . . . . . 0.715 ' CD1' HD22 ' A' ' 414' ' ' LEU . 1.4 t80 . . . . . 0 CA--C 1.537 0.462 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -49.27 -72.84 0.04 OUTLIER 'Trans proline' 0 N--CA 1.485 0.995 0 C-N-CA 124.309 3.339 . . . . 0.0 114.418 -178.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.612 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 38.9 ttm 74.36 49.36 0.11 Allowed 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 172.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 389' ' ' HIS . . . . . 0.703 ' CG ' ' HB2' ' A' ' 393' ' ' ASN . 40.7 m170 47.31 -99.44 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.25 0.62 . . . . 0.0 110.642 -175.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -146.36 15.71 1.3 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.469 -0.787 . . . . 0.0 108.884 174.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.489 HD23 ' H ' ' A' ' 392' ' ' GLY . 2.4 pt? -169.15 -50.97 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -168.079 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 392' ' ' GLY . . . . . 0.539 ' HA3' HD13 ' A' ' 395' ' ' ILE . . . -176.47 50.89 0.11 Allowed Glycine 0 C--N 1.335 0.495 0 C-N-CA 119.609 -1.282 . . . . 0.0 114.214 -172.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 393' ' ' ASN . . . . . 0.703 ' HB2' ' CG ' ' A' ' 389' ' ' HIS . 0.4 OUTLIER -54.21 -41.31 68.48 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 117.401 0.6 . . . . 0.0 109.679 176.761 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 394' ' ' VAL . . . . . 0.67 HG12 ' CE2' ' A' ' 386' ' ' PHE . 0.9 OUTLIER -56.85 -47.08 83.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 -179.249 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 395' ' ' ILE . . . . . 0.669 HG23 HD13 ' A' ' 426' ' ' ILE . 4.3 mp -57.87 -52.22 60.66 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 CA-C-O 117.938 -1.03 . . . . 0.0 113.307 -175.232 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 396' ' ' LYS . . . . . 0.704 ' HG3' ' CZ ' ' A' ' 429' ' ' TYR . 0.1 OUTLIER -62.98 -49.88 72.95 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 121.692 2.042 . . . . 0.0 112.069 -174.165 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 397' ' ' GLY . . . . . 0.538 ' O ' ' HG3' ' A' ' 401' ' ' GLN . . . -54.32 -44.67 76.02 Favored Glycine 0 N--CA 1.435 -1.387 0 C-N-CA 120.099 -1.048 . . . . 0.0 111.035 -177.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 398' ' ' ILE . . . . . 0.874 HD13 HD12 ' A' ' 410' ' ' LEU . 45.4 mt -71.6 -34.37 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -177.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 399' ' ' VAL . . . . . 0.528 HG12 ' HA ' ' A' ' 404' ' ' VAL . 5.4 m -64.09 -39.99 87.46 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 C-N-CA 118.738 -1.185 . . . . 0.0 108.408 -174.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -64.74 -41.24 96.08 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 174.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 401' ' ' GLN . . . . . 0.538 ' HG3' ' O ' ' A' ' 397' ' ' GLY . 32.1 mt-30 -93.07 -48.39 6.52 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -169.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 402' ' ' GLU . . . . . 0.679 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 3.0 mm-40 -113.42 -20.11 11.44 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.448 -171.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 104.77 163.21 24.15 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.125 -0.559 . . . . 0.0 113.137 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 404' ' ' VAL . . . . . 0.655 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.5 m -53.43 -45.21 57.37 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.752 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 -176.374 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 405' ' ' ALA . . . . . 0.546 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -66.41 -30.87 71.34 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.994 -175.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.711 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 92.4 m -77.23 -42.35 37.68 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.241 173.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.51 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.21 -37.71 75.37 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 122.049 0.928 . . . . 0.0 109.215 176.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 408' ' ' TYR . . . . . 0.655 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.64 -52.39 52.15 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 113.593 -1.64 . . . . 0.0 109.961 177.115 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 409' ' ' THR . . . . . 0.734 HG22 HD23 ' A' ' 410' ' ' LEU . 2.7 m -56.22 -46.23 79.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.505 178.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 410' ' ' LEU . . . . . 0.874 HD12 HD13 ' A' ' 398' ' ' ILE . 13.4 mt -72.03 -36.74 69.75 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 -175.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.6 -34.66 77.25 Favored Glycine 0 N--CA 1.44 -1.094 0 C-N-CA 120.085 -1.055 . . . . 0.0 110.708 172.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 412' ' ' MET . . . . . 0.412 ' HB2' ' O ' ' A' ' 409' ' ' THR . 0.4 OUTLIER -67.19 -48.21 68.6 Favored 'General case' 0 C--O 1.221 -0.438 0 C-N-CA 122.129 0.172 . . . . 0.0 111.403 177.672 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 413' ' ' MET . . . . . 0.944 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.7 OUTLIER -71.52 -47.73 53.4 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 118.848 -1.141 . . . . 0.0 112.103 -179.935 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 414' ' ' LEU . . . . . 0.944 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 23.3 mt -67.43 -44.24 79.24 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -175.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 48.1 t -86.97 -23.76 24.96 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.503 0.668 . . . . 0.0 110.011 -177.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 416' ' ' GLY . . . . . 0.447 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 109.69 -175.62 18.84 Favored Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -170.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -79.65 24.3 0.38 Allowed 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.495 0.664 . . . . 0.0 111.291 -172.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 418' ' ' ASN . . . . . 0.447 ' H ' ' C ' ' A' ' 416' ' ' GLY . 79.6 m-20 -71.67 76.04 0.83 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.651 -178.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 419' ' ' TYR . . . . . 0.537 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 12.0 p90 -55.21 -39.0 69.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.537 178.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -55.71 -43.48 76.52 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.833 0.349 . . . . 0.0 111.166 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 421' ' ' LEU . . . . . 0.401 HD22 ' HB2' ' A' ' 418' ' ' ASN . 0.0 OUTLIER -68.22 -48.68 64.53 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.951 -177.621 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 422' ' ' VAL . . . . . 0.43 ' HB ' ' CD1' ' A' ' 408' ' ' TYR . 0.2 OUTLIER -66.36 -39.52 84.34 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.155 -177.277 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.746 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 68.4 p -66.84 -39.38 87.62 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.93 -39.2 89.41 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.199 176.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 425' ' ' ILE . . . . . 0.596 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.79 -51.75 25.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 121.176 -0.209 . . . . 0.0 111.114 -177.375 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 426' ' ' ILE . . . . . 0.681 HG22 HD22 ' A' ' 430' ' ' LEU . 1.2 mm -74.27 -22.88 18.14 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.625 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -172.171 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.746 ' HB2' ' O ' ' A' ' 423' ' ' SER . 0.7 OUTLIER -54.86 -31.45 59.65 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.25 0.548 . . . . 0.0 110.149 -179.728 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -85.31 -5.16 85.57 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.667 178.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.704 ' CZ ' ' HG3' ' A' ' 396' ' ' LYS . 24.9 m-85 -119.76 0.69 10.95 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 121.08 0.467 . . . . 0.0 110.666 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.726 HD23 ' HA ' ' A' ' 427' ' ' ARG . 0.1 OUTLIER -65.94 127.9 93.46 Favored Pre-proline 0 N--CA 1.438 -1.044 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.735 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 431' ' ' PRO . . . . . 0.475 ' HD2' HD12 ' A' ' 430' ' ' LEU . 80.9 Cg_exo -23.41 -70.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.892 1 C-N-CA 125.627 4.218 . . . . 0.0 115.082 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 432' ' ' GLY . . . . . 0.482 ' O ' HG12 ' A' ' 435' ' ' VAL . . . -138.17 -167.4 10.99 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 176.112 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 433' ' ' GLN . . . . . 0.478 ' O ' HG13 ' A' ' 436' ' ' VAL . 19.2 tp60 -69.41 -26.92 64.86 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 117.831 0.815 . . . . 0.0 110.165 179.131 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -68.24 -39.04 82.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.357 -176.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 435' ' ' VAL . . . . . 0.767 HG23 HG11 ' A' ' 463' ' ' VAL . 7.2 p -69.48 -44.01 80.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-O 120.972 0.415 . . . . 0.0 110.527 -177.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.478 HG13 ' O ' ' A' ' 433' ' ' GLN . 0.2 OUTLIER -65.33 -31.36 53.52 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 174.825 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 1.1 m -67.22 -52.82 36.35 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -178.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 438' ' ' ALA . . . . . 0.853 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -58.89 -39.16 80.62 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.12 177.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 439' ' ' LEU . . . . . 0.638 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 1.9 tm? -68.13 -48.52 65.17 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -178.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -59.21 -35.02 72.87 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.519 -1.219 . . . . 0.0 111.171 174.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 441' ' ' GLN . . . . . 0.5 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 3.7 mm-40 -55.13 -49.68 71.17 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.122 -177.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 442' ' ' ARG . . . . . 0.622 ' HG3' ' CG ' ' A' ' 459' ' ' HIS . 0.0 OUTLIER -75.8 -24.64 55.94 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 119.563 -0.855 . . . . 0.0 113.032 175.073 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 443' ' ' LEU . . . . . 0.638 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 70.1 mt -64.18 -35.29 80.3 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-N 118.453 0.569 . . . . 0.0 109.601 175.534 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -57.0 -37.96 72.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.524 173.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 -74.34 -26.75 60.34 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.312 177.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 27.59 98.86 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 176.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 49.2 mt -60.9 -35.13 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-O 121.266 0.555 . . . . 0.0 110.689 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 448' ' ' ASP . . . . . 0.466 ' HB2' ' OG1' ' A' ' 451' ' ' THR . 18.4 m-20 -163.66 -161.79 0.67 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 -177.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -82.38 -69.56 0.61 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 172.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 450' ' ' GLN . . . . . 0.417 ' HG3' ' H ' ' A' ' 450' ' ' GLN . 1.8 pp0? -66.81 -24.78 66.21 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 178.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 451' ' ' THR . . . . . 0.466 ' OG1' ' HB2' ' A' ' 448' ' ' ASP . 14.0 m -70.62 -22.55 62.51 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.788 -173.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 452' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 452' ' ' ARG . 18.3 mtp180 -54.1 -54.22 42.5 Favored 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 171.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 453' ' ' ALA . . . . . 0.537 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -59.13 -47.1 86.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.524 -1.216 . . . . 0.0 112.604 175.101 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 454' ' ' GLU . . . . . 0.446 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 12.0 mm-40 -51.58 -38.39 54.23 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.203 0.525 . . . . 0.0 111.478 -177.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 28.1 p -116.36 15.44 15.78 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.422 -175.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 456' ' ' PHE . . . . . 0.511 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.7 OUTLIER -56.74 -48.99 76.54 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 120.951 0.405 . . . . 0.0 111.777 -171.472 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 457' ' ' ILE . . . . . 0.546 HG23 ' HB1' ' A' ' 405' ' ' ALA . 1.9 mp -75.45 -32.93 26.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 120.841 0.353 . . . . 0.0 110.713 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -57.63 -35.51 70.58 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.694 0.759 . . . . 0.0 109.586 171.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 459' ' ' HIS . . . . . 0.752 ' O ' HG23 ' A' ' 463' ' ' VAL . 71.3 m-70 -71.74 -29.57 64.67 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.755 -1.112 . . . . 0.0 110.613 176.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 460' ' ' LEU . . . . . 0.712 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -74.08 -34.81 64.14 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.912 0.863 . . . . 0.0 108.787 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -72.84 -38.17 67.19 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.311 175.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 462' ' ' ALA . . . . . 0.627 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -55.82 -32.93 64.0 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.807 169.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.853 HG13 ' HB3' ' A' ' 438' ' ' ALA . 61.6 t -63.89 -50.57 76.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 CA-C-N 114.474 -1.239 . . . . 0.0 107.901 177.397 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 464' ' ' TYR . . . . . 0.567 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 15.3 m-30 -53.89 -27.16 28.69 Favored 'General case' 0 C--N 1.332 -0.169 0 O-C-N 124.259 0.974 . . . . 0.0 110.324 178.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.68 -40.95 18.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.689 0.757 . . . . 0.0 109.38 -177.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.627 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.7 mt -56.22 -55.82 16.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 114.295 -1.32 . . . . 0.0 112.289 175.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 0.761 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -103.41 -10.82 18.3 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -171.752 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 468' ' ' GLY . . . . . 0.561 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 93.73 31.74 8.05 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 119.43 -1.367 . . . . 0.0 114.351 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 469' ' ' LEU . . . . . 0.761 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 2.6 mt -88.91 162.3 16.19 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 117.983 0.892 . . . . 0.0 111.435 177.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 39.5 p30 -105.29 -174.45 2.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.349 173.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -67.02 -17.49 64.94 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -175.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -88.48 -0.43 57.2 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 122.101 -0.375 . . . . 0.0 111.321 -175.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 75.85 17.08 80.25 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -173.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -101.55 151.6 21.78 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 177.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 5.6 p -90.61 127.76 36.38 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.95 0.405 . . . . 0.0 111.169 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 476' ' ' ILE . . . . . 0.561 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.5 pp . . . . . 0 C--N 1.325 -0.462 0 CA-C-O 121.806 0.812 . . . . 0.0 110.282 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 386' ' ' PHE . . . . . 0.733 ' CD1' HD22 ' B' ' 414' ' ' LEU . 1.4 t80 . . . . . 0 CA--C 1.538 0.482 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 387' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -49.32 -72.67 0.04 OUTLIER 'Trans proline' 0 N--CA 1.487 1.13 0 C-N-CA 124.492 3.461 . . . . 0.0 114.375 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 388' ' ' MET . . . . . 0.61 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 38.9 ttm 73.98 49.54 0.12 Allowed 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 112.754 0.649 . . . . 0.0 112.754 172.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 389' ' ' HIS . . . . . 0.716 ' CG ' ' HB2' ' B' ' 393' ' ' ASN . 40.7 m170 47.32 -99.84 0.05 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.22 0.608 . . . . 0.0 110.499 -175.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -145.99 15.49 1.36 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.823 174.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 391' ' ' LEU . . . . . 0.482 HD23 ' H ' ' B' ' 392' ' ' GLY . 2.4 pt? -169.15 -50.89 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -168.115 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 392' ' ' GLY . . . . . 0.547 ' HA3' HD13 ' B' ' 395' ' ' ILE . . . -176.51 51.14 0.11 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 119.599 -1.286 . . . . 0.0 114.25 -172.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 393' ' ' ASN . . . . . 0.716 ' HB2' ' CG ' ' B' ' 389' ' ' HIS . 0.4 OUTLIER -54.47 -41.19 69.21 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 117.359 0.579 . . . . 0.0 109.705 176.914 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 394' ' ' VAL . . . . . 0.672 HG12 ' CE2' ' B' ' 386' ' ' PHE . 0.9 OUTLIER -56.86 -47.2 83.41 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 -179.29 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 395' ' ' ILE . . . . . 0.653 HG23 HD13 ' B' ' 426' ' ' ILE . 4.3 mp -57.86 -52.15 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 CA-C-O 117.824 -1.084 . . . . 0.0 113.31 -175.181 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 396' ' ' LYS . . . . . 0.695 ' HG3' ' CZ ' ' B' ' 429' ' ' TYR . 0.1 OUTLIER -62.95 -49.8 73.31 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 121.714 2.052 . . . . 0.0 112.12 -174.201 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 397' ' ' GLY . . . . . 0.537 ' O ' ' HG3' ' B' ' 401' ' ' GLN . . . -54.51 -44.47 77.96 Favored Glycine 0 N--CA 1.436 -1.355 0 C-N-CA 120.05 -1.071 . . . . 0.0 110.986 -177.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 398' ' ' ILE . . . . . 0.883 HD13 HD12 ' B' ' 410' ' ' LEU . 46.2 mt -71.71 -34.27 51.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -177.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 399' ' ' VAL . . . . . 0.527 HG12 ' HA ' ' B' ' 404' ' ' VAL . 5.5 m -64.21 -39.82 86.85 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.501 0 C-N-CA 118.836 -1.145 . . . . 0.0 108.457 -174.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -64.96 -41.11 95.75 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 174.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 401' ' ' GLN . . . . . 0.537 ' HG3' ' O ' ' B' ' 397' ' ' GLY . 32.3 mt-30 -93.13 -48.29 6.55 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -169.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 402' ' ' GLU . . . . . 0.684 ' HG3' ' HE3' ' A' ' 413' ' ' MET . 3.0 mm-40 -113.61 -19.99 11.39 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.44 -171.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 104.58 162.83 24.3 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.061 -0.59 . . . . 0.0 113.224 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 404' ' ' VAL . . . . . 0.647 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.4 m -53.21 -45.32 54.73 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.766 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -176.072 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 405' ' ' ALA . . . . . 0.554 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -66.23 -30.71 71.22 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 119.711 -0.795 . . . . 0.0 112.062 -175.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 406' ' ' THR . . . . . 0.701 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 88.2 m -77.26 -42.51 36.84 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.303 173.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 407' ' ' ALA . . . . . 0.502 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.09 -37.75 75.1 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 122.093 0.949 . . . . 0.0 109.2 176.194 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 408' ' ' TYR . . . . . 0.647 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.51 -52.58 51.69 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 113.631 -1.622 . . . . 0.0 109.975 177.028 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 409' ' ' THR . . . . . 0.74 HG22 HD23 ' B' ' 410' ' ' LEU . 2.7 m -56.17 -46.17 79.44 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.569 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 410' ' ' LEU . . . . . 0.883 HD12 HD13 ' B' ' 398' ' ' ILE . 13.2 mt -71.95 -36.74 69.98 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.808 0.337 . . . . 0.0 110.2 -175.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.51 -34.8 77.21 Favored Glycine 0 N--CA 1.439 -1.109 0 C-N-CA 120.04 -1.076 . . . . 0.0 110.729 172.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 412' ' ' MET . . . . . 0.413 ' HB2' ' O ' ' B' ' 409' ' ' THR . 0.4 OUTLIER -67.11 -48.14 69.01 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 115.808 -0.196 . . . . 0.0 111.423 177.76 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 413' ' ' MET . . . . . 0.931 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.7 OUTLIER -71.38 -48.1 52.11 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 118.884 -1.126 . . . . 0.0 112.119 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 414' ' ' LEU . . . . . 0.931 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 23.4 mt -67.2 -44.24 80.11 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -175.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 48.1 t -86.81 -24.11 25.12 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.592 0.711 . . . . 0.0 109.907 -177.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 416' ' ' GLY . . . . . 0.449 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 109.98 -175.52 18.58 Favored Glycine 0 N--CA 1.43 -1.715 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -170.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -79.71 24.47 0.38 Allowed 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.61 0.719 . . . . 0.0 111.326 -172.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 418' ' ' ASN . . . . . 0.449 ' H ' ' C ' ' B' ' 416' ' ' GLY . 79.9 m-20 -71.75 75.71 0.85 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.785 -178.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 419' ' ' TYR . . . . . 0.531 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 11.8 p90 -54.89 -38.9 68.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.598 178.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -55.73 -43.57 76.69 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.739 0.304 . . . . 0.0 111.061 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 421' ' ' LEU . . . . . 0.416 HD22 ' HB2' ' B' ' 418' ' ' ASN . 0.0 OUTLIER -68.15 -48.63 64.84 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.013 -177.576 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 422' ' ' VAL . . . . . 0.43 ' HB ' ' CD1' ' B' ' 408' ' ' TYR . 0.2 OUTLIER -66.41 -39.44 84.07 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.212 -177.365 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 423' ' ' SER . . . . . 0.771 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 67.3 p -66.97 -39.33 87.18 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.98 -39.11 89.24 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.161 176.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 425' ' ' ILE . . . . . 0.608 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -72.79 -51.7 26.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 116.622 0.211 . . . . 0.0 111.121 -177.334 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 426' ' ' ILE . . . . . 0.677 HG22 HD22 ' B' ' 430' ' ' LEU . 1.2 mm -74.3 -23.06 18.17 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.708 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -172.176 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 427' ' ' ARG . . . . . 0.771 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.7 OUTLIER -54.75 -31.34 58.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.344 0.592 . . . . 0.0 110.305 -179.769 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -85.5 -4.74 85.47 Favored Glycine 0 N--CA 1.446 -0.7 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.65 178.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 429' ' ' TYR . . . . . 0.695 ' CZ ' ' HG3' ' B' ' 396' ' ' LYS . 24.9 m-85 -120.13 0.52 10.72 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 121.105 0.479 . . . . 0.0 110.693 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 430' ' ' LEU . . . . . 0.711 HD23 ' HA ' ' B' ' 427' ' ' ARG . 0.1 OUTLIER -65.77 127.87 93.4 Favored Pre-proline 0 N--CA 1.44 -0.972 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.634 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 431' ' ' PRO . . . . . 0.474 ' HD2' HD12 ' B' ' 430' ' ' LEU . 84.1 Cg_exo -23.47 -70.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.832 1 C-N-CA 125.665 4.243 . . . . 0.0 115.011 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 432' ' ' GLY . . . . . 0.488 ' O ' HG12 ' B' ' 435' ' ' VAL . . . -138.12 -167.54 11.04 Favored Glycine 0 N--CA 1.442 -0.921 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 176.127 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 433' ' ' GLN . . . . . 0.474 ' O ' HG13 ' B' ' 436' ' ' VAL . 19.1 tp60 -69.5 -26.82 64.73 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 117.791 0.796 . . . . 0.0 110.074 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -68.07 -39.51 82.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.227 -176.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 435' ' ' VAL . . . . . 0.776 HG23 HG11 ' B' ' 463' ' ' VAL . 7.3 p -69.05 -44.03 81.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-O 120.968 0.413 . . . . 0.0 110.649 -177.483 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 436' ' ' VAL . . . . . 0.474 HG13 ' O ' ' B' ' 433' ' ' GLN . 0.2 OUTLIER -65.26 -31.22 52.93 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 CA-C-O 121.08 0.467 . . . . 0.0 109.883 174.795 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 1.1 m -67.28 -52.8 36.21 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 -178.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 438' ' ' ALA . . . . . 0.837 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -58.94 -39.19 80.86 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 115.351 -0.841 . . . . 0.0 112.113 177.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 439' ' ' LEU . . . . . 0.624 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 1.9 tm? -68.15 -48.48 65.22 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -178.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -59.26 -34.99 72.9 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.485 -1.234 . . . . 0.0 111.097 174.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 441' ' ' GLN . . . . . 0.5 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 3.6 mm-40 -54.98 -50.02 70.01 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.017 -177.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 442' ' ' ARG . . . . . 0.624 ' HG3' ' CG ' ' B' ' 459' ' ' HIS . 0.0 OUTLIER -75.67 -24.34 56.32 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 119.547 -0.861 . . . . 0.0 113.095 175.261 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 443' ' ' LEU . . . . . 0.624 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 70.2 mt -64.47 -35.2 80.18 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 175.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -56.99 -38.2 72.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.451 173.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -74.22 -26.85 60.49 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.318 177.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 446' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 27.91 98.94 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.625 1.17 . . . . 0.0 114.147 176.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 49.0 mt -61.13 -35.13 63.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-O 121.151 0.5 . . . . 0.0 110.74 -178.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 448' ' ' ASP . . . . . 0.476 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 19.8 m-20 -163.79 -162.14 0.69 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 -177.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -81.85 -69.67 0.6 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 172.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 450' ' ' GLN . . . . . 0.417 ' HG3' ' H ' ' B' ' 450' ' ' GLN . 1.8 pp0? -66.76 -24.72 66.24 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 178.068 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 451' ' ' THR . . . . . 0.476 ' OG1' ' HB2' ' B' ' 448' ' ' ASP . 12.4 m -70.62 -22.53 62.52 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.765 -173.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 452' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -54.2 -54.12 44.25 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 171.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 453' ' ' ALA . . . . . 0.531 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -58.94 -47.35 85.41 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.514 -1.221 . . . . 0.0 112.613 174.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 454' ' ' GLU . . . . . 0.445 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 10.5 mm-40 -51.83 -37.38 51.59 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.284 0.564 . . . . 0.0 111.603 -177.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 28.2 p -117.08 15.34 15.04 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.468 -176.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 456' ' ' PHE . . . . . 0.516 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 0.7 OUTLIER -56.57 -49.1 75.85 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.906 0.384 . . . . 0.0 111.879 -171.522 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 457' ' ' ILE . . . . . 0.554 HG23 ' HB1' ' B' ' 405' ' ' ALA . 1.9 mp -75.25 -33.08 27.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 120.809 0.337 . . . . 0.0 110.855 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -57.44 -35.63 70.35 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.814 0.816 . . . . 0.0 109.482 171.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 459' ' ' HIS . . . . . 0.748 ' O ' HG23 ' B' ' 463' ' ' VAL . 70.8 m-70 -71.89 -29.4 64.31 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.629 176.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 460' ' ' LEU . . . . . 0.717 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -74.14 -34.74 63.98 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.88 0.848 . . . . 0.0 108.882 179.811 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 461' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -72.82 -38.25 67.21 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.288 175.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 462' ' ' ALA . . . . . 0.639 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -55.72 -32.87 63.72 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.692 169.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 463' ' ' VAL . . . . . 0.837 HG13 ' HB3' ' B' ' 438' ' ' ALA . 60.1 t -64.07 -50.6 76.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 CA-C-N 114.433 -1.258 . . . . 0.0 107.961 177.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 464' ' ' TYR . . . . . 0.56 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 15.3 m-30 -53.72 -27.48 28.54 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.327 178.157 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.62 -40.52 18.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.622 0.725 . . . . 0.0 109.43 -177.236 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 466' ' ' ILE . . . . . 0.639 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.6 mt -56.42 -55.92 16.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 114.295 -1.321 . . . . 0.0 112.268 175.247 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 467' ' ' LEU . . . . . 0.776 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -103.36 -10.74 18.4 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -171.884 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 468' ' ' GLY . . . . . 0.585 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 93.84 31.69 8.03 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 119.453 -1.356 . . . . 0.0 114.281 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 469' ' ' LEU . . . . . 0.776 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 2.6 mt -88.91 162.26 16.21 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 117.969 0.885 . . . . 0.0 111.29 177.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 39.7 p30 -105.27 -173.96 2.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.367 173.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 471' ' ' ALA . . . . . . . . . . . . . . . -67.69 -17.06 64.45 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -175.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -88.59 -0.81 57.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.751 0.31 . . . . 0.0 111.136 -176.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 473' ' ' GLY . . . . . . . . . . . . . . . 76.19 16.88 80.38 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 -173.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -101.4 151.96 21.3 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 177.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 5.4 p -90.78 128.21 36.61 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.88 0.372 . . . . 0.0 111.184 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 476' ' ' ILE . . . . . 0.585 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.5 pp . . . . . 0 C--N 1.326 -0.432 0 CA-C-O 121.672 0.748 . . . . 0.0 110.266 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 386' ' ' PHE . . . . . 0.809 ' CD1' HD22 ' A' ' 414' ' ' LEU . 2.6 t80 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 121.082 0.468 . . . . 0.0 110.616 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 387' ' ' PRO . . . . . 0.592 ' HG2' ' OD1' ' B' ' 393' ' ' ASN . 60.9 Cg_endo -72.0 111.27 3.13 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 124.105 3.203 . . . . 0.0 113.701 175.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.486 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 40.0 mtt -103.28 172.7 6.67 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 176.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -57.28 -61.76 2.24 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 175.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -175.49 19.66 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.5 -1.227 . . . . 0.0 108.448 173.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.494 HD23 ' H ' ' A' ' 392' ' ' GLY . 2.1 pt? -169.76 -54.8 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.616 -167.034 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 392' ' ' GLY . . . . . 0.612 ' HA3' HD13 ' A' ' 395' ' ' ILE . . . -174.88 54.77 0.13 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 119.93 -1.129 . . . . 0.0 113.703 -174.293 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 393' ' ' ASN . . . . . 0.587 ' OD1' ' HG2' ' B' ' 387' ' ' PRO . 0.2 OUTLIER -54.25 -41.9 69.29 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 177.707 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 394' ' ' VAL . . . . . 0.748 HG23 HD12 ' A' ' 398' ' ' ILE . 2.0 m -56.35 -47.05 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 395' ' ' ILE . . . . . 0.643 ' H ' HD12 ' A' ' 395' ' ' ILE . 3.9 mp -57.47 -52.12 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 CA-C-O 118.04 -0.981 . . . . 0.0 113.254 -175.092 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 396' ' ' LYS . . . . . 0.68 ' HG3' ' CZ ' ' A' ' 429' ' ' TYR . 0.1 OUTLIER -61.49 -49.3 77.33 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-N 121.52 1.964 . . . . 0.0 111.857 -173.99 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -54.26 -45.14 75.07 Favored Glycine 0 N--CA 1.437 -1.279 0 C-N-CA 119.756 -1.212 . . . . 0.0 111.142 -178.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 398' ' ' ILE . . . . . 0.793 HD13 HD12 ' A' ' 410' ' ' LEU . 39.2 mt -70.94 -34.08 54.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -177.004 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 399' ' ' VAL . . . . . 0.503 HG12 ' HA ' ' A' ' 404' ' ' VAL . 10.6 m -63.5 -39.61 85.96 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 C-N-CA 118.573 -1.251 . . . . 0.0 108.24 -175.021 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -70.91 -33.99 71.09 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 175.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -90.14 -47.27 7.91 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -172.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 402' ' ' GLU . . . . . 0.649 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 2.9 mm-40 -121.61 -20.97 6.34 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.576 -170.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 107.21 162.73 21.86 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.823 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 404' ' ' VAL . . . . . 0.65 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.6 m -53.52 -46.45 59.87 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.771 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -175.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 405' ' ' ALA . . . . . 0.598 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -64.25 -30.39 71.45 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 119.891 -0.724 . . . . 0.0 112.452 -176.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.717 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 91.9 m -77.5 -42.96 33.76 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.223 173.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.466 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -58.46 -37.37 75.33 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 122.117 0.96 . . . . 0.0 109.265 176.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 408' ' ' TYR . . . . . 0.65 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.58 -51.69 57.85 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 113.402 -1.726 . . . . 0.0 109.746 176.687 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 409' ' ' THR . . . . . 0.682 HG22 HD23 ' A' ' 410' ' ' LEU . 14.1 m -55.34 -47.03 76.32 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.588 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 410' ' ' LEU . . . . . 0.793 HD12 HD13 ' A' ' 398' ' ' ILE . 14.8 mt -72.19 -37.12 69.36 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 120.826 0.346 . . . . 0.0 110.164 -174.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.68 -34.46 76.98 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.57 173.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 412' ' ' MET . . . . . 0.429 ' HB2' ' O ' ' A' ' 409' ' ' THR . 0.2 OUTLIER -65.86 -44.03 86.65 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 115.685 -0.258 . . . . 0.0 111.589 177.915 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 413' ' ' MET . . . . . 0.754 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.0 OUTLIER -71.13 -56.49 6.0 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 118.431 -1.308 . . . . 0.0 111.558 177.884 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 414' ' ' LEU . . . . . 0.809 HD22 ' CD1' ' A' ' 386' ' ' PHE . 6.8 mt -62.46 -43.52 98.62 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -171.255 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 37.8 t -85.16 -21.14 29.33 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.701 0.762 . . . . 0.0 109.562 -178.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 416' ' ' GLY . . . . . 0.437 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 103.69 -173.42 21.85 Favored Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -169.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -79.7 24.43 0.38 Allowed 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.563 0.696 . . . . 0.0 111.206 -171.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 418' ' ' ASN . . . . . 0.437 ' H ' ' C ' ' A' ' 416' ' ' GLY . 89.2 m-20 -71.17 73.4 0.65 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.493 179.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 419' ' ' TYR . . . . . 0.53 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 29.9 p90 -56.74 -36.58 69.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.002 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -54.72 -42.69 71.86 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.908 178.057 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.16 -49.14 62.92 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.136 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 422' ' ' VAL . . . . . 0.486 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.5 OUTLIER -66.17 -38.8 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.244 -176.487 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.726 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 57.6 p -67.3 -38.66 85.35 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.072 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -70.07 -37.5 73.17 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.96 176.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 425' ' ' ILE . . . . . 0.602 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.66 -52.51 22.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 121.305 -0.158 . . . . 0.0 111.097 -178.308 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 426' ' ' ILE . . . . . 0.681 HG22 HD22 ' A' ' 430' ' ' LEU . 1.2 mm -73.49 -22.71 19.14 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.699 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -172.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.726 ' HB2' ' O ' ' A' ' 423' ' ' SER . 0.7 OUTLIER -54.04 -32.77 55.48 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.271 0.558 . . . . 0.0 110.119 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -84.74 -6.28 85.6 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.598 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.68 ' CZ ' ' HG3' ' A' ' 396' ' ' LYS . 23.9 m-85 -118.64 0.6 11.54 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 121.105 0.479 . . . . 0.0 110.56 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.7 HD23 ' HA ' ' A' ' 427' ' ' ARG . 0.1 OUTLIER -66.33 127.79 93.48 Favored Pre-proline 0 N--CA 1.437 -1.075 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.348 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 431' ' ' PRO . . . . . 0.509 ' HD2' HD12 ' A' ' 430' ' ' LEU . 83.6 Cg_exo -23.55 -65.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.354 0.836 1 C-N-CA 125.655 4.237 . . . . 0.0 114.983 179.9 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 432' ' ' GLY . . . . . 0.561 ' H ' HG12 ' A' ' 435' ' ' VAL . . . -143.22 -169.2 12.37 Favored Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 175.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 433' ' ' GLN . . . . . 0.496 ' O ' HG13 ' A' ' 436' ' ' VAL . 45.1 tp60 -69.93 -26.66 64.24 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 118.19 0.995 . . . . 0.0 110.111 177.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -62.93 -42.47 99.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.268 -0.424 . . . . 0.0 112.035 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 435' ' ' VAL . . . . . 0.772 HG23 HG11 ' A' ' 463' ' ' VAL . 7.5 p -68.8 -43.17 82.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-O 120.947 0.403 . . . . 0.0 110.766 -177.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.496 HG12 ' O ' ' A' ' 432' ' ' GLY . 0.1 OUTLIER -66.22 -31.74 55.01 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.241 175.712 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.56 -52.39 46.13 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -178.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 438' ' ' ALA . . . . . 0.842 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -57.85 -40.09 79.27 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.997 177.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 439' ' ' LEU . . . . . 0.611 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 2.0 tm? -68.03 -48.54 65.37 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -178.209 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -59.13 -35.16 72.98 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.1 175.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 441' ' ' GLN . . . . . 0.517 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 3.3 mm-40 -54.87 -49.53 70.94 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.126 -178.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 442' ' ' ARG . . . . . 0.622 ' HD2' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -76.43 -24.0 53.96 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 119.736 -0.785 . . . . 0.0 113.058 174.899 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 443' ' ' LEU . . . . . 0.611 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 69.4 mt -64.23 -35.81 82.04 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 118.404 0.547 . . . . 0.0 109.53 174.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -57.46 -37.53 73.02 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.537 173.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -73.73 -27.12 61.03 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.113 177.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 26.68 100.57 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.878 1.271 . . . . 0.0 114.387 176.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 51.8 mt -63.47 -34.94 70.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.046 -178.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 448' ' ' ASP . . . . . 0.452 ' HB2' ' OG1' ' A' ' 451' ' ' THR . 33.5 m-20 -164.21 -162.04 0.65 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -178.196 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -79.55 -71.01 0.47 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 172.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -66.91 -24.82 66.13 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 178.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 451' ' ' THR . . . . . 0.452 ' OG1' ' HB2' ' A' ' 448' ' ' ASP . 15.8 m -70.49 -22.18 62.68 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.104 -0.638 . . . . 0.0 110.836 -173.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 452' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 452' ' ' ARG . 20.9 mtp180 -53.43 -53.83 45.6 Favored 'General case' 0 C--O 1.221 -0.406 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 171.019 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 453' ' ' ALA . . . . . 0.53 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -59.8 -47.83 84.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.388 -1.278 . . . . 0.0 112.58 175.083 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 454' ' ' GLU . . . . . 0.428 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 77.4 mm-40 -50.4 -37.19 36.36 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.181 0.515 . . . . 0.0 111.774 -177.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 29.9 p -117.98 15.22 14.23 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.374 -176.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 456' ' ' PHE . . . . . 0.563 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.8 OUTLIER -56.9 -47.67 79.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.09 0.471 . . . . 0.0 111.718 -171.747 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 457' ' ' ILE . . . . . 0.598 HG23 ' HB1' ' A' ' 405' ' ' ALA . 1.9 mp -76.78 -33.04 20.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.053 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -57.7 -34.49 69.49 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.783 0.802 . . . . 0.0 109.28 171.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 459' ' ' HIS . . . . . 0.735 ' O ' HG23 ' A' ' 463' ' ' VAL . 59.9 m-70 -73.18 -29.33 62.76 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.828 177.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 460' ' ' LEU . . . . . 0.707 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.4 OUTLIER -74.16 -34.68 63.91 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.993 0.902 . . . . 0.0 108.753 179.286 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -72.78 -37.89 67.47 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.257 175.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 462' ' ' ALA . . . . . 0.634 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -55.73 -33.23 64.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.674 169.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.842 HG13 ' HB3' ' A' ' 438' ' ' ALA . 77.8 t -64.48 -50.75 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 CA-C-N 114.603 -1.181 . . . . 0.0 107.906 177.079 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 464' ' ' TYR . . . . . 0.549 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 17.3 m-30 -53.34 -25.8 16.49 Favored 'General case' 0 C--N 1.333 -0.143 0 O-C-N 124.313 1.008 . . . . 0.0 110.605 178.116 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.39 -40.93 15.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.6 0.714 . . . . 0.0 109.437 -178.068 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.634 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.4 mt -55.94 -55.22 19.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 114.272 -1.331 . . . . 0.0 112.199 175.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 0.773 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -103.93 -11.01 17.72 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -172.748 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 468' ' ' GLY . . . . . 0.612 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 93.64 31.82 8.03 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 119.328 -1.415 . . . . 0.0 114.374 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 469' ' ' LEU . . . . . 0.773 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 2.9 mt -89.14 161.84 16.27 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 117.886 0.843 . . . . 0.0 111.361 177.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 38.1 p30 -104.97 -177.01 3.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.569 173.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -60.36 -22.53 63.39 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -176.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -87.89 0.28 56.05 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 122.32 -0.238 . . . . 0.0 111.551 -172.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 473' ' ' GLY . . . . . 0.445 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 77.71 12.31 84.6 Favored Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 110.724 -0.951 . . . . 0.0 110.724 -174.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -101.18 152.48 20.59 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 11.5 p -89.28 129.45 35.83 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.279 0.561 . . . . 0.0 111.118 -178.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 476' ' ' ILE . . . . . 0.612 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.8 pp . . . . . 0 C--N 1.32 -0.712 0 CA-C-O 121.636 0.731 . . . . 0.0 109.953 177.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 386' ' ' PHE . . . . . 0.821 ' CD1' HD22 ' B' ' 414' ' ' LEU . 2.6 t80 . . . . . 0 CA--C 1.528 0.106 0 CA-C-O 120.991 0.424 . . . . 0.0 110.599 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 387' ' ' PRO . . . . . 0.587 ' HG2' ' OD1' ' A' ' 393' ' ' ASN . 60.8 Cg_endo -71.97 111.21 3.11 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 124.059 3.172 . . . . 0.0 113.767 175.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 388' ' ' MET . . . . . 0.482 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 39.9 mtt -103.26 172.62 6.71 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 122.012 -0.43 . . . . 0.0 110.1 177.053 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 389' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -57.4 -61.49 2.45 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 175.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -175.89 19.84 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.647 -1.16 . . . . 0.0 108.311 173.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 391' ' ' LEU . . . . . 0.492 HD23 ' H ' ' B' ' 392' ' ' GLY . 2.1 pt? -169.91 -54.86 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.562 -167.22 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 392' ' ' GLY . . . . . 0.596 ' HA3' HD13 ' B' ' 395' ' ' ILE . . . -174.8 54.9 0.13 Allowed Glycine 0 C--N 1.333 0.408 0 C-N-CA 119.911 -1.138 . . . . 0.0 113.67 -174.357 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 393' ' ' ASN . . . . . 0.592 ' OD1' ' HG2' ' A' ' 387' ' ' PRO . 0.2 OUTLIER -54.33 -41.89 69.56 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 177.728 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 394' ' ' VAL . . . . . 0.756 HG23 HD12 ' B' ' 398' ' ' ILE . 2.0 m -56.34 -47.1 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 -179.369 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 395' ' ' ILE . . . . . 0.641 ' H ' HD12 ' B' ' 395' ' ' ILE . 3.9 mp -57.44 -52.24 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 CA-C-O 117.935 -1.031 . . . . 0.0 113.246 -175.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 396' ' ' LYS . . . . . 0.679 ' HG3' ' CZ ' ' B' ' 429' ' ' TYR . 0.1 OUTLIER -61.42 -49.18 77.92 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 121.488 1.949 . . . . 0.0 111.818 -173.933 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -54.39 -45.18 76.23 Favored Glycine 0 N--CA 1.436 -1.31 0 C-N-CA 119.747 -1.216 . . . . 0.0 111.073 -178.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 398' ' ' ILE . . . . . 0.789 HD13 HD12 ' B' ' 410' ' ' LEU . 39.2 mt -70.96 -34.1 54.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -176.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 399' ' ' VAL . . . . . 0.508 HG12 ' HA ' ' B' ' 404' ' ' VAL . 10.6 m -63.47 -39.73 86.42 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 C-N-CA 118.514 -1.274 . . . . 0.0 108.265 -175.032 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -70.83 -34.12 71.38 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 175.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 401' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -89.84 -47.48 7.86 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -172.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 402' ' ' GLU . . . . . 0.661 ' HG3' ' HE3' ' A' ' 413' ' ' MET . 2.9 mm-40 -121.4 -21.08 6.41 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.653 -170.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 107.42 162.5 21.62 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.843 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 404' ' ' VAL . . . . . 0.659 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.5 m -53.41 -46.44 58.55 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.71 0 N-CA-C 114.506 1.298 . . . . 0.0 114.506 -175.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 405' ' ' ALA . . . . . 0.607 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -64.11 -30.5 71.57 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 119.861 -0.736 . . . . 0.0 112.427 -177.126 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 406' ' ' THR . . . . . 0.714 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 89.0 m -77.36 -43.1 34.06 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 121.749 -0.595 . . . . 0.0 110.282 173.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 407' ' ' ALA . . . . . 0.472 ' HB2' ' HB ' ' B' ' 398' ' ' ILE . . . -58.38 -37.35 75.09 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 122.175 0.988 . . . . 0.0 109.252 176.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 408' ' ' TYR . . . . . 0.659 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.59 -51.67 57.93 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 113.414 -1.721 . . . . 0.0 109.816 176.714 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 409' ' ' THR . . . . . 0.671 HG22 HD23 ' B' ' 410' ' ' LEU . 15.7 m -55.3 -47.1 76.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.568 178.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 410' ' ' LEU . . . . . 0.789 HD12 HD13 ' B' ' 398' ' ' ILE . 14.8 mt -72.29 -37.1 69.09 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.093 -174.202 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.6 -34.42 76.26 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 119.915 -1.136 . . . . 0.0 110.481 173.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 412' ' ' MET . . . . . 0.436 ' HB2' ' O ' ' B' ' 409' ' ' THR . 0.3 OUTLIER -65.92 -44.2 85.87 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 115.667 -0.266 . . . . 0.0 111.597 177.932 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 413' ' ' MET . . . . . 0.742 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.0 OUTLIER -70.97 -56.58 5.89 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 118.414 -1.315 . . . . 0.0 111.47 177.979 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 414' ' ' LEU . . . . . 0.821 HD22 ' CD1' ' B' ' 386' ' ' PHE . 6.8 mt -62.45 -43.48 98.72 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 114.19 1.181 . . . . 0.0 114.19 -171.205 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 37.2 t -85.2 -20.98 29.35 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.797 0.808 . . . . 0.0 109.525 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 416' ' ' GLY . . . . . 0.438 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 103.5 -173.15 21.8 Favored Glycine 0 N--CA 1.428 -1.852 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -169.081 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -79.9 24.52 0.4 Allowed 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.617 0.722 . . . . 0.0 111.336 -171.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 418' ' ' ASN . . . . . 0.438 ' H ' ' C ' ' B' ' 416' ' ' GLY . 89.6 m-20 -71.25 73.38 0.67 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.344 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 419' ' ' TYR . . . . . 0.53 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 29.6 p90 -56.68 -36.63 69.81 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.944 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -54.67 -42.59 71.54 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.864 178.076 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.26 -49.14 62.62 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.123 -178.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 422' ' ' VAL . . . . . 0.475 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.5 OUTLIER -66.23 -38.75 82.59 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.238 -176.422 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 423' ' ' SER . . . . . 0.73 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 59.9 p -67.31 -38.82 85.56 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.124 -178.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -70.01 -37.12 73.54 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.056 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 425' ' ' ILE . . . . . 0.616 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -72.82 -52.97 20.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 120.424 0.154 . . . . 0.0 110.996 -178.501 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 426' ' ' ILE . . . . . 0.677 HG22 HD22 ' B' ' 430' ' ' LEU . 1.2 mm -73.24 -22.82 19.53 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.722 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -172.27 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 427' ' ' ARG . . . . . 0.73 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.7 OUTLIER -53.92 -32.79 54.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.341 0.591 . . . . 0.0 110.098 -179.827 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -85.03 -5.67 85.75 Favored Glycine 0 N--CA 1.443 -0.839 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.599 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 429' ' ' TYR . . . . . 0.679 ' CZ ' ' HG3' ' B' ' 396' ' ' LYS . 23.8 m-85 -119.15 0.56 11.25 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-O 121.017 0.436 . . . . 0.0 110.454 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 430' ' ' LEU . . . . . 0.685 HD23 ' HA ' ' B' ' 427' ' ' ARG . 0.1 OUTLIER -66.34 127.66 93.41 Favored Pre-proline 0 N--CA 1.439 -1.004 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.402 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 431' ' ' PRO . . . . . 0.498 ' HD2' HD12 ' B' ' 430' ' ' LEU . 84.0 Cg_exo -23.45 -65.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.874 1 C-N-CA 125.728 4.285 . . . . 0.0 115.059 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 432' ' ' GLY . . . . . 0.556 ' H ' HG12 ' B' ' 435' ' ' VAL . . . -143.23 -169.15 12.35 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 175.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 433' ' ' GLN . . . . . 0.506 ' O ' HG13 ' B' ' 436' ' ' VAL . 46.0 tp60 -70.2 -26.54 63.93 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 118.186 0.993 . . . . 0.0 109.893 177.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -62.99 -42.41 99.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.979 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 435' ' ' VAL . . . . . 0.778 HG23 HG11 ' B' ' 463' ' ' VAL . 7.3 p -69.03 -42.97 82.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 120.933 0.396 . . . . 0.0 110.742 -177.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 436' ' ' VAL . . . . . 0.506 HG13 ' O ' ' B' ' 433' ' ' GLN . 0.1 OUTLIER -66.38 -31.7 54.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.251 175.628 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.57 -52.39 46.0 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 -178.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 438' ' ' ALA . . . . . 0.825 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -57.88 -40.03 79.27 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.015 177.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 439' ' ' LEU . . . . . 0.612 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 1.9 tm? -68.26 -48.39 65.19 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -178.118 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -59.17 -35.16 73.06 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.515 -1.22 . . . . 0.0 111.061 175.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 441' ' ' GLN . . . . . 0.515 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 3.4 mm-40 -54.7 -49.84 69.72 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.178 -178.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 442' ' ' ARG . . . . . 0.627 ' HD2' ' O ' ' B' ' 438' ' ' ALA . 0.0 OUTLIER -76.17 -23.96 54.75 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 119.663 -0.815 . . . . 0.0 113.092 174.966 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 443' ' ' LEU . . . . . 0.612 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 69.4 mt -64.24 -35.78 81.94 Favored 'General case' 0 CA--C 1.519 -0.218 0 O-C-N 121.773 -0.579 . . . . 0.0 109.53 174.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -57.35 -37.64 72.89 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.533 173.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -73.67 -27.42 61.23 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.044 178.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 446' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 26.87 100.59 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 114.422 1.268 . . . . 0.0 114.422 176.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 52.9 mt -63.54 -34.93 70.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.97 -178.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 448' ' ' ASP . . . . . 0.474 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 30.6 m-20 -164.08 -161.95 0.65 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -178.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -79.55 -71.21 0.46 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 171.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -66.71 -24.97 66.31 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 178.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 451' ' ' THR . . . . . 0.474 ' OG1' ' HB2' ' B' ' 448' ' ' ASP . 13.4 m -70.53 -22.24 62.64 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.775 -173.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 452' ' ' ARG . . . . . 0.432 HH11 ' HD2' ' B' ' 452' ' ' ARG . 20.9 mtp180 -53.39 -53.71 47.22 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 107.481 -1.304 . . . . 0.0 107.481 170.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 453' ' ' ALA . . . . . 0.53 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -59.96 -47.6 85.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.415 -1.266 . . . . 0.0 112.525 175.158 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 454' ' ' GLU . . . . . 0.427 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 77.5 mm-40 -50.53 -37.65 40.35 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.245 0.545 . . . . 0.0 111.685 -177.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 31.2 p -117.64 15.22 14.54 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.325 -175.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 456' ' ' PHE . . . . . 0.566 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 0.8 OUTLIER -56.91 -47.53 80.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.082 0.468 . . . . 0.0 111.72 -171.82 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 457' ' ' ILE . . . . . 0.607 HG23 ' HB1' ' B' ' 405' ' ' ALA . 1.9 mp -77.16 -32.87 19.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.851 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -57.89 -34.28 69.64 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.811 0.815 . . . . 0.0 109.375 170.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 459' ' ' HIS . . . . . 0.729 ' O ' HG23 ' B' ' 463' ' ' VAL . 60.3 m-70 -73.1 -29.58 63.03 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.743 177.09 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 460' ' ' LEU . . . . . 0.71 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.4 OUTLIER -74.13 -34.67 63.97 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.887 0.851 . . . . 0.0 108.794 179.456 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 461' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -72.85 -37.72 67.3 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.258 175.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 462' ' ' ALA . . . . . 0.64 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -55.9 -33.22 64.45 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.584 -1.189 . . . . 0.0 109.722 169.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 463' ' ' VAL . . . . . 0.825 HG13 ' HB3' ' B' ' 438' ' ' ALA . 77.5 t -64.48 -50.77 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 CA-C-N 114.54 -1.209 . . . . 0.0 107.835 177.113 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 464' ' ' TYR . . . . . 0.546 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 17.3 m-30 -53.08 -26.4 16.04 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 124.339 1.024 . . . . 0.0 110.471 178.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.79 -40.89 16.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.619 0.724 . . . . 0.0 109.526 -177.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 466' ' ' ILE . . . . . 0.64 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.4 mt -56.21 -55.11 20.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 114.339 -1.301 . . . . 0.0 112.117 175.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 467' ' ' LEU . . . . . 0.783 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -103.83 -11.07 17.76 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -172.667 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 468' ' ' GLY . . . . . 0.597 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 93.73 31.87 7.97 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 119.441 -1.362 . . . . 0.0 114.398 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 469' ' ' LEU . . . . . 0.783 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 2.8 mt -89.04 162.06 16.22 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 117.866 0.833 . . . . 0.0 111.417 177.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 38.3 p30 -105.17 -177.0 3.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.692 173.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 471' ' ' ALA . . . . . . . . . . . . . . . -60.3 -22.88 63.68 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -176.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -87.79 0.73 55.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.617 -172.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 473' ' ' GLY . . . . . 0.45 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 77.59 12.05 84.88 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.197 -1.001 . . . . 0.0 110.751 -175.037 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -101.09 152.7 20.3 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 11.0 p -89.69 129.22 36.15 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.18 0.514 . . . . 0.0 111.134 -178.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 476' ' ' ILE . . . . . 0.597 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.8 pp . . . . . 0 C--N 1.321 -0.664 0 CA-C-O 121.678 0.751 . . . . 0.0 109.889 177.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 386' ' ' PHE . . . . . 0.694 ' CD1' HD22 ' A' ' 414' ' ' LEU . 1.1 t80 . . . . . 0 N--CA 1.473 0.682 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -42.14 -70.73 0.06 OUTLIER 'Trans proline' 0 N--CA 1.484 0.947 0 C-N-CA 124.48 3.453 . . . . 0.0 114.088 -175.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.634 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 36.4 ttm 77.67 29.65 0.51 Allowed 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 173.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 389' ' ' HIS . . . . . 0.676 ' CG ' ' HB2' ' A' ' 393' ' ' ASN . 42.4 m170 61.35 -82.91 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.291 0.636 . . . . 0.0 110.633 -176.32 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -167.92 14.47 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.246 -0.888 . . . . 0.0 108.702 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.501 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.5 pt? -169.53 -48.23 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -168.043 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 392' ' ' GLY . . . . . 0.581 ' HA3' HD13 ' A' ' 395' ' ' ILE . . . 178.78 48.36 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 119.309 -1.424 . . . . 0.0 114.531 -172.095 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 393' ' ' ASN . . . . . 0.676 ' HB2' ' CG ' ' A' ' 389' ' ' HIS . 0.3 OUTLIER -54.14 -39.79 66.83 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 117.58 0.69 . . . . 0.0 109.405 174.985 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 394' ' ' VAL . . . . . 0.722 HG23 HD12 ' A' ' 398' ' ' ILE . 1.8 m -56.23 -49.18 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 395' ' ' ILE . . . . . 0.689 HG23 HD13 ' A' ' 426' ' ' ILE . 3.7 mp -56.75 -53.41 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -174.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 396' ' ' LYS . . . . . 0.739 ' HG3' ' CE1' ' A' ' 429' ' ' TYR . 0.1 OUTLIER -66.25 -47.21 74.47 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 121.349 1.886 . . . . 0.0 112.06 -172.133 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -52.81 -45.16 61.15 Favored Glycine 0 N--CA 1.434 -1.452 0 C-N-CA 120.132 -1.032 . . . . 0.0 110.882 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 398' ' ' ILE . . . . . 0.722 HD12 HG23 ' A' ' 394' ' ' VAL . 31.2 mt -70.75 -33.87 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 399' ' ' VAL . . . . . 0.537 HG22 ' O ' ' A' ' 396' ' ' LYS . 11.3 m -62.6 -39.58 85.14 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 C-N-CA 118.821 -1.152 . . . . 0.0 108.103 -174.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -70.93 -34.78 71.83 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 175.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 45.3 mm-40 -89.17 -47.71 7.89 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -173.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 402' ' ' GLU . . . . . 0.463 ' HB3' ' HB ' ' A' ' 406' ' ' THR . 3.0 mm-40 -119.75 -20.94 7.44 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.462 -170.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 107.48 162.77 21.61 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.519 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 404' ' ' VAL . . . . . 0.61 HG11 ' HA ' ' A' ' 430' ' ' LEU . 1.7 m -54.12 -45.73 66.28 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.731 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -175.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 405' ' ' ALA . . . . . 0.574 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -64.12 -29.61 70.73 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 119.84 -0.744 . . . . 0.0 112.209 -177.434 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.712 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 85.7 m -77.59 -43.21 32.42 Favored 'General case' 0 C--O 1.219 -0.54 0 O-C-N 121.888 -0.507 . . . . 0.0 110.227 173.086 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.428 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.18 -36.09 72.55 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 122.106 0.955 . . . . 0.0 109.14 176.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 408' ' ' TYR . . . . . 0.586 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -66.34 -52.65 44.89 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 113.446 -1.707 . . . . 0.0 109.749 175.999 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 409' ' ' THR . . . . . 0.634 HG22 HD23 ' A' ' 410' ' ' LEU . 17.3 m -55.48 -47.4 76.21 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.673 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 410' ' ' LEU . . . . . 0.712 HD12 ' CD1' ' A' ' 398' ' ' ILE . 15.0 mt -72.42 -36.68 68.67 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -174.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.73 -35.31 81.11 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.066 -1.064 . . . . 0.0 110.783 172.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -68.64 -48.32 64.33 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 120.644 0.259 . . . . 0.0 111.265 178.555 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 413' ' ' MET . . . . . 0.962 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 1.2 ppp? -71.02 -43.27 68.27 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 118.888 -1.125 . . . . 0.0 112.155 -177.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 414' ' ' LEU . . . . . 0.962 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 12.1 mt -71.31 -45.85 62.08 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -177.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 44.5 t -84.98 -24.3 28.33 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.787 0.803 . . . . 0.0 110.277 -175.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 416' ' ' GLY . . . . . 0.412 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 110.74 -175.69 18.19 Favored Glycine 0 N--CA 1.428 -1.89 0 N-CA-C 109.824 -1.311 . . . . 0.0 109.824 -171.12 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -80.84 24.24 0.5 Allowed 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 121.407 0.622 . . . . 0.0 111.193 -172.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 418' ' ' ASN . . . . . 0.412 ' H ' ' C ' ' A' ' 416' ' ' GLY . 84.5 m-20 -71.74 76.64 0.85 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.701 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 419' ' ' TYR . . . . . 0.549 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 17.1 p90 -54.36 -38.84 66.56 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.656 177.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -55.63 -44.07 76.78 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.634 0.254 . . . . 0.0 111.138 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.78 -48.64 65.76 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.055 -177.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 422' ' ' VAL . . . . . 0.429 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -66.07 -39.42 84.42 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.158 -177.519 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.728 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 64.0 p -67.49 -39.81 85.21 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.024 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -66.26 -39.9 94.56 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.739 -0.743 . . . . 0.0 111.954 175.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 425' ' ' ILE . . . . . 0.632 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.72 -51.91 25.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 121.236 -0.185 . . . . 0.0 111.291 -177.094 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 426' ' ' ILE . . . . . 0.689 HD13 HG23 ' A' ' 395' ' ' ILE . 1.2 mm -73.77 -23.01 18.88 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.885 0 CA-C-O 120.76 0.314 . . . . 0.0 110.176 -171.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.728 ' HB2' ' O ' ' A' ' 423' ' ' SER . 0.8 OUTLIER -54.77 -29.14 53.27 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.981 0.419 . . . . 0.0 110.975 -178.009 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.73 -11.45 68.24 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.641 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.739 ' CE1' ' HG3' ' A' ' 396' ' ' LYS . 15.0 m-85 -113.99 -1.41 13.8 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 121.709 0.766 . . . . 0.0 109.241 -176.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.614 HD12 ' HD2' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -65.94 135.12 95.2 Favored Pre-proline 0 N--CA 1.438 -1.039 0 CA-C-N 114.05 -1.432 . . . . 0.0 108.665 177.694 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 431' ' ' PRO . . . . . 0.815 ' HD2' HG11 ' A' ' 435' ' ' VAL . 43.0 Cg_exo -36.25 -65.71 0.13 Allowed 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 124.804 3.669 . . . . 0.0 114.34 -171.347 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 432' ' ' GLY . . . . . 0.542 ' H ' HG12 ' A' ' 435' ' ' VAL . . . -141.85 -163.18 9.5 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 176.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 433' ' ' GLN . . . . . 0.502 ' O ' HG13 ' A' ' 436' ' ' VAL . 21.7 tp60 -70.73 -27.64 64.12 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 118.103 0.952 . . . . 0.0 110.411 177.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -67.47 -38.89 85.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.031 -176.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 435' ' ' VAL . . . . . 0.815 HG11 ' HD2' ' A' ' 431' ' ' PRO . 7.6 p -68.48 -44.9 82.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.974 0.416 . . . . 0.0 110.602 -178.32 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 433' ' ' GLN . 0.2 OUTLIER -65.41 -29.35 46.9 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.334 175.965 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -70.71 -51.98 23.97 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 438' ' ' ALA . . . . . 0.887 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -58.14 -38.69 77.04 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.692 177.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 439' ' ' LEU . . . . . 0.559 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 2.1 tm? -70.15 -47.21 62.61 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -178.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -57.53 -39.33 76.35 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.406 174.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 441' ' ' GLN . . . . . 0.517 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 9.5 mm-40 -53.54 -49.7 67.08 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 123.958 0.903 . . . . 0.0 110.663 174.21 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 442' ' ' ARG . . . . . 0.818 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 0.6 OUTLIER -56.09 -40.17 73.24 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.762 172.226 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 443' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 31.9 mt -72.21 -32.07 66.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.023 0.44 . . . . 0.0 110.467 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -58.69 -38.2 77.73 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.458 173.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 -74.01 -27.53 61.01 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.219 177.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 446' ' ' GLU . . . . . 0.438 ' HB3' ' O ' ' A' ' 443' ' ' LEU . 10.3 pt-20 19.29 101.01 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 178.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 447' ' ' ILE . . . . . 0.418 HD12 HG22 ' A' ' 451' ' ' THR . 45.0 mt -61.03 -33.88 57.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.382 0.61 . . . . 0.0 110.438 177.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 448' ' ' ASP . . . . . 0.404 ' HB2' ' CB ' ' A' ' 451' ' ' THR . 10.8 m-20 -162.92 -156.14 0.38 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -178.168 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -89.74 -63.97 1.21 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 169.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 2.7 pp0? -69.07 -25.86 64.66 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 178.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 451' ' ' THR . . . . . 0.426 ' HA ' ' HB2' ' A' ' 454' ' ' GLU . 13.5 m -71.28 -22.57 61.94 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.572 -176.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -54.24 -53.77 49.13 Favored 'General case' 0 C--O 1.22 -0.498 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 171.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 453' ' ' ALA . . . . . 0.549 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -57.43 -48.53 78.9 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 114.624 -1.171 . . . . 0.0 112.396 175.173 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 454' ' ' GLU . . . . . 0.426 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 14.7 mm-40 -51.1 -35.11 33.5 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.357 0.599 . . . . 0.0 111.559 -178.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 33.5 p -119.22 16.15 13.15 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.493 -176.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 456' ' ' PHE . . . . . 0.56 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.9 OUTLIER -57.77 -48.35 79.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.914 0.387 . . . . 0.0 111.693 -171.282 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 457' ' ' ILE . . . . . 0.574 HG23 ' HB1' ' A' ' 405' ' ' ALA . 2.0 mp -76.14 -32.63 23.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 120.8 0.333 . . . . 0.0 110.933 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -57.62 -35.05 69.95 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.978 0.894 . . . . 0.0 109.195 171.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 459' ' ' HIS . . . . . 0.726 ' O ' HG23 ' A' ' 463' ' ' VAL . 59.8 m-70 -74.84 -28.99 60.91 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.542 -1.208 . . . . 0.0 110.946 177.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 460' ' ' LEU . . . . . 0.714 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.4 OUTLIER -73.88 -34.94 64.63 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.97 0.89 . . . . 0.0 108.89 179.049 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 461' ' ' ASN . . . . . 0.44 ' O ' ' HB2' ' A' ' 464' ' ' TYR . 22.1 m-80 -73.34 -37.34 66.14 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.862 0.839 . . . . 0.0 108.78 177.15 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 462' ' ' ALA . . . . . 0.592 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -56.46 -35.34 67.8 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.377 -1.283 . . . . 0.0 109.656 169.293 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.887 HG13 ' HB3' ' A' ' 438' ' ' ALA . 68.2 t -60.93 -51.6 71.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 175.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 464' ' ' TYR . . . . . 0.618 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 19.9 m-30 -52.01 -28.34 16.68 Favored 'General case' 0 C--N 1.333 -0.125 0 O-C-N 124.363 1.039 . . . . 0.0 110.765 177.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.5 -40.6 17.45 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.5 0.667 . . . . 0.0 109.67 -177.111 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.592 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.7 mt -56.27 -55.43 18.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 114.395 -1.275 . . . . 0.0 112.198 176.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 0.793 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -101.9 -10.61 19.68 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 -172.667 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 468' ' ' GLY . . . . . 0.619 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 93.7 31.97 7.92 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 119.337 -1.411 . . . . 0.0 114.23 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 469' ' ' LEU . . . . . 0.793 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.7 mt -88.98 161.84 16.39 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 117.808 0.804 . . . . 0.0 111.146 176.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 37.9 p30 -104.55 -176.9 3.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.956 172.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 471' ' ' ALA . . . . . 0.464 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -62.28 -20.48 64.34 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -176.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -87.21 -1.8 58.16 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.655 0.265 . . . . 0.0 111.648 -173.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 79.11 14.21 82.09 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.008 -1.092 . . . . 0.0 110.66 -174.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -100.85 148.86 24.47 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 177.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 3.9 p -88.05 126.73 35.25 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.995 0.426 . . . . 0.0 111.168 -178.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 476' ' ' ILE . . . . . 0.619 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.8 pp . . . . . 0 C--N 1.327 -0.392 0 CA-C-O 121.523 0.678 . . . . 0.0 110.307 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 386' ' ' PHE . . . . . 0.698 ' CD1' HD22 ' B' ' 414' ' ' LEU . 1.2 t80 . . . . . 0 N--CA 1.472 0.661 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 387' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' B' ' 386' ' ' PHE . 5.6 Cg_endo -42.01 -71.45 0.06 OUTLIER 'Trans proline' 0 N--CA 1.482 0.851 0 C-N-CA 124.528 3.486 . . . . 0.0 113.967 -176.036 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 388' ' ' MET . . . . . 0.61 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 36.1 ttm 78.21 29.18 0.47 Allowed 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 173.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 389' ' ' HIS . . . . . 0.667 ' CG ' ' HB2' ' B' ' 393' ' ' ASN . 42.6 m170 61.87 -83.05 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.384 0.674 . . . . 0.0 110.554 -176.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -167.68 14.22 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.731 177.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 391' ' ' LEU . . . . . 0.487 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.5 pt? -169.5 -48.29 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -167.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 392' ' ' GLY . . . . . 0.576 ' HA3' HD13 ' B' ' 395' ' ' ILE . . . 178.61 48.49 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 119.31 -1.424 . . . . 0.0 114.527 -172.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 393' ' ' ASN . . . . . 0.667 ' HB2' ' CG ' ' B' ' 389' ' ' HIS . 0.2 OUTLIER -54.27 -39.61 67.05 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 117.531 0.665 . . . . 0.0 109.355 174.905 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 394' ' ' VAL . . . . . 0.708 HG23 HD12 ' B' ' 398' ' ' ILE . 1.8 m -56.25 -49.17 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 395' ' ' ILE . . . . . 0.685 HG23 HD13 ' B' ' 426' ' ' ILE . 3.7 mp -56.8 -53.39 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 CA-C-O 118.255 -0.879 . . . . 0.0 113.323 -174.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 396' ' ' LYS . . . . . 0.732 ' HG3' ' CE1' ' B' ' 429' ' ' TYR . 0.1 OUTLIER -66.27 -47.0 75.09 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 121.42 1.918 . . . . 0.0 112.054 -172.042 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.0 -45.19 62.19 Favored Glycine 0 N--CA 1.432 -1.571 0 C-N-CA 120.099 -1.048 . . . . 0.0 110.893 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 398' ' ' ILE . . . . . 0.708 HD12 HG23 ' B' ' 394' ' ' VAL . 31.1 mt -70.67 -33.88 54.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 399' ' ' VAL . . . . . 0.536 HG22 ' O ' ' B' ' 396' ' ' LYS . 11.2 m -62.59 -39.52 84.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 C-N-CA 118.664 -1.214 . . . . 0.0 108.07 -174.509 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -70.93 -34.8 71.85 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 175.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 401' ' ' GLN . . . . . . . . . . . . . 46.0 mm-40 -89.11 -47.71 7.9 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -173.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 402' ' ' GLU . . . . . 0.467 ' HB3' ' HB ' ' B' ' 406' ' ' THR . 3.1 mm-40 -119.85 -20.89 7.4 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.558 -170.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 107.44 162.55 21.61 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.52 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 404' ' ' VAL . . . . . 0.601 HG11 ' HA ' ' B' ' 430' ' ' LEU . 1.6 m -53.95 -45.78 64.19 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.754 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -175.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 405' ' ' ALA . . . . . 0.565 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -64.02 -29.81 70.93 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 119.741 -0.784 . . . . 0.0 112.187 -177.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 406' ' ' THR . . . . . 0.696 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 90.1 m -77.34 -43.14 33.98 Favored 'General case' 0 C--O 1.22 -0.499 0 O-C-N 121.867 -0.521 . . . . 0.0 110.343 172.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 407' ' ' ALA . . . . . 0.435 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.16 -36.0 72.37 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 122.162 0.982 . . . . 0.0 109.254 176.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 408' ' ' TYR . . . . . 0.573 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -66.33 -52.74 44.09 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 113.411 -1.722 . . . . 0.0 109.711 176.003 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 409' ' ' THR . . . . . 0.631 HG22 HD23 ' B' ' 410' ' ' LEU . 17.1 m -55.41 -47.37 76.04 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.675 179.234 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 410' ' ' LEU . . . . . 0.703 HD12 ' CD1' ' B' ' 398' ' ' ILE . 15.1 mt -72.5 -36.46 68.39 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -174.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.91 -35.21 81.94 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.058 -1.068 . . . . 0.0 110.769 172.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 412' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -68.6 -48.41 64.21 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-O 120.514 0.197 . . . . 0.0 111.34 178.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 413' ' ' MET . . . . . 0.961 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 1.2 ppp? -71.07 -43.17 68.33 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 118.954 -1.098 . . . . 0.0 112.116 -177.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 414' ' ' LEU . . . . . 0.961 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 11.9 mt -71.21 -46.31 61.45 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -177.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 43.9 t -84.76 -24.4 28.82 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.649 0.738 . . . . 0.0 110.289 -174.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 416' ' ' GLY . . . . . 0.42 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 111.08 -175.83 18.07 Favored Glycine 0 N--CA 1.426 -2.009 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -171.461 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -80.54 24.05 0.48 Allowed 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.482 0.658 . . . . 0.0 111.255 -172.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 418' ' ' ASN . . . . . 0.42 ' H ' ' C ' ' B' ' 416' ' ' GLY . 84.9 m-20 -71.55 76.77 0.8 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.74 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 419' ' ' TYR . . . . . 0.559 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 16.8 p90 -54.4 -39.01 66.84 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.653 177.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -55.73 -43.85 76.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.788 0.328 . . . . 0.0 111.168 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 421' ' ' LEU . . . . . 0.402 HD22 ' HB2' ' B' ' 418' ' ' ASN . 0.0 OUTLIER -67.81 -48.69 65.55 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.033 -178.098 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 422' ' ' VAL . . . . . 0.429 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.2 OUTLIER -66.23 -39.44 84.3 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.398 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.089 -177.396 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 423' ' ' SER . . . . . 0.749 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 64.4 p -67.32 -39.88 85.92 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.924 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -66.38 -39.71 94.29 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.107 175.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 425' ' ' ILE . . . . . 0.649 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -72.79 -51.84 25.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 121.219 -0.192 . . . . 0.0 111.329 -177.218 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 426' ' ' ILE . . . . . 0.685 HD13 HG23 ' B' ' 395' ' ' ILE . 1.2 mm -73.87 -23.04 18.76 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.896 0 O-C-N 122.194 -0.316 . . . . 0.0 110.227 -171.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 427' ' ' ARG . . . . . 0.749 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.8 OUTLIER -54.7 -29.32 52.74 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.074 0.464 . . . . 0.0 111.007 -178.106 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.51 -11.4 68.86 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.638 -0.791 . . . . 0.0 111.637 178.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 429' ' ' TYR . . . . . 0.732 ' CE1' ' HG3' ' B' ' 396' ' ' LYS . 14.9 m-85 -114.13 -1.17 13.76 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-O 121.766 0.793 . . . . 0.0 109.256 -176.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 430' ' ' LEU . . . . . 0.625 HD12 ' HD2' ' B' ' 431' ' ' PRO . 0.0 OUTLIER -66.02 135.13 95.11 Favored Pre-proline 0 N--CA 1.438 -1.031 0 CA-C-N 114.017 -1.447 . . . . 0.0 108.649 177.582 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 431' ' ' PRO . . . . . 0.821 ' HD2' HG11 ' B' ' 435' ' ' VAL . 43.9 Cg_exo -36.21 -65.99 0.13 Allowed 'Trans proline' 0 N--CA 1.474 0.365 0 C-N-CA 124.888 3.725 . . . . 0.0 114.226 -171.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 432' ' ' GLY . . . . . 0.533 ' H ' HG12 ' B' ' 435' ' ' VAL . . . -141.63 -163.36 9.56 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 176.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 433' ' ' GLN . . . . . 0.506 ' O ' HG13 ' B' ' 436' ' ' VAL . 21.3 tp60 -70.54 -27.6 64.28 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 118.079 0.94 . . . . 0.0 110.322 177.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -67.52 -38.94 85.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.995 -176.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 435' ' ' VAL . . . . . 0.821 HG11 ' HD2' ' B' ' 431' ' ' PRO . 7.7 p -68.59 -44.85 82.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-O 120.958 0.409 . . . . 0.0 110.623 -178.321 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 436' ' ' VAL . . . . . 0.506 HG13 ' O ' ' B' ' 433' ' ' GLN . 0.2 OUTLIER -65.19 -29.69 48.06 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.39 175.83 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -70.37 -51.99 25.76 Favored 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 438' ' ' ALA . . . . . 0.875 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -58.15 -38.73 77.18 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.707 177.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 439' ' ' LEU . . . . . 0.566 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 2.1 tm? -70.23 -47.09 62.92 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -178.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -57.67 -39.16 76.45 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.34 174.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 441' ' ' GLN . . . . . 0.518 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 9.2 mm-40 -53.76 -49.62 67.8 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 123.826 0.85 . . . . 0.0 110.624 174.187 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 442' ' ' ARG . . . . . 0.832 ' HG2' ' O ' ' B' ' 438' ' ' ALA . 0.7 OUTLIER -56.15 -40.24 73.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.684 172.228 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 443' ' ' LEU . . . . . 0.566 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 32.5 mt -72.16 -32.03 66.5 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.995 0.426 . . . . 0.0 110.34 -178.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -58.81 -38.06 77.77 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.682 0.753 . . . . 0.0 110.464 173.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -74.03 -27.54 60.99 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.275 177.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 446' ' ' GLU . . . . . 0.437 ' HB3' ' O ' ' B' ' 443' ' ' LEU . 10.8 pt-20 19.3 100.29 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 178.035 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 447' ' ' ILE . . . . . 0.425 HD12 HG22 ' B' ' 451' ' ' THR . 45.2 mt -60.61 -34.03 56.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.382 0.611 . . . . 0.0 110.426 177.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 448' ' ' ASP . . . . . 0.404 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 11.4 m-20 -162.61 -156.31 0.4 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -178.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -89.66 -63.97 1.21 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 169.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 2.7 pp0? -68.87 -25.94 64.88 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 178.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 451' ' ' THR . . . . . 0.429 ' HA ' ' HB2' ' B' ' 454' ' ' GLU . 12.1 m -71.29 -22.57 61.93 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.602 -176.354 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 452' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -54.37 -53.65 51.11 Favored 'General case' 0 C--O 1.219 -0.533 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 171.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 453' ' ' ALA . . . . . 0.559 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -57.71 -48.04 80.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 114.609 -1.178 . . . . 0.0 112.53 175.245 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 454' ' ' GLU . . . . . 0.429 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 11.4 mm-40 -51.53 -34.82 37.98 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.161 0.505 . . . . 0.0 111.578 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 32.4 p -119.63 16.04 12.8 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.424 -176.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 456' ' ' PHE . . . . . 0.565 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 0.9 OUTLIER -57.46 -48.68 78.54 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.664 -171.304 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 457' ' ' ILE . . . . . 0.565 HG23 ' HB1' ' B' ' 405' ' ' ALA . 2.0 mp -75.68 -32.83 25.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.986 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -57.39 -35.29 69.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.959 0.885 . . . . 0.0 109.139 171.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 459' ' ' HIS . . . . . 0.73 ' O ' HG23 ' B' ' 463' ' ' VAL . 60.8 m-70 -74.73 -28.91 60.98 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.44 -1.254 . . . . 0.0 110.998 177.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 460' ' ' LEU . . . . . 0.728 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.4 OUTLIER -73.91 -35.04 64.61 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.9 0.857 . . . . 0.0 108.938 178.944 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 461' ' ' ASN . . . . . 0.42 ' O ' ' HB2' ' B' ' 464' ' ' TYR . 23.5 m-80 -73.24 -37.42 66.37 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.743 177.154 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 462' ' ' ALA . . . . . 0.606 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -56.39 -35.34 67.64 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.711 169.224 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 463' ' ' VAL . . . . . 0.875 HG13 ' HB3' ' B' ' 438' ' ' ALA . 68.3 t -61.01 -51.59 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 175.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 464' ' ' TYR . . . . . 0.611 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 19.9 m-30 -52.0 -28.39 16.8 Favored 'General case' 0 N--CA 1.457 -0.11 0 O-C-N 124.4 1.063 . . . . 0.0 110.764 178.035 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.41 -40.53 17.69 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.633 0.73 . . . . 0.0 109.736 -177.194 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 466' ' ' ILE . . . . . 0.606 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.7 mt -56.04 -55.83 16.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 114.402 -1.272 . . . . 0.0 112.184 176.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 467' ' ' LEU . . . . . 0.801 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -101.83 -10.44 19.88 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -172.468 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 468' ' ' GLY . . . . . 0.616 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 93.75 32.03 7.86 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 119.352 -1.404 . . . . 0.0 114.164 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 469' ' ' LEU . . . . . 0.801 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.7 mt -89.05 161.81 16.35 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 117.81 0.805 . . . . 0.0 111.149 176.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 37.9 p30 -104.59 -176.93 3.22 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.901 172.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 471' ' ' ALA . . . . . 0.468 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -62.22 -20.74 64.52 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -175.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 472' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' B' ' 472' ' ' ARG . 27.7 mmt180 -87.11 -1.68 58.07 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.655 0.264 . . . . 0.0 111.647 -173.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 473' ' ' GLY . . . . . . . . . . . . . . . 78.7 14.62 81.87 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 119.986 -1.102 . . . . 0.0 110.61 -174.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -101.11 149.01 24.4 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 177.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 4.2 p -87.86 127.5 35.34 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.05 0.452 . . . . 0.0 111.006 -178.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 476' ' ' ILE . . . . . 0.616 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.9 pp . . . . . 0 C--N 1.326 -0.445 0 CA-C-O 121.625 0.726 . . . . 0.0 110.225 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 386' ' ' PHE . . . . . 0.817 ' CD1' HD22 ' A' ' 414' ' ' LEU . 4.7 t80 . . . . . 0 CA--C 1.53 0.201 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -47.11 -67.72 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.848 3.032 . . . . 0.0 114.5 -174.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.516 ' HB2' ' HE2' ' A' ' 388' ' ' MET . 34.5 ttm 66.27 160.81 0.14 Allowed 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.792 0.33 . . . . 0.0 111.235 176.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 389' ' ' HIS . . . . . 0.623 ' CE1' ' HA ' ' A' ' 393' ' ' ASN . 34.4 m170 -72.73 -155.68 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 108.353 -0.981 . . . . 0.0 108.353 173.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 390' ' ' GLN . . . . . 0.445 ' CD ' ' H ' ' A' ' 390' ' ' GLN . 5.7 pm0 -77.84 8.77 4.16 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.395 172.087 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.546 HD23 ' H ' ' A' ' 392' ' ' GLY . 2.1 pt? -159.79 -51.84 0.06 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -176.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 392' ' ' GLY . . . . . 0.714 ' HA3' HD13 ' A' ' 395' ' ' ILE . . . -171.05 72.82 0.11 Allowed Glycine 0 CA--C 1.526 0.766 0 C-N-CA 119.438 -1.363 . . . . 0.0 114.762 -173.244 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 393' ' ' ASN . . . . . 0.623 ' HA ' ' CE1' ' A' ' 389' ' ' HIS . 0.0 OUTLIER -66.4 -36.95 84.14 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 175.832 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 394' ' ' VAL . . . . . 0.677 HG23 HD12 ' A' ' 398' ' ' ILE . 1.0 OUTLIER -57.07 -49.09 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 CA-C-N 113.032 -1.894 . . . . 0.0 107.248 178.193 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 395' ' ' ILE . . . . . 0.714 HD13 ' HA3' ' A' ' 392' ' ' GLY . 3.7 mp -58.48 -52.61 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 CA-C-O 117.663 -1.161 . . . . 0.0 113.671 -174.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 396' ' ' LYS . . . . . 0.586 ' O ' HG22 ' A' ' 399' ' ' VAL . 0.0 OUTLIER -61.88 -50.02 73.89 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 122.221 2.282 . . . . 0.0 112.143 -174.56 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 397' ' ' GLY . . . . . 0.434 ' O ' ' HG3' ' A' ' 401' ' ' GLN . . . -53.29 -44.68 65.24 Favored Glycine 0 N--CA 1.432 -1.571 0 CA-C-N 114.713 -1.13 . . . . 0.0 111.045 -176.033 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 398' ' ' ILE . . . . . 0.854 HD13 HD12 ' A' ' 410' ' ' LEU . 37.8 mt -71.34 -34.23 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -178.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 399' ' ' VAL . . . . . 0.586 HG22 ' O ' ' A' ' 396' ' ' LYS . 16.3 m -63.24 -40.33 88.62 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 C-N-CA 118.92 -1.112 . . . . 0.0 108.49 -173.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -64.3 -43.85 93.44 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 175.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 401' ' ' GLN . . . . . 0.434 ' HG3' ' O ' ' A' ' 397' ' ' GLY . 47.8 mt-30 -92.9 -48.38 6.56 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -167.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 402' ' ' GLU . . . . . 0.602 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 1.2 tm-20 -111.52 -19.13 12.66 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.193 0.52 . . . . 0.0 110.82 -173.25 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 104.51 161.33 24.18 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.846 177.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 404' ' ' VAL . . . . . 0.644 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.2 m -53.94 -45.13 63.51 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.866 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -175.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 405' ' ' ALA . . . . . 0.553 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -63.58 -31.65 72.87 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 119.956 -0.697 . . . . 0.0 112.517 -177.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.696 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 88.0 m -77.08 -41.48 42.06 Favored 'General case' 0 C--O 1.222 -0.35 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.46 173.273 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.486 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -58.84 -36.6 74.82 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 122.1 0.953 . . . . 0.0 109.354 175.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 408' ' ' TYR . . . . . 0.644 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -67.18 -51.47 53.23 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 113.525 -1.671 . . . . 0.0 109.729 177.009 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 409' ' ' THR . . . . . 0.675 HG22 HD23 ' A' ' 410' ' ' LEU . 17.1 m -54.55 -47.76 72.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.591 -0.732 . . . . 0.0 112.508 177.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 410' ' ' LEU . . . . . 0.854 HD12 HD13 ' A' ' 398' ' ' ILE . 14.5 mt -72.55 -34.4 67.5 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -175.228 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.59 -34.01 74.46 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.286 -0.959 . . . . 0.0 110.865 170.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 412' ' ' MET . . . . . 0.403 ' HB2' ' O ' ' A' ' 409' ' ' THR . 0.4 OUTLIER -67.89 -48.09 67.0 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 122.547 -0.384 . . . . 0.0 111.17 177.148 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 413' ' ' MET . . . . . 0.922 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.7 OUTLIER -72.32 -48.21 43.89 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 119.176 -1.01 . . . . 0.0 112.569 -179.778 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 414' ' ' LEU . . . . . 0.922 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 15.4 mt -69.18 -46.95 66.23 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -174.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.08 9.62 41.59 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.432 0.634 . . . . 0.0 110.746 -173.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 416' ' ' GLY . . . . . 0.411 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 85.32 -178.46 50.57 Favored Glycine 0 N--CA 1.435 -1.375 0 CA-C-N 115.437 -0.802 . . . . 0.0 111.554 -178.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -79.94 22.66 0.49 Allowed 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.285 0.564 . . . . 0.0 111.108 -173.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 418' ' ' ASN . . . . . 0.415 ' HB3' ' HB3' ' A' ' 421' ' ' LEU . 3.5 m-20 -71.94 75.1 0.9 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.083 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 419' ' ' TYR . . . . . 0.567 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 28.3 p90 -56.6 -36.96 70.0 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.456 177.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -54.81 -42.03 71.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.461 175.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 421' ' ' LEU . . . . . 0.415 ' HB3' ' HB3' ' A' ' 418' ' ' ASN . 0.0 OUTLIER -68.62 -51.89 37.32 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.624 -179.068 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 422' ' ' VAL . . . . . 0.51 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -62.77 -37.1 78.24 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.582 -174.705 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.771 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 58.4 p -69.27 -34.07 74.19 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -68.69 -42.18 80.86 Favored Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.3 174.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 425' ' ' ILE . . . . . 0.571 HG22 HG21 ' A' ' 395' ' ' ILE . 2.6 mp -72.55 -50.98 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 116.921 0.361 . . . . 0.0 111.514 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 426' ' ' ILE . . . . . 0.67 HD13 HG23 ' A' ' 395' ' ' ILE . 1.2 mm -75.19 -23.69 17.26 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.911 0 O-C-N 122.085 -0.384 . . . . 0.0 110.926 -171.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.771 ' HB2' ' O ' ' A' ' 423' ' ' SER . 1.0 OUTLIER -54.3 -33.3 58.44 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.196 0.522 . . . . 0.0 111.009 -177.199 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -84.65 -13.79 71.99 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.316 -0.945 . . . . 0.0 111.021 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.567 ' HD1' HG22 ' A' ' 395' ' ' ILE . 7.3 m-30 -110.83 -2.05 16.29 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.913 0.863 . . . . 0.0 108.758 -174.218 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.635 ' HA ' HG11 ' A' ' 404' ' ' VAL . 0.0 OUTLIER -66.3 138.96 96.12 Favored Pre-proline 0 N--CA 1.441 -0.902 0 CA-C-N 113.972 -1.467 . . . . 0.0 109.027 176.978 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 431' ' ' PRO . . . . . 0.844 ' HD2' HG11 ' A' ' 435' ' ' VAL . 71.0 Cg_exo -37.81 -65.3 0.16 Allowed 'Trans proline' 0 N--CA 1.473 0.312 0 C-N-CA 124.499 3.466 . . . . 0.0 113.874 -173.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 432' ' ' GLY . . . . . 0.544 ' H ' HG12 ' A' ' 435' ' ' VAL . . . -143.86 -163.24 9.8 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 176.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 433' ' ' GLN . . . . . 0.543 ' O ' HG13 ' A' ' 436' ' ' VAL . 43.8 tp60 -71.87 -26.67 62.44 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 118.328 1.064 . . . . 0.0 110.882 177.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -66.29 -40.7 90.22 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -177.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 435' ' ' VAL . . . . . 0.844 HG11 ' HD2' ' A' ' 431' ' ' PRO . 7.5 p -67.08 -44.13 88.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-O 120.962 0.411 . . . . 0.0 110.783 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.543 HG13 ' O ' ' A' ' 433' ' ' GLN . 0.1 OUTLIER -65.98 -31.55 54.19 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.179 176.383 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.2 -52.98 34.58 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -178.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 438' ' ' ALA . . . . . 0.866 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -58.56 -40.06 82.02 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.23 177.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 439' ' ' LEU . . . . . 0.605 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 1.9 tm? -68.13 -48.1 66.3 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -178.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -58.9 -38.44 78.91 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.457 176.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 441' ' ' GLN . . . . . 0.444 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 6.0 mm-40 -53.69 -52.09 61.14 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 123.629 0.771 . . . . 0.0 110.56 177.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 442' ' ' ARG . . . . . 0.543 ' NH1' ' HB1' ' A' ' 462' ' ' ALA . 0.1 OUTLIER -60.95 -34.9 75.45 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.734 174.848 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 443' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 64.1 mt -68.32 -36.55 79.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.744 178.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -56.57 -37.12 70.13 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.527 0.679 . . . . 0.0 110.284 174.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -74.12 -26.75 60.52 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.577 177.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 446' ' ' GLU . . . . . 0.419 ' HB3' ' O ' ' A' ' 443' ' ' LEU . 10.1 pt-20 19.26 103.36 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 176.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 447' ' ' ILE . . . . . 0.431 HD12 HG22 ' A' ' 451' ' ' THR . 43.0 mt -60.95 -34.9 61.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.852 178.075 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 448' ' ' ASP . . . . . 0.456 ' HB2' ' OG1' ' A' ' 451' ' ' THR . 22.1 m-20 -162.43 -158.8 0.53 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -178.151 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 449' ' ' ASP . . . . . 0.529 ' HA ' ' CZ ' ' A' ' 452' ' ' ARG . 9.6 m-20 -86.29 -67.2 0.83 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 170.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 450' ' ' GLN . . . . . 0.406 ' HG3' ' H ' ' A' ' 450' ' ' GLN . 2.1 pp0? -65.94 -25.57 67.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.167 178.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 451' ' ' THR . . . . . 0.463 ' HA ' ' HB2' ' A' ' 454' ' ' GLU . 14.3 m -71.47 -22.6 61.8 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.633 -176.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 452' ' ' ARG . . . . . 0.529 ' CZ ' ' HA ' ' A' ' 449' ' ' ASP . 48.8 mtt85 -54.65 -53.92 48.4 Favored 'General case' 0 C--O 1.219 -0.535 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 171.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 453' ' ' ALA . . . . . 0.567 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -56.69 -47.91 78.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.706 -1.134 . . . . 0.0 112.404 174.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 454' ' ' GLU . . . . . 0.463 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 13.3 mm-40 -52.36 -33.09 41.54 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.14 0.495 . . . . 0.0 111.742 -178.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 28.6 p -120.04 13.17 12.11 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.551 -176.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 456' ' ' PHE . . . . . 0.538 ' CE2' ' HB2' ' A' ' 419' ' ' TYR . 0.6 OUTLIER -56.71 -49.03 76.39 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.003 0.43 . . . . 0.0 111.493 -171.525 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 457' ' ' ILE . . . . . 0.553 HG23 ' HB1' ' A' ' 405' ' ' ALA . 1.9 mp -75.98 -32.02 22.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.067 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -57.88 -35.45 71.0 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.722 0.772 . . . . 0.0 108.939 171.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 459' ' ' HIS . . . . . 0.77 ' O ' HG23 ' A' ' 463' ' ' VAL . 74.2 m-70 -74.44 -29.3 61.42 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.294 178.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 460' ' ' LEU . . . . . 0.728 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -74.1 -35.36 64.17 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.864 0.84 . . . . 0.0 109.241 179.78 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 461' ' ' ASN . . . . . 0.492 ' O ' ' HB2' ' A' ' 464' ' ' TYR . 23.1 m-80 -73.65 -37.25 65.37 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 121.935 0.874 . . . . 0.0 108.922 177.005 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 462' ' ' ALA . . . . . 0.578 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -57.26 -34.8 69.0 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.803 169.224 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.866 HG13 ' HB3' ' A' ' 438' ' ' ALA . 63.7 t -60.46 -50.82 78.85 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.851 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 175.162 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 464' ' ' TYR . . . . . 0.624 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 19.3 m-30 -52.77 -28.25 21.56 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.552 177.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.53 -41.77 19.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.721 0.772 . . . . 0.0 109.457 -178.016 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.578 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.8 mt -57.24 -55.85 18.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 114.269 -1.332 . . . . 0.0 112.076 177.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 0.777 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -101.07 -10.12 20.78 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -172.999 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 468' ' ' GLY . . . . . 0.599 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 94.14 31.59 7.96 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 119.354 -1.403 . . . . 0.0 114.31 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 469' ' ' LEU . . . . . 0.777 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.9 mt -88.58 163.77 15.7 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 117.831 0.815 . . . . 0.0 111.09 176.147 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 37.4 p30 -105.34 -179.27 3.89 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.521 174.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -60.17 -23.25 63.8 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -177.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -87.24 2.34 50.37 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.325 -172.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 473' ' ' GLY . . . . . 0.484 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 77.8 10.61 86.11 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.501 -0.857 . . . . 0.0 111.3 -177.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -101.23 157.98 16.38 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 176.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 475' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 469' ' ' LEU . 16.3 t -94.01 144.3 25.59 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.314 -0.555 . . . . 0.0 110.755 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 476' ' ' ILE . . . . . 0.599 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.5 pp . . . . . 0 C--N 1.323 -0.567 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.513 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 386' ' ' PHE . . . . . 0.817 ' CD1' HD22 ' B' ' 414' ' ' LEU . 4.6 t80 . . . . . 0 CA--C 1.53 0.192 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 387' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -47.22 -67.75 0.11 Allowed 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 123.788 2.992 . . . . 0.0 114.388 -174.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 388' ' ' MET . . . . . 0.531 ' HB2' ' HE2' ' B' ' 388' ' ' MET . 34.6 ttm 66.2 161.01 0.14 Allowed 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.683 0.278 . . . . 0.0 111.247 177.162 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 389' ' ' HIS . . . . . 0.611 ' CE1' ' HA ' ' B' ' 393' ' ' ASN . 34.5 m170 -72.91 -155.14 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 173.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 390' ' ' GLN . . . . . 0.428 ' CD ' ' H ' ' B' ' 390' ' ' GLN . 5.7 pm0 -77.92 8.8 4.19 Favored 'General case' 0 C--N 1.317 -0.837 0 O-C-N 121.914 -0.491 . . . . 0.0 110.428 171.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 391' ' ' LEU . . . . . 0.536 HD23 ' H ' ' B' ' 392' ' ' GLY . 2.1 pt? -160.06 -51.69 0.05 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -176.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 392' ' ' GLY . . . . . 0.715 ' HA3' HD13 ' B' ' 395' ' ' ILE . . . -170.92 72.83 0.11 Allowed Glycine 0 C--N 1.338 0.689 0 C-N-CA 119.513 -1.327 . . . . 0.0 114.746 -173.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 393' ' ' ASN . . . . . 0.611 ' HA ' ' CE1' ' B' ' 389' ' ' HIS . 0.0 OUTLIER -66.28 -37.02 84.46 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 175.711 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 394' ' ' VAL . . . . . 0.687 HG23 HD12 ' B' ' 398' ' ' ILE . 1.0 OUTLIER -57.04 -49.09 80.55 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 CA-C-N 113.039 -1.892 . . . . 0.0 107.216 178.352 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 395' ' ' ILE . . . . . 0.715 HD13 ' HA3' ' B' ' 392' ' ' GLY . 3.7 mp -58.42 -52.6 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.559 0 CA-C-O 117.681 -1.152 . . . . 0.0 113.63 -174.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 396' ' ' LYS . . . . . 0.583 ' O ' HG22 ' B' ' 399' ' ' VAL . 0.0 OUTLIER -62.02 -49.75 74.78 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 122.18 2.264 . . . . 0.0 112.139 -174.4 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 397' ' ' GLY . . . . . 0.44 ' O ' ' HG3' ' B' ' 401' ' ' GLN . . . -53.51 -44.79 67.59 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 114.704 -1.135 . . . . 0.0 110.904 -176.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 398' ' ' ILE . . . . . 0.863 HD13 HD12 ' B' ' 410' ' ' LEU . 38.1 mt -71.24 -34.2 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -178.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 399' ' ' VAL . . . . . 0.583 HG22 ' O ' ' B' ' 396' ' ' LYS . 16.4 m -63.32 -40.19 88.09 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 C-N-CA 118.949 -1.1 . . . . 0.0 108.573 -173.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -64.35 -44.03 92.75 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 174.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 401' ' ' GLN . . . . . 0.44 ' HG3' ' O ' ' B' ' 397' ' ' GLY . 48.0 mt-30 -92.78 -48.45 6.56 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -167.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 402' ' ' GLU . . . . . 0.603 ' HG3' ' HE3' ' A' ' 413' ' ' MET . 1.2 tm-20 -111.36 -19.28 12.67 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.19 0.519 . . . . 0.0 110.842 -173.164 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 104.62 161.31 24.08 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.89 177.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 404' ' ' VAL . . . . . 0.639 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.2 m -54.0 -45.13 64.3 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.812 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -175.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 405' ' ' ALA . . . . . 0.539 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -63.63 -31.46 72.64 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 119.954 -0.698 . . . . 0.0 112.522 -177.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 406' ' ' THR . . . . . 0.692 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 89.6 m -77.14 -41.7 40.76 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.146 -0.622 . . . . 0.0 110.402 173.251 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 407' ' ' ALA . . . . . 0.494 ' HB2' ' HB ' ' B' ' 398' ' ' ILE . . . -58.7 -36.68 74.63 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 122.154 0.978 . . . . 0.0 109.319 175.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 408' ' ' TYR . . . . . 0.639 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -67.27 -51.39 53.42 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 113.512 -1.677 . . . . 0.0 109.693 177.151 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 409' ' ' THR . . . . . 0.665 HG22 HD23 ' B' ' 410' ' ' LEU . 17.6 m -54.49 -47.88 72.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.478 177.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 410' ' ' LEU . . . . . 0.863 HD12 HD13 ' B' ' 398' ' ' ILE . 14.5 mt -72.46 -34.41 67.72 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -175.23 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.48 -33.94 73.54 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 120.311 -0.947 . . . . 0.0 110.954 170.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 412' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -68.04 -48.09 66.61 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 122.406 -0.467 . . . . 0.0 111.21 177.129 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 413' ' ' MET . . . . . 0.917 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.7 OUTLIER -72.18 -47.98 46.67 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 119.201 -0.999 . . . . 0.0 112.627 -179.779 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 414' ' ' LEU . . . . . 0.917 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 15.7 mt -69.62 -46.65 65.74 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -174.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.19 9.36 42.41 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.434 0.635 . . . . 0.0 110.769 -173.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 416' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 85.56 -178.38 50.22 Favored Glycine 0 N--CA 1.435 -1.378 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.64 -178.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -80.08 22.51 0.51 Allowed 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.227 0.537 . . . . 0.0 111.08 -173.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 418' ' ' ASN . . . . . 0.412 ' HB3' ' HB3' ' B' ' 421' ' ' LEU . 3.5 m-20 -71.76 75.06 0.85 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.108 179.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 419' ' ' TYR . . . . . 0.563 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 29.0 p90 -56.59 -36.9 69.91 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.484 177.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -54.91 -41.91 71.55 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.505 175.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 421' ' ' LEU . . . . . 0.412 ' HB3' ' HB3' ' B' ' 418' ' ' ASN . 0.0 OUTLIER -68.75 -51.86 36.66 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.71 -179.201 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 422' ' ' VAL . . . . . 0.501 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.2 OUTLIER -62.72 -37.22 78.48 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.57 -174.776 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 423' ' ' SER . . . . . 0.78 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 57.1 p -69.03 -34.55 75.4 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -68.3 -42.18 83.61 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.347 175.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 425' ' ' ILE . . . . . 0.578 HG22 HG21 ' B' ' 395' ' ' ILE . 2.6 mp -72.43 -51.1 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-N 116.723 0.261 . . . . 0.0 111.566 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 426' ' ' ILE . . . . . 0.651 HD13 HG23 ' B' ' 395' ' ' ILE . 1.2 mm -75.31 -23.51 17.03 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.925 0 O-C-N 121.978 -0.451 . . . . 0.0 110.95 -171.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 427' ' ' ARG . . . . . 0.78 ' HB2' ' O ' ' B' ' 423' ' ' SER . 1.0 OUTLIER -54.42 -33.21 58.99 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.192 0.52 . . . . 0.0 111.008 -177.194 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -84.88 -13.33 72.38 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.417 -0.897 . . . . 0.0 111.032 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 429' ' ' TYR . . . . . 0.575 ' HD1' HG22 ' B' ' 395' ' ' ILE . 7.4 m-30 -111.24 -2.13 15.85 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -174.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 430' ' ' LEU . . . . . 0.631 ' HA ' HG11 ' B' ' 404' ' ' VAL . 0.0 OUTLIER -66.46 138.65 95.8 Favored Pre-proline 0 N--CA 1.441 -0.904 0 CA-C-N 114.001 -1.454 . . . . 0.0 109.08 176.946 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 431' ' ' PRO . . . . . 0.838 ' HD2' HG11 ' B' ' 435' ' ' VAL . 70.0 Cg_exo -37.69 -64.6 0.18 Allowed 'Trans proline' 0 CA--C 1.533 0.426 0 C-N-CA 124.548 3.499 . . . . 0.0 114.045 -173.268 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 432' ' ' GLY . . . . . 0.558 ' H ' HG12 ' B' ' 435' ' ' VAL . . . -144.7 -163.92 10.29 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 176.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 433' ' ' GLN . . . . . 0.546 ' O ' HG13 ' B' ' 436' ' ' VAL . 43.0 tp60 -71.58 -26.79 62.76 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 118.34 1.07 . . . . 0.0 110.762 178.134 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -66.09 -40.6 90.92 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 435' ' ' VAL . . . . . 0.838 HG11 ' HD2' ' B' ' 431' ' ' PRO . 7.5 p -67.33 -44.03 87.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-O 120.981 0.42 . . . . 0.0 110.788 -178.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 436' ' ' VAL . . . . . 0.546 HG13 ' O ' ' B' ' 433' ' ' GLN . 0.1 OUTLIER -65.91 -31.55 54.23 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.103 176.485 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.36 -52.91 34.34 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -178.21 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 438' ' ' ALA . . . . . 0.862 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -58.52 -39.94 81.52 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.157 177.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 439' ' ' LEU . . . . . 0.592 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 1.9 tm? -68.14 -48.13 66.2 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -178.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -58.94 -38.28 78.64 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.665 -1.152 . . . . 0.0 111.507 176.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 441' ' ' GLN . . . . . 0.441 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 6.0 mm-40 -53.87 -52.0 61.86 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 123.496 0.718 . . . . 0.0 110.499 177.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 442' ' ' ARG . . . . . 0.549 ' NH1' ' HB1' ' B' ' 462' ' ' ALA . 0.1 OUTLIER -60.96 -35.07 75.82 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.652 174.984 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 443' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 64.9 mt -68.24 -36.47 79.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.803 178.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -56.64 -37.3 70.57 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.511 0.672 . . . . 0.0 110.346 174.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -74.03 -26.87 60.66 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.467 177.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 446' ' ' GLU . . . . . 0.434 ' HB3' ' O ' ' B' ' 443' ' ' LEU . 10.3 pt-20 19.72 103.26 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 176.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 447' ' ' ILE . . . . . 0.422 HD12 HG22 ' B' ' 451' ' ' THR . 43.3 mt -60.88 -34.68 60.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.927 178.19 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 448' ' ' ASP . . . . . 0.455 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 21.1 m-20 -162.57 -158.56 0.51 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -178.033 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 449' ' ' ASP . . . . . 0.512 ' HA ' ' CZ ' ' B' ' 452' ' ' ARG . 11.0 m-20 -86.59 -67.05 0.84 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 170.374 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -65.87 -25.68 67.29 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 178.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 451' ' ' THR . . . . . 0.475 ' HA ' ' HB2' ' B' ' 454' ' ' GLU . 14.1 m -71.34 -22.66 61.88 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.615 -176.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 452' ' ' ARG . . . . . 0.512 ' CZ ' ' HA ' ' B' ' 449' ' ' ASP . 48.7 mtt180 -54.65 -53.79 50.19 Favored 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 171.49 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 453' ' ' ALA . . . . . 0.563 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -56.75 -47.98 78.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.689 -1.141 . . . . 0.0 112.415 174.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 454' ' ' GLU . . . . . 0.475 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 14.4 mm-40 -52.36 -32.92 40.67 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.028 0.442 . . . . 0.0 111.828 -178.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 27.8 p -120.23 13.38 11.98 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.58 -176.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 456' ' ' PHE . . . . . 0.552 ' CE2' ' HB2' ' B' ' 419' ' ' TYR . 0.7 OUTLIER -56.86 -48.91 77.01 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.09 0.471 . . . . 0.0 111.496 -171.479 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 457' ' ' ILE . . . . . 0.548 HG13 ' HB3' ' B' ' 408' ' ' TYR . 1.9 mp -76.19 -32.08 22.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.968 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -57.81 -35.51 70.96 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.696 0.76 . . . . 0.0 109.025 171.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 459' ' ' HIS . . . . . 0.779 ' O ' HG23 ' B' ' 463' ' ' VAL . 73.4 m-70 -74.39 -29.16 61.42 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.312 178.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 460' ' ' LEU . . . . . 0.733 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -74.05 -35.42 64.3 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.907 0.861 . . . . 0.0 109.198 179.679 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 461' ' ' ASN . . . . . 0.471 ' O ' ' HB2' ' B' ' 464' ' ' TYR . 22.4 m-80 -73.65 -37.3 65.35 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.911 0.862 . . . . 0.0 108.857 177.056 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 462' ' ' ALA . . . . . 0.584 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -57.25 -34.61 68.79 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.383 -1.28 . . . . 0.0 109.84 169.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 463' ' ' VAL . . . . . 0.862 HG13 ' HB3' ' B' ' 438' ' ' ALA . 64.6 t -60.57 -50.9 78.53 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.778 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.085 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 464' ' ' TYR . . . . . 0.616 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 19.2 m-30 -52.83 -28.12 21.34 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.492 177.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.62 -41.94 18.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.593 0.711 . . . . 0.0 109.382 -178.058 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 466' ' ' ILE . . . . . 0.584 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.8 mt -57.06 -55.93 17.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 114.405 -1.27 . . . . 0.0 112.154 177.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 467' ' ' LEU . . . . . 0.77 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -100.75 -10.26 20.97 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -173.009 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 468' ' ' GLY . . . . . 0.607 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 94.18 31.57 7.96 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 119.222 -1.466 . . . . 0.0 114.396 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 469' ' ' LEU . . . . . 0.77 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.9 mt -88.5 163.83 15.73 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 117.954 0.877 . . . . 0.0 111.046 176.055 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 37.4 p30 -105.32 -179.41 3.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.553 174.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 471' ' ' ALA . . . . . . . . . . . . . . . -60.1 -22.84 63.28 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -87.49 2.06 51.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.251 -172.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 473' ' ' GLY . . . . . 0.489 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 78.16 10.47 86.19 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.37 -0.919 . . . . 0.0 111.214 -177.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -101.19 157.87 16.45 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 176.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 475' ' ' SER . . . . . 0.449 ' HA ' ' HA ' ' B' ' 469' ' ' LEU . 16.7 t -93.87 143.83 25.98 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.757 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 476' ' ' ILE . . . . . 0.607 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.5 pp . . . . . 0 C--N 1.322 -0.62 0 CA-C-O 121.498 0.666 . . . . 0.0 110.508 -178.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 386' ' ' PHE . . . . . 0.878 ' CD1' HD22 ' A' ' 414' ' ' LEU . 5.0 t80 . . . . . 0 CA--C 1.529 0.161 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 387' ' ' PRO . . . . . 0.565 ' HG2' ' OD1' ' B' ' 393' ' ' ASN . 1.2 Cg_endo -45.09 -65.21 0.2 Allowed 'Trans proline' 0 CA--C 1.533 0.438 0 C-N-CA 123.667 2.911 . . . . 0.0 114.088 -177.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.781 ' SD ' HG13 ' A' ' 394' ' ' VAL . 18.2 tpp 67.21 160.69 0.16 Allowed 'General case' 0 N--CA 1.472 0.655 0 O-C-N 123.06 0.225 . . . . 0.0 110.814 178.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 389' ' ' HIS . . . . . 0.582 ' CG ' ' HB2' ' A' ' 393' ' ' ASN . 32.3 m170 -70.69 -161.19 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 171.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -72.76 6.99 2.16 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.288 172.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.587 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.1 pt? -161.01 -64.08 0.06 Allowed 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -175.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 392' ' ' GLY . . . . . 0.599 ' HA3' HD13 ' A' ' 395' ' ' ILE . . . -158.36 59.95 0.33 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 119.759 -1.21 . . . . 0.0 114.175 -170.144 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 393' ' ' ASN . . . . . 0.582 ' HB2' ' CG ' ' A' ' 389' ' ' HIS . 0.2 OUTLIER -55.11 -44.06 74.63 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.344 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 394' ' ' VAL . . . . . 0.781 HG13 ' SD ' ' A' ' 388' ' ' MET . 1.1 m -59.08 -44.79 92.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-N 114.32 -1.309 . . . . 0.0 108.247 -177.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 395' ' ' ILE . . . . . 0.68 HG23 HD13 ' A' ' 426' ' ' ILE . 4.2 mp -57.76 -52.05 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 CA-C-O 117.855 -1.069 . . . . 0.0 113.024 -175.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 396' ' ' LYS . . . . . 0.638 ' HG3' ' CZ ' ' A' ' 429' ' ' TYR . 0.1 OUTLIER -62.95 -49.2 75.7 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 121.681 2.037 . . . . 0.0 111.662 -175.766 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -54.69 -45.84 77.01 Favored Glycine 0 N--CA 1.432 -1.589 0 C-N-CA 120.072 -1.061 . . . . 0.0 111.31 -178.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 398' ' ' ILE . . . . . 0.844 HG12 HD21 ' B' ' 414' ' ' LEU . 26.9 mt -71.38 -33.86 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -177.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 399' ' ' VAL . . . . . 0.502 HG12 ' HA ' ' A' ' 404' ' ' VAL . 7.9 m -63.68 -39.58 85.89 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 C-N-CA 118.79 -1.164 . . . . 0.0 108.396 -174.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -69.33 -38.53 78.21 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 175.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 36.5 mm-40 -86.17 -48.8 8.25 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -170.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 402' ' ' GLU . . . . . 0.471 ' HA ' HH11 ' A' ' 472' ' ' ARG . 10.2 tp10 -120.97 -21.04 6.66 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.868 0.366 . . . . 0.0 111.22 -171.187 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 109.7 163.64 19.63 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.985 178.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 404' ' ' VAL . . . . . 0.617 HG11 ' HA ' ' A' ' 430' ' ' LEU . 1.7 m -53.41 -45.56 57.53 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -175.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 405' ' ' ALA . . . . . 0.608 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -64.81 -31.02 72.06 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.702 -0.799 . . . . 0.0 112.288 -176.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.738 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 92.8 m -77.79 -41.35 37.63 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.297 173.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.504 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.86 -37.02 75.58 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 122.233 1.015 . . . . 0.0 109.06 176.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 408' ' ' TYR . . . . . 0.608 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.25 -52.47 54.21 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 113.27 -1.786 . . . . 0.0 109.924 175.761 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 409' ' ' THR . . . . . 0.667 HG22 HD23 ' A' ' 410' ' ' LEU . 18.6 m -55.35 -47.83 75.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.508 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 410' ' ' LEU . . . . . 0.738 ' HG ' ' O ' ' A' ' 406' ' ' THR . 14.3 mt -73.34 -36.86 66.22 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.16 -174.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -59.53 -35.16 84.51 Favored Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.053 -1.07 . . . . 0.0 110.606 172.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 412' ' ' MET . . . . . 0.473 ' HE2' ' HA ' ' A' ' 417' ' ' GLN . 0.0 OUTLIER -66.71 -49.93 64.46 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 120.605 0.24 . . . . 0.0 111.444 178.087 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 413' ' ' MET . . . . . 0.917 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.6 OUTLIER -71.44 -45.0 63.76 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 119.128 -1.029 . . . . 0.0 112.446 -176.069 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 414' ' ' LEU . . . . . 0.917 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 18.3 mt -72.52 -45.39 59.57 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -176.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 32.8 t -84.81 -19.1 33.03 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.795 0.807 . . . . 0.0 109.618 -173.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 416' ' ' GLY . . . . . 0.464 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 106.98 179.61 22.61 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -172.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 417' ' ' GLN . . . . . 0.473 ' HA ' ' HE2' ' A' ' 412' ' ' MET . 1.7 mp0 -79.1 25.43 0.29 Allowed 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 121.557 0.694 . . . . 0.0 111.027 -173.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 418' ' ' ASN . . . . . 0.464 ' H ' ' C ' ' A' ' 416' ' ' GLY . 84.1 m-20 -70.55 73.21 0.53 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.11 178.031 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 419' ' ' TYR . . . . . 0.522 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 5.7 p90 -51.34 -37.75 49.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.928 175.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -54.23 -45.81 72.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.119 176.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.25 -48.78 60.88 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.215 -177.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 422' ' ' VAL . . . . . 0.441 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -66.57 -40.61 86.73 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 C-N-CA 120.289 -0.565 . . . . 0.0 111.115 -175.465 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.724 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 79.1 p -67.53 -38.95 85.0 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.921 -178.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -69.34 -36.47 78.47 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.092 176.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 425' ' ' ILE . . . . . 0.626 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -73.53 -51.61 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 O-C-N 122.904 -0.174 . . . . 0.0 111.09 -178.605 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 426' ' ' ILE . . . . . 0.68 HD13 HG23 ' A' ' 395' ' ' ILE . 1.1 mm -74.63 -22.89 17.64 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.819 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -172.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.724 ' HB2' ' O ' ' A' ' 423' ' ' SER . 0.8 OUTLIER -55.07 -29.78 58.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.302 0.572 . . . . 0.0 110.463 -178.867 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -88.09 -4.38 78.21 Favored Glycine 0 N--CA 1.443 -0.839 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.702 178.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.638 ' CZ ' ' HG3' ' A' ' 396' ' ' LYS . 23.5 m-85 -119.18 -1.31 10.89 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 121.011 0.434 . . . . 0.0 110.314 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.643 HD23 ' HA ' ' A' ' 427' ' ' ARG . 0.1 OUTLIER -66.07 128.89 94.12 Favored Pre-proline 0 N--CA 1.44 -0.935 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.62 179.485 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 431' ' ' PRO . . . . . 0.569 ' HD2' HD12 ' A' ' 430' ' ' LEU . 99.9 Cg_exo -23.67 -68.31 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.736 1 C-N-CA 125.4 4.067 . . . . 0.0 114.62 179.5 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 432' ' ' GLY . . . . . 0.522 ' O ' HG12 ' A' ' 435' ' ' VAL . . . -144.54 -165.76 11.2 Favored Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 175.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 433' ' ' GLN . . . . . 0.509 ' O ' HG13 ' A' ' 436' ' ' VAL . 44.1 tp60 -70.11 -25.81 63.67 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 118.003 0.901 . . . . 0.0 110.568 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -66.84 -40.34 87.91 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -178.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 435' ' ' VAL . . . . . 0.756 HG23 HG11 ' A' ' 463' ' ' VAL . 7.5 p -68.63 -44.62 82.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 120.901 0.382 . . . . 0.0 110.406 -177.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.554 HG21 ' HD3' ' A' ' 427' ' ' ARG . 0.1 OUTLIER -64.4 -30.86 51.33 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 CA-C-O 120.834 0.349 . . . . 0.0 110.643 175.218 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 1.1 m -69.32 -52.03 31.29 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -178.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 438' ' ' ALA . . . . . 0.875 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -58.84 -37.21 75.96 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.551 177.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 439' ' ' LEU . . . . . 0.552 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 2.1 tm? -70.76 -47.8 57.73 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -56.97 -39.01 73.81 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.339 174.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 441' ' ' GLN . . . . . 0.479 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 37.1 mm-40 -53.2 -50.08 65.42 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 123.586 0.754 . . . . 0.0 110.705 173.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 442' ' ' ARG . . . . . 0.8 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 0.9 OUTLIER -56.23 -39.63 72.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.78 173.04 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 443' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 43.2 mt -71.89 -36.91 70.17 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.95 0.405 . . . . 0.0 110.28 -178.166 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -57.86 -37.51 74.05 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.614 173.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -73.16 -26.67 61.28 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.942 178.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 446' ' ' GLU . . . . . 0.404 ' HB3' ' O ' ' A' ' 443' ' ' LEU . 8.9 pt-20 29.3 104.53 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 172.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 447' ' ' ILE . . . . . 0.492 ' HB ' ' HB ' ' A' ' 451' ' ' THR . 64.7 mt -66.08 -32.21 57.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.877 0.846 . . . . 0.0 109.46 171.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 448' ' ' ASP . . . . . 0.47 ' HB3' ' H ' ' A' ' 451' ' ' THR . 4.8 t70 -167.34 -153.87 0.15 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -177.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 449' ' ' ASP . . . . . 0.435 ' O ' ' HG3' ' A' ' 452' ' ' ARG . 4.0 m-20 -90.6 -61.62 1.64 Allowed 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 165.326 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 450' ' ' GLN . . . . . 0.562 ' O ' ' HB3' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -72.59 -26.05 61.56 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.447 -176.794 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 451' ' ' THR . . . . . 0.504 ' HA ' ' HG3' ' A' ' 454' ' ' GLU . 4.0 m -72.8 -21.15 61.03 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.992 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 452' ' ' ARG . . . . . 0.435 ' HG3' ' O ' ' A' ' 449' ' ' ASP . 18.4 mtm180 -55.91 -47.44 77.46 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 107.138 -1.431 . . . . 0.0 107.138 170.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 453' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 450' ' ' GLN . . . -57.59 -49.29 76.88 Favored 'General case' 0 N--CA 1.462 0.163 0 O-C-N 124.142 0.901 . . . . 0.0 111.921 171.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 454' ' ' GLU . . . . . 0.504 ' HG3' ' HA ' ' A' ' 451' ' ' THR . 37.1 mt-10 -46.31 -38.84 9.22 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.471 0.653 . . . . 0.0 111.693 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 30.1 p -121.16 15.74 11.49 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.139 -173.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 456' ' ' PHE . . . . . 0.602 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.8 OUTLIER -55.45 -47.53 75.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.246 0.546 . . . . 0.0 111.349 -171.442 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 457' ' ' ILE . . . . . 0.608 HG23 ' HB1' ' A' ' 405' ' ' ALA . 2.0 mp -77.08 -34.45 21.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.439 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -57.33 -35.89 70.46 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.948 0.88 . . . . 0.0 109.21 171.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 459' ' ' HIS . . . . . 0.734 ' O ' HG23 ' A' ' 463' ' ' VAL . 55.5 m-70 -72.78 -29.21 63.1 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.841 176.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 460' ' ' LEU . . . . . 0.724 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -74.1 -34.16 63.86 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 122.114 0.959 . . . . 0.0 108.683 179.044 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 461' ' ' ASN . . . . . 0.453 ' O ' ' HB2' ' A' ' 464' ' ' TYR . 3.0 m120 -73.27 -38.07 66.07 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.2 -0.909 . . . . 0.0 108.909 176.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 462' ' ' ALA . . . . . 0.607 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -56.24 -35.0 66.9 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.659 169.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.875 HG13 ' HB3' ' A' ' 438' ' ' ALA . 61.9 t -61.01 -50.95 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 175.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 464' ' ' TYR . . . . . 0.587 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 19.4 m-30 -52.95 -29.13 27.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.612 178.376 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.82 -40.18 19.03 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.667 0.746 . . . . 0.0 109.347 -176.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.607 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.7 mt -55.95 -55.55 17.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 114.288 -1.324 . . . . 0.0 112.198 175.007 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 0.774 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -102.9 -9.87 19.52 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 -172.748 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 468' ' ' GLY . . . . . 0.525 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 93.38 31.8 8.16 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 119.308 -1.425 . . . . 0.0 114.07 179.055 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 469' ' ' LEU . . . . . 0.774 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 2.8 mt -89.65 162.77 15.44 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 117.732 0.766 . . . . 0.0 111.272 176.325 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 470' ' ' ASN . . . . . 0.413 ' HB3' ' CG2' ' A' ' 476' ' ' ILE . 37.8 p30 -105.07 -177.68 3.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.142 171.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 471' ' ' ALA . . . . . 0.523 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -60.44 -23.51 64.48 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -176.033 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 472' ' ' ARG . . . . . 0.471 HH11 ' HA ' ' A' ' 402' ' ' GLU . 28.5 mmt180 -87.27 1.09 54.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.38 -170.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 473' ' ' GLY . . . . . 0.451 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 79.29 11.27 85.16 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.376 -0.916 . . . . 0.0 111.348 -177.142 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -101.02 150.82 22.5 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 177.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 11.0 p -88.76 127.81 35.61 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.183 0.516 . . . . 0.0 110.842 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 476' ' ' ILE . . . . . 0.525 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.7 pp . . . . . 0 C--N 1.317 -0.811 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.444 -176.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 386' ' ' PHE . . . . . 0.865 ' CD1' HD22 ' B' ' 414' ' ' LEU . 5.1 t80 . . . . . 0 CA--C 1.529 0.142 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 387' ' ' PRO . . . . . 0.568 ' HG2' ' OD1' ' A' ' 393' ' ' ASN . 1.2 Cg_endo -44.96 -65.44 0.19 Allowed 'Trans proline' 0 CA--C 1.532 0.415 0 C-N-CA 123.55 2.833 . . . . 0.0 114.111 -177.182 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 388' ' ' MET . . . . . 0.776 ' SD ' HG13 ' B' ' 394' ' ' VAL . 18.3 tpp 67.61 160.99 0.17 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.549 0.214 . . . . 0.0 110.779 178.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 389' ' ' HIS . . . . . 0.587 ' CG ' ' HB2' ' B' ' 393' ' ' ASN . 32.5 m170 -70.91 -160.84 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 171.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -73.07 7.22 2.21 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.368 172.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 391' ' ' LEU . . . . . 0.589 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.1 pt? -161.14 -64.14 0.06 Allowed 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 392' ' ' GLY . . . . . 0.606 ' HA3' HD13 ' B' ' 395' ' ' ILE . . . -158.3 59.88 0.33 Allowed Glycine 0 C--N 1.334 0.431 0 C-N-CA 119.81 -1.186 . . . . 0.0 114.175 -170.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 393' ' ' ASN . . . . . 0.587 ' HB2' ' CG ' ' B' ' 389' ' ' HIS . 0.2 OUTLIER -54.98 -44.0 74.03 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-O 121.091 0.472 . . . . 0.0 109.851 178.304 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 394' ' ' VAL . . . . . 0.776 HG13 ' SD ' ' B' ' 388' ' ' MET . 1.1 m -59.2 -44.63 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 114.23 -1.35 . . . . 0.0 108.24 -177.359 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 395' ' ' ILE . . . . . 0.67 HG23 HD13 ' B' ' 426' ' ' ILE . 4.2 mp -57.77 -52.13 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-O 117.934 -1.032 . . . . 0.0 113.015 -175.416 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 396' ' ' LYS . . . . . 0.635 ' HG3' ' CZ ' ' B' ' 429' ' ' TYR . 0.1 OUTLIER -62.91 -49.21 75.7 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 121.661 2.028 . . . . 0.0 111.615 -175.683 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -54.62 -45.91 76.19 Favored Glycine 0 N--CA 1.433 -1.534 0 C-N-CA 120.029 -1.081 . . . . 0.0 111.295 -178.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 398' ' ' ILE . . . . . 0.85 HG12 HD21 ' A' ' 414' ' ' LEU . 26.8 mt -71.24 -34.01 52.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 113.531 0.938 . . . . 0.0 113.531 -177.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 399' ' ' VAL . . . . . 0.509 HG12 ' HA ' ' B' ' 404' ' ' VAL . 8.0 m -63.67 -39.7 86.32 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.519 0 C-N-CA 118.837 -1.145 . . . . 0.0 108.346 -174.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -69.15 -38.54 78.84 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 175.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 401' ' ' GLN . . . . . . . . . . . . . 37.1 mm-40 -86.2 -49.07 8.0 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -170.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 402' ' ' GLU . . . . . 0.488 ' HA ' HH11 ' B' ' 472' ' ' ARG . 9.4 tp10 -120.67 -21.0 6.86 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 120.88 0.372 . . . . 0.0 111.324 -170.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 109.72 163.57 19.6 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.956 178.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 404' ' ' VAL . . . . . 0.613 HG11 ' HA ' ' B' ' 430' ' ' LEU . 1.7 m -53.3 -45.69 56.26 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.705 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -175.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 405' ' ' ALA . . . . . 0.6 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -64.85 -30.88 71.91 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 119.725 -0.79 . . . . 0.0 112.319 -176.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 406' ' ' THR . . . . . 0.736 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 92.5 m -77.86 -41.4 36.98 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 119.961 -0.696 . . . . 0.0 110.231 173.574 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 407' ' ' ALA . . . . . 0.485 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.95 -36.98 75.7 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 122.241 1.019 . . . . 0.0 109.014 176.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 408' ' ' TYR . . . . . 0.599 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.23 -52.44 54.56 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 113.283 -1.78 . . . . 0.0 109.941 175.82 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 409' ' ' THR . . . . . 0.665 HG22 HD23 ' B' ' 410' ' ' LEU . 17.5 m -55.43 -47.72 75.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.572 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 410' ' ' LEU . . . . . 0.736 ' HG ' ' O ' ' B' ' 406' ' ' THR . 14.4 mt -73.34 -37.11 66.21 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.06 -174.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -59.27 -35.32 84.14 Favored Glycine 0 N--CA 1.438 -1.224 0 C-N-CA 120.14 -1.028 . . . . 0.0 110.666 172.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 412' ' ' MET . . . . . 0.489 ' HE2' ' HA ' ' B' ' 417' ' ' GLN . 0.0 OUTLIER -66.51 -49.87 65.09 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-O 120.6 0.238 . . . . 0.0 111.572 177.97 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 413' ' ' MET . . . . . 0.933 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.7 OUTLIER -71.58 -45.21 62.87 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 119.064 -1.054 . . . . 0.0 112.356 -176.196 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 414' ' ' LEU . . . . . 0.933 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 17.9 mt -72.22 -45.64 59.45 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 113.95 1.092 . . . . 0.0 113.95 -176.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 32.8 t -84.89 -18.57 34.34 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.646 0.736 . . . . 0.0 109.599 -173.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 416' ' ' GLY . . . . . 0.469 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 106.61 179.67 22.89 Favored Glycine 0 N--CA 1.429 -1.774 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 -173.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 417' ' ' GLN . . . . . 0.489 ' HA ' ' HE2' ' B' ' 412' ' ' MET . 1.7 mp0 -79.13 25.38 0.29 Allowed 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.532 0.682 . . . . 0.0 111.015 -174.006 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 418' ' ' ASN . . . . . 0.469 ' H ' ' C ' ' B' ' 416' ' ' GLY . 83.8 m-20 -70.6 73.27 0.54 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.166 177.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 419' ' ' TYR . . . . . 0.513 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 5.4 p90 -51.38 -37.77 49.86 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.897 175.416 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -54.25 -45.82 72.47 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.064 176.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.17 -48.84 61.17 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.224 -177.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 422' ' ' VAL . . . . . 0.44 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.2 OUTLIER -66.44 -40.69 87.18 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.096 -175.464 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 423' ' ' SER . . . . . 0.748 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 80.0 p -67.48 -39.29 85.26 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.825 -178.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -68.93 -36.63 82.07 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.067 177.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 425' ' ' ILE . . . . . 0.649 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -73.45 -51.7 24.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 121.401 -0.12 . . . . 0.0 111.035 -178.593 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 426' ' ' ILE . . . . . 0.67 HD13 HG23 ' B' ' 395' ' ' ILE . 1.1 mm -74.76 -22.92 17.48 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.853 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 -172.206 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 427' ' ' ARG . . . . . 0.748 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.8 OUTLIER -54.97 -29.91 57.91 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.339 0.59 . . . . 0.0 110.407 -179.065 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.49 -5.14 79.42 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.79 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 429' ' ' TYR . . . . . 0.635 ' CZ ' ' HG3' ' B' ' 396' ' ' LYS . 23.5 m-85 -118.88 -1.49 11.01 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.118 0.485 . . . . 0.0 110.44 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 430' ' ' LEU . . . . . 0.635 HD23 ' HA ' ' B' ' 427' ' ' ARG . 0.1 OUTLIER -65.85 128.79 94.07 Favored Pre-proline 0 N--CA 1.44 -0.945 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.641 179.589 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 431' ' ' PRO . . . . . 0.554 ' HD2' HD12 ' B' ' 430' ' ' LEU . 99.6 Cg_exo -23.57 -68.37 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.749 1 C-N-CA 125.484 4.123 . . . . 0.0 114.633 179.599 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 432' ' ' GLY . . . . . 0.506 ' O ' HG12 ' B' ' 436' ' ' VAL . . . -144.13 -165.5 10.97 Favored Glycine 0 N--CA 1.444 -0.83 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 175.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 433' ' ' GLN . . . . . 0.512 ' O ' HG13 ' B' ' 436' ' ' VAL . 43.9 tp60 -70.28 -25.73 63.48 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 118.024 0.912 . . . . 0.0 110.734 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -67.2 -40.09 86.44 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -177.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 435' ' ' VAL . . . . . 0.742 HG23 HG11 ' B' ' 463' ' ' VAL . 7.4 p -68.87 -44.58 81.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 120.937 0.399 . . . . 0.0 110.39 -177.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 436' ' ' VAL . . . . . 0.541 HG21 ' HD3' ' B' ' 427' ' ' ARG . 0.1 OUTLIER -64.39 -31.05 51.92 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.499 175.077 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 1.1 m -69.19 -52.04 31.95 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 438' ' ' ALA . . . . . 0.862 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -58.94 -37.28 76.36 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.663 177.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 439' ' ' LEU . . . . . 0.556 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 2.1 tm? -70.75 -47.69 58.35 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -179.181 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -56.9 -39.25 74.08 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.326 174.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 441' ' ' GLN . . . . . 0.479 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 36.7 mm-40 -53.12 -50.04 65.31 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 123.576 0.75 . . . . 0.0 110.644 173.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 442' ' ' ARG . . . . . 0.82 ' HG2' ' O ' ' B' ' 438' ' ' ALA . 0.9 OUTLIER -56.25 -39.66 72.93 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.824 173.066 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 443' ' ' LEU . . . . . 0.556 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 42.4 mt -71.96 -36.73 69.93 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.99 0.424 . . . . 0.0 110.31 -178.237 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -57.97 -37.5 74.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.609 173.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -73.22 -26.42 61.14 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.986 178.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 446' ' ' GLU . . . . . 0.401 ' HB3' ' O ' ' B' ' 443' ' ' LEU . 8.8 pt-20 29.4 104.28 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 172.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 447' ' ' ILE . . . . . 0.499 ' HB ' ' HB ' ' B' ' 451' ' ' THR . 64.4 mt -66.07 -32.39 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 121.911 0.862 . . . . 0.0 109.443 171.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 448' ' ' ASP . . . . . 0.455 ' HB3' ' H ' ' B' ' 451' ' ' THR . 4.6 t70 -167.04 -153.63 0.15 Allowed 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 -177.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 449' ' ' ASP . . . . . 0.438 ' O ' ' HG3' ' B' ' 452' ' ' ARG . 4.9 m-20 -90.87 -61.64 1.63 Allowed 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 165.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 450' ' ' GLN . . . . . 0.556 ' O ' ' HB3' ' B' ' 453' ' ' ALA . 3.0 pp0? -72.55 -26.01 61.58 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.432 -176.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 451' ' ' THR . . . . . 0.521 ' HA ' ' HG3' ' B' ' 454' ' ' GLU . 4.1 m -72.77 -21.07 61.06 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.063 -0.655 . . . . 0.0 111.035 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 452' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' B' ' 449' ' ' ASP . 18.6 mtm180 -56.08 -47.48 77.92 Favored 'General case' 0 C--O 1.215 -0.76 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 170.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 453' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' B' ' 450' ' ' GLN . . . -57.51 -49.2 77.09 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.994 171.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 454' ' ' GLU . . . . . 0.521 ' HG3' ' HA ' ' B' ' 451' ' ' THR . 37.2 mt-10 -46.39 -38.91 9.56 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.571 0.7 . . . . 0.0 111.677 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 31.1 p -121.05 15.82 11.59 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.257 -173.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 456' ' ' PHE . . . . . 0.586 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 0.8 OUTLIER -55.59 -47.73 75.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.209 0.528 . . . . 0.0 111.28 -171.524 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 457' ' ' ILE . . . . . 0.6 HG23 ' HB1' ' B' ' 405' ' ' ALA . 2.0 mp -76.8 -34.64 23.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.387 -179.348 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -57.33 -35.82 70.36 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 122.022 0.915 . . . . 0.0 109.291 172.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 459' ' ' HIS . . . . . 0.731 ' O ' HG23 ' B' ' 463' ' ' VAL . 55.4 m-70 -72.82 -29.04 62.93 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.208 -1.36 . . . . 0.0 110.915 176.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 460' ' ' LEU . . . . . 0.726 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -74.24 -34.17 63.56 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.107 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 461' ' ' ASN . . . . . 0.438 ' O ' ' HB2' ' B' ' 464' ' ' TYR . 3.0 m120 -73.17 -38.29 66.25 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.216 -0.902 . . . . 0.0 108.924 176.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 462' ' ' ALA . . . . . 0.615 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -56.16 -34.83 66.53 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.668 169.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 463' ' ' VAL . . . . . 0.862 HG13 ' HB3' ' B' ' 438' ' ' ALA . 62.7 t -61.04 -51.09 77.18 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 175.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 464' ' ' TYR . . . . . 0.57 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 19.4 m-30 -52.87 -29.09 26.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.642 178.297 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.13 -39.59 19.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.716 0.769 . . . . 0.0 109.501 -176.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 466' ' ' ILE . . . . . 0.615 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.7 mt -56.2 -55.83 16.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 114.344 -1.298 . . . . 0.0 112.115 174.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 467' ' ' LEU . . . . . 0.784 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -102.73 -9.97 19.57 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -172.513 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 468' ' ' GLY . . . . . 0.521 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 93.41 31.92 8.07 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 119.346 -1.407 . . . . 0.0 114.182 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 469' ' ' LEU . . . . . 0.784 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 2.8 mt -89.73 162.81 15.37 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 117.646 0.723 . . . . 0.0 111.062 176.362 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 470' ' ' ASN . . . . . 0.418 ' HB3' ' CG2' ' B' ' 476' ' ' ILE . 37.4 p30 -105.14 -177.82 3.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.23 171.438 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 471' ' ' ALA . . . . . 0.512 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -60.25 -23.51 64.16 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -176.194 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 472' ' ' ARG . . . . . 0.488 HH11 ' HA ' ' B' ' 402' ' ' GLU . 28.7 mmt180 -87.48 1.52 53.25 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.407 -170.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 473' ' ' GLY . . . . . 0.448 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 78.76 11.39 85.29 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.564 -0.827 . . . . 0.0 111.37 -177.141 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -100.94 150.66 22.64 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 177.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 11.9 p -88.35 127.81 35.49 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.207 0.527 . . . . 0.0 110.926 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 476' ' ' ILE . . . . . 0.521 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.7 pp . . . . . 0 C--N 1.317 -0.818 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.485 -176.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 386' ' ' PHE . . . . . 0.758 ' CZ ' HG12 ' A' ' 394' ' ' VAL . 1.6 t80 . . . . . 0 CA--C 1.538 0.495 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -53.55 -51.59 10.54 Favored 'Trans proline' 0 N--CA 1.489 1.214 1 C-N-CA 125.403 4.069 . . . . 0.0 115.952 -176.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.781 ' SD ' HG13 ' A' ' 394' ' ' VAL . 53.8 tpp 74.29 15.63 3.53 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 165.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 389' ' ' HIS . . . . . 0.804 ' CG ' ' HB2' ' A' ' 393' ' ' ASN . 15.6 m170 64.17 7.1 3.26 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.264 -0.897 . . . . 0.0 110.249 -175.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 66.29 25.09 10.54 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.498 -170.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.482 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.6 pt? -164.51 -53.4 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 170.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 392' ' ' GLY . . . . . 0.549 ' HA2' ' SD ' ' A' ' 388' ' ' MET . . . -175.39 49.38 0.13 Allowed Glycine 0 CA--C 1.525 0.659 0 C-N-CA 119.796 -1.192 . . . . 0.0 114.521 -176.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 393' ' ' ASN . . . . . 0.804 ' HB2' ' CG ' ' A' ' 389' ' ' HIS . 0.5 OUTLIER -54.49 -43.31 71.67 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 117.302 0.551 . . . . 0.0 109.81 177.886 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 394' ' ' VAL . . . . . 0.781 HG13 ' SD ' ' A' ' 388' ' ' MET . 0.7 OUTLIER -57.64 -46.12 86.51 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 -177.649 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 395' ' ' ILE . . . . . 0.703 HG21 HG22 ' A' ' 425' ' ' ILE . 4.1 mp -57.36 -52.3 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-O 118.023 -0.989 . . . . 0.0 113.139 -174.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 396' ' ' LYS . . . . . 0.629 ' HG3' ' CZ ' ' A' ' 429' ' ' TYR . 0.0 OUTLIER -63.55 -50.23 70.32 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 121.664 2.029 . . . . 0.0 112.335 -175.738 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 397' ' ' GLY . . . . . 0.568 ' O ' ' HG3' ' A' ' 401' ' ' GLN . . . -54.47 -44.89 77.59 Favored Glycine 0 N--CA 1.435 -1.393 0 C-N-CA 120.04 -1.076 . . . . 0.0 111.025 -177.23 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 398' ' ' ILE . . . . . 0.777 HD13 HD12 ' A' ' 410' ' ' LEU . 31.2 mt -71.28 -34.47 54.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -178.212 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 399' ' ' VAL . . . . . 0.52 HG12 ' HA ' ' A' ' 404' ' ' VAL . 9.9 m -63.66 -39.92 87.14 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 C-N-CA 118.973 -1.091 . . . . 0.0 108.594 -173.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -66.67 -40.99 88.85 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 175.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 401' ' ' GLN . . . . . 0.568 ' HG3' ' O ' ' A' ' 397' ' ' GLY . 38.3 mt-30 -91.84 -47.13 7.49 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -169.386 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 402' ' ' GLU . . . . . 0.697 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 3.0 mm-40 -115.15 -20.35 10.45 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.983 0.421 . . . . 0.0 111.377 -173.006 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 106.14 162.84 22.86 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.874 -0.679 . . . . 0.0 113.027 177.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 404' ' ' VAL . . . . . 0.671 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.2 m -53.61 -42.89 52.34 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.851 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -175.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 405' ' ' ALA . . . . . 0.708 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -69.17 -28.57 66.52 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 119.602 -0.839 . . . . 0.0 112.139 -176.094 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.707 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 89.9 m -77.55 -43.1 33.0 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.139 -0.624 . . . . 0.0 109.972 172.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.51 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.3 -37.64 75.47 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 122.125 0.964 . . . . 0.0 109.285 176.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 408' ' ' TYR . . . . . 0.671 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.6 -52.14 54.38 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 113.606 -1.634 . . . . 0.0 109.734 177.155 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 409' ' ' THR . . . . . 0.667 HG22 HD23 ' A' ' 410' ' ' LEU . 13.0 m -55.51 -47.36 76.34 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.743 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 410' ' ' LEU . . . . . 0.777 HD12 HD13 ' A' ' 398' ' ' ILE . 13.8 mt -72.28 -35.71 68.8 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.197 -175.316 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.92 -35.09 81.48 Favored Glycine 0 N--CA 1.439 -1.142 0 C-N-CA 120.182 -1.009 . . . . 0.0 110.7 172.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -67.55 -47.62 69.31 Favored 'General case' 0 C--O 1.223 -0.309 0 N-CA-C 111.528 0.195 . . . . 0.0 111.528 178.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 413' ' ' MET . . . . . 0.914 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.3 OUTLIER -70.78 -48.26 55.23 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 119.06 -1.056 . . . . 0.0 112.106 -179.461 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 414' ' ' LEU . . . . . 0.914 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 18.6 mt -69.47 -44.23 71.61 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -175.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 33.7 t -86.62 -24.04 25.49 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.526 0.679 . . . . 0.0 110.147 -175.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 112.55 -176.79 18.03 Favored Glycine 0 N--CA 1.429 -1.832 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 -173.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -81.02 22.29 0.64 Allowed 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.367 0.604 . . . . 0.0 111.285 -172.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 418' ' ' ASN . . . . . 0.455 ' HB2' HD22 ' A' ' 421' ' ' LEU . 15.7 m-80 -73.04 74.91 1.21 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.984 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 419' ' ' TYR . . . . . 0.616 ' HB2' ' CE2' ' A' ' 456' ' ' PHE . 27.0 p90 -54.2 -37.57 64.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.324 178.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -54.47 -46.27 73.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.908 0.385 . . . . 0.0 110.987 177.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 421' ' ' LEU . . . . . 0.455 HD22 ' HB2' ' A' ' 418' ' ' ASN . 0.0 OUTLIER -68.51 -47.86 65.87 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.085 -177.291 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 422' ' ' VAL . . . . . 0.466 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -65.33 -38.35 82.34 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 C-N-CA 120.343 -0.543 . . . . 0.0 111.198 -178.451 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.751 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 61.1 p -68.1 -37.46 81.21 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -179.494 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.51 -39.35 91.12 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.237 175.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 425' ' ' ILE . . . . . 0.703 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.78 -52.53 22.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 O-C-N 122.789 -0.242 . . . . 0.0 111.011 -178.376 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 426' ' ' ILE . . . . . 0.7 HG22 HD22 ' A' ' 430' ' ' LEU . 1.2 mm -72.14 -21.76 20.7 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.715 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -172.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.751 ' HB2' ' O ' ' A' ' 423' ' ' SER . 0.7 OUTLIER -54.25 -31.46 53.55 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.52 -179.206 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -84.39 -12.2 76.31 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.463 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.629 ' CZ ' ' HG3' ' A' ' 396' ' ' LYS . 23.3 m-85 -114.69 1.9 14.32 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-O 121.15 0.5 . . . . 0.0 110.45 -176.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.703 HD23 ' HA ' ' A' ' 427' ' ' ARG . 0.1 OUTLIER -65.85 128.11 93.58 Favored Pre-proline 0 N--CA 1.439 -1.008 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.759 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 431' ' ' PRO . . . . . 0.473 ' HD2' HD12 ' A' ' 430' ' ' LEU . 59.1 Cg_exo -22.39 -72.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.355 0.906 1 C-N-CA 125.56 4.173 . . . . 0.0 114.855 179.784 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 432' ' ' GLY . . . . . 0.43 ' O ' HG12 ' A' ' 435' ' ' VAL . . . -132.27 -165.44 11.29 Favored Glycine 0 N--CA 1.439 -1.125 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 175.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 433' ' ' GLN . . . . . 0.617 ' O ' HG13 ' A' ' 436' ' ' VAL . 0.2 OUTLIER -71.21 -28.1 63.97 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 117.575 0.687 . . . . 0.0 110.631 177.513 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -70.24 -36.62 74.61 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -174.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 435' ' ' VAL . . . . . 0.738 HG23 HG11 ' A' ' 463' ' ' VAL . 7.5 p -67.24 -41.46 86.73 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-O 121.056 0.455 . . . . 0.0 110.388 -177.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.617 HG13 ' O ' ' A' ' 433' ' ' GLN . 0.2 OUTLIER -64.63 -34.78 72.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.177 175.682 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.85 -48.53 53.39 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -174.135 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 438' ' ' ALA . . . . . 0.85 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -56.15 -37.24 69.26 Favored 'General case' 0 N--CA 1.432 -1.356 0 O-C-N 123.713 0.633 . . . . 0.0 110.498 175.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 439' ' ' LEU . . . . . 0.558 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 2.1 tm? -67.66 -46.97 70.86 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -178.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -62.08 -33.92 75.32 Favored 'General case' 0 CA--C 1.49 -1.353 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.803 176.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 441' ' ' GLN . . . . . 0.568 ' O ' ' HG2' ' A' ' 445' ' ' GLN . 8.9 mm-40 -58.26 -49.2 77.96 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.199 175.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 442' ' ' ARG . . . . . 0.749 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -57.31 -39.79 76.55 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.852 171.208 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 443' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 33.6 mt -72.38 -34.45 67.95 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.201 0.524 . . . . 0.0 109.932 -178.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -57.94 -36.95 73.25 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.793 173.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 445' ' ' GLN . . . . . 0.568 ' HG2' ' O ' ' A' ' 441' ' ' GLN . 30.6 mm-40 -72.26 -27.52 62.54 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.195 178.025 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 446' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 443' ' ' LEU . 36.7 tt0 35.44 98.09 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 169.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 447' ' ' ILE . . . . . 0.534 ' HB ' ' HB ' ' A' ' 451' ' ' THR . 54.2 mt -73.41 -32.68 37.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.447 0.642 . . . . 0.0 110.447 176.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 448' ' ' ASP . . . . . 0.442 ' HB3' ' H ' ' A' ' 451' ' ' THR . 7.4 t70 -170.21 -158.17 0.16 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 -179.069 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -87.78 -58.81 2.44 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 166.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.88 -33.34 75.38 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.592 -177.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 451' ' ' THR . . . . . 0.534 ' HB ' ' HB ' ' A' ' 447' ' ' ILE . 4.8 m -72.05 -23.36 61.36 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.653 -174.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 452' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 448' ' ' ASP . 13.1 mtp180 -55.13 -54.18 46.55 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 172.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 453' ' ' ALA . . . . . 0.515 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -58.57 -48.52 80.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.616 -1.175 . . . . 0.0 112.561 175.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 454' ' ' GLU . . . . . 0.459 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 27.2 mm-40 -51.2 -37.2 45.32 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.289 0.566 . . . . 0.0 111.597 -178.176 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 27.6 p -117.9 16.92 14.29 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.352 -176.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 456' ' ' PHE . . . . . 0.616 ' CE2' ' HB2' ' A' ' 419' ' ' TYR . 1.1 t80 -58.04 -47.15 84.0 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.006 0.432 . . . . 0.0 111.6 -171.155 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 457' ' ' ILE . . . . . 0.708 HG23 ' HB1' ' A' ' 405' ' ' ALA . 2.0 mp -76.83 -32.43 20.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.044 0.45 . . . . 0.0 110.611 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -57.83 -34.29 69.54 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.717 0.77 . . . . 0.0 109.268 170.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 459' ' ' HIS . . . . . 0.681 ' O ' HG23 ' A' ' 463' ' ' VAL . 57.9 m-70 -76.08 -28.04 57.44 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.635 178.128 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 460' ' ' LEU . . . . . 0.723 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -74.09 -34.63 64.05 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.822 0.82 . . . . 0.0 108.82 178.196 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 461' ' ' ASN . . . . . 0.548 ' HA ' ' CD2' ' A' ' 464' ' ' TYR . 21.4 m-80 -72.63 -37.74 67.95 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.309 -0.86 . . . . 0.0 108.975 176.022 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 462' ' ' ALA . . . . . 0.627 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -56.21 -34.4 66.24 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.442 -1.254 . . . . 0.0 109.729 169.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.85 HG13 ' HB3' ' A' ' 438' ' ' ALA . 64.5 t -61.53 -51.58 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 114.811 -1.086 . . . . 0.0 108.085 176.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 464' ' ' TYR . . . . . 0.748 ' CE2' ' HA ' ' A' ' 471' ' ' ALA . 15.4 m-30 -52.62 -27.37 16.76 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.685 178.199 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.34 -39.11 21.16 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.593 0.711 . . . . 0.0 109.557 -178.093 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.627 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.7 mt -60.17 -55.54 23.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 114.23 -1.35 . . . . 0.0 112.268 176.064 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 0.74 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -100.36 -10.69 20.96 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -173.469 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 468' ' ' GLY . . . . . 0.588 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 93.15 31.18 8.65 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 119.556 -1.307 . . . . 0.0 114.165 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 469' ' ' LEU . . . . . 0.74 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.0 mt -89.98 166.56 13.39 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.24 1.02 . . . . 0.0 111.767 178.184 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 35.1 p30 -106.07 177.57 4.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.271 169.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 471' ' ' ALA . . . . . 0.748 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -71.09 -6.92 42.87 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -173.007 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -92.2 -0.33 57.42 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.022 0.439 . . . . 0.0 110.6 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 77.47 12.79 84.2 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.571 -0.824 . . . . 0.0 111.085 -175.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -100.91 157.9 16.39 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 175.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 475' ' ' SER . . . . . 0.507 ' HA ' HD22 ' A' ' 469' ' ' LEU . 0.6 OUTLIER -93.45 120.06 33.28 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.538 0.685 . . . . 0.0 112.633 -177.03 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 476' ' ' ILE . . . . . 0.588 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.2 pp . . . . . 0 N--CA 1.436 -1.155 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 162.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 386' ' ' PHE . . . . . 0.765 ' CZ ' HG12 ' B' ' 394' ' ' VAL . 1.6 t80 . . . . . 0 CA--C 1.538 0.506 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 387' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' B' ' 386' ' ' PHE . 15.4 Cg_endo -53.68 -51.54 10.59 Favored 'Trans proline' 0 N--CA 1.49 1.294 1 C-N-CA 125.48 4.12 . . . . 0.0 115.895 -176.732 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 388' ' ' MET . . . . . 0.767 ' SD ' HG13 ' B' ' 394' ' ' VAL . 53.8 tpp 74.18 15.7 3.6 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 165.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 389' ' ' HIS . . . . . 0.798 ' CG ' ' HB2' ' B' ' 393' ' ' ASN . 16.1 m170 64.03 7.29 3.28 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.203 -0.936 . . . . 0.0 110.257 -175.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 66.31 24.73 10.56 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.527 -170.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 391' ' ' LEU . . . . . 0.471 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.6 pt? -164.32 -53.23 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 171.054 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 392' ' ' GLY . . . . . 0.55 ' HA2' ' SD ' ' B' ' 388' ' ' MET . . . -175.64 49.51 0.12 Allowed Glycine 0 CA--C 1.524 0.641 0 C-N-CA 119.756 -1.212 . . . . 0.0 114.464 -176.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 393' ' ' ASN . . . . . 0.798 ' HB2' ' CG ' ' B' ' 389' ' ' HIS . 0.5 OUTLIER -54.61 -43.28 72.08 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 117.348 0.574 . . . . 0.0 109.862 177.837 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 394' ' ' VAL . . . . . 0.767 HG13 ' SD ' ' B' ' 388' ' ' MET . 0.7 OUTLIER -57.6 -46.13 86.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -177.818 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 395' ' ' ILE . . . . . 0.693 HG21 HG22 ' B' ' 425' ' ' ILE . 4.1 mp -57.42 -52.26 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-O 117.979 -1.01 . . . . 0.0 113.186 -174.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 396' ' ' LYS . . . . . 0.637 ' HG3' ' CZ ' ' B' ' 429' ' ' TYR . 0.0 OUTLIER -63.58 -50.22 70.32 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 121.661 2.028 . . . . 0.0 112.302 -175.684 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 397' ' ' GLY . . . . . 0.57 ' O ' ' HG3' ' B' ' 401' ' ' GLN . . . -54.39 -44.86 76.74 Favored Glycine 0 N--CA 1.434 -1.449 0 C-N-CA 120.03 -1.081 . . . . 0.0 111.089 -177.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 398' ' ' ILE . . . . . 0.777 HD13 HD12 ' B' ' 410' ' ' LEU . 31.2 mt -71.33 -34.54 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -178.14 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 399' ' ' VAL . . . . . 0.528 HG12 ' HA ' ' B' ' 404' ' ' VAL . 10.0 m -63.66 -39.94 87.2 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.519 0 C-N-CA 118.971 -1.092 . . . . 0.0 108.577 -173.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -66.41 -41.24 89.55 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 175.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 401' ' ' GLN . . . . . 0.57 ' HG3' ' O ' ' B' ' 397' ' ' GLY . 38.3 mt-30 -91.89 -47.19 7.45 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -168.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 402' ' ' GLU . . . . . 0.651 ' HG3' ' HE3' ' A' ' 413' ' ' MET . 2.9 mm-40 -115.01 -20.56 10.45 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.987 0.422 . . . . 0.0 111.276 -172.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 106.19 162.95 22.82 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.099 177.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 404' ' ' VAL . . . . . 0.653 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.3 m -53.53 -42.89 51.63 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.858 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -175.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 405' ' ' ALA . . . . . 0.689 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -69.24 -28.64 66.52 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 119.545 -0.862 . . . . 0.0 112.165 -176.039 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 406' ' ' THR . . . . . 0.703 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 85.9 m -77.4 -43.14 33.69 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.159 -0.616 . . . . 0.0 109.94 172.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 407' ' ' ALA . . . . . 0.49 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.28 -37.54 75.22 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 122.118 0.961 . . . . 0.0 109.351 176.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 408' ' ' TYR . . . . . 0.653 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.69 -52.04 54.65 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 113.568 -1.651 . . . . 0.0 109.8 177.072 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 409' ' ' THR . . . . . 0.656 HG22 HD23 ' B' ' 410' ' ' LEU . 14.8 m -55.46 -47.53 75.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.678 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 410' ' ' LEU . . . . . 0.777 HD12 HD13 ' B' ' 398' ' ' ILE . 13.8 mt -72.14 -35.79 69.18 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 120.838 0.351 . . . . 0.0 110.271 -175.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.94 -35.06 81.48 Favored Glycine 0 N--CA 1.439 -1.144 0 C-N-CA 120.229 -0.986 . . . . 0.0 110.71 172.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 412' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -67.46 -47.75 69.2 Favored 'General case' 0 C--O 1.224 -0.267 0 N-CA-C 111.556 0.206 . . . . 0.0 111.556 178.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 413' ' ' MET . . . . . 0.93 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.3 OUTLIER -70.67 -48.26 55.73 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 118.96 -1.096 . . . . 0.0 112.139 -179.367 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 414' ' ' LEU . . . . . 0.93 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 18.7 mt -69.53 -44.3 71.27 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -175.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 33.5 t -86.55 -23.98 25.63 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.509 0.671 . . . . 0.0 110.158 -175.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 416' ' ' GLY . . . . . . . . . . . . . . . 112.44 -177.06 18.29 Favored Glycine 0 N--CA 1.428 -1.843 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 -173.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -80.93 22.67 0.6 Allowed 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.219 0.533 . . . . 0.0 111.214 -172.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 418' ' ' ASN . . . . . 0.443 ' HB2' HD22 ' B' ' 421' ' ' LEU . 15.6 m-80 -73.09 75.36 1.24 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.884 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 419' ' ' TYR . . . . . 0.631 ' HB2' ' CE2' ' B' ' 456' ' ' PHE . 26.8 p90 -54.86 -37.42 66.22 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.207 178.426 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -54.56 -46.31 73.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.961 0.41 . . . . 0.0 110.889 177.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 421' ' ' LEU . . . . . 0.456 ' O ' HD13 ' B' ' 425' ' ' ILE . 0.0 OUTLIER -68.42 -47.83 66.23 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.136 -177.158 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 422' ' ' VAL . . . . . 0.469 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.2 OUTLIER -65.18 -38.56 82.96 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.218 -178.524 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 423' ' ' SER . . . . . 0.762 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 62.3 p -68.05 -37.37 81.24 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.21 -39.76 92.34 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.307 175.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 425' ' ' ILE . . . . . 0.693 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -72.55 -52.58 22.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 O-C-N 122.785 -0.244 . . . . 0.0 111.003 -178.081 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 426' ' ' ILE . . . . . 0.695 HG22 HD22 ' B' ' 430' ' ' LEU . 1.2 mm -72.21 -21.67 20.56 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.821 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -172.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 427' ' ' ARG . . . . . 0.762 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.7 OUTLIER -54.31 -31.33 53.89 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.216 0.531 . . . . 0.0 110.479 -179.265 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -84.25 -12.39 76.27 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.404 178.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 429' ' ' TYR . . . . . 0.637 ' CZ ' ' HG3' ' B' ' 396' ' ' LYS . 23.2 m-85 -114.77 1.87 14.25 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 121.064 0.459 . . . . 0.0 110.372 -176.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 430' ' ' LEU . . . . . 0.695 HD22 HG22 ' B' ' 426' ' ' ILE . 0.1 OUTLIER -65.77 128.32 93.72 Favored Pre-proline 0 N--CA 1.438 -1.042 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.681 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 431' ' ' PRO . . . . . 0.457 ' HD2' HD12 ' B' ' 430' ' ' LEU . 56.8 Cg_exo -22.48 -73.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.355 0.883 1 C-N-CA 125.702 4.268 . . . . 0.0 114.606 179.563 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 432' ' ' GLY . . . . . 0.446 ' O ' HG12 ' B' ' 435' ' ' VAL . . . -132.34 -165.74 11.36 Favored Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 175.226 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 433' ' ' GLN . . . . . 0.612 ' O ' HG13 ' B' ' 436' ' ' VAL . 0.2 OUTLIER -70.94 -27.96 64.14 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 117.506 0.653 . . . . 0.0 110.643 177.85 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -70.39 -36.43 74.08 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -174.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 435' ' ' VAL . . . . . 0.74 HG23 HG11 ' B' ' 463' ' ' VAL . 7.5 p -67.36 -41.52 86.45 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 CA-C-O 121.102 0.477 . . . . 0.0 110.346 -177.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 436' ' ' VAL . . . . . 0.612 HG13 ' O ' ' B' ' 433' ' ' GLN . 0.2 OUTLIER -64.67 -34.77 72.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.214 175.64 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.87 -48.51 53.42 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 -174.211 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 438' ' ' ALA . . . . . 0.841 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -56.21 -37.17 69.3 Favored 'General case' 0 N--CA 1.433 -1.32 0 O-C-N 123.631 0.582 . . . . 0.0 110.382 175.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 439' ' ' LEU . . . . . 0.568 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 2.1 tm? -67.72 -47.0 70.57 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -62.15 -33.89 75.35 Favored 'General case' 0 CA--C 1.489 -1.378 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.828 176.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 441' ' ' GLN . . . . . 0.568 ' O ' ' HG2' ' B' ' 445' ' ' GLN . 9.0 mm-40 -58.3 -49.19 78.05 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.258 175.356 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 442' ' ' ARG . . . . . 0.743 ' HG2' ' O ' ' B' ' 438' ' ' ALA . 0.0 OUTLIER -57.24 -39.93 76.53 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.913 171.067 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 443' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 33.3 mt -72.26 -34.34 68.16 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.376 0.608 . . . . 0.0 109.918 -178.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -58.02 -36.96 73.44 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.838 173.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 445' ' ' GLN . . . . . 0.568 ' HG2' ' O ' ' B' ' 441' ' ' GLN . 30.6 mm-40 -72.13 -27.66 62.77 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.161 178.034 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 446' ' ' GLU . . . . . 0.487 ' HB2' ' O ' ' B' ' 443' ' ' LEU . 38.0 tt0 35.6 98.07 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 170.001 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 447' ' ' ILE . . . . . 0.528 ' HB ' ' HB ' ' B' ' 451' ' ' THR . 54.4 mt -73.41 -32.71 37.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.629 0.728 . . . . 0.0 110.48 176.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 448' ' ' ASP . . . . . 0.45 ' HB3' ' H ' ' B' ' 451' ' ' THR . 7.7 t70 -170.16 -158.42 0.17 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 -179.014 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -87.55 -58.92 2.4 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 166.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.66 -33.41 75.6 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 115.272 -0.877 . . . . 0.0 112.609 -177.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 451' ' ' THR . . . . . 0.528 ' HB ' ' HB ' ' B' ' 447' ' ' ILE . 4.7 m -72.0 -23.26 61.38 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.671 -174.262 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 452' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' B' ' 448' ' ' ASP . 13.1 mtp180 -55.25 -54.13 47.38 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 172.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 453' ' ' ALA . . . . . 0.508 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -58.51 -48.36 81.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.689 -1.142 . . . . 0.0 112.622 175.365 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 454' ' ' GLU . . . . . 0.458 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 26.2 mm-40 -51.61 -37.3 49.39 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.399 0.619 . . . . 0.0 111.366 -178.042 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 29.1 p -117.71 16.82 14.45 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.471 -176.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 456' ' ' PHE . . . . . 0.631 ' CE2' ' HB2' ' B' ' 419' ' ' TYR . 1.1 t80 -58.01 -47.17 83.87 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.035 0.445 . . . . 0.0 111.571 -171.197 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 457' ' ' ILE . . . . . 0.689 HG23 ' HB1' ' B' ' 405' ' ' ALA . 2.0 mp -76.92 -32.31 19.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.622 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -57.93 -34.29 69.71 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.702 0.763 . . . . 0.0 109.214 170.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 459' ' ' HIS . . . . . 0.682 ' O ' HG23 ' B' ' 463' ' ' VAL . 58.4 m-70 -75.97 -28.14 57.76 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.634 178.028 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 460' ' ' LEU . . . . . 0.728 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.4 OUTLIER -74.06 -34.66 64.11 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.903 0.859 . . . . 0.0 108.82 178.262 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 461' ' ' ASN . . . . . 0.55 ' HA ' ' CD2' ' B' ' 464' ' ' TYR . 22.1 m-80 -72.59 -37.8 68.04 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.965 176.042 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 462' ' ' ALA . . . . . 0.634 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -56.37 -34.25 66.48 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.688 169.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 463' ' ' VAL . . . . . 0.841 HG13 ' HB3' ' B' ' 438' ' ' ALA . 65.3 t -61.49 -51.49 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 176.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 464' ' ' TYR . . . . . 0.747 ' CE2' ' HA ' ' B' ' 471' ' ' ALA . 15.5 m-30 -52.76 -27.24 16.97 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 124.354 1.034 . . . . 0.0 110.745 178.272 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.53 -39.11 20.85 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.703 0.763 . . . . 0.0 109.486 -178.101 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 466' ' ' ILE . . . . . 0.634 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.6 mt -59.76 -55.92 20.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 114.219 -1.355 . . . . 0.0 112.224 176.027 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 467' ' ' LEU . . . . . 0.743 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -100.21 -10.62 21.18 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -173.235 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 468' ' ' GLY . . . . . 0.603 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 93.25 31.06 8.67 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 119.604 -1.284 . . . . 0.0 114.122 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 469' ' ' LEU . . . . . 0.743 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 2.9 mt -90.05 166.51 13.39 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.343 1.072 . . . . 0.0 111.723 178.187 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 34.6 p30 -106.11 177.94 4.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.366 169.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 471' ' ' ALA . . . . . 0.747 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -71.16 -7.08 44.26 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -173.04 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -92.05 -0.44 57.46 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.022 0.439 . . . . 0.0 110.674 -177.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 473' ' ' GLY . . . . . . . . . . . . . . . 77.45 13.06 83.94 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.136 -175.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -101.25 157.99 16.37 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 175.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 475' ' ' SER . . . . . 0.502 ' HA ' HD22 ' B' ' 469' ' ' LEU . 0.5 OUTLIER -93.61 120.2 33.58 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.729 0.776 . . . . 0.0 112.644 -177.081 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 476' ' ' ILE . . . . . 0.603 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.2 pp . . . . . 0 N--CA 1.435 -1.179 0 N-CA-C 105.426 -2.065 . . . . 0.0 105.426 162.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 386' ' ' PHE . . . . . 0.806 ' CD1' HD22 ' A' ' 414' ' ' LEU . 3.6 t80 . . . . . 0 CA--C 1.531 0.23 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 387' ' ' PRO . . . . . 0.452 ' HD2' ' HA ' ' A' ' 386' ' ' PHE . 6.5 Cg_endo -46.47 -71.55 0.05 OUTLIER 'Trans proline' 0 N--CA 1.475 0.44 0 C-N-CA 124.163 3.242 . . . . 0.0 114.412 -175.093 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.604 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 30.7 ttm 70.38 143.96 0.05 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 122.356 0.262 . . . . 0.0 110.717 178.223 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 389' ' ' HIS . . . . . 0.598 ' CD2' ' HB2' ' A' ' 393' ' ' ASN . 32.6 m170 -48.49 -76.17 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 121.42 0.629 . . . . 0.0 110.382 -176.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -166.66 19.49 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 173.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.535 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.6 pt? -168.67 -51.83 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.505 -171.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 392' ' ' GLY . . . . . 0.673 ' HA3' HD13 ' A' ' 395' ' ' ILE . . . -176.22 60.84 0.1 Allowed Glycine 0 C--N 1.336 0.571 0 C-N-CA 119.751 -1.214 . . . . 0.0 114.028 -176.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 393' ' ' ASN . . . . . 0.604 ' HB3' ' HA ' ' A' ' 388' ' ' MET . 0.2 OUTLIER -58.39 -42.08 86.31 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 174.115 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 394' ' ' VAL . . . . . 0.657 HG23 HD12 ' A' ' 398' ' ' ILE . 1.7 m -55.24 -47.06 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 -179.379 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 395' ' ' ILE . . . . . 0.673 HD13 ' HA3' ' A' ' 392' ' ' GLY . 3.6 mp -57.7 -52.65 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 CA-C-O 117.8 -1.095 . . . . 0.0 113.729 -175.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 396' ' ' LYS . . . . . 0.595 ' O ' HG22 ' A' ' 399' ' ' VAL . 0.0 OUTLIER -62.75 -50.15 72.22 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 122.022 2.192 . . . . 0.0 112.298 -173.525 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 397' ' ' GLY . . . . . 0.488 ' O ' ' HG3' ' A' ' 401' ' ' GLN . . . -53.86 -42.09 68.64 Favored Glycine 0 N--CA 1.436 -1.344 0 C-N-CA 119.895 -1.145 . . . . 0.0 110.804 -175.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 398' ' ' ILE . . . . . 0.762 HD13 HD12 ' A' ' 410' ' ' LEU . 36.1 mt -71.64 -34.43 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 CA-C-N 114.263 -0.969 . . . . 0.0 113.517 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 399' ' ' VAL . . . . . 0.595 HG22 ' O ' ' A' ' 396' ' ' LYS . 15.6 m -63.57 -39.94 87.22 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 C-N-CA 118.925 -1.11 . . . . 0.0 108.631 -173.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -68.29 -38.79 82.01 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 176.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 401' ' ' GLN . . . . . 0.488 ' HG3' ' O ' ' A' ' 397' ' ' GLY . 31.8 mt-30 -93.05 -48.46 6.49 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -171.079 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 402' ' ' GLU . . . . . 0.693 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 3.0 mm-40 -113.14 -20.15 11.57 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.2 -172.268 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 105.48 161.51 23.29 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.849 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 404' ' ' VAL . . . . . 0.645 HG11 ' HA ' ' A' ' 430' ' ' LEU . 1.5 m -53.78 -45.23 61.62 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.78 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 -176.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 405' ' ' ALA . . . . . 0.542 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -64.03 -31.16 72.25 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.005 -0.678 . . . . 0.0 112.481 -177.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.699 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 87.1 m -77.38 -42.43 36.46 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.476 -0.489 . . . . 0.0 110.244 173.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.469 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -58.4 -36.85 74.19 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 122.245 1.022 . . . . 0.0 109.311 176.042 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 408' ' ' TYR . . . . . 0.629 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -66.33 -51.92 52.37 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 113.436 -1.711 . . . . 0.0 109.991 176.337 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 409' ' ' THR . . . . . 0.64 HG22 HD23 ' A' ' 410' ' ' LEU . 16.5 m -55.68 -46.91 77.5 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.58 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 410' ' ' LEU . . . . . 0.762 HD12 HD13 ' A' ' 398' ' ' ILE . 14.1 mt -72.36 -34.95 68.37 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -175.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -59.35 -34.22 79.5 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.383 -0.913 . . . . 0.0 110.994 170.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 412' ' ' MET . . . . . 0.423 ' HE2' ' HA ' ' A' ' 417' ' ' GLN . 0.6 OUTLIER -66.71 -48.25 69.8 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 122.611 -0.346 . . . . 0.0 111.119 177.035 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 413' ' ' MET . . . . . 0.9 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.5 OUTLIER -71.53 -51.45 23.5 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 119.363 -0.935 . . . . 0.0 112.656 -179.357 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 414' ' ' LEU . . . . . 0.9 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 12.5 mt -67.55 -46.47 72.67 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -174.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.58 10.98 38.46 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.364 0.602 . . . . 0.0 111.086 -172.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 416' ' ' GLY . . . . . 0.426 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 84.08 179.82 51.84 Favored Glycine 0 N--CA 1.438 -1.187 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.68 -179.006 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 417' ' ' GLN . . . . . 0.423 ' HA ' ' HE2' ' A' ' 412' ' ' MET . 31.1 mm-40 -79.83 23.06 0.46 Allowed 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.364 0.602 . . . . 0.0 110.789 -173.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 418' ' ' ASN . . . . . 0.426 ' H ' ' C ' ' A' ' 416' ' ' GLY . 64.0 m-80 -72.33 77.36 1.01 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.782 -178.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 419' ' ' TYR . . . . . 0.552 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 7.1 p90 -49.83 -38.23 33.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.977 174.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -54.33 -47.72 72.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.749 177.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -48.65 66.02 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.044 -176.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 422' ' ' VAL . . . . . 0.464 ' HB ' ' CD1' ' A' ' 408' ' ' TYR . 0.2 OUTLIER -66.01 -40.49 87.45 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.572 0 C-N-CA 120.281 -0.567 . . . . 0.0 111.355 -176.918 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.816 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 80.6 p -69.24 -37.88 78.22 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -178.228 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.56 -38.96 90.91 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.761 176.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 425' ' ' ILE . . . . . 0.58 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.91 -52.56 21.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.028 -0.086 . . . . 0.0 111.182 -178.279 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 426' ' ' ILE . . . . . 0.686 HG22 HD22 ' A' ' 430' ' ' LEU . 1.1 mm -74.69 -23.59 17.91 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.896 0 O-C-N 121.968 -0.457 . . . . 0.0 110.374 -171.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.816 ' HB2' ' O ' ' A' ' 423' ' ' SER . 1.3 tmm_? -55.44 -30.86 61.3 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.325 0.583 . . . . 0.0 111.007 -177.158 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -86.58 -12.11 70.1 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.203 178.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.537 ' HD1' HG22 ' A' ' 395' ' ' ILE . 7.7 m-30 -112.68 -0.5 15.05 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.615 0.722 . . . . 0.0 109.07 -174.329 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.733 HD23 ' HA ' ' A' ' 427' ' ' ARG . 0.1 OUTLIER -66.07 129.75 94.27 Favored Pre-proline 0 N--CA 1.444 -0.754 0 CA-C-N 114.549 -1.205 . . . . 0.0 108.953 177.508 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 431' ' ' PRO . . . . . 0.544 ' HD2' HD12 ' A' ' 430' ' ' LEU . 81.4 Cg_exo -23.91 -68.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.915 1 C-N-CA 125.489 4.126 . . . . 0.0 114.852 179.117 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 432' ' ' GLY . . . . . 0.502 ' O ' HG12 ' A' ' 435' ' ' VAL . . . -141.51 -167.81 11.32 Favored Glycine 0 N--CA 1.442 -0.91 0 N-CA-C 110.089 -1.205 . . . . 0.0 110.089 176.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 433' ' ' GLN . . . . . 0.517 ' O ' HG13 ' A' ' 436' ' ' VAL . 43.6 tp60 -70.4 -26.96 63.93 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 118.083 0.941 . . . . 0.0 110.449 178.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -64.3 -41.98 96.59 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 435' ' ' VAL . . . . . 0.724 HG23 HG11 ' A' ' 463' ' ' VAL . 7.4 p -67.67 -42.81 86.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 121.018 0.437 . . . . 0.0 110.66 -177.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.517 HG13 ' O ' ' A' ' 433' ' ' GLN . 0.1 OUTLIER -67.26 -31.61 53.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.402 175.735 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.61 -52.76 41.71 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -178.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 438' ' ' ALA . . . . . 0.875 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -58.63 -39.82 81.63 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.936 177.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 439' ' ' LEU . . . . . 0.649 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 1.8 tm? -68.0 -48.39 65.87 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -177.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -60.54 -33.73 73.09 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.074 175.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 441' ' ' GLN . . . . . 0.516 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 3.5 mm-40 -54.83 -50.29 68.96 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.863 -178.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 442' ' ' ARG . . . . . 0.618 ' HG3' ' CG ' ' A' ' 459' ' ' HIS . 0.0 OUTLIER -77.76 -24.12 49.05 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 174.271 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 443' ' ' LEU . . . . . 0.649 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 56.5 mt -64.04 -27.17 68.93 Favored 'General case' 0 CA--C 1.516 -0.356 0 O-C-N 121.496 -0.753 . . . . 0.0 109.985 173.188 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -66.5 -37.12 84.37 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.85 178.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 445' ' ' GLN . . . . . 0.467 ' HG3' ' N ' ' A' ' 446' ' ' GLU . 0.0 OUTLIER -80.25 -30.39 38.47 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.479 -179.923 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 446' ' ' GLU . . . . . 0.467 ' N ' ' HG3' ' A' ' 445' ' ' GLN . 8.6 pt-20 15.21 105.03 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.248 0 O-C-N 125.617 1.823 . . . . 0.0 113.841 -177.37 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 43.6 mt -51.26 -34.44 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.369 -177.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 448' ' ' ASP . . . . . 0.507 ' HB2' ' OG1' ' A' ' 451' ' ' THR . 13.3 m-20 -160.88 -174.59 4.48 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 449' ' ' ASP . . . . . 0.488 ' O ' ' HB3' ' A' ' 452' ' ' ARG . 25.8 t0 -72.41 -62.49 1.42 Allowed 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 174.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 450' ' ' GLN . . . . . 0.401 ' HG3' ' H ' ' A' ' 450' ' ' GLN . 2.7 pp0? -70.22 -27.13 64.23 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 176.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 451' ' ' THR . . . . . 0.507 ' OG1' ' HB2' ' A' ' 448' ' ' ASP . 16.0 m -72.12 -23.06 61.26 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.004 -176.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 452' ' ' ARG . . . . . 0.488 ' HB3' ' O ' ' A' ' 449' ' ' ASP . 43.9 ttt180 -55.96 -52.26 64.79 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 172.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 453' ' ' ALA . . . . . 0.552 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -59.77 -47.21 86.6 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.707 170.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 454' ' ' GLU . . . . . 0.445 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 14.1 mm-40 -51.73 -36.45 47.11 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.137 0.494 . . . . 0.0 111.917 -175.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 24.9 p -115.46 13.98 16.58 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.271 -176.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 456' ' ' PHE . . . . . 0.598 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 1.2 t80 -55.06 -46.4 75.39 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.945 0.402 . . . . 0.0 111.746 -172.227 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 457' ' ' ILE . . . . . 0.542 HG23 ' HB1' ' A' ' 405' ' ' ALA . 1.9 mp -78.19 -33.36 17.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.784 0.326 . . . . 0.0 111.239 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -58.09 -32.71 68.34 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.805 0.812 . . . . 0.0 109.117 171.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 459' ' ' HIS . . . . . 0.748 ' O ' HG23 ' A' ' 463' ' ' VAL . 56.9 m-70 -74.17 -30.04 62.06 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.8 177.127 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 460' ' ' LEU . . . . . 0.705 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -73.99 -34.88 64.35 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.995 0.902 . . . . 0.0 108.988 179.518 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -73.08 -37.02 66.93 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.126 176.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 462' ' ' ALA . . . . . 0.612 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -56.02 -34.25 65.66 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.385 -1.279 . . . . 0.0 109.9 169.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.875 HG13 ' HB3' ' A' ' 438' ' ' ALA . 66.1 t -63.57 -50.83 76.57 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 CA-C-N 114.421 -1.263 . . . . 0.0 108.114 177.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 464' ' ' TYR . . . . . 0.578 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 16.9 m-30 -52.4 -29.15 22.73 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 124.348 1.03 . . . . 0.0 110.257 177.316 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.82 -40.69 22.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.745 0.784 . . . . 0.0 109.498 -177.065 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.612 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.6 mt -57.84 -56.17 17.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 114.304 -1.316 . . . . 0.0 112.269 176.035 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 0.764 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -100.82 -11.23 20.01 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -172.051 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 468' ' ' GLY . . . . . 0.537 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 94.09 31.6 7.98 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 119.366 -1.397 . . . . 0.0 114.321 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 469' ' ' LEU . . . . . 0.764 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.3 mt -88.47 163.02 16.15 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 117.915 0.857 . . . . 0.0 110.92 177.037 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 37.9 p30 -105.17 -178.04 3.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.065 172.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 471' ' ' ALA . . . . . 0.411 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -66.05 -14.65 62.07 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -176.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -88.53 -1.6 58.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.675 0.274 . . . . 0.0 111.148 -175.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 473' ' ' GLY . . . . . 0.483 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 79.04 10.66 85.95 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -175.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -101.43 156.22 17.59 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 176.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 32.1 t -93.25 137.52 32.49 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.248 0.547 . . . . 0.0 111.287 -176.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 476' ' ' ILE . . . . . 0.537 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.4 pp . . . . . 0 C--N 1.321 -0.637 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.878 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 386' ' ' PHE . . . . . 0.825 ' CD1' HD22 ' B' ' 414' ' ' LEU . 3.5 t80 . . . . . 0 CA--C 1.53 0.211 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 387' ' ' PRO . . . . . 0.465 ' HD2' ' HA ' ' B' ' 386' ' ' PHE . 6.7 Cg_endo -46.56 -71.56 0.05 OUTLIER 'Trans proline' 0 N--CA 1.476 0.479 0 C-N-CA 124.17 3.247 . . . . 0.0 114.433 -175.05 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 388' ' ' MET . . . . . 0.59 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 30.8 ttm 70.39 143.57 0.05 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 122.412 0.285 . . . . 0.0 110.896 178.194 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 389' ' ' HIS . . . . . 0.592 ' CD2' ' HB2' ' B' ' 393' ' ' ASN . 32.6 m170 -48.14 -75.93 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.1 0 CA-C-O 121.304 0.574 . . . . 0.0 110.417 -176.375 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -166.92 19.31 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 173.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 391' ' ' LEU . . . . . 0.538 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.6 pt? -168.76 -51.49 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.497 -171.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 392' ' ' GLY . . . . . 0.68 ' HA3' HD13 ' B' ' 395' ' ' ILE . . . -176.44 60.85 0.1 Allowed Glycine 0 CA--C 1.522 0.522 0 C-N-CA 119.794 -1.193 . . . . 0.0 114.151 -176.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 393' ' ' ASN . . . . . 0.592 ' HB2' ' CD2' ' B' ' 389' ' ' HIS . 0.2 OUTLIER -58.47 -42.07 86.68 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 174.095 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 394' ' ' VAL . . . . . 0.664 HG23 HD12 ' B' ' 398' ' ' ILE . 1.7 m -55.18 -47.12 77.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 395' ' ' ILE . . . . . 0.68 HD13 ' HA3' ' B' ' 392' ' ' GLY . 3.6 mp -57.64 -52.65 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 117.779 -1.105 . . . . 0.0 113.751 -175.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 396' ' ' LYS . . . . . 0.597 ' O ' HG22 ' B' ' 399' ' ' VAL . 0.0 OUTLIER -62.71 -50.18 72.14 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 122.043 2.201 . . . . 0.0 112.347 -173.667 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 397' ' ' GLY . . . . . 0.5 ' O ' ' HG3' ' B' ' 401' ' ' GLN . . . -54.06 -41.86 70.02 Favored Glycine 0 N--CA 1.436 -1.345 0 C-N-CA 119.799 -1.191 . . . . 0.0 110.838 -175.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 398' ' ' ILE . . . . . 0.754 HD13 HD12 ' B' ' 410' ' ' LEU . 35.9 mt -71.62 -34.56 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 399' ' ' VAL . . . . . 0.597 HG22 ' O ' ' B' ' 396' ' ' LYS . 15.6 m -63.38 -40.1 87.76 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 C-N-CA 118.94 -1.104 . . . . 0.0 108.68 -174.005 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -68.53 -38.5 80.9 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 176.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 401' ' ' GLN . . . . . 0.5 ' HG3' ' O ' ' B' ' 397' ' ' GLY . 32.9 mt-30 -92.86 -48.39 6.57 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -171.296 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 402' ' ' GLU . . . . . 0.735 ' HG3' ' HE3' ' A' ' 413' ' ' MET . 3.1 mm-40 -113.43 -19.89 11.52 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.154 -172.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 105.12 161.42 23.62 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.947 178.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 404' ' ' VAL . . . . . 0.639 HG11 ' HA ' ' B' ' 430' ' ' LEU . 1.4 m -53.69 -45.37 60.66 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 N-CA-C 114.409 1.262 . . . . 0.0 114.409 -176.379 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 405' ' ' ALA . . . . . 0.522 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -63.97 -31.23 72.35 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 119.954 -0.698 . . . . 0.0 112.504 -177.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 406' ' ' THR . . . . . 0.692 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 89.9 m -77.12 -42.36 38.29 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.298 173.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 407' ' ' ALA . . . . . 0.467 ' HB2' ' HB ' ' B' ' 398' ' ' ILE . . . -58.48 -36.79 74.27 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 122.203 1.001 . . . . 0.0 109.282 176.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 408' ' ' TYR . . . . . 0.616 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -66.46 -51.87 52.28 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 113.43 -1.714 . . . . 0.0 109.937 176.449 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 409' ' ' THR . . . . . 0.646 HG22 HD23 ' B' ' 410' ' ' LEU . 16.6 m -55.45 -47.07 76.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.591 178.543 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 410' ' ' LEU . . . . . 0.754 HD12 HD13 ' B' ' 398' ' ' ILE . 14.1 mt -72.42 -34.78 68.08 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -175.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -59.41 -34.14 79.39 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.308 -0.948 . . . . 0.0 110.998 170.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 412' ' ' MET . . . . . 0.422 ' HB2' ' O ' ' B' ' 409' ' ' THR . 0.6 OUTLIER -66.88 -48.15 69.64 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 122.612 -0.346 . . . . 0.0 111.072 177.163 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 413' ' ' MET . . . . . 0.917 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.5 OUTLIER -71.59 -51.69 22.01 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 119.336 -0.946 . . . . 0.0 112.678 -179.456 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 414' ' ' LEU . . . . . 0.917 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 12.4 mt -67.21 -46.5 73.67 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -174.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.44 10.61 39.27 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.368 0.604 . . . . 0.0 110.975 -172.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 416' ' ' GLY . . . . . 0.426 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 84.16 179.39 51.73 Favored Glycine 0 N--CA 1.438 -1.202 0 C-N-CA 120.638 -0.791 . . . . 0.0 111.609 -178.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -79.5 23.23 0.41 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.564 0.697 . . . . 0.0 110.843 -173.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 418' ' ' ASN . . . . . 0.426 ' H ' ' C ' ' B' ' 416' ' ' GLY . 64.8 m-80 -72.51 77.49 1.06 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.763 -178.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 419' ' ' TYR . . . . . 0.557 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 6.9 p90 -50.0 -38.29 36.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.975 174.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -54.28 -47.64 72.12 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.807 177.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.7 -48.76 65.63 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.963 -176.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 422' ' ' VAL . . . . . 0.461 ' HB ' ' CD1' ' B' ' 408' ' ' TYR . 0.2 OUTLIER -66.01 -40.47 87.38 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.499 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.216 -176.757 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 423' ' ' SER . . . . . 0.814 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 80.3 p -69.15 -37.76 78.43 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -178.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -68.0 -38.61 88.8 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.636 176.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 425' ' ' ILE . . . . . 0.599 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -72.95 -52.91 20.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 O-C-N 123.062 -0.081 . . . . 0.0 111.088 -178.289 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 426' ' ' ILE . . . . . 0.682 HG22 HD22 ' B' ' 430' ' ' LEU . 1.1 mm -74.34 -23.77 18.53 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.89 0 O-C-N 122.182 -0.324 . . . . 0.0 110.376 -171.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 427' ' ' ARG . . . . . 0.814 ' HB2' ' O ' ' B' ' 423' ' ' SER . 1.3 tmm_? -55.33 -30.76 60.88 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.241 0.544 . . . . 0.0 111.024 -177.191 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -86.87 -11.8 69.8 Favored Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 120.445 -0.883 . . . . 0.0 111.224 178.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 429' ' ' TYR . . . . . 0.543 ' HD1' HG22 ' B' ' 395' ' ' ILE . 7.9 m-30 -112.94 -0.39 14.84 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -174.311 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 430' ' ' LEU . . . . . 0.735 HD23 ' HA ' ' B' ' 427' ' ' ARG . 0.1 OUTLIER -66.12 129.72 94.25 Favored Pre-proline 0 N--CA 1.442 -0.837 0 CA-C-N 114.477 -1.238 . . . . 0.0 108.938 177.426 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 431' ' ' PRO . . . . . 0.543 ' HD2' HD12 ' B' ' 430' ' ' LEU . 81.0 Cg_exo -24.05 -69.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.357 1.001 1 C-N-CA 125.399 4.066 . . . . 0.0 114.796 179.224 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 432' ' ' GLY . . . . . 0.516 ' O ' HG12 ' B' ' 435' ' ' VAL . . . -141.28 -168.03 11.34 Favored Glycine 0 N--CA 1.443 -0.886 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 177.04 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 433' ' ' GLN . . . . . 0.531 ' O ' HG13 ' B' ' 436' ' ' VAL . 43.8 tp60 -70.23 -26.93 64.08 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 118.173 0.986 . . . . 0.0 110.411 178.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -63.99 -42.18 97.28 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.964 -178.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 435' ' ' VAL . . . . . 0.718 HG23 HG11 ' B' ' 463' ' ' VAL . 7.3 p -67.76 -42.77 86.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 120.977 0.417 . . . . 0.0 110.649 -177.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 436' ' ' VAL . . . . . 0.531 HG13 ' O ' ' B' ' 433' ' ' GLN . 0.1 OUTLIER -67.31 -31.57 53.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.323 175.732 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.58 -52.74 42.11 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -178.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 438' ' ' ALA . . . . . 0.871 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -58.68 -39.74 81.57 Favored 'General case' 0 N--CA 1.436 -1.128 0 O-C-N 124.042 0.838 . . . . 0.0 111.97 177.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 439' ' ' LEU . . . . . 0.669 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 1.8 tm? -68.03 -48.41 65.73 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -178.014 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.45 -33.7 72.94 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.143 175.256 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 441' ' ' GLN . . . . . 0.513 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 3.4 mm-40 -55.0 -50.25 69.47 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.742 -178.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 442' ' ' ARG . . . . . 0.615 ' HG3' ' CG ' ' B' ' 459' ' ' HIS . 0.0 OUTLIER -77.74 -24.0 49.19 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 174.388 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 443' ' ' LEU . . . . . 0.669 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 55.8 mt -64.31 -26.91 68.69 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 118.755 0.707 . . . . 0.0 109.966 173.118 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -66.71 -37.03 83.89 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.78 178.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 445' ' ' GLN . . . . . 0.464 ' HG3' ' N ' ' B' ' 446' ' ' GLU . 0.0 OUTLIER -80.33 -30.42 38.12 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.584 179.874 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 446' ' ' GLU . . . . . 0.464 ' N ' ' HG3' ' B' ' 445' ' ' GLN . 8.7 pt-20 15.2 105.14 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 O-C-N 125.517 1.761 . . . . 0.0 113.816 -177.215 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 43.7 mt -51.28 -34.23 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.362 -177.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 448' ' ' ASP . . . . . 0.509 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 13.0 m-20 -161.04 -174.45 4.38 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 449' ' ' ASP . . . . . 0.492 ' O ' ' HB3' ' B' ' 452' ' ' ARG . 27.9 t0 -72.26 -62.69 1.34 Allowed 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 174.229 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 2.7 pp0? -70.03 -27.26 64.52 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 176.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 451' ' ' THR . . . . . 0.509 ' OG1' ' HB2' ' B' ' 448' ' ' ASP . 14.6 m -72.07 -23.02 61.29 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 119.749 -0.78 . . . . 0.0 109.946 -176.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 452' ' ' ARG . . . . . 0.492 ' HB3' ' O ' ' B' ' 449' ' ' ASP . 43.5 ttt180 -56.0 -52.15 65.22 Favored 'General case' 0 N--CA 1.415 -2.176 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 172.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 453' ' ' ALA . . . . . 0.557 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -60.05 -46.9 87.99 Favored 'General case' 0 CA--C 1.527 0.081 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 171.012 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 454' ' ' GLU . . . . . 0.447 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 13.5 mm-40 -51.95 -36.25 48.73 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.157 0.503 . . . . 0.0 111.837 -176.024 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 24.9 p -115.61 14.18 16.45 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.368 -176.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 456' ' ' PHE . . . . . 0.606 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 1.2 t80 -55.32 -46.29 76.32 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.944 0.402 . . . . 0.0 111.745 -172.129 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 457' ' ' ILE . . . . . 0.528 ' CG1' ' HB3' ' B' ' 408' ' ' TYR . 1.9 mp -78.16 -33.39 17.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 120.687 0.279 . . . . 0.0 111.273 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -58.06 -32.92 68.49 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.993 0.902 . . . . 0.0 109.078 171.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 459' ' ' HIS . . . . . 0.743 ' O ' HG23 ' B' ' 463' ' ' VAL . 56.4 m-70 -73.98 -29.97 62.25 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.79 177.211 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 460' ' ' LEU . . . . . 0.708 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -74.16 -34.71 63.91 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.814 0.816 . . . . 0.0 108.923 179.649 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 461' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -73.07 -37.34 66.83 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.016 176.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 462' ' ' ALA . . . . . 0.621 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -55.99 -34.04 65.4 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.758 169.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 463' ' ' VAL . . . . . 0.871 HG13 ' HB3' ' B' ' 438' ' ' ALA . 68.4 t -63.49 -51.09 74.95 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-N 114.548 -1.205 . . . . 0.0 108.152 177.322 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 464' ' ' TYR . . . . . 0.563 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 16.9 m-30 -52.3 -29.15 21.97 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 124.347 1.029 . . . . 0.0 110.311 177.382 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.68 -40.98 22.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.614 0.721 . . . . 0.0 109.475 -177.088 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 466' ' ' ILE . . . . . 0.621 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.7 mt -57.42 -56.32 15.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 114.277 -1.329 . . . . 0.0 112.251 176.086 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 467' ' ' LEU . . . . . 0.765 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -100.78 -11.36 19.95 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 114.66 1.355 . . . . 0.0 114.66 -171.971 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 468' ' ' GLY . . . . . 0.551 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 94.24 31.56 7.93 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 119.368 -1.396 . . . . 0.0 114.32 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 469' ' ' LEU . . . . . 0.765 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.3 mt -88.6 162.93 16.09 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 117.873 0.836 . . . . 0.0 110.879 177.181 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 37.8 p30 -105.0 -177.95 3.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.109 172.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 471' ' ' ALA . . . . . 0.408 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -66.41 -14.46 62.19 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -176.141 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -88.43 -1.71 58.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.624 0.249 . . . . 0.0 111.166 -176.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 473' ' ' GLY . . . . . 0.477 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 78.99 10.82 85.83 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -175.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -101.51 156.46 17.46 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 176.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 34.8 t -93.36 137.56 32.55 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.348 0.594 . . . . 0.0 111.264 -176.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 476' ' ' ILE . . . . . 0.551 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.4 pp . . . . . 0 C--N 1.322 -0.608 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.865 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 386' ' ' PHE . . . . . 0.745 ' CD1' HD22 ' A' ' 414' ' ' LEU . 2.1 t80 . . . . . 0 CA--C 1.54 0.577 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 387' ' ' PRO . . . . . 0.472 ' HD2' ' HA ' ' A' ' 386' ' ' PHE . 1.5 Cg_endo -39.85 -62.84 0.33 Allowed 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 124.404 3.403 . . . . 0.0 113.764 -174.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.484 ' C ' ' HB3' ' A' ' 393' ' ' ASN . 6.3 ttp 59.04 38.34 24.11 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 174.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 389' ' ' HIS . . . . . 0.603 ' N ' ' HB3' ' A' ' 393' ' ' ASN . 31.3 m170 51.8 -97.22 0.05 Allowed 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.41 0.624 . . . . 0.0 110.064 -176.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -151.57 23.89 0.7 Allowed 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.186 171.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.477 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.4 pt? -175.77 -47.87 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.221 -172.191 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 392' ' ' GLY . . . . . 0.589 ' HA3' HD13 ' A' ' 395' ' ' ILE . . . -173.22 56.37 0.15 Allowed Glycine 0 CA--C 1.524 0.645 0 C-N-CA 119.443 -1.361 . . . . 0.0 114.796 -172.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 393' ' ' ASN . . . . . 0.615 HD21 ' C ' ' A' ' 393' ' ' ASN . 0.0 OUTLIER -61.72 -37.64 84.93 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-N 117.65 0.725 . . . . 0.0 109.061 174.18 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 394' ' ' VAL . . . . . 0.683 HG12 ' CE2' ' A' ' 386' ' ' PHE . 1.0 OUTLIER -57.2 -49.4 79.89 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 CA-C-N 113.674 -1.603 . . . . 0.0 107.047 179.015 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 395' ' ' ILE . . . . . 0.658 HG23 HD13 ' A' ' 426' ' ' ILE . 3.6 mp -57.69 -52.82 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 CA-C-O 117.745 -1.121 . . . . 0.0 113.605 -174.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 396' ' ' LYS . . . . . 0.606 ' O ' HG22 ' A' ' 399' ' ' VAL . 0.0 OUTLIER -62.54 -49.51 75.02 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 122.017 2.189 . . . . 0.0 112.199 -174.715 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.16 -44.48 63.76 Favored Glycine 0 N--CA 1.435 -1.391 0 C-N-CA 119.98 -1.105 . . . . 0.0 110.98 -176.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 398' ' ' ILE . . . . . 0.741 HD13 HD12 ' A' ' 410' ' ' LEU . 28.5 mt -71.09 -33.94 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 399' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 396' ' ' LYS . 17.3 m -63.29 -39.81 86.67 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 C-N-CA 118.751 -1.18 . . . . 0.0 108.436 -174.06 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -70.62 -37.7 73.84 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 175.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -88.15 -48.86 7.39 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -171.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 402' ' ' GLU . . . . . 0.574 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 1.3 tm-20 -117.93 -19.94 8.98 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.065 0.46 . . . . 0.0 111.213 -170.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 106.45 160.67 22.25 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.673 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 404' ' ' VAL . . . . . 0.654 HG11 ' HA ' ' A' ' 430' ' ' LEU . 1.2 m -54.16 -45.5 66.51 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.862 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -175.279 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 405' ' ' ALA . . . . . 0.557 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -63.15 -31.26 72.36 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 119.794 -0.762 . . . . 0.0 112.403 -177.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.719 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 92.5 m -76.92 -42.03 41.1 Favored 'General case' 0 C--O 1.221 -0.412 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.164 173.209 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.449 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -58.8 -36.79 75.04 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 122.183 0.992 . . . . 0.0 109.301 176.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 408' ' ' TYR . . . . . 0.623 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -66.41 -51.73 53.92 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 113.492 -1.685 . . . . 0.0 109.571 176.762 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 409' ' ' THR . . . . . 0.648 HG22 HD23 ' A' ' 410' ' ' LEU . 17.5 m -55.11 -47.37 75.09 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.436 178.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 410' ' ' LEU . . . . . 0.741 HD12 HD13 ' A' ' 398' ' ' ILE . 15.0 mt -72.59 -35.73 67.99 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -174.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.44 -34.63 76.06 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.15 -1.024 . . . . 0.0 110.893 172.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -69.58 -47.22 64.33 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 413' ' ' MET . . . . . 0.919 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.8 OUTLIER -71.52 -44.84 63.9 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 118.914 -1.114 . . . . 0.0 111.879 -179.425 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 414' ' ' LEU . . . . . 0.919 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 11.7 mt -70.03 -46.37 65.21 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -177.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.451 ' HB2' ' SD ' ' A' ' 388' ' ' MET . 8.4 t -99.86 16.56 23.37 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.319 0.58 . . . . 0.0 110.349 -172.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 75.85 -176.66 50.81 Favored Glycine 0 N--CA 1.437 -1.266 0 C-N-CA 120.354 -0.927 . . . . 0.0 111.721 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -80.56 23.12 0.53 Allowed 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.272 0.558 . . . . 0.0 111.402 -172.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 418' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -71.58 76.98 0.81 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.514 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 419' ' ' TYR . . . . . 0.482 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 21.4 p90 -56.17 -38.04 70.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.518 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -55.71 -42.57 75.45 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.723 0.297 . . . . 0.0 111.081 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.1 -49.05 63.63 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.287 -178.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 422' ' ' VAL . . . . . 0.469 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -65.7 -39.51 85.11 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.259 -177.878 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.798 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 61.8 p -67.73 -37.75 82.61 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 -178.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -68.09 -39.25 88.75 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.129 175.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 425' ' ' ILE . . . . . 0.571 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.23 -52.4 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-O 120.352 0.12 . . . . 0.0 111.035 -177.908 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 426' ' ' ILE . . . . . 0.658 HD13 HG23 ' A' ' 395' ' ' ILE . 1.2 mm -74.75 -23.37 17.7 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.91 0 O-C-N 122.135 -0.353 . . . . 0.0 110.555 -172.214 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.798 ' HB2' ' O ' ' A' ' 423' ' ' SER . 1.5 tmt_? -54.57 -31.8 57.37 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.224 0.535 . . . . 0.0 111.13 -177.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.37 -12.1 67.99 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.217 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.595 ' HD1' HG22 ' A' ' 395' ' ' ILE . 6.1 m-30 -112.0 -1.97 15.23 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -173.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.654 ' HA ' HG11 ' A' ' 404' ' ' VAL . 0.0 OUTLIER -66.05 139.97 96.83 Favored Pre-proline 0 N--CA 1.443 -0.815 0 CA-C-N 114.136 -1.393 . . . . 0.0 109.206 177.349 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 431' ' ' PRO . . . . . 0.812 ' CD ' HG11 ' A' ' 435' ' ' VAL . 77.4 Cg_exo -37.99 -75.45 0.04 OUTLIER 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 124.606 3.537 . . . . 0.0 113.92 -173.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 432' ' ' GLY . . . . . 0.422 ' O ' HG12 ' A' ' 435' ' ' VAL . . . -130.06 -161.63 10.51 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 176.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 433' ' ' GLN . . . . . 0.52 ' O ' HG13 ' A' ' 436' ' ' VAL . 19.0 tp60 -71.47 -28.78 64.18 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 118.038 0.919 . . . . 0.0 110.569 176.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -67.03 -39.19 86.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 0.0 112.123 -175.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 435' ' ' VAL . . . . . 0.812 HG11 ' CD ' ' A' ' 431' ' ' PRO . 6.8 p -66.55 -45.08 89.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.173 0.511 . . . . 0.0 110.736 -177.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 433' ' ' GLN . 0.2 OUTLIER -66.28 -31.91 55.73 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.105 177.014 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -68.01 -52.26 37.63 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -177.513 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 438' ' ' ALA . . . . . 0.84 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -57.58 -40.56 79.29 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.179 177.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 439' ' ' LEU . . . . . 0.611 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 1.9 tm? -68.12 -48.13 66.26 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -178.008 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -59.86 -34.99 73.85 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.085 175.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 441' ' ' GLN . . . . . 0.542 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 4.4 mm-40 -53.62 -49.6 67.49 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.001 -178.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 442' ' ' ARG . . . . . 0.709 ' HD2' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -76.89 -25.28 52.84 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 119.133 -1.027 . . . . 0.0 113.368 174.346 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 443' ' ' LEU . . . . . 0.611 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 66.8 mt -65.59 -27.75 68.64 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 118.653 0.66 . . . . 0.0 109.771 175.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -61.29 -38.37 86.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.937 176.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -78.49 -27.63 46.25 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.319 -1.31 . . . . 0.0 111.149 178.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 25.36 101.58 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 41.5 mt -58.61 -33.59 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 121.353 0.597 . . . . 0.0 111.322 -178.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 448' ' ' ASP . . . . . 0.446 ' HB2' ' OG1' ' A' ' 451' ' ' THR . 8.4 m-20 -162.46 -159.81 0.61 Allowed 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 -178.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 449' ' ' ASP . . . . . 0.405 ' CG ' ' H ' ' A' ' 450' ' ' GLN . 12.3 p-10 -85.39 -64.88 1.08 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 168.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 450' ' ' GLN . . . . . 0.405 ' H ' ' CG ' ' A' ' 449' ' ' ASP . 2.2 pp0? -68.24 -26.11 65.53 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 179.012 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 451' ' ' THR . . . . . 0.452 ' HA ' ' HB2' ' A' ' 454' ' ' GLU . 10.4 m -71.44 -23.13 61.79 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 119.859 -0.736 . . . . 0.0 110.732 -175.264 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 452' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 452' ' ' ARG . 14.7 mtp180 -54.02 -53.95 45.91 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 171.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 453' ' ' ALA . . . . . 0.482 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -58.73 -49.08 78.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.354 -1.293 . . . . 0.0 112.53 174.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 454' ' ' GLU . . . . . 0.452 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 69.0 mm-40 -49.69 -37.15 27.67 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.283 0.563 . . . . 0.0 111.601 -177.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 32.0 p -118.03 15.06 14.18 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.45 -175.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 456' ' ' PHE . . . . . 0.551 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.8 OUTLIER -57.44 -47.47 81.73 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.089 0.471 . . . . 0.0 111.643 -171.28 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 457' ' ' ILE . . . . . 0.557 HG23 ' HB1' ' A' ' 405' ' ' ALA . 1.9 mp -76.92 -32.54 19.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.831 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -57.96 -34.41 69.9 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.905 0.86 . . . . 0.0 109.143 171.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 459' ' ' HIS . . . . . 0.771 ' O ' HG23 ' A' ' 463' ' ' VAL . 63.2 m-70 -74.68 -29.45 61.23 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.725 177.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 460' ' ' LEU . . . . . 0.714 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -73.47 -34.61 65.44 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.793 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 461' ' ' ASN . . . . . 0.458 ' O ' ' HB2' ' A' ' 464' ' ' TYR . 25.1 m-80 -73.11 -37.2 66.78 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.207 176.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 462' ' ' ALA . . . . . 0.598 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -55.75 -36.46 67.31 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.449 169.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.84 HG13 ' HB3' ' A' ' 438' ' ' ALA . 75.5 t -61.9 -51.16 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 CA-C-N 114.274 -1.33 . . . . 0.0 108.098 176.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 464' ' ' TYR . . . . . 0.606 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 18.5 m-30 -51.28 -29.03 13.43 Favored 'General case' 0 N--CA 1.455 -0.195 0 O-C-N 124.551 1.157 . . . . 0.0 110.758 177.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.0 -39.78 19.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.657 0.742 . . . . 0.0 109.76 -176.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.598 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.6 mt -57.89 -55.84 19.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 114.481 -1.236 . . . . 0.0 112.113 176.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 0.791 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -100.22 -10.51 21.29 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 -172.667 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 468' ' ' GLY . . . . . 0.665 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 94.24 32.06 7.64 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 119.238 -1.458 . . . . 0.0 114.259 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 469' ' ' LEU . . . . . 0.791 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 4.3 mt -89.2 158.85 17.73 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 117.827 0.814 . . . . 0.0 110.828 174.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 470' ' ' ASN . . . . . 0.487 HD22 HG23 ' A' ' 476' ' ' ILE . 10.8 p30 -105.8 -178.04 3.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.983 171.117 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -55.35 -27.42 47.12 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -173.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -85.82 7.32 24.33 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.767 0.318 . . . . 0.0 111.406 -170.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 473' ' ' GLY . . . . . 0.448 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 74.63 10.19 82.77 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.227 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -100.39 154.19 18.71 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 177.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 5.6 p -89.77 130.99 35.95 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.218 0.532 . . . . 0.0 111.221 -178.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 476' ' ' ILE . . . . . 0.665 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.8 pp . . . . . 0 C--N 1.323 -0.567 0 CA-C-O 121.564 0.697 . . . . 0.0 109.686 177.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 386' ' ' PHE . . . . . 0.741 ' CD1' HD22 ' B' ' 414' ' ' LEU . 2.1 t80 . . . . . 0 CA--C 1.539 0.544 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 387' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' B' ' 386' ' ' PHE . 1.6 Cg_endo -39.86 -62.98 0.31 Allowed 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 124.427 3.418 . . . . 0.0 113.872 -175.158 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 388' ' ' MET . . . . . 0.488 ' C ' ' HB3' ' B' ' 393' ' ' ASN . 6.3 ttp 59.0 38.52 24.17 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 174.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 389' ' ' HIS . . . . . 0.61 ' N ' ' HB3' ' B' ' 393' ' ' ASN . 31.3 m170 51.71 -97.01 0.05 Allowed 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 121.426 0.631 . . . . 0.0 110.268 -176.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -151.8 23.96 0.67 Allowed 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 171.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 391' ' ' LEU . . . . . 0.481 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.4 pt? -175.75 -47.78 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.357 -172.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 392' ' ' GLY . . . . . 0.591 ' HA3' HD13 ' B' ' 395' ' ' ILE . . . -173.2 56.48 0.15 Allowed Glycine 0 CA--C 1.525 0.685 0 C-N-CA 119.477 -1.344 . . . . 0.0 114.778 -172.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 393' ' ' ASN . . . . . 0.615 HD21 ' C ' ' B' ' 393' ' ' ASN . 0.0 OUTLIER -61.8 -37.62 85.06 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-N 117.649 0.725 . . . . 0.0 109.046 174.216 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 394' ' ' VAL . . . . . 0.692 HG12 ' CE2' ' B' ' 386' ' ' PHE . 1.0 OUTLIER -57.18 -49.4 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 CA-C-N 113.642 -1.617 . . . . 0.0 107.094 179.02 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 395' ' ' ILE . . . . . 0.65 HG23 HD13 ' B' ' 426' ' ' ILE . 3.6 mp -57.68 -52.72 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.315 0 CA-C-O 117.842 -1.075 . . . . 0.0 113.625 -174.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 396' ' ' LYS . . . . . 0.607 ' O ' HG22 ' B' ' 399' ' ' VAL . 0.0 OUTLIER -62.57 -49.74 74.07 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 121.991 2.178 . . . . 0.0 112.032 -174.666 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.06 -44.58 62.8 Favored Glycine 0 N--CA 1.435 -1.405 0 C-N-CA 119.979 -1.105 . . . . 0.0 110.933 -176.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 398' ' ' ILE . . . . . 0.738 HD13 HD12 ' B' ' 410' ' ' LEU . 28.5 mt -71.0 -33.84 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -179.357 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 399' ' ' VAL . . . . . 0.607 HG22 ' O ' ' B' ' 396' ' ' LYS . 17.2 m -63.42 -39.72 86.37 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 C-N-CA 118.753 -1.179 . . . . 0.0 108.483 -174.022 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -70.51 -37.98 74.24 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 175.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 401' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -88.09 -48.61 7.61 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -171.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 402' ' ' GLU . . . . . 0.589 ' HG3' ' HE3' ' A' ' 413' ' ' MET . 1.2 tm-20 -118.14 -19.89 8.86 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.216 -170.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 106.26 160.73 22.44 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.549 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 404' ' ' VAL . . . . . 0.65 HG11 ' HA ' ' B' ' 430' ' ' LEU . 1.2 m -54.19 -45.41 66.77 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.886 0 N-CA-C 114.568 1.322 . . . . 0.0 114.568 -175.301 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 405' ' ' ALA . . . . . 0.535 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -63.2 -31.18 72.26 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 119.819 -0.753 . . . . 0.0 112.43 -177.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 406' ' ' THR . . . . . 0.717 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 92.0 m -76.78 -42.17 41.85 Favored 'General case' 0 C--O 1.221 -0.4 0 O-C-N 121.682 -0.636 . . . . 0.0 110.226 173.017 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 407' ' ' ALA . . . . . 0.456 ' HB2' ' HB ' ' B' ' 398' ' ' ILE . . . -58.89 -36.68 75.06 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 122.204 1.002 . . . . 0.0 109.306 176.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 408' ' ' TYR . . . . . 0.623 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -66.5 -51.69 54.01 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 113.474 -1.694 . . . . 0.0 109.576 176.772 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 409' ' ' THR . . . . . 0.645 HG22 HD23 ' B' ' 410' ' ' LEU . 17.3 m -55.18 -47.29 75.42 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.447 178.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 410' ' ' LEU . . . . . 0.738 HD12 HD13 ' B' ' 398' ' ' ILE . 15.2 mt -72.65 -35.75 67.83 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -174.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.4 -34.72 76.13 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.196 -1.002 . . . . 0.0 110.951 172.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 412' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -69.56 -47.03 65.01 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-O 120.64 0.257 . . . . 0.0 111.612 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 413' ' ' MET . . . . . 0.936 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.9 OUTLIER -71.43 -45.27 63.1 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 118.848 -1.141 . . . . 0.0 111.792 -179.459 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 414' ' ' LEU . . . . . 0.936 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 11.7 mt -69.87 -46.39 65.6 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -177.22 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 415' ' ' SER . . . . . 0.451 ' HB2' ' SD ' ' B' ' 388' ' ' MET . 8.4 t -99.74 16.58 23.12 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.388 0.613 . . . . 0.0 110.515 -172.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 416' ' ' GLY . . . . . . . . . . . . . . . 75.84 -176.66 50.81 Favored Glycine 0 N--CA 1.436 -1.361 0 C-N-CA 120.359 -0.924 . . . . 0.0 111.699 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -80.66 23.11 0.54 Allowed 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.222 0.534 . . . . 0.0 111.397 -172.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 418' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -71.59 76.74 0.81 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.47 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 419' ' ' TYR . . . . . 0.483 ' HB2' ' CE2' ' B' ' 456' ' ' PHE . 21.1 p90 -55.65 -38.15 69.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.66 178.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -55.54 -42.91 75.27 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.952 178.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.73 -49.06 64.57 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.354 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 422' ' ' VAL . . . . . 0.471 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.2 OUTLIER -65.78 -39.29 84.37 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.364 -177.872 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 423' ' ' SER . . . . . 0.811 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 61.6 p -67.98 -37.88 82.03 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -178.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.86 -39.14 89.7 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.241 175.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 425' ' ' ILE . . . . . 0.583 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -72.35 -52.3 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 120.367 0.127 . . . . 0.0 111.145 -178.037 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 426' ' ' ILE . . . . . 0.65 HD13 HG23 ' B' ' 395' ' ' ILE . 1.2 mm -74.79 -23.42 17.68 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.969 0 O-C-N 122.095 -0.378 . . . . 0.0 110.594 -172.292 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 427' ' ' ARG . . . . . 0.811 ' HB2' ' O ' ' B' ' 423' ' ' SER . 1.5 tmt_? -54.59 -31.63 57.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.176 0.512 . . . . 0.0 111.134 -177.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.58 -12.19 67.36 Favored Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.501 -0.857 . . . . 0.0 111.141 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 429' ' ' TYR . . . . . 0.595 ' HD1' HG22 ' B' ' 395' ' ' ILE . 6.1 m-30 -111.77 -2.12 15.39 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.869 0.842 . . . . 0.0 108.797 -174.062 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 430' ' ' LEU . . . . . 0.65 ' HA ' HG11 ' B' ' 404' ' ' VAL . 0.0 OUTLIER -66.18 139.94 96.68 Favored Pre-proline 0 N--CA 1.442 -0.865 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.407 177.555 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 431' ' ' PRO . . . . . 0.812 ' CD ' HG11 ' B' ' 435' ' ' VAL . 77.2 Cg_exo -38.19 -75.03 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 124.633 3.555 . . . . 0.0 113.985 -173.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 432' ' ' GLY . . . . . 0.427 ' O ' HG12 ' B' ' 435' ' ' VAL . . . -130.1 -161.65 10.51 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 176.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 433' ' ' GLN . . . . . 0.529 ' O ' HG13 ' B' ' 436' ' ' VAL . 19.8 tp60 -71.38 -29.15 64.6 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 118.058 0.929 . . . . 0.0 110.506 176.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -66.74 -39.3 87.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.215 -0.448 . . . . 0.0 112.093 -175.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 435' ' ' VAL . . . . . 0.812 HG11 ' CD ' ' B' ' 431' ' ' PRO . 6.8 p -66.44 -45.21 89.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.117 0.484 . . . . 0.0 110.69 -177.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 436' ' ' VAL . . . . . 0.529 HG13 ' O ' ' B' ' 433' ' ' GLN . 0.2 OUTLIER -66.26 -31.75 55.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.091 177.124 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -68.16 -52.27 36.51 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -177.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 438' ' ' ALA . . . . . 0.847 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -57.63 -40.51 79.36 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.139 177.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 439' ' ' LEU . . . . . 0.604 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 1.9 tm? -67.99 -48.22 66.38 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -178.096 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -59.97 -34.76 73.71 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.093 175.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 441' ' ' GLN . . . . . 0.541 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 4.5 mm-40 -53.75 -49.66 67.7 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.967 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 442' ' ' ARG . . . . . 0.714 ' HD2' ' O ' ' B' ' 438' ' ' ALA . 0.0 OUTLIER -76.76 -25.45 53.42 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 119.221 -0.992 . . . . 0.0 113.308 174.441 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 443' ' ' LEU . . . . . 0.604 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 67.4 mt -65.62 -27.41 68.37 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 118.656 0.662 . . . . 0.0 109.806 175.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -61.7 -38.02 86.33 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.954 176.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 34.5 mm-40 -78.74 -27.39 44.78 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.266 -1.334 . . . . 0.0 111.232 178.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 446' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 24.9 101.35 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 41.6 mt -58.09 -33.91 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 121.35 0.595 . . . . 0.0 111.292 -178.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 448' ' ' ASP . . . . . 0.45 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 8.1 m-20 -162.14 -159.62 0.61 Allowed 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -178.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 449' ' ' ASP . . . . . 0.407 ' H ' ' HB3' ' B' ' 448' ' ' ASP . 12.1 p-10 -85.4 -64.87 1.08 Allowed 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 168.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 450' ' ' GLN . . . . . 0.407 ' H ' ' CG ' ' B' ' 449' ' ' ASP . 2.2 pp0? -68.41 -26.05 65.35 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 179.128 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 451' ' ' THR . . . . . 0.45 ' OG1' ' HB2' ' B' ' 448' ' ' ASP . 10.0 m -71.58 -23.09 61.67 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.75 -175.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 452' ' ' ARG . . . . . . . . . . . . . 14.5 mtp180 -53.97 -54.0 45.02 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 171.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 453' ' ' ALA . . . . . 0.478 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -58.68 -49.09 78.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.361 -1.291 . . . . 0.0 112.596 174.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 454' ' ' GLU . . . . . 0.437 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 71.1 mm-40 -49.8 -36.93 28.14 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.218 0.533 . . . . 0.0 111.616 -177.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 32.3 p -118.15 15.0 14.08 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.448 -175.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 456' ' ' PHE . . . . . 0.555 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 0.8 OUTLIER -57.53 -47.27 82.44 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.136 0.493 . . . . 0.0 111.66 -171.266 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 457' ' ' ILE . . . . . 0.535 HG23 ' HB1' ' B' ' 405' ' ' ALA . 1.9 mp -77.15 -32.4 19.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.029 0.442 . . . . 0.0 110.853 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -57.87 -34.62 69.96 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.779 0.799 . . . . 0.0 109.113 171.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 459' ' ' HIS . . . . . 0.769 ' O ' HG23 ' B' ' 463' ' ' VAL . 64.1 m-70 -74.65 -29.47 61.27 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.55 -1.204 . . . . 0.0 110.748 177.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 460' ' ' LEU . . . . . 0.731 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -73.33 -34.52 65.72 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.91 0.862 . . . . 0.0 108.758 178.59 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 461' ' ' ASN . . . . . 0.454 ' O ' ' HB2' ' B' ' 464' ' ' TYR . 23.5 m-80 -73.26 -37.26 66.36 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.15 176.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 462' ' ' ALA . . . . . 0.602 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -55.66 -36.33 66.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.636 -1.165 . . . . 0.0 109.495 169.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 463' ' ' VAL . . . . . 0.847 HG13 ' HB3' ' B' ' 438' ' ' ALA . 75.6 t -62.07 -51.09 76.64 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-N 114.293 -1.321 . . . . 0.0 107.983 176.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 464' ' ' TYR . . . . . 0.614 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 18.6 m-30 -51.47 -28.97 14.75 Favored 'General case' 0 C--N 1.332 -0.167 0 O-C-N 124.496 1.123 . . . . 0.0 110.644 177.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.94 -39.97 19.11 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.719 0.771 . . . . 0.0 109.712 -176.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 466' ' ' ILE . . . . . 0.602 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.6 mt -57.75 -55.7 19.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 114.35 -1.295 . . . . 0.0 112.249 176.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 467' ' ' LEU . . . . . 0.784 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -100.25 -10.58 21.18 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -172.833 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 468' ' ' GLY . . . . . 0.667 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 94.21 32.12 7.62 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 119.308 -1.425 . . . . 0.0 114.313 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 469' ' ' LEU . . . . . 0.784 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 4.3 mt -89.05 159.05 17.76 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 117.814 0.807 . . . . 0.0 110.742 174.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 470' ' ' ASN . . . . . 0.474 HD22 HG23 ' B' ' 476' ' ' ILE . 10.6 p30 -105.88 -178.11 3.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.001 170.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 471' ' ' ALA . . . . . . . . . . . . . . . -55.36 -27.47 47.56 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -173.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -85.67 7.18 24.38 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 122.159 -0.338 . . . . 0.0 111.438 -171.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 473' ' ' GLY . . . . . 0.451 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 74.87 9.96 83.51 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.322 -0.942 . . . . 0.0 111.306 -178.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -100.54 154.41 18.58 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 177.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 6.4 p -89.69 131.06 35.86 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.27 0.557 . . . . 0.0 111.291 -178.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 476' ' ' ILE . . . . . 0.667 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.8 pp . . . . . 0 C--N 1.323 -0.553 0 CA-C-O 121.539 0.685 . . . . 0.0 109.75 177.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 386' ' ' PHE . . . . . 0.75 ' CD1' HD22 ' A' ' 414' ' ' LEU . 1.4 t80 . . . . . 0 CA--C 1.534 0.363 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 387' ' ' PRO . . . . . 0.47 ' HD2' ' HA ' ' A' ' 386' ' ' PHE . 10.0 Cg_endo -48.17 -69.77 0.07 OUTLIER 'Trans proline' 0 N--CA 1.483 0.873 0 C-N-CA 124.722 3.615 . . . . 0.0 115.907 -173.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.535 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 32.6 mtt 72.73 156.24 0.17 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.379 0.671 . . . . 0.0 111.216 -172.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 389' ' ' HIS . . . . . 0.55 ' CG ' ' HB2' ' A' ' 393' ' ' ASN . 32.7 m170 -54.33 -59.67 4.37 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 175.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 390' ' ' GLN . . . . . 0.406 ' H ' HD23 ' A' ' 391' ' ' LEU . 30.1 pt20 -177.55 19.96 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.786 -1.097 . . . . 0.0 108.687 175.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.587 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.3 pt? -170.11 -58.53 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.38 -167.183 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 392' ' ' GLY . . . . . 0.611 ' HA3' HD13 ' A' ' 395' ' ' ILE . . . -172.73 51.31 0.17 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.372 -0.918 . . . . 0.0 113.181 -172.247 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 393' ' ' ASN . . . . . 0.55 ' HB2' ' CG ' ' A' ' 389' ' ' HIS . 0.6 OUTLIER -57.01 -38.56 73.27 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.138 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 394' ' ' VAL . . . . . 0.706 HG12 ' CE2' ' A' ' 386' ' ' PHE . 0.9 OUTLIER -55.88 -46.44 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 179.771 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 395' ' ' ILE . . . . . 0.636 HG23 HD13 ' A' ' 426' ' ' ILE . 4.2 mp -57.82 -51.98 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 CA-C-O 117.902 -1.046 . . . . 0.0 113.047 -175.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 396' ' ' LYS . . . . . 0.702 ' HG3' ' CZ ' ' A' ' 429' ' ' TYR . 0.2 OUTLIER -62.49 -49.19 76.37 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 121.563 1.983 . . . . 0.0 111.816 -173.689 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -54.48 -44.87 77.71 Favored Glycine 0 N--CA 1.434 -1.471 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.0 -178.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 398' ' ' ILE . . . . . 0.86 HD13 HD12 ' A' ' 410' ' ' LEU . 45.0 mt -70.9 -33.87 53.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -177.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 399' ' ' VAL . . . . . 0.533 HG12 ' HA ' ' A' ' 404' ' ' VAL . 10.9 m -64.23 -39.42 85.45 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 C-N-CA 118.667 -1.213 . . . . 0.0 108.324 -175.295 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -70.37 -35.29 73.44 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 175.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -89.42 -47.95 7.66 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -172.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 402' ' ' GLU . . . . . 0.675 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 3.1 mm-40 -121.0 -21.23 6.58 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.795 -170.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 108.03 162.23 20.99 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.952 -0.642 . . . . 0.0 113.046 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 404' ' ' VAL . . . . . 0.68 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.5 m -53.75 -42.51 52.21 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.772 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -175.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 405' ' ' ALA . . . . . 0.63 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -68.86 -29.86 68.26 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 119.708 -0.797 . . . . 0.0 112.073 -175.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.692 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 90.6 m -77.76 -42.5 33.87 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.074 173.201 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.461 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.35 -37.91 76.14 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 122.084 0.945 . . . . 0.0 109.229 176.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 408' ' ' TYR . . . . . 0.68 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.4 -51.79 57.91 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 113.517 -1.674 . . . . 0.0 109.851 176.996 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 409' ' ' THR . . . . . 0.666 HG22 HD23 ' A' ' 410' ' ' LEU . 12.0 m -54.96 -47.08 75.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.586 178.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 410' ' ' LEU . . . . . 0.86 HD12 HD13 ' A' ' 398' ' ' ILE . 14.5 mt -72.24 -36.67 69.15 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.893 0.377 . . . . 0.0 110.213 -174.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.82 -34.94 80.06 Favored Glycine 0 N--CA 1.438 -1.182 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 172.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 412' ' ' MET . . . . . 0.465 ' HB2' ' O ' ' A' ' 409' ' ' THR . 0.6 OUTLIER -66.06 -46.58 77.25 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 115.61 -0.295 . . . . 0.0 111.5 177.252 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 413' ' ' MET . . . . . 0.778 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.0 OUTLIER -70.33 -55.22 9.69 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 118.788 -1.165 . . . . 0.0 111.94 -179.814 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 414' ' ' LEU . . . . . 0.778 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 6.9 mt -64.76 -43.71 92.43 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -172.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 40.8 t -86.05 -20.43 28.8 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.677 0.751 . . . . 0.0 110.032 -177.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 104.03 -175.65 23.2 Favored Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 -171.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 417' ' ' GLN . . . . . 0.44 ' HA ' ' HE2' ' A' ' 412' ' ' MET . 34.5 mm-40 -79.85 24.2 0.41 Allowed 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.186 0.517 . . . . 0.0 111.748 -171.357 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 418' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -71.09 75.04 0.67 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.393 178.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 419' ' ' TYR . . . . . 0.497 ' HB2' ' CE2' ' A' ' 456' ' ' PHE . 14.0 p90 -52.22 -37.07 53.97 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.947 175.079 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 420' ' ' GLN . . . . . 0.411 ' HG3' ' H ' ' A' ' 421' ' ' LEU . 2.5 pt20 -53.7 -47.18 70.76 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.95 176.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 421' ' ' LEU . . . . . 0.411 ' H ' ' HG3' ' A' ' 420' ' ' GLN . 0.0 OUTLIER -68.09 -48.58 65.13 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.192 -177.005 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 422' ' ' VAL . . . . . 0.455 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.3 OUTLIER -66.48 -40.35 86.26 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.345 -176.584 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.772 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 77.2 p -67.33 -37.08 82.73 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 -179.017 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -68.51 -38.67 86.81 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.249 175.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 425' ' ' ILE . . . . . 0.595 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -73.44 -51.92 23.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.461 0.172 . . . . 0.0 111.235 -178.452 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 426' ' ' ILE . . . . . 0.636 HD13 HG23 ' A' ' 395' ' ' ILE . 1.2 mm -74.53 -22.45 17.64 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.845 0 C-N-CA 122.614 0.366 . . . . 0.0 110.092 -171.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.772 ' HB2' ' O ' ' A' ' 423' ' ' SER . 0.5 OUTLIER -54.2 -30.78 51.01 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.227 0.537 . . . . 0.0 110.26 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.92 -4.89 78.19 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.808 179.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.702 ' CZ ' ' HG3' ' A' ' 396' ' ' LYS . 23.7 m-85 -119.09 -2.12 10.81 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 121.573 0.701 . . . . 0.0 110.081 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.602 HD12 ' HD2' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -66.29 135.17 94.81 Favored Pre-proline 0 N--CA 1.439 -0.989 0 CA-C-N 114.664 -1.153 . . . . 0.0 108.881 178.84 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 431' ' ' PRO . . . . . 0.826 ' HD2' HG11 ' A' ' 435' ' ' VAL . 50.6 Cg_exo -36.69 -64.42 0.18 Allowed 'Trans proline' 0 CA--C 1.533 0.442 0 C-N-CA 124.723 3.615 . . . . 0.0 114.247 -172.05 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 432' ' ' GLY . . . . . 0.594 ' H ' HG12 ' A' ' 435' ' ' VAL . . . -144.17 -164.96 10.72 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 176.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 433' ' ' GLN . . . . . 0.48 ' O ' HG13 ' A' ' 436' ' ' VAL . 18.4 tp60 -70.47 -26.93 63.85 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 118.197 0.999 . . . . 0.0 110.347 178.276 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -67.46 -39.49 85.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.312 -0.404 . . . . 0.0 112.045 -177.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 435' ' ' VAL . . . . . 0.826 HG11 ' HD2' ' A' ' 431' ' ' PRO . 7.0 p -67.96 -44.99 84.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-O 120.953 0.406 . . . . 0.0 110.576 -178.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.503 HG12 ' O ' ' A' ' 432' ' ' GLY . 0.1 OUTLIER -66.06 -29.31 46.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.343 176.167 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -69.35 -52.55 26.13 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 438' ' ' ALA . . . . . 0.887 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -58.03 -37.99 75.39 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.57 177.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 439' ' ' LEU . . . . . 0.583 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 2.1 tm? -70.16 -47.17 62.78 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -178.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -57.1 -40.3 76.75 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.21 174.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 441' ' ' GLN . . . . . 0.528 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 11.0 mm-40 -53.51 -49.89 66.58 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 123.751 0.82 . . . . 0.0 110.852 173.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 442' ' ' ARG . . . . . 0.83 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 1.6 mmp_? -55.89 -39.75 72.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.816 171.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 443' ' ' LEU . . . . . 0.583 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 39.2 mt -72.09 -31.15 65.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.788 0.328 . . . . 0.0 110.862 -178.291 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -57.25 -38.29 73.6 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.773 0.796 . . . . 0.0 110.081 171.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -76.44 -25.91 54.89 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.528 -1.214 . . . . 0.0 111.96 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 446' ' ' GLU . . . . . 0.478 ' O ' ' HG3' ' A' ' 446' ' ' GLU . 14.5 pt-20 1.92 105.43 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 125.35 1.46 . . . . 0.0 114.393 -178.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 38.4 mt -58.01 -35.54 52.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.877 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 448' ' ' ASP . . . . . 0.493 ' HB2' ' OG1' ' A' ' 451' ' ' THR . 26.1 m-20 -164.07 -176.55 4.56 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -178.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -66.36 -67.11 0.47 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 173.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -70.03 -26.88 64.25 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 451' ' ' THR . . . . . 0.493 ' OG1' ' HB2' ' A' ' 448' ' ' ASP . 10.7 m -72.43 -23.81 61.13 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.046 -0.661 . . . . 0.0 110.256 -177.15 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 19.7 ttm180 -54.62 -53.06 59.71 Favored 'General case' 0 N--CA 1.413 -2.324 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 171.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 453' ' ' ALA . . . . . 0.493 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -58.37 -47.27 84.38 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.673 172.264 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 454' ' ' GLU . . . . . 0.421 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 16.5 mm-40 -52.31 -38.5 58.64 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.26 0.552 . . . . 0.0 111.369 -176.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 27.3 p -112.26 12.48 20.31 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.362 -176.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 456' ' ' PHE . . . . . 0.547 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 1.0 OUTLIER -55.5 -46.93 76.9 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.037 0.446 . . . . 0.0 111.599 -173.052 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 457' ' ' ILE . . . . . 0.63 HG23 ' HB1' ' A' ' 405' ' ' ALA . 2.0 mp -77.77 -34.37 19.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.022 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -57.83 -34.57 69.82 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.946 0.879 . . . . 0.0 109.203 171.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 459' ' ' HIS . . . . . 0.726 ' O ' HG23 ' A' ' 463' ' ' VAL . 51.3 m-70 -74.0 -28.99 61.73 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.92 176.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 460' ' ' LEU . . . . . 0.721 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -73.69 -34.54 64.9 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.939 0.875 . . . . 0.0 108.717 179.016 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 461' ' ' ASN . . . . . 0.437 ' HA ' ' CD2' ' A' ' 464' ' ' TYR . 23.5 m-80 -73.19 -38.33 66.18 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.004 176.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 462' ' ' ALA . . . . . 0.621 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -56.45 -34.91 67.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.723 169.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.887 HG13 ' HB3' ' A' ' 438' ' ' ALA . 61.5 t -59.96 -50.97 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 114.611 -1.177 . . . . 0.0 107.845 175.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 464' ' ' TYR . . . . . 0.596 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 17.2 m-30 -53.69 -28.26 32.68 Favored 'General case' 0 C--N 1.333 -0.14 0 O-C-N 124.395 1.06 . . . . 0.0 110.743 178.278 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.99 -41.34 20.87 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.691 0.758 . . . . 0.0 109.636 -178.086 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.621 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.5 mt -56.11 -55.35 18.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 114.266 -1.334 . . . . 0.0 112.345 176.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 0.794 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -102.16 -10.42 19.64 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -173.064 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 468' ' ' GLY . . . . . 0.568 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 93.86 31.4 8.19 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 119.396 -1.383 . . . . 0.0 114.348 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 469' ' ' LEU . . . . . 0.794 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 4.4 mt -88.59 164.55 15.33 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 118.01 0.905 . . . . 0.0 111.408 177.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 38.5 p30 -105.24 -176.83 3.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.827 170.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 471' ' ' ALA . . . . . 0.514 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -68.17 -13.67 62.4 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -176.078 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -89.02 -1.19 57.99 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 122.23 -0.294 . . . . 0.0 111.347 -175.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 78.47 12.58 84.12 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.334 -0.936 . . . . 0.0 110.898 -174.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -100.58 151.27 21.79 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 177.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 475' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 469' ' ' LEU . 31.7 t -92.26 136.69 32.98 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.241 0.543 . . . . 0.0 111.023 -177.124 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 476' ' ' ILE . . . . . 0.568 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.3 pp . . . . . 0 C--N 1.319 -0.738 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.087 -178.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 386' ' ' PHE . . . . . 0.764 ' CD1' HD22 ' B' ' 414' ' ' LEU . 1.4 t80 . . . . . 0 CA--C 1.534 0.333 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 387' ' ' PRO . . . . . 0.479 ' HD2' ' HA ' ' B' ' 386' ' ' PHE . 9.5 Cg_endo -48.19 -69.9 0.07 OUTLIER 'Trans proline' 0 N--CA 1.484 0.921 0 C-N-CA 124.703 3.602 . . . . 0.0 115.872 -173.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 388' ' ' MET . . . . . 0.538 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 32.5 mtt 72.94 156.56 0.17 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.222 0.609 . . . . 0.0 111.162 -172.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 389' ' ' HIS . . . . . 0.56 ' CG ' ' HB2' ' B' ' 393' ' ' ASN . 32.7 m170 -54.58 -59.9 4.08 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 175.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 390' ' ' GLN . . . . . 0.4 ' H ' HD23 ' B' ' 391' ' ' LEU . 30.1 pt20 -177.23 19.77 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.649 175.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 391' ' ' LEU . . . . . 0.58 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.3 pt? -169.97 -58.37 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.451 -167.074 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 392' ' ' GLY . . . . . 0.615 ' HA3' HD13 ' B' ' 395' ' ' ILE . . . -172.81 51.51 0.17 Allowed Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.302 -0.951 . . . . 0.0 113.026 -172.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 393' ' ' ASN . . . . . 0.56 ' HB2' ' CG ' ' B' ' 389' ' ' HIS . 0.6 OUTLIER -57.01 -38.54 73.24 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.967 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 394' ' ' VAL . . . . . 0.709 HG12 ' CE2' ' B' ' 386' ' ' PHE . 0.9 OUTLIER -56.07 -46.45 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 395' ' ' ILE . . . . . 0.63 HG23 HD13 ' B' ' 426' ' ' ILE . 4.2 mp -57.63 -52.09 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 CA-C-O 117.973 -1.013 . . . . 0.0 113.04 -175.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 396' ' ' LYS . . . . . 0.707 ' HG3' ' CZ ' ' B' ' 429' ' ' TYR . 0.2 OUTLIER -62.49 -49.27 76.06 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 121.482 1.947 . . . . 0.0 111.8 -173.777 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -54.35 -44.89 76.35 Favored Glycine 0 N--CA 1.434 -1.487 0 C-N-CA 120.103 -1.046 . . . . 0.0 111.02 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 398' ' ' ILE . . . . . 0.867 HD13 HD12 ' B' ' 410' ' ' LEU . 45.0 mt -70.94 -33.81 53.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -177.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 399' ' ' VAL . . . . . 0.534 HG12 ' HA ' ' B' ' 404' ' ' VAL . 10.8 m -64.22 -39.51 85.75 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 C-N-CA 118.592 -1.243 . . . . 0.0 108.346 -175.276 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -70.39 -35.26 73.36 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 175.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 401' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -89.43 -47.81 7.75 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -172.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 402' ' ' GLU . . . . . 0.674 ' HG3' ' HE3' ' A' ' 413' ' ' MET . 3.0 mm-40 -121.09 -21.3 6.5 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.771 -170.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 108.02 162.25 21.0 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.954 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 404' ' ' VAL . . . . . 0.67 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.5 m -53.83 -42.56 53.21 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.809 0 N-CA-C 114.698 1.369 . . . . 0.0 114.698 -175.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 405' ' ' ALA . . . . . 0.642 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -68.82 -29.9 68.34 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 119.77 -0.772 . . . . 0.0 111.991 -175.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 406' ' ' THR . . . . . 0.687 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 92.5 m -77.59 -42.53 34.82 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.161 173.127 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 407' ' ' ALA . . . . . 0.462 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.3 -37.76 75.7 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 122.182 0.992 . . . . 0.0 109.295 176.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 408' ' ' TYR . . . . . 0.67 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.56 -51.86 56.65 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 113.494 -1.685 . . . . 0.0 109.747 177.12 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 409' ' ' THR . . . . . 0.666 HG22 HD23 ' B' ' 410' ' ' LEU . 10.2 m -54.84 -47.13 74.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.636 178.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 410' ' ' LEU . . . . . 0.867 HD12 HD13 ' B' ' 398' ' ' ILE . 14.3 mt -72.05 -36.91 69.73 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.972 0.415 . . . . 0.0 110.263 -174.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.63 -34.87 78.37 Favored Glycine 0 N--CA 1.439 -1.135 0 C-N-CA 120.036 -1.078 . . . . 0.0 110.52 172.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 412' ' ' MET . . . . . 0.468 ' HB2' ' O ' ' B' ' 409' ' ' THR . 0.5 OUTLIER -66.26 -46.47 76.97 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 115.64 -0.28 . . . . 0.0 111.39 177.287 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 413' ' ' MET . . . . . 0.775 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.0 OUTLIER -70.34 -55.02 10.15 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 118.709 -1.197 . . . . 0.0 111.987 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 414' ' ' LEU . . . . . 0.779 HD21 HG12 ' A' ' 398' ' ' ILE . 6.9 mt -64.97 -43.7 91.76 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -172.33 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 43.0 t -86.02 -20.48 28.78 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.79 0.805 . . . . 0.0 109.991 -177.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 416' ' ' GLY . . . . . . . . . . . . . . . 104.06 -175.91 23.34 Favored Glycine 0 N--CA 1.43 -1.758 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -171.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 417' ' ' GLN . . . . . 0.407 ' HA ' ' HE2' ' B' ' 412' ' ' MET . 35.4 mm-40 -79.85 24.45 0.39 Allowed 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.22 0.533 . . . . 0.0 111.808 -171.329 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 418' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -71.28 74.89 0.72 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.456 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 419' ' ' TYR . . . . . 0.494 ' HB2' ' CE2' ' B' ' 456' ' ' PHE . 14.4 p90 -52.09 -37.04 52.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.997 175.185 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 420' ' ' GLN . . . . . 0.401 ' HG3' ' H ' ' B' ' 421' ' ' LEU . 2.5 pt20 -53.67 -47.39 70.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.904 176.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 421' ' ' LEU . . . . . 0.401 ' H ' ' HG3' ' B' ' 420' ' ' GLN . 0.0 OUTLIER -67.98 -48.62 65.3 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.136 -177.011 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 422' ' ' VAL . . . . . 0.456 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.3 OUTLIER -66.51 -40.26 86.0 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.436 -176.476 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 423' ' ' SER . . . . . 0.77 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 77.7 p -67.39 -36.97 82.39 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 -179.075 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -68.58 -38.6 86.44 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.292 175.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 425' ' ' ILE . . . . . 0.612 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -73.37 -51.72 24.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 O-C-N 122.975 -0.132 . . . . 0.0 111.204 -178.318 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 426' ' ' ILE . . . . . 0.63 HD13 HG23 ' B' ' 395' ' ' ILE . 1.2 mm -74.87 -22.42 17.17 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.873 0 C-N-CA 122.627 0.371 . . . . 0.0 110.019 -171.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 427' ' ' ARG . . . . . 0.77 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.5 OUTLIER -54.26 -30.44 50.47 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.275 0.56 . . . . 0.0 110.294 179.85 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.88 -5.4 77.6 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.809 178.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 429' ' ' TYR . . . . . 0.707 ' CZ ' ' HG3' ' B' ' 396' ' ' LYS . 23.7 m-85 -118.9 -1.72 10.97 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 121.415 0.626 . . . . 0.0 110.152 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 430' ' ' LEU . . . . . 0.616 HD12 ' HD2' ' B' ' 431' ' ' PRO . 0.0 OUTLIER -66.42 135.38 94.72 Favored Pre-proline 0 N--CA 1.439 -0.992 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.855 178.777 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 431' ' ' PRO . . . . . 0.825 ' HD2' HG11 ' B' ' 435' ' ' VAL . 52.5 Cg_exo -36.89 -64.51 0.18 Allowed 'Trans proline' 0 CA--C 1.532 0.391 0 C-N-CA 124.716 3.611 . . . . 0.0 114.209 -172.111 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 432' ' ' GLY . . . . . 0.585 ' H ' HG12 ' B' ' 435' ' ' VAL . . . -144.09 -164.48 10.45 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 176.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 433' ' ' GLN . . . . . 0.487 ' O ' HG13 ' B' ' 436' ' ' VAL . 17.5 tp60 -70.67 -26.99 63.69 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 118.198 0.999 . . . . 0.0 110.369 178.272 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -67.64 -39.3 84.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.304 -0.407 . . . . 0.0 112.076 -177.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 435' ' ' VAL . . . . . 0.837 HG23 HG11 ' B' ' 463' ' ' VAL . 7.2 p -68.02 -45.08 84.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-O 120.962 0.411 . . . . 0.0 110.562 -178.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 436' ' ' VAL . . . . . 0.506 HG21 ' NE ' ' B' ' 427' ' ' ARG . 0.1 OUTLIER -66.01 -29.15 45.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.465 176.175 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -69.53 -52.54 25.44 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 438' ' ' ALA . . . . . 0.878 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -57.94 -37.95 75.04 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.618 177.529 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 439' ' ' LEU . . . . . 0.599 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 2.1 tm? -70.18 -47.23 62.48 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -178.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -56.99 -40.37 76.45 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.2 174.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 441' ' ' GLN . . . . . 0.528 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 10.8 mm-40 -53.53 -49.9 66.62 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 123.827 0.851 . . . . 0.0 110.747 174.058 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 442' ' ' ARG . . . . . 0.838 ' HG2' ' O ' ' B' ' 438' ' ' ALA . 1.5 mmp_? -55.99 -39.66 72.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.754 171.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 443' ' ' LEU . . . . . 0.599 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 39.3 mt -72.08 -31.04 65.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.795 0.331 . . . . 0.0 110.816 -178.231 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -57.32 -38.43 74.05 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.769 0.795 . . . . 0.0 110.028 171.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -76.49 -25.91 54.75 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.457 -1.247 . . . . 0.0 111.842 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 446' ' ' GLU . . . . . 0.485 ' O ' ' HG3' ' B' ' 446' ' ' GLU . 14.4 pt-20 2.21 105.73 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 125.292 1.437 . . . . 0.0 114.377 -178.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 39.4 mt -58.59 -35.18 53.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.028 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 448' ' ' ASP . . . . . 0.486 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 23.6 m-20 -164.23 -176.52 4.48 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 -178.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -66.72 -66.84 0.5 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 173.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -70.14 -26.75 64.09 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 179.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 451' ' ' THR . . . . . 0.486 ' OG1' ' HB2' ' B' ' 448' ' ' ASP . 11.3 m -72.42 -23.73 61.12 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.244 -177.288 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 452' ' ' ARG . . . . . . . . . . . . . 19.6 ttm180 -54.61 -53.17 58.15 Favored 'General case' 0 N--CA 1.412 -2.37 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 171.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 453' ' ' ALA . . . . . 0.489 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -58.47 -47.15 84.98 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.703 172.346 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 454' ' ' GLU . . . . . 0.427 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 21.9 mm-40 -52.24 -38.69 58.82 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.305 0.574 . . . . 0.0 111.313 -176.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 25.8 p -112.12 12.46 20.52 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.272 -176.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 456' ' ' PHE . . . . . 0.543 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 1.0 OUTLIER -55.57 -46.91 77.13 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.044 0.45 . . . . 0.0 111.615 -172.984 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 457' ' ' ILE . . . . . 0.642 HG23 ' HB1' ' B' ' 405' ' ' ALA . 2.0 mp -77.85 -34.25 19.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.097 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -58.0 -34.39 69.95 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.969 0.89 . . . . 0.0 109.265 171.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 459' ' ' HIS . . . . . 0.724 ' O ' HG23 ' B' ' 463' ' ' VAL . 52.2 m-70 -73.87 -29.24 61.98 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.943 176.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 460' ' ' LEU . . . . . 0.719 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -73.62 -34.58 65.09 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.934 0.873 . . . . 0.0 108.775 179.192 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 461' ' ' ASN . . . . . 0.441 ' HA ' ' CD2' ' B' ' 464' ' ' TYR . 22.4 m-80 -73.2 -38.09 66.24 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.142 176.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 462' ' ' ALA . . . . . 0.613 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -56.6 -35.08 67.83 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.72 169.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 463' ' ' VAL . . . . . 0.878 HG13 ' HB3' ' B' ' 438' ' ' ALA . 61.0 t -59.79 -51.11 76.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 175.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 464' ' ' TYR . . . . . 0.587 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 17.4 m-30 -53.48 -28.66 31.98 Favored 'General case' 0 C--O 1.225 -0.2 0 O-C-N 124.322 1.014 . . . . 0.0 110.648 178.399 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.72 -41.17 21.66 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.572 0.701 . . . . 0.0 109.701 -178.029 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 466' ' ' ILE . . . . . 0.613 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.5 mt -56.2 -55.66 17.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 114.409 -1.269 . . . . 0.0 112.21 176.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 467' ' ' LEU . . . . . 0.807 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -101.88 -10.6 19.71 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -172.941 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 468' ' ' GLY . . . . . 0.569 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 93.99 31.54 8.05 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 119.419 -1.372 . . . . 0.0 114.29 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 469' ' ' LEU . . . . . 0.807 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 4.4 mt -88.62 164.54 15.31 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 118.059 0.929 . . . . 0.0 111.39 177.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 38.2 p30 -105.22 -176.64 3.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.869 170.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 471' ' ' ALA . . . . . 0.52 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -68.47 -13.64 62.45 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -175.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -88.94 -1.58 58.17 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.705 0.288 . . . . 0.0 111.325 -175.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 473' ' ' GLY . . . . . . . . . . . . . . . 78.86 12.63 83.97 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.263 -0.97 . . . . 0.0 110.884 -174.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -100.59 151.61 21.4 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 475' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' B' ' 469' ' ' LEU . 32.1 t -92.56 136.55 33.12 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.239 0.542 . . . . 0.0 111.023 -177.095 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 476' ' ' ILE . . . . . 0.569 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.3 pp . . . . . 0 C--N 1.32 -0.709 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.115 -178.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 386' ' ' PHE . . . . . 0.8 ' CD1' HD22 ' A' ' 414' ' ' LEU . 3.4 t80 . . . . . 0 CA--C 1.53 0.189 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 387' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 386' ' ' PHE . 5.9 Cg_endo -47.06 -70.87 0.06 OUTLIER 'Trans proline' 0 CA--C 1.532 0.407 0 C-N-CA 123.961 3.107 . . . . 0.0 114.091 -174.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 40.7 ttm 71.98 155.77 0.16 Allowed 'General case' 0 CA--C 1.547 0.841 0 CA-C-O 121.237 0.542 . . . . 0.0 111.893 175.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 389' ' ' HIS . . . . . 0.602 ' H ' ' H ' ' A' ' 393' ' ' ASN . 2.7 m170 -76.6 27.72 0.13 Allowed 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.711 0.804 . . . . 0.0 112.917 -171.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 390' ' ' GLN . . . . . 0.591 ' HG2' ' O ' ' A' ' 389' ' ' HIS . 2.3 pt20 71.2 4.22 4.98 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.562 0.745 . . . . 0.0 109.902 -167.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -164.57 -43.59 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 392' ' ' GLY . . . . . 0.597 ' HA3' HD13 ' A' ' 395' ' ' ILE . . . -175.89 55.42 0.12 Allowed Glycine 0 C--O 1.223 -0.56 0 C-N-CA 118.088 -2.006 . . . . 0.0 115.88 -176.42 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 393' ' ' ASN . . . . . 0.602 ' H ' ' H ' ' A' ' 389' ' ' HIS . 0.0 OUTLIER -60.89 -36.44 79.23 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 118.095 0.948 . . . . 0.0 108.644 176.294 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 394' ' ' VAL . . . . . 0.7 HG23 HD12 ' A' ' 398' ' ' ILE . 1.5 m -58.54 -50.23 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 CA-C-N 113.289 -1.778 . . . . 0.0 107.834 178.311 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 395' ' ' ILE . . . . . 0.633 HG23 HD13 ' A' ' 426' ' ' ILE . 4.0 mp -57.98 -52.5 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 CA-C-O 117.985 -1.007 . . . . 0.0 113.614 -174.018 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 396' ' ' LYS . . . . . 0.608 ' HG3' ' CZ ' ' A' ' 429' ' ' TYR . 0.0 OUTLIER -64.06 -48.2 77.16 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 121.736 2.062 . . . . 0.0 111.493 -173.82 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -54.0 -45.33 71.94 Favored Glycine 0 N--CA 1.431 -1.636 0 C-N-CA 119.846 -1.169 . . . . 0.0 111.044 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 398' ' ' ILE . . . . . 0.733 HD13 HD12 ' A' ' 410' ' ' LEU . 33.2 mt -70.87 -33.87 53.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -178.476 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 399' ' ' VAL . . . . . 0.492 HG22 ' O ' ' A' ' 396' ' ' LYS . 15.3 m -63.75 -39.43 85.34 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 C-N-CA 118.685 -1.206 . . . . 0.0 108.41 -174.509 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -71.11 -35.24 71.71 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 175.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 34.8 mm-40 -88.69 -48.07 7.8 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -172.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 402' ' ' GLU . . . . . 0.506 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 2.7 mm-40 -121.22 -21.36 6.42 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.601 -169.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 108.41 162.61 20.72 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.953 -0.642 . . . . 0.0 113.128 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 404' ' ' VAL . . . . . 0.674 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.5 m -53.67 -41.86 48.74 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.794 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -176.227 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 405' ' ' ALA . . . . . 0.59 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -68.88 -30.96 69.58 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 119.566 -0.854 . . . . 0.0 111.773 -176.185 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.718 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 89.0 m -77.38 -42.56 35.96 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.174 -0.611 . . . . 0.0 110.3 173.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.447 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -58.26 -37.22 74.53 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 122.054 0.931 . . . . 0.0 109.263 176.335 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 408' ' ' TYR . . . . . 0.674 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.77 -52.12 53.51 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 113.558 -1.655 . . . . 0.0 109.761 176.387 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 409' ' ' THR . . . . . 0.666 HG22 HD23 ' A' ' 410' ' ' LEU . 16.0 m -55.32 -47.37 75.74 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.635 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 410' ' ' LEU . . . . . 0.733 HD12 HD13 ' A' ' 398' ' ' ILE . 14.9 mt -72.65 -36.87 68.08 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -174.435 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.66 -34.96 78.96 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 119.83 -1.176 . . . . 0.0 110.641 173.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 412' ' ' MET . . . . . 0.407 ' HB2' ' O ' ' A' ' 409' ' ' THR . 0.3 OUTLIER -66.83 -48.67 68.2 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-O 120.597 0.236 . . . . 0.0 111.475 178.033 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 413' ' ' MET . . . . . 0.933 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.8 OUTLIER -71.35 -44.26 65.38 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 119.022 -1.071 . . . . 0.0 112.037 -178.552 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 414' ' ' LEU . . . . . 0.933 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 17.6 mt -69.02 -45.22 71.04 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -176.651 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 45.5 t -86.45 -24.63 25.57 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.819 0.818 . . . . 0.0 110.099 -176.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 108.93 -174.82 18.81 Favored Glycine 0 N--CA 1.429 -1.779 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -170.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -80.54 23.54 0.51 Allowed 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.244 0.545 . . . . 0.0 111.587 -171.185 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 418' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -72.0 75.28 0.92 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.064 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 419' ' ' TYR . . . . . 0.521 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 9.4 p90 -51.1 -39.03 55.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.493 176.17 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -55.32 -43.99 75.42 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.672 0.272 . . . . 0.0 110.99 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.37 -48.98 63.33 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.073 -178.063 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 422' ' ' VAL . . . . . 0.432 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -66.49 -40.67 87.06 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.522 0 C-N-CA 120.409 -0.517 . . . . 0.0 111.299 -177.021 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.793 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 77.6 p -68.09 -36.66 80.16 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -178.648 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -69.67 -37.95 77.25 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.253 175.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 425' ' ' ILE . . . . . 0.615 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -73.14 -51.92 24.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 O-C-N 122.82 -0.224 . . . . 0.0 111.048 -178.638 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 426' ' ' ILE . . . . . 0.674 HG22 HD22 ' A' ' 430' ' ' LEU . 1.2 mm -74.09 -22.68 18.31 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.756 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -172.48 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.793 ' HB2' ' O ' ' A' ' 423' ' ' SER . 0.8 OUTLIER -54.61 -29.71 52.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.157 0.503 . . . . 0.0 110.484 -179.263 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -88.94 -6.57 71.89 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.693 178.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.608 ' CZ ' ' HG3' ' A' ' 396' ' ' LYS . 22.4 m-85 -117.27 -0.09 12.12 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.095 0.474 . . . . 0.0 110.221 -178.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.674 HD22 HG22 ' A' ' 426' ' ' ILE . 0.1 OUTLIER -66.15 129.13 94.19 Favored Pre-proline 0 N--CA 1.441 -0.876 0 CA-C-N 115.353 -0.84 . . . . 0.0 108.857 177.584 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 431' ' ' PRO . . . . . 0.554 ' HG3' ' O ' ' A' ' 473' ' ' GLY . 73.4 Cg_exo -25.46 -69.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.757 1 C-N-CA 125.318 4.012 . . . . 0.0 114.911 179.68 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 432' ' ' GLY . . . . . 0.526 ' O ' HG12 ' A' ' 435' ' ' VAL . . . -144.07 -165.8 11.09 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 110.061 -1.215 . . . . 0.0 110.061 177.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 433' ' ' GLN . . . . . 0.465 ' O ' HG13 ' A' ' 436' ' ' VAL . 15.8 tp60 -69.62 -27.58 65.19 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 118.127 0.964 . . . . 0.0 110.449 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -67.32 -39.78 85.91 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -176.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 435' ' ' VAL . . . . . 0.679 HG23 HG11 ' A' ' 463' ' ' VAL . 8.8 p -68.49 -44.26 83.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-O 121.107 0.479 . . . . 0.0 110.48 -177.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.491 HG12 ' O ' ' A' ' 432' ' ' GLY . 0.1 OUTLIER -66.95 -31.46 53.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.399 175.305 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.23 -52.45 40.81 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -178.535 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 438' ' ' ALA . . . . . 0.817 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -57.74 -40.05 78.74 Favored 'General case' 0 N--CA 1.439 -1.023 0 O-C-N 123.883 0.739 . . . . 0.0 111.992 177.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 439' ' ' LEU . . . . . 0.594 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 2.0 tm? -68.3 -48.74 64.13 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -178.199 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -59.27 -34.97 72.9 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.442 -1.254 . . . . 0.0 111.135 175.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 441' ' ' GLN . . . . . 0.543 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 3.8 mm-40 -53.39 -49.88 66.31 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.106 -178.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 442' ' ' ARG . . . . . 0.693 ' HG3' ' CG ' ' A' ' 459' ' ' HIS . 0.0 OUTLIER -76.18 -25.03 54.78 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 119.361 -0.936 . . . . 0.0 113.248 174.898 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 443' ' ' LEU . . . . . 0.594 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 56.2 mt -65.3 -33.72 76.65 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.421 0.629 . . . . 0.0 109.718 175.248 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -70.57 -33.88 71.6 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.114 -178.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 445' ' ' GLN . . . . . 0.402 ' HG3' ' N ' ' A' ' 446' ' ' GLU . 0.0 OUTLIER -75.29 -31.15 60.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 114.673 -1.149 . . . . 0.0 108.321 178.43 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 446' ' ' GLU . . . . . 0.402 ' N ' ' HG3' ' A' ' 445' ' ' GLN . 34.9 tt0 48.09 98.47 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 114.812 -1.085 . . . . 0.0 113.2 171.084 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 60.9 mt -65.82 -35.67 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 121.667 0.746 . . . . 0.0 109.785 176.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 448' ' ' ASP . . . . . 0.538 ' O ' ' HG3' ' A' ' 452' ' ' ARG . 18.7 m-20 -169.83 -175.94 2.22 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 -177.637 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -72.16 -67.83 0.51 Allowed 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.6 174.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 450' ' ' GLN . . . . . 0.404 ' HG3' ' H ' ' A' ' 450' ' ' GLN . 2.0 pp0? -66.46 -25.46 66.73 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 178.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 451' ' ' THR . . . . . 0.524 ' OG1' ' HB2' ' A' ' 448' ' ' ASP . 15.3 m -71.13 -23.02 62.0 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.702 -173.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 452' ' ' ARG . . . . . 0.538 ' HG3' ' O ' ' A' ' 448' ' ' ASP . 55.7 mtm180 -55.06 -54.15 46.75 Favored 'General case' 0 C--O 1.218 -0.553 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 170.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 453' ' ' ALA . . . . . 0.521 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -56.99 -48.03 79.42 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 124.278 0.986 . . . . 0.0 112.571 174.01 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 454' ' ' GLU . . . . . 0.422 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 63.9 mm-40 -51.34 -37.49 48.1 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.312 0.577 . . . . 0.0 111.693 -177.493 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 24.6 p -119.13 16.28 13.23 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.187 -175.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 456' ' ' PHE . . . . . 0.515 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.9 OUTLIER -55.19 -47.33 75.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.12 0.486 . . . . 0.0 111.728 -171.58 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 457' ' ' ILE . . . . . 0.59 HG23 ' HB1' ' A' ' 405' ' ' ALA . 1.9 mp -77.11 -34.43 21.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.257 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -57.54 -34.09 68.78 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.891 0.853 . . . . 0.0 109.288 171.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 459' ' ' HIS . . . . . 0.758 ' O ' HG23 ' A' ' 463' ' ' VAL . 52.8 m-70 -73.76 -29.33 62.15 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.357 -1.292 . . . . 0.0 110.926 176.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 460' ' ' LEU . . . . . 0.714 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -73.59 -33.96 64.86 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.863 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -73.05 -38.12 66.61 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.345 175.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 462' ' ' ALA . . . . . 0.613 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -55.82 -34.0 64.98 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.691 169.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.817 HG13 ' HB3' ' A' ' 438' ' ' ALA . 62.6 t -62.8 -50.22 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 CA-C-N 114.363 -1.289 . . . . 0.0 107.996 177.559 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 464' ' ' TYR . . . . . 0.545 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 14.8 m-30 -53.8 -27.67 30.65 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.66 178.029 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.31 -40.83 20.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.635 0.731 . . . . 0.0 109.476 -178.032 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.613 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.6 mt -57.3 -55.63 19.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 114.174 -1.375 . . . . 0.0 112.196 176.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 0.782 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -102.51 -10.65 19.16 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -172.517 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 93.9 32.22 7.68 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 119.114 -1.517 . . . . 0.0 114.201 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 469' ' ' LEU . . . . . 0.782 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.5 mt -88.45 162.2 16.61 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 117.889 0.844 . . . . 0.0 111.378 176.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 37.7 p30 -100.72 -177.76 3.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.651 170.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 471' ' ' ALA . . . . . 0.503 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -69.43 -12.4 61.62 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.557 0.576 . . . . 0.0 112.557 -176.197 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -89.12 2.03 54.74 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.79 0.329 . . . . 0.0 111.219 -175.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 473' ' ' GLY . . . . . 0.554 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 76.42 12.6 84.15 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -175.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -101.67 150.43 23.12 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 177.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 475' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 469' ' ' LEU . 30.7 t -86.59 138.15 31.93 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.025 -0.67 . . . . 0.0 109.819 175.531 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 476' ' ' ILE . . . . . 0.454 ' C ' HD12 ' A' ' 476' ' ' ILE . 2.4 pp . . . . . 0 C--N 1.314 -0.968 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.849 178.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 386' ' ' PHE . . . . . 0.793 ' CD1' HD22 ' B' ' 414' ' ' LEU . 3.3 t80 . . . . . 0 CA--C 1.53 0.199 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 387' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' B' ' 386' ' ' PHE . 5.9 Cg_endo -46.98 -70.88 0.06 OUTLIER 'Trans proline' 0 N--CA 1.475 0.424 0 C-N-CA 123.914 3.076 . . . . 0.0 114.101 -174.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 388' ' ' MET . . . . . . . . . . . . . 40.6 ttm 71.95 155.53 0.15 Allowed 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.265 0.555 . . . . 0.0 111.852 175.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 389' ' ' HIS . . . . . 0.606 ' H ' ' H ' ' B' ' 393' ' ' ASN . 2.6 m170 -76.37 27.83 0.12 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.674 0.79 . . . . 0.0 112.941 -171.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 390' ' ' GLN . . . . . 0.591 ' HG2' ' O ' ' B' ' 389' ' ' HIS . 2.4 pt20 71.31 3.88 4.84 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.509 0.724 . . . . 0.0 109.884 -168.072 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 391' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -164.31 -43.55 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 392' ' ' GLY . . . . . 0.6 ' HA3' HD13 ' B' ' 395' ' ' ILE . . . -175.81 55.39 0.12 Allowed Glycine 0 C--N 1.336 0.576 0 C-N-CA 118.037 -2.03 . . . . 0.0 115.792 -176.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 393' ' ' ASN . . . . . 0.606 ' H ' ' H ' ' B' ' 389' ' ' HIS . 0.0 OUTLIER -60.81 -36.6 79.47 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 118.217 1.008 . . . . 0.0 108.586 176.307 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 394' ' ' VAL . . . . . 0.723 HG23 HD12 ' B' ' 398' ' ' ILE . 1.5 m -58.36 -50.16 79.56 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 CA-C-N 113.306 -1.77 . . . . 0.0 107.904 178.172 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 395' ' ' ILE . . . . . 0.632 HG21 HG22 ' B' ' 425' ' ' ILE . 4.0 mp -58.07 -52.58 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 CA-C-O 118.005 -0.998 . . . . 0.0 113.568 -173.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 396' ' ' LYS . . . . . 0.607 ' HG3' ' CZ ' ' B' ' 429' ' ' TYR . 0.0 OUTLIER -63.96 -48.35 76.81 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 121.65 2.023 . . . . 0.0 111.464 -173.8 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.75 -45.31 69.49 Favored Glycine 0 N--CA 1.432 -1.583 0 C-N-CA 119.9 -1.143 . . . . 0.0 110.961 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 398' ' ' ILE . . . . . 0.737 HD13 HD12 ' B' ' 410' ' ' LEU . 33.4 mt -70.93 -33.98 54.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -178.291 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 399' ' ' VAL . . . . . 0.499 HG22 ' O ' ' B' ' 396' ' ' LYS . 15.3 m -63.73 -39.48 85.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 C-N-CA 118.796 -1.161 . . . . 0.0 108.475 -174.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -70.82 -35.59 72.55 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 175.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 401' ' ' GLN . . . . . . . . . . . . . 34.5 mm-40 -88.7 -48.1 7.77 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -172.293 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 402' ' ' GLU . . . . . 0.472 ' HG3' ' HE3' ' A' ' 413' ' ' MET . 2.7 mm-40 -121.02 -21.48 6.48 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.727 -170.06 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 108.82 162.89 20.4 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.085 -0.579 . . . . 0.0 113.006 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 404' ' ' VAL . . . . . 0.664 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.5 m -53.76 -41.85 49.55 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.719 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 -176.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 405' ' ' ALA . . . . . 0.591 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -68.9 -30.7 69.24 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 119.797 -0.761 . . . . 0.0 111.855 -176.038 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 406' ' ' THR . . . . . 0.72 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 90.7 m -77.81 -42.78 32.61 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.068 174.138 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 407' ' ' ALA . . . . . 0.45 ' HB2' ' HB ' ' B' ' 398' ' ' ILE . . . -58.33 -37.13 74.5 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 122.078 0.942 . . . . 0.0 109.18 176.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 408' ' ' TYR . . . . . 0.664 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -66.0 -52.08 52.52 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 113.595 -1.639 . . . . 0.0 109.725 176.43 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 409' ' ' THR . . . . . 0.664 HG22 HD23 ' B' ' 410' ' ' LEU . 15.9 m -55.33 -47.31 75.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.675 179.265 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 410' ' ' LEU . . . . . 0.737 HD12 HD13 ' B' ' 398' ' ' ILE . 15.0 mt -72.71 -36.82 67.89 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -174.464 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.67 -34.81 78.43 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 119.868 -1.158 . . . . 0.0 110.629 173.078 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 412' ' ' MET . . . . . 0.403 ' HB2' ' O ' ' B' ' 409' ' ' THR . 0.3 OUTLIER -67.05 -48.52 68.04 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-O 120.634 0.254 . . . . 0.0 111.387 178.19 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 413' ' ' MET . . . . . 0.924 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.8 OUTLIER -71.47 -44.29 65.02 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 119.009 -1.076 . . . . 0.0 112.16 -178.706 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 414' ' ' LEU . . . . . 0.924 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 17.7 mt -68.93 -45.5 70.65 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -176.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 47.0 t -86.05 -24.88 26.18 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.641 0.734 . . . . 0.0 110.004 -176.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 416' ' ' GLY . . . . . . . . . . . . . . . 109.17 -174.57 18.37 Favored Glycine 0 N--CA 1.43 -1.734 0 N-CA-C 109.731 -1.347 . . . . 0.0 109.731 -170.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -80.83 23.31 0.55 Allowed 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.287 0.565 . . . . 0.0 111.535 -171.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 418' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -71.94 75.13 0.9 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.102 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 419' ' ' TYR . . . . . 0.525 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 9.1 p90 -51.04 -38.94 54.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.572 176.137 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -55.37 -43.95 75.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.737 0.304 . . . . 0.0 111.092 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.29 -48.98 63.53 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.11 -178.178 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 422' ' ' VAL . . . . . 0.433 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.2 OUTLIER -66.46 -40.84 87.51 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.278 -176.959 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 423' ' ' SER . . . . . 0.785 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 77.3 p -67.97 -36.63 80.37 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -178.618 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -69.62 -38.22 77.97 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.225 176.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 425' ' ' ILE . . . . . 0.632 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -73.02 -51.8 24.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 O-C-N 122.865 -0.197 . . . . 0.0 111.083 -178.52 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 426' ' ' ILE . . . . . 0.669 HG22 HD22 ' B' ' 430' ' ' LEU . 1.2 mm -74.08 -22.64 18.32 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.796 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -172.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 427' ' ' ARG . . . . . 0.785 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.8 OUTLIER -54.58 -29.85 52.62 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.21 0.529 . . . . 0.0 110.561 -179.251 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -88.58 -7.25 72.22 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.729 178.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 429' ' ' TYR . . . . . 0.607 ' CZ ' ' HG3' ' B' ' 396' ' ' LYS . 22.3 m-85 -116.63 -0.26 12.44 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 121.271 0.557 . . . . 0.0 110.295 -178.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 430' ' ' LEU . . . . . 0.669 HD22 HG22 ' B' ' 426' ' ' ILE . 0.1 OUTLIER -66.08 129.04 94.19 Favored Pre-proline 0 N--CA 1.442 -0.842 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.867 177.807 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 431' ' ' PRO . . . . . 0.563 ' HG3' ' O ' ' B' ' 473' ' ' GLY . 75.1 Cg_exo -25.33 -68.86 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 125.283 3.989 . . . . 0.0 114.919 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 432' ' ' GLY . . . . . 0.532 ' O ' HG12 ' B' ' 435' ' ' VAL . . . -144.52 -165.82 11.22 Favored Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 177.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 433' ' ' GLN . . . . . 0.469 ' O ' HG13 ' B' ' 436' ' ' VAL . 15.5 tp60 -69.39 -27.74 65.56 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 118.156 0.978 . . . . 0.0 110.507 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -67.07 -39.89 86.95 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -176.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 435' ' ' VAL . . . . . 0.666 HG23 HG11 ' B' ' 463' ' ' VAL . 8.8 p -68.66 -44.01 82.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-O 121.013 0.435 . . . . 0.0 110.558 -177.39 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 436' ' ' VAL . . . . . 0.487 HG12 ' O ' ' B' ' 432' ' ' GLY . 0.1 OUTLIER -66.99 -31.4 53.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.431 175.075 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.23 -52.52 40.05 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -178.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 438' ' ' ALA . . . . . 0.812 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -57.9 -39.93 79.1 Favored 'General case' 0 N--CA 1.439 -1.01 0 O-C-N 123.902 0.751 . . . . 0.0 111.969 177.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 439' ' ' LEU . . . . . 0.603 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 2.0 tm? -68.36 -48.73 64.03 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -178.188 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 -59.22 -35.02 72.89 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.484 -1.234 . . . . 0.0 111.202 175.084 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 441' ' ' GLN . . . . . 0.537 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 3.8 mm-40 -53.34 -50.04 65.84 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.052 -178.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 442' ' ' ARG . . . . . 0.708 ' HG3' ' CG ' ' B' ' 459' ' ' HIS . 0.0 OUTLIER -75.95 -25.11 55.62 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 119.377 -0.929 . . . . 0.0 113.198 174.892 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 443' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 56.5 mt -65.3 -33.84 76.94 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.289 0.566 . . . . 0.0 109.558 175.399 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -70.37 -34.2 72.32 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.942 -178.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 445' ' ' GLN . . . . . 0.401 ' HG3' ' N ' ' B' ' 446' ' ' GLU . 0.0 OUTLIER -75.1 -31.07 61.06 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.294 178.699 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 446' ' ' GLU . . . . . 0.401 ' N ' ' HG3' ' B' ' 445' ' ' GLN . 34.6 tt0 48.09 98.69 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 114.818 -1.083 . . . . 0.0 113.143 171.087 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 61.1 mt -65.97 -35.79 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 121.712 0.768 . . . . 0.0 109.811 176.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 448' ' ' ASP . . . . . 0.544 ' O ' ' HG3' ' B' ' 452' ' ' ARG . 17.1 m-20 -169.66 -176.02 2.3 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 -177.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -71.76 -67.77 0.51 Allowed 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.535 173.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -66.87 -25.34 66.36 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 451' ' ' THR . . . . . 0.52 ' OG1' ' HB2' ' B' ' 448' ' ' ASP . 15.9 m -71.1 -22.92 62.03 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.756 -173.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 452' ' ' ARG . . . . . 0.544 ' HG3' ' O ' ' B' ' 448' ' ' ASP . 55.9 mtm180 -55.21 -54.14 47.16 Favored 'General case' 0 C--O 1.219 -0.525 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 170.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 453' ' ' ALA . . . . . 0.525 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -56.93 -48.14 78.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.576 173.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 454' ' ' GLU . . . . . 0.424 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 65.1 mm-40 -51.18 -37.84 48.85 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.263 0.554 . . . . 0.0 111.572 -177.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 25.2 p -118.81 16.24 13.51 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.335 -175.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 456' ' ' PHE . . . . . 0.519 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 0.9 OUTLIER -55.15 -47.08 75.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.142 0.496 . . . . 0.0 111.747 -171.708 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 457' ' ' ILE . . . . . 0.591 HG23 ' HB1' ' B' ' 405' ' ' ALA . 1.9 mp -77.33 -34.3 20.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.198 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -57.68 -34.19 69.15 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.88 0.847 . . . . 0.0 109.234 172.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 459' ' ' HIS . . . . . 0.755 ' O ' HG23 ' B' ' 463' ' ' VAL . 51.5 m-70 -73.61 -29.25 62.27 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.981 176.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 460' ' ' LEU . . . . . 0.709 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -73.64 -33.96 64.75 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.765 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 461' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -72.94 -38.43 66.79 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.195 175.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 462' ' ' ALA . . . . . 0.622 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -55.78 -33.8 64.69 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.76 169.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 463' ' ' VAL . . . . . 0.812 HG13 ' HB3' ' B' ' 438' ' ' ALA . 62.9 t -62.91 -50.15 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.008 177.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 464' ' ' TYR . . . . . 0.539 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 15.0 m-30 -53.79 -27.82 31.43 Favored 'General case' 0 C--N 1.332 -0.193 0 O-C-N 124.237 0.961 . . . . 0.0 110.599 178.24 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.27 -40.86 20.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.693 0.758 . . . . 0.0 109.359 -177.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 466' ' ' ILE . . . . . 0.622 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.6 mt -57.23 -55.6 19.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 114.305 -1.316 . . . . 0.0 112.19 176.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 467' ' ' LEU . . . . . 0.782 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -102.69 -10.63 19.04 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -172.389 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 468' ' ' GLY . . . . . . . . . . . . . . . 93.92 32.24 7.66 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 119.013 -1.565 . . . . 0.0 114.304 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 469' ' ' LEU . . . . . 0.782 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.5 mt -88.58 162.27 16.47 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 117.915 0.857 . . . . 0.0 111.249 177.063 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 37.6 p30 -100.86 -177.75 3.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.587 170.208 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 471' ' ' ALA . . . . . 0.51 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -69.81 -11.5 60.9 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -176.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -89.34 1.95 55.07 Favored 'General case' 0 C--N 1.32 -0.682 0 O-C-N 122.262 -0.273 . . . . 0.0 111.213 -176.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 473' ' ' GLY . . . . . 0.563 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 76.43 12.48 84.26 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 -175.384 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -101.61 150.56 22.97 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 475' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' B' ' 469' ' ' LEU . 32.3 t -86.81 137.7 32.2 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.147 -0.621 . . . . 0.0 109.893 175.556 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 476' ' ' ILE . . . . . 0.459 ' C ' HD12 ' B' ' 476' ' ' ILE . 2.4 pp . . . . . 0 C--N 1.315 -0.932 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.923 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 386' ' ' PHE . . . . . 0.717 ' CD1' HD22 ' A' ' 414' ' ' LEU . 2.9 t80 . . . . . 0 N--CA 1.451 -0.394 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 387' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 386' ' ' PHE . 1.3 Cg_endo -43.01 -75.36 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.821 3.014 . . . . 0.0 113.892 -175.172 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 28.5 ttm 67.22 143.43 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.607 0 O-C-N 123.397 0.435 . . . . 0.0 110.305 -178.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 389' ' ' HIS . . . . . 0.632 ' H ' ' HB3' ' A' ' 393' ' ' ASN . 29.3 m170 -54.85 -79.24 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.694 0.759 . . . . 0.0 110.076 -174.142 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 390' ' ' GLN . . . . . 0.407 ' H ' HD23 ' A' ' 391' ' ' LEU . 13.9 pt20 -153.46 19.35 0.55 Allowed 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 170.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.515 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.6 pt? -173.9 -48.54 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.837 -170.313 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 392' ' ' GLY . . . . . 0.621 ' HA3' HD13 ' A' ' 395' ' ' ILE . . . -172.48 53.88 0.17 Allowed Glycine 0 C--O 1.223 -0.593 0 C-N-CA 118.81 -1.662 . . . . 0.0 115.305 -171.44 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 393' ' ' ASN . . . . . 0.632 ' HB3' ' H ' ' A' ' 389' ' ' HIS . 0.0 OUTLIER -57.34 -38.06 73.51 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 118.361 1.081 . . . . 0.0 108.869 176.273 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 394' ' ' VAL . . . . . 0.627 HG23 HD12 ' A' ' 398' ' ' ILE . 1.9 m -58.23 -49.52 81.48 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 CA-C-N 113.189 -1.823 . . . . 0.0 107.77 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 395' ' ' ILE . . . . . 0.676 HG23 HD13 ' A' ' 426' ' ' ILE . 4.2 mp -58.26 -52.8 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 CA-C-O 117.97 -1.014 . . . . 0.0 113.462 -174.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 396' ' ' LYS . . . . . 0.638 ' HG3' ' CZ ' ' A' ' 429' ' ' TYR . 0.1 OUTLIER -63.91 -48.93 74.65 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 121.796 2.089 . . . . 0.0 112.024 -172.865 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -54.02 -45.26 72.36 Favored Glycine 0 N--CA 1.438 -1.181 0 C-N-CA 119.88 -1.153 . . . . 0.0 111.238 -178.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 398' ' ' ILE . . . . . 0.722 ' CD1' HD12 ' A' ' 410' ' ' LEU . 33.6 mt -71.04 -34.56 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -178.117 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 399' ' ' VAL . . . . . 0.517 HG12 ' HA ' ' A' ' 404' ' ' VAL . 11.7 m -63.68 -39.68 86.25 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 C-N-CA 119.05 -1.06 . . . . 0.0 108.728 -173.441 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -67.4 -39.9 85.58 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 176.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -93.43 -50.73 5.3 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -170.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 402' ' ' GLU . . . . . 0.402 ' HG2' HG21 ' A' ' 406' ' ' THR . 16.1 tp10 -108.87 -20.19 13.14 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.227 0.537 . . . . 0.0 110.461 -172.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 105.44 162.5 23.46 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.548 -0.751 . . . . 0.0 113.159 177.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 404' ' ' VAL . . . . . 0.616 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.5 m -52.98 -45.59 52.34 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.738 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -175.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 405' ' ' ALA . . . . . 0.529 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -64.93 -30.06 71.03 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 119.793 -0.763 . . . . 0.0 112.488 -177.119 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.71 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 86.2 m -77.45 -42.42 36.05 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 120.096 -0.642 . . . . 0.0 110.216 173.232 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.5 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.86 -37.23 76.04 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 122.252 1.025 . . . . 0.0 109.043 177.076 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 408' ' ' TYR . . . . . 0.616 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.31 -52.95 50.64 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 113.364 -1.744 . . . . 0.0 109.889 176.687 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 409' ' ' THR . . . . . 0.692 HG22 HD23 ' A' ' 410' ' ' LEU . 9.0 m -55.58 -47.17 76.88 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.395 -0.821 . . . . 0.0 112.557 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 410' ' ' LEU . . . . . 0.722 HD12 ' CD1' ' A' ' 398' ' ' ILE . 14.5 mt -72.4 -36.32 68.62 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.055 -175.007 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -60.0 -35.2 86.48 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 119.973 -1.108 . . . . 0.0 110.789 172.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -67.98 -46.55 71.05 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 115.812 -0.194 . . . . 0.0 111.399 178.487 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 413' ' ' MET . . . . . 0.897 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.4 OUTLIER -70.62 -48.95 52.49 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 118.834 -1.147 . . . . 0.0 111.821 179.691 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 414' ' ' LEU . . . . . 0.897 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 16.0 mt -68.38 -46.69 69.35 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -176.016 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 14.6 t -92.9 -1.86 56.35 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.297 0.57 . . . . 0.0 110.063 -173.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 416' ' ' GLY . . . . . 0.407 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 93.1 -177.55 38.27 Favored Glycine 0 N--CA 1.434 -1.485 0 C-N-CA 120.395 -0.907 . . . . 0.0 110.916 -176.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -79.98 23.36 0.46 Allowed 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.126 0.488 . . . . 0.0 111.31 -172.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 418' ' ' ASN . . . . . 0.407 ' H ' ' C ' ' A' ' 416' ' ' GLY . 5.5 m-20 -71.61 76.0 0.81 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.612 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 419' ' ' TYR . . . . . 0.544 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 11.1 p90 -51.41 -38.55 54.07 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.366 176.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -55.29 -43.79 75.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.671 0.272 . . . . 0.0 110.919 178.002 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.47 -49.17 61.75 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.949 -177.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 422' ' ' VAL . . . . . 0.445 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.3 OUTLIER -66.84 -40.36 85.68 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.214 -176.954 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.743 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 79.2 p -66.98 -38.91 86.92 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.38 -39.5 91.62 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.255 176.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 425' ' ' ILE . . . . . 0.636 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -73.06 -50.82 29.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 121.223 -0.191 . . . . 0.0 111.032 -177.234 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 426' ' ' ILE . . . . . 0.676 HD13 HG23 ' A' ' 395' ' ' ILE . 1.2 mm -74.96 -22.52 17.07 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.823 0 CA-C-O 120.886 0.374 . . . . 0.0 110.27 -172.236 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.743 ' HB2' ' O ' ' A' ' 423' ' ' SER . 0.8 OUTLIER -55.02 -30.13 58.88 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.217 0.532 . . . . 0.0 110.64 -179.008 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.74 -6.06 77.08 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.638 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.638 ' CZ ' ' HG3' ' A' ' 396' ' ' LYS . 22.9 m-85 -118.23 0.54 11.75 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 120.977 0.418 . . . . 0.0 110.665 -177.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.678 HD23 ' HA ' ' A' ' 427' ' ' ARG . 0.1 OUTLIER -65.71 128.2 93.63 Favored Pre-proline 0 N--CA 1.441 -0.907 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 179.032 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 431' ' ' PRO . . . . . 0.455 ' HG3' ' O ' ' A' ' 473' ' ' GLY . 80.8 Cg_exo -23.87 -69.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.905 1 C-N-CA 125.514 4.143 . . . . 0.0 114.857 179.887 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 432' ' ' GLY . . . . . 0.51 ' O ' HG12 ' A' ' 435' ' ' VAL . . . -138.8 -166.9 10.78 Favored Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 174.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 433' ' ' GLN . . . . . 0.506 ' O ' HG13 ' A' ' 436' ' ' VAL . 50.3 tp60 -70.8 -26.88 63.52 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 118.241 1.021 . . . . 0.0 110.457 177.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -64.75 -39.51 93.75 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -177.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 435' ' ' VAL . . . . . 0.794 HG23 HG11 ' A' ' 463' ' ' VAL . 7.5 p -68.72 -43.94 82.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-O 120.968 0.413 . . . . 0.0 110.501 -178.385 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.506 HG13 ' O ' ' A' ' 433' ' ' GLN . 0.1 OUTLIER -67.15 -30.29 48.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.668 175.579 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.48 -51.91 45.6 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 438' ' ' ALA . . . . . 0.827 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -57.0 -43.93 82.27 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.003 177.094 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 439' ' ' LEU . . . . . 0.634 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 2.1 tm? -64.69 -47.64 77.64 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 -176.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -57.86 -39.7 78.4 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.81 -1.086 . . . . 0.0 111.362 175.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 441' ' ' GLN . . . . . 0.607 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 9.2 mm-40 -55.59 -51.25 67.76 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 123.473 0.709 . . . . 0.0 110.83 175.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 442' ' ' ARG . . . . . 0.77 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -58.13 -33.81 69.55 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.798 173.174 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 443' ' ' LEU . . . . . 0.634 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 57.1 mt -72.25 -36.6 69.1 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-O 120.865 0.364 . . . . 0.0 110.227 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -57.49 -37.58 73.18 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.607 0.717 . . . . 0.0 110.67 174.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -73.2 -26.77 61.29 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.238 177.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 446' ' ' GLU . . . . . 0.453 ' HB3' ' O ' ' A' ' 443' ' ' LEU . 7.4 pt-20 23.7 103.13 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 173.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 60.3 mt -62.21 -34.1 62.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.577 0.703 . . . . 0.0 110.13 176.16 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 448' ' ' ASP . . . . . 0.5 ' HB2' ' OG1' ' A' ' 451' ' ' THR . 17.8 m-20 -162.8 -159.43 0.56 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -84.45 -66.35 0.9 Allowed 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 171.473 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 450' ' ' GLN . . . . . 0.513 ' O ' ' HB3' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -70.91 -25.54 62.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.855 0.359 . . . . 0.0 111.895 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 451' ' ' THR . . . . . 0.5 ' OG1' ' HB2' ' A' ' 448' ' ' ASP . 12.4 m -67.4 -22.54 65.54 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 122.037 -0.414 . . . . 0.0 110.679 -178.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 66.4 mtm180 -54.99 -51.37 66.45 Favored 'General case' 0 C--O 1.216 -0.66 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 170.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 453' ' ' ALA . . . . . 0.544 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -53.41 -52.24 60.01 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 124.352 1.033 . . . . 0.0 112.293 173.092 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 454' ' ' GLU . . . . . 0.435 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 23.6 mm-40 -51.15 -32.44 23.11 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.255 0.55 . . . . 0.0 111.987 -178.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 28.7 p -119.69 14.36 12.6 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.972 -175.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 456' ' ' PHE . . . . . 0.535 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.8 OUTLIER -58.37 -47.57 83.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.383 -170.995 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 457' ' ' ILE . . . . . 0.529 HG23 ' HB1' ' A' ' 405' ' ' ALA . 1.9 mp -77.21 -31.42 18.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.08 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -56.47 -39.01 72.48 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 122.025 0.917 . . . . 0.0 108.689 170.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 459' ' ' HIS . . . . . 0.735 ' O ' HG23 ' A' ' 463' ' ' VAL . 50.3 m-70 -73.22 -28.07 61.97 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 114.179 -1.373 . . . . 0.0 110.381 -178.535 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 460' ' ' LEU . . . . . 0.74 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -74.46 -35.11 63.31 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.864 0.84 . . . . 0.0 108.886 178.391 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 461' ' ' ASN . . . . . 0.42 ' O ' ' HB2' ' A' ' 464' ' ' TYR . 23.6 m-80 -73.44 -37.67 65.77 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.92 0.866 . . . . 0.0 109.0 176.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 462' ' ' ALA . . . . . 0.62 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -56.61 -33.32 66.14 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.402 -1.272 . . . . 0.0 109.788 169.254 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.827 HG13 ' HB3' ' A' ' 438' ' ' ALA . 63.2 t -62.19 -50.68 79.0 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.751 0 CA-C-N 114.555 -1.202 . . . . 0.0 107.804 175.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 464' ' ' TYR . . . . . 0.579 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 18.2 m-30 -53.27 -28.2 26.58 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 124.478 1.111 . . . . 0.0 110.38 178.535 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.63 -40.89 20.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.583 0.706 . . . . 0.0 109.676 -177.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.62 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.4 mt -56.61 -55.52 19.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.336 -1.302 . . . . 0.0 112.294 176.086 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 0.783 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -102.66 -10.01 19.59 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -171.985 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 93.57 32.31 7.76 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 119.242 -1.456 . . . . 0.0 114.237 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 469' ' ' LEU . . . . . 0.783 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.3 mt -88.67 165.64 14.63 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 117.862 0.831 . . . . 0.0 111.351 176.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 45.1 p30 -104.05 -178.77 3.75 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.559 170.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 471' ' ' ALA . . . . . 0.556 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -62.1 -21.58 65.1 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -177.229 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -88.17 5.33 41.93 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.418 -172.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 473' ' ' GLY . . . . . 0.455 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 74.92 15.38 81.01 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.346 -0.93 . . . . 0.0 111.047 -177.102 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -101.08 152.13 20.98 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 11.0 p -89.53 130.93 35.78 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.923 0.392 . . . . 0.0 110.978 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 476' ' ' ILE . . . . . . . . . . . . . 2.6 pp . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.309 -178.94 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 386' ' ' PHE . . . . . 0.718 ' CD1' HD22 ' B' ' 414' ' ' LEU . 3.0 t80 . . . . . 0 N--CA 1.451 -0.397 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 387' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -43.08 -75.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.786 2.99 . . . . 0.0 113.892 -175.085 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 388' ' ' MET . . . . . . . . . . . . . 28.4 ttm 67.2 143.76 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.652 0 O-C-N 123.497 0.498 . . . . 0.0 110.155 -178.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 389' ' ' HIS . . . . . 0.634 ' H ' ' HB3' ' B' ' 393' ' ' ASN . 29.5 m170 -55.15 -79.15 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.542 0.687 . . . . 0.0 110.113 -174.262 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 390' ' ' GLN . . . . . 0.413 ' H ' HD23 ' B' ' 391' ' ' LEU . 13.8 pt20 -153.27 19.33 0.56 Allowed 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 170.392 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 391' ' ' LEU . . . . . 0.514 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.5 pt? -173.86 -48.61 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.868 -170.071 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 392' ' ' GLY . . . . . 0.629 ' HA3' HD13 ' B' ' 395' ' ' ILE . . . -172.6 53.91 0.17 Allowed Glycine 0 CA--C 1.524 0.621 0 C-N-CA 118.796 -1.668 . . . . 0.0 115.215 -171.531 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 393' ' ' ASN . . . . . 0.634 ' HB3' ' H ' ' B' ' 389' ' ' HIS . 0.0 OUTLIER -57.29 -38.08 73.43 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 118.295 1.047 . . . . 0.0 108.865 176.228 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 394' ' ' VAL . . . . . 0.62 HG23 HD12 ' B' ' 398' ' ' ILE . 1.8 m -58.27 -49.39 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 CA-C-N 113.213 -1.812 . . . . 0.0 107.791 179.186 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 395' ' ' ILE . . . . . 0.663 HG23 HD13 ' B' ' 426' ' ' ILE . 4.2 mp -58.26 -52.91 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-O 117.849 -1.072 . . . . 0.0 113.441 -174.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 396' ' ' LYS . . . . . 0.636 ' HG3' ' CZ ' ' B' ' 429' ' ' TYR . 0.1 OUTLIER -63.96 -49.18 73.57 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 121.832 2.106 . . . . 0.0 111.93 -172.802 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.79 -45.15 70.22 Favored Glycine 0 N--CA 1.438 -1.193 0 C-N-CA 119.86 -1.162 . . . . 0.0 111.279 -178.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 398' ' ' ILE . . . . . 0.72 HD13 HD12 ' B' ' 410' ' ' LEU . 32.8 mt -71.07 -34.38 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -178.169 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 399' ' ' VAL . . . . . 0.508 HG12 ' HA ' ' B' ' 404' ' ' VAL . 11.5 m -63.77 -39.93 87.18 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 C-N-CA 118.898 -1.121 . . . . 0.0 108.748 -173.476 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -67.34 -39.68 85.81 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 176.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 401' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -93.67 -50.69 5.27 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 -170.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 402' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -108.72 -20.31 13.12 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.191 0.519 . . . . 0.0 110.392 -173.022 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 105.29 162.65 23.62 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.663 -0.699 . . . . 0.0 113.25 177.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 404' ' ' VAL . . . . . 0.604 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.5 m -53.18 -45.36 54.48 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.792 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 -175.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 405' ' ' ALA . . . . . 0.508 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -65.21 -29.86 70.7 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 119.761 -0.775 . . . . 0.0 112.457 -177.032 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 406' ' ' THR . . . . . 0.708 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 85.6 m -77.46 -42.55 35.51 Favored 'General case' 0 C--O 1.222 -0.368 0 C-N-CA 120.191 -0.604 . . . . 0.0 110.238 173.093 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 407' ' ' ALA . . . . . 0.5 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.9 -37.11 75.86 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 122.128 0.966 . . . . 0.0 109.005 177.119 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 408' ' ' TYR . . . . . 0.604 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.44 -52.95 49.5 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 113.394 -1.73 . . . . 0.0 109.863 176.708 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 409' ' ' THR . . . . . 0.683 HG22 HD23 ' B' ' 410' ' ' LEU . 9.9 m -55.61 -47.08 77.13 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.51 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 410' ' ' LEU . . . . . 0.72 HD12 HD13 ' B' ' 398' ' ' ILE . 14.4 mt -72.42 -36.33 68.58 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.045 -175.065 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -59.84 -35.27 86.07 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 119.854 -1.165 . . . . 0.0 110.803 172.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 412' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -68.1 -46.48 70.85 Favored 'General case' 0 C--O 1.224 -0.289 0 CA-C-O 120.486 0.184 . . . . 0.0 111.414 178.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 413' ' ' MET . . . . . 0.888 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.4 OUTLIER -70.82 -48.25 55.08 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 118.847 -1.141 . . . . 0.0 112.038 179.662 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 414' ' ' LEU . . . . . 0.888 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 15.9 mt -68.92 -46.65 67.74 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -176.321 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 13.9 t -93.09 -1.77 56.15 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.296 0.57 . . . . 0.0 110.091 -173.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 416' ' ' GLY . . . . . 0.402 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 93.07 -177.46 38.24 Favored Glycine 0 N--CA 1.435 -1.388 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -176.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -79.95 23.42 0.45 Allowed 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.169 0.509 . . . . 0.0 111.314 -172.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 418' ' ' ASN . . . . . 0.402 ' H ' ' C ' ' B' ' 416' ' ' GLY . 5.4 m-20 -71.6 75.87 0.81 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.567 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 419' ' ' TYR . . . . . 0.552 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 10.9 p90 -51.36 -38.52 53.66 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.387 176.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -55.23 -43.88 74.94 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.753 0.311 . . . . 0.0 110.966 177.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.56 -49.0 62.8 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.852 -177.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 422' ' ' VAL . . . . . 0.449 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.3 OUTLIER -66.8 -40.49 86.03 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.26 -177.069 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 423' ' ' SER . . . . . 0.772 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 79.5 p -66.95 -38.99 87.15 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.47 -39.16 91.28 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.186 176.022 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 425' ' ' ILE . . . . . 0.653 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -73.08 -51.37 26.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.593 0.196 . . . . 0.0 111.025 -177.445 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 426' ' ' ILE . . . . . 0.667 HG22 HD22 ' B' ' 430' ' ' LEU . 1.1 mm -74.6 -22.51 17.56 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.808 0 CA-C-O 120.863 0.363 . . . . 0.0 110.242 -172.117 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 427' ' ' ARG . . . . . 0.772 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.8 OUTLIER -54.98 -30.34 58.95 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.242 0.544 . . . . 0.0 110.586 -178.893 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.57 -6.17 77.54 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.481 178.062 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 429' ' ' TYR . . . . . 0.636 ' CZ ' ' HG3' ' B' ' 396' ' ' LYS . 22.9 m-85 -118.17 0.75 11.83 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 120.996 0.427 . . . . 0.0 110.534 -177.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 430' ' ' LEU . . . . . 0.675 HD23 ' HA ' ' B' ' 427' ' ' ARG . 0.1 OUTLIER -65.72 128.18 93.62 Favored Pre-proline 0 N--CA 1.442 -0.861 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.929 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 431' ' ' PRO . . . . . 0.461 ' HG3' ' O ' ' B' ' 473' ' ' GLY . 80.4 Cg_exo -23.67 -70.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 0.988 1 C-N-CA 125.478 4.119 . . . . 0.0 114.673 179.769 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 432' ' ' GLY . . . . . 0.502 ' O ' HG12 ' B' ' 435' ' ' VAL . . . -138.25 -166.38 10.65 Favored Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 175.11 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 433' ' ' GLN . . . . . 0.516 ' O ' HG13 ' B' ' 436' ' ' VAL . 50.1 tp60 -71.08 -26.85 63.24 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 118.352 1.076 . . . . 0.0 110.46 177.589 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -64.7 -39.7 94.1 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -177.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 435' ' ' VAL . . . . . 0.789 HG23 HG11 ' B' ' 463' ' ' VAL . 7.6 p -68.66 -43.82 82.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 120.938 0.399 . . . . 0.0 110.543 -178.445 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 436' ' ' VAL . . . . . 0.516 HG13 ' O ' ' B' ' 433' ' ' GLN . 0.1 OUTLIER -67.48 -30.1 47.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.766 0.317 . . . . 0.0 110.56 175.669 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 437' ' ' THR . . . . . 0.408 HG22 ' N ' ' B' ' 438' ' ' ALA . 0.9 OUTLIER -67.47 -51.91 45.71 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 179.909 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 438' ' ' ALA . . . . . 0.816 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -57.1 -43.96 82.73 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 124.089 0.868 . . . . 0.0 111.087 177.043 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 439' ' ' LEU . . . . . 0.633 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 2.1 tm? -64.77 -47.47 78.06 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -176.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -58.06 -39.52 78.7 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.293 175.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 441' ' ' GLN . . . . . 0.607 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 9.2 mm-40 -55.77 -51.31 67.87 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 123.447 0.699 . . . . 0.0 110.813 175.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 442' ' ' ARG . . . . . 0.763 ' HG2' ' O ' ' B' ' 438' ' ' ALA . 0.0 OUTLIER -58.08 -33.75 69.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.739 173.207 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 443' ' ' LEU . . . . . 0.633 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 56.6 mt -72.38 -36.2 68.65 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-O 120.927 0.394 . . . . 0.0 110.247 179.079 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -57.68 -37.76 74.0 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.642 174.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -72.99 -26.8 61.47 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.911 -1.04 . . . . 0.0 111.036 178.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 446' ' ' GLU . . . . . 0.45 ' HB3' ' O ' ' B' ' 443' ' ' LEU . 7.5 pt-20 23.79 103.31 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 174.201 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 60.7 mt -62.33 -34.17 62.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.556 0.693 . . . . 0.0 110.091 175.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 448' ' ' ASP . . . . . 0.494 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 15.9 m-20 -162.76 -159.31 0.55 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -84.5 -66.21 0.92 Allowed 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.588 -0.445 . . . . 0.0 109.852 171.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 450' ' ' GLN . . . . . 0.514 ' O ' ' HB3' ' B' ' 453' ' ' ALA . 0.0 OUTLIER -70.94 -25.67 62.84 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.828 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 451' ' ' THR . . . . . 0.494 ' OG1' ' HB2' ' B' ' 448' ' ' ASP . 12.2 m -67.3 -22.66 65.62 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.71 -178.621 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 452' ' ' ARG . . . . . . . . . . . . . 66.0 mtm180 -54.87 -51.54 65.6 Favored 'General case' 0 C--O 1.216 -0.687 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 170.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 453' ' ' ALA . . . . . 0.552 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -53.24 -51.94 60.58 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.338 173.047 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 454' ' ' GLU . . . . . 0.434 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 24.0 mm-40 -51.59 -32.19 27.72 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.128 -178.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 29.6 p -119.84 14.36 12.47 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.985 -175.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 456' ' ' PHE . . . . . 0.537 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 0.8 OUTLIER -58.26 -47.74 82.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.348 -170.98 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 457' ' ' ILE . . . . . 0.533 ' CG1' ' HB3' ' B' ' 408' ' ' TYR . 1.9 mp -77.04 -31.11 18.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.108 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -56.66 -39.16 73.25 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 170.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 459' ' ' HIS . . . . . 0.74 ' O ' HG23 ' B' ' 463' ' ' VAL . 49.5 m-70 -73.21 -27.99 61.92 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.126 -1.397 . . . . 0.0 110.4 -178.36 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 460' ' ' LEU . . . . . 0.736 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -74.54 -35.06 63.12 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.957 0.884 . . . . 0.0 108.975 178.163 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 461' ' ' ASN . . . . . 0.411 ' O ' ' HB2' ' B' ' 464' ' ' TYR . 23.7 m-80 -73.33 -37.63 66.05 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.886 0.85 . . . . 0.0 109.1 176.618 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 462' ' ' ALA . . . . . 0.63 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -56.73 -33.25 66.34 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.326 -1.306 . . . . 0.0 109.839 169.327 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 463' ' ' VAL . . . . . 0.816 HG13 ' HB3' ' B' ' 438' ' ' ALA . 63.9 t -62.32 -50.79 78.5 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.799 0 CA-C-N 114.545 -1.207 . . . . 0.0 107.781 175.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 464' ' ' TYR . . . . . 0.575 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 18.1 m-30 -53.12 -28.18 24.36 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.53 178.424 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.66 -41.2 19.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.594 0.711 . . . . 0.0 109.587 -177.585 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 466' ' ' ILE . . . . . 0.63 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.5 mt -56.29 -55.66 17.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 114.396 -1.275 . . . . 0.0 112.399 176.059 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 467' ' ' LEU . . . . . 0.781 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -102.23 -10.39 19.61 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -172.248 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 468' ' ' GLY . . . . . . . . . . . . . . . 93.75 32.45 7.6 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 119.209 -1.472 . . . . 0.0 114.236 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 469' ' ' LEU . . . . . 0.781 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.3 mt -88.69 165.53 14.69 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 117.929 0.864 . . . . 0.0 111.243 176.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 45.6 p30 -103.9 -178.41 3.65 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.589 170.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 471' ' ' ALA . . . . . 0.547 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -62.66 -21.52 65.77 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -176.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -87.98 5.22 41.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.414 -172.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 473' ' ' GLY . . . . . 0.461 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 75.08 15.2 81.23 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.275 -0.964 . . . . 0.0 111.119 -177.116 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -101.07 151.97 21.17 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 10.3 p -89.48 131.1 35.69 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.05 0.452 . . . . 0.0 110.982 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 476' ' ' ILE . . . . . . . . . . . . . 2.6 pp . . . . . 0 C--N 1.327 -0.396 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.263 -178.828 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 386' ' ' PHE . . . . . 0.761 ' CE2' HG12 ' A' ' 394' ' ' VAL . 2.6 t80 . . . . . 0 CA--C 1.531 0.245 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 387' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 386' ' ' PHE . 40.5 Cg_endo -64.69 105.8 0.68 Allowed 'Trans proline' 0 N--CA 1.478 0.571 0 C-N-CA 123.788 2.992 . . . . 0.0 112.176 173.062 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.626 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 5.2 ttp -122.01 55.26 1.13 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.29 0.567 . . . . 0.0 111.289 -168.518 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 389' ' ' HIS . . . . . 0.573 ' CE1' ' HA ' ' A' ' 393' ' ' ASN . 39.2 m170 52.93 -98.9 0.08 Allowed 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.026 -172.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -148.55 17.12 1.02 Allowed 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 171.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.625 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.5 pt? -167.3 -62.54 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.84 -171.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 392' ' ' GLY . . . . . 0.691 ' HA3' HD13 ' A' ' 395' ' ' ILE . . . -163.14 60.03 0.27 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 119.914 -1.136 . . . . 0.0 114.396 -172.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 393' ' ' ASN . . . . . 0.626 ' HB3' ' HA ' ' A' ' 388' ' ' MET . 0.2 OUTLIER -57.48 -43.39 84.07 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.996 0.427 . . . . 0.0 109.861 174.192 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 394' ' ' VAL . . . . . 0.761 HG12 ' CE2' ' A' ' 386' ' ' PHE . 2.0 m -55.71 -45.91 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 -179.187 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 395' ' ' ILE . . . . . 0.691 HD13 ' HA3' ' A' ' 392' ' ' GLY . 3.7 mp -58.02 -52.72 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 CA-C-O 117.812 -1.09 . . . . 0.0 113.53 -174.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 396' ' ' LYS . . . . . 0.557 ' O ' HG22 ' A' ' 399' ' ' VAL . 0.0 OUTLIER -62.79 -49.62 74.25 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 121.952 2.16 . . . . 0.0 112.186 -174.756 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 397' ' ' GLY . . . . . 0.526 ' O ' ' HG3' ' A' ' 401' ' ' GLN . . . -53.1 -44.44 63.13 Favored Glycine 0 N--CA 1.433 -1.54 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.84 -176.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 398' ' ' ILE . . . . . 0.81 HD13 HD12 ' A' ' 410' ' ' LEU . 39.1 mt -71.52 -33.81 50.78 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -179.183 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 399' ' ' VAL . . . . . 0.557 HG22 ' O ' ' A' ' 396' ' ' LYS . 13.8 m -63.72 -39.88 86.99 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 C-N-CA 118.727 -1.189 . . . . 0.0 108.252 -174.225 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -63.58 -42.96 98.27 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 174.167 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 401' ' ' GLN . . . . . 0.526 ' HG3' ' O ' ' A' ' 397' ' ' GLY . 37.3 mt-30 -92.68 -48.17 6.72 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -169.216 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 402' ' ' GLU . . . . . 0.678 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 2.8 mm-40 -114.38 -19.31 11.28 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.149 0.499 . . . . 0.0 111.494 -171.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 104.15 162.78 24.68 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.886 177.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 404' ' ' VAL . . . . . 0.663 HG11 ' HA ' ' A' ' 430' ' ' LEU . 1.7 m -53.72 -45.46 61.12 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.83 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -175.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 405' ' ' ALA . . . . . 0.558 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -64.87 -31.18 72.29 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 119.787 -0.765 . . . . 0.0 112.328 -176.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.689 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 85.5 m -76.75 -42.78 39.79 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.101 -0.639 . . . . 0.0 110.365 173.308 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.469 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.67 -36.4 74.12 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 122.016 0.912 . . . . 0.0 109.195 176.538 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 408' ' ' TYR . . . . . 0.622 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.83 -52.16 52.87 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 113.649 -1.614 . . . . 0.0 109.771 176.285 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 409' ' ' THR . . . . . 0.668 HG22 HD23 ' A' ' 410' ' ' LEU . 17.6 m -54.67 -47.62 73.38 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.562 178.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 410' ' ' LEU . . . . . 0.81 HD12 HD13 ' A' ' 398' ' ' ILE . 13.6 mt -72.84 -35.99 67.37 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.123 -174.629 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -59.41 -34.77 82.35 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 119.966 -1.111 . . . . 0.0 110.592 173.107 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 412' ' ' MET . . . . . 0.413 ' HB2' ' O ' ' A' ' 409' ' ' THR . 0.3 OUTLIER -65.91 -48.47 71.34 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 115.726 -0.237 . . . . 0.0 111.32 177.719 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 413' ' ' MET . . . . . 0.913 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.5 OUTLIER -71.64 -46.5 58.83 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 118.988 -1.085 . . . . 0.0 111.974 -179.508 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 414' ' ' LEU . . . . . 0.913 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 16.4 mt -68.69 -45.09 72.57 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -176.106 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 33.9 t -86.57 -21.58 26.78 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.483 0.659 . . . . 0.0 110.176 -175.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 416' ' ' GLY . . . . . 0.42 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 107.55 -175.81 20.45 Favored Glycine 0 N--CA 1.429 -1.775 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -171.427 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -79.75 23.68 0.42 Allowed 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.598 0.713 . . . . 0.0 111.405 -172.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 418' ' ' ASN . . . . . 0.42 ' H ' ' C ' ' A' ' 416' ' ' GLY . 62.5 m-80 -71.83 74.77 0.87 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.687 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 419' ' ' TYR . . . . . 0.535 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 23.2 p90 -52.29 -37.32 55.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.764 174.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -53.82 -46.4 71.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.691 177.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 421' ' ' LEU . . . . . 0.408 ' O ' HD13 ' A' ' 425' ' ' ILE . 0.0 OUTLIER -68.96 -49.53 57.13 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.389 -177.837 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 422' ' ' VAL . . . . . 0.457 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -65.74 -39.09 83.83 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.144 -175.879 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.805 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 77.7 p -66.7 -39.24 88.0 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.793 -178.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -68.45 -38.63 86.99 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.136 176.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 425' ' ' ILE . . . . . 0.567 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.18 -52.27 25.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.456 0.17 . . . . 0.0 111.01 -177.259 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 426' ' ' ILE . . . . . 0.666 HD13 HG23 ' A' ' 395' ' ' ILE . 1.1 mm -74.36 -22.75 17.96 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.897 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -173.32 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.805 ' HB2' ' O ' ' A' ' 423' ' ' SER . 1.1 tmt_? -54.64 -33.15 60.2 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.103 0.478 . . . . 0.0 110.699 -177.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -85.87 -10.8 74.98 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.148 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.552 ' HD1' HG22 ' A' ' 395' ' ' ILE . 9.7 m-30 -113.64 -0.14 14.42 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.421 0.629 . . . . 0.0 109.366 -174.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.68 HD23 ' HA ' ' A' ' 427' ' ' ARG . 0.1 OUTLIER -66.02 129.5 94.26 Favored Pre-proline 0 N--CA 1.445 -0.718 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.291 178.267 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 431' ' ' PRO . . . . . 0.546 ' HD2' HD12 ' A' ' 430' ' ' LEU . 94.6 Cg_exo -23.72 -66.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.359 1.088 1 C-N-CA 125.768 4.312 . . . . 0.0 115.122 179.589 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 432' ' ' GLY . . . . . 0.519 ' H ' HG12 ' A' ' 435' ' ' VAL . . . -145.86 -166.41 11.95 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 177.135 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 433' ' ' GLN . . . . . 0.491 ' O ' HG13 ' A' ' 436' ' ' VAL . 17.0 tp60 -70.01 -27.43 64.67 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 117.904 0.852 . . . . 0.0 110.526 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -67.12 -40.97 86.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.995 -177.256 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 435' ' ' VAL . . . . . 0.711 HG23 HG11 ' A' ' 463' ' ' VAL . 7.9 p -67.87 -43.43 86.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 121.004 0.431 . . . . 0.0 110.641 -177.15 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.509 HG12 ' O ' ' A' ' 432' ' ' GLY . 0.1 OUTLIER -66.38 -31.97 55.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.483 175.832 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.29 -52.45 40.4 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -178.535 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 438' ' ' ALA . . . . . 0.865 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -58.35 -38.7 77.73 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.225 177.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 439' ' ' LEU . . . . . 0.605 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 1.9 tm? -68.99 -48.53 62.87 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.19 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -58.89 -35.76 73.56 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.717 -1.128 . . . . 0.0 111.327 176.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 441' ' ' GLN . . . . . 0.448 ' O ' ' HG2' ' A' ' 445' ' ' GLN . 5.8 mm-40 -56.93 -51.35 69.5 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 123.484 0.714 . . . . 0.0 110.6 178.225 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 442' ' ' ARG . . . . . 0.484 ' HG3' ' O ' ' A' ' 438' ' ' ALA . 0.1 OUTLIER -61.56 -33.4 73.8 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.514 174.795 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 443' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 56.6 mt -68.23 -38.52 81.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.136 0.493 . . . . 0.0 109.931 177.163 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 444' ' ' ASP . . . . . 0.412 ' HB3' ' O ' ' A' ' 441' ' ' GLN . 29.4 t70 -57.95 -36.11 72.07 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.63 174.417 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 445' ' ' GLN . . . . . 0.448 ' HG2' ' O ' ' A' ' 441' ' ' GLN . 29.1 mm-40 -72.96 -26.63 61.43 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.8 177.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 32.44 104.33 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 172.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 47.0 mt -72.54 -34.67 48.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.464 0.65 . . . . 0.0 110.041 175.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 448' ' ' ASP . . . . . 0.424 ' HB3' ' H ' ' A' ' 449' ' ' ASP . 11.0 m-20 -165.84 -158.37 0.35 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 -177.448 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 449' ' ' ASP . . . . . 0.424 ' H ' ' HB3' ' A' ' 448' ' ' ASP . 18.4 m-20 -88.12 -67.41 0.83 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 168.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -66.44 -25.84 66.93 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 451' ' ' THR . . . . . 0.463 ' HA ' ' HB2' ' A' ' 454' ' ' GLU . 9.9 m -71.35 -22.98 61.83 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.457 -176.356 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 71.3 mtt180 -54.87 -53.99 48.31 Favored 'General case' 0 C--O 1.217 -0.631 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 171.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 453' ' ' ALA . . . . . 0.535 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -56.33 -48.86 75.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.7 -1.136 . . . . 0.0 112.576 174.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 454' ' ' GLU . . . . . 0.463 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 31.4 mm-40 -52.22 -34.01 43.77 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.07 0.462 . . . . 0.0 111.758 -178.049 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 27.2 p -120.25 14.9 12.21 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.481 -176.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 456' ' ' PHE . . . . . 0.577 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.9 OUTLIER -56.07 -49.21 74.42 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.043 0.449 . . . . 0.0 111.484 -171.057 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 457' ' ' ILE . . . . . 0.558 HG23 ' HB1' ' A' ' 405' ' ' ALA . 1.9 mp -74.56 -32.04 28.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.063 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -58.16 -36.2 72.67 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.604 0.716 . . . . 0.0 109.518 171.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 459' ' ' HIS . . . . . 0.749 ' O ' HG23 ' A' ' 463' ' ' VAL . 87.3 m-70 -72.79 -29.15 63.04 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.048 177.44 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 460' ' ' LEU . . . . . 0.731 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -74.0 -34.92 64.35 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.887 0.851 . . . . 0.0 109.137 -179.916 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 461' ' ' ASN . . . . . 0.46 ' O ' ' HB2' ' A' ' 464' ' ' TYR . 24.3 m-80 -73.08 -38.07 66.54 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.911 0.863 . . . . 0.0 108.985 176.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 462' ' ' ALA . . . . . 0.604 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -57.07 -32.88 66.7 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.394 -1.275 . . . . 0.0 109.874 169.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.865 HG13 ' HB3' ' A' ' 438' ' ' ALA . 60.2 t -62.63 -50.92 77.85 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.856 0 CA-C-N 114.699 -1.137 . . . . 0.0 107.958 175.582 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 464' ' ' TYR . . . . . 0.598 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 17.7 m-30 -52.07 -28.14 16.41 Favored 'General case' 0 N--CA 1.455 -0.182 0 O-C-N 124.353 1.033 . . . . 0.0 110.494 177.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.89 -39.08 20.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.787 0.803 . . . . 0.0 109.724 -178.008 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.604 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.6 mt -58.72 -55.85 20.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 114.357 -1.292 . . . . 0.0 112.189 176.194 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 0.769 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -101.16 -10.05 20.77 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -172.693 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 468' ' ' GLY . . . . . 0.546 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 93.77 30.84 8.62 Favored Glycine 0 CA--C 1.527 0.844 0 C-N-CA 119.646 -1.264 . . . . 0.0 114.169 179.271 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 469' ' ' LEU . . . . . 0.769 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.2 mt -88.69 159.5 17.79 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 117.847 0.823 . . . . 0.0 110.848 177.065 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 470' ' ' ASN . . . . . 0.531 HD22 HG23 ' A' ' 476' ' ' ILE . 13.9 p30 -105.32 -177.77 3.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.145 172.2 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -57.24 -26.18 60.34 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -174.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 -86.87 6.19 33.08 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 122.258 -0.277 . . . . 0.0 111.525 -171.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 473' ' ' GLY . . . . . 0.525 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 76.72 9.26 86.42 Favored Glycine 0 C--O 1.225 -0.447 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.204 -177.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -100.84 157.45 16.71 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 475' ' ' SER . . . . . 0.537 ' HA ' ' HA ' ' A' ' 469' ' ' LEU . 9.5 t -94.66 145.53 24.77 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.246 -0.582 . . . . 0.0 111.074 -178.213 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 476' ' ' ILE . . . . . 0.546 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.0 pp . . . . . 0 C--N 1.323 -0.57 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.035 178.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 386' ' ' PHE . . . . . 0.765 ' CE2' HG12 ' B' ' 394' ' ' VAL . 2.6 t80 . . . . . 0 CA--C 1.531 0.248 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 387' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' B' ' 386' ' ' PHE . 39.8 Cg_endo -64.62 105.3 0.62 Allowed 'Trans proline' 0 N--CA 1.48 0.722 0 C-N-CA 123.801 3.001 . . . . 0.0 112.2 172.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 388' ' ' MET . . . . . 0.63 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 5.2 ttp -121.58 55.29 1.1 Allowed 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.428 0.632 . . . . 0.0 111.368 -168.577 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 389' ' ' HIS . . . . . 0.582 ' CE1' ' HA ' ' B' ' 393' ' ' ASN . 38.9 m170 52.78 -99.19 0.08 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.676 0.79 . . . . 0.0 109.908 -172.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -148.03 16.94 1.09 Allowed 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 171.393 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 391' ' ' LEU . . . . . 0.625 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.5 pt? -167.12 -62.58 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.92 -171.605 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 392' ' ' GLY . . . . . 0.705 ' HA3' HD13 ' B' ' 395' ' ' ILE . . . -163.32 60.13 0.27 Allowed Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 119.861 -1.161 . . . . 0.0 114.343 -172.676 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 393' ' ' ASN . . . . . 0.63 ' HB3' ' HA ' ' B' ' 388' ' ' MET . 0.2 OUTLIER -57.44 -43.47 83.95 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 174.257 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 394' ' ' VAL . . . . . 0.765 HG12 ' CE2' ' B' ' 386' ' ' PHE . 2.0 m -55.68 -45.95 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 -179.167 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 395' ' ' ILE . . . . . 0.705 HD13 ' HA3' ' B' ' 392' ' ' GLY . 3.7 mp -58.07 -52.54 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-O 117.849 -1.072 . . . . 0.0 113.484 -174.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 396' ' ' LYS . . . . . 0.558 ' O ' HG22 ' B' ' 399' ' ' VAL . 0.0 OUTLIER -62.96 -49.74 73.54 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 121.986 2.175 . . . . 0.0 112.159 -174.84 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 397' ' ' GLY . . . . . 0.529 ' O ' ' HG3' ' B' ' 401' ' ' GLN . . . -52.95 -44.33 61.74 Favored Glycine 0 N--CA 1.435 -1.395 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.908 -176.669 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 398' ' ' ILE . . . . . 0.814 HD13 HD12 ' B' ' 410' ' ' LEU . 39.0 mt -71.66 -33.74 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 399' ' ' VAL . . . . . 0.558 HG22 ' O ' ' B' ' 396' ' ' LYS . 14.2 m -63.68 -39.67 86.21 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 C-N-CA 118.755 -1.178 . . . . 0.0 108.478 -174.335 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -64.03 -42.71 96.99 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 174.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 401' ' ' GLN . . . . . 0.529 ' HG3' ' O ' ' B' ' 397' ' ' GLY . 37.5 mt-30 -92.62 -48.22 6.71 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -169.37 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 402' ' ' GLU . . . . . 0.703 ' HG3' ' HE3' ' A' ' 413' ' ' MET . 2.9 mm-40 -114.29 -19.43 11.27 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.175 0.512 . . . . 0.0 111.539 -171.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 104.18 162.69 24.65 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.986 177.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 404' ' ' VAL . . . . . 0.66 HG11 ' HA ' ' B' ' 430' ' ' LEU . 1.6 m -53.63 -45.47 60.06 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.813 0 N-CA-C 114.463 1.282 . . . . 0.0 114.463 -175.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 405' ' ' ALA . . . . . 0.538 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -64.83 -31.32 72.5 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 119.81 -0.756 . . . . 0.0 112.312 -177.04 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 406' ' ' THR . . . . . 0.686 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 85.7 m -76.69 -42.98 39.58 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.169 -0.613 . . . . 0.0 110.187 173.524 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 407' ' ' ALA . . . . . 0.459 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.56 -36.41 73.88 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 122.158 0.98 . . . . 0.0 109.194 176.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 408' ' ' TYR . . . . . 0.614 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.88 -52.2 52.24 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 113.594 -1.639 . . . . 0.0 109.752 176.265 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 409' ' ' THR . . . . . 0.663 HG22 HD23 ' B' ' 410' ' ' LEU . 17.9 m -54.73 -47.57 73.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.545 179.021 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 410' ' ' LEU . . . . . 0.814 HD12 HD13 ' B' ' 398' ' ' ILE . 13.6 mt -72.85 -35.85 67.3 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.189 -174.615 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -59.42 -34.92 83.07 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 119.988 -1.101 . . . . 0.0 110.626 173.037 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 412' ' ' MET . . . . . 0.416 ' HB2' ' O ' ' B' ' 409' ' ' THR . 0.3 OUTLIER -65.78 -48.38 71.99 Favored 'General case' 0 C--O 1.223 -0.341 0 CA-C-N 115.629 -0.285 . . . . 0.0 111.411 177.715 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 413' ' ' MET . . . . . 0.913 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.5 OUTLIER -71.63 -46.38 59.28 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 119.058 -1.057 . . . . 0.0 111.994 -179.373 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 414' ' ' LEU . . . . . 0.913 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 16.5 mt -68.93 -45.16 71.53 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -176.22 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 33.9 t -86.83 -21.34 26.48 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.634 0.731 . . . . 0.0 110.169 -175.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 416' ' ' GLY . . . . . 0.417 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 107.58 -175.86 20.46 Favored Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 -171.505 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -79.81 23.6 0.43 Allowed 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.486 0.66 . . . . 0.0 111.294 -172.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 418' ' ' ASN . . . . . 0.417 ' H ' ' C ' ' B' ' 416' ' ' GLY . 61.6 m-80 -71.81 74.75 0.86 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.696 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 419' ' ' TYR . . . . . 0.538 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 23.9 p90 -52.34 -37.29 55.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.748 174.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -53.7 -46.42 70.71 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.729 177.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 421' ' ' LEU . . . . . 0.413 ' O ' HD13 ' B' ' 425' ' ' ILE . 0.0 OUTLIER -69.02 -49.51 57.04 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.438 -177.806 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 422' ' ' VAL . . . . . 0.458 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.2 OUTLIER -65.9 -39.02 83.47 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.093 -175.852 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 423' ' ' SER . . . . . 0.82 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 78.1 p -66.73 -39.12 87.85 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.818 -178.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -68.62 -38.54 86.19 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.153 176.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 425' ' ' ILE . . . . . 0.585 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -72.21 -52.32 24.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 121.351 -0.14 . . . . 0.0 110.794 -177.282 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 426' ' ' ILE . . . . . 0.653 HD13 HG23 ' B' ' 395' ' ' ILE . 1.1 mm -74.29 -22.71 18.05 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.929 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -173.175 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 427' ' ' ARG . . . . . 0.82 ' HB2' ' O ' ' B' ' 423' ' ' SER . 1.2 tmt_? -54.58 -33.25 59.96 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.166 0.507 . . . . 0.0 110.69 -177.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -85.85 -10.71 75.22 Favored Glycine 0 N--CA 1.44 -1.043 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.222 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 429' ' ' TYR . . . . . 0.554 ' HD1' HG22 ' B' ' 395' ' ' ILE . 9.5 m-30 -113.97 0.23 14.31 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.468 0.652 . . . . 0.0 109.326 -174.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 430' ' ' LEU . . . . . 0.685 HD23 ' HA ' ' B' ' 427' ' ' ARG . 0.1 OUTLIER -66.36 129.4 94.17 Favored Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.302 178.211 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 431' ' ' PRO . . . . . 0.544 ' HD2' HD12 ' B' ' 430' ' ' LEU . 94.3 Cg_exo -23.98 -65.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.36 1.137 1 C-N-CA 125.707 4.271 . . . . 0.0 115.155 179.81 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 432' ' ' GLY . . . . . 0.527 ' H ' HG12 ' B' ' 435' ' ' VAL . . . -146.56 -166.28 12.11 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 176.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 433' ' ' GLN . . . . . 0.486 ' O ' HG13 ' B' ' 436' ' ' VAL . 15.9 tp60 -69.83 -27.33 64.77 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 117.869 0.834 . . . . 0.0 110.617 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -67.23 -41.02 86.38 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -177.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 435' ' ' VAL . . . . . 0.703 HG23 HG11 ' B' ' 463' ' ' VAL . 8.0 p -67.81 -43.65 86.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-O 121.088 0.47 . . . . 0.0 110.683 -177.136 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 436' ' ' VAL . . . . . 0.505 HG12 ' O ' ' B' ' 432' ' ' GLY . 0.1 OUTLIER -66.06 -32.23 57.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.444 175.653 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.12 -52.46 41.51 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -178.346 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 438' ' ' ALA . . . . . 0.855 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -58.33 -38.84 77.97 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.155 177.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 439' ' ' LEU . . . . . 0.6 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 2.0 tm? -68.88 -48.46 63.33 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.16 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -59.1 -35.6 73.69 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.279 176.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 441' ' ' GLN . . . . . 0.447 ' O ' ' HG2' ' B' ' 445' ' ' GLN . 5.7 mm-40 -56.85 -51.5 68.76 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 123.385 0.674 . . . . 0.0 110.556 178.185 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 442' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' B' ' 438' ' ' ALA . 0.1 OUTLIER -61.59 -33.21 73.49 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.58 174.956 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 443' ' ' LEU . . . . . 0.6 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 56.6 mt -68.27 -38.83 82.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.127 0.489 . . . . 0.0 109.856 177.125 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 444' ' ' ASP . . . . . 0.408 ' HB3' ' O ' ' B' ' 441' ' ' GLN . 28.4 t70 -57.96 -35.56 71.34 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.628 174.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 445' ' ' GLN . . . . . 0.447 ' HG2' ' O ' ' B' ' 441' ' ' GLN . 29.3 mm-40 -73.26 -26.67 61.19 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.778 177.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 446' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 32.31 104.72 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 172.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 47.2 mt -72.82 -34.81 47.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.383 0.611 . . . . 0.0 109.975 175.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 448' ' ' ASP . . . . . 0.4 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 12.2 m-20 -165.87 -158.69 0.36 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -177.429 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -88.01 -67.27 0.84 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 169.135 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -66.53 -25.73 66.81 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 451' ' ' THR . . . . . 0.454 ' HA ' ' HB2' ' B' ' 454' ' ' GLU . 10.6 m -71.27 -23.11 61.91 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.421 -176.358 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 452' ' ' ARG . . . . . . . . . . . . . 70.9 mtt180 -54.67 -53.91 48.59 Favored 'General case' 0 C--O 1.217 -0.612 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 171.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 453' ' ' ALA . . . . . 0.538 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -56.48 -48.93 76.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.719 -1.128 . . . . 0.0 112.499 174.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 454' ' ' GLU . . . . . 0.454 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 31.9 mm-40 -52.23 -34.0 43.88 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.161 0.505 . . . . 0.0 111.626 -177.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 26.9 p -120.24 14.96 12.23 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.413 -176.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 456' ' ' PHE . . . . . 0.577 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 0.9 OUTLIER -56.13 -49.18 74.64 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.982 0.42 . . . . 0.0 111.495 -171.262 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 457' ' ' ILE . . . . . 0.548 ' CG1' ' HB3' ' B' ' 408' ' ' TYR . 1.9 mp -74.63 -31.96 28.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.0 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -58.26 -36.1 72.74 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.569 0.7 . . . . 0.0 109.418 171.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 459' ' ' HIS . . . . . 0.761 ' O ' HG23 ' B' ' 463' ' ' VAL . 87.4 m-70 -72.86 -29.18 62.99 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.175 177.44 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 460' ' ' LEU . . . . . 0.743 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -73.94 -34.95 64.51 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.901 0.857 . . . . 0.0 109.063 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 461' ' ' ASN . . . . . 0.43 ' O ' ' HB2' ' B' ' 464' ' ' TYR . 24.9 m-80 -73.3 -37.73 66.1 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.883 0.849 . . . . 0.0 109.075 176.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 462' ' ' ALA . . . . . 0.603 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -57.2 -32.99 67.05 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.832 169.41 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 463' ' ' VAL . . . . . 0.855 HG13 ' HB3' ' B' ' 438' ' ' ALA . 60.9 t -62.41 -51.02 77.39 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.799 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 175.627 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 464' ' ' TYR . . . . . 0.59 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 17.7 m-30 -52.04 -28.06 15.91 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 124.405 1.066 . . . . 0.0 110.616 177.447 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.16 -38.85 20.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.698 0.761 . . . . 0.0 109.766 -177.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 466' ' ' ILE . . . . . 0.603 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.6 mt -58.85 -55.89 20.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 114.44 -1.255 . . . . 0.0 112.229 176.058 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 467' ' ' LEU . . . . . 0.771 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -100.95 -10.22 20.8 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 -172.772 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 468' ' ' GLY . . . . . 0.538 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 93.86 30.89 8.53 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 119.637 -1.268 . . . . 0.0 114.157 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 469' ' ' LEU . . . . . 0.771 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.2 mt -88.62 159.59 17.8 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 117.855 0.828 . . . . 0.0 110.846 177.017 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 470' ' ' ASN . . . . . 0.543 HD22 HG23 ' B' ' 476' ' ' ILE . 13.9 p30 -105.38 -178.05 3.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.107 172.098 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 471' ' ' ALA . . . . . . . . . . . . . . . -56.74 -26.58 57.58 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -174.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 -86.75 6.5 31.12 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 122.178 -0.326 . . . . 0.0 111.73 -171.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 473' ' ' GLY . . . . . 0.523 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 76.33 9.54 85.76 Favored Glycine 0 C--O 1.227 -0.319 0 C-N-CA 120.484 -0.865 . . . . 0.0 111.257 -177.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -100.94 157.65 16.58 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 176.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 475' ' ' SER . . . . . 0.542 ' HA ' ' HA ' ' B' ' 469' ' ' LEU . 9.9 t -95.05 145.3 25.06 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.074 -178.225 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 476' ' ' ILE . . . . . 0.543 HG23 HD22 ' B' ' 470' ' ' ASN . 2.0 pp . . . . . 0 C--N 1.322 -0.6 0 CA-C-O 121.618 0.723 . . . . 0.0 110.054 178.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 386' ' ' PHE . . . . . 0.746 ' CD1' HD22 ' A' ' 414' ' ' LEU . 1.3 t80 . . . . . 0 CA--C 1.538 0.5 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -42.98 -69.35 0.08 OUTLIER 'Trans proline' 0 N--CA 1.479 0.628 0 C-N-CA 124.265 3.31 . . . . 0.0 113.667 -176.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.535 ' SD ' ' HB2' ' A' ' 415' ' ' SER . 6.7 ttp 66.44 34.13 6.41 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 173.113 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 389' ' ' HIS . . . . . 0.476 ' CE1' ' HB2' ' A' ' 393' ' ' ASN . 36.6 m170 53.93 -95.17 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.327 0.584 . . . . 0.0 110.379 -177.102 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -149.63 18.87 0.92 Allowed 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 174.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.619 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.6 pt? -173.49 -54.96 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -169.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 392' ' ' GLY . . . . . 0.619 ' N ' ' HG ' ' A' ' 391' ' ' LEU . . . -167.57 47.08 0.24 Allowed Glycine 0 CA--C 1.525 0.669 0 C-N-CA 119.685 -1.245 . . . . 0.0 114.569 -169.199 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 393' ' ' ASN . . . . . 0.633 HD21 ' C ' ' A' ' 393' ' ' ASN . 0.0 OUTLIER -54.95 -37.58 66.65 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 117.925 0.862 . . . . 0.0 109.495 175.87 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 394' ' ' VAL . . . . . 0.708 HG23 HD12 ' A' ' 398' ' ' ILE . 1.5 m -57.45 -49.97 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 CA-C-N 113.824 -1.535 . . . . 0.0 107.603 178.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 395' ' ' ILE . . . . . 0.649 HG21 HG22 ' A' ' 425' ' ' ILE . 4.0 mp -57.96 -52.88 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 CA-C-O 118.013 -0.994 . . . . 0.0 113.544 -174.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 396' ' ' LYS . . . . . 0.654 ' HG3' ' CZ ' ' A' ' 429' ' ' TYR . 0.1 OUTLIER -64.7 -48.48 74.54 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 121.737 2.062 . . . . 0.0 111.664 -172.525 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.34 -45.49 65.26 Favored Glycine 0 N--CA 1.433 -1.517 0 C-N-CA 120.106 -1.045 . . . . 0.0 110.978 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 398' ' ' ILE . . . . . 0.761 HD13 HD12 ' A' ' 410' ' ' LEU . 35.4 mt -70.95 -33.86 53.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 -178.401 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 399' ' ' VAL . . . . . 0.535 HG12 ' HA ' ' A' ' 404' ' ' VAL . 11.4 m -63.44 -39.88 86.95 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.514 0 C-N-CA 118.73 -1.188 . . . . 0.0 108.539 -173.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -70.93 -37.09 72.88 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 176.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 -86.86 -48.26 8.34 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -171.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 402' ' ' GLU . . . . . 0.527 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 3.0 mm-40 -119.43 -20.92 7.65 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.375 -171.027 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 107.48 161.95 21.47 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.879 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 404' ' ' VAL . . . . . 0.663 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.5 m -53.71 -41.79 48.79 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.784 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -175.295 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 405' ' ' ALA . . . . . 0.671 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -69.23 -29.33 67.25 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.916 -176.336 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.711 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 89.3 m -77.63 -42.79 33.6 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.206 -0.598 . . . . 0.0 110.137 172.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.43 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.42 -36.94 74.38 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 122.062 0.934 . . . . 0.0 109.355 176.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 408' ' ' TYR . . . . . 0.663 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.8 -52.13 53.22 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 113.619 -1.628 . . . . 0.0 109.767 176.372 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 409' ' ' THR . . . . . 0.659 HG22 HD23 ' A' ' 410' ' ' LEU . 17.7 m -55.53 -47.57 76.09 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.592 178.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 410' ' ' LEU . . . . . 0.761 HD12 HD13 ' A' ' 398' ' ' ILE . 15.0 mt -72.85 -35.11 67.17 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -174.677 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.66 -34.3 76.16 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.123 -1.037 . . . . 0.0 111.047 171.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -68.35 -49.51 59.78 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-O 120.527 0.203 . . . . 0.0 111.34 178.405 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 413' ' ' MET . . . . . 0.923 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.9 OUTLIER -71.18 -43.14 68.04 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 119.437 -0.905 . . . . 0.0 112.08 -177.474 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 414' ' ' LEU . . . . . 0.923 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 12.0 mt -73.99 -46.13 45.65 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 113.234 0.828 . . . . 0.0 113.234 -178.345 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.535 ' HB2' ' SD ' ' A' ' 388' ' ' MET . 3.7 t -100.1 17.55 20.85 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.361 0.6 . . . . 0.0 110.928 -170.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 78.87 178.31 50.45 Favored Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 120.285 -0.96 . . . . 0.0 111.768 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -81.72 21.17 0.85 Allowed 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.012 0.434 . . . . 0.0 111.642 -172.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 418' ' ' ASN . . . . . 0.479 ' HB3' ' HB3' ' A' ' 421' ' ' LEU . 6.3 m-20 -73.23 80.89 1.31 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.574 0.702 . . . . 0.0 111.021 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 419' ' ' TYR . . . . . 0.563 ' HB2' ' CE2' ' A' ' 456' ' ' PHE . 10.5 p90 -51.91 -38.24 55.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.761 176.505 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -55.58 -43.67 76.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.87 177.138 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 421' ' ' LEU . . . . . 0.479 ' HB3' ' HB3' ' A' ' 418' ' ' ASN . 0.0 OUTLIER -67.8 -48.54 66.01 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.264 -178.075 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 422' ' ' VAL . . . . . 0.478 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -65.89 -42.22 91.58 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 C-N-CA 120.421 -0.511 . . . . 0.0 111.189 -177.725 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.743 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 29.0 t -69.46 -34.99 75.2 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -178.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.54 -40.54 90.87 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.192 175.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 425' ' ' ILE . . . . . 0.649 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.81 -49.9 36.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-O 120.554 0.216 . . . . 0.0 110.763 -178.914 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 426' ' ' ILE . . . . . 0.622 HD13 HG23 ' A' ' 395' ' ' ILE . 1.2 mm -74.31 -22.41 17.91 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.911 0 C-N-CA 123.055 0.542 . . . . 0.0 110.183 -172.11 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.743 ' HB2' ' O ' ' A' ' 423' ' ' SER . 0.3 OUTLIER -54.72 -28.82 50.83 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 123.031 0.533 . . . . 0.0 111.075 -178.718 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -90.15 -8.32 66.8 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.684 178.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.654 ' CZ ' ' HG3' ' A' ' 396' ' ' LYS . 21.5 m-85 -114.46 -2.86 13.1 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 121.667 0.746 . . . . 0.0 109.619 -178.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.6 HD12 ' HD2' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -65.89 135.79 95.47 Favored Pre-proline 0 N--CA 1.437 -1.088 0 CA-C-N 114.339 -1.3 . . . . 0.0 108.657 178.325 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 431' ' ' PRO . . . . . 0.839 ' HD2' HG11 ' A' ' 435' ' ' VAL . 47.0 Cg_exo -36.42 -65.21 0.15 Allowed 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 124.614 3.543 . . . . 0.0 114.081 -172.342 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 432' ' ' GLY . . . . . 0.567 ' H ' HG12 ' A' ' 435' ' ' VAL . . . -141.94 -165.08 10.32 Favored Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 175.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 433' ' ' GLN . . . . . 0.512 ' O ' HG13 ' A' ' 436' ' ' VAL . 23.9 tp60 -70.26 -26.91 64.05 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 118.198 0.999 . . . . 0.0 110.331 177.192 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -66.29 -40.44 90.05 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -177.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 435' ' ' VAL . . . . . 0.839 HG11 ' HD2' ' A' ' 431' ' ' PRO . 7.0 p -68.14 -44.64 84.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-O 120.892 0.377 . . . . 0.0 110.785 -178.427 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.512 HG13 ' O ' ' A' ' 433' ' ' GLN . 0.2 OUTLIER -65.43 -29.11 46.17 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 CA-C-O 121.057 0.456 . . . . 0.0 110.094 175.862 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 1.1 m -69.26 -52.92 22.87 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 438' ' ' ALA . . . . . 0.879 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -58.77 -38.13 77.79 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.807 177.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 439' ' ' LEU . . . . . 0.577 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 2.2 tm? -69.91 -47.43 62.5 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.023 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -57.62 -39.67 77.44 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.38 174.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 441' ' ' GLN . . . . . 0.491 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 8.9 mm-40 -53.58 -49.54 67.53 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 123.788 0.835 . . . . 0.0 110.855 174.278 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 442' ' ' ARG . . . . . 0.817 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 0.7 OUTLIER -55.85 -39.43 71.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.607 172.034 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 443' ' ' LEU . . . . . 0.577 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 37.1 mt -71.71 -35.56 70.25 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.025 0.44 . . . . 0.0 110.178 -178.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -58.05 -36.97 73.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.631 174.139 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -72.82 -28.03 62.31 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.616 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 446' ' ' GLU . . . . . 0.575 ' HB2' ' O ' ' A' ' 443' ' ' LEU . 31.6 tt0 29.75 96.49 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 172.515 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 42.1 mt -67.91 -35.31 71.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.202 0.525 . . . . 0.0 110.518 177.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 448' ' ' ASP . . . . . 0.62 ' O ' ' HG3' ' A' ' 452' ' ' ARG . 23.2 m-20 -166.15 -170.52 1.73 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -76.7 -62.44 1.63 Allowed 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.176 -0.61 . . . . 0.0 109.405 173.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -70.37 -26.03 63.54 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 451' ' ' THR . . . . . 0.478 ' OG1' ' HB2' ' A' ' 448' ' ' ASP . 17.7 m -71.71 -22.65 61.61 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 119.824 -0.75 . . . . 0.0 110.853 -175.288 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 452' ' ' ARG . . . . . 0.62 ' HG3' ' O ' ' A' ' 448' ' ' ASP . 13.3 mtp180 -53.64 -54.75 33.34 Favored 'General case' 0 C--O 1.218 -0.569 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 170.259 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 453' ' ' ALA . . . . . 0.484 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -57.34 -48.2 79.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.264 -1.335 . . . . 0.0 112.582 175.53 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 454' ' ' GLU . . . . . 0.465 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 20.8 mm-40 -51.83 -35.72 45.55 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.151 0.501 . . . . 0.0 111.752 -177.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 31.2 p -119.22 16.2 13.15 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.314 -176.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 456' ' ' PHE . . . . . 0.563 ' CE2' ' HB2' ' A' ' 419' ' ' TYR . 1.0 OUTLIER -57.05 -48.84 77.55 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.975 0.417 . . . . 0.0 111.819 -171.441 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 457' ' ' ILE . . . . . 0.671 HG23 ' HB1' ' A' ' 405' ' ' ALA . 2.0 mp -75.67 -33.02 25.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.934 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -58.4 -35.08 71.49 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.942 0.877 . . . . 0.0 109.268 172.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 459' ' ' HIS . . . . . 0.715 ' O ' HG23 ' A' ' 463' ' ' VAL . 59.4 m-70 -74.23 -28.87 61.44 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.539 -1.21 . . . . 0.0 110.732 177.124 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 460' ' ' LEU . . . . . 0.707 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.4 OUTLIER -73.64 -34.79 65.14 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.794 0.807 . . . . 0.0 108.914 178.869 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 461' ' ' ASN . . . . . 0.492 ' HA ' ' CD2' ' A' ' 464' ' ' TYR . 20.0 m-80 -73.21 -37.64 66.36 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.276 -0.874 . . . . 0.0 108.872 176.509 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 462' ' ' ALA . . . . . 0.597 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -56.85 -34.92 68.26 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.443 -1.253 . . . . 0.0 109.812 169.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.879 HG13 ' HB3' ' A' ' 438' ' ' ALA . 68.4 t -60.12 -51.22 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 175.547 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 464' ' ' TYR . . . . . 0.618 ' CE2' ' HA ' ' A' ' 471' ' ' ALA . 16.2 m-30 -53.52 -28.33 30.7 Favored 'General case' 0 N--CA 1.456 -0.159 0 O-C-N 124.233 0.958 . . . . 0.0 110.598 178.358 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.19 -39.6 20.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.787 0.803 . . . . 0.0 109.466 -177.333 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.597 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.7 mt -57.62 -55.68 19.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 114.22 -1.354 . . . . 0.0 112.286 175.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 0.787 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -102.83 -10.64 18.92 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -172.343 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 468' ' ' GLY . . . . . 0.697 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 93.93 32.47 7.52 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 118.96 -1.59 . . . . 0.0 114.155 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 469' ' ' LEU . . . . . 0.787 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.7 mt -89.63 166.41 13.64 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 117.793 0.797 . . . . 0.0 111.489 176.139 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 40.4 p30 -106.06 -178.12 3.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.564 -0.743 . . . . 0.0 109.668 169.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 471' ' ' ALA . . . . . 0.618 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -70.71 -9.72 57.83 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -175.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -89.09 -0.63 57.6 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.931 0.396 . . . . 0.0 110.861 -177.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 473' ' ' GLY . . . . . 0.474 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 75.5 16.58 80.54 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -173.175 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -101.57 155.57 18.01 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.275 -0.462 . . . . 0.0 109.818 178.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 3.0 p -94.49 121.06 35.65 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.165 0.507 . . . . 0.0 110.768 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 476' ' ' ILE . . . . . 0.697 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.3 pp . . . . . 0 C--N 1.322 -0.626 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.072 -176.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 386' ' ' PHE . . . . . 0.747 ' CD1' HD22 ' B' ' 414' ' ' LEU . 1.2 t80 . . . . . 0 CA--C 1.537 0.458 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 387' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -43.12 -68.99 0.09 OUTLIER 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 124.049 3.166 . . . . 0.0 113.782 -176.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 388' ' ' MET . . . . . 0.533 ' SD ' ' HB2' ' B' ' 415' ' ' SER . 6.6 ttp 66.23 34.21 6.75 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 173.047 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 389' ' ' HIS . . . . . 0.479 ' CE1' ' HB2' ' B' ' 393' ' ' ASN . 36.6 m170 54.08 -94.62 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.363 0.602 . . . . 0.0 110.546 -177.255 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -150.29 19.22 0.85 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.144 -0.934 . . . . 0.0 108.657 174.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 391' ' ' LEU . . . . . 0.614 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.6 pt? -173.91 -55.01 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -169.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 392' ' ' GLY . . . . . 0.614 ' N ' ' HG ' ' B' ' 391' ' ' LEU . . . -167.57 47.11 0.24 Allowed Glycine 0 CA--C 1.523 0.566 0 C-N-CA 119.796 -1.192 . . . . 0.0 114.736 -169.266 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 393' ' ' ASN . . . . . 0.488 ' HB3' ' C ' ' B' ' 388' ' ' MET . 0.0 OUTLIER -54.92 -37.56 66.54 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 117.915 0.857 . . . . 0.0 109.461 175.94 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 394' ' ' VAL . . . . . 0.692 HG23 HD12 ' B' ' 398' ' ' ILE . 1.5 m -57.5 -49.9 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 113.795 -1.548 . . . . 0.0 107.491 179.04 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 395' ' ' ILE . . . . . 0.66 HG21 HG22 ' B' ' 425' ' ' ILE . 4.0 mp -58.14 -52.86 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-O 117.978 -1.01 . . . . 0.0 113.464 -174.483 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 396' ' ' LYS . . . . . 0.657 ' HG3' ' CZ ' ' B' ' 429' ' ' TYR . 0.1 OUTLIER -64.71 -48.5 74.42 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 121.788 2.086 . . . . 0.0 111.679 -172.476 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.24 -45.49 64.28 Favored Glycine 0 N--CA 1.435 -1.397 0 C-N-CA 120.01 -1.09 . . . . 0.0 110.935 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 398' ' ' ILE . . . . . 0.758 HD13 HD12 ' B' ' 410' ' ' LEU . 36.0 mt -71.05 -33.93 53.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 113.607 0.965 . . . . 0.0 113.607 -178.193 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 399' ' ' VAL . . . . . 0.519 HG12 ' HA ' ' B' ' 404' ' ' VAL . 11.7 m -63.3 -39.86 86.86 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.54 0 C-N-CA 118.827 -1.149 . . . . 0.0 108.559 -174.015 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -70.95 -37.44 72.82 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 176.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 401' ' ' GLN . . . . . . . . . . . . . 34.8 mm-40 -86.66 -47.8 8.85 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -171.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 402' ' ' GLU . . . . . 0.439 ' HG3' ' HE3' ' A' ' 413' ' ' MET . 3.0 mm-40 -119.71 -20.64 7.58 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.385 -171.165 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 107.2 161.98 21.74 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.863 178.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 404' ' ' VAL . . . . . 0.647 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.5 m -53.74 -41.8 49.09 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.862 0 N-CA-C 114.649 1.352 . . . . 0.0 114.649 -175.385 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 405' ' ' ALA . . . . . 0.679 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -69.2 -29.11 67.01 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 119.657 -0.817 . . . . 0.0 112.042 -176.396 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 406' ' ' THR . . . . . 0.708 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 91.6 m -77.74 -42.82 32.89 Favored 'General case' 0 C--O 1.22 -0.474 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.142 172.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 407' ' ' ALA . . . . . 0.429 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.54 -36.82 74.47 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 122.01 0.909 . . . . 0.0 109.375 176.572 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 408' ' ' TYR . . . . . 0.647 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.81 -52.33 51.57 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 113.581 -1.645 . . . . 0.0 109.777 176.185 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 409' ' ' THR . . . . . 0.656 HG22 HD23 ' B' ' 410' ' ' LEU . 17.7 m -55.27 -47.66 75.17 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.676 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 410' ' ' LEU . . . . . 0.758 HD12 HD13 ' B' ' 398' ' ' ILE . 14.9 mt -72.81 -35.16 67.27 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 -174.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.67 -34.25 75.99 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.136 -1.03 . . . . 0.0 111.035 171.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 412' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -68.41 -49.37 60.52 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.558 0.218 . . . . 0.0 111.369 178.362 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 413' ' ' MET . . . . . 0.94 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.9 OUTLIER -71.34 -43.1 67.64 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 119.355 -0.938 . . . . 0.0 112.099 -177.553 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 414' ' ' LEU . . . . . 0.94 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 12.0 mt -73.89 -46.15 46.31 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -178.398 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 415' ' ' SER . . . . . 0.533 ' HB2' ' SD ' ' B' ' 388' ' ' MET . 3.7 t -100.37 17.79 20.61 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.265 0.555 . . . . 0.0 110.897 -170.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 416' ' ' GLY . . . . . . . . . . . . . . . 78.82 178.22 50.26 Favored Glycine 0 N--CA 1.438 -1.189 0 C-N-CA 120.342 -0.932 . . . . 0.0 111.771 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 33.6 mm-40 -81.7 21.25 0.84 Allowed 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.074 0.464 . . . . 0.0 111.496 -172.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 418' ' ' ASN . . . . . 0.481 ' HB3' ' HB3' ' B' ' 421' ' ' LEU . 6.6 m-20 -73.26 80.82 1.33 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.541 0.686 . . . . 0.0 111.067 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 419' ' ' TYR . . . . . 0.558 ' HB2' ' CE2' ' B' ' 456' ' ' PHE . 10.4 p90 -52.02 -38.13 55.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.869 -1.059 . . . . 0.0 111.843 176.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -55.36 -43.81 75.4 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.646 0.26 . . . . 0.0 110.81 176.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 421' ' ' LEU . . . . . 0.481 ' HB3' ' HB3' ' B' ' 418' ' ' ASN . 0.0 OUTLIER -67.73 -48.51 66.25 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.24 -177.908 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 422' ' ' VAL . . . . . 0.479 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.2 OUTLIER -66.05 -42.06 90.8 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.149 -177.579 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 423' ' ' SER . . . . . 0.749 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 25.5 t -69.54 -35.0 75.03 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.52 -40.54 90.93 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.265 175.428 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 425' ' ' ILE . . . . . 0.66 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -72.76 -50.07 36.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 O-C-N 122.834 -0.216 . . . . 0.0 110.824 -179.074 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 426' ' ' ILE . . . . . 0.62 HD13 HG23 ' B' ' 395' ' ' ILE . 1.2 mm -74.41 -22.32 17.76 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.911 0 C-N-CA 122.956 0.502 . . . . 0.0 110.235 -172.014 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 427' ' ' ARG . . . . . 0.749 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.3 OUTLIER -54.7 -28.7 49.74 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 123.023 0.529 . . . . 0.0 111.186 -178.91 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -90.58 -7.77 66.49 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.489 178.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 429' ' ' TYR . . . . . 0.657 ' CZ ' ' HG3' ' B' ' 396' ' ' LYS . 21.6 m-85 -114.94 -2.49 12.85 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.74 0.781 . . . . 0.0 109.571 -178.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 430' ' ' LEU . . . . . 0.608 HD12 ' HD2' ' B' ' 431' ' ' PRO . 0.0 OUTLIER -65.91 135.76 95.44 Favored Pre-proline 0 N--CA 1.437 -1.088 0 CA-C-N 114.462 -1.244 . . . . 0.0 108.679 178.165 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 431' ' ' PRO . . . . . 0.838 ' HD2' HG11 ' B' ' 435' ' ' VAL . 46.5 Cg_exo -36.53 -65.08 0.15 Allowed 'Trans proline' 0 N--CA 1.473 0.322 0 C-N-CA 124.658 3.572 . . . . 0.0 114.09 -172.33 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 432' ' ' GLY . . . . . 0.553 ' H ' HG12 ' B' ' 435' ' ' VAL . . . -142.08 -165.12 10.36 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 175.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 433' ' ' GLN . . . . . 0.506 ' O ' HG13 ' B' ' 436' ' ' VAL . 24.5 tp60 -70.13 -26.89 64.16 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 118.195 0.998 . . . . 0.0 110.423 177.299 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -66.54 -40.01 88.87 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -177.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 435' ' ' VAL . . . . . 0.838 HG11 ' HD2' ' B' ' 431' ' ' PRO . 7.1 p -68.43 -44.63 83.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-O 120.962 0.41 . . . . 0.0 110.702 -178.366 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 436' ' ' VAL . . . . . 0.506 HG13 ' O ' ' B' ' 433' ' ' GLN . 0.1 OUTLIER -65.43 -29.34 46.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.112 175.826 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 1.1 m -69.19 -52.81 24.18 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 438' ' ' ALA . . . . . 0.864 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -58.75 -38.43 78.4 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.744 177.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 439' ' ' LEU . . . . . 0.581 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 2.2 tm? -69.68 -47.34 63.58 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -178.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -57.69 -39.53 77.38 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.291 174.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 441' ' ' GLN . . . . . 0.499 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 8.8 mm-40 -53.8 -49.54 68.1 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 123.733 0.813 . . . . 0.0 110.82 174.316 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 442' ' ' ARG . . . . . 0.83 ' HG2' ' O ' ' B' ' 438' ' ' ALA . 0.7 OUTLIER -55.82 -39.3 71.18 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.609 172.061 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 443' ' ' LEU . . . . . 0.581 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 37.5 mt -71.68 -35.61 70.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.953 0.406 . . . . 0.0 110.19 -178.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -58.16 -37.05 73.93 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.521 174.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -72.74 -28.27 62.54 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.512 178.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 446' ' ' GLU . . . . . 0.573 ' HB2' ' O ' ' B' ' 443' ' ' LEU . 31.7 tt0 30.04 96.96 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 O-C-N 124.686 1.241 . . . . 0.0 114.339 172.464 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 42.7 mt -68.29 -35.27 70.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.112 0.482 . . . . 0.0 110.593 177.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 448' ' ' ASP . . . . . 0.61 ' O ' ' HG3' ' B' ' 452' ' ' ARG . 23.5 m-20 -165.89 -170.26 1.71 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -76.73 -62.64 1.57 Allowed 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 173.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -70.43 -25.91 63.43 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 451' ' ' THR . . . . . 0.468 ' OG1' ' HB2' ' B' ' 448' ' ' ASP . 18.6 m -71.71 -22.74 61.6 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.632 -175.316 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 452' ' ' ARG . . . . . 0.61 ' HG3' ' O ' ' B' ' 448' ' ' ASP . 13.6 mtp180 -53.54 -54.65 34.35 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 170.332 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 453' ' ' ALA . . . . . 0.483 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -57.51 -48.22 79.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.275 -1.33 . . . . 0.0 112.604 175.581 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 454' ' ' GLU . . . . . 0.454 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 20.9 mm-40 -51.67 -35.72 43.57 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.252 0.548 . . . . 0.0 111.736 -177.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 31.1 p -119.28 16.15 13.1 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.362 -176.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 456' ' ' PHE . . . . . 0.558 ' CE2' ' HB2' ' B' ' 419' ' ' TYR . 1.0 OUTLIER -57.13 -48.67 78.08 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.95 0.405 . . . . 0.0 111.766 -171.343 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 457' ' ' ILE . . . . . 0.679 HG23 ' HB1' ' B' ' 405' ' ' ALA . 2.0 mp -75.77 -33.23 25.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.864 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -58.35 -34.95 71.23 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.888 0.851 . . . . 0.0 109.293 172.236 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 459' ' ' HIS . . . . . 0.72 ' O ' HG23 ' B' ' 463' ' ' VAL . 60.1 m-70 -74.33 -28.78 61.31 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.777 177.053 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 460' ' ' LEU . . . . . 0.711 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.4 OUTLIER -73.63 -34.81 65.18 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.869 0.842 . . . . 0.0 108.872 178.94 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 461' ' ' ASN . . . . . 0.494 ' HA ' ' CD2' ' B' ' 464' ' ' TYR . 19.2 m-80 -73.26 -37.69 66.23 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.279 -0.873 . . . . 0.0 108.909 176.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 462' ' ' ALA . . . . . 0.6 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -56.8 -34.9 68.12 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.812 169.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 463' ' ' VAL . . . . . 0.864 HG13 ' HB3' ' B' ' 438' ' ' ALA . 68.6 t -60.12 -51.24 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 175.546 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 464' ' ' TYR . . . . . 0.626 ' CE2' ' HA ' ' B' ' 471' ' ' ALA . 16.4 m-30 -53.51 -28.16 29.58 Favored 'General case' 0 N--CA 1.457 -0.105 0 O-C-N 124.242 0.964 . . . . 0.0 110.551 178.369 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.29 -39.94 20.18 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.706 0.765 . . . . 0.0 109.411 -177.293 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 466' ' ' ILE . . . . . 0.6 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.7 mt -57.4 -55.5 20.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 114.189 -1.369 . . . . 0.0 112.231 176.099 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 467' ' ' LEU . . . . . 0.796 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -103.05 -10.47 18.88 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -172.369 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 468' ' ' GLY . . . . . 0.703 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 93.82 32.52 7.53 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 118.996 -1.573 . . . . 0.0 114.133 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 469' ' ' LEU . . . . . 0.796 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.7 mt -89.63 166.26 13.73 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 117.832 0.816 . . . . 0.0 111.538 176.168 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 41.3 p30 -105.91 -178.19 3.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.72 169.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 471' ' ' ALA . . . . . 0.626 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -70.83 -9.55 57.77 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -175.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -89.27 -0.75 57.71 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.856 0.36 . . . . 0.0 110.908 -177.236 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 473' ' ' GLY . . . . . 0.459 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 75.74 16.53 80.59 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -173.327 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -101.45 155.71 17.9 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.23 -0.485 . . . . 0.0 109.861 178.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 2.7 p -94.93 120.92 35.95 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.193 0.52 . . . . 0.0 110.673 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 476' ' ' ILE . . . . . 0.703 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.3 pp . . . . . 0 C--N 1.322 -0.607 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.189 -176.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 386' ' ' PHE . . . . . 0.748 ' CD1' HD22 ' A' ' 414' ' ' LEU . 2.3 t80 . . . . . 0 CA--C 1.535 0.388 0 CA-C-O 120.491 0.186 . . . . 0.0 110.515 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 387' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 386' ' ' PHE . 40.6 Cg_endo -65.5 111.54 1.89 Allowed 'Trans proline' 0 N--CA 1.482 0.811 0 C-N-CA 123.873 3.049 . . . . 0.0 112.458 173.224 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.626 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 34.2 ttm -121.37 47.92 1.76 Allowed 'General case' 0 C--N 1.321 -0.634 0 O-C-N 121.984 -0.448 . . . . 0.0 111.536 -169.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 389' ' ' HIS . . . . . 0.645 ' CG ' ' HB2' ' A' ' 393' ' ' ASN . 38.0 m170 57.09 -90.17 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 121.484 0.659 . . . . 0.0 109.482 -170.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -160.49 17.36 0.13 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.293 175.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.572 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.3 pt? -167.42 -59.35 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.562 -0.744 . . . . 0.0 112.119 -171.525 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 392' ' ' GLY . . . . . 0.575 ' CA ' HD13 ' A' ' 395' ' ' ILE . . . -167.07 53.33 0.24 Allowed Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.216 -0.993 . . . . 0.0 114.059 -172.048 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 393' ' ' ASN . . . . . 0.645 ' HB2' ' CG ' ' A' ' 389' ' ' HIS . 0.4 OUTLIER -56.35 -44.07 79.7 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 117.314 0.557 . . . . 0.0 110.262 176.811 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 394' ' ' VAL . . . . . 0.713 HG12 ' CE2' ' A' ' 386' ' ' PHE . 1.9 m -55.25 -45.13 77.5 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.777 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 -178.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 395' ' ' ILE . . . . . 0.655 HG23 HD13 ' A' ' 426' ' ' ILE . 3.7 mp -58.02 -52.74 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 CA-C-O 117.853 -1.07 . . . . 0.0 113.544 -175.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 396' ' ' LYS . . . . . 0.511 ' O ' HG22 ' A' ' 399' ' ' VAL . 0.0 OUTLIER -63.2 -48.86 76.52 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 122.044 2.202 . . . . 0.0 112.139 -174.13 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 397' ' ' GLY . . . . . 0.453 ' O ' ' HG3' ' A' ' 401' ' ' GLN . . . -53.02 -44.49 62.33 Favored Glycine 0 N--CA 1.435 -1.414 0 C-N-CA 119.989 -1.101 . . . . 0.0 110.983 -177.33 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 398' ' ' ILE . . . . . 0.782 HD13 HD12 ' A' ' 410' ' ' LEU . 34.6 mt -71.83 -34.01 50.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 399' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 396' ' ' LYS . 11.8 m -64.18 -40.44 89.05 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 C-N-CA 118.742 -1.183 . . . . 0.0 108.402 -173.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -64.27 -41.47 96.91 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 175.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 401' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' A' ' 397' ' ' GLY . 34.8 mt-30 -92.94 -49.74 5.89 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -170.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 402' ' ' GLU . . . . . 0.683 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 2.4 mm-40 -111.74 -20.22 12.17 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.026 0.441 . . . . 0.0 111.227 -171.593 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 104.75 162.18 24.06 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.944 178.083 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 404' ' ' VAL . . . . . 0.654 HG11 ' HA ' ' A' ' 430' ' ' LEU . 1.5 m -54.03 -45.85 65.23 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.784 0 N-CA-C 114.568 1.322 . . . . 0.0 114.568 -175.123 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 405' ' ' ALA . . . . . 0.56 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -63.46 -33.04 74.69 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 119.851 -0.74 . . . . 0.0 112.26 -177.027 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.717 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 93.0 m -76.04 -41.91 49.36 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.199 174.341 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.474 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.49 -36.97 74.59 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 122.139 0.971 . . . . 0.0 109.221 176.36 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 408' ' ' TYR . . . . . 0.624 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -66.46 -52.78 42.6 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 113.471 -1.695 . . . . 0.0 110.06 177.336 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 409' ' ' THR . . . . . 0.76 HG22 HD23 ' A' ' 410' ' ' LEU . 1.7 m -56.4 -45.68 80.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.395 178.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 410' ' ' LEU . . . . . 0.782 HD12 HD13 ' A' ' 398' ' ' ILE . 13.3 mt -71.54 -36.88 71.12 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -176.286 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.95 -35.14 81.93 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.054 -1.07 . . . . 0.0 110.727 172.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -67.2 -47.93 69.42 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 115.719 -0.241 . . . . 0.0 111.386 177.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 413' ' ' MET . . . . . 0.912 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.6 OUTLIER -70.94 -46.81 61.78 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 118.813 -1.155 . . . . 0.0 111.912 -179.772 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 414' ' ' LEU . . . . . 0.912 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 14.7 mt -68.02 -44.96 75.32 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -176.045 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 33.8 t -88.99 -16.28 32.09 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.732 0.777 . . . . 0.0 110.267 -175.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 102.02 -175.8 25.36 Favored Glycine 0 N--CA 1.431 -1.681 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -171.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -79.95 23.63 0.44 Allowed 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.278 0.561 . . . . 0.0 111.7 -171.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 418' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -72.33 77.17 1.01 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.007 -179.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 419' ' ' TYR . . . . . 0.552 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 11.6 p90 -53.01 -38.78 62.61 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.517 176.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.51 -44.14 76.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.784 0.326 . . . . 0.0 110.938 178.471 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.07 -49.36 61.8 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.293 -178.313 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 422' ' ' VAL . . . . . 0.441 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -65.99 -39.53 84.81 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 C-N-CA 120.376 -0.529 . . . . 0.0 111.209 -176.759 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.776 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 78.2 p -68.21 -37.99 81.47 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 -178.461 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -69.06 -37.16 82.31 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.072 176.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 425' ' ' ILE . . . . . 0.564 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.88 -53.32 19.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.42 0.152 . . . . 0.0 111.052 -178.746 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 426' ' ' ILE . . . . . 0.686 HG22 HD22 ' A' ' 430' ' ' LEU . 1.1 mm -73.53 -22.89 19.16 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.828 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -172.297 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.776 ' HB2' ' O ' ' A' ' 423' ' ' SER . 0.9 OUTLIER -54.61 -32.54 58.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.142 0.496 . . . . 0.0 110.432 -178.663 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.02 -7.37 77.64 Favored Glycine 0 N--CA 1.44 -1.074 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.387 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.501 ' HD1' ' CG2' ' A' ' 395' ' ' ILE . 14.4 m-85 -117.21 0.58 12.32 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.079 0.466 . . . . 0.0 109.945 -176.373 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.686 HD22 HG22 ' A' ' 426' ' ' ILE . 0.1 OUTLIER -65.98 129.27 94.24 Favored Pre-proline 0 N--CA 1.446 -0.665 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.251 178.812 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 431' ' ' PRO . . . . . 0.503 ' HD2' HD12 ' A' ' 430' ' ' LEU . 90.3 Cg_exo -24.61 -68.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.359 1.113 1 C-N-CA 125.424 4.083 . . . . 0.0 115.029 179.709 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 432' ' ' GLY . . . . . 0.555 ' O ' HG12 ' A' ' 435' ' ' VAL . . . -142.07 -170.42 12.54 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 177.232 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 433' ' ' GLN . . . . . 0.464 ' O ' HG13 ' A' ' 436' ' ' VAL . 41.4 tp60 -68.13 -26.35 65.75 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 118.006 0.903 . . . . 0.0 110.458 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -66.29 -41.26 90.04 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -178.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 435' ' ' VAL . . . . . 0.742 HG23 HG11 ' A' ' 463' ' ' VAL . 8.0 p -68.65 -43.81 82.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-O 120.929 0.395 . . . . 0.0 110.508 -177.201 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.495 HG12 ' O ' ' A' ' 432' ' ' GLY . 0.1 OUTLIER -65.84 -30.55 50.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.512 175.538 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 1.1 m -69.16 -52.18 30.72 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 438' ' ' ALA . . . . . 0.873 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -58.61 -37.42 75.83 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.823 177.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 439' ' ' LEU . . . . . 0.552 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 2.0 tm? -70.35 -47.18 62.15 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -57.37 -38.85 74.85 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.368 174.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 441' ' ' GLN . . . . . 0.492 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 35.9 mm-40 -53.47 -50.05 66.15 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 123.486 0.714 . . . . 0.0 110.562 174.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 442' ' ' ARG . . . . . 0.799 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 0.8 OUTLIER -56.83 -40.57 76.28 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.752 172.344 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 443' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 40.9 mt -72.64 -26.11 61.53 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.35 0.595 . . . . 0.0 110.865 -178.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -70.22 -36.38 74.5 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.008 177.199 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 445' ' ' GLN . . . . . 0.463 ' HG3' ' N ' ' A' ' 446' ' ' GLU . 0.0 OUTLIER -75.22 -30.19 60.51 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.026 178.098 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 446' ' ' GLU . . . . . 0.513 ' HB3' ' O ' ' A' ' 443' ' ' LEU . 13.6 pt-20 27.52 97.31 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.171 0 O-C-N 125.396 1.685 . . . . 0.0 113.646 175.3 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 49.3 mt -59.25 -35.12 56.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.206 0.527 . . . . 0.0 110.989 -178.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 448' ' ' ASP . . . . . 0.466 ' HB2' ' OG1' ' A' ' 451' ' ' THR . 17.1 m-20 -163.33 -157.8 0.44 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 -178.459 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -87.13 -67.31 0.83 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 171.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -66.2 -25.43 66.92 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 176.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 451' ' ' THR . . . . . 0.483 ' HA ' ' HB2' ' A' ' 454' ' ' GLU . 10.5 m -71.31 -22.64 61.91 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 119.906 -0.717 . . . . 0.0 110.602 -174.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 452' ' ' ARG . . . . . 0.445 ' NH2' ' HB3' ' A' ' 443' ' ' LEU . 19.0 mtp180 -53.53 -54.26 39.77 Favored 'General case' 0 C--O 1.22 -0.495 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 171.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 453' ' ' ALA . . . . . 0.552 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -58.4 -49.4 77.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.525 -1.216 . . . . 0.0 112.808 174.426 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 454' ' ' GLU . . . . . 0.483 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 16.0 mm-40 -51.15 -35.47 36.01 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.1 0.476 . . . . 0.0 112.049 -177.096 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 28.2 p -119.98 16.16 12.51 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.191 -176.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 456' ' ' PHE . . . . . 0.601 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.9 OUTLIER -55.23 -48.62 73.66 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.99 0.424 . . . . 0.0 111.639 -172.351 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 457' ' ' ILE . . . . . 0.56 HG23 ' HB1' ' A' ' 405' ' ' ALA . 1.9 mp -76.96 -33.05 20.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.964 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -57.97 -34.88 70.42 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.786 0.803 . . . . 0.0 109.347 171.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 459' ' ' HIS . . . . . 0.71 ' O ' HG23 ' A' ' 463' ' ' VAL . 63.3 m-70 -74.37 -28.82 61.29 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.639 177.537 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 460' ' ' LEU . . . . . 0.729 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.4 OUTLIER -73.93 -34.6 64.4 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.981 0.896 . . . . 0.0 108.787 178.559 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 461' ' ' ASN . . . . . 0.436 ' O ' ' HB2' ' A' ' 464' ' ' TYR . 26.9 m-80 -73.02 -37.58 66.89 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.992 0.901 . . . . 0.0 108.925 176.482 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 462' ' ' ALA . . . . . 0.598 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -56.49 -34.46 66.97 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.491 -1.232 . . . . 0.0 109.814 169.206 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.873 HG13 ' HB3' ' A' ' 438' ' ' ALA . 68.0 t -61.64 -50.89 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 175.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 464' ' ' TYR . . . . . 0.593 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 17.0 m-30 -53.01 -26.85 16.75 Favored 'General case' 0 C--N 1.33 -0.255 0 O-C-N 124.317 1.011 . . . . 0.0 110.664 177.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.14 -39.7 17.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.576 0.703 . . . . 0.0 109.821 -178.015 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.598 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.7 mt -57.75 -55.64 20.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 114.421 -1.263 . . . . 0.0 112.157 175.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 0.76 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -101.64 -11.04 19.5 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -173.345 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 468' ' ' GLY . . . . . 0.581 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 93.94 31.57 8.06 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 119.38 -1.391 . . . . 0.0 114.353 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 469' ' ' LEU . . . . . 0.76 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 2.5 mt -88.08 159.38 18.26 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 117.777 0.789 . . . . 0.0 110.625 176.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 470' ' ' ASN . . . . . 0.551 HD22 HG23 ' A' ' 476' ' ' ILE . 12.0 p30 -104.76 -179.18 3.87 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.278 172.486 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -56.3 -27.79 56.68 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -173.339 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 -86.66 5.33 36.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.674 0.273 . . . . 0.0 111.607 -171.291 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 473' ' ' GLY . . . . . 0.453 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 77.68 11.84 85.05 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.325 -0.94 . . . . 0.0 111.472 -178.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 474' ' ' GLN . . . . . 0.46 ' HB2' HD21 ' A' ' 470' ' ' ASN . 56.0 mt-30 -101.09 158.0 16.34 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 177.269 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 5.3 p -97.34 122.43 40.37 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.171 0.51 . . . . 0.0 112.074 -176.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 476' ' ' ILE . . . . . 0.581 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.5 pp . . . . . 0 C--N 1.324 -0.507 0 CA-C-O 121.574 0.702 . . . . 0.0 110.005 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 386' ' ' PHE . . . . . 0.76 ' CD1' HD22 ' B' ' 414' ' ' LEU . 2.3 t80 . . . . . 0 CA--C 1.534 0.36 0 CA-C-O 120.572 0.225 . . . . 0.0 110.428 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 387' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' B' ' 386' ' ' PHE . 42.6 Cg_endo -65.69 111.38 1.89 Allowed 'Trans proline' 0 N--CA 1.481 0.76 0 C-N-CA 123.929 3.086 . . . . 0.0 112.431 173.197 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 388' ' ' MET . . . . . 0.615 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 33.8 ttm -121.12 47.88 1.75 Allowed 'General case' 0 C--N 1.32 -0.716 0 O-C-N 122.094 -0.379 . . . . 0.0 111.645 -169.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 389' ' ' HIS . . . . . 0.641 ' CG ' ' HB2' ' B' ' 393' ' ' ASN . 38.4 m170 57.04 -90.21 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.443 0.64 . . . . 0.0 109.481 -171.016 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -160.29 17.0 0.14 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.986 -1.006 . . . . 0.0 108.348 174.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 391' ' ' LEU . . . . . 0.571 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.3 pt? -167.11 -59.55 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.074 -171.344 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 392' ' ' GLY . . . . . 0.571 ' N ' ' HG ' ' B' ' 391' ' ' LEU . . . -166.86 53.28 0.24 Allowed Glycine 0 C--N 1.335 0.523 0 C-N-CA 120.232 -0.985 . . . . 0.0 114.181 -172.029 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 393' ' ' ASN . . . . . 0.641 ' HB2' ' CG ' ' B' ' 389' ' ' HIS . 0.4 OUTLIER -56.2 -44.19 79.21 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 117.238 0.519 . . . . 0.0 110.258 176.789 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 394' ' ' VAL . . . . . 0.715 HG23 HD12 ' B' ' 398' ' ' ILE . 1.9 m -55.32 -45.06 77.73 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.756 0 N-CA-C 106.706 -1.591 . . . . 0.0 106.706 -178.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 395' ' ' ILE . . . . . 0.635 HG23 HD13 ' B' ' 426' ' ' ILE . 3.7 mp -57.98 -52.69 55.14 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.526 0 CA-C-O 117.77 -1.11 . . . . 0.0 113.59 -176.015 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 396' ' ' LYS . . . . . 0.528 ' O ' HG22 ' B' ' 399' ' ' VAL . 0.0 OUTLIER -63.22 -49.24 74.96 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 122.055 2.207 . . . . 0.0 111.932 -174.126 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 397' ' ' GLY . . . . . 0.457 ' O ' ' HG3' ' B' ' 401' ' ' GLN . . . -52.72 -44.43 60.44 Favored Glycine 0 N--CA 1.436 -1.336 0 C-N-CA 119.986 -1.102 . . . . 0.0 111.009 -177.196 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 398' ' ' ILE . . . . . 0.803 HD13 HD12 ' B' ' 410' ' ' LEU . 33.5 mt -71.82 -33.88 49.67 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 399' ' ' VAL . . . . . 0.528 HG22 ' O ' ' B' ' 396' ' ' LYS . 11.9 m -64.38 -40.39 88.88 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 C-N-CA 118.793 -1.163 . . . . 0.0 108.429 -173.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -64.27 -41.65 96.81 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 174.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 401' ' ' GLN . . . . . 0.457 ' HG3' ' O ' ' B' ' 397' ' ' GLY . 35.0 mt-30 -92.86 -49.66 5.94 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -170.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 402' ' ' GLU . . . . . 0.676 ' HG3' ' HE3' ' A' ' 413' ' ' MET . 2.4 mm-40 -111.75 -20.19 12.17 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.018 0.437 . . . . 0.0 111.265 -171.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 104.89 162.33 23.95 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.953 177.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 404' ' ' VAL . . . . . 0.652 HG11 ' HA ' ' B' ' 430' ' ' LEU . 1.6 m -54.08 -45.88 65.89 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.769 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 -175.231 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 405' ' ' ALA . . . . . 0.545 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -63.49 -33.03 74.68 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 119.785 -0.766 . . . . 0.0 112.337 -177.012 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 406' ' ' THR . . . . . 0.699 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 93.5 m -75.95 -42.09 49.61 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.251 174.202 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 407' ' ' ALA . . . . . 0.474 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.45 -36.83 74.28 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 122.145 0.974 . . . . 0.0 109.263 176.297 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 408' ' ' TYR . . . . . 0.611 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -66.53 -52.75 42.46 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 113.541 -1.663 . . . . 0.0 110.027 177.344 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 409' ' ' THR . . . . . 0.773 HG22 HD23 ' B' ' 410' ' ' LEU . 1.8 m -56.31 -45.68 80.15 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.44 178.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 410' ' ' LEU . . . . . 0.803 HD12 HD13 ' B' ' 398' ' ' ILE . 13.4 mt -71.69 -36.91 70.73 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -176.208 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.85 -35.18 81.37 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.064 -1.065 . . . . 0.0 110.73 172.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 412' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -67.34 -47.95 68.94 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 115.693 -0.254 . . . . 0.0 111.301 178.122 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 413' ' ' MET . . . . . 0.92 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.6 OUTLIER -70.91 -46.9 61.69 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 118.811 -1.155 . . . . 0.0 111.881 -179.945 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 414' ' ' LEU . . . . . 0.92 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 14.9 mt -67.84 -44.97 75.97 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -175.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 33.9 t -89.03 -16.46 31.57 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.555 0.693 . . . . 0.0 110.264 -175.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 416' ' ' GLY . . . . . . . . . . . . . . . 102.44 -175.92 24.98 Favored Glycine 0 N--CA 1.43 -1.758 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 -171.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -79.96 23.51 0.45 Allowed 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.362 0.601 . . . . 0.0 111.724 -171.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 418' ' ' ASN . . . . . . . . . . . . . 64.1 m-80 -72.23 77.17 0.98 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.946 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 419' ' ' TYR . . . . . 0.548 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 11.5 p90 -53.13 -38.77 62.96 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.399 176.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.47 -44.08 76.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.613 0.244 . . . . 0.0 110.972 178.52 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.32 -49.33 61.14 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.18 -178.234 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 422' ' ' VAL . . . . . 0.439 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.2 OUTLIER -65.92 -39.37 84.46 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.205 -176.643 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 423' ' ' SER . . . . . 0.796 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 78.4 p -68.5 -37.69 80.32 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.87 -178.436 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -69.32 -37.19 79.93 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.039 176.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 425' ' ' ILE . . . . . 0.572 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -72.65 -53.37 19.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 O-C-N 122.907 -0.173 . . . . 0.0 111.116 -178.828 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 426' ' ' ILE . . . . . 0.681 HG22 HD22 ' B' ' 430' ' ' LEU . 1.1 mm -73.59 -22.77 19.03 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.768 0 CA-C-O 120.801 0.334 . . . . 0.0 110.176 -172.32 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 427' ' ' ARG . . . . . 0.796 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.9 OUTLIER -54.94 -32.21 61.14 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.236 0.541 . . . . 0.0 110.522 -178.63 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -86.98 -7.47 77.58 Favored Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.449 179.003 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 429' ' ' TYR . . . . . 0.514 ' HD1' ' CG2' ' B' ' 395' ' ' ILE . 14.7 m-85 -117.29 0.61 12.29 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.096 0.474 . . . . 0.0 109.856 -176.211 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 430' ' ' LEU . . . . . 0.686 HD23 ' HA ' ' B' ' 427' ' ' ARG . 0.1 OUTLIER -65.86 129.27 94.26 Favored Pre-proline 0 N--CA 1.445 -0.702 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.152 178.816 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 431' ' ' PRO . . . . . 0.5 ' HD2' HD12 ' B' ' 430' ' ' LEU . 87.0 Cg_exo -24.43 -69.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.358 1.068 1 C-N-CA 125.4 4.067 . . . . 0.0 114.879 179.532 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 432' ' ' GLY . . . . . 0.542 ' O ' HG12 ' B' ' 435' ' ' VAL . . . -141.12 -169.87 11.97 Favored Glycine 0 N--CA 1.44 -1.038 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 177.247 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 433' ' ' GLN . . . . . 0.465 ' O ' HG13 ' B' ' 436' ' ' VAL . 41.2 tp60 -68.39 -26.37 65.52 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 118.062 0.931 . . . . 0.0 110.574 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -66.17 -41.46 90.29 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -178.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 435' ' ' VAL . . . . . 0.729 HG23 HG11 ' B' ' 463' ' ' VAL . 7.9 p -68.38 -43.97 83.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-O 121.071 0.463 . . . . 0.0 110.506 -177.318 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 436' ' ' VAL . . . . . 0.499 HG12 ' O ' ' B' ' 432' ' ' GLY . 0.1 OUTLIER -65.76 -30.56 50.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.452 175.65 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 1.1 m -69.08 -52.2 30.87 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -178.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 438' ' ' ALA . . . . . 0.862 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -58.68 -37.32 75.79 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.81 177.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 439' ' ' LEU . . . . . 0.565 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 2.0 tm? -70.38 -47.19 62.07 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -57.37 -38.83 74.84 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.303 174.37 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 441' ' ' GLN . . . . . 0.493 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 35.2 mm-40 -53.46 -50.05 66.13 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 123.519 0.728 . . . . 0.0 110.604 174.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 442' ' ' ARG . . . . . 0.816 ' HG2' ' O ' ' B' ' 438' ' ' ALA . 0.8 OUTLIER -56.68 -40.81 76.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.751 172.215 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 443' ' ' LEU . . . . . 0.565 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 40.6 mt -72.6 -26.14 61.58 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.273 0.558 . . . . 0.0 110.833 -178.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -70.06 -36.51 75.02 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.874 177.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 445' ' ' GLN . . . . . 0.459 ' HG3' ' N ' ' B' ' 446' ' ' GLU . 0.0 OUTLIER -74.94 -30.17 61.16 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.594 -1.185 . . . . 0.0 109.023 178.321 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 446' ' ' GLU . . . . . 0.528 ' HB3' ' O ' ' B' ' 443' ' ' LEU . 13.4 pt-20 27.48 96.9 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 O-C-N 125.42 1.7 . . . . 0.0 113.65 175.252 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 49.7 mt -59.09 -35.0 54.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.158 0.504 . . . . 0.0 110.95 -178.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 448' ' ' ASP . . . . . 0.462 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 16.3 m-20 -163.0 -156.92 0.41 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 -178.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -87.97 -67.21 0.84 Allowed 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 171.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -66.13 -25.45 66.98 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 176.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 451' ' ' THR . . . . . 0.48 ' HA ' ' HB2' ' B' ' 454' ' ' GLU . 10.5 m -71.37 -22.65 61.87 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 119.946 -0.701 . . . . 0.0 110.679 -174.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 452' ' ' ARG . . . . . 0.445 ' NH2' ' HB3' ' B' ' 443' ' ' LEU . 19.0 mtp180 -53.57 -54.27 39.88 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 171.429 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 453' ' ' ALA . . . . . 0.548 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -58.24 -49.49 76.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.507 -1.224 . . . . 0.0 112.707 174.416 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 454' ' ' GLU . . . . . 0.48 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 16.2 mm-40 -51.32 -35.15 36.6 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.22 0.533 . . . . 0.0 112.153 -176.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 28.8 p -120.26 16.19 12.28 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.143 -176.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 456' ' ' PHE . . . . . 0.604 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 1.0 OUTLIER -55.27 -48.73 73.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.957 0.408 . . . . 0.0 111.516 -172.331 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 457' ' ' ILE . . . . . 0.548 ' CG1' ' HB3' ' B' ' 408' ' ' TYR . 1.9 mp -76.46 -33.19 22.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.149 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -58.06 -34.91 70.62 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.821 0.82 . . . . 0.0 109.227 171.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 459' ' ' HIS . . . . . 0.712 ' O ' HG23 ' B' ' 463' ' ' VAL . 63.7 m-70 -74.37 -28.85 61.3 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.583 -1.189 . . . . 0.0 110.596 177.481 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 460' ' ' LEU . . . . . 0.734 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -73.8 -34.75 64.75 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.951 0.881 . . . . 0.0 108.808 178.407 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 461' ' ' ASN . . . . . 0.437 ' O ' ' HB2' ' B' ' 464' ' ' TYR . 26.4 m-80 -72.81 -37.6 67.48 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.34 -0.846 . . . . 0.0 108.965 176.659 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 462' ' ' ALA . . . . . 0.607 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -56.51 -34.48 67.04 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.352 -1.295 . . . . 0.0 109.796 169.245 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 463' ' ' VAL . . . . . 0.862 HG13 ' HB3' ' B' ' 438' ' ' ALA . 65.1 t -61.79 -50.63 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 175.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 464' ' ' TYR . . . . . 0.582 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 17.1 m-30 -53.12 -27.05 18.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.683 177.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.98 -39.69 17.79 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.775 0.798 . . . . 0.0 109.775 -178.073 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 466' ' ' ILE . . . . . 0.607 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.6 mt -57.72 -55.4 21.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.204 175.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 467' ' ' LEU . . . . . 0.756 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -101.73 -11.12 19.37 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 -173.484 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 468' ' ' GLY . . . . . 0.596 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 93.97 31.43 8.13 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 119.241 -1.457 . . . . 0.0 114.35 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 469' ' ' LEU . . . . . 0.756 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 2.5 mt -88.19 159.39 18.18 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 117.818 0.809 . . . . 0.0 110.606 176.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 470' ' ' ASN . . . . . 0.528 HD22 HG23 ' B' ' 476' ' ' ILE . 12.1 p30 -104.82 -179.6 3.99 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.101 172.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 471' ' ' ALA . . . . . . . . . . . . . . . -55.7 -28.21 54.44 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -173.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -86.29 4.95 36.79 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 122.314 -0.241 . . . . 0.0 111.56 -171.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 473' ' ' GLY . . . . . 0.454 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 78.0 11.82 85.01 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.384 -0.913 . . . . 0.0 111.475 -178.499 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 474' ' ' GLN . . . . . 0.463 ' HB2' HD21 ' B' ' 470' ' ' ASN . 56.5 mt-30 -101.07 158.12 16.25 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 177.345 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 6.0 p -97.3 122.64 40.57 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.327 0.584 . . . . 0.0 112.114 -176.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 476' ' ' ILE . . . . . 0.596 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.5 pp . . . . . 0 C--N 1.326 -0.439 0 CA-C-O 121.579 0.704 . . . . 0.0 110.006 178.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 386' ' ' PHE . . . . . 0.787 ' CZ ' HG12 ' A' ' 394' ' ' VAL . 1.4 t80 . . . . . 0 N--CA 1.45 -0.427 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -47.6 -75.25 0.03 OUTLIER 'Trans proline' 0 N--CA 1.479 0.625 0 C-N-CA 124.463 3.442 . . . . 0.0 115.125 -174.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.571 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 28.5 mtt 73.63 146.69 0.08 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.759 0.824 . . . . 0.0 111.225 -171.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 389' ' ' HIS . . . . . 0.522 ' CG ' ' HB2' ' A' ' 393' ' ' ASN . 32.7 m170 -49.29 -65.28 0.59 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.587 0.708 . . . . 0.0 109.519 178.233 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 390' ' ' GLN . . . . . 0.479 ' H ' HD23 ' A' ' 391' ' ' LEU . 28.3 pt20 -168.29 26.65 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.518 -1.219 . . . . 0.0 108.153 173.129 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.662 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.1 pt? -178.04 -65.31 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -167.311 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 392' ' ' GLY . . . . . 0.662 ' N ' ' HG ' ' A' ' 391' ' ' LEU . . . -163.64 49.9 0.3 Allowed Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.955 -0.64 . . . . 0.0 113.154 -168.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 393' ' ' ASN . . . . . 0.571 ' HB3' ' HA ' ' A' ' 388' ' ' MET . 0.4 OUTLIER -56.31 -37.68 70.24 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 177.942 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 394' ' ' VAL . . . . . 0.787 HG12 ' CZ ' ' A' ' 386' ' ' PHE . 0.9 OUTLIER -56.25 -47.39 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 178.681 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 395' ' ' ILE . . . . . 0.663 HG23 HD13 ' A' ' 426' ' ' ILE . 4.2 mp -57.66 -51.8 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.275 0 CA-C-O 118.108 -0.948 . . . . 0.0 112.967 -174.14 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 396' ' ' LYS . . . . . 0.678 ' HG3' ' CZ ' ' A' ' 429' ' ' TYR . 0.2 OUTLIER -62.52 -48.98 77.15 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 121.359 1.891 . . . . 0.0 111.415 -174.205 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -55.19 -45.38 82.67 Favored Glycine 0 N--CA 1.434 -1.486 0 C-N-CA 120.131 -1.033 . . . . 0.0 111.166 -179.004 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 398' ' ' ILE . . . . . 0.739 ' CD1' HD12 ' A' ' 410' ' ' LEU . 28.2 mt -70.46 -33.84 55.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -177.609 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 399' ' ' VAL . . . . . 0.501 HG12 ' HA ' ' A' ' 404' ' ' VAL . 11.8 m -63.89 -39.59 85.97 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 C-N-CA 118.798 -1.161 . . . . 0.0 108.385 -174.708 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -69.92 -36.65 75.53 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 175.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -87.58 -48.19 8.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.089 0.471 . . . . 0.0 111.944 -171.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 402' ' ' GLU . . . . . 0.564 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 1.9 mm-40 -121.41 -20.43 6.63 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.757 -170.086 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 107.4 162.38 21.62 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.046 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 404' ' ' VAL . . . . . 0.636 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.5 m -53.45 -41.82 46.52 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.723 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 -176.322 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 405' ' ' ALA . . . . . 0.655 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -69.04 -30.36 68.7 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.795 -176.044 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.712 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 90.5 m -77.29 -42.31 37.46 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.162 -0.615 . . . . 0.0 109.981 173.744 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.47 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.41 -36.98 74.42 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 122.123 0.963 . . . . 0.0 109.038 176.622 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 408' ' ' TYR . . . . . 0.636 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.7 -52.25 52.87 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 113.445 -1.707 . . . . 0.0 110.083 176.61 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 409' ' ' THR . . . . . 0.72 HG22 HD23 ' A' ' 410' ' ' LEU . 3.4 m -55.71 -46.56 77.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.674 178.674 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 410' ' ' LEU . . . . . 0.739 HD12 ' CD1' ' A' ' 398' ' ' ILE . 14.0 mt -72.22 -35.86 68.98 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.048 0.451 . . . . 0.0 110.358 -174.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -59.63 -34.86 83.7 Favored Glycine 0 N--CA 1.438 -1.205 0 C-N-CA 120.224 -0.989 . . . . 0.0 110.83 171.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -68.26 -43.72 77.18 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 178.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 413' ' ' MET . . . . . 0.731 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.0 OUTLIER -70.5 -57.65 4.55 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 118.822 -1.151 . . . . 0.0 111.549 179.607 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 414' ' ' LEU . . . . . 0.731 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 4.6 mt -67.35 -43.7 80.88 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -172.57 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.425 ' HB2' ' CE ' ' A' ' 388' ' ' MET . 5.2 t -95.45 18.14 13.23 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.482 0.658 . . . . 0.0 109.975 -174.309 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 73.17 -177.93 41.81 Favored Glycine 0 N--CA 1.437 -1.245 0 C-N-CA 120.357 -0.925 . . . . 0.0 111.675 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 33.9 mm-40 -80.69 23.13 0.54 Allowed 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.199 0.524 . . . . 0.0 111.616 -173.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 418' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -71.73 77.65 0.85 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.72 -179.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 419' ' ' TYR . . . . . 0.539 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 14.6 p90 -54.47 -37.85 65.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.549 177.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -54.97 -43.04 73.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.625 0.25 . . . . 0.0 110.644 177.482 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.42 -48.85 63.54 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.152 -178.247 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 422' ' ' VAL . . . . . 0.485 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.3 OUTLIER -66.32 -40.53 86.99 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 C-N-CA 120.235 -0.586 . . . . 0.0 111.239 -177.142 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.758 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 65.9 p -67.06 -38.29 85.52 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -178.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.29 -40.26 92.02 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.129 175.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 425' ' ' ILE . . . . . 0.598 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.61 -50.13 36.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 O-C-N 122.883 -0.187 . . . . 0.0 110.934 -176.996 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 426' ' ' ILE . . . . . 0.696 HG22 HD22 ' A' ' 430' ' ' LEU . 1.2 mm -74.55 -22.62 17.66 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -172.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.758 ' HB2' ' O ' ' A' ' 423' ' ' SER . 0.9 OUTLIER -54.86 -30.2 57.17 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.088 0.47 . . . . 0.0 110.756 -178.581 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -86.81 -9.12 75.11 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.458 178.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.678 ' CZ ' ' HG3' ' A' ' 396' ' ' LYS . 23.0 m-85 -115.87 1.03 13.29 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-O 120.995 0.426 . . . . 0.0 110.478 -177.563 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.699 HD23 ' HA ' ' A' ' 427' ' ' ARG . 0.1 OUTLIER -65.82 127.38 93.05 Favored Pre-proline 0 N--CA 1.439 -1.019 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 178.505 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 431' ' ' PRO . . . . . 0.471 ' HD2' HD12 ' A' ' 430' ' ' LEU . 84.6 Cg_exo -22.7 -74.88 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 1.012 1 C-N-CA 125.653 4.235 . . . . 0.0 114.72 -179.102 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 432' ' ' GLY . . . . . 0.504 ' O ' HG12 ' A' ' 435' ' ' VAL . . . -129.27 -166.53 11.93 Favored Glycine 0 N--CA 1.441 -0.99 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 172.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 433' ' ' GLN . . . . . 0.598 ' O ' HG13 ' A' ' 436' ' ' VAL . 21.6 tt0 -71.61 -26.64 62.67 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 118.838 1.319 . . . . 0.0 110.587 176.12 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -62.26 -38.34 88.92 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.833 -176.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 435' ' ' VAL . . . . . 0.778 HG23 HG11 ' A' ' 463' ' ' VAL . 7.5 p -69.76 -43.34 80.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-O 120.839 0.352 . . . . 0.0 110.611 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.598 HG13 ' O ' ' A' ' 433' ' ' GLN . 0.2 OUTLIER -66.42 -30.17 48.94 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-O 120.822 0.344 . . . . 0.0 110.299 175.028 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -69.37 -52.0 31.35 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -178.156 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 438' ' ' ALA . . . . . 0.845 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -57.42 -43.04 83.48 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.99 176.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 439' ' ' LEU . . . . . 0.626 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 2.0 tm? -65.28 -47.35 76.97 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -176.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -57.99 -39.11 77.42 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.228 174.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 441' ' ' GLN . . . . . 0.581 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 8.7 mm-40 -56.85 -50.46 72.37 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 123.379 0.672 . . . . 0.0 110.631 176.025 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 442' ' ' ARG . . . . . 0.711 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -58.65 -33.78 70.46 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.924 172.601 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 443' ' ' LEU . . . . . 0.626 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 59.5 mt -72.21 -33.99 68.02 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.024 0.44 . . . . 0.0 110.163 178.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -57.69 -36.75 72.37 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.319 173.067 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -72.6 -27.13 61.98 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.963 177.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 446' ' ' GLU . . . . . 0.57 ' HB2' ' O ' ' A' ' 443' ' ' LEU . 38.2 tt0 29.53 96.88 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 170.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 50.3 mt -68.33 -35.46 71.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.062 0.458 . . . . 0.0 110.882 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 448' ' ' ASP . . . . . 0.568 ' O ' ' HG3' ' A' ' 452' ' ' ARG . 36.8 m-20 -165.83 -166.78 0.98 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 -178.265 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -79.63 -63.81 1.33 Allowed 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.23 -0.588 . . . . 0.0 109.525 172.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -69.58 -25.97 64.24 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 178.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 451' ' ' THR . . . . . 0.439 ' HA ' ' HB2' ' A' ' 454' ' ' GLU . 12.1 m -71.85 -22.43 61.54 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.692 -175.405 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 452' ' ' ARG . . . . . 0.568 ' HG3' ' O ' ' A' ' 448' ' ' ASP . 11.1 mtp180 -53.11 -54.51 34.53 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 170.137 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 453' ' ' ALA . . . . . 0.539 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -57.93 -50.42 73.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.363 -1.29 . . . . 0.0 112.595 175.471 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 454' ' ' GLU . . . . . 0.439 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 31.4 mm-40 -49.73 -38.26 32.71 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.386 0.612 . . . . 0.0 111.729 -176.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 32.0 p -117.45 16.03 14.69 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.246 -176.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 456' ' ' PHE . . . . . 0.589 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 1.1 t80 -55.71 -47.36 76.98 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.169 0.509 . . . . 0.0 111.479 -171.336 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 457' ' ' ILE . . . . . 0.655 HG23 ' HB1' ' A' ' 405' ' ' ALA . 2.0 mp -75.41 -32.1 24.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.909 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -58.38 -35.78 72.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.67 0.748 . . . . 0.0 109.361 171.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 459' ' ' HIS . . . . . 0.712 ' O ' HG23 ' A' ' 463' ' ' VAL . 82.8 m-70 -72.44 -29.2 63.48 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.711 -1.132 . . . . 0.0 110.198 178.134 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 460' ' ' LEU . . . . . 0.742 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -74.51 -34.57 63.07 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.913 0.863 . . . . 0.0 108.929 179.129 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 461' ' ' ASN . . . . . 0.443 ' HA ' ' CD2' ' A' ' 464' ' ' TYR . 22.0 m-80 -72.83 -37.81 67.33 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.232 176.037 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 462' ' ' ALA . . . . . 0.628 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -56.62 -33.1 65.95 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.852 169.695 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.845 HG13 ' HB3' ' A' ' 438' ' ' ALA . 63.4 t -62.42 -50.78 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 CA-C-N 114.49 -1.232 . . . . 0.0 107.831 175.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 464' ' ' TYR . . . . . 0.559 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 16.2 m-30 -53.92 -27.77 32.77 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.53 178.431 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.8 -38.91 20.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.868 0.842 . . . . 0.0 109.337 -177.063 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.628 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.7 mt -57.91 -56.08 17.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 114.172 -1.377 . . . . 0.0 112.463 174.554 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 0.764 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -102.78 -10.62 18.97 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -171.512 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 468' ' ' GLY . . . . . 0.589 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 94.12 31.73 7.89 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 119.46 -1.353 . . . . 0.0 114.241 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 469' ' ' LEU . . . . . 0.764 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.1 mt -89.69 164.06 14.86 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 117.718 0.759 . . . . 0.0 111.13 176.081 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 37.6 p30 -105.61 -178.69 3.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.816 171.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 471' ' ' ALA . . . . . 0.544 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -69.98 -5.99 30.17 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -174.314 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -96.75 0.67 49.87 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.9 0.381 . . . . 0.0 110.885 -178.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 473' ' ' GLY . . . . . 0.427 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 79.31 12.47 83.86 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.443 -0.884 . . . . 0.0 111.2 -175.31 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -100.19 157.35 16.65 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 178.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 12.7 p -95.28 127.95 41.74 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.066 0.46 . . . . 0.0 111.333 -178.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 476' ' ' ILE . . . . . 0.589 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.9 pp . . . . . 0 C--N 1.325 -0.489 0 CA-C-O 121.788 0.804 . . . . 0.0 110.212 179.319 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 386' ' ' PHE . . . . . 0.793 ' CZ ' HG12 ' B' ' 394' ' ' VAL . 1.4 t80 . . . . . 0 N--CA 1.451 -0.414 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 387' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -47.38 -75.32 0.03 OUTLIER 'Trans proline' 0 N--CA 1.481 0.763 0 C-N-CA 124.44 3.427 . . . . 0.0 115.164 -174.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 388' ' ' MET . . . . . 0.584 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 28.4 mtt 73.69 146.6 0.08 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.698 0.799 . . . . 0.0 111.116 -171.675 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 389' ' ' HIS . . . . . 0.541 ' CG ' ' HB2' ' B' ' 393' ' ' ASN . 32.8 m170 -49.19 -64.99 0.64 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.606 0.717 . . . . 0.0 109.569 178.196 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 390' ' ' GLN . . . . . 0.472 ' H ' HD23 ' B' ' 391' ' ' LEU . 28.3 pt20 -168.74 26.61 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.509 -1.223 . . . . 0.0 108.245 173.122 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 391' ' ' LEU . . . . . 0.638 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.1 pt? -177.98 -65.44 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -167.195 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 392' ' ' GLY . . . . . 0.638 ' N ' ' HG ' ' B' ' 391' ' ' LEU . . . -163.66 50.1 0.3 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.082 -168.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 393' ' ' ASN . . . . . 0.584 ' HB3' ' HA ' ' B' ' 388' ' ' MET . 0.4 OUTLIER -56.38 -37.77 70.55 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.901 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 394' ' ' VAL . . . . . 0.793 HG12 ' CZ ' ' B' ' 386' ' ' PHE . 0.9 OUTLIER -56.22 -47.36 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 178.705 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 395' ' ' ILE . . . . . 0.647 HG23 HD13 ' B' ' 426' ' ' ILE . 4.3 mp -57.81 -51.67 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 CA-C-O 118.034 -0.984 . . . . 0.0 112.946 -174.168 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 396' ' ' LYS . . . . . 0.674 ' HG3' ' CZ ' ' B' ' 429' ' ' TYR . 0.2 OUTLIER -62.53 -48.8 77.93 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 121.482 1.946 . . . . 0.0 111.537 -174.219 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -55.24 -45.59 82.21 Favored Glycine 0 N--CA 1.434 -1.452 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.132 -179.082 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 398' ' ' ILE . . . . . 0.739 ' CD1' HD12 ' B' ' 410' ' ' LEU . 28.1 mt -70.34 -33.8 55.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -177.609 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 399' ' ' VAL . . . . . 0.513 HG12 ' HA ' ' B' ' 404' ' ' VAL . 12.0 m -63.9 -39.47 85.56 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 C-N-CA 118.754 -1.178 . . . . 0.0 108.489 -174.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -70.12 -36.63 74.95 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 175.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 401' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -87.47 -48.11 8.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.966 0.412 . . . . 0.0 111.988 -171.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 402' ' ' GLU . . . . . 0.576 ' HG3' ' HE3' ' A' ' 413' ' ' MET . 2.0 mm-40 -121.27 -21.02 6.5 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.678 -170.125 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 108.33 162.77 20.83 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.905 -0.664 . . . . 0.0 113.096 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 404' ' ' VAL . . . . . 0.624 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.5 m -53.71 -41.56 47.87 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.751 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -176.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 405' ' ' ALA . . . . . 0.645 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -69.32 -30.36 68.39 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 119.649 -0.821 . . . . 0.0 111.725 -175.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 406' ' ' THR . . . . . 0.705 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 93.8 m -77.56 -42.39 35.49 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 174.201 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 407' ' ' ALA . . . . . 0.465 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.41 -37.12 74.69 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 122.104 0.954 . . . . 0.0 108.935 176.464 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 408' ' ' TYR . . . . . 0.624 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.51 -52.4 52.95 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 113.492 -1.686 . . . . 0.0 110.046 176.534 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 409' ' ' THR . . . . . 0.723 HG22 HD23 ' B' ' 410' ' ' LEU . 3.3 m -55.79 -46.64 77.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.582 178.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 410' ' ' LEU . . . . . 0.739 HD12 ' CD1' ' B' ' 398' ' ' ILE . 13.8 mt -72.05 -36.04 69.5 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.124 0.488 . . . . 0.0 110.314 -174.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -59.59 -34.86 83.54 Favored Glycine 0 N--CA 1.439 -1.142 0 C-N-CA 120.213 -0.994 . . . . 0.0 110.825 171.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 412' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -68.24 -43.78 77.14 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.517 0.191 . . . . 0.0 111.517 178.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 413' ' ' MET . . . . . 0.718 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.0 OUTLIER -70.52 -57.69 4.5 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 118.772 -1.171 . . . . 0.0 111.546 179.721 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 414' ' ' LEU . . . . . 0.718 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 4.7 mt -67.24 -43.74 81.18 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 -172.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 415' ' ' SER . . . . . 0.422 ' HB2' ' CE ' ' B' ' 388' ' ' MET . 5.3 t -95.28 18.03 13.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.421 0.629 . . . . 0.0 110.108 -174.314 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 416' ' ' GLY . . . . . . . . . . . . . . . 73.08 -178.29 40.96 Favored Glycine 0 N--CA 1.438 -1.186 0 C-N-CA 120.427 -0.892 . . . . 0.0 111.659 -178.083 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -80.46 23.22 0.51 Allowed 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.009 0.433 . . . . 0.0 111.493 -173.236 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 418' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -71.58 77.9 0.81 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.834 -179.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 419' ' ' TYR . . . . . 0.54 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 14.5 p90 -54.88 -37.6 66.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.482 178.052 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -54.97 -43.12 73.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.723 0.297 . . . . 0.0 110.651 177.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.46 -48.79 63.6 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.148 -178.145 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 422' ' ' VAL . . . . . 0.482 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.3 OUTLIER -66.34 -40.66 87.28 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 C-N-CA 120.261 -0.576 . . . . 0.0 111.13 -177.17 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 423' ' ' SER . . . . . 0.742 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 69.4 p -67.03 -38.13 85.36 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.659 -0.416 . . . . 0.0 109.903 -178.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.42 -40.02 91.42 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.321 175.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 425' ' ' ILE . . . . . 0.605 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -72.68 -50.24 35.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.553 0.216 . . . . 0.0 110.887 -177.096 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 426' ' ' ILE . . . . . 0.693 HG22 HD22 ' B' ' 430' ' ' LEU . 1.2 mm -74.55 -22.57 17.64 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.815 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -172.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 427' ' ' ARG . . . . . 0.742 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.9 OUTLIER -54.75 -30.61 56.85 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.139 0.495 . . . . 0.0 110.701 -178.563 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -86.57 -8.91 76.32 Favored Glycine 0 N--CA 1.443 -0.89 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.456 178.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 429' ' ' TYR . . . . . 0.674 ' CZ ' ' HG3' ' B' ' 396' ' ' LYS . 22.9 m-85 -116.28 0.98 13.02 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-O 121.089 0.471 . . . . 0.0 110.509 -177.68 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 430' ' ' LEU . . . . . 0.693 HD22 HG22 ' B' ' 426' ' ' ILE . 0.1 OUTLIER -65.68 127.4 93.02 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.394 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 431' ' ' PRO . . . . . 0.466 ' HD2' HD12 ' B' ' 430' ' ' LEU . 86.1 Cg_exo -22.73 -75.44 0.02 OUTLIER 'Trans proline' 0 C--N 1.358 1.06 1 C-N-CA 125.617 4.211 . . . . 0.0 114.699 -179.246 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 432' ' ' GLY . . . . . 0.507 ' O ' HG12 ' B' ' 435' ' ' VAL . . . -128.84 -166.69 12.01 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 173.015 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 433' ' ' GLN . . . . . 0.591 ' O ' HG13 ' B' ' 436' ' ' VAL . 21.9 tt0 -71.44 -26.43 62.73 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 118.854 1.327 . . . . 0.0 110.571 176.147 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -62.58 -38.09 88.73 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -176.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 435' ' ' VAL . . . . . 0.774 HG23 HG11 ' B' ' 463' ' ' VAL . 7.5 p -69.77 -43.53 79.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 120.784 0.326 . . . . 0.0 110.57 -179.146 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 436' ' ' VAL . . . . . 0.591 HG13 ' O ' ' B' ' 433' ' ' GLN . 0.2 OUTLIER -66.35 -30.12 48.84 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 CA-C-O 120.895 0.379 . . . . 0.0 110.366 175.058 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -69.27 -51.97 32.15 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 -178.248 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 438' ' ' ALA . . . . . 0.837 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -57.5 -43.1 83.9 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.005 176.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 439' ' ' LEU . . . . . 0.635 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 2.0 tm? -65.22 -47.27 77.44 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -176.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -58.01 -39.01 77.25 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.235 174.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 441' ' ' GLN . . . . . 0.583 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 8.5 mm-40 -56.93 -50.43 72.6 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 123.368 0.667 . . . . 0.0 110.617 176.043 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 442' ' ' ARG . . . . . 0.707 ' HG2' ' O ' ' B' ' 438' ' ' ALA . 0.0 OUTLIER -58.76 -33.64 70.52 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.9 172.606 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 443' ' ' LEU . . . . . 0.635 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 58.8 mt -72.18 -33.93 68.05 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.037 0.446 . . . . 0.0 110.129 178.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -57.62 -36.82 72.29 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.56 172.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -72.62 -27.36 62.1 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.866 177.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 446' ' ' GLU . . . . . 0.562 ' HB2' ' O ' ' B' ' 443' ' ' LEU . 39.5 tt0 29.79 96.47 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 170.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 52.2 mt -68.28 -35.45 71.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.109 0.48 . . . . 0.0 110.798 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 448' ' ' ASP . . . . . 0.558 ' O ' ' HG3' ' B' ' 452' ' ' ARG . 37.2 m-20 -165.61 -166.57 0.98 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 -178.266 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -80.1 -63.47 1.4 Allowed 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.472 172.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -69.85 -25.96 63.99 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 178.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 451' ' ' THR . . . . . 0.432 ' HA ' ' HB2' ' B' ' 454' ' ' GLU . 14.1 m -71.78 -22.44 61.58 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.664 -175.442 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 452' ' ' ARG . . . . . 0.558 ' HG3' ' O ' ' B' ' 448' ' ' ASP . 11.2 mtp180 -53.11 -54.56 33.91 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 170.116 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 453' ' ' ALA . . . . . 0.54 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -57.97 -50.09 74.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.378 -1.283 . . . . 0.0 112.688 175.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 454' ' ' GLU . . . . . 0.432 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 30.5 mm-40 -50.03 -38.36 37.32 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.472 0.653 . . . . 0.0 111.535 -176.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 32.0 p -117.42 16.11 14.72 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.226 -176.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 456' ' ' PHE . . . . . 0.581 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 1.1 t80 -55.75 -47.27 77.28 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.188 0.518 . . . . 0.0 111.489 -171.463 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 457' ' ' ILE . . . . . 0.645 HG23 ' HB1' ' B' ' 405' ' ' ALA . 2.0 mp -75.66 -32.08 24.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.816 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -58.3 -35.94 72.59 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.733 0.778 . . . . 0.0 109.357 171.22 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 459' ' ' HIS . . . . . 0.707 ' O ' HG23 ' B' ' 463' ' ' VAL . 82.4 m-70 -72.42 -29.1 63.41 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.213 178.086 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 460' ' ' LEU . . . . . 0.747 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -74.55 -34.62 62.98 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.858 0.837 . . . . 0.0 108.911 179.16 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 461' ' ' ASN . . . . . 0.435 ' HA ' ' CD2' ' B' ' 464' ' ' TYR . 22.4 m-80 -72.89 -37.89 67.13 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.253 176.26 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 462' ' ' ALA . . . . . 0.629 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -56.58 -33.17 65.91 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.529 -1.214 . . . . 0.0 109.802 169.627 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 463' ' ' VAL . . . . . 0.837 HG13 ' HB3' ' B' ' 438' ' ' ALA . 64.6 t -62.33 -50.68 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 175.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 464' ' ' TYR . . . . . 0.547 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 16.1 m-30 -54.07 -27.51 33.04 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.623 178.456 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.82 -38.94 20.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.908 0.861 . . . . 0.0 109.413 -177.201 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 466' ' ' ILE . . . . . 0.629 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.8 mt -58.12 -56.2 17.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 114.125 -1.398 . . . . 0.0 112.395 174.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 467' ' ' LEU . . . . . 0.777 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -102.8 -10.39 19.16 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -171.532 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 468' ' ' GLY . . . . . 0.588 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 94.0 31.64 7.99 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 119.344 -1.408 . . . . 0.0 114.205 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 469' ' ' LEU . . . . . 0.777 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.2 mt -89.77 164.03 14.83 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 117.788 0.794 . . . . 0.0 111.152 176.117 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 37.1 p30 -105.57 -178.44 3.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.746 171.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 471' ' ' ALA . . . . . 0.523 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -70.23 -5.65 29.09 Favored 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -174.474 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 472' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' B' ' 472' ' ' ARG . 21.3 mmt180 -97.08 1.13 49.66 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.019 0.438 . . . . 0.0 110.891 -178.305 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 473' ' ' GLY . . . . . 0.426 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 78.95 12.66 83.91 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.36 -0.924 . . . . 0.0 111.079 -175.247 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -100.39 157.47 16.6 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 9.6 p -95.12 127.88 41.52 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.252 0.549 . . . . 0.0 111.448 -178.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 476' ' ' ILE . . . . . 0.588 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.9 pp . . . . . 0 C--N 1.325 -0.474 0 CA-C-O 121.579 0.704 . . . . 0.0 110.205 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 386' ' ' PHE . . . . . 0.77 ' CD1' HD22 ' A' ' 414' ' ' LEU . 2.0 t80 . . . . . 0 CA--C 1.53 0.175 0 CA-C-O 121.104 0.478 . . . . 0.0 110.789 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 387' ' ' PRO . . . . . 0.542 ' HG2' ' OD1' ' B' ' 393' ' ' ASN . 61.7 Cg_endo -72.12 110.02 2.84 Favored 'Trans proline' 0 N--CA 1.481 0.738 0 C-N-CA 124.183 3.255 . . . . 0.0 114.104 175.522 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.449 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 32.8 mtt -104.07 169.07 8.71 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 121.991 -0.443 . . . . 0.0 110.109 175.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -54.84 -62.6 1.55 Allowed 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 177.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -172.3 17.31 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.625 -1.171 . . . . 0.0 108.27 172.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.612 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 1.9 pt? -165.91 -66.15 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.24 -167.14 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 392' ' ' GLY . . . . . 0.612 ' N ' ' HG ' ' A' ' 391' ' ' LEU . . . -162.8 54.87 0.3 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.409 -0.9 . . . . 0.0 113.173 -173.338 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 393' ' ' ASN . . . . . 0.548 ' OD1' ' HG2' ' B' ' 387' ' ' PRO . 0.2 OUTLIER -54.31 -42.25 69.91 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.455 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 394' ' ' VAL . . . . . 0.741 HG12 ' CZ ' ' A' ' 386' ' ' PHE . 0.7 OUTLIER -57.03 -46.22 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -179.48 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 395' ' ' ILE . . . . . 0.647 HG23 HD13 ' A' ' 426' ' ' ILE . 4.2 mp -57.55 -51.77 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.247 0 CA-C-O 118.009 -0.996 . . . . 0.0 112.887 -174.384 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 396' ' ' LYS . . . . . 0.667 ' HG3' ' CZ ' ' A' ' 429' ' ' TYR . 0.1 OUTLIER -62.22 -48.82 78.29 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 121.446 1.93 . . . . 0.0 111.698 -175.163 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -54.95 -45.56 80.5 Favored Glycine 0 N--CA 1.436 -1.341 0 C-N-CA 119.84 -1.171 . . . . 0.0 111.229 -178.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 398' ' ' ILE . . . . . 0.733 HG12 HD21 ' B' ' 414' ' ' LEU . 26.3 mt -70.88 -34.11 54.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -177.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 399' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 396' ' ' LYS . 13.1 m -63.99 -39.38 85.24 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.499 0 C-N-CA 118.784 -1.166 . . . . 0.0 108.43 -174.131 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -71.0 -34.87 71.77 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 175.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 37.1 mm-40 -88.79 -48.0 7.81 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -172.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 402' ' ' GLU . . . . . 0.583 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 1.3 mm-40 -121.2 -20.55 6.7 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.609 -170.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 107.27 162.28 21.72 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.702 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 404' ' ' VAL . . . . . 0.604 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.8 m -53.77 -46.18 62.5 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.739 0 N-CA-C 114.946 1.462 . . . . 0.0 114.946 -175.258 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 405' ' ' ALA . . . . . 0.535 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -64.0 -29.88 71.0 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 119.778 -0.769 . . . . 0.0 112.379 -177.354 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.732 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 93.2 m -77.51 -42.56 35.19 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.119 -0.632 . . . . 0.0 110.204 172.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.464 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.28 -37.22 74.56 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 122.232 1.015 . . . . 0.0 109.25 176.654 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 408' ' ' TYR . . . . . 0.604 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.67 -52.02 54.87 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 113.351 -1.75 . . . . 0.0 109.933 176.382 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 409' ' ' THR . . . . . 0.654 HG22 HD23 ' A' ' 410' ' ' LEU . 16.5 m -55.12 -47.11 75.47 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.479 179.101 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 410' ' ' LEU . . . . . 0.732 ' HG ' ' O ' ' A' ' 406' ' ' THR . 14.7 mt -72.69 -36.92 67.96 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.282 -174.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.74 -34.95 79.51 Favored Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.123 -1.036 . . . . 0.0 110.813 172.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 412' ' ' MET . . . . . 0.401 ' HB2' ' O ' ' A' ' 409' ' ' THR . 0.4 OUTLIER -66.61 -44.78 81.16 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 115.734 -0.233 . . . . 0.0 111.441 177.962 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 413' ' ' MET . . . . . 0.765 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.0 OUTLIER -70.82 -57.1 4.97 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 118.675 -1.21 . . . . 0.0 111.668 179.135 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 414' ' ' LEU . . . . . 0.77 HD22 ' CD1' ' A' ' 386' ' ' PHE . 6.8 mt -64.58 -43.18 94.68 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -171.552 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 32.8 t -86.03 -16.84 36.94 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.734 0.778 . . . . 0.0 109.816 -177.117 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 416' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 100.79 -175.34 26.38 Favored Glycine 0 N--CA 1.429 -1.773 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -170.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 34.0 mm-40 -79.65 24.03 0.39 Allowed 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.207 0.527 . . . . 0.0 111.645 -171.044 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 418' ' ' ASN . . . . . 0.405 ' H ' ' C ' ' A' ' 416' ' ' GLY . 61.2 m-80 -71.4 75.96 0.76 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.146 -178.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 419' ' ' TYR . . . . . 0.515 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 7.4 p90 -50.39 -38.54 43.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.933 173.656 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -54.27 -46.78 72.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.886 178.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.16 -48.98 60.8 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.188 -176.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 422' ' ' VAL . . . . . 0.406 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -66.37 -40.02 85.62 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 C-N-CA 120.368 -0.533 . . . . 0.0 111.146 -175.509 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.703 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 78.2 p -67.31 -38.57 85.2 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.607 -0.437 . . . . 0.0 109.976 -178.495 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -69.56 -37.61 78.11 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.071 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 425' ' ' ILE . . . . . 0.604 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -73.34 -51.9 23.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.466 0.174 . . . . 0.0 111.113 -178.018 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 426' ' ' ILE . . . . . 0.647 HD13 HG23 ' A' ' 395' ' ' ILE . 1.2 mm -74.4 -23.35 18.19 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.829 0 CA-C-O 120.835 0.35 . . . . 0.0 110.241 -171.352 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.703 ' HB2' ' O ' ' A' ' 423' ' ' SER . 1.0 OUTLIER -54.62 -29.33 51.68 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.165 0.507 . . . . 0.0 110.602 179.773 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -86.35 -8.38 77.97 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.858 178.261 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.667 ' CZ ' ' HG3' ' A' ' 396' ' ' LYS . 24.2 m-85 -117.51 -1.09 11.75 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-O 121.465 0.65 . . . . 0.0 110.272 -178.575 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.593 HD12 ' HD2' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -65.99 132.78 94.71 Favored Pre-proline 0 N--CA 1.437 -1.118 0 CA-C-N 114.624 -1.171 . . . . 0.0 108.624 179.241 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 431' ' ' PRO . . . . . 0.829 ' CD ' HG11 ' A' ' 435' ' ' VAL . 42.4 Cg_exo -35.17 -72.36 0.05 OUTLIER 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 124.847 3.698 . . . . 0.0 113.984 -170.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 432' ' ' GLY . . . . . 0.455 ' O ' HG12 ' A' ' 435' ' ' VAL . . . -131.38 -162.49 10.57 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 175.319 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 433' ' ' GLN . . . . . 0.523 ' O ' HG13 ' A' ' 436' ' ' VAL . 22.3 tp60 -71.29 -27.6 63.53 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 118.088 0.944 . . . . 0.0 110.459 177.46 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -68.23 -37.92 81.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.164 -175.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 435' ' ' VAL . . . . . 0.829 HG11 ' CD ' ' A' ' 431' ' ' PRO . 6.7 p -68.45 -46.63 80.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-O 120.979 0.419 . . . . 0.0 110.438 -178.33 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.523 HG13 ' O ' ' A' ' 433' ' ' GLN . 0.2 OUTLIER -63.47 -31.08 51.55 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.321 175.702 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 437' ' ' THR . . . . . 0.573 ' O ' ' HG3' ' A' ' 441' ' ' GLN . 1.0 OUTLIER -69.03 -52.94 23.46 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 -178.028 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 438' ' ' ALA . . . . . 0.891 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -59.43 -36.06 75.19 Favored 'General case' 0 N--CA 1.436 -1.15 0 O-C-N 124.01 0.819 . . . . 0.0 112.01 178.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 439' ' ' LEU . . . . . 0.585 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 1.9 tm? -70.24 -47.91 59.28 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 -59.47 -36.43 75.97 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.18 176.003 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 441' ' ' GLN . . . . . 0.573 ' HG3' ' O ' ' A' ' 437' ' ' THR . 43.4 mt-30 -54.33 -51.47 64.61 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.106 178.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 442' ' ' ARG . . . . . 0.497 ' HG3' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -62.47 -36.87 83.84 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.839 174.869 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 443' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 61.4 mt -66.57 -37.36 84.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.007 0.432 . . . . 0.0 110.195 179.241 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -57.68 -37.81 74.08 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.563 173.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -72.53 -27.48 62.26 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.533 178.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 446' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 443' ' ' LEU . 37.9 tt0 33.55 101.18 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 114.56 1.318 . . . . 0.0 114.56 170.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 54.6 mt -69.87 -35.26 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-O 121.054 0.454 . . . . 0.0 110.745 178.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 448' ' ' ASP . . . . . 0.521 ' O ' ' HG3' ' A' ' 452' ' ' ARG . 16.6 m-20 -168.35 -167.42 0.8 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -176.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -77.06 -69.98 0.49 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.039 0.447 . . . . 0.0 109.807 172.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -66.86 -25.06 66.23 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 178.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 451' ' ' THR . . . . . 0.501 ' OG1' ' HB2' ' A' ' 448' ' ' ASP . 11.7 m -70.89 -22.91 62.21 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 119.989 -0.685 . . . . 0.0 110.86 -174.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 452' ' ' ARG . . . . . 0.521 ' HG3' ' O ' ' A' ' 448' ' ' ASP . 11.6 mtp180 -53.61 -54.0 43.86 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 170.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 453' ' ' ALA . . . . . 0.515 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -58.88 -47.04 86.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.557 -1.201 . . . . 0.0 112.656 175.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 454' ' ' GLU . . . . . 0.443 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 23.6 mm-40 -52.41 -36.17 53.58 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.175 0.512 . . . . 0.0 111.462 -178.442 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 29.5 p -118.38 15.61 13.87 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.449 -176.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 456' ' ' PHE . . . . . 0.553 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.9 OUTLIER -56.83 -48.69 77.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.05 0.452 . . . . 0.0 111.54 -171.704 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 457' ' ' ILE . . . . . 0.553 ' CG1' ' HB3' ' A' ' 408' ' ' TYR . 1.9 mp -76.11 -32.0 22.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.8 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -57.46 -37.08 72.28 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.672 0.749 . . . . 0.0 109.325 171.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 459' ' ' HIS . . . . . 0.774 ' O ' HG23 ' A' ' 463' ' ' VAL . 79.3 m-70 -72.32 -29.14 63.56 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.365 178.121 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 460' ' ' LEU . . . . . 0.73 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -74.18 -35.38 63.97 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.954 0.883 . . . . 0.0 108.992 179.688 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 461' ' ' ASN . . . . . 0.495 ' O ' ' HB2' ' A' ' 464' ' ' TYR . 23.7 m-80 -73.13 -37.67 66.56 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.362 -0.835 . . . . 0.0 108.977 176.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 462' ' ' ALA . . . . . 0.613 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -56.98 -33.58 67.23 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.586 -1.188 . . . . 0.0 109.931 169.278 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.891 HG13 ' HB3' ' A' ' 438' ' ' ALA . 55.2 t -62.66 -50.29 80.36 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.893 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 175.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 464' ' ' TYR . . . . . 0.6 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 20.7 m-30 -52.89 -29.57 29.07 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.481 177.552 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.37 -38.71 19.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.75 0.786 . . . . 0.0 109.636 -176.245 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.613 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.6 mt -56.8 -55.98 16.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 114.289 -1.323 . . . . 0.0 112.271 174.466 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 0.782 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -102.14 -10.07 19.96 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -171.94 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 468' ' ' GLY . . . . . 0.564 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 94.72 31.39 7.83 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 119.481 -1.342 . . . . 0.0 114.345 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 469' ' ' LEU . . . . . 0.782 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 4.2 mt -89.75 160.45 16.54 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 117.862 0.831 . . . . 0.0 110.889 174.469 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 470' ' ' ASN . . . . . 0.448 ' HB3' ' CG2' ' A' ' 476' ' ' ILE . 40.2 p30 -105.53 -178.24 3.6 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.4 170.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 471' ' ' ALA . . . . . 0.447 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -56.91 -27.9 61.33 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -174.132 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -85.08 8.46 17.91 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -171.484 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 74.01 9.08 79.63 Favored Glycine 0 CA--C 1.519 0.344 0 C-N-CA 120.313 -0.946 . . . . 0.0 111.642 -177.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -100.14 155.08 17.93 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 177.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 475' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 469' ' ' LEU . 59.9 p -91.43 136.73 32.9 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.348 0.594 . . . . 0.0 110.837 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 476' ' ' ILE . . . . . 0.564 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.7 pp . . . . . 0 C--N 1.319 -0.743 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.468 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 386' ' ' PHE . . . . . 0.783 ' CD1' HD22 ' B' ' 414' ' ' LEU . 2.0 t80 . . . . . 0 CA--C 1.53 0.21 0 CA-C-O 121.061 0.457 . . . . 0.0 110.846 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 387' ' ' PRO . . . . . 0.548 ' HG2' ' OD1' ' A' ' 393' ' ' ASN . 61.5 Cg_endo -72.23 110.23 2.91 Favored 'Trans proline' 0 N--CA 1.479 0.645 0 C-N-CA 124.166 3.244 . . . . 0.0 114.107 175.424 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 388' ' ' MET . . . . . 0.436 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 33.1 mtt -104.3 169.08 8.69 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 122.103 -0.373 . . . . 0.0 110.127 175.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 389' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -54.98 -62.45 1.65 Allowed 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 177.263 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -172.35 17.06 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.736 -1.12 . . . . 0.0 108.311 172.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 391' ' ' LEU . . . . . 0.606 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.0 pt? -165.82 -66.18 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.269 -167.146 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 392' ' ' GLY . . . . . 0.606 ' N ' ' HG ' ' B' ' 391' ' ' LEU . . . -162.83 54.96 0.3 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.432 -0.889 . . . . 0.0 113.169 -173.297 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 393' ' ' ASN . . . . . 0.542 ' OD1' ' HG2' ' A' ' 387' ' ' PRO . 0.2 OUTLIER -54.3 -42.37 70.0 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 178.41 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 394' ' ' VAL . . . . . 0.751 HG12 ' CZ ' ' B' ' 386' ' ' PHE . 0.7 OUTLIER -56.95 -46.15 83.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -179.388 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 395' ' ' ILE . . . . . 0.64 HG23 HD13 ' B' ' 426' ' ' ILE . 4.2 mp -57.59 -51.8 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-O 117.991 -1.004 . . . . 0.0 112.81 -174.376 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 396' ' ' LYS . . . . . 0.671 ' HG3' ' CZ ' ' B' ' 429' ' ' TYR . 0.1 OUTLIER -62.17 -49.03 77.45 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 121.487 1.949 . . . . 0.0 111.719 -175.142 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -54.77 -45.59 78.7 Favored Glycine 0 N--CA 1.437 -1.252 0 C-N-CA 119.84 -1.171 . . . . 0.0 111.209 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 398' ' ' ILE . . . . . 0.726 HG12 HD21 ' A' ' 414' ' ' LEU . 26.8 mt -70.94 -34.19 54.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 113.361 0.875 . . . . 0.0 113.361 -177.725 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 399' ' ' VAL . . . . . 0.478 HG12 ' HA ' ' B' ' 404' ' ' VAL . 13.5 m -63.82 -39.44 85.43 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.481 0 C-N-CA 118.774 -1.17 . . . . 0.0 108.56 -174.209 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -70.98 -34.83 71.78 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 175.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 401' ' ' GLN . . . . . . . . . . . . . 37.3 mm-40 -89.06 -47.61 7.99 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -172.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 402' ' ' GLU . . . . . 0.588 ' HG3' ' HE3' ' A' ' 413' ' ' MET . 1.3 mm-40 -121.64 -20.47 6.5 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.026 0.441 . . . . 0.0 111.489 -170.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 107.12 162.31 21.87 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.736 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 404' ' ' VAL . . . . . 0.592 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.8 m -53.72 -46.38 62.05 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.792 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -175.409 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 405' ' ' ALA . . . . . 0.539 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -63.87 -29.88 71.02 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 119.639 -0.825 . . . . 0.0 112.464 -177.439 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 406' ' ' THR . . . . . 0.727 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 89.1 m -77.38 -42.78 35.12 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.149 172.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 407' ' ' ALA . . . . . 0.465 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.17 -37.19 74.23 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 122.248 1.023 . . . . 0.0 109.317 176.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 408' ' ' TYR . . . . . 0.592 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.79 -51.97 54.69 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 113.279 -1.782 . . . . 0.0 109.86 176.48 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 409' ' ' THR . . . . . 0.647 HG22 HD23 ' B' ' 410' ' ' LEU . 16.6 m -55.23 -47.08 75.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.427 179.1 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 410' ' ' LEU . . . . . 0.727 ' HG ' ' O ' ' B' ' 406' ' ' THR . 14.7 mt -72.72 -36.82 67.87 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.312 -174.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.84 -34.89 79.97 Favored Glycine 0 N--CA 1.44 -1.074 0 C-N-CA 120.175 -1.012 . . . . 0.0 110.72 172.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 412' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -66.79 -44.52 81.09 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 115.839 -0.18 . . . . 0.0 111.458 177.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 413' ' ' MET . . . . . 0.762 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.0 OUTLIER -70.99 -56.9 5.18 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 118.66 -1.216 . . . . 0.0 111.701 179.035 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 414' ' ' LEU . . . . . 0.783 HD22 ' CD1' ' B' ' 386' ' ' PHE . 6.8 mt -64.71 -43.17 94.31 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -171.514 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 33.1 t -86.29 -16.45 37.5 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.76 0.791 . . . . 0.0 109.745 -176.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 416' ' ' GLY . . . . . 0.407 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 100.41 -175.54 26.99 Favored Glycine 0 N--CA 1.429 -1.831 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -171.052 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -79.48 24.13 0.37 Allowed 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.251 0.548 . . . . 0.0 111.742 -171.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 418' ' ' ASN . . . . . 0.407 ' H ' ' C ' ' B' ' 416' ' ' GLY . 62.5 m-80 -71.55 75.99 0.8 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.025 -179.002 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 419' ' ' TYR . . . . . 0.523 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 7.3 p90 -50.39 -38.49 42.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.936 173.462 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -54.37 -46.56 73.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.939 178.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.25 -49.03 59.96 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.249 -177.16 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 422' ' ' VAL . . . . . 0.41 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.2 OUTLIER -66.31 -40.08 85.86 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.212 -175.514 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 423' ' ' SER . . . . . 0.72 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 78.0 p -67.3 -38.56 85.18 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.921 -178.528 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -69.71 -37.45 76.5 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.11 177.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 425' ' ' ILE . . . . . 0.621 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -73.46 -52.03 23.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.488 0.185 . . . . 0.0 111.186 -178.259 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 426' ' ' ILE . . . . . 0.64 HD13 HG23 ' B' ' 395' ' ' ILE . 1.2 mm -74.13 -23.38 18.6 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.797 0 CA-C-O 120.82 0.343 . . . . 0.0 110.226 -171.321 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 427' ' ' ARG . . . . . 0.72 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.9 OUTLIER -54.68 -29.11 51.84 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.122 0.487 . . . . 0.0 110.666 179.913 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -86.55 -8.75 76.68 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.756 178.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 429' ' ' TYR . . . . . 0.671 ' CZ ' ' HG3' ' B' ' 396' ' ' LYS . 24.3 m-85 -117.1 -0.82 12.02 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 121.465 0.65 . . . . 0.0 110.156 -178.557 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 430' ' ' LEU . . . . . 0.614 HD12 ' HD2' ' B' ' 431' ' ' PRO . 0.0 OUTLIER -66.07 132.97 94.66 Favored Pre-proline 0 N--CA 1.438 -1.054 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.54 179.27 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 431' ' ' PRO . . . . . 0.828 ' CD ' HG11 ' B' ' 435' ' ' VAL . 42.6 Cg_exo -35.23 -71.73 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 124.76 3.64 . . . . 0.0 114.054 -170.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 432' ' ' GLY . . . . . 0.441 ' O ' HG12 ' B' ' 435' ' ' VAL . . . -131.99 -162.15 10.32 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 175.334 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 433' ' ' GLN . . . . . 0.535 ' O ' HG13 ' B' ' 436' ' ' VAL . 22.5 tp60 -71.58 -27.82 63.41 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 118.119 0.96 . . . . 0.0 110.447 177.429 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -68.06 -38.08 82.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.215 -0.448 . . . . 0.0 112.065 -175.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 435' ' ' VAL . . . . . 0.828 HG11 ' CD ' ' B' ' 431' ' ' PRO . 6.7 p -68.17 -46.73 80.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-O 121.068 0.461 . . . . 0.0 110.46 -178.34 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 436' ' ' VAL . . . . . 0.535 HG13 ' O ' ' B' ' 433' ' ' GLN . 0.2 OUTLIER -63.32 -31.44 52.81 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.191 175.759 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 437' ' ' THR . . . . . 0.575 ' O ' ' HG3' ' B' ' 441' ' ' GLN . 1.0 OUTLIER -68.87 -52.74 26.42 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -177.996 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 438' ' ' ALA . . . . . 0.89 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -59.51 -36.12 75.46 Favored 'General case' 0 N--CA 1.435 -1.193 0 O-C-N 124.132 0.895 . . . . 0.0 112.04 178.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 439' ' ' LEU . . . . . 0.588 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 1.9 tm? -70.22 -47.93 59.3 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 -59.43 -36.32 75.69 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.154 175.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 441' ' ' GLN . . . . . 0.575 ' HG3' ' O ' ' B' ' 437' ' ' THR . 43.9 mt-30 -54.44 -51.66 64.26 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 123.755 0.822 . . . . 0.0 110.034 178.76 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 442' ' ' ARG . . . . . 0.486 ' HG3' ' O ' ' B' ' 438' ' ' ALA . 0.0 OUTLIER -62.4 -36.69 83.11 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.461 -0.791 . . . . 0.0 112.855 174.942 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 443' ' ' LEU . . . . . 0.588 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 61.2 mt -66.6 -37.33 84.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.17 0.51 . . . . 0.0 110.237 179.222 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -57.82 -37.69 74.24 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.675 173.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -72.58 -27.39 62.16 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.497 -1.229 . . . . 0.0 110.595 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 446' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' B' ' 443' ' ' LEU . 37.9 tt0 33.41 101.52 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 170.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 54.9 mt -70.35 -35.35 62.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.074 0.464 . . . . 0.0 110.616 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 448' ' ' ASP . . . . . 0.514 ' O ' ' HG3' ' B' ' 452' ' ' ARG . 17.6 m-20 -168.17 -167.27 0.8 Allowed 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 -176.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -77.2 -70.15 0.48 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 173.004 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -66.79 -25.08 66.3 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 451' ' ' THR . . . . . 0.489 ' OG1' ' HB2' ' B' ' 448' ' ' ASP . 13.1 m -70.95 -22.82 62.16 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.688 -174.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 452' ' ' ARG . . . . . 0.514 ' HG3' ' O ' ' B' ' 448' ' ' ASP . 11.7 mtp180 -53.7 -53.92 45.23 Favored 'General case' 0 C--O 1.219 -0.552 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 171.024 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 453' ' ' ALA . . . . . 0.523 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -58.8 -47.28 85.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.517 -1.22 . . . . 0.0 112.666 175.525 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 454' ' ' GLU . . . . . 0.438 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 22.7 mm-40 -52.39 -36.07 53.12 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.321 0.581 . . . . 0.0 111.488 -178.406 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 29.4 p -118.3 15.58 13.94 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.397 -176.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 456' ' ' PHE . . . . . 0.551 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 0.9 OUTLIER -56.88 -48.89 77.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.054 0.454 . . . . 0.0 111.474 -171.712 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 457' ' ' ILE . . . . . 0.564 ' CG1' ' HB3' ' B' ' 408' ' ' TYR . 1.9 mp -75.97 -31.9 22.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.875 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -57.6 -37.06 72.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.693 0.759 . . . . 0.0 109.355 171.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 459' ' ' HIS . . . . . 0.777 ' O ' HG23 ' B' ' 463' ' ' VAL . 79.0 m-70 -72.36 -28.97 63.37 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.385 178.053 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 460' ' ' LEU . . . . . 0.746 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.4 OUTLIER -74.25 -35.4 63.8 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.909 0.861 . . . . 0.0 108.974 179.655 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 461' ' ' ASN . . . . . 0.486 ' O ' ' HB2' ' B' ' 464' ' ' TYR . 23.2 m-80 -73.3 -37.36 66.22 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.864 0.84 . . . . 0.0 109.087 176.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 462' ' ' ALA . . . . . 0.612 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -57.11 -33.65 67.56 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.493 -1.23 . . . . 0.0 109.891 169.098 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 463' ' ' VAL . . . . . 0.89 HG13 ' HB3' ' B' ' 438' ' ' ALA . 55.9 t -62.53 -50.4 79.98 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.871 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 175.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 464' ' ' TYR . . . . . 0.603 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 20.7 m-30 -52.79 -29.45 27.5 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.481 177.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.41 -38.95 19.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.701 0.762 . . . . 0.0 109.601 -176.262 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 466' ' ' ILE . . . . . 0.612 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.6 mt -56.72 -55.77 17.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 114.245 -1.343 . . . . 0.0 112.257 174.605 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 467' ' ' LEU . . . . . 0.776 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -102.3 -9.94 19.94 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -171.943 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 468' ' ' GLY . . . . . 0.567 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 94.53 31.58 7.8 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 119.519 -1.324 . . . . 0.0 114.456 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 469' ' ' LEU . . . . . 0.776 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 4.2 mt -89.89 160.67 16.33 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 117.674 0.737 . . . . 0.0 110.853 174.384 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 470' ' ' ASN . . . . . 0.454 ' HB3' ' CG2' ' B' ' 476' ' ' ILE . 40.1 p30 -105.64 -178.15 3.57 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.365 170.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 471' ' ' ALA . . . . . 0.446 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -57.05 -27.87 62.05 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -174.244 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -85.14 8.63 17.46 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.973 0.361 . . . . 0.0 111.973 -171.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 473' ' ' GLY . . . . . . . . . . . . . . . 74.02 8.96 79.51 Favored Glycine 0 C--O 1.228 -0.221 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.553 -177.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -100.16 154.88 18.08 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 177.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 475' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' B' ' 469' ' ' LEU . 61.1 p -91.12 136.69 32.91 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.329 0.585 . . . . 0.0 110.862 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 476' ' ' ILE . . . . . 0.567 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.7 pp . . . . . 0 C--N 1.318 -0.777 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.47 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 386' ' ' PHE . . . . . 0.775 ' CD1' HD22 ' A' ' 414' ' ' LEU . 1.9 t80 . . . . . 0 CA--C 1.539 0.551 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -55.4 -72.76 0.03 OUTLIER 'Trans proline' 0 N--CA 1.486 1.068 0 C-N-CA 124.488 3.458 . . . . 0.0 114.465 178.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.577 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 10.4 ttp 69.17 59.6 0.33 Allowed 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 170.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 389' ' ' HIS . . . . . 0.557 ' ND1' ' HA ' ' A' ' 393' ' ' ASN . 17.1 m170 51.05 -138.56 1.04 Allowed 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -178.373 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 390' ' ' GLN . . . . . 0.478 ' H ' ' HB3' ' A' ' 389' ' ' HIS . 5.9 pm0 -110.68 22.67 15.14 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 164.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.623 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.5 pt? -168.28 -61.71 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.542 -174.096 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 392' ' ' GLY . . . . . 0.623 ' N ' ' HG ' ' A' ' 391' ' ' LEU . . . -160.51 59.45 0.31 Allowed Glycine 0 C--N 1.337 0.589 0 C-N-CA 119.733 -1.222 . . . . 0.0 114.715 -171.199 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 393' ' ' ASN . . . . . 0.577 ' HB3' ' HA ' ' A' ' 388' ' ' MET . 0.4 OUTLIER -62.4 -39.55 93.61 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 117.4 0.6 . . . . 0.0 109.568 175.714 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 394' ' ' VAL . . . . . 0.663 HG22 HD12 ' A' ' 395' ' ' ILE . 0.6 OUTLIER -56.7 -46.02 82.91 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 179.21 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 395' ' ' ILE . . . . . 0.663 HD12 HG22 ' A' ' 394' ' ' VAL . 4.0 mp -57.79 -52.71 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.323 0 CA-C-O 117.853 -1.07 . . . . 0.0 113.465 -174.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 396' ' ' LYS . . . . . 0.615 ' O ' HG22 ' A' ' 399' ' ' VAL . 0.0 OUTLIER -63.72 -49.76 71.8 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-N 121.972 2.169 . . . . 0.0 111.645 -175.77 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.62 -44.89 68.72 Favored Glycine 0 N--CA 1.428 -1.842 0 CA-C-N 114.473 -1.239 . . . . 0.0 110.818 -175.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 398' ' ' ILE . . . . . 0.743 HG12 HD21 ' B' ' 414' ' ' LEU . 34.8 mt -70.79 -33.05 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 399' ' ' VAL . . . . . 0.615 HG22 ' O ' ' A' ' 396' ' ' LYS . 16.7 m -62.9 -39.73 86.16 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 C-N-CA 118.688 -1.205 . . . . 0.0 108.43 -175.067 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -71.35 -35.03 71.0 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 175.181 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 35.4 mm-40 -88.52 -47.47 8.3 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -172.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 402' ' ' GLU . . . . . 0.617 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 3.1 mm-40 -121.72 -21.03 6.26 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.539 -171.313 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 109.25 160.98 19.44 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.728 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 404' ' ' VAL . . . . . 0.645 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.1 m -53.71 -40.77 44.5 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.771 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -175.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 405' ' ' ALA . . . . . 0.576 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -68.48 -31.55 70.92 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 119.591 -0.844 . . . . 0.0 112.013 -177.122 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.71 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 92.3 m -77.08 -41.51 41.93 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.1 173.641 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.448 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.47 -37.26 75.12 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 122.059 0.933 . . . . 0.0 109.365 176.173 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 408' ' ' TYR . . . . . 0.645 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.6 -52.79 49.38 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 113.709 -1.587 . . . . 0.0 109.973 176.433 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 409' ' ' THR . . . . . 0.739 HG22 HD23 ' A' ' 410' ' ' LEU . 3.2 m -56.09 -46.8 78.93 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 179.168 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 410' ' ' LEU . . . . . 0.739 HD23 HG22 ' A' ' 409' ' ' THR . 13.6 mt -72.36 -37.69 68.73 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -175.558 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.48 -37.03 87.31 Favored Glycine 0 N--CA 1.435 -1.4 0 C-N-CA 119.849 -1.167 . . . . 0.0 110.298 172.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 412' ' ' MET . . . . . 0.439 ' HB2' ' O ' ' A' ' 409' ' ' THR . 0.0 OUTLIER -64.27 -49.98 69.72 Favored 'General case' 0 C--O 1.223 -0.306 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 178.53 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 413' ' ' MET . . . . . 0.933 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 1.0 OUTLIER -71.27 -42.88 68.21 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 118.849 -1.14 . . . . 0.0 112.133 -176.146 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 414' ' ' LEU . . . . . 0.933 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 19.7 mt -69.61 -45.19 69.14 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -177.123 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 54.6 p -85.91 -21.65 27.86 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.511 0.672 . . . . 0.0 110.482 -174.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 108.64 178.65 21.71 Favored Glycine 0 N--CA 1.431 -1.682 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -168.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -80.17 23.94 0.45 Allowed 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.037 0.446 . . . . 0.0 111.859 -173.287 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 418' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -71.35 78.25 0.74 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.677 0.751 . . . . 0.0 110.947 178.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 419' ' ' TYR . . . . . 0.568 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 17.1 p90 -51.86 -38.32 55.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.749 177.314 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -55.12 -45.41 75.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.746 178.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 421' ' ' LEU . . . . . 0.427 HD23 ' N ' ' A' ' 422' ' ' VAL . 0.0 OUTLIER -68.33 -48.58 64.48 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.11 -177.943 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 422' ' ' VAL . . . . . 0.477 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.1 OUTLIER -65.64 -41.78 91.33 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 C-N-CA 120.347 -0.541 . . . . 0.0 110.932 -176.291 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.785 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 29.6 t -69.35 -36.53 76.98 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.7 -178.145 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -69.34 -37.47 80.07 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.84 176.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 425' ' ' ILE . . . . . 0.611 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.41 -51.25 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-O 120.515 0.198 . . . . 0.0 110.621 -179.631 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 426' ' ' ILE . . . . . 0.752 HG22 HD22 ' A' ' 430' ' ' LEU . 1.1 mm -73.38 -22.9 19.37 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.952 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -173.587 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.785 ' HB2' ' O ' ' A' ' 423' ' ' SER . 1.1 tmm_? -54.38 -33.63 59.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.289 0.566 . . . . 0.0 110.893 -177.034 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -86.28 -10.94 73.33 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.404 -0.903 . . . . 0.0 110.853 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.633 ' HD1' HG22 ' A' ' 395' ' ' ILE . 5.4 m-30 -112.91 -1.8 14.47 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -174.501 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.752 HD22 HG22 ' A' ' 426' ' ' ILE . 0.0 OUTLIER -66.61 129.88 94.1 Favored Pre-proline 0 N--CA 1.443 -0.789 0 CA-C-N 114.201 -1.363 . . . . 0.0 108.947 177.203 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 431' ' ' PRO . . . . . 0.585 ' HD2' HD12 ' A' ' 430' ' ' LEU . 79.7 Cg_exo -24.09 -66.95 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.758 1 C-N-CA 125.536 4.157 . . . . 0.0 114.727 179.221 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 432' ' ' GLY . . . . . 0.529 ' H ' HG12 ' A' ' 435' ' ' VAL . . . -145.2 -168.17 12.75 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 176.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 433' ' ' GLN . . . . . 0.515 ' O ' HG13 ' A' ' 436' ' ' VAL . 40.1 tp60 -69.84 -26.26 64.13 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 117.888 0.844 . . . . 0.0 110.459 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -65.85 -40.8 92.07 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.887 -178.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 435' ' ' VAL . . . . . 0.74 HG23 HG11 ' A' ' 463' ' ' VAL . 7.4 p -68.84 -43.39 82.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-O 120.947 0.403 . . . . 0.0 110.755 -177.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.515 HG13 ' O ' ' A' ' 433' ' ' GLN . 0.1 OUTLIER -65.25 -33.42 63.59 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.19 175.73 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 437' ' ' THR . . . . . 0.458 ' O ' ' HG3' ' A' ' 441' ' ' GLN . 1.0 OUTLIER -66.84 -52.86 38.67 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -177.727 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 438' ' ' ALA . . . . . 0.869 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -58.58 -37.79 76.52 Favored 'General case' 0 N--CA 1.436 -1.162 0 O-C-N 123.788 0.68 . . . . 0.0 111.835 178.301 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 439' ' ' LEU . . . . . 0.619 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 2.1 tm? -67.64 -48.78 65.76 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 -179.27 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -60.28 -35.02 74.58 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.535 -1.212 . . . . 0.0 110.729 176.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 441' ' ' GLN . . . . . 0.563 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 13.3 mt-30 -53.32 -50.96 63.88 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.186 -178.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 442' ' ' ARG . . . . . 0.631 ' HD2' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -76.09 -23.38 54.96 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 175.118 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 443' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 47.3 mt -64.09 -35.47 80.87 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 174.072 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -56.89 -36.09 69.71 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.373 172.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -73.16 -27.63 61.77 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.872 178.456 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 446' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 443' ' ' LEU . 33.5 tt0 32.94 89.45 0.01 OUTLIER 'General case' 0 C--N 1.353 0.745 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 170.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 70.8 mt -59.31 -35.82 60.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 175.362 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 448' ' ' ASP . . . . . 0.493 ' HB2' ' OG1' ' A' ' 451' ' ' THR . 24.5 m-20 -166.49 175.34 8.16 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 178.104 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 449' ' ' ASP . . . . . 0.642 ' O ' ' HG2' ' A' ' 452' ' ' ARG . 13.0 m-20 -62.72 -60.03 4.07 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.312 -0.555 . . . . 0.0 109.715 174.579 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 450' ' ' GLN . . . . . 0.453 ' O ' ' HB3' ' A' ' 453' ' ' ALA . 2.6 pp0? -71.93 -28.51 63.51 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 178.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 451' ' ' THR . . . . . 0.493 ' OG1' ' HB2' ' A' ' 448' ' ' ASP . 10.1 m -73.0 -23.54 60.65 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.326 -174.383 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 452' ' ' ARG . . . . . 0.642 ' HG2' ' O ' ' A' ' 449' ' ' ASP . 6.0 ptp180 -64.73 -41.52 95.9 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 174.557 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 453' ' ' ALA . . . . . 0.568 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -58.99 -49.19 78.82 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 123.843 0.714 . . . . 0.0 112.445 168.492 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 454' ' ' GLU . . . . . 0.434 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 33.5 mm-40 -53.97 -33.44 56.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.148 0.499 . . . . 0.0 111.738 -177.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 29.1 p -115.56 15.27 16.65 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.224 -178.37 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 456' ' ' PHE . . . . . 0.559 ' CZ ' ' HB2' ' A' ' 423' ' ' SER . 1.0 OUTLIER -56.78 -47.68 79.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.995 0.426 . . . . 0.0 111.775 -171.667 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 457' ' ' ILE . . . . . 0.576 HG23 ' HB1' ' A' ' 405' ' ' ALA . 1.9 mp -76.41 -33.41 23.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.153 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -57.84 -34.05 69.29 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.955 0.883 . . . . 0.0 108.963 171.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 459' ' ' HIS . . . . . 0.745 ' O ' HG23 ' A' ' 463' ' ' VAL . 45.0 m-70 -74.47 -29.31 61.4 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.197 -1.365 . . . . 0.0 110.947 177.719 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 460' ' ' LEU . . . . . 0.701 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -74.07 -34.78 64.13 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.342 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 24.2 m-80 -73.02 -37.59 66.88 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.047 176.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 462' ' ' ALA . . . . . 0.6 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -55.86 -34.92 65.89 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.659 169.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.869 HG13 ' HB3' ' A' ' 438' ' ' ALA . 73.3 t -61.69 -51.15 76.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-N 114.612 -1.176 . . . . 0.0 108.201 176.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 464' ' ' TYR . . . . . 0.577 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 15.9 m-30 -52.95 -28.16 22.35 Favored 'General case' 0 C--N 1.332 -0.188 0 O-C-N 124.295 0.997 . . . . 0.0 110.614 178.13 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.92 -39.53 19.68 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.76 0.79 . . . . 0.0 109.632 -177.319 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.6 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.7 mt -57.95 -55.86 19.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 114.296 -1.32 . . . . 0.0 112.252 175.344 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 0.753 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -102.46 -10.88 19.01 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -172.274 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 468' ' ' GLY . . . . . 0.635 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 93.94 31.79 7.93 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 119.34 -1.41 . . . . 0.0 114.331 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 469' ' ' LEU . . . . . 0.753 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.1 mt -88.96 161.42 16.63 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 117.838 0.819 . . . . 0.0 110.922 175.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 470' ' ' ASN . . . . . 0.48 HD22 HG23 ' A' ' 476' ' ' ILE . 12.5 p30 -106.33 -176.84 3.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.075 170.43 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 471' ' ' ALA . . . . . 0.445 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -62.62 -19.55 63.89 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -173.227 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -87.77 2.26 51.72 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 122.113 -0.367 . . . . 0.0 111.809 -174.093 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 473' ' ' GLY . . . . . 0.477 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 76.77 11.58 85.26 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.21 -0.995 . . . . 0.0 111.003 -175.604 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -101.32 156.74 17.27 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 176.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 8.2 p -93.92 132.98 37.82 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.087 0.47 . . . . 0.0 111.587 -176.305 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 476' ' ' ILE . . . . . 0.635 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.5 pp . . . . . 0 C--N 1.328 -0.356 0 CA-C-O 121.479 0.657 . . . . 0.0 110.015 177.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 386' ' ' PHE . . . . . 0.784 ' CD1' HD22 ' B' ' 414' ' ' LEU . 1.9 t80 . . . . . 0 CA--C 1.538 0.504 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 387' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -55.59 -72.61 0.03 OUTLIER 'Trans proline' 0 N--CA 1.486 1.078 0 C-N-CA 124.536 3.491 . . . . 0.0 114.456 178.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 388' ' ' MET . . . . . 0.567 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 10.4 ttp 69.34 59.49 0.32 Allowed 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 170.496 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 389' ' ' HIS . . . . . 0.561 ' ND1' ' HA ' ' B' ' 393' ' ' ASN . 17.7 m170 51.28 -138.36 1.07 Allowed 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -178.342 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 390' ' ' GLN . . . . . 0.442 ' H ' ' HB3' ' B' ' 389' ' ' HIS . 5.9 pm0 -110.99 22.81 14.89 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 164.628 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 391' ' ' LEU . . . . . 0.615 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.5 pt? -168.46 -61.73 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.553 -174.044 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 392' ' ' GLY . . . . . 0.628 ' HA3' HD13 ' B' ' 395' ' ' ILE . . . -160.4 59.37 0.31 Allowed Glycine 0 C--N 1.338 0.644 0 C-N-CA 119.65 -1.262 . . . . 0.0 114.649 -171.225 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 393' ' ' ASN . . . . . 0.567 ' HB3' ' HA ' ' B' ' 388' ' ' MET . 0.4 OUTLIER -62.23 -39.71 93.7 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 117.371 0.586 . . . . 0.0 109.535 175.798 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 394' ' ' VAL . . . . . 0.672 HG22 HD12 ' B' ' 395' ' ' ILE . 0.6 OUTLIER -56.62 -46.09 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 179.346 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 395' ' ' ILE . . . . . 0.672 HD12 HG22 ' B' ' 394' ' ' VAL . 4.0 mp -57.86 -52.6 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.37 0 CA-C-O 117.794 -1.098 . . . . 0.0 113.45 -174.761 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 396' ' ' LYS . . . . . 0.616 ' O ' HG22 ' B' ' 399' ' ' VAL . 0.0 OUTLIER -63.58 -49.81 71.9 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-N 121.978 2.172 . . . . 0.0 111.706 -175.885 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.62 -44.86 68.73 Favored Glycine 0 N--CA 1.429 -1.819 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.825 -175.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 398' ' ' ILE . . . . . 0.78 HG12 HD21 ' A' ' 414' ' ' LEU . 35.1 mt -70.79 -33.11 51.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 399' ' ' VAL . . . . . 0.616 HG22 ' O ' ' B' ' 396' ' ' LYS . 16.7 m -62.93 -39.64 85.87 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 C-N-CA 118.678 -1.209 . . . . 0.0 108.362 -175.093 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -71.15 -35.55 71.72 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 175.077 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 401' ' ' GLN . . . . . . . . . . . . . 35.0 mm-40 -88.37 -47.38 8.43 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -172.004 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 402' ' ' GLU . . . . . 0.511 ' HG3' ' HE3' ' A' ' 413' ' ' MET . 3.1 mm-40 -121.75 -21.09 6.23 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.573 -171.476 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 109.34 160.77 19.24 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.797 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 404' ' ' VAL . . . . . 0.632 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.1 m -53.62 -40.72 43.46 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.733 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -175.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 405' ' ' ALA . . . . . 0.563 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -68.39 -31.73 71.29 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 119.689 -0.804 . . . . 0.0 111.989 -177.167 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 406' ' ' THR . . . . . 0.702 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 94.8 m -77.15 -41.38 41.98 Favored 'General case' 0 C--O 1.222 -0.39 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.065 173.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 407' ' ' ALA . . . . . 0.451 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.53 -37.29 75.34 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 122.024 0.916 . . . . 0.0 109.249 176.225 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 408' ' ' TYR . . . . . 0.632 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.54 -52.7 50.59 Favored 'General case' 0 N--CA 1.433 -1.275 0 CA-C-N 113.612 -1.631 . . . . 0.0 110.032 176.376 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 409' ' ' THR . . . . . 0.736 HG22 HD23 ' B' ' 410' ' ' LEU . 3.3 m -56.05 -46.98 78.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.616 179.195 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 410' ' ' LEU . . . . . 0.745 HD12 HD13 ' B' ' 398' ' ' ILE . 13.6 mt -72.31 -37.74 68.86 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -175.493 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.5 -37.18 87.81 Favored Glycine 0 N--CA 1.436 -1.347 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 173.039 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 412' ' ' MET . . . . . 0.442 ' HB2' ' O ' ' B' ' 409' ' ' THR . 0.0 OUTLIER -64.0 -50.11 69.81 Favored 'General case' 0 C--O 1.223 -0.309 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 178.457 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 413' ' ' MET . . . . . 0.939 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 1.0 OUTLIER -71.18 -43.15 68.03 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 118.941 -1.104 . . . . 0.0 112.045 -176.22 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 414' ' ' LEU . . . . . 0.939 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 19.6 mt -69.49 -45.18 69.56 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -176.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 54.7 p -85.95 -21.69 27.76 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.556 0.693 . . . . 0.0 110.462 -174.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 416' ' ' GLY . . . . . . . . . . . . . . . 108.75 178.54 21.64 Favored Glycine 0 N--CA 1.431 -1.687 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -168.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -80.01 23.88 0.44 Allowed 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.038 0.447 . . . . 0.0 112.041 -173.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 418' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -71.44 78.41 0.77 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.699 0.762 . . . . 0.0 110.726 178.196 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 419' ' ' TYR . . . . . 0.569 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 17.1 p90 -51.89 -38.31 55.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.726 177.167 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -55.15 -45.32 75.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.858 178.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 421' ' ' LEU . . . . . 0.418 HD23 ' N ' ' B' ' 422' ' ' VAL . 0.0 OUTLIER -68.4 -48.5 64.49 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.171 -178.031 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 422' ' ' VAL . . . . . 0.473 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.1 OUTLIER -65.7 -41.79 91.21 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.839 -176.291 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 423' ' ' SER . . . . . 0.778 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 28.5 t -69.39 -36.41 76.76 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.71 -178.017 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -69.41 -37.56 79.47 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.909 176.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 425' ' ' ILE . . . . . 0.62 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -72.36 -51.01 31.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.431 0.158 . . . . 0.0 110.623 -179.625 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 426' ' ' ILE . . . . . 0.748 HG22 HD22 ' B' ' 430' ' ' LEU . 1.1 mm -73.68 -22.86 18.95 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.899 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -173.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 427' ' ' ARG . . . . . 0.778 ' HB2' ' O ' ' B' ' 423' ' ' SER . 1.2 tmm_? -54.25 -33.73 59.14 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.284 0.564 . . . . 0.0 110.879 -177.053 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -86.33 -10.66 73.72 Favored Glycine 0 N--CA 1.441 -1.013 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 429' ' ' TYR . . . . . 0.632 ' HD1' HG22 ' B' ' 395' ' ' ILE . 5.6 m-30 -113.12 -1.92 14.28 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.884 0.85 . . . . 0.0 108.711 -174.561 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 430' ' ' LEU . . . . . 0.748 HD22 HG22 ' B' ' 426' ' ' ILE . 0.1 OUTLIER -66.38 130.03 94.18 Favored Pre-proline 0 N--CA 1.444 -0.757 0 CA-C-N 114.098 -1.41 . . . . 0.0 108.865 177.208 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 431' ' ' PRO . . . . . 0.574 ' HD2' HD12 ' B' ' 430' ' ' LEU . 80.2 Cg_exo -24.17 -66.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.759 1 C-N-CA 125.595 4.197 . . . . 0.0 114.697 178.984 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 432' ' ' GLY . . . . . 0.529 ' H ' HG12 ' B' ' 435' ' ' VAL . . . -145.4 -168.03 12.76 Favored Glycine 0 N--CA 1.441 -1.01 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 176.671 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 433' ' ' GLN . . . . . 0.507 ' O ' HG13 ' B' ' 436' ' ' VAL . 40.0 tp60 -69.79 -26.24 64.17 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 117.767 0.784 . . . . 0.0 110.465 179.186 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -65.95 -40.6 91.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.955 -178.138 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 435' ' ' VAL . . . . . 0.732 HG23 HG11 ' B' ' 463' ' ' VAL . 7.5 p -68.95 -43.59 82.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-O 120.85 0.357 . . . . 0.0 110.732 -177.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 436' ' ' VAL . . . . . 0.507 HG13 ' O ' ' B' ' 433' ' ' GLN . 0.1 OUTLIER -65.12 -33.45 63.8 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.234 175.723 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 437' ' ' THR . . . . . 0.453 ' O ' ' HG3' ' B' ' 441' ' ' GLN . 1.0 OUTLIER -67.02 -52.62 40.26 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -177.73 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 438' ' ' ALA . . . . . 0.857 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -58.6 -37.88 76.77 Favored 'General case' 0 N--CA 1.436 -1.151 0 O-C-N 123.809 0.693 . . . . 0.0 111.84 178.19 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 439' ' ' LEU . . . . . 0.61 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 2.1 tm? -67.44 -48.71 66.44 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -179.341 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -60.5 -34.78 74.57 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.498 -1.228 . . . . 0.0 110.773 176.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 441' ' ' GLN . . . . . 0.56 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 13.0 mt-30 -53.5 -50.67 64.9 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.175 -178.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 442' ' ' ARG . . . . . 0.634 ' HD2' ' O ' ' B' ' 438' ' ' ALA . 0.0 OUTLIER -76.33 -23.52 54.25 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 175.141 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 443' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 45.9 mt -63.79 -35.89 82.08 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 173.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -56.82 -35.76 69.17 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.378 172.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -73.21 -27.98 61.92 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.794 178.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 446' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' B' ' 443' ' ' LEU . 33.8 tt0 33.17 89.63 0.01 OUTLIER 'General case' 0 C--N 1.351 0.668 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 170.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 71.1 mt -59.51 -35.52 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 121.552 0.691 . . . . 0.0 109.18 175.13 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 448' ' ' ASP . . . . . 0.498 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 28.6 m-20 -166.72 175.65 7.71 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 177.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 449' ' ' ASP . . . . . 0.646 ' O ' ' HG2' ' B' ' 452' ' ' ARG . 13.6 m-20 -62.88 -60.08 3.97 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.394 -0.522 . . . . 0.0 109.61 174.658 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 450' ' ' GLN . . . . . 0.447 ' O ' ' HB3' ' B' ' 453' ' ' ALA . 2.6 pp0? -71.9 -28.6 63.6 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 178.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 451' ' ' THR . . . . . 0.498 ' OG1' ' HB2' ' B' ' 448' ' ' ASP . 9.8 m -72.99 -23.38 60.64 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 119.621 -0.832 . . . . 0.0 111.39 -174.327 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 452' ' ' ARG . . . . . 0.646 ' HG2' ' O ' ' B' ' 449' ' ' ASP . 6.0 ptp180 -64.73 -41.62 95.81 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 174.516 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 453' ' ' ALA . . . . . 0.569 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -59.06 -49.17 78.92 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 123.751 0.657 . . . . 0.0 112.395 168.514 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 454' ' ' GLU . . . . . 0.432 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 33.5 mm-40 -53.77 -34.19 58.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.493 -177.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 30.0 p -115.04 15.36 17.19 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.255 -178.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 456' ' ' PHE . . . . . 0.567 ' CZ ' ' HB2' ' B' ' 423' ' ' SER . 1.0 OUTLIER -56.83 -47.64 79.86 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.833 -171.726 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 457' ' ' ILE . . . . . 0.563 HG23 ' HB1' ' B' ' 405' ' ' ALA . 1.9 mp -76.31 -33.47 23.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.224 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -57.83 -33.95 69.18 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 122.072 0.939 . . . . 0.0 108.999 171.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 459' ' ' HIS . . . . . 0.747 ' O ' HG23 ' B' ' 463' ' ' VAL . 44.4 m-70 -74.64 -29.25 61.2 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.136 -1.393 . . . . 0.0 110.964 177.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 460' ' ' LEU . . . . . 0.704 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -73.98 -34.64 64.29 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.882 0.849 . . . . 0.0 108.817 179.117 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 461' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 -73.13 -37.61 66.59 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.11 176.117 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 462' ' ' ALA . . . . . 0.61 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -55.91 -34.98 66.07 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.351 -1.295 . . . . 0.0 109.62 169.735 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 463' ' ' VAL . . . . . 0.857 HG13 ' HB3' ' B' ' 438' ' ' ALA . 72.6 t -61.68 -51.21 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-N 114.656 -1.157 . . . . 0.0 108.227 177.054 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 464' ' ' TYR . . . . . 0.57 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 15.8 m-30 -52.8 -28.41 22.41 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 124.347 1.03 . . . . 0.0 110.532 178.062 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.07 -38.9 20.22 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.765 0.793 . . . . 0.0 109.674 -177.155 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 466' ' ' ILE . . . . . 0.61 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.7 mt -58.48 -55.85 20.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 114.419 -1.264 . . . . 0.0 112.181 175.134 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 467' ' ' LEU . . . . . 0.763 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -102.49 -10.72 19.12 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -172.235 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 468' ' ' GLY . . . . . 0.65 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 94.05 31.57 8.01 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 119.38 -1.391 . . . . 0.0 114.312 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 469' ' ' LEU . . . . . 0.763 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.1 mt -88.82 161.33 16.79 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 117.729 0.765 . . . . 0.0 110.883 175.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 470' ' ' ASN . . . . . 0.484 HD22 HG23 ' B' ' 476' ' ' ILE . 12.1 p30 -106.47 -177.06 3.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.014 170.298 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 471' ' ' ALA . . . . . 0.444 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -62.13 -19.66 63.26 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -173.254 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -88.0 2.48 51.67 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 122.06 -0.4 . . . . 0.0 111.775 -173.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 473' ' ' GLY . . . . . 0.483 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 76.52 11.67 84.99 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.33 -0.938 . . . . 0.0 111.035 -175.502 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -101.39 157.02 17.1 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 176.265 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 8.6 p -93.86 133.53 37.18 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.116 0.484 . . . . 0.0 111.387 -176.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 476' ' ' ILE . . . . . 0.65 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.5 pp . . . . . 0 C--N 1.328 -0.333 0 CA-C-O 121.431 0.634 . . . . 0.0 109.888 177.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 386' ' ' PHE . . . . . 0.808 ' CE2' HG12 ' A' ' 394' ' ' VAL . 0.8 OUTLIER . . . . . 0 N--CA 1.449 -0.495 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 387' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 386' ' ' PHE . 26.3 Cg_endo -60.16 102.94 0.19 Allowed 'Trans proline' 0 CA--C 1.531 0.362 0 C-N-CA 123.779 2.986 . . . . 0.0 113.516 177.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.689 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 47.2 mtt -105.98 163.88 12.4 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.27 176.443 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 389' ' ' HIS . . . . . 0.544 ' CE1' ' HA ' ' A' ' 393' ' ' ASN . 17.5 m170 -74.1 39.68 0.12 Allowed 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 390' ' ' GLN . . . . . 0.533 ' O ' ' HG2' ' A' ' 390' ' ' GLN . 64.8 tt0 71.53 16.64 5.86 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.099 0.559 . . . . 0.0 110.673 -171.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.577 HD23 ' H ' ' A' ' 392' ' ' GLY . 2.0 pt? -163.41 -59.5 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 177.508 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 392' ' ' GLY . . . . . 0.772 ' HA3' HD13 ' A' ' 395' ' ' ILE . . . -171.99 67.98 0.12 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 119.714 -1.231 . . . . 0.0 113.988 -173.26 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 393' ' ' ASN . . . . . 0.689 ' HB3' ' HA ' ' A' ' 388' ' ' MET . 0.2 OUTLIER -62.22 -41.14 98.12 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 174.712 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 394' ' ' VAL . . . . . 0.808 HG12 ' CE2' ' A' ' 386' ' ' PHE . 0.9 OUTLIER -55.57 -47.26 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 178.95 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 395' ' ' ILE . . . . . 0.772 HD13 ' HA3' ' A' ' 392' ' ' GLY . 3.6 mp -57.07 -52.08 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 CA-C-O 117.762 -1.113 . . . . 0.0 113.64 -175.401 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 396' ' ' LYS . . . . . 0.602 ' O ' HG22 ' A' ' 399' ' ' VAL . 0.1 OUTLIER -60.62 -51.09 70.9 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 121.873 2.124 . . . . 0.0 112.821 -175.245 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.93 -42.72 70.76 Favored Glycine 0 N--CA 1.438 -1.18 0 C-N-CA 119.554 -1.308 . . . . 0.0 110.894 -174.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 398' ' ' ILE . . . . . 0.942 HD13 HD12 ' A' ' 410' ' ' LEU . 39.4 mt -71.78 -34.29 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 CA-C-N 114.009 -1.095 . . . . 0.0 113.641 -178.688 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 399' ' ' VAL . . . . . 0.602 HG22 ' O ' ' A' ' 396' ' ' LYS . 16.0 m -62.91 -39.56 85.53 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 C-N-CA 118.881 -1.128 . . . . 0.0 108.649 -174.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -69.96 -38.2 76.03 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 175.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -90.19 -48.81 6.93 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -170.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 402' ' ' GLU . . . . . 0.662 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 1.3 mm-40 -116.12 -19.15 10.4 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.106 -170.715 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 104.51 161.0 24.14 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.579 178.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 404' ' ' VAL . . . . . 0.673 HG11 ' HA ' ' A' ' 430' ' ' LEU . 1.5 m -53.42 -45.26 57.29 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.967 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -176.685 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 405' ' ' ALA . . . . . 0.586 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -62.93 -31.23 72.27 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 119.995 -0.682 . . . . 0.0 112.606 -178.03 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.685 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 87.9 m -76.96 -43.14 36.3 Favored 'General case' 0 C--O 1.222 -0.364 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.201 173.366 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.486 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -58.69 -37.22 75.61 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 122.191 0.996 . . . . 0.0 109.297 176.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 408' ' ' TYR . . . . . 0.673 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -66.11 -51.91 53.55 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 113.414 -1.721 . . . . 0.0 109.659 176.568 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 409' ' ' THR . . . . . 0.64 HG22 HD23 ' A' ' 410' ' ' LEU . 13.3 m -54.44 -47.11 73.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.451 178.33 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 410' ' ' LEU . . . . . 0.942 HD12 HD13 ' A' ' 398' ' ' ILE . 14.4 mt -71.57 -37.47 71.06 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 120.944 0.402 . . . . 0.0 109.92 -175.345 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.33 -34.57 75.02 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.017 -1.087 . . . . 0.0 110.53 173.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 412' ' ' MET . . . . . 0.412 ' HB2' ' O ' ' A' ' 409' ' ' THR . 0.4 OUTLIER -67.28 -44.4 79.4 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 115.412 -0.394 . . . . 0.0 111.454 177.836 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 413' ' ' MET . . . . . 0.754 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.0 OUTLIER -70.85 -55.45 8.45 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 118.371 -1.332 . . . . 0.0 111.736 179.187 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 414' ' ' LEU . . . . . 0.754 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 3.9 mt -63.62 -44.51 93.71 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -171.636 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 46.8 t -86.42 -21.05 27.33 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.71 0.767 . . . . 0.0 109.906 -176.331 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 416' ' ' GLY . . . . . 0.422 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 107.37 -176.26 20.85 Favored Glycine 0 N--CA 1.431 -1.667 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -170.186 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -79.72 24.71 0.37 Allowed 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.4 0.619 . . . . 0.0 111.479 -172.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 418' ' ' ASN . . . . . 0.422 ' H ' ' C ' ' A' ' 416' ' ' GLY . 92.6 m-20 -70.83 75.28 0.62 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.856 -178.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 419' ' ' TYR . . . . . 0.518 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 12.1 p90 -50.56 -38.84 47.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.173 175.536 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -54.71 -47.82 73.24 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 123.292 0.37 . . . . 0.0 110.816 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.69 -49.12 64.36 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.419 -177.243 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 422' ' ' VAL . . . . . 0.423 ' HB ' ' CD1' ' A' ' 408' ' ' TYR . 0.2 OUTLIER -65.64 -39.5 85.16 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.552 -176.934 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.763 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 78.6 p -68.75 -36.32 78.22 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.564 -0.454 . . . . 0.0 109.868 -178.088 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -70.32 -38.75 71.05 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.946 175.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 425' ' ' ILE . . . . . 0.554 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -71.74 -51.68 30.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 O-C-N 122.852 -0.205 . . . . 0.0 110.857 -178.195 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 426' ' ' ILE . . . . . 0.714 HG22 HD22 ' A' ' 430' ' ' LEU . 1.1 mm -74.05 -23.44 18.75 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.827 0 C-N-CA 122.407 0.283 . . . . 0.0 110.405 -173.23 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.763 ' HB2' ' O ' ' A' ' 423' ' ' SER . 1.0 OUTLIER -54.77 -31.84 59.21 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.034 0.445 . . . . 0.0 111.496 -177.536 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -85.16 -14.84 68.19 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.228 -0.987 . . . . 0.0 110.859 178.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.6 ' HD1' HG22 ' A' ' 395' ' ' ILE . 5.1 m-30 -111.0 0.2 16.9 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.689 0.757 . . . . 0.0 109.031 -171.566 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.714 HD22 HG22 ' A' ' 426' ' ' ILE . 0.1 OUTLIER -65.48 129.1 94.29 Favored Pre-proline 0 N--CA 1.442 -0.866 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.74 177.576 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 431' ' ' PRO . . . . . 0.495 ' HD2' HD12 ' A' ' 430' ' ' LEU . 81.3 Cg_exo -23.59 -71.19 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.941 1 C-N-CA 125.539 4.159 . . . . 0.0 114.76 179.841 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 432' ' ' GLY . . . . . 0.554 ' O ' HG12 ' A' ' 435' ' ' VAL . . . -138.22 -171.93 12.36 Favored Glycine 0 N--CA 1.441 -1.031 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 176.206 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 433' ' ' GLN . . . . . 0.475 ' O ' HG13 ' A' ' 436' ' ' VAL . 51.3 tp60 -67.46 -25.56 65.95 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 118.106 0.953 . . . . 0.0 110.13 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -63.84 -43.41 96.23 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 435' ' ' VAL . . . . . 0.66 HG23 HG11 ' A' ' 463' ' ' VAL . 8.3 p -69.27 -41.93 81.26 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 CA-C-O 121.082 0.467 . . . . 0.0 110.641 -176.761 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.485 HG12 ' O ' ' A' ' 432' ' ' GLY . 0.1 OUTLIER -67.14 -30.19 48.57 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.082 174.832 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 437' ' ' THR . . . . . 0.488 ' O ' ' HG2' ' A' ' 441' ' ' GLN . 1.1 m -66.71 -53.95 28.13 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.126 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 438' ' ' ALA . . . . . 0.849 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -59.46 -34.59 72.73 Favored 'General case' 0 N--CA 1.434 -1.237 0 O-C-N 124.116 0.885 . . . . 0.0 111.227 178.201 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 439' ' ' LEU . . . . . 0.926 HD23 ' NH2' ' A' ' 442' ' ' ARG . 0.3 OUTLIER -67.11 -50.74 60.46 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.223 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -61.46 -33.89 74.51 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.44 -1.254 . . . . 0.0 111.032 175.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 441' ' ' GLN . . . . . 0.507 ' HB2' ' HA ' ' A' ' 438' ' ' ALA . 7.0 mm100 -55.01 -50.09 69.9 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.68 -175.02 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 442' ' ' ARG . . . . . 0.926 ' NH2' HD23 ' A' ' 439' ' ' LEU . 0.0 OUTLIER -78.08 -25.54 47.68 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 119.511 -0.875 . . . . 0.0 112.687 175.847 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 443' ' ' LEU . . . . . 0.775 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 67.3 mt -67.81 -26.62 66.16 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.7 178.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -64.82 -38.52 91.24 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.842 0.829 . . . . 0.0 109.976 173.254 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -77.24 -26.56 52.7 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.424 -1.262 . . . . 0.0 111.373 179.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 29.43 101.8 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 175.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 51.7 mt -60.07 -35.14 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 121.45 0.643 . . . . 0.0 110.434 -179.001 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 448' ' ' ASP . . . . . 0.464 ' HB2' ' OG1' ' A' ' 451' ' ' THR . 31.8 m-20 -164.77 -162.42 0.64 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -177.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -81.44 -72.05 0.45 Allowed 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 171.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -64.0 -25.14 67.99 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 178.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 451' ' ' THR . . . . . 0.464 ' OG1' ' HB2' ' A' ' 448' ' ' ASP . 8.9 m -71.03 -22.98 62.07 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.998 -174.159 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 452' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 452' ' ' ARG . 17.8 mtp180 -53.41 -54.16 40.88 Favored 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 171.343 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 453' ' ' ALA . . . . . 0.518 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -59.71 -49.61 77.05 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 114.395 -1.275 . . . . 0.0 113.095 175.183 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 454' ' ' GLU . . . . . 0.459 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 20.8 mm-40 -49.23 -38.34 26.24 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.341 0.591 . . . . 0.0 111.849 -176.298 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 26.1 p -120.11 16.55 12.42 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.818 -175.351 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 456' ' ' PHE . . . . . 0.502 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.8 OUTLIER -54.64 -46.8 74.0 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.688 -172.063 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 457' ' ' ILE . . . . . 0.586 HG23 ' HB1' ' A' ' 405' ' ' ALA . 1.9 mp -78.67 -35.22 18.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.64 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -57.23 -36.43 70.91 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 121.841 0.829 . . . . 0.0 109.192 172.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 459' ' ' HIS . . . . . 0.761 ' HB3' ' CZ ' ' A' ' 442' ' ' ARG . 78.9 m-70 -75.2 -30.43 60.63 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.528 177.291 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 460' ' ' LEU . . . . . 0.744 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.6 OUTLIER -67.49 -34.52 77.32 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 179.421 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 461' ' ' ASN . . . . . 0.464 ' O ' ' HB2' ' A' ' 464' ' ' TYR . 17.3 m-80 -72.95 -37.49 67.11 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.347 -1.297 . . . . 0.0 109.04 176.503 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 462' ' ' ALA . . . . . 0.603 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -56.63 -32.19 65.08 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.146 169.329 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.849 HG13 ' HB3' ' A' ' 438' ' ' ALA . 51.3 t -64.88 -49.91 77.65 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.798 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 176.031 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 464' ' ' TYR . . . . . 0.602 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 19.5 m-30 -51.48 -28.98 14.81 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 124.511 1.132 . . . . 0.0 110.454 176.282 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.84 -38.36 19.59 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.602 0.715 . . . . 0.0 109.7 -176.394 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.603 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.7 mt -58.11 -55.48 21.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.149 174.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 0.752 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -101.35 -10.85 19.9 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 -172.317 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 468' ' ' GLY . . . . . 0.583 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 94.13 31.58 7.97 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 119.538 -1.315 . . . . 0.0 114.287 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 469' ' ' LEU . . . . . 0.752 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.1 mt -89.45 164.02 15.01 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 117.801 0.8 . . . . 0.0 110.911 175.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 43.0 p30 -105.0 -179.19 3.87 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.267 172.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 471' ' ' ALA . . . . . 0.467 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -59.62 -23.47 63.02 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -177.228 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -87.43 3.11 48.46 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.157 -173.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 473' ' ' GLY . . . . . 0.448 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 75.45 15.43 81.22 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.393 -0.908 . . . . 0.0 110.973 -176.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -100.95 150.17 23.15 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 178.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 4.4 p -89.61 117.07 28.22 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.286 0.565 . . . . 0.0 111.557 -178.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 476' ' ' ILE . . . . . 0.583 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.8 pp . . . . . 0 C--N 1.32 -0.692 0 CA-C-O 121.722 0.772 . . . . 0.0 110.231 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 386' ' ' PHE . . . . . 0.812 ' CE2' HG12 ' B' ' 394' ' ' VAL . 0.8 OUTLIER . . . . . 0 N--CA 1.448 -0.537 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 387' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' B' ' 386' ' ' PHE . 26.7 Cg_endo -59.92 103.05 0.19 Allowed 'Trans proline' 0 N--CA 1.473 0.312 0 C-N-CA 123.787 2.992 . . . . 0.0 113.473 177.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 388' ' ' MET . . . . . 0.672 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 47.1 mtt -106.04 164.0 12.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.227 176.378 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 389' ' ' HIS . . . . . 0.534 ' CE1' ' HA ' ' B' ' 393' ' ' ASN . 17.3 m170 -74.17 39.86 0.12 Allowed 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 179.068 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 390' ' ' GLN . . . . . 0.525 ' O ' ' HG2' ' B' ' 390' ' ' GLN . 64.6 tt0 71.59 15.98 5.92 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.03 0.532 . . . . 0.0 110.65 -172.189 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 391' ' ' LEU . . . . . 0.569 HD23 ' H ' ' B' ' 392' ' ' GLY . 2.0 pt? -163.05 -59.5 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 177.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 392' ' ' GLY . . . . . 0.773 ' HA3' HD13 ' B' ' 395' ' ' ILE . . . -171.91 68.0 0.13 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 119.729 -1.224 . . . . 0.0 114.028 -173.352 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 393' ' ' ASN . . . . . 0.672 ' HB3' ' HA ' ' B' ' 388' ' ' MET . 0.2 OUTLIER -62.11 -41.2 97.99 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 174.649 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 394' ' ' VAL . . . . . 0.812 HG12 ' CE2' ' B' ' 386' ' ' PHE . 0.9 OUTLIER -55.51 -47.38 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 178.867 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 395' ' ' ILE . . . . . 0.773 HD13 ' HA3' ' B' ' 392' ' ' GLY . 3.6 mp -57.07 -52.01 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 CA-C-O 117.783 -1.103 . . . . 0.0 113.615 -175.453 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 396' ' ' LYS . . . . . 0.6 ' O ' HG22 ' B' ' 399' ' ' VAL . 0.1 OUTLIER -60.65 -51.06 70.98 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 122.049 2.204 . . . . 0.0 112.798 -175.197 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.84 -42.99 70.43 Favored Glycine 0 N--CA 1.438 -1.185 0 C-N-CA 119.595 -1.288 . . . . 0.0 110.927 -174.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 398' ' ' ILE . . . . . 0.961 HD13 HD12 ' B' ' 410' ' ' LEU . 39.1 mt -71.74 -34.19 51.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-N 114.074 -1.063 . . . . 0.0 113.668 -178.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 399' ' ' VAL . . . . . 0.6 HG22 ' O ' ' B' ' 396' ' ' LYS . 15.9 m -62.76 -39.72 85.9 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 C-N-CA 118.837 -1.145 . . . . 0.0 108.617 -174.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -70.07 -38.3 75.72 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 175.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 401' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 -89.94 -48.79 6.99 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -170.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 402' ' ' GLU . . . . . 0.617 ' HG3' ' HE3' ' A' ' 413' ' ' MET . 1.3 mm-40 -116.23 -19.09 10.36 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.257 -170.744 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 104.73 160.86 23.92 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.622 178.003 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 404' ' ' VAL . . . . . 0.667 HG11 ' HA ' ' B' ' 430' ' ' LEU . 1.5 m -53.26 -45.17 55.22 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.954 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -176.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 405' ' ' ALA . . . . . 0.561 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -62.89 -31.36 72.39 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 119.994 -0.683 . . . . 0.0 112.655 -178.171 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 406' ' ' THR . . . . . 0.675 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 86.4 m -77.06 -42.83 36.78 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.232 173.417 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 407' ' ' ALA . . . . . 0.49 ' HB2' ' HB ' ' B' ' 398' ' ' ILE . . . -58.86 -37.12 75.8 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 122.227 1.013 . . . . 0.0 109.281 176.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 408' ' ' TYR . . . . . 0.666 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -66.28 -51.68 55.02 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 113.343 -1.753 . . . . 0.0 109.779 176.588 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 409' ' ' THR . . . . . 0.633 HG22 HD23 ' B' ' 410' ' ' LEU . 13.1 m -54.44 -47.26 73.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.377 178.222 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 410' ' ' LEU . . . . . 0.961 HD12 HD13 ' B' ' 398' ' ' ILE . 14.5 mt -71.59 -37.44 70.98 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 120.92 0.391 . . . . 0.0 109.989 -175.348 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.39 -34.54 75.35 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.031 -1.08 . . . . 0.0 110.499 173.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 412' ' ' MET . . . . . 0.418 ' HB2' ' O ' ' B' ' 409' ' ' THR . 0.4 OUTLIER -67.18 -44.46 79.65 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 115.434 -0.383 . . . . 0.0 111.535 177.771 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 413' ' ' MET . . . . . 0.751 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.0 OUTLIER -70.86 -55.34 8.7 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 118.316 -1.354 . . . . 0.0 111.714 179.187 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 414' ' ' LEU . . . . . 0.751 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 3.9 mt -63.79 -44.43 93.4 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -171.642 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 46.5 t -86.45 -20.89 27.46 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.749 0.785 . . . . 0.0 109.943 -176.243 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 416' ' ' GLY . . . . . 0.424 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 107.18 -176.24 20.97 Favored Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -170.223 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -79.72 24.82 0.37 Allowed 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.21 0.529 . . . . 0.0 111.461 -172.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 418' ' ' ASN . . . . . 0.424 ' H ' ' C ' ' B' ' 416' ' ' GLY . 92.6 m-20 -71.09 75.49 0.67 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.814 -178.572 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 419' ' ' TYR . . . . . 0.531 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 12.4 p90 -50.56 -38.82 47.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.195 175.663 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -54.77 -47.56 73.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.932 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.78 -49.22 63.59 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.45 -177.407 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 422' ' ' VAL . . . . . 0.427 ' HB ' ' CD1' ' B' ' 408' ' ' TYR . 0.2 OUTLIER -65.55 -39.5 85.26 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.494 -176.903 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 423' ' ' SER . . . . . 0.763 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 78.0 p -68.78 -36.38 78.23 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -178.016 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -70.43 -38.44 69.84 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.961 176.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 425' ' ' ILE . . . . . 0.564 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -71.94 -51.85 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-O 120.327 0.108 . . . . 0.0 110.799 -178.207 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 426' ' ' ILE . . . . . 0.709 HG22 HD22 ' B' ' 430' ' ' LEU . 1.1 mm -73.95 -23.42 18.87 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.828 0 C-N-CA 122.37 0.268 . . . . 0.0 110.491 -173.171 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 427' ' ' ARG . . . . . 0.763 ' HB2' ' O ' ' B' ' 423' ' ' SER . 1.0 OUTLIER -54.75 -31.95 59.23 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.045 0.45 . . . . 0.0 111.449 -177.607 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -84.99 -15.11 67.98 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.15 -1.024 . . . . 0.0 110.817 178.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 429' ' ' TYR . . . . . 0.607 ' HD1' HG22 ' B' ' 395' ' ' ILE . 5.1 m-30 -110.62 -0.13 17.35 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -171.505 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 430' ' ' LEU . . . . . 0.72 HD23 ' HA ' ' B' ' 427' ' ' ARG . 0.1 OUTLIER -65.26 129.16 94.35 Favored Pre-proline 0 N--CA 1.441 -0.886 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.821 177.61 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 431' ' ' PRO . . . . . 0.493 ' HD2' HD12 ' B' ' 430' ' ' LEU . 78.8 Cg_exo -23.48 -70.94 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 1.003 1 C-N-CA 125.646 4.23 . . . . 0.0 114.814 179.844 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 432' ' ' GLY . . . . . 0.554 ' O ' HG12 ' B' ' 435' ' ' VAL . . . -138.82 -172.17 12.46 Favored Glycine 0 N--CA 1.441 -0.99 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 176.098 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 433' ' ' GLN . . . . . 0.475 ' O ' HG13 ' B' ' 436' ' ' VAL . 50.2 tp60 -67.11 -25.55 66.26 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 118.136 0.968 . . . . 0.0 110.291 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -63.99 -43.22 96.34 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 435' ' ' VAL . . . . . 0.659 HG23 HG11 ' B' ' 463' ' ' VAL . 8.3 p -69.26 -41.87 81.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-O 120.947 0.403 . . . . 0.0 110.7 -176.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 436' ' ' VAL . . . . . 0.49 HG12 ' O ' ' B' ' 432' ' ' GLY . 0.1 OUTLIER -67.29 -30.19 48.35 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.049 174.937 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 437' ' ' THR . . . . . 0.468 ' O ' ' HG2' ' B' ' 441' ' ' GLN . 1.1 m -66.81 -53.86 28.51 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -179.163 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 438' ' ' ALA . . . . . 0.861 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -59.37 -34.65 72.66 Favored 'General case' 0 N--CA 1.434 -1.227 0 O-C-N 124.071 0.857 . . . . 0.0 111.261 178.137 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 439' ' ' LEU . . . . . 0.923 HD23 ' NH2' ' B' ' 442' ' ' ARG . 0.3 OUTLIER -67.12 -50.72 60.43 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.206 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -61.41 -33.98 74.61 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 114.463 -1.244 . . . . 0.0 111.037 175.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 441' ' ' GLN . . . . . 0.507 ' HB2' ' HA ' ' B' ' 438' ' ' ALA . 6.9 mm100 -54.97 -50.16 69.63 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.772 -175.007 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 442' ' ' ARG . . . . . 0.923 ' NH2' HD23 ' B' ' 439' ' ' LEU . 0.0 OUTLIER -77.97 -25.62 48.25 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 119.558 -0.857 . . . . 0.0 112.654 175.785 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 443' ' ' LEU . . . . . 0.766 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 67.3 mt -67.89 -26.4 65.99 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 120.383 -0.527 . . . . 0.0 109.593 178.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -65.06 -38.48 90.95 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.072 173.342 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -76.95 -27.09 54.7 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.339 -1.3 . . . . 0.0 111.33 179.093 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 446' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 30.08 101.95 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 175.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 52.0 mt -60.51 -34.88 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 121.359 0.599 . . . . 0.0 110.467 -179.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 448' ' ' ASP . . . . . 0.455 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 32.3 m-20 -164.91 -162.39 0.63 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -178.26 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -81.54 -71.76 0.46 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 171.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 450' ' ' GLN . . . . . 0.418 ' HG3' ' H ' ' B' ' 450' ' ' GLN . 1.9 pp0? -64.27 -25.05 67.88 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 178.212 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 451' ' ' THR . . . . . 0.456 ' HA ' ' HB2' ' B' ' 454' ' ' GLU . 9.7 m -71.03 -23.17 62.1 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.046 -174.14 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 452' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' B' ' 452' ' ' ARG . 17.8 mtp180 -53.25 -54.28 38.51 Favored 'General case' 0 C--O 1.221 -0.401 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 171.336 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 453' ' ' ALA . . . . . 0.531 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -59.67 -49.33 78.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.393 -1.276 . . . . 0.0 113.11 175.138 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 454' ' ' GLU . . . . . 0.456 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 22.0 mm-40 -49.38 -38.34 28.27 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.299 0.571 . . . . 0.0 111.909 -176.428 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 25.6 p -120.24 16.57 12.32 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.818 -175.278 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 456' ' ' PHE . . . . . 0.493 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 0.8 OUTLIER -54.48 -46.9 73.49 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.656 -172.127 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 457' ' ' ILE . . . . . 0.561 HG23 ' HB1' ' B' ' 405' ' ' ALA . 1.9 mp -78.64 -35.42 18.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.565 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -57.03 -36.52 70.55 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.884 0.849 . . . . 0.0 109.278 172.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 459' ' ' HIS . . . . . 0.769 ' HB3' ' CZ ' ' B' ' 442' ' ' ARG . 78.7 m-70 -75.21 -30.37 60.59 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.515 177.294 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 460' ' ' LEU . . . . . 0.751 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.6 OUTLIER -67.47 -34.46 77.22 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.364 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 461' ' ' ASN . . . . . 0.455 ' O ' ' HB2' ' B' ' 464' ' ' TYR . 16.9 m-80 -73.03 -37.6 66.84 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.499 -1.228 . . . . 0.0 109.069 176.539 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 462' ' ' ALA . . . . . 0.595 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -56.49 -32.42 65.01 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.628 -1.169 . . . . 0.0 109.957 169.328 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 463' ' ' VAL . . . . . 0.861 HG13 ' HB3' ' B' ' 438' ' ' ALA . 50.9 t -64.8 -49.86 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 176.187 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 464' ' ' TYR . . . . . 0.59 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 19.6 m-30 -51.63 -28.58 14.79 Favored 'General case' 0 C--N 1.333 -0.13 0 O-C-N 124.442 1.089 . . . . 0.0 110.432 176.358 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.04 -38.57 19.02 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.662 0.744 . . . . 0.0 109.813 -176.492 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 466' ' ' ILE . . . . . 0.595 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.7 mt -57.92 -55.31 22.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 114.374 -1.284 . . . . 0.0 112.215 174.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 467' ' ' LEU . . . . . 0.749 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -101.43 -10.94 19.75 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -172.383 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 468' ' ' GLY . . . . . 0.587 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 94.29 31.15 8.16 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 119.424 -1.369 . . . . 0.0 114.378 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 469' ' ' LEU . . . . . 0.749 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.0 mt -89.36 164.25 14.97 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 117.847 0.823 . . . . 0.0 110.921 175.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 42.6 p30 -105.12 -179.34 3.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.297 172.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 471' ' ' ALA . . . . . 0.465 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -59.01 -23.82 62.27 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -177.467 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -87.47 3.34 47.65 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.1 -173.126 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 473' ' ' GLY . . . . . 0.452 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 74.88 15.82 80.74 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.348 -0.929 . . . . 0.0 111.087 -176.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -100.98 150.23 23.1 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 178.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 4.6 p -89.76 117.07 28.33 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.067 0.46 . . . . 0.0 111.459 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 476' ' ' ILE . . . . . 0.587 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.8 pp . . . . . 0 C--N 1.321 -0.64 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.232 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 386' ' ' PHE . . . . . 0.748 ' CD1' HD22 ' A' ' 414' ' ' LEU . 2.1 t80 . . . . . 0 CA--C 1.538 0.501 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.08 -64.1 0.23 Allowed 'Trans proline' 0 N--CA 1.484 0.935 0 C-N-CA 124.361 3.374 . . . . 0.0 113.908 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.639 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 4.5 ttp 63.36 41.94 7.25 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 171.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 389' ' ' HIS . . . . . 0.625 ' CD2' ' HB2' ' A' ' 393' ' ' ASN . 33.0 m170 50.24 -107.34 0.27 Allowed 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 121.236 0.541 . . . . 0.0 109.757 -174.714 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -140.17 18.33 2.43 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 172.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.511 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.5 pt? -165.57 -54.54 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.709 -172.544 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 392' ' ' GLY . . . . . 0.673 ' HA3' HD13 ' A' ' 395' ' ' ILE . . . -171.5 58.49 0.17 Allowed Glycine 0 C--N 1.335 0.491 0 C-N-CA 119.667 -1.254 . . . . 0.0 114.438 -174.04 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 393' ' ' ASN . . . . . 0.639 ' HB3' ' HA ' ' A' ' 388' ' ' MET . 0.2 OUTLIER -59.5 -40.19 86.23 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 117.748 0.774 . . . . 0.0 109.746 174.695 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 394' ' ' VAL . . . . . 0.742 HG23 HD12 ' A' ' 398' ' ' ILE . 1.8 m -56.13 -47.46 80.53 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.598 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 178.395 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 395' ' ' ILE . . . . . 0.673 HD13 ' HA3' ' A' ' 392' ' ' GLY . 3.6 mp -57.56 -52.75 53.3 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.358 0 CA-C-O 117.86 -1.066 . . . . 0.0 113.662 -174.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 396' ' ' LYS . . . . . 0.585 ' O ' HG22 ' A' ' 399' ' ' VAL . 0.0 OUTLIER -63.25 -49.61 73.43 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 121.968 2.167 . . . . 0.0 112.054 -175.131 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -52.99 -44.47 62.03 Favored Glycine 0 N--CA 1.431 -1.658 0 CA-C-N 114.706 -1.133 . . . . 0.0 110.726 -176.044 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 398' ' ' ILE . . . . . 0.854 HD13 HD12 ' A' ' 410' ' ' LEU . 38.0 mt -71.51 -33.13 48.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 399' ' ' VAL . . . . . 0.585 HG22 ' O ' ' A' ' 396' ' ' LYS . 15.7 m -63.26 -39.85 86.81 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 C-N-CA 118.624 -1.23 . . . . 0.0 108.114 -175.45 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -69.63 -35.74 75.5 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 174.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 44.7 mm-40 -89.42 -48.06 7.59 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -172.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 402' ' ' GLU . . . . . 0.518 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 2.4 mm-40 -120.85 -20.36 6.98 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.358 -170.503 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 106.74 161.74 22.14 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.607 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 404' ' ' VAL . . . . . 0.669 HG11 ' HA ' ' A' ' 430' ' ' LEU . 1.4 m -53.7 -45.66 61.09 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.87 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -175.536 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 405' ' ' ALA . . . . . 0.569 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -62.35 -32.62 73.43 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 119.92 -0.712 . . . . 0.0 112.527 -177.642 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.686 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 92.1 m -77.54 -41.26 39.68 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.534 174.148 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.444 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.7 -36.44 74.26 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 122.121 0.962 . . . . 0.0 109.081 175.703 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 408' ' ' TYR . . . . . 0.608 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -66.19 -52.19 50.49 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 113.569 -1.65 . . . . 0.0 109.841 175.961 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 409' ' ' THR . . . . . 0.634 HG22 HD23 ' A' ' 410' ' ' LEU . 18.0 m -54.69 -47.64 73.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.494 178.771 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 410' ' ' LEU . . . . . 0.854 HD12 HD13 ' A' ' 398' ' ' ILE . 14.5 mt -72.46 -36.46 68.5 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.895 -174.643 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.71 -34.56 77.61 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 119.901 -1.142 . . . . 0.0 110.457 173.093 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 412' ' ' MET . . . . . 0.439 ' HB2' ' O ' ' A' ' 409' ' ' THR . 0.5 OUTLIER -67.04 -48.94 66.79 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 115.712 -0.244 . . . . 0.0 111.441 177.595 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 413' ' ' MET . . . . . 0.933 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 1.0 OUTLIER -72.0 -43.51 64.97 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.096 -1.041 . . . . 0.0 112.15 -178.75 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 414' ' ' LEU . . . . . 0.933 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 14.5 mt -69.81 -45.7 67.32 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -176.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 33.0 t -87.45 -23.44 24.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.52 0.676 . . . . 0.0 110.139 -176.034 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 416' ' ' GLY . . . . . 0.401 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 108.92 -175.96 19.57 Favored Glycine 0 N--CA 1.429 -1.784 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -170.673 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 32.4 mm-40 -80.56 23.22 0.52 Allowed 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.312 0.577 . . . . 0.0 111.322 -171.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 418' ' ' ASN . . . . . 0.401 ' H ' ' C ' ' A' ' 416' ' ' GLY . 3.4 m-20 -72.24 75.48 0.98 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.685 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 419' ' ' TYR . . . . . 0.619 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 11.2 p90 -55.48 -38.11 68.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.163 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -54.73 -44.15 73.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.823 0.344 . . . . 0.0 110.913 178.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.9 -49.36 62.38 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.283 -177.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 422' ' ' VAL . . . . . 0.47 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.1 OUTLIER -64.84 -40.94 90.78 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.691 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.068 -177.659 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.788 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 16.0 t -69.46 -36.06 76.23 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 120.326 -0.55 . . . . 0.0 109.635 -176.57 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -70.4 -37.05 69.92 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.989 176.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 425' ' ' ILE . . . . . 0.573 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -71.6 -50.65 38.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.502 0.191 . . . . 0.0 110.558 -179.716 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 426' ' ' ILE . . . . . 0.706 HG22 HD22 ' A' ' 430' ' ' LEU . 1.2 mm -73.68 -23.72 19.46 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.979 0 CA-C-O 120.833 0.349 . . . . 0.0 110.2 -173.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.788 ' HB2' ' O ' ' A' ' 423' ' ' SER . 1.5 tmm_? -55.04 -32.35 61.8 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.26 0.552 . . . . 0.0 111.127 -177.247 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.68 -9.54 71.61 Favored Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 120.412 -0.899 . . . . 0.0 111.041 178.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.591 ' HD1' HG22 ' A' ' 395' ' ' ILE . 7.4 m-30 -114.0 -0.26 14.13 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -175.286 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.706 HD22 HG22 ' A' ' 426' ' ' ILE . 0.0 OUTLIER -66.34 129.04 94.16 Favored Pre-proline 0 N--CA 1.444 -0.773 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.784 177.92 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 431' ' ' PRO . . . . . 0.568 ' HD2' HD12 ' A' ' 430' ' ' LEU . 87.5 Cg_exo -23.45 -73.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.356 0.974 1 C-N-CA 125.62 4.213 . . . . 0.0 114.909 179.901 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 432' ' ' GLY . . . . . 0.548 ' O ' HG12 ' A' ' 435' ' ' VAL . . . -137.99 -170.02 11.76 Favored Glycine 0 N--CA 1.439 -1.105 0 N-CA-C 110.311 -1.115 . . . . 0.0 110.311 176.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 433' ' ' GLN . . . . . 0.443 ' O ' HG13 ' A' ' 436' ' ' VAL . 22.6 tp60 -65.89 -27.42 68.19 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 117.929 0.865 . . . . 0.0 110.315 -178.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -66.41 -40.59 89.69 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -177.017 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 435' ' ' VAL . . . . . 0.647 HG23 HG11 ' A' ' 463' ' ' VAL . 8.5 p -70.22 -43.48 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.09 0 CA-C-O 120.942 0.401 . . . . 0.0 110.655 -177.247 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.471 HG12 ' O ' ' A' ' 432' ' ' GLY . 0.1 OUTLIER -66.29 -30.6 50.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.12 175.044 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 437' ' ' THR . . . . . 0.529 ' O ' ' HG2' ' A' ' 441' ' ' GLN . 1.0 OUTLIER -67.89 -53.19 28.48 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -179.212 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 438' ' ' ALA . . . . . 0.84 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -59.44 -35.17 73.52 Favored 'General case' 0 N--CA 1.437 -1.091 0 O-C-N 123.924 0.765 . . . . 0.0 111.349 178.326 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 439' ' ' LEU . . . . . 0.91 HD23 ' NH2' ' A' ' 442' ' ' ARG . 0.4 OUTLIER -67.14 -50.75 60.19 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 -179.257 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 2.6 tp60 -61.44 -34.16 74.96 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.231 -1.349 . . . . 0.0 111.294 175.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 441' ' ' GLN . . . . . 0.529 ' HG2' ' O ' ' A' ' 437' ' ' THR . 7.4 mm100 -54.65 -49.65 70.06 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.047 -176.028 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 442' ' ' ARG . . . . . 0.91 ' NH2' HD23 ' A' ' 439' ' ' LEU . 0.0 OUTLIER -78.26 -25.65 46.87 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.484 -0.886 . . . . 0.0 112.648 175.72 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 443' ' ' LEU . . . . . 0.751 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 67.6 mt -67.51 -26.38 66.31 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.197 0.522 . . . . 0.0 109.618 178.425 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -64.6 -38.16 90.05 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.969 173.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -76.31 -26.66 56.04 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.43 -1.259 . . . . 0.0 111.102 178.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 28.53 99.05 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 O-C-N 124.702 1.251 . . . . 0.0 114.373 175.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 50.1 mt -59.0 -34.56 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 121.545 0.688 . . . . 0.0 110.579 -179.065 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -163.29 -161.2 0.66 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 -177.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -82.13 -70.83 0.52 Allowed 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 167.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 450' ' ' GLN . . . . . 0.41 ' O ' ' HG2' ' A' ' 454' ' ' GLU . 2.0 pp0? -64.7 -26.38 68.35 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -179.375 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 451' ' ' THR . . . . . 0.427 ' HA ' ' HB2' ' A' ' 454' ' ' GLU . 9.0 m -71.2 -23.18 61.98 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.982 -174.608 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 452' ' ' ARG . . . . . 0.43 ' NH2' ' HB3' ' A' ' 443' ' ' LEU . 19.3 mtp180 -53.19 -54.55 34.35 Favored 'General case' 0 C--O 1.222 -0.381 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 171.544 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 453' ' ' ALA . . . . . 0.619 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -60.34 -48.75 80.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.203 -1.362 . . . . 0.0 113.028 175.479 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 454' ' ' GLU . . . . . 0.427 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 78.6 mm-40 -49.1 -38.3 24.2 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.34 0.59 . . . . 0.0 111.723 -175.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 28.3 p -120.57 16.41 12.03 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.291 -176.16 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 456' ' ' PHE . . . . . 0.495 ' CE2' ' HB2' ' A' ' 419' ' ' TYR . 0.8 OUTLIER -53.66 -47.88 69.95 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.648 -172.042 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 457' ' ' ILE . . . . . 0.569 HG23 ' HB1' ' A' ' 405' ' ' ALA . 1.9 mp -77.59 -35.2 21.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.712 -179.299 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -56.93 -36.13 69.87 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 121.969 0.89 . . . . 0.0 109.055 172.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 459' ' ' HIS . . . . . 0.754 ' HB3' ' CZ ' ' A' ' 442' ' ' ARG . 81.3 m-70 -75.62 -30.4 59.51 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.405 -1.27 . . . . 0.0 110.743 177.396 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 460' ' ' LEU . . . . . 0.743 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.6 OUTLIER -67.84 -34.71 77.24 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.749 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 461' ' ' ASN . . . . . 0.47 ' O ' ' HB2' ' A' ' 464' ' ' TYR . 24.4 m-80 -72.95 -37.3 67.17 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.344 -1.298 . . . . 0.0 108.889 177.098 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 462' ' ' ALA . . . . . 0.562 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -56.98 -32.49 66.13 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.429 -1.26 . . . . 0.0 110.238 168.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.84 HG13 ' HB3' ' A' ' 438' ' ' ALA . 49.4 t -64.12 -49.77 79.92 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 176.061 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 464' ' ' TYR . . . . . 0.602 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 18.8 m-30 -51.99 -28.21 16.12 Favored 'General case' 0 C--N 1.333 -0.137 0 O-C-N 124.435 1.084 . . . . 0.0 110.403 176.084 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.94 -40.5 18.45 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.611 0.72 . . . . 0.0 109.616 -177.344 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.562 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.7 mt -57.33 -54.76 26.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 114.481 -1.236 . . . . 0.0 112.174 176.645 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 0.763 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -101.49 -10.85 19.78 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -172.966 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 468' ' ' GLY . . . . . 0.601 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 94.07 31.18 8.23 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 119.586 -1.292 . . . . 0.0 114.425 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 469' ' ' LEU . . . . . 0.763 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.7 mt -89.08 165.43 14.52 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 117.79 0.795 . . . . 0.0 110.932 176.146 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 37.2 p30 -105.49 -177.82 3.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.9 171.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 471' ' ' ALA . . . . . 0.58 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -66.05 -15.5 63.11 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -176.501 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 -88.02 -1.84 58.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.709 0.29 . . . . 0.0 111.023 -175.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 473' ' ' GLY . . . . . 0.458 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 79.32 12.99 83.29 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.224 -0.989 . . . . 0.0 111.032 -175.344 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -101.17 151.82 21.38 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 176.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 475' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 469' ' ' LEU . 27.5 t -89.73 134.96 33.9 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.155 0.502 . . . . 0.0 110.536 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 476' ' ' ILE . . . . . 0.601 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.6 pp . . . . . 0 C--N 1.318 -0.769 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.2 -176.31 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 386' ' ' PHE . . . . . 0.757 ' CD1' HD22 ' B' ' 414' ' ' LEU . 2.1 t80 . . . . . 0 CA--C 1.538 0.501 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 387' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -51.04 -64.05 0.23 Allowed 'Trans proline' 0 N--CA 1.482 0.836 0 C-N-CA 124.355 3.37 . . . . 0.0 114.014 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 388' ' ' MET . . . . . 0.639 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 4.5 ttp 63.39 41.83 7.29 Favored 'General case' 0 CA--C 1.549 0.941 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 171.579 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 389' ' ' HIS . . . . . 0.62 ' CD2' ' HB2' ' B' ' 393' ' ' ASN . 33.0 m170 50.39 -107.34 0.27 Allowed 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 121.113 0.482 . . . . 0.0 109.794 -174.796 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -140.25 18.49 2.42 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 172.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 391' ' ' LEU . . . . . 0.518 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.5 pt? -165.62 -54.69 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.668 -172.487 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 392' ' ' GLY . . . . . 0.671 ' HA3' HD13 ' B' ' 395' ' ' ILE . . . -171.46 58.63 0.17 Allowed Glycine 0 CA--C 1.523 0.552 0 C-N-CA 119.755 -1.212 . . . . 0.0 114.452 -173.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 393' ' ' ASN . . . . . 0.639 ' HB3' ' HA ' ' B' ' 388' ' ' MET . 0.2 OUTLIER -59.67 -40.18 86.94 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 117.658 0.729 . . . . 0.0 109.665 174.722 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 394' ' ' VAL . . . . . 0.719 HG23 HD12 ' B' ' 398' ' ' ILE . 1.8 m -56.15 -47.48 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 178.371 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 395' ' ' ILE . . . . . 0.671 HD13 ' HA3' ' B' ' 392' ' ' GLY . 3.7 mp -57.68 -52.72 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 CA-C-O 117.846 -1.073 . . . . 0.0 113.738 -174.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 396' ' ' LYS . . . . . 0.587 ' O ' HG22 ' B' ' 399' ' ' VAL . 0.0 OUTLIER -63.07 -49.7 73.51 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 122.117 2.235 . . . . 0.0 111.967 -175.3 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -52.94 -44.53 61.78 Favored Glycine 0 N--CA 1.432 -1.621 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.696 -175.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 398' ' ' ILE . . . . . 0.851 HD13 HD12 ' B' ' 410' ' ' LEU . 38.8 mt -71.45 -33.28 49.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -179.28 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 399' ' ' VAL . . . . . 0.587 HG22 ' O ' ' B' ' 396' ' ' LYS . 15.6 m -63.35 -39.58 85.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 C-N-CA 118.583 -1.247 . . . . 0.0 108.111 -175.262 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -69.8 -35.83 75.17 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 174.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 401' ' ' GLN . . . . . . . . . . . . . 43.8 mm-40 -89.21 -48.01 7.68 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -172.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 402' ' ' GLU . . . . . 0.465 ' HB3' ' HB ' ' B' ' 406' ' ' THR . 2.4 mm-40 -121.09 -20.31 6.85 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.46 -170.474 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 106.99 161.78 21.91 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.658 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 404' ' ' VAL . . . . . 0.664 HG11 ' HA ' ' B' ' 430' ' ' LEU . 1.4 m -53.67 -45.55 60.65 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -175.692 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 405' ' ' ALA . . . . . 0.547 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -62.58 -32.36 73.33 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 119.866 -0.734 . . . . 0.0 112.43 -177.547 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 406' ' ' THR . . . . . 0.678 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 93.7 m -77.72 -41.34 38.17 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.039 -0.664 . . . . 0.0 110.498 174.075 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 407' ' ' ALA . . . . . 0.44 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.69 -36.37 74.1 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 122.122 0.963 . . . . 0.0 109.135 175.733 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 408' ' ' TYR . . . . . 0.601 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -66.16 -52.18 50.69 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 113.581 -1.645 . . . . 0.0 109.866 175.905 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 409' ' ' THR . . . . . 0.63 HG22 HD23 ' B' ' 410' ' ' LEU . 17.9 m -54.74 -47.59 73.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.467 178.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 410' ' ' LEU . . . . . 0.851 HD12 HD13 ' B' ' 398' ' ' ILE . 14.6 mt -72.51 -36.48 68.37 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -174.657 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.57 -34.61 76.87 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 119.891 -1.147 . . . . 0.0 110.481 173.065 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 412' ' ' MET . . . . . 0.436 ' HB2' ' O ' ' B' ' 409' ' ' THR . 0.5 OUTLIER -67.03 -49.15 66.15 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 115.645 -0.277 . . . . 0.0 111.361 177.665 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 413' ' ' MET . . . . . 0.945 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 1.0 OUTLIER -71.84 -43.64 65.19 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.02 -1.072 . . . . 0.0 112.033 -178.63 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 414' ' ' LEU . . . . . 0.945 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 14.4 mt -69.63 -45.91 67.4 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -176.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 33.4 t -87.27 -23.44 24.69 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.625 0.726 . . . . 0.0 110.12 -175.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 416' ' ' GLY . . . . . . . . . . . . . . . 109.0 -175.81 19.43 Favored Glycine 0 N--CA 1.43 -1.714 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -170.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 33.0 mm-40 -80.48 23.05 0.53 Allowed 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.205 0.526 . . . . 0.0 111.419 -172.095 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 418' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -72.19 75.54 0.97 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.684 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 419' ' ' TYR . . . . . 0.612 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 10.7 p90 -55.64 -38.04 69.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.204 -179.431 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -54.91 -43.96 73.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.845 0.355 . . . . 0.0 110.8 178.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.97 -49.34 62.24 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.328 -177.707 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 422' ' ' VAL . . . . . 0.468 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.1 OUTLIER -64.9 -40.97 90.85 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.105 -177.682 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 423' ' ' SER . . . . . 0.777 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 15.0 t -69.54 -35.84 75.83 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 120.297 -0.561 . . . . 0.0 109.569 -176.552 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -70.39 -37.19 70.04 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.964 176.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 425' ' ' ILE . . . . . 0.59 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -71.57 -50.57 38.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.655 0.264 . . . . 0.0 110.59 -179.728 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 426' ' ' ILE . . . . . 0.701 HG22 HD22 ' B' ' 430' ' ' LEU . 1.2 mm -73.81 -23.73 19.28 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.042 0 CA-C-O 120.887 0.375 . . . . 0.0 110.163 -173.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 427' ' ' ARG . . . . . 0.777 ' HB2' ' O ' ' B' ' 423' ' ' SER . 1.5 tmm_? -55.03 -32.52 61.92 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.28 0.562 . . . . 0.0 111.134 -177.308 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.5 -9.44 72.31 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.152 178.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 429' ' ' TYR . . . . . 0.598 ' HD1' HG22 ' B' ' 395' ' ' ILE . 7.5 m-30 -113.98 -0.52 14.06 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -175.322 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 430' ' ' LEU . . . . . 0.708 HD23 ' HA ' ' B' ' 427' ' ' ARG . 0.0 OUTLIER -66.13 129.26 94.21 Favored Pre-proline 0 N--CA 1.444 -0.772 0 CA-C-N 114.532 -1.213 . . . . 0.0 108.782 178.039 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 431' ' ' PRO . . . . . 0.561 ' HD2' HD12 ' B' ' 430' ' ' LEU . 84.3 Cg_exo -23.4 -74.1 0.02 OUTLIER 'Trans proline' 0 C--N 1.356 0.936 1 C-N-CA 125.698 4.265 . . . . 0.0 114.93 179.708 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 432' ' ' GLY . . . . . 0.541 ' O ' HG12 ' B' ' 435' ' ' VAL . . . -137.57 -170.26 11.84 Favored Glycine 0 N--CA 1.441 -0.978 0 N-CA-C 110.301 -1.119 . . . . 0.0 110.301 176.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 433' ' ' GLN . . . . . 0.449 ' O ' HG13 ' B' ' 436' ' ' VAL . 22.7 tp60 -65.77 -27.51 68.34 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 117.865 0.832 . . . . 0.0 110.266 -179.118 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -66.3 -40.94 90.32 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.209 -177.044 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 435' ' ' VAL . . . . . 0.642 HG23 HG11 ' B' ' 463' ' ' VAL . 8.6 p -70.01 -43.32 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-O 120.94 0.4 . . . . 0.0 110.693 -177.2 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 436' ' ' VAL . . . . . 0.476 HG12 ' O ' ' B' ' 432' ' ' GLY . 0.1 OUTLIER -66.46 -30.53 50.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.049 175.139 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 437' ' ' THR . . . . . 0.513 ' O ' ' HG2' ' B' ' 441' ' ' GLN . 1.0 OUTLIER -67.89 -53.43 26.62 Favored 'General case' 0 C--O 1.204 -1.33 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -179.38 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 438' ' ' ALA . . . . . 0.858 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -59.27 -35.21 73.31 Favored 'General case' 0 N--CA 1.438 -1.049 0 O-C-N 123.869 0.731 . . . . 0.0 111.275 178.424 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 439' ' ' LEU . . . . . 0.891 HD23 ' NH2' ' B' ' 442' ' ' ARG . 0.4 OUTLIER -67.08 -50.8 60.45 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -179.286 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 2.6 tp60 -61.45 -34.11 74.88 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 114.354 -1.294 . . . . 0.0 111.252 175.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 441' ' ' GLN . . . . . 0.513 ' HG2' ' O ' ' B' ' 437' ' ' THR . 7.5 mm100 -54.74 -50.01 69.44 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.917 -176.015 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 442' ' ' ARG . . . . . 0.891 ' NH2' HD23 ' B' ' 439' ' ' LEU . 0.0 OUTLIER -77.86 -25.64 48.78 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 119.502 -0.879 . . . . 0.0 112.709 175.752 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 443' ' ' LEU . . . . . 0.749 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 68.2 mt -67.68 -26.21 66.08 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.482 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -64.88 -37.92 89.25 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.95 173.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -76.45 -26.79 55.79 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.444 -1.253 . . . . 0.0 111.043 178.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 446' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 28.6 99.0 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 176.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 50.8 mt -58.96 -34.38 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-O 121.427 0.632 . . . . 0.0 110.601 -179.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 448' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -163.51 -160.89 0.62 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -177.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -82.74 -70.64 0.54 Allowed 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 168.005 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 450' ' ' GLN . . . . . 0.426 ' HG3' ' H ' ' B' ' 450' ' ' GLN . 2.0 pp0? -64.61 -26.31 68.34 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 451' ' ' THR . . . . . 0.417 ' HA ' ' HB2' ' B' ' 454' ' ' GLU . 9.1 m -71.35 -23.19 61.87 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.901 -174.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 452' ' ' ARG . . . . . 0.43 ' NH2' ' HB3' ' B' ' 443' ' ' LEU . 19.4 mtp180 -53.29 -54.45 36.15 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 171.483 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 453' ' ' ALA . . . . . 0.612 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -60.27 -48.74 80.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.36 -1.291 . . . . 0.0 113.032 175.28 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 454' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' B' ' 450' ' ' GLN . 78.7 mm-40 -49.1 -38.57 25.16 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.158 0.504 . . . . 0.0 111.73 -175.618 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 28.4 p -120.58 16.49 12.03 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.163 -175.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 456' ' ' PHE . . . . . 0.499 ' CE2' ' HB2' ' B' ' 419' ' ' TYR . 0.9 OUTLIER -53.41 -48.12 68.98 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.6 -172.273 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 457' ' ' ILE . . . . . 0.547 HG23 ' HB1' ' B' ' 405' ' ' ALA . 1.9 mp -77.41 -35.2 21.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.77 -179.288 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -56.87 -36.12 69.69 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 122.059 0.933 . . . . 0.0 109.073 172.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 459' ' ' HIS . . . . . 0.767 ' HB3' ' CZ ' ' B' ' 442' ' ' ARG . 81.4 m-70 -75.59 -30.6 59.65 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.707 177.404 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 460' ' ' LEU . . . . . 0.748 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.6 OUTLIER -67.8 -34.62 77.12 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.843 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 461' ' ' ASN . . . . . 0.456 ' HA ' ' CD2' ' B' ' 464' ' ' TYR . 25.2 m-80 -72.86 -37.51 67.35 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.394 -1.275 . . . . 0.0 109.007 176.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 462' ' ' ALA . . . . . 0.569 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -56.77 -32.65 65.83 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.462 -1.245 . . . . 0.0 110.174 168.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 463' ' ' VAL . . . . . 0.858 HG13 ' HB3' ' B' ' 438' ' ' ALA . 50.2 t -63.93 -49.7 80.63 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.817 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 176.033 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 464' ' ' TYR . . . . . 0.586 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 18.7 m-30 -52.13 -28.23 17.11 Favored 'General case' 0 C--N 1.332 -0.159 0 O-C-N 124.432 1.082 . . . . 0.0 110.404 176.108 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.05 -40.1 18.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.525 0.679 . . . . 0.0 109.653 -177.228 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 466' ' ' ILE . . . . . 0.569 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.7 mt -57.49 -55.12 22.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 114.355 -1.293 . . . . 0.0 112.117 176.578 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 467' ' ' LEU . . . . . 0.769 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -101.36 -10.73 19.99 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -173.042 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 468' ' ' GLY . . . . . 0.588 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 94.01 31.28 8.2 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 119.412 -1.375 . . . . 0.0 114.343 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 469' ' ' LEU . . . . . 0.769 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.7 mt -89.26 165.08 14.65 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 117.899 0.85 . . . . 0.0 110.859 176.166 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 36.9 p30 -105.32 -177.75 3.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.817 171.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 471' ' ' ALA . . . . . 0.584 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -65.97 -15.66 63.2 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -176.493 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 -87.95 -1.74 58.18 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.081 -175.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 473' ' ' GLY . . . . . 0.448 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 79.01 13.06 83.46 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.333 -0.937 . . . . 0.0 110.963 -175.469 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -100.91 151.63 21.51 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 176.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 475' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' B' ' 469' ' ' LEU . 24.7 t -89.59 135.34 33.66 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.158 0.504 . . . . 0.0 110.299 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 476' ' ' ILE . . . . . 0.588 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.6 pp . . . . . 0 C--N 1.32 -0.711 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.18 -176.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 21.6 ptt180 . . . . . 0 N--CA 1.478 0.964 0 CA-C-O 120.927 0.394 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -129.16 -33.12 1.97 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.826 -178.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 383' ' ' HIS . . . . . 0.443 ' HB3' ' HB3' ' A' ' 388' ' ' MET . 56.4 p-80 -164.03 158.1 19.12 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 121.133 0.492 . . . . 0.0 112.068 -177.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -138.07 -43.77 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.641 177.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 21.0 m -97.49 -55.95 2.67 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.794 0.33 . . . . 0.0 110.88 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 386' ' ' PHE . . . . . 0.793 ' CZ ' HG12 ' A' ' 394' ' ' VAL . 3.4 t80 -76.44 129.22 80.46 Favored Pre-proline 0 C--N 1.329 -0.32 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 387' ' ' PRO . . . . . 0.586 ' HG2' ' OD1' ' B' ' 393' ' ' ASN . 35.6 Cg_endo -66.88 64.14 0.59 Allowed 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 123.91 3.073 . . . . 0.0 113.562 176.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.806 ' SD ' HG13 ' A' ' 394' ' ' VAL . 5.2 tpp -68.15 164.79 19.59 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.868 176.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 389' ' ' HIS . . . . . 0.616 ' CE1' ' HA ' ' A' ' 393' ' ' ASN . 30.6 m170 -65.25 -160.77 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 172.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -71.34 1.48 6.15 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.196 170.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.586 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.1 pt? -155.23 -63.73 0.12 Allowed 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -177.016 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 392' ' ' GLY . . . . . 0.718 ' HA3' HD13 ' A' ' 395' ' ' ILE . . . -158.98 74.93 0.21 Allowed Glycine 0 CA--C 1.523 0.583 0 C-N-CA 120.055 -1.069 . . . . 0.0 114.203 -172.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 393' ' ' ASN . . . . . 0.616 ' HA ' ' CE1' ' A' ' 389' ' ' HIS . 0.0 OUTLIER -65.76 -42.01 91.38 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 177.696 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.806 HG13 ' SD ' ' A' ' 388' ' ' MET . 0.6 OUTLIER -57.3 -46.23 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 179.754 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.718 HD13 ' HA3' ' A' ' 392' ' ' GLY . 4.1 mp -57.43 -52.15 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 CA-C-O 117.743 -1.122 . . . . 0.0 113.301 -173.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 396' ' ' LYS . . . . . 0.594 ' O ' HG22 ' A' ' 399' ' ' VAL . 0.1 OUTLIER -62.14 -50.6 71.22 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-N 122.025 2.193 . . . . 0.0 112.198 -176.776 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.76 -44.65 70.14 Favored Glycine 0 N--CA 1.434 -1.463 0 C-N-CA 119.911 -1.138 . . . . 0.0 110.898 -175.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 398' ' ' ILE . . . . . 0.765 HG12 HD21 ' B' ' 414' ' ' LEU . 27.1 mt -71.22 -34.04 52.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 399' ' ' VAL . . . . . 0.594 HG22 ' O ' ' A' ' 396' ' ' LYS . 16.1 m -62.7 -40.0 86.86 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 C-N-CA 118.898 -1.121 . . . . 0.0 108.576 -174.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -71.25 -36.99 71.98 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 176.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.421 HE21 ' HB3' ' A' ' 401' ' ' GLN . 4.1 mm100 -88.61 -46.79 8.77 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -171.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 402' ' ' GLU . . . . . 0.583 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 2.5 mm-40 -120.35 -20.29 7.31 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.484 -171.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 106.58 162.04 22.34 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.922 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 404' ' ' VAL . . . . . 0.679 HG11 ' HA ' ' A' ' 430' ' ' LEU . 1.5 m -53.61 -45.25 59.53 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.81 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -175.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 405' ' ' ALA . . . . . 0.565 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -64.37 -30.82 71.86 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 119.784 -0.766 . . . . 0.0 112.489 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.716 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 85.2 m -76.96 -42.53 38.71 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.03 173.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.483 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.57 -36.96 74.78 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 122.141 0.972 . . . . 0.0 109.363 177.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 408' ' ' TYR . . . . . 0.624 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -66.2 -52.1 51.25 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 113.469 -1.696 . . . . 0.0 109.686 176.404 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 409' ' ' THR . . . . . 0.664 HG22 HD23 ' A' ' 410' ' ' LEU . 12.3 m -55.15 -47.46 75.08 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.541 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 410' ' ' LEU . . . . . 0.739 HD12 ' CD1' ' A' ' 398' ' ' ILE . 13.7 mt -72.25 -35.79 68.88 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.041 0.448 . . . . 0.0 109.983 -175.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.86 -34.72 79.37 Favored Glycine 0 N--CA 1.439 -1.13 0 C-N-CA 120.238 -0.982 . . . . 0.0 110.755 172.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -69.8 -48.01 60.74 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-O 120.532 0.206 . . . . 0.0 111.362 178.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 413' ' ' MET . . . . . 0.936 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.5 OUTLIER -70.56 -42.0 71.69 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 119.082 -1.047 . . . . 0.0 112.256 -178.289 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 414' ' ' LEU . . . . . 0.936 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 19.4 mt -75.25 -46.45 33.63 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -177.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 25.2 t -86.44 -16.87 35.81 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.757 0.789 . . . . 0.0 109.763 -173.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 416' ' ' GLY . . . . . 0.438 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 106.4 -178.26 22.5 Favored Glycine 0 N--CA 1.43 -1.702 0 N-CA-C 109.934 -1.267 . . . . 0.0 109.934 -171.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -79.76 24.19 0.4 Allowed 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.262 0.554 . . . . 0.0 111.001 -174.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 418' ' ' ASN . . . . . 0.438 ' H ' ' C ' ' A' ' 416' ' ' GLY . 3.8 m-20 -70.99 75.55 0.65 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.864 -177.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 419' ' ' TYR . . . . . 0.581 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 2.3 p90 -49.11 -40.1 30.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.763 176.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -55.39 -45.85 76.61 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.926 0.393 . . . . 0.0 111.007 178.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.74 -48.75 62.96 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.254 -176.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 422' ' ' VAL . . . . . 0.444 ' HB ' ' CD1' ' A' ' 408' ' ' TYR . 0.1 OUTLIER -66.14 -41.36 89.26 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.515 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.126 -175.737 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.815 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 76.9 p -66.95 -39.45 87.29 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.906 -178.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.0 -38.91 93.08 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.442 -0.885 . . . . 0.0 111.883 176.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 425' ' ' ILE . . . . . 0.601 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.94 -52.9 20.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.308 0.099 . . . . 0.0 111.232 -176.956 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 426' ' ' ILE . . . . . 0.7 HG22 HD22 ' A' ' 430' ' ' LEU . 1.1 mm -74.18 -23.6 18.65 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.758 0 O-C-N 122.199 -0.313 . . . . 0.0 110.21 -171.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.815 ' HB2' ' O ' ' A' ' 423' ' ' SER . 2.3 tmm_? -55.4 -31.5 61.88 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.266 0.555 . . . . 0.0 111.022 -177.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -85.37 -12.3 73.33 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.168 178.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.63 ' HD1' HG22 ' A' ' 395' ' ' ILE . 7.5 m-30 -113.15 -0.08 14.77 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.588 0.709 . . . . 0.0 109.297 -173.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.746 HD23 ' HA ' ' A' ' 427' ' ' ARG . 0.1 OUTLIER -65.97 129.69 94.3 Favored Pre-proline 0 N--CA 1.446 -0.631 0 CA-C-N 114.476 -1.238 . . . . 0.0 109.268 178.159 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 431' ' ' PRO . . . . . 0.544 ' HD2' HD12 ' A' ' 430' ' ' LEU . 95.4 Cg_exo -24.05 -60.46 0.05 OUTLIER 'Trans proline' 0 C--N 1.359 1.099 1 C-N-CA 125.709 4.273 . . . . 0.0 115.012 179.736 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 432' ' ' GLY . . . . . 0.566 ' H ' HG12 ' A' ' 435' ' ' VAL . . . -152.68 -170.6 19.26 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 177.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 433' ' ' GLN . . . . . 0.493 ' O ' HG13 ' A' ' 436' ' ' VAL . 17.2 tp60 -66.76 -26.63 67.07 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 118.026 0.913 . . . . 0.0 110.402 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -65.88 -43.27 88.81 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -177.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 435' ' ' VAL . . . . . 0.726 HG23 HG11 ' A' ' 463' ' ' VAL . 7.5 p -67.32 -42.19 87.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-O 121.082 0.467 . . . . 0.0 110.409 -177.005 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.515 HG12 ' O ' ' A' ' 432' ' ' GLY . 0.1 OUTLIER -68.08 -30.66 48.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.83 175.643 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.88 -51.84 43.37 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 438' ' ' ALA . . . . . 0.867 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -58.02 -38.92 77.08 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.929 177.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 439' ' ' LEU . . . . . 0.551 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 1.9 tm? -69.94 -46.96 64.18 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -57.1 -39.17 74.51 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.109 174.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 441' ' ' GLN . . . . . 0.536 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 8.4 mm-40 -54.46 -49.65 69.57 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 123.776 0.83 . . . . 0.0 110.747 174.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 442' ' ' ARG . . . . . 0.818 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 0.9 OUTLIER -56.29 -39.92 73.47 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.729 172.294 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 443' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 46.9 mt -71.64 -33.02 68.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.268 0.556 . . . . 0.0 110.062 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -60.55 -37.77 82.31 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.502 174.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -73.02 -28.69 62.5 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.584 177.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 446' ' ' GLU . . . . . 0.551 ' HB2' ' O ' ' A' ' 443' ' ' LEU . 42.0 tt0 31.41 97.06 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.247 1.202 . . . . 0.0 114.247 172.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 49.3 mt -66.34 -36.05 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 121.294 0.569 . . . . 0.0 110.402 178.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 448' ' ' ASP . . . . . 0.642 ' O ' ' HG3' ' A' ' 452' ' ' ARG . 19.7 m-20 -166.05 -172.4 2.29 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 -179.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -77.58 -61.13 2.09 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.442 175.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -69.17 -26.1 64.68 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 176.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 451' ' ' THR . . . . . 0.509 ' OG1' ' HB2' ' A' ' 448' ' ' ASP . 18.3 m -71.73 -22.24 61.65 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.437 -175.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 452' ' ' ARG . . . . . 0.642 ' HG3' ' O ' ' A' ' 448' ' ' ASP . 13.5 mtp180 -52.97 -54.22 38.25 Favored 'General case' 0 C--O 1.218 -0.567 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 170.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 453' ' ' ALA . . . . . 0.581 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -56.99 -50.06 73.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.443 -1.253 . . . . 0.0 112.623 175.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 454' ' ' GLU . . . . . 0.43 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 40.7 mm-40 -51.41 -35.93 41.33 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.892 -177.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 28.3 p -118.48 16.07 13.79 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.283 -176.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 456' ' ' PHE . . . . . 0.593 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.9 OUTLIER -56.58 -47.73 78.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.06 0.457 . . . . 0.0 111.656 -171.33 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 457' ' ' ILE . . . . . 0.565 HG23 ' HB1' ' A' ' 405' ' ' ALA . 1.9 mp -77.32 -33.06 19.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.964 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -58.05 -35.18 70.97 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.889 0.852 . . . . 0.0 109.385 171.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 459' ' ' HIS . . . . . 0.713 ' O ' HG23 ' A' ' 463' ' ' VAL . 62.1 m-70 -73.81 -28.69 61.75 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.712 177.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 460' ' ' LEU . . . . . 0.735 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -73.85 -34.69 64.62 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.891 0.853 . . . . 0.0 108.968 178.869 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 461' ' ' ASN . . . . . 0.458 ' O ' ' HB2' ' A' ' 464' ' ' TYR . 22.4 m-80 -73.37 -37.3 66.06 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.922 0.868 . . . . 0.0 108.899 176.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 462' ' ' ALA . . . . . 0.635 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -56.54 -34.2 66.84 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.848 169.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.867 HG13 ' HB3' ' A' ' 438' ' ' ALA . 56.0 t -61.69 -50.16 81.37 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.796 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.051 175.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 464' ' ' TYR . . . . . 0.578 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 18.6 m-30 -53.1 -28.45 25.49 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.611 177.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.86 -40.35 22.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.842 0.829 . . . . 0.0 109.596 -178.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.635 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.4 mt -58.02 -55.23 23.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 114.196 -1.366 . . . . 0.0 112.308 177.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.755 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -102.26 -10.04 19.89 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -172.89 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 468' ' ' GLY . . . . . 0.515 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 93.42 31.9 8.08 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 119.173 -1.489 . . . . 0.0 113.932 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 469' ' ' LEU . . . . . 0.755 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.2 mt -89.56 162.84 15.46 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 117.78 0.79 . . . . 0.0 110.732 175.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 470' ' ' ASN . . . . . 0.479 ' HB3' ' CG2' ' A' ' 476' ' ' ILE . 39.0 p30 -102.64 -179.65 4.03 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.902 171.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 471' ' ' ALA . . . . . 0.566 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -61.04 -22.01 64.16 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -175.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 472' ' ' ARG . . . . . 0.459 ' HA ' ' O ' ' A' ' 402' ' ' GLU . 17.4 mmt180 -88.61 6.79 36.56 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.507 -171.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 473' ' ' GLY . . . . . 0.434 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 74.34 13.08 81.78 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.455 -0.879 . . . . 0.0 111.114 -177.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -100.6 152.71 20.1 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 24.0 p -91.03 126.79 36.22 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.297 0.57 . . . . 0.0 110.573 176.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 476' ' ' ILE . . . . . 0.515 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.7 pp -87.74 -3.18 9.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.701 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 477' ' ' ARG . . . . . 0.482 ' HD2' ' O ' ' A' ' 477' ' ' ARG . 1.3 ppt_? -123.79 166.1 16.17 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.158 177.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 83.2 mt -112.72 136.5 52.24 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 . . . . . 0 C--O 1.246 0.901 0 CA-C-O 118.653 -0.689 . . . . 0.0 110.357 179.501 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 381' ' ' ARG . . . . . . . . . . . . . 21.2 ptt180 . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 120.943 0.401 . . . . 0.0 110.39 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 382' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.63 -33.47 2.07 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.706 -178.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 383' ' ' HIS . . . . . 0.452 ' HB3' ' HB3' ' B' ' 388' ' ' MET . 56.4 p-80 -163.66 158.36 20.36 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 121.179 0.514 . . . . 0.0 112.103 -177.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 384' ' ' GLY . . . . . . . . . . . . . . . -137.77 -44.26 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.6 177.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 385' ' ' THR . . . . . . . . . . . . . 23.1 m -97.0 -56.01 2.69 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.869 0.366 . . . . 0.0 110.907 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 386' ' ' PHE . . . . . 0.791 ' CZ ' HG12 ' B' ' 394' ' ' VAL . 3.5 t80 -76.57 129.13 80.42 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 387' ' ' PRO . . . . . 0.592 ' HG2' ' OD1' ' A' ' 393' ' ' ASN . 35.1 Cg_endo -66.83 63.89 0.58 Allowed 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.928 3.085 . . . . 0.0 113.628 177.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 388' ' ' MET . . . . . 0.815 ' SD ' HG13 ' B' ' 394' ' ' VAL . 5.2 tpp -68.05 164.53 19.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.888 176.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 389' ' ' HIS . . . . . 0.61 ' CE1' ' HA ' ' B' ' 393' ' ' ASN . 30.6 m170 -65.2 -160.49 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 172.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 28.9 pt20 -71.59 1.43 6.62 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.241 170.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 391' ' ' LEU . . . . . 0.588 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.2 pt? -155.15 -64.14 0.12 Allowed 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -176.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 392' ' ' GLY . . . . . 0.715 ' HA3' HD13 ' B' ' 395' ' ' ILE . . . -158.55 74.94 0.21 Allowed Glycine 0 CA--C 1.524 0.635 0 C-N-CA 119.988 -1.101 . . . . 0.0 114.243 -172.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 393' ' ' ASN . . . . . 0.61 ' HA ' ' CE1' ' B' ' 389' ' ' HIS . 0.0 OUTLIER -65.74 -42.03 91.49 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 177.697 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 394' ' ' VAL . . . . . 0.815 HG13 ' SD ' ' B' ' 388' ' ' MET . 0.6 OUTLIER -57.27 -46.18 85.06 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 179.72 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 395' ' ' ILE . . . . . 0.715 HD13 ' HA3' ' B' ' 392' ' ' GLY . 4.1 mp -57.53 -52.06 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.575 0 CA-C-O 117.792 -1.099 . . . . 0.0 113.381 -173.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 396' ' ' LYS . . . . . 0.593 ' O ' HG22 ' B' ' 399' ' ' VAL . 0.1 OUTLIER -62.19 -50.67 70.88 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 122.021 2.191 . . . . 0.0 112.178 -176.838 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.7 -44.62 69.47 Favored Glycine 0 N--CA 1.435 -1.421 0 C-N-CA 119.904 -1.141 . . . . 0.0 110.848 -175.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 398' ' ' ILE . . . . . 0.763 HG12 HD21 ' A' ' 414' ' ' LEU . 27.0 mt -71.25 -34.08 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -178.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 399' ' ' VAL . . . . . 0.593 HG22 ' O ' ' B' ' 396' ' ' LYS . 16.1 m -62.58 -40.07 86.93 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 C-N-CA 118.778 -1.169 . . . . 0.0 108.594 -174.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -71.28 -36.76 71.82 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 176.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 401' ' ' GLN . . . . . 0.454 HE21 ' HB3' ' B' ' 401' ' ' GLN . 4.2 mm100 -88.73 -46.72 8.77 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -171.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 402' ' ' GLU . . . . . 0.57 ' HG3' ' HE3' ' A' ' 413' ' ' MET . 2.4 mm-40 -120.52 -20.11 7.27 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.504 -171.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 106.49 162.08 22.42 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.834 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 404' ' ' VAL . . . . . 0.669 HG11 ' HA ' ' B' ' 430' ' ' LEU . 1.5 m -53.66 -45.35 60.28 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.802 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -175.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 405' ' ' ALA . . . . . 0.565 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -64.28 -30.89 71.92 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.425 -177.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 406' ' ' THR . . . . . 0.694 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 87.6 m -76.93 -42.61 38.69 Favored 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 120.099 -0.64 . . . . 0.0 109.986 173.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 407' ' ' ALA . . . . . 0.468 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.56 -37.06 74.93 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 122.171 0.986 . . . . 0.0 109.434 176.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 408' ' ' TYR . . . . . 0.619 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -66.04 -52.08 52.35 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 113.452 -1.704 . . . . 0.0 109.682 176.395 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 409' ' ' THR . . . . . 0.659 HG22 HD23 ' B' ' 410' ' ' LEU . 10.1 m -55.35 -47.4 75.78 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.69 -0.687 . . . . 0.0 112.571 178.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 410' ' ' LEU . . . . . 0.751 HD12 HD13 ' B' ' 398' ' ' ILE . 13.7 mt -72.14 -35.93 69.23 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 120.992 0.425 . . . . 0.0 109.925 -175.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.77 -34.75 78.85 Favored Glycine 0 N--CA 1.438 -1.192 0 C-N-CA 120.236 -0.983 . . . . 0.0 110.779 172.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 412' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -69.85 -47.87 61.03 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-O 120.574 0.226 . . . . 0.0 111.346 178.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 413' ' ' MET . . . . . 0.932 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.5 OUTLIER -70.58 -42.11 71.49 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 119.035 -1.066 . . . . 0.0 112.211 -178.334 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 414' ' ' LEU . . . . . 0.932 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 19.4 mt -75.32 -46.34 33.96 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -176.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 24.8 t -86.34 -16.99 35.71 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.806 0.812 . . . . 0.0 109.717 -173.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 416' ' ' GLY . . . . . 0.443 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 106.33 -178.26 22.55 Favored Glycine 0 N--CA 1.431 -1.662 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 -171.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 33.0 mm-40 -79.72 24.44 0.38 Allowed 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.151 0.5 . . . . 0.0 110.94 -174.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 418' ' ' ASN . . . . . 0.443 ' H ' ' C ' ' B' ' 416' ' ' GLY . 3.9 m-20 -71.19 75.87 0.7 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.807 -177.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 419' ' ' TYR . . . . . 0.585 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 2.2 p90 -49.27 -40.06 33.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.801 -1.09 . . . . 0.0 111.789 176.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -55.33 -46.12 76.37 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.774 0.321 . . . . 0.0 110.963 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.66 -48.81 63.01 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.172 -176.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 422' ' ' VAL . . . . . 0.445 ' HB ' ' CD1' ' B' ' 408' ' ' TYR . 0.1 OUTLIER -66.03 -41.4 89.59 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 C-N-CA 120.371 -0.531 . . . . 0.0 111.076 -175.898 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 423' ' ' SER . . . . . 0.806 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 76.3 p -66.89 -39.33 87.44 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.883 -178.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.08 -38.98 92.8 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.922 176.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 425' ' ' ILE . . . . . 0.616 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -73.05 -52.79 20.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.318 0.104 . . . . 0.0 111.161 -176.869 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 426' ' ' ILE . . . . . 0.691 HG22 HD22 ' B' ' 430' ' ' LEU . 1.1 mm -74.23 -23.55 18.55 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.863 0 O-C-N 122.185 -0.322 . . . . 0.0 110.164 -171.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 427' ' ' ARG . . . . . 0.806 ' HB2' ' O ' ' B' ' 423' ' ' SER . 2.3 tmm_? -55.58 -31.36 62.13 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.221 0.534 . . . . 0.0 110.928 -177.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -85.38 -12.27 73.4 Favored Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.429 -0.891 . . . . 0.0 111.11 178.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 429' ' ' TYR . . . . . 0.629 ' HD1' HG22 ' B' ' 395' ' ' ILE . 7.3 m-30 -113.26 0.27 14.81 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.558 0.694 . . . . 0.0 109.227 -173.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 430' ' ' LEU . . . . . 0.749 HD23 ' HA ' ' B' ' 427' ' ' ARG . 0.1 OUTLIER -66.27 129.71 94.21 Favored Pre-proline 0 N--CA 1.445 -0.696 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.23 178.101 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 431' ' ' PRO . . . . . 0.533 ' HD2' HD12 ' B' ' 430' ' ' LEU . 95.0 Cg_exo -24.06 -60.35 0.05 OUTLIER 'Trans proline' 0 C--N 1.36 1.148 1 C-N-CA 125.602 4.201 . . . . 0.0 115.094 179.747 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 432' ' ' GLY . . . . . 0.576 ' H ' HG12 ' B' ' 435' ' ' VAL . . . -153.18 -171.5 20.53 Favored Glycine 0 N--CA 1.443 -0.887 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 177.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 433' ' ' GLN . . . . . 0.505 ' O ' HG13 ' B' ' 436' ' ' VAL . 16.3 tp60 -66.09 -26.89 67.68 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 118.088 0.944 . . . . 0.0 110.368 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -65.44 -43.42 90.51 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -178.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 435' ' ' VAL . . . . . 0.716 HG23 HG11 ' B' ' 463' ' ' VAL . 7.6 p -67.32 -42.31 87.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 121.104 0.478 . . . . 0.0 110.423 -176.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 436' ' ' VAL . . . . . 0.505 HG13 ' O ' ' B' ' 433' ' ' GLN . 0.1 OUTLIER -68.02 -30.58 48.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.838 175.698 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.93 -51.9 42.4 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 438' ' ' ALA . . . . . 0.854 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -58.11 -38.65 76.86 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.916 177.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 439' ' ' LEU . . . . . 0.562 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 1.9 tm? -70.27 -46.93 63.38 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -57.03 -39.23 74.41 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.127 174.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 441' ' ' GLN . . . . . 0.531 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 8.3 mm-40 -54.24 -49.89 68.44 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 123.888 0.875 . . . . 0.0 110.795 174.154 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 442' ' ' ARG . . . . . 0.827 ' HG2' ' O ' ' B' ' 438' ' ' ALA . 0.9 OUTLIER -56.17 -39.86 73.03 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.65 172.364 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 443' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 47.1 mt -71.74 -32.85 68.16 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.217 0.532 . . . . 0.0 110.119 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -60.76 -37.61 82.4 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.463 174.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -73.28 -28.42 62.1 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.554 177.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 446' ' ' GLU . . . . . 0.552 ' HB2' ' O ' ' B' ' 443' ' ' LEU . 41.3 tt0 31.26 97.02 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 172.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 49.9 mt -66.7 -35.83 75.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.37 0.605 . . . . 0.0 110.343 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 448' ' ' ASP . . . . . 0.646 ' O ' ' HG3' ' B' ' 452' ' ' ARG . 17.5 m-20 -166.12 -172.62 2.34 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -77.51 -61.15 2.08 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.432 175.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -69.05 -26.14 64.82 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 176.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 451' ' ' THR . . . . . 0.506 ' OG1' ' HB2' ' B' ' 448' ' ' ASP . 18.6 m -71.72 -22.1 61.68 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.538 -175.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 452' ' ' ARG . . . . . 0.646 ' HG3' ' O ' ' B' ' 448' ' ' ASP . 13.4 mtp180 -53.07 -54.1 40.54 Favored 'General case' 0 C--O 1.218 -0.553 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 170.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 453' ' ' ALA . . . . . 0.585 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -57.09 -50.11 73.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.381 -1.281 . . . . 0.0 112.585 175.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 454' ' ' GLU . . . . . 0.425 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 45.5 mm-40 -51.4 -36.0 41.6 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.803 -177.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 27.2 p -118.36 16.1 13.89 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.264 -176.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 456' ' ' PHE . . . . . 0.602 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 0.9 OUTLIER -56.65 -47.76 79.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.076 0.465 . . . . 0.0 111.612 -171.178 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 457' ' ' ILE . . . . . 0.565 HG23 ' HB1' ' B' ' 405' ' ' ALA . 1.9 mp -77.16 -33.14 19.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.979 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -58.05 -35.14 70.9 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.88 0.848 . . . . 0.0 109.393 172.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 459' ' ' HIS . . . . . 0.714 ' O ' HG23 ' B' ' 463' ' ' VAL . 62.0 m-70 -73.83 -28.77 61.77 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.731 177.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 460' ' ' LEU . . . . . 0.738 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -73.89 -34.64 64.5 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.906 0.86 . . . . 0.0 108.994 178.881 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 461' ' ' ASN . . . . . 0.453 ' O ' ' HB2' ' B' ' 464' ' ' TYR . 21.7 m-80 -73.25 -37.28 66.39 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.877 0.846 . . . . 0.0 108.869 176.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 462' ' ' ALA . . . . . 0.643 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -56.61 -34.05 66.85 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.981 169.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 463' ' ' VAL . . . . . 0.854 HG13 ' HB3' ' B' ' 438' ' ' ALA . 55.9 t -61.71 -50.07 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-N 114.642 -1.163 . . . . 0.0 107.999 175.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 464' ' ' TYR . . . . . 0.568 ' CE2' ' HA ' ' B' ' 471' ' ' ALA . 18.5 m-30 -53.1 -28.34 24.88 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 114.678 -1.147 . . . . 0.0 110.633 177.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.11 -40.24 22.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.906 0.86 . . . . 0.0 109.62 -178.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 466' ' ' ILE . . . . . 0.643 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.4 mt -57.91 -55.35 22.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 114.209 -1.36 . . . . 0.0 112.235 176.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 467' ' ' LEU . . . . . 0.761 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -102.42 -10.0 19.79 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 114.474 1.286 . . . . 0.0 114.474 -172.821 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 468' ' ' GLY . . . . . 0.518 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 93.46 31.87 8.08 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 119.081 -1.533 . . . . 0.0 113.91 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 469' ' ' LEU . . . . . 0.761 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.2 mt -89.76 162.53 15.49 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 117.677 0.738 . . . . 0.0 110.795 175.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 470' ' ' ASN . . . . . 0.492 ' HB3' ' CG2' ' B' ' 476' ' ' ILE . 39.4 p30 -102.48 -179.54 4.01 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.889 171.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 471' ' ' ALA . . . . . 0.568 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -61.6 -21.64 64.52 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -175.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 472' ' ' ARG . . . . . 0.463 ' HA ' ' O ' ' B' ' 402' ' ' GLU . 17.2 mmt180 -88.67 6.74 37.01 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.431 -171.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 473' ' ' GLY . . . . . 0.431 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 74.5 12.8 82.21 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.145 -177.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -100.4 152.92 19.78 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 25.1 p -91.06 127.03 36.32 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.367 0.603 . . . . 0.0 110.522 176.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 476' ' ' ILE . . . . . 0.518 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.7 pp -88.09 -3.01 9.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 114.92 -1.037 . . . . 0.0 110.621 -179.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 477' ' ' ARG . . . . . 0.473 ' HD2' ' O ' ' B' ' 477' ' ' ARG . 1.3 ppt_? -123.97 166.23 16.06 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.176 177.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 478' ' ' LEU . . . . . . . . . . . . . 83.5 mt -112.86 135.95 53.05 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 479' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.345 -0.836 . . . . 0.0 110.068 178.948 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 . . . . . 0 N--CA 1.481 1.088 0 CA-C-O 120.823 0.344 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -114.61 -30.19 6.58 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -178.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 383' ' ' HIS . . . . . 0.413 ' HB2' ' O ' ' A' ' 386' ' ' PHE . 2.5 p80 -152.03 161.07 43.21 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 119.942 -0.703 . . . . 0.0 111.844 -171.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -110.77 -115.45 3.6 Favored Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 171.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 18.8 m -65.04 -37.08 86.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.195 0.521 . . . . 0.0 111.067 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 386' ' ' PHE . . . . . 0.715 ' CD1' HD22 ' A' ' 414' ' ' LEU . 1.4 t80 -79.9 129.72 69.55 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.012 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -49.27 -72.84 0.04 OUTLIER 'Trans proline' 0 N--CA 1.485 0.995 0 C-N-CA 124.309 3.339 . . . . 0.0 114.418 -178.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.612 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 38.9 ttm 74.36 49.36 0.11 Allowed 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 172.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 389' ' ' HIS . . . . . 0.703 ' CG ' ' HB2' ' A' ' 393' ' ' ASN . 40.7 m170 47.31 -99.44 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.25 0.62 . . . . 0.0 110.642 -175.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -146.36 15.71 1.3 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.469 -0.787 . . . . 0.0 108.884 174.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.489 HD23 ' H ' ' A' ' 392' ' ' GLY . 2.4 pt? -169.15 -50.97 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -168.079 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 392' ' ' GLY . . . . . 0.539 ' HA3' HD13 ' A' ' 395' ' ' ILE . . . -176.47 50.89 0.11 Allowed Glycine 0 C--N 1.335 0.495 0 C-N-CA 119.609 -1.282 . . . . 0.0 114.214 -172.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 393' ' ' ASN . . . . . 0.703 ' HB2' ' CG ' ' A' ' 389' ' ' HIS . 0.4 OUTLIER -54.21 -41.31 68.48 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 117.401 0.6 . . . . 0.0 109.679 176.761 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.67 HG12 ' CE2' ' A' ' 386' ' ' PHE . 0.9 OUTLIER -56.85 -47.08 83.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 -179.249 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.669 HG23 HD13 ' A' ' 426' ' ' ILE . 4.3 mp -57.87 -52.22 60.66 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 CA-C-O 117.938 -1.03 . . . . 0.0 113.307 -175.232 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 396' ' ' LYS . . . . . 0.704 ' HG3' ' CZ ' ' A' ' 429' ' ' TYR . 0.1 OUTLIER -62.98 -49.88 72.95 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 121.692 2.042 . . . . 0.0 112.069 -174.165 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 397' ' ' GLY . . . . . 0.538 ' O ' ' HG3' ' A' ' 401' ' ' GLN . . . -54.32 -44.67 76.02 Favored Glycine 0 N--CA 1.435 -1.387 0 C-N-CA 120.099 -1.048 . . . . 0.0 111.035 -177.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 398' ' ' ILE . . . . . 0.874 HD13 HD12 ' A' ' 410' ' ' LEU . 45.4 mt -71.6 -34.37 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -177.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 399' ' ' VAL . . . . . 0.528 HG12 ' HA ' ' A' ' 404' ' ' VAL . 5.4 m -64.09 -39.99 87.46 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 C-N-CA 118.738 -1.185 . . . . 0.0 108.408 -174.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -64.74 -41.24 96.08 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 174.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.538 ' HG3' ' O ' ' A' ' 397' ' ' GLY . 32.1 mt-30 -93.07 -48.39 6.52 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -169.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 402' ' ' GLU . . . . . 0.679 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 3.0 mm-40 -113.42 -20.11 11.44 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.448 -171.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 104.77 163.21 24.15 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.125 -0.559 . . . . 0.0 113.137 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 404' ' ' VAL . . . . . 0.655 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.5 m -53.43 -45.21 57.37 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.752 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 -176.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 405' ' ' ALA . . . . . 0.546 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -66.41 -30.87 71.34 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.994 -175.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.711 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 92.4 m -77.23 -42.35 37.68 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.241 173.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.51 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.21 -37.71 75.37 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 122.049 0.928 . . . . 0.0 109.215 176.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 408' ' ' TYR . . . . . 0.655 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.64 -52.39 52.15 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 113.593 -1.64 . . . . 0.0 109.961 177.115 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 409' ' ' THR . . . . . 0.734 HG22 HD23 ' A' ' 410' ' ' LEU . 2.7 m -56.22 -46.23 79.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.505 178.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 410' ' ' LEU . . . . . 0.874 HD12 HD13 ' A' ' 398' ' ' ILE . 13.4 mt -72.03 -36.74 69.75 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 -175.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.6 -34.66 77.25 Favored Glycine 0 N--CA 1.44 -1.094 0 C-N-CA 120.085 -1.055 . . . . 0.0 110.708 172.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 412' ' ' MET . . . . . 0.412 ' HB2' ' O ' ' A' ' 409' ' ' THR . 0.4 OUTLIER -67.19 -48.21 68.6 Favored 'General case' 0 C--O 1.221 -0.438 0 C-N-CA 122.129 0.172 . . . . 0.0 111.403 177.672 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 413' ' ' MET . . . . . 0.944 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.7 OUTLIER -71.52 -47.73 53.4 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 118.848 -1.141 . . . . 0.0 112.103 -179.935 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 414' ' ' LEU . . . . . 0.944 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 23.3 mt -67.43 -44.24 79.24 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -175.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 48.1 t -86.97 -23.76 24.96 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.503 0.668 . . . . 0.0 110.011 -177.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 416' ' ' GLY . . . . . 0.447 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 109.69 -175.62 18.84 Favored Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -170.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -79.65 24.3 0.38 Allowed 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.495 0.664 . . . . 0.0 111.291 -172.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 418' ' ' ASN . . . . . 0.447 ' H ' ' C ' ' A' ' 416' ' ' GLY . 79.6 m-20 -71.67 76.04 0.83 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.651 -178.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 419' ' ' TYR . . . . . 0.537 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 12.0 p90 -55.21 -39.0 69.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.537 178.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -55.71 -43.48 76.52 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.833 0.349 . . . . 0.0 111.166 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 421' ' ' LEU . . . . . 0.401 HD22 ' HB2' ' A' ' 418' ' ' ASN . 0.0 OUTLIER -68.22 -48.68 64.53 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.951 -177.621 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 422' ' ' VAL . . . . . 0.43 ' HB ' ' CD1' ' A' ' 408' ' ' TYR . 0.2 OUTLIER -66.36 -39.52 84.34 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.155 -177.277 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.746 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 68.4 p -66.84 -39.38 87.62 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.93 -39.2 89.41 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.199 176.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 425' ' ' ILE . . . . . 0.596 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.79 -51.75 25.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 121.176 -0.209 . . . . 0.0 111.114 -177.375 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 426' ' ' ILE . . . . . 0.681 HG22 HD22 ' A' ' 430' ' ' LEU . 1.2 mm -74.27 -22.88 18.14 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.625 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -172.171 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.746 ' HB2' ' O ' ' A' ' 423' ' ' SER . 0.7 OUTLIER -54.86 -31.45 59.65 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.25 0.548 . . . . 0.0 110.149 -179.728 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -85.31 -5.16 85.57 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.667 178.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.704 ' CZ ' ' HG3' ' A' ' 396' ' ' LYS . 24.9 m-85 -119.76 0.69 10.95 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 121.08 0.467 . . . . 0.0 110.666 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.726 HD23 ' HA ' ' A' ' 427' ' ' ARG . 0.1 OUTLIER -65.94 127.9 93.46 Favored Pre-proline 0 N--CA 1.438 -1.044 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.735 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 431' ' ' PRO . . . . . 0.475 ' HD2' HD12 ' A' ' 430' ' ' LEU . 80.9 Cg_exo -23.41 -70.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.892 1 C-N-CA 125.627 4.218 . . . . 0.0 115.082 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 432' ' ' GLY . . . . . 0.482 ' O ' HG12 ' A' ' 435' ' ' VAL . . . -138.17 -167.4 10.99 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 176.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 433' ' ' GLN . . . . . 0.478 ' O ' HG13 ' A' ' 436' ' ' VAL . 19.2 tp60 -69.41 -26.92 64.86 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 117.831 0.815 . . . . 0.0 110.165 179.131 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -68.24 -39.04 82.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.357 -176.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 435' ' ' VAL . . . . . 0.767 HG23 HG11 ' A' ' 463' ' ' VAL . 7.2 p -69.48 -44.01 80.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-O 120.972 0.415 . . . . 0.0 110.527 -177.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.478 HG13 ' O ' ' A' ' 433' ' ' GLN . 0.2 OUTLIER -65.33 -31.36 53.52 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 174.825 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 1.1 m -67.22 -52.82 36.35 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -178.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 438' ' ' ALA . . . . . 0.853 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -58.89 -39.16 80.62 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.12 177.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 439' ' ' LEU . . . . . 0.638 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 1.9 tm? -68.13 -48.52 65.17 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -178.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -59.21 -35.02 72.87 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.519 -1.219 . . . . 0.0 111.171 174.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 441' ' ' GLN . . . . . 0.5 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 3.7 mm-40 -55.13 -49.68 71.17 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.122 -177.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 442' ' ' ARG . . . . . 0.622 ' HG3' ' CG ' ' A' ' 459' ' ' HIS . 0.0 OUTLIER -75.8 -24.64 55.94 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 119.563 -0.855 . . . . 0.0 113.032 175.073 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 443' ' ' LEU . . . . . 0.638 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 70.1 mt -64.18 -35.29 80.3 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-N 118.453 0.569 . . . . 0.0 109.601 175.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -57.0 -37.96 72.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.524 173.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 -74.34 -26.75 60.34 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.312 177.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 27.59 98.86 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 176.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 49.2 mt -60.9 -35.13 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-O 121.266 0.555 . . . . 0.0 110.689 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 448' ' ' ASP . . . . . 0.466 ' HB2' ' OG1' ' A' ' 451' ' ' THR . 18.4 m-20 -163.66 -161.79 0.67 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 -177.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -82.38 -69.56 0.61 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 172.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 450' ' ' GLN . . . . . 0.417 ' HG3' ' H ' ' A' ' 450' ' ' GLN . 1.8 pp0? -66.81 -24.78 66.21 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 178.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 451' ' ' THR . . . . . 0.466 ' OG1' ' HB2' ' A' ' 448' ' ' ASP . 14.0 m -70.62 -22.55 62.51 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.788 -173.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 452' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 452' ' ' ARG . 18.3 mtp180 -54.1 -54.22 42.5 Favored 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 171.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 453' ' ' ALA . . . . . 0.537 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -59.13 -47.1 86.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.524 -1.216 . . . . 0.0 112.604 175.101 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 454' ' ' GLU . . . . . 0.446 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 12.0 mm-40 -51.58 -38.39 54.23 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.203 0.525 . . . . 0.0 111.478 -177.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 28.1 p -116.36 15.44 15.78 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.422 -175.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 456' ' ' PHE . . . . . 0.511 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.7 OUTLIER -56.74 -48.99 76.54 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 120.951 0.405 . . . . 0.0 111.777 -171.472 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 457' ' ' ILE . . . . . 0.546 HG23 ' HB1' ' A' ' 405' ' ' ALA . 1.9 mp -75.45 -32.93 26.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 120.841 0.353 . . . . 0.0 110.713 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -57.63 -35.51 70.58 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.694 0.759 . . . . 0.0 109.586 171.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 459' ' ' HIS . . . . . 0.752 ' O ' HG23 ' A' ' 463' ' ' VAL . 71.3 m-70 -71.74 -29.57 64.67 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.755 -1.112 . . . . 0.0 110.613 176.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 460' ' ' LEU . . . . . 0.712 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -74.08 -34.81 64.14 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.912 0.863 . . . . 0.0 108.787 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -72.84 -38.17 67.19 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.311 175.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 462' ' ' ALA . . . . . 0.627 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -55.82 -32.93 64.0 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.807 169.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.853 HG13 ' HB3' ' A' ' 438' ' ' ALA . 61.6 t -63.89 -50.57 76.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 CA-C-N 114.474 -1.239 . . . . 0.0 107.901 177.397 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 464' ' ' TYR . . . . . 0.567 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 15.3 m-30 -53.89 -27.16 28.69 Favored 'General case' 0 C--N 1.332 -0.169 0 O-C-N 124.259 0.974 . . . . 0.0 110.324 178.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.68 -40.95 18.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.689 0.757 . . . . 0.0 109.38 -177.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.627 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.7 mt -56.22 -55.82 16.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 114.295 -1.32 . . . . 0.0 112.289 175.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.761 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -103.41 -10.82 18.3 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -171.752 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 468' ' ' GLY . . . . . 0.561 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 93.73 31.74 8.05 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 119.43 -1.367 . . . . 0.0 114.351 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 469' ' ' LEU . . . . . 0.761 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 2.6 mt -88.91 162.3 16.19 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 117.983 0.892 . . . . 0.0 111.435 177.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 39.5 p30 -105.29 -174.45 2.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.349 173.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -67.02 -17.49 64.94 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -175.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -88.48 -0.43 57.2 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 122.101 -0.375 . . . . 0.0 111.321 -175.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 75.85 17.08 80.25 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -173.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -101.55 151.6 21.78 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 177.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 5.6 p -90.61 127.76 36.38 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.95 0.405 . . . . 0.0 111.169 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 476' ' ' ILE . . . . . 0.561 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.5 pp -98.23 10.0 6.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.806 0.812 . . . . 0.0 110.282 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 28.6 mmm180 -77.37 -172.3 2.43 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.959 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 478' ' ' LEU . . . . . 0.404 ' N ' HD12 ' A' ' 478' ' ' LEU . 6.1 mp -80.0 -43.26 22.3 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 . . . . . 0 C--O 1.247 0.94 0 CA-C-O 118.399 -0.81 . . . . 0.0 109.961 179.309 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 381' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 . . . . . 0 N--CA 1.48 1.031 0 CA-C-O 120.756 0.312 . . . . 0.0 110.254 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 382' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -114.61 -30.18 6.58 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -178.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 383' ' ' HIS . . . . . 0.407 ' HB2' ' O ' ' B' ' 386' ' ' PHE . 2.4 p80 -152.23 160.81 43.3 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 119.931 -0.708 . . . . 0.0 111.992 -171.162 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 384' ' ' GLY . . . . . . . . . . . . . . . -110.74 -116.26 3.67 Favored Glycine 0 N--CA 1.44 -1.098 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.269 171.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 385' ' ' THR . . . . . . . . . . . . . 19.3 m -64.37 -36.92 85.72 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.167 0.508 . . . . 0.0 111.154 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 386' ' ' PHE . . . . . 0.733 ' CD1' HD22 ' B' ' 414' ' ' LEU . 1.4 t80 -79.96 130.01 68.31 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.012 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 387' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -49.32 -72.67 0.04 OUTLIER 'Trans proline' 0 N--CA 1.487 1.13 0 C-N-CA 124.492 3.461 . . . . 0.0 114.375 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 388' ' ' MET . . . . . 0.61 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 38.9 ttm 73.98 49.54 0.12 Allowed 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 112.754 0.649 . . . . 0.0 112.754 172.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 389' ' ' HIS . . . . . 0.716 ' CG ' ' HB2' ' B' ' 393' ' ' ASN . 40.7 m170 47.32 -99.84 0.05 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.22 0.608 . . . . 0.0 110.499 -175.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -145.99 15.49 1.36 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.823 174.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 391' ' ' LEU . . . . . 0.482 HD23 ' H ' ' B' ' 392' ' ' GLY . 2.4 pt? -169.15 -50.89 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -168.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 392' ' ' GLY . . . . . 0.547 ' HA3' HD13 ' B' ' 395' ' ' ILE . . . -176.51 51.14 0.11 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 119.599 -1.286 . . . . 0.0 114.25 -172.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 393' ' ' ASN . . . . . 0.716 ' HB2' ' CG ' ' B' ' 389' ' ' HIS . 0.4 OUTLIER -54.47 -41.19 69.21 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 117.359 0.579 . . . . 0.0 109.705 176.914 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 394' ' ' VAL . . . . . 0.672 HG12 ' CE2' ' B' ' 386' ' ' PHE . 0.9 OUTLIER -56.86 -47.2 83.41 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 -179.29 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 395' ' ' ILE . . . . . 0.653 HG23 HD13 ' B' ' 426' ' ' ILE . 4.3 mp -57.86 -52.15 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 CA-C-O 117.824 -1.084 . . . . 0.0 113.31 -175.181 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 396' ' ' LYS . . . . . 0.695 ' HG3' ' CZ ' ' B' ' 429' ' ' TYR . 0.1 OUTLIER -62.95 -49.8 73.31 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 121.714 2.052 . . . . 0.0 112.12 -174.201 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 397' ' ' GLY . . . . . 0.537 ' O ' ' HG3' ' B' ' 401' ' ' GLN . . . -54.51 -44.47 77.96 Favored Glycine 0 N--CA 1.436 -1.355 0 C-N-CA 120.05 -1.071 . . . . 0.0 110.986 -177.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 398' ' ' ILE . . . . . 0.883 HD13 HD12 ' B' ' 410' ' ' LEU . 46.2 mt -71.71 -34.27 51.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -177.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 399' ' ' VAL . . . . . 0.527 HG12 ' HA ' ' B' ' 404' ' ' VAL . 5.5 m -64.21 -39.82 86.85 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.501 0 C-N-CA 118.836 -1.145 . . . . 0.0 108.457 -174.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -64.96 -41.11 95.75 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 174.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 401' ' ' GLN . . . . . 0.537 ' HG3' ' O ' ' B' ' 397' ' ' GLY . 32.3 mt-30 -93.13 -48.29 6.55 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -169.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 402' ' ' GLU . . . . . 0.684 ' HG3' ' HE3' ' A' ' 413' ' ' MET . 3.0 mm-40 -113.61 -19.99 11.39 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.44 -171.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 104.58 162.83 24.3 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.061 -0.59 . . . . 0.0 113.224 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 404' ' ' VAL . . . . . 0.647 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.4 m -53.21 -45.32 54.73 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.766 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -176.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 405' ' ' ALA . . . . . 0.554 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -66.23 -30.71 71.22 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 119.711 -0.795 . . . . 0.0 112.062 -175.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 406' ' ' THR . . . . . 0.701 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 88.2 m -77.26 -42.51 36.84 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.303 173.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 407' ' ' ALA . . . . . 0.502 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.09 -37.75 75.1 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 122.093 0.949 . . . . 0.0 109.2 176.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 408' ' ' TYR . . . . . 0.647 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.51 -52.58 51.69 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 113.631 -1.622 . . . . 0.0 109.975 177.028 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 409' ' ' THR . . . . . 0.74 HG22 HD23 ' B' ' 410' ' ' LEU . 2.7 m -56.17 -46.17 79.44 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.569 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 410' ' ' LEU . . . . . 0.883 HD12 HD13 ' B' ' 398' ' ' ILE . 13.2 mt -71.95 -36.74 69.98 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.808 0.337 . . . . 0.0 110.2 -175.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.51 -34.8 77.21 Favored Glycine 0 N--CA 1.439 -1.109 0 C-N-CA 120.04 -1.076 . . . . 0.0 110.729 172.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 412' ' ' MET . . . . . 0.413 ' HB2' ' O ' ' B' ' 409' ' ' THR . 0.4 OUTLIER -67.11 -48.14 69.01 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 115.808 -0.196 . . . . 0.0 111.423 177.76 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 413' ' ' MET . . . . . 0.931 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.7 OUTLIER -71.38 -48.1 52.11 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 118.884 -1.126 . . . . 0.0 112.119 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 414' ' ' LEU . . . . . 0.931 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 23.4 mt -67.2 -44.24 80.11 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -175.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 48.1 t -86.81 -24.11 25.12 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.592 0.711 . . . . 0.0 109.907 -177.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 416' ' ' GLY . . . . . 0.449 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 109.98 -175.52 18.58 Favored Glycine 0 N--CA 1.43 -1.715 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -170.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -79.71 24.47 0.38 Allowed 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.61 0.719 . . . . 0.0 111.326 -172.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 418' ' ' ASN . . . . . 0.449 ' H ' ' C ' ' B' ' 416' ' ' GLY . 79.9 m-20 -71.75 75.71 0.85 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.785 -178.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 419' ' ' TYR . . . . . 0.531 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 11.8 p90 -54.89 -38.9 68.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.598 178.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -55.73 -43.57 76.69 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.739 0.304 . . . . 0.0 111.061 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 421' ' ' LEU . . . . . 0.416 HD22 ' HB2' ' B' ' 418' ' ' ASN . 0.0 OUTLIER -68.15 -48.63 64.84 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.013 -177.576 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 422' ' ' VAL . . . . . 0.43 ' HB ' ' CD1' ' B' ' 408' ' ' TYR . 0.2 OUTLIER -66.41 -39.44 84.07 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.212 -177.365 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 423' ' ' SER . . . . . 0.771 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 67.3 p -66.97 -39.33 87.18 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.98 -39.11 89.24 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.161 176.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 425' ' ' ILE . . . . . 0.608 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -72.79 -51.7 26.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 116.622 0.211 . . . . 0.0 111.121 -177.334 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 426' ' ' ILE . . . . . 0.677 HG22 HD22 ' B' ' 430' ' ' LEU . 1.2 mm -74.3 -23.06 18.17 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.708 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -172.176 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 427' ' ' ARG . . . . . 0.771 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.7 OUTLIER -54.75 -31.34 58.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.344 0.592 . . . . 0.0 110.305 -179.769 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -85.5 -4.74 85.47 Favored Glycine 0 N--CA 1.446 -0.7 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.65 178.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 429' ' ' TYR . . . . . 0.695 ' CZ ' ' HG3' ' B' ' 396' ' ' LYS . 24.9 m-85 -120.13 0.52 10.72 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 121.105 0.479 . . . . 0.0 110.693 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 430' ' ' LEU . . . . . 0.711 HD23 ' HA ' ' B' ' 427' ' ' ARG . 0.1 OUTLIER -65.77 127.87 93.4 Favored Pre-proline 0 N--CA 1.44 -0.972 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.634 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 431' ' ' PRO . . . . . 0.474 ' HD2' HD12 ' B' ' 430' ' ' LEU . 84.1 Cg_exo -23.47 -70.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.832 1 C-N-CA 125.665 4.243 . . . . 0.0 115.011 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 432' ' ' GLY . . . . . 0.488 ' O ' HG12 ' B' ' 435' ' ' VAL . . . -138.12 -167.54 11.04 Favored Glycine 0 N--CA 1.442 -0.921 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 176.127 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 433' ' ' GLN . . . . . 0.474 ' O ' HG13 ' B' ' 436' ' ' VAL . 19.1 tp60 -69.5 -26.82 64.73 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 117.791 0.796 . . . . 0.0 110.074 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -68.07 -39.51 82.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.227 -176.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 435' ' ' VAL . . . . . 0.776 HG23 HG11 ' B' ' 463' ' ' VAL . 7.3 p -69.05 -44.03 81.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-O 120.968 0.413 . . . . 0.0 110.649 -177.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 436' ' ' VAL . . . . . 0.474 HG13 ' O ' ' B' ' 433' ' ' GLN . 0.2 OUTLIER -65.26 -31.22 52.93 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 CA-C-O 121.08 0.467 . . . . 0.0 109.883 174.795 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 1.1 m -67.28 -52.8 36.21 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 -178.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 438' ' ' ALA . . . . . 0.837 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -58.94 -39.19 80.86 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 115.351 -0.841 . . . . 0.0 112.113 177.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 439' ' ' LEU . . . . . 0.624 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 1.9 tm? -68.15 -48.48 65.22 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -178.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -59.26 -34.99 72.9 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.485 -1.234 . . . . 0.0 111.097 174.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 441' ' ' GLN . . . . . 0.5 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 3.6 mm-40 -54.98 -50.02 70.01 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.017 -177.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 442' ' ' ARG . . . . . 0.624 ' HG3' ' CG ' ' B' ' 459' ' ' HIS . 0.0 OUTLIER -75.67 -24.34 56.32 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 119.547 -0.861 . . . . 0.0 113.095 175.261 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 443' ' ' LEU . . . . . 0.624 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 70.2 mt -64.47 -35.2 80.18 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 175.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -56.99 -38.2 72.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.451 173.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -74.22 -26.85 60.49 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.318 177.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 446' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 27.91 98.94 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.625 1.17 . . . . 0.0 114.147 176.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 49.0 mt -61.13 -35.13 63.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-O 121.151 0.5 . . . . 0.0 110.74 -178.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 448' ' ' ASP . . . . . 0.476 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 19.8 m-20 -163.79 -162.14 0.69 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 -177.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -81.85 -69.67 0.6 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 172.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 450' ' ' GLN . . . . . 0.417 ' HG3' ' H ' ' B' ' 450' ' ' GLN . 1.8 pp0? -66.76 -24.72 66.24 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 178.068 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 451' ' ' THR . . . . . 0.476 ' OG1' ' HB2' ' B' ' 448' ' ' ASP . 12.4 m -70.62 -22.53 62.52 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.765 -173.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 452' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -54.2 -54.12 44.25 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 171.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 453' ' ' ALA . . . . . 0.531 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -58.94 -47.35 85.41 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.514 -1.221 . . . . 0.0 112.613 174.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 454' ' ' GLU . . . . . 0.445 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 10.5 mm-40 -51.83 -37.38 51.59 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.284 0.564 . . . . 0.0 111.603 -177.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 28.2 p -117.08 15.34 15.04 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.468 -176.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 456' ' ' PHE . . . . . 0.516 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 0.7 OUTLIER -56.57 -49.1 75.85 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.906 0.384 . . . . 0.0 111.879 -171.522 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 457' ' ' ILE . . . . . 0.554 HG23 ' HB1' ' B' ' 405' ' ' ALA . 1.9 mp -75.25 -33.08 27.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 120.809 0.337 . . . . 0.0 110.855 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -57.44 -35.63 70.35 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.814 0.816 . . . . 0.0 109.482 171.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 459' ' ' HIS . . . . . 0.748 ' O ' HG23 ' B' ' 463' ' ' VAL . 70.8 m-70 -71.89 -29.4 64.31 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.629 176.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 460' ' ' LEU . . . . . 0.717 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -74.14 -34.74 63.98 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.88 0.848 . . . . 0.0 108.882 179.811 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 461' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -72.82 -38.25 67.21 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.288 175.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 462' ' ' ALA . . . . . 0.639 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -55.72 -32.87 63.72 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.692 169.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 463' ' ' VAL . . . . . 0.837 HG13 ' HB3' ' B' ' 438' ' ' ALA . 60.1 t -64.07 -50.6 76.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 CA-C-N 114.433 -1.258 . . . . 0.0 107.961 177.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 464' ' ' TYR . . . . . 0.56 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 15.3 m-30 -53.72 -27.48 28.54 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.327 178.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.62 -40.52 18.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.622 0.725 . . . . 0.0 109.43 -177.236 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 466' ' ' ILE . . . . . 0.639 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.6 mt -56.42 -55.92 16.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 114.295 -1.321 . . . . 0.0 112.268 175.247 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 467' ' ' LEU . . . . . 0.776 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -103.36 -10.74 18.4 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -171.884 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 468' ' ' GLY . . . . . 0.585 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 93.84 31.69 8.03 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 119.453 -1.356 . . . . 0.0 114.281 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 469' ' ' LEU . . . . . 0.776 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 2.6 mt -88.91 162.26 16.21 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 117.969 0.885 . . . . 0.0 111.29 177.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 39.7 p30 -105.27 -173.96 2.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.367 173.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 471' ' ' ALA . . . . . . . . . . . . . . . -67.69 -17.06 64.45 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -175.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -88.59 -0.81 57.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.751 0.31 . . . . 0.0 111.136 -176.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 473' ' ' GLY . . . . . . . . . . . . . . . 76.19 16.88 80.38 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 -173.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -101.4 151.96 21.3 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 177.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 5.4 p -90.78 128.21 36.61 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.88 0.372 . . . . 0.0 111.184 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 476' ' ' ILE . . . . . 0.585 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.5 pp -98.26 9.45 7.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.672 0.748 . . . . 0.0 110.266 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 477' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 -77.04 -172.63 2.43 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.801 -1.09 . . . . 0.0 111.104 -178.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 478' ' ' LEU . . . . . 0.411 ' N ' HD12 ' B' ' 478' ' ' LEU . 6.0 mp -79.68 -43.08 23.4 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.187 0.518 . . . . 0.0 109.842 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 479' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 . . . . . 0 C--O 1.245 0.835 0 CA-C-O 118.519 -0.753 . . . . 0.0 110.016 179.361 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 . . . . . 0 N--CA 1.478 0.952 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -116.26 -34.27 4.71 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -175.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 383' ' ' HIS . . . . . 0.514 ' HB2' ' O ' ' A' ' 386' ' ' PHE . 3.6 p80 -143.19 154.31 43.73 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.223 -0.591 . . . . 0.0 111.326 -170.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -103.38 -108.79 3.3 Favored Glycine 0 N--CA 1.438 -1.183 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 170.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 47.2 m -75.0 -30.95 61.3 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.873 0.368 . . . . 0.0 111.113 177.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 386' ' ' PHE . . . . . 0.809 ' CD1' HD22 ' A' ' 414' ' ' LEU . 2.6 t80 -75.68 125.06 88.92 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.082 0.468 . . . . 0.0 110.616 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 387' ' ' PRO . . . . . 0.592 ' HG2' ' OD1' ' B' ' 393' ' ' ASN . 60.9 Cg_endo -72.0 111.27 3.13 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 124.105 3.203 . . . . 0.0 113.701 175.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.486 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 40.0 mtt -103.28 172.7 6.67 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 176.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -57.28 -61.76 2.24 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 175.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -175.49 19.66 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.5 -1.227 . . . . 0.0 108.448 173.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.494 HD23 ' H ' ' A' ' 392' ' ' GLY . 2.1 pt? -169.76 -54.8 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.616 -167.034 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 392' ' ' GLY . . . . . 0.612 ' HA3' HD13 ' A' ' 395' ' ' ILE . . . -174.88 54.77 0.13 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 119.93 -1.129 . . . . 0.0 113.703 -174.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 393' ' ' ASN . . . . . 0.587 ' OD1' ' HG2' ' B' ' 387' ' ' PRO . 0.2 OUTLIER -54.25 -41.9 69.29 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 177.707 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.748 HG23 HD12 ' A' ' 398' ' ' ILE . 2.0 m -56.35 -47.05 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.643 ' H ' HD12 ' A' ' 395' ' ' ILE . 3.9 mp -57.47 -52.12 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 CA-C-O 118.04 -0.981 . . . . 0.0 113.254 -175.092 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 396' ' ' LYS . . . . . 0.68 ' HG3' ' CZ ' ' A' ' 429' ' ' TYR . 0.1 OUTLIER -61.49 -49.3 77.33 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-N 121.52 1.964 . . . . 0.0 111.857 -173.99 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -54.26 -45.14 75.07 Favored Glycine 0 N--CA 1.437 -1.279 0 C-N-CA 119.756 -1.212 . . . . 0.0 111.142 -178.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 398' ' ' ILE . . . . . 0.793 HD13 HD12 ' A' ' 410' ' ' LEU . 39.2 mt -70.94 -34.08 54.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -177.004 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 399' ' ' VAL . . . . . 0.503 HG12 ' HA ' ' A' ' 404' ' ' VAL . 10.6 m -63.5 -39.61 85.96 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 C-N-CA 118.573 -1.251 . . . . 0.0 108.24 -175.021 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -70.91 -33.99 71.09 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 175.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.444 HE21 ' HB3' ' A' ' 401' ' ' GLN . 3.2 mm100 -90.14 -47.27 7.91 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -172.197 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 402' ' ' GLU . . . . . 0.649 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 2.9 mm-40 -121.61 -20.97 6.34 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.576 -170.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 107.21 162.73 21.86 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.823 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 404' ' ' VAL . . . . . 0.65 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.6 m -53.52 -46.45 59.87 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.771 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -175.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 405' ' ' ALA . . . . . 0.598 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -64.25 -30.39 71.45 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 119.891 -0.724 . . . . 0.0 112.452 -176.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.717 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 91.9 m -77.5 -42.96 33.76 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.223 173.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.466 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -58.46 -37.37 75.33 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 122.117 0.96 . . . . 0.0 109.265 176.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 408' ' ' TYR . . . . . 0.65 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.58 -51.69 57.85 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 113.402 -1.726 . . . . 0.0 109.746 176.687 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 409' ' ' THR . . . . . 0.682 HG22 HD23 ' A' ' 410' ' ' LEU . 14.1 m -55.34 -47.03 76.32 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.588 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 410' ' ' LEU . . . . . 0.793 HD12 HD13 ' A' ' 398' ' ' ILE . 14.8 mt -72.19 -37.12 69.36 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 120.826 0.346 . . . . 0.0 110.164 -174.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.68 -34.46 76.98 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.57 173.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 412' ' ' MET . . . . . 0.429 ' HB2' ' O ' ' A' ' 409' ' ' THR . 0.2 OUTLIER -65.86 -44.03 86.65 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 115.685 -0.258 . . . . 0.0 111.589 177.915 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 413' ' ' MET . . . . . 0.754 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.0 OUTLIER -71.13 -56.49 6.0 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 118.431 -1.308 . . . . 0.0 111.558 177.884 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 414' ' ' LEU . . . . . 0.809 HD22 ' CD1' ' A' ' 386' ' ' PHE . 6.8 mt -62.46 -43.52 98.62 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -171.255 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 37.8 t -85.16 -21.14 29.33 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.701 0.762 . . . . 0.0 109.562 -178.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 416' ' ' GLY . . . . . 0.437 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 103.69 -173.42 21.85 Favored Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -169.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -79.7 24.43 0.38 Allowed 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.563 0.696 . . . . 0.0 111.206 -171.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 418' ' ' ASN . . . . . 0.437 ' H ' ' C ' ' A' ' 416' ' ' GLY . 89.2 m-20 -71.17 73.4 0.65 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.493 179.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 419' ' ' TYR . . . . . 0.53 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 29.9 p90 -56.74 -36.58 69.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.002 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -54.72 -42.69 71.86 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.908 178.057 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.16 -49.14 62.92 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.136 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 422' ' ' VAL . . . . . 0.486 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.5 OUTLIER -66.17 -38.8 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.244 -176.487 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.726 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 57.6 p -67.3 -38.66 85.35 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.072 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -70.07 -37.5 73.17 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.96 176.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 425' ' ' ILE . . . . . 0.602 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.66 -52.51 22.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 121.305 -0.158 . . . . 0.0 111.097 -178.308 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 426' ' ' ILE . . . . . 0.681 HG22 HD22 ' A' ' 430' ' ' LEU . 1.2 mm -73.49 -22.71 19.14 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.699 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -172.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.726 ' HB2' ' O ' ' A' ' 423' ' ' SER . 0.7 OUTLIER -54.04 -32.77 55.48 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.271 0.558 . . . . 0.0 110.119 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -84.74 -6.28 85.6 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.598 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.68 ' CZ ' ' HG3' ' A' ' 396' ' ' LYS . 23.9 m-85 -118.64 0.6 11.54 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 121.105 0.479 . . . . 0.0 110.56 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.7 HD23 ' HA ' ' A' ' 427' ' ' ARG . 0.1 OUTLIER -66.33 127.79 93.48 Favored Pre-proline 0 N--CA 1.437 -1.075 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.348 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 431' ' ' PRO . . . . . 0.509 ' HD2' HD12 ' A' ' 430' ' ' LEU . 83.6 Cg_exo -23.55 -65.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.354 0.836 1 C-N-CA 125.655 4.237 . . . . 0.0 114.983 179.9 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 432' ' ' GLY . . . . . 0.561 ' H ' HG12 ' A' ' 435' ' ' VAL . . . -143.22 -169.2 12.37 Favored Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 175.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 433' ' ' GLN . . . . . 0.496 ' O ' HG13 ' A' ' 436' ' ' VAL . 45.1 tp60 -69.93 -26.66 64.24 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 118.19 0.995 . . . . 0.0 110.111 177.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -62.93 -42.47 99.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.268 -0.424 . . . . 0.0 112.035 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 435' ' ' VAL . . . . . 0.772 HG23 HG11 ' A' ' 463' ' ' VAL . 7.5 p -68.8 -43.17 82.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-O 120.947 0.403 . . . . 0.0 110.766 -177.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.496 HG12 ' O ' ' A' ' 432' ' ' GLY . 0.1 OUTLIER -66.22 -31.74 55.01 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.241 175.712 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.56 -52.39 46.13 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -178.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 438' ' ' ALA . . . . . 0.842 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -57.85 -40.09 79.27 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.997 177.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 439' ' ' LEU . . . . . 0.611 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 2.0 tm? -68.03 -48.54 65.37 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -178.209 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -59.13 -35.16 72.98 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.1 175.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 441' ' ' GLN . . . . . 0.517 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 3.3 mm-40 -54.87 -49.53 70.94 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.126 -178.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 442' ' ' ARG . . . . . 0.622 ' HD2' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -76.43 -24.0 53.96 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 119.736 -0.785 . . . . 0.0 113.058 174.899 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 443' ' ' LEU . . . . . 0.611 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 69.4 mt -64.23 -35.81 82.04 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 118.404 0.547 . . . . 0.0 109.53 174.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -57.46 -37.53 73.02 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.537 173.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -73.73 -27.12 61.03 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.113 177.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 26.68 100.57 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.878 1.271 . . . . 0.0 114.387 176.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 51.8 mt -63.47 -34.94 70.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.046 -178.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 448' ' ' ASP . . . . . 0.452 ' HB2' ' OG1' ' A' ' 451' ' ' THR . 33.5 m-20 -164.21 -162.04 0.65 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -178.196 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -79.55 -71.01 0.47 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 172.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -66.91 -24.82 66.13 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 178.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 451' ' ' THR . . . . . 0.452 ' OG1' ' HB2' ' A' ' 448' ' ' ASP . 15.8 m -70.49 -22.18 62.68 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.104 -0.638 . . . . 0.0 110.836 -173.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 452' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 452' ' ' ARG . 20.9 mtp180 -53.43 -53.83 45.6 Favored 'General case' 0 C--O 1.221 -0.406 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 171.019 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 453' ' ' ALA . . . . . 0.53 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -59.8 -47.83 84.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.388 -1.278 . . . . 0.0 112.58 175.083 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 454' ' ' GLU . . . . . 0.428 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 77.4 mm-40 -50.4 -37.19 36.36 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.181 0.515 . . . . 0.0 111.774 -177.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 29.9 p -117.98 15.22 14.23 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.374 -176.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 456' ' ' PHE . . . . . 0.563 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.8 OUTLIER -56.9 -47.67 79.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.09 0.471 . . . . 0.0 111.718 -171.747 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 457' ' ' ILE . . . . . 0.598 HG23 ' HB1' ' A' ' 405' ' ' ALA . 1.9 mp -76.78 -33.04 20.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.053 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -57.7 -34.49 69.49 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.783 0.802 . . . . 0.0 109.28 171.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 459' ' ' HIS . . . . . 0.735 ' O ' HG23 ' A' ' 463' ' ' VAL . 59.9 m-70 -73.18 -29.33 62.76 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.828 177.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 460' ' ' LEU . . . . . 0.707 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.4 OUTLIER -74.16 -34.68 63.91 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.993 0.902 . . . . 0.0 108.753 179.286 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -72.78 -37.89 67.47 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.257 175.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 462' ' ' ALA . . . . . 0.634 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -55.73 -33.23 64.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.674 169.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.842 HG13 ' HB3' ' A' ' 438' ' ' ALA . 77.8 t -64.48 -50.75 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 CA-C-N 114.603 -1.181 . . . . 0.0 107.906 177.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 464' ' ' TYR . . . . . 0.549 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 17.3 m-30 -53.34 -25.8 16.49 Favored 'General case' 0 C--N 1.333 -0.143 0 O-C-N 124.313 1.008 . . . . 0.0 110.605 178.116 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.39 -40.93 15.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.6 0.714 . . . . 0.0 109.437 -178.068 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.634 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.4 mt -55.94 -55.22 19.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 114.272 -1.331 . . . . 0.0 112.199 175.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.773 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -103.93 -11.01 17.72 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -172.748 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 468' ' ' GLY . . . . . 0.612 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 93.64 31.82 8.03 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 119.328 -1.415 . . . . 0.0 114.374 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 469' ' ' LEU . . . . . 0.773 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 2.9 mt -89.14 161.84 16.27 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 117.886 0.843 . . . . 0.0 111.361 177.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 38.1 p30 -104.97 -177.01 3.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.569 173.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -60.36 -22.53 63.39 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -176.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -87.89 0.28 56.05 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 122.32 -0.238 . . . . 0.0 111.551 -172.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 473' ' ' GLY . . . . . 0.445 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 77.71 12.31 84.6 Favored Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 110.724 -0.951 . . . . 0.0 110.724 -174.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -101.18 152.48 20.59 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 11.5 p -89.28 129.45 35.83 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.279 0.561 . . . . 0.0 111.118 -178.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 476' ' ' ILE . . . . . 0.612 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.8 pp -94.72 -2.07 10.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.636 0.731 . . . . 0.0 109.953 177.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 23.3 mmt180 -74.86 91.63 2.47 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.562 -1.199 . . . . 0.0 109.494 173.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 88.7 mt -82.82 52.21 2.08 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.384 0.611 . . . . 0.0 110.568 -178.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 . . . . . 0 C--O 1.249 1.057 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.733 -179.353 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 381' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 . . . . . 0 N--CA 1.479 1.016 0 CA-C-O 120.875 0.369 . . . . 0.0 110.046 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 382' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -116.02 -34.72 4.64 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.154 -0.476 . . . . 0.0 112.226 -175.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 383' ' ' HIS . . . . . 0.518 ' HB2' ' O ' ' B' ' 386' ' ' PHE . 3.5 p80 -142.66 154.88 44.76 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.224 -0.59 . . . . 0.0 111.29 -170.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 384' ' ' GLY . . . . . . . . . . . . . . . -103.95 -108.32 3.27 Favored Glycine 0 N--CA 1.438 -1.176 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 170.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 385' ' ' THR . . . . . . . . . . . . . 56.1 m -75.49 -30.55 59.89 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.934 0.397 . . . . 0.0 111.296 177.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 386' ' ' PHE . . . . . 0.821 ' CD1' HD22 ' B' ' 414' ' ' LEU . 2.6 t80 -75.99 124.98 88.62 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 120.991 0.424 . . . . 0.0 110.599 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 387' ' ' PRO . . . . . 0.587 ' HG2' ' OD1' ' A' ' 393' ' ' ASN . 60.8 Cg_endo -71.97 111.21 3.11 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 124.059 3.172 . . . . 0.0 113.767 175.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 388' ' ' MET . . . . . 0.482 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 39.9 mtt -103.26 172.62 6.71 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 122.012 -0.43 . . . . 0.0 110.1 177.053 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 389' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -57.4 -61.49 2.45 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 175.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -175.89 19.84 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.647 -1.16 . . . . 0.0 108.311 173.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 391' ' ' LEU . . . . . 0.492 HD23 ' H ' ' B' ' 392' ' ' GLY . 2.1 pt? -169.91 -54.86 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.562 -167.22 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 392' ' ' GLY . . . . . 0.596 ' HA3' HD13 ' B' ' 395' ' ' ILE . . . -174.8 54.9 0.13 Allowed Glycine 0 C--N 1.333 0.408 0 C-N-CA 119.911 -1.138 . . . . 0.0 113.67 -174.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 393' ' ' ASN . . . . . 0.592 ' OD1' ' HG2' ' A' ' 387' ' ' PRO . 0.2 OUTLIER -54.33 -41.89 69.56 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 177.728 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 394' ' ' VAL . . . . . 0.756 HG23 HD12 ' B' ' 398' ' ' ILE . 2.0 m -56.34 -47.1 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 -179.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 395' ' ' ILE . . . . . 0.641 ' H ' HD12 ' B' ' 395' ' ' ILE . 3.9 mp -57.44 -52.24 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 CA-C-O 117.935 -1.031 . . . . 0.0 113.246 -175.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 396' ' ' LYS . . . . . 0.679 ' HG3' ' CZ ' ' B' ' 429' ' ' TYR . 0.1 OUTLIER -61.42 -49.18 77.92 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 121.488 1.949 . . . . 0.0 111.818 -173.933 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -54.39 -45.18 76.23 Favored Glycine 0 N--CA 1.436 -1.31 0 C-N-CA 119.747 -1.216 . . . . 0.0 111.073 -178.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 398' ' ' ILE . . . . . 0.789 HD13 HD12 ' B' ' 410' ' ' LEU . 39.2 mt -70.96 -34.1 54.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -176.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 399' ' ' VAL . . . . . 0.508 HG12 ' HA ' ' B' ' 404' ' ' VAL . 10.6 m -63.47 -39.73 86.42 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 C-N-CA 118.514 -1.274 . . . . 0.0 108.265 -175.032 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -70.83 -34.12 71.38 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 175.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 401' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -89.84 -47.48 7.86 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -172.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 402' ' ' GLU . . . . . 0.661 ' HG3' ' HE3' ' A' ' 413' ' ' MET . 2.9 mm-40 -121.4 -21.08 6.41 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.653 -170.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 107.42 162.5 21.62 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.843 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 404' ' ' VAL . . . . . 0.659 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.5 m -53.41 -46.44 58.55 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.71 0 N-CA-C 114.506 1.298 . . . . 0.0 114.506 -175.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 405' ' ' ALA . . . . . 0.607 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -64.11 -30.5 71.57 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 119.861 -0.736 . . . . 0.0 112.427 -177.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 406' ' ' THR . . . . . 0.714 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 89.0 m -77.36 -43.1 34.06 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 121.749 -0.595 . . . . 0.0 110.282 173.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 407' ' ' ALA . . . . . 0.472 ' HB2' ' HB ' ' B' ' 398' ' ' ILE . . . -58.38 -37.35 75.09 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 122.175 0.988 . . . . 0.0 109.252 176.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 408' ' ' TYR . . . . . 0.659 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.59 -51.67 57.93 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 113.414 -1.721 . . . . 0.0 109.816 176.714 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 409' ' ' THR . . . . . 0.671 HG22 HD23 ' B' ' 410' ' ' LEU . 15.7 m -55.3 -47.1 76.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.568 178.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 410' ' ' LEU . . . . . 0.789 HD12 HD13 ' B' ' 398' ' ' ILE . 14.8 mt -72.29 -37.1 69.09 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.093 -174.202 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.6 -34.42 76.26 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 119.915 -1.136 . . . . 0.0 110.481 173.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 412' ' ' MET . . . . . 0.436 ' HB2' ' O ' ' B' ' 409' ' ' THR . 0.3 OUTLIER -65.92 -44.2 85.87 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 115.667 -0.266 . . . . 0.0 111.597 177.932 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 413' ' ' MET . . . . . 0.742 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.0 OUTLIER -70.97 -56.58 5.89 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 118.414 -1.315 . . . . 0.0 111.47 177.979 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 414' ' ' LEU . . . . . 0.821 HD22 ' CD1' ' B' ' 386' ' ' PHE . 6.8 mt -62.45 -43.48 98.72 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 114.19 1.181 . . . . 0.0 114.19 -171.205 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 37.2 t -85.2 -20.98 29.35 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.797 0.808 . . . . 0.0 109.525 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 416' ' ' GLY . . . . . 0.438 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 103.5 -173.15 21.8 Favored Glycine 0 N--CA 1.428 -1.852 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -169.081 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -79.9 24.52 0.4 Allowed 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.617 0.722 . . . . 0.0 111.336 -171.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 418' ' ' ASN . . . . . 0.438 ' H ' ' C ' ' B' ' 416' ' ' GLY . 89.6 m-20 -71.25 73.38 0.67 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.344 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 419' ' ' TYR . . . . . 0.53 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 29.6 p90 -56.68 -36.63 69.81 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.944 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -54.67 -42.59 71.54 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.864 178.076 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.26 -49.14 62.62 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.123 -178.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 422' ' ' VAL . . . . . 0.475 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.5 OUTLIER -66.23 -38.75 82.59 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.238 -176.422 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 423' ' ' SER . . . . . 0.73 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 59.9 p -67.31 -38.82 85.56 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.124 -178.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -70.01 -37.12 73.54 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.056 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 425' ' ' ILE . . . . . 0.616 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -72.82 -52.97 20.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 120.424 0.154 . . . . 0.0 110.996 -178.501 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 426' ' ' ILE . . . . . 0.677 HG22 HD22 ' B' ' 430' ' ' LEU . 1.2 mm -73.24 -22.82 19.53 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.722 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -172.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 427' ' ' ARG . . . . . 0.73 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.7 OUTLIER -53.92 -32.79 54.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.341 0.591 . . . . 0.0 110.098 -179.827 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -85.03 -5.67 85.75 Favored Glycine 0 N--CA 1.443 -0.839 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.599 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 429' ' ' TYR . . . . . 0.679 ' CZ ' ' HG3' ' B' ' 396' ' ' LYS . 23.8 m-85 -119.15 0.56 11.25 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-O 121.017 0.436 . . . . 0.0 110.454 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 430' ' ' LEU . . . . . 0.685 HD23 ' HA ' ' B' ' 427' ' ' ARG . 0.1 OUTLIER -66.34 127.66 93.41 Favored Pre-proline 0 N--CA 1.439 -1.004 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.402 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 431' ' ' PRO . . . . . 0.498 ' HD2' HD12 ' B' ' 430' ' ' LEU . 84.0 Cg_exo -23.45 -65.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.874 1 C-N-CA 125.728 4.285 . . . . 0.0 115.059 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 432' ' ' GLY . . . . . 0.556 ' H ' HG12 ' B' ' 435' ' ' VAL . . . -143.23 -169.15 12.35 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 175.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 433' ' ' GLN . . . . . 0.506 ' O ' HG13 ' B' ' 436' ' ' VAL . 46.0 tp60 -70.2 -26.54 63.93 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 118.186 0.993 . . . . 0.0 109.893 177.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -62.99 -42.41 99.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.979 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 435' ' ' VAL . . . . . 0.778 HG23 HG11 ' B' ' 463' ' ' VAL . 7.3 p -69.03 -42.97 82.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 120.933 0.396 . . . . 0.0 110.742 -177.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 436' ' ' VAL . . . . . 0.506 HG13 ' O ' ' B' ' 433' ' ' GLN . 0.1 OUTLIER -66.38 -31.7 54.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.251 175.628 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.57 -52.39 46.0 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 -178.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 438' ' ' ALA . . . . . 0.825 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -57.88 -40.03 79.27 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.015 177.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 439' ' ' LEU . . . . . 0.612 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 1.9 tm? -68.26 -48.39 65.19 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -178.118 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -59.17 -35.16 73.06 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.515 -1.22 . . . . 0.0 111.061 175.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 441' ' ' GLN . . . . . 0.515 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 3.4 mm-40 -54.7 -49.84 69.72 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.178 -178.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 442' ' ' ARG . . . . . 0.627 ' HD2' ' O ' ' B' ' 438' ' ' ALA . 0.0 OUTLIER -76.17 -23.96 54.75 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 119.663 -0.815 . . . . 0.0 113.092 174.966 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 443' ' ' LEU . . . . . 0.612 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 69.4 mt -64.24 -35.78 81.94 Favored 'General case' 0 CA--C 1.519 -0.218 0 O-C-N 121.773 -0.579 . . . . 0.0 109.53 174.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -57.35 -37.64 72.89 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.533 173.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -73.67 -27.42 61.23 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.044 178.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 446' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 26.87 100.59 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 114.422 1.268 . . . . 0.0 114.422 176.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 52.9 mt -63.54 -34.93 70.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.97 -178.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 448' ' ' ASP . . . . . 0.474 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 30.6 m-20 -164.08 -161.95 0.65 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -178.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -79.55 -71.21 0.46 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 171.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -66.71 -24.97 66.31 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 178.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 451' ' ' THR . . . . . 0.474 ' OG1' ' HB2' ' B' ' 448' ' ' ASP . 13.4 m -70.53 -22.24 62.64 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.775 -173.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 452' ' ' ARG . . . . . 0.432 HH11 ' HD2' ' B' ' 452' ' ' ARG . 20.9 mtp180 -53.39 -53.71 47.22 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 107.481 -1.304 . . . . 0.0 107.481 170.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 453' ' ' ALA . . . . . 0.53 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -59.96 -47.6 85.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.415 -1.266 . . . . 0.0 112.525 175.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 454' ' ' GLU . . . . . 0.427 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 77.5 mm-40 -50.53 -37.65 40.35 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.245 0.545 . . . . 0.0 111.685 -177.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 31.2 p -117.64 15.22 14.54 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.325 -175.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 456' ' ' PHE . . . . . 0.566 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 0.8 OUTLIER -56.91 -47.53 80.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.082 0.468 . . . . 0.0 111.72 -171.82 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 457' ' ' ILE . . . . . 0.607 HG23 ' HB1' ' B' ' 405' ' ' ALA . 1.9 mp -77.16 -32.87 19.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.851 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -57.89 -34.28 69.64 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.811 0.815 . . . . 0.0 109.375 170.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 459' ' ' HIS . . . . . 0.729 ' O ' HG23 ' B' ' 463' ' ' VAL . 60.3 m-70 -73.1 -29.58 63.03 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.743 177.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 460' ' ' LEU . . . . . 0.71 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.4 OUTLIER -74.13 -34.67 63.97 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.887 0.851 . . . . 0.0 108.794 179.456 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 461' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -72.85 -37.72 67.3 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.258 175.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 462' ' ' ALA . . . . . 0.64 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -55.9 -33.22 64.45 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.584 -1.189 . . . . 0.0 109.722 169.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 463' ' ' VAL . . . . . 0.825 HG13 ' HB3' ' B' ' 438' ' ' ALA . 77.5 t -64.48 -50.77 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 CA-C-N 114.54 -1.209 . . . . 0.0 107.835 177.113 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 464' ' ' TYR . . . . . 0.546 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 17.3 m-30 -53.08 -26.4 16.04 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 124.339 1.024 . . . . 0.0 110.471 178.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.79 -40.89 16.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.619 0.724 . . . . 0.0 109.526 -177.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 466' ' ' ILE . . . . . 0.64 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.4 mt -56.21 -55.11 20.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 114.339 -1.301 . . . . 0.0 112.117 175.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 467' ' ' LEU . . . . . 0.783 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -103.83 -11.07 17.76 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -172.667 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 468' ' ' GLY . . . . . 0.597 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 93.73 31.87 7.97 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 119.441 -1.362 . . . . 0.0 114.398 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 469' ' ' LEU . . . . . 0.783 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 2.8 mt -89.04 162.06 16.22 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 117.866 0.833 . . . . 0.0 111.417 177.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 38.3 p30 -105.17 -177.0 3.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.692 173.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 471' ' ' ALA . . . . . . . . . . . . . . . -60.3 -22.88 63.68 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -176.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -87.79 0.73 55.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.617 -172.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 473' ' ' GLY . . . . . 0.45 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 77.59 12.05 84.88 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.197 -1.001 . . . . 0.0 110.751 -175.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -101.09 152.7 20.3 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 11.0 p -89.69 129.22 36.15 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.18 0.514 . . . . 0.0 111.134 -178.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 476' ' ' ILE . . . . . 0.597 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.8 pp -94.5 -1.92 10.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.678 0.751 . . . . 0.0 109.889 177.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 477' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -74.91 91.81 2.5 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.432 173.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 478' ' ' LEU . . . . . . . . . . . . . 88.7 mt -82.99 52.26 2.13 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.315 0.579 . . . . 0.0 110.588 -178.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 479' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.376 -0.821 . . . . 0.0 109.707 -179.163 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 . . . . . 0 N--CA 1.479 1.015 0 CA-C-O 121.05 0.452 . . . . 0.0 110.661 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -116.28 -27.05 6.96 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.742 178.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -160.8 161.67 32.09 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.254 -0.578 . . . . 0.0 111.758 -173.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -106.74 -78.91 1.18 Allowed Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 168.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 385' ' ' THR . . . . . 0.465 HG22 ' HA2' ' B' ' 397' ' ' GLY . 5.8 m -97.06 168.21 10.59 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 166.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 386' ' ' PHE . . . . . 0.694 ' CD1' HD22 ' A' ' 414' ' ' LEU . 1.1 t80 73.11 113.04 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.682 0 C-N-CA 122.681 0.393 . . . . 0.0 110.062 -177.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -42.14 -70.73 0.06 OUTLIER 'Trans proline' 0 N--CA 1.484 0.947 0 C-N-CA 124.48 3.453 . . . . 0.0 114.088 -175.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.634 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 36.4 ttm 77.67 29.65 0.51 Allowed 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 173.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 389' ' ' HIS . . . . . 0.676 ' CG ' ' HB2' ' A' ' 393' ' ' ASN . 42.4 m170 61.35 -82.91 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.291 0.636 . . . . 0.0 110.633 -176.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -167.92 14.47 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.246 -0.888 . . . . 0.0 108.702 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.501 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.5 pt? -169.53 -48.23 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -168.043 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 392' ' ' GLY . . . . . 0.581 ' HA3' HD13 ' A' ' 395' ' ' ILE . . . 178.78 48.36 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 119.309 -1.424 . . . . 0.0 114.531 -172.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 393' ' ' ASN . . . . . 0.676 ' HB2' ' CG ' ' A' ' 389' ' ' HIS . 0.3 OUTLIER -54.14 -39.79 66.83 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 117.58 0.69 . . . . 0.0 109.405 174.985 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.722 HG23 HD12 ' A' ' 398' ' ' ILE . 1.8 m -56.23 -49.18 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.689 HG23 HD13 ' A' ' 426' ' ' ILE . 3.7 mp -56.75 -53.41 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -174.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 396' ' ' LYS . . . . . 0.739 ' HG3' ' CE1' ' A' ' 429' ' ' TYR . 0.1 OUTLIER -66.25 -47.21 74.47 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 121.349 1.886 . . . . 0.0 112.06 -172.133 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 397' ' ' GLY . . . . . 0.414 ' HA2' HG22 ' B' ' 385' ' ' THR . . . -52.81 -45.16 61.15 Favored Glycine 0 N--CA 1.434 -1.452 0 C-N-CA 120.132 -1.032 . . . . 0.0 110.882 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 398' ' ' ILE . . . . . 0.722 HD12 HG23 ' A' ' 394' ' ' VAL . 31.2 mt -70.75 -33.87 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 399' ' ' VAL . . . . . 0.537 HG22 ' O ' ' A' ' 396' ' ' LYS . 11.3 m -62.6 -39.58 85.14 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 C-N-CA 118.821 -1.152 . . . . 0.0 108.103 -174.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -70.93 -34.78 71.83 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 175.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.454 HE21 ' HB3' ' A' ' 401' ' ' GLN . 5.5 mm100 -89.17 -47.71 7.89 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -173.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 402' ' ' GLU . . . . . 0.463 ' HB3' ' HB ' ' A' ' 406' ' ' THR . 3.0 mm-40 -119.75 -20.94 7.44 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.462 -170.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 107.48 162.77 21.61 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.519 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 404' ' ' VAL . . . . . 0.61 HG11 ' HA ' ' A' ' 430' ' ' LEU . 1.7 m -54.12 -45.73 66.28 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.731 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -175.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 405' ' ' ALA . . . . . 0.574 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -64.12 -29.61 70.73 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 119.84 -0.744 . . . . 0.0 112.209 -177.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.712 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 85.7 m -77.59 -43.21 32.42 Favored 'General case' 0 C--O 1.219 -0.54 0 O-C-N 121.888 -0.507 . . . . 0.0 110.227 173.086 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.428 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.18 -36.09 72.55 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 122.106 0.955 . . . . 0.0 109.14 176.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 408' ' ' TYR . . . . . 0.586 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -66.34 -52.65 44.89 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 113.446 -1.707 . . . . 0.0 109.749 175.999 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 409' ' ' THR . . . . . 0.634 HG22 HD23 ' A' ' 410' ' ' LEU . 17.3 m -55.48 -47.4 76.21 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.673 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 410' ' ' LEU . . . . . 0.712 HD12 ' CD1' ' A' ' 398' ' ' ILE . 15.0 mt -72.42 -36.68 68.67 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -174.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.73 -35.31 81.11 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.066 -1.064 . . . . 0.0 110.783 172.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -68.64 -48.32 64.33 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 120.644 0.259 . . . . 0.0 111.265 178.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 413' ' ' MET . . . . . 0.962 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 1.2 ppp? -71.02 -43.27 68.27 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 118.888 -1.125 . . . . 0.0 112.155 -177.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 414' ' ' LEU . . . . . 0.962 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 12.1 mt -71.31 -45.85 62.08 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -177.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 44.5 t -84.98 -24.3 28.33 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.787 0.803 . . . . 0.0 110.277 -175.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 416' ' ' GLY . . . . . 0.412 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 110.74 -175.69 18.19 Favored Glycine 0 N--CA 1.428 -1.89 0 N-CA-C 109.824 -1.311 . . . . 0.0 109.824 -171.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -80.84 24.24 0.5 Allowed 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 121.407 0.622 . . . . 0.0 111.193 -172.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 418' ' ' ASN . . . . . 0.412 ' H ' ' C ' ' A' ' 416' ' ' GLY . 84.5 m-20 -71.74 76.64 0.85 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.701 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 419' ' ' TYR . . . . . 0.549 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 17.1 p90 -54.36 -38.84 66.56 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.656 177.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -55.63 -44.07 76.78 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.634 0.254 . . . . 0.0 111.138 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.78 -48.64 65.76 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.055 -177.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 422' ' ' VAL . . . . . 0.429 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -66.07 -39.42 84.42 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.158 -177.519 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.728 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 64.0 p -67.49 -39.81 85.21 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.024 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -66.26 -39.9 94.56 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.739 -0.743 . . . . 0.0 111.954 175.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 425' ' ' ILE . . . . . 0.632 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.72 -51.91 25.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 121.236 -0.185 . . . . 0.0 111.291 -177.094 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 426' ' ' ILE . . . . . 0.689 HD13 HG23 ' A' ' 395' ' ' ILE . 1.2 mm -73.77 -23.01 18.88 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.885 0 CA-C-O 120.76 0.314 . . . . 0.0 110.176 -171.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.728 ' HB2' ' O ' ' A' ' 423' ' ' SER . 0.8 OUTLIER -54.77 -29.14 53.27 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.981 0.419 . . . . 0.0 110.975 -178.009 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.73 -11.45 68.24 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.641 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.739 ' CE1' ' HG3' ' A' ' 396' ' ' LYS . 15.0 m-85 -113.99 -1.41 13.8 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 121.709 0.766 . . . . 0.0 109.241 -176.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.614 HD12 ' HD2' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -65.94 135.12 95.2 Favored Pre-proline 0 N--CA 1.438 -1.039 0 CA-C-N 114.05 -1.432 . . . . 0.0 108.665 177.694 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 431' ' ' PRO . . . . . 0.815 ' HD2' HG11 ' A' ' 435' ' ' VAL . 43.0 Cg_exo -36.25 -65.71 0.13 Allowed 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 124.804 3.669 . . . . 0.0 114.34 -171.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 432' ' ' GLY . . . . . 0.542 ' H ' HG12 ' A' ' 435' ' ' VAL . . . -141.85 -163.18 9.5 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 176.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 433' ' ' GLN . . . . . 0.502 ' O ' HG13 ' A' ' 436' ' ' VAL . 21.7 tp60 -70.73 -27.64 64.12 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 118.103 0.952 . . . . 0.0 110.411 177.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -67.47 -38.89 85.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.031 -176.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 435' ' ' VAL . . . . . 0.815 HG11 ' HD2' ' A' ' 431' ' ' PRO . 7.6 p -68.48 -44.9 82.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.974 0.416 . . . . 0.0 110.602 -178.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 433' ' ' GLN . 0.2 OUTLIER -65.41 -29.35 46.9 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.334 175.965 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -70.71 -51.98 23.97 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 438' ' ' ALA . . . . . 0.887 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -58.14 -38.69 77.04 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.692 177.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 439' ' ' LEU . . . . . 0.559 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 2.1 tm? -70.15 -47.21 62.61 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -178.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -57.53 -39.33 76.35 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.406 174.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 441' ' ' GLN . . . . . 0.517 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 9.5 mm-40 -53.54 -49.7 67.08 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 123.958 0.903 . . . . 0.0 110.663 174.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 442' ' ' ARG . . . . . 0.818 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 0.6 OUTLIER -56.09 -40.17 73.24 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.762 172.226 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 443' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 31.9 mt -72.21 -32.07 66.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.023 0.44 . . . . 0.0 110.467 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -58.69 -38.2 77.73 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.458 173.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 -74.01 -27.53 61.01 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.219 177.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 446' ' ' GLU . . . . . 0.438 ' HB3' ' O ' ' A' ' 443' ' ' LEU . 10.3 pt-20 19.29 101.01 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 178.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 447' ' ' ILE . . . . . 0.418 HD12 HG22 ' A' ' 451' ' ' THR . 45.0 mt -61.03 -33.88 57.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.382 0.61 . . . . 0.0 110.438 177.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 448' ' ' ASP . . . . . 0.404 ' HB2' ' CB ' ' A' ' 451' ' ' THR . 10.8 m-20 -162.92 -156.14 0.38 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -178.168 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -89.74 -63.97 1.21 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 169.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 2.7 pp0? -69.07 -25.86 64.66 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 178.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 451' ' ' THR . . . . . 0.426 ' HA ' ' HB2' ' A' ' 454' ' ' GLU . 13.5 m -71.28 -22.57 61.94 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.572 -176.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -54.24 -53.77 49.13 Favored 'General case' 0 C--O 1.22 -0.498 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 171.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 453' ' ' ALA . . . . . 0.549 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -57.43 -48.53 78.9 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 114.624 -1.171 . . . . 0.0 112.396 175.173 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 454' ' ' GLU . . . . . 0.426 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 14.7 mm-40 -51.1 -35.11 33.5 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.357 0.599 . . . . 0.0 111.559 -178.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 33.5 p -119.22 16.15 13.15 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.493 -176.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 456' ' ' PHE . . . . . 0.56 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.9 OUTLIER -57.77 -48.35 79.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.914 0.387 . . . . 0.0 111.693 -171.282 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 457' ' ' ILE . . . . . 0.574 HG23 ' HB1' ' A' ' 405' ' ' ALA . 2.0 mp -76.14 -32.63 23.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 120.8 0.333 . . . . 0.0 110.933 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -57.62 -35.05 69.95 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.978 0.894 . . . . 0.0 109.195 171.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 459' ' ' HIS . . . . . 0.726 ' O ' HG23 ' A' ' 463' ' ' VAL . 59.8 m-70 -74.84 -28.99 60.91 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.542 -1.208 . . . . 0.0 110.946 177.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 460' ' ' LEU . . . . . 0.714 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.4 OUTLIER -73.88 -34.94 64.63 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.97 0.89 . . . . 0.0 108.89 179.049 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 461' ' ' ASN . . . . . 0.44 ' O ' ' HB2' ' A' ' 464' ' ' TYR . 22.1 m-80 -73.34 -37.34 66.14 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.862 0.839 . . . . 0.0 108.78 177.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 462' ' ' ALA . . . . . 0.592 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -56.46 -35.34 67.8 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.377 -1.283 . . . . 0.0 109.656 169.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.887 HG13 ' HB3' ' A' ' 438' ' ' ALA . 68.2 t -60.93 -51.6 71.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 175.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 464' ' ' TYR . . . . . 0.618 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 19.9 m-30 -52.01 -28.34 16.68 Favored 'General case' 0 C--N 1.333 -0.125 0 O-C-N 124.363 1.039 . . . . 0.0 110.765 177.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.5 -40.6 17.45 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.5 0.667 . . . . 0.0 109.67 -177.111 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.592 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.7 mt -56.27 -55.43 18.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 114.395 -1.275 . . . . 0.0 112.198 176.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.793 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -101.9 -10.61 19.68 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 -172.667 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 468' ' ' GLY . . . . . 0.619 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 93.7 31.97 7.92 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 119.337 -1.411 . . . . 0.0 114.23 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 469' ' ' LEU . . . . . 0.793 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.7 mt -88.98 161.84 16.39 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 117.808 0.804 . . . . 0.0 111.146 176.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 37.9 p30 -104.55 -176.9 3.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.956 172.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 471' ' ' ALA . . . . . 0.464 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -62.28 -20.48 64.34 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -176.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -87.21 -1.8 58.16 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.655 0.265 . . . . 0.0 111.648 -173.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 79.11 14.21 82.09 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.008 -1.092 . . . . 0.0 110.66 -174.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -100.85 148.86 24.47 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 177.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 3.9 p -88.05 126.73 35.25 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.995 0.426 . . . . 0.0 111.168 -178.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 476' ' ' ILE . . . . . 0.619 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.8 pp -98.99 3.75 10.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.523 0.678 . . . . 0.0 110.307 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 -59.6 119.22 7.16 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.623 -1.171 . . . . 0.0 112.088 -177.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 478' ' ' LEU . . . . . 0.502 HD23 ' H ' ' A' ' 478' ' ' LEU . 2.6 pt? -78.23 -12.42 60.0 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.362 0.601 . . . . 0.0 109.632 173.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 . . . . . 0 C--O 1.247 0.922 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.639 179.765 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 381' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 . . . . . 0 N--CA 1.48 1.038 0 CA-C-O 121.238 0.542 . . . . 0.0 110.74 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 382' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -116.33 -26.86 7.0 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.836 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 383' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -160.8 161.87 32.16 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.71 -173.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 384' ' ' GLY . . . . . . . . . . . . . . . -106.98 -78.82 1.17 Allowed Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 168.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 385' ' ' THR . . . . . 0.454 ' O ' ' HB3' ' B' ' 386' ' ' PHE . 5.7 m -97.45 168.02 10.64 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 166.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 386' ' ' PHE . . . . . 0.698 ' CD1' HD22 ' B' ' 414' ' ' LEU . 1.2 t80 73.2 113.03 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.661 0 C-N-CA 122.719 0.408 . . . . 0.0 110.035 -177.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 387' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' B' ' 386' ' ' PHE . 5.6 Cg_endo -42.01 -71.45 0.06 OUTLIER 'Trans proline' 0 N--CA 1.482 0.851 0 C-N-CA 124.528 3.486 . . . . 0.0 113.967 -176.036 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 388' ' ' MET . . . . . 0.61 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 36.1 ttm 78.21 29.18 0.47 Allowed 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 173.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 389' ' ' HIS . . . . . 0.667 ' CG ' ' HB2' ' B' ' 393' ' ' ASN . 42.6 m170 61.87 -83.05 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.384 0.674 . . . . 0.0 110.554 -176.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -167.68 14.22 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.731 177.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 391' ' ' LEU . . . . . 0.487 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.5 pt? -169.5 -48.29 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -167.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 392' ' ' GLY . . . . . 0.576 ' HA3' HD13 ' B' ' 395' ' ' ILE . . . 178.61 48.49 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 119.31 -1.424 . . . . 0.0 114.527 -172.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 393' ' ' ASN . . . . . 0.667 ' HB2' ' CG ' ' B' ' 389' ' ' HIS . 0.2 OUTLIER -54.27 -39.61 67.05 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 117.531 0.665 . . . . 0.0 109.355 174.905 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 394' ' ' VAL . . . . . 0.708 HG23 HD12 ' B' ' 398' ' ' ILE . 1.8 m -56.25 -49.17 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 395' ' ' ILE . . . . . 0.685 HG23 HD13 ' B' ' 426' ' ' ILE . 3.7 mp -56.8 -53.39 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 CA-C-O 118.255 -0.879 . . . . 0.0 113.323 -174.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 396' ' ' LYS . . . . . 0.732 ' HG3' ' CE1' ' B' ' 429' ' ' TYR . 0.1 OUTLIER -66.27 -47.0 75.09 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 121.42 1.918 . . . . 0.0 112.054 -172.042 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 397' ' ' GLY . . . . . 0.465 ' HA2' HG22 ' A' ' 385' ' ' THR . . . -53.0 -45.19 62.19 Favored Glycine 0 N--CA 1.432 -1.571 0 C-N-CA 120.099 -1.048 . . . . 0.0 110.893 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 398' ' ' ILE . . . . . 0.708 HD12 HG23 ' B' ' 394' ' ' VAL . 31.1 mt -70.67 -33.88 54.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 399' ' ' VAL . . . . . 0.536 HG22 ' O ' ' B' ' 396' ' ' LYS . 11.2 m -62.59 -39.52 84.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 C-N-CA 118.664 -1.214 . . . . 0.0 108.07 -174.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -70.93 -34.8 71.85 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 175.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 401' ' ' GLN . . . . . 0.441 HE21 ' HB3' ' B' ' 401' ' ' GLN . 5.7 mm100 -89.11 -47.71 7.9 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -173.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 402' ' ' GLU . . . . . 0.467 ' HB3' ' HB ' ' B' ' 406' ' ' THR . 3.1 mm-40 -119.85 -20.89 7.4 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.558 -170.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 107.44 162.55 21.61 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.52 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 404' ' ' VAL . . . . . 0.601 HG11 ' HA ' ' B' ' 430' ' ' LEU . 1.6 m -53.95 -45.78 64.19 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.754 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -175.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 405' ' ' ALA . . . . . 0.565 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -64.02 -29.81 70.93 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 119.741 -0.784 . . . . 0.0 112.187 -177.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 406' ' ' THR . . . . . 0.696 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 90.1 m -77.34 -43.14 33.98 Favored 'General case' 0 C--O 1.22 -0.499 0 O-C-N 121.867 -0.521 . . . . 0.0 110.343 172.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 407' ' ' ALA . . . . . 0.435 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.16 -36.0 72.37 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 122.162 0.982 . . . . 0.0 109.254 176.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 408' ' ' TYR . . . . . 0.573 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -66.33 -52.74 44.09 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 113.411 -1.722 . . . . 0.0 109.711 176.003 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 409' ' ' THR . . . . . 0.631 HG22 HD23 ' B' ' 410' ' ' LEU . 17.1 m -55.41 -47.37 76.04 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.675 179.234 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 410' ' ' LEU . . . . . 0.703 HD12 ' CD1' ' B' ' 398' ' ' ILE . 15.1 mt -72.5 -36.46 68.39 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -174.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.91 -35.21 81.94 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.058 -1.068 . . . . 0.0 110.769 172.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 412' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -68.6 -48.41 64.21 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-O 120.514 0.197 . . . . 0.0 111.34 178.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 413' ' ' MET . . . . . 0.961 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 1.2 ppp? -71.07 -43.17 68.33 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 118.954 -1.098 . . . . 0.0 112.116 -177.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 414' ' ' LEU . . . . . 0.961 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 11.9 mt -71.21 -46.31 61.45 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -177.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 43.9 t -84.76 -24.4 28.82 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.649 0.738 . . . . 0.0 110.289 -174.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 416' ' ' GLY . . . . . 0.42 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 111.08 -175.83 18.07 Favored Glycine 0 N--CA 1.426 -2.009 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -171.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -80.54 24.05 0.48 Allowed 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.482 0.658 . . . . 0.0 111.255 -172.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 418' ' ' ASN . . . . . 0.42 ' H ' ' C ' ' B' ' 416' ' ' GLY . 84.9 m-20 -71.55 76.77 0.8 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.74 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 419' ' ' TYR . . . . . 0.559 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 16.8 p90 -54.4 -39.01 66.84 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.653 177.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -55.73 -43.85 76.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.788 0.328 . . . . 0.0 111.168 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 421' ' ' LEU . . . . . 0.402 HD22 ' HB2' ' B' ' 418' ' ' ASN . 0.0 OUTLIER -67.81 -48.69 65.55 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.033 -178.098 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 422' ' ' VAL . . . . . 0.429 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.2 OUTLIER -66.23 -39.44 84.3 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.398 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.089 -177.396 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 423' ' ' SER . . . . . 0.749 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 64.4 p -67.32 -39.88 85.92 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.924 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -66.38 -39.71 94.29 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.107 175.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 425' ' ' ILE . . . . . 0.649 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -72.79 -51.84 25.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 121.219 -0.192 . . . . 0.0 111.329 -177.218 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 426' ' ' ILE . . . . . 0.685 HD13 HG23 ' B' ' 395' ' ' ILE . 1.2 mm -73.87 -23.04 18.76 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.896 0 O-C-N 122.194 -0.316 . . . . 0.0 110.227 -171.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 427' ' ' ARG . . . . . 0.749 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.8 OUTLIER -54.7 -29.32 52.74 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.074 0.464 . . . . 0.0 111.007 -178.106 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.51 -11.4 68.86 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.638 -0.791 . . . . 0.0 111.637 178.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 429' ' ' TYR . . . . . 0.732 ' CE1' ' HG3' ' B' ' 396' ' ' LYS . 14.9 m-85 -114.13 -1.17 13.76 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-O 121.766 0.793 . . . . 0.0 109.256 -176.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 430' ' ' LEU . . . . . 0.625 HD12 ' HD2' ' B' ' 431' ' ' PRO . 0.0 OUTLIER -66.02 135.13 95.11 Favored Pre-proline 0 N--CA 1.438 -1.031 0 CA-C-N 114.017 -1.447 . . . . 0.0 108.649 177.582 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 431' ' ' PRO . . . . . 0.821 ' HD2' HG11 ' B' ' 435' ' ' VAL . 43.9 Cg_exo -36.21 -65.99 0.13 Allowed 'Trans proline' 0 N--CA 1.474 0.365 0 C-N-CA 124.888 3.725 . . . . 0.0 114.226 -171.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 432' ' ' GLY . . . . . 0.533 ' H ' HG12 ' B' ' 435' ' ' VAL . . . -141.63 -163.36 9.56 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 176.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 433' ' ' GLN . . . . . 0.506 ' O ' HG13 ' B' ' 436' ' ' VAL . 21.3 tp60 -70.54 -27.6 64.28 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 118.079 0.94 . . . . 0.0 110.322 177.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -67.52 -38.94 85.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.995 -176.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 435' ' ' VAL . . . . . 0.821 HG11 ' HD2' ' B' ' 431' ' ' PRO . 7.7 p -68.59 -44.85 82.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-O 120.958 0.409 . . . . 0.0 110.623 -178.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 436' ' ' VAL . . . . . 0.506 HG13 ' O ' ' B' ' 433' ' ' GLN . 0.2 OUTLIER -65.19 -29.69 48.06 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.39 175.83 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -70.37 -51.99 25.76 Favored 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 438' ' ' ALA . . . . . 0.875 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -58.15 -38.73 77.18 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.707 177.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 439' ' ' LEU . . . . . 0.566 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 2.1 tm? -70.23 -47.09 62.92 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -178.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -57.67 -39.16 76.45 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.34 174.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 441' ' ' GLN . . . . . 0.518 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 9.2 mm-40 -53.76 -49.62 67.8 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 123.826 0.85 . . . . 0.0 110.624 174.187 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 442' ' ' ARG . . . . . 0.832 ' HG2' ' O ' ' B' ' 438' ' ' ALA . 0.7 OUTLIER -56.15 -40.24 73.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.684 172.228 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 443' ' ' LEU . . . . . 0.566 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 32.5 mt -72.16 -32.03 66.5 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.995 0.426 . . . . 0.0 110.34 -178.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -58.81 -38.06 77.77 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.682 0.753 . . . . 0.0 110.464 173.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -74.03 -27.54 60.99 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.275 177.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 446' ' ' GLU . . . . . 0.437 ' HB3' ' O ' ' B' ' 443' ' ' LEU . 10.8 pt-20 19.3 100.29 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 178.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 447' ' ' ILE . . . . . 0.425 HD12 HG22 ' B' ' 451' ' ' THR . 45.2 mt -60.61 -34.03 56.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.382 0.611 . . . . 0.0 110.426 177.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 448' ' ' ASP . . . . . 0.404 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 11.4 m-20 -162.61 -156.31 0.4 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -178.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -89.66 -63.97 1.21 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 169.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 2.7 pp0? -68.87 -25.94 64.88 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 178.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 451' ' ' THR . . . . . 0.429 ' HA ' ' HB2' ' B' ' 454' ' ' GLU . 12.1 m -71.29 -22.57 61.93 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.602 -176.354 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 452' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -54.37 -53.65 51.11 Favored 'General case' 0 C--O 1.219 -0.533 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 171.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 453' ' ' ALA . . . . . 0.559 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -57.71 -48.04 80.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 114.609 -1.178 . . . . 0.0 112.53 175.245 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 454' ' ' GLU . . . . . 0.429 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 11.4 mm-40 -51.53 -34.82 37.98 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.161 0.505 . . . . 0.0 111.578 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 32.4 p -119.63 16.04 12.8 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.424 -176.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 456' ' ' PHE . . . . . 0.565 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 0.9 OUTLIER -57.46 -48.68 78.54 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.664 -171.304 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 457' ' ' ILE . . . . . 0.565 HG23 ' HB1' ' B' ' 405' ' ' ALA . 2.0 mp -75.68 -32.83 25.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.986 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -57.39 -35.29 69.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.959 0.885 . . . . 0.0 109.139 171.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 459' ' ' HIS . . . . . 0.73 ' O ' HG23 ' B' ' 463' ' ' VAL . 60.8 m-70 -74.73 -28.91 60.98 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.44 -1.254 . . . . 0.0 110.998 177.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 460' ' ' LEU . . . . . 0.728 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.4 OUTLIER -73.91 -35.04 64.61 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.9 0.857 . . . . 0.0 108.938 178.944 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 461' ' ' ASN . . . . . 0.42 ' O ' ' HB2' ' B' ' 464' ' ' TYR . 23.5 m-80 -73.24 -37.42 66.37 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.743 177.154 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 462' ' ' ALA . . . . . 0.606 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -56.39 -35.34 67.64 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.711 169.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 463' ' ' VAL . . . . . 0.875 HG13 ' HB3' ' B' ' 438' ' ' ALA . 68.3 t -61.01 -51.59 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 175.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 464' ' ' TYR . . . . . 0.611 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 19.9 m-30 -52.0 -28.39 16.8 Favored 'General case' 0 N--CA 1.457 -0.11 0 O-C-N 124.4 1.063 . . . . 0.0 110.764 178.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.41 -40.53 17.69 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.633 0.73 . . . . 0.0 109.736 -177.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 466' ' ' ILE . . . . . 0.606 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.7 mt -56.04 -55.83 16.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 114.402 -1.272 . . . . 0.0 112.184 176.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 467' ' ' LEU . . . . . 0.801 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -101.83 -10.44 19.88 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -172.468 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 468' ' ' GLY . . . . . 0.616 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 93.75 32.03 7.86 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 119.352 -1.404 . . . . 0.0 114.164 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 469' ' ' LEU . . . . . 0.801 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.7 mt -89.05 161.81 16.35 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 117.81 0.805 . . . . 0.0 111.149 176.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 37.9 p30 -104.59 -176.93 3.22 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.901 172.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 471' ' ' ALA . . . . . 0.468 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -62.22 -20.74 64.52 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -175.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 472' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' B' ' 472' ' ' ARG . 27.7 mmt180 -87.11 -1.68 58.07 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.655 0.264 . . . . 0.0 111.647 -173.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 473' ' ' GLY . . . . . . . . . . . . . . . 78.7 14.62 81.87 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 119.986 -1.102 . . . . 0.0 110.61 -174.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -101.11 149.01 24.4 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 177.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 4.2 p -87.86 127.5 35.34 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.05 0.452 . . . . 0.0 111.006 -178.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 476' ' ' ILE . . . . . 0.616 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.9 pp -99.68 4.19 10.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.625 0.726 . . . . 0.0 110.225 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 477' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 -59.79 119.86 8.45 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.944 -177.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 478' ' ' LEU . . . . . 0.517 HD23 ' H ' ' B' ' 478' ' ' LEU . 2.6 pt? -78.99 -12.59 60.04 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.428 0.632 . . . . 0.0 109.646 173.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 479' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 . . . . . 0 C--O 1.247 0.956 0 CA-C-O 118.283 -0.865 . . . . 0.0 109.45 179.74 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 . . . . . 0 N--CA 1.481 1.09 0 CA-C-O 121.157 0.503 . . . . 0.0 110.657 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.68 -66.12 0.39 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.882 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -121.41 170.75 9.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.411 0.624 . . . . 0.0 112.671 -169.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -119.19 -110.62 2.38 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 114.999 -1.001 . . . . 0.0 111.53 174.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 21.0 m -68.48 -41.75 79.68 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.943 0.401 . . . . 0.0 110.832 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 386' ' ' PHE . . . . . 0.817 ' CD1' HD22 ' A' ' 414' ' ' LEU . 4.7 t80 -70.46 125.82 92.11 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.217 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -47.11 -67.72 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.848 3.032 . . . . 0.0 114.5 -174.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.516 ' HB2' ' HE2' ' A' ' 388' ' ' MET . 34.5 ttm 66.27 160.81 0.14 Allowed 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.792 0.33 . . . . 0.0 111.235 176.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 389' ' ' HIS . . . . . 0.623 ' CE1' ' HA ' ' A' ' 393' ' ' ASN . 34.4 m170 -72.73 -155.68 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 108.353 -0.981 . . . . 0.0 108.353 173.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 390' ' ' GLN . . . . . 0.445 ' CD ' ' H ' ' A' ' 390' ' ' GLN . 5.7 pm0 -77.84 8.77 4.16 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.395 172.087 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.546 HD23 ' H ' ' A' ' 392' ' ' GLY . 2.1 pt? -159.79 -51.84 0.06 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -176.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 392' ' ' GLY . . . . . 0.714 ' HA3' HD13 ' A' ' 395' ' ' ILE . . . -171.05 72.82 0.11 Allowed Glycine 0 CA--C 1.526 0.766 0 C-N-CA 119.438 -1.363 . . . . 0.0 114.762 -173.244 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 393' ' ' ASN . . . . . 0.623 ' HA ' ' CE1' ' A' ' 389' ' ' HIS . 0.0 OUTLIER -66.4 -36.95 84.14 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 175.832 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.677 HG23 HD12 ' A' ' 398' ' ' ILE . 1.0 OUTLIER -57.07 -49.09 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 CA-C-N 113.032 -1.894 . . . . 0.0 107.248 178.193 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.714 HD13 ' HA3' ' A' ' 392' ' ' GLY . 3.7 mp -58.48 -52.61 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 CA-C-O 117.663 -1.161 . . . . 0.0 113.671 -174.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 396' ' ' LYS . . . . . 0.586 ' O ' HG22 ' A' ' 399' ' ' VAL . 0.0 OUTLIER -61.88 -50.02 73.89 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 122.221 2.282 . . . . 0.0 112.143 -174.56 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 397' ' ' GLY . . . . . 0.434 ' O ' ' HG3' ' A' ' 401' ' ' GLN . . . -53.29 -44.68 65.24 Favored Glycine 0 N--CA 1.432 -1.571 0 CA-C-N 114.713 -1.13 . . . . 0.0 111.045 -176.033 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 398' ' ' ILE . . . . . 0.854 HD13 HD12 ' A' ' 410' ' ' LEU . 37.8 mt -71.34 -34.23 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -178.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 399' ' ' VAL . . . . . 0.586 HG22 ' O ' ' A' ' 396' ' ' LYS . 16.3 m -63.24 -40.33 88.62 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 C-N-CA 118.92 -1.112 . . . . 0.0 108.49 -173.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -64.3 -43.85 93.44 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 175.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.572 ' NE2' ' HA ' ' B' ' 414' ' ' LEU . 14.5 mt-30 -92.9 -48.38 6.56 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -167.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 402' ' ' GLU . . . . . 0.602 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 1.2 tm-20 -111.52 -19.13 12.66 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.193 0.52 . . . . 0.0 110.82 -173.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 104.51 161.33 24.18 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.846 177.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 404' ' ' VAL . . . . . 0.644 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.2 m -53.94 -45.13 63.51 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.866 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -175.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 405' ' ' ALA . . . . . 0.553 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -63.58 -31.65 72.87 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 119.956 -0.697 . . . . 0.0 112.517 -177.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.696 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 88.0 m -77.08 -41.48 42.06 Favored 'General case' 0 C--O 1.222 -0.35 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.46 173.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.486 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -58.84 -36.6 74.82 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 122.1 0.953 . . . . 0.0 109.354 175.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 408' ' ' TYR . . . . . 0.644 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -67.18 -51.47 53.23 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 113.525 -1.671 . . . . 0.0 109.729 177.009 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 409' ' ' THR . . . . . 0.675 HG22 HD23 ' A' ' 410' ' ' LEU . 17.1 m -54.55 -47.76 72.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.591 -0.732 . . . . 0.0 112.508 177.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 410' ' ' LEU . . . . . 0.854 HD12 HD13 ' A' ' 398' ' ' ILE . 14.5 mt -72.55 -34.4 67.5 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -175.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.59 -34.01 74.46 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.286 -0.959 . . . . 0.0 110.865 170.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 412' ' ' MET . . . . . 0.403 ' HB2' ' O ' ' A' ' 409' ' ' THR . 0.4 OUTLIER -67.89 -48.09 67.0 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 122.547 -0.384 . . . . 0.0 111.17 177.148 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 413' ' ' MET . . . . . 0.922 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.7 OUTLIER -72.32 -48.21 43.89 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 119.176 -1.01 . . . . 0.0 112.569 -179.778 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 414' ' ' LEU . . . . . 0.922 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 15.4 mt -69.18 -46.95 66.23 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -174.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.08 9.62 41.59 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.432 0.634 . . . . 0.0 110.746 -173.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 416' ' ' GLY . . . . . 0.411 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 85.32 -178.46 50.57 Favored Glycine 0 N--CA 1.435 -1.375 0 CA-C-N 115.437 -0.802 . . . . 0.0 111.554 -178.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -79.94 22.66 0.49 Allowed 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.285 0.564 . . . . 0.0 111.108 -173.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 418' ' ' ASN . . . . . 0.415 ' HB3' ' HB3' ' A' ' 421' ' ' LEU . 3.5 m-20 -71.94 75.1 0.9 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.083 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 419' ' ' TYR . . . . . 0.567 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 28.3 p90 -56.6 -36.96 70.0 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.456 177.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -54.81 -42.03 71.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.461 175.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 421' ' ' LEU . . . . . 0.415 ' HB3' ' HB3' ' A' ' 418' ' ' ASN . 0.0 OUTLIER -68.62 -51.89 37.32 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.624 -179.068 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 422' ' ' VAL . . . . . 0.51 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -62.77 -37.1 78.24 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.582 -174.705 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.771 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 58.4 p -69.27 -34.07 74.19 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -68.69 -42.18 80.86 Favored Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.3 174.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 425' ' ' ILE . . . . . 0.571 HG22 HG21 ' A' ' 395' ' ' ILE . 2.6 mp -72.55 -50.98 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 116.921 0.361 . . . . 0.0 111.514 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 426' ' ' ILE . . . . . 0.67 HD13 HG23 ' A' ' 395' ' ' ILE . 1.2 mm -75.19 -23.69 17.26 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.911 0 O-C-N 122.085 -0.384 . . . . 0.0 110.926 -171.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.771 ' HB2' ' O ' ' A' ' 423' ' ' SER . 1.0 OUTLIER -54.3 -33.3 58.44 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.196 0.522 . . . . 0.0 111.009 -177.199 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -84.65 -13.79 71.99 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.316 -0.945 . . . . 0.0 111.021 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.567 ' HD1' HG22 ' A' ' 395' ' ' ILE . 7.3 m-30 -110.83 -2.05 16.29 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.913 0.863 . . . . 0.0 108.758 -174.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.635 ' HA ' HG11 ' A' ' 404' ' ' VAL . 0.0 OUTLIER -66.3 138.96 96.12 Favored Pre-proline 0 N--CA 1.441 -0.902 0 CA-C-N 113.972 -1.467 . . . . 0.0 109.027 176.978 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 431' ' ' PRO . . . . . 0.844 ' HD2' HG11 ' A' ' 435' ' ' VAL . 71.0 Cg_exo -37.81 -65.3 0.16 Allowed 'Trans proline' 0 N--CA 1.473 0.312 0 C-N-CA 124.499 3.466 . . . . 0.0 113.874 -173.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 432' ' ' GLY . . . . . 0.544 ' H ' HG12 ' A' ' 435' ' ' VAL . . . -143.86 -163.24 9.8 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 176.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 433' ' ' GLN . . . . . 0.543 ' O ' HG13 ' A' ' 436' ' ' VAL . 43.8 tp60 -71.87 -26.67 62.44 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 118.328 1.064 . . . . 0.0 110.882 177.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -66.29 -40.7 90.22 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -177.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 435' ' ' VAL . . . . . 0.844 HG11 ' HD2' ' A' ' 431' ' ' PRO . 7.5 p -67.08 -44.13 88.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-O 120.962 0.411 . . . . 0.0 110.783 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.543 HG13 ' O ' ' A' ' 433' ' ' GLN . 0.1 OUTLIER -65.98 -31.55 54.19 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.179 176.383 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.2 -52.98 34.58 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -178.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 438' ' ' ALA . . . . . 0.866 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -58.56 -40.06 82.02 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.23 177.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 439' ' ' LEU . . . . . 0.605 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 1.9 tm? -68.13 -48.1 66.3 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -178.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -58.9 -38.44 78.91 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.457 176.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 441' ' ' GLN . . . . . 0.444 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 6.0 mm-40 -53.69 -52.09 61.14 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 123.629 0.771 . . . . 0.0 110.56 177.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 442' ' ' ARG . . . . . 0.543 ' NH1' ' HB1' ' A' ' 462' ' ' ALA . 0.1 OUTLIER -60.95 -34.9 75.45 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.734 174.848 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 443' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 64.1 mt -68.32 -36.55 79.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.744 178.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -56.57 -37.12 70.13 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.527 0.679 . . . . 0.0 110.284 174.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -74.12 -26.75 60.52 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.577 177.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 446' ' ' GLU . . . . . 0.419 ' HB3' ' O ' ' A' ' 443' ' ' LEU . 10.1 pt-20 19.26 103.36 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 176.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 447' ' ' ILE . . . . . 0.431 HD12 HG22 ' A' ' 451' ' ' THR . 43.0 mt -60.95 -34.9 61.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.852 178.075 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 448' ' ' ASP . . . . . 0.456 ' HB2' ' OG1' ' A' ' 451' ' ' THR . 22.1 m-20 -162.43 -158.8 0.53 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -178.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 449' ' ' ASP . . . . . 0.529 ' HA ' ' CZ ' ' A' ' 452' ' ' ARG . 9.6 m-20 -86.29 -67.2 0.83 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 170.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 450' ' ' GLN . . . . . 0.406 ' HG3' ' H ' ' A' ' 450' ' ' GLN . 2.1 pp0? -65.94 -25.57 67.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.167 178.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 451' ' ' THR . . . . . 0.463 ' HA ' ' HB2' ' A' ' 454' ' ' GLU . 14.3 m -71.47 -22.6 61.8 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.633 -176.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 452' ' ' ARG . . . . . 0.529 ' CZ ' ' HA ' ' A' ' 449' ' ' ASP . 48.8 mtt85 -54.65 -53.92 48.4 Favored 'General case' 0 C--O 1.219 -0.535 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 171.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 453' ' ' ALA . . . . . 0.567 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -56.69 -47.91 78.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.706 -1.134 . . . . 0.0 112.404 174.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 454' ' ' GLU . . . . . 0.463 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 13.3 mm-40 -52.36 -33.09 41.54 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.14 0.495 . . . . 0.0 111.742 -178.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 28.6 p -120.04 13.17 12.11 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.551 -176.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 456' ' ' PHE . . . . . 0.538 ' CE2' ' HB2' ' A' ' 419' ' ' TYR . 0.6 OUTLIER -56.71 -49.03 76.39 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.003 0.43 . . . . 0.0 111.493 -171.525 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 457' ' ' ILE . . . . . 0.553 HG23 ' HB1' ' A' ' 405' ' ' ALA . 1.9 mp -75.98 -32.02 22.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.067 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -57.88 -35.45 71.0 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.722 0.772 . . . . 0.0 108.939 171.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 459' ' ' HIS . . . . . 0.77 ' O ' HG23 ' A' ' 463' ' ' VAL . 74.2 m-70 -74.44 -29.3 61.42 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.294 178.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 460' ' ' LEU . . . . . 0.728 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -74.1 -35.36 64.17 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.864 0.84 . . . . 0.0 109.241 179.78 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 461' ' ' ASN . . . . . 0.492 ' O ' ' HB2' ' A' ' 464' ' ' TYR . 23.1 m-80 -73.65 -37.25 65.37 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 121.935 0.874 . . . . 0.0 108.922 177.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 462' ' ' ALA . . . . . 0.578 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -57.26 -34.8 69.0 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.803 169.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.866 HG13 ' HB3' ' A' ' 438' ' ' ALA . 63.7 t -60.46 -50.82 78.85 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.851 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 175.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 464' ' ' TYR . . . . . 0.624 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 19.3 m-30 -52.77 -28.25 21.56 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.552 177.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.53 -41.77 19.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.721 0.772 . . . . 0.0 109.457 -178.016 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.578 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.8 mt -57.24 -55.85 18.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 114.269 -1.332 . . . . 0.0 112.076 177.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.777 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -101.07 -10.12 20.78 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -172.999 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 468' ' ' GLY . . . . . 0.599 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 94.14 31.59 7.96 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 119.354 -1.403 . . . . 0.0 114.31 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 469' ' ' LEU . . . . . 0.777 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.9 mt -88.58 163.77 15.7 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 117.831 0.815 . . . . 0.0 111.09 176.147 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 37.4 p30 -105.34 -179.27 3.89 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.521 174.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -60.17 -23.25 63.8 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -177.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -87.24 2.34 50.37 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.325 -172.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 473' ' ' GLY . . . . . 0.484 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 77.8 10.61 86.11 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.501 -0.857 . . . . 0.0 111.3 -177.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -101.23 157.98 16.38 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 176.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 475' ' ' SER . . . . . 0.536 ' OG ' ' HG2' ' A' ' 477' ' ' ARG . 16.3 t -94.01 144.3 25.59 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.314 -0.555 . . . . 0.0 110.755 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 476' ' ' ILE . . . . . 0.599 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.5 pp -108.44 12.32 8.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.513 -178.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 477' ' ' ARG . . . . . 0.536 ' HG2' ' OG ' ' A' ' 475' ' ' SER . 29.9 mmm180 -54.4 111.27 0.75 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.48 -1.236 . . . . 0.0 111.084 177.182 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 62.18 34.8 15.95 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.129 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 . . . . . 0 C--O 1.25 1.083 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.471 177.77 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 381' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 . . . . . 0 N--CA 1.481 1.099 0 CA-C-O 121.195 0.521 . . . . 0.0 110.53 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 382' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.5 -66.42 0.39 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.978 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 383' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -120.85 170.99 8.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.516 0.674 . . . . 0.0 112.75 -169.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 384' ' ' GLY . . . . . . . . . . . . . . . -119.35 -110.33 2.35 Favored Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.408 173.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 385' ' ' THR . . . . . . . . . . . . . 19.4 m -68.48 -41.66 79.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.002 0.43 . . . . 0.0 110.931 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 386' ' ' PHE . . . . . 0.817 ' CD1' HD22 ' B' ' 414' ' ' LEU . 4.6 t80 -70.63 125.93 92.11 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.174 178.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 387' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -47.22 -67.75 0.11 Allowed 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 123.788 2.992 . . . . 0.0 114.388 -174.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 388' ' ' MET . . . . . 0.531 ' HB2' ' HE2' ' B' ' 388' ' ' MET . 34.6 ttm 66.2 161.01 0.14 Allowed 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.683 0.278 . . . . 0.0 111.247 177.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 389' ' ' HIS . . . . . 0.611 ' CE1' ' HA ' ' B' ' 393' ' ' ASN . 34.5 m170 -72.91 -155.14 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 173.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 390' ' ' GLN . . . . . 0.428 ' CD ' ' H ' ' B' ' 390' ' ' GLN . 5.7 pm0 -77.92 8.8 4.19 Favored 'General case' 0 C--N 1.317 -0.837 0 O-C-N 121.914 -0.491 . . . . 0.0 110.428 171.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 391' ' ' LEU . . . . . 0.536 HD23 ' H ' ' B' ' 392' ' ' GLY . 2.1 pt? -160.06 -51.69 0.05 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -176.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 392' ' ' GLY . . . . . 0.715 ' HA3' HD13 ' B' ' 395' ' ' ILE . . . -170.92 72.83 0.11 Allowed Glycine 0 C--N 1.338 0.689 0 C-N-CA 119.513 -1.327 . . . . 0.0 114.746 -173.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 393' ' ' ASN . . . . . 0.611 ' HA ' ' CE1' ' B' ' 389' ' ' HIS . 0.0 OUTLIER -66.28 -37.02 84.46 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 175.711 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 394' ' ' VAL . . . . . 0.687 HG23 HD12 ' B' ' 398' ' ' ILE . 1.0 OUTLIER -57.04 -49.09 80.55 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 CA-C-N 113.039 -1.892 . . . . 0.0 107.216 178.352 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 395' ' ' ILE . . . . . 0.715 HD13 ' HA3' ' B' ' 392' ' ' GLY . 3.7 mp -58.42 -52.6 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.559 0 CA-C-O 117.681 -1.152 . . . . 0.0 113.63 -174.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 396' ' ' LYS . . . . . 0.583 ' O ' HG22 ' B' ' 399' ' ' VAL . 0.0 OUTLIER -62.02 -49.75 74.78 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 122.18 2.264 . . . . 0.0 112.139 -174.4 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 397' ' ' GLY . . . . . 0.44 ' O ' ' HG3' ' B' ' 401' ' ' GLN . . . -53.51 -44.79 67.59 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 114.704 -1.135 . . . . 0.0 110.904 -176.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 398' ' ' ILE . . . . . 0.863 HD13 HD12 ' B' ' 410' ' ' LEU . 38.1 mt -71.24 -34.2 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -178.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 399' ' ' VAL . . . . . 0.583 HG22 ' O ' ' B' ' 396' ' ' LYS . 16.4 m -63.32 -40.19 88.09 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 C-N-CA 118.949 -1.1 . . . . 0.0 108.573 -173.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -64.35 -44.03 92.75 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 174.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 401' ' ' GLN . . . . . 0.576 ' NE2' ' HA ' ' A' ' 414' ' ' LEU . 14.5 mt-30 -92.78 -48.45 6.56 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -167.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 402' ' ' GLU . . . . . 0.603 ' HG3' ' HE3' ' A' ' 413' ' ' MET . 1.2 tm-20 -111.36 -19.28 12.67 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.19 0.519 . . . . 0.0 110.842 -173.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 104.62 161.31 24.08 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.89 177.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 404' ' ' VAL . . . . . 0.639 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.2 m -54.0 -45.13 64.3 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.812 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -175.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 405' ' ' ALA . . . . . 0.539 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -63.63 -31.46 72.64 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 119.954 -0.698 . . . . 0.0 112.522 -177.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 406' ' ' THR . . . . . 0.692 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 89.6 m -77.14 -41.7 40.76 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.146 -0.622 . . . . 0.0 110.402 173.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 407' ' ' ALA . . . . . 0.494 ' HB2' ' HB ' ' B' ' 398' ' ' ILE . . . -58.7 -36.68 74.63 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 122.154 0.978 . . . . 0.0 109.319 175.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 408' ' ' TYR . . . . . 0.639 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -67.27 -51.39 53.42 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 113.512 -1.677 . . . . 0.0 109.693 177.151 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 409' ' ' THR . . . . . 0.665 HG22 HD23 ' B' ' 410' ' ' LEU . 17.6 m -54.49 -47.88 72.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.478 177.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 410' ' ' LEU . . . . . 0.863 HD12 HD13 ' B' ' 398' ' ' ILE . 14.5 mt -72.46 -34.41 67.72 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -175.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.48 -33.94 73.54 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 120.311 -0.947 . . . . 0.0 110.954 170.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 412' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -68.04 -48.09 66.61 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 122.406 -0.467 . . . . 0.0 111.21 177.129 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 413' ' ' MET . . . . . 0.917 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.7 OUTLIER -72.18 -47.98 46.67 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 119.201 -0.999 . . . . 0.0 112.627 -179.779 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 414' ' ' LEU . . . . . 0.917 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 15.7 mt -69.62 -46.65 65.74 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -174.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.19 9.36 42.41 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.434 0.635 . . . . 0.0 110.769 -173.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 416' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 85.56 -178.38 50.22 Favored Glycine 0 N--CA 1.435 -1.378 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.64 -178.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -80.08 22.51 0.51 Allowed 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.227 0.537 . . . . 0.0 111.08 -173.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 418' ' ' ASN . . . . . 0.412 ' HB3' ' HB3' ' B' ' 421' ' ' LEU . 3.5 m-20 -71.76 75.06 0.85 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.108 179.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 419' ' ' TYR . . . . . 0.563 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 29.0 p90 -56.59 -36.9 69.91 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.484 177.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -54.91 -41.91 71.55 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.505 175.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 421' ' ' LEU . . . . . 0.412 ' HB3' ' HB3' ' B' ' 418' ' ' ASN . 0.0 OUTLIER -68.75 -51.86 36.66 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.71 -179.201 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 422' ' ' VAL . . . . . 0.501 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.2 OUTLIER -62.72 -37.22 78.48 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.57 -174.776 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 423' ' ' SER . . . . . 0.78 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 57.1 p -69.03 -34.55 75.4 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -68.3 -42.18 83.61 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.347 175.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 425' ' ' ILE . . . . . 0.578 HG22 HG21 ' B' ' 395' ' ' ILE . 2.6 mp -72.43 -51.1 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-N 116.723 0.261 . . . . 0.0 111.566 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 426' ' ' ILE . . . . . 0.651 HD13 HG23 ' B' ' 395' ' ' ILE . 1.2 mm -75.31 -23.51 17.03 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.925 0 O-C-N 121.978 -0.451 . . . . 0.0 110.95 -171.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 427' ' ' ARG . . . . . 0.78 ' HB2' ' O ' ' B' ' 423' ' ' SER . 1.0 OUTLIER -54.42 -33.21 58.99 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.192 0.52 . . . . 0.0 111.008 -177.194 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -84.88 -13.33 72.38 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.417 -0.897 . . . . 0.0 111.032 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 429' ' ' TYR . . . . . 0.575 ' HD1' HG22 ' B' ' 395' ' ' ILE . 7.4 m-30 -111.24 -2.13 15.85 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -174.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 430' ' ' LEU . . . . . 0.631 ' HA ' HG11 ' B' ' 404' ' ' VAL . 0.0 OUTLIER -66.46 138.65 95.8 Favored Pre-proline 0 N--CA 1.441 -0.904 0 CA-C-N 114.001 -1.454 . . . . 0.0 109.08 176.946 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 431' ' ' PRO . . . . . 0.838 ' HD2' HG11 ' B' ' 435' ' ' VAL . 70.0 Cg_exo -37.69 -64.6 0.18 Allowed 'Trans proline' 0 CA--C 1.533 0.426 0 C-N-CA 124.548 3.499 . . . . 0.0 114.045 -173.268 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 432' ' ' GLY . . . . . 0.558 ' H ' HG12 ' B' ' 435' ' ' VAL . . . -144.7 -163.92 10.29 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 176.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 433' ' ' GLN . . . . . 0.546 ' O ' HG13 ' B' ' 436' ' ' VAL . 43.0 tp60 -71.58 -26.79 62.76 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 118.34 1.07 . . . . 0.0 110.762 178.134 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -66.09 -40.6 90.92 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 435' ' ' VAL . . . . . 0.838 HG11 ' HD2' ' B' ' 431' ' ' PRO . 7.5 p -67.33 -44.03 87.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-O 120.981 0.42 . . . . 0.0 110.788 -178.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 436' ' ' VAL . . . . . 0.546 HG13 ' O ' ' B' ' 433' ' ' GLN . 0.1 OUTLIER -65.91 -31.55 54.23 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.103 176.485 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.36 -52.91 34.34 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -178.21 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 438' ' ' ALA . . . . . 0.862 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -58.52 -39.94 81.52 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.157 177.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 439' ' ' LEU . . . . . 0.592 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 1.9 tm? -68.14 -48.13 66.2 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -178.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -58.94 -38.28 78.64 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.665 -1.152 . . . . 0.0 111.507 176.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 441' ' ' GLN . . . . . 0.441 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 6.0 mm-40 -53.87 -52.0 61.86 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 123.496 0.718 . . . . 0.0 110.499 177.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 442' ' ' ARG . . . . . 0.549 ' NH1' ' HB1' ' B' ' 462' ' ' ALA . 0.1 OUTLIER -60.96 -35.07 75.82 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.652 174.984 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 443' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 64.9 mt -68.24 -36.47 79.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.803 178.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -56.64 -37.3 70.57 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.511 0.672 . . . . 0.0 110.346 174.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -74.03 -26.87 60.66 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.467 177.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 446' ' ' GLU . . . . . 0.434 ' HB3' ' O ' ' B' ' 443' ' ' LEU . 10.3 pt-20 19.72 103.26 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 176.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 447' ' ' ILE . . . . . 0.422 HD12 HG22 ' B' ' 451' ' ' THR . 43.3 mt -60.88 -34.68 60.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.927 178.19 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 448' ' ' ASP . . . . . 0.455 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 21.1 m-20 -162.57 -158.56 0.51 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -178.033 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 449' ' ' ASP . . . . . 0.512 ' HA ' ' CZ ' ' B' ' 452' ' ' ARG . 11.0 m-20 -86.59 -67.05 0.84 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 170.374 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -65.87 -25.68 67.29 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 178.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 451' ' ' THR . . . . . 0.475 ' HA ' ' HB2' ' B' ' 454' ' ' GLU . 14.1 m -71.34 -22.66 61.88 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.615 -176.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 452' ' ' ARG . . . . . 0.512 ' CZ ' ' HA ' ' B' ' 449' ' ' ASP . 48.7 mtt180 -54.65 -53.79 50.19 Favored 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 171.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 453' ' ' ALA . . . . . 0.563 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -56.75 -47.98 78.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.689 -1.141 . . . . 0.0 112.415 174.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 454' ' ' GLU . . . . . 0.475 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 14.4 mm-40 -52.36 -32.92 40.67 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.028 0.442 . . . . 0.0 111.828 -178.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 27.8 p -120.23 13.38 11.98 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.58 -176.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 456' ' ' PHE . . . . . 0.552 ' CE2' ' HB2' ' B' ' 419' ' ' TYR . 0.7 OUTLIER -56.86 -48.91 77.01 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.09 0.471 . . . . 0.0 111.496 -171.479 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 457' ' ' ILE . . . . . 0.548 HG13 ' HB3' ' B' ' 408' ' ' TYR . 1.9 mp -76.19 -32.08 22.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.968 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -57.81 -35.51 70.96 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.696 0.76 . . . . 0.0 109.025 171.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 459' ' ' HIS . . . . . 0.779 ' O ' HG23 ' B' ' 463' ' ' VAL . 73.4 m-70 -74.39 -29.16 61.42 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.312 178.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 460' ' ' LEU . . . . . 0.733 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -74.05 -35.42 64.3 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.907 0.861 . . . . 0.0 109.198 179.679 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 461' ' ' ASN . . . . . 0.471 ' O ' ' HB2' ' B' ' 464' ' ' TYR . 22.4 m-80 -73.65 -37.3 65.35 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.911 0.862 . . . . 0.0 108.857 177.056 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 462' ' ' ALA . . . . . 0.584 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -57.25 -34.61 68.79 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.383 -1.28 . . . . 0.0 109.84 169.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 463' ' ' VAL . . . . . 0.862 HG13 ' HB3' ' B' ' 438' ' ' ALA . 64.6 t -60.57 -50.9 78.53 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.778 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.085 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 464' ' ' TYR . . . . . 0.616 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 19.2 m-30 -52.83 -28.12 21.34 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.492 177.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.62 -41.94 18.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.593 0.711 . . . . 0.0 109.382 -178.058 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 466' ' ' ILE . . . . . 0.584 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.8 mt -57.06 -55.93 17.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 114.405 -1.27 . . . . 0.0 112.154 177.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 467' ' ' LEU . . . . . 0.77 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -100.75 -10.26 20.97 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -173.009 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 468' ' ' GLY . . . . . 0.607 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 94.18 31.57 7.96 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 119.222 -1.466 . . . . 0.0 114.396 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 469' ' ' LEU . . . . . 0.77 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.9 mt -88.5 163.83 15.73 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 117.954 0.877 . . . . 0.0 111.046 176.055 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 37.4 p30 -105.32 -179.41 3.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.553 174.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 471' ' ' ALA . . . . . . . . . . . . . . . -60.1 -22.84 63.28 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -87.49 2.06 51.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.251 -172.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 473' ' ' GLY . . . . . 0.489 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 78.16 10.47 86.19 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.37 -0.919 . . . . 0.0 111.214 -177.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -101.19 157.87 16.45 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 176.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 475' ' ' SER . . . . . 0.548 ' OG ' ' HG2' ' B' ' 477' ' ' ARG . 16.7 t -93.87 143.83 25.98 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.757 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 476' ' ' ILE . . . . . 0.607 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.5 pp -108.18 12.57 8.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.498 0.666 . . . . 0.0 110.508 -178.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 477' ' ' ARG . . . . . 0.548 ' HG2' ' OG ' ' B' ' 475' ' ' SER . 29.9 mmm180 -54.4 111.63 0.83 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.39 -1.277 . . . . 0.0 111.056 177.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 478' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 61.67 34.75 17.38 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.135 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 479' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 . . . . . 0 C--O 1.249 1.052 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.433 177.778 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 . . . . . 0 N--CA 1.479 1.003 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 1.5 t -115.02 -22.04 9.74 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -175.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 383' ' ' HIS . . . . . 0.506 ' HB2' ' O ' ' A' ' 386' ' ' PHE . 1.7 p80 -161.98 160.12 27.33 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.927 -173.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -113.02 -99.8 2.42 Favored Glycine 0 N--CA 1.443 -0.88 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.965 170.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 35.5 m -74.96 -42.53 57.46 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.816 0.341 . . . . 0.0 110.841 177.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 386' ' ' PHE . . . . . 0.878 ' CD1' HD22 ' A' ' 414' ' ' LEU . 5.0 t80 -68.15 122.62 84.79 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.023 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 387' ' ' PRO . . . . . 0.565 ' HG2' ' OD1' ' B' ' 393' ' ' ASN . 1.2 Cg_endo -45.09 -65.21 0.2 Allowed 'Trans proline' 0 CA--C 1.533 0.438 0 C-N-CA 123.667 2.911 . . . . 0.0 114.088 -177.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.781 ' SD ' HG13 ' A' ' 394' ' ' VAL . 18.2 tpp 67.21 160.69 0.16 Allowed 'General case' 0 N--CA 1.472 0.655 0 O-C-N 123.06 0.225 . . . . 0.0 110.814 178.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 389' ' ' HIS . . . . . 0.582 ' CG ' ' HB2' ' A' ' 393' ' ' ASN . 32.3 m170 -70.69 -161.19 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 171.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -72.76 6.99 2.16 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.288 172.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.587 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.1 pt? -161.01 -64.08 0.06 Allowed 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -175.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 392' ' ' GLY . . . . . 0.599 ' HA3' HD13 ' A' ' 395' ' ' ILE . . . -158.36 59.95 0.33 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 119.759 -1.21 . . . . 0.0 114.175 -170.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 393' ' ' ASN . . . . . 0.582 ' HB2' ' CG ' ' A' ' 389' ' ' HIS . 0.2 OUTLIER -55.11 -44.06 74.63 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.344 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.781 HG13 ' SD ' ' A' ' 388' ' ' MET . 1.1 m -59.08 -44.79 92.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-N 114.32 -1.309 . . . . 0.0 108.247 -177.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.68 HG23 HD13 ' A' ' 426' ' ' ILE . 4.2 mp -57.76 -52.05 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 CA-C-O 117.855 -1.069 . . . . 0.0 113.024 -175.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 396' ' ' LYS . . . . . 0.638 ' HG3' ' CZ ' ' A' ' 429' ' ' TYR . 0.1 OUTLIER -62.95 -49.2 75.7 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 121.681 2.037 . . . . 0.0 111.662 -175.766 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -54.69 -45.84 77.01 Favored Glycine 0 N--CA 1.432 -1.589 0 C-N-CA 120.072 -1.061 . . . . 0.0 111.31 -178.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 398' ' ' ILE . . . . . 0.844 HG12 HD21 ' B' ' 414' ' ' LEU . 26.9 mt -71.38 -33.86 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -177.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 399' ' ' VAL . . . . . 0.502 HG12 ' HA ' ' A' ' 404' ' ' VAL . 7.9 m -63.68 -39.58 85.89 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 C-N-CA 118.79 -1.164 . . . . 0.0 108.396 -174.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -69.33 -38.53 78.21 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 175.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.462 HE21 ' HB3' ' A' ' 401' ' ' GLN . 4.1 mm100 -86.17 -48.8 8.25 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -170.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 402' ' ' GLU . . . . . 0.471 ' HA ' HH11 ' A' ' 472' ' ' ARG . 10.2 tp10 -120.97 -21.04 6.66 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.868 0.366 . . . . 0.0 111.22 -171.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 109.7 163.64 19.63 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.985 178.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 404' ' ' VAL . . . . . 0.617 HG11 ' HA ' ' A' ' 430' ' ' LEU . 1.7 m -53.41 -45.56 57.53 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -175.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 405' ' ' ALA . . . . . 0.608 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -64.81 -31.02 72.06 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.702 -0.799 . . . . 0.0 112.288 -176.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.738 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 92.8 m -77.79 -41.35 37.63 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.297 173.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.504 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.86 -37.02 75.58 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 122.233 1.015 . . . . 0.0 109.06 176.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 408' ' ' TYR . . . . . 0.608 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.25 -52.47 54.21 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 113.27 -1.786 . . . . 0.0 109.924 175.761 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 409' ' ' THR . . . . . 0.667 HG22 HD23 ' A' ' 410' ' ' LEU . 18.6 m -55.35 -47.83 75.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.508 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 410' ' ' LEU . . . . . 0.738 ' HG ' ' O ' ' A' ' 406' ' ' THR . 14.3 mt -73.34 -36.86 66.22 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.16 -174.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -59.53 -35.16 84.51 Favored Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.053 -1.07 . . . . 0.0 110.606 172.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 412' ' ' MET . . . . . 0.473 ' HE2' ' HA ' ' A' ' 417' ' ' GLN . 0.0 OUTLIER -66.71 -49.93 64.46 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 120.605 0.24 . . . . 0.0 111.444 178.087 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 413' ' ' MET . . . . . 0.917 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.6 OUTLIER -71.44 -45.0 63.76 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 119.128 -1.029 . . . . 0.0 112.446 -176.069 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 414' ' ' LEU . . . . . 0.917 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 18.3 mt -72.52 -45.39 59.57 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -176.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 32.8 t -84.81 -19.1 33.03 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.795 0.807 . . . . 0.0 109.618 -173.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 416' ' ' GLY . . . . . 0.464 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 106.98 179.61 22.61 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -172.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 417' ' ' GLN . . . . . 0.473 ' HA ' ' HE2' ' A' ' 412' ' ' MET . 1.7 mp0 -79.1 25.43 0.29 Allowed 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 121.557 0.694 . . . . 0.0 111.027 -173.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 418' ' ' ASN . . . . . 0.464 ' H ' ' C ' ' A' ' 416' ' ' GLY . 84.1 m-20 -70.55 73.21 0.53 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.11 178.031 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 419' ' ' TYR . . . . . 0.522 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 5.7 p90 -51.34 -37.75 49.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.928 175.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -54.23 -45.81 72.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.119 176.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.25 -48.78 60.88 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.215 -177.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 422' ' ' VAL . . . . . 0.441 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -66.57 -40.61 86.73 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 C-N-CA 120.289 -0.565 . . . . 0.0 111.115 -175.465 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.724 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 79.1 p -67.53 -38.95 85.0 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.921 -178.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -69.34 -36.47 78.47 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.092 176.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 425' ' ' ILE . . . . . 0.626 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -73.53 -51.61 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 O-C-N 122.904 -0.174 . . . . 0.0 111.09 -178.605 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 426' ' ' ILE . . . . . 0.68 HD13 HG23 ' A' ' 395' ' ' ILE . 1.1 mm -74.63 -22.89 17.64 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.819 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -172.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.724 ' HB2' ' O ' ' A' ' 423' ' ' SER . 0.8 OUTLIER -55.07 -29.78 58.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.302 0.572 . . . . 0.0 110.463 -178.867 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -88.09 -4.38 78.21 Favored Glycine 0 N--CA 1.443 -0.839 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.702 178.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.638 ' CZ ' ' HG3' ' A' ' 396' ' ' LYS . 23.5 m-85 -119.18 -1.31 10.89 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 121.011 0.434 . . . . 0.0 110.314 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.643 HD23 ' HA ' ' A' ' 427' ' ' ARG . 0.1 OUTLIER -66.07 128.89 94.12 Favored Pre-proline 0 N--CA 1.44 -0.935 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.62 179.485 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 431' ' ' PRO . . . . . 0.569 ' HD2' HD12 ' A' ' 430' ' ' LEU . 99.9 Cg_exo -23.67 -68.31 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.736 1 C-N-CA 125.4 4.067 . . . . 0.0 114.62 179.5 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 432' ' ' GLY . . . . . 0.522 ' O ' HG12 ' A' ' 435' ' ' VAL . . . -144.54 -165.76 11.2 Favored Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 175.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 433' ' ' GLN . . . . . 0.509 ' O ' HG13 ' A' ' 436' ' ' VAL . 44.1 tp60 -70.11 -25.81 63.67 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 118.003 0.901 . . . . 0.0 110.568 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -66.84 -40.34 87.91 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -178.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 435' ' ' VAL . . . . . 0.756 HG23 HG11 ' A' ' 463' ' ' VAL . 7.5 p -68.63 -44.62 82.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 120.901 0.382 . . . . 0.0 110.406 -177.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.554 HG21 ' HD3' ' A' ' 427' ' ' ARG . 0.1 OUTLIER -64.4 -30.86 51.33 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 CA-C-O 120.834 0.349 . . . . 0.0 110.643 175.218 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 1.1 m -69.32 -52.03 31.29 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -178.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 438' ' ' ALA . . . . . 0.875 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -58.84 -37.21 75.96 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.551 177.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 439' ' ' LEU . . . . . 0.552 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 2.1 tm? -70.76 -47.8 57.73 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -56.97 -39.01 73.81 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.339 174.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 441' ' ' GLN . . . . . 0.479 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 37.1 mm-40 -53.2 -50.08 65.42 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 123.586 0.754 . . . . 0.0 110.705 173.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 442' ' ' ARG . . . . . 0.8 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 0.9 OUTLIER -56.23 -39.63 72.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.78 173.04 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 443' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 43.2 mt -71.89 -36.91 70.17 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.95 0.405 . . . . 0.0 110.28 -178.166 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -57.86 -37.51 74.05 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.614 173.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -73.16 -26.67 61.28 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.942 178.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 446' ' ' GLU . . . . . 0.404 ' HB3' ' O ' ' A' ' 443' ' ' LEU . 8.9 pt-20 29.3 104.53 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 172.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 447' ' ' ILE . . . . . 0.492 ' HB ' ' HB ' ' A' ' 451' ' ' THR . 64.7 mt -66.08 -32.21 57.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.877 0.846 . . . . 0.0 109.46 171.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 448' ' ' ASP . . . . . 0.47 ' HB3' ' H ' ' A' ' 451' ' ' THR . 4.8 t70 -167.34 -153.87 0.15 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -177.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 449' ' ' ASP . . . . . 0.435 ' O ' ' HG3' ' A' ' 452' ' ' ARG . 4.0 m-20 -90.6 -61.62 1.64 Allowed 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 165.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 450' ' ' GLN . . . . . 0.562 ' O ' ' HB3' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -72.59 -26.05 61.56 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.447 -176.794 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 451' ' ' THR . . . . . 0.504 ' HA ' ' HG3' ' A' ' 454' ' ' GLU . 4.0 m -72.8 -21.15 61.03 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.992 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 452' ' ' ARG . . . . . 0.435 ' HG3' ' O ' ' A' ' 449' ' ' ASP . 18.4 mtm180 -55.91 -47.44 77.46 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 107.138 -1.431 . . . . 0.0 107.138 170.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 453' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 450' ' ' GLN . . . -57.59 -49.29 76.88 Favored 'General case' 0 N--CA 1.462 0.163 0 O-C-N 124.142 0.901 . . . . 0.0 111.921 171.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 454' ' ' GLU . . . . . 0.504 ' HG3' ' HA ' ' A' ' 451' ' ' THR . 37.1 mt-10 -46.31 -38.84 9.22 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.471 0.653 . . . . 0.0 111.693 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 30.1 p -121.16 15.74 11.49 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.139 -173.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 456' ' ' PHE . . . . . 0.602 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.8 OUTLIER -55.45 -47.53 75.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.246 0.546 . . . . 0.0 111.349 -171.442 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 457' ' ' ILE . . . . . 0.608 HG23 ' HB1' ' A' ' 405' ' ' ALA . 2.0 mp -77.08 -34.45 21.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.439 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -57.33 -35.89 70.46 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.948 0.88 . . . . 0.0 109.21 171.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 459' ' ' HIS . . . . . 0.734 ' O ' HG23 ' A' ' 463' ' ' VAL . 55.5 m-70 -72.78 -29.21 63.1 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.841 176.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 460' ' ' LEU . . . . . 0.724 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -74.1 -34.16 63.86 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 122.114 0.959 . . . . 0.0 108.683 179.044 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 461' ' ' ASN . . . . . 0.453 ' O ' ' HB2' ' A' ' 464' ' ' TYR . 3.0 m120 -73.27 -38.07 66.07 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.2 -0.909 . . . . 0.0 108.909 176.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 462' ' ' ALA . . . . . 0.607 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -56.24 -35.0 66.9 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.659 169.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.875 HG13 ' HB3' ' A' ' 438' ' ' ALA . 61.9 t -61.01 -50.95 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 175.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 464' ' ' TYR . . . . . 0.587 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 19.4 m-30 -52.95 -29.13 27.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.612 178.376 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.82 -40.18 19.03 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.667 0.746 . . . . 0.0 109.347 -176.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.607 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.7 mt -55.95 -55.55 17.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 114.288 -1.324 . . . . 0.0 112.198 175.007 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.774 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -102.9 -9.87 19.52 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 -172.748 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 468' ' ' GLY . . . . . 0.525 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 93.38 31.8 8.16 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 119.308 -1.425 . . . . 0.0 114.07 179.055 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 469' ' ' LEU . . . . . 0.774 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 2.8 mt -89.65 162.77 15.44 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 117.732 0.766 . . . . 0.0 111.272 176.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 470' ' ' ASN . . . . . 0.413 ' HB3' ' CG2' ' A' ' 476' ' ' ILE . 37.8 p30 -105.07 -177.68 3.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.142 171.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 471' ' ' ALA . . . . . 0.523 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -60.44 -23.51 64.48 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -176.033 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 472' ' ' ARG . . . . . 0.471 HH11 ' HA ' ' A' ' 402' ' ' GLU . 28.5 mmt180 -87.27 1.09 54.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.38 -170.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 473' ' ' GLY . . . . . 0.451 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 79.29 11.27 85.16 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.376 -0.916 . . . . 0.0 111.348 -177.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -101.02 150.82 22.5 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 177.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 475' ' ' SER . . . . . 0.54 ' OG ' ' HG2' ' A' ' 479' ' ' GLU . 11.0 p -88.76 127.81 35.61 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.183 0.516 . . . . 0.0 110.842 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 476' ' ' ILE . . . . . 0.525 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.7 pp -91.17 -17.71 7.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.444 -176.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 477' ' ' ARG . . . . . 0.491 ' N ' HD12 ' A' ' 476' ' ' ILE . 0.4 OUTLIER -95.48 -166.01 1.38 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.997 179.87 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 39.4 tp -53.19 123.57 12.17 Favored 'General case' 0 C--N 1.328 -0.357 0 O-C-N 123.23 0.332 . . . . 0.0 110.289 177.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 479' ' ' GLU . . . . . 0.54 ' HG2' ' OG ' ' A' ' 475' ' ' SER . 33.4 mt-10 . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.504 -0.76 . . . . 0.0 110.994 -177.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 381' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 382' ' ' THR . . . . . . . . . . . . . 1.6 t -114.74 -22.07 9.88 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -175.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 383' ' ' HIS . . . . . 0.507 ' HB2' ' O ' ' B' ' 386' ' ' PHE . 1.8 p80 -161.86 160.04 27.57 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.941 -173.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 384' ' ' GLY . . . . . . . . . . . . . . . -112.9 -99.25 2.4 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 170.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 385' ' ' THR . . . . . . . . . . . . . 34.1 m -75.83 -41.88 51.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.938 0.369 . . . . 0.0 110.854 177.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 386' ' ' PHE . . . . . 0.865 ' CD1' HD22 ' B' ' 414' ' ' LEU . 5.1 t80 -68.57 122.56 85.08 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 387' ' ' PRO . . . . . 0.568 ' HG2' ' OD1' ' A' ' 393' ' ' ASN . 1.2 Cg_endo -44.96 -65.44 0.19 Allowed 'Trans proline' 0 CA--C 1.532 0.415 0 C-N-CA 123.55 2.833 . . . . 0.0 114.111 -177.182 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 388' ' ' MET . . . . . 0.776 ' SD ' HG13 ' B' ' 394' ' ' VAL . 18.3 tpp 67.61 160.99 0.17 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.549 0.214 . . . . 0.0 110.779 178.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 389' ' ' HIS . . . . . 0.587 ' CG ' ' HB2' ' B' ' 393' ' ' ASN . 32.5 m170 -70.91 -160.84 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 171.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -73.07 7.22 2.21 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.368 172.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 391' ' ' LEU . . . . . 0.589 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.1 pt? -161.14 -64.14 0.06 Allowed 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 392' ' ' GLY . . . . . 0.606 ' HA3' HD13 ' B' ' 395' ' ' ILE . . . -158.3 59.88 0.33 Allowed Glycine 0 C--N 1.334 0.431 0 C-N-CA 119.81 -1.186 . . . . 0.0 114.175 -170.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 393' ' ' ASN . . . . . 0.587 ' HB2' ' CG ' ' B' ' 389' ' ' HIS . 0.2 OUTLIER -54.98 -44.0 74.03 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-O 121.091 0.472 . . . . 0.0 109.851 178.304 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 394' ' ' VAL . . . . . 0.776 HG13 ' SD ' ' B' ' 388' ' ' MET . 1.1 m -59.2 -44.63 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 114.23 -1.35 . . . . 0.0 108.24 -177.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 395' ' ' ILE . . . . . 0.67 HG23 HD13 ' B' ' 426' ' ' ILE . 4.2 mp -57.77 -52.13 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-O 117.934 -1.032 . . . . 0.0 113.015 -175.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 396' ' ' LYS . . . . . 0.635 ' HG3' ' CZ ' ' B' ' 429' ' ' TYR . 0.1 OUTLIER -62.91 -49.21 75.7 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 121.661 2.028 . . . . 0.0 111.615 -175.683 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -54.62 -45.91 76.19 Favored Glycine 0 N--CA 1.433 -1.534 0 C-N-CA 120.029 -1.081 . . . . 0.0 111.295 -178.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 398' ' ' ILE . . . . . 0.85 HG12 HD21 ' A' ' 414' ' ' LEU . 26.8 mt -71.24 -34.01 52.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 113.531 0.938 . . . . 0.0 113.531 -177.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 399' ' ' VAL . . . . . 0.509 HG12 ' HA ' ' B' ' 404' ' ' VAL . 8.0 m -63.67 -39.7 86.32 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.519 0 C-N-CA 118.837 -1.145 . . . . 0.0 108.346 -174.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -69.15 -38.54 78.84 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 175.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 401' ' ' GLN . . . . . . . . . . . . . 4.3 mm100 -86.2 -49.07 8.0 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -170.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 402' ' ' GLU . . . . . 0.488 ' HA ' HH11 ' B' ' 472' ' ' ARG . 9.4 tp10 -120.67 -21.0 6.86 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 120.88 0.372 . . . . 0.0 111.324 -170.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 109.72 163.57 19.6 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.956 178.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 404' ' ' VAL . . . . . 0.613 HG11 ' HA ' ' B' ' 430' ' ' LEU . 1.7 m -53.3 -45.69 56.26 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.705 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -175.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 405' ' ' ALA . . . . . 0.6 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -64.85 -30.88 71.91 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 119.725 -0.79 . . . . 0.0 112.319 -176.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 406' ' ' THR . . . . . 0.736 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 92.5 m -77.86 -41.4 36.98 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 119.961 -0.696 . . . . 0.0 110.231 173.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 407' ' ' ALA . . . . . 0.485 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.95 -36.98 75.7 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 122.241 1.019 . . . . 0.0 109.014 176.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 408' ' ' TYR . . . . . 0.599 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.23 -52.44 54.56 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 113.283 -1.78 . . . . 0.0 109.941 175.82 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 409' ' ' THR . . . . . 0.665 HG22 HD23 ' B' ' 410' ' ' LEU . 17.5 m -55.43 -47.72 75.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.572 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 410' ' ' LEU . . . . . 0.736 ' HG ' ' O ' ' B' ' 406' ' ' THR . 14.4 mt -73.34 -37.11 66.21 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.06 -174.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -59.27 -35.32 84.14 Favored Glycine 0 N--CA 1.438 -1.224 0 C-N-CA 120.14 -1.028 . . . . 0.0 110.666 172.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 412' ' ' MET . . . . . 0.489 ' HE2' ' HA ' ' B' ' 417' ' ' GLN . 0.0 OUTLIER -66.51 -49.87 65.09 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-O 120.6 0.238 . . . . 0.0 111.572 177.97 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 413' ' ' MET . . . . . 0.933 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.7 OUTLIER -71.58 -45.21 62.87 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 119.064 -1.054 . . . . 0.0 112.356 -176.196 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 414' ' ' LEU . . . . . 0.933 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 17.9 mt -72.22 -45.64 59.45 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 113.95 1.092 . . . . 0.0 113.95 -176.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 32.8 t -84.89 -18.57 34.34 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.646 0.736 . . . . 0.0 109.599 -173.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 416' ' ' GLY . . . . . 0.469 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 106.61 179.67 22.89 Favored Glycine 0 N--CA 1.429 -1.774 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 -173.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 417' ' ' GLN . . . . . 0.489 ' HA ' ' HE2' ' B' ' 412' ' ' MET . 1.7 mp0 -79.13 25.38 0.29 Allowed 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.532 0.682 . . . . 0.0 111.015 -174.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 418' ' ' ASN . . . . . 0.469 ' H ' ' C ' ' B' ' 416' ' ' GLY . 83.8 m-20 -70.6 73.27 0.54 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.166 177.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 419' ' ' TYR . . . . . 0.513 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 5.4 p90 -51.38 -37.77 49.86 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.897 175.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -54.25 -45.82 72.47 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.064 176.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.17 -48.84 61.17 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.224 -177.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 422' ' ' VAL . . . . . 0.44 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.2 OUTLIER -66.44 -40.69 87.18 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.096 -175.464 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 423' ' ' SER . . . . . 0.748 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 80.0 p -67.48 -39.29 85.26 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.825 -178.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -68.93 -36.63 82.07 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.067 177.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 425' ' ' ILE . . . . . 0.649 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -73.45 -51.7 24.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 121.401 -0.12 . . . . 0.0 111.035 -178.593 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 426' ' ' ILE . . . . . 0.67 HD13 HG23 ' B' ' 395' ' ' ILE . 1.1 mm -74.76 -22.92 17.48 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.853 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 -172.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 427' ' ' ARG . . . . . 0.748 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.8 OUTLIER -54.97 -29.91 57.91 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.339 0.59 . . . . 0.0 110.407 -179.065 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.49 -5.14 79.42 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.79 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 429' ' ' TYR . . . . . 0.635 ' CZ ' ' HG3' ' B' ' 396' ' ' LYS . 23.5 m-85 -118.88 -1.49 11.01 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.118 0.485 . . . . 0.0 110.44 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 430' ' ' LEU . . . . . 0.635 HD23 ' HA ' ' B' ' 427' ' ' ARG . 0.1 OUTLIER -65.85 128.79 94.07 Favored Pre-proline 0 N--CA 1.44 -0.945 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.641 179.589 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 431' ' ' PRO . . . . . 0.554 ' HD2' HD12 ' B' ' 430' ' ' LEU . 99.6 Cg_exo -23.57 -68.37 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.749 1 C-N-CA 125.484 4.123 . . . . 0.0 114.633 179.599 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 432' ' ' GLY . . . . . 0.506 ' O ' HG12 ' B' ' 436' ' ' VAL . . . -144.13 -165.5 10.97 Favored Glycine 0 N--CA 1.444 -0.83 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 175.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 433' ' ' GLN . . . . . 0.512 ' O ' HG13 ' B' ' 436' ' ' VAL . 43.9 tp60 -70.28 -25.73 63.48 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 118.024 0.912 . . . . 0.0 110.734 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -67.2 -40.09 86.44 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -177.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 435' ' ' VAL . . . . . 0.742 HG23 HG11 ' B' ' 463' ' ' VAL . 7.4 p -68.87 -44.58 81.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 120.937 0.399 . . . . 0.0 110.39 -177.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 436' ' ' VAL . . . . . 0.541 HG21 ' HD3' ' B' ' 427' ' ' ARG . 0.1 OUTLIER -64.39 -31.05 51.92 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.499 175.077 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 1.1 m -69.19 -52.04 31.95 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 438' ' ' ALA . . . . . 0.862 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -58.94 -37.28 76.36 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.663 177.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 439' ' ' LEU . . . . . 0.556 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 2.1 tm? -70.75 -47.69 58.35 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -179.181 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -56.9 -39.25 74.08 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.326 174.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 441' ' ' GLN . . . . . 0.479 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 36.7 mm-40 -53.12 -50.04 65.31 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 123.576 0.75 . . . . 0.0 110.644 173.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 442' ' ' ARG . . . . . 0.82 ' HG2' ' O ' ' B' ' 438' ' ' ALA . 0.9 OUTLIER -56.25 -39.66 72.93 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.824 173.066 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 443' ' ' LEU . . . . . 0.556 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 42.4 mt -71.96 -36.73 69.93 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.99 0.424 . . . . 0.0 110.31 -178.237 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -57.97 -37.5 74.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.609 173.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -73.22 -26.42 61.14 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.986 178.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 446' ' ' GLU . . . . . 0.401 ' HB3' ' O ' ' B' ' 443' ' ' LEU . 8.8 pt-20 29.4 104.28 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 172.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 447' ' ' ILE . . . . . 0.499 ' HB ' ' HB ' ' B' ' 451' ' ' THR . 64.4 mt -66.07 -32.39 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 121.911 0.862 . . . . 0.0 109.443 171.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 448' ' ' ASP . . . . . 0.455 ' HB3' ' H ' ' B' ' 451' ' ' THR . 4.6 t70 -167.04 -153.63 0.15 Allowed 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 -177.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 449' ' ' ASP . . . . . 0.438 ' O ' ' HG3' ' B' ' 452' ' ' ARG . 4.9 m-20 -90.87 -61.64 1.63 Allowed 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 165.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 450' ' ' GLN . . . . . 0.556 ' O ' ' HB3' ' B' ' 453' ' ' ALA . 3.0 pp0? -72.55 -26.01 61.58 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.432 -176.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 451' ' ' THR . . . . . 0.521 ' HA ' ' HG3' ' B' ' 454' ' ' GLU . 4.1 m -72.77 -21.07 61.06 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.063 -0.655 . . . . 0.0 111.035 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 452' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' B' ' 449' ' ' ASP . 18.6 mtm180 -56.08 -47.48 77.92 Favored 'General case' 0 C--O 1.215 -0.76 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 170.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 453' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' B' ' 450' ' ' GLN . . . -57.51 -49.2 77.09 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.994 171.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 454' ' ' GLU . . . . . 0.521 ' HG3' ' HA ' ' B' ' 451' ' ' THR . 37.2 mt-10 -46.39 -38.91 9.56 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.571 0.7 . . . . 0.0 111.677 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 31.1 p -121.05 15.82 11.59 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.257 -173.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 456' ' ' PHE . . . . . 0.586 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 0.8 OUTLIER -55.59 -47.73 75.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.209 0.528 . . . . 0.0 111.28 -171.524 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 457' ' ' ILE . . . . . 0.6 HG23 ' HB1' ' B' ' 405' ' ' ALA . 2.0 mp -76.8 -34.64 23.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.387 -179.348 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -57.33 -35.82 70.36 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 122.022 0.915 . . . . 0.0 109.291 172.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 459' ' ' HIS . . . . . 0.731 ' O ' HG23 ' B' ' 463' ' ' VAL . 55.4 m-70 -72.82 -29.04 62.93 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.208 -1.36 . . . . 0.0 110.915 176.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 460' ' ' LEU . . . . . 0.726 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -74.24 -34.17 63.56 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.107 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 461' ' ' ASN . . . . . 0.438 ' O ' ' HB2' ' B' ' 464' ' ' TYR . 3.0 m120 -73.17 -38.29 66.25 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.216 -0.902 . . . . 0.0 108.924 176.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 462' ' ' ALA . . . . . 0.615 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -56.16 -34.83 66.53 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.668 169.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 463' ' ' VAL . . . . . 0.862 HG13 ' HB3' ' B' ' 438' ' ' ALA . 62.7 t -61.04 -51.09 77.18 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 175.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 464' ' ' TYR . . . . . 0.57 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 19.4 m-30 -52.87 -29.09 26.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.642 178.297 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.13 -39.59 19.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.716 0.769 . . . . 0.0 109.501 -176.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 466' ' ' ILE . . . . . 0.615 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.7 mt -56.2 -55.83 16.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 114.344 -1.298 . . . . 0.0 112.115 174.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 467' ' ' LEU . . . . . 0.784 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -102.73 -9.97 19.57 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -172.513 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 468' ' ' GLY . . . . . 0.521 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 93.41 31.92 8.07 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 119.346 -1.407 . . . . 0.0 114.182 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 469' ' ' LEU . . . . . 0.784 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 2.8 mt -89.73 162.81 15.37 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 117.646 0.723 . . . . 0.0 111.062 176.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 470' ' ' ASN . . . . . 0.418 ' HB3' ' CG2' ' B' ' 476' ' ' ILE . 37.4 p30 -105.14 -177.82 3.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.23 171.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 471' ' ' ALA . . . . . 0.512 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -60.25 -23.51 64.16 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -176.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 472' ' ' ARG . . . . . 0.488 HH11 ' HA ' ' B' ' 402' ' ' GLU . 28.7 mmt180 -87.48 1.52 53.25 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.407 -170.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 473' ' ' GLY . . . . . 0.448 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 78.76 11.39 85.29 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.564 -0.827 . . . . 0.0 111.37 -177.141 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -100.94 150.66 22.64 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 177.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 475' ' ' SER . . . . . 0.56 ' OG ' ' HG2' ' B' ' 479' ' ' GLU . 11.9 p -88.35 127.81 35.49 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.207 0.527 . . . . 0.0 110.926 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 476' ' ' ILE . . . . . 0.521 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.7 pp -91.16 -17.62 7.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.485 -176.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 477' ' ' ARG . . . . . 0.484 ' N ' HD12 ' B' ' 476' ' ' ILE . 0.4 OUTLIER -95.31 -165.72 1.34 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.988 179.87 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 478' ' ' LEU . . . . . . . . . . . . . 39.8 tp -53.16 124.22 13.89 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.234 0.334 . . . . 0.0 110.153 177.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 479' ' ' GLU . . . . . 0.56 ' HG2' ' OG ' ' B' ' 475' ' ' SER . 31.9 mt-10 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.413 -0.803 . . . . 0.0 110.785 -177.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 . . . . . 0 N--CA 1.48 1.048 0 CA-C-O 120.751 0.31 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.01 -24.49 14.6 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.269 177.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 383' ' ' HIS . . . . . 0.518 ' HB2' ' O ' ' A' ' 386' ' ' PHE . 55.1 p-80 -167.75 159.54 11.85 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.928 -175.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -109.15 -110.8 3.38 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.354 172.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 14.2 m -64.63 -36.43 84.24 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.265 0.555 . . . . 0.0 111.462 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 386' ' ' PHE . . . . . 0.758 ' CZ ' HG12 ' A' ' 394' ' ' VAL . 1.6 t80 -81.78 128.37 69.14 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.494 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -53.55 -51.59 10.54 Favored 'Trans proline' 0 N--CA 1.489 1.214 1 C-N-CA 125.403 4.069 . . . . 0.0 115.952 -176.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.781 ' SD ' HG13 ' A' ' 394' ' ' VAL . 53.8 tpp 74.29 15.63 3.53 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 165.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 389' ' ' HIS . . . . . 0.804 ' CG ' ' HB2' ' A' ' 393' ' ' ASN . 15.6 m170 64.17 7.1 3.26 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.264 -0.897 . . . . 0.0 110.249 -175.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 66.29 25.09 10.54 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.498 -170.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.482 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.6 pt? -164.51 -53.4 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 170.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 392' ' ' GLY . . . . . 0.549 ' HA2' ' SD ' ' A' ' 388' ' ' MET . . . -175.39 49.38 0.13 Allowed Glycine 0 CA--C 1.525 0.659 0 C-N-CA 119.796 -1.192 . . . . 0.0 114.521 -176.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 393' ' ' ASN . . . . . 0.804 ' HB2' ' CG ' ' A' ' 389' ' ' HIS . 0.5 OUTLIER -54.49 -43.31 71.67 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 117.302 0.551 . . . . 0.0 109.81 177.886 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.781 HG13 ' SD ' ' A' ' 388' ' ' MET . 0.7 OUTLIER -57.64 -46.12 86.51 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 -177.649 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.703 HG21 HG22 ' A' ' 425' ' ' ILE . 4.1 mp -57.36 -52.3 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-O 118.023 -0.989 . . . . 0.0 113.139 -174.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 396' ' ' LYS . . . . . 0.629 ' HG3' ' CZ ' ' A' ' 429' ' ' TYR . 0.0 OUTLIER -63.55 -50.23 70.32 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 121.664 2.029 . . . . 0.0 112.335 -175.738 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 397' ' ' GLY . . . . . 0.568 ' O ' ' HG3' ' A' ' 401' ' ' GLN . . . -54.47 -44.89 77.59 Favored Glycine 0 N--CA 1.435 -1.393 0 C-N-CA 120.04 -1.076 . . . . 0.0 111.025 -177.23 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 398' ' ' ILE . . . . . 0.777 HD13 HD12 ' A' ' 410' ' ' LEU . 31.2 mt -71.28 -34.47 54.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -178.212 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 399' ' ' VAL . . . . . 0.52 HG12 ' HA ' ' A' ' 404' ' ' VAL . 9.9 m -63.66 -39.92 87.14 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 C-N-CA 118.973 -1.091 . . . . 0.0 108.594 -173.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -66.67 -40.99 88.85 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 175.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.568 ' HG3' ' O ' ' A' ' 397' ' ' GLY . 38.3 mt-30 -91.84 -47.13 7.49 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -169.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 402' ' ' GLU . . . . . 0.697 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 3.0 mm-40 -115.15 -20.35 10.45 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.983 0.421 . . . . 0.0 111.377 -173.006 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 106.14 162.84 22.86 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.874 -0.679 . . . . 0.0 113.027 177.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 404' ' ' VAL . . . . . 0.671 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.2 m -53.61 -42.89 52.34 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.851 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -175.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 405' ' ' ALA . . . . . 0.708 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -69.17 -28.57 66.52 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 119.602 -0.839 . . . . 0.0 112.139 -176.094 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.707 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 89.9 m -77.55 -43.1 33.0 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.139 -0.624 . . . . 0.0 109.972 172.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.51 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.3 -37.64 75.47 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 122.125 0.964 . . . . 0.0 109.285 176.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 408' ' ' TYR . . . . . 0.671 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.6 -52.14 54.38 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 113.606 -1.634 . . . . 0.0 109.734 177.155 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 409' ' ' THR . . . . . 0.667 HG22 HD23 ' A' ' 410' ' ' LEU . 13.0 m -55.51 -47.36 76.34 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.743 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 410' ' ' LEU . . . . . 0.777 HD12 HD13 ' A' ' 398' ' ' ILE . 13.8 mt -72.28 -35.71 68.8 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.197 -175.316 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.92 -35.09 81.48 Favored Glycine 0 N--CA 1.439 -1.142 0 C-N-CA 120.182 -1.009 . . . . 0.0 110.7 172.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -67.55 -47.62 69.31 Favored 'General case' 0 C--O 1.223 -0.309 0 N-CA-C 111.528 0.195 . . . . 0.0 111.528 178.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 413' ' ' MET . . . . . 0.914 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.3 OUTLIER -70.78 -48.26 55.23 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 119.06 -1.056 . . . . 0.0 112.106 -179.461 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 414' ' ' LEU . . . . . 0.914 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 18.6 mt -69.47 -44.23 71.61 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -175.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 383' ' ' HIS . 33.7 t -86.62 -24.04 25.49 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.526 0.679 . . . . 0.0 110.147 -175.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 112.55 -176.79 18.03 Favored Glycine 0 N--CA 1.429 -1.832 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 -173.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -81.02 22.29 0.64 Allowed 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.367 0.604 . . . . 0.0 111.285 -172.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 418' ' ' ASN . . . . . 0.455 ' HB2' HD22 ' A' ' 421' ' ' LEU . 11.4 m120 -73.04 74.91 1.21 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.984 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 419' ' ' TYR . . . . . 0.616 ' HB2' ' CE2' ' A' ' 456' ' ' PHE . 27.0 p90 -54.2 -37.57 64.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.324 178.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -54.47 -46.27 73.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.908 0.385 . . . . 0.0 110.987 177.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 421' ' ' LEU . . . . . 0.455 HD22 ' HB2' ' A' ' 418' ' ' ASN . 0.0 OUTLIER -68.51 -47.86 65.87 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.085 -177.291 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 422' ' ' VAL . . . . . 0.466 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -65.33 -38.35 82.34 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 C-N-CA 120.343 -0.543 . . . . 0.0 111.198 -178.451 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.751 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 61.1 p -68.1 -37.46 81.21 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -179.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.51 -39.35 91.12 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.237 175.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 425' ' ' ILE . . . . . 0.703 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.78 -52.53 22.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 O-C-N 122.789 -0.242 . . . . 0.0 111.011 -178.376 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 426' ' ' ILE . . . . . 0.7 HG22 HD22 ' A' ' 430' ' ' LEU . 1.2 mm -72.14 -21.76 20.7 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.715 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -172.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.751 ' HB2' ' O ' ' A' ' 423' ' ' SER . 0.7 OUTLIER -54.25 -31.46 53.55 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.52 -179.206 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -84.39 -12.2 76.31 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.463 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.629 ' CZ ' ' HG3' ' A' ' 396' ' ' LYS . 23.3 m-85 -114.69 1.9 14.32 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-O 121.15 0.5 . . . . 0.0 110.45 -176.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.703 HD23 ' HA ' ' A' ' 427' ' ' ARG . 0.1 OUTLIER -65.85 128.11 93.58 Favored Pre-proline 0 N--CA 1.439 -1.008 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.759 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 431' ' ' PRO . . . . . 0.473 ' HD2' HD12 ' A' ' 430' ' ' LEU . 59.1 Cg_exo -22.39 -72.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.355 0.906 1 C-N-CA 125.56 4.173 . . . . 0.0 114.855 179.784 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 432' ' ' GLY . . . . . 0.43 ' O ' HG12 ' A' ' 435' ' ' VAL . . . -132.27 -165.44 11.29 Favored Glycine 0 N--CA 1.439 -1.125 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 175.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 433' ' ' GLN . . . . . 0.617 ' O ' HG13 ' A' ' 436' ' ' VAL . 0.2 OUTLIER -71.21 -28.1 63.97 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 117.575 0.687 . . . . 0.0 110.631 177.513 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -70.24 -36.62 74.61 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -174.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 435' ' ' VAL . . . . . 0.738 HG23 HG11 ' A' ' 463' ' ' VAL . 7.5 p -67.24 -41.46 86.73 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-O 121.056 0.455 . . . . 0.0 110.388 -177.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.617 HG13 ' O ' ' A' ' 433' ' ' GLN . 0.2 OUTLIER -64.63 -34.78 72.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.177 175.682 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.85 -48.53 53.39 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -174.135 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 438' ' ' ALA . . . . . 0.85 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -56.15 -37.24 69.26 Favored 'General case' 0 N--CA 1.432 -1.356 0 O-C-N 123.713 0.633 . . . . 0.0 110.498 175.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 439' ' ' LEU . . . . . 0.558 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 2.1 tm? -67.66 -46.97 70.86 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -178.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -62.08 -33.92 75.32 Favored 'General case' 0 CA--C 1.49 -1.353 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.803 176.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 441' ' ' GLN . . . . . 0.568 ' O ' ' HG2' ' A' ' 445' ' ' GLN . 8.9 mm-40 -58.26 -49.2 77.96 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.199 175.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 442' ' ' ARG . . . . . 0.749 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -57.31 -39.79 76.55 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.852 171.208 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 443' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 33.6 mt -72.38 -34.45 67.95 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.201 0.524 . . . . 0.0 109.932 -178.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -57.94 -36.95 73.25 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.793 173.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 445' ' ' GLN . . . . . 0.568 ' HG2' ' O ' ' A' ' 441' ' ' GLN . 30.6 mm-40 -72.26 -27.52 62.54 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.195 178.025 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 446' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 443' ' ' LEU . 36.7 tt0 35.44 98.09 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 169.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 447' ' ' ILE . . . . . 0.534 ' HB ' ' HB ' ' A' ' 451' ' ' THR . 54.2 mt -73.41 -32.68 37.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.447 0.642 . . . . 0.0 110.447 176.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 448' ' ' ASP . . . . . 0.442 ' HB3' ' H ' ' A' ' 451' ' ' THR . 7.4 t70 -170.21 -158.17 0.16 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 -179.069 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -87.78 -58.81 2.44 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 166.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.88 -33.34 75.38 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.592 -177.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 451' ' ' THR . . . . . 0.534 ' HB ' ' HB ' ' A' ' 447' ' ' ILE . 4.8 m -72.05 -23.36 61.36 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.653 -174.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 452' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 448' ' ' ASP . 13.1 mtp180 -55.13 -54.18 46.55 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 172.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 453' ' ' ALA . . . . . 0.515 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -58.57 -48.52 80.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.616 -1.175 . . . . 0.0 112.561 175.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 454' ' ' GLU . . . . . 0.459 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 27.2 mm-40 -51.2 -37.2 45.32 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.289 0.566 . . . . 0.0 111.597 -178.176 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 27.6 p -117.9 16.92 14.29 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.352 -176.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 456' ' ' PHE . . . . . 0.616 ' CE2' ' HB2' ' A' ' 419' ' ' TYR . 1.1 t80 -58.04 -47.15 84.0 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.006 0.432 . . . . 0.0 111.6 -171.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 457' ' ' ILE . . . . . 0.708 HG23 ' HB1' ' A' ' 405' ' ' ALA . 2.0 mp -76.83 -32.43 20.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.044 0.45 . . . . 0.0 110.611 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -57.83 -34.29 69.54 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.717 0.77 . . . . 0.0 109.268 170.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 459' ' ' HIS . . . . . 0.681 ' O ' HG23 ' A' ' 463' ' ' VAL . 57.9 m-70 -76.08 -28.04 57.44 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.635 178.128 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 460' ' ' LEU . . . . . 0.723 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -74.09 -34.63 64.05 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.822 0.82 . . . . 0.0 108.82 178.196 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 461' ' ' ASN . . . . . 0.548 ' HA ' ' CD2' ' A' ' 464' ' ' TYR . 21.4 m-80 -72.63 -37.74 67.95 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.309 -0.86 . . . . 0.0 108.975 176.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 462' ' ' ALA . . . . . 0.627 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -56.21 -34.4 66.24 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.442 -1.254 . . . . 0.0 109.729 169.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.85 HG13 ' HB3' ' A' ' 438' ' ' ALA . 64.5 t -61.53 -51.58 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 114.811 -1.086 . . . . 0.0 108.085 176.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 464' ' ' TYR . . . . . 0.748 ' CE2' ' HA ' ' A' ' 471' ' ' ALA . 15.4 m-30 -52.62 -27.37 16.76 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.685 178.199 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.34 -39.11 21.16 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.593 0.711 . . . . 0.0 109.557 -178.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.627 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.7 mt -60.17 -55.54 23.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 114.23 -1.35 . . . . 0.0 112.268 176.064 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.74 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -100.36 -10.69 20.96 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -173.469 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 468' ' ' GLY . . . . . 0.588 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 93.15 31.18 8.65 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 119.556 -1.307 . . . . 0.0 114.165 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 469' ' ' LEU . . . . . 0.74 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.0 mt -89.98 166.56 13.39 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.24 1.02 . . . . 0.0 111.767 178.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 35.1 p30 -106.07 177.57 4.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.271 169.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 471' ' ' ALA . . . . . 0.748 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -71.09 -6.92 42.87 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -173.007 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -92.2 -0.33 57.42 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.022 0.439 . . . . 0.0 110.6 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 77.47 12.79 84.2 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.571 -0.824 . . . . 0.0 111.085 -175.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -100.91 157.9 16.39 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 175.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 475' ' ' SER . . . . . 0.507 ' HA ' HD22 ' A' ' 469' ' ' LEU . 0.6 OUTLIER -93.45 120.06 33.28 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.538 0.685 . . . . 0.0 112.633 -177.03 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 476' ' ' ILE . . . . . 0.588 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.2 pp -89.4 179.69 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 162.061 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 477' ' ' ARG . . . . . 0.645 ' HD3' ' N ' ' A' ' 477' ' ' ARG . 0.1 OUTLIER -119.43 104.24 10.16 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 118.385 -1.326 . . . . 0.0 111.442 -171.873 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 478' ' ' LEU . . . . . 0.457 HD23 ' H ' ' A' ' 478' ' ' LEU . 2.5 pt? -71.65 176.25 4.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.569 -1.196 . . . . 0.0 111.292 -177.092 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.445 -0.788 . . . . 0.0 110.486 179.778 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 381' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 . . . . . 0 N--CA 1.479 0.98 0 CA-C-O 120.891 0.377 . . . . 0.0 110.471 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 382' ' ' THR . . . . . 0.481 HG23 ' HD2' ' B' ' 383' ' ' HIS . 0.0 OUTLIER -99.8 -24.49 14.66 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.297 177.557 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 383' ' ' HIS . . . . . 0.517 ' HB2' ' O ' ' B' ' 386' ' ' PHE . 17.5 p80 -167.86 159.3 11.43 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.506 -0.477 . . . . 0.0 111.92 -175.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 384' ' ' GLY . . . . . . . . . . . . . . . -109.06 -110.91 3.4 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.378 172.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 385' ' ' THR . . . . . . . . . . . . . 14.1 m -64.5 -36.21 83.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.061 0.458 . . . . 0.0 111.58 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 386' ' ' PHE . . . . . 0.765 ' CZ ' HG12 ' B' ' 394' ' ' VAL . 1.6 t80 -82.08 128.52 67.71 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.577 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 387' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' B' ' 386' ' ' PHE . 15.4 Cg_endo -53.68 -51.54 10.59 Favored 'Trans proline' 0 N--CA 1.49 1.294 1 C-N-CA 125.48 4.12 . . . . 0.0 115.895 -176.732 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 388' ' ' MET . . . . . 0.767 ' SD ' HG13 ' B' ' 394' ' ' VAL . 53.8 tpp 74.18 15.7 3.6 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 165.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 389' ' ' HIS . . . . . 0.798 ' CG ' ' HB2' ' B' ' 393' ' ' ASN . 16.1 m170 64.03 7.29 3.28 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.203 -0.936 . . . . 0.0 110.257 -175.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 66.31 24.73 10.56 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.527 -170.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 391' ' ' LEU . . . . . 0.471 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.6 pt? -164.32 -53.23 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 171.054 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 392' ' ' GLY . . . . . 0.55 ' HA2' ' SD ' ' B' ' 388' ' ' MET . . . -175.64 49.51 0.12 Allowed Glycine 0 CA--C 1.524 0.641 0 C-N-CA 119.756 -1.212 . . . . 0.0 114.464 -176.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 393' ' ' ASN . . . . . 0.798 ' HB2' ' CG ' ' B' ' 389' ' ' HIS . 0.5 OUTLIER -54.61 -43.28 72.08 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 117.348 0.574 . . . . 0.0 109.862 177.837 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 394' ' ' VAL . . . . . 0.767 HG13 ' SD ' ' B' ' 388' ' ' MET . 0.7 OUTLIER -57.6 -46.13 86.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -177.818 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 395' ' ' ILE . . . . . 0.693 HG21 HG22 ' B' ' 425' ' ' ILE . 4.1 mp -57.42 -52.26 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-O 117.979 -1.01 . . . . 0.0 113.186 -174.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 396' ' ' LYS . . . . . 0.637 ' HG3' ' CZ ' ' B' ' 429' ' ' TYR . 0.0 OUTLIER -63.58 -50.22 70.32 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 121.661 2.028 . . . . 0.0 112.302 -175.684 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 397' ' ' GLY . . . . . 0.57 ' O ' ' HG3' ' B' ' 401' ' ' GLN . . . -54.39 -44.86 76.74 Favored Glycine 0 N--CA 1.434 -1.449 0 C-N-CA 120.03 -1.081 . . . . 0.0 111.089 -177.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 398' ' ' ILE . . . . . 0.777 HD13 HD12 ' B' ' 410' ' ' LEU . 31.2 mt -71.33 -34.54 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -178.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 399' ' ' VAL . . . . . 0.528 HG12 ' HA ' ' B' ' 404' ' ' VAL . 10.0 m -63.66 -39.94 87.2 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.519 0 C-N-CA 118.971 -1.092 . . . . 0.0 108.577 -173.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -66.41 -41.24 89.55 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 175.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 401' ' ' GLN . . . . . 0.57 ' HG3' ' O ' ' B' ' 397' ' ' GLY . 38.3 mt-30 -91.89 -47.19 7.45 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -168.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 402' ' ' GLU . . . . . 0.651 ' HG3' ' HE3' ' A' ' 413' ' ' MET . 2.9 mm-40 -115.01 -20.56 10.45 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.987 0.422 . . . . 0.0 111.276 -172.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 106.19 162.95 22.82 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.099 177.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 404' ' ' VAL . . . . . 0.653 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.3 m -53.53 -42.89 51.63 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.858 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -175.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 405' ' ' ALA . . . . . 0.689 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -69.24 -28.64 66.52 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 119.545 -0.862 . . . . 0.0 112.165 -176.039 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 406' ' ' THR . . . . . 0.703 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 85.9 m -77.4 -43.14 33.69 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.159 -0.616 . . . . 0.0 109.94 172.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 407' ' ' ALA . . . . . 0.49 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.28 -37.54 75.22 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 122.118 0.961 . . . . 0.0 109.351 176.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 408' ' ' TYR . . . . . 0.653 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.69 -52.04 54.65 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 113.568 -1.651 . . . . 0.0 109.8 177.072 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 409' ' ' THR . . . . . 0.656 HG22 HD23 ' B' ' 410' ' ' LEU . 14.8 m -55.46 -47.53 75.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.678 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 410' ' ' LEU . . . . . 0.777 HD12 HD13 ' B' ' 398' ' ' ILE . 13.8 mt -72.14 -35.79 69.18 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 120.838 0.351 . . . . 0.0 110.271 -175.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.94 -35.06 81.48 Favored Glycine 0 N--CA 1.439 -1.144 0 C-N-CA 120.229 -0.986 . . . . 0.0 110.71 172.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 412' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -67.46 -47.75 69.2 Favored 'General case' 0 C--O 1.224 -0.267 0 N-CA-C 111.556 0.206 . . . . 0.0 111.556 178.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 413' ' ' MET . . . . . 0.93 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.3 OUTLIER -70.67 -48.26 55.73 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 118.96 -1.096 . . . . 0.0 112.139 -179.367 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 414' ' ' LEU . . . . . 0.93 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 18.7 mt -69.53 -44.3 71.27 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -175.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 33.5 t -86.55 -23.98 25.63 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.509 0.671 . . . . 0.0 110.158 -175.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 416' ' ' GLY . . . . . . . . . . . . . . . 112.44 -177.06 18.29 Favored Glycine 0 N--CA 1.428 -1.843 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 -173.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -80.93 22.67 0.6 Allowed 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.219 0.533 . . . . 0.0 111.214 -172.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 418' ' ' ASN . . . . . 0.443 ' HB2' HD22 ' B' ' 421' ' ' LEU . 11.3 m120 -73.09 75.36 1.24 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.884 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 419' ' ' TYR . . . . . 0.631 ' HB2' ' CE2' ' B' ' 456' ' ' PHE . 26.8 p90 -54.86 -37.42 66.22 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.207 178.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -54.56 -46.31 73.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.961 0.41 . . . . 0.0 110.889 177.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 421' ' ' LEU . . . . . 0.456 ' O ' HD13 ' B' ' 425' ' ' ILE . 0.0 OUTLIER -68.42 -47.83 66.23 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.136 -177.158 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 422' ' ' VAL . . . . . 0.469 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.2 OUTLIER -65.18 -38.56 82.96 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.218 -178.524 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 423' ' ' SER . . . . . 0.762 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 62.3 p -68.05 -37.37 81.24 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.21 -39.76 92.34 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.307 175.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 425' ' ' ILE . . . . . 0.693 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -72.55 -52.58 22.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 O-C-N 122.785 -0.244 . . . . 0.0 111.003 -178.081 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 426' ' ' ILE . . . . . 0.695 HG22 HD22 ' B' ' 430' ' ' LEU . 1.2 mm -72.21 -21.67 20.56 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.821 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -172.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 427' ' ' ARG . . . . . 0.762 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.7 OUTLIER -54.31 -31.33 53.89 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.216 0.531 . . . . 0.0 110.479 -179.265 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -84.25 -12.39 76.27 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.404 178.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 429' ' ' TYR . . . . . 0.637 ' CZ ' ' HG3' ' B' ' 396' ' ' LYS . 23.2 m-85 -114.77 1.87 14.25 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 121.064 0.459 . . . . 0.0 110.372 -176.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 430' ' ' LEU . . . . . 0.695 HD22 HG22 ' B' ' 426' ' ' ILE . 0.1 OUTLIER -65.77 128.32 93.72 Favored Pre-proline 0 N--CA 1.438 -1.042 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.681 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 431' ' ' PRO . . . . . 0.457 ' HD2' HD12 ' B' ' 430' ' ' LEU . 56.8 Cg_exo -22.48 -73.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.355 0.883 1 C-N-CA 125.702 4.268 . . . . 0.0 114.606 179.563 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 432' ' ' GLY . . . . . 0.446 ' O ' HG12 ' B' ' 435' ' ' VAL . . . -132.34 -165.74 11.36 Favored Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 175.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 433' ' ' GLN . . . . . 0.612 ' O ' HG13 ' B' ' 436' ' ' VAL . 0.2 OUTLIER -70.94 -27.96 64.14 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 117.506 0.653 . . . . 0.0 110.643 177.85 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -70.39 -36.43 74.08 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -174.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 435' ' ' VAL . . . . . 0.74 HG23 HG11 ' B' ' 463' ' ' VAL . 7.5 p -67.36 -41.52 86.45 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 CA-C-O 121.102 0.477 . . . . 0.0 110.346 -177.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 436' ' ' VAL . . . . . 0.612 HG13 ' O ' ' B' ' 433' ' ' GLN . 0.2 OUTLIER -64.67 -34.77 72.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.214 175.64 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.87 -48.51 53.42 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 -174.211 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 438' ' ' ALA . . . . . 0.841 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -56.21 -37.17 69.3 Favored 'General case' 0 N--CA 1.433 -1.32 0 O-C-N 123.631 0.582 . . . . 0.0 110.382 175.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 439' ' ' LEU . . . . . 0.568 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 2.1 tm? -67.72 -47.0 70.57 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -62.15 -33.89 75.35 Favored 'General case' 0 CA--C 1.489 -1.378 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.828 176.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 441' ' ' GLN . . . . . 0.568 ' O ' ' HG2' ' B' ' 445' ' ' GLN . 9.0 mm-40 -58.3 -49.19 78.05 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.258 175.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 442' ' ' ARG . . . . . 0.743 ' HG2' ' O ' ' B' ' 438' ' ' ALA . 0.0 OUTLIER -57.24 -39.93 76.53 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.913 171.067 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 443' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 33.3 mt -72.26 -34.34 68.16 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.376 0.608 . . . . 0.0 109.918 -178.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -58.02 -36.96 73.44 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.838 173.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 445' ' ' GLN . . . . . 0.568 ' HG2' ' O ' ' B' ' 441' ' ' GLN . 30.6 mm-40 -72.13 -27.66 62.77 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.161 178.034 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 446' ' ' GLU . . . . . 0.487 ' HB2' ' O ' ' B' ' 443' ' ' LEU . 38.0 tt0 35.6 98.07 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 170.001 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 447' ' ' ILE . . . . . 0.528 ' HB ' ' HB ' ' B' ' 451' ' ' THR . 54.4 mt -73.41 -32.71 37.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.629 0.728 . . . . 0.0 110.48 176.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 448' ' ' ASP . . . . . 0.45 ' HB3' ' H ' ' B' ' 451' ' ' THR . 7.7 t70 -170.16 -158.42 0.17 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 -179.014 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -87.55 -58.92 2.4 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 166.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.66 -33.41 75.6 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 115.272 -0.877 . . . . 0.0 112.609 -177.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 451' ' ' THR . . . . . 0.528 ' HB ' ' HB ' ' B' ' 447' ' ' ILE . 4.7 m -72.0 -23.26 61.38 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.671 -174.262 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 452' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' B' ' 448' ' ' ASP . 13.1 mtp180 -55.25 -54.13 47.38 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 172.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 453' ' ' ALA . . . . . 0.508 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -58.51 -48.36 81.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.689 -1.142 . . . . 0.0 112.622 175.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 454' ' ' GLU . . . . . 0.458 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 26.2 mm-40 -51.61 -37.3 49.39 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.399 0.619 . . . . 0.0 111.366 -178.042 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 29.1 p -117.71 16.82 14.45 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.471 -176.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 456' ' ' PHE . . . . . 0.631 ' CE2' ' HB2' ' B' ' 419' ' ' TYR . 1.1 t80 -58.01 -47.17 83.87 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.035 0.445 . . . . 0.0 111.571 -171.197 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 457' ' ' ILE . . . . . 0.689 HG23 ' HB1' ' B' ' 405' ' ' ALA . 2.0 mp -76.92 -32.31 19.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.622 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -57.93 -34.29 69.71 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.702 0.763 . . . . 0.0 109.214 170.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 459' ' ' HIS . . . . . 0.682 ' O ' HG23 ' B' ' 463' ' ' VAL . 58.4 m-70 -75.97 -28.14 57.76 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.634 178.028 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 460' ' ' LEU . . . . . 0.728 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.4 OUTLIER -74.06 -34.66 64.11 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.903 0.859 . . . . 0.0 108.82 178.262 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 461' ' ' ASN . . . . . 0.55 ' HA ' ' CD2' ' B' ' 464' ' ' TYR . 22.1 m-80 -72.59 -37.8 68.04 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.965 176.042 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 462' ' ' ALA . . . . . 0.634 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -56.37 -34.25 66.48 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.688 169.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 463' ' ' VAL . . . . . 0.841 HG13 ' HB3' ' B' ' 438' ' ' ALA . 65.3 t -61.49 -51.49 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 176.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 464' ' ' TYR . . . . . 0.747 ' CE2' ' HA ' ' B' ' 471' ' ' ALA . 15.5 m-30 -52.76 -27.24 16.97 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 124.354 1.034 . . . . 0.0 110.745 178.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.53 -39.11 20.85 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.703 0.763 . . . . 0.0 109.486 -178.101 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 466' ' ' ILE . . . . . 0.634 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.6 mt -59.76 -55.92 20.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 114.219 -1.355 . . . . 0.0 112.224 176.027 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 467' ' ' LEU . . . . . 0.743 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -100.21 -10.62 21.18 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -173.235 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 468' ' ' GLY . . . . . 0.603 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 93.25 31.06 8.67 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 119.604 -1.284 . . . . 0.0 114.122 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 469' ' ' LEU . . . . . 0.743 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 2.9 mt -90.05 166.51 13.39 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.343 1.072 . . . . 0.0 111.723 178.187 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 34.6 p30 -106.11 177.94 4.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.366 169.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 471' ' ' ALA . . . . . 0.747 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -71.16 -7.08 44.26 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -173.04 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -92.05 -0.44 57.46 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.022 0.439 . . . . 0.0 110.674 -177.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 473' ' ' GLY . . . . . . . . . . . . . . . 77.45 13.06 83.94 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.136 -175.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -101.25 157.99 16.37 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 175.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 475' ' ' SER . . . . . 0.502 ' HA ' HD22 ' B' ' 469' ' ' LEU . 0.5 OUTLIER -93.61 120.2 33.58 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.729 0.776 . . . . 0.0 112.644 -177.081 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 476' ' ' ILE . . . . . 0.603 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.2 pp -89.27 179.97 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 N-CA-C 105.426 -2.065 . . . . 0.0 105.426 162.053 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 477' ' ' ARG . . . . . 0.654 ' HD3' ' N ' ' B' ' 477' ' ' ARG . 0.1 OUTLIER -119.6 103.92 9.83 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 118.427 -1.309 . . . . 0.0 111.485 -172.009 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 478' ' ' LEU . . . . . 0.449 HD23 ' H ' ' B' ' 478' ' ' LEU . 2.5 pt? -71.53 175.91 5.16 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.322 -177.074 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 479' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 . . . . . 0 C--O 1.253 1.249 0 CA-C-O 118.583 -0.722 . . . . 0.0 110.509 179.781 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 381' ' ' ARG . . . . . 0.49 ' HD2' ' OD1' ' A' ' 418' ' ' ASN . 19.1 ptp180 . . . . . 0 N--CA 1.48 1.031 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 382' ' ' THR . . . . . 0.63 ' O ' ' HB3' ' A' ' 415' ' ' SER . 0.1 OUTLIER -131.4 -39.67 1.14 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 -175.369 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -153.41 159.47 42.39 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 119.515 -0.874 . . . . 0.0 112.867 -171.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -115.15 -112.19 2.87 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.048 171.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 11.3 m -58.95 -44.12 91.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.805 0.335 . . . . 0.0 111.72 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 386' ' ' PHE . . . . . 0.806 ' CD1' HD22 ' A' ' 414' ' ' LEU . 3.6 t80 -73.19 121.04 84.1 Favored Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 387' ' ' PRO . . . . . 0.452 ' HD2' ' HA ' ' A' ' 386' ' ' PHE . 6.5 Cg_endo -46.47 -71.55 0.05 OUTLIER 'Trans proline' 0 N--CA 1.475 0.44 0 C-N-CA 124.163 3.242 . . . . 0.0 114.412 -175.093 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.604 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 30.7 ttm 70.38 143.96 0.05 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 122.356 0.262 . . . . 0.0 110.717 178.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 389' ' ' HIS . . . . . 0.598 ' CD2' ' HB2' ' A' ' 393' ' ' ASN . 32.6 m170 -48.49 -76.17 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 121.42 0.629 . . . . 0.0 110.382 -176.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -166.66 19.49 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 173.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.535 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.6 pt? -168.67 -51.83 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.505 -171.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 392' ' ' GLY . . . . . 0.673 ' HA3' HD13 ' A' ' 395' ' ' ILE . . . -176.22 60.84 0.1 Allowed Glycine 0 C--N 1.336 0.571 0 C-N-CA 119.751 -1.214 . . . . 0.0 114.028 -176.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 393' ' ' ASN . . . . . 0.604 ' HB3' ' HA ' ' A' ' 388' ' ' MET . 0.2 OUTLIER -58.39 -42.08 86.31 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 174.115 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.657 HG23 HD12 ' A' ' 398' ' ' ILE . 1.7 m -55.24 -47.06 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 -179.379 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.673 HD13 ' HA3' ' A' ' 392' ' ' GLY . 3.6 mp -57.7 -52.65 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 CA-C-O 117.8 -1.095 . . . . 0.0 113.729 -175.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 396' ' ' LYS . . . . . 0.595 ' O ' HG22 ' A' ' 399' ' ' VAL . 0.0 OUTLIER -62.75 -50.15 72.22 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 122.022 2.192 . . . . 0.0 112.298 -173.525 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 397' ' ' GLY . . . . . 0.488 ' O ' ' HG3' ' A' ' 401' ' ' GLN . . . -53.86 -42.09 68.64 Favored Glycine 0 N--CA 1.436 -1.344 0 C-N-CA 119.895 -1.145 . . . . 0.0 110.804 -175.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 398' ' ' ILE . . . . . 0.762 HD13 HD12 ' A' ' 410' ' ' LEU . 36.1 mt -71.64 -34.43 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 CA-C-N 114.263 -0.969 . . . . 0.0 113.517 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 399' ' ' VAL . . . . . 0.595 HG22 ' O ' ' A' ' 396' ' ' LYS . 15.6 m -63.57 -39.94 87.22 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 C-N-CA 118.925 -1.11 . . . . 0.0 108.631 -173.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -68.29 -38.79 82.01 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 176.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.488 ' HG3' ' O ' ' A' ' 397' ' ' GLY . 31.8 mt-30 -93.05 -48.46 6.49 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -171.079 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 402' ' ' GLU . . . . . 0.693 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 3.0 mm-40 -113.14 -20.15 11.57 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.2 -172.268 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 105.48 161.51 23.29 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.849 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 404' ' ' VAL . . . . . 0.645 HG11 ' HA ' ' A' ' 430' ' ' LEU . 1.5 m -53.78 -45.23 61.62 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.78 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 -176.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 405' ' ' ALA . . . . . 0.542 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -64.03 -31.16 72.25 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.005 -0.678 . . . . 0.0 112.481 -177.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.699 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 87.1 m -77.38 -42.43 36.46 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.476 -0.489 . . . . 0.0 110.244 173.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.469 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -58.4 -36.85 74.19 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 122.245 1.022 . . . . 0.0 109.311 176.042 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 408' ' ' TYR . . . . . 0.629 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -66.33 -51.92 52.37 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 113.436 -1.711 . . . . 0.0 109.991 176.337 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 409' ' ' THR . . . . . 0.64 HG22 HD23 ' A' ' 410' ' ' LEU . 16.5 m -55.68 -46.91 77.5 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.58 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 410' ' ' LEU . . . . . 0.762 HD12 HD13 ' A' ' 398' ' ' ILE . 14.1 mt -72.36 -34.95 68.37 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -175.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -59.35 -34.22 79.5 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.383 -0.913 . . . . 0.0 110.994 170.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 412' ' ' MET . . . . . 0.423 ' HE2' ' HA ' ' A' ' 417' ' ' GLN . 0.6 OUTLIER -66.71 -48.25 69.8 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 122.611 -0.346 . . . . 0.0 111.119 177.035 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 413' ' ' MET . . . . . 0.9 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.5 OUTLIER -71.53 -51.45 23.5 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 119.363 -0.935 . . . . 0.0 112.656 -179.357 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 414' ' ' LEU . . . . . 0.9 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 12.5 mt -67.55 -46.47 72.67 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -174.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.63 ' HB3' ' O ' ' A' ' 382' ' ' THR . 0.1 OUTLIER -97.58 10.98 38.46 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.364 0.602 . . . . 0.0 111.086 -172.66 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 416' ' ' GLY . . . . . 0.426 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 84.08 179.82 51.84 Favored Glycine 0 N--CA 1.438 -1.187 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.68 -179.006 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 417' ' ' GLN . . . . . 0.423 ' HA ' ' HE2' ' A' ' 412' ' ' MET . 31.1 mm-40 -79.83 23.06 0.46 Allowed 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.364 0.602 . . . . 0.0 110.789 -173.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 418' ' ' ASN . . . . . 0.49 ' OD1' ' HD2' ' A' ' 381' ' ' ARG . 64.0 m-80 -72.33 77.36 1.01 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.782 -178.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 419' ' ' TYR . . . . . 0.552 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 7.1 p90 -49.83 -38.23 33.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.977 174.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -54.33 -47.72 72.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.749 177.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -48.65 66.02 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.044 -176.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 422' ' ' VAL . . . . . 0.464 ' HB ' ' CD1' ' A' ' 408' ' ' TYR . 0.2 OUTLIER -66.01 -40.49 87.45 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.572 0 C-N-CA 120.281 -0.567 . . . . 0.0 111.355 -176.918 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.816 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 80.6 p -69.24 -37.88 78.22 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -178.228 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.56 -38.96 90.91 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.761 176.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 425' ' ' ILE . . . . . 0.58 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.91 -52.56 21.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.028 -0.086 . . . . 0.0 111.182 -178.279 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 426' ' ' ILE . . . . . 0.686 HG22 HD22 ' A' ' 430' ' ' LEU . 1.1 mm -74.69 -23.59 17.91 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.896 0 O-C-N 121.968 -0.457 . . . . 0.0 110.374 -171.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.816 ' HB2' ' O ' ' A' ' 423' ' ' SER . 1.3 tmm_? -55.44 -30.86 61.3 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.325 0.583 . . . . 0.0 111.007 -177.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -86.58 -12.11 70.1 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.203 178.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.537 ' HD1' HG22 ' A' ' 395' ' ' ILE . 7.7 m-30 -112.68 -0.5 15.05 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.615 0.722 . . . . 0.0 109.07 -174.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.733 HD23 ' HA ' ' A' ' 427' ' ' ARG . 0.1 OUTLIER -66.07 129.75 94.27 Favored Pre-proline 0 N--CA 1.444 -0.754 0 CA-C-N 114.549 -1.205 . . . . 0.0 108.953 177.508 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 431' ' ' PRO . . . . . 0.544 ' HD2' HD12 ' A' ' 430' ' ' LEU . 81.4 Cg_exo -23.91 -68.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.915 1 C-N-CA 125.489 4.126 . . . . 0.0 114.852 179.117 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 432' ' ' GLY . . . . . 0.502 ' O ' HG12 ' A' ' 435' ' ' VAL . . . -141.51 -167.81 11.32 Favored Glycine 0 N--CA 1.442 -0.91 0 N-CA-C 110.089 -1.205 . . . . 0.0 110.089 176.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 433' ' ' GLN . . . . . 0.517 ' O ' HG13 ' A' ' 436' ' ' VAL . 43.6 tp60 -70.4 -26.96 63.93 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 118.083 0.941 . . . . 0.0 110.449 178.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -64.3 -41.98 96.59 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 435' ' ' VAL . . . . . 0.724 HG23 HG11 ' A' ' 463' ' ' VAL . 7.4 p -67.67 -42.81 86.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 121.018 0.437 . . . . 0.0 110.66 -177.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.517 HG13 ' O ' ' A' ' 433' ' ' GLN . 0.1 OUTLIER -67.26 -31.61 53.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.402 175.735 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.61 -52.76 41.71 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -178.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 438' ' ' ALA . . . . . 0.875 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -58.63 -39.82 81.63 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.936 177.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 439' ' ' LEU . . . . . 0.649 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 1.8 tm? -68.0 -48.39 65.87 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -177.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -60.54 -33.73 73.09 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.074 175.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 441' ' ' GLN . . . . . 0.516 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 3.5 mm-40 -54.83 -50.29 68.96 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.863 -178.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 442' ' ' ARG . . . . . 0.618 ' HG3' ' CG ' ' A' ' 459' ' ' HIS . 0.0 OUTLIER -77.76 -24.12 49.05 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 174.271 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 443' ' ' LEU . . . . . 0.649 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 56.5 mt -64.04 -27.17 68.93 Favored 'General case' 0 CA--C 1.516 -0.356 0 O-C-N 121.496 -0.753 . . . . 0.0 109.985 173.188 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -66.5 -37.12 84.37 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.85 178.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 445' ' ' GLN . . . . . 0.467 ' HG3' ' N ' ' A' ' 446' ' ' GLU . 0.0 OUTLIER -80.25 -30.39 38.47 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.479 -179.923 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 446' ' ' GLU . . . . . 0.467 ' N ' ' HG3' ' A' ' 445' ' ' GLN . 8.6 pt-20 15.21 105.03 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.248 0 O-C-N 125.617 1.823 . . . . 0.0 113.841 -177.37 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 43.6 mt -51.26 -34.44 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.369 -177.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 448' ' ' ASP . . . . . 0.507 ' HB2' ' OG1' ' A' ' 451' ' ' THR . 13.3 m-20 -160.88 -174.59 4.48 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 449' ' ' ASP . . . . . 0.488 ' O ' ' HB3' ' A' ' 452' ' ' ARG . 25.8 t0 -72.41 -62.49 1.42 Allowed 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 174.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 450' ' ' GLN . . . . . 0.401 ' HG3' ' H ' ' A' ' 450' ' ' GLN . 2.7 pp0? -70.22 -27.13 64.23 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 176.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 451' ' ' THR . . . . . 0.507 ' OG1' ' HB2' ' A' ' 448' ' ' ASP . 16.0 m -72.12 -23.06 61.26 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.004 -176.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 452' ' ' ARG . . . . . 0.488 ' HB3' ' O ' ' A' ' 449' ' ' ASP . 43.9 ttt180 -55.96 -52.26 64.79 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 172.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 453' ' ' ALA . . . . . 0.552 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -59.77 -47.21 86.6 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.707 170.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 454' ' ' GLU . . . . . 0.445 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 14.1 mm-40 -51.73 -36.45 47.11 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.137 0.494 . . . . 0.0 111.917 -175.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 24.9 p -115.46 13.98 16.58 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.271 -176.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 456' ' ' PHE . . . . . 0.598 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 1.2 t80 -55.06 -46.4 75.39 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.945 0.402 . . . . 0.0 111.746 -172.227 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 457' ' ' ILE . . . . . 0.542 HG23 ' HB1' ' A' ' 405' ' ' ALA . 1.9 mp -78.19 -33.36 17.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.784 0.326 . . . . 0.0 111.239 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -58.09 -32.71 68.34 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.805 0.812 . . . . 0.0 109.117 171.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 459' ' ' HIS . . . . . 0.748 ' O ' HG23 ' A' ' 463' ' ' VAL . 56.9 m-70 -74.17 -30.04 62.06 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.8 177.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 460' ' ' LEU . . . . . 0.705 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -73.99 -34.88 64.35 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.995 0.902 . . . . 0.0 108.988 179.518 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -73.08 -37.02 66.93 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.126 176.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 462' ' ' ALA . . . . . 0.612 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -56.02 -34.25 65.66 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.385 -1.279 . . . . 0.0 109.9 169.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.875 HG13 ' HB3' ' A' ' 438' ' ' ALA . 66.1 t -63.57 -50.83 76.57 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 CA-C-N 114.421 -1.263 . . . . 0.0 108.114 177.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 464' ' ' TYR . . . . . 0.578 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 16.9 m-30 -52.4 -29.15 22.73 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 124.348 1.03 . . . . 0.0 110.257 177.316 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.82 -40.69 22.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.745 0.784 . . . . 0.0 109.498 -177.065 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.612 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.6 mt -57.84 -56.17 17.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 114.304 -1.316 . . . . 0.0 112.269 176.035 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.764 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -100.82 -11.23 20.01 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -172.051 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 468' ' ' GLY . . . . . 0.537 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 94.09 31.6 7.98 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 119.366 -1.397 . . . . 0.0 114.321 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 469' ' ' LEU . . . . . 0.764 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.3 mt -88.47 163.02 16.15 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 117.915 0.857 . . . . 0.0 110.92 177.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 37.9 p30 -105.17 -178.04 3.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.065 172.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 471' ' ' ALA . . . . . 0.411 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -66.05 -14.65 62.07 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -176.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -88.53 -1.6 58.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.675 0.274 . . . . 0.0 111.148 -175.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 473' ' ' GLY . . . . . 0.483 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 79.04 10.66 85.95 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -175.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -101.43 156.22 17.59 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 176.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 32.1 t -93.25 137.52 32.49 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.248 0.547 . . . . 0.0 111.287 -176.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 476' ' ' ILE . . . . . 0.709 ' O ' ' HD2' ' A' ' 477' ' ' ARG . 2.4 pp -115.61 -19.8 6.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.878 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 477' ' ' ARG . . . . . 0.709 ' HD2' ' O ' ' A' ' 476' ' ' ILE . 0.1 OUTLIER 22.11 63.39 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 174.313 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 478' ' ' LEU . . . . . 0.446 ' H ' HD12 ' A' ' 476' ' ' ILE . 95.4 mt 59.1 83.54 0.13 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.151 -177.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.731 -0.652 . . . . 0.0 110.544 179.735 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 381' ' ' ARG . . . . . 0.476 ' HD2' ' OD1' ' B' ' 418' ' ' ASN . 19.0 ptp180 . . . . . 0 N--CA 1.48 1.058 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 382' ' ' THR . . . . . 0.618 ' O ' ' HB3' ' B' ' 415' ' ' SER . 0.1 OUTLIER -130.95 -39.31 1.21 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -175.22 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 383' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -153.59 159.29 42.11 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 119.428 -0.909 . . . . 0.0 112.85 -171.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 384' ' ' GLY . . . . . . . . . . . . . . . -114.98 -111.95 2.88 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.103 171.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 385' ' ' THR . . . . . . . . . . . . . 14.1 m -59.7 -43.33 94.12 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.856 0.36 . . . . 0.0 111.684 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 386' ' ' PHE . . . . . 0.825 ' CD1' HD22 ' B' ' 414' ' ' LEU . 3.5 t80 -73.59 121.16 84.47 Favored Pre-proline 0 C--N 1.329 -0.322 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 387' ' ' PRO . . . . . 0.465 ' HD2' ' HA ' ' B' ' 386' ' ' PHE . 6.7 Cg_endo -46.56 -71.56 0.05 OUTLIER 'Trans proline' 0 N--CA 1.476 0.479 0 C-N-CA 124.17 3.247 . . . . 0.0 114.433 -175.05 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 388' ' ' MET . . . . . 0.59 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 30.8 ttm 70.39 143.57 0.05 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 122.412 0.285 . . . . 0.0 110.896 178.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 389' ' ' HIS . . . . . 0.592 ' CD2' ' HB2' ' B' ' 393' ' ' ASN . 32.6 m170 -48.14 -75.93 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.1 0 CA-C-O 121.304 0.574 . . . . 0.0 110.417 -176.375 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -166.92 19.31 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 173.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 391' ' ' LEU . . . . . 0.538 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.6 pt? -168.76 -51.49 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.497 -171.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 392' ' ' GLY . . . . . 0.68 ' HA3' HD13 ' B' ' 395' ' ' ILE . . . -176.44 60.85 0.1 Allowed Glycine 0 CA--C 1.522 0.522 0 C-N-CA 119.794 -1.193 . . . . 0.0 114.151 -176.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 393' ' ' ASN . . . . . 0.592 ' HB2' ' CD2' ' B' ' 389' ' ' HIS . 0.2 OUTLIER -58.47 -42.07 86.68 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 174.095 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 394' ' ' VAL . . . . . 0.664 HG23 HD12 ' B' ' 398' ' ' ILE . 1.7 m -55.18 -47.12 77.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 395' ' ' ILE . . . . . 0.68 HD13 ' HA3' ' B' ' 392' ' ' GLY . 3.6 mp -57.64 -52.65 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 117.779 -1.105 . . . . 0.0 113.751 -175.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 396' ' ' LYS . . . . . 0.597 ' O ' HG22 ' B' ' 399' ' ' VAL . 0.0 OUTLIER -62.71 -50.18 72.14 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 122.043 2.201 . . . . 0.0 112.347 -173.667 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 397' ' ' GLY . . . . . 0.5 ' O ' ' HG3' ' B' ' 401' ' ' GLN . . . -54.06 -41.86 70.02 Favored Glycine 0 N--CA 1.436 -1.345 0 C-N-CA 119.799 -1.191 . . . . 0.0 110.838 -175.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 398' ' ' ILE . . . . . 0.754 HD13 HD12 ' B' ' 410' ' ' LEU . 35.9 mt -71.62 -34.56 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 399' ' ' VAL . . . . . 0.597 HG22 ' O ' ' B' ' 396' ' ' LYS . 15.6 m -63.38 -40.1 87.76 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 C-N-CA 118.94 -1.104 . . . . 0.0 108.68 -174.005 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -68.53 -38.5 80.9 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 176.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 401' ' ' GLN . . . . . 0.5 ' HG3' ' O ' ' B' ' 397' ' ' GLY . 32.9 mt-30 -92.86 -48.39 6.57 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -171.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 402' ' ' GLU . . . . . 0.735 ' HG3' ' HE3' ' A' ' 413' ' ' MET . 3.1 mm-40 -113.43 -19.89 11.52 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.154 -172.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 105.12 161.42 23.62 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.947 178.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 404' ' ' VAL . . . . . 0.639 HG11 ' HA ' ' B' ' 430' ' ' LEU . 1.4 m -53.69 -45.37 60.66 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 N-CA-C 114.409 1.262 . . . . 0.0 114.409 -176.379 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 405' ' ' ALA . . . . . 0.522 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -63.97 -31.23 72.35 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 119.954 -0.698 . . . . 0.0 112.504 -177.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 406' ' ' THR . . . . . 0.692 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 89.9 m -77.12 -42.36 38.29 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.298 173.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 407' ' ' ALA . . . . . 0.467 ' HB2' ' HB ' ' B' ' 398' ' ' ILE . . . -58.48 -36.79 74.27 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 122.203 1.001 . . . . 0.0 109.282 176.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 408' ' ' TYR . . . . . 0.616 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -66.46 -51.87 52.28 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 113.43 -1.714 . . . . 0.0 109.937 176.449 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 409' ' ' THR . . . . . 0.646 HG22 HD23 ' B' ' 410' ' ' LEU . 16.6 m -55.45 -47.07 76.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.591 178.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 410' ' ' LEU . . . . . 0.754 HD12 HD13 ' B' ' 398' ' ' ILE . 14.1 mt -72.42 -34.78 68.08 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -175.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -59.41 -34.14 79.39 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.308 -0.948 . . . . 0.0 110.998 170.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 412' ' ' MET . . . . . 0.422 ' HB2' ' O ' ' B' ' 409' ' ' THR . 0.6 OUTLIER -66.88 -48.15 69.64 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 122.612 -0.346 . . . . 0.0 111.072 177.163 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 413' ' ' MET . . . . . 0.917 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.5 OUTLIER -71.59 -51.69 22.01 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 119.336 -0.946 . . . . 0.0 112.678 -179.456 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 414' ' ' LEU . . . . . 0.917 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 12.4 mt -67.21 -46.5 73.67 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -174.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 415' ' ' SER . . . . . 0.618 ' HB3' ' O ' ' B' ' 382' ' ' THR . 0.1 OUTLIER -97.44 10.61 39.27 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.368 0.604 . . . . 0.0 110.975 -172.556 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 416' ' ' GLY . . . . . 0.426 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 84.16 179.39 51.73 Favored Glycine 0 N--CA 1.438 -1.202 0 C-N-CA 120.638 -0.791 . . . . 0.0 111.609 -178.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -79.5 23.23 0.41 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.564 0.697 . . . . 0.0 110.843 -173.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 418' ' ' ASN . . . . . 0.476 ' OD1' ' HD2' ' B' ' 381' ' ' ARG . 64.8 m-80 -72.51 77.49 1.06 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.763 -178.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 419' ' ' TYR . . . . . 0.557 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 6.9 p90 -50.0 -38.29 36.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.975 174.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -54.28 -47.64 72.12 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.807 177.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.7 -48.76 65.63 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.963 -176.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 422' ' ' VAL . . . . . 0.461 ' HB ' ' CD1' ' B' ' 408' ' ' TYR . 0.2 OUTLIER -66.01 -40.47 87.38 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.499 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.216 -176.757 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 423' ' ' SER . . . . . 0.814 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 80.3 p -69.15 -37.76 78.43 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -178.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -68.0 -38.61 88.8 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.636 176.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 425' ' ' ILE . . . . . 0.599 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -72.95 -52.91 20.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 O-C-N 123.062 -0.081 . . . . 0.0 111.088 -178.289 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 426' ' ' ILE . . . . . 0.682 HG22 HD22 ' B' ' 430' ' ' LEU . 1.1 mm -74.34 -23.77 18.53 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.89 0 O-C-N 122.182 -0.324 . . . . 0.0 110.376 -171.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 427' ' ' ARG . . . . . 0.814 ' HB2' ' O ' ' B' ' 423' ' ' SER . 1.3 tmm_? -55.33 -30.76 60.88 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.241 0.544 . . . . 0.0 111.024 -177.191 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -86.87 -11.8 69.8 Favored Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 120.445 -0.883 . . . . 0.0 111.224 178.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 429' ' ' TYR . . . . . 0.543 ' HD1' HG22 ' B' ' 395' ' ' ILE . 7.9 m-30 -112.94 -0.39 14.84 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -174.311 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 430' ' ' LEU . . . . . 0.735 HD23 ' HA ' ' B' ' 427' ' ' ARG . 0.1 OUTLIER -66.12 129.72 94.25 Favored Pre-proline 0 N--CA 1.442 -0.837 0 CA-C-N 114.477 -1.238 . . . . 0.0 108.938 177.426 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 431' ' ' PRO . . . . . 0.543 ' HD2' HD12 ' B' ' 430' ' ' LEU . 81.0 Cg_exo -24.05 -69.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.357 1.001 1 C-N-CA 125.399 4.066 . . . . 0.0 114.796 179.224 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 432' ' ' GLY . . . . . 0.516 ' O ' HG12 ' B' ' 435' ' ' VAL . . . -141.28 -168.03 11.34 Favored Glycine 0 N--CA 1.443 -0.886 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 177.04 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 433' ' ' GLN . . . . . 0.531 ' O ' HG13 ' B' ' 436' ' ' VAL . 43.8 tp60 -70.23 -26.93 64.08 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 118.173 0.986 . . . . 0.0 110.411 178.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -63.99 -42.18 97.28 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.964 -178.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 435' ' ' VAL . . . . . 0.718 HG23 HG11 ' B' ' 463' ' ' VAL . 7.3 p -67.76 -42.77 86.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 120.977 0.417 . . . . 0.0 110.649 -177.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 436' ' ' VAL . . . . . 0.531 HG13 ' O ' ' B' ' 433' ' ' GLN . 0.1 OUTLIER -67.31 -31.57 53.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.323 175.732 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.58 -52.74 42.11 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -178.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 438' ' ' ALA . . . . . 0.871 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -58.68 -39.74 81.57 Favored 'General case' 0 N--CA 1.436 -1.128 0 O-C-N 124.042 0.838 . . . . 0.0 111.97 177.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 439' ' ' LEU . . . . . 0.669 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 1.8 tm? -68.03 -48.41 65.73 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -178.014 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.45 -33.7 72.94 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.143 175.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 441' ' ' GLN . . . . . 0.513 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 3.4 mm-40 -55.0 -50.25 69.47 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.742 -178.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 442' ' ' ARG . . . . . 0.615 ' HG3' ' CG ' ' B' ' 459' ' ' HIS . 0.0 OUTLIER -77.74 -24.0 49.19 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 174.388 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 443' ' ' LEU . . . . . 0.669 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 55.8 mt -64.31 -26.91 68.69 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 118.755 0.707 . . . . 0.0 109.966 173.118 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -66.71 -37.03 83.89 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.78 178.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 445' ' ' GLN . . . . . 0.464 ' HG3' ' N ' ' B' ' 446' ' ' GLU . 0.0 OUTLIER -80.33 -30.42 38.12 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.584 179.874 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 446' ' ' GLU . . . . . 0.464 ' N ' ' HG3' ' B' ' 445' ' ' GLN . 8.7 pt-20 15.2 105.14 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 O-C-N 125.517 1.761 . . . . 0.0 113.816 -177.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 43.7 mt -51.28 -34.23 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.362 -177.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 448' ' ' ASP . . . . . 0.509 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 13.0 m-20 -161.04 -174.45 4.38 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 449' ' ' ASP . . . . . 0.492 ' O ' ' HB3' ' B' ' 452' ' ' ARG . 27.9 t0 -72.26 -62.69 1.34 Allowed 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 174.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 2.7 pp0? -70.03 -27.26 64.52 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 176.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 451' ' ' THR . . . . . 0.509 ' OG1' ' HB2' ' B' ' 448' ' ' ASP . 14.6 m -72.07 -23.02 61.29 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 119.749 -0.78 . . . . 0.0 109.946 -176.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 452' ' ' ARG . . . . . 0.492 ' HB3' ' O ' ' B' ' 449' ' ' ASP . 43.5 ttt180 -56.0 -52.15 65.22 Favored 'General case' 0 N--CA 1.415 -2.176 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 172.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 453' ' ' ALA . . . . . 0.557 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -60.05 -46.9 87.99 Favored 'General case' 0 CA--C 1.527 0.081 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 171.012 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 454' ' ' GLU . . . . . 0.447 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 13.5 mm-40 -51.95 -36.25 48.73 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.157 0.503 . . . . 0.0 111.837 -176.024 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 24.9 p -115.61 14.18 16.45 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.368 -176.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 456' ' ' PHE . . . . . 0.606 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 1.2 t80 -55.32 -46.29 76.32 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.944 0.402 . . . . 0.0 111.745 -172.129 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 457' ' ' ILE . . . . . 0.528 ' CG1' ' HB3' ' B' ' 408' ' ' TYR . 1.9 mp -78.16 -33.39 17.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 120.687 0.279 . . . . 0.0 111.273 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -58.06 -32.92 68.49 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.993 0.902 . . . . 0.0 109.078 171.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 459' ' ' HIS . . . . . 0.743 ' O ' HG23 ' B' ' 463' ' ' VAL . 56.4 m-70 -73.98 -29.97 62.25 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.79 177.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 460' ' ' LEU . . . . . 0.708 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -74.16 -34.71 63.91 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.814 0.816 . . . . 0.0 108.923 179.649 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 461' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -73.07 -37.34 66.83 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.016 176.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 462' ' ' ALA . . . . . 0.621 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -55.99 -34.04 65.4 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.758 169.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 463' ' ' VAL . . . . . 0.871 HG13 ' HB3' ' B' ' 438' ' ' ALA . 68.4 t -63.49 -51.09 74.95 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-N 114.548 -1.205 . . . . 0.0 108.152 177.322 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 464' ' ' TYR . . . . . 0.563 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 16.9 m-30 -52.3 -29.15 21.97 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 124.347 1.029 . . . . 0.0 110.311 177.382 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.68 -40.98 22.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.614 0.721 . . . . 0.0 109.475 -177.088 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 466' ' ' ILE . . . . . 0.621 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.7 mt -57.42 -56.32 15.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 114.277 -1.329 . . . . 0.0 112.251 176.086 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 467' ' ' LEU . . . . . 0.765 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -100.78 -11.36 19.95 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 114.66 1.355 . . . . 0.0 114.66 -171.971 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 468' ' ' GLY . . . . . 0.551 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 94.24 31.56 7.93 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 119.368 -1.396 . . . . 0.0 114.32 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 469' ' ' LEU . . . . . 0.765 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.3 mt -88.6 162.93 16.09 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 117.873 0.836 . . . . 0.0 110.879 177.181 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 37.8 p30 -105.0 -177.95 3.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.109 172.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 471' ' ' ALA . . . . . 0.408 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -66.41 -14.46 62.19 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -176.141 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -88.43 -1.71 58.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.624 0.249 . . . . 0.0 111.166 -176.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 473' ' ' GLY . . . . . 0.477 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 78.99 10.82 85.83 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -175.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -101.51 156.46 17.46 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 176.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 34.8 t -93.36 137.56 32.55 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.348 0.594 . . . . 0.0 111.264 -176.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 476' ' ' ILE . . . . . 0.71 ' O ' ' HD2' ' B' ' 477' ' ' ARG . 2.4 pp -115.64 -19.63 6.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.865 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 477' ' ' ARG . . . . . 0.71 ' HD2' ' O ' ' B' ' 476' ' ' ILE . 0.1 OUTLIER 21.98 62.82 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 115.076 1.509 . . . . 0.0 115.076 174.295 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 478' ' ' LEU . . . . . 0.461 ' H ' HD12 ' B' ' 476' ' ' ILE . 96.4 mt 59.77 83.82 0.13 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.972 -177.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 479' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.659 -0.686 . . . . 0.0 110.629 179.89 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 381' ' ' ARG . . . . . 0.699 ' N ' ' HG ' ' A' ' 415' ' ' SER . 19.6 ptp180 . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 382' ' ' THR . . . . . 0.428 HG22 ' H ' ' A' ' 382' ' ' THR . 0.0 OUTLIER -53.9 -44.52 70.6 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -179.533 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -139.97 119.59 13.22 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 120.898 0.38 . . . . 0.0 111.806 175.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 162.82 85.12 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 -178.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 24.2 m 73.8 123.12 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 122.963 0.505 . . . . 0.0 110.414 -175.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 386' ' ' PHE . . . . . 0.745 ' CD1' HD22 ' A' ' 414' ' ' LEU . 2.1 t80 69.64 111.53 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.542 -171.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 387' ' ' PRO . . . . . 0.472 ' HD2' ' HA ' ' A' ' 386' ' ' PHE . 1.5 Cg_endo -39.85 -62.84 0.33 Allowed 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 124.404 3.403 . . . . 0.0 113.764 -174.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.484 ' C ' ' HB3' ' A' ' 393' ' ' ASN . 6.3 ttp 59.04 38.34 24.11 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 174.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 389' ' ' HIS . . . . . 0.603 ' N ' ' HB3' ' A' ' 393' ' ' ASN . 31.3 m170 51.8 -97.22 0.05 Allowed 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.41 0.624 . . . . 0.0 110.064 -176.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -151.57 23.89 0.7 Allowed 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.186 171.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.477 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.4 pt? -175.77 -47.87 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.221 -172.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 392' ' ' GLY . . . . . 0.589 ' HA3' HD13 ' A' ' 395' ' ' ILE . . . -173.22 56.37 0.15 Allowed Glycine 0 CA--C 1.524 0.645 0 C-N-CA 119.443 -1.361 . . . . 0.0 114.796 -172.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 393' ' ' ASN . . . . . 0.615 HD21 ' C ' ' A' ' 393' ' ' ASN . 0.0 OUTLIER -61.72 -37.64 84.93 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-N 117.65 0.725 . . . . 0.0 109.061 174.18 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.683 HG12 ' CE2' ' A' ' 386' ' ' PHE . 1.0 OUTLIER -57.2 -49.4 79.89 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 CA-C-N 113.674 -1.603 . . . . 0.0 107.047 179.015 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.658 HG23 HD13 ' A' ' 426' ' ' ILE . 3.6 mp -57.69 -52.82 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 CA-C-O 117.745 -1.121 . . . . 0.0 113.605 -174.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 396' ' ' LYS . . . . . 0.606 ' O ' HG22 ' A' ' 399' ' ' VAL . 0.0 OUTLIER -62.54 -49.51 75.02 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 122.017 2.189 . . . . 0.0 112.199 -174.715 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.16 -44.48 63.76 Favored Glycine 0 N--CA 1.435 -1.391 0 C-N-CA 119.98 -1.105 . . . . 0.0 110.98 -176.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 398' ' ' ILE . . . . . 0.741 HD13 HD12 ' A' ' 410' ' ' LEU . 28.5 mt -71.09 -33.94 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 399' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 396' ' ' LYS . 17.3 m -63.29 -39.81 86.67 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 C-N-CA 118.751 -1.18 . . . . 0.0 108.436 -174.06 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -70.62 -37.7 73.84 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 175.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -88.15 -48.86 7.39 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -171.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 402' ' ' GLU . . . . . 0.574 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 1.3 tm-20 -117.93 -19.94 8.98 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.065 0.46 . . . . 0.0 111.213 -170.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 106.45 160.67 22.25 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.673 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 404' ' ' VAL . . . . . 0.654 HG11 ' HA ' ' A' ' 430' ' ' LEU . 1.2 m -54.16 -45.5 66.51 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.862 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -175.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 405' ' ' ALA . . . . . 0.557 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -63.15 -31.26 72.36 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 119.794 -0.762 . . . . 0.0 112.403 -177.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.719 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 92.5 m -76.92 -42.03 41.1 Favored 'General case' 0 C--O 1.221 -0.412 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.164 173.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.449 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -58.8 -36.79 75.04 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 122.183 0.992 . . . . 0.0 109.301 176.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 408' ' ' TYR . . . . . 0.623 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -66.41 -51.73 53.92 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 113.492 -1.685 . . . . 0.0 109.571 176.762 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 409' ' ' THR . . . . . 0.648 HG22 HD23 ' A' ' 410' ' ' LEU . 17.5 m -55.11 -47.37 75.09 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.436 178.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 410' ' ' LEU . . . . . 0.741 HD12 HD13 ' A' ' 398' ' ' ILE . 15.0 mt -72.59 -35.73 67.99 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -174.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.44 -34.63 76.06 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.15 -1.024 . . . . 0.0 110.893 172.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -69.58 -47.22 64.33 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 413' ' ' MET . . . . . 0.919 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.8 OUTLIER -71.52 -44.84 63.9 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 118.914 -1.114 . . . . 0.0 111.879 -179.425 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 414' ' ' LEU . . . . . 0.919 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 11.7 mt -70.03 -46.37 65.21 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -177.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.699 ' HG ' ' N ' ' A' ' 381' ' ' ARG . 8.4 t -99.86 16.56 23.37 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.319 0.58 . . . . 0.0 110.349 -172.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 75.85 -176.66 50.81 Favored Glycine 0 N--CA 1.437 -1.266 0 C-N-CA 120.354 -0.927 . . . . 0.0 111.721 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -80.56 23.12 0.53 Allowed 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.272 0.558 . . . . 0.0 111.402 -172.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 418' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -71.58 76.98 0.81 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.514 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 419' ' ' TYR . . . . . 0.482 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 21.4 p90 -56.17 -38.04 70.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.518 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -55.71 -42.57 75.45 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.723 0.297 . . . . 0.0 111.081 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.1 -49.05 63.63 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.287 -178.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 422' ' ' VAL . . . . . 0.469 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -65.7 -39.51 85.11 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.259 -177.878 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.798 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 61.8 p -67.73 -37.75 82.61 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 -178.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -68.09 -39.25 88.75 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.129 175.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 425' ' ' ILE . . . . . 0.571 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.23 -52.4 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-O 120.352 0.12 . . . . 0.0 111.035 -177.908 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 426' ' ' ILE . . . . . 0.658 HD13 HG23 ' A' ' 395' ' ' ILE . 1.2 mm -74.75 -23.37 17.7 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.91 0 O-C-N 122.135 -0.353 . . . . 0.0 110.555 -172.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.798 ' HB2' ' O ' ' A' ' 423' ' ' SER . 1.5 tmt_? -54.57 -31.8 57.37 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.224 0.535 . . . . 0.0 111.13 -177.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.37 -12.1 67.99 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.217 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.595 ' HD1' HG22 ' A' ' 395' ' ' ILE . 6.1 m-30 -112.0 -1.97 15.23 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -173.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.654 ' HA ' HG11 ' A' ' 404' ' ' VAL . 0.0 OUTLIER -66.05 139.97 96.83 Favored Pre-proline 0 N--CA 1.443 -0.815 0 CA-C-N 114.136 -1.393 . . . . 0.0 109.206 177.349 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 431' ' ' PRO . . . . . 0.812 ' CD ' HG11 ' A' ' 435' ' ' VAL . 77.4 Cg_exo -37.99 -75.45 0.04 OUTLIER 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 124.606 3.537 . . . . 0.0 113.92 -173.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 432' ' ' GLY . . . . . 0.422 ' O ' HG12 ' A' ' 435' ' ' VAL . . . -130.06 -161.63 10.51 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 176.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 433' ' ' GLN . . . . . 0.52 ' O ' HG13 ' A' ' 436' ' ' VAL . 19.0 tp60 -71.47 -28.78 64.18 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 118.038 0.919 . . . . 0.0 110.569 176.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -67.03 -39.19 86.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 0.0 112.123 -175.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 435' ' ' VAL . . . . . 0.812 HG11 ' CD ' ' A' ' 431' ' ' PRO . 6.8 p -66.55 -45.08 89.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.173 0.511 . . . . 0.0 110.736 -177.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 433' ' ' GLN . 0.2 OUTLIER -66.28 -31.91 55.73 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.105 177.014 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -68.01 -52.26 37.63 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -177.513 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 438' ' ' ALA . . . . . 0.84 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -57.58 -40.56 79.29 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.179 177.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 439' ' ' LEU . . . . . 0.611 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 1.9 tm? -68.12 -48.13 66.26 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -178.008 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -59.86 -34.99 73.85 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.085 175.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 441' ' ' GLN . . . . . 0.542 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 4.4 mm-40 -53.62 -49.6 67.49 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.001 -178.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 442' ' ' ARG . . . . . 0.709 ' HD2' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -76.89 -25.28 52.84 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 119.133 -1.027 . . . . 0.0 113.368 174.346 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 443' ' ' LEU . . . . . 0.611 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 66.8 mt -65.59 -27.75 68.64 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 118.653 0.66 . . . . 0.0 109.771 175.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -61.29 -38.37 86.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.937 176.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -78.49 -27.63 46.25 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.319 -1.31 . . . . 0.0 111.149 178.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 25.36 101.58 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 41.5 mt -58.61 -33.59 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 121.353 0.597 . . . . 0.0 111.322 -178.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 448' ' ' ASP . . . . . 0.446 ' HB2' ' OG1' ' A' ' 451' ' ' THR . 8.4 m-20 -162.46 -159.81 0.61 Allowed 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 -178.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 449' ' ' ASP . . . . . 0.405 ' CG ' ' H ' ' A' ' 450' ' ' GLN . 12.3 p-10 -85.39 -64.88 1.08 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 168.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 450' ' ' GLN . . . . . 0.405 ' H ' ' CG ' ' A' ' 449' ' ' ASP . 2.2 pp0? -68.24 -26.11 65.53 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 179.012 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 451' ' ' THR . . . . . 0.452 ' HA ' ' HB2' ' A' ' 454' ' ' GLU . 10.4 m -71.44 -23.13 61.79 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 119.859 -0.736 . . . . 0.0 110.732 -175.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 452' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 452' ' ' ARG . 14.7 mtp180 -54.02 -53.95 45.91 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 171.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 453' ' ' ALA . . . . . 0.482 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -58.73 -49.08 78.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.354 -1.293 . . . . 0.0 112.53 174.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 454' ' ' GLU . . . . . 0.452 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 69.0 mm-40 -49.69 -37.15 27.67 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.283 0.563 . . . . 0.0 111.601 -177.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 32.0 p -118.03 15.06 14.18 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.45 -175.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 456' ' ' PHE . . . . . 0.551 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.8 OUTLIER -57.44 -47.47 81.73 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.089 0.471 . . . . 0.0 111.643 -171.28 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 457' ' ' ILE . . . . . 0.557 HG23 ' HB1' ' A' ' 405' ' ' ALA . 1.9 mp -76.92 -32.54 19.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.831 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -57.96 -34.41 69.9 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.905 0.86 . . . . 0.0 109.143 171.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 459' ' ' HIS . . . . . 0.771 ' O ' HG23 ' A' ' 463' ' ' VAL . 63.2 m-70 -74.68 -29.45 61.23 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.725 177.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 460' ' ' LEU . . . . . 0.714 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -73.47 -34.61 65.44 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.793 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 461' ' ' ASN . . . . . 0.458 ' O ' ' HB2' ' A' ' 464' ' ' TYR . 25.1 m-80 -73.11 -37.2 66.78 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.207 176.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 462' ' ' ALA . . . . . 0.598 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -55.75 -36.46 67.31 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.449 169.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.84 HG13 ' HB3' ' A' ' 438' ' ' ALA . 75.5 t -61.9 -51.16 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 CA-C-N 114.274 -1.33 . . . . 0.0 108.098 176.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 464' ' ' TYR . . . . . 0.606 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 18.5 m-30 -51.28 -29.03 13.43 Favored 'General case' 0 N--CA 1.455 -0.195 0 O-C-N 124.551 1.157 . . . . 0.0 110.758 177.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.0 -39.78 19.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.657 0.742 . . . . 0.0 109.76 -176.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.598 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.6 mt -57.89 -55.84 19.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 114.481 -1.236 . . . . 0.0 112.113 176.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.791 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -100.22 -10.51 21.29 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 -172.667 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 468' ' ' GLY . . . . . 0.665 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 94.24 32.06 7.64 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 119.238 -1.458 . . . . 0.0 114.259 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 469' ' ' LEU . . . . . 0.791 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 4.3 mt -89.2 158.85 17.73 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 117.827 0.814 . . . . 0.0 110.828 174.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 470' ' ' ASN . . . . . 0.487 HD22 HG23 ' A' ' 476' ' ' ILE . 10.8 p30 -105.8 -178.04 3.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.983 171.117 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -55.35 -27.42 47.12 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -173.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -85.82 7.32 24.33 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.767 0.318 . . . . 0.0 111.406 -170.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 473' ' ' GLY . . . . . 0.448 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 74.63 10.19 82.77 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.227 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -100.39 154.19 18.71 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 177.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 5.6 p -89.77 130.99 35.95 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.218 0.532 . . . . 0.0 111.221 -178.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 476' ' ' ILE . . . . . 0.665 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.8 pp -92.64 -4.67 10.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.564 0.697 . . . . 0.0 109.686 177.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 23.7 mmm180 -68.64 -43.83 75.46 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.066 175.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -149.24 150.7 33.01 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.693 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 . . . . . 0 C--O 1.247 0.94 0 CA-C-O 118.662 -0.685 . . . . 0.0 110.332 -179.557 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 381' ' ' ARG . . . . . 0.73 ' N ' ' HG ' ' B' ' 415' ' ' SER . 19.7 ptp180 . . . . . 0 N--CA 1.477 0.907 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 382' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -54.06 -44.4 71.08 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 383' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -140.22 119.66 13.09 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 120.94 0.4 . . . . 0.0 111.768 175.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 384' ' ' GLY . . . . . . . . . . . . . . . 162.78 85.05 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 111.43 -0.668 . . . . 0.0 111.43 -178.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 385' ' ' THR . . . . . . . . . . . . . 25.1 m 73.91 123.15 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 122.973 0.509 . . . . 0.0 110.386 -175.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 386' ' ' PHE . . . . . 0.741 ' CD1' HD22 ' B' ' 414' ' ' LEU . 2.1 t80 69.66 111.85 0.03 OUTLIER Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.534 -171.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 387' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' B' ' 386' ' ' PHE . 1.6 Cg_endo -39.86 -62.98 0.31 Allowed 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 124.427 3.418 . . . . 0.0 113.872 -175.158 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 388' ' ' MET . . . . . 0.488 ' C ' ' HB3' ' B' ' 393' ' ' ASN . 6.3 ttp 59.0 38.52 24.17 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 174.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 389' ' ' HIS . . . . . 0.61 ' N ' ' HB3' ' B' ' 393' ' ' ASN . 31.3 m170 51.71 -97.01 0.05 Allowed 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 121.426 0.631 . . . . 0.0 110.268 -176.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -151.8 23.96 0.67 Allowed 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 171.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 391' ' ' LEU . . . . . 0.481 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.4 pt? -175.75 -47.78 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.357 -172.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 392' ' ' GLY . . . . . 0.591 ' HA3' HD13 ' B' ' 395' ' ' ILE . . . -173.2 56.48 0.15 Allowed Glycine 0 CA--C 1.525 0.685 0 C-N-CA 119.477 -1.344 . . . . 0.0 114.778 -172.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 393' ' ' ASN . . . . . 0.615 HD21 ' C ' ' B' ' 393' ' ' ASN . 0.0 OUTLIER -61.8 -37.62 85.06 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-N 117.649 0.725 . . . . 0.0 109.046 174.216 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 394' ' ' VAL . . . . . 0.692 HG12 ' CE2' ' B' ' 386' ' ' PHE . 1.0 OUTLIER -57.18 -49.4 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 CA-C-N 113.642 -1.617 . . . . 0.0 107.094 179.02 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 395' ' ' ILE . . . . . 0.65 HG23 HD13 ' B' ' 426' ' ' ILE . 3.6 mp -57.68 -52.72 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.315 0 CA-C-O 117.842 -1.075 . . . . 0.0 113.625 -174.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 396' ' ' LYS . . . . . 0.607 ' O ' HG22 ' B' ' 399' ' ' VAL . 0.0 OUTLIER -62.57 -49.74 74.07 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 121.991 2.178 . . . . 0.0 112.032 -174.666 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.06 -44.58 62.8 Favored Glycine 0 N--CA 1.435 -1.405 0 C-N-CA 119.979 -1.105 . . . . 0.0 110.933 -176.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 398' ' ' ILE . . . . . 0.738 HD13 HD12 ' B' ' 410' ' ' LEU . 28.5 mt -71.0 -33.84 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -179.357 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 399' ' ' VAL . . . . . 0.607 HG22 ' O ' ' B' ' 396' ' ' LYS . 17.2 m -63.42 -39.72 86.37 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 C-N-CA 118.753 -1.179 . . . . 0.0 108.483 -174.022 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -70.51 -37.98 74.24 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 175.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 401' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -88.09 -48.61 7.61 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -171.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 402' ' ' GLU . . . . . 0.589 ' HG3' ' HE3' ' A' ' 413' ' ' MET . 1.2 tm-20 -118.14 -19.89 8.86 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.216 -170.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 106.26 160.73 22.44 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.549 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 404' ' ' VAL . . . . . 0.65 HG11 ' HA ' ' B' ' 430' ' ' LEU . 1.2 m -54.19 -45.41 66.77 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.886 0 N-CA-C 114.568 1.322 . . . . 0.0 114.568 -175.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 405' ' ' ALA . . . . . 0.535 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -63.2 -31.18 72.26 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 119.819 -0.753 . . . . 0.0 112.43 -177.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 406' ' ' THR . . . . . 0.717 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 92.0 m -76.78 -42.17 41.85 Favored 'General case' 0 C--O 1.221 -0.4 0 O-C-N 121.682 -0.636 . . . . 0.0 110.226 173.017 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 407' ' ' ALA . . . . . 0.456 ' HB2' ' HB ' ' B' ' 398' ' ' ILE . . . -58.89 -36.68 75.06 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 122.204 1.002 . . . . 0.0 109.306 176.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 408' ' ' TYR . . . . . 0.623 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -66.5 -51.69 54.01 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 113.474 -1.694 . . . . 0.0 109.576 176.772 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 409' ' ' THR . . . . . 0.645 HG22 HD23 ' B' ' 410' ' ' LEU . 17.3 m -55.18 -47.29 75.42 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.447 178.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 410' ' ' LEU . . . . . 0.738 HD12 HD13 ' B' ' 398' ' ' ILE . 15.2 mt -72.65 -35.75 67.83 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -174.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.4 -34.72 76.13 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.196 -1.002 . . . . 0.0 110.951 172.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 412' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -69.56 -47.03 65.01 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-O 120.64 0.257 . . . . 0.0 111.612 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 413' ' ' MET . . . . . 0.936 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.9 OUTLIER -71.43 -45.27 63.1 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 118.848 -1.141 . . . . 0.0 111.792 -179.459 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 414' ' ' LEU . . . . . 0.936 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 11.7 mt -69.87 -46.39 65.6 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -177.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 415' ' ' SER . . . . . 0.73 ' HG ' ' N ' ' B' ' 381' ' ' ARG . 8.4 t -99.74 16.58 23.12 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.388 0.613 . . . . 0.0 110.515 -172.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 416' ' ' GLY . . . . . . . . . . . . . . . 75.84 -176.66 50.81 Favored Glycine 0 N--CA 1.436 -1.361 0 C-N-CA 120.359 -0.924 . . . . 0.0 111.699 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -80.66 23.11 0.54 Allowed 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.222 0.534 . . . . 0.0 111.397 -172.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 418' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -71.59 76.74 0.81 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.47 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 419' ' ' TYR . . . . . 0.483 ' HB2' ' CE2' ' B' ' 456' ' ' PHE . 21.1 p90 -55.65 -38.15 69.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.66 178.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -55.54 -42.91 75.27 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.952 178.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.73 -49.06 64.57 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.354 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 422' ' ' VAL . . . . . 0.471 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.2 OUTLIER -65.78 -39.29 84.37 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.364 -177.872 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 423' ' ' SER . . . . . 0.811 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 61.6 p -67.98 -37.88 82.03 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -178.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.86 -39.14 89.7 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.241 175.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 425' ' ' ILE . . . . . 0.583 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -72.35 -52.3 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 120.367 0.127 . . . . 0.0 111.145 -178.037 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 426' ' ' ILE . . . . . 0.65 HD13 HG23 ' B' ' 395' ' ' ILE . 1.2 mm -74.79 -23.42 17.68 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.969 0 O-C-N 122.095 -0.378 . . . . 0.0 110.594 -172.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 427' ' ' ARG . . . . . 0.811 ' HB2' ' O ' ' B' ' 423' ' ' SER . 1.5 tmt_? -54.59 -31.63 57.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.176 0.512 . . . . 0.0 111.134 -177.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.58 -12.19 67.36 Favored Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.501 -0.857 . . . . 0.0 111.141 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 429' ' ' TYR . . . . . 0.595 ' HD1' HG22 ' B' ' 395' ' ' ILE . 6.1 m-30 -111.77 -2.12 15.39 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.869 0.842 . . . . 0.0 108.797 -174.062 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 430' ' ' LEU . . . . . 0.65 ' HA ' HG11 ' B' ' 404' ' ' VAL . 0.0 OUTLIER -66.18 139.94 96.68 Favored Pre-proline 0 N--CA 1.442 -0.865 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.407 177.555 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 431' ' ' PRO . . . . . 0.812 ' CD ' HG11 ' B' ' 435' ' ' VAL . 77.2 Cg_exo -38.19 -75.03 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 124.633 3.555 . . . . 0.0 113.985 -173.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 432' ' ' GLY . . . . . 0.427 ' O ' HG12 ' B' ' 435' ' ' VAL . . . -130.1 -161.65 10.51 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 176.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 433' ' ' GLN . . . . . 0.529 ' O ' HG13 ' B' ' 436' ' ' VAL . 19.8 tp60 -71.38 -29.15 64.6 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 118.058 0.929 . . . . 0.0 110.506 176.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -66.74 -39.3 87.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.215 -0.448 . . . . 0.0 112.093 -175.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 435' ' ' VAL . . . . . 0.812 HG11 ' CD ' ' B' ' 431' ' ' PRO . 6.8 p -66.44 -45.21 89.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.117 0.484 . . . . 0.0 110.69 -177.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 436' ' ' VAL . . . . . 0.529 HG13 ' O ' ' B' ' 433' ' ' GLN . 0.2 OUTLIER -66.26 -31.75 55.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.091 177.124 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -68.16 -52.27 36.51 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -177.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 438' ' ' ALA . . . . . 0.847 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -57.63 -40.51 79.36 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.139 177.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 439' ' ' LEU . . . . . 0.604 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 1.9 tm? -67.99 -48.22 66.38 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -178.096 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -59.97 -34.76 73.71 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.093 175.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 441' ' ' GLN . . . . . 0.541 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 4.5 mm-40 -53.75 -49.66 67.7 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.967 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 442' ' ' ARG . . . . . 0.714 ' HD2' ' O ' ' B' ' 438' ' ' ALA . 0.0 OUTLIER -76.76 -25.45 53.42 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 119.221 -0.992 . . . . 0.0 113.308 174.441 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 443' ' ' LEU . . . . . 0.604 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 67.4 mt -65.62 -27.41 68.37 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 118.656 0.662 . . . . 0.0 109.806 175.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -61.7 -38.02 86.33 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.954 176.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 34.5 mm-40 -78.74 -27.39 44.78 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.266 -1.334 . . . . 0.0 111.232 178.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 446' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 24.9 101.35 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 41.6 mt -58.09 -33.91 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 121.35 0.595 . . . . 0.0 111.292 -178.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 448' ' ' ASP . . . . . 0.45 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 8.1 m-20 -162.14 -159.62 0.61 Allowed 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -178.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 449' ' ' ASP . . . . . 0.407 ' H ' ' HB3' ' B' ' 448' ' ' ASP . 12.1 p-10 -85.4 -64.87 1.08 Allowed 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 168.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 450' ' ' GLN . . . . . 0.407 ' H ' ' CG ' ' B' ' 449' ' ' ASP . 2.2 pp0? -68.41 -26.05 65.35 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 179.128 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 451' ' ' THR . . . . . 0.45 ' OG1' ' HB2' ' B' ' 448' ' ' ASP . 10.0 m -71.58 -23.09 61.67 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.75 -175.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 452' ' ' ARG . . . . . . . . . . . . . 14.5 mtp180 -53.97 -54.0 45.02 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 171.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 453' ' ' ALA . . . . . 0.478 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -58.68 -49.09 78.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.361 -1.291 . . . . 0.0 112.596 174.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 454' ' ' GLU . . . . . 0.437 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 71.1 mm-40 -49.8 -36.93 28.14 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.218 0.533 . . . . 0.0 111.616 -177.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 32.3 p -118.15 15.0 14.08 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.448 -175.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 456' ' ' PHE . . . . . 0.555 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 0.8 OUTLIER -57.53 -47.27 82.44 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.136 0.493 . . . . 0.0 111.66 -171.266 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 457' ' ' ILE . . . . . 0.535 HG23 ' HB1' ' B' ' 405' ' ' ALA . 1.9 mp -77.15 -32.4 19.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.029 0.442 . . . . 0.0 110.853 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -57.87 -34.62 69.96 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.779 0.799 . . . . 0.0 109.113 171.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 459' ' ' HIS . . . . . 0.769 ' O ' HG23 ' B' ' 463' ' ' VAL . 64.1 m-70 -74.65 -29.47 61.27 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.55 -1.204 . . . . 0.0 110.748 177.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 460' ' ' LEU . . . . . 0.731 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -73.33 -34.52 65.72 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.91 0.862 . . . . 0.0 108.758 178.59 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 461' ' ' ASN . . . . . 0.454 ' O ' ' HB2' ' B' ' 464' ' ' TYR . 23.5 m-80 -73.26 -37.26 66.36 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.15 176.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 462' ' ' ALA . . . . . 0.602 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -55.66 -36.33 66.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.636 -1.165 . . . . 0.0 109.495 169.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 463' ' ' VAL . . . . . 0.847 HG13 ' HB3' ' B' ' 438' ' ' ALA . 75.6 t -62.07 -51.09 76.64 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-N 114.293 -1.321 . . . . 0.0 107.983 176.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 464' ' ' TYR . . . . . 0.614 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 18.6 m-30 -51.47 -28.97 14.75 Favored 'General case' 0 C--N 1.332 -0.167 0 O-C-N 124.496 1.123 . . . . 0.0 110.644 177.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.94 -39.97 19.11 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.719 0.771 . . . . 0.0 109.712 -176.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 466' ' ' ILE . . . . . 0.602 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.6 mt -57.75 -55.7 19.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 114.35 -1.295 . . . . 0.0 112.249 176.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 467' ' ' LEU . . . . . 0.784 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -100.25 -10.58 21.18 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -172.833 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 468' ' ' GLY . . . . . 0.667 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 94.21 32.12 7.62 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 119.308 -1.425 . . . . 0.0 114.313 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 469' ' ' LEU . . . . . 0.784 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 4.3 mt -89.05 159.05 17.76 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 117.814 0.807 . . . . 0.0 110.742 174.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 470' ' ' ASN . . . . . 0.474 HD22 HG23 ' B' ' 476' ' ' ILE . 10.6 p30 -105.88 -178.11 3.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.001 170.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 471' ' ' ALA . . . . . . . . . . . . . . . -55.36 -27.47 47.56 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -173.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -85.67 7.18 24.38 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 122.159 -0.338 . . . . 0.0 111.438 -171.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 473' ' ' GLY . . . . . 0.451 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 74.87 9.96 83.51 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.322 -0.942 . . . . 0.0 111.306 -178.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -100.54 154.41 18.58 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 177.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 6.4 p -89.69 131.06 35.86 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.27 0.557 . . . . 0.0 111.291 -178.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 476' ' ' ILE . . . . . 0.667 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.8 pp -92.62 -4.97 10.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.539 0.685 . . . . 0.0 109.75 177.255 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 477' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 -68.29 -43.92 76.64 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.06 175.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 478' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -149.28 150.25 32.25 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.743 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 479' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 . . . . . 0 C--O 1.246 0.898 0 CA-C-O 118.587 -0.72 . . . . 0.0 110.342 -179.259 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 . . . . . 0 N--CA 1.479 0.982 0 CA-C-O 120.962 0.41 . . . . 0.0 110.559 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 382' ' ' THR . . . . . 0.557 HG23 ' HD2' ' A' ' 383' ' ' HIS . 0.0 OUTLIER -116.13 -27.94 6.74 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.914 -0.584 . . . . 0.0 112.16 -176.489 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 383' ' ' HIS . . . . . 0.557 ' HD2' HG23 ' A' ' 382' ' ' THR . 15.1 p80 -159.17 157.94 31.82 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.089 -0.644 . . . . 0.0 111.757 -173.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -103.92 -115.87 4.13 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.099 171.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 34.3 m -66.51 -31.16 71.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.941 0.401 . . . . 0.0 111.51 -178.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 386' ' ' PHE . . . . . 0.75 ' CD1' HD22 ' A' ' 414' ' ' LEU . 1.4 t80 -80.7 120.61 79.56 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.302 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 387' ' ' PRO . . . . . 0.47 ' HD2' ' HA ' ' A' ' 386' ' ' PHE . 10.0 Cg_endo -48.17 -69.77 0.07 OUTLIER 'Trans proline' 0 N--CA 1.483 0.873 0 C-N-CA 124.722 3.615 . . . . 0.0 115.907 -173.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.535 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 32.6 mtt 72.73 156.24 0.17 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.379 0.671 . . . . 0.0 111.216 -172.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 389' ' ' HIS . . . . . 0.55 ' CG ' ' HB2' ' A' ' 393' ' ' ASN . 32.7 m170 -54.33 -59.67 4.37 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 175.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 390' ' ' GLN . . . . . 0.406 ' H ' HD23 ' A' ' 391' ' ' LEU . 30.1 pt20 -177.55 19.96 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.786 -1.097 . . . . 0.0 108.687 175.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.587 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.3 pt? -170.11 -58.53 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.38 -167.183 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 392' ' ' GLY . . . . . 0.611 ' HA3' HD13 ' A' ' 395' ' ' ILE . . . -172.73 51.31 0.17 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.372 -0.918 . . . . 0.0 113.181 -172.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 393' ' ' ASN . . . . . 0.55 ' HB2' ' CG ' ' A' ' 389' ' ' HIS . 0.6 OUTLIER -57.01 -38.56 73.27 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.138 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.706 HG12 ' CE2' ' A' ' 386' ' ' PHE . 0.9 OUTLIER -55.88 -46.44 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 179.771 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.636 HG23 HD13 ' A' ' 426' ' ' ILE . 4.2 mp -57.82 -51.98 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 CA-C-O 117.902 -1.046 . . . . 0.0 113.047 -175.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 396' ' ' LYS . . . . . 0.702 ' HG3' ' CZ ' ' A' ' 429' ' ' TYR . 0.2 OUTLIER -62.49 -49.19 76.37 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 121.563 1.983 . . . . 0.0 111.816 -173.689 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -54.48 -44.87 77.71 Favored Glycine 0 N--CA 1.434 -1.471 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.0 -178.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 398' ' ' ILE . . . . . 0.86 HD13 HD12 ' A' ' 410' ' ' LEU . 45.0 mt -70.9 -33.87 53.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -177.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 399' ' ' VAL . . . . . 0.533 HG12 ' HA ' ' A' ' 404' ' ' VAL . 10.9 m -64.23 -39.42 85.45 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 C-N-CA 118.667 -1.213 . . . . 0.0 108.324 -175.295 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -70.37 -35.29 73.44 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 175.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.427 HE21 ' HB3' ' A' ' 401' ' ' GLN . 2.7 mm100 -89.42 -47.95 7.66 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -172.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 402' ' ' GLU . . . . . 0.675 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 3.1 mm-40 -121.0 -21.23 6.58 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.795 -170.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 108.03 162.23 20.99 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.952 -0.642 . . . . 0.0 113.046 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 404' ' ' VAL . . . . . 0.68 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.5 m -53.75 -42.51 52.21 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.772 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -175.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 405' ' ' ALA . . . . . 0.63 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -68.86 -29.86 68.26 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 119.708 -0.797 . . . . 0.0 112.073 -175.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.692 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 90.6 m -77.76 -42.5 33.87 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.074 173.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.461 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.35 -37.91 76.14 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 122.084 0.945 . . . . 0.0 109.229 176.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 408' ' ' TYR . . . . . 0.68 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.4 -51.79 57.91 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 113.517 -1.674 . . . . 0.0 109.851 176.996 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 409' ' ' THR . . . . . 0.666 HG22 HD23 ' A' ' 410' ' ' LEU . 12.0 m -54.96 -47.08 75.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.586 178.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 410' ' ' LEU . . . . . 0.86 HD12 HD13 ' A' ' 398' ' ' ILE . 14.5 mt -72.24 -36.67 69.15 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.893 0.377 . . . . 0.0 110.213 -174.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.82 -34.94 80.06 Favored Glycine 0 N--CA 1.438 -1.182 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 172.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 412' ' ' MET . . . . . 0.465 ' HB2' ' O ' ' A' ' 409' ' ' THR . 0.6 OUTLIER -66.06 -46.58 77.25 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 115.61 -0.295 . . . . 0.0 111.5 177.252 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 413' ' ' MET . . . . . 0.778 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.0 OUTLIER -70.33 -55.22 9.69 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 118.788 -1.165 . . . . 0.0 111.94 -179.814 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 414' ' ' LEU . . . . . 0.778 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 6.9 mt -64.76 -43.71 92.43 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -172.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 40.8 t -86.05 -20.43 28.8 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.677 0.751 . . . . 0.0 110.032 -177.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 104.03 -175.65 23.2 Favored Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 -171.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 417' ' ' GLN . . . . . 0.44 ' HA ' ' HE2' ' A' ' 412' ' ' MET . 34.5 mm-40 -79.85 24.2 0.41 Allowed 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.186 0.517 . . . . 0.0 111.748 -171.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 418' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -71.09 75.04 0.67 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.393 178.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 419' ' ' TYR . . . . . 0.497 ' HB2' ' CE2' ' A' ' 456' ' ' PHE . 14.0 p90 -52.22 -37.07 53.97 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.947 175.079 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 420' ' ' GLN . . . . . 0.411 ' HG3' ' H ' ' A' ' 421' ' ' LEU . 2.5 pt20 -53.7 -47.18 70.76 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.95 176.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 421' ' ' LEU . . . . . 0.411 ' H ' ' HG3' ' A' ' 420' ' ' GLN . 0.0 OUTLIER -68.09 -48.58 65.13 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.192 -177.005 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 422' ' ' VAL . . . . . 0.455 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.3 OUTLIER -66.48 -40.35 86.26 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.345 -176.584 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.772 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 77.2 p -67.33 -37.08 82.73 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 -179.017 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -68.51 -38.67 86.81 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.249 175.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 425' ' ' ILE . . . . . 0.595 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -73.44 -51.92 23.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.461 0.172 . . . . 0.0 111.235 -178.452 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 426' ' ' ILE . . . . . 0.636 HD13 HG23 ' A' ' 395' ' ' ILE . 1.2 mm -74.53 -22.45 17.64 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.845 0 C-N-CA 122.614 0.366 . . . . 0.0 110.092 -171.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.772 ' HB2' ' O ' ' A' ' 423' ' ' SER . 0.5 OUTLIER -54.2 -30.78 51.01 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.227 0.537 . . . . 0.0 110.26 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.92 -4.89 78.19 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.808 179.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.702 ' CZ ' ' HG3' ' A' ' 396' ' ' LYS . 23.7 m-85 -119.09 -2.12 10.81 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 121.573 0.701 . . . . 0.0 110.081 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.602 HD12 ' HD2' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -66.29 135.17 94.81 Favored Pre-proline 0 N--CA 1.439 -0.989 0 CA-C-N 114.664 -1.153 . . . . 0.0 108.881 178.84 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 431' ' ' PRO . . . . . 0.826 ' HD2' HG11 ' A' ' 435' ' ' VAL . 50.6 Cg_exo -36.69 -64.42 0.18 Allowed 'Trans proline' 0 CA--C 1.533 0.442 0 C-N-CA 124.723 3.615 . . . . 0.0 114.247 -172.05 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 432' ' ' GLY . . . . . 0.594 ' H ' HG12 ' A' ' 435' ' ' VAL . . . -144.17 -164.96 10.72 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 176.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 433' ' ' GLN . . . . . 0.48 ' O ' HG13 ' A' ' 436' ' ' VAL . 18.4 tp60 -70.47 -26.93 63.85 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 118.197 0.999 . . . . 0.0 110.347 178.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -67.46 -39.49 85.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.312 -0.404 . . . . 0.0 112.045 -177.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 435' ' ' VAL . . . . . 0.826 HG11 ' HD2' ' A' ' 431' ' ' PRO . 7.0 p -67.96 -44.99 84.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-O 120.953 0.406 . . . . 0.0 110.576 -178.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.503 HG12 ' O ' ' A' ' 432' ' ' GLY . 0.1 OUTLIER -66.06 -29.31 46.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.343 176.167 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -69.35 -52.55 26.13 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 438' ' ' ALA . . . . . 0.887 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -58.03 -37.99 75.39 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.57 177.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 439' ' ' LEU . . . . . 0.583 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 2.1 tm? -70.16 -47.17 62.78 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -178.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -57.1 -40.3 76.75 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.21 174.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 441' ' ' GLN . . . . . 0.528 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 11.0 mm-40 -53.51 -49.89 66.58 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 123.751 0.82 . . . . 0.0 110.852 173.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 442' ' ' ARG . . . . . 0.83 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 1.6 mmp_? -55.89 -39.75 72.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.816 171.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 443' ' ' LEU . . . . . 0.583 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 39.2 mt -72.09 -31.15 65.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.788 0.328 . . . . 0.0 110.862 -178.291 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -57.25 -38.29 73.6 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.773 0.796 . . . . 0.0 110.081 171.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -76.44 -25.91 54.89 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.528 -1.214 . . . . 0.0 111.96 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 446' ' ' GLU . . . . . 0.478 ' O ' ' HG3' ' A' ' 446' ' ' GLU . 14.5 pt-20 1.92 105.43 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 125.35 1.46 . . . . 0.0 114.393 -178.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 38.4 mt -58.01 -35.54 52.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.877 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 448' ' ' ASP . . . . . 0.493 ' HB2' ' OG1' ' A' ' 451' ' ' THR . 26.1 m-20 -164.07 -176.55 4.56 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -178.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -66.36 -67.11 0.47 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 173.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -70.03 -26.88 64.25 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 451' ' ' THR . . . . . 0.493 ' OG1' ' HB2' ' A' ' 448' ' ' ASP . 10.7 m -72.43 -23.81 61.13 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.046 -0.661 . . . . 0.0 110.256 -177.15 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 19.7 ttm180 -54.62 -53.06 59.71 Favored 'General case' 0 N--CA 1.413 -2.324 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 171.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 453' ' ' ALA . . . . . 0.493 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -58.37 -47.27 84.38 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.673 172.264 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 454' ' ' GLU . . . . . 0.421 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 16.5 mm-40 -52.31 -38.5 58.64 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.26 0.552 . . . . 0.0 111.369 -176.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 27.3 p -112.26 12.48 20.31 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.362 -176.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 456' ' ' PHE . . . . . 0.547 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 1.0 OUTLIER -55.5 -46.93 76.9 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.037 0.446 . . . . 0.0 111.599 -173.052 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 457' ' ' ILE . . . . . 0.63 HG23 ' HB1' ' A' ' 405' ' ' ALA . 2.0 mp -77.77 -34.37 19.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.022 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -57.83 -34.57 69.82 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.946 0.879 . . . . 0.0 109.203 171.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 459' ' ' HIS . . . . . 0.726 ' O ' HG23 ' A' ' 463' ' ' VAL . 51.3 m-70 -74.0 -28.99 61.73 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.92 176.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 460' ' ' LEU . . . . . 0.721 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -73.69 -34.54 64.9 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.939 0.875 . . . . 0.0 108.717 179.016 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 461' ' ' ASN . . . . . 0.437 ' HA ' ' CD2' ' A' ' 464' ' ' TYR . 23.5 m-80 -73.19 -38.33 66.18 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.004 176.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 462' ' ' ALA . . . . . 0.621 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -56.45 -34.91 67.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.723 169.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.887 HG13 ' HB3' ' A' ' 438' ' ' ALA . 61.5 t -59.96 -50.97 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 114.611 -1.177 . . . . 0.0 107.845 175.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 464' ' ' TYR . . . . . 0.596 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 17.2 m-30 -53.69 -28.26 32.68 Favored 'General case' 0 C--N 1.333 -0.14 0 O-C-N 124.395 1.06 . . . . 0.0 110.743 178.278 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.99 -41.34 20.87 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.691 0.758 . . . . 0.0 109.636 -178.086 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.621 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.5 mt -56.11 -55.35 18.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 114.266 -1.334 . . . . 0.0 112.345 176.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.794 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -102.16 -10.42 19.64 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -173.064 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 468' ' ' GLY . . . . . 0.568 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 93.86 31.4 8.19 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 119.396 -1.383 . . . . 0.0 114.348 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 469' ' ' LEU . . . . . 0.794 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 4.4 mt -88.59 164.55 15.33 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 118.01 0.905 . . . . 0.0 111.408 177.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 38.5 p30 -105.24 -176.83 3.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.827 170.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 471' ' ' ALA . . . . . 0.514 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -68.17 -13.67 62.4 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -176.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -89.02 -1.19 57.99 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 122.23 -0.294 . . . . 0.0 111.347 -175.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 78.47 12.58 84.12 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.334 -0.936 . . . . 0.0 110.898 -174.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -100.58 151.27 21.79 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 177.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 475' ' ' SER . . . . . 0.527 ' OG ' ' HG3' ' A' ' 477' ' ' ARG . 31.7 t -92.26 136.69 32.98 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.241 0.543 . . . . 0.0 111.023 -177.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 476' ' ' ILE . . . . . 0.649 ' O ' ' HD2' ' A' ' 477' ' ' ARG . 2.3 pp -115.48 -29.67 2.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.087 -178.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 477' ' ' ARG . . . . . 0.649 ' HD2' ' O ' ' A' ' 476' ' ' ILE . 0.2 OUTLIER 17.46 69.88 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 O-C-N 125.164 1.54 . . . . 0.0 114.998 178.258 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 95.9 mt -89.25 40.32 0.98 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.101 -177.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.764 -0.636 . . . . 0.0 109.835 178.653 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 381' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 . . . . . 0 N--CA 1.48 1.051 0 CA-C-O 120.915 0.388 . . . . 0.0 110.414 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 382' ' ' THR . . . . . 0.556 HG23 ' HD2' ' B' ' 383' ' ' HIS . 0.0 OUTLIER -116.09 -27.95 6.75 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.21 -176.511 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 383' ' ' HIS . . . . . 0.556 ' HD2' HG23 ' B' ' 382' ' ' THR . 15.4 p80 -159.13 157.76 31.55 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.161 -0.616 . . . . 0.0 111.693 -173.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 384' ' ' GLY . . . . . . . . . . . . . . . -103.79 -115.68 4.11 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.472 -0.87 . . . . 0.0 111.116 171.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 385' ' ' THR . . . . . . . . . . . . . 33.8 m -66.69 -30.81 71.14 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.919 0.39 . . . . 0.0 111.593 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 386' ' ' PHE . . . . . 0.764 ' CD1' HD22 ' B' ' 414' ' ' LEU . 1.4 t80 -81.1 120.72 79.39 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.102 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 387' ' ' PRO . . . . . 0.479 ' HD2' ' HA ' ' B' ' 386' ' ' PHE . 9.5 Cg_endo -48.19 -69.9 0.07 OUTLIER 'Trans proline' 0 N--CA 1.484 0.921 0 C-N-CA 124.703 3.602 . . . . 0.0 115.872 -173.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 388' ' ' MET . . . . . 0.538 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 32.5 mtt 72.94 156.56 0.17 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.222 0.609 . . . . 0.0 111.162 -172.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 389' ' ' HIS . . . . . 0.56 ' CG ' ' HB2' ' B' ' 393' ' ' ASN . 32.7 m170 -54.58 -59.9 4.08 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 175.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 390' ' ' GLN . . . . . 0.4 ' H ' HD23 ' B' ' 391' ' ' LEU . 30.1 pt20 -177.23 19.77 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.649 175.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 391' ' ' LEU . . . . . 0.58 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.3 pt? -169.97 -58.37 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.451 -167.074 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 392' ' ' GLY . . . . . 0.615 ' HA3' HD13 ' B' ' 395' ' ' ILE . . . -172.81 51.51 0.17 Allowed Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.302 -0.951 . . . . 0.0 113.026 -172.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 393' ' ' ASN . . . . . 0.56 ' HB2' ' CG ' ' B' ' 389' ' ' HIS . 0.6 OUTLIER -57.01 -38.54 73.24 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.967 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 394' ' ' VAL . . . . . 0.709 HG12 ' CE2' ' B' ' 386' ' ' PHE . 0.9 OUTLIER -56.07 -46.45 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 395' ' ' ILE . . . . . 0.63 HG23 HD13 ' B' ' 426' ' ' ILE . 4.2 mp -57.63 -52.09 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 CA-C-O 117.973 -1.013 . . . . 0.0 113.04 -175.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 396' ' ' LYS . . . . . 0.707 ' HG3' ' CZ ' ' B' ' 429' ' ' TYR . 0.2 OUTLIER -62.49 -49.27 76.06 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 121.482 1.947 . . . . 0.0 111.8 -173.777 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -54.35 -44.89 76.35 Favored Glycine 0 N--CA 1.434 -1.487 0 C-N-CA 120.103 -1.046 . . . . 0.0 111.02 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 398' ' ' ILE . . . . . 0.867 HD13 HD12 ' B' ' 410' ' ' LEU . 45.0 mt -70.94 -33.81 53.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -177.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 399' ' ' VAL . . . . . 0.534 HG12 ' HA ' ' B' ' 404' ' ' VAL . 10.8 m -64.22 -39.51 85.75 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 C-N-CA 118.592 -1.243 . . . . 0.0 108.346 -175.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -70.39 -35.26 73.36 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 175.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 401' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -89.43 -47.81 7.75 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -172.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 402' ' ' GLU . . . . . 0.674 ' HG3' ' HE3' ' A' ' 413' ' ' MET . 3.0 mm-40 -121.09 -21.3 6.5 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.771 -170.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 108.02 162.25 21.0 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.954 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 404' ' ' VAL . . . . . 0.67 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.5 m -53.83 -42.56 53.21 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.809 0 N-CA-C 114.698 1.369 . . . . 0.0 114.698 -175.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 405' ' ' ALA . . . . . 0.642 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -68.82 -29.9 68.34 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 119.77 -0.772 . . . . 0.0 111.991 -175.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 406' ' ' THR . . . . . 0.687 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 92.5 m -77.59 -42.53 34.82 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.161 173.127 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 407' ' ' ALA . . . . . 0.462 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.3 -37.76 75.7 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 122.182 0.992 . . . . 0.0 109.295 176.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 408' ' ' TYR . . . . . 0.67 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.56 -51.86 56.65 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 113.494 -1.685 . . . . 0.0 109.747 177.12 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 409' ' ' THR . . . . . 0.666 HG22 HD23 ' B' ' 410' ' ' LEU . 10.2 m -54.84 -47.13 74.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.636 178.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 410' ' ' LEU . . . . . 0.867 HD12 HD13 ' B' ' 398' ' ' ILE . 14.3 mt -72.05 -36.91 69.73 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.972 0.415 . . . . 0.0 110.263 -174.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.63 -34.87 78.37 Favored Glycine 0 N--CA 1.439 -1.135 0 C-N-CA 120.036 -1.078 . . . . 0.0 110.52 172.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 412' ' ' MET . . . . . 0.468 ' HB2' ' O ' ' B' ' 409' ' ' THR . 0.5 OUTLIER -66.26 -46.47 76.97 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 115.64 -0.28 . . . . 0.0 111.39 177.287 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 413' ' ' MET . . . . . 0.775 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.0 OUTLIER -70.34 -55.02 10.15 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 118.709 -1.197 . . . . 0.0 111.987 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 414' ' ' LEU . . . . . 0.779 HD21 HG12 ' A' ' 398' ' ' ILE . 6.9 mt -64.97 -43.7 91.76 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -172.33 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 43.0 t -86.02 -20.48 28.78 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.79 0.805 . . . . 0.0 109.991 -177.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 416' ' ' GLY . . . . . . . . . . . . . . . 104.06 -175.91 23.34 Favored Glycine 0 N--CA 1.43 -1.758 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -171.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 417' ' ' GLN . . . . . 0.407 ' HA ' ' HE2' ' B' ' 412' ' ' MET . 35.4 mm-40 -79.85 24.45 0.39 Allowed 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.22 0.533 . . . . 0.0 111.808 -171.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 418' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -71.28 74.89 0.72 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.456 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 419' ' ' TYR . . . . . 0.494 ' HB2' ' CE2' ' B' ' 456' ' ' PHE . 14.4 p90 -52.09 -37.04 52.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.997 175.185 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 420' ' ' GLN . . . . . 0.401 ' HG3' ' H ' ' B' ' 421' ' ' LEU . 2.5 pt20 -53.67 -47.39 70.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.904 176.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 421' ' ' LEU . . . . . 0.401 ' H ' ' HG3' ' B' ' 420' ' ' GLN . 0.0 OUTLIER -67.98 -48.62 65.3 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.136 -177.011 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 422' ' ' VAL . . . . . 0.456 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.3 OUTLIER -66.51 -40.26 86.0 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.436 -176.476 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 423' ' ' SER . . . . . 0.77 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 77.7 p -67.39 -36.97 82.39 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 -179.075 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -68.58 -38.6 86.44 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.292 175.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 425' ' ' ILE . . . . . 0.612 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -73.37 -51.72 24.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 O-C-N 122.975 -0.132 . . . . 0.0 111.204 -178.318 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 426' ' ' ILE . . . . . 0.63 HD13 HG23 ' B' ' 395' ' ' ILE . 1.2 mm -74.87 -22.42 17.17 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.873 0 C-N-CA 122.627 0.371 . . . . 0.0 110.019 -171.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 427' ' ' ARG . . . . . 0.77 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.5 OUTLIER -54.26 -30.44 50.47 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.275 0.56 . . . . 0.0 110.294 179.85 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.88 -5.4 77.6 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.809 178.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 429' ' ' TYR . . . . . 0.707 ' CZ ' ' HG3' ' B' ' 396' ' ' LYS . 23.7 m-85 -118.9 -1.72 10.97 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 121.415 0.626 . . . . 0.0 110.152 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 430' ' ' LEU . . . . . 0.616 HD12 ' HD2' ' B' ' 431' ' ' PRO . 0.0 OUTLIER -66.42 135.38 94.72 Favored Pre-proline 0 N--CA 1.439 -0.992 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.855 178.777 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 431' ' ' PRO . . . . . 0.825 ' HD2' HG11 ' B' ' 435' ' ' VAL . 52.5 Cg_exo -36.89 -64.51 0.18 Allowed 'Trans proline' 0 CA--C 1.532 0.391 0 C-N-CA 124.716 3.611 . . . . 0.0 114.209 -172.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 432' ' ' GLY . . . . . 0.585 ' H ' HG12 ' B' ' 435' ' ' VAL . . . -144.09 -164.48 10.45 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 176.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 433' ' ' GLN . . . . . 0.487 ' O ' HG13 ' B' ' 436' ' ' VAL . 17.5 tp60 -70.67 -26.99 63.69 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 118.198 0.999 . . . . 0.0 110.369 178.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -67.64 -39.3 84.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.304 -0.407 . . . . 0.0 112.076 -177.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 435' ' ' VAL . . . . . 0.837 HG23 HG11 ' B' ' 463' ' ' VAL . 7.2 p -68.02 -45.08 84.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-O 120.962 0.411 . . . . 0.0 110.562 -178.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 436' ' ' VAL . . . . . 0.506 HG21 ' NE ' ' B' ' 427' ' ' ARG . 0.1 OUTLIER -66.01 -29.15 45.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.465 176.175 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -69.53 -52.54 25.44 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 438' ' ' ALA . . . . . 0.878 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -57.94 -37.95 75.04 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.618 177.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 439' ' ' LEU . . . . . 0.599 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 2.1 tm? -70.18 -47.23 62.48 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -178.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -56.99 -40.37 76.45 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.2 174.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 441' ' ' GLN . . . . . 0.528 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 10.8 mm-40 -53.53 -49.9 66.62 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 123.827 0.851 . . . . 0.0 110.747 174.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 442' ' ' ARG . . . . . 0.838 ' HG2' ' O ' ' B' ' 438' ' ' ALA . 1.5 mmp_? -55.99 -39.66 72.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.754 171.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 443' ' ' LEU . . . . . 0.599 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 39.3 mt -72.08 -31.04 65.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.795 0.331 . . . . 0.0 110.816 -178.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -57.32 -38.43 74.05 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.769 0.795 . . . . 0.0 110.028 171.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -76.49 -25.91 54.75 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.457 -1.247 . . . . 0.0 111.842 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 446' ' ' GLU . . . . . 0.485 ' O ' ' HG3' ' B' ' 446' ' ' GLU . 14.4 pt-20 2.21 105.73 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 125.292 1.437 . . . . 0.0 114.377 -178.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 39.4 mt -58.59 -35.18 53.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.028 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 448' ' ' ASP . . . . . 0.486 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 23.6 m-20 -164.23 -176.52 4.48 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 -178.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -66.72 -66.84 0.5 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 173.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -70.14 -26.75 64.09 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 179.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 451' ' ' THR . . . . . 0.486 ' OG1' ' HB2' ' B' ' 448' ' ' ASP . 11.3 m -72.42 -23.73 61.12 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.244 -177.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 452' ' ' ARG . . . . . . . . . . . . . 19.6 ttm180 -54.61 -53.17 58.15 Favored 'General case' 0 N--CA 1.412 -2.37 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 171.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 453' ' ' ALA . . . . . 0.489 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -58.47 -47.15 84.98 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.703 172.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 454' ' ' GLU . . . . . 0.427 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 21.9 mm-40 -52.24 -38.69 58.82 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.305 0.574 . . . . 0.0 111.313 -176.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 25.8 p -112.12 12.46 20.52 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.272 -176.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 456' ' ' PHE . . . . . 0.543 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 1.0 OUTLIER -55.57 -46.91 77.13 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.044 0.45 . . . . 0.0 111.615 -172.984 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 457' ' ' ILE . . . . . 0.642 HG23 ' HB1' ' B' ' 405' ' ' ALA . 2.0 mp -77.85 -34.25 19.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.097 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -58.0 -34.39 69.95 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.969 0.89 . . . . 0.0 109.265 171.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 459' ' ' HIS . . . . . 0.724 ' O ' HG23 ' B' ' 463' ' ' VAL . 52.2 m-70 -73.87 -29.24 61.98 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.943 176.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 460' ' ' LEU . . . . . 0.719 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -73.62 -34.58 65.09 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.934 0.873 . . . . 0.0 108.775 179.192 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 461' ' ' ASN . . . . . 0.441 ' HA ' ' CD2' ' B' ' 464' ' ' TYR . 22.4 m-80 -73.2 -38.09 66.24 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.142 176.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 462' ' ' ALA . . . . . 0.613 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -56.6 -35.08 67.83 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.72 169.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 463' ' ' VAL . . . . . 0.878 HG13 ' HB3' ' B' ' 438' ' ' ALA . 61.0 t -59.79 -51.11 76.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 175.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 464' ' ' TYR . . . . . 0.587 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 17.4 m-30 -53.48 -28.66 31.98 Favored 'General case' 0 C--O 1.225 -0.2 0 O-C-N 124.322 1.014 . . . . 0.0 110.648 178.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.72 -41.17 21.66 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.572 0.701 . . . . 0.0 109.701 -178.029 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 466' ' ' ILE . . . . . 0.613 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.5 mt -56.2 -55.66 17.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 114.409 -1.269 . . . . 0.0 112.21 176.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 467' ' ' LEU . . . . . 0.807 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -101.88 -10.6 19.71 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -172.941 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 468' ' ' GLY . . . . . 0.569 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 93.99 31.54 8.05 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 119.419 -1.372 . . . . 0.0 114.29 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 469' ' ' LEU . . . . . 0.807 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 4.4 mt -88.62 164.54 15.31 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 118.059 0.929 . . . . 0.0 111.39 177.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 38.2 p30 -105.22 -176.64 3.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.869 170.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 471' ' ' ALA . . . . . 0.52 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -68.47 -13.64 62.45 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -175.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -88.94 -1.58 58.17 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.705 0.288 . . . . 0.0 111.325 -175.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 473' ' ' GLY . . . . . . . . . . . . . . . 78.86 12.63 83.97 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.263 -0.97 . . . . 0.0 110.884 -174.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -100.59 151.61 21.4 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 475' ' ' SER . . . . . 0.546 ' OG ' ' HG3' ' B' ' 477' ' ' ARG . 32.1 t -92.56 136.55 33.12 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.239 0.542 . . . . 0.0 111.023 -177.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 476' ' ' ILE . . . . . 0.664 ' O ' ' HD2' ' B' ' 477' ' ' ARG . 2.3 pp -115.41 -29.88 2.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.115 -178.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 477' ' ' ARG . . . . . 0.664 ' HD2' ' O ' ' B' ' 476' ' ' ILE . 0.2 OUTLIER 17.59 69.45 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 178.288 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 478' ' ' LEU . . . . . . . . . . . . . 95.8 mt -89.03 40.36 0.98 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.058 -177.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 479' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.635 -0.698 . . . . 0.0 109.883 178.634 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 . . . . . 0 N--CA 1.48 1.034 0 CA-C-O 120.681 0.277 . . . . 0.0 110.304 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 382' ' ' THR . . . . . 0.631 ' OG1' ' HA ' ' A' ' 391' ' ' LEU . 2.4 t -109.67 -20.79 12.7 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.768 178.339 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 383' ' ' HIS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 415' ' ' SER . 1.8 p80 -159.83 171.47 19.4 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.504 -174.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -118.31 -113.42 2.58 Favored Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.374 172.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 25.4 m -69.42 -41.47 76.3 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.654 0.264 . . . . 0.0 111.456 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 386' ' ' PHE . . . . . 0.8 ' CD1' HD22 ' A' ' 414' ' ' LEU . 3.4 t80 -65.68 125.77 90.39 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.247 179.049 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 387' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 386' ' ' PHE . 5.9 Cg_endo -47.06 -70.87 0.06 OUTLIER 'Trans proline' 0 CA--C 1.532 0.407 0 C-N-CA 123.961 3.107 . . . . 0.0 114.091 -174.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 40.7 ttm 71.98 155.77 0.16 Allowed 'General case' 0 CA--C 1.547 0.841 0 CA-C-O 121.237 0.542 . . . . 0.0 111.893 175.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 389' ' ' HIS . . . . . 0.602 ' H ' ' H ' ' A' ' 393' ' ' ASN . 2.7 m170 -76.6 27.72 0.13 Allowed 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.711 0.804 . . . . 0.0 112.917 -171.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 390' ' ' GLN . . . . . 0.591 ' HG2' ' O ' ' A' ' 389' ' ' HIS . 2.3 pt20 71.2 4.22 4.98 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.562 0.745 . . . . 0.0 109.902 -167.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.631 ' HA ' ' OG1' ' A' ' 382' ' ' THR . 2.1 pt? -164.57 -43.59 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 392' ' ' GLY . . . . . 0.597 ' HA3' HD13 ' A' ' 395' ' ' ILE . . . -175.89 55.42 0.12 Allowed Glycine 0 C--O 1.223 -0.56 0 C-N-CA 118.088 -2.006 . . . . 0.0 115.88 -176.42 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 393' ' ' ASN . . . . . 0.602 ' H ' ' H ' ' A' ' 389' ' ' HIS . 0.0 OUTLIER -60.89 -36.44 79.23 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 118.095 0.948 . . . . 0.0 108.644 176.294 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.7 HG23 HD12 ' A' ' 398' ' ' ILE . 1.5 m -58.54 -50.23 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 CA-C-N 113.289 -1.778 . . . . 0.0 107.834 178.311 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.633 HG23 HD13 ' A' ' 426' ' ' ILE . 4.0 mp -57.98 -52.5 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 CA-C-O 117.985 -1.007 . . . . 0.0 113.614 -174.018 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 396' ' ' LYS . . . . . 0.608 ' HG3' ' CZ ' ' A' ' 429' ' ' TYR . 0.0 OUTLIER -64.06 -48.2 77.16 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 121.736 2.062 . . . . 0.0 111.493 -173.82 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -54.0 -45.33 71.94 Favored Glycine 0 N--CA 1.431 -1.636 0 C-N-CA 119.846 -1.169 . . . . 0.0 111.044 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 398' ' ' ILE . . . . . 0.733 HD13 HD12 ' A' ' 410' ' ' LEU . 33.2 mt -70.87 -33.87 53.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -178.476 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 399' ' ' VAL . . . . . 0.492 HG22 ' O ' ' A' ' 396' ' ' LYS . 15.3 m -63.75 -39.43 85.34 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 C-N-CA 118.685 -1.206 . . . . 0.0 108.41 -174.509 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -71.11 -35.24 71.71 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 175.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.471 HE21 ' HB3' ' A' ' 401' ' ' GLN . 3.8 mm100 -88.69 -48.07 7.8 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -172.304 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 402' ' ' GLU . . . . . 0.506 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 2.7 mm-40 -121.22 -21.36 6.42 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.601 -169.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 108.41 162.61 20.72 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.953 -0.642 . . . . 0.0 113.128 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 404' ' ' VAL . . . . . 0.674 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.5 m -53.67 -41.86 48.74 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.794 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -176.227 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 405' ' ' ALA . . . . . 0.59 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -68.88 -30.96 69.58 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 119.566 -0.854 . . . . 0.0 111.773 -176.185 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.718 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 89.0 m -77.38 -42.56 35.96 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.174 -0.611 . . . . 0.0 110.3 173.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.447 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -58.26 -37.22 74.53 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 122.054 0.931 . . . . 0.0 109.263 176.335 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 408' ' ' TYR . . . . . 0.674 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.77 -52.12 53.51 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 113.558 -1.655 . . . . 0.0 109.761 176.387 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 409' ' ' THR . . . . . 0.666 HG22 HD23 ' A' ' 410' ' ' LEU . 16.0 m -55.32 -47.37 75.74 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.635 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 410' ' ' LEU . . . . . 0.733 HD12 HD13 ' A' ' 398' ' ' ILE . 14.9 mt -72.65 -36.87 68.08 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -174.435 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.66 -34.96 78.96 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 119.83 -1.176 . . . . 0.0 110.641 173.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 412' ' ' MET . . . . . 0.407 ' HB2' ' O ' ' A' ' 409' ' ' THR . 0.3 OUTLIER -66.83 -48.67 68.2 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-O 120.597 0.236 . . . . 0.0 111.475 178.033 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 413' ' ' MET . . . . . 0.933 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.8 OUTLIER -71.35 -44.26 65.38 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 119.022 -1.071 . . . . 0.0 112.037 -178.552 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 414' ' ' LEU . . . . . 0.933 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 17.6 mt -69.02 -45.22 71.04 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -176.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 383' ' ' HIS . 45.5 t -86.45 -24.63 25.57 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.819 0.818 . . . . 0.0 110.099 -176.443 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 108.93 -174.82 18.81 Favored Glycine 0 N--CA 1.429 -1.779 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -170.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -80.54 23.54 0.51 Allowed 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.244 0.545 . . . . 0.0 111.587 -171.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 418' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -72.0 75.28 0.92 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.064 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 419' ' ' TYR . . . . . 0.521 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 9.4 p90 -51.1 -39.03 55.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.493 176.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -55.32 -43.99 75.42 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.672 0.272 . . . . 0.0 110.99 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.37 -48.98 63.33 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.073 -178.063 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 422' ' ' VAL . . . . . 0.432 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -66.49 -40.67 87.06 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.522 0 C-N-CA 120.409 -0.517 . . . . 0.0 111.299 -177.021 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.793 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 77.6 p -68.09 -36.66 80.16 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -178.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -69.67 -37.95 77.25 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.253 175.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 425' ' ' ILE . . . . . 0.615 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -73.14 -51.92 24.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 O-C-N 122.82 -0.224 . . . . 0.0 111.048 -178.638 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 426' ' ' ILE . . . . . 0.674 HG22 HD22 ' A' ' 430' ' ' LEU . 1.2 mm -74.09 -22.68 18.31 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.756 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -172.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.793 ' HB2' ' O ' ' A' ' 423' ' ' SER . 0.8 OUTLIER -54.61 -29.71 52.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.157 0.503 . . . . 0.0 110.484 -179.263 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -88.94 -6.57 71.89 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.693 178.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.608 ' CZ ' ' HG3' ' A' ' 396' ' ' LYS . 22.4 m-85 -117.27 -0.09 12.12 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.095 0.474 . . . . 0.0 110.221 -178.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.674 HD22 HG22 ' A' ' 426' ' ' ILE . 0.1 OUTLIER -66.15 129.13 94.19 Favored Pre-proline 0 N--CA 1.441 -0.876 0 CA-C-N 115.353 -0.84 . . . . 0.0 108.857 177.584 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 431' ' ' PRO . . . . . 0.554 ' HG3' ' O ' ' A' ' 473' ' ' GLY . 73.4 Cg_exo -25.46 -69.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.757 1 C-N-CA 125.318 4.012 . . . . 0.0 114.911 179.68 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 432' ' ' GLY . . . . . 0.526 ' O ' HG12 ' A' ' 435' ' ' VAL . . . -144.07 -165.8 11.09 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 110.061 -1.215 . . . . 0.0 110.061 177.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 433' ' ' GLN . . . . . 0.465 ' O ' HG13 ' A' ' 436' ' ' VAL . 15.8 tp60 -69.62 -27.58 65.19 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 118.127 0.964 . . . . 0.0 110.449 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -67.32 -39.78 85.91 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -176.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 435' ' ' VAL . . . . . 0.679 HG23 HG11 ' A' ' 463' ' ' VAL . 8.8 p -68.49 -44.26 83.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-O 121.107 0.479 . . . . 0.0 110.48 -177.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.491 HG12 ' O ' ' A' ' 432' ' ' GLY . 0.1 OUTLIER -66.95 -31.46 53.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.399 175.305 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.23 -52.45 40.81 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -178.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 438' ' ' ALA . . . . . 0.817 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -57.74 -40.05 78.74 Favored 'General case' 0 N--CA 1.439 -1.023 0 O-C-N 123.883 0.739 . . . . 0.0 111.992 177.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 439' ' ' LEU . . . . . 0.594 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 2.0 tm? -68.3 -48.74 64.13 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -178.199 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -59.27 -34.97 72.9 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.442 -1.254 . . . . 0.0 111.135 175.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 441' ' ' GLN . . . . . 0.543 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 3.8 mm-40 -53.39 -49.88 66.31 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.106 -178.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 442' ' ' ARG . . . . . 0.693 ' HG3' ' CG ' ' A' ' 459' ' ' HIS . 0.0 OUTLIER -76.18 -25.03 54.78 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 119.361 -0.936 . . . . 0.0 113.248 174.898 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 443' ' ' LEU . . . . . 0.594 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 56.2 mt -65.3 -33.72 76.65 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.421 0.629 . . . . 0.0 109.718 175.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -70.57 -33.88 71.6 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.114 -178.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 445' ' ' GLN . . . . . 0.402 ' HG3' ' N ' ' A' ' 446' ' ' GLU . 0.0 OUTLIER -75.29 -31.15 60.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 114.673 -1.149 . . . . 0.0 108.321 178.43 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 446' ' ' GLU . . . . . 0.402 ' N ' ' HG3' ' A' ' 445' ' ' GLN . 34.9 tt0 48.09 98.47 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 114.812 -1.085 . . . . 0.0 113.2 171.084 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 60.9 mt -65.82 -35.67 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 121.667 0.746 . . . . 0.0 109.785 176.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 448' ' ' ASP . . . . . 0.538 ' O ' ' HG3' ' A' ' 452' ' ' ARG . 18.7 m-20 -169.83 -175.94 2.22 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 -177.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -72.16 -67.83 0.51 Allowed 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.6 174.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 450' ' ' GLN . . . . . 0.404 ' HG3' ' H ' ' A' ' 450' ' ' GLN . 2.0 pp0? -66.46 -25.46 66.73 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 178.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 451' ' ' THR . . . . . 0.524 ' OG1' ' HB2' ' A' ' 448' ' ' ASP . 15.3 m -71.13 -23.02 62.0 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.702 -173.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 452' ' ' ARG . . . . . 0.538 ' HG3' ' O ' ' A' ' 448' ' ' ASP . 55.7 mtm180 -55.06 -54.15 46.75 Favored 'General case' 0 C--O 1.218 -0.553 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 170.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 453' ' ' ALA . . . . . 0.521 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -56.99 -48.03 79.42 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 124.278 0.986 . . . . 0.0 112.571 174.01 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 454' ' ' GLU . . . . . 0.422 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 63.9 mm-40 -51.34 -37.49 48.1 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.312 0.577 . . . . 0.0 111.693 -177.493 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 24.6 p -119.13 16.28 13.23 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.187 -175.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 456' ' ' PHE . . . . . 0.515 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.9 OUTLIER -55.19 -47.33 75.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.12 0.486 . . . . 0.0 111.728 -171.58 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 457' ' ' ILE . . . . . 0.59 HG23 ' HB1' ' A' ' 405' ' ' ALA . 1.9 mp -77.11 -34.43 21.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.257 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -57.54 -34.09 68.78 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.891 0.853 . . . . 0.0 109.288 171.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 459' ' ' HIS . . . . . 0.758 ' O ' HG23 ' A' ' 463' ' ' VAL . 52.8 m-70 -73.76 -29.33 62.15 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.357 -1.292 . . . . 0.0 110.926 176.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 460' ' ' LEU . . . . . 0.714 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -73.59 -33.96 64.86 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.863 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -73.05 -38.12 66.61 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.345 175.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 462' ' ' ALA . . . . . 0.613 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -55.82 -34.0 64.98 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.691 169.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.817 HG13 ' HB3' ' A' ' 438' ' ' ALA . 62.6 t -62.8 -50.22 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 CA-C-N 114.363 -1.289 . . . . 0.0 107.996 177.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 464' ' ' TYR . . . . . 0.545 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 14.8 m-30 -53.8 -27.67 30.65 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.66 178.029 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.31 -40.83 20.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.635 0.731 . . . . 0.0 109.476 -178.032 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.613 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.6 mt -57.3 -55.63 19.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 114.174 -1.375 . . . . 0.0 112.196 176.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.782 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -102.51 -10.65 19.16 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -172.517 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 93.9 32.22 7.68 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 119.114 -1.517 . . . . 0.0 114.201 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 469' ' ' LEU . . . . . 0.782 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.5 mt -88.45 162.2 16.61 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 117.889 0.844 . . . . 0.0 111.378 176.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 37.7 p30 -100.72 -177.76 3.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.651 170.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 471' ' ' ALA . . . . . 0.503 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -69.43 -12.4 61.62 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.557 0.576 . . . . 0.0 112.557 -176.197 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -89.12 2.03 54.74 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.79 0.329 . . . . 0.0 111.219 -175.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 473' ' ' GLY . . . . . 0.554 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 76.42 12.6 84.15 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -175.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -101.67 150.43 23.12 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 177.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 475' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 469' ' ' LEU . 30.7 t -86.59 138.15 31.93 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.025 -0.67 . . . . 0.0 109.819 175.531 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 476' ' ' ILE . . . . . 0.637 HD12 ' N ' ' A' ' 477' ' ' ARG . 2.4 pp -103.84 -14.51 8.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.849 178.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 477' ' ' ARG . . . . . 0.637 ' N ' HD12 ' A' ' 476' ' ' ILE . 0.0 OUTLIER 59.23 -81.65 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 114.48 -1.236 . . . . 0.0 111.544 178.187 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 45.7 tp -143.36 83.66 1.79 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 177.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 . . . . . 0 C--O 1.253 1.24 0 CA-C-O 118.608 -0.711 . . . . 0.0 110.371 -177.397 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 381' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 . . . . . 0 N--CA 1.482 1.129 0 N-CA-C 110.197 -0.298 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 382' ' ' THR . . . . . 0.632 ' OG1' ' HA ' ' B' ' 391' ' ' LEU . 2.1 t -110.24 -20.77 12.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.662 178.49 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 383' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -159.77 171.58 19.25 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.571 -175.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 384' ' ' GLY . . . . . . . . . . . . . . . -118.37 -113.32 2.57 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.406 172.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 385' ' ' THR . . . . . . . . . . . . . 24.7 m -69.51 -41.48 75.97 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.816 0.341 . . . . 0.0 111.516 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 386' ' ' PHE . . . . . 0.793 ' CD1' HD22 ' B' ' 414' ' ' LEU . 3.3 t80 -65.73 125.7 90.3 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.273 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 387' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' B' ' 386' ' ' PHE . 5.9 Cg_endo -46.98 -70.88 0.06 OUTLIER 'Trans proline' 0 N--CA 1.475 0.424 0 C-N-CA 123.914 3.076 . . . . 0.0 114.101 -174.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 388' ' ' MET . . . . . . . . . . . . . 40.6 ttm 71.95 155.53 0.15 Allowed 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.265 0.555 . . . . 0.0 111.852 175.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 389' ' ' HIS . . . . . 0.606 ' H ' ' H ' ' B' ' 393' ' ' ASN . 2.6 m170 -76.37 27.83 0.12 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.674 0.79 . . . . 0.0 112.941 -171.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 390' ' ' GLN . . . . . 0.591 ' HG2' ' O ' ' B' ' 389' ' ' HIS . 2.4 pt20 71.31 3.88 4.84 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.509 0.724 . . . . 0.0 109.884 -168.072 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 391' ' ' LEU . . . . . 0.632 ' HA ' ' OG1' ' B' ' 382' ' ' THR . 2.1 pt? -164.31 -43.55 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 392' ' ' GLY . . . . . 0.6 ' HA3' HD13 ' B' ' 395' ' ' ILE . . . -175.81 55.39 0.12 Allowed Glycine 0 C--N 1.336 0.576 0 C-N-CA 118.037 -2.03 . . . . 0.0 115.792 -176.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 393' ' ' ASN . . . . . 0.606 ' H ' ' H ' ' B' ' 389' ' ' HIS . 0.0 OUTLIER -60.81 -36.6 79.47 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 118.217 1.008 . . . . 0.0 108.586 176.307 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 394' ' ' VAL . . . . . 0.723 HG23 HD12 ' B' ' 398' ' ' ILE . 1.5 m -58.36 -50.16 79.56 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 CA-C-N 113.306 -1.77 . . . . 0.0 107.904 178.172 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 395' ' ' ILE . . . . . 0.632 HG21 HG22 ' B' ' 425' ' ' ILE . 4.0 mp -58.07 -52.58 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 CA-C-O 118.005 -0.998 . . . . 0.0 113.568 -173.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 396' ' ' LYS . . . . . 0.607 ' HG3' ' CZ ' ' B' ' 429' ' ' TYR . 0.0 OUTLIER -63.96 -48.35 76.81 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 121.65 2.023 . . . . 0.0 111.464 -173.8 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.75 -45.31 69.49 Favored Glycine 0 N--CA 1.432 -1.583 0 C-N-CA 119.9 -1.143 . . . . 0.0 110.961 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 398' ' ' ILE . . . . . 0.737 HD13 HD12 ' B' ' 410' ' ' LEU . 33.4 mt -70.93 -33.98 54.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -178.291 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 399' ' ' VAL . . . . . 0.499 HG22 ' O ' ' B' ' 396' ' ' LYS . 15.3 m -63.73 -39.48 85.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 C-N-CA 118.796 -1.161 . . . . 0.0 108.475 -174.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -70.82 -35.59 72.55 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 175.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 401' ' ' GLN . . . . . 0.413 HE21 ' HB3' ' B' ' 401' ' ' GLN . 3.7 mm100 -88.7 -48.1 7.77 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -172.293 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 402' ' ' GLU . . . . . 0.472 ' HG3' ' HE3' ' A' ' 413' ' ' MET . 2.7 mm-40 -121.02 -21.48 6.48 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.727 -170.06 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 108.82 162.89 20.4 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.085 -0.579 . . . . 0.0 113.006 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 404' ' ' VAL . . . . . 0.664 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.5 m -53.76 -41.85 49.55 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.719 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 -176.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 405' ' ' ALA . . . . . 0.591 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -68.9 -30.7 69.24 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 119.797 -0.761 . . . . 0.0 111.855 -176.038 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 406' ' ' THR . . . . . 0.72 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 90.7 m -77.81 -42.78 32.61 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.068 174.138 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 407' ' ' ALA . . . . . 0.45 ' HB2' ' HB ' ' B' ' 398' ' ' ILE . . . -58.33 -37.13 74.5 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 122.078 0.942 . . . . 0.0 109.18 176.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 408' ' ' TYR . . . . . 0.664 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -66.0 -52.08 52.52 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 113.595 -1.639 . . . . 0.0 109.725 176.43 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 409' ' ' THR . . . . . 0.664 HG22 HD23 ' B' ' 410' ' ' LEU . 15.9 m -55.33 -47.31 75.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.675 179.265 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 410' ' ' LEU . . . . . 0.737 HD12 HD13 ' B' ' 398' ' ' ILE . 15.0 mt -72.71 -36.82 67.89 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -174.464 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.67 -34.81 78.43 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 119.868 -1.158 . . . . 0.0 110.629 173.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 412' ' ' MET . . . . . 0.403 ' HB2' ' O ' ' B' ' 409' ' ' THR . 0.3 OUTLIER -67.05 -48.52 68.04 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-O 120.634 0.254 . . . . 0.0 111.387 178.19 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 413' ' ' MET . . . . . 0.924 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.8 OUTLIER -71.47 -44.29 65.02 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 119.009 -1.076 . . . . 0.0 112.16 -178.706 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 414' ' ' LEU . . . . . 0.924 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 17.7 mt -68.93 -45.5 70.65 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -176.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 47.0 t -86.05 -24.88 26.18 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.641 0.734 . . . . 0.0 110.004 -176.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 416' ' ' GLY . . . . . . . . . . . . . . . 109.17 -174.57 18.37 Favored Glycine 0 N--CA 1.43 -1.734 0 N-CA-C 109.731 -1.347 . . . . 0.0 109.731 -170.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -80.83 23.31 0.55 Allowed 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.287 0.565 . . . . 0.0 111.535 -171.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 418' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -71.94 75.13 0.9 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.102 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 419' ' ' TYR . . . . . 0.525 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 9.1 p90 -51.04 -38.94 54.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.572 176.137 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -55.37 -43.95 75.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.737 0.304 . . . . 0.0 111.092 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.29 -48.98 63.53 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.11 -178.178 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 422' ' ' VAL . . . . . 0.433 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.2 OUTLIER -66.46 -40.84 87.51 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.278 -176.959 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 423' ' ' SER . . . . . 0.785 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 77.3 p -67.97 -36.63 80.37 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -178.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -69.62 -38.22 77.97 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.225 176.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 425' ' ' ILE . . . . . 0.632 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -73.02 -51.8 24.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 O-C-N 122.865 -0.197 . . . . 0.0 111.083 -178.52 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 426' ' ' ILE . . . . . 0.669 HG22 HD22 ' B' ' 430' ' ' LEU . 1.2 mm -74.08 -22.64 18.32 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.796 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -172.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 427' ' ' ARG . . . . . 0.785 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.8 OUTLIER -54.58 -29.85 52.62 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.21 0.529 . . . . 0.0 110.561 -179.251 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -88.58 -7.25 72.22 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.729 178.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 429' ' ' TYR . . . . . 0.607 ' CZ ' ' HG3' ' B' ' 396' ' ' LYS . 22.3 m-85 -116.63 -0.26 12.44 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 121.271 0.557 . . . . 0.0 110.295 -178.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 430' ' ' LEU . . . . . 0.669 HD22 HG22 ' B' ' 426' ' ' ILE . 0.1 OUTLIER -66.08 129.04 94.19 Favored Pre-proline 0 N--CA 1.442 -0.842 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.867 177.807 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 431' ' ' PRO . . . . . 0.563 ' HG3' ' O ' ' B' ' 473' ' ' GLY . 75.1 Cg_exo -25.33 -68.86 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 125.283 3.989 . . . . 0.0 114.919 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 432' ' ' GLY . . . . . 0.532 ' O ' HG12 ' B' ' 435' ' ' VAL . . . -144.52 -165.82 11.22 Favored Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 177.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 433' ' ' GLN . . . . . 0.469 ' O ' HG13 ' B' ' 436' ' ' VAL . 15.5 tp60 -69.39 -27.74 65.56 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 118.156 0.978 . . . . 0.0 110.507 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -67.07 -39.89 86.95 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -176.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 435' ' ' VAL . . . . . 0.666 HG23 HG11 ' B' ' 463' ' ' VAL . 8.8 p -68.66 -44.01 82.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-O 121.013 0.435 . . . . 0.0 110.558 -177.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 436' ' ' VAL . . . . . 0.487 HG12 ' O ' ' B' ' 432' ' ' GLY . 0.1 OUTLIER -66.99 -31.4 53.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.431 175.075 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.23 -52.52 40.05 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -178.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 438' ' ' ALA . . . . . 0.812 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -57.9 -39.93 79.1 Favored 'General case' 0 N--CA 1.439 -1.01 0 O-C-N 123.902 0.751 . . . . 0.0 111.969 177.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 439' ' ' LEU . . . . . 0.603 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 2.0 tm? -68.36 -48.73 64.03 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -178.188 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 -59.22 -35.02 72.89 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.484 -1.234 . . . . 0.0 111.202 175.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 441' ' ' GLN . . . . . 0.537 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 3.8 mm-40 -53.34 -50.04 65.84 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.052 -178.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 442' ' ' ARG . . . . . 0.708 ' HG3' ' CG ' ' B' ' 459' ' ' HIS . 0.0 OUTLIER -75.95 -25.11 55.62 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 119.377 -0.929 . . . . 0.0 113.198 174.892 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 443' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 56.5 mt -65.3 -33.84 76.94 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.289 0.566 . . . . 0.0 109.558 175.399 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -70.37 -34.2 72.32 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.942 -178.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 445' ' ' GLN . . . . . 0.401 ' HG3' ' N ' ' B' ' 446' ' ' GLU . 0.0 OUTLIER -75.1 -31.07 61.06 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.294 178.699 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 446' ' ' GLU . . . . . 0.401 ' N ' ' HG3' ' B' ' 445' ' ' GLN . 34.6 tt0 48.09 98.69 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 114.818 -1.083 . . . . 0.0 113.143 171.087 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 61.1 mt -65.97 -35.79 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 121.712 0.768 . . . . 0.0 109.811 176.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 448' ' ' ASP . . . . . 0.544 ' O ' ' HG3' ' B' ' 452' ' ' ARG . 17.1 m-20 -169.66 -176.02 2.3 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 -177.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -71.76 -67.77 0.51 Allowed 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.535 173.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -66.87 -25.34 66.36 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 451' ' ' THR . . . . . 0.52 ' OG1' ' HB2' ' B' ' 448' ' ' ASP . 15.9 m -71.1 -22.92 62.03 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.756 -173.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 452' ' ' ARG . . . . . 0.544 ' HG3' ' O ' ' B' ' 448' ' ' ASP . 55.9 mtm180 -55.21 -54.14 47.16 Favored 'General case' 0 C--O 1.219 -0.525 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 170.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 453' ' ' ALA . . . . . 0.525 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -56.93 -48.14 78.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.576 173.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 454' ' ' GLU . . . . . 0.424 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 65.1 mm-40 -51.18 -37.84 48.85 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.263 0.554 . . . . 0.0 111.572 -177.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 25.2 p -118.81 16.24 13.51 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.335 -175.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 456' ' ' PHE . . . . . 0.519 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 0.9 OUTLIER -55.15 -47.08 75.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.142 0.496 . . . . 0.0 111.747 -171.708 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 457' ' ' ILE . . . . . 0.591 HG23 ' HB1' ' B' ' 405' ' ' ALA . 1.9 mp -77.33 -34.3 20.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.198 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -57.68 -34.19 69.15 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.88 0.847 . . . . 0.0 109.234 172.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 459' ' ' HIS . . . . . 0.755 ' O ' HG23 ' B' ' 463' ' ' VAL . 51.5 m-70 -73.61 -29.25 62.27 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.981 176.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 460' ' ' LEU . . . . . 0.709 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -73.64 -33.96 64.75 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.765 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 461' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -72.94 -38.43 66.79 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.195 175.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 462' ' ' ALA . . . . . 0.622 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -55.78 -33.8 64.69 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.76 169.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 463' ' ' VAL . . . . . 0.812 HG13 ' HB3' ' B' ' 438' ' ' ALA . 62.9 t -62.91 -50.15 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.008 177.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 464' ' ' TYR . . . . . 0.539 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 15.0 m-30 -53.79 -27.82 31.43 Favored 'General case' 0 C--N 1.332 -0.193 0 O-C-N 124.237 0.961 . . . . 0.0 110.599 178.24 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.27 -40.86 20.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.693 0.758 . . . . 0.0 109.359 -177.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 466' ' ' ILE . . . . . 0.622 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.6 mt -57.23 -55.6 19.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 114.305 -1.316 . . . . 0.0 112.19 176.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 467' ' ' LEU . . . . . 0.782 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -102.69 -10.63 19.04 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -172.389 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 468' ' ' GLY . . . . . . . . . . . . . . . 93.92 32.24 7.66 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 119.013 -1.565 . . . . 0.0 114.304 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 469' ' ' LEU . . . . . 0.782 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.5 mt -88.58 162.27 16.47 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 117.915 0.857 . . . . 0.0 111.249 177.063 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 37.6 p30 -100.86 -177.75 3.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.587 170.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 471' ' ' ALA . . . . . 0.51 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -69.81 -11.5 60.9 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -176.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -89.34 1.95 55.07 Favored 'General case' 0 C--N 1.32 -0.682 0 O-C-N 122.262 -0.273 . . . . 0.0 111.213 -176.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 473' ' ' GLY . . . . . 0.563 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 76.43 12.48 84.26 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 -175.384 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -101.61 150.56 22.97 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 475' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' B' ' 469' ' ' LEU . 32.3 t -86.81 137.7 32.2 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.147 -0.621 . . . . 0.0 109.893 175.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 476' ' ' ILE . . . . . 0.643 HD12 ' N ' ' B' ' 477' ' ' ARG . 2.4 pp -103.52 -14.51 8.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.923 179.119 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 477' ' ' ARG . . . . . 0.643 ' N ' HD12 ' B' ' 476' ' ' ILE . 0.0 OUTLIER 59.32 -81.88 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 114.494 -1.23 . . . . 0.0 111.477 178.088 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 478' ' ' LEU . . . . . . . . . . . . . 45.5 tp -143.2 83.34 1.78 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 479' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 . . . . . 0 C--O 1.246 0.88 0 CA-C-O 118.478 -0.772 . . . . 0.0 110.31 -177.646 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 . . . . . 0 N--CA 1.481 1.121 0 CA-C-O 121.18 0.514 . . . . 0.0 111.348 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 1.2 t -77.58 -46.41 22.29 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.536 176.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -86.18 56.27 3.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.296 0.57 . . . . 0.0 110.871 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -99.07 88.75 0.85 Allowed Glycine 0 N--CA 1.442 -0.961 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.762 -178.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 24.4 m 71.57 -60.34 0.52 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.058 0.543 . . . . 0.0 110.971 -178.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 386' ' ' PHE . . . . . 0.717 ' CD1' HD22 ' A' ' 414' ' ' LEU . 2.9 t80 -75.95 126.34 87.04 Favored Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 172.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 387' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 386' ' ' PHE . 1.3 Cg_endo -43.01 -75.36 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.821 3.014 . . . . 0.0 113.892 -175.172 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 28.5 ttm 67.22 143.43 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.607 0 O-C-N 123.397 0.435 . . . . 0.0 110.305 -178.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 389' ' ' HIS . . . . . 0.632 ' H ' ' HB3' ' A' ' 393' ' ' ASN . 29.3 m170 -54.85 -79.24 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.694 0.759 . . . . 0.0 110.076 -174.142 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 390' ' ' GLN . . . . . 0.407 ' H ' HD23 ' A' ' 391' ' ' LEU . 13.9 pt20 -153.46 19.35 0.55 Allowed 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 170.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.515 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.6 pt? -173.9 -48.54 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.837 -170.313 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 392' ' ' GLY . . . . . 0.621 ' HA3' HD13 ' A' ' 395' ' ' ILE . . . -172.48 53.88 0.17 Allowed Glycine 0 C--O 1.223 -0.593 0 C-N-CA 118.81 -1.662 . . . . 0.0 115.305 -171.44 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 393' ' ' ASN . . . . . 0.632 ' HB3' ' H ' ' A' ' 389' ' ' HIS . 0.0 OUTLIER -57.34 -38.06 73.51 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 118.361 1.081 . . . . 0.0 108.869 176.273 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.627 HG23 HD12 ' A' ' 398' ' ' ILE . 1.9 m -58.23 -49.52 81.48 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 CA-C-N 113.189 -1.823 . . . . 0.0 107.77 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.676 HG23 HD13 ' A' ' 426' ' ' ILE . 4.2 mp -58.26 -52.8 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 CA-C-O 117.97 -1.014 . . . . 0.0 113.462 -174.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 396' ' ' LYS . . . . . 0.638 ' HG3' ' CZ ' ' A' ' 429' ' ' TYR . 0.1 OUTLIER -63.91 -48.93 74.65 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 121.796 2.089 . . . . 0.0 112.024 -172.865 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -54.02 -45.26 72.36 Favored Glycine 0 N--CA 1.438 -1.181 0 C-N-CA 119.88 -1.153 . . . . 0.0 111.238 -178.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 398' ' ' ILE . . . . . 0.722 ' CD1' HD12 ' A' ' 410' ' ' LEU . 33.6 mt -71.04 -34.56 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -178.117 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 399' ' ' VAL . . . . . 0.517 HG12 ' HA ' ' A' ' 404' ' ' VAL . 11.7 m -63.68 -39.68 86.25 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 C-N-CA 119.05 -1.06 . . . . 0.0 108.728 -173.441 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -67.4 -39.9 85.58 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 176.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -93.43 -50.73 5.3 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -170.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 402' ' ' GLU . . . . . 0.402 ' HG2' HG21 ' A' ' 406' ' ' THR . 16.1 tp10 -108.87 -20.19 13.14 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.227 0.537 . . . . 0.0 110.461 -172.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 105.44 162.5 23.46 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.548 -0.751 . . . . 0.0 113.159 177.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 404' ' ' VAL . . . . . 0.616 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.5 m -52.98 -45.59 52.34 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.738 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -175.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 405' ' ' ALA . . . . . 0.529 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -64.93 -30.06 71.03 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 119.793 -0.763 . . . . 0.0 112.488 -177.119 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.71 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 86.2 m -77.45 -42.42 36.05 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 120.096 -0.642 . . . . 0.0 110.216 173.232 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.5 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.86 -37.23 76.04 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 122.252 1.025 . . . . 0.0 109.043 177.076 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 408' ' ' TYR . . . . . 0.616 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.31 -52.95 50.64 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 113.364 -1.744 . . . . 0.0 109.889 176.687 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 409' ' ' THR . . . . . 0.692 HG22 HD23 ' A' ' 410' ' ' LEU . 9.0 m -55.58 -47.17 76.88 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.395 -0.821 . . . . 0.0 112.557 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 410' ' ' LEU . . . . . 0.722 HD12 ' CD1' ' A' ' 398' ' ' ILE . 14.5 mt -72.4 -36.32 68.62 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.055 -175.007 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -60.0 -35.2 86.48 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 119.973 -1.108 . . . . 0.0 110.789 172.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -67.98 -46.55 71.05 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 115.812 -0.194 . . . . 0.0 111.399 178.487 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 413' ' ' MET . . . . . 0.897 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.4 OUTLIER -70.62 -48.95 52.49 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 118.834 -1.147 . . . . 0.0 111.821 179.691 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 414' ' ' LEU . . . . . 0.897 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 16.0 mt -68.38 -46.69 69.35 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -176.016 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 14.6 t -92.9 -1.86 56.35 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.297 0.57 . . . . 0.0 110.063 -173.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 416' ' ' GLY . . . . . 0.407 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 93.1 -177.55 38.27 Favored Glycine 0 N--CA 1.434 -1.485 0 C-N-CA 120.395 -0.907 . . . . 0.0 110.916 -176.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -79.98 23.36 0.46 Allowed 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.126 0.488 . . . . 0.0 111.31 -172.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 418' ' ' ASN . . . . . 0.407 ' H ' ' C ' ' A' ' 416' ' ' GLY . 5.5 m-20 -71.61 76.0 0.81 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.612 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 419' ' ' TYR . . . . . 0.544 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 11.1 p90 -51.41 -38.55 54.07 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.366 176.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -55.29 -43.79 75.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.671 0.272 . . . . 0.0 110.919 178.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.47 -49.17 61.75 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.949 -177.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 422' ' ' VAL . . . . . 0.445 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.3 OUTLIER -66.84 -40.36 85.68 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.214 -176.954 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.743 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 79.2 p -66.98 -38.91 86.92 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.38 -39.5 91.62 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.255 176.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 425' ' ' ILE . . . . . 0.636 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -73.06 -50.82 29.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 121.223 -0.191 . . . . 0.0 111.032 -177.234 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 426' ' ' ILE . . . . . 0.676 HD13 HG23 ' A' ' 395' ' ' ILE . 1.2 mm -74.96 -22.52 17.07 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.823 0 CA-C-O 120.886 0.374 . . . . 0.0 110.27 -172.236 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.743 ' HB2' ' O ' ' A' ' 423' ' ' SER . 0.8 OUTLIER -55.02 -30.13 58.88 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.217 0.532 . . . . 0.0 110.64 -179.008 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.74 -6.06 77.08 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.638 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.638 ' CZ ' ' HG3' ' A' ' 396' ' ' LYS . 22.9 m-85 -118.23 0.54 11.75 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 120.977 0.418 . . . . 0.0 110.665 -177.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.678 HD23 ' HA ' ' A' ' 427' ' ' ARG . 0.1 OUTLIER -65.71 128.2 93.63 Favored Pre-proline 0 N--CA 1.441 -0.907 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 179.032 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 431' ' ' PRO . . . . . 0.455 ' HG3' ' O ' ' A' ' 473' ' ' GLY . 80.8 Cg_exo -23.87 -69.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.905 1 C-N-CA 125.514 4.143 . . . . 0.0 114.857 179.887 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 432' ' ' GLY . . . . . 0.51 ' O ' HG12 ' A' ' 435' ' ' VAL . . . -138.8 -166.9 10.78 Favored Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 174.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 433' ' ' GLN . . . . . 0.506 ' O ' HG13 ' A' ' 436' ' ' VAL . 50.3 tp60 -70.8 -26.88 63.52 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 118.241 1.021 . . . . 0.0 110.457 177.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -64.75 -39.51 93.75 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -177.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 435' ' ' VAL . . . . . 0.794 HG23 HG11 ' A' ' 463' ' ' VAL . 7.5 p -68.72 -43.94 82.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-O 120.968 0.413 . . . . 0.0 110.501 -178.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.506 HG13 ' O ' ' A' ' 433' ' ' GLN . 0.1 OUTLIER -67.15 -30.29 48.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.668 175.579 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.48 -51.91 45.6 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 438' ' ' ALA . . . . . 0.827 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -57.0 -43.93 82.27 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.003 177.094 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 439' ' ' LEU . . . . . 0.634 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 2.1 tm? -64.69 -47.64 77.64 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 -176.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -57.86 -39.7 78.4 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.81 -1.086 . . . . 0.0 111.362 175.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 441' ' ' GLN . . . . . 0.607 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 9.2 mm-40 -55.59 -51.25 67.76 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 123.473 0.709 . . . . 0.0 110.83 175.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 442' ' ' ARG . . . . . 0.77 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -58.13 -33.81 69.55 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.798 173.174 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 443' ' ' LEU . . . . . 0.634 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 57.1 mt -72.25 -36.6 69.1 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-O 120.865 0.364 . . . . 0.0 110.227 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -57.49 -37.58 73.18 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.607 0.717 . . . . 0.0 110.67 174.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -73.2 -26.77 61.29 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.238 177.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 446' ' ' GLU . . . . . 0.453 ' HB3' ' O ' ' A' ' 443' ' ' LEU . 7.4 pt-20 23.7 103.13 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 173.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 60.3 mt -62.21 -34.1 62.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.577 0.703 . . . . 0.0 110.13 176.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 448' ' ' ASP . . . . . 0.5 ' HB2' ' OG1' ' A' ' 451' ' ' THR . 17.8 m-20 -162.8 -159.43 0.56 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -84.45 -66.35 0.9 Allowed 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 171.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 450' ' ' GLN . . . . . 0.513 ' O ' ' HB3' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -70.91 -25.54 62.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.855 0.359 . . . . 0.0 111.895 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 451' ' ' THR . . . . . 0.5 ' OG1' ' HB2' ' A' ' 448' ' ' ASP . 12.4 m -67.4 -22.54 65.54 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 122.037 -0.414 . . . . 0.0 110.679 -178.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 66.4 mtm180 -54.99 -51.37 66.45 Favored 'General case' 0 C--O 1.216 -0.66 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 170.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 453' ' ' ALA . . . . . 0.544 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -53.41 -52.24 60.01 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 124.352 1.033 . . . . 0.0 112.293 173.092 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 454' ' ' GLU . . . . . 0.435 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 23.6 mm-40 -51.15 -32.44 23.11 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.255 0.55 . . . . 0.0 111.987 -178.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 28.7 p -119.69 14.36 12.6 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.972 -175.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 456' ' ' PHE . . . . . 0.535 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.8 OUTLIER -58.37 -47.57 83.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.383 -170.995 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 457' ' ' ILE . . . . . 0.529 HG23 ' HB1' ' A' ' 405' ' ' ALA . 1.9 mp -77.21 -31.42 18.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.08 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -56.47 -39.01 72.48 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 122.025 0.917 . . . . 0.0 108.689 170.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 459' ' ' HIS . . . . . 0.735 ' O ' HG23 ' A' ' 463' ' ' VAL . 50.3 m-70 -73.22 -28.07 61.97 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 114.179 -1.373 . . . . 0.0 110.381 -178.535 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 460' ' ' LEU . . . . . 0.74 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -74.46 -35.11 63.31 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.864 0.84 . . . . 0.0 108.886 178.391 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 461' ' ' ASN . . . . . 0.42 ' O ' ' HB2' ' A' ' 464' ' ' TYR . 23.6 m-80 -73.44 -37.67 65.77 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.92 0.866 . . . . 0.0 109.0 176.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 462' ' ' ALA . . . . . 0.62 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -56.61 -33.32 66.14 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.402 -1.272 . . . . 0.0 109.788 169.254 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.827 HG13 ' HB3' ' A' ' 438' ' ' ALA . 63.2 t -62.19 -50.68 79.0 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.751 0 CA-C-N 114.555 -1.202 . . . . 0.0 107.804 175.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 464' ' ' TYR . . . . . 0.579 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 18.2 m-30 -53.27 -28.2 26.58 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 124.478 1.111 . . . . 0.0 110.38 178.535 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.63 -40.89 20.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.583 0.706 . . . . 0.0 109.676 -177.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.62 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.4 mt -56.61 -55.52 19.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.336 -1.302 . . . . 0.0 112.294 176.086 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.783 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -102.66 -10.01 19.59 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -171.985 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 93.57 32.31 7.76 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 119.242 -1.456 . . . . 0.0 114.237 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 469' ' ' LEU . . . . . 0.783 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.3 mt -88.67 165.64 14.63 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 117.862 0.831 . . . . 0.0 111.351 176.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 45.1 p30 -104.05 -178.77 3.75 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.559 170.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 471' ' ' ALA . . . . . 0.556 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -62.1 -21.58 65.1 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -177.229 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -88.17 5.33 41.93 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.418 -172.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 473' ' ' GLY . . . . . 0.455 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 74.92 15.38 81.01 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.346 -0.93 . . . . 0.0 111.047 -177.102 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -101.08 152.13 20.98 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 11.0 p -89.53 130.93 35.78 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.923 0.392 . . . . 0.0 110.978 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 476' ' ' ILE . . . . . 0.763 HD12 ' N ' ' A' ' 477' ' ' ARG . 2.6 pp -112.16 -27.47 2.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.309 -178.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 477' ' ' ARG . . . . . 0.763 ' N ' HD12 ' A' ' 476' ' ' ILE . 0.0 OUTLIER 61.0 -76.75 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.966 0.907 . . . . 0.0 111.853 -179.69 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -102.56 110.15 22.0 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 479' ' ' GLU . . . . . 0.443 ' HB2' HD13 ' A' ' 476' ' ' ILE . 18.8 tt0 . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.769 -0.634 . . . . 0.0 110.354 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 381' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 . . . . . 0 N--CA 1.482 1.148 0 CA-C-O 121.163 0.506 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 382' ' ' THR . . . . . 0.407 HG22 ' H ' ' B' ' 382' ' ' THR . 1.2 t -77.34 -46.13 23.88 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.581 176.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 383' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -86.49 56.07 3.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.361 0.6 . . . . 0.0 110.791 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 384' ' ' GLY . . . . . . . . . . . . . . . -99.1 89.09 0.87 Allowed Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.789 -178.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 385' ' ' THR . . . . . . . . . . . . . 23.9 m 71.38 -60.48 0.51 Allowed 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.004 0.522 . . . . 0.0 110.923 -178.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 386' ' ' PHE . . . . . 0.718 ' CD1' HD22 ' B' ' 414' ' ' LEU . 3.0 t80 -76.01 126.4 86.89 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 172.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 387' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -43.08 -75.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.786 2.99 . . . . 0.0 113.892 -175.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 388' ' ' MET . . . . . . . . . . . . . 28.4 ttm 67.2 143.76 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.652 0 O-C-N 123.497 0.498 . . . . 0.0 110.155 -178.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 389' ' ' HIS . . . . . 0.634 ' H ' ' HB3' ' B' ' 393' ' ' ASN . 29.5 m170 -55.15 -79.15 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.542 0.687 . . . . 0.0 110.113 -174.262 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 390' ' ' GLN . . . . . 0.413 ' H ' HD23 ' B' ' 391' ' ' LEU . 13.8 pt20 -153.27 19.33 0.56 Allowed 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 170.392 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 391' ' ' LEU . . . . . 0.514 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.5 pt? -173.86 -48.61 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.868 -170.071 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 392' ' ' GLY . . . . . 0.629 ' HA3' HD13 ' B' ' 395' ' ' ILE . . . -172.6 53.91 0.17 Allowed Glycine 0 CA--C 1.524 0.621 0 C-N-CA 118.796 -1.668 . . . . 0.0 115.215 -171.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 393' ' ' ASN . . . . . 0.634 ' HB3' ' H ' ' B' ' 389' ' ' HIS . 0.0 OUTLIER -57.29 -38.08 73.43 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 118.295 1.047 . . . . 0.0 108.865 176.228 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 394' ' ' VAL . . . . . 0.62 HG23 HD12 ' B' ' 398' ' ' ILE . 1.8 m -58.27 -49.39 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 CA-C-N 113.213 -1.812 . . . . 0.0 107.791 179.186 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 395' ' ' ILE . . . . . 0.663 HG23 HD13 ' B' ' 426' ' ' ILE . 4.2 mp -58.26 -52.91 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-O 117.849 -1.072 . . . . 0.0 113.441 -174.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 396' ' ' LYS . . . . . 0.636 ' HG3' ' CZ ' ' B' ' 429' ' ' TYR . 0.1 OUTLIER -63.96 -49.18 73.57 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 121.832 2.106 . . . . 0.0 111.93 -172.802 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.79 -45.15 70.22 Favored Glycine 0 N--CA 1.438 -1.193 0 C-N-CA 119.86 -1.162 . . . . 0.0 111.279 -178.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 398' ' ' ILE . . . . . 0.72 HD13 HD12 ' B' ' 410' ' ' LEU . 32.8 mt -71.07 -34.38 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -178.169 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 399' ' ' VAL . . . . . 0.508 HG12 ' HA ' ' B' ' 404' ' ' VAL . 11.5 m -63.77 -39.93 87.18 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 C-N-CA 118.898 -1.121 . . . . 0.0 108.748 -173.476 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -67.34 -39.68 85.81 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 176.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 401' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -93.67 -50.69 5.27 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 -170.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 402' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -108.72 -20.31 13.12 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.191 0.519 . . . . 0.0 110.392 -173.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 105.29 162.65 23.62 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.663 -0.699 . . . . 0.0 113.25 177.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 404' ' ' VAL . . . . . 0.604 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.5 m -53.18 -45.36 54.48 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.792 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 -175.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 405' ' ' ALA . . . . . 0.508 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -65.21 -29.86 70.7 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 119.761 -0.775 . . . . 0.0 112.457 -177.032 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 406' ' ' THR . . . . . 0.708 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 85.6 m -77.46 -42.55 35.51 Favored 'General case' 0 C--O 1.222 -0.368 0 C-N-CA 120.191 -0.604 . . . . 0.0 110.238 173.093 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 407' ' ' ALA . . . . . 0.5 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.9 -37.11 75.86 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 122.128 0.966 . . . . 0.0 109.005 177.119 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 408' ' ' TYR . . . . . 0.604 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.44 -52.95 49.5 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 113.394 -1.73 . . . . 0.0 109.863 176.708 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 409' ' ' THR . . . . . 0.683 HG22 HD23 ' B' ' 410' ' ' LEU . 9.9 m -55.61 -47.08 77.13 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.51 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 410' ' ' LEU . . . . . 0.72 HD12 HD13 ' B' ' 398' ' ' ILE . 14.4 mt -72.42 -36.33 68.58 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.045 -175.065 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -59.84 -35.27 86.07 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 119.854 -1.165 . . . . 0.0 110.803 172.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 412' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -68.1 -46.48 70.85 Favored 'General case' 0 C--O 1.224 -0.289 0 CA-C-O 120.486 0.184 . . . . 0.0 111.414 178.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 413' ' ' MET . . . . . 0.888 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.4 OUTLIER -70.82 -48.25 55.08 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 118.847 -1.141 . . . . 0.0 112.038 179.662 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 414' ' ' LEU . . . . . 0.888 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 15.9 mt -68.92 -46.65 67.74 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -176.321 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 13.9 t -93.09 -1.77 56.15 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.296 0.57 . . . . 0.0 110.091 -173.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 416' ' ' GLY . . . . . 0.402 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 93.07 -177.46 38.24 Favored Glycine 0 N--CA 1.435 -1.388 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -176.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -79.95 23.42 0.45 Allowed 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.169 0.509 . . . . 0.0 111.314 -172.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 418' ' ' ASN . . . . . 0.402 ' H ' ' C ' ' B' ' 416' ' ' GLY . 5.4 m-20 -71.6 75.87 0.81 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.567 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 419' ' ' TYR . . . . . 0.552 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 10.9 p90 -51.36 -38.52 53.66 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.387 176.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -55.23 -43.88 74.94 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.753 0.311 . . . . 0.0 110.966 177.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.56 -49.0 62.8 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.852 -177.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 422' ' ' VAL . . . . . 0.449 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.3 OUTLIER -66.8 -40.49 86.03 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.26 -177.069 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 423' ' ' SER . . . . . 0.772 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 79.5 p -66.95 -38.99 87.15 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.47 -39.16 91.28 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.186 176.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 425' ' ' ILE . . . . . 0.653 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -73.08 -51.37 26.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.593 0.196 . . . . 0.0 111.025 -177.445 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 426' ' ' ILE . . . . . 0.667 HG22 HD22 ' B' ' 430' ' ' LEU . 1.1 mm -74.6 -22.51 17.56 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.808 0 CA-C-O 120.863 0.363 . . . . 0.0 110.242 -172.117 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 427' ' ' ARG . . . . . 0.772 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.8 OUTLIER -54.98 -30.34 58.95 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.242 0.544 . . . . 0.0 110.586 -178.893 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.57 -6.17 77.54 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.481 178.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 429' ' ' TYR . . . . . 0.636 ' CZ ' ' HG3' ' B' ' 396' ' ' LYS . 22.9 m-85 -118.17 0.75 11.83 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 120.996 0.427 . . . . 0.0 110.534 -177.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 430' ' ' LEU . . . . . 0.675 HD23 ' HA ' ' B' ' 427' ' ' ARG . 0.1 OUTLIER -65.72 128.18 93.62 Favored Pre-proline 0 N--CA 1.442 -0.861 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.929 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 431' ' ' PRO . . . . . 0.461 ' HG3' ' O ' ' B' ' 473' ' ' GLY . 80.4 Cg_exo -23.67 -70.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 0.988 1 C-N-CA 125.478 4.119 . . . . 0.0 114.673 179.769 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 432' ' ' GLY . . . . . 0.502 ' O ' HG12 ' B' ' 435' ' ' VAL . . . -138.25 -166.38 10.65 Favored Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 175.11 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 433' ' ' GLN . . . . . 0.516 ' O ' HG13 ' B' ' 436' ' ' VAL . 50.1 tp60 -71.08 -26.85 63.24 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 118.352 1.076 . . . . 0.0 110.46 177.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -64.7 -39.7 94.1 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -177.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 435' ' ' VAL . . . . . 0.789 HG23 HG11 ' B' ' 463' ' ' VAL . 7.6 p -68.66 -43.82 82.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 120.938 0.399 . . . . 0.0 110.543 -178.445 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 436' ' ' VAL . . . . . 0.516 HG13 ' O ' ' B' ' 433' ' ' GLN . 0.1 OUTLIER -67.48 -30.1 47.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.766 0.317 . . . . 0.0 110.56 175.669 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 437' ' ' THR . . . . . 0.408 HG22 ' N ' ' B' ' 438' ' ' ALA . 0.9 OUTLIER -67.47 -51.91 45.71 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 179.909 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 438' ' ' ALA . . . . . 0.816 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -57.1 -43.96 82.73 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 124.089 0.868 . . . . 0.0 111.087 177.043 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 439' ' ' LEU . . . . . 0.633 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 2.1 tm? -64.77 -47.47 78.06 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -176.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -58.06 -39.52 78.7 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.293 175.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 441' ' ' GLN . . . . . 0.607 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 9.2 mm-40 -55.77 -51.31 67.87 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 123.447 0.699 . . . . 0.0 110.813 175.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 442' ' ' ARG . . . . . 0.763 ' HG2' ' O ' ' B' ' 438' ' ' ALA . 0.0 OUTLIER -58.08 -33.75 69.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.739 173.207 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 443' ' ' LEU . . . . . 0.633 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 56.6 mt -72.38 -36.2 68.65 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-O 120.927 0.394 . . . . 0.0 110.247 179.079 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -57.68 -37.76 74.0 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.642 174.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -72.99 -26.8 61.47 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.911 -1.04 . . . . 0.0 111.036 178.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 446' ' ' GLU . . . . . 0.45 ' HB3' ' O ' ' B' ' 443' ' ' LEU . 7.5 pt-20 23.79 103.31 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 174.201 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 60.7 mt -62.33 -34.17 62.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.556 0.693 . . . . 0.0 110.091 175.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 448' ' ' ASP . . . . . 0.494 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 15.9 m-20 -162.76 -159.31 0.55 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -84.5 -66.21 0.92 Allowed 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.588 -0.445 . . . . 0.0 109.852 171.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 450' ' ' GLN . . . . . 0.514 ' O ' ' HB3' ' B' ' 453' ' ' ALA . 0.0 OUTLIER -70.94 -25.67 62.84 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.828 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 451' ' ' THR . . . . . 0.494 ' OG1' ' HB2' ' B' ' 448' ' ' ASP . 12.2 m -67.3 -22.66 65.62 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.71 -178.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 452' ' ' ARG . . . . . . . . . . . . . 66.0 mtm180 -54.87 -51.54 65.6 Favored 'General case' 0 C--O 1.216 -0.687 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 170.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 453' ' ' ALA . . . . . 0.552 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -53.24 -51.94 60.58 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.338 173.047 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 454' ' ' GLU . . . . . 0.434 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 24.0 mm-40 -51.59 -32.19 27.72 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.128 -178.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 29.6 p -119.84 14.36 12.47 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.985 -175.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 456' ' ' PHE . . . . . 0.537 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 0.8 OUTLIER -58.26 -47.74 82.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.348 -170.98 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 457' ' ' ILE . . . . . 0.533 ' CG1' ' HB3' ' B' ' 408' ' ' TYR . 1.9 mp -77.04 -31.11 18.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.108 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -56.66 -39.16 73.25 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 170.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 459' ' ' HIS . . . . . 0.74 ' O ' HG23 ' B' ' 463' ' ' VAL . 49.5 m-70 -73.21 -27.99 61.92 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.126 -1.397 . . . . 0.0 110.4 -178.36 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 460' ' ' LEU . . . . . 0.736 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -74.54 -35.06 63.12 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.957 0.884 . . . . 0.0 108.975 178.163 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 461' ' ' ASN . . . . . 0.411 ' O ' ' HB2' ' B' ' 464' ' ' TYR . 23.7 m-80 -73.33 -37.63 66.05 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.886 0.85 . . . . 0.0 109.1 176.618 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 462' ' ' ALA . . . . . 0.63 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -56.73 -33.25 66.34 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.326 -1.306 . . . . 0.0 109.839 169.327 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 463' ' ' VAL . . . . . 0.816 HG13 ' HB3' ' B' ' 438' ' ' ALA . 63.9 t -62.32 -50.79 78.5 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.799 0 CA-C-N 114.545 -1.207 . . . . 0.0 107.781 175.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 464' ' ' TYR . . . . . 0.575 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 18.1 m-30 -53.12 -28.18 24.36 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.53 178.424 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.66 -41.2 19.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.594 0.711 . . . . 0.0 109.587 -177.585 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 466' ' ' ILE . . . . . 0.63 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.5 mt -56.29 -55.66 17.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 114.396 -1.275 . . . . 0.0 112.399 176.059 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 467' ' ' LEU . . . . . 0.781 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -102.23 -10.39 19.61 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -172.248 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 468' ' ' GLY . . . . . . . . . . . . . . . 93.75 32.45 7.6 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 119.209 -1.472 . . . . 0.0 114.236 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 469' ' ' LEU . . . . . 0.781 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.3 mt -88.69 165.53 14.69 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 117.929 0.864 . . . . 0.0 111.243 176.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 45.6 p30 -103.9 -178.41 3.65 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.589 170.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 471' ' ' ALA . . . . . 0.547 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -62.66 -21.52 65.77 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -176.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -87.98 5.22 41.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.414 -172.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 473' ' ' GLY . . . . . 0.461 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 75.08 15.2 81.23 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.275 -0.964 . . . . 0.0 111.119 -177.116 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -101.07 151.97 21.17 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 10.3 p -89.48 131.1 35.69 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.05 0.452 . . . . 0.0 110.982 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 476' ' ' ILE . . . . . 0.765 HD12 ' N ' ' B' ' 477' ' ' ARG . 2.6 pp -112.45 -27.2 2.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.263 -178.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 477' ' ' ARG . . . . . 0.765 ' N ' HD12 ' B' ' 476' ' ' ILE . 0.0 OUTLIER 60.8 -76.6 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.011 0.925 . . . . 0.0 111.829 -179.768 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 478' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -102.98 109.97 21.71 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 479' ' ' GLU . . . . . 0.428 ' HB2' HD13 ' B' ' 476' ' ' ILE . 20.9 tt0 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.78 -0.628 . . . . 0.0 110.096 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 381' ' ' ARG . . . . . 0.469 ' HD2' ' OD1' ' A' ' 418' ' ' ASN . 19.9 ptp180 . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -151.1 -59.77 0.17 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.322 177.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 383' ' ' HIS . . . . . 0.706 ' HB2' ' O ' ' A' ' 386' ' ' PHE . 25.4 p-80 -124.82 138.55 54.26 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.372 -0.531 . . . . 0.0 112.215 -170.261 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -114.68 -68.01 0.46 Allowed Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.015 176.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 7.3 m -97.41 -34.47 11.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.004 0.431 . . . . 0.0 110.873 178.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 386' ' ' PHE . . . . . 0.761 ' CE2' HG12 ' A' ' 394' ' ' VAL . 2.6 t80 -92.48 123.68 61.38 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.414 -177.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 387' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 386' ' ' PHE . 40.5 Cg_endo -64.69 105.8 0.68 Allowed 'Trans proline' 0 N--CA 1.478 0.571 0 C-N-CA 123.788 2.992 . . . . 0.0 112.176 173.062 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.626 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 5.2 ttp -122.01 55.26 1.13 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.29 0.567 . . . . 0.0 111.289 -168.518 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 389' ' ' HIS . . . . . 0.573 ' CE1' ' HA ' ' A' ' 393' ' ' ASN . 39.2 m170 52.93 -98.9 0.08 Allowed 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.026 -172.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -148.55 17.12 1.02 Allowed 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 171.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.625 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.5 pt? -167.3 -62.54 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.84 -171.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 392' ' ' GLY . . . . . 0.691 ' HA3' HD13 ' A' ' 395' ' ' ILE . . . -163.14 60.03 0.27 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 119.914 -1.136 . . . . 0.0 114.396 -172.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 393' ' ' ASN . . . . . 0.626 ' HB3' ' HA ' ' A' ' 388' ' ' MET . 0.2 OUTLIER -57.48 -43.39 84.07 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.996 0.427 . . . . 0.0 109.861 174.192 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.761 HG12 ' CE2' ' A' ' 386' ' ' PHE . 2.0 m -55.71 -45.91 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 -179.187 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.691 HD13 ' HA3' ' A' ' 392' ' ' GLY . 3.7 mp -58.02 -52.72 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 CA-C-O 117.812 -1.09 . . . . 0.0 113.53 -174.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 396' ' ' LYS . . . . . 0.557 ' O ' HG22 ' A' ' 399' ' ' VAL . 0.0 OUTLIER -62.79 -49.62 74.25 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 121.952 2.16 . . . . 0.0 112.186 -174.756 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 397' ' ' GLY . . . . . 0.526 ' O ' ' HG3' ' A' ' 401' ' ' GLN . . . -53.1 -44.44 63.13 Favored Glycine 0 N--CA 1.433 -1.54 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.84 -176.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 398' ' ' ILE . . . . . 0.81 HD13 HD12 ' A' ' 410' ' ' LEU . 39.1 mt -71.52 -33.81 50.78 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -179.183 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 399' ' ' VAL . . . . . 0.557 HG22 ' O ' ' A' ' 396' ' ' LYS . 13.8 m -63.72 -39.88 86.99 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 C-N-CA 118.727 -1.189 . . . . 0.0 108.252 -174.225 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -63.58 -42.96 98.27 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 174.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.526 ' HG3' ' O ' ' A' ' 397' ' ' GLY . 37.3 mt-30 -92.68 -48.17 6.72 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -169.216 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 402' ' ' GLU . . . . . 0.678 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 2.8 mm-40 -114.38 -19.31 11.28 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.149 0.499 . . . . 0.0 111.494 -171.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 104.15 162.78 24.68 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.886 177.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 404' ' ' VAL . . . . . 0.663 HG11 ' HA ' ' A' ' 430' ' ' LEU . 1.7 m -53.72 -45.46 61.12 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.83 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -175.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 405' ' ' ALA . . . . . 0.558 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -64.87 -31.18 72.29 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 119.787 -0.765 . . . . 0.0 112.328 -176.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.689 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 85.5 m -76.75 -42.78 39.79 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.101 -0.639 . . . . 0.0 110.365 173.308 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.469 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.67 -36.4 74.12 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 122.016 0.912 . . . . 0.0 109.195 176.538 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 408' ' ' TYR . . . . . 0.622 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.83 -52.16 52.87 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 113.649 -1.614 . . . . 0.0 109.771 176.285 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 409' ' ' THR . . . . . 0.668 HG22 HD23 ' A' ' 410' ' ' LEU . 17.6 m -54.67 -47.62 73.38 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.562 178.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 410' ' ' LEU . . . . . 0.81 HD12 HD13 ' A' ' 398' ' ' ILE . 13.6 mt -72.84 -35.99 67.37 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.123 -174.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -59.41 -34.77 82.35 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 119.966 -1.111 . . . . 0.0 110.592 173.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 412' ' ' MET . . . . . 0.413 ' HB2' ' O ' ' A' ' 409' ' ' THR . 0.3 OUTLIER -65.91 -48.47 71.34 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 115.726 -0.237 . . . . 0.0 111.32 177.719 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 413' ' ' MET . . . . . 0.913 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.5 OUTLIER -71.64 -46.5 58.83 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 118.988 -1.085 . . . . 0.0 111.974 -179.508 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 414' ' ' LEU . . . . . 0.913 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 16.4 mt -68.69 -45.09 72.57 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -176.106 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.518 ' HB2' ' HE1' ' A' ' 388' ' ' MET . 33.9 t -86.57 -21.58 26.78 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.483 0.659 . . . . 0.0 110.176 -175.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 416' ' ' GLY . . . . . 0.42 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 107.55 -175.81 20.45 Favored Glycine 0 N--CA 1.429 -1.775 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -171.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -79.75 23.68 0.42 Allowed 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.598 0.713 . . . . 0.0 111.405 -172.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 418' ' ' ASN . . . . . 0.469 ' OD1' ' HD2' ' A' ' 381' ' ' ARG . 62.5 m-80 -71.83 74.77 0.87 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.687 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 419' ' ' TYR . . . . . 0.535 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 23.2 p90 -52.29 -37.32 55.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.764 174.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -53.82 -46.4 71.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.691 177.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 421' ' ' LEU . . . . . 0.408 ' O ' HD13 ' A' ' 425' ' ' ILE . 0.0 OUTLIER -68.96 -49.53 57.13 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.389 -177.837 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 422' ' ' VAL . . . . . 0.457 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -65.74 -39.09 83.83 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.144 -175.879 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.805 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 77.7 p -66.7 -39.24 88.0 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.793 -178.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -68.45 -38.63 86.99 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.136 176.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 425' ' ' ILE . . . . . 0.567 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.18 -52.27 25.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.456 0.17 . . . . 0.0 111.01 -177.259 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 426' ' ' ILE . . . . . 0.666 HD13 HG23 ' A' ' 395' ' ' ILE . 1.1 mm -74.36 -22.75 17.96 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.897 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -173.32 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.805 ' HB2' ' O ' ' A' ' 423' ' ' SER . 1.1 tmt_? -54.64 -33.15 60.2 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.103 0.478 . . . . 0.0 110.699 -177.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -85.87 -10.8 74.98 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.148 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.552 ' HD1' HG22 ' A' ' 395' ' ' ILE . 9.7 m-30 -113.64 -0.14 14.42 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.421 0.629 . . . . 0.0 109.366 -174.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.68 HD23 ' HA ' ' A' ' 427' ' ' ARG . 0.1 OUTLIER -66.02 129.5 94.26 Favored Pre-proline 0 N--CA 1.445 -0.718 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.291 178.267 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 431' ' ' PRO . . . . . 0.546 ' HD2' HD12 ' A' ' 430' ' ' LEU . 94.6 Cg_exo -23.72 -66.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.359 1.088 1 C-N-CA 125.768 4.312 . . . . 0.0 115.122 179.589 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 432' ' ' GLY . . . . . 0.519 ' H ' HG12 ' A' ' 435' ' ' VAL . . . -145.86 -166.41 11.95 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 177.135 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 433' ' ' GLN . . . . . 0.491 ' O ' HG13 ' A' ' 436' ' ' VAL . 17.0 tp60 -70.01 -27.43 64.67 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 117.904 0.852 . . . . 0.0 110.526 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -67.12 -40.97 86.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.995 -177.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 435' ' ' VAL . . . . . 0.711 HG23 HG11 ' A' ' 463' ' ' VAL . 7.9 p -67.87 -43.43 86.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 121.004 0.431 . . . . 0.0 110.641 -177.15 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.509 HG12 ' O ' ' A' ' 432' ' ' GLY . 0.1 OUTLIER -66.38 -31.97 55.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.483 175.832 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.29 -52.45 40.4 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -178.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 438' ' ' ALA . . . . . 0.865 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -58.35 -38.7 77.73 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.225 177.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 439' ' ' LEU . . . . . 0.605 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 1.9 tm? -68.99 -48.53 62.87 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.19 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -58.89 -35.76 73.56 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.717 -1.128 . . . . 0.0 111.327 176.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 441' ' ' GLN . . . . . 0.448 ' O ' ' HG2' ' A' ' 445' ' ' GLN . 5.8 mm-40 -56.93 -51.35 69.5 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 123.484 0.714 . . . . 0.0 110.6 178.225 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 442' ' ' ARG . . . . . 0.484 ' HG3' ' O ' ' A' ' 438' ' ' ALA . 0.1 OUTLIER -61.56 -33.4 73.8 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.514 174.795 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 443' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 56.6 mt -68.23 -38.52 81.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.136 0.493 . . . . 0.0 109.931 177.163 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 444' ' ' ASP . . . . . 0.412 ' HB3' ' O ' ' A' ' 441' ' ' GLN . 29.4 t70 -57.95 -36.11 72.07 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.63 174.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 445' ' ' GLN . . . . . 0.448 ' HG2' ' O ' ' A' ' 441' ' ' GLN . 29.1 mm-40 -72.96 -26.63 61.43 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.8 177.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 32.44 104.33 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 172.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 47.0 mt -72.54 -34.67 48.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.464 0.65 . . . . 0.0 110.041 175.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 448' ' ' ASP . . . . . 0.424 ' HB3' ' H ' ' A' ' 449' ' ' ASP . 11.0 m-20 -165.84 -158.37 0.35 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 -177.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 449' ' ' ASP . . . . . 0.424 ' H ' ' HB3' ' A' ' 448' ' ' ASP . 18.4 m-20 -88.12 -67.41 0.83 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 168.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -66.44 -25.84 66.93 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 451' ' ' THR . . . . . 0.463 ' HA ' ' HB2' ' A' ' 454' ' ' GLU . 9.9 m -71.35 -22.98 61.83 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.457 -176.356 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 71.3 mtt180 -54.87 -53.99 48.31 Favored 'General case' 0 C--O 1.217 -0.631 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 171.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 453' ' ' ALA . . . . . 0.535 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -56.33 -48.86 75.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.7 -1.136 . . . . 0.0 112.576 174.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 454' ' ' GLU . . . . . 0.463 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 31.4 mm-40 -52.22 -34.01 43.77 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.07 0.462 . . . . 0.0 111.758 -178.049 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 27.2 p -120.25 14.9 12.21 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.481 -176.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 456' ' ' PHE . . . . . 0.577 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.9 OUTLIER -56.07 -49.21 74.42 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.043 0.449 . . . . 0.0 111.484 -171.057 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 457' ' ' ILE . . . . . 0.558 HG23 ' HB1' ' A' ' 405' ' ' ALA . 1.9 mp -74.56 -32.04 28.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.063 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -58.16 -36.2 72.67 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.604 0.716 . . . . 0.0 109.518 171.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 459' ' ' HIS . . . . . 0.749 ' O ' HG23 ' A' ' 463' ' ' VAL . 87.3 m-70 -72.79 -29.15 63.04 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.048 177.44 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 460' ' ' LEU . . . . . 0.731 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -74.0 -34.92 64.35 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.887 0.851 . . . . 0.0 109.137 -179.916 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 461' ' ' ASN . . . . . 0.46 ' O ' ' HB2' ' A' ' 464' ' ' TYR . 24.3 m-80 -73.08 -38.07 66.54 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.911 0.863 . . . . 0.0 108.985 176.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 462' ' ' ALA . . . . . 0.604 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -57.07 -32.88 66.7 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.394 -1.275 . . . . 0.0 109.874 169.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.865 HG13 ' HB3' ' A' ' 438' ' ' ALA . 60.2 t -62.63 -50.92 77.85 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.856 0 CA-C-N 114.699 -1.137 . . . . 0.0 107.958 175.582 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 464' ' ' TYR . . . . . 0.598 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 17.7 m-30 -52.07 -28.14 16.41 Favored 'General case' 0 N--CA 1.455 -0.182 0 O-C-N 124.353 1.033 . . . . 0.0 110.494 177.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.89 -39.08 20.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.787 0.803 . . . . 0.0 109.724 -178.008 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.604 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.6 mt -58.72 -55.85 20.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 114.357 -1.292 . . . . 0.0 112.189 176.194 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.769 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -101.16 -10.05 20.77 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -172.693 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 468' ' ' GLY . . . . . 0.546 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 93.77 30.84 8.62 Favored Glycine 0 CA--C 1.527 0.844 0 C-N-CA 119.646 -1.264 . . . . 0.0 114.169 179.271 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 469' ' ' LEU . . . . . 0.769 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.2 mt -88.69 159.5 17.79 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 117.847 0.823 . . . . 0.0 110.848 177.065 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 470' ' ' ASN . . . . . 0.531 HD22 HG23 ' A' ' 476' ' ' ILE . 13.9 p30 -105.32 -177.77 3.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.145 172.2 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -57.24 -26.18 60.34 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -174.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 -86.87 6.19 33.08 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 122.258 -0.277 . . . . 0.0 111.525 -171.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 473' ' ' GLY . . . . . 0.525 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 76.72 9.26 86.42 Favored Glycine 0 C--O 1.225 -0.447 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.204 -177.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -100.84 157.45 16.71 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 475' ' ' SER . . . . . 0.537 ' HA ' ' HA ' ' A' ' 469' ' ' LEU . 9.5 t -94.66 145.53 24.77 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.246 -0.582 . . . . 0.0 111.074 -178.213 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 476' ' ' ILE . . . . . 0.546 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.0 pp -104.8 12.71 7.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.035 178.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 477' ' ' ARG . . . . . 0.475 ' HG2' ' OG ' ' A' ' 475' ' ' SER . 29.4 mmt180 -62.75 120.48 11.34 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.684 176.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 71.8 mt -115.22 44.09 1.89 Allowed 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 . . . . . 0 C--O 1.247 0.967 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.08 -175.582 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 381' ' ' ARG . . . . . 0.471 ' HD2' ' OD1' ' B' ' 418' ' ' ASN . 20.0 ptp180 . . . . . 0 N--CA 1.479 0.976 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 382' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.99 -59.6 0.17 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.372 177.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 383' ' ' HIS . . . . . 0.706 ' HB2' ' O ' ' B' ' 386' ' ' PHE . 25.2 p-80 -125.16 138.99 54.14 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.362 -0.535 . . . . 0.0 112.111 -170.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 384' ' ' GLY . . . . . . . . . . . . . . . -115.13 -68.0 0.44 Allowed Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.922 176.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 385' ' ' THR . . . . . . . . . . . . . 7.3 m -97.16 -35.02 10.91 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.018 0.437 . . . . 0.0 110.732 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 386' ' ' PHE . . . . . 0.765 ' CE2' HG12 ' B' ' 394' ' ' VAL . 2.6 t80 -92.22 123.5 62.34 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.221 -177.23 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 387' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' B' ' 386' ' ' PHE . 39.8 Cg_endo -64.62 105.3 0.62 Allowed 'Trans proline' 0 N--CA 1.48 0.722 0 C-N-CA 123.801 3.001 . . . . 0.0 112.2 172.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 388' ' ' MET . . . . . 0.63 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 5.2 ttp -121.58 55.29 1.1 Allowed 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.428 0.632 . . . . 0.0 111.368 -168.577 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 389' ' ' HIS . . . . . 0.582 ' CE1' ' HA ' ' B' ' 393' ' ' ASN . 38.9 m170 52.78 -99.19 0.08 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.676 0.79 . . . . 0.0 109.908 -172.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -148.03 16.94 1.09 Allowed 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 171.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 391' ' ' LEU . . . . . 0.625 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.5 pt? -167.12 -62.58 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.92 -171.605 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 392' ' ' GLY . . . . . 0.705 ' HA3' HD13 ' B' ' 395' ' ' ILE . . . -163.32 60.13 0.27 Allowed Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 119.861 -1.161 . . . . 0.0 114.343 -172.676 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 393' ' ' ASN . . . . . 0.63 ' HB3' ' HA ' ' B' ' 388' ' ' MET . 0.2 OUTLIER -57.44 -43.47 83.95 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 174.257 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 394' ' ' VAL . . . . . 0.765 HG12 ' CE2' ' B' ' 386' ' ' PHE . 2.0 m -55.68 -45.95 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 -179.167 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 395' ' ' ILE . . . . . 0.705 HD13 ' HA3' ' B' ' 392' ' ' GLY . 3.7 mp -58.07 -52.54 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-O 117.849 -1.072 . . . . 0.0 113.484 -174.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 396' ' ' LYS . . . . . 0.558 ' O ' HG22 ' B' ' 399' ' ' VAL . 0.0 OUTLIER -62.96 -49.74 73.54 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 121.986 2.175 . . . . 0.0 112.159 -174.84 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 397' ' ' GLY . . . . . 0.529 ' O ' ' HG3' ' B' ' 401' ' ' GLN . . . -52.95 -44.33 61.74 Favored Glycine 0 N--CA 1.435 -1.395 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.908 -176.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 398' ' ' ILE . . . . . 0.814 HD13 HD12 ' B' ' 410' ' ' LEU . 39.0 mt -71.66 -33.74 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 399' ' ' VAL . . . . . 0.558 HG22 ' O ' ' B' ' 396' ' ' LYS . 14.2 m -63.68 -39.67 86.21 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 C-N-CA 118.755 -1.178 . . . . 0.0 108.478 -174.335 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -64.03 -42.71 96.99 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 174.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 401' ' ' GLN . . . . . 0.529 ' HG3' ' O ' ' B' ' 397' ' ' GLY . 37.5 mt-30 -92.62 -48.22 6.71 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -169.37 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 402' ' ' GLU . . . . . 0.703 ' HG3' ' HE3' ' A' ' 413' ' ' MET . 2.9 mm-40 -114.29 -19.43 11.27 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.175 0.512 . . . . 0.0 111.539 -171.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 104.18 162.69 24.65 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.986 177.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 404' ' ' VAL . . . . . 0.66 HG11 ' HA ' ' B' ' 430' ' ' LEU . 1.6 m -53.63 -45.47 60.06 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.813 0 N-CA-C 114.463 1.282 . . . . 0.0 114.463 -175.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 405' ' ' ALA . . . . . 0.538 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -64.83 -31.32 72.5 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 119.81 -0.756 . . . . 0.0 112.312 -177.04 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 406' ' ' THR . . . . . 0.686 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 85.7 m -76.69 -42.98 39.58 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.169 -0.613 . . . . 0.0 110.187 173.524 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 407' ' ' ALA . . . . . 0.459 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.56 -36.41 73.88 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 122.158 0.98 . . . . 0.0 109.194 176.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 408' ' ' TYR . . . . . 0.614 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.88 -52.2 52.24 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 113.594 -1.639 . . . . 0.0 109.752 176.265 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 409' ' ' THR . . . . . 0.663 HG22 HD23 ' B' ' 410' ' ' LEU . 17.9 m -54.73 -47.57 73.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.545 179.021 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 410' ' ' LEU . . . . . 0.814 HD12 HD13 ' B' ' 398' ' ' ILE . 13.6 mt -72.85 -35.85 67.3 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.189 -174.615 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -59.42 -34.92 83.07 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 119.988 -1.101 . . . . 0.0 110.626 173.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 412' ' ' MET . . . . . 0.416 ' HB2' ' O ' ' B' ' 409' ' ' THR . 0.3 OUTLIER -65.78 -48.38 71.99 Favored 'General case' 0 C--O 1.223 -0.341 0 CA-C-N 115.629 -0.285 . . . . 0.0 111.411 177.715 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 413' ' ' MET . . . . . 0.913 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.5 OUTLIER -71.63 -46.38 59.28 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 119.058 -1.057 . . . . 0.0 111.994 -179.373 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 414' ' ' LEU . . . . . 0.913 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 16.5 mt -68.93 -45.16 71.53 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -176.22 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 415' ' ' SER . . . . . 0.573 ' HB2' ' HE1' ' B' ' 388' ' ' MET . 33.9 t -86.83 -21.34 26.48 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.634 0.731 . . . . 0.0 110.169 -175.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 416' ' ' GLY . . . . . 0.417 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 107.58 -175.86 20.46 Favored Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 -171.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -79.81 23.6 0.43 Allowed 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.486 0.66 . . . . 0.0 111.294 -172.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 418' ' ' ASN . . . . . 0.471 ' OD1' ' HD2' ' B' ' 381' ' ' ARG . 61.6 m-80 -71.81 74.75 0.86 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.696 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 419' ' ' TYR . . . . . 0.538 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 23.9 p90 -52.34 -37.29 55.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.748 174.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -53.7 -46.42 70.71 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.729 177.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 421' ' ' LEU . . . . . 0.413 ' O ' HD13 ' B' ' 425' ' ' ILE . 0.0 OUTLIER -69.02 -49.51 57.04 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.438 -177.806 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 422' ' ' VAL . . . . . 0.458 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.2 OUTLIER -65.9 -39.02 83.47 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.093 -175.852 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 423' ' ' SER . . . . . 0.82 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 78.1 p -66.73 -39.12 87.85 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.818 -178.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -68.62 -38.54 86.19 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.153 176.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 425' ' ' ILE . . . . . 0.585 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -72.21 -52.32 24.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 121.351 -0.14 . . . . 0.0 110.794 -177.282 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 426' ' ' ILE . . . . . 0.653 HD13 HG23 ' B' ' 395' ' ' ILE . 1.1 mm -74.29 -22.71 18.05 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.929 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -173.175 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 427' ' ' ARG . . . . . 0.82 ' HB2' ' O ' ' B' ' 423' ' ' SER . 1.2 tmt_? -54.58 -33.25 59.96 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.166 0.507 . . . . 0.0 110.69 -177.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -85.85 -10.71 75.22 Favored Glycine 0 N--CA 1.44 -1.043 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.222 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 429' ' ' TYR . . . . . 0.554 ' HD1' HG22 ' B' ' 395' ' ' ILE . 9.5 m-30 -113.97 0.23 14.31 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.468 0.652 . . . . 0.0 109.326 -174.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 430' ' ' LEU . . . . . 0.685 HD23 ' HA ' ' B' ' 427' ' ' ARG . 0.1 OUTLIER -66.36 129.4 94.17 Favored Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.302 178.211 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 431' ' ' PRO . . . . . 0.544 ' HD2' HD12 ' B' ' 430' ' ' LEU . 94.3 Cg_exo -23.98 -65.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.36 1.137 1 C-N-CA 125.707 4.271 . . . . 0.0 115.155 179.81 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 432' ' ' GLY . . . . . 0.527 ' H ' HG12 ' B' ' 435' ' ' VAL . . . -146.56 -166.28 12.11 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 176.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 433' ' ' GLN . . . . . 0.486 ' O ' HG13 ' B' ' 436' ' ' VAL . 15.9 tp60 -69.83 -27.33 64.77 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 117.869 0.834 . . . . 0.0 110.617 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -67.23 -41.02 86.38 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -177.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 435' ' ' VAL . . . . . 0.703 HG23 HG11 ' B' ' 463' ' ' VAL . 8.0 p -67.81 -43.65 86.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-O 121.088 0.47 . . . . 0.0 110.683 -177.136 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 436' ' ' VAL . . . . . 0.505 HG12 ' O ' ' B' ' 432' ' ' GLY . 0.1 OUTLIER -66.06 -32.23 57.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.444 175.653 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.12 -52.46 41.51 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -178.346 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 438' ' ' ALA . . . . . 0.855 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -58.33 -38.84 77.97 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.155 177.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 439' ' ' LEU . . . . . 0.6 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 2.0 tm? -68.88 -48.46 63.33 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.16 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -59.1 -35.6 73.69 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.279 176.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 441' ' ' GLN . . . . . 0.447 ' O ' ' HG2' ' B' ' 445' ' ' GLN . 5.7 mm-40 -56.85 -51.5 68.76 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 123.385 0.674 . . . . 0.0 110.556 178.185 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 442' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' B' ' 438' ' ' ALA . 0.1 OUTLIER -61.59 -33.21 73.49 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.58 174.956 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 443' ' ' LEU . . . . . 0.6 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 56.6 mt -68.27 -38.83 82.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.127 0.489 . . . . 0.0 109.856 177.125 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 444' ' ' ASP . . . . . 0.408 ' HB3' ' O ' ' B' ' 441' ' ' GLN . 28.4 t70 -57.96 -35.56 71.34 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.628 174.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 445' ' ' GLN . . . . . 0.447 ' HG2' ' O ' ' B' ' 441' ' ' GLN . 29.3 mm-40 -73.26 -26.67 61.19 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.778 177.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 446' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 32.31 104.72 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 172.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 47.2 mt -72.82 -34.81 47.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.383 0.611 . . . . 0.0 109.975 175.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 448' ' ' ASP . . . . . 0.4 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 12.2 m-20 -165.87 -158.69 0.36 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -177.429 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -88.01 -67.27 0.84 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 169.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -66.53 -25.73 66.81 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 451' ' ' THR . . . . . 0.454 ' HA ' ' HB2' ' B' ' 454' ' ' GLU . 10.6 m -71.27 -23.11 61.91 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.421 -176.358 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 452' ' ' ARG . . . . . . . . . . . . . 70.9 mtt180 -54.67 -53.91 48.59 Favored 'General case' 0 C--O 1.217 -0.612 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 171.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 453' ' ' ALA . . . . . 0.538 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -56.48 -48.93 76.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.719 -1.128 . . . . 0.0 112.499 174.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 454' ' ' GLU . . . . . 0.454 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 31.9 mm-40 -52.23 -34.0 43.88 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.161 0.505 . . . . 0.0 111.626 -177.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 26.9 p -120.24 14.96 12.23 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.413 -176.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 456' ' ' PHE . . . . . 0.577 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 0.9 OUTLIER -56.13 -49.18 74.64 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.982 0.42 . . . . 0.0 111.495 -171.262 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 457' ' ' ILE . . . . . 0.548 ' CG1' ' HB3' ' B' ' 408' ' ' TYR . 1.9 mp -74.63 -31.96 28.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.0 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -58.26 -36.1 72.74 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.569 0.7 . . . . 0.0 109.418 171.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 459' ' ' HIS . . . . . 0.761 ' O ' HG23 ' B' ' 463' ' ' VAL . 87.4 m-70 -72.86 -29.18 62.99 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.175 177.44 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 460' ' ' LEU . . . . . 0.743 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -73.94 -34.95 64.51 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.901 0.857 . . . . 0.0 109.063 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 461' ' ' ASN . . . . . 0.43 ' O ' ' HB2' ' B' ' 464' ' ' TYR . 24.9 m-80 -73.3 -37.73 66.1 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.883 0.849 . . . . 0.0 109.075 176.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 462' ' ' ALA . . . . . 0.603 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -57.2 -32.99 67.05 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.832 169.41 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 463' ' ' VAL . . . . . 0.855 HG13 ' HB3' ' B' ' 438' ' ' ALA . 60.9 t -62.41 -51.02 77.39 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.799 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 175.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 464' ' ' TYR . . . . . 0.59 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 17.7 m-30 -52.04 -28.06 15.91 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 124.405 1.066 . . . . 0.0 110.616 177.447 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.16 -38.85 20.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.698 0.761 . . . . 0.0 109.766 -177.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 466' ' ' ILE . . . . . 0.603 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.6 mt -58.85 -55.89 20.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 114.44 -1.255 . . . . 0.0 112.229 176.058 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 467' ' ' LEU . . . . . 0.771 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -100.95 -10.22 20.8 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 -172.772 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 468' ' ' GLY . . . . . 0.538 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 93.86 30.89 8.53 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 119.637 -1.268 . . . . 0.0 114.157 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 469' ' ' LEU . . . . . 0.771 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.2 mt -88.62 159.59 17.8 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 117.855 0.828 . . . . 0.0 110.846 177.017 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 470' ' ' ASN . . . . . 0.543 HD22 HG23 ' B' ' 476' ' ' ILE . 13.9 p30 -105.38 -178.05 3.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.107 172.098 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 471' ' ' ALA . . . . . . . . . . . . . . . -56.74 -26.58 57.58 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -174.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 -86.75 6.5 31.12 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 122.178 -0.326 . . . . 0.0 111.73 -171.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 473' ' ' GLY . . . . . 0.523 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 76.33 9.54 85.76 Favored Glycine 0 C--O 1.227 -0.319 0 C-N-CA 120.484 -0.865 . . . . 0.0 111.257 -177.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -100.94 157.65 16.58 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 176.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 475' ' ' SER . . . . . 0.542 ' HA ' ' HA ' ' B' ' 469' ' ' LEU . 9.9 t -95.05 145.3 25.06 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.074 -178.225 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 476' ' ' ILE . . . . . 0.543 HG23 HD22 ' B' ' 470' ' ' ASN . 2.0 pp -104.66 12.62 7.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.618 0.723 . . . . 0.0 110.054 178.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 477' ' ' ARG . . . . . 0.475 ' HG2' ' OG ' ' B' ' 475' ' ' SER . 29.6 mmt180 -62.89 120.2 10.86 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.758 176.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 478' ' ' LEU . . . . . . . . . . . . . 70.8 mt -115.04 44.14 1.85 Allowed 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 479' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 . . . . . 0 C--O 1.247 0.963 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.372 -175.617 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 381' ' ' ARG . . . . . 0.769 ' N ' ' HG ' ' A' ' 415' ' ' SER . 5.8 ptm180 . . . . . 0 N--CA 1.479 1.019 0 N-CA-C 111.205 0.076 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -175.02 -53.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.644 0.259 . . . . 0.0 111.207 -178.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -129.99 141.99 50.68 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.702 0.287 . . . . 0.0 110.784 176.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 179.07 82.75 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.671 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 3.5 m 72.24 -58.17 0.6 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.171 0.588 . . . . 0.0 110.733 -176.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 386' ' ' PHE . . . . . 0.746 ' CD1' HD22 ' A' ' 414' ' ' LEU . 1.3 t80 -83.13 126.29 72.61 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.359 177.205 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -42.98 -69.35 0.08 OUTLIER 'Trans proline' 0 N--CA 1.479 0.628 0 C-N-CA 124.265 3.31 . . . . 0.0 113.667 -176.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.535 ' SD ' ' HB2' ' A' ' 415' ' ' SER . 6.7 ttp 66.44 34.13 6.41 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 173.113 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 389' ' ' HIS . . . . . 0.476 ' CE1' ' HB2' ' A' ' 393' ' ' ASN . 36.6 m170 53.93 -95.17 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.327 0.584 . . . . 0.0 110.379 -177.102 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -149.63 18.87 0.92 Allowed 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 174.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.619 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.6 pt? -173.49 -54.96 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -169.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 392' ' ' GLY . . . . . 0.619 ' N ' ' HG ' ' A' ' 391' ' ' LEU . . . -167.57 47.08 0.24 Allowed Glycine 0 CA--C 1.525 0.669 0 C-N-CA 119.685 -1.245 . . . . 0.0 114.569 -169.199 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 393' ' ' ASN . . . . . 0.633 HD21 ' C ' ' A' ' 393' ' ' ASN . 0.0 OUTLIER -54.95 -37.58 66.65 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 117.925 0.862 . . . . 0.0 109.495 175.87 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.708 HG23 HD12 ' A' ' 398' ' ' ILE . 1.5 m -57.45 -49.97 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 CA-C-N 113.824 -1.535 . . . . 0.0 107.603 178.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.649 HG21 HG22 ' A' ' 425' ' ' ILE . 4.0 mp -57.96 -52.88 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 CA-C-O 118.013 -0.994 . . . . 0.0 113.544 -174.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 396' ' ' LYS . . . . . 0.654 ' HG3' ' CZ ' ' A' ' 429' ' ' TYR . 0.1 OUTLIER -64.7 -48.48 74.54 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 121.737 2.062 . . . . 0.0 111.664 -172.525 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.34 -45.49 65.26 Favored Glycine 0 N--CA 1.433 -1.517 0 C-N-CA 120.106 -1.045 . . . . 0.0 110.978 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 398' ' ' ILE . . . . . 0.761 HD13 HD12 ' A' ' 410' ' ' LEU . 35.4 mt -70.95 -33.86 53.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 -178.401 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 399' ' ' VAL . . . . . 0.535 HG12 ' HA ' ' A' ' 404' ' ' VAL . 11.4 m -63.44 -39.88 86.95 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.514 0 C-N-CA 118.73 -1.188 . . . . 0.0 108.539 -173.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 400' ' ' ASP . . . . . 0.409 ' HB3' HG21 ' B' ' 385' ' ' THR . 12.3 t70 -70.93 -37.09 72.88 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 176.226 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.47 HE21 ' HB3' ' A' ' 401' ' ' GLN . 4.2 mm100 -86.86 -48.26 8.34 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -171.307 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 402' ' ' GLU . . . . . 0.527 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 3.0 mm-40 -119.43 -20.92 7.65 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.375 -171.027 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 107.48 161.95 21.47 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.879 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 404' ' ' VAL . . . . . 0.663 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.5 m -53.71 -41.79 48.79 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.784 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -175.295 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 405' ' ' ALA . . . . . 0.671 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -69.23 -29.33 67.25 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.916 -176.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.711 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 89.3 m -77.63 -42.79 33.6 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.206 -0.598 . . . . 0.0 110.137 172.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.43 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.42 -36.94 74.38 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 122.062 0.934 . . . . 0.0 109.355 176.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 408' ' ' TYR . . . . . 0.663 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.8 -52.13 53.22 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 113.619 -1.628 . . . . 0.0 109.767 176.372 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 409' ' ' THR . . . . . 0.659 HG22 HD23 ' A' ' 410' ' ' LEU . 17.7 m -55.53 -47.57 76.09 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.592 178.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 410' ' ' LEU . . . . . 0.761 HD12 HD13 ' A' ' 398' ' ' ILE . 15.0 mt -72.85 -35.11 67.17 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -174.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.66 -34.3 76.16 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.123 -1.037 . . . . 0.0 111.047 171.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -68.35 -49.51 59.78 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-O 120.527 0.203 . . . . 0.0 111.34 178.405 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 413' ' ' MET . . . . . 0.923 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.9 OUTLIER -71.18 -43.14 68.04 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 119.437 -0.905 . . . . 0.0 112.08 -177.474 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 414' ' ' LEU . . . . . 0.923 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 12.0 mt -73.99 -46.13 45.65 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 113.234 0.828 . . . . 0.0 113.234 -178.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.769 ' HG ' ' N ' ' A' ' 381' ' ' ARG . 3.7 t -100.1 17.55 20.85 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.361 0.6 . . . . 0.0 110.928 -170.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 78.87 178.31 50.45 Favored Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 120.285 -0.96 . . . . 0.0 111.768 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -81.72 21.17 0.85 Allowed 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.012 0.434 . . . . 0.0 111.642 -172.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 418' ' ' ASN . . . . . 0.479 ' HB3' ' HB3' ' A' ' 421' ' ' LEU . 6.3 m-20 -73.23 80.89 1.31 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.574 0.702 . . . . 0.0 111.021 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 419' ' ' TYR . . . . . 0.563 ' HB2' ' CE2' ' A' ' 456' ' ' PHE . 10.5 p90 -51.91 -38.24 55.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.761 176.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -55.58 -43.67 76.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.87 177.138 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 421' ' ' LEU . . . . . 0.479 ' HB3' ' HB3' ' A' ' 418' ' ' ASN . 0.0 OUTLIER -67.8 -48.54 66.01 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.264 -178.075 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 422' ' ' VAL . . . . . 0.478 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -65.89 -42.22 91.58 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 C-N-CA 120.421 -0.511 . . . . 0.0 111.189 -177.725 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.743 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 29.0 t -69.46 -34.99 75.2 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -178.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.54 -40.54 90.87 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.192 175.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 425' ' ' ILE . . . . . 0.649 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.81 -49.9 36.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-O 120.554 0.216 . . . . 0.0 110.763 -178.914 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 426' ' ' ILE . . . . . 0.622 HD13 HG23 ' A' ' 395' ' ' ILE . 1.2 mm -74.31 -22.41 17.91 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.911 0 C-N-CA 123.055 0.542 . . . . 0.0 110.183 -172.11 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.743 ' HB2' ' O ' ' A' ' 423' ' ' SER . 0.3 OUTLIER -54.72 -28.82 50.83 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 123.031 0.533 . . . . 0.0 111.075 -178.718 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -90.15 -8.32 66.8 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.684 178.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.654 ' CZ ' ' HG3' ' A' ' 396' ' ' LYS . 21.5 m-85 -114.46 -2.86 13.1 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 121.667 0.746 . . . . 0.0 109.619 -178.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.6 HD12 ' HD2' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -65.89 135.79 95.47 Favored Pre-proline 0 N--CA 1.437 -1.088 0 CA-C-N 114.339 -1.3 . . . . 0.0 108.657 178.325 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 431' ' ' PRO . . . . . 0.839 ' HD2' HG11 ' A' ' 435' ' ' VAL . 47.0 Cg_exo -36.42 -65.21 0.15 Allowed 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 124.614 3.543 . . . . 0.0 114.081 -172.342 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 432' ' ' GLY . . . . . 0.567 ' H ' HG12 ' A' ' 435' ' ' VAL . . . -141.94 -165.08 10.32 Favored Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 175.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 433' ' ' GLN . . . . . 0.512 ' O ' HG13 ' A' ' 436' ' ' VAL . 23.9 tp60 -70.26 -26.91 64.05 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 118.198 0.999 . . . . 0.0 110.331 177.192 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -66.29 -40.44 90.05 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -177.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 435' ' ' VAL . . . . . 0.839 HG11 ' HD2' ' A' ' 431' ' ' PRO . 7.0 p -68.14 -44.64 84.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-O 120.892 0.377 . . . . 0.0 110.785 -178.427 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.512 HG13 ' O ' ' A' ' 433' ' ' GLN . 0.2 OUTLIER -65.43 -29.11 46.17 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 CA-C-O 121.057 0.456 . . . . 0.0 110.094 175.862 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 1.1 m -69.26 -52.92 22.87 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 438' ' ' ALA . . . . . 0.879 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -58.77 -38.13 77.79 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.807 177.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 439' ' ' LEU . . . . . 0.577 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 2.2 tm? -69.91 -47.43 62.5 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.023 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -57.62 -39.67 77.44 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.38 174.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 441' ' ' GLN . . . . . 0.491 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 8.9 mm-40 -53.58 -49.54 67.53 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 123.788 0.835 . . . . 0.0 110.855 174.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 442' ' ' ARG . . . . . 0.817 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 0.7 OUTLIER -55.85 -39.43 71.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.607 172.034 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 443' ' ' LEU . . . . . 0.577 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 37.1 mt -71.71 -35.56 70.25 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.025 0.44 . . . . 0.0 110.178 -178.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -58.05 -36.97 73.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.631 174.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -72.82 -28.03 62.31 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.616 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 446' ' ' GLU . . . . . 0.575 ' HB2' ' O ' ' A' ' 443' ' ' LEU . 31.6 tt0 29.75 96.49 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 172.515 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 42.1 mt -67.91 -35.31 71.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.202 0.525 . . . . 0.0 110.518 177.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 448' ' ' ASP . . . . . 0.62 ' O ' ' HG3' ' A' ' 452' ' ' ARG . 23.2 m-20 -166.15 -170.52 1.73 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -76.7 -62.44 1.63 Allowed 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.176 -0.61 . . . . 0.0 109.405 173.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -70.37 -26.03 63.54 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 451' ' ' THR . . . . . 0.478 ' OG1' ' HB2' ' A' ' 448' ' ' ASP . 17.7 m -71.71 -22.65 61.61 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 119.824 -0.75 . . . . 0.0 110.853 -175.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 452' ' ' ARG . . . . . 0.62 ' HG3' ' O ' ' A' ' 448' ' ' ASP . 13.3 mtp180 -53.64 -54.75 33.34 Favored 'General case' 0 C--O 1.218 -0.569 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 170.259 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 453' ' ' ALA . . . . . 0.484 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -57.34 -48.2 79.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.264 -1.335 . . . . 0.0 112.582 175.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 454' ' ' GLU . . . . . 0.465 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 20.8 mm-40 -51.83 -35.72 45.55 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.151 0.501 . . . . 0.0 111.752 -177.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 31.2 p -119.22 16.2 13.15 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.314 -176.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 456' ' ' PHE . . . . . 0.563 ' CE2' ' HB2' ' A' ' 419' ' ' TYR . 1.0 OUTLIER -57.05 -48.84 77.55 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.975 0.417 . . . . 0.0 111.819 -171.441 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 457' ' ' ILE . . . . . 0.671 HG23 ' HB1' ' A' ' 405' ' ' ALA . 2.0 mp -75.67 -33.02 25.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.934 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -58.4 -35.08 71.49 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.942 0.877 . . . . 0.0 109.268 172.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 459' ' ' HIS . . . . . 0.715 ' O ' HG23 ' A' ' 463' ' ' VAL . 59.4 m-70 -74.23 -28.87 61.44 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.539 -1.21 . . . . 0.0 110.732 177.124 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 460' ' ' LEU . . . . . 0.707 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.4 OUTLIER -73.64 -34.79 65.14 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.794 0.807 . . . . 0.0 108.914 178.869 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 461' ' ' ASN . . . . . 0.492 ' HA ' ' CD2' ' A' ' 464' ' ' TYR . 20.0 m-80 -73.21 -37.64 66.36 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.276 -0.874 . . . . 0.0 108.872 176.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 462' ' ' ALA . . . . . 0.597 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -56.85 -34.92 68.26 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.443 -1.253 . . . . 0.0 109.812 169.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.879 HG13 ' HB3' ' A' ' 438' ' ' ALA . 68.4 t -60.12 -51.22 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 175.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 464' ' ' TYR . . . . . 0.618 ' CE2' ' HA ' ' A' ' 471' ' ' ALA . 16.2 m-30 -53.52 -28.33 30.7 Favored 'General case' 0 N--CA 1.456 -0.159 0 O-C-N 124.233 0.958 . . . . 0.0 110.598 178.358 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.19 -39.6 20.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.787 0.803 . . . . 0.0 109.466 -177.333 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.597 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.7 mt -57.62 -55.68 19.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 114.22 -1.354 . . . . 0.0 112.286 175.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.787 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -102.83 -10.64 18.92 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -172.343 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 468' ' ' GLY . . . . . 0.697 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 93.93 32.47 7.52 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 118.96 -1.59 . . . . 0.0 114.155 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 469' ' ' LEU . . . . . 0.787 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.7 mt -89.63 166.41 13.64 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 117.793 0.797 . . . . 0.0 111.489 176.139 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 40.4 p30 -106.06 -178.12 3.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.564 -0.743 . . . . 0.0 109.668 169.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 471' ' ' ALA . . . . . 0.618 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -70.71 -9.72 57.83 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -175.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -89.09 -0.63 57.6 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.931 0.396 . . . . 0.0 110.861 -177.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 473' ' ' GLY . . . . . 0.474 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 75.5 16.58 80.54 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -173.175 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -101.57 155.57 18.01 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.275 -0.462 . . . . 0.0 109.818 178.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 3.0 p -94.49 121.06 35.65 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.165 0.507 . . . . 0.0 110.768 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 476' ' ' ILE . . . . . 0.697 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.3 pp -87.08 -51.15 13.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.072 -176.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 477' ' ' ARG . . . . . 0.6 ' N ' HD12 ' A' ' 476' ' ' ILE . 1.0 OUTLIER 46.44 65.12 1.27 Allowed 'General case' 0 C--N 1.329 -0.301 0 O-C-N 123.84 0.713 . . . . 0.0 110.777 178.203 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 90.8 mt 59.69 73.1 0.49 Allowed 'General case' 0 C--N 1.332 -0.152 0 O-C-N 123.653 0.596 . . . . 0.0 110.239 -172.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 479' ' ' GLU . . . . . 0.438 ' HB2' ' HB ' ' A' ' 476' ' ' ILE . 27.1 tt0 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.496 -0.764 . . . . 0.0 110.61 -177.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 381' ' ' ARG . . . . . 0.737 ' N ' ' HG ' ' B' ' 415' ' ' SER . 5.9 ptm180 . . . . . 0 N--CA 1.479 1.017 0 N-CA-C 111.307 0.114 . . . . 0.0 111.307 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 382' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -174.66 -53.26 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.573 0.225 . . . . 0.0 111.134 -178.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 383' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -129.98 141.88 50.7 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.675 0.274 . . . . 0.0 110.797 176.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 384' ' ' GLY . . . . . . . . . . . . . . . 179.0 82.43 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.726 -178.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 385' ' ' THR . . . . . 0.409 HG21 ' HB3' ' A' ' 400' ' ' ASP . 3.5 m 72.32 -58.25 0.6 Allowed 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.255 0.622 . . . . 0.0 110.598 -176.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 386' ' ' PHE . . . . . 0.747 ' CD1' HD22 ' B' ' 414' ' ' LEU . 1.2 t80 -83.22 126.18 72.66 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.36 177.409 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 387' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -43.12 -68.99 0.09 OUTLIER 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 124.049 3.166 . . . . 0.0 113.782 -176.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 388' ' ' MET . . . . . 0.533 ' SD ' ' HB2' ' B' ' 415' ' ' SER . 6.6 ttp 66.23 34.21 6.75 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 173.047 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 389' ' ' HIS . . . . . 0.479 ' CE1' ' HB2' ' B' ' 393' ' ' ASN . 36.6 m170 54.08 -94.62 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.363 0.602 . . . . 0.0 110.546 -177.255 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -150.29 19.22 0.85 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.144 -0.934 . . . . 0.0 108.657 174.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 391' ' ' LEU . . . . . 0.614 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.6 pt? -173.91 -55.01 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -169.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 392' ' ' GLY . . . . . 0.614 ' N ' ' HG ' ' B' ' 391' ' ' LEU . . . -167.57 47.11 0.24 Allowed Glycine 0 CA--C 1.523 0.566 0 C-N-CA 119.796 -1.192 . . . . 0.0 114.736 -169.266 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 393' ' ' ASN . . . . . 0.488 ' HB3' ' C ' ' B' ' 388' ' ' MET . 0.0 OUTLIER -54.92 -37.56 66.54 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 117.915 0.857 . . . . 0.0 109.461 175.94 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 394' ' ' VAL . . . . . 0.692 HG23 HD12 ' B' ' 398' ' ' ILE . 1.5 m -57.5 -49.9 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 113.795 -1.548 . . . . 0.0 107.491 179.04 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 395' ' ' ILE . . . . . 0.66 HG21 HG22 ' B' ' 425' ' ' ILE . 4.0 mp -58.14 -52.86 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-O 117.978 -1.01 . . . . 0.0 113.464 -174.483 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 396' ' ' LYS . . . . . 0.657 ' HG3' ' CZ ' ' B' ' 429' ' ' TYR . 0.1 OUTLIER -64.71 -48.5 74.42 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 121.788 2.086 . . . . 0.0 111.679 -172.476 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.24 -45.49 64.28 Favored Glycine 0 N--CA 1.435 -1.397 0 C-N-CA 120.01 -1.09 . . . . 0.0 110.935 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 398' ' ' ILE . . . . . 0.758 HD13 HD12 ' B' ' 410' ' ' LEU . 36.0 mt -71.05 -33.93 53.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 113.607 0.965 . . . . 0.0 113.607 -178.193 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 399' ' ' VAL . . . . . 0.519 HG12 ' HA ' ' B' ' 404' ' ' VAL . 11.7 m -63.3 -39.86 86.86 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.54 0 C-N-CA 118.827 -1.149 . . . . 0.0 108.559 -174.015 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -70.95 -37.44 72.82 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 176.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 401' ' ' GLN . . . . . 0.401 HE21 ' HB3' ' B' ' 401' ' ' GLN . 3.9 mm100 -86.66 -47.8 8.85 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -171.414 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 402' ' ' GLU . . . . . 0.439 ' HG3' ' HE3' ' A' ' 413' ' ' MET . 3.0 mm-40 -119.71 -20.64 7.58 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.385 -171.165 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 107.2 161.98 21.74 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.863 178.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 404' ' ' VAL . . . . . 0.647 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.5 m -53.74 -41.8 49.09 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.862 0 N-CA-C 114.649 1.352 . . . . 0.0 114.649 -175.385 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 405' ' ' ALA . . . . . 0.679 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -69.2 -29.11 67.01 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 119.657 -0.817 . . . . 0.0 112.042 -176.396 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 406' ' ' THR . . . . . 0.708 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 91.6 m -77.74 -42.82 32.89 Favored 'General case' 0 C--O 1.22 -0.474 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.142 172.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 407' ' ' ALA . . . . . 0.429 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.54 -36.82 74.47 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 122.01 0.909 . . . . 0.0 109.375 176.572 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 408' ' ' TYR . . . . . 0.647 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.81 -52.33 51.57 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 113.581 -1.645 . . . . 0.0 109.777 176.185 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 409' ' ' THR . . . . . 0.656 HG22 HD23 ' B' ' 410' ' ' LEU . 17.7 m -55.27 -47.66 75.17 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.676 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 410' ' ' LEU . . . . . 0.758 HD12 HD13 ' B' ' 398' ' ' ILE . 14.9 mt -72.81 -35.16 67.27 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 -174.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.67 -34.25 75.99 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.136 -1.03 . . . . 0.0 111.035 171.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 412' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -68.41 -49.37 60.52 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.558 0.218 . . . . 0.0 111.369 178.362 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 413' ' ' MET . . . . . 0.94 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.9 OUTLIER -71.34 -43.1 67.64 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 119.355 -0.938 . . . . 0.0 112.099 -177.553 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 414' ' ' LEU . . . . . 0.94 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 12.0 mt -73.89 -46.15 46.31 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -178.398 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 415' ' ' SER . . . . . 0.737 ' HG ' ' N ' ' B' ' 381' ' ' ARG . 3.7 t -100.37 17.79 20.61 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.265 0.555 . . . . 0.0 110.897 -170.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 416' ' ' GLY . . . . . . . . . . . . . . . 78.82 178.22 50.26 Favored Glycine 0 N--CA 1.438 -1.189 0 C-N-CA 120.342 -0.932 . . . . 0.0 111.771 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 33.6 mm-40 -81.7 21.25 0.84 Allowed 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.074 0.464 . . . . 0.0 111.496 -172.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 418' ' ' ASN . . . . . 0.481 ' HB3' ' HB3' ' B' ' 421' ' ' LEU . 6.6 m-20 -73.26 80.82 1.33 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.541 0.686 . . . . 0.0 111.067 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 419' ' ' TYR . . . . . 0.558 ' HB2' ' CE2' ' B' ' 456' ' ' PHE . 10.4 p90 -52.02 -38.13 55.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.869 -1.059 . . . . 0.0 111.843 176.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -55.36 -43.81 75.4 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.646 0.26 . . . . 0.0 110.81 176.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 421' ' ' LEU . . . . . 0.481 ' HB3' ' HB3' ' B' ' 418' ' ' ASN . 0.0 OUTLIER -67.73 -48.51 66.25 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.24 -177.908 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 422' ' ' VAL . . . . . 0.479 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.2 OUTLIER -66.05 -42.06 90.8 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.149 -177.579 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 423' ' ' SER . . . . . 0.749 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 25.5 t -69.54 -35.0 75.03 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.52 -40.54 90.93 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.265 175.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 425' ' ' ILE . . . . . 0.66 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -72.76 -50.07 36.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 O-C-N 122.834 -0.216 . . . . 0.0 110.824 -179.074 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 426' ' ' ILE . . . . . 0.62 HD13 HG23 ' B' ' 395' ' ' ILE . 1.2 mm -74.41 -22.32 17.76 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.911 0 C-N-CA 122.956 0.502 . . . . 0.0 110.235 -172.014 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 427' ' ' ARG . . . . . 0.749 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.3 OUTLIER -54.7 -28.7 49.74 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 123.023 0.529 . . . . 0.0 111.186 -178.91 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -90.58 -7.77 66.49 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.489 178.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 429' ' ' TYR . . . . . 0.657 ' CZ ' ' HG3' ' B' ' 396' ' ' LYS . 21.6 m-85 -114.94 -2.49 12.85 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.74 0.781 . . . . 0.0 109.571 -178.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 430' ' ' LEU . . . . . 0.608 HD12 ' HD2' ' B' ' 431' ' ' PRO . 0.0 OUTLIER -65.91 135.76 95.44 Favored Pre-proline 0 N--CA 1.437 -1.088 0 CA-C-N 114.462 -1.244 . . . . 0.0 108.679 178.165 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 431' ' ' PRO . . . . . 0.838 ' HD2' HG11 ' B' ' 435' ' ' VAL . 46.5 Cg_exo -36.53 -65.08 0.15 Allowed 'Trans proline' 0 N--CA 1.473 0.322 0 C-N-CA 124.658 3.572 . . . . 0.0 114.09 -172.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 432' ' ' GLY . . . . . 0.553 ' H ' HG12 ' B' ' 435' ' ' VAL . . . -142.08 -165.12 10.36 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 175.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 433' ' ' GLN . . . . . 0.506 ' O ' HG13 ' B' ' 436' ' ' VAL . 24.5 tp60 -70.13 -26.89 64.16 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 118.195 0.998 . . . . 0.0 110.423 177.299 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -66.54 -40.01 88.87 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -177.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 435' ' ' VAL . . . . . 0.838 HG11 ' HD2' ' B' ' 431' ' ' PRO . 7.1 p -68.43 -44.63 83.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-O 120.962 0.41 . . . . 0.0 110.702 -178.366 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 436' ' ' VAL . . . . . 0.506 HG13 ' O ' ' B' ' 433' ' ' GLN . 0.1 OUTLIER -65.43 -29.34 46.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.112 175.826 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 1.1 m -69.19 -52.81 24.18 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 438' ' ' ALA . . . . . 0.864 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -58.75 -38.43 78.4 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.744 177.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 439' ' ' LEU . . . . . 0.581 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 2.2 tm? -69.68 -47.34 63.58 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -178.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -57.69 -39.53 77.38 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.291 174.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 441' ' ' GLN . . . . . 0.499 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 8.8 mm-40 -53.8 -49.54 68.1 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 123.733 0.813 . . . . 0.0 110.82 174.316 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 442' ' ' ARG . . . . . 0.83 ' HG2' ' O ' ' B' ' 438' ' ' ALA . 0.7 OUTLIER -55.82 -39.3 71.18 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.609 172.061 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 443' ' ' LEU . . . . . 0.581 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 37.5 mt -71.68 -35.61 70.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.953 0.406 . . . . 0.0 110.19 -178.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -58.16 -37.05 73.93 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.521 174.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -72.74 -28.27 62.54 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.512 178.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 446' ' ' GLU . . . . . 0.573 ' HB2' ' O ' ' B' ' 443' ' ' LEU . 31.7 tt0 30.04 96.96 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 O-C-N 124.686 1.241 . . . . 0.0 114.339 172.464 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 42.7 mt -68.29 -35.27 70.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.112 0.482 . . . . 0.0 110.593 177.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 448' ' ' ASP . . . . . 0.61 ' O ' ' HG3' ' B' ' 452' ' ' ARG . 23.5 m-20 -165.89 -170.26 1.71 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -76.73 -62.64 1.57 Allowed 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 173.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -70.43 -25.91 63.43 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 451' ' ' THR . . . . . 0.468 ' OG1' ' HB2' ' B' ' 448' ' ' ASP . 18.6 m -71.71 -22.74 61.6 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.632 -175.316 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 452' ' ' ARG . . . . . 0.61 ' HG3' ' O ' ' B' ' 448' ' ' ASP . 13.6 mtp180 -53.54 -54.65 34.35 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 170.332 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 453' ' ' ALA . . . . . 0.483 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -57.51 -48.22 79.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.275 -1.33 . . . . 0.0 112.604 175.581 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 454' ' ' GLU . . . . . 0.454 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 20.9 mm-40 -51.67 -35.72 43.57 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.252 0.548 . . . . 0.0 111.736 -177.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 31.1 p -119.28 16.15 13.1 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.362 -176.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 456' ' ' PHE . . . . . 0.558 ' CE2' ' HB2' ' B' ' 419' ' ' TYR . 1.0 OUTLIER -57.13 -48.67 78.08 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.95 0.405 . . . . 0.0 111.766 -171.343 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 457' ' ' ILE . . . . . 0.679 HG23 ' HB1' ' B' ' 405' ' ' ALA . 2.0 mp -75.77 -33.23 25.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.864 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -58.35 -34.95 71.23 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.888 0.851 . . . . 0.0 109.293 172.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 459' ' ' HIS . . . . . 0.72 ' O ' HG23 ' B' ' 463' ' ' VAL . 60.1 m-70 -74.33 -28.78 61.31 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.777 177.053 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 460' ' ' LEU . . . . . 0.711 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.4 OUTLIER -73.63 -34.81 65.18 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.869 0.842 . . . . 0.0 108.872 178.94 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 461' ' ' ASN . . . . . 0.494 ' HA ' ' CD2' ' B' ' 464' ' ' TYR . 19.2 m-80 -73.26 -37.69 66.23 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.279 -0.873 . . . . 0.0 108.909 176.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 462' ' ' ALA . . . . . 0.6 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -56.8 -34.9 68.12 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.812 169.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 463' ' ' VAL . . . . . 0.864 HG13 ' HB3' ' B' ' 438' ' ' ALA . 68.6 t -60.12 -51.24 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 175.546 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 464' ' ' TYR . . . . . 0.626 ' CE2' ' HA ' ' B' ' 471' ' ' ALA . 16.4 m-30 -53.51 -28.16 29.58 Favored 'General case' 0 N--CA 1.457 -0.105 0 O-C-N 124.242 0.964 . . . . 0.0 110.551 178.369 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.29 -39.94 20.18 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.706 0.765 . . . . 0.0 109.411 -177.293 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 466' ' ' ILE . . . . . 0.6 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.7 mt -57.4 -55.5 20.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 114.189 -1.369 . . . . 0.0 112.231 176.099 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 467' ' ' LEU . . . . . 0.796 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -103.05 -10.47 18.88 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -172.369 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 468' ' ' GLY . . . . . 0.703 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 93.82 32.52 7.53 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 118.996 -1.573 . . . . 0.0 114.133 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 469' ' ' LEU . . . . . 0.796 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.7 mt -89.63 166.26 13.73 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 117.832 0.816 . . . . 0.0 111.538 176.168 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 41.3 p30 -105.91 -178.19 3.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.72 169.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 471' ' ' ALA . . . . . 0.626 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -70.83 -9.55 57.77 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -175.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -89.27 -0.75 57.71 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.856 0.36 . . . . 0.0 110.908 -177.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 473' ' ' GLY . . . . . 0.459 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 75.74 16.53 80.59 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -173.327 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -101.45 155.71 17.9 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.23 -0.485 . . . . 0.0 109.861 178.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 2.7 p -94.93 120.92 35.95 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.193 0.52 . . . . 0.0 110.673 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 476' ' ' ILE . . . . . 0.703 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.3 pp -86.87 -50.8 13.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.189 -176.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 477' ' ' ARG . . . . . 0.603 ' N ' HD12 ' B' ' 476' ' ' ILE . 1.1 mmt85 46.15 65.08 1.26 Allowed 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.936 0.773 . . . . 0.0 110.713 178.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 478' ' ' LEU . . . . . . . . . . . . . 91.0 mt 60.13 72.5 0.52 Allowed 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.274 -173.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 479' ' ' GLU . . . . . 0.432 ' HB2' ' HB ' ' B' ' 476' ' ' ILE . 25.9 tt0 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.48 -0.772 . . . . 0.0 110.619 -177.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 381' ' ' ARG . . . . . 0.536 ' HD2' ' OD1' ' A' ' 418' ' ' ASN . 13.9 ptp180 . . . . . 0 N--CA 1.479 1.021 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.61 -39.13 0.35 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -176.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 383' ' ' HIS . . . . . 0.557 ' HB2' ' O ' ' A' ' 386' ' ' PHE . 51.1 p-80 -165.08 152.37 10.97 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.228 -0.589 . . . . 0.0 112.237 -173.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -118.85 -86.6 1.07 Allowed Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.682 174.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 5.3 m -68.73 -41.25 79.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.062 0.458 . . . . 0.0 111.488 -179.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 386' ' ' PHE . . . . . 0.748 ' CD1' HD22 ' A' ' 414' ' ' LEU . 2.3 t80 -88.8 123.67 67.18 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.515 -176.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 387' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 386' ' ' PHE . 40.6 Cg_endo -65.5 111.54 1.89 Allowed 'Trans proline' 0 N--CA 1.482 0.811 0 C-N-CA 123.873 3.049 . . . . 0.0 112.458 173.224 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.626 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 34.2 ttm -121.37 47.92 1.76 Allowed 'General case' 0 C--N 1.321 -0.634 0 O-C-N 121.984 -0.448 . . . . 0.0 111.536 -169.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 389' ' ' HIS . . . . . 0.645 ' CG ' ' HB2' ' A' ' 393' ' ' ASN . 38.0 m170 57.09 -90.17 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 121.484 0.659 . . . . 0.0 109.482 -170.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -160.49 17.36 0.13 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.293 175.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.572 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.3 pt? -167.42 -59.35 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.562 -0.744 . . . . 0.0 112.119 -171.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 392' ' ' GLY . . . . . 0.575 ' CA ' HD13 ' A' ' 395' ' ' ILE . . . -167.07 53.33 0.24 Allowed Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.216 -0.993 . . . . 0.0 114.059 -172.048 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 393' ' ' ASN . . . . . 0.645 ' HB2' ' CG ' ' A' ' 389' ' ' HIS . 0.4 OUTLIER -56.35 -44.07 79.7 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 117.314 0.557 . . . . 0.0 110.262 176.811 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.713 HG12 ' CE2' ' A' ' 386' ' ' PHE . 1.9 m -55.25 -45.13 77.5 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.777 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 -178.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.655 HG23 HD13 ' A' ' 426' ' ' ILE . 3.7 mp -58.02 -52.74 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 CA-C-O 117.853 -1.07 . . . . 0.0 113.544 -175.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 396' ' ' LYS . . . . . 0.511 ' O ' HG22 ' A' ' 399' ' ' VAL . 0.0 OUTLIER -63.2 -48.86 76.52 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 122.044 2.202 . . . . 0.0 112.139 -174.13 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 397' ' ' GLY . . . . . 0.453 ' O ' ' HG3' ' A' ' 401' ' ' GLN . . . -53.02 -44.49 62.33 Favored Glycine 0 N--CA 1.435 -1.414 0 C-N-CA 119.989 -1.101 . . . . 0.0 110.983 -177.33 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 398' ' ' ILE . . . . . 0.782 HD13 HD12 ' A' ' 410' ' ' LEU . 34.6 mt -71.83 -34.01 50.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 399' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 396' ' ' LYS . 11.8 m -64.18 -40.44 89.05 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 C-N-CA 118.742 -1.183 . . . . 0.0 108.402 -173.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -64.27 -41.47 96.91 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 175.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' A' ' 397' ' ' GLY . 34.8 mt-30 -92.94 -49.74 5.89 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -170.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 402' ' ' GLU . . . . . 0.683 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 2.4 mm-40 -111.74 -20.22 12.17 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.026 0.441 . . . . 0.0 111.227 -171.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 104.75 162.18 24.06 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.944 178.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 404' ' ' VAL . . . . . 0.654 HG11 ' HA ' ' A' ' 430' ' ' LEU . 1.5 m -54.03 -45.85 65.23 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.784 0 N-CA-C 114.568 1.322 . . . . 0.0 114.568 -175.123 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 405' ' ' ALA . . . . . 0.56 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -63.46 -33.04 74.69 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 119.851 -0.74 . . . . 0.0 112.26 -177.027 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.717 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 93.0 m -76.04 -41.91 49.36 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.199 174.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.474 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.49 -36.97 74.59 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 122.139 0.971 . . . . 0.0 109.221 176.36 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 408' ' ' TYR . . . . . 0.624 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -66.46 -52.78 42.6 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 113.471 -1.695 . . . . 0.0 110.06 177.336 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 409' ' ' THR . . . . . 0.76 HG22 HD23 ' A' ' 410' ' ' LEU . 1.7 m -56.4 -45.68 80.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.395 178.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 410' ' ' LEU . . . . . 0.782 HD12 HD13 ' A' ' 398' ' ' ILE . 13.3 mt -71.54 -36.88 71.12 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -176.286 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.95 -35.14 81.93 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.054 -1.07 . . . . 0.0 110.727 172.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -67.2 -47.93 69.42 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 115.719 -0.241 . . . . 0.0 111.386 177.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 413' ' ' MET . . . . . 0.912 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.6 OUTLIER -70.94 -46.81 61.78 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 118.813 -1.155 . . . . 0.0 111.912 -179.772 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 414' ' ' LEU . . . . . 0.912 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 14.7 mt -68.02 -44.96 75.32 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -176.045 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 33.8 t -88.99 -16.28 32.09 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.732 0.777 . . . . 0.0 110.267 -175.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 102.02 -175.8 25.36 Favored Glycine 0 N--CA 1.431 -1.681 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -171.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -79.95 23.63 0.44 Allowed 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.278 0.561 . . . . 0.0 111.7 -171.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 418' ' ' ASN . . . . . 0.536 ' OD1' ' HD2' ' A' ' 381' ' ' ARG . 64.8 m-80 -72.33 77.17 1.01 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.007 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 419' ' ' TYR . . . . . 0.552 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 11.6 p90 -53.01 -38.78 62.61 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.517 176.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.51 -44.14 76.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.784 0.326 . . . . 0.0 110.938 178.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.07 -49.36 61.8 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.293 -178.313 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 422' ' ' VAL . . . . . 0.441 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -65.99 -39.53 84.81 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 C-N-CA 120.376 -0.529 . . . . 0.0 111.209 -176.759 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.776 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 78.2 p -68.21 -37.99 81.47 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 -178.461 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -69.06 -37.16 82.31 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.072 176.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 425' ' ' ILE . . . . . 0.564 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.88 -53.32 19.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.42 0.152 . . . . 0.0 111.052 -178.746 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 426' ' ' ILE . . . . . 0.686 HG22 HD22 ' A' ' 430' ' ' LEU . 1.1 mm -73.53 -22.89 19.16 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.828 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -172.297 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.776 ' HB2' ' O ' ' A' ' 423' ' ' SER . 0.9 OUTLIER -54.61 -32.54 58.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.142 0.496 . . . . 0.0 110.432 -178.663 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.02 -7.37 77.64 Favored Glycine 0 N--CA 1.44 -1.074 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.387 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.501 ' HD1' ' CG2' ' A' ' 395' ' ' ILE . 14.4 m-85 -117.21 0.58 12.32 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.079 0.466 . . . . 0.0 109.945 -176.373 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.686 HD22 HG22 ' A' ' 426' ' ' ILE . 0.1 OUTLIER -65.98 129.27 94.24 Favored Pre-proline 0 N--CA 1.446 -0.665 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.251 178.812 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 431' ' ' PRO . . . . . 0.503 ' HD2' HD12 ' A' ' 430' ' ' LEU . 90.3 Cg_exo -24.61 -68.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.359 1.113 1 C-N-CA 125.424 4.083 . . . . 0.0 115.029 179.709 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 432' ' ' GLY . . . . . 0.555 ' O ' HG12 ' A' ' 435' ' ' VAL . . . -142.07 -170.42 12.54 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 177.232 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 433' ' ' GLN . . . . . 0.464 ' O ' HG13 ' A' ' 436' ' ' VAL . 41.4 tp60 -68.13 -26.35 65.75 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 118.006 0.903 . . . . 0.0 110.458 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -66.29 -41.26 90.04 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -178.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 435' ' ' VAL . . . . . 0.742 HG23 HG11 ' A' ' 463' ' ' VAL . 8.0 p -68.65 -43.81 82.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-O 120.929 0.395 . . . . 0.0 110.508 -177.201 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.495 HG12 ' O ' ' A' ' 432' ' ' GLY . 0.1 OUTLIER -65.84 -30.55 50.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.512 175.538 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 1.1 m -69.16 -52.18 30.72 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 438' ' ' ALA . . . . . 0.873 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -58.61 -37.42 75.83 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.823 177.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 439' ' ' LEU . . . . . 0.552 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 2.0 tm? -70.35 -47.18 62.15 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -57.37 -38.85 74.85 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.368 174.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 441' ' ' GLN . . . . . 0.492 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 35.9 mm-40 -53.47 -50.05 66.15 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 123.486 0.714 . . . . 0.0 110.562 174.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 442' ' ' ARG . . . . . 0.799 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 0.8 OUTLIER -56.83 -40.57 76.28 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.752 172.344 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 443' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 40.9 mt -72.64 -26.11 61.53 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.35 0.595 . . . . 0.0 110.865 -178.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -70.22 -36.38 74.5 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.008 177.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 445' ' ' GLN . . . . . 0.463 ' HG3' ' N ' ' A' ' 446' ' ' GLU . 0.0 OUTLIER -75.22 -30.19 60.51 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.026 178.098 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 446' ' ' GLU . . . . . 0.513 ' HB3' ' O ' ' A' ' 443' ' ' LEU . 13.6 pt-20 27.52 97.31 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.171 0 O-C-N 125.396 1.685 . . . . 0.0 113.646 175.3 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 49.3 mt -59.25 -35.12 56.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.206 0.527 . . . . 0.0 110.989 -178.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 448' ' ' ASP . . . . . 0.466 ' HB2' ' OG1' ' A' ' 451' ' ' THR . 17.1 m-20 -163.33 -157.8 0.44 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 -178.459 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -87.13 -67.31 0.83 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 171.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -66.2 -25.43 66.92 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 176.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 451' ' ' THR . . . . . 0.483 ' HA ' ' HB2' ' A' ' 454' ' ' GLU . 10.5 m -71.31 -22.64 61.91 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 119.906 -0.717 . . . . 0.0 110.602 -174.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 452' ' ' ARG . . . . . 0.445 ' NH2' ' HB3' ' A' ' 443' ' ' LEU . 19.0 mtp180 -53.53 -54.26 39.77 Favored 'General case' 0 C--O 1.22 -0.495 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 171.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 453' ' ' ALA . . . . . 0.552 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -58.4 -49.4 77.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.525 -1.216 . . . . 0.0 112.808 174.426 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 454' ' ' GLU . . . . . 0.483 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 16.0 mm-40 -51.15 -35.47 36.01 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.1 0.476 . . . . 0.0 112.049 -177.096 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 28.2 p -119.98 16.16 12.51 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.191 -176.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 456' ' ' PHE . . . . . 0.601 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.9 OUTLIER -55.23 -48.62 73.66 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.99 0.424 . . . . 0.0 111.639 -172.351 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 457' ' ' ILE . . . . . 0.56 HG23 ' HB1' ' A' ' 405' ' ' ALA . 1.9 mp -76.96 -33.05 20.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.964 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -57.97 -34.88 70.42 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.786 0.803 . . . . 0.0 109.347 171.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 459' ' ' HIS . . . . . 0.71 ' O ' HG23 ' A' ' 463' ' ' VAL . 63.3 m-70 -74.37 -28.82 61.29 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.639 177.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 460' ' ' LEU . . . . . 0.729 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.4 OUTLIER -73.93 -34.6 64.4 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.981 0.896 . . . . 0.0 108.787 178.559 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 461' ' ' ASN . . . . . 0.436 ' O ' ' HB2' ' A' ' 464' ' ' TYR . 26.9 m-80 -73.02 -37.58 66.89 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.992 0.901 . . . . 0.0 108.925 176.482 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 462' ' ' ALA . . . . . 0.598 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -56.49 -34.46 66.97 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.491 -1.232 . . . . 0.0 109.814 169.206 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.873 HG13 ' HB3' ' A' ' 438' ' ' ALA . 68.0 t -61.64 -50.89 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 175.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 464' ' ' TYR . . . . . 0.593 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 17.0 m-30 -53.01 -26.85 16.75 Favored 'General case' 0 C--N 1.33 -0.255 0 O-C-N 124.317 1.011 . . . . 0.0 110.664 177.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.14 -39.7 17.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.576 0.703 . . . . 0.0 109.821 -178.015 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.598 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.7 mt -57.75 -55.64 20.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 114.421 -1.263 . . . . 0.0 112.157 175.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.76 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -101.64 -11.04 19.5 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -173.345 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 468' ' ' GLY . . . . . 0.581 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 93.94 31.57 8.06 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 119.38 -1.391 . . . . 0.0 114.353 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 469' ' ' LEU . . . . . 0.76 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 2.5 mt -88.08 159.38 18.26 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 117.777 0.789 . . . . 0.0 110.625 176.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 470' ' ' ASN . . . . . 0.551 HD22 HG23 ' A' ' 476' ' ' ILE . 12.0 p30 -104.76 -179.18 3.87 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.278 172.486 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -56.3 -27.79 56.68 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -173.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 -86.66 5.33 36.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.674 0.273 . . . . 0.0 111.607 -171.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 473' ' ' GLY . . . . . 0.453 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 77.68 11.84 85.05 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.325 -0.94 . . . . 0.0 111.472 -178.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 474' ' ' GLN . . . . . 0.46 ' HB2' HD21 ' A' ' 470' ' ' ASN . 56.0 mt-30 -101.09 158.0 16.34 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 177.269 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 5.3 p -97.34 122.43 40.37 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.171 0.51 . . . . 0.0 112.074 -176.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 476' ' ' ILE . . . . . 0.581 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.5 pp -85.8 -7.98 11.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.574 0.702 . . . . 0.0 110.005 178.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 30.2 mmm180 -70.24 -24.86 63.15 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.838 -1.073 . . . . 0.0 109.955 174.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 85.3 mt -108.79 -51.8 2.84 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.629 -177.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.666 -0.683 . . . . 0.0 110.741 -179.145 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 381' ' ' ARG . . . . . 0.554 ' HD2' ' OD1' ' B' ' 418' ' ' ASN . 13.5 ptp180 . . . . . 0 N--CA 1.478 0.929 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 382' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.86 -39.12 0.38 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -176.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 383' ' ' HIS . . . . . 0.552 ' HB2' ' O ' ' B' ' 386' ' ' PHE . 51.3 p-80 -164.88 152.77 11.69 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.163 -0.615 . . . . 0.0 112.223 -173.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 384' ' ' GLY . . . . . . . . . . . . . . . -119.18 -86.97 1.07 Allowed Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.603 173.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 385' ' ' THR . . . . . . . . . . . . . 5.6 m -68.35 -41.36 80.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.898 0.38 . . . . 0.0 111.431 -178.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 386' ' ' PHE . . . . . 0.76 ' CD1' HD22 ' B' ' 414' ' ' LEU . 2.3 t80 -88.79 123.66 67.23 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.428 -176.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 387' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' B' ' 386' ' ' PHE . 42.6 Cg_endo -65.69 111.38 1.89 Allowed 'Trans proline' 0 N--CA 1.481 0.76 0 C-N-CA 123.929 3.086 . . . . 0.0 112.431 173.197 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 388' ' ' MET . . . . . 0.615 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 33.8 ttm -121.12 47.88 1.75 Allowed 'General case' 0 C--N 1.32 -0.716 0 O-C-N 122.094 -0.379 . . . . 0.0 111.645 -169.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 389' ' ' HIS . . . . . 0.641 ' CG ' ' HB2' ' B' ' 393' ' ' ASN . 38.4 m170 57.04 -90.21 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.443 0.64 . . . . 0.0 109.481 -171.016 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -160.29 17.0 0.14 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.986 -1.006 . . . . 0.0 108.348 174.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 391' ' ' LEU . . . . . 0.571 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.3 pt? -167.11 -59.55 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.074 -171.344 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 392' ' ' GLY . . . . . 0.571 ' N ' ' HG ' ' B' ' 391' ' ' LEU . . . -166.86 53.28 0.24 Allowed Glycine 0 C--N 1.335 0.523 0 C-N-CA 120.232 -0.985 . . . . 0.0 114.181 -172.029 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 393' ' ' ASN . . . . . 0.641 ' HB2' ' CG ' ' B' ' 389' ' ' HIS . 0.4 OUTLIER -56.2 -44.19 79.21 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 117.238 0.519 . . . . 0.0 110.258 176.789 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 394' ' ' VAL . . . . . 0.715 HG23 HD12 ' B' ' 398' ' ' ILE . 1.9 m -55.32 -45.06 77.73 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.756 0 N-CA-C 106.706 -1.591 . . . . 0.0 106.706 -178.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 395' ' ' ILE . . . . . 0.635 HG23 HD13 ' B' ' 426' ' ' ILE . 3.7 mp -57.98 -52.69 55.14 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.526 0 CA-C-O 117.77 -1.11 . . . . 0.0 113.59 -176.015 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 396' ' ' LYS . . . . . 0.528 ' O ' HG22 ' B' ' 399' ' ' VAL . 0.0 OUTLIER -63.22 -49.24 74.96 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 122.055 2.207 . . . . 0.0 111.932 -174.126 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 397' ' ' GLY . . . . . 0.457 ' O ' ' HG3' ' B' ' 401' ' ' GLN . . . -52.72 -44.43 60.44 Favored Glycine 0 N--CA 1.436 -1.336 0 C-N-CA 119.986 -1.102 . . . . 0.0 111.009 -177.196 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 398' ' ' ILE . . . . . 0.803 HD13 HD12 ' B' ' 410' ' ' LEU . 33.5 mt -71.82 -33.88 49.67 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 399' ' ' VAL . . . . . 0.528 HG22 ' O ' ' B' ' 396' ' ' LYS . 11.9 m -64.38 -40.39 88.88 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 C-N-CA 118.793 -1.163 . . . . 0.0 108.429 -173.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -64.27 -41.65 96.81 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 174.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 401' ' ' GLN . . . . . 0.457 ' HG3' ' O ' ' B' ' 397' ' ' GLY . 35.0 mt-30 -92.86 -49.66 5.94 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -170.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 402' ' ' GLU . . . . . 0.676 ' HG3' ' HE3' ' A' ' 413' ' ' MET . 2.4 mm-40 -111.75 -20.19 12.17 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.018 0.437 . . . . 0.0 111.265 -171.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 104.89 162.33 23.95 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.953 177.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 404' ' ' VAL . . . . . 0.652 HG11 ' HA ' ' B' ' 430' ' ' LEU . 1.6 m -54.08 -45.88 65.89 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.769 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 -175.231 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 405' ' ' ALA . . . . . 0.545 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -63.49 -33.03 74.68 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 119.785 -0.766 . . . . 0.0 112.337 -177.012 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 406' ' ' THR . . . . . 0.699 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 93.5 m -75.95 -42.09 49.61 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.251 174.202 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 407' ' ' ALA . . . . . 0.474 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.45 -36.83 74.28 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 122.145 0.974 . . . . 0.0 109.263 176.297 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 408' ' ' TYR . . . . . 0.611 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -66.53 -52.75 42.46 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 113.541 -1.663 . . . . 0.0 110.027 177.344 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 409' ' ' THR . . . . . 0.773 HG22 HD23 ' B' ' 410' ' ' LEU . 1.8 m -56.31 -45.68 80.15 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.44 178.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 410' ' ' LEU . . . . . 0.803 HD12 HD13 ' B' ' 398' ' ' ILE . 13.4 mt -71.69 -36.91 70.73 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -176.208 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.85 -35.18 81.37 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.064 -1.065 . . . . 0.0 110.73 172.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 412' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -67.34 -47.95 68.94 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 115.693 -0.254 . . . . 0.0 111.301 178.122 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 413' ' ' MET . . . . . 0.92 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.6 OUTLIER -70.91 -46.9 61.69 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 118.811 -1.155 . . . . 0.0 111.881 -179.945 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 414' ' ' LEU . . . . . 0.92 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 14.9 mt -67.84 -44.97 75.97 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -175.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 33.9 t -89.03 -16.46 31.57 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.555 0.693 . . . . 0.0 110.264 -175.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 416' ' ' GLY . . . . . . . . . . . . . . . 102.44 -175.92 24.98 Favored Glycine 0 N--CA 1.43 -1.758 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 -171.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -79.96 23.51 0.45 Allowed 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.362 0.601 . . . . 0.0 111.724 -171.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 418' ' ' ASN . . . . . 0.554 ' OD1' ' HD2' ' B' ' 381' ' ' ARG . 64.1 m-80 -72.23 77.17 0.98 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.946 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 419' ' ' TYR . . . . . 0.548 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 11.5 p90 -53.13 -38.77 62.96 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.399 176.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.47 -44.08 76.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.613 0.244 . . . . 0.0 110.972 178.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.32 -49.33 61.14 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.18 -178.234 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 422' ' ' VAL . . . . . 0.439 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.2 OUTLIER -65.92 -39.37 84.46 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.205 -176.643 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 423' ' ' SER . . . . . 0.796 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 78.4 p -68.5 -37.69 80.32 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.87 -178.436 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -69.32 -37.19 79.93 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.039 176.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 425' ' ' ILE . . . . . 0.572 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -72.65 -53.37 19.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 O-C-N 122.907 -0.173 . . . . 0.0 111.116 -178.828 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 426' ' ' ILE . . . . . 0.681 HG22 HD22 ' B' ' 430' ' ' LEU . 1.1 mm -73.59 -22.77 19.03 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.768 0 CA-C-O 120.801 0.334 . . . . 0.0 110.176 -172.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 427' ' ' ARG . . . . . 0.796 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.9 OUTLIER -54.94 -32.21 61.14 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.236 0.541 . . . . 0.0 110.522 -178.63 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -86.98 -7.47 77.58 Favored Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.449 179.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 429' ' ' TYR . . . . . 0.514 ' HD1' ' CG2' ' B' ' 395' ' ' ILE . 14.7 m-85 -117.29 0.61 12.29 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.096 0.474 . . . . 0.0 109.856 -176.211 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 430' ' ' LEU . . . . . 0.686 HD23 ' HA ' ' B' ' 427' ' ' ARG . 0.1 OUTLIER -65.86 129.27 94.26 Favored Pre-proline 0 N--CA 1.445 -0.702 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.152 178.816 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 431' ' ' PRO . . . . . 0.5 ' HD2' HD12 ' B' ' 430' ' ' LEU . 87.0 Cg_exo -24.43 -69.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.358 1.068 1 C-N-CA 125.4 4.067 . . . . 0.0 114.879 179.532 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 432' ' ' GLY . . . . . 0.542 ' O ' HG12 ' B' ' 435' ' ' VAL . . . -141.12 -169.87 11.97 Favored Glycine 0 N--CA 1.44 -1.038 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 177.247 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 433' ' ' GLN . . . . . 0.465 ' O ' HG13 ' B' ' 436' ' ' VAL . 41.2 tp60 -68.39 -26.37 65.52 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 118.062 0.931 . . . . 0.0 110.574 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -66.17 -41.46 90.29 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -178.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 435' ' ' VAL . . . . . 0.729 HG23 HG11 ' B' ' 463' ' ' VAL . 7.9 p -68.38 -43.97 83.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-O 121.071 0.463 . . . . 0.0 110.506 -177.318 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 436' ' ' VAL . . . . . 0.499 HG12 ' O ' ' B' ' 432' ' ' GLY . 0.1 OUTLIER -65.76 -30.56 50.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.452 175.65 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 1.1 m -69.08 -52.2 30.87 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -178.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 438' ' ' ALA . . . . . 0.862 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -58.68 -37.32 75.79 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.81 177.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 439' ' ' LEU . . . . . 0.565 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 2.0 tm? -70.38 -47.19 62.07 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -57.37 -38.83 74.84 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.303 174.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 441' ' ' GLN . . . . . 0.493 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 35.2 mm-40 -53.46 -50.05 66.13 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 123.519 0.728 . . . . 0.0 110.604 174.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 442' ' ' ARG . . . . . 0.816 ' HG2' ' O ' ' B' ' 438' ' ' ALA . 0.8 OUTLIER -56.68 -40.81 76.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.751 172.215 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 443' ' ' LEU . . . . . 0.565 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 40.6 mt -72.6 -26.14 61.58 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.273 0.558 . . . . 0.0 110.833 -178.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -70.06 -36.51 75.02 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.874 177.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 445' ' ' GLN . . . . . 0.459 ' HG3' ' N ' ' B' ' 446' ' ' GLU . 0.0 OUTLIER -74.94 -30.17 61.16 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.594 -1.185 . . . . 0.0 109.023 178.321 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 446' ' ' GLU . . . . . 0.528 ' HB3' ' O ' ' B' ' 443' ' ' LEU . 13.4 pt-20 27.48 96.9 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 O-C-N 125.42 1.7 . . . . 0.0 113.65 175.252 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 49.7 mt -59.09 -35.0 54.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.158 0.504 . . . . 0.0 110.95 -178.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 448' ' ' ASP . . . . . 0.462 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 16.3 m-20 -163.0 -156.92 0.41 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 -178.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -87.97 -67.21 0.84 Allowed 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 171.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -66.13 -25.45 66.98 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 176.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 451' ' ' THR . . . . . 0.48 ' HA ' ' HB2' ' B' ' 454' ' ' GLU . 10.5 m -71.37 -22.65 61.87 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 119.946 -0.701 . . . . 0.0 110.679 -174.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 452' ' ' ARG . . . . . 0.445 ' NH2' ' HB3' ' B' ' 443' ' ' LEU . 19.0 mtp180 -53.57 -54.27 39.88 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 171.429 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 453' ' ' ALA . . . . . 0.548 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -58.24 -49.49 76.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.507 -1.224 . . . . 0.0 112.707 174.416 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 454' ' ' GLU . . . . . 0.48 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 16.2 mm-40 -51.32 -35.15 36.6 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.22 0.533 . . . . 0.0 112.153 -176.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 28.8 p -120.26 16.19 12.28 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.143 -176.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 456' ' ' PHE . . . . . 0.604 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 1.0 OUTLIER -55.27 -48.73 73.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.957 0.408 . . . . 0.0 111.516 -172.331 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 457' ' ' ILE . . . . . 0.548 ' CG1' ' HB3' ' B' ' 408' ' ' TYR . 1.9 mp -76.46 -33.19 22.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.149 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -58.06 -34.91 70.62 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.821 0.82 . . . . 0.0 109.227 171.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 459' ' ' HIS . . . . . 0.712 ' O ' HG23 ' B' ' 463' ' ' VAL . 63.7 m-70 -74.37 -28.85 61.3 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.583 -1.189 . . . . 0.0 110.596 177.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 460' ' ' LEU . . . . . 0.734 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -73.8 -34.75 64.75 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.951 0.881 . . . . 0.0 108.808 178.407 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 461' ' ' ASN . . . . . 0.437 ' O ' ' HB2' ' B' ' 464' ' ' TYR . 26.4 m-80 -72.81 -37.6 67.48 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.34 -0.846 . . . . 0.0 108.965 176.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 462' ' ' ALA . . . . . 0.607 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -56.51 -34.48 67.04 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.352 -1.295 . . . . 0.0 109.796 169.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 463' ' ' VAL . . . . . 0.862 HG13 ' HB3' ' B' ' 438' ' ' ALA . 65.1 t -61.79 -50.63 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 175.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 464' ' ' TYR . . . . . 0.582 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 17.1 m-30 -53.12 -27.05 18.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.683 177.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.98 -39.69 17.79 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.775 0.798 . . . . 0.0 109.775 -178.073 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 466' ' ' ILE . . . . . 0.607 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.6 mt -57.72 -55.4 21.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.204 175.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 467' ' ' LEU . . . . . 0.756 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -101.73 -11.12 19.37 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 -173.484 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 468' ' ' GLY . . . . . 0.596 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 93.97 31.43 8.13 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 119.241 -1.457 . . . . 0.0 114.35 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 469' ' ' LEU . . . . . 0.756 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 2.5 mt -88.19 159.39 18.18 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 117.818 0.809 . . . . 0.0 110.606 176.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 470' ' ' ASN . . . . . 0.528 HD22 HG23 ' B' ' 476' ' ' ILE . 12.1 p30 -104.82 -179.6 3.99 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.101 172.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 471' ' ' ALA . . . . . . . . . . . . . . . -55.7 -28.21 54.44 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -173.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -86.29 4.95 36.79 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 122.314 -0.241 . . . . 0.0 111.56 -171.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 473' ' ' GLY . . . . . 0.454 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 78.0 11.82 85.01 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.384 -0.913 . . . . 0.0 111.475 -178.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 474' ' ' GLN . . . . . 0.463 ' HB2' HD21 ' B' ' 470' ' ' ASN . 56.5 mt-30 -101.07 158.12 16.25 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 177.345 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 6.0 p -97.3 122.64 40.57 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.327 0.584 . . . . 0.0 112.114 -176.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 476' ' ' ILE . . . . . 0.596 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.5 pp -85.9 -7.87 11.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.579 0.704 . . . . 0.0 110.006 178.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 477' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -70.46 -25.08 63.01 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.787 174.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 478' ' ' LEU . . . . . . . . . . . . . 85.4 mt -108.49 -51.34 2.9 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.75 -177.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 479' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.669 -0.681 . . . . 0.0 110.79 -179.226 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 381' ' ' ARG . . . . . 0.682 ' N ' ' HG ' ' A' ' 415' ' ' SER . 18.9 ptt180 . . . . . 0 N--CA 1.475 0.817 0 CA-C-O 120.51 0.195 . . . . 0.0 110.777 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 382' ' ' THR . . . . . 0.429 ' N ' ' HG3' ' A' ' 381' ' ' ARG . 0.1 OUTLIER 173.7 -46.0 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 123.01 0.524 . . . . 0.0 109.74 -176.211 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -132.39 131.38 41.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.529 177.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -145.35 -135.76 2.89 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 177.124 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 385' ' ' THR . . . . . 0.433 HG21 ' HB3' ' B' ' 400' ' ' ASP . 25.6 m -69.05 -32.15 71.44 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 171.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 386' ' ' PHE . . . . . 0.787 ' CZ ' HG12 ' A' ' 394' ' ' VAL . 1.4 t80 -91.75 122.53 65.37 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.252 -0.886 . . . . 0.0 108.694 172.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -47.6 -75.25 0.03 OUTLIER 'Trans proline' 0 N--CA 1.479 0.625 0 C-N-CA 124.463 3.442 . . . . 0.0 115.125 -174.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.571 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 28.5 mtt 73.63 146.69 0.08 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.759 0.824 . . . . 0.0 111.225 -171.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 389' ' ' HIS . . . . . 0.522 ' CG ' ' HB2' ' A' ' 393' ' ' ASN . 32.7 m170 -49.29 -65.28 0.59 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.587 0.708 . . . . 0.0 109.519 178.233 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 390' ' ' GLN . . . . . 0.479 ' H ' HD23 ' A' ' 391' ' ' LEU . 28.3 pt20 -168.29 26.65 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.518 -1.219 . . . . 0.0 108.153 173.129 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.662 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.1 pt? -178.04 -65.31 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -167.311 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 392' ' ' GLY . . . . . 0.662 ' N ' ' HG ' ' A' ' 391' ' ' LEU . . . -163.64 49.9 0.3 Allowed Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.955 -0.64 . . . . 0.0 113.154 -168.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 393' ' ' ASN . . . . . 0.571 ' HB3' ' HA ' ' A' ' 388' ' ' MET . 0.4 OUTLIER -56.31 -37.68 70.24 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 177.942 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.787 HG12 ' CZ ' ' A' ' 386' ' ' PHE . 0.9 OUTLIER -56.25 -47.39 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 178.681 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.663 HG23 HD13 ' A' ' 426' ' ' ILE . 4.2 mp -57.66 -51.8 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.275 0 CA-C-O 118.108 -0.948 . . . . 0.0 112.967 -174.14 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 396' ' ' LYS . . . . . 0.678 ' HG3' ' CZ ' ' A' ' 429' ' ' TYR . 0.2 OUTLIER -62.52 -48.98 77.15 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 121.359 1.891 . . . . 0.0 111.415 -174.205 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -55.19 -45.38 82.67 Favored Glycine 0 N--CA 1.434 -1.486 0 C-N-CA 120.131 -1.033 . . . . 0.0 111.166 -179.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 398' ' ' ILE . . . . . 0.739 ' CD1' HD12 ' A' ' 410' ' ' LEU . 28.2 mt -70.46 -33.84 55.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -177.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 399' ' ' VAL . . . . . 0.501 HG12 ' HA ' ' A' ' 404' ' ' VAL . 11.8 m -63.89 -39.59 85.97 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 C-N-CA 118.798 -1.161 . . . . 0.0 108.385 -174.708 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 400' ' ' ASP . . . . . 0.433 ' HB3' HG21 ' B' ' 385' ' ' THR . 37.5 t70 -69.92 -36.65 75.53 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 175.281 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -87.58 -48.19 8.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.089 0.471 . . . . 0.0 111.944 -171.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 402' ' ' GLU . . . . . 0.564 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 1.9 mm-40 -121.41 -20.43 6.63 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.757 -170.086 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 107.4 162.38 21.62 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.046 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 404' ' ' VAL . . . . . 0.636 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.5 m -53.45 -41.82 46.52 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.723 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 -176.322 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 405' ' ' ALA . . . . . 0.655 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -69.04 -30.36 68.7 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.795 -176.044 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.712 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 90.5 m -77.29 -42.31 37.46 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.162 -0.615 . . . . 0.0 109.981 173.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.47 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.41 -36.98 74.42 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 122.123 0.963 . . . . 0.0 109.038 176.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 408' ' ' TYR . . . . . 0.636 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.7 -52.25 52.87 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 113.445 -1.707 . . . . 0.0 110.083 176.61 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 409' ' ' THR . . . . . 0.72 HG22 HD23 ' A' ' 410' ' ' LEU . 3.4 m -55.71 -46.56 77.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.674 178.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 410' ' ' LEU . . . . . 0.739 HD12 ' CD1' ' A' ' 398' ' ' ILE . 14.0 mt -72.22 -35.86 68.98 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.048 0.451 . . . . 0.0 110.358 -174.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -59.63 -34.86 83.7 Favored Glycine 0 N--CA 1.438 -1.205 0 C-N-CA 120.224 -0.989 . . . . 0.0 110.83 171.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -68.26 -43.72 77.18 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 178.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 413' ' ' MET . . . . . 0.731 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.0 OUTLIER -70.5 -57.65 4.55 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 118.822 -1.151 . . . . 0.0 111.549 179.607 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 414' ' ' LEU . . . . . 0.731 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 4.6 mt -67.35 -43.7 80.88 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -172.57 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.682 ' HG ' ' N ' ' A' ' 381' ' ' ARG . 5.2 t -95.45 18.14 13.23 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.482 0.658 . . . . 0.0 109.975 -174.309 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 73.17 -177.93 41.81 Favored Glycine 0 N--CA 1.437 -1.245 0 C-N-CA 120.357 -0.925 . . . . 0.0 111.675 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 33.9 mm-40 -80.69 23.13 0.54 Allowed 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.199 0.524 . . . . 0.0 111.616 -173.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 418' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -71.73 77.65 0.85 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.72 -179.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 419' ' ' TYR . . . . . 0.539 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 14.6 p90 -54.47 -37.85 65.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.549 177.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -54.97 -43.04 73.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.625 0.25 . . . . 0.0 110.644 177.482 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.42 -48.85 63.54 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.152 -178.247 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 422' ' ' VAL . . . . . 0.485 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.3 OUTLIER -66.32 -40.53 86.99 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 C-N-CA 120.235 -0.586 . . . . 0.0 111.239 -177.142 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.758 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 65.9 p -67.06 -38.29 85.52 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -178.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.29 -40.26 92.02 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.129 175.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 425' ' ' ILE . . . . . 0.598 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.61 -50.13 36.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 O-C-N 122.883 -0.187 . . . . 0.0 110.934 -176.996 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 426' ' ' ILE . . . . . 0.696 HG22 HD22 ' A' ' 430' ' ' LEU . 1.2 mm -74.55 -22.62 17.66 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -172.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.758 ' HB2' ' O ' ' A' ' 423' ' ' SER . 0.9 OUTLIER -54.86 -30.2 57.17 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.088 0.47 . . . . 0.0 110.756 -178.581 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -86.81 -9.12 75.11 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.458 178.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.678 ' CZ ' ' HG3' ' A' ' 396' ' ' LYS . 23.0 m-85 -115.87 1.03 13.29 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-O 120.995 0.426 . . . . 0.0 110.478 -177.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.699 HD23 ' HA ' ' A' ' 427' ' ' ARG . 0.1 OUTLIER -65.82 127.38 93.05 Favored Pre-proline 0 N--CA 1.439 -1.019 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 178.505 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 431' ' ' PRO . . . . . 0.471 ' HD2' HD12 ' A' ' 430' ' ' LEU . 84.6 Cg_exo -22.7 -74.88 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 1.012 1 C-N-CA 125.653 4.235 . . . . 0.0 114.72 -179.102 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 432' ' ' GLY . . . . . 0.504 ' O ' HG12 ' A' ' 435' ' ' VAL . . . -129.27 -166.53 11.93 Favored Glycine 0 N--CA 1.441 -0.99 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 172.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 433' ' ' GLN . . . . . 0.598 ' O ' HG13 ' A' ' 436' ' ' VAL . 21.6 tt0 -71.61 -26.64 62.67 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 118.838 1.319 . . . . 0.0 110.587 176.12 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -62.26 -38.34 88.92 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.833 -176.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 435' ' ' VAL . . . . . 0.778 HG23 HG11 ' A' ' 463' ' ' VAL . 7.5 p -69.76 -43.34 80.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-O 120.839 0.352 . . . . 0.0 110.611 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.598 HG13 ' O ' ' A' ' 433' ' ' GLN . 0.2 OUTLIER -66.42 -30.17 48.94 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-O 120.822 0.344 . . . . 0.0 110.299 175.028 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -69.37 -52.0 31.35 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -178.156 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 438' ' ' ALA . . . . . 0.845 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -57.42 -43.04 83.48 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.99 176.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 439' ' ' LEU . . . . . 0.626 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 2.0 tm? -65.28 -47.35 76.97 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -176.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -57.99 -39.11 77.42 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.228 174.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 441' ' ' GLN . . . . . 0.581 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 8.7 mm-40 -56.85 -50.46 72.37 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 123.379 0.672 . . . . 0.0 110.631 176.025 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 442' ' ' ARG . . . . . 0.711 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -58.65 -33.78 70.46 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.924 172.601 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 443' ' ' LEU . . . . . 0.626 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 59.5 mt -72.21 -33.99 68.02 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.024 0.44 . . . . 0.0 110.163 178.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -57.69 -36.75 72.37 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.319 173.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -72.6 -27.13 61.98 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.963 177.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 446' ' ' GLU . . . . . 0.57 ' HB2' ' O ' ' A' ' 443' ' ' LEU . 38.2 tt0 29.53 96.88 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 170.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 50.3 mt -68.33 -35.46 71.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.062 0.458 . . . . 0.0 110.882 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 448' ' ' ASP . . . . . 0.568 ' O ' ' HG3' ' A' ' 452' ' ' ARG . 36.8 m-20 -165.83 -166.78 0.98 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 -178.265 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -79.63 -63.81 1.33 Allowed 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.23 -0.588 . . . . 0.0 109.525 172.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -69.58 -25.97 64.24 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 178.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 451' ' ' THR . . . . . 0.439 ' HA ' ' HB2' ' A' ' 454' ' ' GLU . 12.1 m -71.85 -22.43 61.54 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.692 -175.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 452' ' ' ARG . . . . . 0.568 ' HG3' ' O ' ' A' ' 448' ' ' ASP . 11.1 mtp180 -53.11 -54.51 34.53 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 170.137 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 453' ' ' ALA . . . . . 0.539 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -57.93 -50.42 73.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.363 -1.29 . . . . 0.0 112.595 175.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 454' ' ' GLU . . . . . 0.439 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 31.4 mm-40 -49.73 -38.26 32.71 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.386 0.612 . . . . 0.0 111.729 -176.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 32.0 p -117.45 16.03 14.69 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.246 -176.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 456' ' ' PHE . . . . . 0.589 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 1.1 t80 -55.71 -47.36 76.98 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.169 0.509 . . . . 0.0 111.479 -171.336 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 457' ' ' ILE . . . . . 0.655 HG23 ' HB1' ' A' ' 405' ' ' ALA . 2.0 mp -75.41 -32.1 24.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.909 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -58.38 -35.78 72.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.67 0.748 . . . . 0.0 109.361 171.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 459' ' ' HIS . . . . . 0.712 ' O ' HG23 ' A' ' 463' ' ' VAL . 82.8 m-70 -72.44 -29.2 63.48 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.711 -1.132 . . . . 0.0 110.198 178.134 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 460' ' ' LEU . . . . . 0.742 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -74.51 -34.57 63.07 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.913 0.863 . . . . 0.0 108.929 179.129 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 461' ' ' ASN . . . . . 0.443 ' HA ' ' CD2' ' A' ' 464' ' ' TYR . 22.0 m-80 -72.83 -37.81 67.33 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.232 176.037 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 462' ' ' ALA . . . . . 0.628 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -56.62 -33.1 65.95 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.852 169.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.845 HG13 ' HB3' ' A' ' 438' ' ' ALA . 63.4 t -62.42 -50.78 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 CA-C-N 114.49 -1.232 . . . . 0.0 107.831 175.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 464' ' ' TYR . . . . . 0.559 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 16.2 m-30 -53.92 -27.77 32.77 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.53 178.431 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.8 -38.91 20.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.868 0.842 . . . . 0.0 109.337 -177.063 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.628 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.7 mt -57.91 -56.08 17.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 114.172 -1.377 . . . . 0.0 112.463 174.554 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.764 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -102.78 -10.62 18.97 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -171.512 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 468' ' ' GLY . . . . . 0.589 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 94.12 31.73 7.89 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 119.46 -1.353 . . . . 0.0 114.241 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 469' ' ' LEU . . . . . 0.764 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.1 mt -89.69 164.06 14.86 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 117.718 0.759 . . . . 0.0 111.13 176.081 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 37.6 p30 -105.61 -178.69 3.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.816 171.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 471' ' ' ALA . . . . . 0.544 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -69.98 -5.99 30.17 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -174.314 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -96.75 0.67 49.87 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.9 0.381 . . . . 0.0 110.885 -178.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 473' ' ' GLY . . . . . 0.427 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 79.31 12.47 83.86 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.443 -0.884 . . . . 0.0 111.2 -175.31 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -100.19 157.35 16.65 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 178.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 12.7 p -95.28 127.95 41.74 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.066 0.46 . . . . 0.0 111.333 -178.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 476' ' ' ILE . . . . . 0.589 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.9 pp -98.71 5.69 9.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.788 0.804 . . . . 0.0 110.212 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -66.36 -30.8 71.27 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.443 -1.253 . . . . 0.0 110.515 176.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 84.3 mt 54.85 62.06 2.69 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.54 0.686 . . . . 0.0 110.688 177.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 . . . . . 0 C--O 1.25 1.093 0 CA-C-N 115.087 -0.961 . . . . 0.0 109.946 -179.766 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 381' ' ' ARG . . . . . 0.702 ' N ' ' HG ' ' B' ' 415' ' ' SER . 18.9 ptt180 . . . . . 0 N--CA 1.477 0.921 0 CA-C-O 120.476 0.179 . . . . 0.0 110.774 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 382' ' ' THR . . . . . 0.432 ' N ' ' HG3' ' B' ' 381' ' ' ARG . 0.1 OUTLIER 173.87 -45.97 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 123.04 0.536 . . . . 0.0 109.711 -176.116 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 383' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -132.49 131.43 41.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.589 177.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 384' ' ' GLY . . . . . . . . . . . . . . . -145.15 -136.15 2.96 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 177.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 385' ' ' THR . . . . . 0.433 HG21 ' HB3' ' A' ' 400' ' ' ASP . 26.0 m -68.8 -32.38 72.05 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 171.579 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 386' ' ' PHE . . . . . 0.793 ' CZ ' HG12 ' B' ' 394' ' ' VAL . 1.4 t80 -91.61 122.41 65.77 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 172.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 387' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -47.38 -75.32 0.03 OUTLIER 'Trans proline' 0 N--CA 1.481 0.763 0 C-N-CA 124.44 3.427 . . . . 0.0 115.164 -174.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 388' ' ' MET . . . . . 0.584 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 28.4 mtt 73.69 146.6 0.08 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.698 0.799 . . . . 0.0 111.116 -171.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 389' ' ' HIS . . . . . 0.541 ' CG ' ' HB2' ' B' ' 393' ' ' ASN . 32.8 m170 -49.19 -64.99 0.64 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.606 0.717 . . . . 0.0 109.569 178.196 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 390' ' ' GLN . . . . . 0.472 ' H ' HD23 ' B' ' 391' ' ' LEU . 28.3 pt20 -168.74 26.61 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.509 -1.223 . . . . 0.0 108.245 173.122 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 391' ' ' LEU . . . . . 0.638 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.1 pt? -177.98 -65.44 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -167.195 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 392' ' ' GLY . . . . . 0.638 ' N ' ' HG ' ' B' ' 391' ' ' LEU . . . -163.66 50.1 0.3 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.082 -168.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 393' ' ' ASN . . . . . 0.584 ' HB3' ' HA ' ' B' ' 388' ' ' MET . 0.4 OUTLIER -56.38 -37.77 70.55 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.901 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 394' ' ' VAL . . . . . 0.793 HG12 ' CZ ' ' B' ' 386' ' ' PHE . 0.9 OUTLIER -56.22 -47.36 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 178.705 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 395' ' ' ILE . . . . . 0.647 HG23 HD13 ' B' ' 426' ' ' ILE . 4.3 mp -57.81 -51.67 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 CA-C-O 118.034 -0.984 . . . . 0.0 112.946 -174.168 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 396' ' ' LYS . . . . . 0.674 ' HG3' ' CZ ' ' B' ' 429' ' ' TYR . 0.2 OUTLIER -62.53 -48.8 77.93 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 121.482 1.946 . . . . 0.0 111.537 -174.219 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -55.24 -45.59 82.21 Favored Glycine 0 N--CA 1.434 -1.452 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.132 -179.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 398' ' ' ILE . . . . . 0.739 ' CD1' HD12 ' B' ' 410' ' ' LEU . 28.1 mt -70.34 -33.8 55.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -177.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 399' ' ' VAL . . . . . 0.513 HG12 ' HA ' ' B' ' 404' ' ' VAL . 12.0 m -63.9 -39.47 85.56 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 C-N-CA 118.754 -1.178 . . . . 0.0 108.489 -174.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 400' ' ' ASP . . . . . 0.433 ' HB3' HG21 ' A' ' 385' ' ' THR . 37.3 t70 -70.12 -36.63 74.95 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 175.261 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 401' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -87.47 -48.11 8.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.966 0.412 . . . . 0.0 111.988 -171.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 402' ' ' GLU . . . . . 0.576 ' HG3' ' HE3' ' A' ' 413' ' ' MET . 2.0 mm-40 -121.27 -21.02 6.5 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.678 -170.125 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 108.33 162.77 20.83 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.905 -0.664 . . . . 0.0 113.096 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 404' ' ' VAL . . . . . 0.624 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.5 m -53.71 -41.56 47.87 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.751 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -176.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 405' ' ' ALA . . . . . 0.645 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -69.32 -30.36 68.39 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 119.649 -0.821 . . . . 0.0 111.725 -175.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 406' ' ' THR . . . . . 0.705 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 93.8 m -77.56 -42.39 35.49 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 174.201 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 407' ' ' ALA . . . . . 0.465 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.41 -37.12 74.69 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 122.104 0.954 . . . . 0.0 108.935 176.464 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 408' ' ' TYR . . . . . 0.624 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.51 -52.4 52.95 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 113.492 -1.686 . . . . 0.0 110.046 176.534 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 409' ' ' THR . . . . . 0.723 HG22 HD23 ' B' ' 410' ' ' LEU . 3.3 m -55.79 -46.64 77.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.582 178.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 410' ' ' LEU . . . . . 0.739 HD12 ' CD1' ' B' ' 398' ' ' ILE . 13.8 mt -72.05 -36.04 69.5 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.124 0.488 . . . . 0.0 110.314 -174.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -59.59 -34.86 83.54 Favored Glycine 0 N--CA 1.439 -1.142 0 C-N-CA 120.213 -0.994 . . . . 0.0 110.825 171.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 412' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -68.24 -43.78 77.14 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.517 0.191 . . . . 0.0 111.517 178.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 413' ' ' MET . . . . . 0.718 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.0 OUTLIER -70.52 -57.69 4.5 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 118.772 -1.171 . . . . 0.0 111.546 179.721 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 414' ' ' LEU . . . . . 0.718 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 4.7 mt -67.24 -43.74 81.18 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 -172.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 415' ' ' SER . . . . . 0.702 ' HG ' ' N ' ' B' ' 381' ' ' ARG . 5.3 t -95.28 18.03 13.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.421 0.629 . . . . 0.0 110.108 -174.314 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 416' ' ' GLY . . . . . . . . . . . . . . . 73.08 -178.29 40.96 Favored Glycine 0 N--CA 1.438 -1.186 0 C-N-CA 120.427 -0.892 . . . . 0.0 111.659 -178.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -80.46 23.22 0.51 Allowed 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.009 0.433 . . . . 0.0 111.493 -173.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 418' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -71.58 77.9 0.81 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.834 -179.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 419' ' ' TYR . . . . . 0.54 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 14.5 p90 -54.88 -37.6 66.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.482 178.052 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -54.97 -43.12 73.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.723 0.297 . . . . 0.0 110.651 177.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.46 -48.79 63.6 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.148 -178.145 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 422' ' ' VAL . . . . . 0.482 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.3 OUTLIER -66.34 -40.66 87.28 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 C-N-CA 120.261 -0.576 . . . . 0.0 111.13 -177.17 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 423' ' ' SER . . . . . 0.742 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 69.4 p -67.03 -38.13 85.36 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.659 -0.416 . . . . 0.0 109.903 -178.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.42 -40.02 91.42 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.321 175.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 425' ' ' ILE . . . . . 0.605 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -72.68 -50.24 35.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.553 0.216 . . . . 0.0 110.887 -177.096 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 426' ' ' ILE . . . . . 0.693 HG22 HD22 ' B' ' 430' ' ' LEU . 1.2 mm -74.55 -22.57 17.64 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.815 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -172.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 427' ' ' ARG . . . . . 0.742 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.9 OUTLIER -54.75 -30.61 56.85 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.139 0.495 . . . . 0.0 110.701 -178.563 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -86.57 -8.91 76.32 Favored Glycine 0 N--CA 1.443 -0.89 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.456 178.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 429' ' ' TYR . . . . . 0.674 ' CZ ' ' HG3' ' B' ' 396' ' ' LYS . 22.9 m-85 -116.28 0.98 13.02 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-O 121.089 0.471 . . . . 0.0 110.509 -177.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 430' ' ' LEU . . . . . 0.693 HD22 HG22 ' B' ' 426' ' ' ILE . 0.1 OUTLIER -65.68 127.4 93.02 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.394 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 431' ' ' PRO . . . . . 0.466 ' HD2' HD12 ' B' ' 430' ' ' LEU . 86.1 Cg_exo -22.73 -75.44 0.02 OUTLIER 'Trans proline' 0 C--N 1.358 1.06 1 C-N-CA 125.617 4.211 . . . . 0.0 114.699 -179.246 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 432' ' ' GLY . . . . . 0.507 ' O ' HG12 ' B' ' 435' ' ' VAL . . . -128.84 -166.69 12.01 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 173.015 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 433' ' ' GLN . . . . . 0.591 ' O ' HG13 ' B' ' 436' ' ' VAL . 21.9 tt0 -71.44 -26.43 62.73 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 118.854 1.327 . . . . 0.0 110.571 176.147 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -62.58 -38.09 88.73 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -176.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 435' ' ' VAL . . . . . 0.774 HG23 HG11 ' B' ' 463' ' ' VAL . 7.5 p -69.77 -43.53 79.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 120.784 0.326 . . . . 0.0 110.57 -179.146 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 436' ' ' VAL . . . . . 0.591 HG13 ' O ' ' B' ' 433' ' ' GLN . 0.2 OUTLIER -66.35 -30.12 48.84 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 CA-C-O 120.895 0.379 . . . . 0.0 110.366 175.058 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -69.27 -51.97 32.15 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 -178.248 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 438' ' ' ALA . . . . . 0.837 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -57.5 -43.1 83.9 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.005 176.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 439' ' ' LEU . . . . . 0.635 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 2.0 tm? -65.22 -47.27 77.44 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -176.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -58.01 -39.01 77.25 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.235 174.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 441' ' ' GLN . . . . . 0.583 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 8.5 mm-40 -56.93 -50.43 72.6 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 123.368 0.667 . . . . 0.0 110.617 176.043 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 442' ' ' ARG . . . . . 0.707 ' HG2' ' O ' ' B' ' 438' ' ' ALA . 0.0 OUTLIER -58.76 -33.64 70.52 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.9 172.606 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 443' ' ' LEU . . . . . 0.635 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 58.8 mt -72.18 -33.93 68.05 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.037 0.446 . . . . 0.0 110.129 178.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -57.62 -36.82 72.29 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.56 172.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -72.62 -27.36 62.1 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.866 177.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 446' ' ' GLU . . . . . 0.562 ' HB2' ' O ' ' B' ' 443' ' ' LEU . 39.5 tt0 29.79 96.47 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 170.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 52.2 mt -68.28 -35.45 71.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.109 0.48 . . . . 0.0 110.798 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 448' ' ' ASP . . . . . 0.558 ' O ' ' HG3' ' B' ' 452' ' ' ARG . 37.2 m-20 -165.61 -166.57 0.98 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 -178.266 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -80.1 -63.47 1.4 Allowed 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.472 172.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -69.85 -25.96 63.99 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 178.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 451' ' ' THR . . . . . 0.432 ' HA ' ' HB2' ' B' ' 454' ' ' GLU . 14.1 m -71.78 -22.44 61.58 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.664 -175.442 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 452' ' ' ARG . . . . . 0.558 ' HG3' ' O ' ' B' ' 448' ' ' ASP . 11.2 mtp180 -53.11 -54.56 33.91 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 170.116 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 453' ' ' ALA . . . . . 0.54 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -57.97 -50.09 74.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.378 -1.283 . . . . 0.0 112.688 175.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 454' ' ' GLU . . . . . 0.432 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 30.5 mm-40 -50.03 -38.36 37.32 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.472 0.653 . . . . 0.0 111.535 -176.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 32.0 p -117.42 16.11 14.72 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.226 -176.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 456' ' ' PHE . . . . . 0.581 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 1.1 t80 -55.75 -47.27 77.28 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.188 0.518 . . . . 0.0 111.489 -171.463 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 457' ' ' ILE . . . . . 0.645 HG23 ' HB1' ' B' ' 405' ' ' ALA . 2.0 mp -75.66 -32.08 24.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.816 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -58.3 -35.94 72.59 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.733 0.778 . . . . 0.0 109.357 171.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 459' ' ' HIS . . . . . 0.707 ' O ' HG23 ' B' ' 463' ' ' VAL . 82.4 m-70 -72.42 -29.1 63.41 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.213 178.086 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 460' ' ' LEU . . . . . 0.747 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -74.55 -34.62 62.98 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.858 0.837 . . . . 0.0 108.911 179.16 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 461' ' ' ASN . . . . . 0.435 ' HA ' ' CD2' ' B' ' 464' ' ' TYR . 22.4 m-80 -72.89 -37.89 67.13 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.253 176.26 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 462' ' ' ALA . . . . . 0.629 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -56.58 -33.17 65.91 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.529 -1.214 . . . . 0.0 109.802 169.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 463' ' ' VAL . . . . . 0.837 HG13 ' HB3' ' B' ' 438' ' ' ALA . 64.6 t -62.33 -50.68 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 175.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 464' ' ' TYR . . . . . 0.547 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 16.1 m-30 -54.07 -27.51 33.04 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.623 178.456 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.82 -38.94 20.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.908 0.861 . . . . 0.0 109.413 -177.201 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 466' ' ' ILE . . . . . 0.629 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.8 mt -58.12 -56.2 17.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 114.125 -1.398 . . . . 0.0 112.395 174.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 467' ' ' LEU . . . . . 0.777 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -102.8 -10.39 19.16 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -171.532 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 468' ' ' GLY . . . . . 0.588 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 94.0 31.64 7.99 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 119.344 -1.408 . . . . 0.0 114.205 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 469' ' ' LEU . . . . . 0.777 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.2 mt -89.77 164.03 14.83 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 117.788 0.794 . . . . 0.0 111.152 176.117 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 37.1 p30 -105.57 -178.44 3.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.746 171.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 471' ' ' ALA . . . . . 0.523 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -70.23 -5.65 29.09 Favored 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -174.474 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 472' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' B' ' 472' ' ' ARG . 21.3 mmt180 -97.08 1.13 49.66 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.019 0.438 . . . . 0.0 110.891 -178.305 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 473' ' ' GLY . . . . . 0.426 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 78.95 12.66 83.91 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.36 -0.924 . . . . 0.0 111.079 -175.247 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -100.39 157.47 16.6 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 9.6 p -95.12 127.88 41.52 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.252 0.549 . . . . 0.0 111.448 -178.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 476' ' ' ILE . . . . . 0.588 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.9 pp -98.76 5.62 9.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.579 0.704 . . . . 0.0 110.205 179.282 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 477' ' ' ARG . . . . . . . . . . . . . 27.5 mmm180 -66.08 -31.29 72.07 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.508 176.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 478' ' ' LEU . . . . . . . . . . . . . 84.1 mt 55.43 61.83 2.71 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.476 0.655 . . . . 0.0 110.647 177.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 479' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 . . . . . 0 C--O 1.25 1.097 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.094 -179.493 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 381' ' ' ARG . . . . . 0.445 ' HD2' ' OD1' ' A' ' 418' ' ' ASN . 10.4 ptp180 . . . . . 0 N--CA 1.479 1.022 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.89 -31.2 1.17 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -176.366 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 383' ' ' HIS . . . . . 0.483 ' HB2' ' O ' ' A' ' 386' ' ' PHE . 1.3 p80 -150.76 160.93 43.53 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.022 -0.671 . . . . 0.0 112.028 -169.505 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -106.66 -109.71 3.41 Favored Glycine 0 N--CA 1.44 -1.059 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 168.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 39.1 m -74.04 -31.59 62.95 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.931 0.396 . . . . 0.0 111.175 177.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 386' ' ' PHE . . . . . 0.77 ' CD1' HD22 ' A' ' 414' ' ' LEU . 2.0 t80 -74.74 126.49 88.44 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 121.104 0.478 . . . . 0.0 110.789 -178.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 387' ' ' PRO . . . . . 0.542 ' HG2' ' OD1' ' B' ' 393' ' ' ASN . 61.7 Cg_endo -72.12 110.02 2.84 Favored 'Trans proline' 0 N--CA 1.481 0.738 0 C-N-CA 124.183 3.255 . . . . 0.0 114.104 175.522 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.449 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 32.8 mtt -104.07 169.07 8.71 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 121.991 -0.443 . . . . 0.0 110.109 175.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -54.84 -62.6 1.55 Allowed 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 177.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -172.3 17.31 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.625 -1.171 . . . . 0.0 108.27 172.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.612 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 1.9 pt? -165.91 -66.15 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.24 -167.14 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 392' ' ' GLY . . . . . 0.612 ' N ' ' HG ' ' A' ' 391' ' ' LEU . . . -162.8 54.87 0.3 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.409 -0.9 . . . . 0.0 113.173 -173.338 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 393' ' ' ASN . . . . . 0.548 ' OD1' ' HG2' ' B' ' 387' ' ' PRO . 0.2 OUTLIER -54.31 -42.25 69.91 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.455 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.741 HG12 ' CZ ' ' A' ' 386' ' ' PHE . 0.7 OUTLIER -57.03 -46.22 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -179.48 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.647 HG23 HD13 ' A' ' 426' ' ' ILE . 4.2 mp -57.55 -51.77 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.247 0 CA-C-O 118.009 -0.996 . . . . 0.0 112.887 -174.384 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 396' ' ' LYS . . . . . 0.667 ' HG3' ' CZ ' ' A' ' 429' ' ' TYR . 0.1 OUTLIER -62.22 -48.82 78.29 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 121.446 1.93 . . . . 0.0 111.698 -175.163 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -54.95 -45.56 80.5 Favored Glycine 0 N--CA 1.436 -1.341 0 C-N-CA 119.84 -1.171 . . . . 0.0 111.229 -178.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 398' ' ' ILE . . . . . 0.733 HG12 HD21 ' B' ' 414' ' ' LEU . 26.3 mt -70.88 -34.11 54.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -177.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 399' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 396' ' ' LYS . 13.1 m -63.99 -39.38 85.24 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.499 0 C-N-CA 118.784 -1.166 . . . . 0.0 108.43 -174.131 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -71.0 -34.87 71.77 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 175.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.467 HE21 ' HB3' ' A' ' 401' ' ' GLN . 4.1 mm100 -88.79 -48.0 7.81 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -172.344 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 402' ' ' GLU . . . . . 0.583 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 1.3 mm-40 -121.2 -20.55 6.7 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.609 -170.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 107.27 162.28 21.72 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.702 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 404' ' ' VAL . . . . . 0.604 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.8 m -53.77 -46.18 62.5 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.739 0 N-CA-C 114.946 1.462 . . . . 0.0 114.946 -175.258 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 405' ' ' ALA . . . . . 0.535 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -64.0 -29.88 71.0 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 119.778 -0.769 . . . . 0.0 112.379 -177.354 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.732 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 93.2 m -77.51 -42.56 35.19 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.119 -0.632 . . . . 0.0 110.204 172.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.464 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.28 -37.22 74.56 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 122.232 1.015 . . . . 0.0 109.25 176.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 408' ' ' TYR . . . . . 0.604 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.67 -52.02 54.87 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 113.351 -1.75 . . . . 0.0 109.933 176.382 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 409' ' ' THR . . . . . 0.654 HG22 HD23 ' A' ' 410' ' ' LEU . 16.5 m -55.12 -47.11 75.47 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.479 179.101 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 410' ' ' LEU . . . . . 0.732 ' HG ' ' O ' ' A' ' 406' ' ' THR . 14.7 mt -72.69 -36.92 67.96 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.282 -174.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.74 -34.95 79.51 Favored Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.123 -1.036 . . . . 0.0 110.813 172.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 412' ' ' MET . . . . . 0.401 ' HB2' ' O ' ' A' ' 409' ' ' THR . 0.4 OUTLIER -66.61 -44.78 81.16 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 115.734 -0.233 . . . . 0.0 111.441 177.962 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 413' ' ' MET . . . . . 0.765 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.0 OUTLIER -70.82 -57.1 4.97 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 118.675 -1.21 . . . . 0.0 111.668 179.135 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 414' ' ' LEU . . . . . 0.77 HD22 ' CD1' ' A' ' 386' ' ' PHE . 6.8 mt -64.58 -43.18 94.68 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -171.552 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 32.8 t -86.03 -16.84 36.94 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.734 0.778 . . . . 0.0 109.816 -177.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 416' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 100.79 -175.34 26.38 Favored Glycine 0 N--CA 1.429 -1.773 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -170.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 34.0 mm-40 -79.65 24.03 0.39 Allowed 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.207 0.527 . . . . 0.0 111.645 -171.044 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 418' ' ' ASN . . . . . 0.445 ' OD1' ' HD2' ' A' ' 381' ' ' ARG . 61.2 m-80 -71.4 75.96 0.76 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.146 -178.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 419' ' ' TYR . . . . . 0.515 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 7.4 p90 -50.39 -38.54 43.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.933 173.656 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -54.27 -46.78 72.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.886 178.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.16 -48.98 60.8 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.188 -176.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 422' ' ' VAL . . . . . 0.406 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -66.37 -40.02 85.62 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 C-N-CA 120.368 -0.533 . . . . 0.0 111.146 -175.509 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.703 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 78.2 p -67.31 -38.57 85.2 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.607 -0.437 . . . . 0.0 109.976 -178.495 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -69.56 -37.61 78.11 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.071 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 425' ' ' ILE . . . . . 0.604 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -73.34 -51.9 23.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.466 0.174 . . . . 0.0 111.113 -178.018 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 426' ' ' ILE . . . . . 0.647 HD13 HG23 ' A' ' 395' ' ' ILE . 1.2 mm -74.4 -23.35 18.19 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.829 0 CA-C-O 120.835 0.35 . . . . 0.0 110.241 -171.352 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.703 ' HB2' ' O ' ' A' ' 423' ' ' SER . 1.0 OUTLIER -54.62 -29.33 51.68 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.165 0.507 . . . . 0.0 110.602 179.773 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -86.35 -8.38 77.97 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.858 178.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.667 ' CZ ' ' HG3' ' A' ' 396' ' ' LYS . 24.2 m-85 -117.51 -1.09 11.75 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-O 121.465 0.65 . . . . 0.0 110.272 -178.575 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.593 HD12 ' HD2' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -65.99 132.78 94.71 Favored Pre-proline 0 N--CA 1.437 -1.118 0 CA-C-N 114.624 -1.171 . . . . 0.0 108.624 179.241 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 431' ' ' PRO . . . . . 0.829 ' CD ' HG11 ' A' ' 435' ' ' VAL . 42.4 Cg_exo -35.17 -72.36 0.05 OUTLIER 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 124.847 3.698 . . . . 0.0 113.984 -170.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 432' ' ' GLY . . . . . 0.455 ' O ' HG12 ' A' ' 435' ' ' VAL . . . -131.38 -162.49 10.57 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 175.319 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 433' ' ' GLN . . . . . 0.523 ' O ' HG13 ' A' ' 436' ' ' VAL . 22.3 tp60 -71.29 -27.6 63.53 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 118.088 0.944 . . . . 0.0 110.459 177.46 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -68.23 -37.92 81.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.164 -175.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 435' ' ' VAL . . . . . 0.829 HG11 ' CD ' ' A' ' 431' ' ' PRO . 6.7 p -68.45 -46.63 80.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-O 120.979 0.419 . . . . 0.0 110.438 -178.33 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.523 HG13 ' O ' ' A' ' 433' ' ' GLN . 0.2 OUTLIER -63.47 -31.08 51.55 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.321 175.702 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 437' ' ' THR . . . . . 0.573 ' O ' ' HG3' ' A' ' 441' ' ' GLN . 1.0 OUTLIER -69.03 -52.94 23.46 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 -178.028 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 438' ' ' ALA . . . . . 0.891 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -59.43 -36.06 75.19 Favored 'General case' 0 N--CA 1.436 -1.15 0 O-C-N 124.01 0.819 . . . . 0.0 112.01 178.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 439' ' ' LEU . . . . . 0.585 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 1.9 tm? -70.24 -47.91 59.28 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 -59.47 -36.43 75.97 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.18 176.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 441' ' ' GLN . . . . . 0.573 ' HG3' ' O ' ' A' ' 437' ' ' THR . 43.4 mt-30 -54.33 -51.47 64.61 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.106 178.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 442' ' ' ARG . . . . . 0.497 ' HG3' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -62.47 -36.87 83.84 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.839 174.869 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 443' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 61.4 mt -66.57 -37.36 84.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.007 0.432 . . . . 0.0 110.195 179.241 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -57.68 -37.81 74.08 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.563 173.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -72.53 -27.48 62.26 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.533 178.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 446' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 443' ' ' LEU . 37.9 tt0 33.55 101.18 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 114.56 1.318 . . . . 0.0 114.56 170.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 54.6 mt -69.87 -35.26 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-O 121.054 0.454 . . . . 0.0 110.745 178.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 448' ' ' ASP . . . . . 0.521 ' O ' ' HG3' ' A' ' 452' ' ' ARG . 16.6 m-20 -168.35 -167.42 0.8 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -176.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -77.06 -69.98 0.49 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.039 0.447 . . . . 0.0 109.807 172.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -66.86 -25.06 66.23 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 178.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 451' ' ' THR . . . . . 0.501 ' OG1' ' HB2' ' A' ' 448' ' ' ASP . 11.7 m -70.89 -22.91 62.21 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 119.989 -0.685 . . . . 0.0 110.86 -174.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 452' ' ' ARG . . . . . 0.521 ' HG3' ' O ' ' A' ' 448' ' ' ASP . 11.6 mtp180 -53.61 -54.0 43.86 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 170.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 453' ' ' ALA . . . . . 0.515 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -58.88 -47.04 86.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.557 -1.201 . . . . 0.0 112.656 175.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 454' ' ' GLU . . . . . 0.443 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 23.6 mm-40 -52.41 -36.17 53.58 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.175 0.512 . . . . 0.0 111.462 -178.442 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 29.5 p -118.38 15.61 13.87 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.449 -176.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 456' ' ' PHE . . . . . 0.553 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.9 OUTLIER -56.83 -48.69 77.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.05 0.452 . . . . 0.0 111.54 -171.704 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 457' ' ' ILE . . . . . 0.553 ' CG1' ' HB3' ' A' ' 408' ' ' TYR . 1.9 mp -76.11 -32.0 22.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.8 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -57.46 -37.08 72.28 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.672 0.749 . . . . 0.0 109.325 171.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 459' ' ' HIS . . . . . 0.774 ' O ' HG23 ' A' ' 463' ' ' VAL . 79.3 m-70 -72.32 -29.14 63.56 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.365 178.121 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 460' ' ' LEU . . . . . 0.73 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -74.18 -35.38 63.97 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.954 0.883 . . . . 0.0 108.992 179.688 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 461' ' ' ASN . . . . . 0.495 ' O ' ' HB2' ' A' ' 464' ' ' TYR . 23.7 m-80 -73.13 -37.67 66.56 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.362 -0.835 . . . . 0.0 108.977 176.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 462' ' ' ALA . . . . . 0.613 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -56.98 -33.58 67.23 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.586 -1.188 . . . . 0.0 109.931 169.278 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.891 HG13 ' HB3' ' A' ' 438' ' ' ALA . 55.2 t -62.66 -50.29 80.36 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.893 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 175.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 464' ' ' TYR . . . . . 0.6 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 20.7 m-30 -52.89 -29.57 29.07 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.481 177.552 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.37 -38.71 19.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.75 0.786 . . . . 0.0 109.636 -176.245 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.613 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.6 mt -56.8 -55.98 16.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 114.289 -1.323 . . . . 0.0 112.271 174.466 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.782 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -102.14 -10.07 19.96 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -171.94 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 468' ' ' GLY . . . . . 0.564 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 94.72 31.39 7.83 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 119.481 -1.342 . . . . 0.0 114.345 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 469' ' ' LEU . . . . . 0.782 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 4.2 mt -89.75 160.45 16.54 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 117.862 0.831 . . . . 0.0 110.889 174.469 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 470' ' ' ASN . . . . . 0.448 ' HB3' ' CG2' ' A' ' 476' ' ' ILE . 40.2 p30 -105.53 -178.24 3.6 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.4 170.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 471' ' ' ALA . . . . . 0.447 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -56.91 -27.9 61.33 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -174.132 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -85.08 8.46 17.91 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -171.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 74.01 9.08 79.63 Favored Glycine 0 CA--C 1.519 0.344 0 C-N-CA 120.313 -0.946 . . . . 0.0 111.642 -177.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -100.14 155.08 17.93 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 177.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 475' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 469' ' ' LEU . 59.9 p -91.43 136.73 32.9 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.348 0.594 . . . . 0.0 110.837 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 476' ' ' ILE . . . . . 0.564 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.7 pp -94.45 -19.41 6.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.468 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 477' ' ' ARG . . . . . 0.524 ' O ' ' HD3' ' A' ' 477' ' ' ARG . 0.0 OUTLIER -96.07 162.1 13.69 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.857 174.015 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 97.9 mt -126.28 143.08 51.28 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.968 0.413 . . . . 0.0 110.665 -177.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.407 -0.806 . . . . 0.0 109.67 176.543 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 381' ' ' ARG . . . . . 0.435 ' HD2' ' OD1' ' B' ' 418' ' ' ASN . 10.4 ptp180 . . . . . 0 N--CA 1.48 1.056 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 382' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.43 -31.05 1.1 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -176.355 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 383' ' ' HIS . . . . . 0.473 ' HB2' ' O ' ' B' ' 386' ' ' PHE . 1.3 p80 -151.08 161.06 43.45 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 119.935 -0.706 . . . . 0.0 112.003 -169.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 384' ' ' GLY . . . . . . . . . . . . . . . -106.82 -110.04 3.44 Favored Glycine 0 N--CA 1.439 -1.128 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 168.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 385' ' ' THR . . . . . . . . . . . . . 34.8 m -73.44 -32.53 64.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.907 0.384 . . . . 0.0 111.083 177.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 386' ' ' PHE . . . . . 0.783 ' CD1' HD22 ' B' ' 414' ' ' LEU . 2.0 t80 -74.0 126.62 89.17 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 121.061 0.457 . . . . 0.0 110.846 -178.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 387' ' ' PRO . . . . . 0.548 ' HG2' ' OD1' ' A' ' 393' ' ' ASN . 61.5 Cg_endo -72.23 110.23 2.91 Favored 'Trans proline' 0 N--CA 1.479 0.645 0 C-N-CA 124.166 3.244 . . . . 0.0 114.107 175.424 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 388' ' ' MET . . . . . 0.436 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 33.1 mtt -104.3 169.08 8.69 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 122.103 -0.373 . . . . 0.0 110.127 175.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 389' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -54.98 -62.45 1.65 Allowed 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 177.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -172.35 17.06 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.736 -1.12 . . . . 0.0 108.311 172.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 391' ' ' LEU . . . . . 0.606 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.0 pt? -165.82 -66.18 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.269 -167.146 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 392' ' ' GLY . . . . . 0.606 ' N ' ' HG ' ' B' ' 391' ' ' LEU . . . -162.83 54.96 0.3 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.432 -0.889 . . . . 0.0 113.169 -173.297 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 393' ' ' ASN . . . . . 0.542 ' OD1' ' HG2' ' A' ' 387' ' ' PRO . 0.2 OUTLIER -54.3 -42.37 70.0 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 178.41 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 394' ' ' VAL . . . . . 0.751 HG12 ' CZ ' ' B' ' 386' ' ' PHE . 0.7 OUTLIER -56.95 -46.15 83.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -179.388 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 395' ' ' ILE . . . . . 0.64 HG23 HD13 ' B' ' 426' ' ' ILE . 4.2 mp -57.59 -51.8 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-O 117.991 -1.004 . . . . 0.0 112.81 -174.376 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 396' ' ' LYS . . . . . 0.671 ' HG3' ' CZ ' ' B' ' 429' ' ' TYR . 0.1 OUTLIER -62.17 -49.03 77.45 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 121.487 1.949 . . . . 0.0 111.719 -175.142 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -54.77 -45.59 78.7 Favored Glycine 0 N--CA 1.437 -1.252 0 C-N-CA 119.84 -1.171 . . . . 0.0 111.209 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 398' ' ' ILE . . . . . 0.726 HG12 HD21 ' A' ' 414' ' ' LEU . 26.8 mt -70.94 -34.19 54.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 113.361 0.875 . . . . 0.0 113.361 -177.725 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 399' ' ' VAL . . . . . 0.478 HG12 ' HA ' ' B' ' 404' ' ' VAL . 13.5 m -63.82 -39.44 85.43 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.481 0 C-N-CA 118.774 -1.17 . . . . 0.0 108.56 -174.209 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -70.98 -34.83 71.78 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 175.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 401' ' ' GLN . . . . . 0.41 HE21 ' HB3' ' B' ' 401' ' ' GLN . 4.2 mm100 -89.06 -47.61 7.99 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -172.357 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 402' ' ' GLU . . . . . 0.588 ' HG3' ' HE3' ' A' ' 413' ' ' MET . 1.3 mm-40 -121.64 -20.47 6.5 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.026 0.441 . . . . 0.0 111.489 -170.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 107.12 162.31 21.87 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.736 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 404' ' ' VAL . . . . . 0.592 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.8 m -53.72 -46.38 62.05 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.792 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -175.409 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 405' ' ' ALA . . . . . 0.539 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -63.87 -29.88 71.02 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 119.639 -0.825 . . . . 0.0 112.464 -177.439 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 406' ' ' THR . . . . . 0.727 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 89.1 m -77.38 -42.78 35.12 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.149 172.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 407' ' ' ALA . . . . . 0.465 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.17 -37.19 74.23 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 122.248 1.023 . . . . 0.0 109.317 176.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 408' ' ' TYR . . . . . 0.592 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.79 -51.97 54.69 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 113.279 -1.782 . . . . 0.0 109.86 176.48 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 409' ' ' THR . . . . . 0.647 HG22 HD23 ' B' ' 410' ' ' LEU . 16.6 m -55.23 -47.08 75.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.427 179.1 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 410' ' ' LEU . . . . . 0.727 ' HG ' ' O ' ' B' ' 406' ' ' THR . 14.7 mt -72.72 -36.82 67.87 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.312 -174.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.84 -34.89 79.97 Favored Glycine 0 N--CA 1.44 -1.074 0 C-N-CA 120.175 -1.012 . . . . 0.0 110.72 172.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 412' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -66.79 -44.52 81.09 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 115.839 -0.18 . . . . 0.0 111.458 177.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 413' ' ' MET . . . . . 0.762 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.0 OUTLIER -70.99 -56.9 5.18 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 118.66 -1.216 . . . . 0.0 111.701 179.035 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 414' ' ' LEU . . . . . 0.783 HD22 ' CD1' ' B' ' 386' ' ' PHE . 6.8 mt -64.71 -43.17 94.31 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -171.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 33.1 t -86.29 -16.45 37.5 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.76 0.791 . . . . 0.0 109.745 -176.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 416' ' ' GLY . . . . . 0.407 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 100.41 -175.54 26.99 Favored Glycine 0 N--CA 1.429 -1.831 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -171.052 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -79.48 24.13 0.37 Allowed 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.251 0.548 . . . . 0.0 111.742 -171.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 418' ' ' ASN . . . . . 0.435 ' OD1' ' HD2' ' B' ' 381' ' ' ARG . 62.5 m-80 -71.55 75.99 0.8 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.025 -179.002 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 419' ' ' TYR . . . . . 0.523 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 7.3 p90 -50.39 -38.49 42.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.936 173.462 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -54.37 -46.56 73.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.939 178.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.25 -49.03 59.96 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.249 -177.16 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 422' ' ' VAL . . . . . 0.41 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.2 OUTLIER -66.31 -40.08 85.86 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.212 -175.514 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 423' ' ' SER . . . . . 0.72 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 78.0 p -67.3 -38.56 85.18 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.921 -178.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -69.71 -37.45 76.5 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.11 177.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 425' ' ' ILE . . . . . 0.621 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -73.46 -52.03 23.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.488 0.185 . . . . 0.0 111.186 -178.259 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 426' ' ' ILE . . . . . 0.64 HD13 HG23 ' B' ' 395' ' ' ILE . 1.2 mm -74.13 -23.38 18.6 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.797 0 CA-C-O 120.82 0.343 . . . . 0.0 110.226 -171.321 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 427' ' ' ARG . . . . . 0.72 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.9 OUTLIER -54.68 -29.11 51.84 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.122 0.487 . . . . 0.0 110.666 179.913 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -86.55 -8.75 76.68 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.756 178.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 429' ' ' TYR . . . . . 0.671 ' CZ ' ' HG3' ' B' ' 396' ' ' LYS . 24.3 m-85 -117.1 -0.82 12.02 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 121.465 0.65 . . . . 0.0 110.156 -178.557 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 430' ' ' LEU . . . . . 0.614 HD12 ' HD2' ' B' ' 431' ' ' PRO . 0.0 OUTLIER -66.07 132.97 94.66 Favored Pre-proline 0 N--CA 1.438 -1.054 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.54 179.27 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 431' ' ' PRO . . . . . 0.828 ' CD ' HG11 ' B' ' 435' ' ' VAL . 42.6 Cg_exo -35.23 -71.73 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 124.76 3.64 . . . . 0.0 114.054 -170.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 432' ' ' GLY . . . . . 0.441 ' O ' HG12 ' B' ' 435' ' ' VAL . . . -131.99 -162.15 10.32 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 175.334 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 433' ' ' GLN . . . . . 0.535 ' O ' HG13 ' B' ' 436' ' ' VAL . 22.5 tp60 -71.58 -27.82 63.41 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 118.119 0.96 . . . . 0.0 110.447 177.429 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -68.06 -38.08 82.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.215 -0.448 . . . . 0.0 112.065 -175.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 435' ' ' VAL . . . . . 0.828 HG11 ' CD ' ' B' ' 431' ' ' PRO . 6.7 p -68.17 -46.73 80.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-O 121.068 0.461 . . . . 0.0 110.46 -178.34 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 436' ' ' VAL . . . . . 0.535 HG13 ' O ' ' B' ' 433' ' ' GLN . 0.2 OUTLIER -63.32 -31.44 52.81 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.191 175.759 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 437' ' ' THR . . . . . 0.575 ' O ' ' HG3' ' B' ' 441' ' ' GLN . 1.0 OUTLIER -68.87 -52.74 26.42 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -177.996 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 438' ' ' ALA . . . . . 0.89 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -59.51 -36.12 75.46 Favored 'General case' 0 N--CA 1.435 -1.193 0 O-C-N 124.132 0.895 . . . . 0.0 112.04 178.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 439' ' ' LEU . . . . . 0.588 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 1.9 tm? -70.22 -47.93 59.3 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 -59.43 -36.32 75.69 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.154 175.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 441' ' ' GLN . . . . . 0.575 ' HG3' ' O ' ' B' ' 437' ' ' THR . 43.9 mt-30 -54.44 -51.66 64.26 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 123.755 0.822 . . . . 0.0 110.034 178.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 442' ' ' ARG . . . . . 0.486 ' HG3' ' O ' ' B' ' 438' ' ' ALA . 0.0 OUTLIER -62.4 -36.69 83.11 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.461 -0.791 . . . . 0.0 112.855 174.942 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 443' ' ' LEU . . . . . 0.588 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 61.2 mt -66.6 -37.33 84.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.17 0.51 . . . . 0.0 110.237 179.222 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -57.82 -37.69 74.24 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.675 173.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -72.58 -27.39 62.16 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.497 -1.229 . . . . 0.0 110.595 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 446' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' B' ' 443' ' ' LEU . 37.9 tt0 33.41 101.52 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 170.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 54.9 mt -70.35 -35.35 62.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.074 0.464 . . . . 0.0 110.616 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 448' ' ' ASP . . . . . 0.514 ' O ' ' HG3' ' B' ' 452' ' ' ARG . 17.6 m-20 -168.17 -167.27 0.8 Allowed 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 -176.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -77.2 -70.15 0.48 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 173.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -66.79 -25.08 66.3 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 451' ' ' THR . . . . . 0.489 ' OG1' ' HB2' ' B' ' 448' ' ' ASP . 13.1 m -70.95 -22.82 62.16 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.688 -174.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 452' ' ' ARG . . . . . 0.514 ' HG3' ' O ' ' B' ' 448' ' ' ASP . 11.7 mtp180 -53.7 -53.92 45.23 Favored 'General case' 0 C--O 1.219 -0.552 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 171.024 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 453' ' ' ALA . . . . . 0.523 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -58.8 -47.28 85.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.517 -1.22 . . . . 0.0 112.666 175.525 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 454' ' ' GLU . . . . . 0.438 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 22.7 mm-40 -52.39 -36.07 53.12 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.321 0.581 . . . . 0.0 111.488 -178.406 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 29.4 p -118.3 15.58 13.94 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.397 -176.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 456' ' ' PHE . . . . . 0.551 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 0.9 OUTLIER -56.88 -48.89 77.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.054 0.454 . . . . 0.0 111.474 -171.712 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 457' ' ' ILE . . . . . 0.564 ' CG1' ' HB3' ' B' ' 408' ' ' TYR . 1.9 mp -75.97 -31.9 22.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.875 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -57.6 -37.06 72.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.693 0.759 . . . . 0.0 109.355 171.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 459' ' ' HIS . . . . . 0.777 ' O ' HG23 ' B' ' 463' ' ' VAL . 79.0 m-70 -72.36 -28.97 63.37 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.385 178.053 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 460' ' ' LEU . . . . . 0.746 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.4 OUTLIER -74.25 -35.4 63.8 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.909 0.861 . . . . 0.0 108.974 179.655 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 461' ' ' ASN . . . . . 0.486 ' O ' ' HB2' ' B' ' 464' ' ' TYR . 23.2 m-80 -73.3 -37.36 66.22 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.864 0.84 . . . . 0.0 109.087 176.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 462' ' ' ALA . . . . . 0.612 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -57.11 -33.65 67.56 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.493 -1.23 . . . . 0.0 109.891 169.098 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 463' ' ' VAL . . . . . 0.89 HG13 ' HB3' ' B' ' 438' ' ' ALA . 55.9 t -62.53 -50.4 79.98 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.871 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 175.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 464' ' ' TYR . . . . . 0.603 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 20.7 m-30 -52.79 -29.45 27.5 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.481 177.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.41 -38.95 19.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.701 0.762 . . . . 0.0 109.601 -176.262 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 466' ' ' ILE . . . . . 0.612 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.6 mt -56.72 -55.77 17.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 114.245 -1.343 . . . . 0.0 112.257 174.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 467' ' ' LEU . . . . . 0.776 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -102.3 -9.94 19.94 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -171.943 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 468' ' ' GLY . . . . . 0.567 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 94.53 31.58 7.8 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 119.519 -1.324 . . . . 0.0 114.456 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 469' ' ' LEU . . . . . 0.776 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 4.2 mt -89.89 160.67 16.33 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 117.674 0.737 . . . . 0.0 110.853 174.384 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 470' ' ' ASN . . . . . 0.454 ' HB3' ' CG2' ' B' ' 476' ' ' ILE . 40.1 p30 -105.64 -178.15 3.57 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.365 170.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 471' ' ' ALA . . . . . 0.446 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -57.05 -27.87 62.05 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -174.244 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -85.14 8.63 17.46 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.973 0.361 . . . . 0.0 111.973 -171.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 473' ' ' GLY . . . . . . . . . . . . . . . 74.02 8.96 79.51 Favored Glycine 0 C--O 1.228 -0.221 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.553 -177.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -100.16 154.88 18.08 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 177.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 475' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' B' ' 469' ' ' LEU . 61.1 p -91.12 136.69 32.91 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.329 0.585 . . . . 0.0 110.862 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 476' ' ' ILE . . . . . 0.567 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.7 pp -94.27 -19.85 6.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.47 179.443 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 477' ' ' ARG . . . . . 0.527 ' O ' ' HD3' ' B' ' 477' ' ' ARG . 0.0 OUTLIER -95.68 162.27 13.68 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.713 174.188 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 478' ' ' LEU . . . . . . . . . . . . . 98.1 mt -126.33 143.52 51.13 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.843 0.354 . . . . 0.0 110.664 -177.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 479' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.4 -0.809 . . . . 0.0 109.637 176.666 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 . . . . . 0 N--CA 1.479 0.996 0 CA-C-O 121.018 0.437 . . . . 0.0 110.686 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 382' ' ' THR . . . . . 0.55 ' OG1' ' HA ' ' A' ' 391' ' ' LEU . 0.0 OUTLIER -97.44 -29.58 13.41 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.481 174.302 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 383' ' ' HIS . . . . . 0.461 ' HB2' ' O ' ' A' ' 386' ' ' PHE . 19.0 p80 -159.28 159.37 33.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.924 0.392 . . . . 0.0 111.323 -176.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -114.84 -117.76 3.21 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.38 174.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 31.2 m -58.78 -35.13 72.3 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 121.167 0.508 . . . . 0.0 111.196 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 386' ' ' PHE . . . . . 0.775 ' CD1' HD22 ' A' ' 414' ' ' LEU . 1.9 t80 -82.16 128.31 68.28 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 176.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -55.4 -72.76 0.03 OUTLIER 'Trans proline' 0 N--CA 1.486 1.068 0 C-N-CA 124.488 3.458 . . . . 0.0 114.465 178.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.577 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 10.4 ttp 69.17 59.6 0.33 Allowed 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 170.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 389' ' ' HIS . . . . . 0.557 ' ND1' ' HA ' ' A' ' 393' ' ' ASN . 17.1 m170 51.05 -138.56 1.04 Allowed 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -178.373 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 390' ' ' GLN . . . . . 0.478 ' H ' ' HB3' ' A' ' 389' ' ' HIS . 5.9 pm0 -110.68 22.67 15.14 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 164.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.623 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.5 pt? -168.28 -61.71 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.542 -174.096 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 392' ' ' GLY . . . . . 0.623 ' N ' ' HG ' ' A' ' 391' ' ' LEU . . . -160.51 59.45 0.31 Allowed Glycine 0 C--N 1.337 0.589 0 C-N-CA 119.733 -1.222 . . . . 0.0 114.715 -171.199 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 393' ' ' ASN . . . . . 0.577 ' HB3' ' HA ' ' A' ' 388' ' ' MET . 0.4 OUTLIER -62.4 -39.55 93.61 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 117.4 0.6 . . . . 0.0 109.568 175.714 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.663 HG22 HD12 ' A' ' 395' ' ' ILE . 0.6 OUTLIER -56.7 -46.02 82.91 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 179.21 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.663 HD12 HG22 ' A' ' 394' ' ' VAL . 4.0 mp -57.79 -52.71 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.323 0 CA-C-O 117.853 -1.07 . . . . 0.0 113.465 -174.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 396' ' ' LYS . . . . . 0.615 ' O ' HG22 ' A' ' 399' ' ' VAL . 0.0 OUTLIER -63.72 -49.76 71.8 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-N 121.972 2.169 . . . . 0.0 111.645 -175.77 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.62 -44.89 68.72 Favored Glycine 0 N--CA 1.428 -1.842 0 CA-C-N 114.473 -1.239 . . . . 0.0 110.818 -175.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 398' ' ' ILE . . . . . 0.743 HG12 HD21 ' B' ' 414' ' ' LEU . 34.8 mt -70.79 -33.05 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 399' ' ' VAL . . . . . 0.615 HG22 ' O ' ' A' ' 396' ' ' LYS . 16.7 m -62.9 -39.73 86.16 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 C-N-CA 118.688 -1.205 . . . . 0.0 108.43 -175.067 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -71.35 -35.03 71.0 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 175.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.453 HE21 ' HB3' ' A' ' 401' ' ' GLN . 3.9 mm100 -88.52 -47.47 8.3 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -172.298 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 402' ' ' GLU . . . . . 0.617 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 3.1 mm-40 -121.72 -21.03 6.26 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.539 -171.313 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 109.25 160.98 19.44 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.728 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 404' ' ' VAL . . . . . 0.645 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.1 m -53.71 -40.77 44.5 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.771 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -175.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 405' ' ' ALA . . . . . 0.576 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -68.48 -31.55 70.92 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 119.591 -0.844 . . . . 0.0 112.013 -177.122 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.71 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 92.3 m -77.08 -41.51 41.93 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.1 173.641 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.448 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.47 -37.26 75.12 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 122.059 0.933 . . . . 0.0 109.365 176.173 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 408' ' ' TYR . . . . . 0.645 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.6 -52.79 49.38 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 113.709 -1.587 . . . . 0.0 109.973 176.433 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 409' ' ' THR . . . . . 0.739 HG22 HD23 ' A' ' 410' ' ' LEU . 3.2 m -56.09 -46.8 78.93 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 179.168 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 410' ' ' LEU . . . . . 0.739 HD23 HG22 ' A' ' 409' ' ' THR . 13.6 mt -72.36 -37.69 68.73 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -175.558 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.48 -37.03 87.31 Favored Glycine 0 N--CA 1.435 -1.4 0 C-N-CA 119.849 -1.167 . . . . 0.0 110.298 172.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 412' ' ' MET . . . . . 0.439 ' HB2' ' O ' ' A' ' 409' ' ' THR . 0.0 OUTLIER -64.27 -49.98 69.72 Favored 'General case' 0 C--O 1.223 -0.306 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 178.53 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 413' ' ' MET . . . . . 0.933 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 1.0 OUTLIER -71.27 -42.88 68.21 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 118.849 -1.14 . . . . 0.0 112.133 -176.146 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 414' ' ' LEU . . . . . 0.933 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 19.7 mt -69.61 -45.19 69.14 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -177.123 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.408 ' HB3' ' HE1' ' A' ' 388' ' ' MET . 54.6 p -85.91 -21.65 27.86 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.511 0.672 . . . . 0.0 110.482 -174.577 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 108.64 178.65 21.71 Favored Glycine 0 N--CA 1.431 -1.682 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -168.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -80.17 23.94 0.45 Allowed 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.037 0.446 . . . . 0.0 111.859 -173.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 418' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -71.35 78.25 0.74 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.677 0.751 . . . . 0.0 110.947 178.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 419' ' ' TYR . . . . . 0.568 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 17.1 p90 -51.86 -38.32 55.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.749 177.314 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -55.12 -45.41 75.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.746 178.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 421' ' ' LEU . . . . . 0.427 HD23 ' N ' ' A' ' 422' ' ' VAL . 0.0 OUTLIER -68.33 -48.58 64.48 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.11 -177.943 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 422' ' ' VAL . . . . . 0.477 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.1 OUTLIER -65.64 -41.78 91.33 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 C-N-CA 120.347 -0.541 . . . . 0.0 110.932 -176.291 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.785 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 29.6 t -69.35 -36.53 76.98 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.7 -178.145 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -69.34 -37.47 80.07 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.84 176.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 425' ' ' ILE . . . . . 0.611 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.41 -51.25 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-O 120.515 0.198 . . . . 0.0 110.621 -179.631 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 426' ' ' ILE . . . . . 0.752 HG22 HD22 ' A' ' 430' ' ' LEU . 1.1 mm -73.38 -22.9 19.37 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.952 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -173.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.785 ' HB2' ' O ' ' A' ' 423' ' ' SER . 1.1 tmm_? -54.38 -33.63 59.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.289 0.566 . . . . 0.0 110.893 -177.034 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -86.28 -10.94 73.33 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.404 -0.903 . . . . 0.0 110.853 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.633 ' HD1' HG22 ' A' ' 395' ' ' ILE . 5.4 m-30 -112.91 -1.8 14.47 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -174.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.752 HD22 HG22 ' A' ' 426' ' ' ILE . 0.0 OUTLIER -66.61 129.88 94.1 Favored Pre-proline 0 N--CA 1.443 -0.789 0 CA-C-N 114.201 -1.363 . . . . 0.0 108.947 177.203 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 431' ' ' PRO . . . . . 0.585 ' HD2' HD12 ' A' ' 430' ' ' LEU . 79.7 Cg_exo -24.09 -66.95 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.758 1 C-N-CA 125.536 4.157 . . . . 0.0 114.727 179.221 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 432' ' ' GLY . . . . . 0.529 ' H ' HG12 ' A' ' 435' ' ' VAL . . . -145.2 -168.17 12.75 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 176.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 433' ' ' GLN . . . . . 0.515 ' O ' HG13 ' A' ' 436' ' ' VAL . 40.1 tp60 -69.84 -26.26 64.13 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 117.888 0.844 . . . . 0.0 110.459 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -65.85 -40.8 92.07 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.887 -178.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 435' ' ' VAL . . . . . 0.74 HG23 HG11 ' A' ' 463' ' ' VAL . 7.4 p -68.84 -43.39 82.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-O 120.947 0.403 . . . . 0.0 110.755 -177.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.515 HG13 ' O ' ' A' ' 433' ' ' GLN . 0.1 OUTLIER -65.25 -33.42 63.59 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.19 175.73 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 437' ' ' THR . . . . . 0.458 ' O ' ' HG3' ' A' ' 441' ' ' GLN . 1.0 OUTLIER -66.84 -52.86 38.67 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -177.727 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 438' ' ' ALA . . . . . 0.869 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -58.58 -37.79 76.52 Favored 'General case' 0 N--CA 1.436 -1.162 0 O-C-N 123.788 0.68 . . . . 0.0 111.835 178.301 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 439' ' ' LEU . . . . . 0.619 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 2.1 tm? -67.64 -48.78 65.76 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 -179.27 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -60.28 -35.02 74.58 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.535 -1.212 . . . . 0.0 110.729 176.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 441' ' ' GLN . . . . . 0.563 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 13.3 mt-30 -53.32 -50.96 63.88 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.186 -178.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 442' ' ' ARG . . . . . 0.631 ' HD2' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -76.09 -23.38 54.96 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 175.118 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 443' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 47.3 mt -64.09 -35.47 80.87 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 174.072 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -56.89 -36.09 69.71 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.373 172.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -73.16 -27.63 61.77 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.872 178.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 446' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 443' ' ' LEU . 33.5 tt0 32.94 89.45 0.01 OUTLIER 'General case' 0 C--N 1.353 0.745 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 170.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 70.8 mt -59.31 -35.82 60.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 175.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 448' ' ' ASP . . . . . 0.493 ' HB2' ' OG1' ' A' ' 451' ' ' THR . 24.5 m-20 -166.49 175.34 8.16 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 178.104 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 449' ' ' ASP . . . . . 0.642 ' O ' ' HG2' ' A' ' 452' ' ' ARG . 13.0 m-20 -62.72 -60.03 4.07 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.312 -0.555 . . . . 0.0 109.715 174.579 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 450' ' ' GLN . . . . . 0.453 ' O ' ' HB3' ' A' ' 453' ' ' ALA . 2.6 pp0? -71.93 -28.51 63.51 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 178.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 451' ' ' THR . . . . . 0.493 ' OG1' ' HB2' ' A' ' 448' ' ' ASP . 10.1 m -73.0 -23.54 60.65 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.326 -174.383 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 452' ' ' ARG . . . . . 0.642 ' HG2' ' O ' ' A' ' 449' ' ' ASP . 6.0 ptp180 -64.73 -41.52 95.9 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 174.557 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 453' ' ' ALA . . . . . 0.568 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -58.99 -49.19 78.82 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 123.843 0.714 . . . . 0.0 112.445 168.492 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 454' ' ' GLU . . . . . 0.434 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 33.5 mm-40 -53.97 -33.44 56.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.148 0.499 . . . . 0.0 111.738 -177.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 29.1 p -115.56 15.27 16.65 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.224 -178.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 456' ' ' PHE . . . . . 0.559 ' CZ ' ' HB2' ' A' ' 423' ' ' SER . 1.0 OUTLIER -56.78 -47.68 79.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.995 0.426 . . . . 0.0 111.775 -171.667 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 457' ' ' ILE . . . . . 0.576 HG23 ' HB1' ' A' ' 405' ' ' ALA . 1.9 mp -76.41 -33.41 23.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.153 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -57.84 -34.05 69.29 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.955 0.883 . . . . 0.0 108.963 171.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 459' ' ' HIS . . . . . 0.745 ' O ' HG23 ' A' ' 463' ' ' VAL . 45.0 m-70 -74.47 -29.31 61.4 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.197 -1.365 . . . . 0.0 110.947 177.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 460' ' ' LEU . . . . . 0.701 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -74.07 -34.78 64.13 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.342 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 24.2 m-80 -73.02 -37.59 66.88 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.047 176.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 462' ' ' ALA . . . . . 0.6 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -55.86 -34.92 65.89 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.659 169.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.869 HG13 ' HB3' ' A' ' 438' ' ' ALA . 73.3 t -61.69 -51.15 76.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-N 114.612 -1.176 . . . . 0.0 108.201 176.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 464' ' ' TYR . . . . . 0.577 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 15.9 m-30 -52.95 -28.16 22.35 Favored 'General case' 0 C--N 1.332 -0.188 0 O-C-N 124.295 0.997 . . . . 0.0 110.614 178.13 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.92 -39.53 19.68 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.76 0.79 . . . . 0.0 109.632 -177.319 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.6 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.7 mt -57.95 -55.86 19.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 114.296 -1.32 . . . . 0.0 112.252 175.344 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.753 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -102.46 -10.88 19.01 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -172.274 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 468' ' ' GLY . . . . . 0.635 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 93.94 31.79 7.93 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 119.34 -1.41 . . . . 0.0 114.331 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 469' ' ' LEU . . . . . 0.753 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.1 mt -88.96 161.42 16.63 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 117.838 0.819 . . . . 0.0 110.922 175.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 470' ' ' ASN . . . . . 0.48 HD22 HG23 ' A' ' 476' ' ' ILE . 12.5 p30 -106.33 -176.84 3.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.075 170.43 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 471' ' ' ALA . . . . . 0.445 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -62.62 -19.55 63.89 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -173.227 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -87.77 2.26 51.72 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 122.113 -0.367 . . . . 0.0 111.809 -174.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 473' ' ' GLY . . . . . 0.477 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 76.77 11.58 85.26 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.21 -0.995 . . . . 0.0 111.003 -175.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -101.32 156.74 17.27 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 176.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 8.2 p -93.92 132.98 37.82 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.087 0.47 . . . . 0.0 111.587 -176.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 476' ' ' ILE . . . . . 0.635 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.5 pp -96.87 -3.78 10.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.479 0.657 . . . . 0.0 110.015 177.429 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 28.1 mmm180 -71.01 -39.08 72.6 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.045 176.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 86.9 mt 55.88 62.62 2.32 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.5 0.667 . . . . 0.0 110.523 179.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 . . . . . 0 C--O 1.246 0.911 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.027 -179.986 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 381' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 . . . . . 0 N--CA 1.478 0.949 0 CA-C-O 120.965 0.412 . . . . 0.0 110.842 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 382' ' ' THR . . . . . 0.558 ' OG1' ' HA ' ' B' ' 391' ' ' LEU . 0.0 OUTLIER -97.39 -29.47 13.49 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.42 174.652 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 383' ' ' HIS . . . . . 0.463 ' HB2' ' O ' ' B' ' 386' ' ' PHE . 19.0 p80 -159.5 159.29 33.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.052 0.453 . . . . 0.0 111.29 -176.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 384' ' ' GLY . . . . . . . . . . . . . . . -114.78 -118.02 3.24 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 174.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 385' ' ' THR . . . . . . . . . . . . . 30.0 m -58.45 -35.14 71.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.219 0.533 . . . . 0.0 111.304 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 386' ' ' PHE . . . . . 0.784 ' CD1' HD22 ' B' ' 414' ' ' LEU . 1.9 t80 -82.19 128.22 68.53 Favored Pre-proline 0 C--N 1.324 -0.534 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 176.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 387' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -55.59 -72.61 0.03 OUTLIER 'Trans proline' 0 N--CA 1.486 1.078 0 C-N-CA 124.536 3.491 . . . . 0.0 114.456 178.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 388' ' ' MET . . . . . 0.567 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 10.4 ttp 69.34 59.49 0.32 Allowed 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 170.496 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 389' ' ' HIS . . . . . 0.561 ' ND1' ' HA ' ' B' ' 393' ' ' ASN . 17.7 m170 51.28 -138.36 1.07 Allowed 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -178.342 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 390' ' ' GLN . . . . . 0.442 ' H ' ' HB3' ' B' ' 389' ' ' HIS . 5.9 pm0 -110.99 22.81 14.89 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 164.628 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 391' ' ' LEU . . . . . 0.615 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.5 pt? -168.46 -61.73 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.553 -174.044 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 392' ' ' GLY . . . . . 0.628 ' HA3' HD13 ' B' ' 395' ' ' ILE . . . -160.4 59.37 0.31 Allowed Glycine 0 C--N 1.338 0.644 0 C-N-CA 119.65 -1.262 . . . . 0.0 114.649 -171.225 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 393' ' ' ASN . . . . . 0.567 ' HB3' ' HA ' ' B' ' 388' ' ' MET . 0.4 OUTLIER -62.23 -39.71 93.7 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 117.371 0.586 . . . . 0.0 109.535 175.798 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 394' ' ' VAL . . . . . 0.672 HG22 HD12 ' B' ' 395' ' ' ILE . 0.6 OUTLIER -56.62 -46.09 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 179.346 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 395' ' ' ILE . . . . . 0.672 HD12 HG22 ' B' ' 394' ' ' VAL . 4.0 mp -57.86 -52.6 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.37 0 CA-C-O 117.794 -1.098 . . . . 0.0 113.45 -174.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 396' ' ' LYS . . . . . 0.616 ' O ' HG22 ' B' ' 399' ' ' VAL . 0.0 OUTLIER -63.58 -49.81 71.9 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-N 121.978 2.172 . . . . 0.0 111.706 -175.885 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.62 -44.86 68.73 Favored Glycine 0 N--CA 1.429 -1.819 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.825 -175.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 398' ' ' ILE . . . . . 0.78 HG12 HD21 ' A' ' 414' ' ' LEU . 35.1 mt -70.79 -33.11 51.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 399' ' ' VAL . . . . . 0.616 HG22 ' O ' ' B' ' 396' ' ' LYS . 16.7 m -62.93 -39.64 85.87 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 C-N-CA 118.678 -1.209 . . . . 0.0 108.362 -175.093 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -71.15 -35.55 71.72 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 175.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 401' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -88.37 -47.38 8.43 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -172.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 402' ' ' GLU . . . . . 0.511 ' HG3' ' HE3' ' A' ' 413' ' ' MET . 3.1 mm-40 -121.75 -21.09 6.23 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.573 -171.476 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 109.34 160.77 19.24 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.797 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 404' ' ' VAL . . . . . 0.632 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.1 m -53.62 -40.72 43.46 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.733 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -175.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 405' ' ' ALA . . . . . 0.563 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -68.39 -31.73 71.29 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 119.689 -0.804 . . . . 0.0 111.989 -177.167 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 406' ' ' THR . . . . . 0.702 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 94.8 m -77.15 -41.38 41.98 Favored 'General case' 0 C--O 1.222 -0.39 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.065 173.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 407' ' ' ALA . . . . . 0.451 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.53 -37.29 75.34 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 122.024 0.916 . . . . 0.0 109.249 176.225 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 408' ' ' TYR . . . . . 0.632 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.54 -52.7 50.59 Favored 'General case' 0 N--CA 1.433 -1.275 0 CA-C-N 113.612 -1.631 . . . . 0.0 110.032 176.376 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 409' ' ' THR . . . . . 0.736 HG22 HD23 ' B' ' 410' ' ' LEU . 3.3 m -56.05 -46.98 78.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.616 179.195 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 410' ' ' LEU . . . . . 0.745 HD12 HD13 ' B' ' 398' ' ' ILE . 13.6 mt -72.31 -37.74 68.86 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -175.493 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.5 -37.18 87.81 Favored Glycine 0 N--CA 1.436 -1.347 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 173.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 412' ' ' MET . . . . . 0.442 ' HB2' ' O ' ' B' ' 409' ' ' THR . 0.0 OUTLIER -64.0 -50.11 69.81 Favored 'General case' 0 C--O 1.223 -0.309 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 178.457 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 413' ' ' MET . . . . . 0.939 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 1.0 OUTLIER -71.18 -43.15 68.03 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 118.941 -1.104 . . . . 0.0 112.045 -176.22 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 414' ' ' LEU . . . . . 0.939 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 19.6 mt -69.49 -45.18 69.56 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -176.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 415' ' ' SER . . . . . 0.421 ' HB3' ' HE1' ' B' ' 388' ' ' MET . 54.7 p -85.95 -21.69 27.76 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.556 0.693 . . . . 0.0 110.462 -174.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 416' ' ' GLY . . . . . . . . . . . . . . . 108.75 178.54 21.64 Favored Glycine 0 N--CA 1.431 -1.687 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -168.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -80.01 23.88 0.44 Allowed 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.038 0.447 . . . . 0.0 112.041 -173.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 418' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -71.44 78.41 0.77 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.699 0.762 . . . . 0.0 110.726 178.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 419' ' ' TYR . . . . . 0.569 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 17.1 p90 -51.89 -38.31 55.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.726 177.167 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -55.15 -45.32 75.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.858 178.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 421' ' ' LEU . . . . . 0.418 HD23 ' N ' ' B' ' 422' ' ' VAL . 0.0 OUTLIER -68.4 -48.5 64.49 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.171 -178.031 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 422' ' ' VAL . . . . . 0.473 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.1 OUTLIER -65.7 -41.79 91.21 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.839 -176.291 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 423' ' ' SER . . . . . 0.778 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 28.5 t -69.39 -36.41 76.76 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.71 -178.017 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -69.41 -37.56 79.47 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.909 176.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 425' ' ' ILE . . . . . 0.62 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -72.36 -51.01 31.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.431 0.158 . . . . 0.0 110.623 -179.625 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 426' ' ' ILE . . . . . 0.748 HG22 HD22 ' B' ' 430' ' ' LEU . 1.1 mm -73.68 -22.86 18.95 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.899 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -173.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 427' ' ' ARG . . . . . 0.778 ' HB2' ' O ' ' B' ' 423' ' ' SER . 1.2 tmm_? -54.25 -33.73 59.14 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.284 0.564 . . . . 0.0 110.879 -177.053 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -86.33 -10.66 73.72 Favored Glycine 0 N--CA 1.441 -1.013 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 429' ' ' TYR . . . . . 0.632 ' HD1' HG22 ' B' ' 395' ' ' ILE . 5.6 m-30 -113.12 -1.92 14.28 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.884 0.85 . . . . 0.0 108.711 -174.561 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 430' ' ' LEU . . . . . 0.748 HD22 HG22 ' B' ' 426' ' ' ILE . 0.1 OUTLIER -66.38 130.03 94.18 Favored Pre-proline 0 N--CA 1.444 -0.757 0 CA-C-N 114.098 -1.41 . . . . 0.0 108.865 177.208 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 431' ' ' PRO . . . . . 0.574 ' HD2' HD12 ' B' ' 430' ' ' LEU . 80.2 Cg_exo -24.17 -66.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.759 1 C-N-CA 125.595 4.197 . . . . 0.0 114.697 178.984 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 432' ' ' GLY . . . . . 0.529 ' H ' HG12 ' B' ' 435' ' ' VAL . . . -145.4 -168.03 12.76 Favored Glycine 0 N--CA 1.441 -1.01 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 176.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 433' ' ' GLN . . . . . 0.507 ' O ' HG13 ' B' ' 436' ' ' VAL . 40.0 tp60 -69.79 -26.24 64.17 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 117.767 0.784 . . . . 0.0 110.465 179.186 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -65.95 -40.6 91.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.955 -178.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 435' ' ' VAL . . . . . 0.732 HG23 HG11 ' B' ' 463' ' ' VAL . 7.5 p -68.95 -43.59 82.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-O 120.85 0.357 . . . . 0.0 110.732 -177.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 436' ' ' VAL . . . . . 0.507 HG13 ' O ' ' B' ' 433' ' ' GLN . 0.1 OUTLIER -65.12 -33.45 63.8 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.234 175.723 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 437' ' ' THR . . . . . 0.453 ' O ' ' HG3' ' B' ' 441' ' ' GLN . 1.0 OUTLIER -67.02 -52.62 40.26 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -177.73 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 438' ' ' ALA . . . . . 0.857 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -58.6 -37.88 76.77 Favored 'General case' 0 N--CA 1.436 -1.151 0 O-C-N 123.809 0.693 . . . . 0.0 111.84 178.19 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 439' ' ' LEU . . . . . 0.61 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 2.1 tm? -67.44 -48.71 66.44 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -179.341 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -60.5 -34.78 74.57 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.498 -1.228 . . . . 0.0 110.773 176.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 441' ' ' GLN . . . . . 0.56 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 13.0 mt-30 -53.5 -50.67 64.9 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.175 -178.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 442' ' ' ARG . . . . . 0.634 ' HD2' ' O ' ' B' ' 438' ' ' ALA . 0.0 OUTLIER -76.33 -23.52 54.25 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 175.141 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 443' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 45.9 mt -63.79 -35.89 82.08 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 173.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -56.82 -35.76 69.17 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.378 172.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -73.21 -27.98 61.92 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.794 178.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 446' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' B' ' 443' ' ' LEU . 33.8 tt0 33.17 89.63 0.01 OUTLIER 'General case' 0 C--N 1.351 0.668 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 170.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 71.1 mt -59.51 -35.52 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 121.552 0.691 . . . . 0.0 109.18 175.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 448' ' ' ASP . . . . . 0.498 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 28.6 m-20 -166.72 175.65 7.71 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 177.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 449' ' ' ASP . . . . . 0.646 ' O ' ' HG2' ' B' ' 452' ' ' ARG . 13.6 m-20 -62.88 -60.08 3.97 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.394 -0.522 . . . . 0.0 109.61 174.658 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 450' ' ' GLN . . . . . 0.447 ' O ' ' HB3' ' B' ' 453' ' ' ALA . 2.6 pp0? -71.9 -28.6 63.6 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 178.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 451' ' ' THR . . . . . 0.498 ' OG1' ' HB2' ' B' ' 448' ' ' ASP . 9.8 m -72.99 -23.38 60.64 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 119.621 -0.832 . . . . 0.0 111.39 -174.327 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 452' ' ' ARG . . . . . 0.646 ' HG2' ' O ' ' B' ' 449' ' ' ASP . 6.0 ptp180 -64.73 -41.62 95.81 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 174.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 453' ' ' ALA . . . . . 0.569 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -59.06 -49.17 78.92 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 123.751 0.657 . . . . 0.0 112.395 168.514 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 454' ' ' GLU . . . . . 0.432 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 33.5 mm-40 -53.77 -34.19 58.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.493 -177.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 30.0 p -115.04 15.36 17.19 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.255 -178.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 456' ' ' PHE . . . . . 0.567 ' CZ ' ' HB2' ' B' ' 423' ' ' SER . 1.0 OUTLIER -56.83 -47.64 79.86 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.833 -171.726 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 457' ' ' ILE . . . . . 0.563 HG23 ' HB1' ' B' ' 405' ' ' ALA . 1.9 mp -76.31 -33.47 23.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.224 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -57.83 -33.95 69.18 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 122.072 0.939 . . . . 0.0 108.999 171.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 459' ' ' HIS . . . . . 0.747 ' O ' HG23 ' B' ' 463' ' ' VAL . 44.4 m-70 -74.64 -29.25 61.2 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.136 -1.393 . . . . 0.0 110.964 177.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 460' ' ' LEU . . . . . 0.704 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -73.98 -34.64 64.29 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.882 0.849 . . . . 0.0 108.817 179.117 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 461' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 -73.13 -37.61 66.59 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.11 176.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 462' ' ' ALA . . . . . 0.61 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -55.91 -34.98 66.07 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.351 -1.295 . . . . 0.0 109.62 169.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 463' ' ' VAL . . . . . 0.857 HG13 ' HB3' ' B' ' 438' ' ' ALA . 72.6 t -61.68 -51.21 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-N 114.656 -1.157 . . . . 0.0 108.227 177.054 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 464' ' ' TYR . . . . . 0.57 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 15.8 m-30 -52.8 -28.41 22.41 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 124.347 1.03 . . . . 0.0 110.532 178.062 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.07 -38.9 20.22 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.765 0.793 . . . . 0.0 109.674 -177.155 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 466' ' ' ILE . . . . . 0.61 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.7 mt -58.48 -55.85 20.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 114.419 -1.264 . . . . 0.0 112.181 175.134 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 467' ' ' LEU . . . . . 0.763 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -102.49 -10.72 19.12 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -172.235 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 468' ' ' GLY . . . . . 0.65 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 94.05 31.57 8.01 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 119.38 -1.391 . . . . 0.0 114.312 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 469' ' ' LEU . . . . . 0.763 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.1 mt -88.82 161.33 16.79 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 117.729 0.765 . . . . 0.0 110.883 175.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 470' ' ' ASN . . . . . 0.484 HD22 HG23 ' B' ' 476' ' ' ILE . 12.1 p30 -106.47 -177.06 3.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.014 170.298 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 471' ' ' ALA . . . . . 0.444 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -62.13 -19.66 63.26 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -173.254 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -88.0 2.48 51.67 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 122.06 -0.4 . . . . 0.0 111.775 -173.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 473' ' ' GLY . . . . . 0.483 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 76.52 11.67 84.99 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.33 -0.938 . . . . 0.0 111.035 -175.502 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -101.39 157.02 17.1 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 176.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 8.6 p -93.86 133.53 37.18 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.116 0.484 . . . . 0.0 111.387 -176.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 476' ' ' ILE . . . . . 0.65 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.5 pp -97.32 -3.92 9.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.431 0.634 . . . . 0.0 109.888 177.288 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 477' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -71.17 -38.81 72.14 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.056 176.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 478' ' ' LEU . . . . . . . . . . . . . 86.5 mt 55.83 62.62 2.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.449 0.642 . . . . 0.0 110.633 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 479' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 . . . . . 0 C--O 1.247 0.947 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.053 -179.86 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 . . . . . 0 N--CA 1.478 0.955 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 1.3 t -111.21 -43.22 3.76 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.637 172.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 29.4 m-70 -85.67 74.99 10.16 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.931 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -72.73 -77.67 0.56 Allowed Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 119.966 -1.111 . . . . 0.0 111.054 176.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 385' ' ' THR . . . . . 0.472 HG22 ' O ' ' A' ' 385' ' ' THR . 23.8 m -139.96 22.07 2.45 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 122.573 1.178 . . . . 0.0 108.871 172.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 386' ' ' PHE . . . . . 0.808 ' CE2' HG12 ' A' ' 394' ' ' VAL . 0.8 OUTLIER -139.45 123.78 11.19 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 114.746 -1.115 . . . . 0.0 108.842 -178.319 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 387' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 386' ' ' PHE . 26.3 Cg_endo -60.16 102.94 0.19 Allowed 'Trans proline' 0 CA--C 1.531 0.362 0 C-N-CA 123.779 2.986 . . . . 0.0 113.516 177.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.689 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 47.2 mtt -105.98 163.88 12.4 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.27 176.443 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 389' ' ' HIS . . . . . 0.544 ' CE1' ' HA ' ' A' ' 393' ' ' ASN . 17.5 m170 -74.1 39.68 0.12 Allowed 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 390' ' ' GLN . . . . . 0.533 ' O ' ' HG2' ' A' ' 390' ' ' GLN . 64.8 tt0 71.53 16.64 5.86 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.099 0.559 . . . . 0.0 110.673 -171.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.577 HD23 ' H ' ' A' ' 392' ' ' GLY . 2.0 pt? -163.41 -59.5 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 177.508 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 392' ' ' GLY . . . . . 0.772 ' HA3' HD13 ' A' ' 395' ' ' ILE . . . -171.99 67.98 0.12 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 119.714 -1.231 . . . . 0.0 113.988 -173.26 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 393' ' ' ASN . . . . . 0.689 ' HB3' ' HA ' ' A' ' 388' ' ' MET . 0.2 OUTLIER -62.22 -41.14 98.12 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 174.712 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.808 HG12 ' CE2' ' A' ' 386' ' ' PHE . 0.9 OUTLIER -55.57 -47.26 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 178.95 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.772 HD13 ' HA3' ' A' ' 392' ' ' GLY . 3.6 mp -57.07 -52.08 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 CA-C-O 117.762 -1.113 . . . . 0.0 113.64 -175.401 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 396' ' ' LYS . . . . . 0.602 ' O ' HG22 ' A' ' 399' ' ' VAL . 0.1 OUTLIER -60.62 -51.09 70.9 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 121.873 2.124 . . . . 0.0 112.821 -175.245 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.93 -42.72 70.76 Favored Glycine 0 N--CA 1.438 -1.18 0 C-N-CA 119.554 -1.308 . . . . 0.0 110.894 -174.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 398' ' ' ILE . . . . . 0.942 HD13 HD12 ' A' ' 410' ' ' LEU . 39.4 mt -71.78 -34.29 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 CA-C-N 114.009 -1.095 . . . . 0.0 113.641 -178.688 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 399' ' ' VAL . . . . . 0.602 HG22 ' O ' ' A' ' 396' ' ' LYS . 16.0 m -62.91 -39.56 85.53 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 C-N-CA 118.881 -1.128 . . . . 0.0 108.649 -174.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -69.96 -38.2 76.03 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 175.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.443 HE21 ' HB3' ' A' ' 401' ' ' GLN . 2.5 mm100 -90.19 -48.81 6.93 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -170.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 402' ' ' GLU . . . . . 0.662 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 1.3 mm-40 -116.12 -19.15 10.4 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.106 -170.715 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 104.51 161.0 24.14 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.579 178.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 404' ' ' VAL . . . . . 0.673 HG11 ' HA ' ' A' ' 430' ' ' LEU . 1.5 m -53.42 -45.26 57.29 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.967 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -176.685 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 405' ' ' ALA . . . . . 0.586 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -62.93 -31.23 72.27 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 119.995 -0.682 . . . . 0.0 112.606 -178.03 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.685 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 87.9 m -76.96 -43.14 36.3 Favored 'General case' 0 C--O 1.222 -0.364 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.201 173.366 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.486 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -58.69 -37.22 75.61 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 122.191 0.996 . . . . 0.0 109.297 176.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 408' ' ' TYR . . . . . 0.673 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -66.11 -51.91 53.55 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 113.414 -1.721 . . . . 0.0 109.659 176.568 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 409' ' ' THR . . . . . 0.64 HG22 HD23 ' A' ' 410' ' ' LEU . 13.3 m -54.44 -47.11 73.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.451 178.33 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 410' ' ' LEU . . . . . 0.942 HD12 HD13 ' A' ' 398' ' ' ILE . 14.4 mt -71.57 -37.47 71.06 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 120.944 0.402 . . . . 0.0 109.92 -175.345 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.33 -34.57 75.02 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.017 -1.087 . . . . 0.0 110.53 173.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 412' ' ' MET . . . . . 0.412 ' HB2' ' O ' ' A' ' 409' ' ' THR . 0.4 OUTLIER -67.28 -44.4 79.4 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 115.412 -0.394 . . . . 0.0 111.454 177.836 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 413' ' ' MET . . . . . 0.754 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.0 OUTLIER -70.85 -55.45 8.45 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 118.371 -1.332 . . . . 0.0 111.736 179.187 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 414' ' ' LEU . . . . . 0.754 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 3.9 mt -63.62 -44.51 93.71 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -171.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 46.8 t -86.42 -21.05 27.33 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.71 0.767 . . . . 0.0 109.906 -176.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 416' ' ' GLY . . . . . 0.422 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 107.37 -176.26 20.85 Favored Glycine 0 N--CA 1.431 -1.667 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -170.186 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -79.72 24.71 0.37 Allowed 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.4 0.619 . . . . 0.0 111.479 -172.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 418' ' ' ASN . . . . . 0.422 ' H ' ' C ' ' A' ' 416' ' ' GLY . 13.7 m120 -70.83 75.28 0.62 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.856 -178.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 419' ' ' TYR . . . . . 0.518 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 12.1 p90 -50.56 -38.84 47.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.173 175.536 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -54.71 -47.82 73.24 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 123.292 0.37 . . . . 0.0 110.816 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.69 -49.12 64.36 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.419 -177.243 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 422' ' ' VAL . . . . . 0.423 ' HB ' ' CD1' ' A' ' 408' ' ' TYR . 0.2 OUTLIER -65.64 -39.5 85.16 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.552 -176.934 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.763 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 78.6 p -68.75 -36.32 78.22 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.564 -0.454 . . . . 0.0 109.868 -178.088 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -70.32 -38.75 71.05 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.946 175.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 425' ' ' ILE . . . . . 0.554 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -71.74 -51.68 30.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 O-C-N 122.852 -0.205 . . . . 0.0 110.857 -178.195 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 426' ' ' ILE . . . . . 0.714 HG22 HD22 ' A' ' 430' ' ' LEU . 1.1 mm -74.05 -23.44 18.75 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.827 0 C-N-CA 122.407 0.283 . . . . 0.0 110.405 -173.23 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.763 ' HB2' ' O ' ' A' ' 423' ' ' SER . 1.0 OUTLIER -54.77 -31.84 59.21 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.034 0.445 . . . . 0.0 111.496 -177.536 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -85.16 -14.84 68.19 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.228 -0.987 . . . . 0.0 110.859 178.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.6 ' HD1' HG22 ' A' ' 395' ' ' ILE . 5.1 m-30 -111.0 0.2 16.9 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.689 0.757 . . . . 0.0 109.031 -171.566 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.714 HD22 HG22 ' A' ' 426' ' ' ILE . 0.1 OUTLIER -65.48 129.1 94.29 Favored Pre-proline 0 N--CA 1.442 -0.866 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.74 177.576 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 431' ' ' PRO . . . . . 0.495 ' HD2' HD12 ' A' ' 430' ' ' LEU . 81.3 Cg_exo -23.59 -71.19 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.941 1 C-N-CA 125.539 4.159 . . . . 0.0 114.76 179.841 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 432' ' ' GLY . . . . . 0.554 ' O ' HG12 ' A' ' 435' ' ' VAL . . . -138.22 -171.93 12.36 Favored Glycine 0 N--CA 1.441 -1.031 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 176.206 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 433' ' ' GLN . . . . . 0.475 ' O ' HG13 ' A' ' 436' ' ' VAL . 51.3 tp60 -67.46 -25.56 65.95 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 118.106 0.953 . . . . 0.0 110.13 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -63.84 -43.41 96.23 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 435' ' ' VAL . . . . . 0.66 HG23 HG11 ' A' ' 463' ' ' VAL . 8.3 p -69.27 -41.93 81.26 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 CA-C-O 121.082 0.467 . . . . 0.0 110.641 -176.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.485 HG12 ' O ' ' A' ' 432' ' ' GLY . 0.1 OUTLIER -67.14 -30.19 48.57 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.082 174.832 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 437' ' ' THR . . . . . 0.488 ' O ' ' HG2' ' A' ' 441' ' ' GLN . 1.1 m -66.71 -53.95 28.13 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.126 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 438' ' ' ALA . . . . . 0.849 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -59.46 -34.59 72.73 Favored 'General case' 0 N--CA 1.434 -1.237 0 O-C-N 124.116 0.885 . . . . 0.0 111.227 178.201 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 439' ' ' LEU . . . . . 0.926 HD23 ' NH2' ' A' ' 442' ' ' ARG . 0.3 OUTLIER -67.11 -50.74 60.46 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.223 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -61.46 -33.89 74.51 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.44 -1.254 . . . . 0.0 111.032 175.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 441' ' ' GLN . . . . . 0.507 ' HB2' ' HA ' ' A' ' 438' ' ' ALA . 7.0 mm100 -55.01 -50.09 69.9 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.68 -175.02 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 442' ' ' ARG . . . . . 0.926 ' NH2' HD23 ' A' ' 439' ' ' LEU . 0.0 OUTLIER -78.08 -25.54 47.68 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 119.511 -0.875 . . . . 0.0 112.687 175.847 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 443' ' ' LEU . . . . . 0.775 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 67.3 mt -67.81 -26.62 66.16 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.7 178.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -64.82 -38.52 91.24 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.842 0.829 . . . . 0.0 109.976 173.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -77.24 -26.56 52.7 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.424 -1.262 . . . . 0.0 111.373 179.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 29.43 101.8 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 175.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 51.7 mt -60.07 -35.14 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 121.45 0.643 . . . . 0.0 110.434 -179.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 448' ' ' ASP . . . . . 0.464 ' HB2' ' OG1' ' A' ' 451' ' ' THR . 31.8 m-20 -164.77 -162.42 0.64 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -177.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -81.44 -72.05 0.45 Allowed 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 171.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -64.0 -25.14 67.99 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 178.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 451' ' ' THR . . . . . 0.464 ' OG1' ' HB2' ' A' ' 448' ' ' ASP . 8.9 m -71.03 -22.98 62.07 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.998 -174.159 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 452' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 452' ' ' ARG . 17.8 mtp180 -53.41 -54.16 40.88 Favored 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 171.343 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 453' ' ' ALA . . . . . 0.518 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -59.71 -49.61 77.05 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 114.395 -1.275 . . . . 0.0 113.095 175.183 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 454' ' ' GLU . . . . . 0.459 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 20.8 mm-40 -49.23 -38.34 26.24 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.341 0.591 . . . . 0.0 111.849 -176.298 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 26.1 p -120.11 16.55 12.42 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.818 -175.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 456' ' ' PHE . . . . . 0.502 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.8 OUTLIER -54.64 -46.8 74.0 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.688 -172.063 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 457' ' ' ILE . . . . . 0.586 HG23 ' HB1' ' A' ' 405' ' ' ALA . 1.9 mp -78.67 -35.22 18.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.64 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -57.23 -36.43 70.91 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 121.841 0.829 . . . . 0.0 109.192 172.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 459' ' ' HIS . . . . . 0.761 ' HB3' ' CZ ' ' A' ' 442' ' ' ARG . 78.9 m-70 -75.2 -30.43 60.63 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.528 177.291 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 460' ' ' LEU . . . . . 0.744 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.6 OUTLIER -67.49 -34.52 77.32 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 179.421 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 461' ' ' ASN . . . . . 0.464 ' O ' ' HB2' ' A' ' 464' ' ' TYR . 17.3 m-80 -72.95 -37.49 67.11 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.347 -1.297 . . . . 0.0 109.04 176.503 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 462' ' ' ALA . . . . . 0.603 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -56.63 -32.19 65.08 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.146 169.329 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.849 HG13 ' HB3' ' A' ' 438' ' ' ALA . 51.3 t -64.88 -49.91 77.65 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.798 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 176.031 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 464' ' ' TYR . . . . . 0.602 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 19.5 m-30 -51.48 -28.98 14.81 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 124.511 1.132 . . . . 0.0 110.454 176.282 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.84 -38.36 19.59 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.602 0.715 . . . . 0.0 109.7 -176.394 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.603 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.7 mt -58.11 -55.48 21.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.149 174.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.752 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -101.35 -10.85 19.9 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 -172.317 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 468' ' ' GLY . . . . . 0.583 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 94.13 31.58 7.97 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 119.538 -1.315 . . . . 0.0 114.287 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 469' ' ' LEU . . . . . 0.752 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.1 mt -89.45 164.02 15.01 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 117.801 0.8 . . . . 0.0 110.911 175.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 43.0 p30 -105.0 -179.19 3.87 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.267 172.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 471' ' ' ALA . . . . . 0.467 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -59.62 -23.47 63.02 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -177.228 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -87.43 3.11 48.46 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.157 -173.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 473' ' ' GLY . . . . . 0.448 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 75.45 15.43 81.22 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.393 -0.908 . . . . 0.0 110.973 -176.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -100.95 150.17 23.15 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 178.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 4.4 p -89.61 117.07 28.22 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.286 0.565 . . . . 0.0 111.557 -178.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 476' ' ' ILE . . . . . 0.583 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.8 pp -85.92 1.63 5.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.722 0.772 . . . . 0.0 110.231 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 -62.39 -34.48 76.8 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.243 173.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 478' ' ' LEU . . . . . 0.437 HD23 ' N ' ' A' ' 478' ' ' LEU . 1.8 pt? -141.62 114.3 8.42 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.041 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.286 -0.864 . . . . 0.0 109.802 179.672 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 381' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 . . . . . 0 N--CA 1.48 1.05 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 382' ' ' THR . . . . . . . . . . . . . 1.3 t -111.37 -43.17 3.74 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.685 172.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 383' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -85.66 75.0 10.17 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.828 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 384' ' ' GLY . . . . . . . . . . . . . . . -72.74 -77.63 0.57 Allowed Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.004 -1.093 . . . . 0.0 111.115 176.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 385' ' ' THR . . . . . 0.476 HG22 ' O ' ' B' ' 385' ' ' THR . 24.6 m -140.39 22.61 2.36 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 122.575 1.179 . . . . 0.0 108.874 172.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 386' ' ' PHE . . . . . 0.812 ' CE2' HG12 ' B' ' 394' ' ' VAL . 0.8 OUTLIER -140.1 123.45 10.41 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.773 -178.227 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 387' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' B' ' 386' ' ' PHE . 26.7 Cg_endo -59.92 103.05 0.19 Allowed 'Trans proline' 0 N--CA 1.473 0.312 0 C-N-CA 123.787 2.992 . . . . 0.0 113.473 177.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 388' ' ' MET . . . . . 0.672 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 47.1 mtt -106.04 164.0 12.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.227 176.378 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 389' ' ' HIS . . . . . 0.534 ' CE1' ' HA ' ' B' ' 393' ' ' ASN . 17.3 m170 -74.17 39.86 0.12 Allowed 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 179.068 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 390' ' ' GLN . . . . . 0.525 ' O ' ' HG2' ' B' ' 390' ' ' GLN . 64.6 tt0 71.59 15.98 5.92 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.03 0.532 . . . . 0.0 110.65 -172.189 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 391' ' ' LEU . . . . . 0.569 HD23 ' H ' ' B' ' 392' ' ' GLY . 2.0 pt? -163.05 -59.5 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 177.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 392' ' ' GLY . . . . . 0.773 ' HA3' HD13 ' B' ' 395' ' ' ILE . . . -171.91 68.0 0.13 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 119.729 -1.224 . . . . 0.0 114.028 -173.352 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 393' ' ' ASN . . . . . 0.672 ' HB3' ' HA ' ' B' ' 388' ' ' MET . 0.2 OUTLIER -62.11 -41.2 97.99 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 174.649 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 394' ' ' VAL . . . . . 0.812 HG12 ' CE2' ' B' ' 386' ' ' PHE . 0.9 OUTLIER -55.51 -47.38 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 178.867 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 395' ' ' ILE . . . . . 0.773 HD13 ' HA3' ' B' ' 392' ' ' GLY . 3.6 mp -57.07 -52.01 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 CA-C-O 117.783 -1.103 . . . . 0.0 113.615 -175.453 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 396' ' ' LYS . . . . . 0.6 ' O ' HG22 ' B' ' 399' ' ' VAL . 0.1 OUTLIER -60.65 -51.06 70.98 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 122.049 2.204 . . . . 0.0 112.798 -175.197 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.84 -42.99 70.43 Favored Glycine 0 N--CA 1.438 -1.185 0 C-N-CA 119.595 -1.288 . . . . 0.0 110.927 -174.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 398' ' ' ILE . . . . . 0.961 HD13 HD12 ' B' ' 410' ' ' LEU . 39.1 mt -71.74 -34.19 51.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-N 114.074 -1.063 . . . . 0.0 113.668 -178.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 399' ' ' VAL . . . . . 0.6 HG22 ' O ' ' B' ' 396' ' ' LYS . 15.9 m -62.76 -39.72 85.9 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 C-N-CA 118.837 -1.145 . . . . 0.0 108.617 -174.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -70.07 -38.3 75.72 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 175.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 401' ' ' GLN . . . . . 0.433 HE21 ' HB3' ' B' ' 401' ' ' GLN . 2.4 mm100 -89.94 -48.79 6.99 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -170.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 402' ' ' GLU . . . . . 0.617 ' HG3' ' HE3' ' A' ' 413' ' ' MET . 1.3 mm-40 -116.23 -19.09 10.36 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.257 -170.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 104.73 160.86 23.92 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.622 178.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 404' ' ' VAL . . . . . 0.667 HG11 ' HA ' ' B' ' 430' ' ' LEU . 1.5 m -53.26 -45.17 55.22 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.954 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -176.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 405' ' ' ALA . . . . . 0.561 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -62.89 -31.36 72.39 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 119.994 -0.683 . . . . 0.0 112.655 -178.171 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 406' ' ' THR . . . . . 0.675 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 86.4 m -77.06 -42.83 36.78 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.232 173.417 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 407' ' ' ALA . . . . . 0.49 ' HB2' ' HB ' ' B' ' 398' ' ' ILE . . . -58.86 -37.12 75.8 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 122.227 1.013 . . . . 0.0 109.281 176.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 408' ' ' TYR . . . . . 0.666 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -66.28 -51.68 55.02 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 113.343 -1.753 . . . . 0.0 109.779 176.588 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 409' ' ' THR . . . . . 0.633 HG22 HD23 ' B' ' 410' ' ' LEU . 13.1 m -54.44 -47.26 73.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.377 178.222 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 410' ' ' LEU . . . . . 0.961 HD12 HD13 ' B' ' 398' ' ' ILE . 14.5 mt -71.59 -37.44 70.98 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 120.92 0.391 . . . . 0.0 109.989 -175.348 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.39 -34.54 75.35 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.031 -1.08 . . . . 0.0 110.499 173.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 412' ' ' MET . . . . . 0.418 ' HB2' ' O ' ' B' ' 409' ' ' THR . 0.4 OUTLIER -67.18 -44.46 79.65 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 115.434 -0.383 . . . . 0.0 111.535 177.771 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 413' ' ' MET . . . . . 0.751 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.0 OUTLIER -70.86 -55.34 8.7 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 118.316 -1.354 . . . . 0.0 111.714 179.187 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 414' ' ' LEU . . . . . 0.751 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 3.9 mt -63.79 -44.43 93.4 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -171.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 46.5 t -86.45 -20.89 27.46 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.749 0.785 . . . . 0.0 109.943 -176.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 416' ' ' GLY . . . . . 0.424 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 107.18 -176.24 20.97 Favored Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -170.223 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -79.72 24.82 0.37 Allowed 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.21 0.529 . . . . 0.0 111.461 -172.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 418' ' ' ASN . . . . . 0.424 ' H ' ' C ' ' B' ' 416' ' ' GLY . 13.7 m120 -71.09 75.49 0.67 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.814 -178.572 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 419' ' ' TYR . . . . . 0.531 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 12.4 p90 -50.56 -38.82 47.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.195 175.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -54.77 -47.56 73.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.932 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.78 -49.22 63.59 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.45 -177.407 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 422' ' ' VAL . . . . . 0.427 ' HB ' ' CD1' ' B' ' 408' ' ' TYR . 0.2 OUTLIER -65.55 -39.5 85.26 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.494 -176.903 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 423' ' ' SER . . . . . 0.763 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 78.0 p -68.78 -36.38 78.23 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -178.016 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -70.43 -38.44 69.84 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.961 176.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 425' ' ' ILE . . . . . 0.564 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -71.94 -51.85 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-O 120.327 0.108 . . . . 0.0 110.799 -178.207 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 426' ' ' ILE . . . . . 0.709 HG22 HD22 ' B' ' 430' ' ' LEU . 1.1 mm -73.95 -23.42 18.87 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.828 0 C-N-CA 122.37 0.268 . . . . 0.0 110.491 -173.171 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 427' ' ' ARG . . . . . 0.763 ' HB2' ' O ' ' B' ' 423' ' ' SER . 1.0 OUTLIER -54.75 -31.95 59.23 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.045 0.45 . . . . 0.0 111.449 -177.607 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -84.99 -15.11 67.98 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.15 -1.024 . . . . 0.0 110.817 178.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 429' ' ' TYR . . . . . 0.607 ' HD1' HG22 ' B' ' 395' ' ' ILE . 5.1 m-30 -110.62 -0.13 17.35 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -171.505 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 430' ' ' LEU . . . . . 0.72 HD23 ' HA ' ' B' ' 427' ' ' ARG . 0.1 OUTLIER -65.26 129.16 94.35 Favored Pre-proline 0 N--CA 1.441 -0.886 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.821 177.61 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 431' ' ' PRO . . . . . 0.493 ' HD2' HD12 ' B' ' 430' ' ' LEU . 78.8 Cg_exo -23.48 -70.94 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 1.003 1 C-N-CA 125.646 4.23 . . . . 0.0 114.814 179.844 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 432' ' ' GLY . . . . . 0.554 ' O ' HG12 ' B' ' 435' ' ' VAL . . . -138.82 -172.17 12.46 Favored Glycine 0 N--CA 1.441 -0.99 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 176.098 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 433' ' ' GLN . . . . . 0.475 ' O ' HG13 ' B' ' 436' ' ' VAL . 50.2 tp60 -67.11 -25.55 66.26 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 118.136 0.968 . . . . 0.0 110.291 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -63.99 -43.22 96.34 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 435' ' ' VAL . . . . . 0.659 HG23 HG11 ' B' ' 463' ' ' VAL . 8.3 p -69.26 -41.87 81.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-O 120.947 0.403 . . . . 0.0 110.7 -176.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 436' ' ' VAL . . . . . 0.49 HG12 ' O ' ' B' ' 432' ' ' GLY . 0.1 OUTLIER -67.29 -30.19 48.35 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.049 174.937 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 437' ' ' THR . . . . . 0.468 ' O ' ' HG2' ' B' ' 441' ' ' GLN . 1.1 m -66.81 -53.86 28.51 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -179.163 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 438' ' ' ALA . . . . . 0.861 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -59.37 -34.65 72.66 Favored 'General case' 0 N--CA 1.434 -1.227 0 O-C-N 124.071 0.857 . . . . 0.0 111.261 178.137 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 439' ' ' LEU . . . . . 0.923 HD23 ' NH2' ' B' ' 442' ' ' ARG . 0.3 OUTLIER -67.12 -50.72 60.43 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.206 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -61.41 -33.98 74.61 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 114.463 -1.244 . . . . 0.0 111.037 175.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 441' ' ' GLN . . . . . 0.507 ' HB2' ' HA ' ' B' ' 438' ' ' ALA . 6.9 mm100 -54.97 -50.16 69.63 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.772 -175.007 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 442' ' ' ARG . . . . . 0.923 ' NH2' HD23 ' B' ' 439' ' ' LEU . 0.0 OUTLIER -77.97 -25.62 48.25 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 119.558 -0.857 . . . . 0.0 112.654 175.785 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 443' ' ' LEU . . . . . 0.766 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 67.3 mt -67.89 -26.4 65.99 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 120.383 -0.527 . . . . 0.0 109.593 178.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -65.06 -38.48 90.95 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.072 173.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -76.95 -27.09 54.7 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.339 -1.3 . . . . 0.0 111.33 179.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 446' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 30.08 101.95 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 175.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 52.0 mt -60.51 -34.88 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 121.359 0.599 . . . . 0.0 110.467 -179.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 448' ' ' ASP . . . . . 0.455 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 32.3 m-20 -164.91 -162.39 0.63 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -178.26 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -81.54 -71.76 0.46 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 171.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 450' ' ' GLN . . . . . 0.418 ' HG3' ' H ' ' B' ' 450' ' ' GLN . 1.9 pp0? -64.27 -25.05 67.88 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 178.212 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 451' ' ' THR . . . . . 0.456 ' HA ' ' HB2' ' B' ' 454' ' ' GLU . 9.7 m -71.03 -23.17 62.1 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.046 -174.14 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 452' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' B' ' 452' ' ' ARG . 17.8 mtp180 -53.25 -54.28 38.51 Favored 'General case' 0 C--O 1.221 -0.401 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 171.336 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 453' ' ' ALA . . . . . 0.531 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -59.67 -49.33 78.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.393 -1.276 . . . . 0.0 113.11 175.138 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 454' ' ' GLU . . . . . 0.456 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 22.0 mm-40 -49.38 -38.34 28.27 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.299 0.571 . . . . 0.0 111.909 -176.428 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 25.6 p -120.24 16.57 12.32 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.818 -175.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 456' ' ' PHE . . . . . 0.493 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 0.8 OUTLIER -54.48 -46.9 73.49 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.656 -172.127 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 457' ' ' ILE . . . . . 0.561 HG23 ' HB1' ' B' ' 405' ' ' ALA . 1.9 mp -78.64 -35.42 18.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.565 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -57.03 -36.52 70.55 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.884 0.849 . . . . 0.0 109.278 172.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 459' ' ' HIS . . . . . 0.769 ' HB3' ' CZ ' ' B' ' 442' ' ' ARG . 78.7 m-70 -75.21 -30.37 60.59 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.515 177.294 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 460' ' ' LEU . . . . . 0.751 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.6 OUTLIER -67.47 -34.46 77.22 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.364 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 461' ' ' ASN . . . . . 0.455 ' O ' ' HB2' ' B' ' 464' ' ' TYR . 16.9 m-80 -73.03 -37.6 66.84 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.499 -1.228 . . . . 0.0 109.069 176.539 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 462' ' ' ALA . . . . . 0.595 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -56.49 -32.42 65.01 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.628 -1.169 . . . . 0.0 109.957 169.328 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 463' ' ' VAL . . . . . 0.861 HG13 ' HB3' ' B' ' 438' ' ' ALA . 50.9 t -64.8 -49.86 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 176.187 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 464' ' ' TYR . . . . . 0.59 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 19.6 m-30 -51.63 -28.58 14.79 Favored 'General case' 0 C--N 1.333 -0.13 0 O-C-N 124.442 1.089 . . . . 0.0 110.432 176.358 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.04 -38.57 19.02 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.662 0.744 . . . . 0.0 109.813 -176.492 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 466' ' ' ILE . . . . . 0.595 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.7 mt -57.92 -55.31 22.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 114.374 -1.284 . . . . 0.0 112.215 174.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 467' ' ' LEU . . . . . 0.749 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -101.43 -10.94 19.75 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -172.383 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 468' ' ' GLY . . . . . 0.587 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 94.29 31.15 8.16 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 119.424 -1.369 . . . . 0.0 114.378 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 469' ' ' LEU . . . . . 0.749 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.0 mt -89.36 164.25 14.97 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 117.847 0.823 . . . . 0.0 110.921 175.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 42.6 p30 -105.12 -179.34 3.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.297 172.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 471' ' ' ALA . . . . . 0.465 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -59.01 -23.82 62.27 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -177.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -87.47 3.34 47.65 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.1 -173.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 473' ' ' GLY . . . . . 0.452 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 74.88 15.82 80.74 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.348 -0.929 . . . . 0.0 111.087 -176.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -100.98 150.23 23.1 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 178.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 4.6 p -89.76 117.07 28.33 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.067 0.46 . . . . 0.0 111.459 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 476' ' ' ILE . . . . . 0.587 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.8 pp -85.76 1.1 5.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.232 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 477' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -61.94 -34.49 76.19 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.155 173.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 478' ' ' LEU . . . . . 0.435 ' O ' ' HG ' ' B' ' 478' ' ' LEU . 1.8 pt? -141.88 114.22 8.26 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.188 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 479' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.488 -0.767 . . . . 0.0 109.863 179.908 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 381' ' ' ARG . . . . . 0.441 ' HG3' ' H ' ' A' ' 382' ' ' THR . 23.2 ptt180 . . . . . 0 N--CA 1.483 1.193 0 N-CA-C 111.371 0.137 . . . . 0.0 111.371 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 382' ' ' THR . . . . . 0.529 ' O ' ' HE3' ' A' ' 388' ' ' MET . 0.0 OUTLIER -176.25 -47.34 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -176.772 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 383' ' ' HIS . . . . . 0.468 ' HB2' ' O ' ' A' ' 386' ' ' PHE . 48.9 p-80 -155.04 157.21 37.24 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.379 -0.529 . . . . 0.0 111.858 -173.314 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -121.31 -80.89 0.59 Allowed Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.563 174.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 21.5 m -76.48 -57.9 3.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.792 0.329 . . . . 0.0 111.224 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 386' ' ' PHE . . . . . 0.748 ' CD1' HD22 ' A' ' 414' ' ' LEU . 2.1 t80 -69.94 129.01 91.35 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.08 -64.1 0.23 Allowed 'Trans proline' 0 N--CA 1.484 0.935 0 C-N-CA 124.361 3.374 . . . . 0.0 113.908 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.639 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 4.5 ttp 63.36 41.94 7.25 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 171.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 389' ' ' HIS . . . . . 0.625 ' CD2' ' HB2' ' A' ' 393' ' ' ASN . 33.0 m170 50.24 -107.34 0.27 Allowed 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 121.236 0.541 . . . . 0.0 109.757 -174.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -140.17 18.33 2.43 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 172.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.511 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.5 pt? -165.57 -54.54 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.709 -172.544 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 392' ' ' GLY . . . . . 0.673 ' HA3' HD13 ' A' ' 395' ' ' ILE . . . -171.5 58.49 0.17 Allowed Glycine 0 C--N 1.335 0.491 0 C-N-CA 119.667 -1.254 . . . . 0.0 114.438 -174.04 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 393' ' ' ASN . . . . . 0.639 ' HB3' ' HA ' ' A' ' 388' ' ' MET . 0.2 OUTLIER -59.5 -40.19 86.23 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 117.748 0.774 . . . . 0.0 109.746 174.695 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.742 HG23 HD12 ' A' ' 398' ' ' ILE . 1.8 m -56.13 -47.46 80.53 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.598 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 178.395 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.673 HD13 ' HA3' ' A' ' 392' ' ' GLY . 3.6 mp -57.56 -52.75 53.3 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.358 0 CA-C-O 117.86 -1.066 . . . . 0.0 113.662 -174.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 396' ' ' LYS . . . . . 0.585 ' O ' HG22 ' A' ' 399' ' ' VAL . 0.0 OUTLIER -63.25 -49.61 73.43 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 121.968 2.167 . . . . 0.0 112.054 -175.131 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -52.99 -44.47 62.03 Favored Glycine 0 N--CA 1.431 -1.658 0 CA-C-N 114.706 -1.133 . . . . 0.0 110.726 -176.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 398' ' ' ILE . . . . . 0.854 HD13 HD12 ' A' ' 410' ' ' LEU . 38.0 mt -71.51 -33.13 48.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 399' ' ' VAL . . . . . 0.585 HG22 ' O ' ' A' ' 396' ' ' LYS . 15.7 m -63.26 -39.85 86.81 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 C-N-CA 118.624 -1.23 . . . . 0.0 108.114 -175.45 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -69.63 -35.74 75.5 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 174.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 44.7 mm-40 -89.42 -48.06 7.59 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -172.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 402' ' ' GLU . . . . . 0.518 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 2.4 mm-40 -120.85 -20.36 6.98 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.358 -170.503 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 106.74 161.74 22.14 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.607 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 404' ' ' VAL . . . . . 0.669 HG11 ' HA ' ' A' ' 430' ' ' LEU . 1.4 m -53.7 -45.66 61.09 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.87 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -175.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 405' ' ' ALA . . . . . 0.569 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -62.35 -32.62 73.43 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 119.92 -0.712 . . . . 0.0 112.527 -177.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.686 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 92.1 m -77.54 -41.26 39.68 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.534 174.148 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.444 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.7 -36.44 74.26 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 122.121 0.962 . . . . 0.0 109.081 175.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 408' ' ' TYR . . . . . 0.608 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -66.19 -52.19 50.49 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 113.569 -1.65 . . . . 0.0 109.841 175.961 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 409' ' ' THR . . . . . 0.634 HG22 HD23 ' A' ' 410' ' ' LEU . 18.0 m -54.69 -47.64 73.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.494 178.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 410' ' ' LEU . . . . . 0.854 HD12 HD13 ' A' ' 398' ' ' ILE . 14.5 mt -72.46 -36.46 68.5 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.895 -174.643 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.71 -34.56 77.61 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 119.901 -1.142 . . . . 0.0 110.457 173.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 412' ' ' MET . . . . . 0.439 ' HB2' ' O ' ' A' ' 409' ' ' THR . 0.5 OUTLIER -67.04 -48.94 66.79 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 115.712 -0.244 . . . . 0.0 111.441 177.595 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 413' ' ' MET . . . . . 0.933 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 1.0 OUTLIER -72.0 -43.51 64.97 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.096 -1.041 . . . . 0.0 112.15 -178.75 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 414' ' ' LEU . . . . . 0.933 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 14.5 mt -69.81 -45.7 67.32 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -176.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 33.0 t -87.45 -23.44 24.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.52 0.676 . . . . 0.0 110.139 -176.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 416' ' ' GLY . . . . . 0.401 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 108.92 -175.96 19.57 Favored Glycine 0 N--CA 1.429 -1.784 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -170.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 32.4 mm-40 -80.56 23.22 0.52 Allowed 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.312 0.577 . . . . 0.0 111.322 -171.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 418' ' ' ASN . . . . . 0.401 ' H ' ' C ' ' A' ' 416' ' ' GLY . 3.4 m-20 -72.24 75.48 0.98 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.685 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 419' ' ' TYR . . . . . 0.619 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 11.2 p90 -55.48 -38.11 68.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.163 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -54.73 -44.15 73.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.823 0.344 . . . . 0.0 110.913 178.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.9 -49.36 62.38 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.283 -177.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 422' ' ' VAL . . . . . 0.47 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.1 OUTLIER -64.84 -40.94 90.78 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.691 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.068 -177.659 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.788 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 16.0 t -69.46 -36.06 76.23 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 120.326 -0.55 . . . . 0.0 109.635 -176.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -70.4 -37.05 69.92 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.989 176.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 425' ' ' ILE . . . . . 0.573 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -71.6 -50.65 38.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.502 0.191 . . . . 0.0 110.558 -179.716 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 426' ' ' ILE . . . . . 0.706 HG22 HD22 ' A' ' 430' ' ' LEU . 1.2 mm -73.68 -23.72 19.46 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.979 0 CA-C-O 120.833 0.349 . . . . 0.0 110.2 -173.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.788 ' HB2' ' O ' ' A' ' 423' ' ' SER . 1.5 tmm_? -55.04 -32.35 61.8 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.26 0.552 . . . . 0.0 111.127 -177.247 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.68 -9.54 71.61 Favored Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 120.412 -0.899 . . . . 0.0 111.041 178.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.591 ' HD1' HG22 ' A' ' 395' ' ' ILE . 7.4 m-30 -114.0 -0.26 14.13 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -175.286 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.706 HD22 HG22 ' A' ' 426' ' ' ILE . 0.0 OUTLIER -66.34 129.04 94.16 Favored Pre-proline 0 N--CA 1.444 -0.773 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.784 177.92 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 431' ' ' PRO . . . . . 0.568 ' HD2' HD12 ' A' ' 430' ' ' LEU . 87.5 Cg_exo -23.45 -73.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.356 0.974 1 C-N-CA 125.62 4.213 . . . . 0.0 114.909 179.901 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 432' ' ' GLY . . . . . 0.548 ' O ' HG12 ' A' ' 435' ' ' VAL . . . -137.99 -170.02 11.76 Favored Glycine 0 N--CA 1.439 -1.105 0 N-CA-C 110.311 -1.115 . . . . 0.0 110.311 176.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 433' ' ' GLN . . . . . 0.443 ' O ' HG13 ' A' ' 436' ' ' VAL . 22.6 tp60 -65.89 -27.42 68.19 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 117.929 0.865 . . . . 0.0 110.315 -178.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -66.41 -40.59 89.69 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -177.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 435' ' ' VAL . . . . . 0.647 HG23 HG11 ' A' ' 463' ' ' VAL . 8.5 p -70.22 -43.48 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.09 0 CA-C-O 120.942 0.401 . . . . 0.0 110.655 -177.247 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.471 HG12 ' O ' ' A' ' 432' ' ' GLY . 0.1 OUTLIER -66.29 -30.6 50.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.12 175.044 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 437' ' ' THR . . . . . 0.529 ' O ' ' HG2' ' A' ' 441' ' ' GLN . 1.0 OUTLIER -67.89 -53.19 28.48 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -179.212 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 438' ' ' ALA . . . . . 0.84 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -59.44 -35.17 73.52 Favored 'General case' 0 N--CA 1.437 -1.091 0 O-C-N 123.924 0.765 . . . . 0.0 111.349 178.326 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 439' ' ' LEU . . . . . 0.91 HD23 ' NH2' ' A' ' 442' ' ' ARG . 0.4 OUTLIER -67.14 -50.75 60.19 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 -179.257 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 2.6 tp60 -61.44 -34.16 74.96 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.231 -1.349 . . . . 0.0 111.294 175.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 441' ' ' GLN . . . . . 0.529 ' HG2' ' O ' ' A' ' 437' ' ' THR . 7.4 mm100 -54.65 -49.65 70.06 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.047 -176.028 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 442' ' ' ARG . . . . . 0.91 ' NH2' HD23 ' A' ' 439' ' ' LEU . 0.0 OUTLIER -78.26 -25.65 46.87 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.484 -0.886 . . . . 0.0 112.648 175.72 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 443' ' ' LEU . . . . . 0.751 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 67.6 mt -67.51 -26.38 66.31 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.197 0.522 . . . . 0.0 109.618 178.425 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -64.6 -38.16 90.05 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.969 173.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -76.31 -26.66 56.04 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.43 -1.259 . . . . 0.0 111.102 178.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 28.53 99.05 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 O-C-N 124.702 1.251 . . . . 0.0 114.373 175.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 50.1 mt -59.0 -34.56 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 121.545 0.688 . . . . 0.0 110.579 -179.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -163.29 -161.2 0.66 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 -177.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -82.13 -70.83 0.52 Allowed 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 167.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 450' ' ' GLN . . . . . 0.41 ' O ' ' HG2' ' A' ' 454' ' ' GLU . 2.0 pp0? -64.7 -26.38 68.35 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -179.375 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 451' ' ' THR . . . . . 0.427 ' HA ' ' HB2' ' A' ' 454' ' ' GLU . 9.0 m -71.2 -23.18 61.98 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.982 -174.608 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 452' ' ' ARG . . . . . 0.43 ' NH2' ' HB3' ' A' ' 443' ' ' LEU . 19.3 mtp180 -53.19 -54.55 34.35 Favored 'General case' 0 C--O 1.222 -0.381 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 171.544 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 453' ' ' ALA . . . . . 0.619 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -60.34 -48.75 80.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.203 -1.362 . . . . 0.0 113.028 175.479 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 454' ' ' GLU . . . . . 0.427 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 78.6 mm-40 -49.1 -38.3 24.2 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.34 0.59 . . . . 0.0 111.723 -175.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 28.3 p -120.57 16.41 12.03 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.291 -176.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 456' ' ' PHE . . . . . 0.495 ' CE2' ' HB2' ' A' ' 419' ' ' TYR . 0.8 OUTLIER -53.66 -47.88 69.95 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.648 -172.042 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 457' ' ' ILE . . . . . 0.569 HG23 ' HB1' ' A' ' 405' ' ' ALA . 1.9 mp -77.59 -35.2 21.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.712 -179.299 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -56.93 -36.13 69.87 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 121.969 0.89 . . . . 0.0 109.055 172.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 459' ' ' HIS . . . . . 0.754 ' HB3' ' CZ ' ' A' ' 442' ' ' ARG . 81.3 m-70 -75.62 -30.4 59.51 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.405 -1.27 . . . . 0.0 110.743 177.396 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 460' ' ' LEU . . . . . 0.743 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.6 OUTLIER -67.84 -34.71 77.24 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.749 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 461' ' ' ASN . . . . . 0.47 ' O ' ' HB2' ' A' ' 464' ' ' TYR . 24.4 m-80 -72.95 -37.3 67.17 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.344 -1.298 . . . . 0.0 108.889 177.098 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 462' ' ' ALA . . . . . 0.562 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -56.98 -32.49 66.13 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.429 -1.26 . . . . 0.0 110.238 168.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.84 HG13 ' HB3' ' A' ' 438' ' ' ALA . 49.4 t -64.12 -49.77 79.92 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 176.061 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 464' ' ' TYR . . . . . 0.602 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 18.8 m-30 -51.99 -28.21 16.12 Favored 'General case' 0 C--N 1.333 -0.137 0 O-C-N 124.435 1.084 . . . . 0.0 110.403 176.084 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.94 -40.5 18.45 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.611 0.72 . . . . 0.0 109.616 -177.344 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.562 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.7 mt -57.33 -54.76 26.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 114.481 -1.236 . . . . 0.0 112.174 176.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.763 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -101.49 -10.85 19.78 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -172.966 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 468' ' ' GLY . . . . . 0.601 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 94.07 31.18 8.23 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 119.586 -1.292 . . . . 0.0 114.425 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 469' ' ' LEU . . . . . 0.763 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.7 mt -89.08 165.43 14.52 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 117.79 0.795 . . . . 0.0 110.932 176.146 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 37.2 p30 -105.49 -177.82 3.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.9 171.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 471' ' ' ALA . . . . . 0.58 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -66.05 -15.5 63.11 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -176.501 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 -88.02 -1.84 58.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.709 0.29 . . . . 0.0 111.023 -175.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 473' ' ' GLY . . . . . 0.458 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 79.32 12.99 83.29 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.224 -0.989 . . . . 0.0 111.032 -175.344 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -101.17 151.82 21.38 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 176.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 475' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 469' ' ' LEU . 27.5 t -89.73 134.96 33.9 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.155 0.502 . . . . 0.0 110.536 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 476' ' ' ILE . . . . . 0.601 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.6 pp -105.69 -41.89 6.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.2 -176.31 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 477' ' ' ARG . . . . . 0.591 ' N ' HD12 ' A' ' 476' ' ' ILE . 22.3 mmm180 41.87 57.2 3.23 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 123.756 0.66 . . . . 0.0 111.422 178.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 478' ' ' LEU . . . . . 0.423 ' H ' HD12 ' A' ' 476' ' ' ILE . 2.6 tm? -163.37 126.82 2.75 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -175.431 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.877 -0.583 . . . . 0.0 109.78 178.998 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 381' ' ' ARG . . . . . 0.436 ' HG3' ' H ' ' B' ' 382' ' ' THR . 23.7 ptt180 . . . . . 0 N--CA 1.483 1.178 0 CA-C-O 120.361 0.124 . . . . 0.0 111.262 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 382' ' ' THR . . . . . 0.547 ' O ' ' HE3' ' B' ' 388' ' ' MET . 0.0 OUTLIER -176.41 -47.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -176.964 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 383' ' ' HIS . . . . . 0.469 ' HB2' ' O ' ' B' ' 386' ' ' PHE . 49.1 p-80 -155.32 157.14 36.71 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.9 -173.313 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 384' ' ' GLY . . . . . . . . . . . . . . . -121.16 -80.85 0.6 Allowed Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.585 174.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 385' ' ' THR . . . . . . . . . . . . . 19.7 m -76.34 -57.94 3.57 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.618 0.247 . . . . 0.0 111.159 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 386' ' ' PHE . . . . . 0.757 ' CD1' HD22 ' B' ' 414' ' ' LEU . 2.1 t80 -70.1 129.03 91.12 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 387' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -51.04 -64.05 0.23 Allowed 'Trans proline' 0 N--CA 1.482 0.836 0 C-N-CA 124.355 3.37 . . . . 0.0 114.014 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 388' ' ' MET . . . . . 0.639 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 4.5 ttp 63.39 41.83 7.29 Favored 'General case' 0 CA--C 1.549 0.941 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 171.579 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 389' ' ' HIS . . . . . 0.62 ' CD2' ' HB2' ' B' ' 393' ' ' ASN . 33.0 m170 50.39 -107.34 0.27 Allowed 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 121.113 0.482 . . . . 0.0 109.794 -174.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -140.25 18.49 2.42 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 172.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 391' ' ' LEU . . . . . 0.518 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.5 pt? -165.62 -54.69 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.668 -172.487 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 392' ' ' GLY . . . . . 0.671 ' HA3' HD13 ' B' ' 395' ' ' ILE . . . -171.46 58.63 0.17 Allowed Glycine 0 CA--C 1.523 0.552 0 C-N-CA 119.755 -1.212 . . . . 0.0 114.452 -173.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 393' ' ' ASN . . . . . 0.639 ' HB3' ' HA ' ' B' ' 388' ' ' MET . 0.2 OUTLIER -59.67 -40.18 86.94 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 117.658 0.729 . . . . 0.0 109.665 174.722 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 394' ' ' VAL . . . . . 0.719 HG23 HD12 ' B' ' 398' ' ' ILE . 1.8 m -56.15 -47.48 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 178.371 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 395' ' ' ILE . . . . . 0.671 HD13 ' HA3' ' B' ' 392' ' ' GLY . 3.7 mp -57.68 -52.72 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 CA-C-O 117.846 -1.073 . . . . 0.0 113.738 -174.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 396' ' ' LYS . . . . . 0.587 ' O ' HG22 ' B' ' 399' ' ' VAL . 0.0 OUTLIER -63.07 -49.7 73.51 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 122.117 2.235 . . . . 0.0 111.967 -175.3 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -52.94 -44.53 61.78 Favored Glycine 0 N--CA 1.432 -1.621 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.696 -175.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 398' ' ' ILE . . . . . 0.851 HD13 HD12 ' B' ' 410' ' ' LEU . 38.8 mt -71.45 -33.28 49.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -179.28 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 399' ' ' VAL . . . . . 0.587 HG22 ' O ' ' B' ' 396' ' ' LYS . 15.6 m -63.35 -39.58 85.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 C-N-CA 118.583 -1.247 . . . . 0.0 108.111 -175.262 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -69.8 -35.83 75.17 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 174.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 401' ' ' GLN . . . . . . . . . . . . . 43.8 mm-40 -89.21 -48.01 7.68 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -172.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 402' ' ' GLU . . . . . 0.465 ' HB3' ' HB ' ' B' ' 406' ' ' THR . 2.4 mm-40 -121.09 -20.31 6.85 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.46 -170.474 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 106.99 161.78 21.91 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.658 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 404' ' ' VAL . . . . . 0.664 HG11 ' HA ' ' B' ' 430' ' ' LEU . 1.4 m -53.67 -45.55 60.65 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -175.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 405' ' ' ALA . . . . . 0.547 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -62.58 -32.36 73.33 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 119.866 -0.734 . . . . 0.0 112.43 -177.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 406' ' ' THR . . . . . 0.678 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 93.7 m -77.72 -41.34 38.17 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.039 -0.664 . . . . 0.0 110.498 174.075 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 407' ' ' ALA . . . . . 0.44 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.69 -36.37 74.1 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 122.122 0.963 . . . . 0.0 109.135 175.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 408' ' ' TYR . . . . . 0.601 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -66.16 -52.18 50.69 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 113.581 -1.645 . . . . 0.0 109.866 175.905 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 409' ' ' THR . . . . . 0.63 HG22 HD23 ' B' ' 410' ' ' LEU . 17.9 m -54.74 -47.59 73.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.467 178.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 410' ' ' LEU . . . . . 0.851 HD12 HD13 ' B' ' 398' ' ' ILE . 14.6 mt -72.51 -36.48 68.37 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -174.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.57 -34.61 76.87 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 119.891 -1.147 . . . . 0.0 110.481 173.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 412' ' ' MET . . . . . 0.436 ' HB2' ' O ' ' B' ' 409' ' ' THR . 0.5 OUTLIER -67.03 -49.15 66.15 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 115.645 -0.277 . . . . 0.0 111.361 177.665 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 413' ' ' MET . . . . . 0.945 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 1.0 OUTLIER -71.84 -43.64 65.19 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.02 -1.072 . . . . 0.0 112.033 -178.63 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 414' ' ' LEU . . . . . 0.945 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 14.4 mt -69.63 -45.91 67.4 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -176.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 33.4 t -87.27 -23.44 24.69 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.625 0.726 . . . . 0.0 110.12 -175.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 416' ' ' GLY . . . . . . . . . . . . . . . 109.0 -175.81 19.43 Favored Glycine 0 N--CA 1.43 -1.714 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -170.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 33.0 mm-40 -80.48 23.05 0.53 Allowed 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.205 0.526 . . . . 0.0 111.419 -172.095 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 418' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -72.19 75.54 0.97 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.684 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 419' ' ' TYR . . . . . 0.612 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 10.7 p90 -55.64 -38.04 69.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.204 -179.431 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -54.91 -43.96 73.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.845 0.355 . . . . 0.0 110.8 178.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.97 -49.34 62.24 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.328 -177.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 422' ' ' VAL . . . . . 0.468 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.1 OUTLIER -64.9 -40.97 90.85 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.105 -177.682 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 423' ' ' SER . . . . . 0.777 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 15.0 t -69.54 -35.84 75.83 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 120.297 -0.561 . . . . 0.0 109.569 -176.552 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -70.39 -37.19 70.04 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.964 176.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 425' ' ' ILE . . . . . 0.59 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -71.57 -50.57 38.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.655 0.264 . . . . 0.0 110.59 -179.728 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 426' ' ' ILE . . . . . 0.701 HG22 HD22 ' B' ' 430' ' ' LEU . 1.2 mm -73.81 -23.73 19.28 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.042 0 CA-C-O 120.887 0.375 . . . . 0.0 110.163 -173.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 427' ' ' ARG . . . . . 0.777 ' HB2' ' O ' ' B' ' 423' ' ' SER . 1.5 tmm_? -55.03 -32.52 61.92 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.28 0.562 . . . . 0.0 111.134 -177.308 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.5 -9.44 72.31 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.152 178.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 429' ' ' TYR . . . . . 0.598 ' HD1' HG22 ' B' ' 395' ' ' ILE . 7.5 m-30 -113.98 -0.52 14.06 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -175.322 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 430' ' ' LEU . . . . . 0.708 HD23 ' HA ' ' B' ' 427' ' ' ARG . 0.0 OUTLIER -66.13 129.26 94.21 Favored Pre-proline 0 N--CA 1.444 -0.772 0 CA-C-N 114.532 -1.213 . . . . 0.0 108.782 178.039 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 431' ' ' PRO . . . . . 0.561 ' HD2' HD12 ' B' ' 430' ' ' LEU . 84.3 Cg_exo -23.4 -74.1 0.02 OUTLIER 'Trans proline' 0 C--N 1.356 0.936 1 C-N-CA 125.698 4.265 . . . . 0.0 114.93 179.708 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 432' ' ' GLY . . . . . 0.541 ' O ' HG12 ' B' ' 435' ' ' VAL . . . -137.57 -170.26 11.84 Favored Glycine 0 N--CA 1.441 -0.978 0 N-CA-C 110.301 -1.119 . . . . 0.0 110.301 176.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 433' ' ' GLN . . . . . 0.449 ' O ' HG13 ' B' ' 436' ' ' VAL . 22.7 tp60 -65.77 -27.51 68.34 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 117.865 0.832 . . . . 0.0 110.266 -179.118 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -66.3 -40.94 90.32 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.209 -177.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 435' ' ' VAL . . . . . 0.642 HG23 HG11 ' B' ' 463' ' ' VAL . 8.6 p -70.01 -43.32 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-O 120.94 0.4 . . . . 0.0 110.693 -177.2 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 436' ' ' VAL . . . . . 0.476 HG12 ' O ' ' B' ' 432' ' ' GLY . 0.1 OUTLIER -66.46 -30.53 50.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.049 175.139 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 437' ' ' THR . . . . . 0.513 ' O ' ' HG2' ' B' ' 441' ' ' GLN . 1.0 OUTLIER -67.89 -53.43 26.62 Favored 'General case' 0 C--O 1.204 -1.33 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -179.38 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 438' ' ' ALA . . . . . 0.858 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -59.27 -35.21 73.31 Favored 'General case' 0 N--CA 1.438 -1.049 0 O-C-N 123.869 0.731 . . . . 0.0 111.275 178.424 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 439' ' ' LEU . . . . . 0.891 HD23 ' NH2' ' B' ' 442' ' ' ARG . 0.4 OUTLIER -67.08 -50.8 60.45 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -179.286 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 2.6 tp60 -61.45 -34.11 74.88 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 114.354 -1.294 . . . . 0.0 111.252 175.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 441' ' ' GLN . . . . . 0.513 ' HG2' ' O ' ' B' ' 437' ' ' THR . 7.5 mm100 -54.74 -50.01 69.44 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.917 -176.015 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 442' ' ' ARG . . . . . 0.891 ' NH2' HD23 ' B' ' 439' ' ' LEU . 0.0 OUTLIER -77.86 -25.64 48.78 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 119.502 -0.879 . . . . 0.0 112.709 175.752 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 443' ' ' LEU . . . . . 0.749 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 68.2 mt -67.68 -26.21 66.08 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.482 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -64.88 -37.92 89.25 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.95 173.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -76.45 -26.79 55.79 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.444 -1.253 . . . . 0.0 111.043 178.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 446' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 28.6 99.0 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 176.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 50.8 mt -58.96 -34.38 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-O 121.427 0.632 . . . . 0.0 110.601 -179.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 448' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -163.51 -160.89 0.62 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -177.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -82.74 -70.64 0.54 Allowed 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 168.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 450' ' ' GLN . . . . . 0.426 ' HG3' ' H ' ' B' ' 450' ' ' GLN . 2.0 pp0? -64.61 -26.31 68.34 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 451' ' ' THR . . . . . 0.417 ' HA ' ' HB2' ' B' ' 454' ' ' GLU . 9.1 m -71.35 -23.19 61.87 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.901 -174.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 452' ' ' ARG . . . . . 0.43 ' NH2' ' HB3' ' B' ' 443' ' ' LEU . 19.4 mtp180 -53.29 -54.45 36.15 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 171.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 453' ' ' ALA . . . . . 0.612 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -60.27 -48.74 80.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.36 -1.291 . . . . 0.0 113.032 175.28 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 454' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' B' ' 450' ' ' GLN . 78.7 mm-40 -49.1 -38.57 25.16 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.158 0.504 . . . . 0.0 111.73 -175.618 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 28.4 p -120.58 16.49 12.03 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.163 -175.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 456' ' ' PHE . . . . . 0.499 ' CE2' ' HB2' ' B' ' 419' ' ' TYR . 0.9 OUTLIER -53.41 -48.12 68.98 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.6 -172.273 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 457' ' ' ILE . . . . . 0.547 HG23 ' HB1' ' B' ' 405' ' ' ALA . 1.9 mp -77.41 -35.2 21.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.77 -179.288 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -56.87 -36.12 69.69 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 122.059 0.933 . . . . 0.0 109.073 172.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 459' ' ' HIS . . . . . 0.767 ' HB3' ' CZ ' ' B' ' 442' ' ' ARG . 81.4 m-70 -75.59 -30.6 59.65 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.707 177.404 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 460' ' ' LEU . . . . . 0.748 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.6 OUTLIER -67.8 -34.62 77.12 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.843 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 461' ' ' ASN . . . . . 0.456 ' HA ' ' CD2' ' B' ' 464' ' ' TYR . 25.2 m-80 -72.86 -37.51 67.35 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.394 -1.275 . . . . 0.0 109.007 176.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 462' ' ' ALA . . . . . 0.569 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -56.77 -32.65 65.83 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.462 -1.245 . . . . 0.0 110.174 168.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 463' ' ' VAL . . . . . 0.858 HG13 ' HB3' ' B' ' 438' ' ' ALA . 50.2 t -63.93 -49.7 80.63 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.817 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 176.033 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 464' ' ' TYR . . . . . 0.586 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 18.7 m-30 -52.13 -28.23 17.11 Favored 'General case' 0 C--N 1.332 -0.159 0 O-C-N 124.432 1.082 . . . . 0.0 110.404 176.108 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.05 -40.1 18.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.525 0.679 . . . . 0.0 109.653 -177.228 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 466' ' ' ILE . . . . . 0.569 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.7 mt -57.49 -55.12 22.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 114.355 -1.293 . . . . 0.0 112.117 176.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 467' ' ' LEU . . . . . 0.769 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -101.36 -10.73 19.99 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -173.042 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 468' ' ' GLY . . . . . 0.588 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 94.01 31.28 8.2 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 119.412 -1.375 . . . . 0.0 114.343 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 469' ' ' LEU . . . . . 0.769 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.7 mt -89.26 165.08 14.65 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 117.899 0.85 . . . . 0.0 110.859 176.166 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 36.9 p30 -105.32 -177.75 3.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.817 171.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 471' ' ' ALA . . . . . 0.584 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -65.97 -15.66 63.2 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -176.493 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 -87.95 -1.74 58.18 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.081 -175.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 473' ' ' GLY . . . . . 0.448 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 79.01 13.06 83.46 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.333 -0.937 . . . . 0.0 110.963 -175.469 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -100.91 151.63 21.51 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 176.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 475' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' B' ' 469' ' ' LEU . 24.7 t -89.59 135.34 33.66 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.158 0.504 . . . . 0.0 110.299 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 476' ' ' ILE . . . . . 0.591 HD12 ' N ' ' B' ' 477' ' ' ARG . 2.6 pp -105.92 -42.12 6.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.18 -176.627 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 477' ' ' ARG . . . . . 0.591 ' N ' HD12 ' B' ' 476' ' ' ILE . 22.1 mmm180 41.92 56.88 3.35 Favored 'General case' 0 N--CA 1.466 0.325 0 O-C-N 123.844 0.715 . . . . 0.0 111.639 178.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 478' ' ' LEU . . . . . 0.421 ' H ' HD12 ' B' ' 476' ' ' ILE . 2.6 tm? -163.14 126.32 2.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.375 -175.138 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 479' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.643 -0.694 . . . . 0.0 109.755 179.205 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 386' ' ' PHE . . . . . 0.793 ' CZ ' HG12 ' A' ' 394' ' ' VAL . 3.4 t80 . . . . . 0 CA--C 1.531 0.239 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . 0.586 ' HG2' ' OD1' ' B' ' 393' ' ' ASN . 35.6 Cg_endo -66.88 64.14 0.59 Allowed 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 123.91 3.073 . . . . 0.0 113.562 176.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.806 ' SD ' HG13 ' A' ' 394' ' ' VAL . 5.2 tpp -68.15 164.79 19.59 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.868 176.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 389' ' ' HIS . . . . . 0.616 ' CE1' ' HA ' ' A' ' 393' ' ' ASN . 30.6 m170 -65.25 -160.77 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 172.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -71.34 1.48 6.15 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.196 170.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.586 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.1 pt? -155.23 -63.73 0.12 Allowed 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -177.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . 0.718 ' HA3' HD13 ' A' ' 395' ' ' ILE . . . -158.98 74.93 0.21 Allowed Glycine 0 CA--C 1.523 0.583 0 C-N-CA 120.055 -1.069 . . . . 0.0 114.203 -172.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . 0.616 ' HA ' ' CE1' ' A' ' 389' ' ' HIS . 0.0 OUTLIER -65.76 -42.01 91.38 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 177.696 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . 0.806 HG13 ' SD ' ' A' ' 388' ' ' MET . 0.6 OUTLIER -57.3 -46.23 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 179.754 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . 0.718 HD13 ' HA3' ' A' ' 392' ' ' GLY . 4.1 mp -57.43 -52.15 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 CA-C-O 117.743 -1.122 . . . . 0.0 113.301 -173.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . 0.594 ' O ' HG22 ' A' ' 399' ' ' VAL . 0.1 OUTLIER -62.14 -50.6 71.22 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-N 122.025 2.193 . . . . 0.0 112.198 -176.776 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.76 -44.65 70.14 Favored Glycine 0 N--CA 1.434 -1.463 0 C-N-CA 119.911 -1.138 . . . . 0.0 110.898 -175.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . 0.765 HG12 HD21 ' B' ' 414' ' ' LEU . 27.1 mt -71.22 -34.04 52.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . 0.594 HG22 ' O ' ' A' ' 396' ' ' LYS . 16.1 m -62.7 -40.0 86.86 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 C-N-CA 118.898 -1.121 . . . . 0.0 108.576 -174.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -71.25 -36.99 71.98 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 176.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.421 HE21 ' HB3' ' A' ' 401' ' ' GLN . 4.1 mm100 -88.61 -46.79 8.77 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -171.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . 0.583 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 2.5 mm-40 -120.35 -20.29 7.31 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.484 -171.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 106.58 162.04 22.34 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.922 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . 0.679 HG11 ' HA ' ' A' ' 430' ' ' LEU . 1.5 m -53.61 -45.25 59.53 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.81 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -175.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . 0.565 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -64.37 -30.82 71.86 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 119.784 -0.766 . . . . 0.0 112.489 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.716 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 85.2 m -76.96 -42.53 38.71 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.03 173.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.483 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.57 -36.96 74.78 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 122.141 0.972 . . . . 0.0 109.363 177.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 408' ' ' TYR . . . . . 0.624 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -66.2 -52.1 51.25 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 113.469 -1.696 . . . . 0.0 109.686 176.404 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 409' ' ' THR . . . . . 0.664 HG22 HD23 ' A' ' 410' ' ' LEU . 12.3 m -55.15 -47.46 75.08 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.541 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . 0.739 HD12 ' CD1' ' A' ' 398' ' ' ILE . 13.7 mt -72.25 -35.79 68.88 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.041 0.448 . . . . 0.0 109.983 -175.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.86 -34.72 79.37 Favored Glycine 0 N--CA 1.439 -1.13 0 C-N-CA 120.238 -0.982 . . . . 0.0 110.755 172.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -69.8 -48.01 60.74 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-O 120.532 0.206 . . . . 0.0 111.362 178.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 413' ' ' MET . . . . . 0.936 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.5 OUTLIER -70.56 -42.0 71.69 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 119.082 -1.047 . . . . 0.0 112.256 -178.289 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . 0.936 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 19.4 mt -75.25 -46.45 33.63 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -177.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 25.2 t -86.44 -16.87 35.81 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.757 0.789 . . . . 0.0 109.763 -173.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . 0.438 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 106.4 -178.26 22.5 Favored Glycine 0 N--CA 1.43 -1.702 0 N-CA-C 109.934 -1.267 . . . . 0.0 109.934 -171.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -79.76 24.19 0.4 Allowed 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.262 0.554 . . . . 0.0 111.001 -174.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 418' ' ' ASN . . . . . 0.438 ' H ' ' C ' ' A' ' 416' ' ' GLY . 3.8 m-20 -70.99 75.55 0.65 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.864 -177.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 419' ' ' TYR . . . . . 0.581 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 2.3 p90 -49.11 -40.1 30.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.763 176.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -55.39 -45.85 76.61 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.926 0.393 . . . . 0.0 111.007 178.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.74 -48.75 62.96 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.254 -176.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . 0.444 ' HB ' ' CD1' ' A' ' 408' ' ' TYR . 0.1 OUTLIER -66.14 -41.36 89.26 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.515 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.126 -175.737 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.815 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 76.9 p -66.95 -39.45 87.29 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.906 -178.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.0 -38.91 93.08 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.442 -0.885 . . . . 0.0 111.883 176.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . 0.601 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.94 -52.9 20.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.308 0.099 . . . . 0.0 111.232 -176.956 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . 0.7 HG22 HD22 ' A' ' 430' ' ' LEU . 1.1 mm -74.18 -23.6 18.65 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.758 0 O-C-N 122.199 -0.313 . . . . 0.0 110.21 -171.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.815 ' HB2' ' O ' ' A' ' 423' ' ' SER . 2.3 tmm_? -55.4 -31.5 61.88 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.266 0.555 . . . . 0.0 111.022 -177.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -85.37 -12.3 73.33 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.168 178.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.63 ' HD1' HG22 ' A' ' 395' ' ' ILE . 7.5 m-30 -113.15 -0.08 14.77 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.588 0.709 . . . . 0.0 109.297 -173.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.746 HD23 ' HA ' ' A' ' 427' ' ' ARG . 0.1 OUTLIER -65.97 129.69 94.3 Favored Pre-proline 0 N--CA 1.446 -0.631 0 CA-C-N 114.476 -1.238 . . . . 0.0 109.268 178.159 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 431' ' ' PRO . . . . . 0.544 ' HD2' HD12 ' A' ' 430' ' ' LEU . 95.4 Cg_exo -24.05 -60.46 0.05 OUTLIER 'Trans proline' 0 C--N 1.359 1.099 1 C-N-CA 125.709 4.273 . . . . 0.0 115.012 179.736 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . 0.566 ' H ' HG12 ' A' ' 435' ' ' VAL . . . -152.68 -170.6 19.26 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 177.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . 0.493 ' O ' HG13 ' A' ' 436' ' ' VAL . 17.2 tp60 -66.76 -26.63 67.07 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 118.026 0.913 . . . . 0.0 110.402 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -65.88 -43.27 88.81 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -177.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 435' ' ' VAL . . . . . 0.726 HG23 HG11 ' A' ' 463' ' ' VAL . 7.5 p -67.32 -42.19 87.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-O 121.082 0.467 . . . . 0.0 110.409 -177.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.515 HG12 ' O ' ' A' ' 432' ' ' GLY . 0.1 OUTLIER -68.08 -30.66 48.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.83 175.643 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.88 -51.84 43.37 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . 0.867 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -58.02 -38.92 77.08 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.929 177.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 439' ' ' LEU . . . . . 0.551 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 1.9 tm? -69.94 -46.96 64.18 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.1 -39.17 74.51 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.109 174.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 441' ' ' GLN . . . . . 0.536 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 8.4 mm-40 -54.46 -49.65 69.57 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 123.776 0.83 . . . . 0.0 110.747 174.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . 0.818 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 0.9 OUTLIER -56.29 -39.92 73.47 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.729 172.294 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 443' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 46.9 mt -71.64 -33.02 68.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.268 0.556 . . . . 0.0 110.062 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -60.55 -37.77 82.31 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.502 174.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -73.02 -28.69 62.5 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.584 177.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 446' ' ' GLU . . . . . 0.551 ' HB2' ' O ' ' A' ' 443' ' ' LEU . 42.0 tt0 31.41 97.06 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.247 1.202 . . . . 0.0 114.247 172.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 49.3 mt -66.34 -36.05 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 121.294 0.569 . . . . 0.0 110.402 178.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . 0.642 ' O ' ' HG3' ' A' ' 452' ' ' ARG . 19.7 m-20 -166.05 -172.4 2.29 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 -179.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -77.58 -61.13 2.09 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.442 175.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.17 -26.1 64.68 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 176.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 451' ' ' THR . . . . . 0.509 ' OG1' ' HB2' ' A' ' 448' ' ' ASP . 18.3 m -71.73 -22.24 61.65 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.437 -175.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . 0.642 ' HG3' ' O ' ' A' ' 448' ' ' ASP . 13.5 mtp180 -52.97 -54.22 38.25 Favored 'General case' 0 C--O 1.218 -0.567 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 170.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 453' ' ' ALA . . . . . 0.581 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -56.99 -50.06 73.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.443 -1.253 . . . . 0.0 112.623 175.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . 0.43 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 40.7 mm-40 -51.41 -35.93 41.33 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.892 -177.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 28.3 p -118.48 16.07 13.79 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.283 -176.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . 0.593 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.9 OUTLIER -56.58 -47.73 78.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.06 0.457 . . . . 0.0 111.656 -171.33 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . 0.565 HG23 ' HB1' ' A' ' 405' ' ' ALA . 1.9 mp -77.32 -33.06 19.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.964 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -58.05 -35.18 70.97 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.889 0.852 . . . . 0.0 109.385 171.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . 0.713 ' O ' HG23 ' A' ' 463' ' ' VAL . 62.1 m-70 -73.81 -28.69 61.75 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.712 177.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . 0.735 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -73.85 -34.69 64.62 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.891 0.853 . . . . 0.0 108.968 178.869 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . 0.458 ' O ' ' HB2' ' A' ' 464' ' ' TYR . 22.4 m-80 -73.37 -37.3 66.06 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.922 0.868 . . . . 0.0 108.899 176.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 462' ' ' ALA . . . . . 0.635 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -56.54 -34.2 66.84 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.848 169.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.867 HG13 ' HB3' ' A' ' 438' ' ' ALA . 56.0 t -61.69 -50.16 81.37 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.796 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.051 175.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 464' ' ' TYR . . . . . 0.578 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 18.6 m-30 -53.1 -28.45 25.49 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.611 177.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.86 -40.35 22.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.842 0.829 . . . . 0.0 109.596 -178.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.635 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.4 mt -58.02 -55.23 23.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 114.196 -1.366 . . . . 0.0 112.308 177.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 0.755 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -102.26 -10.04 19.89 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -172.89 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . 0.515 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 93.42 31.9 8.08 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 119.173 -1.489 . . . . 0.0 113.932 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 469' ' ' LEU . . . . . 0.755 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.2 mt -89.56 162.84 15.46 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 117.78 0.79 . . . . 0.0 110.732 175.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . 0.479 ' HB3' ' CG2' ' A' ' 476' ' ' ILE . 39.0 p30 -102.64 -179.65 4.03 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.902 171.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 471' ' ' ALA . . . . . 0.566 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -61.04 -22.01 64.16 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -175.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 472' ' ' ARG . . . . . 0.459 ' HA ' ' O ' ' A' ' 402' ' ' GLU . 17.4 mmt180 -88.61 6.79 36.56 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.507 -171.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 473' ' ' GLY . . . . . 0.434 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 74.34 13.08 81.78 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.455 -0.879 . . . . 0.0 111.114 -177.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -100.6 152.71 20.1 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 24.0 p -91.03 126.79 36.22 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.297 0.57 . . . . 0.0 110.573 176.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 476' ' ' ILE . . . . . 0.515 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.7 pp . . . . . 0 C--N 1.315 -0.933 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.701 -179.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 386' ' ' PHE . . . . . 0.791 ' CZ ' HG12 ' B' ' 394' ' ' VAL . 3.5 t80 . . . . . 0 CA--C 1.53 0.184 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 387' ' ' PRO . . . . . 0.592 ' HG2' ' OD1' ' A' ' 393' ' ' ASN . 35.1 Cg_endo -66.83 63.89 0.58 Allowed 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.928 3.085 . . . . 0.0 113.628 177.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 388' ' ' MET . . . . . 0.815 ' SD ' HG13 ' B' ' 394' ' ' VAL . 5.2 tpp -68.05 164.53 19.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.888 176.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 389' ' ' HIS . . . . . 0.61 ' CE1' ' HA ' ' B' ' 393' ' ' ASN . 30.6 m170 -65.2 -160.49 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 172.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -71.59 1.43 6.62 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.241 170.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 391' ' ' LEU . . . . . 0.588 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.2 pt? -155.15 -64.14 0.12 Allowed 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -176.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 392' ' ' GLY . . . . . 0.715 ' HA3' HD13 ' B' ' 395' ' ' ILE . . . -158.55 74.94 0.21 Allowed Glycine 0 CA--C 1.524 0.635 0 C-N-CA 119.988 -1.101 . . . . 0.0 114.243 -172.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 393' ' ' ASN . . . . . 0.61 ' HA ' ' CE1' ' B' ' 389' ' ' HIS . 0.0 OUTLIER -65.74 -42.03 91.49 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 177.697 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 394' ' ' VAL . . . . . 0.815 HG13 ' SD ' ' B' ' 388' ' ' MET . 0.6 OUTLIER -57.27 -46.18 85.06 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 179.72 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 395' ' ' ILE . . . . . 0.715 HD13 ' HA3' ' B' ' 392' ' ' GLY . 4.1 mp -57.53 -52.06 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.575 0 CA-C-O 117.792 -1.099 . . . . 0.0 113.381 -173.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 396' ' ' LYS . . . . . 0.593 ' O ' HG22 ' B' ' 399' ' ' VAL . 0.1 OUTLIER -62.19 -50.67 70.88 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 122.021 2.191 . . . . 0.0 112.178 -176.838 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.7 -44.62 69.47 Favored Glycine 0 N--CA 1.435 -1.421 0 C-N-CA 119.904 -1.141 . . . . 0.0 110.848 -175.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 398' ' ' ILE . . . . . 0.763 HG12 HD21 ' A' ' 414' ' ' LEU . 27.0 mt -71.25 -34.08 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -178.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 399' ' ' VAL . . . . . 0.593 HG22 ' O ' ' B' ' 396' ' ' LYS . 16.1 m -62.58 -40.07 86.93 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 C-N-CA 118.778 -1.169 . . . . 0.0 108.594 -174.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -71.28 -36.76 71.82 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 176.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 401' ' ' GLN . . . . . 0.454 HE21 ' HB3' ' B' ' 401' ' ' GLN . 4.2 mm100 -88.73 -46.72 8.77 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -171.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 402' ' ' GLU . . . . . 0.57 ' HG3' ' HE3' ' A' ' 413' ' ' MET . 2.4 mm-40 -120.52 -20.11 7.27 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.504 -171.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 106.49 162.08 22.42 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.834 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 404' ' ' VAL . . . . . 0.669 HG11 ' HA ' ' B' ' 430' ' ' LEU . 1.5 m -53.66 -45.35 60.28 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.802 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -175.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 405' ' ' ALA . . . . . 0.565 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -64.28 -30.89 71.92 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.425 -177.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 406' ' ' THR . . . . . 0.694 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 87.6 m -76.93 -42.61 38.69 Favored 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 120.099 -0.64 . . . . 0.0 109.986 173.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 407' ' ' ALA . . . . . 0.468 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.56 -37.06 74.93 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 122.171 0.986 . . . . 0.0 109.434 176.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 408' ' ' TYR . . . . . 0.619 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -66.04 -52.08 52.35 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 113.452 -1.704 . . . . 0.0 109.682 176.395 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 409' ' ' THR . . . . . 0.659 HG22 HD23 ' B' ' 410' ' ' LEU . 10.1 m -55.35 -47.4 75.78 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.69 -0.687 . . . . 0.0 112.571 178.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 410' ' ' LEU . . . . . 0.751 HD12 HD13 ' B' ' 398' ' ' ILE . 13.7 mt -72.14 -35.93 69.23 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 120.992 0.425 . . . . 0.0 109.925 -175.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.77 -34.75 78.85 Favored Glycine 0 N--CA 1.438 -1.192 0 C-N-CA 120.236 -0.983 . . . . 0.0 110.779 172.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 412' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -69.85 -47.87 61.03 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-O 120.574 0.226 . . . . 0.0 111.346 178.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 413' ' ' MET . . . . . 0.932 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.5 OUTLIER -70.58 -42.11 71.49 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 119.035 -1.066 . . . . 0.0 112.211 -178.334 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 414' ' ' LEU . . . . . 0.932 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 19.4 mt -75.32 -46.34 33.96 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -176.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 415' ' ' SER . . . . . 0.432 ' HB2' ' HE1' ' B' ' 388' ' ' MET . 24.8 t -86.34 -16.99 35.71 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.806 0.812 . . . . 0.0 109.717 -173.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 416' ' ' GLY . . . . . 0.443 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 106.33 -178.26 22.55 Favored Glycine 0 N--CA 1.431 -1.662 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 -171.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 33.0 mm-40 -79.72 24.44 0.38 Allowed 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.151 0.5 . . . . 0.0 110.94 -174.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 418' ' ' ASN . . . . . 0.443 ' H ' ' C ' ' B' ' 416' ' ' GLY . 3.9 m-20 -71.19 75.87 0.7 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.807 -177.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 419' ' ' TYR . . . . . 0.585 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 2.2 p90 -49.27 -40.06 33.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.801 -1.09 . . . . 0.0 111.789 176.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -55.33 -46.12 76.37 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.774 0.321 . . . . 0.0 110.963 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.66 -48.81 63.01 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.172 -176.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 422' ' ' VAL . . . . . 0.445 ' HB ' ' CD1' ' B' ' 408' ' ' TYR . 0.1 OUTLIER -66.03 -41.4 89.59 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 C-N-CA 120.371 -0.531 . . . . 0.0 111.076 -175.898 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 423' ' ' SER . . . . . 0.806 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 76.3 p -66.89 -39.33 87.44 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.883 -178.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.08 -38.98 92.8 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.922 176.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 425' ' ' ILE . . . . . 0.616 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -73.05 -52.79 20.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.318 0.104 . . . . 0.0 111.161 -176.869 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 426' ' ' ILE . . . . . 0.691 HG22 HD22 ' B' ' 430' ' ' LEU . 1.1 mm -74.23 -23.55 18.55 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.863 0 O-C-N 122.185 -0.322 . . . . 0.0 110.164 -171.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 427' ' ' ARG . . . . . 0.806 ' HB2' ' O ' ' B' ' 423' ' ' SER . 2.3 tmm_? -55.58 -31.36 62.13 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.221 0.534 . . . . 0.0 110.928 -177.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -85.38 -12.27 73.4 Favored Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.429 -0.891 . . . . 0.0 111.11 178.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 429' ' ' TYR . . . . . 0.629 ' HD1' HG22 ' B' ' 395' ' ' ILE . 7.3 m-30 -113.26 0.27 14.81 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.558 0.694 . . . . 0.0 109.227 -173.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 430' ' ' LEU . . . . . 0.749 HD23 ' HA ' ' B' ' 427' ' ' ARG . 0.1 OUTLIER -66.27 129.71 94.21 Favored Pre-proline 0 N--CA 1.445 -0.696 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.23 178.101 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 431' ' ' PRO . . . . . 0.533 ' HD2' HD12 ' B' ' 430' ' ' LEU . 95.0 Cg_exo -24.06 -60.35 0.05 OUTLIER 'Trans proline' 0 C--N 1.36 1.148 1 C-N-CA 125.602 4.201 . . . . 0.0 115.094 179.747 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 432' ' ' GLY . . . . . 0.576 ' H ' HG12 ' B' ' 435' ' ' VAL . . . -153.18 -171.5 20.53 Favored Glycine 0 N--CA 1.443 -0.887 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 177.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 433' ' ' GLN . . . . . 0.505 ' O ' HG13 ' B' ' 436' ' ' VAL . 16.3 tp60 -66.09 -26.89 67.68 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 118.088 0.944 . . . . 0.0 110.368 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -65.44 -43.42 90.51 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -178.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 435' ' ' VAL . . . . . 0.716 HG23 HG11 ' B' ' 463' ' ' VAL . 7.6 p -67.32 -42.31 87.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 121.104 0.478 . . . . 0.0 110.423 -176.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 436' ' ' VAL . . . . . 0.505 HG13 ' O ' ' B' ' 433' ' ' GLN . 0.1 OUTLIER -68.02 -30.58 48.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.838 175.698 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.93 -51.9 42.4 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 438' ' ' ALA . . . . . 0.854 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -58.11 -38.65 76.86 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.916 177.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 439' ' ' LEU . . . . . 0.562 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 1.9 tm? -70.27 -46.93 63.38 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.03 -39.23 74.41 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.127 174.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 441' ' ' GLN . . . . . 0.531 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 8.3 mm-40 -54.24 -49.89 68.44 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 123.888 0.875 . . . . 0.0 110.795 174.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 442' ' ' ARG . . . . . 0.827 ' HG2' ' O ' ' B' ' 438' ' ' ALA . 0.9 OUTLIER -56.17 -39.86 73.03 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.65 172.364 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 443' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 47.1 mt -71.74 -32.85 68.16 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.217 0.532 . . . . 0.0 110.119 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -60.76 -37.61 82.4 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.463 174.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -73.28 -28.42 62.1 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.554 177.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 446' ' ' GLU . . . . . 0.552 ' HB2' ' O ' ' B' ' 443' ' ' LEU . 41.3 tt0 31.26 97.02 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 172.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 49.9 mt -66.7 -35.83 75.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.37 0.605 . . . . 0.0 110.343 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 448' ' ' ASP . . . . . 0.646 ' O ' ' HG3' ' B' ' 452' ' ' ARG . 17.5 m-20 -166.12 -172.62 2.34 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -77.51 -61.15 2.08 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.432 175.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.05 -26.14 64.82 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 176.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 451' ' ' THR . . . . . 0.506 ' OG1' ' HB2' ' B' ' 448' ' ' ASP . 18.6 m -71.72 -22.1 61.68 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.538 -175.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 452' ' ' ARG . . . . . 0.646 ' HG3' ' O ' ' B' ' 448' ' ' ASP . 13.4 mtp180 -53.07 -54.1 40.54 Favored 'General case' 0 C--O 1.218 -0.553 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 170.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 453' ' ' ALA . . . . . 0.585 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -57.09 -50.11 73.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.381 -1.281 . . . . 0.0 112.585 175.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 454' ' ' GLU . . . . . 0.425 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 45.5 mm-40 -51.4 -36.0 41.6 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.803 -177.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 27.2 p -118.36 16.1 13.89 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.264 -176.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 456' ' ' PHE . . . . . 0.602 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 0.9 OUTLIER -56.65 -47.76 79.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.076 0.465 . . . . 0.0 111.612 -171.178 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 457' ' ' ILE . . . . . 0.565 HG23 ' HB1' ' B' ' 405' ' ' ALA . 1.9 mp -77.16 -33.14 19.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.979 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -58.05 -35.14 70.9 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.88 0.848 . . . . 0.0 109.393 172.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 459' ' ' HIS . . . . . 0.714 ' O ' HG23 ' B' ' 463' ' ' VAL . 62.0 m-70 -73.83 -28.77 61.77 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.731 177.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 460' ' ' LEU . . . . . 0.738 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -73.89 -34.64 64.5 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.906 0.86 . . . . 0.0 108.994 178.881 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 461' ' ' ASN . . . . . 0.453 ' O ' ' HB2' ' B' ' 464' ' ' TYR . 21.7 m-80 -73.25 -37.28 66.39 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.877 0.846 . . . . 0.0 108.869 176.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 462' ' ' ALA . . . . . 0.643 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -56.61 -34.05 66.85 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.981 169.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 463' ' ' VAL . . . . . 0.854 HG13 ' HB3' ' B' ' 438' ' ' ALA . 55.9 t -61.71 -50.07 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-N 114.642 -1.163 . . . . 0.0 107.999 175.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 464' ' ' TYR . . . . . 0.568 ' CE2' ' HA ' ' B' ' 471' ' ' ALA . 18.5 m-30 -53.1 -28.34 24.88 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 114.678 -1.147 . . . . 0.0 110.633 177.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.11 -40.24 22.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.906 0.86 . . . . 0.0 109.62 -178.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 466' ' ' ILE . . . . . 0.643 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.4 mt -57.91 -55.35 22.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 114.209 -1.36 . . . . 0.0 112.235 176.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 467' ' ' LEU . . . . . 0.761 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -102.42 -10.0 19.79 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 114.474 1.286 . . . . 0.0 114.474 -172.821 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 468' ' ' GLY . . . . . 0.518 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 93.46 31.87 8.08 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 119.081 -1.533 . . . . 0.0 113.91 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 469' ' ' LEU . . . . . 0.761 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.2 mt -89.76 162.53 15.49 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 117.677 0.738 . . . . 0.0 110.795 175.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 470' ' ' ASN . . . . . 0.492 ' HB3' ' CG2' ' B' ' 476' ' ' ILE . 39.4 p30 -102.48 -179.54 4.01 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.889 171.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 471' ' ' ALA . . . . . 0.568 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -61.6 -21.64 64.52 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -175.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 472' ' ' ARG . . . . . 0.463 ' HA ' ' O ' ' B' ' 402' ' ' GLU . 17.2 mmt180 -88.67 6.74 37.01 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.431 -171.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 473' ' ' GLY . . . . . 0.431 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 74.5 12.8 82.21 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.145 -177.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -100.4 152.92 19.78 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 25.1 p -91.06 127.03 36.32 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.367 0.603 . . . . 0.0 110.522 176.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 476' ' ' ILE . . . . . 0.518 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.7 pp . . . . . 0 C--N 1.315 -0.894 0 CA-C-N 114.92 -1.037 . . . . 0.0 110.621 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 386' ' ' PHE . . . . . 0.715 ' CD1' HD22 ' A' ' 414' ' ' LEU . 1.4 t80 . . . . . 0 CA--C 1.537 0.462 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -49.27 -72.84 0.04 OUTLIER 'Trans proline' 0 N--CA 1.485 0.995 0 C-N-CA 124.309 3.339 . . . . 0.0 114.418 -178.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.612 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 38.9 ttm 74.36 49.36 0.11 Allowed 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 172.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 389' ' ' HIS . . . . . 0.703 ' CG ' ' HB2' ' A' ' 393' ' ' ASN . 40.7 m170 47.31 -99.44 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.25 0.62 . . . . 0.0 110.642 -175.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -146.36 15.71 1.3 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.469 -0.787 . . . . 0.0 108.884 174.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.489 HD23 ' H ' ' A' ' 392' ' ' GLY . 2.4 pt? -169.15 -50.97 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -168.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . 0.539 ' HA3' HD13 ' A' ' 395' ' ' ILE . . . -176.47 50.89 0.11 Allowed Glycine 0 C--N 1.335 0.495 0 C-N-CA 119.609 -1.282 . . . . 0.0 114.214 -172.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . 0.703 ' HB2' ' CG ' ' A' ' 389' ' ' HIS . 0.4 OUTLIER -54.21 -41.31 68.48 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 117.401 0.6 . . . . 0.0 109.679 176.761 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . 0.67 HG12 ' CE2' ' A' ' 386' ' ' PHE . 0.9 OUTLIER -56.85 -47.08 83.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 -179.249 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . 0.669 HG23 HD13 ' A' ' 426' ' ' ILE . 4.3 mp -57.87 -52.22 60.66 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 CA-C-O 117.938 -1.03 . . . . 0.0 113.307 -175.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . 0.704 ' HG3' ' CZ ' ' A' ' 429' ' ' TYR . 0.1 OUTLIER -62.98 -49.88 72.95 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 121.692 2.042 . . . . 0.0 112.069 -174.165 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . 0.538 ' O ' ' HG3' ' A' ' 401' ' ' GLN . . . -54.32 -44.67 76.02 Favored Glycine 0 N--CA 1.435 -1.387 0 C-N-CA 120.099 -1.048 . . . . 0.0 111.035 -177.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . 0.874 HD13 HD12 ' A' ' 410' ' ' LEU . 45.4 mt -71.6 -34.37 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -177.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . 0.528 HG12 ' HA ' ' A' ' 404' ' ' VAL . 5.4 m -64.09 -39.99 87.46 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 C-N-CA 118.738 -1.185 . . . . 0.0 108.408 -174.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -64.74 -41.24 96.08 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 174.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.538 ' HG3' ' O ' ' A' ' 397' ' ' GLY . 32.1 mt-30 -93.07 -48.39 6.52 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -169.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . 0.679 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 3.0 mm-40 -113.42 -20.11 11.44 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.448 -171.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 104.77 163.21 24.15 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.125 -0.559 . . . . 0.0 113.137 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . 0.655 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.5 m -53.43 -45.21 57.37 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.752 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 -176.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . 0.546 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -66.41 -30.87 71.34 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.994 -175.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.711 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 92.4 m -77.23 -42.35 37.68 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.241 173.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.51 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.21 -37.71 75.37 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 122.049 0.928 . . . . 0.0 109.215 176.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 408' ' ' TYR . . . . . 0.655 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.64 -52.39 52.15 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 113.593 -1.64 . . . . 0.0 109.961 177.115 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 409' ' ' THR . . . . . 0.734 HG22 HD23 ' A' ' 410' ' ' LEU . 2.7 m -56.22 -46.23 79.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.505 178.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . 0.874 HD12 HD13 ' A' ' 398' ' ' ILE . 13.4 mt -72.03 -36.74 69.75 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 -175.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.6 -34.66 77.25 Favored Glycine 0 N--CA 1.44 -1.094 0 C-N-CA 120.085 -1.055 . . . . 0.0 110.708 172.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 412' ' ' MET . . . . . 0.412 ' HB2' ' O ' ' A' ' 409' ' ' THR . 0.4 OUTLIER -67.19 -48.21 68.6 Favored 'General case' 0 C--O 1.221 -0.438 0 C-N-CA 122.129 0.172 . . . . 0.0 111.403 177.672 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 413' ' ' MET . . . . . 0.944 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.7 OUTLIER -71.52 -47.73 53.4 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 118.848 -1.141 . . . . 0.0 112.103 -179.935 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . 0.944 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 23.3 mt -67.43 -44.24 79.24 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -175.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 48.1 t -86.97 -23.76 24.96 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.503 0.668 . . . . 0.0 110.011 -177.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . 0.447 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 109.69 -175.62 18.84 Favored Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -170.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -79.65 24.3 0.38 Allowed 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.495 0.664 . . . . 0.0 111.291 -172.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 418' ' ' ASN . . . . . 0.447 ' H ' ' C ' ' A' ' 416' ' ' GLY . 79.6 m-20 -71.67 76.04 0.83 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.651 -178.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 419' ' ' TYR . . . . . 0.537 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 12.0 p90 -55.21 -39.0 69.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.537 178.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -55.71 -43.48 76.52 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.833 0.349 . . . . 0.0 111.166 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . 0.401 HD22 ' HB2' ' A' ' 418' ' ' ASN . 0.0 OUTLIER -68.22 -48.68 64.53 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.951 -177.621 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . 0.43 ' HB ' ' CD1' ' A' ' 408' ' ' TYR . 0.2 OUTLIER -66.36 -39.52 84.34 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.155 -177.277 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.746 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 68.4 p -66.84 -39.38 87.62 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.93 -39.2 89.41 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.199 176.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . 0.596 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.79 -51.75 25.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 121.176 -0.209 . . . . 0.0 111.114 -177.375 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . 0.681 HG22 HD22 ' A' ' 430' ' ' LEU . 1.2 mm -74.27 -22.88 18.14 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.625 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -172.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.746 ' HB2' ' O ' ' A' ' 423' ' ' SER . 0.7 OUTLIER -54.86 -31.45 59.65 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.25 0.548 . . . . 0.0 110.149 -179.728 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -85.31 -5.16 85.57 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.667 178.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.704 ' CZ ' ' HG3' ' A' ' 396' ' ' LYS . 24.9 m-85 -119.76 0.69 10.95 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 121.08 0.467 . . . . 0.0 110.666 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.726 HD23 ' HA ' ' A' ' 427' ' ' ARG . 0.1 OUTLIER -65.94 127.9 93.46 Favored Pre-proline 0 N--CA 1.438 -1.044 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.735 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 431' ' ' PRO . . . . . 0.475 ' HD2' HD12 ' A' ' 430' ' ' LEU . 80.9 Cg_exo -23.41 -70.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.892 1 C-N-CA 125.627 4.218 . . . . 0.0 115.082 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . 0.482 ' O ' HG12 ' A' ' 435' ' ' VAL . . . -138.17 -167.4 10.99 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 176.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . 0.478 ' O ' HG13 ' A' ' 436' ' ' VAL . 19.2 tp60 -69.41 -26.92 64.86 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 117.831 0.815 . . . . 0.0 110.165 179.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -68.24 -39.04 82.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.357 -176.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 435' ' ' VAL . . . . . 0.767 HG23 HG11 ' A' ' 463' ' ' VAL . 7.2 p -69.48 -44.01 80.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-O 120.972 0.415 . . . . 0.0 110.527 -177.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.478 HG13 ' O ' ' A' ' 433' ' ' GLN . 0.2 OUTLIER -65.33 -31.36 53.52 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 174.825 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 1.1 m -67.22 -52.82 36.35 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -178.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . 0.853 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -58.89 -39.16 80.62 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.12 177.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 439' ' ' LEU . . . . . 0.638 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 1.9 tm? -68.13 -48.52 65.17 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -178.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.21 -35.02 72.87 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.519 -1.219 . . . . 0.0 111.171 174.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 441' ' ' GLN . . . . . 0.5 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 3.7 mm-40 -55.13 -49.68 71.17 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.122 -177.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . 0.622 ' HG3' ' CG ' ' A' ' 459' ' ' HIS . 0.0 OUTLIER -75.8 -24.64 55.94 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 119.563 -0.855 . . . . 0.0 113.032 175.073 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 443' ' ' LEU . . . . . 0.638 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 70.1 mt -64.18 -35.29 80.3 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-N 118.453 0.569 . . . . 0.0 109.601 175.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -57.0 -37.96 72.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.524 173.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 -74.34 -26.75 60.34 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.312 177.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 27.59 98.86 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 176.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 49.2 mt -60.9 -35.13 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-O 121.266 0.555 . . . . 0.0 110.689 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . 0.466 ' HB2' ' OG1' ' A' ' 451' ' ' THR . 18.4 m-20 -163.66 -161.79 0.67 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 -177.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -82.38 -69.56 0.61 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 172.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 450' ' ' GLN . . . . . 0.417 ' HG3' ' H ' ' A' ' 450' ' ' GLN . 0.0 OUTLIER -66.81 -24.78 66.21 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 178.059 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 451' ' ' THR . . . . . 0.466 ' OG1' ' HB2' ' A' ' 448' ' ' ASP . 14.0 m -70.62 -22.55 62.51 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.788 -173.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 452' ' ' ARG . 18.3 mtp180 -54.1 -54.22 42.5 Favored 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 171.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 453' ' ' ALA . . . . . 0.537 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -59.13 -47.1 86.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.524 -1.216 . . . . 0.0 112.604 175.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . 0.446 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 12.0 mm-40 -51.58 -38.39 54.23 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.203 0.525 . . . . 0.0 111.478 -177.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 28.1 p -116.36 15.44 15.78 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.422 -175.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . 0.511 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.7 OUTLIER -56.74 -48.99 76.54 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 120.951 0.405 . . . . 0.0 111.777 -171.472 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . 0.546 HG23 ' HB1' ' A' ' 405' ' ' ALA . 1.9 mp -75.45 -32.93 26.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 120.841 0.353 . . . . 0.0 110.713 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -57.63 -35.51 70.58 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.694 0.759 . . . . 0.0 109.586 171.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . 0.752 ' O ' HG23 ' A' ' 463' ' ' VAL . 71.3 m-70 -71.74 -29.57 64.67 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.755 -1.112 . . . . 0.0 110.613 176.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . 0.712 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -74.08 -34.81 64.14 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.912 0.863 . . . . 0.0 108.787 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -72.84 -38.17 67.19 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.311 175.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 462' ' ' ALA . . . . . 0.627 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -55.82 -32.93 64.0 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.807 169.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.853 HG13 ' HB3' ' A' ' 438' ' ' ALA . 61.6 t -63.89 -50.57 76.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 CA-C-N 114.474 -1.239 . . . . 0.0 107.901 177.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 464' ' ' TYR . . . . . 0.567 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 15.3 m-30 -53.89 -27.16 28.69 Favored 'General case' 0 C--N 1.332 -0.169 0 O-C-N 124.259 0.974 . . . . 0.0 110.324 178.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.68 -40.95 18.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.689 0.757 . . . . 0.0 109.38 -177.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.627 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.7 mt -56.22 -55.82 16.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 114.295 -1.32 . . . . 0.0 112.289 175.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 0.761 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -103.41 -10.82 18.3 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -171.752 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . 0.561 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 93.73 31.74 8.05 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 119.43 -1.367 . . . . 0.0 114.351 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 469' ' ' LEU . . . . . 0.761 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 2.6 mt -88.91 162.3 16.19 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 117.983 0.892 . . . . 0.0 111.435 177.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 39.5 p30 -105.29 -174.45 2.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.349 173.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -67.02 -17.49 64.94 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -175.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -88.48 -0.43 57.2 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 122.101 -0.375 . . . . 0.0 111.321 -175.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 75.85 17.08 80.25 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -173.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -101.55 151.6 21.78 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 177.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 5.6 p -90.61 127.76 36.38 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.95 0.405 . . . . 0.0 111.169 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 476' ' ' ILE . . . . . 0.561 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.5 pp . . . . . 0 C--N 1.325 -0.462 0 CA-C-O 121.806 0.812 . . . . 0.0 110.282 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 386' ' ' PHE . . . . . 0.733 ' CD1' HD22 ' B' ' 414' ' ' LEU . 1.4 t80 . . . . . 0 CA--C 1.538 0.482 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 387' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -49.32 -72.67 0.04 OUTLIER 'Trans proline' 0 N--CA 1.487 1.13 0 C-N-CA 124.492 3.461 . . . . 0.0 114.375 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 388' ' ' MET . . . . . 0.61 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 38.9 ttm 73.98 49.54 0.12 Allowed 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 112.754 0.649 . . . . 0.0 112.754 172.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 389' ' ' HIS . . . . . 0.716 ' CG ' ' HB2' ' B' ' 393' ' ' ASN . 40.7 m170 47.32 -99.84 0.05 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.22 0.608 . . . . 0.0 110.499 -175.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -145.99 15.49 1.36 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.823 174.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 391' ' ' LEU . . . . . 0.482 HD23 ' H ' ' B' ' 392' ' ' GLY . 2.4 pt? -169.15 -50.89 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -168.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 392' ' ' GLY . . . . . 0.547 ' HA3' HD13 ' B' ' 395' ' ' ILE . . . -176.51 51.14 0.11 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 119.599 -1.286 . . . . 0.0 114.25 -172.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 393' ' ' ASN . . . . . 0.716 ' HB2' ' CG ' ' B' ' 389' ' ' HIS . 0.4 OUTLIER -54.47 -41.19 69.21 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 117.359 0.579 . . . . 0.0 109.705 176.914 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 394' ' ' VAL . . . . . 0.672 HG12 ' CE2' ' B' ' 386' ' ' PHE . 0.9 OUTLIER -56.86 -47.2 83.41 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 -179.29 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 395' ' ' ILE . . . . . 0.653 HG23 HD13 ' B' ' 426' ' ' ILE . 4.3 mp -57.86 -52.15 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 CA-C-O 117.824 -1.084 . . . . 0.0 113.31 -175.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 396' ' ' LYS . . . . . 0.695 ' HG3' ' CZ ' ' B' ' 429' ' ' TYR . 0.1 OUTLIER -62.95 -49.8 73.31 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 121.714 2.052 . . . . 0.0 112.12 -174.201 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 397' ' ' GLY . . . . . 0.537 ' O ' ' HG3' ' B' ' 401' ' ' GLN . . . -54.51 -44.47 77.96 Favored Glycine 0 N--CA 1.436 -1.355 0 C-N-CA 120.05 -1.071 . . . . 0.0 110.986 -177.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 398' ' ' ILE . . . . . 0.883 HD13 HD12 ' B' ' 410' ' ' LEU . 46.2 mt -71.71 -34.27 51.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -177.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 399' ' ' VAL . . . . . 0.527 HG12 ' HA ' ' B' ' 404' ' ' VAL . 5.5 m -64.21 -39.82 86.85 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.501 0 C-N-CA 118.836 -1.145 . . . . 0.0 108.457 -174.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -64.96 -41.11 95.75 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 174.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 401' ' ' GLN . . . . . 0.537 ' HG3' ' O ' ' B' ' 397' ' ' GLY . 32.3 mt-30 -93.13 -48.29 6.55 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -169.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 402' ' ' GLU . . . . . 0.684 ' HG3' ' HE3' ' A' ' 413' ' ' MET . 3.0 mm-40 -113.61 -19.99 11.39 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.44 -171.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 104.58 162.83 24.3 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.061 -0.59 . . . . 0.0 113.224 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 404' ' ' VAL . . . . . 0.647 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.4 m -53.21 -45.32 54.73 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.766 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -176.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 405' ' ' ALA . . . . . 0.554 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -66.23 -30.71 71.22 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 119.711 -0.795 . . . . 0.0 112.062 -175.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 406' ' ' THR . . . . . 0.701 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 88.2 m -77.26 -42.51 36.84 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.303 173.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 407' ' ' ALA . . . . . 0.502 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.09 -37.75 75.1 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 122.093 0.949 . . . . 0.0 109.2 176.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 408' ' ' TYR . . . . . 0.647 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.51 -52.58 51.69 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 113.631 -1.622 . . . . 0.0 109.975 177.028 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 409' ' ' THR . . . . . 0.74 HG22 HD23 ' B' ' 410' ' ' LEU . 2.7 m -56.17 -46.17 79.44 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.569 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 410' ' ' LEU . . . . . 0.883 HD12 HD13 ' B' ' 398' ' ' ILE . 13.2 mt -71.95 -36.74 69.98 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.808 0.337 . . . . 0.0 110.2 -175.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.51 -34.8 77.21 Favored Glycine 0 N--CA 1.439 -1.109 0 C-N-CA 120.04 -1.076 . . . . 0.0 110.729 172.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 412' ' ' MET . . . . . 0.413 ' HB2' ' O ' ' B' ' 409' ' ' THR . 0.4 OUTLIER -67.11 -48.14 69.01 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 115.808 -0.196 . . . . 0.0 111.423 177.76 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 413' ' ' MET . . . . . 0.931 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.7 OUTLIER -71.38 -48.1 52.11 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 118.884 -1.126 . . . . 0.0 112.119 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 414' ' ' LEU . . . . . 0.931 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 23.4 mt -67.2 -44.24 80.11 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -175.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 48.1 t -86.81 -24.11 25.12 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.592 0.711 . . . . 0.0 109.907 -177.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 416' ' ' GLY . . . . . 0.449 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 109.98 -175.52 18.58 Favored Glycine 0 N--CA 1.43 -1.715 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -170.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -79.71 24.47 0.38 Allowed 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.61 0.719 . . . . 0.0 111.326 -172.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 418' ' ' ASN . . . . . 0.449 ' H ' ' C ' ' B' ' 416' ' ' GLY . 79.9 m-20 -71.75 75.71 0.85 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.785 -178.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 419' ' ' TYR . . . . . 0.531 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 11.8 p90 -54.89 -38.9 68.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.598 178.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -55.73 -43.57 76.69 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.739 0.304 . . . . 0.0 111.061 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 421' ' ' LEU . . . . . 0.416 HD22 ' HB2' ' B' ' 418' ' ' ASN . 0.0 OUTLIER -68.15 -48.63 64.84 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.013 -177.576 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 422' ' ' VAL . . . . . 0.43 ' HB ' ' CD1' ' B' ' 408' ' ' TYR . 0.2 OUTLIER -66.41 -39.44 84.07 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.212 -177.365 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 423' ' ' SER . . . . . 0.771 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 67.3 p -66.97 -39.33 87.18 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.98 -39.11 89.24 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.161 176.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 425' ' ' ILE . . . . . 0.608 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -72.79 -51.7 26.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 116.622 0.211 . . . . 0.0 111.121 -177.334 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 426' ' ' ILE . . . . . 0.677 HG22 HD22 ' B' ' 430' ' ' LEU . 1.2 mm -74.3 -23.06 18.17 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.708 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -172.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 427' ' ' ARG . . . . . 0.771 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.7 OUTLIER -54.75 -31.34 58.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.344 0.592 . . . . 0.0 110.305 -179.769 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -85.5 -4.74 85.47 Favored Glycine 0 N--CA 1.446 -0.7 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.65 178.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 429' ' ' TYR . . . . . 0.695 ' CZ ' ' HG3' ' B' ' 396' ' ' LYS . 24.9 m-85 -120.13 0.52 10.72 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 121.105 0.479 . . . . 0.0 110.693 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 430' ' ' LEU . . . . . 0.711 HD23 ' HA ' ' B' ' 427' ' ' ARG . 0.1 OUTLIER -65.77 127.87 93.4 Favored Pre-proline 0 N--CA 1.44 -0.972 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.634 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 431' ' ' PRO . . . . . 0.474 ' HD2' HD12 ' B' ' 430' ' ' LEU . 84.1 Cg_exo -23.47 -70.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.832 1 C-N-CA 125.665 4.243 . . . . 0.0 115.011 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 432' ' ' GLY . . . . . 0.488 ' O ' HG12 ' B' ' 435' ' ' VAL . . . -138.12 -167.54 11.04 Favored Glycine 0 N--CA 1.442 -0.921 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 176.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 433' ' ' GLN . . . . . 0.474 ' O ' HG13 ' B' ' 436' ' ' VAL . 19.1 tp60 -69.5 -26.82 64.73 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 117.791 0.796 . . . . 0.0 110.074 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -68.07 -39.51 82.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.227 -176.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 435' ' ' VAL . . . . . 0.776 HG23 HG11 ' B' ' 463' ' ' VAL . 7.3 p -69.05 -44.03 81.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-O 120.968 0.413 . . . . 0.0 110.649 -177.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 436' ' ' VAL . . . . . 0.474 HG13 ' O ' ' B' ' 433' ' ' GLN . 0.2 OUTLIER -65.26 -31.22 52.93 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 CA-C-O 121.08 0.467 . . . . 0.0 109.883 174.795 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 1.1 m -67.28 -52.8 36.21 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 -178.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 438' ' ' ALA . . . . . 0.837 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -58.94 -39.19 80.86 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 115.351 -0.841 . . . . 0.0 112.113 177.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 439' ' ' LEU . . . . . 0.624 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 1.9 tm? -68.15 -48.48 65.22 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -178.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.26 -34.99 72.9 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.485 -1.234 . . . . 0.0 111.097 174.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 441' ' ' GLN . . . . . 0.5 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 3.6 mm-40 -54.98 -50.02 70.01 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.017 -177.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 442' ' ' ARG . . . . . 0.624 ' HG3' ' CG ' ' B' ' 459' ' ' HIS . 0.0 OUTLIER -75.67 -24.34 56.32 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 119.547 -0.861 . . . . 0.0 113.095 175.261 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 443' ' ' LEU . . . . . 0.624 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 70.2 mt -64.47 -35.2 80.18 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 175.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -56.99 -38.2 72.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.451 173.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -74.22 -26.85 60.49 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.318 177.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 446' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 27.91 98.94 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.625 1.17 . . . . 0.0 114.147 176.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 49.0 mt -61.13 -35.13 63.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-O 121.151 0.5 . . . . 0.0 110.74 -178.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 448' ' ' ASP . . . . . 0.476 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 19.8 m-20 -163.79 -162.14 0.69 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 -177.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -81.85 -69.67 0.6 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 172.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 450' ' ' GLN . . . . . 0.417 ' HG3' ' H ' ' B' ' 450' ' ' GLN . 0.0 OUTLIER -66.76 -24.72 66.24 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 178.068 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 451' ' ' THR . . . . . 0.476 ' OG1' ' HB2' ' B' ' 448' ' ' ASP . 12.4 m -70.62 -22.53 62.52 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.765 -173.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 452' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -54.2 -54.12 44.25 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 171.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 453' ' ' ALA . . . . . 0.531 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -58.94 -47.35 85.41 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.514 -1.221 . . . . 0.0 112.613 174.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 454' ' ' GLU . . . . . 0.445 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 10.5 mm-40 -51.83 -37.38 51.59 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.284 0.564 . . . . 0.0 111.603 -177.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 28.2 p -117.08 15.34 15.04 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.468 -176.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 456' ' ' PHE . . . . . 0.516 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 0.7 OUTLIER -56.57 -49.1 75.85 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.906 0.384 . . . . 0.0 111.879 -171.522 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 457' ' ' ILE . . . . . 0.554 HG23 ' HB1' ' B' ' 405' ' ' ALA . 1.9 mp -75.25 -33.08 27.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 120.809 0.337 . . . . 0.0 110.855 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -57.44 -35.63 70.35 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.814 0.816 . . . . 0.0 109.482 171.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 459' ' ' HIS . . . . . 0.748 ' O ' HG23 ' B' ' 463' ' ' VAL . 70.8 m-70 -71.89 -29.4 64.31 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.629 176.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 460' ' ' LEU . . . . . 0.717 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -74.14 -34.74 63.98 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.88 0.848 . . . . 0.0 108.882 179.811 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 461' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -72.82 -38.25 67.21 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.288 175.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 462' ' ' ALA . . . . . 0.639 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -55.72 -32.87 63.72 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.692 169.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 463' ' ' VAL . . . . . 0.837 HG13 ' HB3' ' B' ' 438' ' ' ALA . 60.1 t -64.07 -50.6 76.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 CA-C-N 114.433 -1.258 . . . . 0.0 107.961 177.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 464' ' ' TYR . . . . . 0.56 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 15.3 m-30 -53.72 -27.48 28.54 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.327 178.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.62 -40.52 18.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.622 0.725 . . . . 0.0 109.43 -177.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 466' ' ' ILE . . . . . 0.639 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.6 mt -56.42 -55.92 16.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 114.295 -1.321 . . . . 0.0 112.268 175.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 467' ' ' LEU . . . . . 0.776 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -103.36 -10.74 18.4 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -171.884 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 468' ' ' GLY . . . . . 0.585 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 93.84 31.69 8.03 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 119.453 -1.356 . . . . 0.0 114.281 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 469' ' ' LEU . . . . . 0.776 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 2.6 mt -88.91 162.26 16.21 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 117.969 0.885 . . . . 0.0 111.29 177.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 39.7 p30 -105.27 -173.96 2.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.367 173.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 471' ' ' ALA . . . . . . . . . . . . . . . -67.69 -17.06 64.45 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -175.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -88.59 -0.81 57.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.751 0.31 . . . . 0.0 111.136 -176.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 473' ' ' GLY . . . . . . . . . . . . . . . 76.19 16.88 80.38 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 -173.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -101.4 151.96 21.3 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 177.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 5.4 p -90.78 128.21 36.61 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.88 0.372 . . . . 0.0 111.184 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 476' ' ' ILE . . . . . 0.585 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.5 pp . . . . . 0 C--N 1.326 -0.432 0 CA-C-O 121.672 0.748 . . . . 0.0 110.266 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 386' ' ' PHE . . . . . 0.809 ' CD1' HD22 ' A' ' 414' ' ' LEU . 2.6 t80 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 121.082 0.468 . . . . 0.0 110.616 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . 0.592 ' HG2' ' OD1' ' B' ' 393' ' ' ASN . 60.9 Cg_endo -72.0 111.27 3.13 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 124.105 3.203 . . . . 0.0 113.701 175.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.486 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 40.0 mtt -103.28 172.7 6.67 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 176.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -57.28 -61.76 2.24 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 175.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -175.49 19.66 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.5 -1.227 . . . . 0.0 108.448 173.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.494 HD23 ' H ' ' A' ' 392' ' ' GLY . 2.1 pt? -169.76 -54.8 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.616 -167.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . 0.612 ' HA3' HD13 ' A' ' 395' ' ' ILE . . . -174.88 54.77 0.13 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 119.93 -1.129 . . . . 0.0 113.703 -174.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . 0.587 ' OD1' ' HG2' ' B' ' 387' ' ' PRO . 0.2 OUTLIER -54.25 -41.9 69.29 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 177.707 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . 0.748 HG23 HD12 ' A' ' 398' ' ' ILE . 2.0 m -56.35 -47.05 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . 0.643 ' H ' HD12 ' A' ' 395' ' ' ILE . 3.9 mp -57.47 -52.12 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 CA-C-O 118.04 -0.981 . . . . 0.0 113.254 -175.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . 0.68 ' HG3' ' CZ ' ' A' ' 429' ' ' TYR . 0.1 OUTLIER -61.49 -49.3 77.33 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-N 121.52 1.964 . . . . 0.0 111.857 -173.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -54.26 -45.14 75.07 Favored Glycine 0 N--CA 1.437 -1.279 0 C-N-CA 119.756 -1.212 . . . . 0.0 111.142 -178.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . 0.793 HD13 HD12 ' A' ' 410' ' ' LEU . 39.2 mt -70.94 -34.08 54.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -177.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . 0.503 HG12 ' HA ' ' A' ' 404' ' ' VAL . 10.6 m -63.5 -39.61 85.96 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 C-N-CA 118.573 -1.251 . . . . 0.0 108.24 -175.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -70.91 -33.99 71.09 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 175.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.444 HE21 ' HB3' ' A' ' 401' ' ' GLN . 3.2 mm100 -90.14 -47.27 7.91 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -172.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . 0.649 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 2.9 mm-40 -121.61 -20.97 6.34 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.576 -170.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 107.21 162.73 21.86 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.823 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . 0.65 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.6 m -53.52 -46.45 59.87 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.771 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -175.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . 0.598 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -64.25 -30.39 71.45 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 119.891 -0.724 . . . . 0.0 112.452 -176.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.717 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 91.9 m -77.5 -42.96 33.76 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.223 173.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.466 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -58.46 -37.37 75.33 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 122.117 0.96 . . . . 0.0 109.265 176.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 408' ' ' TYR . . . . . 0.65 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.58 -51.69 57.85 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 113.402 -1.726 . . . . 0.0 109.746 176.687 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 409' ' ' THR . . . . . 0.682 HG22 HD23 ' A' ' 410' ' ' LEU . 14.1 m -55.34 -47.03 76.32 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.588 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . 0.793 HD12 HD13 ' A' ' 398' ' ' ILE . 14.8 mt -72.19 -37.12 69.36 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 120.826 0.346 . . . . 0.0 110.164 -174.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.68 -34.46 76.98 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.57 173.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 412' ' ' MET . . . . . 0.429 ' HB2' ' O ' ' A' ' 409' ' ' THR . 0.2 OUTLIER -65.86 -44.03 86.65 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 115.685 -0.258 . . . . 0.0 111.589 177.915 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 413' ' ' MET . . . . . 0.754 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.0 OUTLIER -71.13 -56.49 6.0 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 118.431 -1.308 . . . . 0.0 111.558 177.884 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . 0.809 HD22 ' CD1' ' A' ' 386' ' ' PHE . 6.8 mt -62.46 -43.52 98.62 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -171.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 37.8 t -85.16 -21.14 29.33 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.701 0.762 . . . . 0.0 109.562 -178.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . 0.437 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 103.69 -173.42 21.85 Favored Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -169.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -79.7 24.43 0.38 Allowed 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.563 0.696 . . . . 0.0 111.206 -171.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 418' ' ' ASN . . . . . 0.437 ' H ' ' C ' ' A' ' 416' ' ' GLY . 89.2 m-20 -71.17 73.4 0.65 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.493 179.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 419' ' ' TYR . . . . . 0.53 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 29.9 p90 -56.74 -36.58 69.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.002 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -54.72 -42.69 71.86 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.908 178.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.16 -49.14 62.92 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.136 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . 0.486 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.5 OUTLIER -66.17 -38.8 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.244 -176.487 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.726 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 57.6 p -67.3 -38.66 85.35 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.072 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -70.07 -37.5 73.17 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.96 176.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . 0.602 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.66 -52.51 22.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 121.305 -0.158 . . . . 0.0 111.097 -178.308 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . 0.681 HG22 HD22 ' A' ' 430' ' ' LEU . 1.2 mm -73.49 -22.71 19.14 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.699 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -172.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.726 ' HB2' ' O ' ' A' ' 423' ' ' SER . 0.7 OUTLIER -54.04 -32.77 55.48 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.271 0.558 . . . . 0.0 110.119 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -84.74 -6.28 85.6 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.598 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.68 ' CZ ' ' HG3' ' A' ' 396' ' ' LYS . 23.9 m-85 -118.64 0.6 11.54 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 121.105 0.479 . . . . 0.0 110.56 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.7 HD23 ' HA ' ' A' ' 427' ' ' ARG . 0.1 OUTLIER -66.33 127.79 93.48 Favored Pre-proline 0 N--CA 1.437 -1.075 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.348 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 431' ' ' PRO . . . . . 0.509 ' HD2' HD12 ' A' ' 430' ' ' LEU . 83.6 Cg_exo -23.55 -65.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.354 0.836 1 C-N-CA 125.655 4.237 . . . . 0.0 114.983 179.9 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . 0.561 ' H ' HG12 ' A' ' 435' ' ' VAL . . . -143.22 -169.2 12.37 Favored Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 175.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . 0.496 ' O ' HG13 ' A' ' 436' ' ' VAL . 45.1 tp60 -69.93 -26.66 64.24 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 118.19 0.995 . . . . 0.0 110.111 177.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -62.93 -42.47 99.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.268 -0.424 . . . . 0.0 112.035 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 435' ' ' VAL . . . . . 0.772 HG23 HG11 ' A' ' 463' ' ' VAL . 7.5 p -68.8 -43.17 82.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-O 120.947 0.403 . . . . 0.0 110.766 -177.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.496 HG12 ' O ' ' A' ' 432' ' ' GLY . 0.1 OUTLIER -66.22 -31.74 55.01 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.241 175.712 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.56 -52.39 46.13 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -178.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . 0.842 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -57.85 -40.09 79.27 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.997 177.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 439' ' ' LEU . . . . . 0.611 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 2.0 tm? -68.03 -48.54 65.37 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -178.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.13 -35.16 72.98 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.1 175.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 441' ' ' GLN . . . . . 0.517 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 3.3 mm-40 -54.87 -49.53 70.94 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.126 -178.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . 0.622 ' HD2' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -76.43 -24.0 53.96 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 119.736 -0.785 . . . . 0.0 113.058 174.899 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 443' ' ' LEU . . . . . 0.611 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 69.4 mt -64.23 -35.81 82.04 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 118.404 0.547 . . . . 0.0 109.53 174.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -57.46 -37.53 73.02 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.537 173.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -73.73 -27.12 61.03 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.113 177.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 26.68 100.57 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.878 1.271 . . . . 0.0 114.387 176.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 51.8 mt -63.47 -34.94 70.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.046 -178.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . 0.452 ' HB2' ' OG1' ' A' ' 451' ' ' THR . 33.5 m-20 -164.21 -162.04 0.65 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -178.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -79.55 -71.01 0.47 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 172.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -24.82 66.13 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 178.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 451' ' ' THR . . . . . 0.452 ' OG1' ' HB2' ' A' ' 448' ' ' ASP . 15.8 m -70.49 -22.18 62.68 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.104 -0.638 . . . . 0.0 110.836 -173.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 452' ' ' ARG . 20.9 mtp180 -53.43 -53.83 45.6 Favored 'General case' 0 C--O 1.221 -0.406 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 171.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 453' ' ' ALA . . . . . 0.53 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -59.8 -47.83 84.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.388 -1.278 . . . . 0.0 112.58 175.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . 0.428 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 77.4 mm-40 -50.4 -37.19 36.36 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.181 0.515 . . . . 0.0 111.774 -177.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 29.9 p -117.98 15.22 14.23 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.374 -176.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . 0.563 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.8 OUTLIER -56.9 -47.67 79.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.09 0.471 . . . . 0.0 111.718 -171.747 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . 0.598 HG23 ' HB1' ' A' ' 405' ' ' ALA . 1.9 mp -76.78 -33.04 20.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.053 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -57.7 -34.49 69.49 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.783 0.802 . . . . 0.0 109.28 171.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . 0.735 ' O ' HG23 ' A' ' 463' ' ' VAL . 59.9 m-70 -73.18 -29.33 62.76 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.828 177.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . 0.707 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.4 OUTLIER -74.16 -34.68 63.91 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.993 0.902 . . . . 0.0 108.753 179.286 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -72.78 -37.89 67.47 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.257 175.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 462' ' ' ALA . . . . . 0.634 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -55.73 -33.23 64.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.674 169.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.842 HG13 ' HB3' ' A' ' 438' ' ' ALA . 77.8 t -64.48 -50.75 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 CA-C-N 114.603 -1.181 . . . . 0.0 107.906 177.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 464' ' ' TYR . . . . . 0.549 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 17.3 m-30 -53.34 -25.8 16.49 Favored 'General case' 0 C--N 1.333 -0.143 0 O-C-N 124.313 1.008 . . . . 0.0 110.605 178.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.39 -40.93 15.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.6 0.714 . . . . 0.0 109.437 -178.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.634 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.4 mt -55.94 -55.22 19.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 114.272 -1.331 . . . . 0.0 112.199 175.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 0.773 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -103.93 -11.01 17.72 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -172.748 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . 0.612 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 93.64 31.82 8.03 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 119.328 -1.415 . . . . 0.0 114.374 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 469' ' ' LEU . . . . . 0.773 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 2.9 mt -89.14 161.84 16.27 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 117.886 0.843 . . . . 0.0 111.361 177.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 38.1 p30 -104.97 -177.01 3.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.569 173.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -60.36 -22.53 63.39 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -176.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -87.89 0.28 56.05 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 122.32 -0.238 . . . . 0.0 111.551 -172.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 473' ' ' GLY . . . . . 0.445 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 77.71 12.31 84.6 Favored Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 110.724 -0.951 . . . . 0.0 110.724 -174.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -101.18 152.48 20.59 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 11.5 p -89.28 129.45 35.83 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.279 0.561 . . . . 0.0 111.118 -178.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 476' ' ' ILE . . . . . 0.612 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.8 pp . . . . . 0 C--N 1.32 -0.712 0 CA-C-O 121.636 0.731 . . . . 0.0 109.953 177.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 386' ' ' PHE . . . . . 0.821 ' CD1' HD22 ' B' ' 414' ' ' LEU . 2.6 t80 . . . . . 0 CA--C 1.528 0.106 0 CA-C-O 120.991 0.424 . . . . 0.0 110.599 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 387' ' ' PRO . . . . . 0.587 ' HG2' ' OD1' ' A' ' 393' ' ' ASN . 60.8 Cg_endo -71.97 111.21 3.11 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 124.059 3.172 . . . . 0.0 113.767 175.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 388' ' ' MET . . . . . 0.482 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 39.9 mtt -103.26 172.62 6.71 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 122.012 -0.43 . . . . 0.0 110.1 177.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 389' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -57.4 -61.49 2.45 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 175.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -175.89 19.84 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.647 -1.16 . . . . 0.0 108.311 173.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 391' ' ' LEU . . . . . 0.492 HD23 ' H ' ' B' ' 392' ' ' GLY . 2.1 pt? -169.91 -54.86 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.562 -167.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 392' ' ' GLY . . . . . 0.596 ' HA3' HD13 ' B' ' 395' ' ' ILE . . . -174.8 54.9 0.13 Allowed Glycine 0 C--N 1.333 0.408 0 C-N-CA 119.911 -1.138 . . . . 0.0 113.67 -174.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 393' ' ' ASN . . . . . 0.592 ' OD1' ' HG2' ' A' ' 387' ' ' PRO . 0.2 OUTLIER -54.33 -41.89 69.56 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 177.728 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 394' ' ' VAL . . . . . 0.756 HG23 HD12 ' B' ' 398' ' ' ILE . 2.0 m -56.34 -47.1 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 -179.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 395' ' ' ILE . . . . . 0.641 ' H ' HD12 ' B' ' 395' ' ' ILE . 3.9 mp -57.44 -52.24 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 CA-C-O 117.935 -1.031 . . . . 0.0 113.246 -175.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 396' ' ' LYS . . . . . 0.679 ' HG3' ' CZ ' ' B' ' 429' ' ' TYR . 0.1 OUTLIER -61.42 -49.18 77.92 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 121.488 1.949 . . . . 0.0 111.818 -173.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -54.39 -45.18 76.23 Favored Glycine 0 N--CA 1.436 -1.31 0 C-N-CA 119.747 -1.216 . . . . 0.0 111.073 -178.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 398' ' ' ILE . . . . . 0.789 HD13 HD12 ' B' ' 410' ' ' LEU . 39.2 mt -70.96 -34.1 54.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -176.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 399' ' ' VAL . . . . . 0.508 HG12 ' HA ' ' B' ' 404' ' ' VAL . 10.6 m -63.47 -39.73 86.42 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 C-N-CA 118.514 -1.274 . . . . 0.0 108.265 -175.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -70.83 -34.12 71.38 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 175.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 401' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -89.84 -47.48 7.86 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -172.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 402' ' ' GLU . . . . . 0.661 ' HG3' ' HE3' ' A' ' 413' ' ' MET . 2.9 mm-40 -121.4 -21.08 6.41 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.653 -170.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 107.42 162.5 21.62 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.843 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 404' ' ' VAL . . . . . 0.659 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.5 m -53.41 -46.44 58.55 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.71 0 N-CA-C 114.506 1.298 . . . . 0.0 114.506 -175.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 405' ' ' ALA . . . . . 0.607 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -64.11 -30.5 71.57 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 119.861 -0.736 . . . . 0.0 112.427 -177.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 406' ' ' THR . . . . . 0.714 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 89.0 m -77.36 -43.1 34.06 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 121.749 -0.595 . . . . 0.0 110.282 173.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 407' ' ' ALA . . . . . 0.472 ' HB2' ' HB ' ' B' ' 398' ' ' ILE . . . -58.38 -37.35 75.09 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 122.175 0.988 . . . . 0.0 109.252 176.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 408' ' ' TYR . . . . . 0.659 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.59 -51.67 57.93 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 113.414 -1.721 . . . . 0.0 109.816 176.714 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 409' ' ' THR . . . . . 0.671 HG22 HD23 ' B' ' 410' ' ' LEU . 15.7 m -55.3 -47.1 76.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.568 178.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 410' ' ' LEU . . . . . 0.789 HD12 HD13 ' B' ' 398' ' ' ILE . 14.8 mt -72.29 -37.1 69.09 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.093 -174.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.6 -34.42 76.26 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 119.915 -1.136 . . . . 0.0 110.481 173.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 412' ' ' MET . . . . . 0.436 ' HB2' ' O ' ' B' ' 409' ' ' THR . 0.3 OUTLIER -65.92 -44.2 85.87 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 115.667 -0.266 . . . . 0.0 111.597 177.932 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 413' ' ' MET . . . . . 0.742 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.0 OUTLIER -70.97 -56.58 5.89 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 118.414 -1.315 . . . . 0.0 111.47 177.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 414' ' ' LEU . . . . . 0.821 HD22 ' CD1' ' B' ' 386' ' ' PHE . 6.8 mt -62.45 -43.48 98.72 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 114.19 1.181 . . . . 0.0 114.19 -171.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 37.2 t -85.2 -20.98 29.35 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.797 0.808 . . . . 0.0 109.525 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 416' ' ' GLY . . . . . 0.438 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 103.5 -173.15 21.8 Favored Glycine 0 N--CA 1.428 -1.852 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -169.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -79.9 24.52 0.4 Allowed 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.617 0.722 . . . . 0.0 111.336 -171.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 418' ' ' ASN . . . . . 0.438 ' H ' ' C ' ' B' ' 416' ' ' GLY . 89.6 m-20 -71.25 73.38 0.67 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.344 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 419' ' ' TYR . . . . . 0.53 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 29.6 p90 -56.68 -36.63 69.81 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.944 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -54.67 -42.59 71.54 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.864 178.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.26 -49.14 62.62 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.123 -178.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 422' ' ' VAL . . . . . 0.475 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.5 OUTLIER -66.23 -38.75 82.59 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.238 -176.422 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 423' ' ' SER . . . . . 0.73 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 59.9 p -67.31 -38.82 85.56 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.124 -178.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -70.01 -37.12 73.54 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.056 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 425' ' ' ILE . . . . . 0.616 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -72.82 -52.97 20.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 120.424 0.154 . . . . 0.0 110.996 -178.501 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 426' ' ' ILE . . . . . 0.677 HG22 HD22 ' B' ' 430' ' ' LEU . 1.2 mm -73.24 -22.82 19.53 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.722 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -172.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 427' ' ' ARG . . . . . 0.73 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.7 OUTLIER -53.92 -32.79 54.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.341 0.591 . . . . 0.0 110.098 -179.827 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -85.03 -5.67 85.75 Favored Glycine 0 N--CA 1.443 -0.839 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.599 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 429' ' ' TYR . . . . . 0.679 ' CZ ' ' HG3' ' B' ' 396' ' ' LYS . 23.8 m-85 -119.15 0.56 11.25 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-O 121.017 0.436 . . . . 0.0 110.454 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 430' ' ' LEU . . . . . 0.685 HD23 ' HA ' ' B' ' 427' ' ' ARG . 0.1 OUTLIER -66.34 127.66 93.41 Favored Pre-proline 0 N--CA 1.439 -1.004 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.402 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 431' ' ' PRO . . . . . 0.498 ' HD2' HD12 ' B' ' 430' ' ' LEU . 84.0 Cg_exo -23.45 -65.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.874 1 C-N-CA 125.728 4.285 . . . . 0.0 115.059 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 432' ' ' GLY . . . . . 0.556 ' H ' HG12 ' B' ' 435' ' ' VAL . . . -143.23 -169.15 12.35 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 175.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 433' ' ' GLN . . . . . 0.506 ' O ' HG13 ' B' ' 436' ' ' VAL . 46.0 tp60 -70.2 -26.54 63.93 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 118.186 0.993 . . . . 0.0 109.893 177.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -62.99 -42.41 99.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.979 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 435' ' ' VAL . . . . . 0.778 HG23 HG11 ' B' ' 463' ' ' VAL . 7.3 p -69.03 -42.97 82.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 120.933 0.396 . . . . 0.0 110.742 -177.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 436' ' ' VAL . . . . . 0.506 HG13 ' O ' ' B' ' 433' ' ' GLN . 0.1 OUTLIER -66.38 -31.7 54.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.251 175.628 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.57 -52.39 46.0 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 -178.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 438' ' ' ALA . . . . . 0.825 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -57.88 -40.03 79.27 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.015 177.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 439' ' ' LEU . . . . . 0.612 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 1.9 tm? -68.26 -48.39 65.19 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -178.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.17 -35.16 73.06 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.515 -1.22 . . . . 0.0 111.061 175.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 441' ' ' GLN . . . . . 0.515 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 3.4 mm-40 -54.7 -49.84 69.72 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.178 -178.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 442' ' ' ARG . . . . . 0.627 ' HD2' ' O ' ' B' ' 438' ' ' ALA . 0.0 OUTLIER -76.17 -23.96 54.75 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 119.663 -0.815 . . . . 0.0 113.092 174.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 443' ' ' LEU . . . . . 0.612 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 69.4 mt -64.24 -35.78 81.94 Favored 'General case' 0 CA--C 1.519 -0.218 0 O-C-N 121.773 -0.579 . . . . 0.0 109.53 174.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -57.35 -37.64 72.89 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.533 173.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -73.67 -27.42 61.23 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.044 178.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 446' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 26.87 100.59 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 114.422 1.268 . . . . 0.0 114.422 176.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 52.9 mt -63.54 -34.93 70.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.97 -178.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 448' ' ' ASP . . . . . 0.474 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 30.6 m-20 -164.08 -161.95 0.65 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -178.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -79.55 -71.21 0.46 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 171.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.71 -24.97 66.31 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 178.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 451' ' ' THR . . . . . 0.474 ' OG1' ' HB2' ' B' ' 448' ' ' ASP . 13.4 m -70.53 -22.24 62.64 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.775 -173.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 452' ' ' ARG . . . . . 0.432 HH11 ' HD2' ' B' ' 452' ' ' ARG . 20.9 mtp180 -53.39 -53.71 47.22 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 107.481 -1.304 . . . . 0.0 107.481 170.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 453' ' ' ALA . . . . . 0.53 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -59.96 -47.6 85.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.415 -1.266 . . . . 0.0 112.525 175.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 454' ' ' GLU . . . . . 0.427 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 77.5 mm-40 -50.53 -37.65 40.35 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.245 0.545 . . . . 0.0 111.685 -177.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 31.2 p -117.64 15.22 14.54 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.325 -175.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 456' ' ' PHE . . . . . 0.566 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 0.8 OUTLIER -56.91 -47.53 80.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.082 0.468 . . . . 0.0 111.72 -171.82 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 457' ' ' ILE . . . . . 0.607 HG23 ' HB1' ' B' ' 405' ' ' ALA . 1.9 mp -77.16 -32.87 19.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.851 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -57.89 -34.28 69.64 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.811 0.815 . . . . 0.0 109.375 170.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 459' ' ' HIS . . . . . 0.729 ' O ' HG23 ' B' ' 463' ' ' VAL . 60.3 m-70 -73.1 -29.58 63.03 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.743 177.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 460' ' ' LEU . . . . . 0.71 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.4 OUTLIER -74.13 -34.67 63.97 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.887 0.851 . . . . 0.0 108.794 179.456 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 461' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -72.85 -37.72 67.3 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.258 175.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 462' ' ' ALA . . . . . 0.64 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -55.9 -33.22 64.45 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.584 -1.189 . . . . 0.0 109.722 169.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 463' ' ' VAL . . . . . 0.825 HG13 ' HB3' ' B' ' 438' ' ' ALA . 77.5 t -64.48 -50.77 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 CA-C-N 114.54 -1.209 . . . . 0.0 107.835 177.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 464' ' ' TYR . . . . . 0.546 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 17.3 m-30 -53.08 -26.4 16.04 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 124.339 1.024 . . . . 0.0 110.471 178.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.79 -40.89 16.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.619 0.724 . . . . 0.0 109.526 -177.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 466' ' ' ILE . . . . . 0.64 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.4 mt -56.21 -55.11 20.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 114.339 -1.301 . . . . 0.0 112.117 175.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 467' ' ' LEU . . . . . 0.783 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -103.83 -11.07 17.76 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -172.667 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 468' ' ' GLY . . . . . 0.597 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 93.73 31.87 7.97 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 119.441 -1.362 . . . . 0.0 114.398 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 469' ' ' LEU . . . . . 0.783 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 2.8 mt -89.04 162.06 16.22 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 117.866 0.833 . . . . 0.0 111.417 177.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 38.3 p30 -105.17 -177.0 3.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.692 173.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 471' ' ' ALA . . . . . . . . . . . . . . . -60.3 -22.88 63.68 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -176.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -87.79 0.73 55.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.617 -172.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 473' ' ' GLY . . . . . 0.45 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 77.59 12.05 84.88 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.197 -1.001 . . . . 0.0 110.751 -175.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -101.09 152.7 20.3 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 11.0 p -89.69 129.22 36.15 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.18 0.514 . . . . 0.0 111.134 -178.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 476' ' ' ILE . . . . . 0.597 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.8 pp . . . . . 0 C--N 1.321 -0.664 0 CA-C-O 121.678 0.751 . . . . 0.0 109.889 177.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 386' ' ' PHE . . . . . 0.694 ' CD1' HD22 ' A' ' 414' ' ' LEU . 1.1 t80 . . . . . 0 N--CA 1.473 0.682 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -42.14 -70.73 0.06 OUTLIER 'Trans proline' 0 N--CA 1.484 0.947 0 C-N-CA 124.48 3.453 . . . . 0.0 114.088 -175.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.634 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 36.4 ttm 77.67 29.65 0.51 Allowed 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 173.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 389' ' ' HIS . . . . . 0.676 ' CG ' ' HB2' ' A' ' 393' ' ' ASN . 42.4 m170 61.35 -82.91 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.291 0.636 . . . . 0.0 110.633 -176.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -167.92 14.47 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.246 -0.888 . . . . 0.0 108.702 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.501 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.5 pt? -169.53 -48.23 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -168.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . 0.581 ' HA3' HD13 ' A' ' 395' ' ' ILE . . . 178.78 48.36 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 119.309 -1.424 . . . . 0.0 114.531 -172.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . 0.676 ' HB2' ' CG ' ' A' ' 389' ' ' HIS . 0.3 OUTLIER -54.14 -39.79 66.83 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 117.58 0.69 . . . . 0.0 109.405 174.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . 0.722 HG23 HD12 ' A' ' 398' ' ' ILE . 1.8 m -56.23 -49.18 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . 0.689 HG23 HD13 ' A' ' 426' ' ' ILE . 3.7 mp -56.75 -53.41 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -174.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . 0.739 ' HG3' ' CE1' ' A' ' 429' ' ' TYR . 0.1 OUTLIER -66.25 -47.21 74.47 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 121.349 1.886 . . . . 0.0 112.06 -172.133 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -52.81 -45.16 61.15 Favored Glycine 0 N--CA 1.434 -1.452 0 C-N-CA 120.132 -1.032 . . . . 0.0 110.882 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . 0.722 HD12 HG23 ' A' ' 394' ' ' VAL . 31.2 mt -70.75 -33.87 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . 0.537 HG22 ' O ' ' A' ' 396' ' ' LYS . 11.3 m -62.6 -39.58 85.14 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 C-N-CA 118.821 -1.152 . . . . 0.0 108.103 -174.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -70.93 -34.78 71.83 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 175.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.454 HE21 ' HB3' ' A' ' 401' ' ' GLN . 5.5 mm100 -89.17 -47.71 7.89 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -173.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . 0.463 ' HB3' ' HB ' ' A' ' 406' ' ' THR . 3.0 mm-40 -119.75 -20.94 7.44 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.462 -170.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 107.48 162.77 21.61 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.519 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . 0.61 HG11 ' HA ' ' A' ' 430' ' ' LEU . 1.7 m -54.12 -45.73 66.28 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.731 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -175.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . 0.574 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -64.12 -29.61 70.73 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 119.84 -0.744 . . . . 0.0 112.209 -177.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.712 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 85.7 m -77.59 -43.21 32.42 Favored 'General case' 0 C--O 1.219 -0.54 0 O-C-N 121.888 -0.507 . . . . 0.0 110.227 173.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.428 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.18 -36.09 72.55 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 122.106 0.955 . . . . 0.0 109.14 176.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 408' ' ' TYR . . . . . 0.586 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -66.34 -52.65 44.89 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 113.446 -1.707 . . . . 0.0 109.749 175.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 409' ' ' THR . . . . . 0.634 HG22 HD23 ' A' ' 410' ' ' LEU . 17.3 m -55.48 -47.4 76.21 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.673 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . 0.712 HD12 ' CD1' ' A' ' 398' ' ' ILE . 15.0 mt -72.42 -36.68 68.67 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -174.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.73 -35.31 81.11 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.066 -1.064 . . . . 0.0 110.783 172.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -68.64 -48.32 64.33 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 120.644 0.259 . . . . 0.0 111.265 178.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 413' ' ' MET . . . . . 0.962 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 1.2 ppp? -71.02 -43.27 68.27 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 118.888 -1.125 . . . . 0.0 112.155 -177.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . 0.962 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 12.1 mt -71.31 -45.85 62.08 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -177.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 44.5 t -84.98 -24.3 28.33 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.787 0.803 . . . . 0.0 110.277 -175.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . 0.412 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 110.74 -175.69 18.19 Favored Glycine 0 N--CA 1.428 -1.89 0 N-CA-C 109.824 -1.311 . . . . 0.0 109.824 -171.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -80.84 24.24 0.5 Allowed 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 121.407 0.622 . . . . 0.0 111.193 -172.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 418' ' ' ASN . . . . . 0.412 ' H ' ' C ' ' A' ' 416' ' ' GLY . 84.5 m-20 -71.74 76.64 0.85 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.701 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 419' ' ' TYR . . . . . 0.549 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 17.1 p90 -54.36 -38.84 66.56 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.656 177.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -55.63 -44.07 76.78 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.634 0.254 . . . . 0.0 111.138 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.78 -48.64 65.76 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.055 -177.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . 0.429 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -66.07 -39.42 84.42 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.158 -177.519 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.728 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 64.0 p -67.49 -39.81 85.21 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.024 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -66.26 -39.9 94.56 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.739 -0.743 . . . . 0.0 111.954 175.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . 0.632 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.72 -51.91 25.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 121.236 -0.185 . . . . 0.0 111.291 -177.094 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . 0.689 HD13 HG23 ' A' ' 395' ' ' ILE . 1.2 mm -73.77 -23.01 18.88 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.885 0 CA-C-O 120.76 0.314 . . . . 0.0 110.176 -171.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.728 ' HB2' ' O ' ' A' ' 423' ' ' SER . 0.8 OUTLIER -54.77 -29.14 53.27 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.981 0.419 . . . . 0.0 110.975 -178.009 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.73 -11.45 68.24 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.641 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.739 ' CE1' ' HG3' ' A' ' 396' ' ' LYS . 15.0 m-85 -113.99 -1.41 13.8 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 121.709 0.766 . . . . 0.0 109.241 -176.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.614 HD12 ' HD2' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -65.94 135.12 95.2 Favored Pre-proline 0 N--CA 1.438 -1.039 0 CA-C-N 114.05 -1.432 . . . . 0.0 108.665 177.694 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 431' ' ' PRO . . . . . 0.815 ' HD2' HG11 ' A' ' 435' ' ' VAL . 43.0 Cg_exo -36.25 -65.71 0.13 Allowed 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 124.804 3.669 . . . . 0.0 114.34 -171.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . 0.542 ' H ' HG12 ' A' ' 435' ' ' VAL . . . -141.85 -163.18 9.5 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 176.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . 0.502 ' O ' HG13 ' A' ' 436' ' ' VAL . 21.7 tp60 -70.73 -27.64 64.12 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 118.103 0.952 . . . . 0.0 110.411 177.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -67.47 -38.89 85.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.031 -176.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 435' ' ' VAL . . . . . 0.815 HG11 ' HD2' ' A' ' 431' ' ' PRO . 7.6 p -68.48 -44.9 82.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.974 0.416 . . . . 0.0 110.602 -178.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 433' ' ' GLN . 0.2 OUTLIER -65.41 -29.35 46.9 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.334 175.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -70.71 -51.98 23.97 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . 0.887 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -58.14 -38.69 77.04 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.692 177.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 439' ' ' LEU . . . . . 0.559 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 2.1 tm? -70.15 -47.21 62.61 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -178.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.53 -39.33 76.35 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.406 174.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 441' ' ' GLN . . . . . 0.517 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 9.5 mm-40 -53.54 -49.7 67.08 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 123.958 0.903 . . . . 0.0 110.663 174.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . 0.818 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 0.6 OUTLIER -56.09 -40.17 73.24 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.762 172.226 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 443' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 31.9 mt -72.21 -32.07 66.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.023 0.44 . . . . 0.0 110.467 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -58.69 -38.2 77.73 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.458 173.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 -74.01 -27.53 61.01 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.219 177.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 446' ' ' GLU . . . . . 0.438 ' HB3' ' O ' ' A' ' 443' ' ' LEU . 10.3 pt-20 19.29 101.01 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 178.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 447' ' ' ILE . . . . . 0.418 HD12 HG22 ' A' ' 451' ' ' THR . 45.0 mt -61.03 -33.88 57.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.382 0.61 . . . . 0.0 110.438 177.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . 0.404 ' HB2' ' CB ' ' A' ' 451' ' ' THR . 10.8 m-20 -162.92 -156.14 0.38 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -178.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -89.74 -63.97 1.21 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 169.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.07 -25.86 64.66 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 178.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 451' ' ' THR . . . . . 0.426 ' HA ' ' HB2' ' A' ' 454' ' ' GLU . 13.5 m -71.28 -22.57 61.94 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.572 -176.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -54.24 -53.77 49.13 Favored 'General case' 0 C--O 1.22 -0.498 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 171.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 453' ' ' ALA . . . . . 0.549 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -57.43 -48.53 78.9 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 114.624 -1.171 . . . . 0.0 112.396 175.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . 0.426 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 14.7 mm-40 -51.1 -35.11 33.5 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.357 0.599 . . . . 0.0 111.559 -178.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 33.5 p -119.22 16.15 13.15 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.493 -176.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . 0.56 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.9 OUTLIER -57.77 -48.35 79.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.914 0.387 . . . . 0.0 111.693 -171.282 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . 0.574 HG23 ' HB1' ' A' ' 405' ' ' ALA . 2.0 mp -76.14 -32.63 23.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 120.8 0.333 . . . . 0.0 110.933 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -57.62 -35.05 69.95 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.978 0.894 . . . . 0.0 109.195 171.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . 0.726 ' O ' HG23 ' A' ' 463' ' ' VAL . 59.8 m-70 -74.84 -28.99 60.91 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.542 -1.208 . . . . 0.0 110.946 177.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . 0.714 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.4 OUTLIER -73.88 -34.94 64.63 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.97 0.89 . . . . 0.0 108.89 179.049 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . 0.44 ' O ' ' HB2' ' A' ' 464' ' ' TYR . 22.1 m-80 -73.34 -37.34 66.14 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.862 0.839 . . . . 0.0 108.78 177.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 462' ' ' ALA . . . . . 0.592 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -56.46 -35.34 67.8 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.377 -1.283 . . . . 0.0 109.656 169.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.887 HG13 ' HB3' ' A' ' 438' ' ' ALA . 68.2 t -60.93 -51.6 71.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 175.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 464' ' ' TYR . . . . . 0.618 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 19.9 m-30 -52.01 -28.34 16.68 Favored 'General case' 0 C--N 1.333 -0.125 0 O-C-N 124.363 1.039 . . . . 0.0 110.765 177.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.5 -40.6 17.45 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.5 0.667 . . . . 0.0 109.67 -177.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.592 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.7 mt -56.27 -55.43 18.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 114.395 -1.275 . . . . 0.0 112.198 176.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 0.793 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -101.9 -10.61 19.68 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 -172.667 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . 0.619 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 93.7 31.97 7.92 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 119.337 -1.411 . . . . 0.0 114.23 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 469' ' ' LEU . . . . . 0.793 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.7 mt -88.98 161.84 16.39 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 117.808 0.804 . . . . 0.0 111.146 176.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 37.9 p30 -104.55 -176.9 3.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.956 172.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 471' ' ' ALA . . . . . 0.464 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -62.28 -20.48 64.34 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -176.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -87.21 -1.8 58.16 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.655 0.265 . . . . 0.0 111.648 -173.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 79.11 14.21 82.09 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.008 -1.092 . . . . 0.0 110.66 -174.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -100.85 148.86 24.47 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 177.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 3.9 p -88.05 126.73 35.25 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.995 0.426 . . . . 0.0 111.168 -178.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 476' ' ' ILE . . . . . 0.619 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.8 pp . . . . . 0 C--N 1.327 -0.392 0 CA-C-O 121.523 0.678 . . . . 0.0 110.307 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 386' ' ' PHE . . . . . 0.698 ' CD1' HD22 ' B' ' 414' ' ' LEU . 1.2 t80 . . . . . 0 N--CA 1.472 0.661 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 387' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' B' ' 386' ' ' PHE . 5.6 Cg_endo -42.01 -71.45 0.06 OUTLIER 'Trans proline' 0 N--CA 1.482 0.851 0 C-N-CA 124.528 3.486 . . . . 0.0 113.967 -176.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 388' ' ' MET . . . . . 0.61 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 36.1 ttm 78.21 29.18 0.47 Allowed 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 173.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 389' ' ' HIS . . . . . 0.667 ' CG ' ' HB2' ' B' ' 393' ' ' ASN . 42.6 m170 61.87 -83.05 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.384 0.674 . . . . 0.0 110.554 -176.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -167.68 14.22 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.731 177.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 391' ' ' LEU . . . . . 0.487 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.5 pt? -169.5 -48.29 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -167.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 392' ' ' GLY . . . . . 0.576 ' HA3' HD13 ' B' ' 395' ' ' ILE . . . 178.61 48.49 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 119.31 -1.424 . . . . 0.0 114.527 -172.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 393' ' ' ASN . . . . . 0.667 ' HB2' ' CG ' ' B' ' 389' ' ' HIS . 0.2 OUTLIER -54.27 -39.61 67.05 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 117.531 0.665 . . . . 0.0 109.355 174.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 394' ' ' VAL . . . . . 0.708 HG23 HD12 ' B' ' 398' ' ' ILE . 1.8 m -56.25 -49.17 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 395' ' ' ILE . . . . . 0.685 HG23 HD13 ' B' ' 426' ' ' ILE . 3.7 mp -56.8 -53.39 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 CA-C-O 118.255 -0.879 . . . . 0.0 113.323 -174.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 396' ' ' LYS . . . . . 0.732 ' HG3' ' CE1' ' B' ' 429' ' ' TYR . 0.1 OUTLIER -66.27 -47.0 75.09 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 121.42 1.918 . . . . 0.0 112.054 -172.042 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.0 -45.19 62.19 Favored Glycine 0 N--CA 1.432 -1.571 0 C-N-CA 120.099 -1.048 . . . . 0.0 110.893 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 398' ' ' ILE . . . . . 0.708 HD12 HG23 ' B' ' 394' ' ' VAL . 31.1 mt -70.67 -33.88 54.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 399' ' ' VAL . . . . . 0.536 HG22 ' O ' ' B' ' 396' ' ' LYS . 11.2 m -62.59 -39.52 84.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 C-N-CA 118.664 -1.214 . . . . 0.0 108.07 -174.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -70.93 -34.8 71.85 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 175.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 401' ' ' GLN . . . . . 0.441 HE21 ' HB3' ' B' ' 401' ' ' GLN . 5.7 mm100 -89.11 -47.71 7.9 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -173.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 402' ' ' GLU . . . . . 0.467 ' HB3' ' HB ' ' B' ' 406' ' ' THR . 3.1 mm-40 -119.85 -20.89 7.4 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.558 -170.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 107.44 162.55 21.61 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.52 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 404' ' ' VAL . . . . . 0.601 HG11 ' HA ' ' B' ' 430' ' ' LEU . 1.6 m -53.95 -45.78 64.19 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.754 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -175.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 405' ' ' ALA . . . . . 0.565 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -64.02 -29.81 70.93 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 119.741 -0.784 . . . . 0.0 112.187 -177.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 406' ' ' THR . . . . . 0.696 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 90.1 m -77.34 -43.14 33.98 Favored 'General case' 0 C--O 1.22 -0.499 0 O-C-N 121.867 -0.521 . . . . 0.0 110.343 172.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 407' ' ' ALA . . . . . 0.435 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.16 -36.0 72.37 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 122.162 0.982 . . . . 0.0 109.254 176.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 408' ' ' TYR . . . . . 0.573 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -66.33 -52.74 44.09 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 113.411 -1.722 . . . . 0.0 109.711 176.003 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 409' ' ' THR . . . . . 0.631 HG22 HD23 ' B' ' 410' ' ' LEU . 17.1 m -55.41 -47.37 76.04 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.675 179.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 410' ' ' LEU . . . . . 0.703 HD12 ' CD1' ' B' ' 398' ' ' ILE . 15.1 mt -72.5 -36.46 68.39 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -174.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.91 -35.21 81.94 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.058 -1.068 . . . . 0.0 110.769 172.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 412' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -68.6 -48.41 64.21 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-O 120.514 0.197 . . . . 0.0 111.34 178.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 413' ' ' MET . . . . . 0.961 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 1.2 ppp? -71.07 -43.17 68.33 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 118.954 -1.098 . . . . 0.0 112.116 -177.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 414' ' ' LEU . . . . . 0.961 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 11.9 mt -71.21 -46.31 61.45 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -177.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 43.9 t -84.76 -24.4 28.82 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.649 0.738 . . . . 0.0 110.289 -174.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 416' ' ' GLY . . . . . 0.42 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 111.08 -175.83 18.07 Favored Glycine 0 N--CA 1.426 -2.009 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -171.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -80.54 24.05 0.48 Allowed 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.482 0.658 . . . . 0.0 111.255 -172.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 418' ' ' ASN . . . . . 0.42 ' H ' ' C ' ' B' ' 416' ' ' GLY . 84.9 m-20 -71.55 76.77 0.8 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.74 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 419' ' ' TYR . . . . . 0.559 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 16.8 p90 -54.4 -39.01 66.84 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.653 177.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -55.73 -43.85 76.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.788 0.328 . . . . 0.0 111.168 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 421' ' ' LEU . . . . . 0.402 HD22 ' HB2' ' B' ' 418' ' ' ASN . 0.0 OUTLIER -67.81 -48.69 65.55 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.033 -178.098 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 422' ' ' VAL . . . . . 0.429 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.2 OUTLIER -66.23 -39.44 84.3 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.398 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.089 -177.396 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 423' ' ' SER . . . . . 0.749 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 64.4 p -67.32 -39.88 85.92 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.924 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -66.38 -39.71 94.29 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.107 175.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 425' ' ' ILE . . . . . 0.649 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -72.79 -51.84 25.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 121.219 -0.192 . . . . 0.0 111.329 -177.218 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 426' ' ' ILE . . . . . 0.685 HD13 HG23 ' B' ' 395' ' ' ILE . 1.2 mm -73.87 -23.04 18.76 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.896 0 O-C-N 122.194 -0.316 . . . . 0.0 110.227 -171.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 427' ' ' ARG . . . . . 0.749 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.8 OUTLIER -54.7 -29.32 52.74 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.074 0.464 . . . . 0.0 111.007 -178.106 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.51 -11.4 68.86 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.638 -0.791 . . . . 0.0 111.637 178.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 429' ' ' TYR . . . . . 0.732 ' CE1' ' HG3' ' B' ' 396' ' ' LYS . 14.9 m-85 -114.13 -1.17 13.76 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-O 121.766 0.793 . . . . 0.0 109.256 -176.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 430' ' ' LEU . . . . . 0.625 HD12 ' HD2' ' B' ' 431' ' ' PRO . 0.0 OUTLIER -66.02 135.13 95.11 Favored Pre-proline 0 N--CA 1.438 -1.031 0 CA-C-N 114.017 -1.447 . . . . 0.0 108.649 177.582 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 431' ' ' PRO . . . . . 0.821 ' HD2' HG11 ' B' ' 435' ' ' VAL . 43.9 Cg_exo -36.21 -65.99 0.13 Allowed 'Trans proline' 0 N--CA 1.474 0.365 0 C-N-CA 124.888 3.725 . . . . 0.0 114.226 -171.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 432' ' ' GLY . . . . . 0.533 ' H ' HG12 ' B' ' 435' ' ' VAL . . . -141.63 -163.36 9.56 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 176.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 433' ' ' GLN . . . . . 0.506 ' O ' HG13 ' B' ' 436' ' ' VAL . 21.3 tp60 -70.54 -27.6 64.28 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 118.079 0.94 . . . . 0.0 110.322 177.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -67.52 -38.94 85.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.995 -176.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 435' ' ' VAL . . . . . 0.821 HG11 ' HD2' ' B' ' 431' ' ' PRO . 7.7 p -68.59 -44.85 82.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-O 120.958 0.409 . . . . 0.0 110.623 -178.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 436' ' ' VAL . . . . . 0.506 HG13 ' O ' ' B' ' 433' ' ' GLN . 0.2 OUTLIER -65.19 -29.69 48.06 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.39 175.83 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -70.37 -51.99 25.76 Favored 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 438' ' ' ALA . . . . . 0.875 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -58.15 -38.73 77.18 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.707 177.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 439' ' ' LEU . . . . . 0.566 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 2.1 tm? -70.23 -47.09 62.92 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -178.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.67 -39.16 76.45 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.34 174.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 441' ' ' GLN . . . . . 0.518 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 9.2 mm-40 -53.76 -49.62 67.8 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 123.826 0.85 . . . . 0.0 110.624 174.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 442' ' ' ARG . . . . . 0.832 ' HG2' ' O ' ' B' ' 438' ' ' ALA . 0.7 OUTLIER -56.15 -40.24 73.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.684 172.228 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 443' ' ' LEU . . . . . 0.566 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 32.5 mt -72.16 -32.03 66.5 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.995 0.426 . . . . 0.0 110.34 -178.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -58.81 -38.06 77.77 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.682 0.753 . . . . 0.0 110.464 173.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -74.03 -27.54 60.99 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.275 177.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 446' ' ' GLU . . . . . 0.437 ' HB3' ' O ' ' B' ' 443' ' ' LEU . 10.8 pt-20 19.3 100.29 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 178.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 447' ' ' ILE . . . . . 0.425 HD12 HG22 ' B' ' 451' ' ' THR . 45.2 mt -60.61 -34.03 56.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.382 0.611 . . . . 0.0 110.426 177.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 448' ' ' ASP . . . . . 0.404 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 11.4 m-20 -162.61 -156.31 0.4 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -178.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -89.66 -63.97 1.21 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 169.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.87 -25.94 64.88 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 178.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 451' ' ' THR . . . . . 0.429 ' HA ' ' HB2' ' B' ' 454' ' ' GLU . 12.1 m -71.29 -22.57 61.93 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.602 -176.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 452' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -54.37 -53.65 51.11 Favored 'General case' 0 C--O 1.219 -0.533 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 171.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 453' ' ' ALA . . . . . 0.559 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -57.71 -48.04 80.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 114.609 -1.178 . . . . 0.0 112.53 175.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 454' ' ' GLU . . . . . 0.429 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 11.4 mm-40 -51.53 -34.82 37.98 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.161 0.505 . . . . 0.0 111.578 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 32.4 p -119.63 16.04 12.8 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.424 -176.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 456' ' ' PHE . . . . . 0.565 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 0.9 OUTLIER -57.46 -48.68 78.54 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.664 -171.304 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 457' ' ' ILE . . . . . 0.565 HG23 ' HB1' ' B' ' 405' ' ' ALA . 2.0 mp -75.68 -32.83 25.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.986 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -57.39 -35.29 69.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.959 0.885 . . . . 0.0 109.139 171.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 459' ' ' HIS . . . . . 0.73 ' O ' HG23 ' B' ' 463' ' ' VAL . 60.8 m-70 -74.73 -28.91 60.98 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.44 -1.254 . . . . 0.0 110.998 177.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 460' ' ' LEU . . . . . 0.728 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.4 OUTLIER -73.91 -35.04 64.61 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.9 0.857 . . . . 0.0 108.938 178.944 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 461' ' ' ASN . . . . . 0.42 ' O ' ' HB2' ' B' ' 464' ' ' TYR . 23.5 m-80 -73.24 -37.42 66.37 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.743 177.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 462' ' ' ALA . . . . . 0.606 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -56.39 -35.34 67.64 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.711 169.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 463' ' ' VAL . . . . . 0.875 HG13 ' HB3' ' B' ' 438' ' ' ALA . 68.3 t -61.01 -51.59 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 175.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 464' ' ' TYR . . . . . 0.611 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 19.9 m-30 -52.0 -28.39 16.8 Favored 'General case' 0 N--CA 1.457 -0.11 0 O-C-N 124.4 1.063 . . . . 0.0 110.764 178.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.41 -40.53 17.69 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.633 0.73 . . . . 0.0 109.736 -177.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 466' ' ' ILE . . . . . 0.606 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.7 mt -56.04 -55.83 16.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 114.402 -1.272 . . . . 0.0 112.184 176.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 467' ' ' LEU . . . . . 0.801 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -101.83 -10.44 19.88 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -172.468 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 468' ' ' GLY . . . . . 0.616 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 93.75 32.03 7.86 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 119.352 -1.404 . . . . 0.0 114.164 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 469' ' ' LEU . . . . . 0.801 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.7 mt -89.05 161.81 16.35 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 117.81 0.805 . . . . 0.0 111.149 176.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 37.9 p30 -104.59 -176.93 3.22 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.901 172.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 471' ' ' ALA . . . . . 0.468 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -62.22 -20.74 64.52 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -175.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 472' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' B' ' 472' ' ' ARG . 27.7 mmt180 -87.11 -1.68 58.07 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.655 0.264 . . . . 0.0 111.647 -173.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 473' ' ' GLY . . . . . . . . . . . . . . . 78.7 14.62 81.87 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 119.986 -1.102 . . . . 0.0 110.61 -174.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -101.11 149.01 24.4 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 177.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 4.2 p -87.86 127.5 35.34 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.05 0.452 . . . . 0.0 111.006 -178.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 476' ' ' ILE . . . . . 0.616 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.9 pp . . . . . 0 C--N 1.326 -0.445 0 CA-C-O 121.625 0.726 . . . . 0.0 110.225 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 386' ' ' PHE . . . . . 0.817 ' CD1' HD22 ' A' ' 414' ' ' LEU . 4.7 t80 . . . . . 0 CA--C 1.53 0.201 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -47.11 -67.72 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.848 3.032 . . . . 0.0 114.5 -174.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.516 ' HB2' ' HE2' ' A' ' 388' ' ' MET . 34.5 ttm 66.27 160.81 0.14 Allowed 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.792 0.33 . . . . 0.0 111.235 176.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 389' ' ' HIS . . . . . 0.623 ' CE1' ' HA ' ' A' ' 393' ' ' ASN . 34.4 m170 -72.73 -155.68 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 108.353 -0.981 . . . . 0.0 108.353 173.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . 0.445 ' CD ' ' H ' ' A' ' 390' ' ' GLN . 5.7 pm0 -77.84 8.77 4.16 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.395 172.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.546 HD23 ' H ' ' A' ' 392' ' ' GLY . 2.1 pt? -159.79 -51.84 0.06 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -176.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . 0.714 ' HA3' HD13 ' A' ' 395' ' ' ILE . . . -171.05 72.82 0.11 Allowed Glycine 0 CA--C 1.526 0.766 0 C-N-CA 119.438 -1.363 . . . . 0.0 114.762 -173.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . 0.623 ' HA ' ' CE1' ' A' ' 389' ' ' HIS . 0.0 OUTLIER -66.4 -36.95 84.14 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 175.832 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . 0.677 HG23 HD12 ' A' ' 398' ' ' ILE . 1.0 OUTLIER -57.07 -49.09 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 CA-C-N 113.032 -1.894 . . . . 0.0 107.248 178.193 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . 0.714 HD13 ' HA3' ' A' ' 392' ' ' GLY . 3.7 mp -58.48 -52.61 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 CA-C-O 117.663 -1.161 . . . . 0.0 113.671 -174.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . 0.586 ' O ' HG22 ' A' ' 399' ' ' VAL . 0.0 OUTLIER -61.88 -50.02 73.89 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 122.221 2.282 . . . . 0.0 112.143 -174.56 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . 0.434 ' O ' ' HG3' ' A' ' 401' ' ' GLN . . . -53.29 -44.68 65.24 Favored Glycine 0 N--CA 1.432 -1.571 0 CA-C-N 114.713 -1.13 . . . . 0.0 111.045 -176.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . 0.854 HD13 HD12 ' A' ' 410' ' ' LEU . 37.8 mt -71.34 -34.23 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -178.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . 0.586 HG22 ' O ' ' A' ' 396' ' ' LYS . 16.3 m -63.24 -40.33 88.62 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 C-N-CA 118.92 -1.112 . . . . 0.0 108.49 -173.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -64.3 -43.85 93.44 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 175.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.572 ' NE2' ' HA ' ' B' ' 414' ' ' LEU . 14.5 mt-30 -92.9 -48.38 6.56 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -167.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . 0.602 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 1.2 tm-20 -111.52 -19.13 12.66 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.193 0.52 . . . . 0.0 110.82 -173.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 104.51 161.33 24.18 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.846 177.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . 0.644 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.2 m -53.94 -45.13 63.51 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.866 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -175.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . 0.553 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -63.58 -31.65 72.87 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 119.956 -0.697 . . . . 0.0 112.517 -177.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.696 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 88.0 m -77.08 -41.48 42.06 Favored 'General case' 0 C--O 1.222 -0.35 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.46 173.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.486 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -58.84 -36.6 74.82 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 122.1 0.953 . . . . 0.0 109.354 175.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 408' ' ' TYR . . . . . 0.644 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -67.18 -51.47 53.23 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 113.525 -1.671 . . . . 0.0 109.729 177.009 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 409' ' ' THR . . . . . 0.675 HG22 HD23 ' A' ' 410' ' ' LEU . 17.1 m -54.55 -47.76 72.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.591 -0.732 . . . . 0.0 112.508 177.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . 0.854 HD12 HD13 ' A' ' 398' ' ' ILE . 14.5 mt -72.55 -34.4 67.5 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -175.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.59 -34.01 74.46 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.286 -0.959 . . . . 0.0 110.865 170.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 412' ' ' MET . . . . . 0.403 ' HB2' ' O ' ' A' ' 409' ' ' THR . 0.4 OUTLIER -67.89 -48.09 67.0 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 122.547 -0.384 . . . . 0.0 111.17 177.148 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 413' ' ' MET . . . . . 0.922 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.7 OUTLIER -72.32 -48.21 43.89 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 119.176 -1.01 . . . . 0.0 112.569 -179.778 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . 0.922 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 15.4 mt -69.18 -46.95 66.23 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -174.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.08 9.62 41.59 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.432 0.634 . . . . 0.0 110.746 -173.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . 0.411 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 85.32 -178.46 50.57 Favored Glycine 0 N--CA 1.435 -1.375 0 CA-C-N 115.437 -0.802 . . . . 0.0 111.554 -178.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -79.94 22.66 0.49 Allowed 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.285 0.564 . . . . 0.0 111.108 -173.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 418' ' ' ASN . . . . . 0.415 ' HB3' ' HB3' ' A' ' 421' ' ' LEU . 3.5 m-20 -71.94 75.1 0.9 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.083 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 419' ' ' TYR . . . . . 0.567 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 28.3 p90 -56.6 -36.96 70.0 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.456 177.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -54.81 -42.03 71.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.461 175.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . 0.415 ' HB3' ' HB3' ' A' ' 418' ' ' ASN . 0.0 OUTLIER -68.62 -51.89 37.32 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.624 -179.068 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . 0.51 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -62.77 -37.1 78.24 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.582 -174.705 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.771 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 58.4 p -69.27 -34.07 74.19 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -68.69 -42.18 80.86 Favored Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.3 174.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . 0.571 HG22 HG21 ' A' ' 395' ' ' ILE . 2.6 mp -72.55 -50.98 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 116.921 0.361 . . . . 0.0 111.514 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . 0.67 HD13 HG23 ' A' ' 395' ' ' ILE . 1.2 mm -75.19 -23.69 17.26 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.911 0 O-C-N 122.085 -0.384 . . . . 0.0 110.926 -171.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.771 ' HB2' ' O ' ' A' ' 423' ' ' SER . 1.0 OUTLIER -54.3 -33.3 58.44 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.196 0.522 . . . . 0.0 111.009 -177.199 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -84.65 -13.79 71.99 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.316 -0.945 . . . . 0.0 111.021 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.567 ' HD1' HG22 ' A' ' 395' ' ' ILE . 7.3 m-30 -110.83 -2.05 16.29 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.913 0.863 . . . . 0.0 108.758 -174.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.635 ' HA ' HG11 ' A' ' 404' ' ' VAL . 0.0 OUTLIER -66.3 138.96 96.12 Favored Pre-proline 0 N--CA 1.441 -0.902 0 CA-C-N 113.972 -1.467 . . . . 0.0 109.027 176.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 431' ' ' PRO . . . . . 0.844 ' HD2' HG11 ' A' ' 435' ' ' VAL . 71.0 Cg_exo -37.81 -65.3 0.16 Allowed 'Trans proline' 0 N--CA 1.473 0.312 0 C-N-CA 124.499 3.466 . . . . 0.0 113.874 -173.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . 0.544 ' H ' HG12 ' A' ' 435' ' ' VAL . . . -143.86 -163.24 9.8 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 176.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . 0.543 ' O ' HG13 ' A' ' 436' ' ' VAL . 43.8 tp60 -71.87 -26.67 62.44 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 118.328 1.064 . . . . 0.0 110.882 177.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -66.29 -40.7 90.22 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -177.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 435' ' ' VAL . . . . . 0.844 HG11 ' HD2' ' A' ' 431' ' ' PRO . 7.5 p -67.08 -44.13 88.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-O 120.962 0.411 . . . . 0.0 110.783 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.543 HG13 ' O ' ' A' ' 433' ' ' GLN . 0.1 OUTLIER -65.98 -31.55 54.19 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.179 176.383 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.2 -52.98 34.58 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -178.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . 0.866 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -58.56 -40.06 82.02 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.23 177.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 439' ' ' LEU . . . . . 0.605 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 1.9 tm? -68.13 -48.1 66.3 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -178.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.9 -38.44 78.91 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.457 176.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 441' ' ' GLN . . . . . 0.444 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 6.0 mm-40 -53.69 -52.09 61.14 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 123.629 0.771 . . . . 0.0 110.56 177.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . 0.543 ' NH1' ' HB1' ' A' ' 462' ' ' ALA . 0.1 OUTLIER -60.95 -34.9 75.45 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.734 174.848 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 443' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 64.1 mt -68.32 -36.55 79.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.744 178.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -56.57 -37.12 70.13 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.527 0.679 . . . . 0.0 110.284 174.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -74.12 -26.75 60.52 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.577 177.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 446' ' ' GLU . . . . . 0.419 ' HB3' ' O ' ' A' ' 443' ' ' LEU . 10.1 pt-20 19.26 103.36 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 176.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 447' ' ' ILE . . . . . 0.431 HD12 HG22 ' A' ' 451' ' ' THR . 43.0 mt -60.95 -34.9 61.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.852 178.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . 0.456 ' HB2' ' OG1' ' A' ' 451' ' ' THR . 22.1 m-20 -162.43 -158.8 0.53 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -178.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 449' ' ' ASP . . . . . 0.529 ' HA ' ' CZ ' ' A' ' 452' ' ' ARG . 9.6 m-20 -86.29 -67.2 0.83 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 170.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 450' ' ' GLN . . . . . 0.406 ' HG3' ' H ' ' A' ' 450' ' ' GLN . 0.0 OUTLIER -65.94 -25.57 67.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.167 178.562 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 451' ' ' THR . . . . . 0.463 ' HA ' ' HB2' ' A' ' 454' ' ' GLU . 14.3 m -71.47 -22.6 61.8 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.633 -176.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . 0.529 ' CZ ' ' HA ' ' A' ' 449' ' ' ASP . 48.8 mtt85 -54.65 -53.92 48.4 Favored 'General case' 0 C--O 1.219 -0.535 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 171.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 453' ' ' ALA . . . . . 0.567 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -56.69 -47.91 78.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.706 -1.134 . . . . 0.0 112.404 174.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . 0.463 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 13.3 mm-40 -52.36 -33.09 41.54 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.14 0.495 . . . . 0.0 111.742 -178.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 28.6 p -120.04 13.17 12.11 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.551 -176.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . 0.538 ' CE2' ' HB2' ' A' ' 419' ' ' TYR . 0.6 OUTLIER -56.71 -49.03 76.39 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.003 0.43 . . . . 0.0 111.493 -171.525 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . 0.553 HG23 ' HB1' ' A' ' 405' ' ' ALA . 1.9 mp -75.98 -32.02 22.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.067 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -57.88 -35.45 71.0 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.722 0.772 . . . . 0.0 108.939 171.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . 0.77 ' O ' HG23 ' A' ' 463' ' ' VAL . 74.2 m-70 -74.44 -29.3 61.42 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.294 178.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . 0.728 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -74.1 -35.36 64.17 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.864 0.84 . . . . 0.0 109.241 179.78 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . 0.492 ' O ' ' HB2' ' A' ' 464' ' ' TYR . 23.1 m-80 -73.65 -37.25 65.37 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 121.935 0.874 . . . . 0.0 108.922 177.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 462' ' ' ALA . . . . . 0.578 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -57.26 -34.8 69.0 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.803 169.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.866 HG13 ' HB3' ' A' ' 438' ' ' ALA . 63.7 t -60.46 -50.82 78.85 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.851 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 175.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 464' ' ' TYR . . . . . 0.624 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 19.3 m-30 -52.77 -28.25 21.56 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.552 177.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.53 -41.77 19.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.721 0.772 . . . . 0.0 109.457 -178.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.578 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.8 mt -57.24 -55.85 18.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 114.269 -1.332 . . . . 0.0 112.076 177.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 0.777 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -101.07 -10.12 20.78 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -172.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . 0.599 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 94.14 31.59 7.96 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 119.354 -1.403 . . . . 0.0 114.31 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 469' ' ' LEU . . . . . 0.777 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.9 mt -88.58 163.77 15.7 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 117.831 0.815 . . . . 0.0 111.09 176.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 37.4 p30 -105.34 -179.27 3.89 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.521 174.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -60.17 -23.25 63.8 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -177.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -87.24 2.34 50.37 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.325 -172.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 473' ' ' GLY . . . . . 0.484 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 77.8 10.61 86.11 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.501 -0.857 . . . . 0.0 111.3 -177.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -101.23 157.98 16.38 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 176.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 475' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 469' ' ' LEU . 16.3 t -94.01 144.3 25.59 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.314 -0.555 . . . . 0.0 110.755 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 476' ' ' ILE . . . . . 0.599 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.5 pp . . . . . 0 C--N 1.323 -0.567 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.513 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 386' ' ' PHE . . . . . 0.817 ' CD1' HD22 ' B' ' 414' ' ' LEU . 4.6 t80 . . . . . 0 CA--C 1.53 0.192 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 387' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -47.22 -67.75 0.11 Allowed 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 123.788 2.992 . . . . 0.0 114.388 -174.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 388' ' ' MET . . . . . 0.531 ' HB2' ' HE2' ' B' ' 388' ' ' MET . 34.6 ttm 66.2 161.01 0.14 Allowed 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.683 0.278 . . . . 0.0 111.247 177.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 389' ' ' HIS . . . . . 0.611 ' CE1' ' HA ' ' B' ' 393' ' ' ASN . 34.5 m170 -72.91 -155.14 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 173.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 390' ' ' GLN . . . . . 0.428 ' CD ' ' H ' ' B' ' 390' ' ' GLN . 5.7 pm0 -77.92 8.8 4.19 Favored 'General case' 0 C--N 1.317 -0.837 0 O-C-N 121.914 -0.491 . . . . 0.0 110.428 171.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 391' ' ' LEU . . . . . 0.536 HD23 ' H ' ' B' ' 392' ' ' GLY . 2.1 pt? -160.06 -51.69 0.05 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -176.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 392' ' ' GLY . . . . . 0.715 ' HA3' HD13 ' B' ' 395' ' ' ILE . . . -170.92 72.83 0.11 Allowed Glycine 0 C--N 1.338 0.689 0 C-N-CA 119.513 -1.327 . . . . 0.0 114.746 -173.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 393' ' ' ASN . . . . . 0.611 ' HA ' ' CE1' ' B' ' 389' ' ' HIS . 0.0 OUTLIER -66.28 -37.02 84.46 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 175.711 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 394' ' ' VAL . . . . . 0.687 HG23 HD12 ' B' ' 398' ' ' ILE . 1.0 OUTLIER -57.04 -49.09 80.55 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 CA-C-N 113.039 -1.892 . . . . 0.0 107.216 178.352 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 395' ' ' ILE . . . . . 0.715 HD13 ' HA3' ' B' ' 392' ' ' GLY . 3.7 mp -58.42 -52.6 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.559 0 CA-C-O 117.681 -1.152 . . . . 0.0 113.63 -174.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 396' ' ' LYS . . . . . 0.583 ' O ' HG22 ' B' ' 399' ' ' VAL . 0.0 OUTLIER -62.02 -49.75 74.78 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 122.18 2.264 . . . . 0.0 112.139 -174.4 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 397' ' ' GLY . . . . . 0.44 ' O ' ' HG3' ' B' ' 401' ' ' GLN . . . -53.51 -44.79 67.59 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 114.704 -1.135 . . . . 0.0 110.904 -176.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 398' ' ' ILE . . . . . 0.863 HD13 HD12 ' B' ' 410' ' ' LEU . 38.1 mt -71.24 -34.2 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -178.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 399' ' ' VAL . . . . . 0.583 HG22 ' O ' ' B' ' 396' ' ' LYS . 16.4 m -63.32 -40.19 88.09 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 C-N-CA 118.949 -1.1 . . . . 0.0 108.573 -173.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -64.35 -44.03 92.75 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 174.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 401' ' ' GLN . . . . . 0.576 ' NE2' ' HA ' ' A' ' 414' ' ' LEU . 14.5 mt-30 -92.78 -48.45 6.56 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -167.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 402' ' ' GLU . . . . . 0.603 ' HG3' ' HE3' ' A' ' 413' ' ' MET . 1.2 tm-20 -111.36 -19.28 12.67 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.19 0.519 . . . . 0.0 110.842 -173.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 104.62 161.31 24.08 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.89 177.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 404' ' ' VAL . . . . . 0.639 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.2 m -54.0 -45.13 64.3 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.812 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -175.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 405' ' ' ALA . . . . . 0.539 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -63.63 -31.46 72.64 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 119.954 -0.698 . . . . 0.0 112.522 -177.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 406' ' ' THR . . . . . 0.692 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 89.6 m -77.14 -41.7 40.76 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.146 -0.622 . . . . 0.0 110.402 173.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 407' ' ' ALA . . . . . 0.494 ' HB2' ' HB ' ' B' ' 398' ' ' ILE . . . -58.7 -36.68 74.63 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 122.154 0.978 . . . . 0.0 109.319 175.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 408' ' ' TYR . . . . . 0.639 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -67.27 -51.39 53.42 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 113.512 -1.677 . . . . 0.0 109.693 177.151 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 409' ' ' THR . . . . . 0.665 HG22 HD23 ' B' ' 410' ' ' LEU . 17.6 m -54.49 -47.88 72.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.478 177.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 410' ' ' LEU . . . . . 0.863 HD12 HD13 ' B' ' 398' ' ' ILE . 14.5 mt -72.46 -34.41 67.72 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -175.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.48 -33.94 73.54 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 120.311 -0.947 . . . . 0.0 110.954 170.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 412' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -68.04 -48.09 66.61 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 122.406 -0.467 . . . . 0.0 111.21 177.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 413' ' ' MET . . . . . 0.917 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.7 OUTLIER -72.18 -47.98 46.67 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 119.201 -0.999 . . . . 0.0 112.627 -179.779 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 414' ' ' LEU . . . . . 0.917 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 15.7 mt -69.62 -46.65 65.74 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -174.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.19 9.36 42.41 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.434 0.635 . . . . 0.0 110.769 -173.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 416' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 85.56 -178.38 50.22 Favored Glycine 0 N--CA 1.435 -1.378 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.64 -178.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -80.08 22.51 0.51 Allowed 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.227 0.537 . . . . 0.0 111.08 -173.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 418' ' ' ASN . . . . . 0.412 ' HB3' ' HB3' ' B' ' 421' ' ' LEU . 3.5 m-20 -71.76 75.06 0.85 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.108 179.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 419' ' ' TYR . . . . . 0.563 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 29.0 p90 -56.59 -36.9 69.91 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.484 177.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -54.91 -41.91 71.55 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.505 175.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 421' ' ' LEU . . . . . 0.412 ' HB3' ' HB3' ' B' ' 418' ' ' ASN . 0.0 OUTLIER -68.75 -51.86 36.66 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.71 -179.201 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 422' ' ' VAL . . . . . 0.501 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.2 OUTLIER -62.72 -37.22 78.48 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.57 -174.776 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 423' ' ' SER . . . . . 0.78 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 57.1 p -69.03 -34.55 75.4 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -68.3 -42.18 83.61 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.347 175.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 425' ' ' ILE . . . . . 0.578 HG22 HG21 ' B' ' 395' ' ' ILE . 2.6 mp -72.43 -51.1 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-N 116.723 0.261 . . . . 0.0 111.566 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 426' ' ' ILE . . . . . 0.651 HD13 HG23 ' B' ' 395' ' ' ILE . 1.2 mm -75.31 -23.51 17.03 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.925 0 O-C-N 121.978 -0.451 . . . . 0.0 110.95 -171.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 427' ' ' ARG . . . . . 0.78 ' HB2' ' O ' ' B' ' 423' ' ' SER . 1.0 OUTLIER -54.42 -33.21 58.99 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.192 0.52 . . . . 0.0 111.008 -177.194 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -84.88 -13.33 72.38 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.417 -0.897 . . . . 0.0 111.032 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 429' ' ' TYR . . . . . 0.575 ' HD1' HG22 ' B' ' 395' ' ' ILE . 7.4 m-30 -111.24 -2.13 15.85 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -174.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 430' ' ' LEU . . . . . 0.631 ' HA ' HG11 ' B' ' 404' ' ' VAL . 0.0 OUTLIER -66.46 138.65 95.8 Favored Pre-proline 0 N--CA 1.441 -0.904 0 CA-C-N 114.001 -1.454 . . . . 0.0 109.08 176.946 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 431' ' ' PRO . . . . . 0.838 ' HD2' HG11 ' B' ' 435' ' ' VAL . 70.0 Cg_exo -37.69 -64.6 0.18 Allowed 'Trans proline' 0 CA--C 1.533 0.426 0 C-N-CA 124.548 3.499 . . . . 0.0 114.045 -173.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 432' ' ' GLY . . . . . 0.558 ' H ' HG12 ' B' ' 435' ' ' VAL . . . -144.7 -163.92 10.29 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 176.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 433' ' ' GLN . . . . . 0.546 ' O ' HG13 ' B' ' 436' ' ' VAL . 43.0 tp60 -71.58 -26.79 62.76 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 118.34 1.07 . . . . 0.0 110.762 178.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -66.09 -40.6 90.92 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 435' ' ' VAL . . . . . 0.838 HG11 ' HD2' ' B' ' 431' ' ' PRO . 7.5 p -67.33 -44.03 87.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-O 120.981 0.42 . . . . 0.0 110.788 -178.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 436' ' ' VAL . . . . . 0.546 HG13 ' O ' ' B' ' 433' ' ' GLN . 0.1 OUTLIER -65.91 -31.55 54.23 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.103 176.485 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.36 -52.91 34.34 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -178.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 438' ' ' ALA . . . . . 0.862 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -58.52 -39.94 81.52 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.157 177.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 439' ' ' LEU . . . . . 0.592 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 1.9 tm? -68.14 -48.13 66.2 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -178.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.94 -38.28 78.64 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.665 -1.152 . . . . 0.0 111.507 176.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 441' ' ' GLN . . . . . 0.441 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 6.0 mm-40 -53.87 -52.0 61.86 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 123.496 0.718 . . . . 0.0 110.499 177.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 442' ' ' ARG . . . . . 0.549 ' NH1' ' HB1' ' B' ' 462' ' ' ALA . 0.1 OUTLIER -60.96 -35.07 75.82 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.652 174.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 443' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 64.9 mt -68.24 -36.47 79.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.803 178.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -56.64 -37.3 70.57 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.511 0.672 . . . . 0.0 110.346 174.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -74.03 -26.87 60.66 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.467 177.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 446' ' ' GLU . . . . . 0.434 ' HB3' ' O ' ' B' ' 443' ' ' LEU . 10.3 pt-20 19.72 103.26 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 176.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 447' ' ' ILE . . . . . 0.422 HD12 HG22 ' B' ' 451' ' ' THR . 43.3 mt -60.88 -34.68 60.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.927 178.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 448' ' ' ASP . . . . . 0.455 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 21.1 m-20 -162.57 -158.56 0.51 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -178.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 449' ' ' ASP . . . . . 0.512 ' HA ' ' CZ ' ' B' ' 452' ' ' ARG . 11.0 m-20 -86.59 -67.05 0.84 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 170.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.87 -25.68 67.29 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 178.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 451' ' ' THR . . . . . 0.475 ' HA ' ' HB2' ' B' ' 454' ' ' GLU . 14.1 m -71.34 -22.66 61.88 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.615 -176.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 452' ' ' ARG . . . . . 0.512 ' CZ ' ' HA ' ' B' ' 449' ' ' ASP . 48.7 mtt180 -54.65 -53.79 50.19 Favored 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 171.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 453' ' ' ALA . . . . . 0.563 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -56.75 -47.98 78.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.689 -1.141 . . . . 0.0 112.415 174.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 454' ' ' GLU . . . . . 0.475 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 14.4 mm-40 -52.36 -32.92 40.67 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.028 0.442 . . . . 0.0 111.828 -178.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 27.8 p -120.23 13.38 11.98 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.58 -176.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 456' ' ' PHE . . . . . 0.552 ' CE2' ' HB2' ' B' ' 419' ' ' TYR . 0.7 OUTLIER -56.86 -48.91 77.01 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.09 0.471 . . . . 0.0 111.496 -171.479 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 457' ' ' ILE . . . . . 0.548 HG13 ' HB3' ' B' ' 408' ' ' TYR . 1.9 mp -76.19 -32.08 22.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.968 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -57.81 -35.51 70.96 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.696 0.76 . . . . 0.0 109.025 171.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 459' ' ' HIS . . . . . 0.779 ' O ' HG23 ' B' ' 463' ' ' VAL . 73.4 m-70 -74.39 -29.16 61.42 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.312 178.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 460' ' ' LEU . . . . . 0.733 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -74.05 -35.42 64.3 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.907 0.861 . . . . 0.0 109.198 179.679 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 461' ' ' ASN . . . . . 0.471 ' O ' ' HB2' ' B' ' 464' ' ' TYR . 22.4 m-80 -73.65 -37.3 65.35 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.911 0.862 . . . . 0.0 108.857 177.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 462' ' ' ALA . . . . . 0.584 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -57.25 -34.61 68.79 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.383 -1.28 . . . . 0.0 109.84 169.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 463' ' ' VAL . . . . . 0.862 HG13 ' HB3' ' B' ' 438' ' ' ALA . 64.6 t -60.57 -50.9 78.53 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.778 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 464' ' ' TYR . . . . . 0.616 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 19.2 m-30 -52.83 -28.12 21.34 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.492 177.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.62 -41.94 18.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.593 0.711 . . . . 0.0 109.382 -178.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 466' ' ' ILE . . . . . 0.584 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.8 mt -57.06 -55.93 17.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 114.405 -1.27 . . . . 0.0 112.154 177.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 467' ' ' LEU . . . . . 0.77 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -100.75 -10.26 20.97 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -173.009 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 468' ' ' GLY . . . . . 0.607 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 94.18 31.57 7.96 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 119.222 -1.466 . . . . 0.0 114.396 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 469' ' ' LEU . . . . . 0.77 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.9 mt -88.5 163.83 15.73 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 117.954 0.877 . . . . 0.0 111.046 176.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 37.4 p30 -105.32 -179.41 3.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.553 174.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 471' ' ' ALA . . . . . . . . . . . . . . . -60.1 -22.84 63.28 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -87.49 2.06 51.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.251 -172.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 473' ' ' GLY . . . . . 0.489 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 78.16 10.47 86.19 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.37 -0.919 . . . . 0.0 111.214 -177.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -101.19 157.87 16.45 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 176.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 475' ' ' SER . . . . . 0.449 ' HA ' ' HA ' ' B' ' 469' ' ' LEU . 16.7 t -93.87 143.83 25.98 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.757 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 476' ' ' ILE . . . . . 0.607 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.5 pp . . . . . 0 C--N 1.322 -0.62 0 CA-C-O 121.498 0.666 . . . . 0.0 110.508 -178.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 386' ' ' PHE . . . . . 0.878 ' CD1' HD22 ' A' ' 414' ' ' LEU . 5.0 t80 . . . . . 0 CA--C 1.529 0.161 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . 0.565 ' HG2' ' OD1' ' B' ' 393' ' ' ASN . 1.2 Cg_endo -45.09 -65.21 0.2 Allowed 'Trans proline' 0 CA--C 1.533 0.438 0 C-N-CA 123.667 2.911 . . . . 0.0 114.088 -177.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.781 ' SD ' HG13 ' A' ' 394' ' ' VAL . 18.2 tpp 67.21 160.69 0.16 Allowed 'General case' 0 N--CA 1.472 0.655 0 O-C-N 123.06 0.225 . . . . 0.0 110.814 178.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 389' ' ' HIS . . . . . 0.582 ' CG ' ' HB2' ' A' ' 393' ' ' ASN . 32.3 m170 -70.69 -161.19 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 171.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -72.76 6.99 2.16 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.288 172.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.587 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.1 pt? -161.01 -64.08 0.06 Allowed 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -175.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . 0.599 ' HA3' HD13 ' A' ' 395' ' ' ILE . . . -158.36 59.95 0.33 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 119.759 -1.21 . . . . 0.0 114.175 -170.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . 0.582 ' HB2' ' CG ' ' A' ' 389' ' ' HIS . 0.2 OUTLIER -55.11 -44.06 74.63 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.344 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . 0.781 HG13 ' SD ' ' A' ' 388' ' ' MET . 1.1 m -59.08 -44.79 92.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-N 114.32 -1.309 . . . . 0.0 108.247 -177.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . 0.68 HG23 HD13 ' A' ' 426' ' ' ILE . 4.2 mp -57.76 -52.05 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 CA-C-O 117.855 -1.069 . . . . 0.0 113.024 -175.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . 0.638 ' HG3' ' CZ ' ' A' ' 429' ' ' TYR . 0.1 OUTLIER -62.95 -49.2 75.7 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 121.681 2.037 . . . . 0.0 111.662 -175.766 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -54.69 -45.84 77.01 Favored Glycine 0 N--CA 1.432 -1.589 0 C-N-CA 120.072 -1.061 . . . . 0.0 111.31 -178.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . 0.844 HG12 HD21 ' B' ' 414' ' ' LEU . 26.9 mt -71.38 -33.86 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -177.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . 0.502 HG12 ' HA ' ' A' ' 404' ' ' VAL . 7.9 m -63.68 -39.58 85.89 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 C-N-CA 118.79 -1.164 . . . . 0.0 108.396 -174.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -69.33 -38.53 78.21 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 175.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.462 HE21 ' HB3' ' A' ' 401' ' ' GLN . 4.1 mm100 -86.17 -48.8 8.25 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -170.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . 0.471 ' HA ' HH11 ' A' ' 472' ' ' ARG . 10.2 tp10 -120.97 -21.04 6.66 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.868 0.366 . . . . 0.0 111.22 -171.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 109.7 163.64 19.63 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.985 178.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . 0.617 HG11 ' HA ' ' A' ' 430' ' ' LEU . 1.7 m -53.41 -45.56 57.53 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -175.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . 0.608 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -64.81 -31.02 72.06 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.702 -0.799 . . . . 0.0 112.288 -176.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.738 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 92.8 m -77.79 -41.35 37.63 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.297 173.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.504 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.86 -37.02 75.58 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 122.233 1.015 . . . . 0.0 109.06 176.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 408' ' ' TYR . . . . . 0.608 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.25 -52.47 54.21 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 113.27 -1.786 . . . . 0.0 109.924 175.761 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 409' ' ' THR . . . . . 0.667 HG22 HD23 ' A' ' 410' ' ' LEU . 18.6 m -55.35 -47.83 75.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.508 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . 0.738 ' HG ' ' O ' ' A' ' 406' ' ' THR . 14.3 mt -73.34 -36.86 66.22 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.16 -174.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -59.53 -35.16 84.51 Favored Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.053 -1.07 . . . . 0.0 110.606 172.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 412' ' ' MET . . . . . 0.473 ' HE2' ' HA ' ' A' ' 417' ' ' GLN . 0.0 OUTLIER -66.71 -49.93 64.46 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 120.605 0.24 . . . . 0.0 111.444 178.087 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 413' ' ' MET . . . . . 0.917 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.6 OUTLIER -71.44 -45.0 63.76 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 119.128 -1.029 . . . . 0.0 112.446 -176.069 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . 0.917 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 18.3 mt -72.52 -45.39 59.57 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -176.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 32.8 t -84.81 -19.1 33.03 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.795 0.807 . . . . 0.0 109.618 -173.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . 0.464 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 106.98 179.61 22.61 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -172.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 417' ' ' GLN . . . . . 0.473 ' HA ' ' HE2' ' A' ' 412' ' ' MET . 1.7 mp0 -79.1 25.43 0.29 Allowed 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 121.557 0.694 . . . . 0.0 111.027 -173.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 418' ' ' ASN . . . . . 0.464 ' H ' ' C ' ' A' ' 416' ' ' GLY . 84.1 m-20 -70.55 73.21 0.53 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.11 178.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 419' ' ' TYR . . . . . 0.522 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 5.7 p90 -51.34 -37.75 49.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.928 175.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -54.23 -45.81 72.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.119 176.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.25 -48.78 60.88 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.215 -177.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . 0.441 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -66.57 -40.61 86.73 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 C-N-CA 120.289 -0.565 . . . . 0.0 111.115 -175.465 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.724 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 79.1 p -67.53 -38.95 85.0 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.921 -178.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -69.34 -36.47 78.47 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.092 176.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . 0.626 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -73.53 -51.61 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 O-C-N 122.904 -0.174 . . . . 0.0 111.09 -178.605 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . 0.68 HD13 HG23 ' A' ' 395' ' ' ILE . 1.1 mm -74.63 -22.89 17.64 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.819 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -172.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.724 ' HB2' ' O ' ' A' ' 423' ' ' SER . 0.8 OUTLIER -55.07 -29.78 58.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.302 0.572 . . . . 0.0 110.463 -178.867 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -88.09 -4.38 78.21 Favored Glycine 0 N--CA 1.443 -0.839 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.702 178.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.638 ' CZ ' ' HG3' ' A' ' 396' ' ' LYS . 23.5 m-85 -119.18 -1.31 10.89 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 121.011 0.434 . . . . 0.0 110.314 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.643 HD23 ' HA ' ' A' ' 427' ' ' ARG . 0.1 OUTLIER -66.07 128.89 94.12 Favored Pre-proline 0 N--CA 1.44 -0.935 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.62 179.485 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 431' ' ' PRO . . . . . 0.569 ' HD2' HD12 ' A' ' 430' ' ' LEU . 99.9 Cg_exo -23.67 -68.31 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.736 1 C-N-CA 125.4 4.067 . . . . 0.0 114.62 179.5 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . 0.522 ' O ' HG12 ' A' ' 435' ' ' VAL . . . -144.54 -165.76 11.2 Favored Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 175.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . 0.509 ' O ' HG13 ' A' ' 436' ' ' VAL . 44.1 tp60 -70.11 -25.81 63.67 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 118.003 0.901 . . . . 0.0 110.568 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -66.84 -40.34 87.91 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -178.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 435' ' ' VAL . . . . . 0.756 HG23 HG11 ' A' ' 463' ' ' VAL . 7.5 p -68.63 -44.62 82.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 120.901 0.382 . . . . 0.0 110.406 -177.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.554 HG21 ' HD3' ' A' ' 427' ' ' ARG . 0.1 OUTLIER -64.4 -30.86 51.33 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 CA-C-O 120.834 0.349 . . . . 0.0 110.643 175.218 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 1.1 m -69.32 -52.03 31.29 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -178.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . 0.875 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -58.84 -37.21 75.96 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.551 177.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 439' ' ' LEU . . . . . 0.552 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 2.1 tm? -70.76 -47.8 57.73 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.97 -39.01 73.81 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.339 174.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 441' ' ' GLN . . . . . 0.479 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 37.1 mm-40 -53.2 -50.08 65.42 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 123.586 0.754 . . . . 0.0 110.705 173.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . 0.8 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 0.9 OUTLIER -56.23 -39.63 72.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.78 173.04 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 443' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 43.2 mt -71.89 -36.91 70.17 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.95 0.405 . . . . 0.0 110.28 -178.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -57.86 -37.51 74.05 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.614 173.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -73.16 -26.67 61.28 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.942 178.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 446' ' ' GLU . . . . . 0.404 ' HB3' ' O ' ' A' ' 443' ' ' LEU . 8.9 pt-20 29.3 104.53 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 172.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 447' ' ' ILE . . . . . 0.492 ' HB ' ' HB ' ' A' ' 451' ' ' THR . 64.7 mt -66.08 -32.21 57.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.877 0.846 . . . . 0.0 109.46 171.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . 0.47 ' HB3' ' H ' ' A' ' 451' ' ' THR . 4.8 t70 -167.34 -153.87 0.15 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -177.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 449' ' ' ASP . . . . . 0.435 ' O ' ' HG3' ' A' ' 452' ' ' ARG . 4.0 m-20 -90.6 -61.62 1.64 Allowed 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 165.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 450' ' ' GLN . . . . . 0.562 ' O ' ' HB3' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -72.59 -26.05 61.56 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.447 -176.794 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 451' ' ' THR . . . . . 0.504 ' HA ' ' HG3' ' A' ' 454' ' ' GLU . 4.0 m -72.8 -21.15 61.03 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.992 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . 0.435 ' HG3' ' O ' ' A' ' 449' ' ' ASP . 18.4 mtm180 -55.91 -47.44 77.46 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 107.138 -1.431 . . . . 0.0 107.138 170.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 453' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 450' ' ' GLN . . . -57.59 -49.29 76.88 Favored 'General case' 0 N--CA 1.462 0.163 0 O-C-N 124.142 0.901 . . . . 0.0 111.921 171.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . 0.504 ' HG3' ' HA ' ' A' ' 451' ' ' THR . 37.1 mt-10 -46.31 -38.84 9.22 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.471 0.653 . . . . 0.0 111.693 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 30.1 p -121.16 15.74 11.49 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.139 -173.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . 0.602 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.8 OUTLIER -55.45 -47.53 75.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.246 0.546 . . . . 0.0 111.349 -171.442 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . 0.608 HG23 ' HB1' ' A' ' 405' ' ' ALA . 2.0 mp -77.08 -34.45 21.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.439 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -57.33 -35.89 70.46 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.948 0.88 . . . . 0.0 109.21 171.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . 0.734 ' O ' HG23 ' A' ' 463' ' ' VAL . 55.5 m-70 -72.78 -29.21 63.1 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.841 176.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . 0.724 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -74.1 -34.16 63.86 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 122.114 0.959 . . . . 0.0 108.683 179.044 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . 0.453 ' O ' ' HB2' ' A' ' 464' ' ' TYR . 1.3 m-80 -73.27 -38.07 66.07 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.2 -0.909 . . . . 0.0 108.909 176.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 462' ' ' ALA . . . . . 0.607 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -56.24 -35.0 66.9 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.659 169.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.875 HG13 ' HB3' ' A' ' 438' ' ' ALA . 61.9 t -61.01 -50.95 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 175.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 464' ' ' TYR . . . . . 0.587 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 19.4 m-30 -52.95 -29.13 27.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.612 178.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.82 -40.18 19.03 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.667 0.746 . . . . 0.0 109.347 -176.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.607 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.7 mt -55.95 -55.55 17.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 114.288 -1.324 . . . . 0.0 112.198 175.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 0.774 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -102.9 -9.87 19.52 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 -172.748 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . 0.525 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 93.38 31.8 8.16 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 119.308 -1.425 . . . . 0.0 114.07 179.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 469' ' ' LEU . . . . . 0.774 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 2.8 mt -89.65 162.77 15.44 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 117.732 0.766 . . . . 0.0 111.272 176.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . 0.413 ' HB3' ' CG2' ' A' ' 476' ' ' ILE . 37.8 p30 -105.07 -177.68 3.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.142 171.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 471' ' ' ALA . . . . . 0.523 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -60.44 -23.51 64.48 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -176.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 472' ' ' ARG . . . . . 0.471 HH11 ' HA ' ' A' ' 402' ' ' GLU . 28.5 mmt180 -87.27 1.09 54.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.38 -170.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 473' ' ' GLY . . . . . 0.451 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 79.29 11.27 85.16 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.376 -0.916 . . . . 0.0 111.348 -177.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -101.02 150.82 22.5 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 177.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 11.0 p -88.76 127.81 35.61 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.183 0.516 . . . . 0.0 110.842 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 476' ' ' ILE . . . . . 0.525 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.7 pp . . . . . 0 C--N 1.317 -0.811 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.444 -176.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 386' ' ' PHE . . . . . 0.865 ' CD1' HD22 ' B' ' 414' ' ' LEU . 5.1 t80 . . . . . 0 CA--C 1.529 0.142 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 387' ' ' PRO . . . . . 0.568 ' HG2' ' OD1' ' A' ' 393' ' ' ASN . 1.2 Cg_endo -44.96 -65.44 0.19 Allowed 'Trans proline' 0 CA--C 1.532 0.415 0 C-N-CA 123.55 2.833 . . . . 0.0 114.111 -177.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 388' ' ' MET . . . . . 0.776 ' SD ' HG13 ' B' ' 394' ' ' VAL . 18.3 tpp 67.61 160.99 0.17 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.549 0.214 . . . . 0.0 110.779 178.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 389' ' ' HIS . . . . . 0.587 ' CG ' ' HB2' ' B' ' 393' ' ' ASN . 32.5 m170 -70.91 -160.84 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 171.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -73.07 7.22 2.21 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.368 172.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 391' ' ' LEU . . . . . 0.589 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.1 pt? -161.14 -64.14 0.06 Allowed 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 392' ' ' GLY . . . . . 0.606 ' HA3' HD13 ' B' ' 395' ' ' ILE . . . -158.3 59.88 0.33 Allowed Glycine 0 C--N 1.334 0.431 0 C-N-CA 119.81 -1.186 . . . . 0.0 114.175 -170.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 393' ' ' ASN . . . . . 0.587 ' HB2' ' CG ' ' B' ' 389' ' ' HIS . 0.2 OUTLIER -54.98 -44.0 74.03 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-O 121.091 0.472 . . . . 0.0 109.851 178.304 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 394' ' ' VAL . . . . . 0.776 HG13 ' SD ' ' B' ' 388' ' ' MET . 1.1 m -59.2 -44.63 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 114.23 -1.35 . . . . 0.0 108.24 -177.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 395' ' ' ILE . . . . . 0.67 HG23 HD13 ' B' ' 426' ' ' ILE . 4.2 mp -57.77 -52.13 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-O 117.934 -1.032 . . . . 0.0 113.015 -175.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 396' ' ' LYS . . . . . 0.635 ' HG3' ' CZ ' ' B' ' 429' ' ' TYR . 0.1 OUTLIER -62.91 -49.21 75.7 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 121.661 2.028 . . . . 0.0 111.615 -175.683 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -54.62 -45.91 76.19 Favored Glycine 0 N--CA 1.433 -1.534 0 C-N-CA 120.029 -1.081 . . . . 0.0 111.295 -178.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 398' ' ' ILE . . . . . 0.85 HG12 HD21 ' A' ' 414' ' ' LEU . 26.8 mt -71.24 -34.01 52.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 113.531 0.938 . . . . 0.0 113.531 -177.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 399' ' ' VAL . . . . . 0.509 HG12 ' HA ' ' B' ' 404' ' ' VAL . 8.0 m -63.67 -39.7 86.32 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.519 0 C-N-CA 118.837 -1.145 . . . . 0.0 108.346 -174.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -69.15 -38.54 78.84 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 175.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 401' ' ' GLN . . . . . . . . . . . . . 4.3 mm100 -86.2 -49.07 8.0 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -170.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 402' ' ' GLU . . . . . 0.488 ' HA ' HH11 ' B' ' 472' ' ' ARG . 9.4 tp10 -120.67 -21.0 6.86 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 120.88 0.372 . . . . 0.0 111.324 -170.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 109.72 163.57 19.6 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.956 178.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 404' ' ' VAL . . . . . 0.613 HG11 ' HA ' ' B' ' 430' ' ' LEU . 1.7 m -53.3 -45.69 56.26 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.705 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -175.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 405' ' ' ALA . . . . . 0.6 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -64.85 -30.88 71.91 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 119.725 -0.79 . . . . 0.0 112.319 -176.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 406' ' ' THR . . . . . 0.736 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 92.5 m -77.86 -41.4 36.98 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 119.961 -0.696 . . . . 0.0 110.231 173.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 407' ' ' ALA . . . . . 0.485 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.95 -36.98 75.7 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 122.241 1.019 . . . . 0.0 109.014 176.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 408' ' ' TYR . . . . . 0.599 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.23 -52.44 54.56 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 113.283 -1.78 . . . . 0.0 109.941 175.82 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 409' ' ' THR . . . . . 0.665 HG22 HD23 ' B' ' 410' ' ' LEU . 17.5 m -55.43 -47.72 75.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.572 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 410' ' ' LEU . . . . . 0.736 ' HG ' ' O ' ' B' ' 406' ' ' THR . 14.4 mt -73.34 -37.11 66.21 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.06 -174.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -59.27 -35.32 84.14 Favored Glycine 0 N--CA 1.438 -1.224 0 C-N-CA 120.14 -1.028 . . . . 0.0 110.666 172.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 412' ' ' MET . . . . . 0.489 ' HE2' ' HA ' ' B' ' 417' ' ' GLN . 0.0 OUTLIER -66.51 -49.87 65.09 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-O 120.6 0.238 . . . . 0.0 111.572 177.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 413' ' ' MET . . . . . 0.933 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.7 OUTLIER -71.58 -45.21 62.87 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 119.064 -1.054 . . . . 0.0 112.356 -176.196 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 414' ' ' LEU . . . . . 0.933 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 17.9 mt -72.22 -45.64 59.45 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 113.95 1.092 . . . . 0.0 113.95 -176.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 32.8 t -84.89 -18.57 34.34 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.646 0.736 . . . . 0.0 109.599 -173.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 416' ' ' GLY . . . . . 0.469 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 106.61 179.67 22.89 Favored Glycine 0 N--CA 1.429 -1.774 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 -173.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 417' ' ' GLN . . . . . 0.489 ' HA ' ' HE2' ' B' ' 412' ' ' MET . 1.7 mp0 -79.13 25.38 0.29 Allowed 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.532 0.682 . . . . 0.0 111.015 -174.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 418' ' ' ASN . . . . . 0.469 ' H ' ' C ' ' B' ' 416' ' ' GLY . 83.8 m-20 -70.6 73.27 0.54 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.166 177.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 419' ' ' TYR . . . . . 0.513 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 5.4 p90 -51.38 -37.77 49.86 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.897 175.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -54.25 -45.82 72.47 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.064 176.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.17 -48.84 61.17 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.224 -177.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 422' ' ' VAL . . . . . 0.44 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.2 OUTLIER -66.44 -40.69 87.18 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.096 -175.464 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 423' ' ' SER . . . . . 0.748 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 80.0 p -67.48 -39.29 85.26 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.825 -178.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -68.93 -36.63 82.07 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.067 177.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 425' ' ' ILE . . . . . 0.649 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -73.45 -51.7 24.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 121.401 -0.12 . . . . 0.0 111.035 -178.593 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 426' ' ' ILE . . . . . 0.67 HD13 HG23 ' B' ' 395' ' ' ILE . 1.1 mm -74.76 -22.92 17.48 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.853 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 -172.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 427' ' ' ARG . . . . . 0.748 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.8 OUTLIER -54.97 -29.91 57.91 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.339 0.59 . . . . 0.0 110.407 -179.065 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.49 -5.14 79.42 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.79 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 429' ' ' TYR . . . . . 0.635 ' CZ ' ' HG3' ' B' ' 396' ' ' LYS . 23.5 m-85 -118.88 -1.49 11.01 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.118 0.485 . . . . 0.0 110.44 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 430' ' ' LEU . . . . . 0.635 HD23 ' HA ' ' B' ' 427' ' ' ARG . 0.1 OUTLIER -65.85 128.79 94.07 Favored Pre-proline 0 N--CA 1.44 -0.945 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.641 179.589 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 431' ' ' PRO . . . . . 0.554 ' HD2' HD12 ' B' ' 430' ' ' LEU . 99.6 Cg_exo -23.57 -68.37 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.749 1 C-N-CA 125.484 4.123 . . . . 0.0 114.633 179.599 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 432' ' ' GLY . . . . . 0.506 ' O ' HG12 ' B' ' 436' ' ' VAL . . . -144.13 -165.5 10.97 Favored Glycine 0 N--CA 1.444 -0.83 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 175.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 433' ' ' GLN . . . . . 0.512 ' O ' HG13 ' B' ' 436' ' ' VAL . 43.9 tp60 -70.28 -25.73 63.48 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 118.024 0.912 . . . . 0.0 110.734 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -67.2 -40.09 86.44 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -177.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 435' ' ' VAL . . . . . 0.742 HG23 HG11 ' B' ' 463' ' ' VAL . 7.4 p -68.87 -44.58 81.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 120.937 0.399 . . . . 0.0 110.39 -177.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 436' ' ' VAL . . . . . 0.541 HG21 ' HD3' ' B' ' 427' ' ' ARG . 0.1 OUTLIER -64.39 -31.05 51.92 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.499 175.077 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 1.1 m -69.19 -52.04 31.95 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 438' ' ' ALA . . . . . 0.862 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -58.94 -37.28 76.36 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.663 177.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 439' ' ' LEU . . . . . 0.556 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 2.1 tm? -70.75 -47.69 58.35 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -179.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.9 -39.25 74.08 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.326 174.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 441' ' ' GLN . . . . . 0.479 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 36.7 mm-40 -53.12 -50.04 65.31 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 123.576 0.75 . . . . 0.0 110.644 173.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 442' ' ' ARG . . . . . 0.82 ' HG2' ' O ' ' B' ' 438' ' ' ALA . 0.9 OUTLIER -56.25 -39.66 72.93 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.824 173.066 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 443' ' ' LEU . . . . . 0.556 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 42.4 mt -71.96 -36.73 69.93 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.99 0.424 . . . . 0.0 110.31 -178.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -57.97 -37.5 74.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.609 173.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -73.22 -26.42 61.14 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.986 178.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 446' ' ' GLU . . . . . 0.401 ' HB3' ' O ' ' B' ' 443' ' ' LEU . 8.8 pt-20 29.4 104.28 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 172.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 447' ' ' ILE . . . . . 0.499 ' HB ' ' HB ' ' B' ' 451' ' ' THR . 64.4 mt -66.07 -32.39 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 121.911 0.862 . . . . 0.0 109.443 171.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 448' ' ' ASP . . . . . 0.455 ' HB3' ' H ' ' B' ' 451' ' ' THR . 4.6 t70 -167.04 -153.63 0.15 Allowed 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 -177.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 449' ' ' ASP . . . . . 0.438 ' O ' ' HG3' ' B' ' 452' ' ' ARG . 4.9 m-20 -90.87 -61.64 1.63 Allowed 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 165.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 450' ' ' GLN . . . . . 0.556 ' O ' ' HB3' ' B' ' 453' ' ' ALA . 0.0 OUTLIER -72.55 -26.01 61.58 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.432 -176.908 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 451' ' ' THR . . . . . 0.521 ' HA ' ' HG3' ' B' ' 454' ' ' GLU . 4.1 m -72.77 -21.07 61.06 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.063 -0.655 . . . . 0.0 111.035 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 452' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' B' ' 449' ' ' ASP . 18.6 mtm180 -56.08 -47.48 77.92 Favored 'General case' 0 C--O 1.215 -0.76 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 170.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 453' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' B' ' 450' ' ' GLN . . . -57.51 -49.2 77.09 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.994 171.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 454' ' ' GLU . . . . . 0.521 ' HG3' ' HA ' ' B' ' 451' ' ' THR . 37.2 mt-10 -46.39 -38.91 9.56 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.571 0.7 . . . . 0.0 111.677 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 31.1 p -121.05 15.82 11.59 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.257 -173.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 456' ' ' PHE . . . . . 0.586 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 0.8 OUTLIER -55.59 -47.73 75.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.209 0.528 . . . . 0.0 111.28 -171.524 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 457' ' ' ILE . . . . . 0.6 HG23 ' HB1' ' B' ' 405' ' ' ALA . 2.0 mp -76.8 -34.64 23.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.387 -179.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -57.33 -35.82 70.36 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 122.022 0.915 . . . . 0.0 109.291 172.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 459' ' ' HIS . . . . . 0.731 ' O ' HG23 ' B' ' 463' ' ' VAL . 55.4 m-70 -72.82 -29.04 62.93 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.208 -1.36 . . . . 0.0 110.915 176.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 460' ' ' LEU . . . . . 0.726 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -74.24 -34.17 63.56 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.107 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 461' ' ' ASN . . . . . 0.438 ' O ' ' HB2' ' B' ' 464' ' ' TYR . 1.3 m-80 -73.17 -38.29 66.25 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.216 -0.902 . . . . 0.0 108.924 176.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 462' ' ' ALA . . . . . 0.615 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -56.16 -34.83 66.53 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.668 169.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 463' ' ' VAL . . . . . 0.862 HG13 ' HB3' ' B' ' 438' ' ' ALA . 62.7 t -61.04 -51.09 77.18 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 175.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 464' ' ' TYR . . . . . 0.57 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 19.4 m-30 -52.87 -29.09 26.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.642 178.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.13 -39.59 19.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.716 0.769 . . . . 0.0 109.501 -176.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 466' ' ' ILE . . . . . 0.615 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.7 mt -56.2 -55.83 16.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 114.344 -1.298 . . . . 0.0 112.115 174.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 467' ' ' LEU . . . . . 0.784 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -102.73 -9.97 19.57 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -172.513 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 468' ' ' GLY . . . . . 0.521 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 93.41 31.92 8.07 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 119.346 -1.407 . . . . 0.0 114.182 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 469' ' ' LEU . . . . . 0.784 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 2.8 mt -89.73 162.81 15.37 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 117.646 0.723 . . . . 0.0 111.062 176.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 470' ' ' ASN . . . . . 0.418 ' HB3' ' CG2' ' B' ' 476' ' ' ILE . 37.4 p30 -105.14 -177.82 3.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.23 171.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 471' ' ' ALA . . . . . 0.512 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -60.25 -23.51 64.16 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -176.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 472' ' ' ARG . . . . . 0.488 HH11 ' HA ' ' B' ' 402' ' ' GLU . 28.7 mmt180 -87.48 1.52 53.25 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.407 -170.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 473' ' ' GLY . . . . . 0.448 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 78.76 11.39 85.29 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.564 -0.827 . . . . 0.0 111.37 -177.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -100.94 150.66 22.64 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 177.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 11.9 p -88.35 127.81 35.49 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.207 0.527 . . . . 0.0 110.926 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 476' ' ' ILE . . . . . 0.521 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.7 pp . . . . . 0 C--N 1.317 -0.818 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.485 -176.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 386' ' ' PHE . . . . . 0.758 ' CZ ' HG12 ' A' ' 394' ' ' VAL . 1.6 t80 . . . . . 0 CA--C 1.538 0.495 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -53.55 -51.59 10.54 Favored 'Trans proline' 0 N--CA 1.489 1.214 1 C-N-CA 125.403 4.069 . . . . 0.0 115.952 -176.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.781 ' SD ' HG13 ' A' ' 394' ' ' VAL . 53.8 tpp 74.29 15.63 3.53 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 165.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 389' ' ' HIS . . . . . 0.804 ' CG ' ' HB2' ' A' ' 393' ' ' ASN . 15.6 m170 64.17 7.1 3.26 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.264 -0.897 . . . . 0.0 110.249 -175.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 66.29 25.09 10.54 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.498 -170.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.482 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.6 pt? -164.51 -53.4 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 170.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . 0.549 ' HA2' ' SD ' ' A' ' 388' ' ' MET . . . -175.39 49.38 0.13 Allowed Glycine 0 CA--C 1.525 0.659 0 C-N-CA 119.796 -1.192 . . . . 0.0 114.521 -176.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . 0.804 ' HB2' ' CG ' ' A' ' 389' ' ' HIS . 0.5 OUTLIER -54.49 -43.31 71.67 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 117.302 0.551 . . . . 0.0 109.81 177.886 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . 0.781 HG13 ' SD ' ' A' ' 388' ' ' MET . 0.7 OUTLIER -57.64 -46.12 86.51 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 -177.649 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . 0.703 HG21 HG22 ' A' ' 425' ' ' ILE . 4.1 mp -57.36 -52.3 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-O 118.023 -0.989 . . . . 0.0 113.139 -174.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . 0.629 ' HG3' ' CZ ' ' A' ' 429' ' ' TYR . 0.0 OUTLIER -63.55 -50.23 70.32 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 121.664 2.029 . . . . 0.0 112.335 -175.738 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . 0.568 ' O ' ' HG3' ' A' ' 401' ' ' GLN . . . -54.47 -44.89 77.59 Favored Glycine 0 N--CA 1.435 -1.393 0 C-N-CA 120.04 -1.076 . . . . 0.0 111.025 -177.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . 0.777 HD13 HD12 ' A' ' 410' ' ' LEU . 31.2 mt -71.28 -34.47 54.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -178.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . 0.52 HG12 ' HA ' ' A' ' 404' ' ' VAL . 9.9 m -63.66 -39.92 87.14 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 C-N-CA 118.973 -1.091 . . . . 0.0 108.594 -173.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -66.67 -40.99 88.85 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 175.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.568 ' HG3' ' O ' ' A' ' 397' ' ' GLY . 36.2 mt-30 -91.84 -47.13 7.49 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -169.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . 0.697 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 3.0 mm-40 -115.15 -20.35 10.45 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.983 0.421 . . . . 0.0 111.377 -173.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 106.14 162.84 22.86 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.874 -0.679 . . . . 0.0 113.027 177.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . 0.671 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.2 m -53.61 -42.89 52.34 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.851 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -175.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . 0.708 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -69.17 -28.57 66.52 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 119.602 -0.839 . . . . 0.0 112.139 -176.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.707 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 89.9 m -77.55 -43.1 33.0 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.139 -0.624 . . . . 0.0 109.972 172.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.51 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.3 -37.64 75.47 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 122.125 0.964 . . . . 0.0 109.285 176.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 408' ' ' TYR . . . . . 0.671 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.6 -52.14 54.38 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 113.606 -1.634 . . . . 0.0 109.734 177.155 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 409' ' ' THR . . . . . 0.667 HG22 HD23 ' A' ' 410' ' ' LEU . 13.0 m -55.51 -47.36 76.34 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.743 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . 0.777 HD12 HD13 ' A' ' 398' ' ' ILE . 13.8 mt -72.28 -35.71 68.8 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.197 -175.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.92 -35.09 81.48 Favored Glycine 0 N--CA 1.439 -1.142 0 C-N-CA 120.182 -1.009 . . . . 0.0 110.7 172.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -67.55 -47.62 69.31 Favored 'General case' 0 C--O 1.223 -0.309 0 N-CA-C 111.528 0.195 . . . . 0.0 111.528 178.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 413' ' ' MET . . . . . 0.914 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.3 OUTLIER -70.78 -48.26 55.23 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 119.06 -1.056 . . . . 0.0 112.106 -179.461 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . 0.914 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 18.6 mt -69.47 -44.23 71.61 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -175.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 33.7 t -86.62 -24.04 25.49 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.526 0.679 . . . . 0.0 110.147 -175.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 112.55 -176.79 18.03 Favored Glycine 0 N--CA 1.429 -1.832 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 -173.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -81.02 22.29 0.64 Allowed 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.367 0.604 . . . . 0.0 111.285 -172.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 418' ' ' ASN . . . . . 0.455 ' HB2' HD22 ' A' ' 421' ' ' LEU . 11.4 m120 -73.04 74.91 1.21 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.984 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 419' ' ' TYR . . . . . 0.616 ' HB2' ' CE2' ' A' ' 456' ' ' PHE . 27.0 p90 -54.2 -37.57 64.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.324 178.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -54.47 -46.27 73.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.908 0.385 . . . . 0.0 110.987 177.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . 0.455 HD22 ' HB2' ' A' ' 418' ' ' ASN . 0.0 OUTLIER -68.51 -47.86 65.87 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.085 -177.291 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . 0.466 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -65.33 -38.35 82.34 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 C-N-CA 120.343 -0.543 . . . . 0.0 111.198 -178.451 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.751 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 61.1 p -68.1 -37.46 81.21 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -179.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.51 -39.35 91.12 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.237 175.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . 0.703 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.78 -52.53 22.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 O-C-N 122.789 -0.242 . . . . 0.0 111.011 -178.376 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . 0.7 HG22 HD22 ' A' ' 430' ' ' LEU . 1.2 mm -72.14 -21.76 20.7 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.715 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -172.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.751 ' HB2' ' O ' ' A' ' 423' ' ' SER . 0.7 OUTLIER -54.25 -31.46 53.55 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.52 -179.206 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -84.39 -12.2 76.31 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.463 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.629 ' CZ ' ' HG3' ' A' ' 396' ' ' LYS . 23.3 m-85 -114.69 1.9 14.32 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-O 121.15 0.5 . . . . 0.0 110.45 -176.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.703 HD23 ' HA ' ' A' ' 427' ' ' ARG . 0.1 OUTLIER -65.85 128.11 93.58 Favored Pre-proline 0 N--CA 1.439 -1.008 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.759 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 431' ' ' PRO . . . . . 0.473 ' HD2' HD12 ' A' ' 430' ' ' LEU . 59.1 Cg_exo -22.39 -72.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.355 0.906 1 C-N-CA 125.56 4.173 . . . . 0.0 114.855 179.784 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . 0.43 ' O ' HG12 ' A' ' 435' ' ' VAL . . . -132.27 -165.44 11.29 Favored Glycine 0 N--CA 1.439 -1.125 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 175.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . 0.617 ' O ' HG13 ' A' ' 436' ' ' VAL . 1.0 OUTLIER -71.21 -28.1 63.97 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 117.575 0.687 . . . . 0.0 110.631 177.513 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -70.24 -36.62 74.61 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -174.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 435' ' ' VAL . . . . . 0.738 HG23 HG11 ' A' ' 463' ' ' VAL . 7.5 p -67.24 -41.46 86.73 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-O 121.056 0.455 . . . . 0.0 110.388 -177.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.617 HG13 ' O ' ' A' ' 433' ' ' GLN . 0.2 OUTLIER -64.63 -34.78 72.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.177 175.682 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.85 -48.53 53.39 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -174.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . 0.85 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -56.15 -37.24 69.26 Favored 'General case' 0 N--CA 1.432 -1.356 0 O-C-N 123.713 0.633 . . . . 0.0 110.498 175.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 439' ' ' LEU . . . . . 0.558 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 2.1 tm? -67.66 -46.97 70.86 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -178.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . 0.492 ' NE2' HD12 ' A' ' 443' ' ' LEU . 0.4 OUTLIER -62.08 -33.92 75.32 Favored 'General case' 0 CA--C 1.49 -1.353 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.803 176.192 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 441' ' ' GLN . . . . . 0.568 ' O ' ' HG2' ' A' ' 445' ' ' GLN . 8.9 mm-40 -58.26 -49.2 77.96 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.199 175.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . 0.749 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -57.31 -39.79 76.55 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.852 171.208 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 443' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 33.6 mt -72.38 -34.45 67.95 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.201 0.524 . . . . 0.0 109.932 -178.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -57.94 -36.95 73.25 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.793 173.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 445' ' ' GLN . . . . . 0.568 ' HG2' ' O ' ' A' ' 441' ' ' GLN . 30.6 mm-40 -72.26 -27.52 62.54 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.195 178.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 446' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 443' ' ' LEU . 36.7 tt0 35.44 98.09 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 169.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 447' ' ' ILE . . . . . 0.534 ' HB ' ' HB ' ' A' ' 451' ' ' THR . 54.2 mt -73.41 -32.68 37.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.447 0.642 . . . . 0.0 110.447 176.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . 0.442 ' HB3' ' H ' ' A' ' 451' ' ' THR . 7.4 t70 -170.21 -158.17 0.16 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 -179.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -87.78 -58.81 2.44 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 166.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 450' ' ' GLN . . . . . 0.486 ' C ' HE21 ' A' ' 450' ' ' GLN . 0.0 OUTLIER -66.88 -33.34 75.38 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.592 -177.523 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 451' ' ' THR . . . . . 0.534 ' HB ' ' HB ' ' A' ' 447' ' ' ILE . 4.8 m -72.05 -23.36 61.36 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.653 -174.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 448' ' ' ASP . 13.1 mtp180 -55.13 -54.18 46.55 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 172.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 453' ' ' ALA . . . . . 0.515 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -58.57 -48.52 80.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.616 -1.175 . . . . 0.0 112.561 175.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . 0.459 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 27.2 mm-40 -51.2 -37.2 45.32 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.289 0.566 . . . . 0.0 111.597 -178.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 27.6 p -117.9 16.92 14.29 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.352 -176.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . 0.616 ' CE2' ' HB2' ' A' ' 419' ' ' TYR . 1.1 t80 -58.04 -47.15 84.0 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.006 0.432 . . . . 0.0 111.6 -171.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . 0.708 HG23 ' HB1' ' A' ' 405' ' ' ALA . 2.0 mp -76.83 -32.43 20.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.044 0.45 . . . . 0.0 110.611 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -57.83 -34.29 69.54 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.717 0.77 . . . . 0.0 109.268 170.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . 0.681 ' O ' HG23 ' A' ' 463' ' ' VAL . 57.9 m-70 -76.08 -28.04 57.44 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.635 178.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . 0.723 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -74.09 -34.63 64.05 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.822 0.82 . . . . 0.0 108.82 178.196 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . 0.548 ' HA ' ' CD2' ' A' ' 464' ' ' TYR . 21.4 m-80 -72.63 -37.74 67.95 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.309 -0.86 . . . . 0.0 108.975 176.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 462' ' ' ALA . . . . . 0.627 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -56.21 -34.4 66.24 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.442 -1.254 . . . . 0.0 109.729 169.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.85 HG13 ' HB3' ' A' ' 438' ' ' ALA . 64.5 t -61.53 -51.58 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 114.811 -1.086 . . . . 0.0 108.085 176.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 464' ' ' TYR . . . . . 0.748 ' CE2' ' HA ' ' A' ' 471' ' ' ALA . 15.4 m-30 -52.62 -27.37 16.76 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.685 178.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.34 -39.11 21.16 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.593 0.711 . . . . 0.0 109.557 -178.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.627 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.7 mt -60.17 -55.54 23.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 114.23 -1.35 . . . . 0.0 112.268 176.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 0.74 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -100.36 -10.69 20.96 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -173.469 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . 0.588 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 93.15 31.18 8.65 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 119.556 -1.307 . . . . 0.0 114.165 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 469' ' ' LEU . . . . . 0.74 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.0 mt -89.98 166.56 13.39 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.24 1.02 . . . . 0.0 111.767 178.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 35.1 p30 -106.07 177.57 4.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.271 169.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 471' ' ' ALA . . . . . 0.748 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -71.09 -6.92 42.87 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -173.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -92.2 -0.33 57.42 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.022 0.439 . . . . 0.0 110.6 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 77.47 12.79 84.2 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.571 -0.824 . . . . 0.0 111.085 -175.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -100.91 157.9 16.39 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 175.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 475' ' ' SER . . . . . 0.507 ' HA ' HD22 ' A' ' 469' ' ' LEU . 0.6 OUTLIER -93.45 120.06 33.28 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.538 0.685 . . . . 0.0 112.633 -177.03 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 476' ' ' ILE . . . . . 0.588 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.2 pp . . . . . 0 N--CA 1.436 -1.155 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 162.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 386' ' ' PHE . . . . . 0.765 ' CZ ' HG12 ' B' ' 394' ' ' VAL . 1.6 t80 . . . . . 0 CA--C 1.538 0.506 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 387' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' B' ' 386' ' ' PHE . 15.4 Cg_endo -53.68 -51.54 10.59 Favored 'Trans proline' 0 N--CA 1.49 1.294 1 C-N-CA 125.48 4.12 . . . . 0.0 115.895 -176.732 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 388' ' ' MET . . . . . 0.767 ' SD ' HG13 ' B' ' 394' ' ' VAL . 53.8 tpp 74.18 15.7 3.6 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 165.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 389' ' ' HIS . . . . . 0.798 ' CG ' ' HB2' ' B' ' 393' ' ' ASN . 16.1 m170 64.03 7.29 3.28 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.203 -0.936 . . . . 0.0 110.257 -175.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 66.31 24.73 10.56 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.527 -170.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 391' ' ' LEU . . . . . 0.471 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.6 pt? -164.32 -53.23 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 171.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 392' ' ' GLY . . . . . 0.55 ' HA2' ' SD ' ' B' ' 388' ' ' MET . . . -175.64 49.51 0.12 Allowed Glycine 0 CA--C 1.524 0.641 0 C-N-CA 119.756 -1.212 . . . . 0.0 114.464 -176.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 393' ' ' ASN . . . . . 0.798 ' HB2' ' CG ' ' B' ' 389' ' ' HIS . 0.5 OUTLIER -54.61 -43.28 72.08 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 117.348 0.574 . . . . 0.0 109.862 177.837 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 394' ' ' VAL . . . . . 0.767 HG13 ' SD ' ' B' ' 388' ' ' MET . 0.7 OUTLIER -57.6 -46.13 86.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -177.818 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 395' ' ' ILE . . . . . 0.693 HG21 HG22 ' B' ' 425' ' ' ILE . 4.1 mp -57.42 -52.26 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-O 117.979 -1.01 . . . . 0.0 113.186 -174.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 396' ' ' LYS . . . . . 0.637 ' HG3' ' CZ ' ' B' ' 429' ' ' TYR . 0.0 OUTLIER -63.58 -50.22 70.32 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 121.661 2.028 . . . . 0.0 112.302 -175.684 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 397' ' ' GLY . . . . . 0.57 ' O ' ' HG3' ' B' ' 401' ' ' GLN . . . -54.39 -44.86 76.74 Favored Glycine 0 N--CA 1.434 -1.449 0 C-N-CA 120.03 -1.081 . . . . 0.0 111.089 -177.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 398' ' ' ILE . . . . . 0.777 HD13 HD12 ' B' ' 410' ' ' LEU . 31.2 mt -71.33 -34.54 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -178.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 399' ' ' VAL . . . . . 0.528 HG12 ' HA ' ' B' ' 404' ' ' VAL . 10.0 m -63.66 -39.94 87.2 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.519 0 C-N-CA 118.971 -1.092 . . . . 0.0 108.577 -173.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -66.41 -41.24 89.55 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 175.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 401' ' ' GLN . . . . . 0.57 ' HG3' ' O ' ' B' ' 397' ' ' GLY . 36.4 mt-30 -91.89 -47.19 7.45 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -168.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 402' ' ' GLU . . . . . 0.651 ' HG3' ' HE3' ' A' ' 413' ' ' MET . 2.9 mm-40 -115.01 -20.56 10.45 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.987 0.422 . . . . 0.0 111.276 -172.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 106.19 162.95 22.82 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.099 177.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 404' ' ' VAL . . . . . 0.653 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.3 m -53.53 -42.89 51.63 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.858 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -175.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 405' ' ' ALA . . . . . 0.689 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -69.24 -28.64 66.52 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 119.545 -0.862 . . . . 0.0 112.165 -176.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 406' ' ' THR . . . . . 0.703 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 85.9 m -77.4 -43.14 33.69 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.159 -0.616 . . . . 0.0 109.94 172.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 407' ' ' ALA . . . . . 0.49 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.28 -37.54 75.22 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 122.118 0.961 . . . . 0.0 109.351 176.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 408' ' ' TYR . . . . . 0.653 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.69 -52.04 54.65 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 113.568 -1.651 . . . . 0.0 109.8 177.072 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 409' ' ' THR . . . . . 0.656 HG22 HD23 ' B' ' 410' ' ' LEU . 14.8 m -55.46 -47.53 75.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.678 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 410' ' ' LEU . . . . . 0.777 HD12 HD13 ' B' ' 398' ' ' ILE . 13.8 mt -72.14 -35.79 69.18 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 120.838 0.351 . . . . 0.0 110.271 -175.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.94 -35.06 81.48 Favored Glycine 0 N--CA 1.439 -1.144 0 C-N-CA 120.229 -0.986 . . . . 0.0 110.71 172.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 412' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -67.46 -47.75 69.2 Favored 'General case' 0 C--O 1.224 -0.267 0 N-CA-C 111.556 0.206 . . . . 0.0 111.556 178.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 413' ' ' MET . . . . . 0.93 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.3 OUTLIER -70.67 -48.26 55.73 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 118.96 -1.096 . . . . 0.0 112.139 -179.367 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 414' ' ' LEU . . . . . 0.93 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 18.7 mt -69.53 -44.3 71.27 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -175.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 33.5 t -86.55 -23.98 25.63 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.509 0.671 . . . . 0.0 110.158 -175.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 416' ' ' GLY . . . . . . . . . . . . . . . 112.44 -177.06 18.29 Favored Glycine 0 N--CA 1.428 -1.843 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 -173.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -80.93 22.67 0.6 Allowed 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.219 0.533 . . . . 0.0 111.214 -172.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 418' ' ' ASN . . . . . 0.443 ' HB2' HD22 ' B' ' 421' ' ' LEU . 11.3 m120 -73.09 75.36 1.24 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.884 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 419' ' ' TYR . . . . . 0.631 ' HB2' ' CE2' ' B' ' 456' ' ' PHE . 26.8 p90 -54.86 -37.42 66.22 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.207 178.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -54.56 -46.31 73.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.961 0.41 . . . . 0.0 110.889 177.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 421' ' ' LEU . . . . . 0.456 ' O ' HD13 ' B' ' 425' ' ' ILE . 0.0 OUTLIER -68.42 -47.83 66.23 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.136 -177.158 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 422' ' ' VAL . . . . . 0.469 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.2 OUTLIER -65.18 -38.56 82.96 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.218 -178.524 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 423' ' ' SER . . . . . 0.762 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 62.3 p -68.05 -37.37 81.24 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.21 -39.76 92.34 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.307 175.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 425' ' ' ILE . . . . . 0.693 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -72.55 -52.58 22.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 O-C-N 122.785 -0.244 . . . . 0.0 111.003 -178.081 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 426' ' ' ILE . . . . . 0.695 HG22 HD22 ' B' ' 430' ' ' LEU . 1.2 mm -72.21 -21.67 20.56 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.821 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -172.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 427' ' ' ARG . . . . . 0.762 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.7 OUTLIER -54.31 -31.33 53.89 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.216 0.531 . . . . 0.0 110.479 -179.265 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -84.25 -12.39 76.27 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.404 178.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 429' ' ' TYR . . . . . 0.637 ' CZ ' ' HG3' ' B' ' 396' ' ' LYS . 23.2 m-85 -114.77 1.87 14.25 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 121.064 0.459 . . . . 0.0 110.372 -176.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 430' ' ' LEU . . . . . 0.695 HD22 HG22 ' B' ' 426' ' ' ILE . 0.1 OUTLIER -65.77 128.32 93.72 Favored Pre-proline 0 N--CA 1.438 -1.042 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.681 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 431' ' ' PRO . . . . . 0.457 ' HD2' HD12 ' B' ' 430' ' ' LEU . 56.8 Cg_exo -22.48 -73.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.355 0.883 1 C-N-CA 125.702 4.268 . . . . 0.0 114.606 179.563 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 432' ' ' GLY . . . . . 0.446 ' O ' HG12 ' B' ' 435' ' ' VAL . . . -132.34 -165.74 11.36 Favored Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 175.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 433' ' ' GLN . . . . . 0.612 ' O ' HG13 ' B' ' 436' ' ' VAL . 1.0 OUTLIER -70.94 -27.96 64.14 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 117.506 0.653 . . . . 0.0 110.643 177.85 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -70.39 -36.43 74.08 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -174.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 435' ' ' VAL . . . . . 0.74 HG23 HG11 ' B' ' 463' ' ' VAL . 7.5 p -67.36 -41.52 86.45 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 CA-C-O 121.102 0.477 . . . . 0.0 110.346 -177.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 436' ' ' VAL . . . . . 0.612 HG13 ' O ' ' B' ' 433' ' ' GLN . 0.2 OUTLIER -64.67 -34.77 72.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.214 175.64 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.87 -48.51 53.42 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 -174.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 438' ' ' ALA . . . . . 0.841 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -56.21 -37.17 69.3 Favored 'General case' 0 N--CA 1.433 -1.32 0 O-C-N 123.631 0.582 . . . . 0.0 110.382 175.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 439' ' ' LEU . . . . . 0.568 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 2.1 tm? -67.72 -47.0 70.57 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 440' ' ' GLN . . . . . 0.501 ' NE2' HD12 ' B' ' 443' ' ' LEU . 0.3 OUTLIER -62.15 -33.89 75.35 Favored 'General case' 0 CA--C 1.489 -1.378 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.828 176.178 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 441' ' ' GLN . . . . . 0.568 ' O ' ' HG2' ' B' ' 445' ' ' GLN . 9.0 mm-40 -58.3 -49.19 78.05 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.258 175.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 442' ' ' ARG . . . . . 0.743 ' HG2' ' O ' ' B' ' 438' ' ' ALA . 0.0 OUTLIER -57.24 -39.93 76.53 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.913 171.067 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 443' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 33.3 mt -72.26 -34.34 68.16 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.376 0.608 . . . . 0.0 109.918 -178.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -58.02 -36.96 73.44 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.838 173.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 445' ' ' GLN . . . . . 0.568 ' HG2' ' O ' ' B' ' 441' ' ' GLN . 30.6 mm-40 -72.13 -27.66 62.77 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.161 178.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 446' ' ' GLU . . . . . 0.487 ' HB2' ' O ' ' B' ' 443' ' ' LEU . 38.0 tt0 35.6 98.07 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 170.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 447' ' ' ILE . . . . . 0.528 ' HB ' ' HB ' ' B' ' 451' ' ' THR . 54.4 mt -73.41 -32.71 37.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.629 0.728 . . . . 0.0 110.48 176.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 448' ' ' ASP . . . . . 0.45 ' HB3' ' H ' ' B' ' 451' ' ' THR . 7.7 t70 -170.16 -158.42 0.17 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 -179.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -87.55 -58.92 2.4 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 166.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 450' ' ' GLN . . . . . 0.498 ' C ' HE21 ' B' ' 450' ' ' GLN . 0.0 OUTLIER -66.66 -33.41 75.6 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 115.272 -0.877 . . . . 0.0 112.609 -177.562 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 451' ' ' THR . . . . . 0.528 ' HB ' ' HB ' ' B' ' 447' ' ' ILE . 4.7 m -72.0 -23.26 61.38 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.671 -174.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 452' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' B' ' 448' ' ' ASP . 13.1 mtp180 -55.25 -54.13 47.38 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 172.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 453' ' ' ALA . . . . . 0.508 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -58.51 -48.36 81.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.689 -1.142 . . . . 0.0 112.622 175.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 454' ' ' GLU . . . . . 0.458 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 26.2 mm-40 -51.61 -37.3 49.39 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.399 0.619 . . . . 0.0 111.366 -178.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 29.1 p -117.71 16.82 14.45 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.471 -176.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 456' ' ' PHE . . . . . 0.631 ' CE2' ' HB2' ' B' ' 419' ' ' TYR . 1.1 t80 -58.01 -47.17 83.87 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.035 0.445 . . . . 0.0 111.571 -171.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 457' ' ' ILE . . . . . 0.689 HG23 ' HB1' ' B' ' 405' ' ' ALA . 2.0 mp -76.92 -32.31 19.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.622 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -57.93 -34.29 69.71 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.702 0.763 . . . . 0.0 109.214 170.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 459' ' ' HIS . . . . . 0.682 ' O ' HG23 ' B' ' 463' ' ' VAL . 58.4 m-70 -75.97 -28.14 57.76 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.634 178.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 460' ' ' LEU . . . . . 0.728 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.4 OUTLIER -74.06 -34.66 64.11 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.903 0.859 . . . . 0.0 108.82 178.262 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 461' ' ' ASN . . . . . 0.55 ' HA ' ' CD2' ' B' ' 464' ' ' TYR . 22.1 m-80 -72.59 -37.8 68.04 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.965 176.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 462' ' ' ALA . . . . . 0.634 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -56.37 -34.25 66.48 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.688 169.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 463' ' ' VAL . . . . . 0.841 HG13 ' HB3' ' B' ' 438' ' ' ALA . 65.3 t -61.49 -51.49 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 176.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 464' ' ' TYR . . . . . 0.747 ' CE2' ' HA ' ' B' ' 471' ' ' ALA . 15.5 m-30 -52.76 -27.24 16.97 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 124.354 1.034 . . . . 0.0 110.745 178.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.53 -39.11 20.85 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.703 0.763 . . . . 0.0 109.486 -178.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 466' ' ' ILE . . . . . 0.634 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.6 mt -59.76 -55.92 20.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 114.219 -1.355 . . . . 0.0 112.224 176.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 467' ' ' LEU . . . . . 0.743 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -100.21 -10.62 21.18 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -173.235 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 468' ' ' GLY . . . . . 0.603 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 93.25 31.06 8.67 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 119.604 -1.284 . . . . 0.0 114.122 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 469' ' ' LEU . . . . . 0.743 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 2.9 mt -90.05 166.51 13.39 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.343 1.072 . . . . 0.0 111.723 178.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 34.6 p30 -106.11 177.94 4.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.366 169.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 471' ' ' ALA . . . . . 0.747 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -71.16 -7.08 44.26 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -173.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -92.05 -0.44 57.46 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.022 0.439 . . . . 0.0 110.674 -177.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 473' ' ' GLY . . . . . . . . . . . . . . . 77.45 13.06 83.94 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.136 -175.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -101.25 157.99 16.37 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 175.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 475' ' ' SER . . . . . 0.502 ' HA ' HD22 ' B' ' 469' ' ' LEU . 0.5 OUTLIER -93.61 120.2 33.58 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.729 0.776 . . . . 0.0 112.644 -177.081 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 476' ' ' ILE . . . . . 0.603 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.2 pp . . . . . 0 N--CA 1.435 -1.179 0 N-CA-C 105.426 -2.065 . . . . 0.0 105.426 162.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 386' ' ' PHE . . . . . 0.806 ' CD1' HD22 ' A' ' 414' ' ' LEU . 3.6 t80 . . . . . 0 CA--C 1.531 0.23 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . 0.452 ' HD2' ' HA ' ' A' ' 386' ' ' PHE . 6.5 Cg_endo -46.47 -71.55 0.05 OUTLIER 'Trans proline' 0 N--CA 1.475 0.44 0 C-N-CA 124.163 3.242 . . . . 0.0 114.412 -175.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.604 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 30.7 ttm 70.38 143.96 0.05 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 122.356 0.262 . . . . 0.0 110.717 178.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 389' ' ' HIS . . . . . 0.598 ' CD2' ' HB2' ' A' ' 393' ' ' ASN . 32.6 m170 -48.49 -76.17 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 121.42 0.629 . . . . 0.0 110.382 -176.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -166.66 19.49 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 173.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.535 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.6 pt? -168.67 -51.83 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.505 -171.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . 0.673 ' HA3' HD13 ' A' ' 395' ' ' ILE . . . -176.22 60.84 0.1 Allowed Glycine 0 C--N 1.336 0.571 0 C-N-CA 119.751 -1.214 . . . . 0.0 114.028 -176.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . 0.604 ' HB3' ' HA ' ' A' ' 388' ' ' MET . 0.2 OUTLIER -58.39 -42.08 86.31 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 174.115 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . 0.657 HG23 HD12 ' A' ' 398' ' ' ILE . 1.7 m -55.24 -47.06 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 -179.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . 0.673 HD13 ' HA3' ' A' ' 392' ' ' GLY . 3.6 mp -57.7 -52.65 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 CA-C-O 117.8 -1.095 . . . . 0.0 113.729 -175.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . 0.595 ' O ' HG22 ' A' ' 399' ' ' VAL . 0.0 OUTLIER -62.75 -50.15 72.22 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 122.022 2.192 . . . . 0.0 112.298 -173.525 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . 0.488 ' O ' ' HG3' ' A' ' 401' ' ' GLN . . . -53.86 -42.09 68.64 Favored Glycine 0 N--CA 1.436 -1.344 0 C-N-CA 119.895 -1.145 . . . . 0.0 110.804 -175.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . 0.762 HD13 HD12 ' A' ' 410' ' ' LEU . 36.1 mt -71.64 -34.43 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 CA-C-N 114.263 -0.969 . . . . 0.0 113.517 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . 0.595 HG22 ' O ' ' A' ' 396' ' ' LYS . 15.6 m -63.57 -39.94 87.22 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 C-N-CA 118.925 -1.11 . . . . 0.0 108.631 -173.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -68.29 -38.79 82.01 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 176.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.488 ' HG3' ' O ' ' A' ' 397' ' ' GLY . 33.1 mt-30 -93.05 -48.46 6.49 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -171.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . 0.693 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 3.0 mm-40 -113.14 -20.15 11.57 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.2 -172.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 105.48 161.51 23.29 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.849 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . 0.645 HG11 ' HA ' ' A' ' 430' ' ' LEU . 1.5 m -53.78 -45.23 61.62 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.78 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 -176.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . 0.542 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -64.03 -31.16 72.25 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.005 -0.678 . . . . 0.0 112.481 -177.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.699 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 87.1 m -77.38 -42.43 36.46 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.476 -0.489 . . . . 0.0 110.244 173.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.469 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -58.4 -36.85 74.19 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 122.245 1.022 . . . . 0.0 109.311 176.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 408' ' ' TYR . . . . . 0.629 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -66.33 -51.92 52.37 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 113.436 -1.711 . . . . 0.0 109.991 176.337 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 409' ' ' THR . . . . . 0.64 HG22 HD23 ' A' ' 410' ' ' LEU . 16.5 m -55.68 -46.91 77.5 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.58 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . 0.762 HD12 HD13 ' A' ' 398' ' ' ILE . 14.1 mt -72.36 -34.95 68.37 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -175.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -59.35 -34.22 79.5 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.383 -0.913 . . . . 0.0 110.994 170.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 412' ' ' MET . . . . . 0.423 ' HE2' ' HA ' ' A' ' 417' ' ' GLN . 0.6 OUTLIER -66.71 -48.25 69.8 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 122.611 -0.346 . . . . 0.0 111.119 177.035 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 413' ' ' MET . . . . . 0.9 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.5 OUTLIER -71.53 -51.45 23.5 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 119.363 -0.935 . . . . 0.0 112.656 -179.357 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . 0.9 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 12.5 mt -67.55 -46.47 72.67 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -174.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.58 10.98 38.46 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.364 0.602 . . . . 0.0 111.086 -172.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . 0.426 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 84.08 179.82 51.84 Favored Glycine 0 N--CA 1.438 -1.187 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.68 -179.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 417' ' ' GLN . . . . . 0.423 ' HA ' ' HE2' ' A' ' 412' ' ' MET . 31.1 mm-40 -79.83 23.06 0.46 Allowed 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.364 0.602 . . . . 0.0 110.789 -173.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 418' ' ' ASN . . . . . 0.426 ' H ' ' C ' ' A' ' 416' ' ' GLY . 64.0 m-80 -72.33 77.36 1.01 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.782 -178.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 419' ' ' TYR . . . . . 0.552 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 7.1 p90 -49.83 -38.23 33.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.977 174.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -54.33 -47.72 72.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.749 177.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -48.65 66.02 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.044 -176.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . 0.464 ' HB ' ' CD1' ' A' ' 408' ' ' TYR . 0.2 OUTLIER -66.01 -40.49 87.45 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.572 0 C-N-CA 120.281 -0.567 . . . . 0.0 111.355 -176.918 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.816 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 80.6 p -69.24 -37.88 78.22 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -178.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.56 -38.96 90.91 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.761 176.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . 0.58 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.91 -52.56 21.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.028 -0.086 . . . . 0.0 111.182 -178.279 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . 0.686 HG22 HD22 ' A' ' 430' ' ' LEU . 1.1 mm -74.69 -23.59 17.91 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.896 0 O-C-N 121.968 -0.457 . . . . 0.0 110.374 -171.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.816 ' HB2' ' O ' ' A' ' 423' ' ' SER . 1.3 tmm_? -55.44 -30.86 61.3 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.325 0.583 . . . . 0.0 111.007 -177.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -86.58 -12.11 70.1 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.203 178.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.537 ' HD1' HG22 ' A' ' 395' ' ' ILE . 7.7 m-30 -112.68 -0.5 15.05 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.615 0.722 . . . . 0.0 109.07 -174.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.733 HD23 ' HA ' ' A' ' 427' ' ' ARG . 0.1 OUTLIER -66.07 129.75 94.27 Favored Pre-proline 0 N--CA 1.444 -0.754 0 CA-C-N 114.549 -1.205 . . . . 0.0 108.953 177.508 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 431' ' ' PRO . . . . . 0.544 ' HD2' HD12 ' A' ' 430' ' ' LEU . 81.4 Cg_exo -23.91 -68.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.915 1 C-N-CA 125.489 4.126 . . . . 0.0 114.852 179.117 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . 0.502 ' O ' HG12 ' A' ' 435' ' ' VAL . . . -141.51 -167.81 11.32 Favored Glycine 0 N--CA 1.442 -0.91 0 N-CA-C 110.089 -1.205 . . . . 0.0 110.089 176.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . 0.517 ' O ' HG13 ' A' ' 436' ' ' VAL . 43.6 tp60 -70.4 -26.96 63.93 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 118.083 0.941 . . . . 0.0 110.449 178.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -64.3 -41.98 96.59 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 435' ' ' VAL . . . . . 0.724 HG23 HG11 ' A' ' 463' ' ' VAL . 7.4 p -67.67 -42.81 86.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 121.018 0.437 . . . . 0.0 110.66 -177.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.517 HG13 ' O ' ' A' ' 433' ' ' GLN . 0.1 OUTLIER -67.26 -31.61 53.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.402 175.735 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.61 -52.76 41.71 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -178.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . 0.875 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -58.63 -39.82 81.63 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.936 177.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 439' ' ' LEU . . . . . 0.649 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 1.8 tm? -68.0 -48.39 65.87 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -177.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -60.54 -33.73 73.09 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.074 175.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 441' ' ' GLN . . . . . 0.516 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 3.5 mm-40 -54.83 -50.29 68.96 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.863 -178.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . 0.618 ' HG3' ' CG ' ' A' ' 459' ' ' HIS . 0.0 OUTLIER -77.76 -24.12 49.05 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 174.271 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 443' ' ' LEU . . . . . 0.649 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 56.5 mt -64.04 -27.17 68.93 Favored 'General case' 0 CA--C 1.516 -0.356 0 O-C-N 121.496 -0.753 . . . . 0.0 109.985 173.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -66.5 -37.12 84.37 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.85 178.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 445' ' ' GLN . . . . . 0.467 ' HG3' ' N ' ' A' ' 446' ' ' GLU . 0.0 OUTLIER -80.25 -30.39 38.47 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.479 -179.923 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 446' ' ' GLU . . . . . 0.467 ' N ' ' HG3' ' A' ' 445' ' ' GLN . 8.6 pt-20 15.21 105.03 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.248 0 O-C-N 125.617 1.823 . . . . 0.0 113.841 -177.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 43.6 mt -51.26 -34.44 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.369 -177.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . 0.507 ' HB2' ' OG1' ' A' ' 451' ' ' THR . 13.3 m-20 -160.88 -174.59 4.48 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 449' ' ' ASP . . . . . 0.488 ' O ' ' HB3' ' A' ' 452' ' ' ARG . 25.8 t0 -72.41 -62.49 1.42 Allowed 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 174.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 450' ' ' GLN . . . . . 0.401 ' HG3' ' H ' ' A' ' 450' ' ' GLN . 0.0 OUTLIER -70.22 -27.13 64.23 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 176.799 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 451' ' ' THR . . . . . 0.507 ' OG1' ' HB2' ' A' ' 448' ' ' ASP . 16.0 m -72.12 -23.06 61.26 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.004 -176.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . 0.488 ' HB3' ' O ' ' A' ' 449' ' ' ASP . 43.9 ttt180 -55.96 -52.26 64.79 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 172.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 453' ' ' ALA . . . . . 0.552 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -59.77 -47.21 86.6 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.707 170.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . 0.445 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 14.1 mm-40 -51.73 -36.45 47.11 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.137 0.494 . . . . 0.0 111.917 -175.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 24.9 p -115.46 13.98 16.58 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.271 -176.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . 0.598 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 1.2 t80 -55.06 -46.4 75.39 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.945 0.402 . . . . 0.0 111.746 -172.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . 0.542 HG23 ' HB1' ' A' ' 405' ' ' ALA . 1.9 mp -78.19 -33.36 17.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.784 0.326 . . . . 0.0 111.239 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -58.09 -32.71 68.34 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.805 0.812 . . . . 0.0 109.117 171.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . 0.748 ' O ' HG23 ' A' ' 463' ' ' VAL . 56.9 m-70 -74.17 -30.04 62.06 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.8 177.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . 0.705 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -73.99 -34.88 64.35 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.995 0.902 . . . . 0.0 108.988 179.518 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -73.08 -37.02 66.93 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.126 176.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 462' ' ' ALA . . . . . 0.612 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -56.02 -34.25 65.66 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.385 -1.279 . . . . 0.0 109.9 169.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.875 HG13 ' HB3' ' A' ' 438' ' ' ALA . 66.1 t -63.57 -50.83 76.57 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 CA-C-N 114.421 -1.263 . . . . 0.0 108.114 177.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 464' ' ' TYR . . . . . 0.578 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 16.9 m-30 -52.4 -29.15 22.73 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 124.348 1.03 . . . . 0.0 110.257 177.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.82 -40.69 22.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.745 0.784 . . . . 0.0 109.498 -177.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.612 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.6 mt -57.84 -56.17 17.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 114.304 -1.316 . . . . 0.0 112.269 176.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 0.764 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -100.82 -11.23 20.01 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -172.051 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . 0.537 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 94.09 31.6 7.98 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 119.366 -1.397 . . . . 0.0 114.321 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 469' ' ' LEU . . . . . 0.764 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.3 mt -88.47 163.02 16.15 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 117.915 0.857 . . . . 0.0 110.92 177.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 37.9 p30 -105.17 -178.04 3.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.065 172.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 471' ' ' ALA . . . . . 0.411 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -66.05 -14.65 62.07 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -176.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -88.53 -1.6 58.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.675 0.274 . . . . 0.0 111.148 -175.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 473' ' ' GLY . . . . . 0.483 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 79.04 10.66 85.95 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -175.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -101.43 156.22 17.59 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 176.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 32.1 t -93.25 137.52 32.49 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.248 0.547 . . . . 0.0 111.287 -176.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 476' ' ' ILE . . . . . 0.537 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.4 pp . . . . . 0 C--N 1.321 -0.637 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.878 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 386' ' ' PHE . . . . . 0.825 ' CD1' HD22 ' B' ' 414' ' ' LEU . 3.5 t80 . . . . . 0 CA--C 1.53 0.211 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 387' ' ' PRO . . . . . 0.465 ' HD2' ' HA ' ' B' ' 386' ' ' PHE . 6.7 Cg_endo -46.56 -71.56 0.05 OUTLIER 'Trans proline' 0 N--CA 1.476 0.479 0 C-N-CA 124.17 3.247 . . . . 0.0 114.433 -175.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 388' ' ' MET . . . . . 0.59 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 30.8 ttm 70.39 143.57 0.05 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 122.412 0.285 . . . . 0.0 110.896 178.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 389' ' ' HIS . . . . . 0.592 ' CD2' ' HB2' ' B' ' 393' ' ' ASN . 32.6 m170 -48.14 -75.93 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.1 0 CA-C-O 121.304 0.574 . . . . 0.0 110.417 -176.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -166.92 19.31 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 173.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 391' ' ' LEU . . . . . 0.538 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.6 pt? -168.76 -51.49 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.497 -171.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 392' ' ' GLY . . . . . 0.68 ' HA3' HD13 ' B' ' 395' ' ' ILE . . . -176.44 60.85 0.1 Allowed Glycine 0 CA--C 1.522 0.522 0 C-N-CA 119.794 -1.193 . . . . 0.0 114.151 -176.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 393' ' ' ASN . . . . . 0.592 ' HB2' ' CD2' ' B' ' 389' ' ' HIS . 0.2 OUTLIER -58.47 -42.07 86.68 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 174.095 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 394' ' ' VAL . . . . . 0.664 HG23 HD12 ' B' ' 398' ' ' ILE . 1.7 m -55.18 -47.12 77.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 395' ' ' ILE . . . . . 0.68 HD13 ' HA3' ' B' ' 392' ' ' GLY . 3.6 mp -57.64 -52.65 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 117.779 -1.105 . . . . 0.0 113.751 -175.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 396' ' ' LYS . . . . . 0.597 ' O ' HG22 ' B' ' 399' ' ' VAL . 0.0 OUTLIER -62.71 -50.18 72.14 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 122.043 2.201 . . . . 0.0 112.347 -173.667 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 397' ' ' GLY . . . . . 0.5 ' O ' ' HG3' ' B' ' 401' ' ' GLN . . . -54.06 -41.86 70.02 Favored Glycine 0 N--CA 1.436 -1.345 0 C-N-CA 119.799 -1.191 . . . . 0.0 110.838 -175.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 398' ' ' ILE . . . . . 0.754 HD13 HD12 ' B' ' 410' ' ' LEU . 35.9 mt -71.62 -34.56 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 399' ' ' VAL . . . . . 0.597 HG22 ' O ' ' B' ' 396' ' ' LYS . 15.6 m -63.38 -40.1 87.76 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 C-N-CA 118.94 -1.104 . . . . 0.0 108.68 -174.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -68.53 -38.5 80.9 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 176.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 401' ' ' GLN . . . . . 0.5 ' HG3' ' O ' ' B' ' 397' ' ' GLY . 32.9 mt-30 -92.86 -48.39 6.57 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -171.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 402' ' ' GLU . . . . . 0.735 ' HG3' ' HE3' ' A' ' 413' ' ' MET . 3.1 mm-40 -113.43 -19.89 11.52 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.154 -172.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 105.12 161.42 23.62 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.947 178.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 404' ' ' VAL . . . . . 0.639 HG11 ' HA ' ' B' ' 430' ' ' LEU . 1.4 m -53.69 -45.37 60.66 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 N-CA-C 114.409 1.262 . . . . 0.0 114.409 -176.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 405' ' ' ALA . . . . . 0.522 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -63.97 -31.23 72.35 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 119.954 -0.698 . . . . 0.0 112.504 -177.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 406' ' ' THR . . . . . 0.692 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 89.9 m -77.12 -42.36 38.29 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.298 173.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 407' ' ' ALA . . . . . 0.467 ' HB2' ' HB ' ' B' ' 398' ' ' ILE . . . -58.48 -36.79 74.27 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 122.203 1.001 . . . . 0.0 109.282 176.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 408' ' ' TYR . . . . . 0.616 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -66.46 -51.87 52.28 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 113.43 -1.714 . . . . 0.0 109.937 176.449 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 409' ' ' THR . . . . . 0.646 HG22 HD23 ' B' ' 410' ' ' LEU . 16.6 m -55.45 -47.07 76.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.591 178.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 410' ' ' LEU . . . . . 0.754 HD12 HD13 ' B' ' 398' ' ' ILE . 14.1 mt -72.42 -34.78 68.08 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -175.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -59.41 -34.14 79.39 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.308 -0.948 . . . . 0.0 110.998 170.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 412' ' ' MET . . . . . 0.422 ' HB2' ' O ' ' B' ' 409' ' ' THR . 0.6 OUTLIER -66.88 -48.15 69.64 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 122.612 -0.346 . . . . 0.0 111.072 177.163 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 413' ' ' MET . . . . . 0.917 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.5 OUTLIER -71.59 -51.69 22.01 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 119.336 -0.946 . . . . 0.0 112.678 -179.456 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 414' ' ' LEU . . . . . 0.917 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 12.4 mt -67.21 -46.5 73.67 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -174.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.44 10.61 39.27 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.368 0.604 . . . . 0.0 110.975 -172.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 416' ' ' GLY . . . . . 0.426 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 84.16 179.39 51.73 Favored Glycine 0 N--CA 1.438 -1.202 0 C-N-CA 120.638 -0.791 . . . . 0.0 111.609 -178.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -79.5 23.23 0.41 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.564 0.697 . . . . 0.0 110.843 -173.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 418' ' ' ASN . . . . . 0.426 ' H ' ' C ' ' B' ' 416' ' ' GLY . 64.8 m-80 -72.51 77.49 1.06 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.763 -178.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 419' ' ' TYR . . . . . 0.557 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 6.9 p90 -50.0 -38.29 36.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.975 174.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -54.28 -47.64 72.12 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.807 177.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.7 -48.76 65.63 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.963 -176.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 422' ' ' VAL . . . . . 0.461 ' HB ' ' CD1' ' B' ' 408' ' ' TYR . 0.2 OUTLIER -66.01 -40.47 87.38 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.499 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.216 -176.757 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 423' ' ' SER . . . . . 0.814 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 80.3 p -69.15 -37.76 78.43 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -178.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -68.0 -38.61 88.8 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.636 176.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 425' ' ' ILE . . . . . 0.599 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -72.95 -52.91 20.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 O-C-N 123.062 -0.081 . . . . 0.0 111.088 -178.289 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 426' ' ' ILE . . . . . 0.682 HG22 HD22 ' B' ' 430' ' ' LEU . 1.1 mm -74.34 -23.77 18.53 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.89 0 O-C-N 122.182 -0.324 . . . . 0.0 110.376 -171.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 427' ' ' ARG . . . . . 0.814 ' HB2' ' O ' ' B' ' 423' ' ' SER . 1.3 tmm_? -55.33 -30.76 60.88 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.241 0.544 . . . . 0.0 111.024 -177.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -86.87 -11.8 69.8 Favored Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 120.445 -0.883 . . . . 0.0 111.224 178.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 429' ' ' TYR . . . . . 0.543 ' HD1' HG22 ' B' ' 395' ' ' ILE . 7.9 m-30 -112.94 -0.39 14.84 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -174.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 430' ' ' LEU . . . . . 0.735 HD23 ' HA ' ' B' ' 427' ' ' ARG . 0.1 OUTLIER -66.12 129.72 94.25 Favored Pre-proline 0 N--CA 1.442 -0.837 0 CA-C-N 114.477 -1.238 . . . . 0.0 108.938 177.426 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 431' ' ' PRO . . . . . 0.543 ' HD2' HD12 ' B' ' 430' ' ' LEU . 81.0 Cg_exo -24.05 -69.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.357 1.001 1 C-N-CA 125.399 4.066 . . . . 0.0 114.796 179.224 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 432' ' ' GLY . . . . . 0.516 ' O ' HG12 ' B' ' 435' ' ' VAL . . . -141.28 -168.03 11.34 Favored Glycine 0 N--CA 1.443 -0.886 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 177.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 433' ' ' GLN . . . . . 0.531 ' O ' HG13 ' B' ' 436' ' ' VAL . 43.8 tp60 -70.23 -26.93 64.08 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 118.173 0.986 . . . . 0.0 110.411 178.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -63.99 -42.18 97.28 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.964 -178.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 435' ' ' VAL . . . . . 0.718 HG23 HG11 ' B' ' 463' ' ' VAL . 7.3 p -67.76 -42.77 86.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 120.977 0.417 . . . . 0.0 110.649 -177.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 436' ' ' VAL . . . . . 0.531 HG13 ' O ' ' B' ' 433' ' ' GLN . 0.1 OUTLIER -67.31 -31.57 53.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.323 175.732 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.58 -52.74 42.11 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -178.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 438' ' ' ALA . . . . . 0.871 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -58.68 -39.74 81.57 Favored 'General case' 0 N--CA 1.436 -1.128 0 O-C-N 124.042 0.838 . . . . 0.0 111.97 177.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 439' ' ' LEU . . . . . 0.669 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 1.8 tm? -68.03 -48.41 65.73 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -178.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.45 -33.7 72.94 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.143 175.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 441' ' ' GLN . . . . . 0.513 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 3.4 mm-40 -55.0 -50.25 69.47 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.742 -178.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 442' ' ' ARG . . . . . 0.615 ' HG3' ' CG ' ' B' ' 459' ' ' HIS . 0.0 OUTLIER -77.74 -24.0 49.19 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 174.388 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 443' ' ' LEU . . . . . 0.669 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 55.8 mt -64.31 -26.91 68.69 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 118.755 0.707 . . . . 0.0 109.966 173.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -66.71 -37.03 83.89 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.78 178.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 445' ' ' GLN . . . . . 0.464 ' HG3' ' N ' ' B' ' 446' ' ' GLU . 0.0 OUTLIER -80.33 -30.42 38.12 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.584 179.874 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 446' ' ' GLU . . . . . 0.464 ' N ' ' HG3' ' B' ' 445' ' ' GLN . 8.7 pt-20 15.2 105.14 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 O-C-N 125.517 1.761 . . . . 0.0 113.816 -177.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 43.7 mt -51.28 -34.23 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.362 -177.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 448' ' ' ASP . . . . . 0.509 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 13.0 m-20 -161.04 -174.45 4.38 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 449' ' ' ASP . . . . . 0.492 ' O ' ' HB3' ' B' ' 452' ' ' ARG . 27.9 t0 -72.26 -62.69 1.34 Allowed 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 174.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.03 -27.26 64.52 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 176.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 451' ' ' THR . . . . . 0.509 ' OG1' ' HB2' ' B' ' 448' ' ' ASP . 14.6 m -72.07 -23.02 61.29 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 119.749 -0.78 . . . . 0.0 109.946 -176.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 452' ' ' ARG . . . . . 0.492 ' HB3' ' O ' ' B' ' 449' ' ' ASP . 43.5 ttt180 -56.0 -52.15 65.22 Favored 'General case' 0 N--CA 1.415 -2.176 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 172.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 453' ' ' ALA . . . . . 0.557 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -60.05 -46.9 87.99 Favored 'General case' 0 CA--C 1.527 0.081 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 171.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 454' ' ' GLU . . . . . 0.447 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 13.5 mm-40 -51.95 -36.25 48.73 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.157 0.503 . . . . 0.0 111.837 -176.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 24.9 p -115.61 14.18 16.45 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.368 -176.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 456' ' ' PHE . . . . . 0.606 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 1.2 t80 -55.32 -46.29 76.32 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.944 0.402 . . . . 0.0 111.745 -172.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 457' ' ' ILE . . . . . 0.528 ' CG1' ' HB3' ' B' ' 408' ' ' TYR . 1.9 mp -78.16 -33.39 17.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 120.687 0.279 . . . . 0.0 111.273 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -58.06 -32.92 68.49 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.993 0.902 . . . . 0.0 109.078 171.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 459' ' ' HIS . . . . . 0.743 ' O ' HG23 ' B' ' 463' ' ' VAL . 56.4 m-70 -73.98 -29.97 62.25 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.79 177.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 460' ' ' LEU . . . . . 0.708 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -74.16 -34.71 63.91 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.814 0.816 . . . . 0.0 108.923 179.649 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 461' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -73.07 -37.34 66.83 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.016 176.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 462' ' ' ALA . . . . . 0.621 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -55.99 -34.04 65.4 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.758 169.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 463' ' ' VAL . . . . . 0.871 HG13 ' HB3' ' B' ' 438' ' ' ALA . 68.4 t -63.49 -51.09 74.95 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-N 114.548 -1.205 . . . . 0.0 108.152 177.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 464' ' ' TYR . . . . . 0.563 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 16.9 m-30 -52.3 -29.15 21.97 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 124.347 1.029 . . . . 0.0 110.311 177.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.68 -40.98 22.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.614 0.721 . . . . 0.0 109.475 -177.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 466' ' ' ILE . . . . . 0.621 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.7 mt -57.42 -56.32 15.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 114.277 -1.329 . . . . 0.0 112.251 176.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 467' ' ' LEU . . . . . 0.765 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -100.78 -11.36 19.95 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 114.66 1.355 . . . . 0.0 114.66 -171.971 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 468' ' ' GLY . . . . . 0.551 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 94.24 31.56 7.93 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 119.368 -1.396 . . . . 0.0 114.32 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 469' ' ' LEU . . . . . 0.765 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.3 mt -88.6 162.93 16.09 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 117.873 0.836 . . . . 0.0 110.879 177.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 37.8 p30 -105.0 -177.95 3.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.109 172.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 471' ' ' ALA . . . . . 0.408 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -66.41 -14.46 62.19 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -176.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -88.43 -1.71 58.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.624 0.249 . . . . 0.0 111.166 -176.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 473' ' ' GLY . . . . . 0.477 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 78.99 10.82 85.83 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -175.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -101.51 156.46 17.46 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 176.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 34.8 t -93.36 137.56 32.55 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.348 0.594 . . . . 0.0 111.264 -176.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 476' ' ' ILE . . . . . 0.551 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.4 pp . . . . . 0 C--N 1.322 -0.608 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.865 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 386' ' ' PHE . . . . . 0.745 ' CD1' HD22 ' A' ' 414' ' ' LEU . 2.1 t80 . . . . . 0 CA--C 1.54 0.577 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . 0.472 ' HD2' ' HA ' ' A' ' 386' ' ' PHE . 1.5 Cg_endo -39.85 -62.84 0.33 Allowed 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 124.404 3.403 . . . . 0.0 113.764 -174.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.484 ' C ' ' HB3' ' A' ' 393' ' ' ASN . 6.3 ttp 59.04 38.34 24.11 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 174.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 389' ' ' HIS . . . . . 0.603 ' N ' ' HB3' ' A' ' 393' ' ' ASN . 31.3 m170 51.8 -97.22 0.05 Allowed 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.41 0.624 . . . . 0.0 110.064 -176.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -151.57 23.89 0.7 Allowed 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.186 171.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.477 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.4 pt? -175.77 -47.87 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.221 -172.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . 0.589 ' HA3' HD13 ' A' ' 395' ' ' ILE . . . -173.22 56.37 0.15 Allowed Glycine 0 CA--C 1.524 0.645 0 C-N-CA 119.443 -1.361 . . . . 0.0 114.796 -172.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . 0.603 ' HB3' ' N ' ' A' ' 389' ' ' HIS . 0.0 OUTLIER -61.72 -37.64 84.93 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-N 117.65 0.725 . . . . 0.0 109.061 174.18 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . 0.683 HG12 ' CE2' ' A' ' 386' ' ' PHE . 1.0 OUTLIER -57.2 -49.4 79.89 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 CA-C-N 113.674 -1.603 . . . . 0.0 107.047 179.015 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . 0.658 HG23 HD13 ' A' ' 426' ' ' ILE . 3.6 mp -57.69 -52.82 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 CA-C-O 117.745 -1.121 . . . . 0.0 113.605 -174.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . 0.606 ' O ' HG22 ' A' ' 399' ' ' VAL . 0.0 OUTLIER -62.54 -49.51 75.02 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 122.017 2.189 . . . . 0.0 112.199 -174.715 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.16 -44.48 63.76 Favored Glycine 0 N--CA 1.435 -1.391 0 C-N-CA 119.98 -1.105 . . . . 0.0 110.98 -176.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . 0.741 HD13 HD12 ' A' ' 410' ' ' LEU . 28.5 mt -71.09 -33.94 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 396' ' ' LYS . 17.3 m -63.29 -39.81 86.67 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 C-N-CA 118.751 -1.18 . . . . 0.0 108.436 -174.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -70.62 -37.7 73.84 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 175.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.46 HE21 ' HB3' ' A' ' 401' ' ' GLN . 3.3 mm100 -88.15 -48.86 7.39 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -171.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . 0.574 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 1.3 tm-20 -117.93 -19.94 8.98 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.065 0.46 . . . . 0.0 111.213 -170.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 106.45 160.67 22.25 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.673 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . 0.654 HG11 ' HA ' ' A' ' 430' ' ' LEU . 1.2 m -54.16 -45.5 66.51 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.862 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -175.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . 0.557 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -63.15 -31.26 72.36 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 119.794 -0.762 . . . . 0.0 112.403 -177.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.719 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 92.5 m -76.92 -42.03 41.1 Favored 'General case' 0 C--O 1.221 -0.412 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.164 173.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.449 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -58.8 -36.79 75.04 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 122.183 0.992 . . . . 0.0 109.301 176.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 408' ' ' TYR . . . . . 0.623 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -66.41 -51.73 53.92 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 113.492 -1.685 . . . . 0.0 109.571 176.762 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 409' ' ' THR . . . . . 0.648 HG22 HD23 ' A' ' 410' ' ' LEU . 17.5 m -55.11 -47.37 75.09 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.436 178.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . 0.741 HD12 HD13 ' A' ' 398' ' ' ILE . 15.0 mt -72.59 -35.73 67.99 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -174.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.44 -34.63 76.06 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.15 -1.024 . . . . 0.0 110.893 172.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -69.58 -47.22 64.33 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 413' ' ' MET . . . . . 0.919 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.8 OUTLIER -71.52 -44.84 63.9 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 118.914 -1.114 . . . . 0.0 111.879 -179.425 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . 0.919 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 11.7 mt -70.03 -46.37 65.21 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -177.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.451 ' HB2' ' SD ' ' A' ' 388' ' ' MET . 8.4 t -99.86 16.56 23.37 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.319 0.58 . . . . 0.0 110.349 -172.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 75.85 -176.66 50.81 Favored Glycine 0 N--CA 1.437 -1.266 0 C-N-CA 120.354 -0.927 . . . . 0.0 111.721 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -80.56 23.12 0.53 Allowed 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.272 0.558 . . . . 0.0 111.402 -172.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 418' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -71.58 76.98 0.81 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.514 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 419' ' ' TYR . . . . . 0.482 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 21.4 p90 -56.17 -38.04 70.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.518 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -55.71 -42.57 75.45 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.723 0.297 . . . . 0.0 111.081 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.1 -49.05 63.63 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.287 -178.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . 0.469 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -65.7 -39.51 85.11 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.259 -177.878 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.798 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 61.8 p -67.73 -37.75 82.61 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 -178.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -68.09 -39.25 88.75 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.129 175.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . 0.571 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.23 -52.4 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-O 120.352 0.12 . . . . 0.0 111.035 -177.908 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . 0.658 HD13 HG23 ' A' ' 395' ' ' ILE . 1.2 mm -74.75 -23.37 17.7 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.91 0 O-C-N 122.135 -0.353 . . . . 0.0 110.555 -172.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.798 ' HB2' ' O ' ' A' ' 423' ' ' SER . 1.5 tmt_? -54.57 -31.8 57.37 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.224 0.535 . . . . 0.0 111.13 -177.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.37 -12.1 67.99 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.217 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.595 ' HD1' HG22 ' A' ' 395' ' ' ILE . 6.1 m-30 -112.0 -1.97 15.23 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -173.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.654 ' HA ' HG11 ' A' ' 404' ' ' VAL . 0.0 OUTLIER -66.05 139.97 96.83 Favored Pre-proline 0 N--CA 1.443 -0.815 0 CA-C-N 114.136 -1.393 . . . . 0.0 109.206 177.349 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 431' ' ' PRO . . . . . 0.812 ' CD ' HG11 ' A' ' 435' ' ' VAL . 77.4 Cg_exo -37.99 -75.45 0.04 OUTLIER 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 124.606 3.537 . . . . 0.0 113.92 -173.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . 0.422 ' O ' HG12 ' A' ' 435' ' ' VAL . . . -130.06 -161.63 10.51 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 176.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . 0.52 ' O ' HG13 ' A' ' 436' ' ' VAL . 19.0 tp60 -71.47 -28.78 64.18 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 118.038 0.919 . . . . 0.0 110.569 176.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -67.03 -39.19 86.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 0.0 112.123 -175.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 435' ' ' VAL . . . . . 0.812 HG11 ' CD ' ' A' ' 431' ' ' PRO . 6.8 p -66.55 -45.08 89.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.173 0.511 . . . . 0.0 110.736 -177.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 433' ' ' GLN . 0.2 OUTLIER -66.28 -31.91 55.73 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.105 177.014 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -68.01 -52.26 37.63 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -177.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . 0.84 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -57.58 -40.56 79.29 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.179 177.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 439' ' ' LEU . . . . . 0.611 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 1.9 tm? -68.12 -48.13 66.26 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -178.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.86 -34.99 73.85 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.085 175.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 441' ' ' GLN . . . . . 0.542 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 4.4 mm-40 -53.62 -49.6 67.49 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.001 -178.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . 0.709 ' HD2' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -76.89 -25.28 52.84 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 119.133 -1.027 . . . . 0.0 113.368 174.346 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 443' ' ' LEU . . . . . 0.611 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 66.8 mt -65.59 -27.75 68.64 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 118.653 0.66 . . . . 0.0 109.771 175.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -61.29 -38.37 86.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.937 176.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -78.49 -27.63 46.25 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.319 -1.31 . . . . 0.0 111.149 178.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 25.36 101.58 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 41.5 mt -58.61 -33.59 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 121.353 0.597 . . . . 0.0 111.322 -178.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . 0.446 ' HB2' ' OG1' ' A' ' 451' ' ' THR . 8.4 m-20 -162.46 -159.81 0.61 Allowed 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 -178.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 449' ' ' ASP . . . . . 0.405 ' CG ' ' H ' ' A' ' 450' ' ' GLN . 12.3 p-10 -85.39 -64.88 1.08 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 168.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 450' ' ' GLN . . . . . 0.405 ' H ' ' CG ' ' A' ' 449' ' ' ASP . 0.0 OUTLIER -68.24 -26.11 65.53 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 179.012 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 451' ' ' THR . . . . . 0.452 ' HA ' ' HB2' ' A' ' 454' ' ' GLU . 10.4 m -71.44 -23.13 61.79 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 119.859 -0.736 . . . . 0.0 110.732 -175.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 452' ' ' ARG . 14.7 mtp180 -54.02 -53.95 45.91 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 171.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 453' ' ' ALA . . . . . 0.482 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -58.73 -49.08 78.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.354 -1.293 . . . . 0.0 112.53 174.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . 0.452 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 69.0 mm-40 -49.69 -37.15 27.67 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.283 0.563 . . . . 0.0 111.601 -177.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 32.0 p -118.03 15.06 14.18 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.45 -175.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . 0.551 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.8 OUTLIER -57.44 -47.47 81.73 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.089 0.471 . . . . 0.0 111.643 -171.28 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . 0.557 HG23 ' HB1' ' A' ' 405' ' ' ALA . 1.9 mp -76.92 -32.54 19.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.831 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -57.96 -34.41 69.9 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.905 0.86 . . . . 0.0 109.143 171.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . 0.771 ' O ' HG23 ' A' ' 463' ' ' VAL . 63.2 m-70 -74.68 -29.45 61.23 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.725 177.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . 0.714 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -73.47 -34.61 65.44 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.793 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . 0.458 ' O ' ' HB2' ' A' ' 464' ' ' TYR . 25.1 m-80 -73.11 -37.2 66.78 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.207 176.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 462' ' ' ALA . . . . . 0.598 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -55.75 -36.46 67.31 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.449 169.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.84 HG13 ' HB3' ' A' ' 438' ' ' ALA . 75.5 t -61.9 -51.16 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 CA-C-N 114.274 -1.33 . . . . 0.0 108.098 176.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 464' ' ' TYR . . . . . 0.606 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 18.5 m-30 -51.28 -29.03 13.43 Favored 'General case' 0 N--CA 1.455 -0.195 0 O-C-N 124.551 1.157 . . . . 0.0 110.758 177.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.0 -39.78 19.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.657 0.742 . . . . 0.0 109.76 -176.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.598 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.6 mt -57.89 -55.84 19.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 114.481 -1.236 . . . . 0.0 112.113 176.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 0.791 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -100.22 -10.51 21.29 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 -172.667 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . 0.665 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 94.24 32.06 7.64 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 119.238 -1.458 . . . . 0.0 114.259 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 469' ' ' LEU . . . . . 0.791 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 4.3 mt -89.2 158.85 17.73 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 117.827 0.814 . . . . 0.0 110.828 174.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . 0.487 HD22 HG23 ' A' ' 476' ' ' ILE . 10.8 p30 -105.8 -178.04 3.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.983 171.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -55.35 -27.42 47.12 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -173.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -85.82 7.32 24.33 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.767 0.318 . . . . 0.0 111.406 -170.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 473' ' ' GLY . . . . . 0.448 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 74.63 10.19 82.77 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.227 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -100.39 154.19 18.71 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 177.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 5.6 p -89.77 130.99 35.95 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.218 0.532 . . . . 0.0 111.221 -178.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 476' ' ' ILE . . . . . 0.665 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.8 pp . . . . . 0 C--N 1.323 -0.567 0 CA-C-O 121.564 0.697 . . . . 0.0 109.686 177.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 386' ' ' PHE . . . . . 0.741 ' CD1' HD22 ' B' ' 414' ' ' LEU . 2.1 t80 . . . . . 0 CA--C 1.539 0.544 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 387' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' B' ' 386' ' ' PHE . 1.6 Cg_endo -39.86 -62.98 0.31 Allowed 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 124.427 3.418 . . . . 0.0 113.872 -175.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 388' ' ' MET . . . . . 0.488 ' C ' ' HB3' ' B' ' 393' ' ' ASN . 6.3 ttp 59.0 38.52 24.17 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 174.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 389' ' ' HIS . . . . . 0.61 ' N ' ' HB3' ' B' ' 393' ' ' ASN . 31.3 m170 51.71 -97.01 0.05 Allowed 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 121.426 0.631 . . . . 0.0 110.268 -176.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -151.8 23.96 0.67 Allowed 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 171.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 391' ' ' LEU . . . . . 0.481 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.4 pt? -175.75 -47.78 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.357 -172.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 392' ' ' GLY . . . . . 0.591 ' HA3' HD13 ' B' ' 395' ' ' ILE . . . -173.2 56.48 0.15 Allowed Glycine 0 CA--C 1.525 0.685 0 C-N-CA 119.477 -1.344 . . . . 0.0 114.778 -172.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 393' ' ' ASN . . . . . 0.61 ' HB3' ' N ' ' B' ' 389' ' ' HIS . 0.0 OUTLIER -61.8 -37.62 85.06 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-N 117.649 0.725 . . . . 0.0 109.046 174.216 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 394' ' ' VAL . . . . . 0.692 HG12 ' CE2' ' B' ' 386' ' ' PHE . 1.0 OUTLIER -57.18 -49.4 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 CA-C-N 113.642 -1.617 . . . . 0.0 107.094 179.02 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 395' ' ' ILE . . . . . 0.65 HG23 HD13 ' B' ' 426' ' ' ILE . 3.6 mp -57.68 -52.72 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.315 0 CA-C-O 117.842 -1.075 . . . . 0.0 113.625 -174.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 396' ' ' LYS . . . . . 0.607 ' O ' HG22 ' B' ' 399' ' ' VAL . 0.0 OUTLIER -62.57 -49.74 74.07 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 121.991 2.178 . . . . 0.0 112.032 -174.666 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.06 -44.58 62.8 Favored Glycine 0 N--CA 1.435 -1.405 0 C-N-CA 119.979 -1.105 . . . . 0.0 110.933 -176.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 398' ' ' ILE . . . . . 0.738 HD13 HD12 ' B' ' 410' ' ' LEU . 28.5 mt -71.0 -33.84 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -179.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 399' ' ' VAL . . . . . 0.607 HG22 ' O ' ' B' ' 396' ' ' LYS . 17.2 m -63.42 -39.72 86.37 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 C-N-CA 118.753 -1.179 . . . . 0.0 108.483 -174.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -70.51 -37.98 74.24 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 175.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 401' ' ' GLN . . . . . 0.455 HE21 ' HB3' ' B' ' 401' ' ' GLN . 3.3 mm100 -88.09 -48.61 7.61 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -171.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 402' ' ' GLU . . . . . 0.589 ' HG3' ' HE3' ' A' ' 413' ' ' MET . 1.2 tm-20 -118.14 -19.89 8.86 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.216 -170.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 106.26 160.73 22.44 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.549 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 404' ' ' VAL . . . . . 0.65 HG11 ' HA ' ' B' ' 430' ' ' LEU . 1.2 m -54.19 -45.41 66.77 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.886 0 N-CA-C 114.568 1.322 . . . . 0.0 114.568 -175.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 405' ' ' ALA . . . . . 0.535 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -63.2 -31.18 72.26 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 119.819 -0.753 . . . . 0.0 112.43 -177.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 406' ' ' THR . . . . . 0.717 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 92.0 m -76.78 -42.17 41.85 Favored 'General case' 0 C--O 1.221 -0.4 0 O-C-N 121.682 -0.636 . . . . 0.0 110.226 173.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 407' ' ' ALA . . . . . 0.456 ' HB2' ' HB ' ' B' ' 398' ' ' ILE . . . -58.89 -36.68 75.06 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 122.204 1.002 . . . . 0.0 109.306 176.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 408' ' ' TYR . . . . . 0.623 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -66.5 -51.69 54.01 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 113.474 -1.694 . . . . 0.0 109.576 176.772 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 409' ' ' THR . . . . . 0.645 HG22 HD23 ' B' ' 410' ' ' LEU . 17.3 m -55.18 -47.29 75.42 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.447 178.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 410' ' ' LEU . . . . . 0.738 HD12 HD13 ' B' ' 398' ' ' ILE . 15.2 mt -72.65 -35.75 67.83 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -174.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.4 -34.72 76.13 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.196 -1.002 . . . . 0.0 110.951 172.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 412' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -69.56 -47.03 65.01 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-O 120.64 0.257 . . . . 0.0 111.612 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 413' ' ' MET . . . . . 0.936 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.9 OUTLIER -71.43 -45.27 63.1 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 118.848 -1.141 . . . . 0.0 111.792 -179.459 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 414' ' ' LEU . . . . . 0.936 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 11.7 mt -69.87 -46.39 65.6 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -177.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 415' ' ' SER . . . . . 0.451 ' HB2' ' SD ' ' B' ' 388' ' ' MET . 8.4 t -99.74 16.58 23.12 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.388 0.613 . . . . 0.0 110.515 -172.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 416' ' ' GLY . . . . . . . . . . . . . . . 75.84 -176.66 50.81 Favored Glycine 0 N--CA 1.436 -1.361 0 C-N-CA 120.359 -0.924 . . . . 0.0 111.699 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -80.66 23.11 0.54 Allowed 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.222 0.534 . . . . 0.0 111.397 -172.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 418' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -71.59 76.74 0.81 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.47 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 419' ' ' TYR . . . . . 0.483 ' HB2' ' CE2' ' B' ' 456' ' ' PHE . 21.1 p90 -55.65 -38.15 69.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.66 178.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -55.54 -42.91 75.27 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.952 178.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.73 -49.06 64.57 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.354 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 422' ' ' VAL . . . . . 0.471 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.2 OUTLIER -65.78 -39.29 84.37 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.364 -177.872 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 423' ' ' SER . . . . . 0.811 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 61.6 p -67.98 -37.88 82.03 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -178.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.86 -39.14 89.7 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.241 175.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 425' ' ' ILE . . . . . 0.583 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -72.35 -52.3 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 120.367 0.127 . . . . 0.0 111.145 -178.037 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 426' ' ' ILE . . . . . 0.65 HD13 HG23 ' B' ' 395' ' ' ILE . 1.2 mm -74.79 -23.42 17.68 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.969 0 O-C-N 122.095 -0.378 . . . . 0.0 110.594 -172.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 427' ' ' ARG . . . . . 0.811 ' HB2' ' O ' ' B' ' 423' ' ' SER . 1.5 tmt_? -54.59 -31.63 57.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.176 0.512 . . . . 0.0 111.134 -177.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.58 -12.19 67.36 Favored Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.501 -0.857 . . . . 0.0 111.141 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 429' ' ' TYR . . . . . 0.595 ' HD1' HG22 ' B' ' 395' ' ' ILE . 6.1 m-30 -111.77 -2.12 15.39 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.869 0.842 . . . . 0.0 108.797 -174.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 430' ' ' LEU . . . . . 0.65 ' HA ' HG11 ' B' ' 404' ' ' VAL . 0.0 OUTLIER -66.18 139.94 96.68 Favored Pre-proline 0 N--CA 1.442 -0.865 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.407 177.555 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 431' ' ' PRO . . . . . 0.812 ' CD ' HG11 ' B' ' 435' ' ' VAL . 77.2 Cg_exo -38.19 -75.03 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 124.633 3.555 . . . . 0.0 113.985 -173.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 432' ' ' GLY . . . . . 0.427 ' O ' HG12 ' B' ' 435' ' ' VAL . . . -130.1 -161.65 10.51 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 176.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 433' ' ' GLN . . . . . 0.529 ' O ' HG13 ' B' ' 436' ' ' VAL . 19.8 tp60 -71.38 -29.15 64.6 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 118.058 0.929 . . . . 0.0 110.506 176.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -66.74 -39.3 87.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.215 -0.448 . . . . 0.0 112.093 -175.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 435' ' ' VAL . . . . . 0.812 HG11 ' CD ' ' B' ' 431' ' ' PRO . 6.8 p -66.44 -45.21 89.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.117 0.484 . . . . 0.0 110.69 -177.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 436' ' ' VAL . . . . . 0.529 HG13 ' O ' ' B' ' 433' ' ' GLN . 0.2 OUTLIER -66.26 -31.75 55.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.091 177.124 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -68.16 -52.27 36.51 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -177.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 438' ' ' ALA . . . . . 0.847 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -57.63 -40.51 79.36 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.139 177.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 439' ' ' LEU . . . . . 0.604 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 1.9 tm? -67.99 -48.22 66.38 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -178.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.97 -34.76 73.71 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.093 175.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 441' ' ' GLN . . . . . 0.541 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 4.5 mm-40 -53.75 -49.66 67.7 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.967 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 442' ' ' ARG . . . . . 0.714 ' HD2' ' O ' ' B' ' 438' ' ' ALA . 0.0 OUTLIER -76.76 -25.45 53.42 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 119.221 -0.992 . . . . 0.0 113.308 174.441 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 443' ' ' LEU . . . . . 0.604 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 67.4 mt -65.62 -27.41 68.37 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 118.656 0.662 . . . . 0.0 109.806 175.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -61.7 -38.02 86.33 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.954 176.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 34.5 mm-40 -78.74 -27.39 44.78 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.266 -1.334 . . . . 0.0 111.232 178.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 446' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 24.9 101.35 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 41.6 mt -58.09 -33.91 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 121.35 0.595 . . . . 0.0 111.292 -178.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 448' ' ' ASP . . . . . 0.45 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 8.1 m-20 -162.14 -159.62 0.61 Allowed 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -178.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 449' ' ' ASP . . . . . 0.407 ' H ' ' HB3' ' B' ' 448' ' ' ASP . 12.1 p-10 -85.4 -64.87 1.08 Allowed 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 168.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 450' ' ' GLN . . . . . 0.407 ' H ' ' CG ' ' B' ' 449' ' ' ASP . 0.0 OUTLIER -68.41 -26.05 65.35 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 179.128 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 451' ' ' THR . . . . . 0.45 ' OG1' ' HB2' ' B' ' 448' ' ' ASP . 10.0 m -71.58 -23.09 61.67 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.75 -175.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 452' ' ' ARG . . . . . . . . . . . . . 14.5 mtp180 -53.97 -54.0 45.02 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 171.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 453' ' ' ALA . . . . . 0.478 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -58.68 -49.09 78.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.361 -1.291 . . . . 0.0 112.596 174.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 454' ' ' GLU . . . . . 0.437 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 71.1 mm-40 -49.8 -36.93 28.14 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.218 0.533 . . . . 0.0 111.616 -177.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 32.3 p -118.15 15.0 14.08 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.448 -175.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 456' ' ' PHE . . . . . 0.555 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 0.8 OUTLIER -57.53 -47.27 82.44 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.136 0.493 . . . . 0.0 111.66 -171.266 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 457' ' ' ILE . . . . . 0.535 HG23 ' HB1' ' B' ' 405' ' ' ALA . 1.9 mp -77.15 -32.4 19.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.029 0.442 . . . . 0.0 110.853 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -57.87 -34.62 69.96 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.779 0.799 . . . . 0.0 109.113 171.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 459' ' ' HIS . . . . . 0.769 ' O ' HG23 ' B' ' 463' ' ' VAL . 64.1 m-70 -74.65 -29.47 61.27 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.55 -1.204 . . . . 0.0 110.748 177.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 460' ' ' LEU . . . . . 0.731 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -73.33 -34.52 65.72 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.91 0.862 . . . . 0.0 108.758 178.59 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 461' ' ' ASN . . . . . 0.454 ' O ' ' HB2' ' B' ' 464' ' ' TYR . 23.5 m-80 -73.26 -37.26 66.36 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.15 176.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 462' ' ' ALA . . . . . 0.602 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -55.66 -36.33 66.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.636 -1.165 . . . . 0.0 109.495 169.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 463' ' ' VAL . . . . . 0.847 HG13 ' HB3' ' B' ' 438' ' ' ALA . 75.6 t -62.07 -51.09 76.64 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-N 114.293 -1.321 . . . . 0.0 107.983 176.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 464' ' ' TYR . . . . . 0.614 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 18.6 m-30 -51.47 -28.97 14.75 Favored 'General case' 0 C--N 1.332 -0.167 0 O-C-N 124.496 1.123 . . . . 0.0 110.644 177.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.94 -39.97 19.11 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.719 0.771 . . . . 0.0 109.712 -176.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 466' ' ' ILE . . . . . 0.602 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.6 mt -57.75 -55.7 19.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 114.35 -1.295 . . . . 0.0 112.249 176.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 467' ' ' LEU . . . . . 0.784 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -100.25 -10.58 21.18 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -172.833 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 468' ' ' GLY . . . . . 0.667 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 94.21 32.12 7.62 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 119.308 -1.425 . . . . 0.0 114.313 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 469' ' ' LEU . . . . . 0.784 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 4.3 mt -89.05 159.05 17.76 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 117.814 0.807 . . . . 0.0 110.742 174.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 470' ' ' ASN . . . . . 0.474 HD22 HG23 ' B' ' 476' ' ' ILE . 10.6 p30 -105.88 -178.11 3.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.001 170.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 471' ' ' ALA . . . . . . . . . . . . . . . -55.36 -27.47 47.56 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -173.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -85.67 7.18 24.38 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 122.159 -0.338 . . . . 0.0 111.438 -171.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 473' ' ' GLY . . . . . 0.451 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 74.87 9.96 83.51 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.322 -0.942 . . . . 0.0 111.306 -178.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -100.54 154.41 18.58 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 177.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 6.4 p -89.69 131.06 35.86 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.27 0.557 . . . . 0.0 111.291 -178.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 476' ' ' ILE . . . . . 0.667 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.8 pp . . . . . 0 C--N 1.323 -0.553 0 CA-C-O 121.539 0.685 . . . . 0.0 109.75 177.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 386' ' ' PHE . . . . . 0.75 ' CD1' HD22 ' A' ' 414' ' ' LEU . 1.4 t80 . . . . . 0 CA--C 1.534 0.363 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . 0.47 ' HD2' ' HA ' ' A' ' 386' ' ' PHE . 10.0 Cg_endo -48.17 -69.77 0.07 OUTLIER 'Trans proline' 0 N--CA 1.483 0.873 0 C-N-CA 124.722 3.615 . . . . 0.0 115.907 -173.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.535 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 32.6 mtt 72.73 156.24 0.17 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.379 0.671 . . . . 0.0 111.216 -172.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 389' ' ' HIS . . . . . 0.55 ' CG ' ' HB2' ' A' ' 393' ' ' ASN . 32.7 m170 -54.33 -59.67 4.37 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 175.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . 0.406 ' H ' HD23 ' A' ' 391' ' ' LEU . 4.4 pt20 -177.55 19.96 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.786 -1.097 . . . . 0.0 108.687 175.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.587 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.3 pt? -170.11 -58.53 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.38 -167.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . 0.611 ' HA3' HD13 ' A' ' 395' ' ' ILE . . . -172.73 51.31 0.17 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.372 -0.918 . . . . 0.0 113.181 -172.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . 0.55 ' HB2' ' CG ' ' A' ' 389' ' ' HIS . 0.6 OUTLIER -57.01 -38.56 73.27 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.138 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . 0.706 HG12 ' CE2' ' A' ' 386' ' ' PHE . 0.9 OUTLIER -55.88 -46.44 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 179.771 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . 0.636 HG23 HD13 ' A' ' 426' ' ' ILE . 4.2 mp -57.82 -51.98 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 CA-C-O 117.902 -1.046 . . . . 0.0 113.047 -175.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . 0.702 ' HG3' ' CZ ' ' A' ' 429' ' ' TYR . 0.2 OUTLIER -62.49 -49.19 76.37 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 121.563 1.983 . . . . 0.0 111.816 -173.689 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -54.48 -44.87 77.71 Favored Glycine 0 N--CA 1.434 -1.471 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.0 -178.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . 0.86 HD13 HD12 ' A' ' 410' ' ' LEU . 45.0 mt -70.9 -33.87 53.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -177.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . 0.533 HG12 ' HA ' ' A' ' 404' ' ' VAL . 10.9 m -64.23 -39.42 85.45 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 C-N-CA 118.667 -1.213 . . . . 0.0 108.324 -175.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -70.37 -35.29 73.44 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 175.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.427 HE21 ' HB3' ' A' ' 401' ' ' GLN . 2.7 mm100 -89.42 -47.95 7.66 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -172.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . 0.675 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 3.1 mm-40 -121.0 -21.23 6.58 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.795 -170.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 108.03 162.23 20.99 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.952 -0.642 . . . . 0.0 113.046 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . 0.68 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.5 m -53.75 -42.51 52.21 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.772 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -175.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . 0.63 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -68.86 -29.86 68.26 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 119.708 -0.797 . . . . 0.0 112.073 -175.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.692 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 90.6 m -77.76 -42.5 33.87 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.074 173.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.461 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.35 -37.91 76.14 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 122.084 0.945 . . . . 0.0 109.229 176.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 408' ' ' TYR . . . . . 0.68 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.4 -51.79 57.91 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 113.517 -1.674 . . . . 0.0 109.851 176.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 409' ' ' THR . . . . . 0.666 HG22 HD23 ' A' ' 410' ' ' LEU . 12.0 m -54.96 -47.08 75.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.586 178.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . 0.86 HD12 HD13 ' A' ' 398' ' ' ILE . 14.5 mt -72.24 -36.67 69.15 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.893 0.377 . . . . 0.0 110.213 -174.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.82 -34.94 80.06 Favored Glycine 0 N--CA 1.438 -1.182 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 172.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 412' ' ' MET . . . . . 0.465 ' HB2' ' O ' ' A' ' 409' ' ' THR . 0.6 OUTLIER -66.06 -46.58 77.25 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 115.61 -0.295 . . . . 0.0 111.5 177.252 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 413' ' ' MET . . . . . 0.778 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.0 OUTLIER -70.33 -55.22 9.69 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 118.788 -1.165 . . . . 0.0 111.94 -179.814 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . 0.778 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 6.9 mt -64.76 -43.71 92.43 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -172.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 40.8 t -86.05 -20.43 28.8 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.677 0.751 . . . . 0.0 110.032 -177.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 104.03 -175.65 23.2 Favored Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 -171.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 417' ' ' GLN . . . . . 0.44 ' HA ' ' HE2' ' A' ' 412' ' ' MET . 34.5 mm-40 -79.85 24.2 0.41 Allowed 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.186 0.517 . . . . 0.0 111.748 -171.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 418' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -71.09 75.04 0.67 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.393 178.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 419' ' ' TYR . . . . . 0.497 ' HB2' ' CE2' ' A' ' 456' ' ' PHE . 14.0 p90 -52.22 -37.07 53.97 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.947 175.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 420' ' ' GLN . . . . . 0.411 ' HG3' ' H ' ' A' ' 421' ' ' LEU . 2.5 pt20 -53.7 -47.18 70.76 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.95 176.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . 0.411 ' H ' ' HG3' ' A' ' 420' ' ' GLN . 0.0 OUTLIER -68.09 -48.58 65.13 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.192 -177.005 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . 0.455 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.3 OUTLIER -66.48 -40.35 86.26 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.345 -176.584 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.772 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 77.2 p -67.33 -37.08 82.73 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 -179.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -68.51 -38.67 86.81 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.249 175.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . 0.595 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -73.44 -51.92 23.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.461 0.172 . . . . 0.0 111.235 -178.452 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . 0.636 HD13 HG23 ' A' ' 395' ' ' ILE . 1.2 mm -74.53 -22.45 17.64 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.845 0 C-N-CA 122.614 0.366 . . . . 0.0 110.092 -171.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.772 ' HB2' ' O ' ' A' ' 423' ' ' SER . 0.5 OUTLIER -54.2 -30.78 51.01 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.227 0.537 . . . . 0.0 110.26 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.92 -4.89 78.19 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.808 179.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.702 ' CZ ' ' HG3' ' A' ' 396' ' ' LYS . 23.7 m-85 -119.09 -2.12 10.81 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 121.573 0.701 . . . . 0.0 110.081 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.602 HD12 ' HD2' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -66.29 135.17 94.81 Favored Pre-proline 0 N--CA 1.439 -0.989 0 CA-C-N 114.664 -1.153 . . . . 0.0 108.881 178.84 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 431' ' ' PRO . . . . . 0.826 ' HD2' HG11 ' A' ' 435' ' ' VAL . 50.6 Cg_exo -36.69 -64.42 0.18 Allowed 'Trans proline' 0 CA--C 1.533 0.442 0 C-N-CA 124.723 3.615 . . . . 0.0 114.247 -172.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . 0.594 ' H ' HG12 ' A' ' 435' ' ' VAL . . . -144.17 -164.96 10.72 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 176.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . 0.48 ' O ' HG13 ' A' ' 436' ' ' VAL . 18.4 tp60 -70.47 -26.93 63.85 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 118.197 0.999 . . . . 0.0 110.347 178.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -67.46 -39.49 85.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.312 -0.404 . . . . 0.0 112.045 -177.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 435' ' ' VAL . . . . . 0.826 HG11 ' HD2' ' A' ' 431' ' ' PRO . 7.0 p -67.96 -44.99 84.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-O 120.953 0.406 . . . . 0.0 110.576 -178.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.503 HG12 ' O ' ' A' ' 432' ' ' GLY . 0.1 OUTLIER -66.06 -29.31 46.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.343 176.167 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -69.35 -52.55 26.13 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . 0.887 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -58.03 -37.99 75.39 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.57 177.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 439' ' ' LEU . . . . . 0.583 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 2.1 tm? -70.16 -47.17 62.78 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -178.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.1 -40.3 76.75 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.21 174.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 441' ' ' GLN . . . . . 0.528 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 11.0 mm-40 -53.51 -49.89 66.58 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 123.751 0.82 . . . . 0.0 110.852 173.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . 0.83 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 1.6 mmp_? -55.89 -39.75 72.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.816 171.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 443' ' ' LEU . . . . . 0.583 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 39.2 mt -72.09 -31.15 65.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.788 0.328 . . . . 0.0 110.862 -178.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -57.25 -38.29 73.6 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.773 0.796 . . . . 0.0 110.081 171.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -76.44 -25.91 54.89 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.528 -1.214 . . . . 0.0 111.96 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 446' ' ' GLU . . . . . 0.478 ' O ' ' HG3' ' A' ' 446' ' ' GLU . 14.5 pt-20 1.92 105.43 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 125.35 1.46 . . . . 0.0 114.393 -178.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 38.4 mt -58.01 -35.54 52.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.877 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . 0.493 ' HB2' ' OG1' ' A' ' 451' ' ' THR . 26.1 m-20 -164.07 -176.55 4.56 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -178.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -66.36 -67.11 0.47 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 173.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.03 -26.88 64.25 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 451' ' ' THR . . . . . 0.493 ' OG1' ' HB2' ' A' ' 448' ' ' ASP . 10.7 m -72.43 -23.81 61.13 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.046 -0.661 . . . . 0.0 110.256 -177.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 19.7 ttm180 -54.62 -53.06 59.71 Favored 'General case' 0 N--CA 1.413 -2.324 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 171.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 453' ' ' ALA . . . . . 0.493 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -58.37 -47.27 84.38 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.673 172.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . 0.421 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 16.5 mm-40 -52.31 -38.5 58.64 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.26 0.552 . . . . 0.0 111.369 -176.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 27.3 p -112.26 12.48 20.31 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.362 -176.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . 0.547 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 1.0 OUTLIER -55.5 -46.93 76.9 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.037 0.446 . . . . 0.0 111.599 -173.052 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . 0.63 HG23 ' HB1' ' A' ' 405' ' ' ALA . 2.0 mp -77.77 -34.37 19.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.022 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -57.83 -34.57 69.82 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.946 0.879 . . . . 0.0 109.203 171.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . 0.726 ' O ' HG23 ' A' ' 463' ' ' VAL . 51.3 m-70 -74.0 -28.99 61.73 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.92 176.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . 0.721 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -73.69 -34.54 64.9 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.939 0.875 . . . . 0.0 108.717 179.016 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . 0.437 ' HA ' ' CD2' ' A' ' 464' ' ' TYR . 23.5 m-80 -73.19 -38.33 66.18 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.004 176.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 462' ' ' ALA . . . . . 0.621 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -56.45 -34.91 67.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.723 169.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.887 HG13 ' HB3' ' A' ' 438' ' ' ALA . 61.5 t -59.96 -50.97 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 114.611 -1.177 . . . . 0.0 107.845 175.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 464' ' ' TYR . . . . . 0.596 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 17.2 m-30 -53.69 -28.26 32.68 Favored 'General case' 0 C--N 1.333 -0.14 0 O-C-N 124.395 1.06 . . . . 0.0 110.743 178.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.99 -41.34 20.87 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.691 0.758 . . . . 0.0 109.636 -178.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.621 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.5 mt -56.11 -55.35 18.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 114.266 -1.334 . . . . 0.0 112.345 176.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 0.794 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -102.16 -10.42 19.64 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -173.064 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . 0.568 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 93.86 31.4 8.19 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 119.396 -1.383 . . . . 0.0 114.348 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 469' ' ' LEU . . . . . 0.794 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 4.4 mt -88.59 164.55 15.33 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 118.01 0.905 . . . . 0.0 111.408 177.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 38.5 p30 -105.24 -176.83 3.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.827 170.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 471' ' ' ALA . . . . . 0.514 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -68.17 -13.67 62.4 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -176.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -89.02 -1.19 57.99 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 122.23 -0.294 . . . . 0.0 111.347 -175.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 78.47 12.58 84.12 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.334 -0.936 . . . . 0.0 110.898 -174.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -100.58 151.27 21.79 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 177.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 475' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 469' ' ' LEU . 31.7 t -92.26 136.69 32.98 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.241 0.543 . . . . 0.0 111.023 -177.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 476' ' ' ILE . . . . . 0.568 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.3 pp . . . . . 0 C--N 1.319 -0.738 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.087 -178.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 386' ' ' PHE . . . . . 0.764 ' CD1' HD22 ' B' ' 414' ' ' LEU . 1.4 t80 . . . . . 0 CA--C 1.534 0.333 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 387' ' ' PRO . . . . . 0.479 ' HD2' ' HA ' ' B' ' 386' ' ' PHE . 9.5 Cg_endo -48.19 -69.9 0.07 OUTLIER 'Trans proline' 0 N--CA 1.484 0.921 0 C-N-CA 124.703 3.602 . . . . 0.0 115.872 -173.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 388' ' ' MET . . . . . 0.538 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 32.5 mtt 72.94 156.56 0.17 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.222 0.609 . . . . 0.0 111.162 -172.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 389' ' ' HIS . . . . . 0.56 ' CG ' ' HB2' ' B' ' 393' ' ' ASN . 32.7 m170 -54.58 -59.9 4.08 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 175.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 390' ' ' GLN . . . . . 0.4 ' H ' HD23 ' B' ' 391' ' ' LEU . 4.6 pt20 -177.23 19.77 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.649 175.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 391' ' ' LEU . . . . . 0.58 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.3 pt? -169.97 -58.37 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.451 -167.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 392' ' ' GLY . . . . . 0.615 ' HA3' HD13 ' B' ' 395' ' ' ILE . . . -172.81 51.51 0.17 Allowed Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.302 -0.951 . . . . 0.0 113.026 -172.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 393' ' ' ASN . . . . . 0.56 ' HB2' ' CG ' ' B' ' 389' ' ' HIS . 0.6 OUTLIER -57.01 -38.54 73.24 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 394' ' ' VAL . . . . . 0.709 HG12 ' CE2' ' B' ' 386' ' ' PHE . 0.9 OUTLIER -56.07 -46.45 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 395' ' ' ILE . . . . . 0.63 HG23 HD13 ' B' ' 426' ' ' ILE . 4.2 mp -57.63 -52.09 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 CA-C-O 117.973 -1.013 . . . . 0.0 113.04 -175.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 396' ' ' LYS . . . . . 0.707 ' HG3' ' CZ ' ' B' ' 429' ' ' TYR . 0.2 OUTLIER -62.49 -49.27 76.06 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 121.482 1.947 . . . . 0.0 111.8 -173.777 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -54.35 -44.89 76.35 Favored Glycine 0 N--CA 1.434 -1.487 0 C-N-CA 120.103 -1.046 . . . . 0.0 111.02 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 398' ' ' ILE . . . . . 0.867 HD13 HD12 ' B' ' 410' ' ' LEU . 45.0 mt -70.94 -33.81 53.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -177.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 399' ' ' VAL . . . . . 0.534 HG12 ' HA ' ' B' ' 404' ' ' VAL . 10.8 m -64.22 -39.51 85.75 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 C-N-CA 118.592 -1.243 . . . . 0.0 108.346 -175.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -70.39 -35.26 73.36 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 175.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 401' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -89.43 -47.81 7.75 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -172.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 402' ' ' GLU . . . . . 0.674 ' HG3' ' HE3' ' A' ' 413' ' ' MET . 3.0 mm-40 -121.09 -21.3 6.5 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.771 -170.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 108.02 162.25 21.0 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.954 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 404' ' ' VAL . . . . . 0.67 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.5 m -53.83 -42.56 53.21 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.809 0 N-CA-C 114.698 1.369 . . . . 0.0 114.698 -175.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 405' ' ' ALA . . . . . 0.642 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -68.82 -29.9 68.34 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 119.77 -0.772 . . . . 0.0 111.991 -175.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 406' ' ' THR . . . . . 0.687 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 92.5 m -77.59 -42.53 34.82 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.161 173.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 407' ' ' ALA . . . . . 0.462 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.3 -37.76 75.7 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 122.182 0.992 . . . . 0.0 109.295 176.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 408' ' ' TYR . . . . . 0.67 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.56 -51.86 56.65 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 113.494 -1.685 . . . . 0.0 109.747 177.12 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 409' ' ' THR . . . . . 0.666 HG22 HD23 ' B' ' 410' ' ' LEU . 10.2 m -54.84 -47.13 74.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.636 178.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 410' ' ' LEU . . . . . 0.867 HD12 HD13 ' B' ' 398' ' ' ILE . 14.3 mt -72.05 -36.91 69.73 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.972 0.415 . . . . 0.0 110.263 -174.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.63 -34.87 78.37 Favored Glycine 0 N--CA 1.439 -1.135 0 C-N-CA 120.036 -1.078 . . . . 0.0 110.52 172.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 412' ' ' MET . . . . . 0.468 ' HB2' ' O ' ' B' ' 409' ' ' THR . 0.5 OUTLIER -66.26 -46.47 76.97 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 115.64 -0.28 . . . . 0.0 111.39 177.287 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 413' ' ' MET . . . . . 0.775 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.0 OUTLIER -70.34 -55.02 10.15 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 118.709 -1.197 . . . . 0.0 111.987 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 414' ' ' LEU . . . . . 0.779 HD21 HG12 ' A' ' 398' ' ' ILE . 6.9 mt -64.97 -43.7 91.76 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -172.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 43.0 t -86.02 -20.48 28.78 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.79 0.805 . . . . 0.0 109.991 -177.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 416' ' ' GLY . . . . . . . . . . . . . . . 104.06 -175.91 23.34 Favored Glycine 0 N--CA 1.43 -1.758 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -171.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 417' ' ' GLN . . . . . 0.407 ' HA ' ' HE2' ' B' ' 412' ' ' MET . 35.4 mm-40 -79.85 24.45 0.39 Allowed 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.22 0.533 . . . . 0.0 111.808 -171.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 418' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -71.28 74.89 0.72 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.456 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 419' ' ' TYR . . . . . 0.494 ' HB2' ' CE2' ' B' ' 456' ' ' PHE . 14.4 p90 -52.09 -37.04 52.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.997 175.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 420' ' ' GLN . . . . . 0.401 ' HG3' ' H ' ' B' ' 421' ' ' LEU . 2.5 pt20 -53.67 -47.39 70.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.904 176.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 421' ' ' LEU . . . . . 0.401 ' H ' ' HG3' ' B' ' 420' ' ' GLN . 0.0 OUTLIER -67.98 -48.62 65.3 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.136 -177.011 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 422' ' ' VAL . . . . . 0.456 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.3 OUTLIER -66.51 -40.26 86.0 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.436 -176.476 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 423' ' ' SER . . . . . 0.77 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 77.7 p -67.39 -36.97 82.39 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 -179.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -68.58 -38.6 86.44 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.292 175.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 425' ' ' ILE . . . . . 0.612 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -73.37 -51.72 24.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 O-C-N 122.975 -0.132 . . . . 0.0 111.204 -178.318 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 426' ' ' ILE . . . . . 0.63 HD13 HG23 ' B' ' 395' ' ' ILE . 1.2 mm -74.87 -22.42 17.17 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.873 0 C-N-CA 122.627 0.371 . . . . 0.0 110.019 -171.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 427' ' ' ARG . . . . . 0.77 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.5 OUTLIER -54.26 -30.44 50.47 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.275 0.56 . . . . 0.0 110.294 179.85 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.88 -5.4 77.6 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.809 178.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 429' ' ' TYR . . . . . 0.707 ' CZ ' ' HG3' ' B' ' 396' ' ' LYS . 23.7 m-85 -118.9 -1.72 10.97 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 121.415 0.626 . . . . 0.0 110.152 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 430' ' ' LEU . . . . . 0.616 HD12 ' HD2' ' B' ' 431' ' ' PRO . 0.0 OUTLIER -66.42 135.38 94.72 Favored Pre-proline 0 N--CA 1.439 -0.992 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.855 178.777 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 431' ' ' PRO . . . . . 0.825 ' HD2' HG11 ' B' ' 435' ' ' VAL . 52.5 Cg_exo -36.89 -64.51 0.18 Allowed 'Trans proline' 0 CA--C 1.532 0.391 0 C-N-CA 124.716 3.611 . . . . 0.0 114.209 -172.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 432' ' ' GLY . . . . . 0.585 ' H ' HG12 ' B' ' 435' ' ' VAL . . . -144.09 -164.48 10.45 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 176.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 433' ' ' GLN . . . . . 0.487 ' O ' HG13 ' B' ' 436' ' ' VAL . 17.5 tp60 -70.67 -26.99 63.69 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 118.198 0.999 . . . . 0.0 110.369 178.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -67.64 -39.3 84.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.304 -0.407 . . . . 0.0 112.076 -177.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 435' ' ' VAL . . . . . 0.837 HG23 HG11 ' B' ' 463' ' ' VAL . 7.2 p -68.02 -45.08 84.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-O 120.962 0.411 . . . . 0.0 110.562 -178.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 436' ' ' VAL . . . . . 0.506 HG21 ' NE ' ' B' ' 427' ' ' ARG . 0.1 OUTLIER -66.01 -29.15 45.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.465 176.175 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -69.53 -52.54 25.44 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 438' ' ' ALA . . . . . 0.878 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -57.94 -37.95 75.04 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.618 177.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 439' ' ' LEU . . . . . 0.599 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 2.1 tm? -70.18 -47.23 62.48 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -178.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.99 -40.37 76.45 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.2 174.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 441' ' ' GLN . . . . . 0.528 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 10.8 mm-40 -53.53 -49.9 66.62 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 123.827 0.851 . . . . 0.0 110.747 174.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 442' ' ' ARG . . . . . 0.838 ' HG2' ' O ' ' B' ' 438' ' ' ALA . 1.5 mmp_? -55.99 -39.66 72.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.754 171.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 443' ' ' LEU . . . . . 0.599 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 39.3 mt -72.08 -31.04 65.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.795 0.331 . . . . 0.0 110.816 -178.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -57.32 -38.43 74.05 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.769 0.795 . . . . 0.0 110.028 171.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -76.49 -25.91 54.75 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.457 -1.247 . . . . 0.0 111.842 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 446' ' ' GLU . . . . . 0.485 ' O ' ' HG3' ' B' ' 446' ' ' GLU . 14.4 pt-20 2.21 105.73 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 125.292 1.437 . . . . 0.0 114.377 -178.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 39.4 mt -58.59 -35.18 53.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.028 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 448' ' ' ASP . . . . . 0.486 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 23.6 m-20 -164.23 -176.52 4.48 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 -178.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -66.72 -66.84 0.5 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 173.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.14 -26.75 64.09 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 179.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 451' ' ' THR . . . . . 0.486 ' OG1' ' HB2' ' B' ' 448' ' ' ASP . 11.3 m -72.42 -23.73 61.12 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.244 -177.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 452' ' ' ARG . . . . . . . . . . . . . 19.6 ttm180 -54.61 -53.17 58.15 Favored 'General case' 0 N--CA 1.412 -2.37 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 171.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 453' ' ' ALA . . . . . 0.489 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -58.47 -47.15 84.98 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.703 172.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 454' ' ' GLU . . . . . 0.427 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 21.9 mm-40 -52.24 -38.69 58.82 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.305 0.574 . . . . 0.0 111.313 -176.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 25.8 p -112.12 12.46 20.52 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.272 -176.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 456' ' ' PHE . . . . . 0.543 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 1.0 OUTLIER -55.57 -46.91 77.13 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.044 0.45 . . . . 0.0 111.615 -172.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 457' ' ' ILE . . . . . 0.642 HG23 ' HB1' ' B' ' 405' ' ' ALA . 2.0 mp -77.85 -34.25 19.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.097 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -58.0 -34.39 69.95 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.969 0.89 . . . . 0.0 109.265 171.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 459' ' ' HIS . . . . . 0.724 ' O ' HG23 ' B' ' 463' ' ' VAL . 52.2 m-70 -73.87 -29.24 61.98 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.943 176.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 460' ' ' LEU . . . . . 0.719 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -73.62 -34.58 65.09 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.934 0.873 . . . . 0.0 108.775 179.192 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 461' ' ' ASN . . . . . 0.441 ' HA ' ' CD2' ' B' ' 464' ' ' TYR . 22.4 m-80 -73.2 -38.09 66.24 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.142 176.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 462' ' ' ALA . . . . . 0.613 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -56.6 -35.08 67.83 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.72 169.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 463' ' ' VAL . . . . . 0.878 HG13 ' HB3' ' B' ' 438' ' ' ALA . 61.0 t -59.79 -51.11 76.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 175.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 464' ' ' TYR . . . . . 0.587 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 17.4 m-30 -53.48 -28.66 31.98 Favored 'General case' 0 C--O 1.225 -0.2 0 O-C-N 124.322 1.014 . . . . 0.0 110.648 178.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.72 -41.17 21.66 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.572 0.701 . . . . 0.0 109.701 -178.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 466' ' ' ILE . . . . . 0.613 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.5 mt -56.2 -55.66 17.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 114.409 -1.269 . . . . 0.0 112.21 176.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 467' ' ' LEU . . . . . 0.807 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -101.88 -10.6 19.71 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -172.941 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 468' ' ' GLY . . . . . 0.569 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 93.99 31.54 8.05 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 119.419 -1.372 . . . . 0.0 114.29 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 469' ' ' LEU . . . . . 0.807 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 4.4 mt -88.62 164.54 15.31 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 118.059 0.929 . . . . 0.0 111.39 177.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 38.2 p30 -105.22 -176.64 3.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.869 170.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 471' ' ' ALA . . . . . 0.52 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -68.47 -13.64 62.45 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -175.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -88.94 -1.58 58.17 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.705 0.288 . . . . 0.0 111.325 -175.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 473' ' ' GLY . . . . . . . . . . . . . . . 78.86 12.63 83.97 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.263 -0.97 . . . . 0.0 110.884 -174.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -100.59 151.61 21.4 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 475' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' B' ' 469' ' ' LEU . 32.1 t -92.56 136.55 33.12 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.239 0.542 . . . . 0.0 111.023 -177.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 476' ' ' ILE . . . . . 0.569 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.3 pp . . . . . 0 C--N 1.32 -0.709 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.115 -178.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 386' ' ' PHE . . . . . 0.8 ' CD1' HD22 ' A' ' 414' ' ' LEU . 3.4 t80 . . . . . 0 CA--C 1.53 0.189 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 386' ' ' PHE . 5.9 Cg_endo -47.06 -70.87 0.06 OUTLIER 'Trans proline' 0 CA--C 1.532 0.407 0 C-N-CA 123.961 3.107 . . . . 0.0 114.091 -174.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 40.7 ttm 71.98 155.77 0.16 Allowed 'General case' 0 CA--C 1.547 0.841 0 CA-C-O 121.237 0.542 . . . . 0.0 111.893 175.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 389' ' ' HIS . . . . . 0.602 ' H ' ' H ' ' A' ' 393' ' ' ASN . 2.7 m170 -76.6 27.72 0.13 Allowed 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.711 0.804 . . . . 0.0 112.917 -171.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . 0.591 ' HG2' ' O ' ' A' ' 389' ' ' HIS . 2.3 pt20 71.2 4.22 4.98 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.562 0.745 . . . . 0.0 109.902 -167.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -164.57 -43.59 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . 0.597 ' HA3' HD13 ' A' ' 395' ' ' ILE . . . -175.89 55.42 0.12 Allowed Glycine 0 C--O 1.223 -0.56 0 C-N-CA 118.088 -2.006 . . . . 0.0 115.88 -176.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . 0.602 ' H ' ' H ' ' A' ' 389' ' ' HIS . 0.0 OUTLIER -60.89 -36.44 79.23 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 118.095 0.948 . . . . 0.0 108.644 176.294 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . 0.7 HG23 HD12 ' A' ' 398' ' ' ILE . 1.5 m -58.54 -50.23 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 CA-C-N 113.289 -1.778 . . . . 0.0 107.834 178.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . 0.633 HG23 HD13 ' A' ' 426' ' ' ILE . 4.0 mp -57.98 -52.5 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 CA-C-O 117.985 -1.007 . . . . 0.0 113.614 -174.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . 0.608 ' HG3' ' CZ ' ' A' ' 429' ' ' TYR . 0.0 OUTLIER -64.06 -48.2 77.16 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 121.736 2.062 . . . . 0.0 111.493 -173.82 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -54.0 -45.33 71.94 Favored Glycine 0 N--CA 1.431 -1.636 0 C-N-CA 119.846 -1.169 . . . . 0.0 111.044 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . 0.733 HD13 HD12 ' A' ' 410' ' ' LEU . 33.2 mt -70.87 -33.87 53.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -178.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . 0.492 HG22 ' O ' ' A' ' 396' ' ' LYS . 15.3 m -63.75 -39.43 85.34 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 C-N-CA 118.685 -1.206 . . . . 0.0 108.41 -174.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -71.11 -35.24 71.71 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 175.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.471 HE21 ' HB3' ' A' ' 401' ' ' GLN . 3.8 mm100 -88.69 -48.07 7.8 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -172.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . 0.506 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 2.7 mm-40 -121.22 -21.36 6.42 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.601 -169.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 108.41 162.61 20.72 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.953 -0.642 . . . . 0.0 113.128 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . 0.674 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.5 m -53.67 -41.86 48.74 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.794 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -176.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . 0.59 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -68.88 -30.96 69.58 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 119.566 -0.854 . . . . 0.0 111.773 -176.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.718 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 89.0 m -77.38 -42.56 35.96 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.174 -0.611 . . . . 0.0 110.3 173.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.447 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -58.26 -37.22 74.53 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 122.054 0.931 . . . . 0.0 109.263 176.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 408' ' ' TYR . . . . . 0.674 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.77 -52.12 53.51 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 113.558 -1.655 . . . . 0.0 109.761 176.387 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 409' ' ' THR . . . . . 0.666 HG22 HD23 ' A' ' 410' ' ' LEU . 16.0 m -55.32 -47.37 75.74 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.635 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . 0.733 HD12 HD13 ' A' ' 398' ' ' ILE . 14.9 mt -72.65 -36.87 68.08 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -174.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.66 -34.96 78.96 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 119.83 -1.176 . . . . 0.0 110.641 173.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 412' ' ' MET . . . . . 0.407 ' HB2' ' O ' ' A' ' 409' ' ' THR . 0.3 OUTLIER -66.83 -48.67 68.2 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-O 120.597 0.236 . . . . 0.0 111.475 178.033 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 413' ' ' MET . . . . . 0.933 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.8 OUTLIER -71.35 -44.26 65.38 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 119.022 -1.071 . . . . 0.0 112.037 -178.552 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . 0.933 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 17.6 mt -69.02 -45.22 71.04 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -176.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 45.5 t -86.45 -24.63 25.57 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.819 0.818 . . . . 0.0 110.099 -176.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 108.93 -174.82 18.81 Favored Glycine 0 N--CA 1.429 -1.779 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -170.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -80.54 23.54 0.51 Allowed 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.244 0.545 . . . . 0.0 111.587 -171.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 418' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -72.0 75.28 0.92 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.064 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 419' ' ' TYR . . . . . 0.521 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 9.4 p90 -51.1 -39.03 55.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.493 176.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -55.32 -43.99 75.42 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.672 0.272 . . . . 0.0 110.99 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.37 -48.98 63.33 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.073 -178.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . 0.432 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -66.49 -40.67 87.06 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.522 0 C-N-CA 120.409 -0.517 . . . . 0.0 111.299 -177.021 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.793 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 77.6 p -68.09 -36.66 80.16 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -178.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -69.67 -37.95 77.25 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.253 175.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . 0.615 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -73.14 -51.92 24.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 O-C-N 122.82 -0.224 . . . . 0.0 111.048 -178.638 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . 0.674 HG22 HD22 ' A' ' 430' ' ' LEU . 1.2 mm -74.09 -22.68 18.31 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.756 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -172.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.793 ' HB2' ' O ' ' A' ' 423' ' ' SER . 0.8 OUTLIER -54.61 -29.71 52.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.157 0.503 . . . . 0.0 110.484 -179.263 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -88.94 -6.57 71.89 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.693 178.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.608 ' CZ ' ' HG3' ' A' ' 396' ' ' LYS . 22.4 m-85 -117.27 -0.09 12.12 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.095 0.474 . . . . 0.0 110.221 -178.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.674 HD22 HG22 ' A' ' 426' ' ' ILE . 0.1 OUTLIER -66.15 129.13 94.19 Favored Pre-proline 0 N--CA 1.441 -0.876 0 CA-C-N 115.353 -0.84 . . . . 0.0 108.857 177.584 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 431' ' ' PRO . . . . . 0.554 ' HG3' ' O ' ' A' ' 473' ' ' GLY . 73.4 Cg_exo -25.46 -69.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.757 1 C-N-CA 125.318 4.012 . . . . 0.0 114.911 179.68 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . 0.526 ' O ' HG12 ' A' ' 435' ' ' VAL . . . -144.07 -165.8 11.09 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 110.061 -1.215 . . . . 0.0 110.061 177.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . 0.465 ' O ' HG13 ' A' ' 436' ' ' VAL . 15.8 tp60 -69.62 -27.58 65.19 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 118.127 0.964 . . . . 0.0 110.449 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -67.32 -39.78 85.91 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -176.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 435' ' ' VAL . . . . . 0.679 HG23 HG11 ' A' ' 463' ' ' VAL . 8.8 p -68.49 -44.26 83.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-O 121.107 0.479 . . . . 0.0 110.48 -177.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.491 HG12 ' O ' ' A' ' 432' ' ' GLY . 0.1 OUTLIER -66.95 -31.46 53.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.399 175.305 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.23 -52.45 40.81 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -178.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . 0.817 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -57.74 -40.05 78.74 Favored 'General case' 0 N--CA 1.439 -1.023 0 O-C-N 123.883 0.739 . . . . 0.0 111.992 177.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 439' ' ' LEU . . . . . 0.594 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 2.0 tm? -68.3 -48.74 64.13 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -178.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.27 -34.97 72.9 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.442 -1.254 . . . . 0.0 111.135 175.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 441' ' ' GLN . . . . . 0.543 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 3.8 mm-40 -53.39 -49.88 66.31 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.106 -178.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . 0.693 ' HG3' ' CG ' ' A' ' 459' ' ' HIS . 0.0 OUTLIER -76.18 -25.03 54.78 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 119.361 -0.936 . . . . 0.0 113.248 174.898 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 443' ' ' LEU . . . . . 0.594 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 56.2 mt -65.3 -33.72 76.65 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.421 0.629 . . . . 0.0 109.718 175.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -70.57 -33.88 71.6 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.114 -178.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 445' ' ' GLN . . . . . 0.402 ' HG3' ' N ' ' A' ' 446' ' ' GLU . 0.0 OUTLIER -75.29 -31.15 60.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 114.673 -1.149 . . . . 0.0 108.321 178.43 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 446' ' ' GLU . . . . . 0.402 ' N ' ' HG3' ' A' ' 445' ' ' GLN . 34.9 tt0 48.09 98.47 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 114.812 -1.085 . . . . 0.0 113.2 171.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 60.9 mt -65.82 -35.67 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 121.667 0.746 . . . . 0.0 109.785 176.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . 0.538 ' O ' ' HG3' ' A' ' 452' ' ' ARG . 18.7 m-20 -169.83 -175.94 2.22 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 -177.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -72.16 -67.83 0.51 Allowed 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.6 174.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 450' ' ' GLN . . . . . 0.404 ' HG3' ' H ' ' A' ' 450' ' ' GLN . 0.0 OUTLIER -66.46 -25.46 66.73 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 178.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 451' ' ' THR . . . . . 0.524 ' OG1' ' HB2' ' A' ' 448' ' ' ASP . 15.3 m -71.13 -23.02 62.0 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.702 -173.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . 0.538 ' HG3' ' O ' ' A' ' 448' ' ' ASP . 55.7 mtm180 -55.06 -54.15 46.75 Favored 'General case' 0 C--O 1.218 -0.553 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 170.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 453' ' ' ALA . . . . . 0.521 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -56.99 -48.03 79.42 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 124.278 0.986 . . . . 0.0 112.571 174.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . 0.422 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 63.9 mm-40 -51.34 -37.49 48.1 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.312 0.577 . . . . 0.0 111.693 -177.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 24.6 p -119.13 16.28 13.23 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.187 -175.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . 0.515 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.9 OUTLIER -55.19 -47.33 75.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.12 0.486 . . . . 0.0 111.728 -171.58 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . 0.59 HG23 ' HB1' ' A' ' 405' ' ' ALA . 1.9 mp -77.11 -34.43 21.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.257 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -57.54 -34.09 68.78 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.891 0.853 . . . . 0.0 109.288 171.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . 0.758 ' O ' HG23 ' A' ' 463' ' ' VAL . 52.8 m-70 -73.76 -29.33 62.15 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.357 -1.292 . . . . 0.0 110.926 176.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . 0.714 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -73.59 -33.96 64.86 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.863 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -73.05 -38.12 66.61 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.345 175.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 462' ' ' ALA . . . . . 0.613 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -55.82 -34.0 64.98 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.691 169.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.817 HG13 ' HB3' ' A' ' 438' ' ' ALA . 62.6 t -62.8 -50.22 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 CA-C-N 114.363 -1.289 . . . . 0.0 107.996 177.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 464' ' ' TYR . . . . . 0.545 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 14.8 m-30 -53.8 -27.67 30.65 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.66 178.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.31 -40.83 20.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.635 0.731 . . . . 0.0 109.476 -178.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.613 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.6 mt -57.3 -55.63 19.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 114.174 -1.375 . . . . 0.0 112.196 176.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 0.782 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -102.51 -10.65 19.16 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -172.517 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 93.9 32.22 7.68 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 119.114 -1.517 . . . . 0.0 114.201 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 469' ' ' LEU . . . . . 0.782 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.5 mt -88.45 162.2 16.61 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 117.889 0.844 . . . . 0.0 111.378 176.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 37.7 p30 -100.72 -177.76 3.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.651 170.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 471' ' ' ALA . . . . . 0.503 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -69.43 -12.4 61.62 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.557 0.576 . . . . 0.0 112.557 -176.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -89.12 2.03 54.74 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.79 0.329 . . . . 0.0 111.219 -175.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 473' ' ' GLY . . . . . 0.554 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 76.42 12.6 84.15 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -175.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -101.67 150.43 23.12 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 177.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 475' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 469' ' ' LEU . 30.7 t -86.59 138.15 31.93 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.025 -0.67 . . . . 0.0 109.819 175.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 476' ' ' ILE . . . . . 0.454 ' C ' HD12 ' A' ' 476' ' ' ILE . 2.4 pp . . . . . 0 C--N 1.314 -0.968 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.849 178.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 386' ' ' PHE . . . . . 0.793 ' CD1' HD22 ' B' ' 414' ' ' LEU . 3.3 t80 . . . . . 0 CA--C 1.53 0.199 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 387' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' B' ' 386' ' ' PHE . 5.9 Cg_endo -46.98 -70.88 0.06 OUTLIER 'Trans proline' 0 N--CA 1.475 0.424 0 C-N-CA 123.914 3.076 . . . . 0.0 114.101 -174.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 388' ' ' MET . . . . . . . . . . . . . 40.6 ttm 71.95 155.53 0.15 Allowed 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.265 0.555 . . . . 0.0 111.852 175.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 389' ' ' HIS . . . . . 0.606 ' H ' ' H ' ' B' ' 393' ' ' ASN . 2.6 m170 -76.37 27.83 0.12 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.674 0.79 . . . . 0.0 112.941 -171.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 390' ' ' GLN . . . . . 0.591 ' HG2' ' O ' ' B' ' 389' ' ' HIS . 2.4 pt20 71.31 3.88 4.84 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.509 0.724 . . . . 0.0 109.884 -168.072 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 391' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -164.31 -43.55 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 392' ' ' GLY . . . . . 0.6 ' HA3' HD13 ' B' ' 395' ' ' ILE . . . -175.81 55.39 0.12 Allowed Glycine 0 C--N 1.336 0.576 0 C-N-CA 118.037 -2.03 . . . . 0.0 115.792 -176.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 393' ' ' ASN . . . . . 0.606 ' H ' ' H ' ' B' ' 389' ' ' HIS . 0.0 OUTLIER -60.81 -36.6 79.47 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 118.217 1.008 . . . . 0.0 108.586 176.307 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 394' ' ' VAL . . . . . 0.723 HG23 HD12 ' B' ' 398' ' ' ILE . 1.5 m -58.36 -50.16 79.56 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 CA-C-N 113.306 -1.77 . . . . 0.0 107.904 178.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 395' ' ' ILE . . . . . 0.632 HG21 HG22 ' B' ' 425' ' ' ILE . 4.0 mp -58.07 -52.58 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 CA-C-O 118.005 -0.998 . . . . 0.0 113.568 -173.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 396' ' ' LYS . . . . . 0.607 ' HG3' ' CZ ' ' B' ' 429' ' ' TYR . 0.0 OUTLIER -63.96 -48.35 76.81 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 121.65 2.023 . . . . 0.0 111.464 -173.8 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.75 -45.31 69.49 Favored Glycine 0 N--CA 1.432 -1.583 0 C-N-CA 119.9 -1.143 . . . . 0.0 110.961 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 398' ' ' ILE . . . . . 0.737 HD13 HD12 ' B' ' 410' ' ' LEU . 33.4 mt -70.93 -33.98 54.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -178.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 399' ' ' VAL . . . . . 0.499 HG22 ' O ' ' B' ' 396' ' ' LYS . 15.3 m -63.73 -39.48 85.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 C-N-CA 118.796 -1.161 . . . . 0.0 108.475 -174.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -70.82 -35.59 72.55 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 175.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 401' ' ' GLN . . . . . 0.413 HE21 ' HB3' ' B' ' 401' ' ' GLN . 3.7 mm100 -88.7 -48.1 7.77 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -172.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 402' ' ' GLU . . . . . 0.472 ' HG3' ' HE3' ' A' ' 413' ' ' MET . 2.7 mm-40 -121.02 -21.48 6.48 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.727 -170.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 108.82 162.89 20.4 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.085 -0.579 . . . . 0.0 113.006 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 404' ' ' VAL . . . . . 0.664 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.5 m -53.76 -41.85 49.55 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.719 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 -176.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 405' ' ' ALA . . . . . 0.591 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -68.9 -30.7 69.24 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 119.797 -0.761 . . . . 0.0 111.855 -176.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 406' ' ' THR . . . . . 0.72 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 90.7 m -77.81 -42.78 32.61 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.068 174.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 407' ' ' ALA . . . . . 0.45 ' HB2' ' HB ' ' B' ' 398' ' ' ILE . . . -58.33 -37.13 74.5 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 122.078 0.942 . . . . 0.0 109.18 176.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 408' ' ' TYR . . . . . 0.664 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -66.0 -52.08 52.52 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 113.595 -1.639 . . . . 0.0 109.725 176.43 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 409' ' ' THR . . . . . 0.664 HG22 HD23 ' B' ' 410' ' ' LEU . 15.9 m -55.33 -47.31 75.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.675 179.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 410' ' ' LEU . . . . . 0.737 HD12 HD13 ' B' ' 398' ' ' ILE . 15.0 mt -72.71 -36.82 67.89 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -174.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.67 -34.81 78.43 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 119.868 -1.158 . . . . 0.0 110.629 173.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 412' ' ' MET . . . . . 0.403 ' HB2' ' O ' ' B' ' 409' ' ' THR . 0.3 OUTLIER -67.05 -48.52 68.04 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-O 120.634 0.254 . . . . 0.0 111.387 178.19 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 413' ' ' MET . . . . . 0.924 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.8 OUTLIER -71.47 -44.29 65.02 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 119.009 -1.076 . . . . 0.0 112.16 -178.706 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 414' ' ' LEU . . . . . 0.924 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 17.7 mt -68.93 -45.5 70.65 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -176.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 47.0 t -86.05 -24.88 26.18 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.641 0.734 . . . . 0.0 110.004 -176.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 416' ' ' GLY . . . . . . . . . . . . . . . 109.17 -174.57 18.37 Favored Glycine 0 N--CA 1.43 -1.734 0 N-CA-C 109.731 -1.347 . . . . 0.0 109.731 -170.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -80.83 23.31 0.55 Allowed 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.287 0.565 . . . . 0.0 111.535 -171.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 418' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -71.94 75.13 0.9 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.102 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 419' ' ' TYR . . . . . 0.525 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 9.1 p90 -51.04 -38.94 54.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.572 176.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -55.37 -43.95 75.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.737 0.304 . . . . 0.0 111.092 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.29 -48.98 63.53 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.11 -178.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 422' ' ' VAL . . . . . 0.433 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.2 OUTLIER -66.46 -40.84 87.51 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.278 -176.959 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 423' ' ' SER . . . . . 0.785 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 77.3 p -67.97 -36.63 80.37 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -178.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -69.62 -38.22 77.97 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.225 176.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 425' ' ' ILE . . . . . 0.632 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -73.02 -51.8 24.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 O-C-N 122.865 -0.197 . . . . 0.0 111.083 -178.52 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 426' ' ' ILE . . . . . 0.669 HG22 HD22 ' B' ' 430' ' ' LEU . 1.2 mm -74.08 -22.64 18.32 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.796 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -172.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 427' ' ' ARG . . . . . 0.785 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.8 OUTLIER -54.58 -29.85 52.62 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.21 0.529 . . . . 0.0 110.561 -179.251 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -88.58 -7.25 72.22 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.729 178.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 429' ' ' TYR . . . . . 0.607 ' CZ ' ' HG3' ' B' ' 396' ' ' LYS . 22.3 m-85 -116.63 -0.26 12.44 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 121.271 0.557 . . . . 0.0 110.295 -178.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 430' ' ' LEU . . . . . 0.669 HD22 HG22 ' B' ' 426' ' ' ILE . 0.1 OUTLIER -66.08 129.04 94.19 Favored Pre-proline 0 N--CA 1.442 -0.842 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.867 177.807 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 431' ' ' PRO . . . . . 0.563 ' HG3' ' O ' ' B' ' 473' ' ' GLY . 75.1 Cg_exo -25.33 -68.86 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 125.283 3.989 . . . . 0.0 114.919 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 432' ' ' GLY . . . . . 0.532 ' O ' HG12 ' B' ' 435' ' ' VAL . . . -144.52 -165.82 11.22 Favored Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 177.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 433' ' ' GLN . . . . . 0.469 ' O ' HG13 ' B' ' 436' ' ' VAL . 15.5 tp60 -69.39 -27.74 65.56 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 118.156 0.978 . . . . 0.0 110.507 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -67.07 -39.89 86.95 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -176.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 435' ' ' VAL . . . . . 0.666 HG23 HG11 ' B' ' 463' ' ' VAL . 8.8 p -68.66 -44.01 82.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-O 121.013 0.435 . . . . 0.0 110.558 -177.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 436' ' ' VAL . . . . . 0.487 HG12 ' O ' ' B' ' 432' ' ' GLY . 0.1 OUTLIER -66.99 -31.4 53.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.431 175.075 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.23 -52.52 40.05 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -178.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 438' ' ' ALA . . . . . 0.812 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -57.9 -39.93 79.1 Favored 'General case' 0 N--CA 1.439 -1.01 0 O-C-N 123.902 0.751 . . . . 0.0 111.969 177.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 439' ' ' LEU . . . . . 0.603 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 2.0 tm? -68.36 -48.73 64.03 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -178.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.22 -35.02 72.89 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.484 -1.234 . . . . 0.0 111.202 175.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 441' ' ' GLN . . . . . 0.537 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 3.8 mm-40 -53.34 -50.04 65.84 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.052 -178.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 442' ' ' ARG . . . . . 0.708 ' HG3' ' CG ' ' B' ' 459' ' ' HIS . 0.0 OUTLIER -75.95 -25.11 55.62 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 119.377 -0.929 . . . . 0.0 113.198 174.892 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 443' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 56.5 mt -65.3 -33.84 76.94 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.289 0.566 . . . . 0.0 109.558 175.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -70.37 -34.2 72.32 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.942 -178.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 445' ' ' GLN . . . . . 0.401 ' HG3' ' N ' ' B' ' 446' ' ' GLU . 0.0 OUTLIER -75.1 -31.07 61.06 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.294 178.699 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 446' ' ' GLU . . . . . 0.401 ' N ' ' HG3' ' B' ' 445' ' ' GLN . 34.6 tt0 48.09 98.69 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 114.818 -1.083 . . . . 0.0 113.143 171.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 61.1 mt -65.97 -35.79 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 121.712 0.768 . . . . 0.0 109.811 176.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 448' ' ' ASP . . . . . 0.544 ' O ' ' HG3' ' B' ' 452' ' ' ARG . 17.1 m-20 -169.66 -176.02 2.3 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 -177.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -71.76 -67.77 0.51 Allowed 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.535 173.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.87 -25.34 66.36 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 451' ' ' THR . . . . . 0.52 ' OG1' ' HB2' ' B' ' 448' ' ' ASP . 15.9 m -71.1 -22.92 62.03 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.756 -173.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 452' ' ' ARG . . . . . 0.544 ' HG3' ' O ' ' B' ' 448' ' ' ASP . 55.9 mtm180 -55.21 -54.14 47.16 Favored 'General case' 0 C--O 1.219 -0.525 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 170.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 453' ' ' ALA . . . . . 0.525 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -56.93 -48.14 78.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.576 173.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 454' ' ' GLU . . . . . 0.424 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 65.1 mm-40 -51.18 -37.84 48.85 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.263 0.554 . . . . 0.0 111.572 -177.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 25.2 p -118.81 16.24 13.51 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.335 -175.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 456' ' ' PHE . . . . . 0.519 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 0.9 OUTLIER -55.15 -47.08 75.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.142 0.496 . . . . 0.0 111.747 -171.708 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 457' ' ' ILE . . . . . 0.591 HG23 ' HB1' ' B' ' 405' ' ' ALA . 1.9 mp -77.33 -34.3 20.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.198 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -57.68 -34.19 69.15 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.88 0.847 . . . . 0.0 109.234 172.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 459' ' ' HIS . . . . . 0.755 ' O ' HG23 ' B' ' 463' ' ' VAL . 51.5 m-70 -73.61 -29.25 62.27 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.981 176.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 460' ' ' LEU . . . . . 0.709 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -73.64 -33.96 64.75 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.765 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 461' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -72.94 -38.43 66.79 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.195 175.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 462' ' ' ALA . . . . . 0.622 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -55.78 -33.8 64.69 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.76 169.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 463' ' ' VAL . . . . . 0.812 HG13 ' HB3' ' B' ' 438' ' ' ALA . 62.9 t -62.91 -50.15 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.008 177.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 464' ' ' TYR . . . . . 0.539 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 15.0 m-30 -53.79 -27.82 31.43 Favored 'General case' 0 C--N 1.332 -0.193 0 O-C-N 124.237 0.961 . . . . 0.0 110.599 178.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.27 -40.86 20.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.693 0.758 . . . . 0.0 109.359 -177.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 466' ' ' ILE . . . . . 0.622 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.6 mt -57.23 -55.6 19.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 114.305 -1.316 . . . . 0.0 112.19 176.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 467' ' ' LEU . . . . . 0.782 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -102.69 -10.63 19.04 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -172.389 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 468' ' ' GLY . . . . . . . . . . . . . . . 93.92 32.24 7.66 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 119.013 -1.565 . . . . 0.0 114.304 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 469' ' ' LEU . . . . . 0.782 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.5 mt -88.58 162.27 16.47 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 117.915 0.857 . . . . 0.0 111.249 177.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 37.6 p30 -100.86 -177.75 3.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.587 170.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 471' ' ' ALA . . . . . 0.51 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -69.81 -11.5 60.9 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -176.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -89.34 1.95 55.07 Favored 'General case' 0 C--N 1.32 -0.682 0 O-C-N 122.262 -0.273 . . . . 0.0 111.213 -176.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 473' ' ' GLY . . . . . 0.563 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 76.43 12.48 84.26 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 -175.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -101.61 150.56 22.97 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 475' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' B' ' 469' ' ' LEU . 32.3 t -86.81 137.7 32.2 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.147 -0.621 . . . . 0.0 109.893 175.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 476' ' ' ILE . . . . . 0.459 ' C ' HD12 ' B' ' 476' ' ' ILE . 2.4 pp . . . . . 0 C--N 1.315 -0.932 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.923 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 386' ' ' PHE . . . . . 0.717 ' CD1' HD22 ' A' ' 414' ' ' LEU . 2.9 t80 . . . . . 0 N--CA 1.451 -0.394 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 386' ' ' PHE . 1.3 Cg_endo -43.01 -75.36 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.821 3.014 . . . . 0.0 113.892 -175.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 28.5 ttm 67.22 143.43 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.607 0 O-C-N 123.397 0.435 . . . . 0.0 110.305 -178.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 389' ' ' HIS . . . . . 0.632 ' H ' ' HB3' ' A' ' 393' ' ' ASN . 29.3 m170 -54.85 -79.24 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.694 0.759 . . . . 0.0 110.076 -174.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . 0.407 ' H ' HD23 ' A' ' 391' ' ' LEU . 13.9 pt20 -153.46 19.35 0.55 Allowed 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 170.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.515 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.6 pt? -173.9 -48.54 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.837 -170.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . 0.621 ' HA3' HD13 ' A' ' 395' ' ' ILE . . . -172.48 53.88 0.17 Allowed Glycine 0 C--O 1.223 -0.593 0 C-N-CA 118.81 -1.662 . . . . 0.0 115.305 -171.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . 0.632 ' HB3' ' H ' ' A' ' 389' ' ' HIS . 0.0 OUTLIER -57.34 -38.06 73.51 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 118.361 1.081 . . . . 0.0 108.869 176.273 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . 0.627 HG23 HD12 ' A' ' 398' ' ' ILE . 1.9 m -58.23 -49.52 81.48 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 CA-C-N 113.189 -1.823 . . . . 0.0 107.77 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . 0.676 HG23 HD13 ' A' ' 426' ' ' ILE . 4.2 mp -58.26 -52.8 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 CA-C-O 117.97 -1.014 . . . . 0.0 113.462 -174.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . 0.638 ' HG3' ' CZ ' ' A' ' 429' ' ' TYR . 0.1 OUTLIER -63.91 -48.93 74.65 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 121.796 2.089 . . . . 0.0 112.024 -172.865 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -54.02 -45.26 72.36 Favored Glycine 0 N--CA 1.438 -1.181 0 C-N-CA 119.88 -1.153 . . . . 0.0 111.238 -178.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . 0.722 ' CD1' HD12 ' A' ' 410' ' ' LEU . 33.6 mt -71.04 -34.56 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -178.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . 0.517 HG12 ' HA ' ' A' ' 404' ' ' VAL . 11.7 m -63.68 -39.68 86.25 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 C-N-CA 119.05 -1.06 . . . . 0.0 108.728 -173.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -67.4 -39.9 85.58 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 176.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -93.43 -50.73 5.3 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -170.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . 0.402 ' HG2' HG21 ' A' ' 406' ' ' THR . 16.1 tp10 -108.87 -20.19 13.14 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.227 0.537 . . . . 0.0 110.461 -172.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 105.44 162.5 23.46 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.548 -0.751 . . . . 0.0 113.159 177.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . 0.616 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.5 m -52.98 -45.59 52.34 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.738 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -175.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . 0.529 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -64.93 -30.06 71.03 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 119.793 -0.763 . . . . 0.0 112.488 -177.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.71 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 86.2 m -77.45 -42.42 36.05 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 120.096 -0.642 . . . . 0.0 110.216 173.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.5 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.86 -37.23 76.04 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 122.252 1.025 . . . . 0.0 109.043 177.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 408' ' ' TYR . . . . . 0.616 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.31 -52.95 50.64 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 113.364 -1.744 . . . . 0.0 109.889 176.687 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 409' ' ' THR . . . . . 0.692 HG22 HD23 ' A' ' 410' ' ' LEU . 9.0 m -55.58 -47.17 76.88 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.395 -0.821 . . . . 0.0 112.557 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . 0.722 HD12 ' CD1' ' A' ' 398' ' ' ILE . 14.5 mt -72.4 -36.32 68.62 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.055 -175.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -60.0 -35.2 86.48 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 119.973 -1.108 . . . . 0.0 110.789 172.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -67.98 -46.55 71.05 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 115.812 -0.194 . . . . 0.0 111.399 178.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 413' ' ' MET . . . . . 0.897 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.4 OUTLIER -70.62 -48.95 52.49 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 118.834 -1.147 . . . . 0.0 111.821 179.691 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . 0.897 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 16.0 mt -68.38 -46.69 69.35 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -176.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 14.6 t -92.9 -1.86 56.35 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.297 0.57 . . . . 0.0 110.063 -173.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . 0.407 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 93.1 -177.55 38.27 Favored Glycine 0 N--CA 1.434 -1.485 0 C-N-CA 120.395 -0.907 . . . . 0.0 110.916 -176.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -79.98 23.36 0.46 Allowed 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.126 0.488 . . . . 0.0 111.31 -172.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 418' ' ' ASN . . . . . 0.407 ' H ' ' C ' ' A' ' 416' ' ' GLY . 5.5 m-20 -71.61 76.0 0.81 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.612 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 419' ' ' TYR . . . . . 0.544 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 11.1 p90 -51.41 -38.55 54.07 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.366 176.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -55.29 -43.79 75.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.671 0.272 . . . . 0.0 110.919 178.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.47 -49.17 61.75 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.949 -177.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . 0.445 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.3 OUTLIER -66.84 -40.36 85.68 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.214 -176.954 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.743 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 79.2 p -66.98 -38.91 86.92 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.38 -39.5 91.62 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.255 176.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . 0.636 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -73.06 -50.82 29.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 121.223 -0.191 . . . . 0.0 111.032 -177.234 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . 0.676 HD13 HG23 ' A' ' 395' ' ' ILE . 1.2 mm -74.96 -22.52 17.07 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.823 0 CA-C-O 120.886 0.374 . . . . 0.0 110.27 -172.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.743 ' HB2' ' O ' ' A' ' 423' ' ' SER . 0.8 OUTLIER -55.02 -30.13 58.88 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.217 0.532 . . . . 0.0 110.64 -179.008 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.74 -6.06 77.08 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.638 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.638 ' CZ ' ' HG3' ' A' ' 396' ' ' LYS . 22.9 m-85 -118.23 0.54 11.75 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 120.977 0.418 . . . . 0.0 110.665 -177.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.678 HD23 ' HA ' ' A' ' 427' ' ' ARG . 0.1 OUTLIER -65.71 128.2 93.63 Favored Pre-proline 0 N--CA 1.441 -0.907 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 179.032 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 431' ' ' PRO . . . . . 0.455 ' HG3' ' O ' ' A' ' 473' ' ' GLY . 80.8 Cg_exo -23.87 -69.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.905 1 C-N-CA 125.514 4.143 . . . . 0.0 114.857 179.887 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . 0.51 ' O ' HG12 ' A' ' 435' ' ' VAL . . . -138.8 -166.9 10.78 Favored Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 174.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . 0.506 ' O ' HG13 ' A' ' 436' ' ' VAL . 50.3 tp60 -70.8 -26.88 63.52 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 118.241 1.021 . . . . 0.0 110.457 177.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -64.75 -39.51 93.75 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -177.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 435' ' ' VAL . . . . . 0.794 HG23 HG11 ' A' ' 463' ' ' VAL . 7.5 p -68.72 -43.94 82.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-O 120.968 0.413 . . . . 0.0 110.501 -178.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.506 HG13 ' O ' ' A' ' 433' ' ' GLN . 0.1 OUTLIER -67.15 -30.29 48.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.668 175.579 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.48 -51.91 45.6 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . 0.827 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -57.0 -43.93 82.27 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.003 177.094 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 439' ' ' LEU . . . . . 0.634 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 2.1 tm? -64.69 -47.64 77.64 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 -176.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.86 -39.7 78.4 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.81 -1.086 . . . . 0.0 111.362 175.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 441' ' ' GLN . . . . . 0.607 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 9.2 mm-40 -55.59 -51.25 67.76 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 123.473 0.709 . . . . 0.0 110.83 175.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . 0.77 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -58.13 -33.81 69.55 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.798 173.174 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 443' ' ' LEU . . . . . 0.634 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 57.1 mt -72.25 -36.6 69.1 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-O 120.865 0.364 . . . . 0.0 110.227 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -57.49 -37.58 73.18 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.607 0.717 . . . . 0.0 110.67 174.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -73.2 -26.77 61.29 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.238 177.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 446' ' ' GLU . . . . . 0.453 ' HB3' ' O ' ' A' ' 443' ' ' LEU . 7.4 pt-20 23.7 103.13 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 173.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 60.3 mt -62.21 -34.1 62.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.577 0.703 . . . . 0.0 110.13 176.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . 0.5 ' HB2' ' OG1' ' A' ' 451' ' ' THR . 17.8 m-20 -162.8 -159.43 0.56 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -84.45 -66.35 0.9 Allowed 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 171.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 450' ' ' GLN . . . . . 0.513 ' O ' ' HB3' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -70.91 -25.54 62.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.855 0.359 . . . . 0.0 111.895 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 451' ' ' THR . . . . . 0.5 ' OG1' ' HB2' ' A' ' 448' ' ' ASP . 12.4 m -67.4 -22.54 65.54 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 122.037 -0.414 . . . . 0.0 110.679 -178.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 66.4 mtm180 -54.99 -51.37 66.45 Favored 'General case' 0 C--O 1.216 -0.66 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 170.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 453' ' ' ALA . . . . . 0.544 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -53.41 -52.24 60.01 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 124.352 1.033 . . . . 0.0 112.293 173.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . 0.435 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 23.6 mm-40 -51.15 -32.44 23.11 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.255 0.55 . . . . 0.0 111.987 -178.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 28.7 p -119.69 14.36 12.6 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.972 -175.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . 0.535 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.8 OUTLIER -58.37 -47.57 83.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.383 -170.995 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . 0.529 HG23 ' HB1' ' A' ' 405' ' ' ALA . 1.9 mp -77.21 -31.42 18.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.08 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -56.47 -39.01 72.48 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 122.025 0.917 . . . . 0.0 108.689 170.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . 0.735 ' O ' HG23 ' A' ' 463' ' ' VAL . 50.3 m-70 -73.22 -28.07 61.97 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 114.179 -1.373 . . . . 0.0 110.381 -178.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . 0.74 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -74.46 -35.11 63.31 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.864 0.84 . . . . 0.0 108.886 178.391 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . 0.42 ' O ' ' HB2' ' A' ' 464' ' ' TYR . 23.6 m-80 -73.44 -37.67 65.77 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.92 0.866 . . . . 0.0 109.0 176.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 462' ' ' ALA . . . . . 0.62 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -56.61 -33.32 66.14 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.402 -1.272 . . . . 0.0 109.788 169.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.827 HG13 ' HB3' ' A' ' 438' ' ' ALA . 63.2 t -62.19 -50.68 79.0 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.751 0 CA-C-N 114.555 -1.202 . . . . 0.0 107.804 175.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 464' ' ' TYR . . . . . 0.579 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 18.2 m-30 -53.27 -28.2 26.58 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 124.478 1.111 . . . . 0.0 110.38 178.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.63 -40.89 20.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.583 0.706 . . . . 0.0 109.676 -177.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.62 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.4 mt -56.61 -55.52 19.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.336 -1.302 . . . . 0.0 112.294 176.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 0.783 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -102.66 -10.01 19.59 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -171.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 93.57 32.31 7.76 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 119.242 -1.456 . . . . 0.0 114.237 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 469' ' ' LEU . . . . . 0.783 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.3 mt -88.67 165.64 14.63 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 117.862 0.831 . . . . 0.0 111.351 176.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 45.1 p30 -104.05 -178.77 3.75 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.559 170.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 471' ' ' ALA . . . . . 0.556 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -62.1 -21.58 65.1 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -177.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -88.17 5.33 41.93 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.418 -172.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 473' ' ' GLY . . . . . 0.455 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 74.92 15.38 81.01 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.346 -0.93 . . . . 0.0 111.047 -177.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -101.08 152.13 20.98 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 11.0 p -89.53 130.93 35.78 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.923 0.392 . . . . 0.0 110.978 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 476' ' ' ILE . . . . . . . . . . . . . 2.6 pp . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.309 -178.94 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 386' ' ' PHE . . . . . 0.718 ' CD1' HD22 ' B' ' 414' ' ' LEU . 3.0 t80 . . . . . 0 N--CA 1.451 -0.397 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 387' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -43.08 -75.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.786 2.99 . . . . 0.0 113.892 -175.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 388' ' ' MET . . . . . . . . . . . . . 28.4 ttm 67.2 143.76 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.652 0 O-C-N 123.497 0.498 . . . . 0.0 110.155 -178.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 389' ' ' HIS . . . . . 0.634 ' H ' ' HB3' ' B' ' 393' ' ' ASN . 29.5 m170 -55.15 -79.15 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.542 0.687 . . . . 0.0 110.113 -174.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 390' ' ' GLN . . . . . 0.413 ' H ' HD23 ' B' ' 391' ' ' LEU . 13.8 pt20 -153.27 19.33 0.56 Allowed 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 170.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 391' ' ' LEU . . . . . 0.514 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.5 pt? -173.86 -48.61 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.868 -170.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 392' ' ' GLY . . . . . 0.629 ' HA3' HD13 ' B' ' 395' ' ' ILE . . . -172.6 53.91 0.17 Allowed Glycine 0 CA--C 1.524 0.621 0 C-N-CA 118.796 -1.668 . . . . 0.0 115.215 -171.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 393' ' ' ASN . . . . . 0.634 ' HB3' ' H ' ' B' ' 389' ' ' HIS . 0.0 OUTLIER -57.29 -38.08 73.43 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 118.295 1.047 . . . . 0.0 108.865 176.228 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 394' ' ' VAL . . . . . 0.62 HG23 HD12 ' B' ' 398' ' ' ILE . 1.8 m -58.27 -49.39 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 CA-C-N 113.213 -1.812 . . . . 0.0 107.791 179.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 395' ' ' ILE . . . . . 0.663 HG23 HD13 ' B' ' 426' ' ' ILE . 4.2 mp -58.26 -52.91 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-O 117.849 -1.072 . . . . 0.0 113.441 -174.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 396' ' ' LYS . . . . . 0.636 ' HG3' ' CZ ' ' B' ' 429' ' ' TYR . 0.1 OUTLIER -63.96 -49.18 73.57 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 121.832 2.106 . . . . 0.0 111.93 -172.802 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.79 -45.15 70.22 Favored Glycine 0 N--CA 1.438 -1.193 0 C-N-CA 119.86 -1.162 . . . . 0.0 111.279 -178.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 398' ' ' ILE . . . . . 0.72 HD13 HD12 ' B' ' 410' ' ' LEU . 32.8 mt -71.07 -34.38 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -178.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 399' ' ' VAL . . . . . 0.508 HG12 ' HA ' ' B' ' 404' ' ' VAL . 11.5 m -63.77 -39.93 87.18 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 C-N-CA 118.898 -1.121 . . . . 0.0 108.748 -173.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -67.34 -39.68 85.81 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 176.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 401' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -93.67 -50.69 5.27 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 -170.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 402' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -108.72 -20.31 13.12 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.191 0.519 . . . . 0.0 110.392 -173.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 105.29 162.65 23.62 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.663 -0.699 . . . . 0.0 113.25 177.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 404' ' ' VAL . . . . . 0.604 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.5 m -53.18 -45.36 54.48 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.792 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 -175.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 405' ' ' ALA . . . . . 0.508 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -65.21 -29.86 70.7 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 119.761 -0.775 . . . . 0.0 112.457 -177.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 406' ' ' THR . . . . . 0.708 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 85.6 m -77.46 -42.55 35.51 Favored 'General case' 0 C--O 1.222 -0.368 0 C-N-CA 120.191 -0.604 . . . . 0.0 110.238 173.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 407' ' ' ALA . . . . . 0.5 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.9 -37.11 75.86 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 122.128 0.966 . . . . 0.0 109.005 177.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 408' ' ' TYR . . . . . 0.604 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.44 -52.95 49.5 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 113.394 -1.73 . . . . 0.0 109.863 176.708 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 409' ' ' THR . . . . . 0.683 HG22 HD23 ' B' ' 410' ' ' LEU . 9.9 m -55.61 -47.08 77.13 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.51 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 410' ' ' LEU . . . . . 0.72 HD12 HD13 ' B' ' 398' ' ' ILE . 14.4 mt -72.42 -36.33 68.58 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.045 -175.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -59.84 -35.27 86.07 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 119.854 -1.165 . . . . 0.0 110.803 172.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 412' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -68.1 -46.48 70.85 Favored 'General case' 0 C--O 1.224 -0.289 0 CA-C-O 120.486 0.184 . . . . 0.0 111.414 178.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 413' ' ' MET . . . . . 0.888 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.4 OUTLIER -70.82 -48.25 55.08 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 118.847 -1.141 . . . . 0.0 112.038 179.662 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 414' ' ' LEU . . . . . 0.888 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 15.9 mt -68.92 -46.65 67.74 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -176.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 13.9 t -93.09 -1.77 56.15 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.296 0.57 . . . . 0.0 110.091 -173.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 416' ' ' GLY . . . . . 0.402 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 93.07 -177.46 38.24 Favored Glycine 0 N--CA 1.435 -1.388 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -176.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -79.95 23.42 0.45 Allowed 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.169 0.509 . . . . 0.0 111.314 -172.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 418' ' ' ASN . . . . . 0.402 ' H ' ' C ' ' B' ' 416' ' ' GLY . 5.4 m-20 -71.6 75.87 0.81 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.567 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 419' ' ' TYR . . . . . 0.552 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 10.9 p90 -51.36 -38.52 53.66 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.387 176.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -55.23 -43.88 74.94 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.753 0.311 . . . . 0.0 110.966 177.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.56 -49.0 62.8 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.852 -177.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 422' ' ' VAL . . . . . 0.449 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.3 OUTLIER -66.8 -40.49 86.03 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.26 -177.069 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 423' ' ' SER . . . . . 0.772 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 79.5 p -66.95 -38.99 87.15 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.47 -39.16 91.28 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.186 176.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 425' ' ' ILE . . . . . 0.653 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -73.08 -51.37 26.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.593 0.196 . . . . 0.0 111.025 -177.445 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 426' ' ' ILE . . . . . 0.667 HG22 HD22 ' B' ' 430' ' ' LEU . 1.1 mm -74.6 -22.51 17.56 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.808 0 CA-C-O 120.863 0.363 . . . . 0.0 110.242 -172.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 427' ' ' ARG . . . . . 0.772 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.8 OUTLIER -54.98 -30.34 58.95 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.242 0.544 . . . . 0.0 110.586 -178.893 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.57 -6.17 77.54 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.481 178.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 429' ' ' TYR . . . . . 0.636 ' CZ ' ' HG3' ' B' ' 396' ' ' LYS . 22.9 m-85 -118.17 0.75 11.83 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 120.996 0.427 . . . . 0.0 110.534 -177.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 430' ' ' LEU . . . . . 0.675 HD23 ' HA ' ' B' ' 427' ' ' ARG . 0.1 OUTLIER -65.72 128.18 93.62 Favored Pre-proline 0 N--CA 1.442 -0.861 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.929 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 431' ' ' PRO . . . . . 0.461 ' HG3' ' O ' ' B' ' 473' ' ' GLY . 80.4 Cg_exo -23.67 -70.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 0.988 1 C-N-CA 125.478 4.119 . . . . 0.0 114.673 179.769 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 432' ' ' GLY . . . . . 0.502 ' O ' HG12 ' B' ' 435' ' ' VAL . . . -138.25 -166.38 10.65 Favored Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 175.11 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 433' ' ' GLN . . . . . 0.516 ' O ' HG13 ' B' ' 436' ' ' VAL . 50.1 tp60 -71.08 -26.85 63.24 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 118.352 1.076 . . . . 0.0 110.46 177.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -64.7 -39.7 94.1 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -177.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 435' ' ' VAL . . . . . 0.789 HG23 HG11 ' B' ' 463' ' ' VAL . 7.6 p -68.66 -43.82 82.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 120.938 0.399 . . . . 0.0 110.543 -178.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 436' ' ' VAL . . . . . 0.516 HG13 ' O ' ' B' ' 433' ' ' GLN . 0.1 OUTLIER -67.48 -30.1 47.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.766 0.317 . . . . 0.0 110.56 175.669 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 437' ' ' THR . . . . . 0.408 HG22 ' N ' ' B' ' 438' ' ' ALA . 0.9 OUTLIER -67.47 -51.91 45.71 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 179.909 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 438' ' ' ALA . . . . . 0.816 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -57.1 -43.96 82.73 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 124.089 0.868 . . . . 0.0 111.087 177.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 439' ' ' LEU . . . . . 0.633 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 2.1 tm? -64.77 -47.47 78.06 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -176.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.06 -39.52 78.7 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.293 175.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 441' ' ' GLN . . . . . 0.607 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 9.2 mm-40 -55.77 -51.31 67.87 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 123.447 0.699 . . . . 0.0 110.813 175.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 442' ' ' ARG . . . . . 0.763 ' HG2' ' O ' ' B' ' 438' ' ' ALA . 0.0 OUTLIER -58.08 -33.75 69.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.739 173.207 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 443' ' ' LEU . . . . . 0.633 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 56.6 mt -72.38 -36.2 68.65 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-O 120.927 0.394 . . . . 0.0 110.247 179.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -57.68 -37.76 74.0 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.642 174.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -72.99 -26.8 61.47 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.911 -1.04 . . . . 0.0 111.036 178.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 446' ' ' GLU . . . . . 0.45 ' HB3' ' O ' ' B' ' 443' ' ' LEU . 7.5 pt-20 23.79 103.31 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 174.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 60.7 mt -62.33 -34.17 62.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.556 0.693 . . . . 0.0 110.091 175.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 448' ' ' ASP . . . . . 0.494 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 15.9 m-20 -162.76 -159.31 0.55 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -84.5 -66.21 0.92 Allowed 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.588 -0.445 . . . . 0.0 109.852 171.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 450' ' ' GLN . . . . . 0.514 ' O ' ' HB3' ' B' ' 453' ' ' ALA . 0.0 OUTLIER -70.94 -25.67 62.84 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.828 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 451' ' ' THR . . . . . 0.494 ' OG1' ' HB2' ' B' ' 448' ' ' ASP . 12.2 m -67.3 -22.66 65.62 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.71 -178.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 452' ' ' ARG . . . . . . . . . . . . . 66.0 mtm180 -54.87 -51.54 65.6 Favored 'General case' 0 C--O 1.216 -0.687 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 170.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 453' ' ' ALA . . . . . 0.552 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -53.24 -51.94 60.58 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.338 173.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 454' ' ' GLU . . . . . 0.434 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 24.0 mm-40 -51.59 -32.19 27.72 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.128 -178.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 29.6 p -119.84 14.36 12.47 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.985 -175.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 456' ' ' PHE . . . . . 0.537 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 0.8 OUTLIER -58.26 -47.74 82.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.348 -170.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 457' ' ' ILE . . . . . 0.533 ' CG1' ' HB3' ' B' ' 408' ' ' TYR . 1.9 mp -77.04 -31.11 18.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.108 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -56.66 -39.16 73.25 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 170.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 459' ' ' HIS . . . . . 0.74 ' O ' HG23 ' B' ' 463' ' ' VAL . 49.5 m-70 -73.21 -27.99 61.92 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.126 -1.397 . . . . 0.0 110.4 -178.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 460' ' ' LEU . . . . . 0.736 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -74.54 -35.06 63.12 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.957 0.884 . . . . 0.0 108.975 178.163 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 461' ' ' ASN . . . . . 0.411 ' O ' ' HB2' ' B' ' 464' ' ' TYR . 23.7 m-80 -73.33 -37.63 66.05 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.886 0.85 . . . . 0.0 109.1 176.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 462' ' ' ALA . . . . . 0.63 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -56.73 -33.25 66.34 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.326 -1.306 . . . . 0.0 109.839 169.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 463' ' ' VAL . . . . . 0.816 HG13 ' HB3' ' B' ' 438' ' ' ALA . 63.9 t -62.32 -50.79 78.5 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.799 0 CA-C-N 114.545 -1.207 . . . . 0.0 107.781 175.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 464' ' ' TYR . . . . . 0.575 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 18.1 m-30 -53.12 -28.18 24.36 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.53 178.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.66 -41.2 19.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.594 0.711 . . . . 0.0 109.587 -177.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 466' ' ' ILE . . . . . 0.63 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.5 mt -56.29 -55.66 17.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 114.396 -1.275 . . . . 0.0 112.399 176.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 467' ' ' LEU . . . . . 0.781 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -102.23 -10.39 19.61 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -172.248 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 468' ' ' GLY . . . . . . . . . . . . . . . 93.75 32.45 7.6 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 119.209 -1.472 . . . . 0.0 114.236 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 469' ' ' LEU . . . . . 0.781 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.3 mt -88.69 165.53 14.69 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 117.929 0.864 . . . . 0.0 111.243 176.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 45.6 p30 -103.9 -178.41 3.65 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.589 170.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 471' ' ' ALA . . . . . 0.547 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -62.66 -21.52 65.77 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -176.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -87.98 5.22 41.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.414 -172.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 473' ' ' GLY . . . . . 0.461 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 75.08 15.2 81.23 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.275 -0.964 . . . . 0.0 111.119 -177.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -101.07 151.97 21.17 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 10.3 p -89.48 131.1 35.69 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.05 0.452 . . . . 0.0 110.982 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 476' ' ' ILE . . . . . . . . . . . . . 2.6 pp . . . . . 0 C--N 1.327 -0.396 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.263 -178.828 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 386' ' ' PHE . . . . . 0.761 ' CE2' HG12 ' A' ' 394' ' ' VAL . 2.6 t80 . . . . . 0 CA--C 1.531 0.245 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 386' ' ' PHE . 40.5 Cg_endo -64.69 105.8 0.68 Allowed 'Trans proline' 0 N--CA 1.478 0.571 0 C-N-CA 123.788 2.992 . . . . 0.0 112.176 173.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.626 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 5.2 ttp -122.01 55.26 1.13 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.29 0.567 . . . . 0.0 111.289 -168.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 389' ' ' HIS . . . . . 0.573 ' CE1' ' HA ' ' A' ' 393' ' ' ASN . 39.2 m170 52.93 -98.9 0.08 Allowed 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.026 -172.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -148.55 17.12 1.02 Allowed 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 171.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.625 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.5 pt? -167.3 -62.54 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.84 -171.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . 0.691 ' HA3' HD13 ' A' ' 395' ' ' ILE . . . -163.14 60.03 0.27 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 119.914 -1.136 . . . . 0.0 114.396 -172.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . 0.626 ' HB3' ' HA ' ' A' ' 388' ' ' MET . 0.2 OUTLIER -57.48 -43.39 84.07 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.996 0.427 . . . . 0.0 109.861 174.192 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . 0.761 HG12 ' CE2' ' A' ' 386' ' ' PHE . 2.0 m -55.71 -45.91 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 -179.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . 0.691 HD13 ' HA3' ' A' ' 392' ' ' GLY . 3.7 mp -58.02 -52.72 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 CA-C-O 117.812 -1.09 . . . . 0.0 113.53 -174.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . 0.557 ' O ' HG22 ' A' ' 399' ' ' VAL . 0.0 OUTLIER -62.79 -49.62 74.25 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 121.952 2.16 . . . . 0.0 112.186 -174.756 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . 0.526 ' O ' ' HG3' ' A' ' 401' ' ' GLN . . . -53.1 -44.44 63.13 Favored Glycine 0 N--CA 1.433 -1.54 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.84 -176.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . 0.81 HD13 HD12 ' A' ' 410' ' ' LEU . 39.1 mt -71.52 -33.81 50.78 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -179.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . 0.557 HG22 ' O ' ' A' ' 396' ' ' LYS . 13.8 m -63.72 -39.88 86.99 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 C-N-CA 118.727 -1.189 . . . . 0.0 108.252 -174.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -63.58 -42.96 98.27 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 174.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.526 ' HG3' ' O ' ' A' ' 397' ' ' GLY . 36.4 mt-30 -92.68 -48.17 6.72 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -169.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . 0.678 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 2.8 mm-40 -114.38 -19.31 11.28 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.149 0.499 . . . . 0.0 111.494 -171.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 104.15 162.78 24.68 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.886 177.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . 0.663 HG11 ' HA ' ' A' ' 430' ' ' LEU . 1.7 m -53.72 -45.46 61.12 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.83 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -175.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . 0.558 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -64.87 -31.18 72.29 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 119.787 -0.765 . . . . 0.0 112.328 -176.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.689 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 85.5 m -76.75 -42.78 39.79 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.101 -0.639 . . . . 0.0 110.365 173.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.469 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.67 -36.4 74.12 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 122.016 0.912 . . . . 0.0 109.195 176.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 408' ' ' TYR . . . . . 0.622 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.83 -52.16 52.87 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 113.649 -1.614 . . . . 0.0 109.771 176.285 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 409' ' ' THR . . . . . 0.668 HG22 HD23 ' A' ' 410' ' ' LEU . 17.6 m -54.67 -47.62 73.38 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.562 178.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . 0.81 HD12 HD13 ' A' ' 398' ' ' ILE . 13.6 mt -72.84 -35.99 67.37 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.123 -174.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -59.41 -34.77 82.35 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 119.966 -1.111 . . . . 0.0 110.592 173.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 412' ' ' MET . . . . . 0.413 ' HB2' ' O ' ' A' ' 409' ' ' THR . 0.3 OUTLIER -65.91 -48.47 71.34 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 115.726 -0.237 . . . . 0.0 111.32 177.719 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 413' ' ' MET . . . . . 0.913 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.5 OUTLIER -71.64 -46.5 58.83 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 118.988 -1.085 . . . . 0.0 111.974 -179.508 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . 0.913 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 16.4 mt -68.69 -45.09 72.57 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -176.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 33.9 t -86.57 -21.58 26.78 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.483 0.659 . . . . 0.0 110.176 -175.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . 0.42 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 107.55 -175.81 20.45 Favored Glycine 0 N--CA 1.429 -1.775 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -171.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -79.75 23.68 0.42 Allowed 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.598 0.713 . . . . 0.0 111.405 -172.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 418' ' ' ASN . . . . . 0.42 ' H ' ' C ' ' A' ' 416' ' ' GLY . 62.5 m-80 -71.83 74.77 0.87 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.687 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 419' ' ' TYR . . . . . 0.535 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 23.2 p90 -52.29 -37.32 55.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.764 174.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -53.82 -46.4 71.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.691 177.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . 0.408 ' O ' HD13 ' A' ' 425' ' ' ILE . 0.0 OUTLIER -68.96 -49.53 57.13 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.389 -177.837 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . 0.457 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -65.74 -39.09 83.83 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.144 -175.879 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.805 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 77.7 p -66.7 -39.24 88.0 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.793 -178.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -68.45 -38.63 86.99 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.136 176.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . 0.567 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.18 -52.27 25.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.456 0.17 . . . . 0.0 111.01 -177.259 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . 0.666 HD13 HG23 ' A' ' 395' ' ' ILE . 1.1 mm -74.36 -22.75 17.96 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.897 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -173.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.805 ' HB2' ' O ' ' A' ' 423' ' ' SER . 1.1 tmt_? -54.64 -33.15 60.2 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.103 0.478 . . . . 0.0 110.699 -177.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -85.87 -10.8 74.98 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.148 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.552 ' HD1' HG22 ' A' ' 395' ' ' ILE . 9.7 m-30 -113.64 -0.14 14.42 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.421 0.629 . . . . 0.0 109.366 -174.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.68 HD23 ' HA ' ' A' ' 427' ' ' ARG . 0.1 OUTLIER -66.02 129.5 94.26 Favored Pre-proline 0 N--CA 1.445 -0.718 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.291 178.267 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 431' ' ' PRO . . . . . 0.546 ' HD2' HD12 ' A' ' 430' ' ' LEU . 94.6 Cg_exo -23.72 -66.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.359 1.088 1 C-N-CA 125.768 4.312 . . . . 0.0 115.122 179.589 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . 0.519 ' H ' HG12 ' A' ' 435' ' ' VAL . . . -145.86 -166.41 11.95 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 177.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . 0.491 ' O ' HG13 ' A' ' 436' ' ' VAL . 17.0 tp60 -70.01 -27.43 64.67 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 117.904 0.852 . . . . 0.0 110.526 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -67.12 -40.97 86.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.995 -177.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 435' ' ' VAL . . . . . 0.711 HG23 HG11 ' A' ' 463' ' ' VAL . 7.9 p -67.87 -43.43 86.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 121.004 0.431 . . . . 0.0 110.641 -177.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.509 HG12 ' O ' ' A' ' 432' ' ' GLY . 0.1 OUTLIER -66.38 -31.97 55.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.483 175.832 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.29 -52.45 40.4 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -178.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . 0.865 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -58.35 -38.7 77.73 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.225 177.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 439' ' ' LEU . . . . . 0.605 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 1.9 tm? -68.99 -48.53 62.87 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.89 -35.76 73.56 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.717 -1.128 . . . . 0.0 111.327 176.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 441' ' ' GLN . . . . . 0.448 ' O ' ' HG2' ' A' ' 445' ' ' GLN . 5.8 mm-40 -56.93 -51.35 69.5 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 123.484 0.714 . . . . 0.0 110.6 178.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . 0.484 ' HG3' ' O ' ' A' ' 438' ' ' ALA . 0.1 OUTLIER -61.56 -33.4 73.8 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.514 174.795 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 443' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 56.6 mt -68.23 -38.52 81.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.136 0.493 . . . . 0.0 109.931 177.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 444' ' ' ASP . . . . . 0.412 ' HB3' ' O ' ' A' ' 441' ' ' GLN . 29.4 t70 -57.95 -36.11 72.07 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.63 174.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 445' ' ' GLN . . . . . 0.448 ' HG2' ' O ' ' A' ' 441' ' ' GLN . 29.1 mm-40 -72.96 -26.63 61.43 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.8 177.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 32.44 104.33 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 172.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 47.0 mt -72.54 -34.67 48.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.464 0.65 . . . . 0.0 110.041 175.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . 0.424 ' HB3' ' H ' ' A' ' 449' ' ' ASP . 11.0 m-20 -165.84 -158.37 0.35 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 -177.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 449' ' ' ASP . . . . . 0.424 ' H ' ' HB3' ' A' ' 448' ' ' ASP . 18.4 m-20 -88.12 -67.41 0.83 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 168.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.44 -25.84 66.93 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 451' ' ' THR . . . . . 0.463 ' HA ' ' HB2' ' A' ' 454' ' ' GLU . 9.9 m -71.35 -22.98 61.83 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.457 -176.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 71.3 mtt180 -54.87 -53.99 48.31 Favored 'General case' 0 C--O 1.217 -0.631 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 171.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 453' ' ' ALA . . . . . 0.535 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -56.33 -48.86 75.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.7 -1.136 . . . . 0.0 112.576 174.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . 0.463 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 31.4 mm-40 -52.22 -34.01 43.77 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.07 0.462 . . . . 0.0 111.758 -178.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 27.2 p -120.25 14.9 12.21 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.481 -176.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . 0.577 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.9 OUTLIER -56.07 -49.21 74.42 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.043 0.449 . . . . 0.0 111.484 -171.057 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . 0.558 HG23 ' HB1' ' A' ' 405' ' ' ALA . 1.9 mp -74.56 -32.04 28.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.063 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -58.16 -36.2 72.67 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.604 0.716 . . . . 0.0 109.518 171.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . 0.749 ' O ' HG23 ' A' ' 463' ' ' VAL . 87.3 m-70 -72.79 -29.15 63.04 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.048 177.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . 0.731 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -74.0 -34.92 64.35 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.887 0.851 . . . . 0.0 109.137 -179.916 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . 0.46 ' O ' ' HB2' ' A' ' 464' ' ' TYR . 24.3 m-80 -73.08 -38.07 66.54 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.911 0.863 . . . . 0.0 108.985 176.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 462' ' ' ALA . . . . . 0.604 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -57.07 -32.88 66.7 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.394 -1.275 . . . . 0.0 109.874 169.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.865 HG13 ' HB3' ' A' ' 438' ' ' ALA . 60.2 t -62.63 -50.92 77.85 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.856 0 CA-C-N 114.699 -1.137 . . . . 0.0 107.958 175.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 464' ' ' TYR . . . . . 0.598 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 17.7 m-30 -52.07 -28.14 16.41 Favored 'General case' 0 N--CA 1.455 -0.182 0 O-C-N 124.353 1.033 . . . . 0.0 110.494 177.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.89 -39.08 20.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.787 0.803 . . . . 0.0 109.724 -178.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.604 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.6 mt -58.72 -55.85 20.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 114.357 -1.292 . . . . 0.0 112.189 176.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 0.769 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -101.16 -10.05 20.77 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -172.693 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . 0.546 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 93.77 30.84 8.62 Favored Glycine 0 CA--C 1.527 0.844 0 C-N-CA 119.646 -1.264 . . . . 0.0 114.169 179.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 469' ' ' LEU . . . . . 0.769 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.2 mt -88.69 159.5 17.79 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 117.847 0.823 . . . . 0.0 110.848 177.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . 0.531 HD22 HG23 ' A' ' 476' ' ' ILE . 13.9 p30 -105.32 -177.77 3.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.145 172.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -57.24 -26.18 60.34 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -174.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 -86.87 6.19 33.08 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 122.258 -0.277 . . . . 0.0 111.525 -171.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 473' ' ' GLY . . . . . 0.525 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 76.72 9.26 86.42 Favored Glycine 0 C--O 1.225 -0.447 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.204 -177.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -100.84 157.45 16.71 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 475' ' ' SER . . . . . 0.537 ' HA ' ' HA ' ' A' ' 469' ' ' LEU . 9.5 t -94.66 145.53 24.77 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.246 -0.582 . . . . 0.0 111.074 -178.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 476' ' ' ILE . . . . . 0.546 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.0 pp . . . . . 0 C--N 1.323 -0.57 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.035 178.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 386' ' ' PHE . . . . . 0.765 ' CE2' HG12 ' B' ' 394' ' ' VAL . 2.6 t80 . . . . . 0 CA--C 1.531 0.248 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 387' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' B' ' 386' ' ' PHE . 39.8 Cg_endo -64.62 105.3 0.62 Allowed 'Trans proline' 0 N--CA 1.48 0.722 0 C-N-CA 123.801 3.001 . . . . 0.0 112.2 172.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 388' ' ' MET . . . . . 0.63 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 5.2 ttp -121.58 55.29 1.1 Allowed 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.428 0.632 . . . . 0.0 111.368 -168.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 389' ' ' HIS . . . . . 0.582 ' CE1' ' HA ' ' B' ' 393' ' ' ASN . 38.9 m170 52.78 -99.19 0.08 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.676 0.79 . . . . 0.0 109.908 -172.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -148.03 16.94 1.09 Allowed 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 171.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 391' ' ' LEU . . . . . 0.625 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.5 pt? -167.12 -62.58 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.92 -171.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 392' ' ' GLY . . . . . 0.705 ' HA3' HD13 ' B' ' 395' ' ' ILE . . . -163.32 60.13 0.27 Allowed Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 119.861 -1.161 . . . . 0.0 114.343 -172.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 393' ' ' ASN . . . . . 0.63 ' HB3' ' HA ' ' B' ' 388' ' ' MET . 0.2 OUTLIER -57.44 -43.47 83.95 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 174.257 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 394' ' ' VAL . . . . . 0.765 HG12 ' CE2' ' B' ' 386' ' ' PHE . 2.0 m -55.68 -45.95 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 -179.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 395' ' ' ILE . . . . . 0.705 HD13 ' HA3' ' B' ' 392' ' ' GLY . 3.7 mp -58.07 -52.54 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-O 117.849 -1.072 . . . . 0.0 113.484 -174.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 396' ' ' LYS . . . . . 0.558 ' O ' HG22 ' B' ' 399' ' ' VAL . 0.0 OUTLIER -62.96 -49.74 73.54 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 121.986 2.175 . . . . 0.0 112.159 -174.84 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 397' ' ' GLY . . . . . 0.529 ' O ' ' HG3' ' B' ' 401' ' ' GLN . . . -52.95 -44.33 61.74 Favored Glycine 0 N--CA 1.435 -1.395 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.908 -176.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 398' ' ' ILE . . . . . 0.814 HD13 HD12 ' B' ' 410' ' ' LEU . 39.0 mt -71.66 -33.74 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 399' ' ' VAL . . . . . 0.558 HG22 ' O ' ' B' ' 396' ' ' LYS . 14.2 m -63.68 -39.67 86.21 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 C-N-CA 118.755 -1.178 . . . . 0.0 108.478 -174.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -64.03 -42.71 96.99 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 174.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 401' ' ' GLN . . . . . 0.529 ' HG3' ' O ' ' B' ' 397' ' ' GLY . 36.7 mt-30 -92.62 -48.22 6.71 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -169.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 402' ' ' GLU . . . . . 0.703 ' HG3' ' HE3' ' A' ' 413' ' ' MET . 2.9 mm-40 -114.29 -19.43 11.27 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.175 0.512 . . . . 0.0 111.539 -171.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 104.18 162.69 24.65 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.986 177.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 404' ' ' VAL . . . . . 0.66 HG11 ' HA ' ' B' ' 430' ' ' LEU . 1.6 m -53.63 -45.47 60.06 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.813 0 N-CA-C 114.463 1.282 . . . . 0.0 114.463 -175.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 405' ' ' ALA . . . . . 0.538 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -64.83 -31.32 72.5 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 119.81 -0.756 . . . . 0.0 112.312 -177.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 406' ' ' THR . . . . . 0.686 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 85.7 m -76.69 -42.98 39.58 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.169 -0.613 . . . . 0.0 110.187 173.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 407' ' ' ALA . . . . . 0.459 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.56 -36.41 73.88 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 122.158 0.98 . . . . 0.0 109.194 176.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 408' ' ' TYR . . . . . 0.614 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.88 -52.2 52.24 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 113.594 -1.639 . . . . 0.0 109.752 176.265 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 409' ' ' THR . . . . . 0.663 HG22 HD23 ' B' ' 410' ' ' LEU . 17.9 m -54.73 -47.57 73.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.545 179.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 410' ' ' LEU . . . . . 0.814 HD12 HD13 ' B' ' 398' ' ' ILE . 13.6 mt -72.85 -35.85 67.3 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.189 -174.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -59.42 -34.92 83.07 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 119.988 -1.101 . . . . 0.0 110.626 173.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 412' ' ' MET . . . . . 0.416 ' HB2' ' O ' ' B' ' 409' ' ' THR . 0.3 OUTLIER -65.78 -48.38 71.99 Favored 'General case' 0 C--O 1.223 -0.341 0 CA-C-N 115.629 -0.285 . . . . 0.0 111.411 177.715 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 413' ' ' MET . . . . . 0.913 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.5 OUTLIER -71.63 -46.38 59.28 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 119.058 -1.057 . . . . 0.0 111.994 -179.373 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 414' ' ' LEU . . . . . 0.913 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 16.5 mt -68.93 -45.16 71.53 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -176.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 33.9 t -86.83 -21.34 26.48 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.634 0.731 . . . . 0.0 110.169 -175.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 416' ' ' GLY . . . . . 0.417 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 107.58 -175.86 20.46 Favored Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 -171.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -79.81 23.6 0.43 Allowed 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.486 0.66 . . . . 0.0 111.294 -172.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 418' ' ' ASN . . . . . 0.417 ' H ' ' C ' ' B' ' 416' ' ' GLY . 61.6 m-80 -71.81 74.75 0.86 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.696 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 419' ' ' TYR . . . . . 0.538 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 23.9 p90 -52.34 -37.29 55.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.748 174.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -53.7 -46.42 70.71 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.729 177.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 421' ' ' LEU . . . . . 0.413 ' O ' HD13 ' B' ' 425' ' ' ILE . 0.0 OUTLIER -69.02 -49.51 57.04 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.438 -177.806 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 422' ' ' VAL . . . . . 0.458 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.2 OUTLIER -65.9 -39.02 83.47 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.093 -175.852 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 423' ' ' SER . . . . . 0.82 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 78.1 p -66.73 -39.12 87.85 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.818 -178.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -68.62 -38.54 86.19 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.153 176.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 425' ' ' ILE . . . . . 0.585 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -72.21 -52.32 24.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 121.351 -0.14 . . . . 0.0 110.794 -177.282 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 426' ' ' ILE . . . . . 0.653 HD13 HG23 ' B' ' 395' ' ' ILE . 1.1 mm -74.29 -22.71 18.05 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.929 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -173.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 427' ' ' ARG . . . . . 0.82 ' HB2' ' O ' ' B' ' 423' ' ' SER . 1.2 tmt_? -54.58 -33.25 59.96 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.166 0.507 . . . . 0.0 110.69 -177.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -85.85 -10.71 75.22 Favored Glycine 0 N--CA 1.44 -1.043 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.222 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 429' ' ' TYR . . . . . 0.554 ' HD1' HG22 ' B' ' 395' ' ' ILE . 9.5 m-30 -113.97 0.23 14.31 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.468 0.652 . . . . 0.0 109.326 -174.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 430' ' ' LEU . . . . . 0.685 HD23 ' HA ' ' B' ' 427' ' ' ARG . 0.1 OUTLIER -66.36 129.4 94.17 Favored Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.302 178.211 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 431' ' ' PRO . . . . . 0.544 ' HD2' HD12 ' B' ' 430' ' ' LEU . 94.3 Cg_exo -23.98 -65.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.36 1.137 1 C-N-CA 125.707 4.271 . . . . 0.0 115.155 179.81 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 432' ' ' GLY . . . . . 0.527 ' H ' HG12 ' B' ' 435' ' ' VAL . . . -146.56 -166.28 12.11 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 176.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 433' ' ' GLN . . . . . 0.486 ' O ' HG13 ' B' ' 436' ' ' VAL . 15.9 tp60 -69.83 -27.33 64.77 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 117.869 0.834 . . . . 0.0 110.617 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -67.23 -41.02 86.38 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -177.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 435' ' ' VAL . . . . . 0.703 HG23 HG11 ' B' ' 463' ' ' VAL . 8.0 p -67.81 -43.65 86.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-O 121.088 0.47 . . . . 0.0 110.683 -177.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 436' ' ' VAL . . . . . 0.505 HG12 ' O ' ' B' ' 432' ' ' GLY . 0.1 OUTLIER -66.06 -32.23 57.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.444 175.653 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.12 -52.46 41.51 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -178.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 438' ' ' ALA . . . . . 0.855 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -58.33 -38.84 77.97 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.155 177.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 439' ' ' LEU . . . . . 0.6 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 2.0 tm? -68.88 -48.46 63.33 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.1 -35.6 73.69 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.279 176.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 441' ' ' GLN . . . . . 0.447 ' O ' ' HG2' ' B' ' 445' ' ' GLN . 5.7 mm-40 -56.85 -51.5 68.76 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 123.385 0.674 . . . . 0.0 110.556 178.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 442' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' B' ' 438' ' ' ALA . 0.1 OUTLIER -61.59 -33.21 73.49 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.58 174.956 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 443' ' ' LEU . . . . . 0.6 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 56.6 mt -68.27 -38.83 82.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.127 0.489 . . . . 0.0 109.856 177.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 444' ' ' ASP . . . . . 0.408 ' HB3' ' O ' ' B' ' 441' ' ' GLN . 28.4 t70 -57.96 -35.56 71.34 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.628 174.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 445' ' ' GLN . . . . . 0.447 ' HG2' ' O ' ' B' ' 441' ' ' GLN . 29.3 mm-40 -73.26 -26.67 61.19 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.778 177.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 446' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 32.31 104.72 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 172.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 47.2 mt -72.82 -34.81 47.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.383 0.611 . . . . 0.0 109.975 175.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 448' ' ' ASP . . . . . 0.4 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 12.2 m-20 -165.87 -158.69 0.36 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -177.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -88.01 -67.27 0.84 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 169.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.53 -25.73 66.81 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 179.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 451' ' ' THR . . . . . 0.454 ' HA ' ' HB2' ' B' ' 454' ' ' GLU . 10.6 m -71.27 -23.11 61.91 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.421 -176.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 452' ' ' ARG . . . . . . . . . . . . . 70.9 mtt180 -54.67 -53.91 48.59 Favored 'General case' 0 C--O 1.217 -0.612 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 171.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 453' ' ' ALA . . . . . 0.538 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -56.48 -48.93 76.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.719 -1.128 . . . . 0.0 112.499 174.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 454' ' ' GLU . . . . . 0.454 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 31.9 mm-40 -52.23 -34.0 43.88 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.161 0.505 . . . . 0.0 111.626 -177.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 26.9 p -120.24 14.96 12.23 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.413 -176.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 456' ' ' PHE . . . . . 0.577 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 0.9 OUTLIER -56.13 -49.18 74.64 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.982 0.42 . . . . 0.0 111.495 -171.262 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 457' ' ' ILE . . . . . 0.548 ' CG1' ' HB3' ' B' ' 408' ' ' TYR . 1.9 mp -74.63 -31.96 28.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.0 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -58.26 -36.1 72.74 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.569 0.7 . . . . 0.0 109.418 171.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 459' ' ' HIS . . . . . 0.761 ' O ' HG23 ' B' ' 463' ' ' VAL . 87.4 m-70 -72.86 -29.18 62.99 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.175 177.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 460' ' ' LEU . . . . . 0.743 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -73.94 -34.95 64.51 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.901 0.857 . . . . 0.0 109.063 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 461' ' ' ASN . . . . . 0.43 ' O ' ' HB2' ' B' ' 464' ' ' TYR . 24.9 m-80 -73.3 -37.73 66.1 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.883 0.849 . . . . 0.0 109.075 176.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 462' ' ' ALA . . . . . 0.603 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -57.2 -32.99 67.05 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.832 169.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 463' ' ' VAL . . . . . 0.855 HG13 ' HB3' ' B' ' 438' ' ' ALA . 60.9 t -62.41 -51.02 77.39 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.799 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 175.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 464' ' ' TYR . . . . . 0.59 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 17.7 m-30 -52.04 -28.06 15.91 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 124.405 1.066 . . . . 0.0 110.616 177.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.16 -38.85 20.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.698 0.761 . . . . 0.0 109.766 -177.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 466' ' ' ILE . . . . . 0.603 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.6 mt -58.85 -55.89 20.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 114.44 -1.255 . . . . 0.0 112.229 176.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 467' ' ' LEU . . . . . 0.771 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -100.95 -10.22 20.8 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 -172.772 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 468' ' ' GLY . . . . . 0.538 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 93.86 30.89 8.53 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 119.637 -1.268 . . . . 0.0 114.157 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 469' ' ' LEU . . . . . 0.771 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.2 mt -88.62 159.59 17.8 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 117.855 0.828 . . . . 0.0 110.846 177.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 470' ' ' ASN . . . . . 0.543 HD22 HG23 ' B' ' 476' ' ' ILE . 13.9 p30 -105.38 -178.05 3.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.107 172.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 471' ' ' ALA . . . . . . . . . . . . . . . -56.74 -26.58 57.58 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -174.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 -86.75 6.5 31.12 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 122.178 -0.326 . . . . 0.0 111.73 -171.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 473' ' ' GLY . . . . . 0.523 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 76.33 9.54 85.76 Favored Glycine 0 C--O 1.227 -0.319 0 C-N-CA 120.484 -0.865 . . . . 0.0 111.257 -177.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -100.94 157.65 16.58 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 176.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 475' ' ' SER . . . . . 0.542 ' HA ' ' HA ' ' B' ' 469' ' ' LEU . 9.9 t -95.05 145.3 25.06 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.074 -178.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 476' ' ' ILE . . . . . 0.543 HG23 HD22 ' B' ' 470' ' ' ASN . 2.0 pp . . . . . 0 C--N 1.322 -0.6 0 CA-C-O 121.618 0.723 . . . . 0.0 110.054 178.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 386' ' ' PHE . . . . . 0.746 ' CD1' HD22 ' A' ' 414' ' ' LEU . 1.3 t80 . . . . . 0 CA--C 1.538 0.5 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -42.98 -69.35 0.08 OUTLIER 'Trans proline' 0 N--CA 1.479 0.628 0 C-N-CA 124.265 3.31 . . . . 0.0 113.667 -176.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.535 ' SD ' ' HB2' ' A' ' 415' ' ' SER . 6.7 ttp 66.44 34.13 6.41 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 173.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 389' ' ' HIS . . . . . 0.476 ' CE1' ' HB2' ' A' ' 393' ' ' ASN . 36.6 m170 53.93 -95.17 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.327 0.584 . . . . 0.0 110.379 -177.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -149.63 18.87 0.92 Allowed 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 174.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.619 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.6 pt? -173.49 -54.96 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -169.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . 0.619 ' N ' ' HG ' ' A' ' 391' ' ' LEU . . . -167.57 47.08 0.24 Allowed Glycine 0 CA--C 1.525 0.669 0 C-N-CA 119.685 -1.245 . . . . 0.0 114.569 -169.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . 0.497 ' HB3' ' C ' ' A' ' 388' ' ' MET . 0.0 OUTLIER -54.95 -37.58 66.65 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 117.925 0.862 . . . . 0.0 109.495 175.87 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . 0.708 HG23 HD12 ' A' ' 398' ' ' ILE . 1.5 m -57.45 -49.97 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 CA-C-N 113.824 -1.535 . . . . 0.0 107.603 178.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . 0.649 HG21 HG22 ' A' ' 425' ' ' ILE . 4.0 mp -57.96 -52.88 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 CA-C-O 118.013 -0.994 . . . . 0.0 113.544 -174.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . 0.654 ' HG3' ' CZ ' ' A' ' 429' ' ' TYR . 0.1 OUTLIER -64.7 -48.48 74.54 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 121.737 2.062 . . . . 0.0 111.664 -172.525 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.34 -45.49 65.26 Favored Glycine 0 N--CA 1.433 -1.517 0 C-N-CA 120.106 -1.045 . . . . 0.0 110.978 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . 0.761 HD13 HD12 ' A' ' 410' ' ' LEU . 35.4 mt -70.95 -33.86 53.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 -178.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . 0.535 HG12 ' HA ' ' A' ' 404' ' ' VAL . 11.4 m -63.44 -39.88 86.95 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.514 0 C-N-CA 118.73 -1.188 . . . . 0.0 108.539 -173.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -70.93 -37.09 72.88 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 176.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.47 HE21 ' HB3' ' A' ' 401' ' ' GLN . 4.2 mm100 -86.86 -48.26 8.34 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -171.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . 0.527 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 3.0 mm-40 -119.43 -20.92 7.65 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.375 -171.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 107.48 161.95 21.47 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.879 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . 0.663 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.5 m -53.71 -41.79 48.79 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.784 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -175.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . 0.671 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -69.23 -29.33 67.25 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.916 -176.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.711 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 89.3 m -77.63 -42.79 33.6 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.206 -0.598 . . . . 0.0 110.137 172.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.43 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.42 -36.94 74.38 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 122.062 0.934 . . . . 0.0 109.355 176.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 408' ' ' TYR . . . . . 0.663 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.8 -52.13 53.22 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 113.619 -1.628 . . . . 0.0 109.767 176.372 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 409' ' ' THR . . . . . 0.659 HG22 HD23 ' A' ' 410' ' ' LEU . 17.7 m -55.53 -47.57 76.09 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.592 178.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . 0.761 HD12 HD13 ' A' ' 398' ' ' ILE . 15.0 mt -72.85 -35.11 67.17 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -174.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.66 -34.3 76.16 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.123 -1.037 . . . . 0.0 111.047 171.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -68.35 -49.51 59.78 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-O 120.527 0.203 . . . . 0.0 111.34 178.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 413' ' ' MET . . . . . 0.923 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.9 OUTLIER -71.18 -43.14 68.04 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 119.437 -0.905 . . . . 0.0 112.08 -177.474 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . 0.923 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 12.0 mt -73.99 -46.13 45.65 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 113.234 0.828 . . . . 0.0 113.234 -178.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.535 ' HB2' ' SD ' ' A' ' 388' ' ' MET . 3.7 t -100.1 17.55 20.85 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.361 0.6 . . . . 0.0 110.928 -170.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 78.87 178.31 50.45 Favored Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 120.285 -0.96 . . . . 0.0 111.768 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -81.72 21.17 0.85 Allowed 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.012 0.434 . . . . 0.0 111.642 -172.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 418' ' ' ASN . . . . . 0.479 ' HB3' ' HB3' ' A' ' 421' ' ' LEU . 6.3 m-20 -73.23 80.89 1.31 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.574 0.702 . . . . 0.0 111.021 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 419' ' ' TYR . . . . . 0.563 ' HB2' ' CE2' ' A' ' 456' ' ' PHE . 10.5 p90 -51.91 -38.24 55.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.761 176.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -55.58 -43.67 76.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.87 177.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . 0.479 ' HB3' ' HB3' ' A' ' 418' ' ' ASN . 0.0 OUTLIER -67.8 -48.54 66.01 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.264 -178.075 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . 0.478 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -65.89 -42.22 91.58 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 C-N-CA 120.421 -0.511 . . . . 0.0 111.189 -177.725 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.743 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 29.0 t -69.46 -34.99 75.2 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -178.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.54 -40.54 90.87 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.192 175.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . 0.649 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.81 -49.9 36.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-O 120.554 0.216 . . . . 0.0 110.763 -178.914 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . 0.622 HD13 HG23 ' A' ' 395' ' ' ILE . 1.2 mm -74.31 -22.41 17.91 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.911 0 C-N-CA 123.055 0.542 . . . . 0.0 110.183 -172.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.743 ' HB2' ' O ' ' A' ' 423' ' ' SER . 0.3 OUTLIER -54.72 -28.82 50.83 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 123.031 0.533 . . . . 0.0 111.075 -178.718 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -90.15 -8.32 66.8 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.684 178.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.654 ' CZ ' ' HG3' ' A' ' 396' ' ' LYS . 21.5 m-85 -114.46 -2.86 13.1 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 121.667 0.746 . . . . 0.0 109.619 -178.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.6 HD12 ' HD2' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -65.89 135.79 95.47 Favored Pre-proline 0 N--CA 1.437 -1.088 0 CA-C-N 114.339 -1.3 . . . . 0.0 108.657 178.325 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 431' ' ' PRO . . . . . 0.839 ' HD2' HG11 ' A' ' 435' ' ' VAL . 47.0 Cg_exo -36.42 -65.21 0.15 Allowed 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 124.614 3.543 . . . . 0.0 114.081 -172.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . 0.567 ' H ' HG12 ' A' ' 435' ' ' VAL . . . -141.94 -165.08 10.32 Favored Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 175.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . 0.512 ' O ' HG13 ' A' ' 436' ' ' VAL . 23.9 tp60 -70.26 -26.91 64.05 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 118.198 0.999 . . . . 0.0 110.331 177.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -66.29 -40.44 90.05 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -177.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 435' ' ' VAL . . . . . 0.839 HG11 ' HD2' ' A' ' 431' ' ' PRO . 7.0 p -68.14 -44.64 84.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-O 120.892 0.377 . . . . 0.0 110.785 -178.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.512 HG13 ' O ' ' A' ' 433' ' ' GLN . 0.2 OUTLIER -65.43 -29.11 46.17 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 CA-C-O 121.057 0.456 . . . . 0.0 110.094 175.862 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 1.1 m -69.26 -52.92 22.87 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . 0.879 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -58.77 -38.13 77.79 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.807 177.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 439' ' ' LEU . . . . . 0.577 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 2.2 tm? -69.91 -47.43 62.5 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.62 -39.67 77.44 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.38 174.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 441' ' ' GLN . . . . . 0.491 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 8.9 mm-40 -53.58 -49.54 67.53 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 123.788 0.835 . . . . 0.0 110.855 174.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . 0.817 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 0.7 OUTLIER -55.85 -39.43 71.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.607 172.034 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 443' ' ' LEU . . . . . 0.577 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 37.1 mt -71.71 -35.56 70.25 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.025 0.44 . . . . 0.0 110.178 -178.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -58.05 -36.97 73.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.631 174.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -72.82 -28.03 62.31 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.616 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 446' ' ' GLU . . . . . 0.575 ' HB2' ' O ' ' A' ' 443' ' ' LEU . 31.6 tt0 29.75 96.49 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 172.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 42.1 mt -67.91 -35.31 71.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.202 0.525 . . . . 0.0 110.518 177.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . 0.62 ' O ' ' HG3' ' A' ' 452' ' ' ARG . 23.2 m-20 -166.15 -170.52 1.73 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -76.7 -62.44 1.63 Allowed 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.176 -0.61 . . . . 0.0 109.405 173.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.37 -26.03 63.54 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 178.007 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 451' ' ' THR . . . . . 0.478 ' OG1' ' HB2' ' A' ' 448' ' ' ASP . 17.7 m -71.71 -22.65 61.61 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 119.824 -0.75 . . . . 0.0 110.853 -175.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . 0.62 ' HG3' ' O ' ' A' ' 448' ' ' ASP . 13.3 mtp180 -53.64 -54.75 33.34 Favored 'General case' 0 C--O 1.218 -0.569 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 170.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 453' ' ' ALA . . . . . 0.484 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -57.34 -48.2 79.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.264 -1.335 . . . . 0.0 112.582 175.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . 0.465 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 20.8 mm-40 -51.83 -35.72 45.55 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.151 0.501 . . . . 0.0 111.752 -177.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 31.2 p -119.22 16.2 13.15 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.314 -176.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . 0.563 ' CE2' ' HB2' ' A' ' 419' ' ' TYR . 1.0 OUTLIER -57.05 -48.84 77.55 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.975 0.417 . . . . 0.0 111.819 -171.441 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . 0.671 HG23 ' HB1' ' A' ' 405' ' ' ALA . 2.0 mp -75.67 -33.02 25.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.934 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -58.4 -35.08 71.49 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.942 0.877 . . . . 0.0 109.268 172.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . 0.715 ' O ' HG23 ' A' ' 463' ' ' VAL . 59.4 m-70 -74.23 -28.87 61.44 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.539 -1.21 . . . . 0.0 110.732 177.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . 0.707 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.4 OUTLIER -73.64 -34.79 65.14 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.794 0.807 . . . . 0.0 108.914 178.869 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . 0.492 ' HA ' ' CD2' ' A' ' 464' ' ' TYR . 20.0 m-80 -73.21 -37.64 66.36 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.276 -0.874 . . . . 0.0 108.872 176.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 462' ' ' ALA . . . . . 0.597 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -56.85 -34.92 68.26 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.443 -1.253 . . . . 0.0 109.812 169.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.879 HG13 ' HB3' ' A' ' 438' ' ' ALA . 68.4 t -60.12 -51.22 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 175.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 464' ' ' TYR . . . . . 0.618 ' CE2' ' HA ' ' A' ' 471' ' ' ALA . 16.2 m-30 -53.52 -28.33 30.7 Favored 'General case' 0 N--CA 1.456 -0.159 0 O-C-N 124.233 0.958 . . . . 0.0 110.598 178.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.19 -39.6 20.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.787 0.803 . . . . 0.0 109.466 -177.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.597 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.7 mt -57.62 -55.68 19.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 114.22 -1.354 . . . . 0.0 112.286 175.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 0.787 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -102.83 -10.64 18.92 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -172.343 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . 0.697 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 93.93 32.47 7.52 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 118.96 -1.59 . . . . 0.0 114.155 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 469' ' ' LEU . . . . . 0.787 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.7 mt -89.63 166.41 13.64 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 117.793 0.797 . . . . 0.0 111.489 176.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 40.4 p30 -106.06 -178.12 3.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.564 -0.743 . . . . 0.0 109.668 169.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 471' ' ' ALA . . . . . 0.618 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -70.71 -9.72 57.83 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -175.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -89.09 -0.63 57.6 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.931 0.396 . . . . 0.0 110.861 -177.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 473' ' ' GLY . . . . . 0.474 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 75.5 16.58 80.54 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -173.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -101.57 155.57 18.01 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.275 -0.462 . . . . 0.0 109.818 178.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 3.0 p -94.49 121.06 35.65 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.165 0.507 . . . . 0.0 110.768 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 476' ' ' ILE . . . . . 0.697 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.3 pp . . . . . 0 C--N 1.322 -0.626 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.072 -176.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 386' ' ' PHE . . . . . 0.747 ' CD1' HD22 ' B' ' 414' ' ' LEU . 1.2 t80 . . . . . 0 CA--C 1.537 0.458 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 387' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -43.12 -68.99 0.09 OUTLIER 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 124.049 3.166 . . . . 0.0 113.782 -176.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 388' ' ' MET . . . . . 0.533 ' SD ' ' HB2' ' B' ' 415' ' ' SER . 6.6 ttp 66.23 34.21 6.75 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 173.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 389' ' ' HIS . . . . . 0.479 ' CE1' ' HB2' ' B' ' 393' ' ' ASN . 36.6 m170 54.08 -94.62 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.363 0.602 . . . . 0.0 110.546 -177.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -150.29 19.22 0.85 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.144 -0.934 . . . . 0.0 108.657 174.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 391' ' ' LEU . . . . . 0.614 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.6 pt? -173.91 -55.01 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -169.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 392' ' ' GLY . . . . . 0.614 ' N ' ' HG ' ' B' ' 391' ' ' LEU . . . -167.57 47.11 0.24 Allowed Glycine 0 CA--C 1.523 0.566 0 C-N-CA 119.796 -1.192 . . . . 0.0 114.736 -169.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 393' ' ' ASN . . . . . 0.488 ' HB3' ' C ' ' B' ' 388' ' ' MET . 0.0 OUTLIER -54.92 -37.56 66.54 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 117.915 0.857 . . . . 0.0 109.461 175.94 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 394' ' ' VAL . . . . . 0.692 HG23 HD12 ' B' ' 398' ' ' ILE . 1.5 m -57.5 -49.9 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 113.795 -1.548 . . . . 0.0 107.491 179.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 395' ' ' ILE . . . . . 0.66 HG21 HG22 ' B' ' 425' ' ' ILE . 4.0 mp -58.14 -52.86 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-O 117.978 -1.01 . . . . 0.0 113.464 -174.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 396' ' ' LYS . . . . . 0.657 ' HG3' ' CZ ' ' B' ' 429' ' ' TYR . 0.1 OUTLIER -64.71 -48.5 74.42 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 121.788 2.086 . . . . 0.0 111.679 -172.476 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.24 -45.49 64.28 Favored Glycine 0 N--CA 1.435 -1.397 0 C-N-CA 120.01 -1.09 . . . . 0.0 110.935 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 398' ' ' ILE . . . . . 0.758 HD13 HD12 ' B' ' 410' ' ' LEU . 36.0 mt -71.05 -33.93 53.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 113.607 0.965 . . . . 0.0 113.607 -178.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 399' ' ' VAL . . . . . 0.519 HG12 ' HA ' ' B' ' 404' ' ' VAL . 11.7 m -63.3 -39.86 86.86 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.54 0 C-N-CA 118.827 -1.149 . . . . 0.0 108.559 -174.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -70.95 -37.44 72.82 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 176.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 401' ' ' GLN . . . . . 0.401 HE21 ' HB3' ' B' ' 401' ' ' GLN . 3.9 mm100 -86.66 -47.8 8.85 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -171.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 402' ' ' GLU . . . . . 0.439 ' HG3' ' HE3' ' A' ' 413' ' ' MET . 3.0 mm-40 -119.71 -20.64 7.58 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.385 -171.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 107.2 161.98 21.74 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.863 178.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 404' ' ' VAL . . . . . 0.647 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.5 m -53.74 -41.8 49.09 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.862 0 N-CA-C 114.649 1.352 . . . . 0.0 114.649 -175.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 405' ' ' ALA . . . . . 0.679 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -69.2 -29.11 67.01 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 119.657 -0.817 . . . . 0.0 112.042 -176.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 406' ' ' THR . . . . . 0.708 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 91.6 m -77.74 -42.82 32.89 Favored 'General case' 0 C--O 1.22 -0.474 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.142 172.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 407' ' ' ALA . . . . . 0.429 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.54 -36.82 74.47 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 122.01 0.909 . . . . 0.0 109.375 176.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 408' ' ' TYR . . . . . 0.647 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.81 -52.33 51.57 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 113.581 -1.645 . . . . 0.0 109.777 176.185 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 409' ' ' THR . . . . . 0.656 HG22 HD23 ' B' ' 410' ' ' LEU . 17.7 m -55.27 -47.66 75.17 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.676 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 410' ' ' LEU . . . . . 0.758 HD12 HD13 ' B' ' 398' ' ' ILE . 14.9 mt -72.81 -35.16 67.27 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 -174.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.67 -34.25 75.99 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.136 -1.03 . . . . 0.0 111.035 171.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 412' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -68.41 -49.37 60.52 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.558 0.218 . . . . 0.0 111.369 178.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 413' ' ' MET . . . . . 0.94 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.9 OUTLIER -71.34 -43.1 67.64 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 119.355 -0.938 . . . . 0.0 112.099 -177.553 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 414' ' ' LEU . . . . . 0.94 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 12.0 mt -73.89 -46.15 46.31 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -178.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 415' ' ' SER . . . . . 0.533 ' HB2' ' SD ' ' B' ' 388' ' ' MET . 3.7 t -100.37 17.79 20.61 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.265 0.555 . . . . 0.0 110.897 -170.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 416' ' ' GLY . . . . . . . . . . . . . . . 78.82 178.22 50.26 Favored Glycine 0 N--CA 1.438 -1.189 0 C-N-CA 120.342 -0.932 . . . . 0.0 111.771 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 33.6 mm-40 -81.7 21.25 0.84 Allowed 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.074 0.464 . . . . 0.0 111.496 -172.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 418' ' ' ASN . . . . . 0.481 ' HB3' ' HB3' ' B' ' 421' ' ' LEU . 6.6 m-20 -73.26 80.82 1.33 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.541 0.686 . . . . 0.0 111.067 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 419' ' ' TYR . . . . . 0.558 ' HB2' ' CE2' ' B' ' 456' ' ' PHE . 10.4 p90 -52.02 -38.13 55.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.869 -1.059 . . . . 0.0 111.843 176.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -55.36 -43.81 75.4 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.646 0.26 . . . . 0.0 110.81 176.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 421' ' ' LEU . . . . . 0.481 ' HB3' ' HB3' ' B' ' 418' ' ' ASN . 0.0 OUTLIER -67.73 -48.51 66.25 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.24 -177.908 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 422' ' ' VAL . . . . . 0.479 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.2 OUTLIER -66.05 -42.06 90.8 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.149 -177.579 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 423' ' ' SER . . . . . 0.749 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 25.5 t -69.54 -35.0 75.03 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.52 -40.54 90.93 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.265 175.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 425' ' ' ILE . . . . . 0.66 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -72.76 -50.07 36.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 O-C-N 122.834 -0.216 . . . . 0.0 110.824 -179.074 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 426' ' ' ILE . . . . . 0.62 HD13 HG23 ' B' ' 395' ' ' ILE . 1.2 mm -74.41 -22.32 17.76 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.911 0 C-N-CA 122.956 0.502 . . . . 0.0 110.235 -172.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 427' ' ' ARG . . . . . 0.749 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.3 OUTLIER -54.7 -28.7 49.74 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 123.023 0.529 . . . . 0.0 111.186 -178.91 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -90.58 -7.77 66.49 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.489 178.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 429' ' ' TYR . . . . . 0.657 ' CZ ' ' HG3' ' B' ' 396' ' ' LYS . 21.6 m-85 -114.94 -2.49 12.85 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.74 0.781 . . . . 0.0 109.571 -178.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 430' ' ' LEU . . . . . 0.608 HD12 ' HD2' ' B' ' 431' ' ' PRO . 0.0 OUTLIER -65.91 135.76 95.44 Favored Pre-proline 0 N--CA 1.437 -1.088 0 CA-C-N 114.462 -1.244 . . . . 0.0 108.679 178.165 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 431' ' ' PRO . . . . . 0.838 ' HD2' HG11 ' B' ' 435' ' ' VAL . 46.5 Cg_exo -36.53 -65.08 0.15 Allowed 'Trans proline' 0 N--CA 1.473 0.322 0 C-N-CA 124.658 3.572 . . . . 0.0 114.09 -172.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 432' ' ' GLY . . . . . 0.553 ' H ' HG12 ' B' ' 435' ' ' VAL . . . -142.08 -165.12 10.36 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 175.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 433' ' ' GLN . . . . . 0.506 ' O ' HG13 ' B' ' 436' ' ' VAL . 24.5 tp60 -70.13 -26.89 64.16 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 118.195 0.998 . . . . 0.0 110.423 177.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -66.54 -40.01 88.87 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -177.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 435' ' ' VAL . . . . . 0.838 HG11 ' HD2' ' B' ' 431' ' ' PRO . 7.1 p -68.43 -44.63 83.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-O 120.962 0.41 . . . . 0.0 110.702 -178.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 436' ' ' VAL . . . . . 0.506 HG13 ' O ' ' B' ' 433' ' ' GLN . 0.1 OUTLIER -65.43 -29.34 46.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.112 175.826 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 1.1 m -69.19 -52.81 24.18 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 438' ' ' ALA . . . . . 0.864 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -58.75 -38.43 78.4 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.744 177.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 439' ' ' LEU . . . . . 0.581 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 2.2 tm? -69.68 -47.34 63.58 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -178.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.69 -39.53 77.38 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.291 174.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 441' ' ' GLN . . . . . 0.499 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 8.8 mm-40 -53.8 -49.54 68.1 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 123.733 0.813 . . . . 0.0 110.82 174.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 442' ' ' ARG . . . . . 0.83 ' HG2' ' O ' ' B' ' 438' ' ' ALA . 0.7 OUTLIER -55.82 -39.3 71.18 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.609 172.061 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 443' ' ' LEU . . . . . 0.581 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 37.5 mt -71.68 -35.61 70.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.953 0.406 . . . . 0.0 110.19 -178.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -58.16 -37.05 73.93 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.521 174.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -72.74 -28.27 62.54 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.512 178.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 446' ' ' GLU . . . . . 0.573 ' HB2' ' O ' ' B' ' 443' ' ' LEU . 31.7 tt0 30.04 96.96 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 O-C-N 124.686 1.241 . . . . 0.0 114.339 172.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 42.7 mt -68.29 -35.27 70.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.112 0.482 . . . . 0.0 110.593 177.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 448' ' ' ASP . . . . . 0.61 ' O ' ' HG3' ' B' ' 452' ' ' ARG . 23.5 m-20 -165.89 -170.26 1.71 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -76.73 -62.64 1.57 Allowed 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 173.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.43 -25.91 63.43 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 178.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 451' ' ' THR . . . . . 0.468 ' OG1' ' HB2' ' B' ' 448' ' ' ASP . 18.6 m -71.71 -22.74 61.6 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.632 -175.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 452' ' ' ARG . . . . . 0.61 ' HG3' ' O ' ' B' ' 448' ' ' ASP . 13.6 mtp180 -53.54 -54.65 34.35 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 170.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 453' ' ' ALA . . . . . 0.483 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -57.51 -48.22 79.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.275 -1.33 . . . . 0.0 112.604 175.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 454' ' ' GLU . . . . . 0.454 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 20.9 mm-40 -51.67 -35.72 43.57 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.252 0.548 . . . . 0.0 111.736 -177.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 31.1 p -119.28 16.15 13.1 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.362 -176.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 456' ' ' PHE . . . . . 0.558 ' CE2' ' HB2' ' B' ' 419' ' ' TYR . 1.0 OUTLIER -57.13 -48.67 78.08 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.95 0.405 . . . . 0.0 111.766 -171.343 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 457' ' ' ILE . . . . . 0.679 HG23 ' HB1' ' B' ' 405' ' ' ALA . 2.0 mp -75.77 -33.23 25.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.864 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -58.35 -34.95 71.23 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.888 0.851 . . . . 0.0 109.293 172.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 459' ' ' HIS . . . . . 0.72 ' O ' HG23 ' B' ' 463' ' ' VAL . 60.1 m-70 -74.33 -28.78 61.31 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.777 177.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 460' ' ' LEU . . . . . 0.711 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.4 OUTLIER -73.63 -34.81 65.18 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.869 0.842 . . . . 0.0 108.872 178.94 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 461' ' ' ASN . . . . . 0.494 ' HA ' ' CD2' ' B' ' 464' ' ' TYR . 19.2 m-80 -73.26 -37.69 66.23 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.279 -0.873 . . . . 0.0 108.909 176.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 462' ' ' ALA . . . . . 0.6 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -56.8 -34.9 68.12 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.812 169.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 463' ' ' VAL . . . . . 0.864 HG13 ' HB3' ' B' ' 438' ' ' ALA . 68.6 t -60.12 -51.24 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 175.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 464' ' ' TYR . . . . . 0.626 ' CE2' ' HA ' ' B' ' 471' ' ' ALA . 16.4 m-30 -53.51 -28.16 29.58 Favored 'General case' 0 N--CA 1.457 -0.105 0 O-C-N 124.242 0.964 . . . . 0.0 110.551 178.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.29 -39.94 20.18 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.706 0.765 . . . . 0.0 109.411 -177.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 466' ' ' ILE . . . . . 0.6 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.7 mt -57.4 -55.5 20.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 114.189 -1.369 . . . . 0.0 112.231 176.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 467' ' ' LEU . . . . . 0.796 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -103.05 -10.47 18.88 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -172.369 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 468' ' ' GLY . . . . . 0.703 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 93.82 32.52 7.53 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 118.996 -1.573 . . . . 0.0 114.133 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 469' ' ' LEU . . . . . 0.796 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.7 mt -89.63 166.26 13.73 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 117.832 0.816 . . . . 0.0 111.538 176.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 41.3 p30 -105.91 -178.19 3.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.72 169.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 471' ' ' ALA . . . . . 0.626 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -70.83 -9.55 57.77 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -175.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -89.27 -0.75 57.71 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.856 0.36 . . . . 0.0 110.908 -177.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 473' ' ' GLY . . . . . 0.459 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 75.74 16.53 80.59 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -173.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -101.45 155.71 17.9 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.23 -0.485 . . . . 0.0 109.861 178.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 2.7 p -94.93 120.92 35.95 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.193 0.52 . . . . 0.0 110.673 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 476' ' ' ILE . . . . . 0.703 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.3 pp . . . . . 0 C--N 1.322 -0.607 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.189 -176.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 386' ' ' PHE . . . . . 0.748 ' CD1' HD22 ' A' ' 414' ' ' LEU . 2.3 t80 . . . . . 0 CA--C 1.535 0.388 0 CA-C-O 120.491 0.186 . . . . 0.0 110.515 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 386' ' ' PHE . 40.6 Cg_endo -65.5 111.54 1.89 Allowed 'Trans proline' 0 N--CA 1.482 0.811 0 C-N-CA 123.873 3.049 . . . . 0.0 112.458 173.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.626 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 34.2 ttm -121.37 47.92 1.76 Allowed 'General case' 0 C--N 1.321 -0.634 0 O-C-N 121.984 -0.448 . . . . 0.0 111.536 -169.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 389' ' ' HIS . . . . . 0.645 ' CG ' ' HB2' ' A' ' 393' ' ' ASN . 38.0 m170 57.09 -90.17 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 121.484 0.659 . . . . 0.0 109.482 -170.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -160.49 17.36 0.13 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.293 175.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.572 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.3 pt? -167.42 -59.35 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.562 -0.744 . . . . 0.0 112.119 -171.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . 0.575 ' CA ' HD13 ' A' ' 395' ' ' ILE . . . -167.07 53.33 0.24 Allowed Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.216 -0.993 . . . . 0.0 114.059 -172.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . 0.645 ' HB2' ' CG ' ' A' ' 389' ' ' HIS . 0.4 OUTLIER -56.35 -44.07 79.7 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 117.314 0.557 . . . . 0.0 110.262 176.811 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . 0.713 HG12 ' CE2' ' A' ' 386' ' ' PHE . 1.9 m -55.25 -45.13 77.5 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.777 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 -178.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . 0.655 HG23 HD13 ' A' ' 426' ' ' ILE . 3.7 mp -58.02 -52.74 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 CA-C-O 117.853 -1.07 . . . . 0.0 113.544 -175.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . 0.511 ' O ' HG22 ' A' ' 399' ' ' VAL . 0.0 OUTLIER -63.2 -48.86 76.52 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 122.044 2.202 . . . . 0.0 112.139 -174.13 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . 0.453 ' O ' ' HG3' ' A' ' 401' ' ' GLN . . . -53.02 -44.49 62.33 Favored Glycine 0 N--CA 1.435 -1.414 0 C-N-CA 119.989 -1.101 . . . . 0.0 110.983 -177.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . 0.782 HD13 HD12 ' A' ' 410' ' ' LEU . 34.6 mt -71.83 -34.01 50.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 396' ' ' LYS . 11.8 m -64.18 -40.44 89.05 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 C-N-CA 118.742 -1.183 . . . . 0.0 108.402 -173.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -64.27 -41.47 96.91 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 175.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' A' ' 397' ' ' GLY . 34.9 mt-30 -92.94 -49.74 5.89 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -170.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . 0.683 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 2.4 mm-40 -111.74 -20.22 12.17 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.026 0.441 . . . . 0.0 111.227 -171.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 104.75 162.18 24.06 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.944 178.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . 0.654 HG11 ' HA ' ' A' ' 430' ' ' LEU . 1.5 m -54.03 -45.85 65.23 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.784 0 N-CA-C 114.568 1.322 . . . . 0.0 114.568 -175.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . 0.56 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -63.46 -33.04 74.69 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 119.851 -0.74 . . . . 0.0 112.26 -177.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.717 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 93.0 m -76.04 -41.91 49.36 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.199 174.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.474 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.49 -36.97 74.59 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 122.139 0.971 . . . . 0.0 109.221 176.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 408' ' ' TYR . . . . . 0.624 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -66.46 -52.78 42.6 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 113.471 -1.695 . . . . 0.0 110.06 177.336 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 409' ' ' THR . . . . . 0.76 HG22 HD23 ' A' ' 410' ' ' LEU . 1.7 m -56.4 -45.68 80.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.395 178.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . 0.782 HD12 HD13 ' A' ' 398' ' ' ILE . 13.3 mt -71.54 -36.88 71.12 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -176.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.95 -35.14 81.93 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.054 -1.07 . . . . 0.0 110.727 172.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -67.2 -47.93 69.42 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 115.719 -0.241 . . . . 0.0 111.386 177.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 413' ' ' MET . . . . . 0.912 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.6 OUTLIER -70.94 -46.81 61.78 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 118.813 -1.155 . . . . 0.0 111.912 -179.772 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . 0.912 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 14.7 mt -68.02 -44.96 75.32 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -176.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 33.8 t -88.99 -16.28 32.09 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.732 0.777 . . . . 0.0 110.267 -175.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 102.02 -175.8 25.36 Favored Glycine 0 N--CA 1.431 -1.681 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -171.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -79.95 23.63 0.44 Allowed 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.278 0.561 . . . . 0.0 111.7 -171.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 418' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -72.33 77.17 1.01 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.007 -179.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 419' ' ' TYR . . . . . 0.552 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 11.6 p90 -53.01 -38.78 62.61 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.517 176.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.51 -44.14 76.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.784 0.326 . . . . 0.0 110.938 178.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.07 -49.36 61.8 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.293 -178.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . 0.441 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -65.99 -39.53 84.81 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 C-N-CA 120.376 -0.529 . . . . 0.0 111.209 -176.759 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.776 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 78.2 p -68.21 -37.99 81.47 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 -178.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -69.06 -37.16 82.31 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.072 176.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . 0.564 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.88 -53.32 19.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.42 0.152 . . . . 0.0 111.052 -178.746 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . 0.686 HG22 HD22 ' A' ' 430' ' ' LEU . 1.1 mm -73.53 -22.89 19.16 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.828 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -172.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.776 ' HB2' ' O ' ' A' ' 423' ' ' SER . 0.9 OUTLIER -54.61 -32.54 58.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.142 0.496 . . . . 0.0 110.432 -178.663 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.02 -7.37 77.64 Favored Glycine 0 N--CA 1.44 -1.074 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.387 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.501 ' HD1' ' CG2' ' A' ' 395' ' ' ILE . 14.4 m-85 -117.21 0.58 12.32 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.079 0.466 . . . . 0.0 109.945 -176.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.686 HD22 HG22 ' A' ' 426' ' ' ILE . 0.1 OUTLIER -65.98 129.27 94.24 Favored Pre-proline 0 N--CA 1.446 -0.665 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.251 178.812 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 431' ' ' PRO . . . . . 0.503 ' HD2' HD12 ' A' ' 430' ' ' LEU . 90.3 Cg_exo -24.61 -68.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.359 1.113 1 C-N-CA 125.424 4.083 . . . . 0.0 115.029 179.709 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . 0.555 ' O ' HG12 ' A' ' 435' ' ' VAL . . . -142.07 -170.42 12.54 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 177.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . 0.464 ' O ' HG13 ' A' ' 436' ' ' VAL . 41.4 tp60 -68.13 -26.35 65.75 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 118.006 0.903 . . . . 0.0 110.458 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -66.29 -41.26 90.04 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -178.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 435' ' ' VAL . . . . . 0.742 HG23 HG11 ' A' ' 463' ' ' VAL . 8.0 p -68.65 -43.81 82.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-O 120.929 0.395 . . . . 0.0 110.508 -177.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.495 HG12 ' O ' ' A' ' 432' ' ' GLY . 0.1 OUTLIER -65.84 -30.55 50.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.512 175.538 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 1.1 m -69.16 -52.18 30.72 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . 0.873 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -58.61 -37.42 75.83 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.823 177.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 439' ' ' LEU . . . . . 0.552 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 2.0 tm? -70.35 -47.18 62.15 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.37 -38.85 74.85 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.368 174.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 441' ' ' GLN . . . . . 0.492 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 35.9 mm-40 -53.47 -50.05 66.15 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 123.486 0.714 . . . . 0.0 110.562 174.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . 0.799 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 0.8 OUTLIER -56.83 -40.57 76.28 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.752 172.344 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 443' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 40.9 mt -72.64 -26.11 61.53 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.35 0.595 . . . . 0.0 110.865 -178.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -70.22 -36.38 74.5 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.008 177.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 445' ' ' GLN . . . . . 0.463 ' HG3' ' N ' ' A' ' 446' ' ' GLU . 0.0 OUTLIER -75.22 -30.19 60.51 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.026 178.098 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 446' ' ' GLU . . . . . 0.513 ' HB3' ' O ' ' A' ' 443' ' ' LEU . 13.6 pt-20 27.52 97.31 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.171 0 O-C-N 125.396 1.685 . . . . 0.0 113.646 175.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 49.3 mt -59.25 -35.12 56.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.206 0.527 . . . . 0.0 110.989 -178.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . 0.466 ' HB2' ' OG1' ' A' ' 451' ' ' THR . 17.1 m-20 -163.33 -157.8 0.44 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 -178.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -87.13 -67.31 0.83 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 171.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.2 -25.43 66.92 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 176.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 451' ' ' THR . . . . . 0.483 ' HA ' ' HB2' ' A' ' 454' ' ' GLU . 10.5 m -71.31 -22.64 61.91 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 119.906 -0.717 . . . . 0.0 110.602 -174.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . 0.445 ' NH2' ' HB3' ' A' ' 443' ' ' LEU . 19.0 mtp180 -53.53 -54.26 39.77 Favored 'General case' 0 C--O 1.22 -0.495 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 171.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 453' ' ' ALA . . . . . 0.552 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -58.4 -49.4 77.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.525 -1.216 . . . . 0.0 112.808 174.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . 0.483 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 16.0 mm-40 -51.15 -35.47 36.01 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.1 0.476 . . . . 0.0 112.049 -177.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 28.2 p -119.98 16.16 12.51 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.191 -176.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . 0.601 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.9 OUTLIER -55.23 -48.62 73.66 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.99 0.424 . . . . 0.0 111.639 -172.351 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . 0.56 HG23 ' HB1' ' A' ' 405' ' ' ALA . 1.9 mp -76.96 -33.05 20.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.964 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -57.97 -34.88 70.42 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.786 0.803 . . . . 0.0 109.347 171.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . 0.71 ' O ' HG23 ' A' ' 463' ' ' VAL . 63.3 m-70 -74.37 -28.82 61.29 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.639 177.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . 0.729 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.4 OUTLIER -73.93 -34.6 64.4 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.981 0.896 . . . . 0.0 108.787 178.559 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . 0.436 ' O ' ' HB2' ' A' ' 464' ' ' TYR . 26.9 m-80 -73.02 -37.58 66.89 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.992 0.901 . . . . 0.0 108.925 176.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 462' ' ' ALA . . . . . 0.598 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -56.49 -34.46 66.97 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.491 -1.232 . . . . 0.0 109.814 169.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.873 HG13 ' HB3' ' A' ' 438' ' ' ALA . 68.0 t -61.64 -50.89 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 175.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 464' ' ' TYR . . . . . 0.593 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 17.0 m-30 -53.01 -26.85 16.75 Favored 'General case' 0 C--N 1.33 -0.255 0 O-C-N 124.317 1.011 . . . . 0.0 110.664 177.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.14 -39.7 17.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.576 0.703 . . . . 0.0 109.821 -178.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.598 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.7 mt -57.75 -55.64 20.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 114.421 -1.263 . . . . 0.0 112.157 175.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 0.76 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -101.64 -11.04 19.5 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -173.345 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . 0.581 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 93.94 31.57 8.06 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 119.38 -1.391 . . . . 0.0 114.353 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 469' ' ' LEU . . . . . 0.76 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 2.5 mt -88.08 159.38 18.26 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 117.777 0.789 . . . . 0.0 110.625 176.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . 0.551 HD22 HG23 ' A' ' 476' ' ' ILE . 12.0 p30 -104.76 -179.18 3.87 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.278 172.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -56.3 -27.79 56.68 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -173.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 -86.66 5.33 36.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.674 0.273 . . . . 0.0 111.607 -171.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 473' ' ' GLY . . . . . 0.453 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 77.68 11.84 85.05 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.325 -0.94 . . . . 0.0 111.472 -178.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 474' ' ' GLN . . . . . 0.46 ' HB2' HD21 ' A' ' 470' ' ' ASN . 56.0 mt-30 -101.09 158.0 16.34 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 177.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 5.3 p -97.34 122.43 40.37 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.171 0.51 . . . . 0.0 112.074 -176.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 476' ' ' ILE . . . . . 0.581 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.5 pp . . . . . 0 C--N 1.324 -0.507 0 CA-C-O 121.574 0.702 . . . . 0.0 110.005 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 386' ' ' PHE . . . . . 0.76 ' CD1' HD22 ' B' ' 414' ' ' LEU . 2.3 t80 . . . . . 0 CA--C 1.534 0.36 0 CA-C-O 120.572 0.225 . . . . 0.0 110.428 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 387' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' B' ' 386' ' ' PHE . 42.6 Cg_endo -65.69 111.38 1.89 Allowed 'Trans proline' 0 N--CA 1.481 0.76 0 C-N-CA 123.929 3.086 . . . . 0.0 112.431 173.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 388' ' ' MET . . . . . 0.615 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 33.8 ttm -121.12 47.88 1.75 Allowed 'General case' 0 C--N 1.32 -0.716 0 O-C-N 122.094 -0.379 . . . . 0.0 111.645 -169.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 389' ' ' HIS . . . . . 0.641 ' CG ' ' HB2' ' B' ' 393' ' ' ASN . 38.4 m170 57.04 -90.21 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.443 0.64 . . . . 0.0 109.481 -171.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -160.29 17.0 0.14 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.986 -1.006 . . . . 0.0 108.348 174.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 391' ' ' LEU . . . . . 0.571 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.3 pt? -167.11 -59.55 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.074 -171.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 392' ' ' GLY . . . . . 0.571 ' N ' ' HG ' ' B' ' 391' ' ' LEU . . . -166.86 53.28 0.24 Allowed Glycine 0 C--N 1.335 0.523 0 C-N-CA 120.232 -0.985 . . . . 0.0 114.181 -172.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 393' ' ' ASN . . . . . 0.641 ' HB2' ' CG ' ' B' ' 389' ' ' HIS . 0.4 OUTLIER -56.2 -44.19 79.21 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 117.238 0.519 . . . . 0.0 110.258 176.789 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 394' ' ' VAL . . . . . 0.715 HG23 HD12 ' B' ' 398' ' ' ILE . 1.9 m -55.32 -45.06 77.73 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.756 0 N-CA-C 106.706 -1.591 . . . . 0.0 106.706 -178.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 395' ' ' ILE . . . . . 0.635 HG23 HD13 ' B' ' 426' ' ' ILE . 3.7 mp -57.98 -52.69 55.14 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.526 0 CA-C-O 117.77 -1.11 . . . . 0.0 113.59 -176.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 396' ' ' LYS . . . . . 0.528 ' O ' HG22 ' B' ' 399' ' ' VAL . 0.0 OUTLIER -63.22 -49.24 74.96 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 122.055 2.207 . . . . 0.0 111.932 -174.126 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 397' ' ' GLY . . . . . 0.457 ' O ' ' HG3' ' B' ' 401' ' ' GLN . . . -52.72 -44.43 60.44 Favored Glycine 0 N--CA 1.436 -1.336 0 C-N-CA 119.986 -1.102 . . . . 0.0 111.009 -177.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 398' ' ' ILE . . . . . 0.803 HD13 HD12 ' B' ' 410' ' ' LEU . 33.5 mt -71.82 -33.88 49.67 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 399' ' ' VAL . . . . . 0.528 HG22 ' O ' ' B' ' 396' ' ' LYS . 11.9 m -64.38 -40.39 88.88 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 C-N-CA 118.793 -1.163 . . . . 0.0 108.429 -173.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -64.27 -41.65 96.81 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 174.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 401' ' ' GLN . . . . . 0.457 ' HG3' ' O ' ' B' ' 397' ' ' GLY . 35.2 mt-30 -92.86 -49.66 5.94 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -170.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 402' ' ' GLU . . . . . 0.676 ' HG3' ' HE3' ' A' ' 413' ' ' MET . 2.4 mm-40 -111.75 -20.19 12.17 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.018 0.437 . . . . 0.0 111.265 -171.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 104.89 162.33 23.95 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.953 177.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 404' ' ' VAL . . . . . 0.652 HG11 ' HA ' ' B' ' 430' ' ' LEU . 1.6 m -54.08 -45.88 65.89 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.769 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 -175.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 405' ' ' ALA . . . . . 0.545 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -63.49 -33.03 74.68 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 119.785 -0.766 . . . . 0.0 112.337 -177.012 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 406' ' ' THR . . . . . 0.699 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 93.5 m -75.95 -42.09 49.61 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.251 174.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 407' ' ' ALA . . . . . 0.474 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.45 -36.83 74.28 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 122.145 0.974 . . . . 0.0 109.263 176.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 408' ' ' TYR . . . . . 0.611 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -66.53 -52.75 42.46 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 113.541 -1.663 . . . . 0.0 110.027 177.344 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 409' ' ' THR . . . . . 0.773 HG22 HD23 ' B' ' 410' ' ' LEU . 1.8 m -56.31 -45.68 80.15 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.44 178.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 410' ' ' LEU . . . . . 0.803 HD12 HD13 ' B' ' 398' ' ' ILE . 13.4 mt -71.69 -36.91 70.73 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -176.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.85 -35.18 81.37 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.064 -1.065 . . . . 0.0 110.73 172.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 412' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -67.34 -47.95 68.94 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 115.693 -0.254 . . . . 0.0 111.301 178.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 413' ' ' MET . . . . . 0.92 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.6 OUTLIER -70.91 -46.9 61.69 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 118.811 -1.155 . . . . 0.0 111.881 -179.945 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 414' ' ' LEU . . . . . 0.92 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 14.9 mt -67.84 -44.97 75.97 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -175.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 33.9 t -89.03 -16.46 31.57 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.555 0.693 . . . . 0.0 110.264 -175.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 416' ' ' GLY . . . . . . . . . . . . . . . 102.44 -175.92 24.98 Favored Glycine 0 N--CA 1.43 -1.758 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 -171.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -79.96 23.51 0.45 Allowed 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.362 0.601 . . . . 0.0 111.724 -171.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 418' ' ' ASN . . . . . . . . . . . . . 64.1 m-80 -72.23 77.17 0.98 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.946 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 419' ' ' TYR . . . . . 0.548 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 11.5 p90 -53.13 -38.77 62.96 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.399 176.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.47 -44.08 76.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.613 0.244 . . . . 0.0 110.972 178.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.32 -49.33 61.14 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.18 -178.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 422' ' ' VAL . . . . . 0.439 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.2 OUTLIER -65.92 -39.37 84.46 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.205 -176.643 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 423' ' ' SER . . . . . 0.796 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 78.4 p -68.5 -37.69 80.32 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.87 -178.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -69.32 -37.19 79.93 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.039 176.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 425' ' ' ILE . . . . . 0.572 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -72.65 -53.37 19.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 O-C-N 122.907 -0.173 . . . . 0.0 111.116 -178.828 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 426' ' ' ILE . . . . . 0.681 HG22 HD22 ' B' ' 430' ' ' LEU . 1.1 mm -73.59 -22.77 19.03 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.768 0 CA-C-O 120.801 0.334 . . . . 0.0 110.176 -172.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 427' ' ' ARG . . . . . 0.796 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.9 OUTLIER -54.94 -32.21 61.14 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.236 0.541 . . . . 0.0 110.522 -178.63 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -86.98 -7.47 77.58 Favored Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.449 179.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 429' ' ' TYR . . . . . 0.514 ' HD1' ' CG2' ' B' ' 395' ' ' ILE . 14.7 m-85 -117.29 0.61 12.29 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.096 0.474 . . . . 0.0 109.856 -176.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 430' ' ' LEU . . . . . 0.686 HD23 ' HA ' ' B' ' 427' ' ' ARG . 0.1 OUTLIER -65.86 129.27 94.26 Favored Pre-proline 0 N--CA 1.445 -0.702 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.152 178.816 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 431' ' ' PRO . . . . . 0.5 ' HD2' HD12 ' B' ' 430' ' ' LEU . 87.0 Cg_exo -24.43 -69.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.358 1.068 1 C-N-CA 125.4 4.067 . . . . 0.0 114.879 179.532 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 432' ' ' GLY . . . . . 0.542 ' O ' HG12 ' B' ' 435' ' ' VAL . . . -141.12 -169.87 11.97 Favored Glycine 0 N--CA 1.44 -1.038 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 177.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 433' ' ' GLN . . . . . 0.465 ' O ' HG13 ' B' ' 436' ' ' VAL . 41.2 tp60 -68.39 -26.37 65.52 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 118.062 0.931 . . . . 0.0 110.574 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -66.17 -41.46 90.29 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -178.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 435' ' ' VAL . . . . . 0.729 HG23 HG11 ' B' ' 463' ' ' VAL . 7.9 p -68.38 -43.97 83.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-O 121.071 0.463 . . . . 0.0 110.506 -177.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 436' ' ' VAL . . . . . 0.499 HG12 ' O ' ' B' ' 432' ' ' GLY . 0.1 OUTLIER -65.76 -30.56 50.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.452 175.65 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 1.1 m -69.08 -52.2 30.87 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -178.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 438' ' ' ALA . . . . . 0.862 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -58.68 -37.32 75.79 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.81 177.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 439' ' ' LEU . . . . . 0.565 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 2.0 tm? -70.38 -47.19 62.07 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.37 -38.83 74.84 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.303 174.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 441' ' ' GLN . . . . . 0.493 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 35.2 mm-40 -53.46 -50.05 66.13 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 123.519 0.728 . . . . 0.0 110.604 174.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 442' ' ' ARG . . . . . 0.816 ' HG2' ' O ' ' B' ' 438' ' ' ALA . 0.8 OUTLIER -56.68 -40.81 76.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.751 172.215 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 443' ' ' LEU . . . . . 0.565 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 40.6 mt -72.6 -26.14 61.58 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.273 0.558 . . . . 0.0 110.833 -178.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -70.06 -36.51 75.02 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.874 177.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 445' ' ' GLN . . . . . 0.459 ' HG3' ' N ' ' B' ' 446' ' ' GLU . 0.0 OUTLIER -74.94 -30.17 61.16 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.594 -1.185 . . . . 0.0 109.023 178.321 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 446' ' ' GLU . . . . . 0.528 ' HB3' ' O ' ' B' ' 443' ' ' LEU . 13.4 pt-20 27.48 96.9 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 O-C-N 125.42 1.7 . . . . 0.0 113.65 175.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 49.7 mt -59.09 -35.0 54.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.158 0.504 . . . . 0.0 110.95 -178.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 448' ' ' ASP . . . . . 0.462 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 16.3 m-20 -163.0 -156.92 0.41 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 -178.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -87.97 -67.21 0.84 Allowed 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 171.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.13 -25.45 66.98 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 176.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 451' ' ' THR . . . . . 0.48 ' HA ' ' HB2' ' B' ' 454' ' ' GLU . 10.5 m -71.37 -22.65 61.87 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 119.946 -0.701 . . . . 0.0 110.679 -174.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 452' ' ' ARG . . . . . 0.445 ' NH2' ' HB3' ' B' ' 443' ' ' LEU . 19.0 mtp180 -53.57 -54.27 39.88 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 171.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 453' ' ' ALA . . . . . 0.548 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -58.24 -49.49 76.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.507 -1.224 . . . . 0.0 112.707 174.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 454' ' ' GLU . . . . . 0.48 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 16.2 mm-40 -51.32 -35.15 36.6 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.22 0.533 . . . . 0.0 112.153 -176.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 28.8 p -120.26 16.19 12.28 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.143 -176.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 456' ' ' PHE . . . . . 0.604 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 1.0 OUTLIER -55.27 -48.73 73.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.957 0.408 . . . . 0.0 111.516 -172.331 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 457' ' ' ILE . . . . . 0.548 ' CG1' ' HB3' ' B' ' 408' ' ' TYR . 1.9 mp -76.46 -33.19 22.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.149 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -58.06 -34.91 70.62 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.821 0.82 . . . . 0.0 109.227 171.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 459' ' ' HIS . . . . . 0.712 ' O ' HG23 ' B' ' 463' ' ' VAL . 63.7 m-70 -74.37 -28.85 61.3 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.583 -1.189 . . . . 0.0 110.596 177.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 460' ' ' LEU . . . . . 0.734 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -73.8 -34.75 64.75 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.951 0.881 . . . . 0.0 108.808 178.407 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 461' ' ' ASN . . . . . 0.437 ' O ' ' HB2' ' B' ' 464' ' ' TYR . 26.4 m-80 -72.81 -37.6 67.48 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.34 -0.846 . . . . 0.0 108.965 176.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 462' ' ' ALA . . . . . 0.607 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -56.51 -34.48 67.04 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.352 -1.295 . . . . 0.0 109.796 169.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 463' ' ' VAL . . . . . 0.862 HG13 ' HB3' ' B' ' 438' ' ' ALA . 65.1 t -61.79 -50.63 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 175.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 464' ' ' TYR . . . . . 0.582 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 17.1 m-30 -53.12 -27.05 18.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.683 177.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.98 -39.69 17.79 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.775 0.798 . . . . 0.0 109.775 -178.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 466' ' ' ILE . . . . . 0.607 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.6 mt -57.72 -55.4 21.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.204 175.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 467' ' ' LEU . . . . . 0.756 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -101.73 -11.12 19.37 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 -173.484 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 468' ' ' GLY . . . . . 0.596 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 93.97 31.43 8.13 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 119.241 -1.457 . . . . 0.0 114.35 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 469' ' ' LEU . . . . . 0.756 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 2.5 mt -88.19 159.39 18.18 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 117.818 0.809 . . . . 0.0 110.606 176.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 470' ' ' ASN . . . . . 0.528 HD22 HG23 ' B' ' 476' ' ' ILE . 12.1 p30 -104.82 -179.6 3.99 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.101 172.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 471' ' ' ALA . . . . . . . . . . . . . . . -55.7 -28.21 54.44 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -173.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -86.29 4.95 36.79 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 122.314 -0.241 . . . . 0.0 111.56 -171.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 473' ' ' GLY . . . . . 0.454 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 78.0 11.82 85.01 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.384 -0.913 . . . . 0.0 111.475 -178.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 474' ' ' GLN . . . . . 0.463 ' HB2' HD21 ' B' ' 470' ' ' ASN . 56.5 mt-30 -101.07 158.12 16.25 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 177.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 6.0 p -97.3 122.64 40.57 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.327 0.584 . . . . 0.0 112.114 -176.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 476' ' ' ILE . . . . . 0.596 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.5 pp . . . . . 0 C--N 1.326 -0.439 0 CA-C-O 121.579 0.704 . . . . 0.0 110.006 178.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 386' ' ' PHE . . . . . 0.787 ' CZ ' HG12 ' A' ' 394' ' ' VAL . 1.4 t80 . . . . . 0 N--CA 1.45 -0.427 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -47.6 -75.25 0.03 OUTLIER 'Trans proline' 0 N--CA 1.479 0.625 0 C-N-CA 124.463 3.442 . . . . 0.0 115.125 -174.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.571 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 28.5 mtt 73.63 146.69 0.08 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.759 0.824 . . . . 0.0 111.225 -171.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 389' ' ' HIS . . . . . 0.522 ' CG ' ' HB2' ' A' ' 393' ' ' ASN . 32.7 m170 -49.29 -65.28 0.59 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.587 0.708 . . . . 0.0 109.519 178.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . 0.479 ' H ' HD23 ' A' ' 391' ' ' LEU . 3.7 pt20 -168.29 26.65 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.518 -1.219 . . . . 0.0 108.153 173.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.662 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.1 pt? -178.04 -65.31 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -167.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . 0.662 ' N ' ' HG ' ' A' ' 391' ' ' LEU . . . -163.64 49.9 0.3 Allowed Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.955 -0.64 . . . . 0.0 113.154 -168.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . 0.571 ' HB3' ' HA ' ' A' ' 388' ' ' MET . 0.4 OUTLIER -56.31 -37.68 70.24 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 177.942 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . 0.787 HG12 ' CZ ' ' A' ' 386' ' ' PHE . 0.9 OUTLIER -56.25 -47.39 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 178.681 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . 0.663 HG23 HD13 ' A' ' 426' ' ' ILE . 4.2 mp -57.66 -51.8 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.275 0 CA-C-O 118.108 -0.948 . . . . 0.0 112.967 -174.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . 0.678 ' HG3' ' CZ ' ' A' ' 429' ' ' TYR . 0.2 OUTLIER -62.52 -48.98 77.15 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 121.359 1.891 . . . . 0.0 111.415 -174.205 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -55.19 -45.38 82.67 Favored Glycine 0 N--CA 1.434 -1.486 0 C-N-CA 120.131 -1.033 . . . . 0.0 111.166 -179.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . 0.739 ' CD1' HD12 ' A' ' 410' ' ' LEU . 28.2 mt -70.46 -33.84 55.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -177.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . 0.501 HG12 ' HA ' ' A' ' 404' ' ' VAL . 11.8 m -63.89 -39.59 85.97 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 C-N-CA 118.798 -1.161 . . . . 0.0 108.385 -174.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -69.92 -36.65 75.53 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 175.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.452 HE21 ' HB3' ' A' ' 401' ' ' GLN . 2.9 mm100 -87.58 -48.19 8.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.089 0.471 . . . . 0.0 111.944 -171.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . 0.564 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 1.9 mm-40 -121.41 -20.43 6.63 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.757 -170.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 107.4 162.38 21.62 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.046 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . 0.636 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.5 m -53.45 -41.82 46.52 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.723 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 -176.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . 0.655 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -69.04 -30.36 68.7 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.795 -176.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.712 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 90.5 m -77.29 -42.31 37.46 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.162 -0.615 . . . . 0.0 109.981 173.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.47 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.41 -36.98 74.42 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 122.123 0.963 . . . . 0.0 109.038 176.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 408' ' ' TYR . . . . . 0.636 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.7 -52.25 52.87 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 113.445 -1.707 . . . . 0.0 110.083 176.61 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 409' ' ' THR . . . . . 0.72 HG22 HD23 ' A' ' 410' ' ' LEU . 3.4 m -55.71 -46.56 77.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.674 178.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . 0.739 HD12 ' CD1' ' A' ' 398' ' ' ILE . 14.0 mt -72.22 -35.86 68.98 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.048 0.451 . . . . 0.0 110.358 -174.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -59.63 -34.86 83.7 Favored Glycine 0 N--CA 1.438 -1.205 0 C-N-CA 120.224 -0.989 . . . . 0.0 110.83 171.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -68.26 -43.72 77.18 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 178.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 413' ' ' MET . . . . . 0.731 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.0 OUTLIER -70.5 -57.65 4.55 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 118.822 -1.151 . . . . 0.0 111.549 179.607 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . 0.731 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 4.6 mt -67.35 -43.7 80.88 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -172.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.425 ' HB2' ' CE ' ' A' ' 388' ' ' MET . 5.2 t -95.45 18.14 13.23 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.482 0.658 . . . . 0.0 109.975 -174.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 73.17 -177.93 41.81 Favored Glycine 0 N--CA 1.437 -1.245 0 C-N-CA 120.357 -0.925 . . . . 0.0 111.675 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 33.9 mm-40 -80.69 23.13 0.54 Allowed 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.199 0.524 . . . . 0.0 111.616 -173.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 418' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -71.73 77.65 0.85 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.72 -179.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 419' ' ' TYR . . . . . 0.539 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 14.6 p90 -54.47 -37.85 65.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.549 177.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -54.97 -43.04 73.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.625 0.25 . . . . 0.0 110.644 177.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.42 -48.85 63.54 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.152 -178.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . 0.485 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.3 OUTLIER -66.32 -40.53 86.99 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 C-N-CA 120.235 -0.586 . . . . 0.0 111.239 -177.142 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.758 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 65.9 p -67.06 -38.29 85.52 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -178.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.29 -40.26 92.02 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.129 175.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . 0.598 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.61 -50.13 36.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 O-C-N 122.883 -0.187 . . . . 0.0 110.934 -176.996 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . 0.696 HG22 HD22 ' A' ' 430' ' ' LEU . 1.2 mm -74.55 -22.62 17.66 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -172.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.758 ' HB2' ' O ' ' A' ' 423' ' ' SER . 0.9 OUTLIER -54.86 -30.2 57.17 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.088 0.47 . . . . 0.0 110.756 -178.581 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -86.81 -9.12 75.11 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.458 178.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.678 ' CZ ' ' HG3' ' A' ' 396' ' ' LYS . 23.0 m-85 -115.87 1.03 13.29 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-O 120.995 0.426 . . . . 0.0 110.478 -177.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.699 HD23 ' HA ' ' A' ' 427' ' ' ARG . 0.1 OUTLIER -65.82 127.38 93.05 Favored Pre-proline 0 N--CA 1.439 -1.019 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 178.505 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 431' ' ' PRO . . . . . 0.471 ' HD2' HD12 ' A' ' 430' ' ' LEU . 84.6 Cg_exo -22.7 -74.88 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 1.012 1 C-N-CA 125.653 4.235 . . . . 0.0 114.72 -179.102 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . 0.504 ' O ' HG12 ' A' ' 435' ' ' VAL . . . -129.27 -166.53 11.93 Favored Glycine 0 N--CA 1.441 -0.99 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 172.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . 0.598 ' O ' HG13 ' A' ' 436' ' ' VAL . 21.6 tt0 -71.61 -26.64 62.67 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 118.838 1.319 . . . . 0.0 110.587 176.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -62.26 -38.34 88.92 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.833 -176.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 435' ' ' VAL . . . . . 0.778 HG23 HG11 ' A' ' 463' ' ' VAL . 7.5 p -69.76 -43.34 80.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-O 120.839 0.352 . . . . 0.0 110.611 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.598 HG13 ' O ' ' A' ' 433' ' ' GLN . 0.2 OUTLIER -66.42 -30.17 48.94 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-O 120.822 0.344 . . . . 0.0 110.299 175.028 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -69.37 -52.0 31.35 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -178.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . 0.845 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -57.42 -43.04 83.48 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.99 176.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 439' ' ' LEU . . . . . 0.626 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 2.0 tm? -65.28 -47.35 76.97 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -176.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.99 -39.11 77.42 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.228 174.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 441' ' ' GLN . . . . . 0.581 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 8.7 mm-40 -56.85 -50.46 72.37 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 123.379 0.672 . . . . 0.0 110.631 176.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . 0.711 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -58.65 -33.78 70.46 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.924 172.601 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 443' ' ' LEU . . . . . 0.626 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 59.5 mt -72.21 -33.99 68.02 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.024 0.44 . . . . 0.0 110.163 178.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -57.69 -36.75 72.37 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.319 173.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -72.6 -27.13 61.98 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.963 177.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 446' ' ' GLU . . . . . 0.57 ' HB2' ' O ' ' A' ' 443' ' ' LEU . 38.2 tt0 29.53 96.88 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 170.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 50.3 mt -68.33 -35.46 71.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.062 0.458 . . . . 0.0 110.882 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . 0.568 ' O ' ' HG3' ' A' ' 452' ' ' ARG . 36.8 m-20 -165.83 -166.78 0.98 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 -178.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -79.63 -63.81 1.33 Allowed 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.23 -0.588 . . . . 0.0 109.525 172.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.58 -25.97 64.24 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 178.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 451' ' ' THR . . . . . 0.439 ' HA ' ' HB2' ' A' ' 454' ' ' GLU . 12.1 m -71.85 -22.43 61.54 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.692 -175.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . 0.568 ' HG3' ' O ' ' A' ' 448' ' ' ASP . 11.1 mtp180 -53.11 -54.51 34.53 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 170.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 453' ' ' ALA . . . . . 0.539 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -57.93 -50.42 73.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.363 -1.29 . . . . 0.0 112.595 175.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . 0.439 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 31.4 mm-40 -49.73 -38.26 32.71 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.386 0.612 . . . . 0.0 111.729 -176.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 32.0 p -117.45 16.03 14.69 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.246 -176.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . 0.589 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 1.1 t80 -55.71 -47.36 76.98 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.169 0.509 . . . . 0.0 111.479 -171.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . 0.655 HG23 ' HB1' ' A' ' 405' ' ' ALA . 2.0 mp -75.41 -32.1 24.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.909 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -58.38 -35.78 72.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.67 0.748 . . . . 0.0 109.361 171.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . 0.712 ' O ' HG23 ' A' ' 463' ' ' VAL . 82.8 m-70 -72.44 -29.2 63.48 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.711 -1.132 . . . . 0.0 110.198 178.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . 0.742 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -74.51 -34.57 63.07 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.913 0.863 . . . . 0.0 108.929 179.129 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . 0.443 ' HA ' ' CD2' ' A' ' 464' ' ' TYR . 22.0 m-80 -72.83 -37.81 67.33 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.232 176.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 462' ' ' ALA . . . . . 0.628 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -56.62 -33.1 65.95 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.852 169.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.845 HG13 ' HB3' ' A' ' 438' ' ' ALA . 63.4 t -62.42 -50.78 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 CA-C-N 114.49 -1.232 . . . . 0.0 107.831 175.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 464' ' ' TYR . . . . . 0.559 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 16.2 m-30 -53.92 -27.77 32.77 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.53 178.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.8 -38.91 20.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.868 0.842 . . . . 0.0 109.337 -177.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.628 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.7 mt -57.91 -56.08 17.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 114.172 -1.377 . . . . 0.0 112.463 174.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 0.764 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -102.78 -10.62 18.97 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -171.512 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . 0.589 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 94.12 31.73 7.89 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 119.46 -1.353 . . . . 0.0 114.241 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 469' ' ' LEU . . . . . 0.764 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.1 mt -89.69 164.06 14.86 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 117.718 0.759 . . . . 0.0 111.13 176.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 37.6 p30 -105.61 -178.69 3.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.816 171.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 471' ' ' ALA . . . . . 0.544 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -69.98 -5.99 30.17 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -174.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -96.75 0.67 49.87 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.9 0.381 . . . . 0.0 110.885 -178.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 473' ' ' GLY . . . . . 0.427 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 79.31 12.47 83.86 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.443 -0.884 . . . . 0.0 111.2 -175.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -100.19 157.35 16.65 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 178.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 12.7 p -95.28 127.95 41.74 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.066 0.46 . . . . 0.0 111.333 -178.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 476' ' ' ILE . . . . . 0.589 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.9 pp . . . . . 0 C--N 1.325 -0.489 0 CA-C-O 121.788 0.804 . . . . 0.0 110.212 179.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 386' ' ' PHE . . . . . 0.793 ' CZ ' HG12 ' B' ' 394' ' ' VAL . 1.4 t80 . . . . . 0 N--CA 1.451 -0.414 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 387' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -47.38 -75.32 0.03 OUTLIER 'Trans proline' 0 N--CA 1.481 0.763 0 C-N-CA 124.44 3.427 . . . . 0.0 115.164 -174.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 388' ' ' MET . . . . . 0.584 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 28.4 mtt 73.69 146.6 0.08 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.698 0.799 . . . . 0.0 111.116 -171.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 389' ' ' HIS . . . . . 0.541 ' CG ' ' HB2' ' B' ' 393' ' ' ASN . 32.8 m170 -49.19 -64.99 0.64 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.606 0.717 . . . . 0.0 109.569 178.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 390' ' ' GLN . . . . . 0.472 ' H ' HD23 ' B' ' 391' ' ' LEU . 3.7 pt20 -168.74 26.61 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.509 -1.223 . . . . 0.0 108.245 173.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 391' ' ' LEU . . . . . 0.638 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.1 pt? -177.98 -65.44 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -167.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 392' ' ' GLY . . . . . 0.638 ' N ' ' HG ' ' B' ' 391' ' ' LEU . . . -163.66 50.1 0.3 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.082 -168.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 393' ' ' ASN . . . . . 0.584 ' HB3' ' HA ' ' B' ' 388' ' ' MET . 0.4 OUTLIER -56.38 -37.77 70.55 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.901 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 394' ' ' VAL . . . . . 0.793 HG12 ' CZ ' ' B' ' 386' ' ' PHE . 0.9 OUTLIER -56.22 -47.36 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 178.705 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 395' ' ' ILE . . . . . 0.647 HG23 HD13 ' B' ' 426' ' ' ILE . 4.3 mp -57.81 -51.67 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 CA-C-O 118.034 -0.984 . . . . 0.0 112.946 -174.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 396' ' ' LYS . . . . . 0.674 ' HG3' ' CZ ' ' B' ' 429' ' ' TYR . 0.2 OUTLIER -62.53 -48.8 77.93 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 121.482 1.946 . . . . 0.0 111.537 -174.219 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -55.24 -45.59 82.21 Favored Glycine 0 N--CA 1.434 -1.452 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.132 -179.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 398' ' ' ILE . . . . . 0.739 ' CD1' HD12 ' B' ' 410' ' ' LEU . 28.1 mt -70.34 -33.8 55.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -177.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 399' ' ' VAL . . . . . 0.513 HG12 ' HA ' ' B' ' 404' ' ' VAL . 12.0 m -63.9 -39.47 85.56 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 C-N-CA 118.754 -1.178 . . . . 0.0 108.489 -174.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -70.12 -36.63 74.95 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 175.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 401' ' ' GLN . . . . . . . . . . . . . 3.0 mm100 -87.47 -48.11 8.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.966 0.412 . . . . 0.0 111.988 -171.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 402' ' ' GLU . . . . . 0.576 ' HG3' ' HE3' ' A' ' 413' ' ' MET . 2.0 mm-40 -121.27 -21.02 6.5 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.678 -170.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 108.33 162.77 20.83 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.905 -0.664 . . . . 0.0 113.096 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 404' ' ' VAL . . . . . 0.624 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.5 m -53.71 -41.56 47.87 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.751 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -176.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 405' ' ' ALA . . . . . 0.645 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -69.32 -30.36 68.39 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 119.649 -0.821 . . . . 0.0 111.725 -175.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 406' ' ' THR . . . . . 0.705 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 93.8 m -77.56 -42.39 35.49 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 174.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 407' ' ' ALA . . . . . 0.465 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.41 -37.12 74.69 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 122.104 0.954 . . . . 0.0 108.935 176.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 408' ' ' TYR . . . . . 0.624 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.51 -52.4 52.95 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 113.492 -1.686 . . . . 0.0 110.046 176.534 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 409' ' ' THR . . . . . 0.723 HG22 HD23 ' B' ' 410' ' ' LEU . 3.3 m -55.79 -46.64 77.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.582 178.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 410' ' ' LEU . . . . . 0.739 HD12 ' CD1' ' B' ' 398' ' ' ILE . 13.8 mt -72.05 -36.04 69.5 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.124 0.488 . . . . 0.0 110.314 -174.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -59.59 -34.86 83.54 Favored Glycine 0 N--CA 1.439 -1.142 0 C-N-CA 120.213 -0.994 . . . . 0.0 110.825 171.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 412' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -68.24 -43.78 77.14 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.517 0.191 . . . . 0.0 111.517 178.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 413' ' ' MET . . . . . 0.718 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.0 OUTLIER -70.52 -57.69 4.5 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 118.772 -1.171 . . . . 0.0 111.546 179.721 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 414' ' ' LEU . . . . . 0.718 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 4.7 mt -67.24 -43.74 81.18 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 -172.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 415' ' ' SER . . . . . 0.422 ' HB2' ' CE ' ' B' ' 388' ' ' MET . 5.3 t -95.28 18.03 13.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.421 0.629 . . . . 0.0 110.108 -174.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 416' ' ' GLY . . . . . . . . . . . . . . . 73.08 -178.29 40.96 Favored Glycine 0 N--CA 1.438 -1.186 0 C-N-CA 120.427 -0.892 . . . . 0.0 111.659 -178.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -80.46 23.22 0.51 Allowed 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.009 0.433 . . . . 0.0 111.493 -173.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 418' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -71.58 77.9 0.81 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.834 -179.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 419' ' ' TYR . . . . . 0.54 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 14.5 p90 -54.88 -37.6 66.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.482 178.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -54.97 -43.12 73.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.723 0.297 . . . . 0.0 110.651 177.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.46 -48.79 63.6 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.148 -178.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 422' ' ' VAL . . . . . 0.482 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.3 OUTLIER -66.34 -40.66 87.28 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 C-N-CA 120.261 -0.576 . . . . 0.0 111.13 -177.17 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 423' ' ' SER . . . . . 0.742 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 69.4 p -67.03 -38.13 85.36 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.659 -0.416 . . . . 0.0 109.903 -178.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.42 -40.02 91.42 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.321 175.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 425' ' ' ILE . . . . . 0.605 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -72.68 -50.24 35.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.553 0.216 . . . . 0.0 110.887 -177.096 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 426' ' ' ILE . . . . . 0.693 HG22 HD22 ' B' ' 430' ' ' LEU . 1.2 mm -74.55 -22.57 17.64 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.815 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -172.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 427' ' ' ARG . . . . . 0.742 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.9 OUTLIER -54.75 -30.61 56.85 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.139 0.495 . . . . 0.0 110.701 -178.563 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -86.57 -8.91 76.32 Favored Glycine 0 N--CA 1.443 -0.89 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.456 178.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 429' ' ' TYR . . . . . 0.674 ' CZ ' ' HG3' ' B' ' 396' ' ' LYS . 22.9 m-85 -116.28 0.98 13.02 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-O 121.089 0.471 . . . . 0.0 110.509 -177.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 430' ' ' LEU . . . . . 0.693 HD22 HG22 ' B' ' 426' ' ' ILE . 0.1 OUTLIER -65.68 127.4 93.02 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.394 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 431' ' ' PRO . . . . . 0.466 ' HD2' HD12 ' B' ' 430' ' ' LEU . 86.1 Cg_exo -22.73 -75.44 0.02 OUTLIER 'Trans proline' 0 C--N 1.358 1.06 1 C-N-CA 125.617 4.211 . . . . 0.0 114.699 -179.246 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 432' ' ' GLY . . . . . 0.507 ' O ' HG12 ' B' ' 435' ' ' VAL . . . -128.84 -166.69 12.01 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 173.015 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 433' ' ' GLN . . . . . 0.591 ' O ' HG13 ' B' ' 436' ' ' VAL . 21.9 tt0 -71.44 -26.43 62.73 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 118.854 1.327 . . . . 0.0 110.571 176.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -62.58 -38.09 88.73 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -176.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 435' ' ' VAL . . . . . 0.774 HG23 HG11 ' B' ' 463' ' ' VAL . 7.5 p -69.77 -43.53 79.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 120.784 0.326 . . . . 0.0 110.57 -179.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 436' ' ' VAL . . . . . 0.591 HG13 ' O ' ' B' ' 433' ' ' GLN . 0.2 OUTLIER -66.35 -30.12 48.84 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 CA-C-O 120.895 0.379 . . . . 0.0 110.366 175.058 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -69.27 -51.97 32.15 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 -178.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 438' ' ' ALA . . . . . 0.837 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -57.5 -43.1 83.9 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.005 176.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 439' ' ' LEU . . . . . 0.635 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 2.0 tm? -65.22 -47.27 77.44 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -176.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.01 -39.01 77.25 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.235 174.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 441' ' ' GLN . . . . . 0.583 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 8.5 mm-40 -56.93 -50.43 72.6 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 123.368 0.667 . . . . 0.0 110.617 176.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 442' ' ' ARG . . . . . 0.707 ' HG2' ' O ' ' B' ' 438' ' ' ALA . 0.0 OUTLIER -58.76 -33.64 70.52 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.9 172.606 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 443' ' ' LEU . . . . . 0.635 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 58.8 mt -72.18 -33.93 68.05 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.037 0.446 . . . . 0.0 110.129 178.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -57.62 -36.82 72.29 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.56 172.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -72.62 -27.36 62.1 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.866 177.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 446' ' ' GLU . . . . . 0.562 ' HB2' ' O ' ' B' ' 443' ' ' LEU . 39.5 tt0 29.79 96.47 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 170.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 52.2 mt -68.28 -35.45 71.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.109 0.48 . . . . 0.0 110.798 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 448' ' ' ASP . . . . . 0.558 ' O ' ' HG3' ' B' ' 452' ' ' ARG . 37.2 m-20 -165.61 -166.57 0.98 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 -178.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -80.1 -63.47 1.4 Allowed 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.472 172.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.85 -25.96 63.99 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 178.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 451' ' ' THR . . . . . 0.432 ' HA ' ' HB2' ' B' ' 454' ' ' GLU . 14.1 m -71.78 -22.44 61.58 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.664 -175.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 452' ' ' ARG . . . . . 0.558 ' HG3' ' O ' ' B' ' 448' ' ' ASP . 11.2 mtp180 -53.11 -54.56 33.91 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 170.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 453' ' ' ALA . . . . . 0.54 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -57.97 -50.09 74.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.378 -1.283 . . . . 0.0 112.688 175.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 454' ' ' GLU . . . . . 0.432 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 30.5 mm-40 -50.03 -38.36 37.32 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.472 0.653 . . . . 0.0 111.535 -176.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 32.0 p -117.42 16.11 14.72 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.226 -176.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 456' ' ' PHE . . . . . 0.581 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 1.1 t80 -55.75 -47.27 77.28 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.188 0.518 . . . . 0.0 111.489 -171.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 457' ' ' ILE . . . . . 0.645 HG23 ' HB1' ' B' ' 405' ' ' ALA . 2.0 mp -75.66 -32.08 24.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.816 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -58.3 -35.94 72.59 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.733 0.778 . . . . 0.0 109.357 171.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 459' ' ' HIS . . . . . 0.707 ' O ' HG23 ' B' ' 463' ' ' VAL . 82.4 m-70 -72.42 -29.1 63.41 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.213 178.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 460' ' ' LEU . . . . . 0.747 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -74.55 -34.62 62.98 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.858 0.837 . . . . 0.0 108.911 179.16 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 461' ' ' ASN . . . . . 0.435 ' HA ' ' CD2' ' B' ' 464' ' ' TYR . 22.4 m-80 -72.89 -37.89 67.13 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.253 176.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 462' ' ' ALA . . . . . 0.629 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -56.58 -33.17 65.91 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.529 -1.214 . . . . 0.0 109.802 169.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 463' ' ' VAL . . . . . 0.837 HG13 ' HB3' ' B' ' 438' ' ' ALA . 64.6 t -62.33 -50.68 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 175.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 464' ' ' TYR . . . . . 0.547 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 16.1 m-30 -54.07 -27.51 33.04 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.623 178.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.82 -38.94 20.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.908 0.861 . . . . 0.0 109.413 -177.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 466' ' ' ILE . . . . . 0.629 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.8 mt -58.12 -56.2 17.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 114.125 -1.398 . . . . 0.0 112.395 174.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 467' ' ' LEU . . . . . 0.777 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -102.8 -10.39 19.16 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -171.532 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 468' ' ' GLY . . . . . 0.588 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 94.0 31.64 7.99 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 119.344 -1.408 . . . . 0.0 114.205 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 469' ' ' LEU . . . . . 0.777 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.2 mt -89.77 164.03 14.83 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 117.788 0.794 . . . . 0.0 111.152 176.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 37.1 p30 -105.57 -178.44 3.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.746 171.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 471' ' ' ALA . . . . . 0.523 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -70.23 -5.65 29.09 Favored 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -174.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 472' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' B' ' 472' ' ' ARG . 21.3 mmt180 -97.08 1.13 49.66 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.019 0.438 . . . . 0.0 110.891 -178.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 473' ' ' GLY . . . . . 0.426 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 78.95 12.66 83.91 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.36 -0.924 . . . . 0.0 111.079 -175.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -100.39 157.47 16.6 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 9.6 p -95.12 127.88 41.52 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.252 0.549 . . . . 0.0 111.448 -178.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 476' ' ' ILE . . . . . 0.588 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.9 pp . . . . . 0 C--N 1.325 -0.474 0 CA-C-O 121.579 0.704 . . . . 0.0 110.205 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 386' ' ' PHE . . . . . 0.77 ' CD1' HD22 ' A' ' 414' ' ' LEU . 2.0 t80 . . . . . 0 CA--C 1.53 0.175 0 CA-C-O 121.104 0.478 . . . . 0.0 110.789 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . 0.542 ' HG2' ' OD1' ' B' ' 393' ' ' ASN . 61.7 Cg_endo -72.12 110.02 2.84 Favored 'Trans proline' 0 N--CA 1.481 0.738 0 C-N-CA 124.183 3.255 . . . . 0.0 114.104 175.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.449 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 32.8 mtt -104.07 169.07 8.71 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 121.991 -0.443 . . . . 0.0 110.109 175.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -54.84 -62.6 1.55 Allowed 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 177.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -172.3 17.31 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.625 -1.171 . . . . 0.0 108.27 172.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.612 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 1.9 pt? -165.91 -66.15 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.24 -167.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . 0.612 ' N ' ' HG ' ' A' ' 391' ' ' LEU . . . -162.8 54.87 0.3 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.409 -0.9 . . . . 0.0 113.173 -173.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . 0.548 ' OD1' ' HG2' ' B' ' 387' ' ' PRO . 0.2 OUTLIER -54.31 -42.25 69.91 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.455 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . 0.741 HG12 ' CZ ' ' A' ' 386' ' ' PHE . 0.7 OUTLIER -57.03 -46.22 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -179.48 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . 0.647 HG23 HD13 ' A' ' 426' ' ' ILE . 4.2 mp -57.55 -51.77 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.247 0 CA-C-O 118.009 -0.996 . . . . 0.0 112.887 -174.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . 0.667 ' HG3' ' CZ ' ' A' ' 429' ' ' TYR . 0.1 OUTLIER -62.22 -48.82 78.29 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 121.446 1.93 . . . . 0.0 111.698 -175.163 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -54.95 -45.56 80.5 Favored Glycine 0 N--CA 1.436 -1.341 0 C-N-CA 119.84 -1.171 . . . . 0.0 111.229 -178.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . 0.733 HG12 HD21 ' B' ' 414' ' ' LEU . 26.3 mt -70.88 -34.11 54.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -177.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 396' ' ' LYS . 13.1 m -63.99 -39.38 85.24 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.499 0 C-N-CA 118.784 -1.166 . . . . 0.0 108.43 -174.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -71.0 -34.87 71.77 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 175.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.467 HE21 ' HB3' ' A' ' 401' ' ' GLN . 4.1 mm100 -88.79 -48.0 7.81 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -172.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . 0.583 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 1.3 mm-40 -121.2 -20.55 6.7 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.609 -170.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 107.27 162.28 21.72 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.702 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . 0.604 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.8 m -53.77 -46.18 62.5 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.739 0 N-CA-C 114.946 1.462 . . . . 0.0 114.946 -175.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . 0.535 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -64.0 -29.88 71.0 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 119.778 -0.769 . . . . 0.0 112.379 -177.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.732 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 93.2 m -77.51 -42.56 35.19 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.119 -0.632 . . . . 0.0 110.204 172.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.464 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.28 -37.22 74.56 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 122.232 1.015 . . . . 0.0 109.25 176.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 408' ' ' TYR . . . . . 0.604 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.67 -52.02 54.87 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 113.351 -1.75 . . . . 0.0 109.933 176.382 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 409' ' ' THR . . . . . 0.654 HG22 HD23 ' A' ' 410' ' ' LEU . 16.5 m -55.12 -47.11 75.47 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.479 179.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . 0.732 ' HG ' ' O ' ' A' ' 406' ' ' THR . 14.7 mt -72.69 -36.92 67.96 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.282 -174.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.74 -34.95 79.51 Favored Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.123 -1.036 . . . . 0.0 110.813 172.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 412' ' ' MET . . . . . 0.401 ' HB2' ' O ' ' A' ' 409' ' ' THR . 0.4 OUTLIER -66.61 -44.78 81.16 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 115.734 -0.233 . . . . 0.0 111.441 177.962 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 413' ' ' MET . . . . . 0.765 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.0 OUTLIER -70.82 -57.1 4.97 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 118.675 -1.21 . . . . 0.0 111.668 179.135 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . 0.77 HD22 ' CD1' ' A' ' 386' ' ' PHE . 6.8 mt -64.58 -43.18 94.68 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -171.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 32.8 t -86.03 -16.84 36.94 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.734 0.778 . . . . 0.0 109.816 -177.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 100.79 -175.34 26.38 Favored Glycine 0 N--CA 1.429 -1.773 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -170.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 34.0 mm-40 -79.65 24.03 0.39 Allowed 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.207 0.527 . . . . 0.0 111.645 -171.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 418' ' ' ASN . . . . . 0.405 ' H ' ' C ' ' A' ' 416' ' ' GLY . 61.2 m-80 -71.4 75.96 0.76 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.146 -178.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 419' ' ' TYR . . . . . 0.515 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 7.4 p90 -50.39 -38.54 43.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.933 173.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -54.27 -46.78 72.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.886 178.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.16 -48.98 60.8 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.188 -176.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . 0.406 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -66.37 -40.02 85.62 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 C-N-CA 120.368 -0.533 . . . . 0.0 111.146 -175.509 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.703 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 78.2 p -67.31 -38.57 85.2 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.607 -0.437 . . . . 0.0 109.976 -178.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -69.56 -37.61 78.11 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.071 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . 0.604 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -73.34 -51.9 23.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.466 0.174 . . . . 0.0 111.113 -178.018 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . 0.647 HD13 HG23 ' A' ' 395' ' ' ILE . 1.2 mm -74.4 -23.35 18.19 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.829 0 CA-C-O 120.835 0.35 . . . . 0.0 110.241 -171.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.703 ' HB2' ' O ' ' A' ' 423' ' ' SER . 1.0 OUTLIER -54.62 -29.33 51.68 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.165 0.507 . . . . 0.0 110.602 179.773 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -86.35 -8.38 77.97 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.858 178.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.667 ' CZ ' ' HG3' ' A' ' 396' ' ' LYS . 24.2 m-85 -117.51 -1.09 11.75 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-O 121.465 0.65 . . . . 0.0 110.272 -178.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.593 HD12 ' HD2' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -65.99 132.78 94.71 Favored Pre-proline 0 N--CA 1.437 -1.118 0 CA-C-N 114.624 -1.171 . . . . 0.0 108.624 179.241 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 431' ' ' PRO . . . . . 0.829 ' CD ' HG11 ' A' ' 435' ' ' VAL . 42.4 Cg_exo -35.17 -72.36 0.05 OUTLIER 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 124.847 3.698 . . . . 0.0 113.984 -170.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . 0.455 ' O ' HG12 ' A' ' 435' ' ' VAL . . . -131.38 -162.49 10.57 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 175.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . 0.523 ' O ' HG13 ' A' ' 436' ' ' VAL . 22.3 tp60 -71.29 -27.6 63.53 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 118.088 0.944 . . . . 0.0 110.459 177.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -68.23 -37.92 81.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.164 -175.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 435' ' ' VAL . . . . . 0.829 HG11 ' CD ' ' A' ' 431' ' ' PRO . 6.7 p -68.45 -46.63 80.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-O 120.979 0.419 . . . . 0.0 110.438 -178.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.523 HG13 ' O ' ' A' ' 433' ' ' GLN . 0.2 OUTLIER -63.47 -31.08 51.55 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.321 175.702 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 437' ' ' THR . . . . . 0.573 ' O ' ' HG3' ' A' ' 441' ' ' GLN . 1.0 OUTLIER -69.03 -52.94 23.46 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 -178.028 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . 0.891 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -59.43 -36.06 75.19 Favored 'General case' 0 N--CA 1.436 -1.15 0 O-C-N 124.01 0.819 . . . . 0.0 112.01 178.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 439' ' ' LEU . . . . . 0.585 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 1.9 tm? -70.24 -47.91 59.28 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.47 -36.43 75.97 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.18 176.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 441' ' ' GLN . . . . . 0.573 ' HG3' ' O ' ' A' ' 437' ' ' THR . 43.4 mt-30 -54.33 -51.47 64.61 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.106 178.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . 0.497 ' HG3' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -62.47 -36.87 83.84 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.839 174.869 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 443' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 61.4 mt -66.57 -37.36 84.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.007 0.432 . . . . 0.0 110.195 179.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -57.68 -37.81 74.08 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.563 173.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -72.53 -27.48 62.26 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.533 178.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 446' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 443' ' ' LEU . 37.9 tt0 33.55 101.18 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 114.56 1.318 . . . . 0.0 114.56 170.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 54.6 mt -69.87 -35.26 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-O 121.054 0.454 . . . . 0.0 110.745 178.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . 0.521 ' O ' ' HG3' ' A' ' 452' ' ' ARG . 16.6 m-20 -168.35 -167.42 0.8 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -176.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -77.06 -69.98 0.49 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.039 0.447 . . . . 0.0 109.807 172.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.86 -25.06 66.23 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 178.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 451' ' ' THR . . . . . 0.501 ' OG1' ' HB2' ' A' ' 448' ' ' ASP . 11.7 m -70.89 -22.91 62.21 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 119.989 -0.685 . . . . 0.0 110.86 -174.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . 0.521 ' HG3' ' O ' ' A' ' 448' ' ' ASP . 11.6 mtp180 -53.61 -54.0 43.86 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 170.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 453' ' ' ALA . . . . . 0.515 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -58.88 -47.04 86.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.557 -1.201 . . . . 0.0 112.656 175.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . 0.443 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 23.6 mm-40 -52.41 -36.17 53.58 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.175 0.512 . . . . 0.0 111.462 -178.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 29.5 p -118.38 15.61 13.87 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.449 -176.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . 0.553 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.9 OUTLIER -56.83 -48.69 77.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.05 0.452 . . . . 0.0 111.54 -171.704 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . 0.553 ' CG1' ' HB3' ' A' ' 408' ' ' TYR . 1.9 mp -76.11 -32.0 22.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.8 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -57.46 -37.08 72.28 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.672 0.749 . . . . 0.0 109.325 171.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . 0.774 ' O ' HG23 ' A' ' 463' ' ' VAL . 79.3 m-70 -72.32 -29.14 63.56 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.365 178.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . 0.73 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -74.18 -35.38 63.97 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.954 0.883 . . . . 0.0 108.992 179.688 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . 0.495 ' O ' ' HB2' ' A' ' 464' ' ' TYR . 23.7 m-80 -73.13 -37.67 66.56 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.362 -0.835 . . . . 0.0 108.977 176.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 462' ' ' ALA . . . . . 0.613 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -56.98 -33.58 67.23 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.586 -1.188 . . . . 0.0 109.931 169.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.891 HG13 ' HB3' ' A' ' 438' ' ' ALA . 55.2 t -62.66 -50.29 80.36 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.893 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 175.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 464' ' ' TYR . . . . . 0.6 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 20.7 m-30 -52.89 -29.57 29.07 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.481 177.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.37 -38.71 19.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.75 0.786 . . . . 0.0 109.636 -176.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.613 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.6 mt -56.8 -55.98 16.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 114.289 -1.323 . . . . 0.0 112.271 174.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 0.782 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -102.14 -10.07 19.96 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -171.94 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . 0.564 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 94.72 31.39 7.83 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 119.481 -1.342 . . . . 0.0 114.345 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 469' ' ' LEU . . . . . 0.782 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 4.2 mt -89.75 160.45 16.54 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 117.862 0.831 . . . . 0.0 110.889 174.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . 0.607 HD22 ' C ' ' A' ' 470' ' ' ASN . 0.2 OUTLIER -105.53 -178.24 3.6 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.4 170.948 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 471' ' ' ALA . . . . . 0.447 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -56.91 -27.9 61.33 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -174.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -85.08 8.46 17.91 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -171.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 74.01 9.08 79.63 Favored Glycine 0 CA--C 1.519 0.344 0 C-N-CA 120.313 -0.946 . . . . 0.0 111.642 -177.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -100.14 155.08 17.93 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 177.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 475' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 469' ' ' LEU . 59.9 p -91.43 136.73 32.9 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.348 0.594 . . . . 0.0 110.837 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 476' ' ' ILE . . . . . 0.564 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.7 pp . . . . . 0 C--N 1.319 -0.743 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.468 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 386' ' ' PHE . . . . . 0.783 ' CD1' HD22 ' B' ' 414' ' ' LEU . 2.0 t80 . . . . . 0 CA--C 1.53 0.21 0 CA-C-O 121.061 0.457 . . . . 0.0 110.846 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 387' ' ' PRO . . . . . 0.548 ' HG2' ' OD1' ' A' ' 393' ' ' ASN . 61.5 Cg_endo -72.23 110.23 2.91 Favored 'Trans proline' 0 N--CA 1.479 0.645 0 C-N-CA 124.166 3.244 . . . . 0.0 114.107 175.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 388' ' ' MET . . . . . 0.436 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 33.1 mtt -104.3 169.08 8.69 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 122.103 -0.373 . . . . 0.0 110.127 175.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 389' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -54.98 -62.45 1.65 Allowed 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 177.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -172.35 17.06 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.736 -1.12 . . . . 0.0 108.311 172.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 391' ' ' LEU . . . . . 0.606 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.0 pt? -165.82 -66.18 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.269 -167.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 392' ' ' GLY . . . . . 0.606 ' N ' ' HG ' ' B' ' 391' ' ' LEU . . . -162.83 54.96 0.3 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.432 -0.889 . . . . 0.0 113.169 -173.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 393' ' ' ASN . . . . . 0.542 ' OD1' ' HG2' ' A' ' 387' ' ' PRO . 0.2 OUTLIER -54.3 -42.37 70.0 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 178.41 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 394' ' ' VAL . . . . . 0.751 HG12 ' CZ ' ' B' ' 386' ' ' PHE . 0.7 OUTLIER -56.95 -46.15 83.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -179.388 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 395' ' ' ILE . . . . . 0.64 HG23 HD13 ' B' ' 426' ' ' ILE . 4.2 mp -57.59 -51.8 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-O 117.991 -1.004 . . . . 0.0 112.81 -174.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 396' ' ' LYS . . . . . 0.671 ' HG3' ' CZ ' ' B' ' 429' ' ' TYR . 0.1 OUTLIER -62.17 -49.03 77.45 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 121.487 1.949 . . . . 0.0 111.719 -175.142 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -54.77 -45.59 78.7 Favored Glycine 0 N--CA 1.437 -1.252 0 C-N-CA 119.84 -1.171 . . . . 0.0 111.209 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 398' ' ' ILE . . . . . 0.726 HG12 HD21 ' A' ' 414' ' ' LEU . 26.8 mt -70.94 -34.19 54.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 113.361 0.875 . . . . 0.0 113.361 -177.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 399' ' ' VAL . . . . . 0.478 HG12 ' HA ' ' B' ' 404' ' ' VAL . 13.5 m -63.82 -39.44 85.43 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.481 0 C-N-CA 118.774 -1.17 . . . . 0.0 108.56 -174.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -70.98 -34.83 71.78 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 175.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 401' ' ' GLN . . . . . 0.41 HE21 ' HB3' ' B' ' 401' ' ' GLN . 4.2 mm100 -89.06 -47.61 7.99 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -172.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 402' ' ' GLU . . . . . 0.588 ' HG3' ' HE3' ' A' ' 413' ' ' MET . 1.3 mm-40 -121.64 -20.47 6.5 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.026 0.441 . . . . 0.0 111.489 -170.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 107.12 162.31 21.87 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.736 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 404' ' ' VAL . . . . . 0.592 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.8 m -53.72 -46.38 62.05 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.792 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -175.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 405' ' ' ALA . . . . . 0.539 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -63.87 -29.88 71.02 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 119.639 -0.825 . . . . 0.0 112.464 -177.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 406' ' ' THR . . . . . 0.727 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 89.1 m -77.38 -42.78 35.12 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.149 172.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 407' ' ' ALA . . . . . 0.465 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.17 -37.19 74.23 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 122.248 1.023 . . . . 0.0 109.317 176.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 408' ' ' TYR . . . . . 0.592 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.79 -51.97 54.69 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 113.279 -1.782 . . . . 0.0 109.86 176.48 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 409' ' ' THR . . . . . 0.647 HG22 HD23 ' B' ' 410' ' ' LEU . 16.6 m -55.23 -47.08 75.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.427 179.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 410' ' ' LEU . . . . . 0.727 ' HG ' ' O ' ' B' ' 406' ' ' THR . 14.7 mt -72.72 -36.82 67.87 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.312 -174.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.84 -34.89 79.97 Favored Glycine 0 N--CA 1.44 -1.074 0 C-N-CA 120.175 -1.012 . . . . 0.0 110.72 172.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 412' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -66.79 -44.52 81.09 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 115.839 -0.18 . . . . 0.0 111.458 177.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 413' ' ' MET . . . . . 0.762 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.0 OUTLIER -70.99 -56.9 5.18 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 118.66 -1.216 . . . . 0.0 111.701 179.035 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 414' ' ' LEU . . . . . 0.783 HD22 ' CD1' ' B' ' 386' ' ' PHE . 6.8 mt -64.71 -43.17 94.31 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -171.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 33.1 t -86.29 -16.45 37.5 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.76 0.791 . . . . 0.0 109.745 -176.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 416' ' ' GLY . . . . . 0.407 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 100.41 -175.54 26.99 Favored Glycine 0 N--CA 1.429 -1.831 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -171.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -79.48 24.13 0.37 Allowed 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.251 0.548 . . . . 0.0 111.742 -171.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 418' ' ' ASN . . . . . 0.407 ' H ' ' C ' ' B' ' 416' ' ' GLY . 62.5 m-80 -71.55 75.99 0.8 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.025 -179.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 419' ' ' TYR . . . . . 0.523 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 7.3 p90 -50.39 -38.49 42.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.936 173.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -54.37 -46.56 73.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.939 178.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.25 -49.03 59.96 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.249 -177.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 422' ' ' VAL . . . . . 0.41 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.2 OUTLIER -66.31 -40.08 85.86 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.212 -175.514 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 423' ' ' SER . . . . . 0.72 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 78.0 p -67.3 -38.56 85.18 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.921 -178.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -69.71 -37.45 76.5 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.11 177.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 425' ' ' ILE . . . . . 0.621 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -73.46 -52.03 23.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.488 0.185 . . . . 0.0 111.186 -178.259 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 426' ' ' ILE . . . . . 0.64 HD13 HG23 ' B' ' 395' ' ' ILE . 1.2 mm -74.13 -23.38 18.6 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.797 0 CA-C-O 120.82 0.343 . . . . 0.0 110.226 -171.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 427' ' ' ARG . . . . . 0.72 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.9 OUTLIER -54.68 -29.11 51.84 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.122 0.487 . . . . 0.0 110.666 179.913 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -86.55 -8.75 76.68 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.756 178.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 429' ' ' TYR . . . . . 0.671 ' CZ ' ' HG3' ' B' ' 396' ' ' LYS . 24.3 m-85 -117.1 -0.82 12.02 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 121.465 0.65 . . . . 0.0 110.156 -178.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 430' ' ' LEU . . . . . 0.614 HD12 ' HD2' ' B' ' 431' ' ' PRO . 0.0 OUTLIER -66.07 132.97 94.66 Favored Pre-proline 0 N--CA 1.438 -1.054 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.54 179.27 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 431' ' ' PRO . . . . . 0.828 ' CD ' HG11 ' B' ' 435' ' ' VAL . 42.6 Cg_exo -35.23 -71.73 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 124.76 3.64 . . . . 0.0 114.054 -170.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 432' ' ' GLY . . . . . 0.441 ' O ' HG12 ' B' ' 435' ' ' VAL . . . -131.99 -162.15 10.32 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 175.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 433' ' ' GLN . . . . . 0.535 ' O ' HG13 ' B' ' 436' ' ' VAL . 22.5 tp60 -71.58 -27.82 63.41 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 118.119 0.96 . . . . 0.0 110.447 177.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -68.06 -38.08 82.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.215 -0.448 . . . . 0.0 112.065 -175.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 435' ' ' VAL . . . . . 0.828 HG11 ' CD ' ' B' ' 431' ' ' PRO . 6.7 p -68.17 -46.73 80.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-O 121.068 0.461 . . . . 0.0 110.46 -178.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 436' ' ' VAL . . . . . 0.535 HG13 ' O ' ' B' ' 433' ' ' GLN . 0.2 OUTLIER -63.32 -31.44 52.81 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.191 175.759 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 437' ' ' THR . . . . . 0.575 ' O ' ' HG3' ' B' ' 441' ' ' GLN . 1.0 OUTLIER -68.87 -52.74 26.42 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -177.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 438' ' ' ALA . . . . . 0.89 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -59.51 -36.12 75.46 Favored 'General case' 0 N--CA 1.435 -1.193 0 O-C-N 124.132 0.895 . . . . 0.0 112.04 178.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 439' ' ' LEU . . . . . 0.588 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 1.9 tm? -70.22 -47.93 59.3 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.43 -36.32 75.69 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.154 175.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 441' ' ' GLN . . . . . 0.575 ' HG3' ' O ' ' B' ' 437' ' ' THR . 43.9 mt-30 -54.44 -51.66 64.26 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 123.755 0.822 . . . . 0.0 110.034 178.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 442' ' ' ARG . . . . . 0.486 ' HG3' ' O ' ' B' ' 438' ' ' ALA . 0.0 OUTLIER -62.4 -36.69 83.11 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.461 -0.791 . . . . 0.0 112.855 174.942 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 443' ' ' LEU . . . . . 0.588 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 61.2 mt -66.6 -37.33 84.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.17 0.51 . . . . 0.0 110.237 179.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -57.82 -37.69 74.24 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.675 173.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -72.58 -27.39 62.16 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.497 -1.229 . . . . 0.0 110.595 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 446' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' B' ' 443' ' ' LEU . 37.9 tt0 33.41 101.52 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 170.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 54.9 mt -70.35 -35.35 62.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.074 0.464 . . . . 0.0 110.616 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 448' ' ' ASP . . . . . 0.514 ' O ' ' HG3' ' B' ' 452' ' ' ARG . 17.6 m-20 -168.17 -167.27 0.8 Allowed 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 -176.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -77.2 -70.15 0.48 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 173.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.79 -25.08 66.3 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 178.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 451' ' ' THR . . . . . 0.489 ' OG1' ' HB2' ' B' ' 448' ' ' ASP . 13.1 m -70.95 -22.82 62.16 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.688 -174.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 452' ' ' ARG . . . . . 0.514 ' HG3' ' O ' ' B' ' 448' ' ' ASP . 11.7 mtp180 -53.7 -53.92 45.23 Favored 'General case' 0 C--O 1.219 -0.552 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 171.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 453' ' ' ALA . . . . . 0.523 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -58.8 -47.28 85.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.517 -1.22 . . . . 0.0 112.666 175.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 454' ' ' GLU . . . . . 0.438 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 22.7 mm-40 -52.39 -36.07 53.12 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.321 0.581 . . . . 0.0 111.488 -178.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 29.4 p -118.3 15.58 13.94 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.397 -176.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 456' ' ' PHE . . . . . 0.551 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 0.9 OUTLIER -56.88 -48.89 77.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.054 0.454 . . . . 0.0 111.474 -171.712 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 457' ' ' ILE . . . . . 0.564 ' CG1' ' HB3' ' B' ' 408' ' ' TYR . 1.9 mp -75.97 -31.9 22.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.875 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -57.6 -37.06 72.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.693 0.759 . . . . 0.0 109.355 171.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 459' ' ' HIS . . . . . 0.777 ' O ' HG23 ' B' ' 463' ' ' VAL . 79.0 m-70 -72.36 -28.97 63.37 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.385 178.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 460' ' ' LEU . . . . . 0.746 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.4 OUTLIER -74.25 -35.4 63.8 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.909 0.861 . . . . 0.0 108.974 179.655 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 461' ' ' ASN . . . . . 0.486 ' O ' ' HB2' ' B' ' 464' ' ' TYR . 23.2 m-80 -73.3 -37.36 66.22 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.864 0.84 . . . . 0.0 109.087 176.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 462' ' ' ALA . . . . . 0.612 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -57.11 -33.65 67.56 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.493 -1.23 . . . . 0.0 109.891 169.098 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 463' ' ' VAL . . . . . 0.89 HG13 ' HB3' ' B' ' 438' ' ' ALA . 55.9 t -62.53 -50.4 79.98 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.871 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 175.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 464' ' ' TYR . . . . . 0.603 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 20.7 m-30 -52.79 -29.45 27.5 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.481 177.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.41 -38.95 19.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.701 0.762 . . . . 0.0 109.601 -176.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 466' ' ' ILE . . . . . 0.612 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.6 mt -56.72 -55.77 17.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 114.245 -1.343 . . . . 0.0 112.257 174.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 467' ' ' LEU . . . . . 0.776 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -102.3 -9.94 19.94 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -171.943 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 468' ' ' GLY . . . . . 0.567 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 94.53 31.58 7.8 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 119.519 -1.324 . . . . 0.0 114.456 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 469' ' ' LEU . . . . . 0.776 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 4.2 mt -89.89 160.67 16.33 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 117.674 0.737 . . . . 0.0 110.853 174.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 470' ' ' ASN . . . . . 0.612 HD22 ' C ' ' B' ' 470' ' ' ASN . 0.2 OUTLIER -105.64 -178.15 3.57 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.365 170.96 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 471' ' ' ALA . . . . . 0.446 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -57.05 -27.87 62.05 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -174.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -85.14 8.63 17.46 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.973 0.361 . . . . 0.0 111.973 -171.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 473' ' ' GLY . . . . . . . . . . . . . . . 74.02 8.96 79.51 Favored Glycine 0 C--O 1.228 -0.221 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.553 -177.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -100.16 154.88 18.08 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 177.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 475' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' B' ' 469' ' ' LEU . 61.1 p -91.12 136.69 32.91 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.329 0.585 . . . . 0.0 110.862 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 476' ' ' ILE . . . . . 0.567 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.7 pp . . . . . 0 C--N 1.318 -0.777 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.47 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 386' ' ' PHE . . . . . 0.775 ' CD1' HD22 ' A' ' 414' ' ' LEU . 1.9 t80 . . . . . 0 CA--C 1.539 0.551 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -55.4 -72.76 0.03 OUTLIER 'Trans proline' 0 N--CA 1.486 1.068 0 C-N-CA 124.488 3.458 . . . . 0.0 114.465 178.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.577 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 10.4 ttp 69.17 59.6 0.33 Allowed 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 170.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 389' ' ' HIS . . . . . 0.557 ' ND1' ' HA ' ' A' ' 393' ' ' ASN . 17.1 m170 51.05 -138.56 1.04 Allowed 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -178.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . 0.478 ' H ' ' HB3' ' A' ' 389' ' ' HIS . 5.9 pm0 -110.68 22.67 15.14 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 164.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.623 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.5 pt? -168.28 -61.71 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.542 -174.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . 0.623 ' N ' ' HG ' ' A' ' 391' ' ' LEU . . . -160.51 59.45 0.31 Allowed Glycine 0 C--N 1.337 0.589 0 C-N-CA 119.733 -1.222 . . . . 0.0 114.715 -171.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . 0.577 ' HB3' ' HA ' ' A' ' 388' ' ' MET . 0.4 OUTLIER -62.4 -39.55 93.61 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 117.4 0.6 . . . . 0.0 109.568 175.714 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . 0.663 HG22 HD12 ' A' ' 395' ' ' ILE . 0.6 OUTLIER -56.7 -46.02 82.91 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 179.21 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . 0.663 HD12 HG22 ' A' ' 394' ' ' VAL . 4.0 mp -57.79 -52.71 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.323 0 CA-C-O 117.853 -1.07 . . . . 0.0 113.465 -174.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . 0.615 ' O ' HG22 ' A' ' 399' ' ' VAL . 0.0 OUTLIER -63.72 -49.76 71.8 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-N 121.972 2.169 . . . . 0.0 111.645 -175.77 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.62 -44.89 68.72 Favored Glycine 0 N--CA 1.428 -1.842 0 CA-C-N 114.473 -1.239 . . . . 0.0 110.818 -175.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . 0.743 HG12 HD21 ' B' ' 414' ' ' LEU . 34.8 mt -70.79 -33.05 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . 0.615 HG22 ' O ' ' A' ' 396' ' ' LYS . 16.7 m -62.9 -39.73 86.16 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 C-N-CA 118.688 -1.205 . . . . 0.0 108.43 -175.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -71.35 -35.03 71.0 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 175.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.453 HE21 ' HB3' ' A' ' 401' ' ' GLN . 3.9 mm100 -88.52 -47.47 8.3 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -172.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . 0.617 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 3.1 mm-40 -121.72 -21.03 6.26 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.539 -171.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 109.25 160.98 19.44 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.728 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . 0.645 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.1 m -53.71 -40.77 44.5 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.771 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -175.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . 0.576 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -68.48 -31.55 70.92 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 119.591 -0.844 . . . . 0.0 112.013 -177.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.71 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 92.3 m -77.08 -41.51 41.93 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.1 173.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.448 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.47 -37.26 75.12 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 122.059 0.933 . . . . 0.0 109.365 176.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 408' ' ' TYR . . . . . 0.645 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.6 -52.79 49.38 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 113.709 -1.587 . . . . 0.0 109.973 176.433 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 409' ' ' THR . . . . . 0.739 HG22 HD23 ' A' ' 410' ' ' LEU . 3.2 m -56.09 -46.8 78.93 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 179.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . 0.739 HD23 HG22 ' A' ' 409' ' ' THR . 13.6 mt -72.36 -37.69 68.73 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -175.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.48 -37.03 87.31 Favored Glycine 0 N--CA 1.435 -1.4 0 C-N-CA 119.849 -1.167 . . . . 0.0 110.298 172.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 412' ' ' MET . . . . . 0.439 ' HB2' ' O ' ' A' ' 409' ' ' THR . 0.0 OUTLIER -64.27 -49.98 69.72 Favored 'General case' 0 C--O 1.223 -0.306 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 178.53 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 413' ' ' MET . . . . . 0.933 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 1.0 OUTLIER -71.27 -42.88 68.21 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 118.849 -1.14 . . . . 0.0 112.133 -176.146 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . 0.933 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 19.7 mt -69.61 -45.19 69.14 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -177.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 54.6 p -85.91 -21.65 27.86 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.511 0.672 . . . . 0.0 110.482 -174.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 108.64 178.65 21.71 Favored Glycine 0 N--CA 1.431 -1.682 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -168.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -80.17 23.94 0.45 Allowed 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.037 0.446 . . . . 0.0 111.859 -173.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 418' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -71.35 78.25 0.74 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.677 0.751 . . . . 0.0 110.947 178.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 419' ' ' TYR . . . . . 0.568 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 17.1 p90 -51.86 -38.32 55.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.749 177.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -55.12 -45.41 75.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.746 178.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . 0.427 HD23 ' N ' ' A' ' 422' ' ' VAL . 0.0 OUTLIER -68.33 -48.58 64.48 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.11 -177.943 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . 0.477 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.1 OUTLIER -65.64 -41.78 91.33 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 C-N-CA 120.347 -0.541 . . . . 0.0 110.932 -176.291 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.785 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 29.6 t -69.35 -36.53 76.98 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.7 -178.145 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -69.34 -37.47 80.07 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.84 176.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . 0.611 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.41 -51.25 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-O 120.515 0.198 . . . . 0.0 110.621 -179.631 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . 0.752 HG22 HD22 ' A' ' 430' ' ' LEU . 1.1 mm -73.38 -22.9 19.37 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.952 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -173.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.785 ' HB2' ' O ' ' A' ' 423' ' ' SER . 1.1 tmm_? -54.38 -33.63 59.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.289 0.566 . . . . 0.0 110.893 -177.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -86.28 -10.94 73.33 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.404 -0.903 . . . . 0.0 110.853 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.633 ' HD1' HG22 ' A' ' 395' ' ' ILE . 5.4 m-30 -112.91 -1.8 14.47 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -174.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.752 HD22 HG22 ' A' ' 426' ' ' ILE . 0.0 OUTLIER -66.61 129.88 94.1 Favored Pre-proline 0 N--CA 1.443 -0.789 0 CA-C-N 114.201 -1.363 . . . . 0.0 108.947 177.203 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 431' ' ' PRO . . . . . 0.585 ' HD2' HD12 ' A' ' 430' ' ' LEU . 79.7 Cg_exo -24.09 -66.95 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.758 1 C-N-CA 125.536 4.157 . . . . 0.0 114.727 179.221 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . 0.529 ' H ' HG12 ' A' ' 435' ' ' VAL . . . -145.2 -168.17 12.75 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 176.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . 0.515 ' O ' HG13 ' A' ' 436' ' ' VAL . 40.1 tp60 -69.84 -26.26 64.13 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 117.888 0.844 . . . . 0.0 110.459 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -65.85 -40.8 92.07 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.887 -178.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 435' ' ' VAL . . . . . 0.74 HG23 HG11 ' A' ' 463' ' ' VAL . 7.4 p -68.84 -43.39 82.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-O 120.947 0.403 . . . . 0.0 110.755 -177.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.515 HG13 ' O ' ' A' ' 433' ' ' GLN . 0.1 OUTLIER -65.25 -33.42 63.59 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.19 175.73 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 437' ' ' THR . . . . . 0.458 ' O ' ' HG3' ' A' ' 441' ' ' GLN . 1.0 OUTLIER -66.84 -52.86 38.67 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -177.727 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . 0.869 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -58.58 -37.79 76.52 Favored 'General case' 0 N--CA 1.436 -1.162 0 O-C-N 123.788 0.68 . . . . 0.0 111.835 178.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 439' ' ' LEU . . . . . 0.619 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 2.1 tm? -67.64 -48.78 65.76 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 -179.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.28 -35.02 74.58 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.535 -1.212 . . . . 0.0 110.729 176.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 441' ' ' GLN . . . . . 0.563 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 13.3 mt-30 -53.32 -50.96 63.88 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.186 -178.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . 0.631 ' HD2' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -76.09 -23.38 54.96 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 175.118 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 443' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 47.3 mt -64.09 -35.47 80.87 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 174.072 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -56.89 -36.09 69.71 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.373 172.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -73.16 -27.63 61.77 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.872 178.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 446' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 443' ' ' LEU . 33.5 tt0 32.94 89.45 0.01 OUTLIER 'General case' 0 C--N 1.353 0.745 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 170.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 70.8 mt -59.31 -35.82 60.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 175.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . 0.493 ' HB2' ' OG1' ' A' ' 451' ' ' THR . 24.5 m-20 -166.49 175.34 8.16 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 178.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 449' ' ' ASP . . . . . 0.642 ' O ' ' HG2' ' A' ' 452' ' ' ARG . 13.0 m-20 -62.72 -60.03 4.07 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.312 -0.555 . . . . 0.0 109.715 174.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 450' ' ' GLN . . . . . 0.453 ' O ' ' HB3' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -71.93 -28.51 63.51 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 178.856 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 451' ' ' THR . . . . . 0.493 ' OG1' ' HB2' ' A' ' 448' ' ' ASP . 10.1 m -73.0 -23.54 60.65 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.326 -174.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . 0.642 ' HG2' ' O ' ' A' ' 449' ' ' ASP . 6.0 ptp180 -64.73 -41.52 95.9 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 174.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 453' ' ' ALA . . . . . 0.568 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -58.99 -49.19 78.82 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 123.843 0.714 . . . . 0.0 112.445 168.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . 0.434 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 33.5 mm-40 -53.97 -33.44 56.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.148 0.499 . . . . 0.0 111.738 -177.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 29.1 p -115.56 15.27 16.65 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.224 -178.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . 0.559 ' CZ ' ' HB2' ' A' ' 423' ' ' SER . 1.0 OUTLIER -56.78 -47.68 79.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.995 0.426 . . . . 0.0 111.775 -171.667 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . 0.576 HG23 ' HB1' ' A' ' 405' ' ' ALA . 1.9 mp -76.41 -33.41 23.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.153 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -57.84 -34.05 69.29 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.955 0.883 . . . . 0.0 108.963 171.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . 0.745 ' O ' HG23 ' A' ' 463' ' ' VAL . 45.0 m-70 -74.47 -29.31 61.4 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.197 -1.365 . . . . 0.0 110.947 177.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . 0.701 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -74.07 -34.78 64.13 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.342 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 24.2 m-80 -73.02 -37.59 66.88 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.047 176.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 462' ' ' ALA . . . . . 0.6 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -55.86 -34.92 65.89 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.659 169.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.869 HG13 ' HB3' ' A' ' 438' ' ' ALA . 73.3 t -61.69 -51.15 76.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-N 114.612 -1.176 . . . . 0.0 108.201 176.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 464' ' ' TYR . . . . . 0.577 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 15.9 m-30 -52.95 -28.16 22.35 Favored 'General case' 0 C--N 1.332 -0.188 0 O-C-N 124.295 0.997 . . . . 0.0 110.614 178.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.92 -39.53 19.68 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.76 0.79 . . . . 0.0 109.632 -177.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.6 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.7 mt -57.95 -55.86 19.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 114.296 -1.32 . . . . 0.0 112.252 175.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 0.753 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -102.46 -10.88 19.01 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -172.274 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . 0.635 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 93.94 31.79 7.93 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 119.34 -1.41 . . . . 0.0 114.331 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 469' ' ' LEU . . . . . 0.753 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.1 mt -88.96 161.42 16.63 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 117.838 0.819 . . . . 0.0 110.922 175.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . 0.48 HD22 HG23 ' A' ' 476' ' ' ILE . 12.5 p30 -106.33 -176.84 3.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.075 170.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 471' ' ' ALA . . . . . 0.445 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -62.62 -19.55 63.89 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -173.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -87.77 2.26 51.72 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 122.113 -0.367 . . . . 0.0 111.809 -174.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 473' ' ' GLY . . . . . 0.477 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 76.77 11.58 85.26 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.21 -0.995 . . . . 0.0 111.003 -175.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -101.32 156.74 17.27 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 176.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 8.2 p -93.92 132.98 37.82 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.087 0.47 . . . . 0.0 111.587 -176.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 476' ' ' ILE . . . . . 0.635 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.5 pp . . . . . 0 C--N 1.328 -0.356 0 CA-C-O 121.479 0.657 . . . . 0.0 110.015 177.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 386' ' ' PHE . . . . . 0.784 ' CD1' HD22 ' B' ' 414' ' ' LEU . 1.9 t80 . . . . . 0 CA--C 1.538 0.504 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 387' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -55.59 -72.61 0.03 OUTLIER 'Trans proline' 0 N--CA 1.486 1.078 0 C-N-CA 124.536 3.491 . . . . 0.0 114.456 178.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 388' ' ' MET . . . . . 0.567 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 10.4 ttp 69.34 59.49 0.32 Allowed 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 170.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 389' ' ' HIS . . . . . 0.561 ' ND1' ' HA ' ' B' ' 393' ' ' ASN . 17.7 m170 51.28 -138.36 1.07 Allowed 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -178.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 390' ' ' GLN . . . . . 0.442 ' H ' ' HB3' ' B' ' 389' ' ' HIS . 5.9 pm0 -110.99 22.81 14.89 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 164.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 391' ' ' LEU . . . . . 0.615 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.5 pt? -168.46 -61.73 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.553 -174.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 392' ' ' GLY . . . . . 0.628 ' HA3' HD13 ' B' ' 395' ' ' ILE . . . -160.4 59.37 0.31 Allowed Glycine 0 C--N 1.338 0.644 0 C-N-CA 119.65 -1.262 . . . . 0.0 114.649 -171.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 393' ' ' ASN . . . . . 0.567 ' HB3' ' HA ' ' B' ' 388' ' ' MET . 0.4 OUTLIER -62.23 -39.71 93.7 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 117.371 0.586 . . . . 0.0 109.535 175.798 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 394' ' ' VAL . . . . . 0.672 HG22 HD12 ' B' ' 395' ' ' ILE . 0.6 OUTLIER -56.62 -46.09 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 179.346 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 395' ' ' ILE . . . . . 0.672 HD12 HG22 ' B' ' 394' ' ' VAL . 4.0 mp -57.86 -52.6 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.37 0 CA-C-O 117.794 -1.098 . . . . 0.0 113.45 -174.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 396' ' ' LYS . . . . . 0.616 ' O ' HG22 ' B' ' 399' ' ' VAL . 0.0 OUTLIER -63.58 -49.81 71.9 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-N 121.978 2.172 . . . . 0.0 111.706 -175.885 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.62 -44.86 68.73 Favored Glycine 0 N--CA 1.429 -1.819 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.825 -175.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 398' ' ' ILE . . . . . 0.78 HG12 HD21 ' A' ' 414' ' ' LEU . 35.1 mt -70.79 -33.11 51.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 399' ' ' VAL . . . . . 0.616 HG22 ' O ' ' B' ' 396' ' ' LYS . 16.7 m -62.93 -39.64 85.87 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 C-N-CA 118.678 -1.209 . . . . 0.0 108.362 -175.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -71.15 -35.55 71.72 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 175.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 401' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -88.37 -47.38 8.43 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -172.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 402' ' ' GLU . . . . . 0.511 ' HG3' ' HE3' ' A' ' 413' ' ' MET . 3.1 mm-40 -121.75 -21.09 6.23 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.573 -171.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 109.34 160.77 19.24 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.797 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 404' ' ' VAL . . . . . 0.632 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.1 m -53.62 -40.72 43.46 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.733 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -175.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 405' ' ' ALA . . . . . 0.563 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -68.39 -31.73 71.29 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 119.689 -0.804 . . . . 0.0 111.989 -177.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 406' ' ' THR . . . . . 0.702 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 94.8 m -77.15 -41.38 41.98 Favored 'General case' 0 C--O 1.222 -0.39 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.065 173.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 407' ' ' ALA . . . . . 0.451 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.53 -37.29 75.34 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 122.024 0.916 . . . . 0.0 109.249 176.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 408' ' ' TYR . . . . . 0.632 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.54 -52.7 50.59 Favored 'General case' 0 N--CA 1.433 -1.275 0 CA-C-N 113.612 -1.631 . . . . 0.0 110.032 176.376 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 409' ' ' THR . . . . . 0.736 HG22 HD23 ' B' ' 410' ' ' LEU . 3.3 m -56.05 -46.98 78.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.616 179.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 410' ' ' LEU . . . . . 0.745 HD12 HD13 ' B' ' 398' ' ' ILE . 13.6 mt -72.31 -37.74 68.86 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -175.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.5 -37.18 87.81 Favored Glycine 0 N--CA 1.436 -1.347 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 173.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 412' ' ' MET . . . . . 0.442 ' HB2' ' O ' ' B' ' 409' ' ' THR . 0.0 OUTLIER -64.0 -50.11 69.81 Favored 'General case' 0 C--O 1.223 -0.309 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 178.457 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 413' ' ' MET . . . . . 0.939 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 1.0 OUTLIER -71.18 -43.15 68.03 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 118.941 -1.104 . . . . 0.0 112.045 -176.22 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 414' ' ' LEU . . . . . 0.939 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 19.6 mt -69.49 -45.18 69.56 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -176.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 54.7 p -85.95 -21.69 27.76 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.556 0.693 . . . . 0.0 110.462 -174.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 416' ' ' GLY . . . . . . . . . . . . . . . 108.75 178.54 21.64 Favored Glycine 0 N--CA 1.431 -1.687 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -168.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -80.01 23.88 0.44 Allowed 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.038 0.447 . . . . 0.0 112.041 -173.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 418' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -71.44 78.41 0.77 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.699 0.762 . . . . 0.0 110.726 178.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 419' ' ' TYR . . . . . 0.569 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 17.1 p90 -51.89 -38.31 55.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.726 177.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -55.15 -45.32 75.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.858 178.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 421' ' ' LEU . . . . . 0.418 HD23 ' N ' ' B' ' 422' ' ' VAL . 0.0 OUTLIER -68.4 -48.5 64.49 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.171 -178.031 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 422' ' ' VAL . . . . . 0.473 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.1 OUTLIER -65.7 -41.79 91.21 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.839 -176.291 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 423' ' ' SER . . . . . 0.778 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 28.5 t -69.39 -36.41 76.76 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.71 -178.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -69.41 -37.56 79.47 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.909 176.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 425' ' ' ILE . . . . . 0.62 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -72.36 -51.01 31.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.431 0.158 . . . . 0.0 110.623 -179.625 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 426' ' ' ILE . . . . . 0.748 HG22 HD22 ' B' ' 430' ' ' LEU . 1.1 mm -73.68 -22.86 18.95 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.899 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -173.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 427' ' ' ARG . . . . . 0.778 ' HB2' ' O ' ' B' ' 423' ' ' SER . 1.2 tmm_? -54.25 -33.73 59.14 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.284 0.564 . . . . 0.0 110.879 -177.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -86.33 -10.66 73.72 Favored Glycine 0 N--CA 1.441 -1.013 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 429' ' ' TYR . . . . . 0.632 ' HD1' HG22 ' B' ' 395' ' ' ILE . 5.6 m-30 -113.12 -1.92 14.28 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.884 0.85 . . . . 0.0 108.711 -174.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 430' ' ' LEU . . . . . 0.748 HD22 HG22 ' B' ' 426' ' ' ILE . 0.1 OUTLIER -66.38 130.03 94.18 Favored Pre-proline 0 N--CA 1.444 -0.757 0 CA-C-N 114.098 -1.41 . . . . 0.0 108.865 177.208 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 431' ' ' PRO . . . . . 0.574 ' HD2' HD12 ' B' ' 430' ' ' LEU . 80.2 Cg_exo -24.17 -66.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.759 1 C-N-CA 125.595 4.197 . . . . 0.0 114.697 178.984 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 432' ' ' GLY . . . . . 0.529 ' H ' HG12 ' B' ' 435' ' ' VAL . . . -145.4 -168.03 12.76 Favored Glycine 0 N--CA 1.441 -1.01 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 176.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 433' ' ' GLN . . . . . 0.507 ' O ' HG13 ' B' ' 436' ' ' VAL . 40.0 tp60 -69.79 -26.24 64.17 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 117.767 0.784 . . . . 0.0 110.465 179.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -65.95 -40.6 91.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.955 -178.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 435' ' ' VAL . . . . . 0.732 HG23 HG11 ' B' ' 463' ' ' VAL . 7.5 p -68.95 -43.59 82.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-O 120.85 0.357 . . . . 0.0 110.732 -177.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 436' ' ' VAL . . . . . 0.507 HG13 ' O ' ' B' ' 433' ' ' GLN . 0.1 OUTLIER -65.12 -33.45 63.8 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.234 175.723 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 437' ' ' THR . . . . . 0.453 ' O ' ' HG3' ' B' ' 441' ' ' GLN . 1.0 OUTLIER -67.02 -52.62 40.26 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -177.73 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 438' ' ' ALA . . . . . 0.857 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -58.6 -37.88 76.77 Favored 'General case' 0 N--CA 1.436 -1.151 0 O-C-N 123.809 0.693 . . . . 0.0 111.84 178.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 439' ' ' LEU . . . . . 0.61 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 2.1 tm? -67.44 -48.71 66.44 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -179.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.5 -34.78 74.57 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.498 -1.228 . . . . 0.0 110.773 176.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 441' ' ' GLN . . . . . 0.56 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 13.0 mt-30 -53.5 -50.67 64.9 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.175 -178.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 442' ' ' ARG . . . . . 0.634 ' HD2' ' O ' ' B' ' 438' ' ' ALA . 0.0 OUTLIER -76.33 -23.52 54.25 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 175.141 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 443' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 45.9 mt -63.79 -35.89 82.08 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 173.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -56.82 -35.76 69.17 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.378 172.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -73.21 -27.98 61.92 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.794 178.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 446' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' B' ' 443' ' ' LEU . 33.8 tt0 33.17 89.63 0.01 OUTLIER 'General case' 0 C--N 1.351 0.668 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 170.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 71.1 mt -59.51 -35.52 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 121.552 0.691 . . . . 0.0 109.18 175.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 448' ' ' ASP . . . . . 0.498 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 28.6 m-20 -166.72 175.65 7.71 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 177.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 449' ' ' ASP . . . . . 0.646 ' O ' ' HG2' ' B' ' 452' ' ' ARG . 13.6 m-20 -62.88 -60.08 3.97 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.394 -0.522 . . . . 0.0 109.61 174.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 450' ' ' GLN . . . . . 0.447 ' O ' ' HB3' ' B' ' 453' ' ' ALA . 0.0 OUTLIER -71.9 -28.6 63.6 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 178.998 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 451' ' ' THR . . . . . 0.498 ' OG1' ' HB2' ' B' ' 448' ' ' ASP . 9.8 m -72.99 -23.38 60.64 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 119.621 -0.832 . . . . 0.0 111.39 -174.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 452' ' ' ARG . . . . . 0.646 ' HG2' ' O ' ' B' ' 449' ' ' ASP . 6.0 ptp180 -64.73 -41.62 95.81 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 174.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 453' ' ' ALA . . . . . 0.569 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -59.06 -49.17 78.92 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 123.751 0.657 . . . . 0.0 112.395 168.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 454' ' ' GLU . . . . . 0.432 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 33.5 mm-40 -53.77 -34.19 58.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.493 -177.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 30.0 p -115.04 15.36 17.19 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.255 -178.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 456' ' ' PHE . . . . . 0.567 ' CZ ' ' HB2' ' B' ' 423' ' ' SER . 1.0 OUTLIER -56.83 -47.64 79.86 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.833 -171.726 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 457' ' ' ILE . . . . . 0.563 HG23 ' HB1' ' B' ' 405' ' ' ALA . 1.9 mp -76.31 -33.47 23.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.224 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -57.83 -33.95 69.18 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 122.072 0.939 . . . . 0.0 108.999 171.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 459' ' ' HIS . . . . . 0.747 ' O ' HG23 ' B' ' 463' ' ' VAL . 44.4 m-70 -74.64 -29.25 61.2 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.136 -1.393 . . . . 0.0 110.964 177.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 460' ' ' LEU . . . . . 0.704 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -73.98 -34.64 64.29 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.882 0.849 . . . . 0.0 108.817 179.117 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 461' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 -73.13 -37.61 66.59 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.11 176.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 462' ' ' ALA . . . . . 0.61 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -55.91 -34.98 66.07 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.351 -1.295 . . . . 0.0 109.62 169.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 463' ' ' VAL . . . . . 0.857 HG13 ' HB3' ' B' ' 438' ' ' ALA . 72.6 t -61.68 -51.21 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-N 114.656 -1.157 . . . . 0.0 108.227 177.054 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 464' ' ' TYR . . . . . 0.57 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 15.8 m-30 -52.8 -28.41 22.41 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 124.347 1.03 . . . . 0.0 110.532 178.062 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.07 -38.9 20.22 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.765 0.793 . . . . 0.0 109.674 -177.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 466' ' ' ILE . . . . . 0.61 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.7 mt -58.48 -55.85 20.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 114.419 -1.264 . . . . 0.0 112.181 175.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 467' ' ' LEU . . . . . 0.763 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -102.49 -10.72 19.12 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -172.235 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 468' ' ' GLY . . . . . 0.65 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 94.05 31.57 8.01 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 119.38 -1.391 . . . . 0.0 114.312 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 469' ' ' LEU . . . . . 0.763 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.1 mt -88.82 161.33 16.79 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 117.729 0.765 . . . . 0.0 110.883 175.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 470' ' ' ASN . . . . . 0.484 HD22 HG23 ' B' ' 476' ' ' ILE . 12.1 p30 -106.47 -177.06 3.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.014 170.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 471' ' ' ALA . . . . . 0.444 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -62.13 -19.66 63.26 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -173.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -88.0 2.48 51.67 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 122.06 -0.4 . . . . 0.0 111.775 -173.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 473' ' ' GLY . . . . . 0.483 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 76.52 11.67 84.99 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.33 -0.938 . . . . 0.0 111.035 -175.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -101.39 157.02 17.1 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 176.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 8.6 p -93.86 133.53 37.18 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.116 0.484 . . . . 0.0 111.387 -176.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 476' ' ' ILE . . . . . 0.65 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.5 pp . . . . . 0 C--N 1.328 -0.333 0 CA-C-O 121.431 0.634 . . . . 0.0 109.888 177.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 386' ' ' PHE . . . . . 0.808 ' CE2' HG12 ' A' ' 394' ' ' VAL . 0.8 OUTLIER . . . . . 0 N--CA 1.449 -0.495 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 386' ' ' PHE . 26.3 Cg_endo -60.16 102.94 0.19 Allowed 'Trans proline' 0 CA--C 1.531 0.362 0 C-N-CA 123.779 2.986 . . . . 0.0 113.516 177.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.689 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 47.2 mtt -105.98 163.88 12.4 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.27 176.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 389' ' ' HIS . . . . . 0.544 ' CE1' ' HA ' ' A' ' 393' ' ' ASN . 17.5 m170 -74.1 39.68 0.12 Allowed 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . 0.533 ' O ' ' HG2' ' A' ' 390' ' ' GLN . 9.8 tt0 71.53 16.64 5.86 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.099 0.559 . . . . 0.0 110.673 -171.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.577 HD23 ' H ' ' A' ' 392' ' ' GLY . 2.0 pt? -163.41 -59.5 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 177.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . 0.772 ' HA3' HD13 ' A' ' 395' ' ' ILE . . . -171.99 67.98 0.12 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 119.714 -1.231 . . . . 0.0 113.988 -173.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . 0.689 ' HB3' ' HA ' ' A' ' 388' ' ' MET . 0.2 OUTLIER -62.22 -41.14 98.12 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 174.712 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . 0.808 HG12 ' CE2' ' A' ' 386' ' ' PHE . 0.9 OUTLIER -55.57 -47.26 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 178.95 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . 0.772 HD13 ' HA3' ' A' ' 392' ' ' GLY . 3.6 mp -57.07 -52.08 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 CA-C-O 117.762 -1.113 . . . . 0.0 113.64 -175.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . 0.602 ' O ' HG22 ' A' ' 399' ' ' VAL . 0.1 OUTLIER -60.62 -51.09 70.9 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 121.873 2.124 . . . . 0.0 112.821 -175.245 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.93 -42.72 70.76 Favored Glycine 0 N--CA 1.438 -1.18 0 C-N-CA 119.554 -1.308 . . . . 0.0 110.894 -174.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . 0.942 HD13 HD12 ' A' ' 410' ' ' LEU . 39.4 mt -71.78 -34.29 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 CA-C-N 114.009 -1.095 . . . . 0.0 113.641 -178.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . 0.602 HG22 ' O ' ' A' ' 396' ' ' LYS . 16.0 m -62.91 -39.56 85.53 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 C-N-CA 118.881 -1.128 . . . . 0.0 108.649 -174.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -69.96 -38.2 76.03 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 175.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.443 HE21 ' HB3' ' A' ' 401' ' ' GLN . 2.5 mm100 -90.19 -48.81 6.93 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -170.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . 0.662 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 1.3 mm-40 -116.12 -19.15 10.4 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.106 -170.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 104.51 161.0 24.14 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.579 178.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . 0.673 HG11 ' HA ' ' A' ' 430' ' ' LEU . 1.5 m -53.42 -45.26 57.29 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.967 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -176.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . 0.586 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -62.93 -31.23 72.27 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 119.995 -0.682 . . . . 0.0 112.606 -178.03 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.685 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 87.9 m -76.96 -43.14 36.3 Favored 'General case' 0 C--O 1.222 -0.364 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.201 173.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.486 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -58.69 -37.22 75.61 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 122.191 0.996 . . . . 0.0 109.297 176.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 408' ' ' TYR . . . . . 0.673 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -66.11 -51.91 53.55 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 113.414 -1.721 . . . . 0.0 109.659 176.568 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 409' ' ' THR . . . . . 0.64 HG22 HD23 ' A' ' 410' ' ' LEU . 13.3 m -54.44 -47.11 73.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.451 178.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . 0.942 HD12 HD13 ' A' ' 398' ' ' ILE . 14.4 mt -71.57 -37.47 71.06 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 120.944 0.402 . . . . 0.0 109.92 -175.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.33 -34.57 75.02 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.017 -1.087 . . . . 0.0 110.53 173.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 412' ' ' MET . . . . . 0.412 ' HB2' ' O ' ' A' ' 409' ' ' THR . 0.4 OUTLIER -67.28 -44.4 79.4 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 115.412 -0.394 . . . . 0.0 111.454 177.836 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 413' ' ' MET . . . . . 0.754 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.0 OUTLIER -70.85 -55.45 8.45 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 118.371 -1.332 . . . . 0.0 111.736 179.187 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . 0.754 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 3.9 mt -63.62 -44.51 93.71 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -171.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 46.8 t -86.42 -21.05 27.33 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.71 0.767 . . . . 0.0 109.906 -176.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . 0.422 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 107.37 -176.26 20.85 Favored Glycine 0 N--CA 1.431 -1.667 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -170.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -79.72 24.71 0.37 Allowed 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.4 0.619 . . . . 0.0 111.479 -172.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 418' ' ' ASN . . . . . 0.422 ' H ' ' C ' ' A' ' 416' ' ' GLY . 92.6 m-20 -70.83 75.28 0.62 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.856 -178.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 419' ' ' TYR . . . . . 0.518 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 12.1 p90 -50.56 -38.84 47.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.173 175.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -54.71 -47.82 73.24 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 123.292 0.37 . . . . 0.0 110.816 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.69 -49.12 64.36 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.419 -177.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . 0.423 ' HB ' ' CD1' ' A' ' 408' ' ' TYR . 0.2 OUTLIER -65.64 -39.5 85.16 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.552 -176.934 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.763 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 78.6 p -68.75 -36.32 78.22 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.564 -0.454 . . . . 0.0 109.868 -178.088 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -70.32 -38.75 71.05 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.946 175.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . 0.554 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -71.74 -51.68 30.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 O-C-N 122.852 -0.205 . . . . 0.0 110.857 -178.195 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . 0.714 HG22 HD22 ' A' ' 430' ' ' LEU . 1.1 mm -74.05 -23.44 18.75 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.827 0 C-N-CA 122.407 0.283 . . . . 0.0 110.405 -173.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.763 ' HB2' ' O ' ' A' ' 423' ' ' SER . 1.0 OUTLIER -54.77 -31.84 59.21 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.034 0.445 . . . . 0.0 111.496 -177.536 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -85.16 -14.84 68.19 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.228 -0.987 . . . . 0.0 110.859 178.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.6 ' HD1' HG22 ' A' ' 395' ' ' ILE . 5.1 m-30 -111.0 0.2 16.9 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.689 0.757 . . . . 0.0 109.031 -171.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.714 HD22 HG22 ' A' ' 426' ' ' ILE . 0.1 OUTLIER -65.48 129.1 94.29 Favored Pre-proline 0 N--CA 1.442 -0.866 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.74 177.576 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 431' ' ' PRO . . . . . 0.495 ' HD2' HD12 ' A' ' 430' ' ' LEU . 81.3 Cg_exo -23.59 -71.19 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.941 1 C-N-CA 125.539 4.159 . . . . 0.0 114.76 179.841 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . 0.554 ' O ' HG12 ' A' ' 435' ' ' VAL . . . -138.22 -171.93 12.36 Favored Glycine 0 N--CA 1.441 -1.031 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 176.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . 0.475 ' O ' HG13 ' A' ' 436' ' ' VAL . 51.3 tp60 -67.46 -25.56 65.95 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 118.106 0.953 . . . . 0.0 110.13 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -63.84 -43.41 96.23 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 435' ' ' VAL . . . . . 0.66 HG23 HG11 ' A' ' 463' ' ' VAL . 8.3 p -69.27 -41.93 81.26 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 CA-C-O 121.082 0.467 . . . . 0.0 110.641 -176.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.485 HG12 ' O ' ' A' ' 432' ' ' GLY . 0.1 OUTLIER -67.14 -30.19 48.57 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.082 174.832 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 437' ' ' THR . . . . . 0.488 ' O ' ' HG2' ' A' ' 441' ' ' GLN . 1.1 m -66.71 -53.95 28.13 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . 0.849 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -59.46 -34.59 72.73 Favored 'General case' 0 N--CA 1.434 -1.237 0 O-C-N 124.116 0.885 . . . . 0.0 111.227 178.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 439' ' ' LEU . . . . . 0.926 HD23 ' NH2' ' A' ' 442' ' ' ARG . 0.3 OUTLIER -67.11 -50.74 60.46 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.223 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.46 -33.89 74.51 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.44 -1.254 . . . . 0.0 111.032 175.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 441' ' ' GLN . . . . . 0.507 ' HB2' ' HA ' ' A' ' 438' ' ' ALA . 7.0 mm100 -55.01 -50.09 69.9 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.68 -175.02 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . 0.926 ' NH2' HD23 ' A' ' 439' ' ' LEU . 0.0 OUTLIER -78.08 -25.54 47.68 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 119.511 -0.875 . . . . 0.0 112.687 175.847 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 443' ' ' LEU . . . . . 0.775 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 67.3 mt -67.81 -26.62 66.16 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.7 178.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -64.82 -38.52 91.24 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.842 0.829 . . . . 0.0 109.976 173.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -77.24 -26.56 52.7 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.424 -1.262 . . . . 0.0 111.373 179.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 29.43 101.8 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 175.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 51.7 mt -60.07 -35.14 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 121.45 0.643 . . . . 0.0 110.434 -179.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . 0.464 ' HB2' ' OG1' ' A' ' 451' ' ' THR . 31.8 m-20 -164.77 -162.42 0.64 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -177.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -81.44 -72.05 0.45 Allowed 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 171.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.0 -25.14 67.99 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 178.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 451' ' ' THR . . . . . 0.464 ' OG1' ' HB2' ' A' ' 448' ' ' ASP . 8.9 m -71.03 -22.98 62.07 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.998 -174.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 452' ' ' ARG . 17.8 mtp180 -53.41 -54.16 40.88 Favored 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 171.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 453' ' ' ALA . . . . . 0.518 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -59.71 -49.61 77.05 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 114.395 -1.275 . . . . 0.0 113.095 175.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . 0.459 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 20.8 mm-40 -49.23 -38.34 26.24 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.341 0.591 . . . . 0.0 111.849 -176.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 26.1 p -120.11 16.55 12.42 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.818 -175.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . 0.502 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.8 OUTLIER -54.64 -46.8 74.0 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.688 -172.063 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . 0.586 HG23 ' HB1' ' A' ' 405' ' ' ALA . 1.9 mp -78.67 -35.22 18.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.64 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -57.23 -36.43 70.91 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 121.841 0.829 . . . . 0.0 109.192 172.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . 0.761 ' HB3' ' CZ ' ' A' ' 442' ' ' ARG . 78.9 m-70 -75.2 -30.43 60.63 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.528 177.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . 0.744 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.6 OUTLIER -67.49 -34.52 77.32 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 179.421 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . 0.464 ' O ' ' HB2' ' A' ' 464' ' ' TYR . 17.3 m-80 -72.95 -37.49 67.11 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.347 -1.297 . . . . 0.0 109.04 176.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 462' ' ' ALA . . . . . 0.603 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -56.63 -32.19 65.08 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.146 169.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.849 HG13 ' HB3' ' A' ' 438' ' ' ALA . 51.3 t -64.88 -49.91 77.65 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.798 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 176.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 464' ' ' TYR . . . . . 0.602 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 19.5 m-30 -51.48 -28.98 14.81 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 124.511 1.132 . . . . 0.0 110.454 176.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.84 -38.36 19.59 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.602 0.715 . . . . 0.0 109.7 -176.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.603 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.7 mt -58.11 -55.48 21.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.149 174.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 0.752 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -101.35 -10.85 19.9 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 -172.317 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . 0.583 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 94.13 31.58 7.97 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 119.538 -1.315 . . . . 0.0 114.287 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 469' ' ' LEU . . . . . 0.752 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.1 mt -89.45 164.02 15.01 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 117.801 0.8 . . . . 0.0 110.911 175.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 43.0 p30 -105.0 -179.19 3.87 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.267 172.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 471' ' ' ALA . . . . . 0.467 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -59.62 -23.47 63.02 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -177.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -87.43 3.11 48.46 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.157 -173.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 473' ' ' GLY . . . . . 0.448 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 75.45 15.43 81.22 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.393 -0.908 . . . . 0.0 110.973 -176.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -100.95 150.17 23.15 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 178.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 4.4 p -89.61 117.07 28.22 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.286 0.565 . . . . 0.0 111.557 -178.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 476' ' ' ILE . . . . . 0.583 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.8 pp . . . . . 0 C--N 1.32 -0.692 0 CA-C-O 121.722 0.772 . . . . 0.0 110.231 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 386' ' ' PHE . . . . . 0.812 ' CE2' HG12 ' B' ' 394' ' ' VAL . 0.8 OUTLIER . . . . . 0 N--CA 1.448 -0.537 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 387' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' B' ' 386' ' ' PHE . 26.7 Cg_endo -59.92 103.05 0.19 Allowed 'Trans proline' 0 N--CA 1.473 0.312 0 C-N-CA 123.787 2.992 . . . . 0.0 113.473 177.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 388' ' ' MET . . . . . 0.672 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 47.1 mtt -106.04 164.0 12.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.227 176.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 389' ' ' HIS . . . . . 0.534 ' CE1' ' HA ' ' B' ' 393' ' ' ASN . 17.3 m170 -74.17 39.86 0.12 Allowed 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 179.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 390' ' ' GLN . . . . . 0.525 ' O ' ' HG2' ' B' ' 390' ' ' GLN . 9.8 tt0 71.59 15.98 5.92 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.03 0.532 . . . . 0.0 110.65 -172.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 391' ' ' LEU . . . . . 0.569 HD23 ' H ' ' B' ' 392' ' ' GLY . 2.0 pt? -163.05 -59.5 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 177.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 392' ' ' GLY . . . . . 0.773 ' HA3' HD13 ' B' ' 395' ' ' ILE . . . -171.91 68.0 0.13 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 119.729 -1.224 . . . . 0.0 114.028 -173.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 393' ' ' ASN . . . . . 0.672 ' HB3' ' HA ' ' B' ' 388' ' ' MET . 0.2 OUTLIER -62.11 -41.2 97.99 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 174.649 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 394' ' ' VAL . . . . . 0.812 HG12 ' CE2' ' B' ' 386' ' ' PHE . 0.9 OUTLIER -55.51 -47.38 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 178.867 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 395' ' ' ILE . . . . . 0.773 HD13 ' HA3' ' B' ' 392' ' ' GLY . 3.6 mp -57.07 -52.01 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 CA-C-O 117.783 -1.103 . . . . 0.0 113.615 -175.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 396' ' ' LYS . . . . . 0.6 ' O ' HG22 ' B' ' 399' ' ' VAL . 0.1 OUTLIER -60.65 -51.06 70.98 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 122.049 2.204 . . . . 0.0 112.798 -175.197 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.84 -42.99 70.43 Favored Glycine 0 N--CA 1.438 -1.185 0 C-N-CA 119.595 -1.288 . . . . 0.0 110.927 -174.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 398' ' ' ILE . . . . . 0.961 HD13 HD12 ' B' ' 410' ' ' LEU . 39.1 mt -71.74 -34.19 51.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-N 114.074 -1.063 . . . . 0.0 113.668 -178.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 399' ' ' VAL . . . . . 0.6 HG22 ' O ' ' B' ' 396' ' ' LYS . 15.9 m -62.76 -39.72 85.9 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 C-N-CA 118.837 -1.145 . . . . 0.0 108.617 -174.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -70.07 -38.3 75.72 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 175.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 401' ' ' GLN . . . . . 0.433 HE21 ' HB3' ' B' ' 401' ' ' GLN . 2.4 mm100 -89.94 -48.79 6.99 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -170.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 402' ' ' GLU . . . . . 0.617 ' HG3' ' HE3' ' A' ' 413' ' ' MET . 1.3 mm-40 -116.23 -19.09 10.36 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.257 -170.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 104.73 160.86 23.92 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.622 178.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 404' ' ' VAL . . . . . 0.667 HG11 ' HA ' ' B' ' 430' ' ' LEU . 1.5 m -53.26 -45.17 55.22 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.954 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -176.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 405' ' ' ALA . . . . . 0.561 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -62.89 -31.36 72.39 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 119.994 -0.683 . . . . 0.0 112.655 -178.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 406' ' ' THR . . . . . 0.675 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 86.4 m -77.06 -42.83 36.78 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.232 173.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 407' ' ' ALA . . . . . 0.49 ' HB2' ' HB ' ' B' ' 398' ' ' ILE . . . -58.86 -37.12 75.8 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 122.227 1.013 . . . . 0.0 109.281 176.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 408' ' ' TYR . . . . . 0.666 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -66.28 -51.68 55.02 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 113.343 -1.753 . . . . 0.0 109.779 176.588 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 409' ' ' THR . . . . . 0.633 HG22 HD23 ' B' ' 410' ' ' LEU . 13.1 m -54.44 -47.26 73.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.377 178.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 410' ' ' LEU . . . . . 0.961 HD12 HD13 ' B' ' 398' ' ' ILE . 14.5 mt -71.59 -37.44 70.98 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 120.92 0.391 . . . . 0.0 109.989 -175.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.39 -34.54 75.35 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.031 -1.08 . . . . 0.0 110.499 173.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 412' ' ' MET . . . . . 0.418 ' HB2' ' O ' ' B' ' 409' ' ' THR . 0.4 OUTLIER -67.18 -44.46 79.65 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 115.434 -0.383 . . . . 0.0 111.535 177.771 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 413' ' ' MET . . . . . 0.751 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.0 OUTLIER -70.86 -55.34 8.7 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 118.316 -1.354 . . . . 0.0 111.714 179.187 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 414' ' ' LEU . . . . . 0.751 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 3.9 mt -63.79 -44.43 93.4 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -171.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 46.5 t -86.45 -20.89 27.46 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.749 0.785 . . . . 0.0 109.943 -176.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 416' ' ' GLY . . . . . 0.424 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 107.18 -176.24 20.97 Favored Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -170.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -79.72 24.82 0.37 Allowed 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.21 0.529 . . . . 0.0 111.461 -172.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 418' ' ' ASN . . . . . 0.424 ' H ' ' C ' ' B' ' 416' ' ' GLY . 92.6 m-20 -71.09 75.49 0.67 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.814 -178.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 419' ' ' TYR . . . . . 0.531 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 12.4 p90 -50.56 -38.82 47.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.195 175.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -54.77 -47.56 73.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.932 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.78 -49.22 63.59 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.45 -177.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 422' ' ' VAL . . . . . 0.427 ' HB ' ' CD1' ' B' ' 408' ' ' TYR . 0.2 OUTLIER -65.55 -39.5 85.26 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.494 -176.903 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 423' ' ' SER . . . . . 0.763 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 78.0 p -68.78 -36.38 78.23 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -178.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -70.43 -38.44 69.84 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.961 176.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 425' ' ' ILE . . . . . 0.564 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -71.94 -51.85 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-O 120.327 0.108 . . . . 0.0 110.799 -178.207 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 426' ' ' ILE . . . . . 0.709 HG22 HD22 ' B' ' 430' ' ' LEU . 1.1 mm -73.95 -23.42 18.87 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.828 0 C-N-CA 122.37 0.268 . . . . 0.0 110.491 -173.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 427' ' ' ARG . . . . . 0.763 ' HB2' ' O ' ' B' ' 423' ' ' SER . 1.0 OUTLIER -54.75 -31.95 59.23 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.045 0.45 . . . . 0.0 111.449 -177.607 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -84.99 -15.11 67.98 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.15 -1.024 . . . . 0.0 110.817 178.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 429' ' ' TYR . . . . . 0.607 ' HD1' HG22 ' B' ' 395' ' ' ILE . 5.1 m-30 -110.62 -0.13 17.35 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -171.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 430' ' ' LEU . . . . . 0.72 HD23 ' HA ' ' B' ' 427' ' ' ARG . 0.1 OUTLIER -65.26 129.16 94.35 Favored Pre-proline 0 N--CA 1.441 -0.886 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.821 177.61 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 431' ' ' PRO . . . . . 0.493 ' HD2' HD12 ' B' ' 430' ' ' LEU . 78.8 Cg_exo -23.48 -70.94 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 1.003 1 C-N-CA 125.646 4.23 . . . . 0.0 114.814 179.844 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 432' ' ' GLY . . . . . 0.554 ' O ' HG12 ' B' ' 435' ' ' VAL . . . -138.82 -172.17 12.46 Favored Glycine 0 N--CA 1.441 -0.99 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 176.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 433' ' ' GLN . . . . . 0.475 ' O ' HG13 ' B' ' 436' ' ' VAL . 50.2 tp60 -67.11 -25.55 66.26 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 118.136 0.968 . . . . 0.0 110.291 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -63.99 -43.22 96.34 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 435' ' ' VAL . . . . . 0.659 HG23 HG11 ' B' ' 463' ' ' VAL . 8.3 p -69.26 -41.87 81.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-O 120.947 0.403 . . . . 0.0 110.7 -176.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 436' ' ' VAL . . . . . 0.49 HG12 ' O ' ' B' ' 432' ' ' GLY . 0.1 OUTLIER -67.29 -30.19 48.35 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.049 174.937 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 437' ' ' THR . . . . . 0.468 ' O ' ' HG2' ' B' ' 441' ' ' GLN . 1.1 m -66.81 -53.86 28.51 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -179.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 438' ' ' ALA . . . . . 0.861 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -59.37 -34.65 72.66 Favored 'General case' 0 N--CA 1.434 -1.227 0 O-C-N 124.071 0.857 . . . . 0.0 111.261 178.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 439' ' ' LEU . . . . . 0.923 HD23 ' NH2' ' B' ' 442' ' ' ARG . 0.3 OUTLIER -67.12 -50.72 60.43 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.206 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.41 -33.98 74.61 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 114.463 -1.244 . . . . 0.0 111.037 175.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 441' ' ' GLN . . . . . 0.507 ' HB2' ' HA ' ' B' ' 438' ' ' ALA . 6.9 mm100 -54.97 -50.16 69.63 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.772 -175.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 442' ' ' ARG . . . . . 0.923 ' NH2' HD23 ' B' ' 439' ' ' LEU . 0.0 OUTLIER -77.97 -25.62 48.25 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 119.558 -0.857 . . . . 0.0 112.654 175.785 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 443' ' ' LEU . . . . . 0.766 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 67.3 mt -67.89 -26.4 65.99 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 120.383 -0.527 . . . . 0.0 109.593 178.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -65.06 -38.48 90.95 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.072 173.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -76.95 -27.09 54.7 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.339 -1.3 . . . . 0.0 111.33 179.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 446' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 30.08 101.95 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 175.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 52.0 mt -60.51 -34.88 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 121.359 0.599 . . . . 0.0 110.467 -179.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 448' ' ' ASP . . . . . 0.455 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 32.3 m-20 -164.91 -162.39 0.63 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -178.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -81.54 -71.76 0.46 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 171.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 450' ' ' GLN . . . . . 0.418 ' HG3' ' H ' ' B' ' 450' ' ' GLN . 0.0 OUTLIER -64.27 -25.05 67.88 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 178.212 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 451' ' ' THR . . . . . 0.456 ' HA ' ' HB2' ' B' ' 454' ' ' GLU . 9.7 m -71.03 -23.17 62.1 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.046 -174.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 452' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' B' ' 452' ' ' ARG . 17.8 mtp180 -53.25 -54.28 38.51 Favored 'General case' 0 C--O 1.221 -0.401 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 171.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 453' ' ' ALA . . . . . 0.531 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -59.67 -49.33 78.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.393 -1.276 . . . . 0.0 113.11 175.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 454' ' ' GLU . . . . . 0.456 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 22.0 mm-40 -49.38 -38.34 28.27 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.299 0.571 . . . . 0.0 111.909 -176.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 25.6 p -120.24 16.57 12.32 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.818 -175.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 456' ' ' PHE . . . . . 0.493 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 0.8 OUTLIER -54.48 -46.9 73.49 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.656 -172.127 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 457' ' ' ILE . . . . . 0.561 HG23 ' HB1' ' B' ' 405' ' ' ALA . 1.9 mp -78.64 -35.42 18.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.565 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -57.03 -36.52 70.55 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.884 0.849 . . . . 0.0 109.278 172.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 459' ' ' HIS . . . . . 0.769 ' HB3' ' CZ ' ' B' ' 442' ' ' ARG . 78.7 m-70 -75.21 -30.37 60.59 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.515 177.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 460' ' ' LEU . . . . . 0.751 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.6 OUTLIER -67.47 -34.46 77.22 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.364 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 461' ' ' ASN . . . . . 0.455 ' O ' ' HB2' ' B' ' 464' ' ' TYR . 16.9 m-80 -73.03 -37.6 66.84 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.499 -1.228 . . . . 0.0 109.069 176.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 462' ' ' ALA . . . . . 0.595 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -56.49 -32.42 65.01 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.628 -1.169 . . . . 0.0 109.957 169.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 463' ' ' VAL . . . . . 0.861 HG13 ' HB3' ' B' ' 438' ' ' ALA . 50.9 t -64.8 -49.86 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 176.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 464' ' ' TYR . . . . . 0.59 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 19.6 m-30 -51.63 -28.58 14.79 Favored 'General case' 0 C--N 1.333 -0.13 0 O-C-N 124.442 1.089 . . . . 0.0 110.432 176.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.04 -38.57 19.02 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.662 0.744 . . . . 0.0 109.813 -176.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 466' ' ' ILE . . . . . 0.595 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.7 mt -57.92 -55.31 22.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 114.374 -1.284 . . . . 0.0 112.215 174.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 467' ' ' LEU . . . . . 0.749 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -101.43 -10.94 19.75 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -172.383 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 468' ' ' GLY . . . . . 0.587 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 94.29 31.15 8.16 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 119.424 -1.369 . . . . 0.0 114.378 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 469' ' ' LEU . . . . . 0.749 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.0 mt -89.36 164.25 14.97 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 117.847 0.823 . . . . 0.0 110.921 175.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 42.6 p30 -105.12 -179.34 3.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.297 172.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 471' ' ' ALA . . . . . 0.465 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -59.01 -23.82 62.27 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -177.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -87.47 3.34 47.65 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.1 -173.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 473' ' ' GLY . . . . . 0.452 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 74.88 15.82 80.74 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.348 -0.929 . . . . 0.0 111.087 -176.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -100.98 150.23 23.1 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 178.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 4.6 p -89.76 117.07 28.33 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.067 0.46 . . . . 0.0 111.459 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 476' ' ' ILE . . . . . 0.587 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.8 pp . . . . . 0 C--N 1.321 -0.64 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.232 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 386' ' ' PHE . . . . . 0.748 ' CD1' HD22 ' A' ' 414' ' ' LEU . 2.1 t80 . . . . . 0 CA--C 1.538 0.501 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.08 -64.1 0.23 Allowed 'Trans proline' 0 N--CA 1.484 0.935 0 C-N-CA 124.361 3.374 . . . . 0.0 113.908 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.639 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 4.5 ttp 63.36 41.94 7.25 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 171.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 389' ' ' HIS . . . . . 0.625 ' CD2' ' HB2' ' A' ' 393' ' ' ASN . 33.0 m170 50.24 -107.34 0.27 Allowed 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 121.236 0.541 . . . . 0.0 109.757 -174.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -140.17 18.33 2.43 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 172.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.511 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.5 pt? -165.57 -54.54 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.709 -172.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . 0.673 ' HA3' HD13 ' A' ' 395' ' ' ILE . . . -171.5 58.49 0.17 Allowed Glycine 0 C--N 1.335 0.491 0 C-N-CA 119.667 -1.254 . . . . 0.0 114.438 -174.04 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . 0.639 ' HB3' ' HA ' ' A' ' 388' ' ' MET . 0.2 OUTLIER -59.5 -40.19 86.23 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 117.748 0.774 . . . . 0.0 109.746 174.695 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . 0.742 HG23 HD12 ' A' ' 398' ' ' ILE . 1.8 m -56.13 -47.46 80.53 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.598 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 178.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . 0.673 HD13 ' HA3' ' A' ' 392' ' ' GLY . 3.6 mp -57.56 -52.75 53.3 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.358 0 CA-C-O 117.86 -1.066 . . . . 0.0 113.662 -174.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . 0.585 ' O ' HG22 ' A' ' 399' ' ' VAL . 0.0 OUTLIER -63.25 -49.61 73.43 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 121.968 2.167 . . . . 0.0 112.054 -175.131 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -52.99 -44.47 62.03 Favored Glycine 0 N--CA 1.431 -1.658 0 CA-C-N 114.706 -1.133 . . . . 0.0 110.726 -176.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . 0.854 HD13 HD12 ' A' ' 410' ' ' LEU . 38.0 mt -71.51 -33.13 48.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . 0.585 HG22 ' O ' ' A' ' 396' ' ' LYS . 15.7 m -63.26 -39.85 86.81 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 C-N-CA 118.624 -1.23 . . . . 0.0 108.114 -175.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -69.63 -35.74 75.5 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 174.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.443 HE21 ' HB3' ' A' ' 401' ' ' GLN . 5.5 mm100 -89.42 -48.06 7.59 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -172.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . 0.518 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 2.4 mm-40 -120.85 -20.36 6.98 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.358 -170.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 106.74 161.74 22.14 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.607 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . 0.669 HG11 ' HA ' ' A' ' 430' ' ' LEU . 1.4 m -53.7 -45.66 61.09 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.87 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -175.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . 0.569 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -62.35 -32.62 73.43 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 119.92 -0.712 . . . . 0.0 112.527 -177.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.686 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 92.1 m -77.54 -41.26 39.68 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.534 174.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.444 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.7 -36.44 74.26 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 122.121 0.962 . . . . 0.0 109.081 175.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 408' ' ' TYR . . . . . 0.608 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -66.19 -52.19 50.49 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 113.569 -1.65 . . . . 0.0 109.841 175.961 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 409' ' ' THR . . . . . 0.634 HG22 HD23 ' A' ' 410' ' ' LEU . 18.0 m -54.69 -47.64 73.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.494 178.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . 0.854 HD12 HD13 ' A' ' 398' ' ' ILE . 14.5 mt -72.46 -36.46 68.5 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.895 -174.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.71 -34.56 77.61 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 119.901 -1.142 . . . . 0.0 110.457 173.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 412' ' ' MET . . . . . 0.439 ' HB2' ' O ' ' A' ' 409' ' ' THR . 0.5 OUTLIER -67.04 -48.94 66.79 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 115.712 -0.244 . . . . 0.0 111.441 177.595 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 413' ' ' MET . . . . . 0.933 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 1.0 OUTLIER -72.0 -43.51 64.97 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.096 -1.041 . . . . 0.0 112.15 -178.75 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . 0.933 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 14.5 mt -69.81 -45.7 67.32 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -176.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 33.0 t -87.45 -23.44 24.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.52 0.676 . . . . 0.0 110.139 -176.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . 0.401 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 108.92 -175.96 19.57 Favored Glycine 0 N--CA 1.429 -1.784 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -170.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 32.4 mm-40 -80.56 23.22 0.52 Allowed 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.312 0.577 . . . . 0.0 111.322 -171.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 418' ' ' ASN . . . . . 0.401 ' H ' ' C ' ' A' ' 416' ' ' GLY . 3.4 m-20 -72.24 75.48 0.98 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.685 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 419' ' ' TYR . . . . . 0.619 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 11.2 p90 -55.48 -38.11 68.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.163 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -54.73 -44.15 73.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.823 0.344 . . . . 0.0 110.913 178.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.9 -49.36 62.38 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.283 -177.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . 0.47 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.1 OUTLIER -64.84 -40.94 90.78 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.691 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.068 -177.659 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.788 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 16.0 t -69.46 -36.06 76.23 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 120.326 -0.55 . . . . 0.0 109.635 -176.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -70.4 -37.05 69.92 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.989 176.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . 0.573 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -71.6 -50.65 38.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.502 0.191 . . . . 0.0 110.558 -179.716 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . 0.706 HG22 HD22 ' A' ' 430' ' ' LEU . 1.2 mm -73.68 -23.72 19.46 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.979 0 CA-C-O 120.833 0.349 . . . . 0.0 110.2 -173.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.788 ' HB2' ' O ' ' A' ' 423' ' ' SER . 1.5 tmm_? -55.04 -32.35 61.8 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.26 0.552 . . . . 0.0 111.127 -177.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.68 -9.54 71.61 Favored Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 120.412 -0.899 . . . . 0.0 111.041 178.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.591 ' HD1' HG22 ' A' ' 395' ' ' ILE . 7.4 m-30 -114.0 -0.26 14.13 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -175.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.706 HD22 HG22 ' A' ' 426' ' ' ILE . 0.0 OUTLIER -66.34 129.04 94.16 Favored Pre-proline 0 N--CA 1.444 -0.773 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.784 177.92 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 431' ' ' PRO . . . . . 0.568 ' HD2' HD12 ' A' ' 430' ' ' LEU . 87.5 Cg_exo -23.45 -73.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.356 0.974 1 C-N-CA 125.62 4.213 . . . . 0.0 114.909 179.901 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . 0.548 ' O ' HG12 ' A' ' 435' ' ' VAL . . . -137.99 -170.02 11.76 Favored Glycine 0 N--CA 1.439 -1.105 0 N-CA-C 110.311 -1.115 . . . . 0.0 110.311 176.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . 0.443 ' O ' HG13 ' A' ' 436' ' ' VAL . 22.6 tp60 -65.89 -27.42 68.19 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 117.929 0.865 . . . . 0.0 110.315 -178.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -66.41 -40.59 89.69 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -177.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 435' ' ' VAL . . . . . 0.647 HG23 HG11 ' A' ' 463' ' ' VAL . 8.5 p -70.22 -43.48 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.09 0 CA-C-O 120.942 0.401 . . . . 0.0 110.655 -177.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.471 HG12 ' O ' ' A' ' 432' ' ' GLY . 0.1 OUTLIER -66.29 -30.6 50.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.12 175.044 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 437' ' ' THR . . . . . 0.529 ' O ' ' HG2' ' A' ' 441' ' ' GLN . 1.0 OUTLIER -67.89 -53.19 28.48 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -179.212 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . 0.84 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -59.44 -35.17 73.52 Favored 'General case' 0 N--CA 1.437 -1.091 0 O-C-N 123.924 0.765 . . . . 0.0 111.349 178.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 439' ' ' LEU . . . . . 0.91 HD23 ' NH2' ' A' ' 442' ' ' ARG . 0.4 OUTLIER -67.14 -50.75 60.19 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 -179.257 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.44 -34.16 74.96 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.231 -1.349 . . . . 0.0 111.294 175.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 441' ' ' GLN . . . . . 0.529 ' HG2' ' O ' ' A' ' 437' ' ' THR . 7.4 mm100 -54.65 -49.65 70.06 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.047 -176.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . 0.91 ' NH2' HD23 ' A' ' 439' ' ' LEU . 0.0 OUTLIER -78.26 -25.65 46.87 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.484 -0.886 . . . . 0.0 112.648 175.72 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 443' ' ' LEU . . . . . 0.751 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 67.6 mt -67.51 -26.38 66.31 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.197 0.522 . . . . 0.0 109.618 178.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -64.6 -38.16 90.05 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.969 173.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -76.31 -26.66 56.04 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.43 -1.259 . . . . 0.0 111.102 178.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 28.53 99.05 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 O-C-N 124.702 1.251 . . . . 0.0 114.373 175.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 50.1 mt -59.0 -34.56 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 121.545 0.688 . . . . 0.0 110.579 -179.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -163.29 -161.2 0.66 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 -177.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -82.13 -70.83 0.52 Allowed 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 167.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 450' ' ' GLN . . . . . 0.41 ' O ' ' HG2' ' A' ' 454' ' ' GLU . 0.0 OUTLIER -64.7 -26.38 68.35 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -179.375 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 451' ' ' THR . . . . . 0.427 ' HA ' ' HB2' ' A' ' 454' ' ' GLU . 9.0 m -71.2 -23.18 61.98 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.982 -174.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . 0.43 ' NH2' ' HB3' ' A' ' 443' ' ' LEU . 19.3 mtp180 -53.19 -54.55 34.35 Favored 'General case' 0 C--O 1.222 -0.381 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 171.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 453' ' ' ALA . . . . . 0.619 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -60.34 -48.75 80.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.203 -1.362 . . . . 0.0 113.028 175.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . 0.427 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 78.6 mm-40 -49.1 -38.3 24.2 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.34 0.59 . . . . 0.0 111.723 -175.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 28.3 p -120.57 16.41 12.03 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.291 -176.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . 0.495 ' CE2' ' HB2' ' A' ' 419' ' ' TYR . 0.8 OUTLIER -53.66 -47.88 69.95 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.648 -172.042 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . 0.569 HG23 ' HB1' ' A' ' 405' ' ' ALA . 1.9 mp -77.59 -35.2 21.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.712 -179.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -56.93 -36.13 69.87 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 121.969 0.89 . . . . 0.0 109.055 172.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . 0.754 ' HB3' ' CZ ' ' A' ' 442' ' ' ARG . 81.3 m-70 -75.62 -30.4 59.51 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.405 -1.27 . . . . 0.0 110.743 177.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . 0.743 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.6 OUTLIER -67.84 -34.71 77.24 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.749 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . 0.47 ' O ' ' HB2' ' A' ' 464' ' ' TYR . 24.4 m-80 -72.95 -37.3 67.17 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.344 -1.298 . . . . 0.0 108.889 177.098 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 462' ' ' ALA . . . . . 0.562 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -56.98 -32.49 66.13 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.429 -1.26 . . . . 0.0 110.238 168.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.84 HG13 ' HB3' ' A' ' 438' ' ' ALA . 49.4 t -64.12 -49.77 79.92 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 176.061 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 464' ' ' TYR . . . . . 0.602 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 18.8 m-30 -51.99 -28.21 16.12 Favored 'General case' 0 C--N 1.333 -0.137 0 O-C-N 124.435 1.084 . . . . 0.0 110.403 176.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.94 -40.5 18.45 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.611 0.72 . . . . 0.0 109.616 -177.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.562 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.7 mt -57.33 -54.76 26.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 114.481 -1.236 . . . . 0.0 112.174 176.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 0.763 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -101.49 -10.85 19.78 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -172.966 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . 0.601 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 94.07 31.18 8.23 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 119.586 -1.292 . . . . 0.0 114.425 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 469' ' ' LEU . . . . . 0.763 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.7 mt -89.08 165.43 14.52 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 117.79 0.795 . . . . 0.0 110.932 176.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 37.2 p30 -105.49 -177.82 3.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.9 171.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 471' ' ' ALA . . . . . 0.58 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -66.05 -15.5 63.11 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -176.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 -88.02 -1.84 58.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.709 0.29 . . . . 0.0 111.023 -175.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 473' ' ' GLY . . . . . 0.458 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 79.32 12.99 83.29 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.224 -0.989 . . . . 0.0 111.032 -175.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -101.17 151.82 21.38 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 176.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 475' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 469' ' ' LEU . 27.5 t -89.73 134.96 33.9 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.155 0.502 . . . . 0.0 110.536 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 476' ' ' ILE . . . . . 0.601 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.6 pp . . . . . 0 C--N 1.318 -0.769 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.2 -176.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 386' ' ' PHE . . . . . 0.757 ' CD1' HD22 ' B' ' 414' ' ' LEU . 2.1 t80 . . . . . 0 CA--C 1.538 0.501 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 387' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -51.04 -64.05 0.23 Allowed 'Trans proline' 0 N--CA 1.482 0.836 0 C-N-CA 124.355 3.37 . . . . 0.0 114.014 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 388' ' ' MET . . . . . 0.639 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 4.5 ttp 63.39 41.83 7.29 Favored 'General case' 0 CA--C 1.549 0.941 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 171.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 389' ' ' HIS . . . . . 0.62 ' CD2' ' HB2' ' B' ' 393' ' ' ASN . 33.0 m170 50.39 -107.34 0.27 Allowed 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 121.113 0.482 . . . . 0.0 109.794 -174.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -140.25 18.49 2.42 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 172.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 391' ' ' LEU . . . . . 0.518 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.5 pt? -165.62 -54.69 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.668 -172.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 392' ' ' GLY . . . . . 0.671 ' HA3' HD13 ' B' ' 395' ' ' ILE . . . -171.46 58.63 0.17 Allowed Glycine 0 CA--C 1.523 0.552 0 C-N-CA 119.755 -1.212 . . . . 0.0 114.452 -173.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 393' ' ' ASN . . . . . 0.639 ' HB3' ' HA ' ' B' ' 388' ' ' MET . 0.2 OUTLIER -59.67 -40.18 86.94 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 117.658 0.729 . . . . 0.0 109.665 174.722 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 394' ' ' VAL . . . . . 0.719 HG23 HD12 ' B' ' 398' ' ' ILE . 1.8 m -56.15 -47.48 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 178.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 395' ' ' ILE . . . . . 0.671 HD13 ' HA3' ' B' ' 392' ' ' GLY . 3.7 mp -57.68 -52.72 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 CA-C-O 117.846 -1.073 . . . . 0.0 113.738 -174.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 396' ' ' LYS . . . . . 0.587 ' O ' HG22 ' B' ' 399' ' ' VAL . 0.0 OUTLIER -63.07 -49.7 73.51 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 122.117 2.235 . . . . 0.0 111.967 -175.3 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -52.94 -44.53 61.78 Favored Glycine 0 N--CA 1.432 -1.621 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.696 -175.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 398' ' ' ILE . . . . . 0.851 HD13 HD12 ' B' ' 410' ' ' LEU . 38.8 mt -71.45 -33.28 49.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -179.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 399' ' ' VAL . . . . . 0.587 HG22 ' O ' ' B' ' 396' ' ' LYS . 15.6 m -63.35 -39.58 85.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 C-N-CA 118.583 -1.247 . . . . 0.0 108.111 -175.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -69.8 -35.83 75.17 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 174.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 401' ' ' GLN . . . . . 0.446 HE21 ' HB3' ' B' ' 401' ' ' GLN . 5.3 mm100 -89.21 -48.01 7.68 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -172.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 402' ' ' GLU . . . . . 0.465 ' HB3' ' HB ' ' B' ' 406' ' ' THR . 2.4 mm-40 -121.09 -20.31 6.85 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.46 -170.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 106.99 161.78 21.91 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.658 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 404' ' ' VAL . . . . . 0.664 HG11 ' HA ' ' B' ' 430' ' ' LEU . 1.4 m -53.67 -45.55 60.65 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -175.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 405' ' ' ALA . . . . . 0.547 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -62.58 -32.36 73.33 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 119.866 -0.734 . . . . 0.0 112.43 -177.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 406' ' ' THR . . . . . 0.678 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 93.7 m -77.72 -41.34 38.17 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.039 -0.664 . . . . 0.0 110.498 174.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 407' ' ' ALA . . . . . 0.44 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.69 -36.37 74.1 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 122.122 0.963 . . . . 0.0 109.135 175.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 408' ' ' TYR . . . . . 0.601 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -66.16 -52.18 50.69 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 113.581 -1.645 . . . . 0.0 109.866 175.905 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 409' ' ' THR . . . . . 0.63 HG22 HD23 ' B' ' 410' ' ' LEU . 17.9 m -54.74 -47.59 73.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.467 178.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 410' ' ' LEU . . . . . 0.851 HD12 HD13 ' B' ' 398' ' ' ILE . 14.6 mt -72.51 -36.48 68.37 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -174.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.57 -34.61 76.87 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 119.891 -1.147 . . . . 0.0 110.481 173.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 412' ' ' MET . . . . . 0.436 ' HB2' ' O ' ' B' ' 409' ' ' THR . 0.5 OUTLIER -67.03 -49.15 66.15 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 115.645 -0.277 . . . . 0.0 111.361 177.665 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 413' ' ' MET . . . . . 0.945 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 1.0 OUTLIER -71.84 -43.64 65.19 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.02 -1.072 . . . . 0.0 112.033 -178.63 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 414' ' ' LEU . . . . . 0.945 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 14.4 mt -69.63 -45.91 67.4 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -176.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 33.4 t -87.27 -23.44 24.69 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.625 0.726 . . . . 0.0 110.12 -175.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 416' ' ' GLY . . . . . . . . . . . . . . . 109.0 -175.81 19.43 Favored Glycine 0 N--CA 1.43 -1.714 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -170.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 33.0 mm-40 -80.48 23.05 0.53 Allowed 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.205 0.526 . . . . 0.0 111.419 -172.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 418' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -72.19 75.54 0.97 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.684 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 419' ' ' TYR . . . . . 0.612 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 10.7 p90 -55.64 -38.04 69.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.204 -179.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -54.91 -43.96 73.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.845 0.355 . . . . 0.0 110.8 178.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.97 -49.34 62.24 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.328 -177.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 422' ' ' VAL . . . . . 0.468 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.1 OUTLIER -64.9 -40.97 90.85 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.105 -177.682 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 423' ' ' SER . . . . . 0.777 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 15.0 t -69.54 -35.84 75.83 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 120.297 -0.561 . . . . 0.0 109.569 -176.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -70.39 -37.19 70.04 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.964 176.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 425' ' ' ILE . . . . . 0.59 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -71.57 -50.57 38.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.655 0.264 . . . . 0.0 110.59 -179.728 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 426' ' ' ILE . . . . . 0.701 HG22 HD22 ' B' ' 430' ' ' LEU . 1.2 mm -73.81 -23.73 19.28 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.042 0 CA-C-O 120.887 0.375 . . . . 0.0 110.163 -173.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 427' ' ' ARG . . . . . 0.777 ' HB2' ' O ' ' B' ' 423' ' ' SER . 1.5 tmm_? -55.03 -32.52 61.92 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.28 0.562 . . . . 0.0 111.134 -177.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.5 -9.44 72.31 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.152 178.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 429' ' ' TYR . . . . . 0.598 ' HD1' HG22 ' B' ' 395' ' ' ILE . 7.5 m-30 -113.98 -0.52 14.06 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -175.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 430' ' ' LEU . . . . . 0.708 HD23 ' HA ' ' B' ' 427' ' ' ARG . 0.0 OUTLIER -66.13 129.26 94.21 Favored Pre-proline 0 N--CA 1.444 -0.772 0 CA-C-N 114.532 -1.213 . . . . 0.0 108.782 178.039 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 431' ' ' PRO . . . . . 0.561 ' HD2' HD12 ' B' ' 430' ' ' LEU . 84.3 Cg_exo -23.4 -74.1 0.02 OUTLIER 'Trans proline' 0 C--N 1.356 0.936 1 C-N-CA 125.698 4.265 . . . . 0.0 114.93 179.708 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 432' ' ' GLY . . . . . 0.541 ' O ' HG12 ' B' ' 435' ' ' VAL . . . -137.57 -170.26 11.84 Favored Glycine 0 N--CA 1.441 -0.978 0 N-CA-C 110.301 -1.119 . . . . 0.0 110.301 176.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 433' ' ' GLN . . . . . 0.449 ' O ' HG13 ' B' ' 436' ' ' VAL . 22.7 tp60 -65.77 -27.51 68.34 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 117.865 0.832 . . . . 0.0 110.266 -179.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -66.3 -40.94 90.32 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.209 -177.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 435' ' ' VAL . . . . . 0.642 HG23 HG11 ' B' ' 463' ' ' VAL . 8.6 p -70.01 -43.32 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-O 120.94 0.4 . . . . 0.0 110.693 -177.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 436' ' ' VAL . . . . . 0.476 HG12 ' O ' ' B' ' 432' ' ' GLY . 0.1 OUTLIER -66.46 -30.53 50.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.049 175.139 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 437' ' ' THR . . . . . 0.513 ' O ' ' HG2' ' B' ' 441' ' ' GLN . 1.0 OUTLIER -67.89 -53.43 26.62 Favored 'General case' 0 C--O 1.204 -1.33 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -179.38 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 438' ' ' ALA . . . . . 0.858 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -59.27 -35.21 73.31 Favored 'General case' 0 N--CA 1.438 -1.049 0 O-C-N 123.869 0.731 . . . . 0.0 111.275 178.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 439' ' ' LEU . . . . . 0.891 HD23 ' NH2' ' B' ' 442' ' ' ARG . 0.4 OUTLIER -67.08 -50.8 60.45 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -179.286 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.45 -34.11 74.88 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 114.354 -1.294 . . . . 0.0 111.252 175.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 441' ' ' GLN . . . . . 0.513 ' HG2' ' O ' ' B' ' 437' ' ' THR . 7.5 mm100 -54.74 -50.01 69.44 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.917 -176.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 442' ' ' ARG . . . . . 0.891 ' NH2' HD23 ' B' ' 439' ' ' LEU . 0.0 OUTLIER -77.86 -25.64 48.78 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 119.502 -0.879 . . . . 0.0 112.709 175.752 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 443' ' ' LEU . . . . . 0.749 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 68.2 mt -67.68 -26.21 66.08 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -64.88 -37.92 89.25 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.95 173.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -76.45 -26.79 55.79 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.444 -1.253 . . . . 0.0 111.043 178.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 446' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 28.6 99.0 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 176.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 50.8 mt -58.96 -34.38 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-O 121.427 0.632 . . . . 0.0 110.601 -179.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 448' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -163.51 -160.89 0.62 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -177.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -82.74 -70.64 0.54 Allowed 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 168.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 450' ' ' GLN . . . . . 0.426 ' HG3' ' H ' ' B' ' 450' ' ' GLN . 0.0 OUTLIER -64.61 -26.31 68.34 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -179.502 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 451' ' ' THR . . . . . 0.417 ' HA ' ' HB2' ' B' ' 454' ' ' GLU . 9.1 m -71.35 -23.19 61.87 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.901 -174.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 452' ' ' ARG . . . . . 0.43 ' NH2' ' HB3' ' B' ' 443' ' ' LEU . 19.4 mtp180 -53.29 -54.45 36.15 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 171.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 453' ' ' ALA . . . . . 0.612 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -60.27 -48.74 80.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.36 -1.291 . . . . 0.0 113.032 175.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 454' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' B' ' 450' ' ' GLN . 78.7 mm-40 -49.1 -38.57 25.16 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.158 0.504 . . . . 0.0 111.73 -175.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 28.4 p -120.58 16.49 12.03 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.163 -175.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 456' ' ' PHE . . . . . 0.499 ' CE2' ' HB2' ' B' ' 419' ' ' TYR . 0.9 OUTLIER -53.41 -48.12 68.98 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.6 -172.273 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 457' ' ' ILE . . . . . 0.547 HG23 ' HB1' ' B' ' 405' ' ' ALA . 1.9 mp -77.41 -35.2 21.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.77 -179.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -56.87 -36.12 69.69 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 122.059 0.933 . . . . 0.0 109.073 172.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 459' ' ' HIS . . . . . 0.767 ' HB3' ' CZ ' ' B' ' 442' ' ' ARG . 81.4 m-70 -75.59 -30.6 59.65 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.707 177.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 460' ' ' LEU . . . . . 0.748 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.6 OUTLIER -67.8 -34.62 77.12 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.843 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 461' ' ' ASN . . . . . 0.456 ' HA ' ' CD2' ' B' ' 464' ' ' TYR . 25.2 m-80 -72.86 -37.51 67.35 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.394 -1.275 . . . . 0.0 109.007 176.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 462' ' ' ALA . . . . . 0.569 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -56.77 -32.65 65.83 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.462 -1.245 . . . . 0.0 110.174 168.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 463' ' ' VAL . . . . . 0.858 HG13 ' HB3' ' B' ' 438' ' ' ALA . 50.2 t -63.93 -49.7 80.63 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.817 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 176.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 464' ' ' TYR . . . . . 0.586 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 18.7 m-30 -52.13 -28.23 17.11 Favored 'General case' 0 C--N 1.332 -0.159 0 O-C-N 124.432 1.082 . . . . 0.0 110.404 176.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.05 -40.1 18.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.525 0.679 . . . . 0.0 109.653 -177.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 466' ' ' ILE . . . . . 0.569 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.7 mt -57.49 -55.12 22.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 114.355 -1.293 . . . . 0.0 112.117 176.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 467' ' ' LEU . . . . . 0.769 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -101.36 -10.73 19.99 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -173.042 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 468' ' ' GLY . . . . . 0.588 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 94.01 31.28 8.2 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 119.412 -1.375 . . . . 0.0 114.343 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 469' ' ' LEU . . . . . 0.769 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.7 mt -89.26 165.08 14.65 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 117.899 0.85 . . . . 0.0 110.859 176.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 36.9 p30 -105.32 -177.75 3.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.817 171.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 471' ' ' ALA . . . . . 0.584 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -65.97 -15.66 63.2 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -176.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 -87.95 -1.74 58.18 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.081 -175.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 473' ' ' GLY . . . . . 0.448 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 79.01 13.06 83.46 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.333 -0.937 . . . . 0.0 110.963 -175.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -100.91 151.63 21.51 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 176.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 475' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' B' ' 469' ' ' LEU . 24.7 t -89.59 135.34 33.66 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.158 0.504 . . . . 0.0 110.299 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 476' ' ' ILE . . . . . 0.588 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.6 pp . . . . . 0 C--N 1.32 -0.711 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.18 -176.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 21.6 ptt180 . . . . . 0 N--CA 1.478 0.964 0 CA-C-O 120.927 0.394 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . 0.435 HG23 ' HD2' ' A' ' 383' ' ' HIS . 0.1 OUTLIER -129.16 -33.12 1.97 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.826 -178.047 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' HIS . . . . . 0.443 ' HB3' ' HB3' ' A' ' 388' ' ' MET . 13.7 p80 -164.03 158.1 19.12 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 121.133 0.492 . . . . 0.0 112.068 -177.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -138.07 -43.77 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.641 177.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 21.0 m -97.49 -55.95 2.67 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.794 0.33 . . . . 0.0 110.88 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' PHE . . . . . 0.793 ' CZ ' HG12 ' A' ' 394' ' ' VAL . 3.4 t80 -76.44 129.22 80.46 Favored Pre-proline 0 C--N 1.329 -0.32 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . 0.586 ' HG2' ' OD1' ' B' ' 393' ' ' ASN . 35.6 Cg_endo -66.88 64.14 0.59 Allowed 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 123.91 3.073 . . . . 0.0 113.562 176.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.806 ' SD ' HG13 ' A' ' 394' ' ' VAL . 5.2 tpp -68.15 164.79 19.59 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.868 176.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' HIS . . . . . 0.616 ' CE1' ' HA ' ' A' ' 393' ' ' ASN . 30.6 m170 -65.25 -160.77 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 172.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -71.34 1.48 6.15 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.196 170.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.586 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.1 pt? -155.23 -63.73 0.12 Allowed 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -177.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . 0.718 ' HA3' HD13 ' A' ' 395' ' ' ILE . . . -158.98 74.93 0.21 Allowed Glycine 0 CA--C 1.523 0.583 0 C-N-CA 120.055 -1.069 . . . . 0.0 114.203 -172.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . 0.616 ' HA ' ' CE1' ' A' ' 389' ' ' HIS . 0.0 OUTLIER -65.76 -42.01 91.38 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 177.696 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.806 HG13 ' SD ' ' A' ' 388' ' ' MET . 0.6 OUTLIER -57.3 -46.23 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 179.754 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.718 HD13 ' HA3' ' A' ' 392' ' ' GLY . 4.1 mp -57.43 -52.15 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 CA-C-O 117.743 -1.122 . . . . 0.0 113.301 -173.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . 0.594 ' O ' HG22 ' A' ' 399' ' ' VAL . 0.1 OUTLIER -62.14 -50.6 71.22 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-N 122.025 2.193 . . . . 0.0 112.198 -176.776 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.76 -44.65 70.14 Favored Glycine 0 N--CA 1.434 -1.463 0 C-N-CA 119.911 -1.138 . . . . 0.0 110.898 -175.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . 0.765 HG12 HD21 ' B' ' 414' ' ' LEU . 27.1 mt -71.22 -34.04 52.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . 0.594 HG22 ' O ' ' A' ' 396' ' ' LYS . 16.1 m -62.7 -40.0 86.86 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 C-N-CA 118.898 -1.121 . . . . 0.0 108.576 -174.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -71.25 -36.99 71.98 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 176.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.421 HE21 ' HB3' ' A' ' 401' ' ' GLN . 4.1 mm100 -88.61 -46.79 8.77 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -171.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . 0.583 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 2.5 mm-40 -120.35 -20.29 7.31 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.484 -171.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 106.58 162.04 22.34 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.922 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . 0.679 HG11 ' HA ' ' A' ' 430' ' ' LEU . 1.5 m -53.61 -45.25 59.53 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.81 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -175.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . 0.565 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -64.37 -30.82 71.86 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 119.784 -0.766 . . . . 0.0 112.489 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.716 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 85.2 m -76.96 -42.53 38.71 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.03 173.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.483 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.57 -36.96 74.78 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 122.141 0.972 . . . . 0.0 109.363 177.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 408' ' ' TYR . . . . . 0.624 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -66.2 -52.1 51.25 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 113.469 -1.696 . . . . 0.0 109.686 176.404 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 409' ' ' THR . . . . . 0.664 HG22 HD23 ' A' ' 410' ' ' LEU . 12.3 m -55.15 -47.46 75.08 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.541 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . 0.739 HD12 ' CD1' ' A' ' 398' ' ' ILE . 13.7 mt -72.25 -35.79 68.88 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.041 0.448 . . . . 0.0 109.983 -175.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.86 -34.72 79.37 Favored Glycine 0 N--CA 1.439 -1.13 0 C-N-CA 120.238 -0.982 . . . . 0.0 110.755 172.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -69.8 -48.01 60.74 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-O 120.532 0.206 . . . . 0.0 111.362 178.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 413' ' ' MET . . . . . 0.936 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.5 OUTLIER -70.56 -42.0 71.69 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 119.082 -1.047 . . . . 0.0 112.256 -178.289 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . 0.936 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 19.4 mt -75.25 -46.45 33.63 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -177.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 25.2 t -86.44 -16.87 35.81 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.757 0.789 . . . . 0.0 109.763 -173.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . 0.438 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 106.4 -178.26 22.5 Favored Glycine 0 N--CA 1.43 -1.702 0 N-CA-C 109.934 -1.267 . . . . 0.0 109.934 -171.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -79.76 24.19 0.4 Allowed 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.262 0.554 . . . . 0.0 111.001 -174.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 418' ' ' ASN . . . . . 0.438 ' H ' ' C ' ' A' ' 416' ' ' GLY . 3.8 m-20 -70.99 75.55 0.65 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.864 -177.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 419' ' ' TYR . . . . . 0.581 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 2.3 p90 -49.11 -40.1 30.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.763 176.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -55.39 -45.85 76.61 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.926 0.393 . . . . 0.0 111.007 178.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.74 -48.75 62.96 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.254 -176.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . 0.444 ' HB ' ' CD1' ' A' ' 408' ' ' TYR . 0.1 OUTLIER -66.14 -41.36 89.26 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.515 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.126 -175.737 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.815 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 76.9 p -66.95 -39.45 87.29 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.906 -178.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.0 -38.91 93.08 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.442 -0.885 . . . . 0.0 111.883 176.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . 0.601 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.94 -52.9 20.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.308 0.099 . . . . 0.0 111.232 -176.956 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . 0.7 HG22 HD22 ' A' ' 430' ' ' LEU . 1.1 mm -74.18 -23.6 18.65 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.758 0 O-C-N 122.199 -0.313 . . . . 0.0 110.21 -171.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.815 ' HB2' ' O ' ' A' ' 423' ' ' SER . 2.3 tmm_? -55.4 -31.5 61.88 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.266 0.555 . . . . 0.0 111.022 -177.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -85.37 -12.3 73.33 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.168 178.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.63 ' HD1' HG22 ' A' ' 395' ' ' ILE . 7.5 m-30 -113.15 -0.08 14.77 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.588 0.709 . . . . 0.0 109.297 -173.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.746 HD23 ' HA ' ' A' ' 427' ' ' ARG . 0.1 OUTLIER -65.97 129.69 94.3 Favored Pre-proline 0 N--CA 1.446 -0.631 0 CA-C-N 114.476 -1.238 . . . . 0.0 109.268 178.159 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . 0.544 ' HD2' HD12 ' A' ' 430' ' ' LEU . 95.4 Cg_exo -24.05 -60.46 0.05 OUTLIER 'Trans proline' 0 C--N 1.359 1.099 1 C-N-CA 125.709 4.273 . . . . 0.0 115.012 179.736 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . 0.566 ' H ' HG12 ' A' ' 435' ' ' VAL . . . -152.68 -170.6 19.26 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 177.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . 0.493 ' O ' HG13 ' A' ' 436' ' ' VAL . 17.2 tp60 -66.76 -26.63 67.07 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 118.026 0.913 . . . . 0.0 110.402 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -65.88 -43.27 88.81 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -177.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 435' ' ' VAL . . . . . 0.726 HG23 HG11 ' A' ' 463' ' ' VAL . 7.5 p -67.32 -42.19 87.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-O 121.082 0.467 . . . . 0.0 110.409 -177.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.515 HG12 ' O ' ' A' ' 432' ' ' GLY . 0.1 OUTLIER -68.08 -30.66 48.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.83 175.643 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.88 -51.84 43.37 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . 0.867 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -58.02 -38.92 77.08 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.929 177.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 439' ' ' LEU . . . . . 0.551 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 1.9 tm? -69.94 -46.96 64.18 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.1 -39.17 74.51 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.109 174.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 441' ' ' GLN . . . . . 0.536 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 8.4 mm-40 -54.46 -49.65 69.57 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 123.776 0.83 . . . . 0.0 110.747 174.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . 0.818 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 0.9 OUTLIER -56.29 -39.92 73.47 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.729 172.294 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 443' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 46.9 mt -71.64 -33.02 68.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.268 0.556 . . . . 0.0 110.062 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -60.55 -37.77 82.31 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.502 174.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -73.02 -28.69 62.5 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.584 177.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 446' ' ' GLU . . . . . 0.551 ' HB2' ' O ' ' A' ' 443' ' ' LEU . 42.0 tt0 31.41 97.06 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.247 1.202 . . . . 0.0 114.247 172.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 49.3 mt -66.34 -36.05 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 121.294 0.569 . . . . 0.0 110.402 178.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . 0.642 ' O ' ' HG3' ' A' ' 452' ' ' ARG . 19.7 m-20 -166.05 -172.4 2.29 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 -179.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -77.58 -61.13 2.09 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.442 175.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.17 -26.1 64.68 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 176.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 451' ' ' THR . . . . . 0.509 ' OG1' ' HB2' ' A' ' 448' ' ' ASP . 18.3 m -71.73 -22.24 61.65 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.437 -175.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . 0.642 ' HG3' ' O ' ' A' ' 448' ' ' ASP . 13.5 mtp180 -52.97 -54.22 38.25 Favored 'General case' 0 C--O 1.218 -0.567 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 170.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 453' ' ' ALA . . . . . 0.581 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -56.99 -50.06 73.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.443 -1.253 . . . . 0.0 112.623 175.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . 0.43 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 40.7 mm-40 -51.41 -35.93 41.33 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.892 -177.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 28.3 p -118.48 16.07 13.79 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.283 -176.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . 0.593 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.9 OUTLIER -56.58 -47.73 78.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.06 0.457 . . . . 0.0 111.656 -171.33 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . 0.565 HG23 ' HB1' ' A' ' 405' ' ' ALA . 1.9 mp -77.32 -33.06 19.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.964 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -58.05 -35.18 70.97 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.889 0.852 . . . . 0.0 109.385 171.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . 0.713 ' O ' HG23 ' A' ' 463' ' ' VAL . 62.1 m-70 -73.81 -28.69 61.75 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.712 177.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . 0.735 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -73.85 -34.69 64.62 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.891 0.853 . . . . 0.0 108.968 178.869 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . 0.458 ' O ' ' HB2' ' A' ' 464' ' ' TYR . 22.4 m-80 -73.37 -37.3 66.06 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.922 0.868 . . . . 0.0 108.899 176.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 462' ' ' ALA . . . . . 0.635 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -56.54 -34.2 66.84 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.848 169.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.867 HG13 ' HB3' ' A' ' 438' ' ' ALA . 56.0 t -61.69 -50.16 81.37 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.796 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.051 175.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 464' ' ' TYR . . . . . 0.578 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 18.6 m-30 -53.1 -28.45 25.49 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.611 177.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.86 -40.35 22.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.842 0.829 . . . . 0.0 109.596 -178.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.635 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.4 mt -58.02 -55.23 23.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 114.196 -1.366 . . . . 0.0 112.308 177.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.755 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -102.26 -10.04 19.89 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -172.89 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . 0.515 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 93.42 31.9 8.08 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 119.173 -1.489 . . . . 0.0 113.932 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 469' ' ' LEU . . . . . 0.755 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.2 mt -89.56 162.84 15.46 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 117.78 0.79 . . . . 0.0 110.732 175.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . 0.479 ' HB3' ' CG2' ' A' ' 476' ' ' ILE . 39.0 p30 -102.64 -179.65 4.03 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.902 171.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 471' ' ' ALA . . . . . 0.566 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -61.04 -22.01 64.16 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -175.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 472' ' ' ARG . . . . . 0.459 ' HA ' ' O ' ' A' ' 402' ' ' GLU . 17.4 mmt180 -88.61 6.79 36.56 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.507 -171.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . 0.434 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 74.34 13.08 81.78 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.455 -0.879 . . . . 0.0 111.114 -177.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -100.6 152.71 20.1 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 24.0 p -91.03 126.79 36.22 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.297 0.57 . . . . 0.0 110.573 176.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 476' ' ' ILE . . . . . 0.515 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.7 pp -87.74 -3.18 9.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.701 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 477' ' ' ARG . . . . . 0.482 ' HD2' ' O ' ' A' ' 477' ' ' ARG . 1.3 ppt_? -123.79 166.1 16.17 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.158 177.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 83.2 mt -112.72 136.5 52.24 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 . . . . . 0 C--O 1.246 0.901 0 CA-C-O 118.653 -0.689 . . . . 0.0 110.357 179.501 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 381' ' ' ARG . . . . . . . . . . . . . 21.2 ptt180 . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 120.943 0.401 . . . . 0.0 110.39 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 382' ' ' THR . . . . . 0.415 HG23 ' HD2' ' B' ' 383' ' ' HIS . 0.1 OUTLIER -128.63 -33.47 2.07 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.706 -178.089 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 383' ' ' HIS . . . . . 0.452 ' HB3' ' HB3' ' B' ' 388' ' ' MET . 13.7 p80 -163.66 158.36 20.36 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 121.179 0.514 . . . . 0.0 112.103 -177.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 384' ' ' GLY . . . . . . . . . . . . . . . -137.77 -44.26 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.6 177.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 385' ' ' THR . . . . . . . . . . . . . 23.1 m -97.0 -56.01 2.69 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.869 0.366 . . . . 0.0 110.907 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 386' ' ' PHE . . . . . 0.791 ' CZ ' HG12 ' B' ' 394' ' ' VAL . 3.5 t80 -76.57 129.13 80.42 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 387' ' ' PRO . . . . . 0.592 ' HG2' ' OD1' ' A' ' 393' ' ' ASN . 35.1 Cg_endo -66.83 63.89 0.58 Allowed 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.928 3.085 . . . . 0.0 113.628 177.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 388' ' ' MET . . . . . 0.815 ' SD ' HG13 ' B' ' 394' ' ' VAL . 5.2 tpp -68.05 164.53 19.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.888 176.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 389' ' ' HIS . . . . . 0.61 ' CE1' ' HA ' ' B' ' 393' ' ' ASN . 30.6 m170 -65.2 -160.49 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 172.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -71.59 1.43 6.62 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.241 170.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 391' ' ' LEU . . . . . 0.588 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.2 pt? -155.15 -64.14 0.12 Allowed 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -176.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 392' ' ' GLY . . . . . 0.715 ' HA3' HD13 ' B' ' 395' ' ' ILE . . . -158.55 74.94 0.21 Allowed Glycine 0 CA--C 1.524 0.635 0 C-N-CA 119.988 -1.101 . . . . 0.0 114.243 -172.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 393' ' ' ASN . . . . . 0.61 ' HA ' ' CE1' ' B' ' 389' ' ' HIS . 0.0 OUTLIER -65.74 -42.03 91.49 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 177.697 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 394' ' ' VAL . . . . . 0.815 HG13 ' SD ' ' B' ' 388' ' ' MET . 0.6 OUTLIER -57.27 -46.18 85.06 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 179.72 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 395' ' ' ILE . . . . . 0.715 HD13 ' HA3' ' B' ' 392' ' ' GLY . 4.1 mp -57.53 -52.06 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.575 0 CA-C-O 117.792 -1.099 . . . . 0.0 113.381 -173.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 396' ' ' LYS . . . . . 0.593 ' O ' HG22 ' B' ' 399' ' ' VAL . 0.1 OUTLIER -62.19 -50.67 70.88 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 122.021 2.191 . . . . 0.0 112.178 -176.838 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.7 -44.62 69.47 Favored Glycine 0 N--CA 1.435 -1.421 0 C-N-CA 119.904 -1.141 . . . . 0.0 110.848 -175.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . 0.763 HG12 HD21 ' A' ' 414' ' ' LEU . 27.0 mt -71.25 -34.08 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -178.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 399' ' ' VAL . . . . . 0.593 HG22 ' O ' ' B' ' 396' ' ' LYS . 16.1 m -62.58 -40.07 86.93 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 C-N-CA 118.778 -1.169 . . . . 0.0 108.594 -174.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -71.28 -36.76 71.82 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 176.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 401' ' ' GLN . . . . . 0.454 HE21 ' HB3' ' B' ' 401' ' ' GLN . 4.2 mm100 -88.73 -46.72 8.77 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -171.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 402' ' ' GLU . . . . . 0.57 ' HG3' ' HE3' ' A' ' 413' ' ' MET . 2.4 mm-40 -120.52 -20.11 7.27 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.504 -171.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 106.49 162.08 22.42 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.834 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 404' ' ' VAL . . . . . 0.669 HG11 ' HA ' ' B' ' 430' ' ' LEU . 1.5 m -53.66 -45.35 60.28 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.802 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -175.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 405' ' ' ALA . . . . . 0.565 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -64.28 -30.89 71.92 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.425 -177.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 406' ' ' THR . . . . . 0.694 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 87.6 m -76.93 -42.61 38.69 Favored 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 120.099 -0.64 . . . . 0.0 109.986 173.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 407' ' ' ALA . . . . . 0.468 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.56 -37.06 74.93 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 122.171 0.986 . . . . 0.0 109.434 176.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 408' ' ' TYR . . . . . 0.619 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -66.04 -52.08 52.35 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 113.452 -1.704 . . . . 0.0 109.682 176.395 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 409' ' ' THR . . . . . 0.659 HG22 HD23 ' B' ' 410' ' ' LEU . 10.1 m -55.35 -47.4 75.78 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.69 -0.687 . . . . 0.0 112.571 178.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 410' ' ' LEU . . . . . 0.751 HD12 HD13 ' B' ' 398' ' ' ILE . 13.7 mt -72.14 -35.93 69.23 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 120.992 0.425 . . . . 0.0 109.925 -175.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.77 -34.75 78.85 Favored Glycine 0 N--CA 1.438 -1.192 0 C-N-CA 120.236 -0.983 . . . . 0.0 110.779 172.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 412' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -69.85 -47.87 61.03 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-O 120.574 0.226 . . . . 0.0 111.346 178.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 413' ' ' MET . . . . . 0.932 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.5 OUTLIER -70.58 -42.11 71.49 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 119.035 -1.066 . . . . 0.0 112.211 -178.334 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 414' ' ' LEU . . . . . 0.932 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 19.4 mt -75.32 -46.34 33.96 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -176.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 24.8 t -86.34 -16.99 35.71 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.806 0.812 . . . . 0.0 109.717 -173.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 416' ' ' GLY . . . . . 0.443 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 106.33 -178.26 22.55 Favored Glycine 0 N--CA 1.431 -1.662 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 -171.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 33.0 mm-40 -79.72 24.44 0.38 Allowed 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.151 0.5 . . . . 0.0 110.94 -174.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 418' ' ' ASN . . . . . 0.443 ' H ' ' C ' ' B' ' 416' ' ' GLY . 3.9 m-20 -71.19 75.87 0.7 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.807 -177.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 419' ' ' TYR . . . . . 0.585 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 2.2 p90 -49.27 -40.06 33.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.801 -1.09 . . . . 0.0 111.789 176.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -55.33 -46.12 76.37 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.774 0.321 . . . . 0.0 110.963 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.66 -48.81 63.01 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.172 -176.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 422' ' ' VAL . . . . . 0.445 ' HB ' ' CD1' ' B' ' 408' ' ' TYR . 0.1 OUTLIER -66.03 -41.4 89.59 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 C-N-CA 120.371 -0.531 . . . . 0.0 111.076 -175.898 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 423' ' ' SER . . . . . 0.806 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 76.3 p -66.89 -39.33 87.44 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.883 -178.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.08 -38.98 92.8 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.922 176.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 425' ' ' ILE . . . . . 0.616 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -73.05 -52.79 20.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.318 0.104 . . . . 0.0 111.161 -176.869 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 426' ' ' ILE . . . . . 0.691 HG22 HD22 ' B' ' 430' ' ' LEU . 1.1 mm -74.23 -23.55 18.55 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.863 0 O-C-N 122.185 -0.322 . . . . 0.0 110.164 -171.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 427' ' ' ARG . . . . . 0.806 ' HB2' ' O ' ' B' ' 423' ' ' SER . 2.3 tmm_? -55.58 -31.36 62.13 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.221 0.534 . . . . 0.0 110.928 -177.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -85.38 -12.27 73.4 Favored Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.429 -0.891 . . . . 0.0 111.11 178.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 429' ' ' TYR . . . . . 0.629 ' HD1' HG22 ' B' ' 395' ' ' ILE . 7.3 m-30 -113.26 0.27 14.81 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.558 0.694 . . . . 0.0 109.227 -173.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 430' ' ' LEU . . . . . 0.749 HD23 ' HA ' ' B' ' 427' ' ' ARG . 0.1 OUTLIER -66.27 129.71 94.21 Favored Pre-proline 0 N--CA 1.445 -0.696 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.23 178.101 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 431' ' ' PRO . . . . . 0.533 ' HD2' HD12 ' B' ' 430' ' ' LEU . 95.0 Cg_exo -24.06 -60.35 0.05 OUTLIER 'Trans proline' 0 C--N 1.36 1.148 1 C-N-CA 125.602 4.201 . . . . 0.0 115.094 179.747 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 432' ' ' GLY . . . . . 0.576 ' H ' HG12 ' B' ' 435' ' ' VAL . . . -153.18 -171.5 20.53 Favored Glycine 0 N--CA 1.443 -0.887 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 177.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 433' ' ' GLN . . . . . 0.505 ' O ' HG13 ' B' ' 436' ' ' VAL . 16.3 tp60 -66.09 -26.89 67.68 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 118.088 0.944 . . . . 0.0 110.368 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -65.44 -43.42 90.51 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -178.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 435' ' ' VAL . . . . . 0.716 HG23 HG11 ' B' ' 463' ' ' VAL . 7.6 p -67.32 -42.31 87.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 121.104 0.478 . . . . 0.0 110.423 -176.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 436' ' ' VAL . . . . . 0.505 HG13 ' O ' ' B' ' 433' ' ' GLN . 0.1 OUTLIER -68.02 -30.58 48.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.838 175.698 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.93 -51.9 42.4 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 438' ' ' ALA . . . . . 0.854 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -58.11 -38.65 76.86 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.916 177.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 439' ' ' LEU . . . . . 0.562 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 1.9 tm? -70.27 -46.93 63.38 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.03 -39.23 74.41 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.127 174.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 441' ' ' GLN . . . . . 0.531 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 8.3 mm-40 -54.24 -49.89 68.44 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 123.888 0.875 . . . . 0.0 110.795 174.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 442' ' ' ARG . . . . . 0.827 ' HG2' ' O ' ' B' ' 438' ' ' ALA . 0.9 OUTLIER -56.17 -39.86 73.03 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.65 172.364 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 443' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 47.1 mt -71.74 -32.85 68.16 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.217 0.532 . . . . 0.0 110.119 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -60.76 -37.61 82.4 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.463 174.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -73.28 -28.42 62.1 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.554 177.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 446' ' ' GLU . . . . . 0.552 ' HB2' ' O ' ' B' ' 443' ' ' LEU . 41.3 tt0 31.26 97.02 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 172.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 49.9 mt -66.7 -35.83 75.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.37 0.605 . . . . 0.0 110.343 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 448' ' ' ASP . . . . . 0.646 ' O ' ' HG3' ' B' ' 452' ' ' ARG . 17.5 m-20 -166.12 -172.62 2.34 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -77.51 -61.15 2.08 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.432 175.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.05 -26.14 64.82 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 176.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 451' ' ' THR . . . . . 0.506 ' OG1' ' HB2' ' B' ' 448' ' ' ASP . 18.6 m -71.72 -22.1 61.68 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.538 -175.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 452' ' ' ARG . . . . . 0.646 ' HG3' ' O ' ' B' ' 448' ' ' ASP . 13.4 mtp180 -53.07 -54.1 40.54 Favored 'General case' 0 C--O 1.218 -0.553 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 170.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 453' ' ' ALA . . . . . 0.585 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -57.09 -50.11 73.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.381 -1.281 . . . . 0.0 112.585 175.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 454' ' ' GLU . . . . . 0.425 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 45.5 mm-40 -51.4 -36.0 41.6 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.803 -177.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 27.2 p -118.36 16.1 13.89 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.264 -176.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 456' ' ' PHE . . . . . 0.602 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 0.9 OUTLIER -56.65 -47.76 79.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.076 0.465 . . . . 0.0 111.612 -171.178 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 457' ' ' ILE . . . . . 0.565 HG23 ' HB1' ' B' ' 405' ' ' ALA . 1.9 mp -77.16 -33.14 19.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.979 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -58.05 -35.14 70.9 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.88 0.848 . . . . 0.0 109.393 172.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 459' ' ' HIS . . . . . 0.714 ' O ' HG23 ' B' ' 463' ' ' VAL . 62.0 m-70 -73.83 -28.77 61.77 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.731 177.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 460' ' ' LEU . . . . . 0.738 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -73.89 -34.64 64.5 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.906 0.86 . . . . 0.0 108.994 178.881 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 461' ' ' ASN . . . . . 0.453 ' O ' ' HB2' ' B' ' 464' ' ' TYR . 21.7 m-80 -73.25 -37.28 66.39 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.877 0.846 . . . . 0.0 108.869 176.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 462' ' ' ALA . . . . . 0.643 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -56.61 -34.05 66.85 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.981 169.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 463' ' ' VAL . . . . . 0.854 HG13 ' HB3' ' B' ' 438' ' ' ALA . 55.9 t -61.71 -50.07 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-N 114.642 -1.163 . . . . 0.0 107.999 175.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 464' ' ' TYR . . . . . 0.568 ' CE2' ' HA ' ' B' ' 471' ' ' ALA . 18.5 m-30 -53.1 -28.34 24.88 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 114.678 -1.147 . . . . 0.0 110.633 177.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.11 -40.24 22.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.906 0.86 . . . . 0.0 109.62 -178.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 466' ' ' ILE . . . . . 0.643 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.4 mt -57.91 -55.35 22.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 114.209 -1.36 . . . . 0.0 112.235 176.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 467' ' ' LEU . . . . . 0.761 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -102.42 -10.0 19.79 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 114.474 1.286 . . . . 0.0 114.474 -172.821 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 468' ' ' GLY . . . . . 0.518 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 93.46 31.87 8.08 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 119.081 -1.533 . . . . 0.0 113.91 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 469' ' ' LEU . . . . . 0.761 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.2 mt -89.76 162.53 15.49 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 117.677 0.738 . . . . 0.0 110.795 175.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 470' ' ' ASN . . . . . 0.492 ' HB3' ' CG2' ' B' ' 476' ' ' ILE . 39.4 p30 -102.48 -179.54 4.01 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.889 171.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 471' ' ' ALA . . . . . 0.568 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -61.6 -21.64 64.52 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -175.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 472' ' ' ARG . . . . . 0.463 ' HA ' ' O ' ' B' ' 402' ' ' GLU . 17.2 mmt180 -88.67 6.74 37.01 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.431 -171.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 473' ' ' GLY . . . . . 0.431 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 74.5 12.8 82.21 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.145 -177.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -100.4 152.92 19.78 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 25.1 p -91.06 127.03 36.32 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.367 0.603 . . . . 0.0 110.522 176.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 476' ' ' ILE . . . . . 0.518 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.7 pp -88.09 -3.01 9.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 114.92 -1.037 . . . . 0.0 110.621 -179.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 477' ' ' ARG . . . . . 0.473 ' HD2' ' O ' ' B' ' 477' ' ' ARG . 1.3 ppt_? -123.97 166.23 16.06 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.176 177.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 478' ' ' LEU . . . . . . . . . . . . . 83.5 mt -112.86 135.95 53.05 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 479' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.345 -0.836 . . . . 0.0 110.068 178.948 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 . . . . . 0 N--CA 1.481 1.088 0 CA-C-O 120.823 0.344 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -114.61 -30.19 6.58 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -178.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' HIS . . . . . 0.413 ' HB2' ' O ' ' A' ' 386' ' ' PHE . 2.5 p80 -152.03 161.07 43.21 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 119.942 -0.703 . . . . 0.0 111.844 -171.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -110.77 -115.45 3.6 Favored Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 171.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 18.8 m -65.04 -37.08 86.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.195 0.521 . . . . 0.0 111.067 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' PHE . . . . . 0.715 ' CD1' HD22 ' A' ' 414' ' ' LEU . 1.4 t80 -79.9 129.72 69.55 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.012 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -49.27 -72.84 0.04 OUTLIER 'Trans proline' 0 N--CA 1.485 0.995 0 C-N-CA 124.309 3.339 . . . . 0.0 114.418 -178.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.612 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 38.9 ttm 74.36 49.36 0.11 Allowed 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 172.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' HIS . . . . . 0.703 ' CG ' ' HB2' ' A' ' 393' ' ' ASN . 40.7 m170 47.31 -99.44 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.25 0.62 . . . . 0.0 110.642 -175.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -146.36 15.71 1.3 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.469 -0.787 . . . . 0.0 108.884 174.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.489 HD23 ' H ' ' A' ' 392' ' ' GLY . 2.4 pt? -169.15 -50.97 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -168.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . 0.539 ' HA3' HD13 ' A' ' 395' ' ' ILE . . . -176.47 50.89 0.11 Allowed Glycine 0 C--N 1.335 0.495 0 C-N-CA 119.609 -1.282 . . . . 0.0 114.214 -172.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . 0.703 ' HB2' ' CG ' ' A' ' 389' ' ' HIS . 0.4 OUTLIER -54.21 -41.31 68.48 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 117.401 0.6 . . . . 0.0 109.679 176.761 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.67 HG12 ' CE2' ' A' ' 386' ' ' PHE . 0.9 OUTLIER -56.85 -47.08 83.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 -179.249 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.669 HG23 HD13 ' A' ' 426' ' ' ILE . 4.3 mp -57.87 -52.22 60.66 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 CA-C-O 117.938 -1.03 . . . . 0.0 113.307 -175.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . 0.704 ' HG3' ' CZ ' ' A' ' 429' ' ' TYR . 0.1 OUTLIER -62.98 -49.88 72.95 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 121.692 2.042 . . . . 0.0 112.069 -174.165 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . 0.538 ' O ' ' HG3' ' A' ' 401' ' ' GLN . . . -54.32 -44.67 76.02 Favored Glycine 0 N--CA 1.435 -1.387 0 C-N-CA 120.099 -1.048 . . . . 0.0 111.035 -177.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . 0.874 HD13 HD12 ' A' ' 410' ' ' LEU . 45.4 mt -71.6 -34.37 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -177.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . 0.528 HG12 ' HA ' ' A' ' 404' ' ' VAL . 5.4 m -64.09 -39.99 87.46 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 C-N-CA 118.738 -1.185 . . . . 0.0 108.408 -174.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -64.74 -41.24 96.08 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 174.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.538 ' HG3' ' O ' ' A' ' 397' ' ' GLY . 32.1 mt-30 -93.07 -48.39 6.52 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -169.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . 0.679 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 3.0 mm-40 -113.42 -20.11 11.44 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.448 -171.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 104.77 163.21 24.15 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.125 -0.559 . . . . 0.0 113.137 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . 0.655 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.5 m -53.43 -45.21 57.37 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.752 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 -176.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . 0.546 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -66.41 -30.87 71.34 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.994 -175.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.711 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 92.4 m -77.23 -42.35 37.68 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.241 173.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.51 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.21 -37.71 75.37 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 122.049 0.928 . . . . 0.0 109.215 176.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 408' ' ' TYR . . . . . 0.655 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.64 -52.39 52.15 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 113.593 -1.64 . . . . 0.0 109.961 177.115 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 409' ' ' THR . . . . . 0.734 HG22 HD23 ' A' ' 410' ' ' LEU . 2.7 m -56.22 -46.23 79.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.505 178.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . 0.874 HD12 HD13 ' A' ' 398' ' ' ILE . 13.4 mt -72.03 -36.74 69.75 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 -175.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.6 -34.66 77.25 Favored Glycine 0 N--CA 1.44 -1.094 0 C-N-CA 120.085 -1.055 . . . . 0.0 110.708 172.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 412' ' ' MET . . . . . 0.412 ' HB2' ' O ' ' A' ' 409' ' ' THR . 0.4 OUTLIER -67.19 -48.21 68.6 Favored 'General case' 0 C--O 1.221 -0.438 0 C-N-CA 122.129 0.172 . . . . 0.0 111.403 177.672 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 413' ' ' MET . . . . . 0.944 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.7 OUTLIER -71.52 -47.73 53.4 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 118.848 -1.141 . . . . 0.0 112.103 -179.935 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . 0.944 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 23.3 mt -67.43 -44.24 79.24 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -175.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 48.1 t -86.97 -23.76 24.96 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.503 0.668 . . . . 0.0 110.011 -177.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . 0.447 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 109.69 -175.62 18.84 Favored Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -170.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -79.65 24.3 0.38 Allowed 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.495 0.664 . . . . 0.0 111.291 -172.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 418' ' ' ASN . . . . . 0.447 ' H ' ' C ' ' A' ' 416' ' ' GLY . 79.6 m-20 -71.67 76.04 0.83 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.651 -178.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 419' ' ' TYR . . . . . 0.537 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 12.0 p90 -55.21 -39.0 69.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.537 178.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -55.71 -43.48 76.52 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.833 0.349 . . . . 0.0 111.166 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . 0.401 HD22 ' HB2' ' A' ' 418' ' ' ASN . 0.0 OUTLIER -68.22 -48.68 64.53 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.951 -177.621 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . 0.43 ' HB ' ' CD1' ' A' ' 408' ' ' TYR . 0.2 OUTLIER -66.36 -39.52 84.34 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.155 -177.277 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.746 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 68.4 p -66.84 -39.38 87.62 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.93 -39.2 89.41 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.199 176.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . 0.596 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.79 -51.75 25.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 121.176 -0.209 . . . . 0.0 111.114 -177.375 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . 0.681 HG22 HD22 ' A' ' 430' ' ' LEU . 1.2 mm -74.27 -22.88 18.14 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.625 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -172.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.746 ' HB2' ' O ' ' A' ' 423' ' ' SER . 0.7 OUTLIER -54.86 -31.45 59.65 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.25 0.548 . . . . 0.0 110.149 -179.728 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -85.31 -5.16 85.57 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.667 178.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.704 ' CZ ' ' HG3' ' A' ' 396' ' ' LYS . 24.9 m-85 -119.76 0.69 10.95 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 121.08 0.467 . . . . 0.0 110.666 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.726 HD23 ' HA ' ' A' ' 427' ' ' ARG . 0.1 OUTLIER -65.94 127.9 93.46 Favored Pre-proline 0 N--CA 1.438 -1.044 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.735 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . 0.475 ' HD2' HD12 ' A' ' 430' ' ' LEU . 80.9 Cg_exo -23.41 -70.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.892 1 C-N-CA 125.627 4.218 . . . . 0.0 115.082 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . 0.482 ' O ' HG12 ' A' ' 435' ' ' VAL . . . -138.17 -167.4 10.99 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 176.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . 0.478 ' O ' HG13 ' A' ' 436' ' ' VAL . 19.2 tp60 -69.41 -26.92 64.86 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 117.831 0.815 . . . . 0.0 110.165 179.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -68.24 -39.04 82.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.357 -176.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 435' ' ' VAL . . . . . 0.767 HG23 HG11 ' A' ' 463' ' ' VAL . 7.2 p -69.48 -44.01 80.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-O 120.972 0.415 . . . . 0.0 110.527 -177.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.478 HG13 ' O ' ' A' ' 433' ' ' GLN . 0.2 OUTLIER -65.33 -31.36 53.52 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 174.825 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 1.1 m -67.22 -52.82 36.35 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -178.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . 0.853 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -58.89 -39.16 80.62 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.12 177.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 439' ' ' LEU . . . . . 0.638 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 1.9 tm? -68.13 -48.52 65.17 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -178.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.21 -35.02 72.87 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.519 -1.219 . . . . 0.0 111.171 174.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 441' ' ' GLN . . . . . 0.5 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 3.7 mm-40 -55.13 -49.68 71.17 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.122 -177.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . 0.622 ' HG3' ' CG ' ' A' ' 459' ' ' HIS . 0.0 OUTLIER -75.8 -24.64 55.94 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 119.563 -0.855 . . . . 0.0 113.032 175.073 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 443' ' ' LEU . . . . . 0.638 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 70.1 mt -64.18 -35.29 80.3 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-N 118.453 0.569 . . . . 0.0 109.601 175.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -57.0 -37.96 72.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.524 173.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 -74.34 -26.75 60.34 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.312 177.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 27.59 98.86 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 176.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 49.2 mt -60.9 -35.13 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-O 121.266 0.555 . . . . 0.0 110.689 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . 0.466 ' HB2' ' OG1' ' A' ' 451' ' ' THR . 18.4 m-20 -163.66 -161.79 0.67 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 -177.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -82.38 -69.56 0.61 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 172.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 450' ' ' GLN . . . . . 0.417 ' HG3' ' H ' ' A' ' 450' ' ' GLN . 0.0 OUTLIER -66.81 -24.78 66.21 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 178.059 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 451' ' ' THR . . . . . 0.466 ' OG1' ' HB2' ' A' ' 448' ' ' ASP . 14.0 m -70.62 -22.55 62.51 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.788 -173.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 452' ' ' ARG . 18.3 mtp180 -54.1 -54.22 42.5 Favored 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 171.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 453' ' ' ALA . . . . . 0.537 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -59.13 -47.1 86.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.524 -1.216 . . . . 0.0 112.604 175.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . 0.446 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 12.0 mm-40 -51.58 -38.39 54.23 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.203 0.525 . . . . 0.0 111.478 -177.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 28.1 p -116.36 15.44 15.78 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.422 -175.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . 0.511 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.7 OUTLIER -56.74 -48.99 76.54 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 120.951 0.405 . . . . 0.0 111.777 -171.472 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . 0.546 HG23 ' HB1' ' A' ' 405' ' ' ALA . 1.9 mp -75.45 -32.93 26.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 120.841 0.353 . . . . 0.0 110.713 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -57.63 -35.51 70.58 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.694 0.759 . . . . 0.0 109.586 171.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . 0.752 ' O ' HG23 ' A' ' 463' ' ' VAL . 71.3 m-70 -71.74 -29.57 64.67 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.755 -1.112 . . . . 0.0 110.613 176.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . 0.712 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -74.08 -34.81 64.14 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.912 0.863 . . . . 0.0 108.787 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -72.84 -38.17 67.19 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.311 175.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 462' ' ' ALA . . . . . 0.627 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -55.82 -32.93 64.0 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.807 169.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.853 HG13 ' HB3' ' A' ' 438' ' ' ALA . 61.6 t -63.89 -50.57 76.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 CA-C-N 114.474 -1.239 . . . . 0.0 107.901 177.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 464' ' ' TYR . . . . . 0.567 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 15.3 m-30 -53.89 -27.16 28.69 Favored 'General case' 0 C--N 1.332 -0.169 0 O-C-N 124.259 0.974 . . . . 0.0 110.324 178.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.68 -40.95 18.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.689 0.757 . . . . 0.0 109.38 -177.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.627 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.7 mt -56.22 -55.82 16.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 114.295 -1.32 . . . . 0.0 112.289 175.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.761 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -103.41 -10.82 18.3 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -171.752 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . 0.561 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 93.73 31.74 8.05 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 119.43 -1.367 . . . . 0.0 114.351 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 469' ' ' LEU . . . . . 0.761 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 2.6 mt -88.91 162.3 16.19 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 117.983 0.892 . . . . 0.0 111.435 177.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 39.5 p30 -105.29 -174.45 2.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.349 173.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -67.02 -17.49 64.94 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -175.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -88.48 -0.43 57.2 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 122.101 -0.375 . . . . 0.0 111.321 -175.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 75.85 17.08 80.25 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -173.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -101.55 151.6 21.78 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 177.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 5.6 p -90.61 127.76 36.38 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.95 0.405 . . . . 0.0 111.169 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 476' ' ' ILE . . . . . 0.561 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.5 pp -98.23 10.0 6.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.806 0.812 . . . . 0.0 110.282 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 28.6 mmm180 -77.37 -172.3 2.43 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.959 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . 0.404 ' N ' HD12 ' A' ' 478' ' ' LEU . 6.1 mp -80.0 -43.26 22.3 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 . . . . . 0 C--O 1.247 0.94 0 CA-C-O 118.399 -0.81 . . . . 0.0 109.961 179.309 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 381' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 . . . . . 0 N--CA 1.48 1.031 0 CA-C-O 120.756 0.312 . . . . 0.0 110.254 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 382' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -114.61 -30.18 6.58 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -178.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 383' ' ' HIS . . . . . 0.407 ' HB2' ' O ' ' B' ' 386' ' ' PHE . 2.4 p80 -152.23 160.81 43.3 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 119.931 -0.708 . . . . 0.0 111.992 -171.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 384' ' ' GLY . . . . . . . . . . . . . . . -110.74 -116.26 3.67 Favored Glycine 0 N--CA 1.44 -1.098 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.269 171.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 385' ' ' THR . . . . . . . . . . . . . 19.3 m -64.37 -36.92 85.72 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.167 0.508 . . . . 0.0 111.154 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 386' ' ' PHE . . . . . 0.733 ' CD1' HD22 ' B' ' 414' ' ' LEU . 1.4 t80 -79.96 130.01 68.31 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.012 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 387' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -49.32 -72.67 0.04 OUTLIER 'Trans proline' 0 N--CA 1.487 1.13 0 C-N-CA 124.492 3.461 . . . . 0.0 114.375 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 388' ' ' MET . . . . . 0.61 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 38.9 ttm 73.98 49.54 0.12 Allowed 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 112.754 0.649 . . . . 0.0 112.754 172.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 389' ' ' HIS . . . . . 0.716 ' CG ' ' HB2' ' B' ' 393' ' ' ASN . 40.7 m170 47.32 -99.84 0.05 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.22 0.608 . . . . 0.0 110.499 -175.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -145.99 15.49 1.36 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.823 174.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 391' ' ' LEU . . . . . 0.482 HD23 ' H ' ' B' ' 392' ' ' GLY . 2.4 pt? -169.15 -50.89 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -168.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 392' ' ' GLY . . . . . 0.547 ' HA3' HD13 ' B' ' 395' ' ' ILE . . . -176.51 51.14 0.11 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 119.599 -1.286 . . . . 0.0 114.25 -172.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 393' ' ' ASN . . . . . 0.716 ' HB2' ' CG ' ' B' ' 389' ' ' HIS . 0.4 OUTLIER -54.47 -41.19 69.21 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 117.359 0.579 . . . . 0.0 109.705 176.914 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 394' ' ' VAL . . . . . 0.672 HG12 ' CE2' ' B' ' 386' ' ' PHE . 0.9 OUTLIER -56.86 -47.2 83.41 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 -179.29 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 395' ' ' ILE . . . . . 0.653 HG23 HD13 ' B' ' 426' ' ' ILE . 4.3 mp -57.86 -52.15 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 CA-C-O 117.824 -1.084 . . . . 0.0 113.31 -175.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 396' ' ' LYS . . . . . 0.695 ' HG3' ' CZ ' ' B' ' 429' ' ' TYR . 0.1 OUTLIER -62.95 -49.8 73.31 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 121.714 2.052 . . . . 0.0 112.12 -174.201 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 397' ' ' GLY . . . . . 0.537 ' O ' ' HG3' ' B' ' 401' ' ' GLN . . . -54.51 -44.47 77.96 Favored Glycine 0 N--CA 1.436 -1.355 0 C-N-CA 120.05 -1.071 . . . . 0.0 110.986 -177.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . 0.883 HD13 HD12 ' B' ' 410' ' ' LEU . 46.2 mt -71.71 -34.27 51.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -177.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 399' ' ' VAL . . . . . 0.527 HG12 ' HA ' ' B' ' 404' ' ' VAL . 5.5 m -64.21 -39.82 86.85 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.501 0 C-N-CA 118.836 -1.145 . . . . 0.0 108.457 -174.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -64.96 -41.11 95.75 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 174.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 401' ' ' GLN . . . . . 0.537 ' HG3' ' O ' ' B' ' 397' ' ' GLY . 32.3 mt-30 -93.13 -48.29 6.55 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -169.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 402' ' ' GLU . . . . . 0.684 ' HG3' ' HE3' ' A' ' 413' ' ' MET . 3.0 mm-40 -113.61 -19.99 11.39 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.44 -171.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 104.58 162.83 24.3 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.061 -0.59 . . . . 0.0 113.224 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 404' ' ' VAL . . . . . 0.647 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.4 m -53.21 -45.32 54.73 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.766 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -176.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 405' ' ' ALA . . . . . 0.554 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -66.23 -30.71 71.22 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 119.711 -0.795 . . . . 0.0 112.062 -175.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 406' ' ' THR . . . . . 0.701 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 88.2 m -77.26 -42.51 36.84 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.303 173.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 407' ' ' ALA . . . . . 0.502 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.09 -37.75 75.1 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 122.093 0.949 . . . . 0.0 109.2 176.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 408' ' ' TYR . . . . . 0.647 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.51 -52.58 51.69 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 113.631 -1.622 . . . . 0.0 109.975 177.028 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 409' ' ' THR . . . . . 0.74 HG22 HD23 ' B' ' 410' ' ' LEU . 2.7 m -56.17 -46.17 79.44 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.569 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 410' ' ' LEU . . . . . 0.883 HD12 HD13 ' B' ' 398' ' ' ILE . 13.2 mt -71.95 -36.74 69.98 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.808 0.337 . . . . 0.0 110.2 -175.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.51 -34.8 77.21 Favored Glycine 0 N--CA 1.439 -1.109 0 C-N-CA 120.04 -1.076 . . . . 0.0 110.729 172.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 412' ' ' MET . . . . . 0.413 ' HB2' ' O ' ' B' ' 409' ' ' THR . 0.4 OUTLIER -67.11 -48.14 69.01 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 115.808 -0.196 . . . . 0.0 111.423 177.76 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 413' ' ' MET . . . . . 0.931 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.7 OUTLIER -71.38 -48.1 52.11 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 118.884 -1.126 . . . . 0.0 112.119 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 414' ' ' LEU . . . . . 0.931 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 23.4 mt -67.2 -44.24 80.11 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -175.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 48.1 t -86.81 -24.11 25.12 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.592 0.711 . . . . 0.0 109.907 -177.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 416' ' ' GLY . . . . . 0.449 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 109.98 -175.52 18.58 Favored Glycine 0 N--CA 1.43 -1.715 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -170.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -79.71 24.47 0.38 Allowed 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.61 0.719 . . . . 0.0 111.326 -172.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 418' ' ' ASN . . . . . 0.449 ' H ' ' C ' ' B' ' 416' ' ' GLY . 79.9 m-20 -71.75 75.71 0.85 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.785 -178.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 419' ' ' TYR . . . . . 0.531 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 11.8 p90 -54.89 -38.9 68.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.598 178.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -55.73 -43.57 76.69 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.739 0.304 . . . . 0.0 111.061 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 421' ' ' LEU . . . . . 0.416 HD22 ' HB2' ' B' ' 418' ' ' ASN . 0.0 OUTLIER -68.15 -48.63 64.84 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.013 -177.576 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 422' ' ' VAL . . . . . 0.43 ' HB ' ' CD1' ' B' ' 408' ' ' TYR . 0.2 OUTLIER -66.41 -39.44 84.07 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.212 -177.365 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 423' ' ' SER . . . . . 0.771 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 67.3 p -66.97 -39.33 87.18 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.98 -39.11 89.24 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.161 176.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 425' ' ' ILE . . . . . 0.608 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -72.79 -51.7 26.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 116.622 0.211 . . . . 0.0 111.121 -177.334 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 426' ' ' ILE . . . . . 0.677 HG22 HD22 ' B' ' 430' ' ' LEU . 1.2 mm -74.3 -23.06 18.17 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.708 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -172.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 427' ' ' ARG . . . . . 0.771 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.7 OUTLIER -54.75 -31.34 58.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.344 0.592 . . . . 0.0 110.305 -179.769 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -85.5 -4.74 85.47 Favored Glycine 0 N--CA 1.446 -0.7 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.65 178.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 429' ' ' TYR . . . . . 0.695 ' CZ ' ' HG3' ' B' ' 396' ' ' LYS . 24.9 m-85 -120.13 0.52 10.72 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 121.105 0.479 . . . . 0.0 110.693 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 430' ' ' LEU . . . . . 0.711 HD23 ' HA ' ' B' ' 427' ' ' ARG . 0.1 OUTLIER -65.77 127.87 93.4 Favored Pre-proline 0 N--CA 1.44 -0.972 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.634 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 431' ' ' PRO . . . . . 0.474 ' HD2' HD12 ' B' ' 430' ' ' LEU . 84.1 Cg_exo -23.47 -70.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.832 1 C-N-CA 125.665 4.243 . . . . 0.0 115.011 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 432' ' ' GLY . . . . . 0.488 ' O ' HG12 ' B' ' 435' ' ' VAL . . . -138.12 -167.54 11.04 Favored Glycine 0 N--CA 1.442 -0.921 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 176.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 433' ' ' GLN . . . . . 0.474 ' O ' HG13 ' B' ' 436' ' ' VAL . 19.1 tp60 -69.5 -26.82 64.73 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 117.791 0.796 . . . . 0.0 110.074 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -68.07 -39.51 82.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.227 -176.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 435' ' ' VAL . . . . . 0.776 HG23 HG11 ' B' ' 463' ' ' VAL . 7.3 p -69.05 -44.03 81.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-O 120.968 0.413 . . . . 0.0 110.649 -177.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 436' ' ' VAL . . . . . 0.474 HG13 ' O ' ' B' ' 433' ' ' GLN . 0.2 OUTLIER -65.26 -31.22 52.93 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 CA-C-O 121.08 0.467 . . . . 0.0 109.883 174.795 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 1.1 m -67.28 -52.8 36.21 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 -178.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 438' ' ' ALA . . . . . 0.837 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -58.94 -39.19 80.86 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 115.351 -0.841 . . . . 0.0 112.113 177.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 439' ' ' LEU . . . . . 0.624 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 1.9 tm? -68.15 -48.48 65.22 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -178.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.26 -34.99 72.9 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.485 -1.234 . . . . 0.0 111.097 174.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 441' ' ' GLN . . . . . 0.5 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 3.6 mm-40 -54.98 -50.02 70.01 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.017 -177.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 442' ' ' ARG . . . . . 0.624 ' HG3' ' CG ' ' B' ' 459' ' ' HIS . 0.0 OUTLIER -75.67 -24.34 56.32 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 119.547 -0.861 . . . . 0.0 113.095 175.261 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 443' ' ' LEU . . . . . 0.624 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 70.2 mt -64.47 -35.2 80.18 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 175.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -56.99 -38.2 72.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.451 173.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -74.22 -26.85 60.49 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.318 177.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 446' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 27.91 98.94 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.625 1.17 . . . . 0.0 114.147 176.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 49.0 mt -61.13 -35.13 63.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-O 121.151 0.5 . . . . 0.0 110.74 -178.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 448' ' ' ASP . . . . . 0.476 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 19.8 m-20 -163.79 -162.14 0.69 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 -177.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -81.85 -69.67 0.6 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 172.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 450' ' ' GLN . . . . . 0.417 ' HG3' ' H ' ' B' ' 450' ' ' GLN . 0.0 OUTLIER -66.76 -24.72 66.24 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 178.068 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 451' ' ' THR . . . . . 0.476 ' OG1' ' HB2' ' B' ' 448' ' ' ASP . 12.4 m -70.62 -22.53 62.52 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.765 -173.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 452' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -54.2 -54.12 44.25 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 171.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 453' ' ' ALA . . . . . 0.531 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -58.94 -47.35 85.41 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.514 -1.221 . . . . 0.0 112.613 174.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 454' ' ' GLU . . . . . 0.445 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 10.5 mm-40 -51.83 -37.38 51.59 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.284 0.564 . . . . 0.0 111.603 -177.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 28.2 p -117.08 15.34 15.04 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.468 -176.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 456' ' ' PHE . . . . . 0.516 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 0.7 OUTLIER -56.57 -49.1 75.85 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.906 0.384 . . . . 0.0 111.879 -171.522 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 457' ' ' ILE . . . . . 0.554 HG23 ' HB1' ' B' ' 405' ' ' ALA . 1.9 mp -75.25 -33.08 27.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 120.809 0.337 . . . . 0.0 110.855 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -57.44 -35.63 70.35 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.814 0.816 . . . . 0.0 109.482 171.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 459' ' ' HIS . . . . . 0.748 ' O ' HG23 ' B' ' 463' ' ' VAL . 70.8 m-70 -71.89 -29.4 64.31 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.629 176.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 460' ' ' LEU . . . . . 0.717 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -74.14 -34.74 63.98 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.88 0.848 . . . . 0.0 108.882 179.811 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 461' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -72.82 -38.25 67.21 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.288 175.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 462' ' ' ALA . . . . . 0.639 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -55.72 -32.87 63.72 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.692 169.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 463' ' ' VAL . . . . . 0.837 HG13 ' HB3' ' B' ' 438' ' ' ALA . 60.1 t -64.07 -50.6 76.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 CA-C-N 114.433 -1.258 . . . . 0.0 107.961 177.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 464' ' ' TYR . . . . . 0.56 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 15.3 m-30 -53.72 -27.48 28.54 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.327 178.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.62 -40.52 18.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.622 0.725 . . . . 0.0 109.43 -177.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 466' ' ' ILE . . . . . 0.639 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.6 mt -56.42 -55.92 16.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 114.295 -1.321 . . . . 0.0 112.268 175.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 467' ' ' LEU . . . . . 0.776 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -103.36 -10.74 18.4 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -171.884 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 468' ' ' GLY . . . . . 0.585 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 93.84 31.69 8.03 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 119.453 -1.356 . . . . 0.0 114.281 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 469' ' ' LEU . . . . . 0.776 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 2.6 mt -88.91 162.26 16.21 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 117.969 0.885 . . . . 0.0 111.29 177.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 39.7 p30 -105.27 -173.96 2.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.367 173.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 471' ' ' ALA . . . . . . . . . . . . . . . -67.69 -17.06 64.45 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -175.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -88.59 -0.81 57.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.751 0.31 . . . . 0.0 111.136 -176.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 473' ' ' GLY . . . . . . . . . . . . . . . 76.19 16.88 80.38 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 -173.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -101.4 151.96 21.3 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 177.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 5.4 p -90.78 128.21 36.61 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.88 0.372 . . . . 0.0 111.184 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 476' ' ' ILE . . . . . 0.585 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.5 pp -98.26 9.45 7.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.672 0.748 . . . . 0.0 110.266 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 477' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 -77.04 -172.63 2.43 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.801 -1.09 . . . . 0.0 111.104 -178.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 478' ' ' LEU . . . . . 0.411 ' N ' HD12 ' B' ' 478' ' ' LEU . 6.0 mp -79.68 -43.08 23.4 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.187 0.518 . . . . 0.0 109.842 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 479' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 . . . . . 0 C--O 1.245 0.835 0 CA-C-O 118.519 -0.753 . . . . 0.0 110.016 179.361 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 . . . . . 0 N--CA 1.478 0.952 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -116.26 -34.27 4.71 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -175.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' HIS . . . . . 0.514 ' HB2' ' O ' ' A' ' 386' ' ' PHE . 3.6 p80 -143.19 154.31 43.73 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.223 -0.591 . . . . 0.0 111.326 -170.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -103.38 -108.79 3.3 Favored Glycine 0 N--CA 1.438 -1.183 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 170.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 47.2 m -75.0 -30.95 61.3 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.873 0.368 . . . . 0.0 111.113 177.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' PHE . . . . . 0.809 ' CD1' HD22 ' A' ' 414' ' ' LEU . 2.6 t80 -75.68 125.06 88.92 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.082 0.468 . . . . 0.0 110.616 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . 0.592 ' HG2' ' OD1' ' B' ' 393' ' ' ASN . 60.9 Cg_endo -72.0 111.27 3.13 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 124.105 3.203 . . . . 0.0 113.701 175.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.486 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 40.0 mtt -103.28 172.7 6.67 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 176.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -57.28 -61.76 2.24 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 175.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -175.49 19.66 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.5 -1.227 . . . . 0.0 108.448 173.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.494 HD23 ' H ' ' A' ' 392' ' ' GLY . 2.1 pt? -169.76 -54.8 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.616 -167.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . 0.612 ' HA3' HD13 ' A' ' 395' ' ' ILE . . . -174.88 54.77 0.13 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 119.93 -1.129 . . . . 0.0 113.703 -174.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . 0.587 ' OD1' ' HG2' ' B' ' 387' ' ' PRO . 0.2 OUTLIER -54.25 -41.9 69.29 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 177.707 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.748 HG23 HD12 ' A' ' 398' ' ' ILE . 2.0 m -56.35 -47.05 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.643 ' H ' HD12 ' A' ' 395' ' ' ILE . 3.9 mp -57.47 -52.12 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 CA-C-O 118.04 -0.981 . . . . 0.0 113.254 -175.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . 0.68 ' HG3' ' CZ ' ' A' ' 429' ' ' TYR . 0.1 OUTLIER -61.49 -49.3 77.33 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-N 121.52 1.964 . . . . 0.0 111.857 -173.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -54.26 -45.14 75.07 Favored Glycine 0 N--CA 1.437 -1.279 0 C-N-CA 119.756 -1.212 . . . . 0.0 111.142 -178.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . 0.793 HD13 HD12 ' A' ' 410' ' ' LEU . 39.2 mt -70.94 -34.08 54.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -177.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . 0.503 HG12 ' HA ' ' A' ' 404' ' ' VAL . 10.6 m -63.5 -39.61 85.96 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 C-N-CA 118.573 -1.251 . . . . 0.0 108.24 -175.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -70.91 -33.99 71.09 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 175.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.444 HE21 ' HB3' ' A' ' 401' ' ' GLN . 3.2 mm100 -90.14 -47.27 7.91 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -172.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . 0.649 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 2.9 mm-40 -121.61 -20.97 6.34 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.576 -170.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 107.21 162.73 21.86 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.823 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . 0.65 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.6 m -53.52 -46.45 59.87 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.771 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -175.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . 0.598 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -64.25 -30.39 71.45 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 119.891 -0.724 . . . . 0.0 112.452 -176.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.717 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 91.9 m -77.5 -42.96 33.76 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.223 173.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.466 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -58.46 -37.37 75.33 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 122.117 0.96 . . . . 0.0 109.265 176.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 408' ' ' TYR . . . . . 0.65 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.58 -51.69 57.85 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 113.402 -1.726 . . . . 0.0 109.746 176.687 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 409' ' ' THR . . . . . 0.682 HG22 HD23 ' A' ' 410' ' ' LEU . 14.1 m -55.34 -47.03 76.32 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.588 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . 0.793 HD12 HD13 ' A' ' 398' ' ' ILE . 14.8 mt -72.19 -37.12 69.36 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 120.826 0.346 . . . . 0.0 110.164 -174.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.68 -34.46 76.98 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.57 173.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 412' ' ' MET . . . . . 0.429 ' HB2' ' O ' ' A' ' 409' ' ' THR . 0.2 OUTLIER -65.86 -44.03 86.65 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 115.685 -0.258 . . . . 0.0 111.589 177.915 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 413' ' ' MET . . . . . 0.754 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.0 OUTLIER -71.13 -56.49 6.0 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 118.431 -1.308 . . . . 0.0 111.558 177.884 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . 0.809 HD22 ' CD1' ' A' ' 386' ' ' PHE . 6.8 mt -62.46 -43.52 98.62 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -171.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 37.8 t -85.16 -21.14 29.33 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.701 0.762 . . . . 0.0 109.562 -178.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . 0.437 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 103.69 -173.42 21.85 Favored Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -169.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -79.7 24.43 0.38 Allowed 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.563 0.696 . . . . 0.0 111.206 -171.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 418' ' ' ASN . . . . . 0.437 ' H ' ' C ' ' A' ' 416' ' ' GLY . 89.2 m-20 -71.17 73.4 0.65 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.493 179.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 419' ' ' TYR . . . . . 0.53 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 29.9 p90 -56.74 -36.58 69.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.002 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -54.72 -42.69 71.86 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.908 178.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.16 -49.14 62.92 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.136 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . 0.486 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.5 OUTLIER -66.17 -38.8 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.244 -176.487 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.726 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 57.6 p -67.3 -38.66 85.35 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.072 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -70.07 -37.5 73.17 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.96 176.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . 0.602 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.66 -52.51 22.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 121.305 -0.158 . . . . 0.0 111.097 -178.308 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . 0.681 HG22 HD22 ' A' ' 430' ' ' LEU . 1.2 mm -73.49 -22.71 19.14 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.699 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -172.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.726 ' HB2' ' O ' ' A' ' 423' ' ' SER . 0.7 OUTLIER -54.04 -32.77 55.48 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.271 0.558 . . . . 0.0 110.119 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -84.74 -6.28 85.6 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.598 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.68 ' CZ ' ' HG3' ' A' ' 396' ' ' LYS . 23.9 m-85 -118.64 0.6 11.54 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 121.105 0.479 . . . . 0.0 110.56 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.7 HD23 ' HA ' ' A' ' 427' ' ' ARG . 0.1 OUTLIER -66.33 127.79 93.48 Favored Pre-proline 0 N--CA 1.437 -1.075 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.348 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . 0.509 ' HD2' HD12 ' A' ' 430' ' ' LEU . 83.6 Cg_exo -23.55 -65.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.354 0.836 1 C-N-CA 125.655 4.237 . . . . 0.0 114.983 179.9 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . 0.561 ' H ' HG12 ' A' ' 435' ' ' VAL . . . -143.22 -169.2 12.37 Favored Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 175.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . 0.496 ' O ' HG13 ' A' ' 436' ' ' VAL . 45.1 tp60 -69.93 -26.66 64.24 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 118.19 0.995 . . . . 0.0 110.111 177.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -62.93 -42.47 99.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.268 -0.424 . . . . 0.0 112.035 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 435' ' ' VAL . . . . . 0.772 HG23 HG11 ' A' ' 463' ' ' VAL . 7.5 p -68.8 -43.17 82.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-O 120.947 0.403 . . . . 0.0 110.766 -177.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.496 HG12 ' O ' ' A' ' 432' ' ' GLY . 0.1 OUTLIER -66.22 -31.74 55.01 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.241 175.712 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.56 -52.39 46.13 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -178.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . 0.842 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -57.85 -40.09 79.27 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.997 177.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 439' ' ' LEU . . . . . 0.611 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 2.0 tm? -68.03 -48.54 65.37 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -178.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.13 -35.16 72.98 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.1 175.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 441' ' ' GLN . . . . . 0.517 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 3.3 mm-40 -54.87 -49.53 70.94 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.126 -178.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . 0.622 ' HD2' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -76.43 -24.0 53.96 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 119.736 -0.785 . . . . 0.0 113.058 174.899 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 443' ' ' LEU . . . . . 0.611 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 69.4 mt -64.23 -35.81 82.04 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 118.404 0.547 . . . . 0.0 109.53 174.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -57.46 -37.53 73.02 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.537 173.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -73.73 -27.12 61.03 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.113 177.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 26.68 100.57 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.878 1.271 . . . . 0.0 114.387 176.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 51.8 mt -63.47 -34.94 70.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.046 -178.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . 0.452 ' HB2' ' OG1' ' A' ' 451' ' ' THR . 33.5 m-20 -164.21 -162.04 0.65 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -178.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -79.55 -71.01 0.47 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 172.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -24.82 66.13 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 178.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 451' ' ' THR . . . . . 0.452 ' OG1' ' HB2' ' A' ' 448' ' ' ASP . 15.8 m -70.49 -22.18 62.68 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.104 -0.638 . . . . 0.0 110.836 -173.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 452' ' ' ARG . 20.9 mtp180 -53.43 -53.83 45.6 Favored 'General case' 0 C--O 1.221 -0.406 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 171.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 453' ' ' ALA . . . . . 0.53 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -59.8 -47.83 84.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.388 -1.278 . . . . 0.0 112.58 175.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . 0.428 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 77.4 mm-40 -50.4 -37.19 36.36 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.181 0.515 . . . . 0.0 111.774 -177.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 29.9 p -117.98 15.22 14.23 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.374 -176.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . 0.563 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.8 OUTLIER -56.9 -47.67 79.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.09 0.471 . . . . 0.0 111.718 -171.747 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . 0.598 HG23 ' HB1' ' A' ' 405' ' ' ALA . 1.9 mp -76.78 -33.04 20.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.053 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -57.7 -34.49 69.49 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.783 0.802 . . . . 0.0 109.28 171.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . 0.735 ' O ' HG23 ' A' ' 463' ' ' VAL . 59.9 m-70 -73.18 -29.33 62.76 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.828 177.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . 0.707 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.4 OUTLIER -74.16 -34.68 63.91 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.993 0.902 . . . . 0.0 108.753 179.286 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -72.78 -37.89 67.47 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.257 175.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 462' ' ' ALA . . . . . 0.634 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -55.73 -33.23 64.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.674 169.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.842 HG13 ' HB3' ' A' ' 438' ' ' ALA . 77.8 t -64.48 -50.75 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 CA-C-N 114.603 -1.181 . . . . 0.0 107.906 177.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 464' ' ' TYR . . . . . 0.549 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 17.3 m-30 -53.34 -25.8 16.49 Favored 'General case' 0 C--N 1.333 -0.143 0 O-C-N 124.313 1.008 . . . . 0.0 110.605 178.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.39 -40.93 15.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.6 0.714 . . . . 0.0 109.437 -178.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.634 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.4 mt -55.94 -55.22 19.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 114.272 -1.331 . . . . 0.0 112.199 175.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.773 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -103.93 -11.01 17.72 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -172.748 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . 0.612 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 93.64 31.82 8.03 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 119.328 -1.415 . . . . 0.0 114.374 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 469' ' ' LEU . . . . . 0.773 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 2.9 mt -89.14 161.84 16.27 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 117.886 0.843 . . . . 0.0 111.361 177.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 38.1 p30 -104.97 -177.01 3.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.569 173.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -60.36 -22.53 63.39 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -176.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -87.89 0.28 56.05 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 122.32 -0.238 . . . . 0.0 111.551 -172.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . 0.445 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 77.71 12.31 84.6 Favored Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 110.724 -0.951 . . . . 0.0 110.724 -174.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -101.18 152.48 20.59 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 11.5 p -89.28 129.45 35.83 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.279 0.561 . . . . 0.0 111.118 -178.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 476' ' ' ILE . . . . . 0.612 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.8 pp -94.72 -2.07 10.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.636 0.731 . . . . 0.0 109.953 177.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 23.3 mmt180 -74.86 91.63 2.47 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.562 -1.199 . . . . 0.0 109.494 173.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 88.7 mt -82.82 52.21 2.08 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.384 0.611 . . . . 0.0 110.568 -178.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 . . . . . 0 C--O 1.249 1.057 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.733 -179.353 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 381' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 . . . . . 0 N--CA 1.479 1.016 0 CA-C-O 120.875 0.369 . . . . 0.0 110.046 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 382' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -116.02 -34.72 4.64 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.154 -0.476 . . . . 0.0 112.226 -175.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 383' ' ' HIS . . . . . 0.518 ' HB2' ' O ' ' B' ' 386' ' ' PHE . 3.5 p80 -142.66 154.88 44.76 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.224 -0.59 . . . . 0.0 111.29 -170.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 384' ' ' GLY . . . . . . . . . . . . . . . -103.95 -108.32 3.27 Favored Glycine 0 N--CA 1.438 -1.176 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 170.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 385' ' ' THR . . . . . . . . . . . . . 56.1 m -75.49 -30.55 59.89 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.934 0.397 . . . . 0.0 111.296 177.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 386' ' ' PHE . . . . . 0.821 ' CD1' HD22 ' B' ' 414' ' ' LEU . 2.6 t80 -75.99 124.98 88.62 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 120.991 0.424 . . . . 0.0 110.599 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 387' ' ' PRO . . . . . 0.587 ' HG2' ' OD1' ' A' ' 393' ' ' ASN . 60.8 Cg_endo -71.97 111.21 3.11 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 124.059 3.172 . . . . 0.0 113.767 175.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 388' ' ' MET . . . . . 0.482 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 39.9 mtt -103.26 172.62 6.71 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 122.012 -0.43 . . . . 0.0 110.1 177.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 389' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -57.4 -61.49 2.45 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 175.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -175.89 19.84 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.647 -1.16 . . . . 0.0 108.311 173.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 391' ' ' LEU . . . . . 0.492 HD23 ' H ' ' B' ' 392' ' ' GLY . 2.1 pt? -169.91 -54.86 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.562 -167.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 392' ' ' GLY . . . . . 0.596 ' HA3' HD13 ' B' ' 395' ' ' ILE . . . -174.8 54.9 0.13 Allowed Glycine 0 C--N 1.333 0.408 0 C-N-CA 119.911 -1.138 . . . . 0.0 113.67 -174.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 393' ' ' ASN . . . . . 0.592 ' OD1' ' HG2' ' A' ' 387' ' ' PRO . 0.2 OUTLIER -54.33 -41.89 69.56 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 177.728 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 394' ' ' VAL . . . . . 0.756 HG23 HD12 ' B' ' 398' ' ' ILE . 2.0 m -56.34 -47.1 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 -179.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 395' ' ' ILE . . . . . 0.641 ' H ' HD12 ' B' ' 395' ' ' ILE . 3.9 mp -57.44 -52.24 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 CA-C-O 117.935 -1.031 . . . . 0.0 113.246 -175.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 396' ' ' LYS . . . . . 0.679 ' HG3' ' CZ ' ' B' ' 429' ' ' TYR . 0.1 OUTLIER -61.42 -49.18 77.92 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 121.488 1.949 . . . . 0.0 111.818 -173.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -54.39 -45.18 76.23 Favored Glycine 0 N--CA 1.436 -1.31 0 C-N-CA 119.747 -1.216 . . . . 0.0 111.073 -178.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . 0.789 HD13 HD12 ' B' ' 410' ' ' LEU . 39.2 mt -70.96 -34.1 54.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -176.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 399' ' ' VAL . . . . . 0.508 HG12 ' HA ' ' B' ' 404' ' ' VAL . 10.6 m -63.47 -39.73 86.42 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 C-N-CA 118.514 -1.274 . . . . 0.0 108.265 -175.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -70.83 -34.12 71.38 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 175.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 401' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -89.84 -47.48 7.86 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -172.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 402' ' ' GLU . . . . . 0.661 ' HG3' ' HE3' ' A' ' 413' ' ' MET . 2.9 mm-40 -121.4 -21.08 6.41 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.653 -170.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 107.42 162.5 21.62 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.843 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 404' ' ' VAL . . . . . 0.659 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.5 m -53.41 -46.44 58.55 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.71 0 N-CA-C 114.506 1.298 . . . . 0.0 114.506 -175.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 405' ' ' ALA . . . . . 0.607 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -64.11 -30.5 71.57 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 119.861 -0.736 . . . . 0.0 112.427 -177.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 406' ' ' THR . . . . . 0.714 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 89.0 m -77.36 -43.1 34.06 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 121.749 -0.595 . . . . 0.0 110.282 173.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 407' ' ' ALA . . . . . 0.472 ' HB2' ' HB ' ' B' ' 398' ' ' ILE . . . -58.38 -37.35 75.09 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 122.175 0.988 . . . . 0.0 109.252 176.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 408' ' ' TYR . . . . . 0.659 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.59 -51.67 57.93 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 113.414 -1.721 . . . . 0.0 109.816 176.714 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 409' ' ' THR . . . . . 0.671 HG22 HD23 ' B' ' 410' ' ' LEU . 15.7 m -55.3 -47.1 76.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.568 178.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 410' ' ' LEU . . . . . 0.789 HD12 HD13 ' B' ' 398' ' ' ILE . 14.8 mt -72.29 -37.1 69.09 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.093 -174.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.6 -34.42 76.26 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 119.915 -1.136 . . . . 0.0 110.481 173.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 412' ' ' MET . . . . . 0.436 ' HB2' ' O ' ' B' ' 409' ' ' THR . 0.3 OUTLIER -65.92 -44.2 85.87 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 115.667 -0.266 . . . . 0.0 111.597 177.932 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 413' ' ' MET . . . . . 0.742 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.0 OUTLIER -70.97 -56.58 5.89 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 118.414 -1.315 . . . . 0.0 111.47 177.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 414' ' ' LEU . . . . . 0.821 HD22 ' CD1' ' B' ' 386' ' ' PHE . 6.8 mt -62.45 -43.48 98.72 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 114.19 1.181 . . . . 0.0 114.19 -171.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 37.2 t -85.2 -20.98 29.35 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.797 0.808 . . . . 0.0 109.525 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 416' ' ' GLY . . . . . 0.438 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 103.5 -173.15 21.8 Favored Glycine 0 N--CA 1.428 -1.852 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -169.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -79.9 24.52 0.4 Allowed 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.617 0.722 . . . . 0.0 111.336 -171.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 418' ' ' ASN . . . . . 0.438 ' H ' ' C ' ' B' ' 416' ' ' GLY . 89.6 m-20 -71.25 73.38 0.67 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.344 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 419' ' ' TYR . . . . . 0.53 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 29.6 p90 -56.68 -36.63 69.81 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.944 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -54.67 -42.59 71.54 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.864 178.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.26 -49.14 62.62 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.123 -178.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 422' ' ' VAL . . . . . 0.475 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.5 OUTLIER -66.23 -38.75 82.59 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.238 -176.422 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 423' ' ' SER . . . . . 0.73 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 59.9 p -67.31 -38.82 85.56 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.124 -178.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -70.01 -37.12 73.54 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.056 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 425' ' ' ILE . . . . . 0.616 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -72.82 -52.97 20.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 120.424 0.154 . . . . 0.0 110.996 -178.501 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 426' ' ' ILE . . . . . 0.677 HG22 HD22 ' B' ' 430' ' ' LEU . 1.2 mm -73.24 -22.82 19.53 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.722 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -172.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 427' ' ' ARG . . . . . 0.73 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.7 OUTLIER -53.92 -32.79 54.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.341 0.591 . . . . 0.0 110.098 -179.827 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -85.03 -5.67 85.75 Favored Glycine 0 N--CA 1.443 -0.839 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.599 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 429' ' ' TYR . . . . . 0.679 ' CZ ' ' HG3' ' B' ' 396' ' ' LYS . 23.8 m-85 -119.15 0.56 11.25 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-O 121.017 0.436 . . . . 0.0 110.454 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 430' ' ' LEU . . . . . 0.685 HD23 ' HA ' ' B' ' 427' ' ' ARG . 0.1 OUTLIER -66.34 127.66 93.41 Favored Pre-proline 0 N--CA 1.439 -1.004 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.402 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 431' ' ' PRO . . . . . 0.498 ' HD2' HD12 ' B' ' 430' ' ' LEU . 84.0 Cg_exo -23.45 -65.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.874 1 C-N-CA 125.728 4.285 . . . . 0.0 115.059 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 432' ' ' GLY . . . . . 0.556 ' H ' HG12 ' B' ' 435' ' ' VAL . . . -143.23 -169.15 12.35 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 175.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 433' ' ' GLN . . . . . 0.506 ' O ' HG13 ' B' ' 436' ' ' VAL . 46.0 tp60 -70.2 -26.54 63.93 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 118.186 0.993 . . . . 0.0 109.893 177.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -62.99 -42.41 99.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.979 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 435' ' ' VAL . . . . . 0.778 HG23 HG11 ' B' ' 463' ' ' VAL . 7.3 p -69.03 -42.97 82.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 120.933 0.396 . . . . 0.0 110.742 -177.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 436' ' ' VAL . . . . . 0.506 HG13 ' O ' ' B' ' 433' ' ' GLN . 0.1 OUTLIER -66.38 -31.7 54.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.251 175.628 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.57 -52.39 46.0 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 -178.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 438' ' ' ALA . . . . . 0.825 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -57.88 -40.03 79.27 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.015 177.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 439' ' ' LEU . . . . . 0.612 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 1.9 tm? -68.26 -48.39 65.19 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -178.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.17 -35.16 73.06 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.515 -1.22 . . . . 0.0 111.061 175.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 441' ' ' GLN . . . . . 0.515 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 3.4 mm-40 -54.7 -49.84 69.72 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.178 -178.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 442' ' ' ARG . . . . . 0.627 ' HD2' ' O ' ' B' ' 438' ' ' ALA . 0.0 OUTLIER -76.17 -23.96 54.75 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 119.663 -0.815 . . . . 0.0 113.092 174.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 443' ' ' LEU . . . . . 0.612 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 69.4 mt -64.24 -35.78 81.94 Favored 'General case' 0 CA--C 1.519 -0.218 0 O-C-N 121.773 -0.579 . . . . 0.0 109.53 174.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -57.35 -37.64 72.89 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.533 173.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -73.67 -27.42 61.23 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.044 178.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 446' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 26.87 100.59 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 114.422 1.268 . . . . 0.0 114.422 176.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 52.9 mt -63.54 -34.93 70.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.97 -178.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 448' ' ' ASP . . . . . 0.474 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 30.6 m-20 -164.08 -161.95 0.65 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -178.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -79.55 -71.21 0.46 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 171.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.71 -24.97 66.31 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 178.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 451' ' ' THR . . . . . 0.474 ' OG1' ' HB2' ' B' ' 448' ' ' ASP . 13.4 m -70.53 -22.24 62.64 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.775 -173.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 452' ' ' ARG . . . . . 0.432 HH11 ' HD2' ' B' ' 452' ' ' ARG . 20.9 mtp180 -53.39 -53.71 47.22 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 107.481 -1.304 . . . . 0.0 107.481 170.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 453' ' ' ALA . . . . . 0.53 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -59.96 -47.6 85.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.415 -1.266 . . . . 0.0 112.525 175.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 454' ' ' GLU . . . . . 0.427 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 77.5 mm-40 -50.53 -37.65 40.35 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.245 0.545 . . . . 0.0 111.685 -177.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 31.2 p -117.64 15.22 14.54 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.325 -175.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 456' ' ' PHE . . . . . 0.566 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 0.8 OUTLIER -56.91 -47.53 80.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.082 0.468 . . . . 0.0 111.72 -171.82 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 457' ' ' ILE . . . . . 0.607 HG23 ' HB1' ' B' ' 405' ' ' ALA . 1.9 mp -77.16 -32.87 19.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.851 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -57.89 -34.28 69.64 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.811 0.815 . . . . 0.0 109.375 170.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 459' ' ' HIS . . . . . 0.729 ' O ' HG23 ' B' ' 463' ' ' VAL . 60.3 m-70 -73.1 -29.58 63.03 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.743 177.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 460' ' ' LEU . . . . . 0.71 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.4 OUTLIER -74.13 -34.67 63.97 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.887 0.851 . . . . 0.0 108.794 179.456 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 461' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -72.85 -37.72 67.3 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.258 175.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 462' ' ' ALA . . . . . 0.64 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -55.9 -33.22 64.45 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.584 -1.189 . . . . 0.0 109.722 169.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 463' ' ' VAL . . . . . 0.825 HG13 ' HB3' ' B' ' 438' ' ' ALA . 77.5 t -64.48 -50.77 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 CA-C-N 114.54 -1.209 . . . . 0.0 107.835 177.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 464' ' ' TYR . . . . . 0.546 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 17.3 m-30 -53.08 -26.4 16.04 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 124.339 1.024 . . . . 0.0 110.471 178.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.79 -40.89 16.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.619 0.724 . . . . 0.0 109.526 -177.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 466' ' ' ILE . . . . . 0.64 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.4 mt -56.21 -55.11 20.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 114.339 -1.301 . . . . 0.0 112.117 175.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 467' ' ' LEU . . . . . 0.783 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -103.83 -11.07 17.76 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -172.667 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 468' ' ' GLY . . . . . 0.597 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 93.73 31.87 7.97 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 119.441 -1.362 . . . . 0.0 114.398 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 469' ' ' LEU . . . . . 0.783 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 2.8 mt -89.04 162.06 16.22 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 117.866 0.833 . . . . 0.0 111.417 177.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 38.3 p30 -105.17 -177.0 3.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.692 173.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 471' ' ' ALA . . . . . . . . . . . . . . . -60.3 -22.88 63.68 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -176.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -87.79 0.73 55.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.617 -172.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 473' ' ' GLY . . . . . 0.45 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 77.59 12.05 84.88 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.197 -1.001 . . . . 0.0 110.751 -175.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -101.09 152.7 20.3 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 11.0 p -89.69 129.22 36.15 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.18 0.514 . . . . 0.0 111.134 -178.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 476' ' ' ILE . . . . . 0.597 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.8 pp -94.5 -1.92 10.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.678 0.751 . . . . 0.0 109.889 177.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 477' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -74.91 91.81 2.5 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.432 173.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 478' ' ' LEU . . . . . . . . . . . . . 88.7 mt -82.99 52.26 2.13 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.315 0.579 . . . . 0.0 110.588 -178.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 479' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.376 -0.821 . . . . 0.0 109.707 -179.163 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 . . . . . 0 N--CA 1.479 1.015 0 CA-C-O 121.05 0.452 . . . . 0.0 110.661 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -116.28 -27.05 6.96 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.742 178.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -160.8 161.67 32.09 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.254 -0.578 . . . . 0.0 111.758 -173.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -106.74 -78.91 1.18 Allowed Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 168.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . 0.465 HG22 ' HA2' ' B' ' 397' ' ' GLY . 5.8 m -97.06 168.21 10.59 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 166.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' PHE . . . . . 0.694 ' CD1' HD22 ' A' ' 414' ' ' LEU . 1.1 t80 73.11 113.04 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.682 0 C-N-CA 122.681 0.393 . . . . 0.0 110.062 -177.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -42.14 -70.73 0.06 OUTLIER 'Trans proline' 0 N--CA 1.484 0.947 0 C-N-CA 124.48 3.453 . . . . 0.0 114.088 -175.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.634 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 36.4 ttm 77.67 29.65 0.51 Allowed 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 173.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' HIS . . . . . 0.676 ' CG ' ' HB2' ' A' ' 393' ' ' ASN . 42.4 m170 61.35 -82.91 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.291 0.636 . . . . 0.0 110.633 -176.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -167.92 14.47 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.246 -0.888 . . . . 0.0 108.702 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.501 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.5 pt? -169.53 -48.23 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -168.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . 0.581 ' HA3' HD13 ' A' ' 395' ' ' ILE . . . 178.78 48.36 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 119.309 -1.424 . . . . 0.0 114.531 -172.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . 0.676 ' HB2' ' CG ' ' A' ' 389' ' ' HIS . 0.3 OUTLIER -54.14 -39.79 66.83 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 117.58 0.69 . . . . 0.0 109.405 174.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.722 HG23 HD12 ' A' ' 398' ' ' ILE . 1.8 m -56.23 -49.18 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.689 HG23 HD13 ' A' ' 426' ' ' ILE . 3.7 mp -56.75 -53.41 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -174.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . 0.739 ' HG3' ' CE1' ' A' ' 429' ' ' TYR . 0.1 OUTLIER -66.25 -47.21 74.47 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 121.349 1.886 . . . . 0.0 112.06 -172.133 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . 0.414 ' HA2' HG22 ' B' ' 385' ' ' THR . . . -52.81 -45.16 61.15 Favored Glycine 0 N--CA 1.434 -1.452 0 C-N-CA 120.132 -1.032 . . . . 0.0 110.882 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . 0.722 HD12 HG23 ' A' ' 394' ' ' VAL . 31.2 mt -70.75 -33.87 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . 0.537 HG22 ' O ' ' A' ' 396' ' ' LYS . 11.3 m -62.6 -39.58 85.14 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 C-N-CA 118.821 -1.152 . . . . 0.0 108.103 -174.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -70.93 -34.78 71.83 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 175.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.454 HE21 ' HB3' ' A' ' 401' ' ' GLN . 5.5 mm100 -89.17 -47.71 7.89 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -173.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . 0.463 ' HB3' ' HB ' ' A' ' 406' ' ' THR . 3.0 mm-40 -119.75 -20.94 7.44 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.462 -170.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 107.48 162.77 21.61 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.519 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . 0.61 HG11 ' HA ' ' A' ' 430' ' ' LEU . 1.7 m -54.12 -45.73 66.28 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.731 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -175.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . 0.574 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -64.12 -29.61 70.73 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 119.84 -0.744 . . . . 0.0 112.209 -177.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.712 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 85.7 m -77.59 -43.21 32.42 Favored 'General case' 0 C--O 1.219 -0.54 0 O-C-N 121.888 -0.507 . . . . 0.0 110.227 173.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.428 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.18 -36.09 72.55 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 122.106 0.955 . . . . 0.0 109.14 176.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 408' ' ' TYR . . . . . 0.586 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -66.34 -52.65 44.89 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 113.446 -1.707 . . . . 0.0 109.749 175.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 409' ' ' THR . . . . . 0.634 HG22 HD23 ' A' ' 410' ' ' LEU . 17.3 m -55.48 -47.4 76.21 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.673 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . 0.712 HD12 ' CD1' ' A' ' 398' ' ' ILE . 15.0 mt -72.42 -36.68 68.67 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -174.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.73 -35.31 81.11 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.066 -1.064 . . . . 0.0 110.783 172.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -68.64 -48.32 64.33 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 120.644 0.259 . . . . 0.0 111.265 178.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 413' ' ' MET . . . . . 0.962 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 1.2 ppp? -71.02 -43.27 68.27 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 118.888 -1.125 . . . . 0.0 112.155 -177.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . 0.962 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 12.1 mt -71.31 -45.85 62.08 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -177.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 44.5 t -84.98 -24.3 28.33 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.787 0.803 . . . . 0.0 110.277 -175.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . 0.412 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 110.74 -175.69 18.19 Favored Glycine 0 N--CA 1.428 -1.89 0 N-CA-C 109.824 -1.311 . . . . 0.0 109.824 -171.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -80.84 24.24 0.5 Allowed 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 121.407 0.622 . . . . 0.0 111.193 -172.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 418' ' ' ASN . . . . . 0.412 ' H ' ' C ' ' A' ' 416' ' ' GLY . 84.5 m-20 -71.74 76.64 0.85 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.701 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 419' ' ' TYR . . . . . 0.549 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 17.1 p90 -54.36 -38.84 66.56 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.656 177.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -55.63 -44.07 76.78 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.634 0.254 . . . . 0.0 111.138 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.78 -48.64 65.76 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.055 -177.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . 0.429 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -66.07 -39.42 84.42 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.158 -177.519 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.728 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 64.0 p -67.49 -39.81 85.21 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.024 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -66.26 -39.9 94.56 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.739 -0.743 . . . . 0.0 111.954 175.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . 0.632 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.72 -51.91 25.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 121.236 -0.185 . . . . 0.0 111.291 -177.094 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . 0.689 HD13 HG23 ' A' ' 395' ' ' ILE . 1.2 mm -73.77 -23.01 18.88 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.885 0 CA-C-O 120.76 0.314 . . . . 0.0 110.176 -171.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.728 ' HB2' ' O ' ' A' ' 423' ' ' SER . 0.8 OUTLIER -54.77 -29.14 53.27 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.981 0.419 . . . . 0.0 110.975 -178.009 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.73 -11.45 68.24 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.641 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.739 ' CE1' ' HG3' ' A' ' 396' ' ' LYS . 15.0 m-85 -113.99 -1.41 13.8 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 121.709 0.766 . . . . 0.0 109.241 -176.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.614 HD12 ' HD2' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -65.94 135.12 95.2 Favored Pre-proline 0 N--CA 1.438 -1.039 0 CA-C-N 114.05 -1.432 . . . . 0.0 108.665 177.694 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . 0.815 ' HD2' HG11 ' A' ' 435' ' ' VAL . 43.0 Cg_exo -36.25 -65.71 0.13 Allowed 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 124.804 3.669 . . . . 0.0 114.34 -171.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . 0.542 ' H ' HG12 ' A' ' 435' ' ' VAL . . . -141.85 -163.18 9.5 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 176.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . 0.502 ' O ' HG13 ' A' ' 436' ' ' VAL . 21.7 tp60 -70.73 -27.64 64.12 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 118.103 0.952 . . . . 0.0 110.411 177.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -67.47 -38.89 85.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.031 -176.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 435' ' ' VAL . . . . . 0.815 HG11 ' HD2' ' A' ' 431' ' ' PRO . 7.6 p -68.48 -44.9 82.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.974 0.416 . . . . 0.0 110.602 -178.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 433' ' ' GLN . 0.2 OUTLIER -65.41 -29.35 46.9 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.334 175.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -70.71 -51.98 23.97 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . 0.887 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -58.14 -38.69 77.04 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.692 177.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 439' ' ' LEU . . . . . 0.559 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 2.1 tm? -70.15 -47.21 62.61 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -178.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.53 -39.33 76.35 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.406 174.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 441' ' ' GLN . . . . . 0.517 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 9.5 mm-40 -53.54 -49.7 67.08 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 123.958 0.903 . . . . 0.0 110.663 174.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . 0.818 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 0.6 OUTLIER -56.09 -40.17 73.24 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.762 172.226 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 443' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 31.9 mt -72.21 -32.07 66.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.023 0.44 . . . . 0.0 110.467 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -58.69 -38.2 77.73 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.458 173.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 -74.01 -27.53 61.01 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.219 177.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 446' ' ' GLU . . . . . 0.438 ' HB3' ' O ' ' A' ' 443' ' ' LEU . 10.3 pt-20 19.29 101.01 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 178.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 447' ' ' ILE . . . . . 0.418 HD12 HG22 ' A' ' 451' ' ' THR . 45.0 mt -61.03 -33.88 57.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.382 0.61 . . . . 0.0 110.438 177.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . 0.404 ' HB2' ' CB ' ' A' ' 451' ' ' THR . 10.8 m-20 -162.92 -156.14 0.38 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -178.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -89.74 -63.97 1.21 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 169.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.07 -25.86 64.66 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 178.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 451' ' ' THR . . . . . 0.426 ' HA ' ' HB2' ' A' ' 454' ' ' GLU . 13.5 m -71.28 -22.57 61.94 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.572 -176.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -54.24 -53.77 49.13 Favored 'General case' 0 C--O 1.22 -0.498 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 171.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 453' ' ' ALA . . . . . 0.549 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -57.43 -48.53 78.9 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 114.624 -1.171 . . . . 0.0 112.396 175.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . 0.426 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 14.7 mm-40 -51.1 -35.11 33.5 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.357 0.599 . . . . 0.0 111.559 -178.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 33.5 p -119.22 16.15 13.15 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.493 -176.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . 0.56 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.9 OUTLIER -57.77 -48.35 79.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.914 0.387 . . . . 0.0 111.693 -171.282 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . 0.574 HG23 ' HB1' ' A' ' 405' ' ' ALA . 2.0 mp -76.14 -32.63 23.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 120.8 0.333 . . . . 0.0 110.933 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -57.62 -35.05 69.95 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.978 0.894 . . . . 0.0 109.195 171.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . 0.726 ' O ' HG23 ' A' ' 463' ' ' VAL . 59.8 m-70 -74.84 -28.99 60.91 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.542 -1.208 . . . . 0.0 110.946 177.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . 0.714 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.4 OUTLIER -73.88 -34.94 64.63 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.97 0.89 . . . . 0.0 108.89 179.049 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . 0.44 ' O ' ' HB2' ' A' ' 464' ' ' TYR . 22.1 m-80 -73.34 -37.34 66.14 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.862 0.839 . . . . 0.0 108.78 177.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 462' ' ' ALA . . . . . 0.592 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -56.46 -35.34 67.8 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.377 -1.283 . . . . 0.0 109.656 169.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.887 HG13 ' HB3' ' A' ' 438' ' ' ALA . 68.2 t -60.93 -51.6 71.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 175.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 464' ' ' TYR . . . . . 0.618 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 19.9 m-30 -52.01 -28.34 16.68 Favored 'General case' 0 C--N 1.333 -0.125 0 O-C-N 124.363 1.039 . . . . 0.0 110.765 177.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.5 -40.6 17.45 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.5 0.667 . . . . 0.0 109.67 -177.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.592 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.7 mt -56.27 -55.43 18.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 114.395 -1.275 . . . . 0.0 112.198 176.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.793 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -101.9 -10.61 19.68 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 -172.667 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . 0.619 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 93.7 31.97 7.92 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 119.337 -1.411 . . . . 0.0 114.23 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 469' ' ' LEU . . . . . 0.793 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.7 mt -88.98 161.84 16.39 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 117.808 0.804 . . . . 0.0 111.146 176.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 37.9 p30 -104.55 -176.9 3.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.956 172.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 471' ' ' ALA . . . . . 0.464 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -62.28 -20.48 64.34 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -176.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -87.21 -1.8 58.16 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.655 0.265 . . . . 0.0 111.648 -173.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 79.11 14.21 82.09 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.008 -1.092 . . . . 0.0 110.66 -174.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -100.85 148.86 24.47 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 177.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 3.9 p -88.05 126.73 35.25 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.995 0.426 . . . . 0.0 111.168 -178.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 476' ' ' ILE . . . . . 0.619 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.8 pp -98.99 3.75 10.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.523 0.678 . . . . 0.0 110.307 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 -59.6 119.22 7.16 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.623 -1.171 . . . . 0.0 112.088 -177.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . 0.502 HD23 ' H ' ' A' ' 478' ' ' LEU . 2.6 pt? -78.23 -12.42 60.0 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.362 0.601 . . . . 0.0 109.632 173.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 . . . . . 0 C--O 1.247 0.922 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.639 179.765 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 381' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 . . . . . 0 N--CA 1.48 1.038 0 CA-C-O 121.238 0.542 . . . . 0.0 110.74 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 382' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -116.33 -26.86 7.0 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.836 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 383' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -160.8 161.87 32.16 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.71 -173.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 384' ' ' GLY . . . . . . . . . . . . . . . -106.98 -78.82 1.17 Allowed Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 168.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 385' ' ' THR . . . . . 0.454 ' O ' ' HB3' ' B' ' 386' ' ' PHE . 5.7 m -97.45 168.02 10.64 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 166.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 386' ' ' PHE . . . . . 0.698 ' CD1' HD22 ' B' ' 414' ' ' LEU . 1.2 t80 73.2 113.03 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.661 0 C-N-CA 122.719 0.408 . . . . 0.0 110.035 -177.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 387' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' B' ' 386' ' ' PHE . 5.6 Cg_endo -42.01 -71.45 0.06 OUTLIER 'Trans proline' 0 N--CA 1.482 0.851 0 C-N-CA 124.528 3.486 . . . . 0.0 113.967 -176.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 388' ' ' MET . . . . . 0.61 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 36.1 ttm 78.21 29.18 0.47 Allowed 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 173.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 389' ' ' HIS . . . . . 0.667 ' CG ' ' HB2' ' B' ' 393' ' ' ASN . 42.6 m170 61.87 -83.05 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.384 0.674 . . . . 0.0 110.554 -176.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -167.68 14.22 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.731 177.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 391' ' ' LEU . . . . . 0.487 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.5 pt? -169.5 -48.29 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -167.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 392' ' ' GLY . . . . . 0.576 ' HA3' HD13 ' B' ' 395' ' ' ILE . . . 178.61 48.49 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 119.31 -1.424 . . . . 0.0 114.527 -172.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 393' ' ' ASN . . . . . 0.667 ' HB2' ' CG ' ' B' ' 389' ' ' HIS . 0.2 OUTLIER -54.27 -39.61 67.05 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 117.531 0.665 . . . . 0.0 109.355 174.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 394' ' ' VAL . . . . . 0.708 HG23 HD12 ' B' ' 398' ' ' ILE . 1.8 m -56.25 -49.17 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 395' ' ' ILE . . . . . 0.685 HG23 HD13 ' B' ' 426' ' ' ILE . 3.7 mp -56.8 -53.39 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 CA-C-O 118.255 -0.879 . . . . 0.0 113.323 -174.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 396' ' ' LYS . . . . . 0.732 ' HG3' ' CE1' ' B' ' 429' ' ' TYR . 0.1 OUTLIER -66.27 -47.0 75.09 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 121.42 1.918 . . . . 0.0 112.054 -172.042 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 397' ' ' GLY . . . . . 0.465 ' HA2' HG22 ' A' ' 385' ' ' THR . . . -53.0 -45.19 62.19 Favored Glycine 0 N--CA 1.432 -1.571 0 C-N-CA 120.099 -1.048 . . . . 0.0 110.893 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . 0.708 HD12 HG23 ' B' ' 394' ' ' VAL . 31.1 mt -70.67 -33.88 54.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 399' ' ' VAL . . . . . 0.536 HG22 ' O ' ' B' ' 396' ' ' LYS . 11.2 m -62.59 -39.52 84.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 C-N-CA 118.664 -1.214 . . . . 0.0 108.07 -174.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -70.93 -34.8 71.85 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 175.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 401' ' ' GLN . . . . . 0.441 HE21 ' HB3' ' B' ' 401' ' ' GLN . 5.7 mm100 -89.11 -47.71 7.9 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -173.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 402' ' ' GLU . . . . . 0.467 ' HB3' ' HB ' ' B' ' 406' ' ' THR . 3.1 mm-40 -119.85 -20.89 7.4 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.558 -170.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 107.44 162.55 21.61 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.52 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 404' ' ' VAL . . . . . 0.601 HG11 ' HA ' ' B' ' 430' ' ' LEU . 1.6 m -53.95 -45.78 64.19 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.754 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -175.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 405' ' ' ALA . . . . . 0.565 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -64.02 -29.81 70.93 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 119.741 -0.784 . . . . 0.0 112.187 -177.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 406' ' ' THR . . . . . 0.696 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 90.1 m -77.34 -43.14 33.98 Favored 'General case' 0 C--O 1.22 -0.499 0 O-C-N 121.867 -0.521 . . . . 0.0 110.343 172.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 407' ' ' ALA . . . . . 0.435 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.16 -36.0 72.37 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 122.162 0.982 . . . . 0.0 109.254 176.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 408' ' ' TYR . . . . . 0.573 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -66.33 -52.74 44.09 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 113.411 -1.722 . . . . 0.0 109.711 176.003 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 409' ' ' THR . . . . . 0.631 HG22 HD23 ' B' ' 410' ' ' LEU . 17.1 m -55.41 -47.37 76.04 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.675 179.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 410' ' ' LEU . . . . . 0.703 HD12 ' CD1' ' B' ' 398' ' ' ILE . 15.1 mt -72.5 -36.46 68.39 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -174.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.91 -35.21 81.94 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.058 -1.068 . . . . 0.0 110.769 172.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 412' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -68.6 -48.41 64.21 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-O 120.514 0.197 . . . . 0.0 111.34 178.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 413' ' ' MET . . . . . 0.961 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 1.2 ppp? -71.07 -43.17 68.33 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 118.954 -1.098 . . . . 0.0 112.116 -177.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 414' ' ' LEU . . . . . 0.961 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 11.9 mt -71.21 -46.31 61.45 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -177.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 43.9 t -84.76 -24.4 28.82 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.649 0.738 . . . . 0.0 110.289 -174.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 416' ' ' GLY . . . . . 0.42 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 111.08 -175.83 18.07 Favored Glycine 0 N--CA 1.426 -2.009 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -171.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -80.54 24.05 0.48 Allowed 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.482 0.658 . . . . 0.0 111.255 -172.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 418' ' ' ASN . . . . . 0.42 ' H ' ' C ' ' B' ' 416' ' ' GLY . 84.9 m-20 -71.55 76.77 0.8 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.74 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 419' ' ' TYR . . . . . 0.559 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 16.8 p90 -54.4 -39.01 66.84 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.653 177.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -55.73 -43.85 76.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.788 0.328 . . . . 0.0 111.168 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 421' ' ' LEU . . . . . 0.402 HD22 ' HB2' ' B' ' 418' ' ' ASN . 0.0 OUTLIER -67.81 -48.69 65.55 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.033 -178.098 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 422' ' ' VAL . . . . . 0.429 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.2 OUTLIER -66.23 -39.44 84.3 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.398 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.089 -177.396 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 423' ' ' SER . . . . . 0.749 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 64.4 p -67.32 -39.88 85.92 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.924 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -66.38 -39.71 94.29 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.107 175.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 425' ' ' ILE . . . . . 0.649 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -72.79 -51.84 25.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 121.219 -0.192 . . . . 0.0 111.329 -177.218 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 426' ' ' ILE . . . . . 0.685 HD13 HG23 ' B' ' 395' ' ' ILE . 1.2 mm -73.87 -23.04 18.76 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.896 0 O-C-N 122.194 -0.316 . . . . 0.0 110.227 -171.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 427' ' ' ARG . . . . . 0.749 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.8 OUTLIER -54.7 -29.32 52.74 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.074 0.464 . . . . 0.0 111.007 -178.106 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.51 -11.4 68.86 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.638 -0.791 . . . . 0.0 111.637 178.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 429' ' ' TYR . . . . . 0.732 ' CE1' ' HG3' ' B' ' 396' ' ' LYS . 14.9 m-85 -114.13 -1.17 13.76 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-O 121.766 0.793 . . . . 0.0 109.256 -176.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 430' ' ' LEU . . . . . 0.625 HD12 ' HD2' ' B' ' 431' ' ' PRO . 0.0 OUTLIER -66.02 135.13 95.11 Favored Pre-proline 0 N--CA 1.438 -1.031 0 CA-C-N 114.017 -1.447 . . . . 0.0 108.649 177.582 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 431' ' ' PRO . . . . . 0.821 ' HD2' HG11 ' B' ' 435' ' ' VAL . 43.9 Cg_exo -36.21 -65.99 0.13 Allowed 'Trans proline' 0 N--CA 1.474 0.365 0 C-N-CA 124.888 3.725 . . . . 0.0 114.226 -171.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 432' ' ' GLY . . . . . 0.533 ' H ' HG12 ' B' ' 435' ' ' VAL . . . -141.63 -163.36 9.56 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 176.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 433' ' ' GLN . . . . . 0.506 ' O ' HG13 ' B' ' 436' ' ' VAL . 21.3 tp60 -70.54 -27.6 64.28 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 118.079 0.94 . . . . 0.0 110.322 177.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -67.52 -38.94 85.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.995 -176.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 435' ' ' VAL . . . . . 0.821 HG11 ' HD2' ' B' ' 431' ' ' PRO . 7.7 p -68.59 -44.85 82.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-O 120.958 0.409 . . . . 0.0 110.623 -178.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 436' ' ' VAL . . . . . 0.506 HG13 ' O ' ' B' ' 433' ' ' GLN . 0.2 OUTLIER -65.19 -29.69 48.06 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.39 175.83 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -70.37 -51.99 25.76 Favored 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 438' ' ' ALA . . . . . 0.875 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -58.15 -38.73 77.18 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.707 177.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 439' ' ' LEU . . . . . 0.566 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 2.1 tm? -70.23 -47.09 62.92 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -178.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.67 -39.16 76.45 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.34 174.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 441' ' ' GLN . . . . . 0.518 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 9.2 mm-40 -53.76 -49.62 67.8 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 123.826 0.85 . . . . 0.0 110.624 174.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 442' ' ' ARG . . . . . 0.832 ' HG2' ' O ' ' B' ' 438' ' ' ALA . 0.7 OUTLIER -56.15 -40.24 73.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.684 172.228 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 443' ' ' LEU . . . . . 0.566 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 32.5 mt -72.16 -32.03 66.5 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.995 0.426 . . . . 0.0 110.34 -178.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -58.81 -38.06 77.77 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.682 0.753 . . . . 0.0 110.464 173.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -74.03 -27.54 60.99 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.275 177.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 446' ' ' GLU . . . . . 0.437 ' HB3' ' O ' ' B' ' 443' ' ' LEU . 10.8 pt-20 19.3 100.29 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 178.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 447' ' ' ILE . . . . . 0.425 HD12 HG22 ' B' ' 451' ' ' THR . 45.2 mt -60.61 -34.03 56.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.382 0.611 . . . . 0.0 110.426 177.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 448' ' ' ASP . . . . . 0.404 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 11.4 m-20 -162.61 -156.31 0.4 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -178.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -89.66 -63.97 1.21 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 169.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.87 -25.94 64.88 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 178.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 451' ' ' THR . . . . . 0.429 ' HA ' ' HB2' ' B' ' 454' ' ' GLU . 12.1 m -71.29 -22.57 61.93 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.602 -176.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 452' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -54.37 -53.65 51.11 Favored 'General case' 0 C--O 1.219 -0.533 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 171.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 453' ' ' ALA . . . . . 0.559 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -57.71 -48.04 80.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 114.609 -1.178 . . . . 0.0 112.53 175.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 454' ' ' GLU . . . . . 0.429 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 11.4 mm-40 -51.53 -34.82 37.98 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.161 0.505 . . . . 0.0 111.578 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 32.4 p -119.63 16.04 12.8 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.424 -176.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 456' ' ' PHE . . . . . 0.565 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 0.9 OUTLIER -57.46 -48.68 78.54 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.664 -171.304 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 457' ' ' ILE . . . . . 0.565 HG23 ' HB1' ' B' ' 405' ' ' ALA . 2.0 mp -75.68 -32.83 25.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.986 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -57.39 -35.29 69.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.959 0.885 . . . . 0.0 109.139 171.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 459' ' ' HIS . . . . . 0.73 ' O ' HG23 ' B' ' 463' ' ' VAL . 60.8 m-70 -74.73 -28.91 60.98 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.44 -1.254 . . . . 0.0 110.998 177.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 460' ' ' LEU . . . . . 0.728 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.4 OUTLIER -73.91 -35.04 64.61 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.9 0.857 . . . . 0.0 108.938 178.944 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 461' ' ' ASN . . . . . 0.42 ' O ' ' HB2' ' B' ' 464' ' ' TYR . 23.5 m-80 -73.24 -37.42 66.37 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.743 177.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 462' ' ' ALA . . . . . 0.606 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -56.39 -35.34 67.64 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.711 169.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 463' ' ' VAL . . . . . 0.875 HG13 ' HB3' ' B' ' 438' ' ' ALA . 68.3 t -61.01 -51.59 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 175.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 464' ' ' TYR . . . . . 0.611 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 19.9 m-30 -52.0 -28.39 16.8 Favored 'General case' 0 N--CA 1.457 -0.11 0 O-C-N 124.4 1.063 . . . . 0.0 110.764 178.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.41 -40.53 17.69 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.633 0.73 . . . . 0.0 109.736 -177.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 466' ' ' ILE . . . . . 0.606 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.7 mt -56.04 -55.83 16.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 114.402 -1.272 . . . . 0.0 112.184 176.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 467' ' ' LEU . . . . . 0.801 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -101.83 -10.44 19.88 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -172.468 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 468' ' ' GLY . . . . . 0.616 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 93.75 32.03 7.86 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 119.352 -1.404 . . . . 0.0 114.164 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 469' ' ' LEU . . . . . 0.801 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.7 mt -89.05 161.81 16.35 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 117.81 0.805 . . . . 0.0 111.149 176.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 37.9 p30 -104.59 -176.93 3.22 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.901 172.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 471' ' ' ALA . . . . . 0.468 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -62.22 -20.74 64.52 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -175.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 472' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' B' ' 472' ' ' ARG . 27.7 mmt180 -87.11 -1.68 58.07 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.655 0.264 . . . . 0.0 111.647 -173.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 473' ' ' GLY . . . . . . . . . . . . . . . 78.7 14.62 81.87 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 119.986 -1.102 . . . . 0.0 110.61 -174.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -101.11 149.01 24.4 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 177.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 4.2 p -87.86 127.5 35.34 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.05 0.452 . . . . 0.0 111.006 -178.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 476' ' ' ILE . . . . . 0.616 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.9 pp -99.68 4.19 10.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.625 0.726 . . . . 0.0 110.225 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 477' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 -59.79 119.86 8.45 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.944 -177.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 478' ' ' LEU . . . . . 0.517 HD23 ' H ' ' B' ' 478' ' ' LEU . 2.6 pt? -78.99 -12.59 60.04 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.428 0.632 . . . . 0.0 109.646 173.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 479' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 . . . . . 0 C--O 1.247 0.956 0 CA-C-O 118.283 -0.865 . . . . 0.0 109.45 179.74 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 . . . . . 0 N--CA 1.481 1.09 0 CA-C-O 121.157 0.503 . . . . 0.0 110.657 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.68 -66.12 0.39 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.882 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -121.41 170.75 9.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.411 0.624 . . . . 0.0 112.671 -169.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -119.19 -110.62 2.38 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 114.999 -1.001 . . . . 0.0 111.53 174.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 21.0 m -68.48 -41.75 79.68 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.943 0.401 . . . . 0.0 110.832 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' PHE . . . . . 0.817 ' CD1' HD22 ' A' ' 414' ' ' LEU . 4.7 t80 -70.46 125.82 92.11 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.217 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -47.11 -67.72 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.848 3.032 . . . . 0.0 114.5 -174.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.516 ' HB2' ' HE2' ' A' ' 388' ' ' MET . 34.5 ttm 66.27 160.81 0.14 Allowed 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.792 0.33 . . . . 0.0 111.235 176.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' HIS . . . . . 0.623 ' CE1' ' HA ' ' A' ' 393' ' ' ASN . 34.4 m170 -72.73 -155.68 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 108.353 -0.981 . . . . 0.0 108.353 173.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . 0.445 ' CD ' ' H ' ' A' ' 390' ' ' GLN . 5.7 pm0 -77.84 8.77 4.16 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.395 172.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.546 HD23 ' H ' ' A' ' 392' ' ' GLY . 2.1 pt? -159.79 -51.84 0.06 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -176.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . 0.714 ' HA3' HD13 ' A' ' 395' ' ' ILE . . . -171.05 72.82 0.11 Allowed Glycine 0 CA--C 1.526 0.766 0 C-N-CA 119.438 -1.363 . . . . 0.0 114.762 -173.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . 0.623 ' HA ' ' CE1' ' A' ' 389' ' ' HIS . 0.0 OUTLIER -66.4 -36.95 84.14 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 175.832 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.677 HG23 HD12 ' A' ' 398' ' ' ILE . 1.0 OUTLIER -57.07 -49.09 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 CA-C-N 113.032 -1.894 . . . . 0.0 107.248 178.193 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.714 HD13 ' HA3' ' A' ' 392' ' ' GLY . 3.7 mp -58.48 -52.61 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 CA-C-O 117.663 -1.161 . . . . 0.0 113.671 -174.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . 0.586 ' O ' HG22 ' A' ' 399' ' ' VAL . 0.0 OUTLIER -61.88 -50.02 73.89 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 122.221 2.282 . . . . 0.0 112.143 -174.56 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . 0.434 ' O ' ' HG3' ' A' ' 401' ' ' GLN . . . -53.29 -44.68 65.24 Favored Glycine 0 N--CA 1.432 -1.571 0 CA-C-N 114.713 -1.13 . . . . 0.0 111.045 -176.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . 0.854 HD13 HD12 ' A' ' 410' ' ' LEU . 37.8 mt -71.34 -34.23 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -178.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . 0.586 HG22 ' O ' ' A' ' 396' ' ' LYS . 16.3 m -63.24 -40.33 88.62 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 C-N-CA 118.92 -1.112 . . . . 0.0 108.49 -173.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -64.3 -43.85 93.44 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 175.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.572 ' NE2' ' HA ' ' B' ' 414' ' ' LEU . 14.5 mt-30 -92.9 -48.38 6.56 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -167.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . 0.602 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 1.2 tm-20 -111.52 -19.13 12.66 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.193 0.52 . . . . 0.0 110.82 -173.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 104.51 161.33 24.18 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.846 177.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . 0.644 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.2 m -53.94 -45.13 63.51 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.866 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -175.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . 0.553 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -63.58 -31.65 72.87 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 119.956 -0.697 . . . . 0.0 112.517 -177.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.696 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 88.0 m -77.08 -41.48 42.06 Favored 'General case' 0 C--O 1.222 -0.35 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.46 173.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.486 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -58.84 -36.6 74.82 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 122.1 0.953 . . . . 0.0 109.354 175.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 408' ' ' TYR . . . . . 0.644 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -67.18 -51.47 53.23 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 113.525 -1.671 . . . . 0.0 109.729 177.009 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 409' ' ' THR . . . . . 0.675 HG22 HD23 ' A' ' 410' ' ' LEU . 17.1 m -54.55 -47.76 72.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.591 -0.732 . . . . 0.0 112.508 177.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . 0.854 HD12 HD13 ' A' ' 398' ' ' ILE . 14.5 mt -72.55 -34.4 67.5 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -175.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.59 -34.01 74.46 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.286 -0.959 . . . . 0.0 110.865 170.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 412' ' ' MET . . . . . 0.403 ' HB2' ' O ' ' A' ' 409' ' ' THR . 0.4 OUTLIER -67.89 -48.09 67.0 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 122.547 -0.384 . . . . 0.0 111.17 177.148 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 413' ' ' MET . . . . . 0.922 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.7 OUTLIER -72.32 -48.21 43.89 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 119.176 -1.01 . . . . 0.0 112.569 -179.778 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . 0.922 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 15.4 mt -69.18 -46.95 66.23 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -174.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.08 9.62 41.59 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.432 0.634 . . . . 0.0 110.746 -173.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . 0.411 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 85.32 -178.46 50.57 Favored Glycine 0 N--CA 1.435 -1.375 0 CA-C-N 115.437 -0.802 . . . . 0.0 111.554 -178.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -79.94 22.66 0.49 Allowed 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.285 0.564 . . . . 0.0 111.108 -173.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 418' ' ' ASN . . . . . 0.415 ' HB3' ' HB3' ' A' ' 421' ' ' LEU . 3.5 m-20 -71.94 75.1 0.9 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.083 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 419' ' ' TYR . . . . . 0.567 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 28.3 p90 -56.6 -36.96 70.0 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.456 177.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -54.81 -42.03 71.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.461 175.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . 0.415 ' HB3' ' HB3' ' A' ' 418' ' ' ASN . 0.0 OUTLIER -68.62 -51.89 37.32 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.624 -179.068 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . 0.51 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -62.77 -37.1 78.24 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.582 -174.705 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.771 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 58.4 p -69.27 -34.07 74.19 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -68.69 -42.18 80.86 Favored Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.3 174.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . 0.571 HG22 HG21 ' A' ' 395' ' ' ILE . 2.6 mp -72.55 -50.98 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 116.921 0.361 . . . . 0.0 111.514 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . 0.67 HD13 HG23 ' A' ' 395' ' ' ILE . 1.2 mm -75.19 -23.69 17.26 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.911 0 O-C-N 122.085 -0.384 . . . . 0.0 110.926 -171.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.771 ' HB2' ' O ' ' A' ' 423' ' ' SER . 1.0 OUTLIER -54.3 -33.3 58.44 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.196 0.522 . . . . 0.0 111.009 -177.199 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -84.65 -13.79 71.99 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.316 -0.945 . . . . 0.0 111.021 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.567 ' HD1' HG22 ' A' ' 395' ' ' ILE . 7.3 m-30 -110.83 -2.05 16.29 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.913 0.863 . . . . 0.0 108.758 -174.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.635 ' HA ' HG11 ' A' ' 404' ' ' VAL . 0.0 OUTLIER -66.3 138.96 96.12 Favored Pre-proline 0 N--CA 1.441 -0.902 0 CA-C-N 113.972 -1.467 . . . . 0.0 109.027 176.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . 0.844 ' HD2' HG11 ' A' ' 435' ' ' VAL . 71.0 Cg_exo -37.81 -65.3 0.16 Allowed 'Trans proline' 0 N--CA 1.473 0.312 0 C-N-CA 124.499 3.466 . . . . 0.0 113.874 -173.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . 0.544 ' H ' HG12 ' A' ' 435' ' ' VAL . . . -143.86 -163.24 9.8 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 176.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . 0.543 ' O ' HG13 ' A' ' 436' ' ' VAL . 43.8 tp60 -71.87 -26.67 62.44 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 118.328 1.064 . . . . 0.0 110.882 177.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -66.29 -40.7 90.22 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -177.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 435' ' ' VAL . . . . . 0.844 HG11 ' HD2' ' A' ' 431' ' ' PRO . 7.5 p -67.08 -44.13 88.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-O 120.962 0.411 . . . . 0.0 110.783 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.543 HG13 ' O ' ' A' ' 433' ' ' GLN . 0.1 OUTLIER -65.98 -31.55 54.19 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.179 176.383 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.2 -52.98 34.58 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -178.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . 0.866 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -58.56 -40.06 82.02 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.23 177.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 439' ' ' LEU . . . . . 0.605 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 1.9 tm? -68.13 -48.1 66.3 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -178.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.9 -38.44 78.91 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.457 176.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 441' ' ' GLN . . . . . 0.444 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 6.0 mm-40 -53.69 -52.09 61.14 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 123.629 0.771 . . . . 0.0 110.56 177.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . 0.543 ' NH1' ' HB1' ' A' ' 462' ' ' ALA . 0.1 OUTLIER -60.95 -34.9 75.45 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.734 174.848 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 443' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 64.1 mt -68.32 -36.55 79.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.744 178.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -56.57 -37.12 70.13 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.527 0.679 . . . . 0.0 110.284 174.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -74.12 -26.75 60.52 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.577 177.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 446' ' ' GLU . . . . . 0.419 ' HB3' ' O ' ' A' ' 443' ' ' LEU . 10.1 pt-20 19.26 103.36 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 176.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 447' ' ' ILE . . . . . 0.431 HD12 HG22 ' A' ' 451' ' ' THR . 43.0 mt -60.95 -34.9 61.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.852 178.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . 0.456 ' HB2' ' OG1' ' A' ' 451' ' ' THR . 22.1 m-20 -162.43 -158.8 0.53 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -178.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 449' ' ' ASP . . . . . 0.529 ' HA ' ' CZ ' ' A' ' 452' ' ' ARG . 9.6 m-20 -86.29 -67.2 0.83 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 170.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 450' ' ' GLN . . . . . 0.406 ' HG3' ' H ' ' A' ' 450' ' ' GLN . 0.0 OUTLIER -65.94 -25.57 67.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.167 178.562 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 451' ' ' THR . . . . . 0.463 ' HA ' ' HB2' ' A' ' 454' ' ' GLU . 14.3 m -71.47 -22.6 61.8 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.633 -176.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . 0.529 ' CZ ' ' HA ' ' A' ' 449' ' ' ASP . 48.8 mtt85 -54.65 -53.92 48.4 Favored 'General case' 0 C--O 1.219 -0.535 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 171.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 453' ' ' ALA . . . . . 0.567 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -56.69 -47.91 78.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.706 -1.134 . . . . 0.0 112.404 174.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . 0.463 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 13.3 mm-40 -52.36 -33.09 41.54 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.14 0.495 . . . . 0.0 111.742 -178.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 28.6 p -120.04 13.17 12.11 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.551 -176.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . 0.538 ' CE2' ' HB2' ' A' ' 419' ' ' TYR . 0.6 OUTLIER -56.71 -49.03 76.39 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.003 0.43 . . . . 0.0 111.493 -171.525 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . 0.553 HG23 ' HB1' ' A' ' 405' ' ' ALA . 1.9 mp -75.98 -32.02 22.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.067 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -57.88 -35.45 71.0 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.722 0.772 . . . . 0.0 108.939 171.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . 0.77 ' O ' HG23 ' A' ' 463' ' ' VAL . 74.2 m-70 -74.44 -29.3 61.42 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.294 178.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . 0.728 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -74.1 -35.36 64.17 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.864 0.84 . . . . 0.0 109.241 179.78 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . 0.492 ' O ' ' HB2' ' A' ' 464' ' ' TYR . 23.1 m-80 -73.65 -37.25 65.37 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 121.935 0.874 . . . . 0.0 108.922 177.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 462' ' ' ALA . . . . . 0.578 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -57.26 -34.8 69.0 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.803 169.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.866 HG13 ' HB3' ' A' ' 438' ' ' ALA . 63.7 t -60.46 -50.82 78.85 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.851 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 175.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 464' ' ' TYR . . . . . 0.624 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 19.3 m-30 -52.77 -28.25 21.56 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.552 177.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.53 -41.77 19.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.721 0.772 . . . . 0.0 109.457 -178.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.578 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.8 mt -57.24 -55.85 18.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 114.269 -1.332 . . . . 0.0 112.076 177.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.777 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -101.07 -10.12 20.78 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -172.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . 0.599 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 94.14 31.59 7.96 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 119.354 -1.403 . . . . 0.0 114.31 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 469' ' ' LEU . . . . . 0.777 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.9 mt -88.58 163.77 15.7 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 117.831 0.815 . . . . 0.0 111.09 176.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 37.4 p30 -105.34 -179.27 3.89 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.521 174.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -60.17 -23.25 63.8 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -177.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -87.24 2.34 50.37 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.325 -172.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . 0.484 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 77.8 10.61 86.11 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.501 -0.857 . . . . 0.0 111.3 -177.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -101.23 157.98 16.38 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 176.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . 0.536 ' OG ' ' HG2' ' A' ' 477' ' ' ARG . 16.3 t -94.01 144.3 25.59 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.314 -0.555 . . . . 0.0 110.755 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 476' ' ' ILE . . . . . 0.599 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.5 pp -108.44 12.32 8.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.513 -178.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 477' ' ' ARG . . . . . 0.536 ' HG2' ' OG ' ' A' ' 475' ' ' SER . 29.9 mmm180 -54.4 111.27 0.75 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.48 -1.236 . . . . 0.0 111.084 177.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 62.18 34.8 15.95 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.129 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 . . . . . 0 C--O 1.25 1.083 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.471 177.77 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 381' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 . . . . . 0 N--CA 1.481 1.099 0 CA-C-O 121.195 0.521 . . . . 0.0 110.53 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 382' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.5 -66.42 0.39 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.978 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 383' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -120.85 170.99 8.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.516 0.674 . . . . 0.0 112.75 -169.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 384' ' ' GLY . . . . . . . . . . . . . . . -119.35 -110.33 2.35 Favored Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.408 173.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 385' ' ' THR . . . . . . . . . . . . . 19.4 m -68.48 -41.66 79.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.002 0.43 . . . . 0.0 110.931 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 386' ' ' PHE . . . . . 0.817 ' CD1' HD22 ' B' ' 414' ' ' LEU . 4.6 t80 -70.63 125.93 92.11 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.174 178.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 387' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -47.22 -67.75 0.11 Allowed 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 123.788 2.992 . . . . 0.0 114.388 -174.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 388' ' ' MET . . . . . 0.531 ' HB2' ' HE2' ' B' ' 388' ' ' MET . 34.6 ttm 66.2 161.01 0.14 Allowed 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.683 0.278 . . . . 0.0 111.247 177.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 389' ' ' HIS . . . . . 0.611 ' CE1' ' HA ' ' B' ' 393' ' ' ASN . 34.5 m170 -72.91 -155.14 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 173.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 390' ' ' GLN . . . . . 0.428 ' CD ' ' H ' ' B' ' 390' ' ' GLN . 5.7 pm0 -77.92 8.8 4.19 Favored 'General case' 0 C--N 1.317 -0.837 0 O-C-N 121.914 -0.491 . . . . 0.0 110.428 171.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 391' ' ' LEU . . . . . 0.536 HD23 ' H ' ' B' ' 392' ' ' GLY . 2.1 pt? -160.06 -51.69 0.05 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -176.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 392' ' ' GLY . . . . . 0.715 ' HA3' HD13 ' B' ' 395' ' ' ILE . . . -170.92 72.83 0.11 Allowed Glycine 0 C--N 1.338 0.689 0 C-N-CA 119.513 -1.327 . . . . 0.0 114.746 -173.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 393' ' ' ASN . . . . . 0.611 ' HA ' ' CE1' ' B' ' 389' ' ' HIS . 0.0 OUTLIER -66.28 -37.02 84.46 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 175.711 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 394' ' ' VAL . . . . . 0.687 HG23 HD12 ' B' ' 398' ' ' ILE . 1.0 OUTLIER -57.04 -49.09 80.55 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 CA-C-N 113.039 -1.892 . . . . 0.0 107.216 178.352 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 395' ' ' ILE . . . . . 0.715 HD13 ' HA3' ' B' ' 392' ' ' GLY . 3.7 mp -58.42 -52.6 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.559 0 CA-C-O 117.681 -1.152 . . . . 0.0 113.63 -174.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 396' ' ' LYS . . . . . 0.583 ' O ' HG22 ' B' ' 399' ' ' VAL . 0.0 OUTLIER -62.02 -49.75 74.78 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 122.18 2.264 . . . . 0.0 112.139 -174.4 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 397' ' ' GLY . . . . . 0.44 ' O ' ' HG3' ' B' ' 401' ' ' GLN . . . -53.51 -44.79 67.59 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 114.704 -1.135 . . . . 0.0 110.904 -176.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . 0.863 HD13 HD12 ' B' ' 410' ' ' LEU . 38.1 mt -71.24 -34.2 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -178.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 399' ' ' VAL . . . . . 0.583 HG22 ' O ' ' B' ' 396' ' ' LYS . 16.4 m -63.32 -40.19 88.09 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 C-N-CA 118.949 -1.1 . . . . 0.0 108.573 -173.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -64.35 -44.03 92.75 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 174.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 401' ' ' GLN . . . . . 0.576 ' NE2' ' HA ' ' A' ' 414' ' ' LEU . 14.5 mt-30 -92.78 -48.45 6.56 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -167.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 402' ' ' GLU . . . . . 0.603 ' HG3' ' HE3' ' A' ' 413' ' ' MET . 1.2 tm-20 -111.36 -19.28 12.67 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.19 0.519 . . . . 0.0 110.842 -173.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 104.62 161.31 24.08 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.89 177.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 404' ' ' VAL . . . . . 0.639 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.2 m -54.0 -45.13 64.3 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.812 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -175.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 405' ' ' ALA . . . . . 0.539 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -63.63 -31.46 72.64 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 119.954 -0.698 . . . . 0.0 112.522 -177.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 406' ' ' THR . . . . . 0.692 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 89.6 m -77.14 -41.7 40.76 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.146 -0.622 . . . . 0.0 110.402 173.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 407' ' ' ALA . . . . . 0.494 ' HB2' ' HB ' ' B' ' 398' ' ' ILE . . . -58.7 -36.68 74.63 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 122.154 0.978 . . . . 0.0 109.319 175.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 408' ' ' TYR . . . . . 0.639 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -67.27 -51.39 53.42 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 113.512 -1.677 . . . . 0.0 109.693 177.151 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 409' ' ' THR . . . . . 0.665 HG22 HD23 ' B' ' 410' ' ' LEU . 17.6 m -54.49 -47.88 72.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.478 177.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 410' ' ' LEU . . . . . 0.863 HD12 HD13 ' B' ' 398' ' ' ILE . 14.5 mt -72.46 -34.41 67.72 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -175.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.48 -33.94 73.54 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 120.311 -0.947 . . . . 0.0 110.954 170.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 412' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -68.04 -48.09 66.61 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 122.406 -0.467 . . . . 0.0 111.21 177.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 413' ' ' MET . . . . . 0.917 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.7 OUTLIER -72.18 -47.98 46.67 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 119.201 -0.999 . . . . 0.0 112.627 -179.779 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 414' ' ' LEU . . . . . 0.917 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 15.7 mt -69.62 -46.65 65.74 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -174.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.19 9.36 42.41 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.434 0.635 . . . . 0.0 110.769 -173.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 416' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 85.56 -178.38 50.22 Favored Glycine 0 N--CA 1.435 -1.378 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.64 -178.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -80.08 22.51 0.51 Allowed 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.227 0.537 . . . . 0.0 111.08 -173.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 418' ' ' ASN . . . . . 0.412 ' HB3' ' HB3' ' B' ' 421' ' ' LEU . 3.5 m-20 -71.76 75.06 0.85 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.108 179.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 419' ' ' TYR . . . . . 0.563 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 29.0 p90 -56.59 -36.9 69.91 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.484 177.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -54.91 -41.91 71.55 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.505 175.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 421' ' ' LEU . . . . . 0.412 ' HB3' ' HB3' ' B' ' 418' ' ' ASN . 0.0 OUTLIER -68.75 -51.86 36.66 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.71 -179.201 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 422' ' ' VAL . . . . . 0.501 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.2 OUTLIER -62.72 -37.22 78.48 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.57 -174.776 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 423' ' ' SER . . . . . 0.78 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 57.1 p -69.03 -34.55 75.4 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -68.3 -42.18 83.61 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.347 175.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 425' ' ' ILE . . . . . 0.578 HG22 HG21 ' B' ' 395' ' ' ILE . 2.6 mp -72.43 -51.1 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-N 116.723 0.261 . . . . 0.0 111.566 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 426' ' ' ILE . . . . . 0.651 HD13 HG23 ' B' ' 395' ' ' ILE . 1.2 mm -75.31 -23.51 17.03 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.925 0 O-C-N 121.978 -0.451 . . . . 0.0 110.95 -171.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 427' ' ' ARG . . . . . 0.78 ' HB2' ' O ' ' B' ' 423' ' ' SER . 1.0 OUTLIER -54.42 -33.21 58.99 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.192 0.52 . . . . 0.0 111.008 -177.194 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -84.88 -13.33 72.38 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.417 -0.897 . . . . 0.0 111.032 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 429' ' ' TYR . . . . . 0.575 ' HD1' HG22 ' B' ' 395' ' ' ILE . 7.4 m-30 -111.24 -2.13 15.85 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -174.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 430' ' ' LEU . . . . . 0.631 ' HA ' HG11 ' B' ' 404' ' ' VAL . 0.0 OUTLIER -66.46 138.65 95.8 Favored Pre-proline 0 N--CA 1.441 -0.904 0 CA-C-N 114.001 -1.454 . . . . 0.0 109.08 176.946 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 431' ' ' PRO . . . . . 0.838 ' HD2' HG11 ' B' ' 435' ' ' VAL . 70.0 Cg_exo -37.69 -64.6 0.18 Allowed 'Trans proline' 0 CA--C 1.533 0.426 0 C-N-CA 124.548 3.499 . . . . 0.0 114.045 -173.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 432' ' ' GLY . . . . . 0.558 ' H ' HG12 ' B' ' 435' ' ' VAL . . . -144.7 -163.92 10.29 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 176.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 433' ' ' GLN . . . . . 0.546 ' O ' HG13 ' B' ' 436' ' ' VAL . 43.0 tp60 -71.58 -26.79 62.76 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 118.34 1.07 . . . . 0.0 110.762 178.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -66.09 -40.6 90.92 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 435' ' ' VAL . . . . . 0.838 HG11 ' HD2' ' B' ' 431' ' ' PRO . 7.5 p -67.33 -44.03 87.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-O 120.981 0.42 . . . . 0.0 110.788 -178.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 436' ' ' VAL . . . . . 0.546 HG13 ' O ' ' B' ' 433' ' ' GLN . 0.1 OUTLIER -65.91 -31.55 54.23 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.103 176.485 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.36 -52.91 34.34 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -178.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 438' ' ' ALA . . . . . 0.862 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -58.52 -39.94 81.52 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.157 177.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 439' ' ' LEU . . . . . 0.592 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 1.9 tm? -68.14 -48.13 66.2 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -178.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.94 -38.28 78.64 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.665 -1.152 . . . . 0.0 111.507 176.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 441' ' ' GLN . . . . . 0.441 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 6.0 mm-40 -53.87 -52.0 61.86 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 123.496 0.718 . . . . 0.0 110.499 177.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 442' ' ' ARG . . . . . 0.549 ' NH1' ' HB1' ' B' ' 462' ' ' ALA . 0.1 OUTLIER -60.96 -35.07 75.82 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.652 174.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 443' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 64.9 mt -68.24 -36.47 79.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.803 178.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -56.64 -37.3 70.57 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.511 0.672 . . . . 0.0 110.346 174.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -74.03 -26.87 60.66 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.467 177.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 446' ' ' GLU . . . . . 0.434 ' HB3' ' O ' ' B' ' 443' ' ' LEU . 10.3 pt-20 19.72 103.26 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 176.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 447' ' ' ILE . . . . . 0.422 HD12 HG22 ' B' ' 451' ' ' THR . 43.3 mt -60.88 -34.68 60.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.927 178.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 448' ' ' ASP . . . . . 0.455 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 21.1 m-20 -162.57 -158.56 0.51 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -178.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 449' ' ' ASP . . . . . 0.512 ' HA ' ' CZ ' ' B' ' 452' ' ' ARG . 11.0 m-20 -86.59 -67.05 0.84 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 170.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.87 -25.68 67.29 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 178.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 451' ' ' THR . . . . . 0.475 ' HA ' ' HB2' ' B' ' 454' ' ' GLU . 14.1 m -71.34 -22.66 61.88 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.615 -176.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 452' ' ' ARG . . . . . 0.512 ' CZ ' ' HA ' ' B' ' 449' ' ' ASP . 48.7 mtt180 -54.65 -53.79 50.19 Favored 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 171.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 453' ' ' ALA . . . . . 0.563 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -56.75 -47.98 78.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.689 -1.141 . . . . 0.0 112.415 174.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 454' ' ' GLU . . . . . 0.475 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 14.4 mm-40 -52.36 -32.92 40.67 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.028 0.442 . . . . 0.0 111.828 -178.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 27.8 p -120.23 13.38 11.98 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.58 -176.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 456' ' ' PHE . . . . . 0.552 ' CE2' ' HB2' ' B' ' 419' ' ' TYR . 0.7 OUTLIER -56.86 -48.91 77.01 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.09 0.471 . . . . 0.0 111.496 -171.479 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 457' ' ' ILE . . . . . 0.548 HG13 ' HB3' ' B' ' 408' ' ' TYR . 1.9 mp -76.19 -32.08 22.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.968 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -57.81 -35.51 70.96 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.696 0.76 . . . . 0.0 109.025 171.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 459' ' ' HIS . . . . . 0.779 ' O ' HG23 ' B' ' 463' ' ' VAL . 73.4 m-70 -74.39 -29.16 61.42 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.312 178.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 460' ' ' LEU . . . . . 0.733 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -74.05 -35.42 64.3 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.907 0.861 . . . . 0.0 109.198 179.679 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 461' ' ' ASN . . . . . 0.471 ' O ' ' HB2' ' B' ' 464' ' ' TYR . 22.4 m-80 -73.65 -37.3 65.35 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.911 0.862 . . . . 0.0 108.857 177.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 462' ' ' ALA . . . . . 0.584 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -57.25 -34.61 68.79 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.383 -1.28 . . . . 0.0 109.84 169.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 463' ' ' VAL . . . . . 0.862 HG13 ' HB3' ' B' ' 438' ' ' ALA . 64.6 t -60.57 -50.9 78.53 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.778 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 464' ' ' TYR . . . . . 0.616 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 19.2 m-30 -52.83 -28.12 21.34 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.492 177.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.62 -41.94 18.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.593 0.711 . . . . 0.0 109.382 -178.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 466' ' ' ILE . . . . . 0.584 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.8 mt -57.06 -55.93 17.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 114.405 -1.27 . . . . 0.0 112.154 177.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 467' ' ' LEU . . . . . 0.77 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -100.75 -10.26 20.97 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -173.009 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 468' ' ' GLY . . . . . 0.607 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 94.18 31.57 7.96 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 119.222 -1.466 . . . . 0.0 114.396 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 469' ' ' LEU . . . . . 0.77 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.9 mt -88.5 163.83 15.73 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 117.954 0.877 . . . . 0.0 111.046 176.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 37.4 p30 -105.32 -179.41 3.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.553 174.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 471' ' ' ALA . . . . . . . . . . . . . . . -60.1 -22.84 63.28 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -87.49 2.06 51.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.251 -172.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 473' ' ' GLY . . . . . 0.489 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 78.16 10.47 86.19 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.37 -0.919 . . . . 0.0 111.214 -177.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -101.19 157.87 16.45 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 176.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 475' ' ' SER . . . . . 0.548 ' OG ' ' HG2' ' B' ' 477' ' ' ARG . 16.7 t -93.87 143.83 25.98 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.757 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 476' ' ' ILE . . . . . 0.607 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.5 pp -108.18 12.57 8.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.498 0.666 . . . . 0.0 110.508 -178.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 477' ' ' ARG . . . . . 0.548 ' HG2' ' OG ' ' B' ' 475' ' ' SER . 29.9 mmm180 -54.4 111.63 0.83 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.39 -1.277 . . . . 0.0 111.056 177.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 478' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 61.67 34.75 17.38 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.135 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 479' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 . . . . . 0 C--O 1.249 1.052 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.433 177.778 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 . . . . . 0 N--CA 1.479 1.003 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 1.5 t -115.02 -22.04 9.74 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -175.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' HIS . . . . . 0.506 ' HB2' ' O ' ' A' ' 386' ' ' PHE . 1.7 p80 -161.98 160.12 27.33 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.927 -173.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -113.02 -99.8 2.42 Favored Glycine 0 N--CA 1.443 -0.88 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.965 170.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 35.5 m -74.96 -42.53 57.46 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.816 0.341 . . . . 0.0 110.841 177.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' PHE . . . . . 0.878 ' CD1' HD22 ' A' ' 414' ' ' LEU . 5.0 t80 -68.15 122.62 84.79 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.023 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . 0.565 ' HG2' ' OD1' ' B' ' 393' ' ' ASN . 1.2 Cg_endo -45.09 -65.21 0.2 Allowed 'Trans proline' 0 CA--C 1.533 0.438 0 C-N-CA 123.667 2.911 . . . . 0.0 114.088 -177.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.781 ' SD ' HG13 ' A' ' 394' ' ' VAL . 18.2 tpp 67.21 160.69 0.16 Allowed 'General case' 0 N--CA 1.472 0.655 0 O-C-N 123.06 0.225 . . . . 0.0 110.814 178.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' HIS . . . . . 0.582 ' CG ' ' HB2' ' A' ' 393' ' ' ASN . 32.3 m170 -70.69 -161.19 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 171.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -72.76 6.99 2.16 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.288 172.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.587 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.1 pt? -161.01 -64.08 0.06 Allowed 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -175.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . 0.599 ' HA3' HD13 ' A' ' 395' ' ' ILE . . . -158.36 59.95 0.33 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 119.759 -1.21 . . . . 0.0 114.175 -170.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . 0.582 ' HB2' ' CG ' ' A' ' 389' ' ' HIS . 0.2 OUTLIER -55.11 -44.06 74.63 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.344 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.781 HG13 ' SD ' ' A' ' 388' ' ' MET . 1.1 m -59.08 -44.79 92.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-N 114.32 -1.309 . . . . 0.0 108.247 -177.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.68 HG23 HD13 ' A' ' 426' ' ' ILE . 4.2 mp -57.76 -52.05 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 CA-C-O 117.855 -1.069 . . . . 0.0 113.024 -175.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . 0.638 ' HG3' ' CZ ' ' A' ' 429' ' ' TYR . 0.1 OUTLIER -62.95 -49.2 75.7 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 121.681 2.037 . . . . 0.0 111.662 -175.766 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -54.69 -45.84 77.01 Favored Glycine 0 N--CA 1.432 -1.589 0 C-N-CA 120.072 -1.061 . . . . 0.0 111.31 -178.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . 0.844 HG12 HD21 ' B' ' 414' ' ' LEU . 26.9 mt -71.38 -33.86 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -177.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . 0.502 HG12 ' HA ' ' A' ' 404' ' ' VAL . 7.9 m -63.68 -39.58 85.89 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 C-N-CA 118.79 -1.164 . . . . 0.0 108.396 -174.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -69.33 -38.53 78.21 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 175.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.462 HE21 ' HB3' ' A' ' 401' ' ' GLN . 4.1 mm100 -86.17 -48.8 8.25 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -170.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . 0.471 ' HA ' HH11 ' A' ' 472' ' ' ARG . 10.2 tp10 -120.97 -21.04 6.66 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.868 0.366 . . . . 0.0 111.22 -171.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 109.7 163.64 19.63 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.985 178.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . 0.617 HG11 ' HA ' ' A' ' 430' ' ' LEU . 1.7 m -53.41 -45.56 57.53 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -175.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . 0.608 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -64.81 -31.02 72.06 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.702 -0.799 . . . . 0.0 112.288 -176.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.738 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 92.8 m -77.79 -41.35 37.63 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.297 173.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.504 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.86 -37.02 75.58 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 122.233 1.015 . . . . 0.0 109.06 176.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 408' ' ' TYR . . . . . 0.608 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.25 -52.47 54.21 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 113.27 -1.786 . . . . 0.0 109.924 175.761 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 409' ' ' THR . . . . . 0.667 HG22 HD23 ' A' ' 410' ' ' LEU . 18.6 m -55.35 -47.83 75.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.508 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . 0.738 ' HG ' ' O ' ' A' ' 406' ' ' THR . 14.3 mt -73.34 -36.86 66.22 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.16 -174.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -59.53 -35.16 84.51 Favored Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.053 -1.07 . . . . 0.0 110.606 172.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 412' ' ' MET . . . . . 0.473 ' HE2' ' HA ' ' A' ' 417' ' ' GLN . 0.0 OUTLIER -66.71 -49.93 64.46 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 120.605 0.24 . . . . 0.0 111.444 178.087 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 413' ' ' MET . . . . . 0.917 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.6 OUTLIER -71.44 -45.0 63.76 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 119.128 -1.029 . . . . 0.0 112.446 -176.069 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . 0.917 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 18.3 mt -72.52 -45.39 59.57 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -176.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 32.8 t -84.81 -19.1 33.03 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.795 0.807 . . . . 0.0 109.618 -173.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . 0.464 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 106.98 179.61 22.61 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -172.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 417' ' ' GLN . . . . . 0.473 ' HA ' ' HE2' ' A' ' 412' ' ' MET . 1.7 mp0 -79.1 25.43 0.29 Allowed 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 121.557 0.694 . . . . 0.0 111.027 -173.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 418' ' ' ASN . . . . . 0.464 ' H ' ' C ' ' A' ' 416' ' ' GLY . 84.1 m-20 -70.55 73.21 0.53 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.11 178.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 419' ' ' TYR . . . . . 0.522 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 5.7 p90 -51.34 -37.75 49.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.928 175.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -54.23 -45.81 72.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.119 176.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.25 -48.78 60.88 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.215 -177.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . 0.441 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -66.57 -40.61 86.73 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 C-N-CA 120.289 -0.565 . . . . 0.0 111.115 -175.465 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.724 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 79.1 p -67.53 -38.95 85.0 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.921 -178.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -69.34 -36.47 78.47 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.092 176.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . 0.626 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -73.53 -51.61 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 O-C-N 122.904 -0.174 . . . . 0.0 111.09 -178.605 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . 0.68 HD13 HG23 ' A' ' 395' ' ' ILE . 1.1 mm -74.63 -22.89 17.64 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.819 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -172.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.724 ' HB2' ' O ' ' A' ' 423' ' ' SER . 0.8 OUTLIER -55.07 -29.78 58.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.302 0.572 . . . . 0.0 110.463 -178.867 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -88.09 -4.38 78.21 Favored Glycine 0 N--CA 1.443 -0.839 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.702 178.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.638 ' CZ ' ' HG3' ' A' ' 396' ' ' LYS . 23.5 m-85 -119.18 -1.31 10.89 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 121.011 0.434 . . . . 0.0 110.314 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.643 HD23 ' HA ' ' A' ' 427' ' ' ARG . 0.1 OUTLIER -66.07 128.89 94.12 Favored Pre-proline 0 N--CA 1.44 -0.935 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.62 179.485 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . 0.569 ' HD2' HD12 ' A' ' 430' ' ' LEU . 99.9 Cg_exo -23.67 -68.31 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.736 1 C-N-CA 125.4 4.067 . . . . 0.0 114.62 179.5 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . 0.522 ' O ' HG12 ' A' ' 435' ' ' VAL . . . -144.54 -165.76 11.2 Favored Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 175.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . 0.509 ' O ' HG13 ' A' ' 436' ' ' VAL . 44.1 tp60 -70.11 -25.81 63.67 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 118.003 0.901 . . . . 0.0 110.568 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -66.84 -40.34 87.91 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -178.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 435' ' ' VAL . . . . . 0.756 HG23 HG11 ' A' ' 463' ' ' VAL . 7.5 p -68.63 -44.62 82.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 120.901 0.382 . . . . 0.0 110.406 -177.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.554 HG21 ' HD3' ' A' ' 427' ' ' ARG . 0.1 OUTLIER -64.4 -30.86 51.33 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 CA-C-O 120.834 0.349 . . . . 0.0 110.643 175.218 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 1.1 m -69.32 -52.03 31.29 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -178.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . 0.875 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -58.84 -37.21 75.96 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.551 177.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 439' ' ' LEU . . . . . 0.552 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 2.1 tm? -70.76 -47.8 57.73 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.97 -39.01 73.81 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.339 174.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 441' ' ' GLN . . . . . 0.479 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 37.1 mm-40 -53.2 -50.08 65.42 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 123.586 0.754 . . . . 0.0 110.705 173.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . 0.8 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 0.9 OUTLIER -56.23 -39.63 72.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.78 173.04 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 443' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 43.2 mt -71.89 -36.91 70.17 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.95 0.405 . . . . 0.0 110.28 -178.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -57.86 -37.51 74.05 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.614 173.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -73.16 -26.67 61.28 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.942 178.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 446' ' ' GLU . . . . . 0.404 ' HB3' ' O ' ' A' ' 443' ' ' LEU . 8.9 pt-20 29.3 104.53 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 172.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 447' ' ' ILE . . . . . 0.492 ' HB ' ' HB ' ' A' ' 451' ' ' THR . 64.7 mt -66.08 -32.21 57.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.877 0.846 . . . . 0.0 109.46 171.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . 0.47 ' HB3' ' H ' ' A' ' 451' ' ' THR . 4.8 t70 -167.34 -153.87 0.15 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -177.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 449' ' ' ASP . . . . . 0.435 ' O ' ' HG3' ' A' ' 452' ' ' ARG . 4.0 m-20 -90.6 -61.62 1.64 Allowed 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 165.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 450' ' ' GLN . . . . . 0.562 ' O ' ' HB3' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -72.59 -26.05 61.56 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.447 -176.794 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 451' ' ' THR . . . . . 0.504 ' HA ' ' HG3' ' A' ' 454' ' ' GLU . 4.0 m -72.8 -21.15 61.03 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.992 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . 0.435 ' HG3' ' O ' ' A' ' 449' ' ' ASP . 18.4 mtm180 -55.91 -47.44 77.46 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 107.138 -1.431 . . . . 0.0 107.138 170.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 453' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 450' ' ' GLN . . . -57.59 -49.29 76.88 Favored 'General case' 0 N--CA 1.462 0.163 0 O-C-N 124.142 0.901 . . . . 0.0 111.921 171.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . 0.504 ' HG3' ' HA ' ' A' ' 451' ' ' THR . 37.1 mt-10 -46.31 -38.84 9.22 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.471 0.653 . . . . 0.0 111.693 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 30.1 p -121.16 15.74 11.49 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.139 -173.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . 0.602 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.8 OUTLIER -55.45 -47.53 75.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.246 0.546 . . . . 0.0 111.349 -171.442 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . 0.608 HG23 ' HB1' ' A' ' 405' ' ' ALA . 2.0 mp -77.08 -34.45 21.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.439 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -57.33 -35.89 70.46 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.948 0.88 . . . . 0.0 109.21 171.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . 0.734 ' O ' HG23 ' A' ' 463' ' ' VAL . 55.5 m-70 -72.78 -29.21 63.1 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.841 176.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . 0.724 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -74.1 -34.16 63.86 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 122.114 0.959 . . . . 0.0 108.683 179.044 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . 0.453 ' O ' ' HB2' ' A' ' 464' ' ' TYR . 1.3 m-80 -73.27 -38.07 66.07 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.2 -0.909 . . . . 0.0 108.909 176.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 462' ' ' ALA . . . . . 0.607 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -56.24 -35.0 66.9 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.659 169.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.875 HG13 ' HB3' ' A' ' 438' ' ' ALA . 61.9 t -61.01 -50.95 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 175.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 464' ' ' TYR . . . . . 0.587 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 19.4 m-30 -52.95 -29.13 27.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.612 178.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.82 -40.18 19.03 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.667 0.746 . . . . 0.0 109.347 -176.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.607 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.7 mt -55.95 -55.55 17.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 114.288 -1.324 . . . . 0.0 112.198 175.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.774 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -102.9 -9.87 19.52 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 -172.748 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . 0.525 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 93.38 31.8 8.16 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 119.308 -1.425 . . . . 0.0 114.07 179.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 469' ' ' LEU . . . . . 0.774 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 2.8 mt -89.65 162.77 15.44 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 117.732 0.766 . . . . 0.0 111.272 176.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . 0.413 ' HB3' ' CG2' ' A' ' 476' ' ' ILE . 37.8 p30 -105.07 -177.68 3.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.142 171.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 471' ' ' ALA . . . . . 0.523 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -60.44 -23.51 64.48 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -176.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 472' ' ' ARG . . . . . 0.471 HH11 ' HA ' ' A' ' 402' ' ' GLU . 28.5 mmt180 -87.27 1.09 54.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.38 -170.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . 0.451 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 79.29 11.27 85.16 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.376 -0.916 . . . . 0.0 111.348 -177.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -101.02 150.82 22.5 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 177.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . 0.54 ' OG ' ' HG2' ' A' ' 479' ' ' GLU . 11.0 p -88.76 127.81 35.61 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.183 0.516 . . . . 0.0 110.842 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 476' ' ' ILE . . . . . 0.525 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.7 pp -91.17 -17.71 7.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.444 -176.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 477' ' ' ARG . . . . . 0.491 ' N ' HD12 ' A' ' 476' ' ' ILE . 0.4 OUTLIER -95.48 -166.01 1.38 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.997 179.87 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 39.4 tp -53.19 123.57 12.17 Favored 'General case' 0 C--N 1.328 -0.357 0 O-C-N 123.23 0.332 . . . . 0.0 110.289 177.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 479' ' ' GLU . . . . . 0.54 ' HG2' ' OG ' ' A' ' 475' ' ' SER . 33.4 mt-10 . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.504 -0.76 . . . . 0.0 110.994 -177.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 381' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 382' ' ' THR . . . . . . . . . . . . . 1.6 t -114.74 -22.07 9.88 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -175.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 383' ' ' HIS . . . . . 0.507 ' HB2' ' O ' ' B' ' 386' ' ' PHE . 1.8 p80 -161.86 160.04 27.57 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.941 -173.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 384' ' ' GLY . . . . . . . . . . . . . . . -112.9 -99.25 2.4 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 170.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 385' ' ' THR . . . . . . . . . . . . . 34.1 m -75.83 -41.88 51.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.938 0.369 . . . . 0.0 110.854 177.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 386' ' ' PHE . . . . . 0.865 ' CD1' HD22 ' B' ' 414' ' ' LEU . 5.1 t80 -68.57 122.56 85.08 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 387' ' ' PRO . . . . . 0.568 ' HG2' ' OD1' ' A' ' 393' ' ' ASN . 1.2 Cg_endo -44.96 -65.44 0.19 Allowed 'Trans proline' 0 CA--C 1.532 0.415 0 C-N-CA 123.55 2.833 . . . . 0.0 114.111 -177.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 388' ' ' MET . . . . . 0.776 ' SD ' HG13 ' B' ' 394' ' ' VAL . 18.3 tpp 67.61 160.99 0.17 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.549 0.214 . . . . 0.0 110.779 178.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 389' ' ' HIS . . . . . 0.587 ' CG ' ' HB2' ' B' ' 393' ' ' ASN . 32.5 m170 -70.91 -160.84 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 171.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -73.07 7.22 2.21 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.368 172.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 391' ' ' LEU . . . . . 0.589 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.1 pt? -161.14 -64.14 0.06 Allowed 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 392' ' ' GLY . . . . . 0.606 ' HA3' HD13 ' B' ' 395' ' ' ILE . . . -158.3 59.88 0.33 Allowed Glycine 0 C--N 1.334 0.431 0 C-N-CA 119.81 -1.186 . . . . 0.0 114.175 -170.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 393' ' ' ASN . . . . . 0.587 ' HB2' ' CG ' ' B' ' 389' ' ' HIS . 0.2 OUTLIER -54.98 -44.0 74.03 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-O 121.091 0.472 . . . . 0.0 109.851 178.304 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 394' ' ' VAL . . . . . 0.776 HG13 ' SD ' ' B' ' 388' ' ' MET . 1.1 m -59.2 -44.63 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 114.23 -1.35 . . . . 0.0 108.24 -177.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 395' ' ' ILE . . . . . 0.67 HG23 HD13 ' B' ' 426' ' ' ILE . 4.2 mp -57.77 -52.13 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-O 117.934 -1.032 . . . . 0.0 113.015 -175.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 396' ' ' LYS . . . . . 0.635 ' HG3' ' CZ ' ' B' ' 429' ' ' TYR . 0.1 OUTLIER -62.91 -49.21 75.7 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 121.661 2.028 . . . . 0.0 111.615 -175.683 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -54.62 -45.91 76.19 Favored Glycine 0 N--CA 1.433 -1.534 0 C-N-CA 120.029 -1.081 . . . . 0.0 111.295 -178.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . 0.85 HG12 HD21 ' A' ' 414' ' ' LEU . 26.8 mt -71.24 -34.01 52.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 113.531 0.938 . . . . 0.0 113.531 -177.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 399' ' ' VAL . . . . . 0.509 HG12 ' HA ' ' B' ' 404' ' ' VAL . 8.0 m -63.67 -39.7 86.32 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.519 0 C-N-CA 118.837 -1.145 . . . . 0.0 108.346 -174.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -69.15 -38.54 78.84 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 175.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 401' ' ' GLN . . . . . . . . . . . . . 4.3 mm100 -86.2 -49.07 8.0 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -170.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 402' ' ' GLU . . . . . 0.488 ' HA ' HH11 ' B' ' 472' ' ' ARG . 9.4 tp10 -120.67 -21.0 6.86 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 120.88 0.372 . . . . 0.0 111.324 -170.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 109.72 163.57 19.6 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.956 178.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 404' ' ' VAL . . . . . 0.613 HG11 ' HA ' ' B' ' 430' ' ' LEU . 1.7 m -53.3 -45.69 56.26 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.705 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -175.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 405' ' ' ALA . . . . . 0.6 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -64.85 -30.88 71.91 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 119.725 -0.79 . . . . 0.0 112.319 -176.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 406' ' ' THR . . . . . 0.736 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 92.5 m -77.86 -41.4 36.98 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 119.961 -0.696 . . . . 0.0 110.231 173.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 407' ' ' ALA . . . . . 0.485 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.95 -36.98 75.7 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 122.241 1.019 . . . . 0.0 109.014 176.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 408' ' ' TYR . . . . . 0.599 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.23 -52.44 54.56 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 113.283 -1.78 . . . . 0.0 109.941 175.82 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 409' ' ' THR . . . . . 0.665 HG22 HD23 ' B' ' 410' ' ' LEU . 17.5 m -55.43 -47.72 75.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.572 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 410' ' ' LEU . . . . . 0.736 ' HG ' ' O ' ' B' ' 406' ' ' THR . 14.4 mt -73.34 -37.11 66.21 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.06 -174.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -59.27 -35.32 84.14 Favored Glycine 0 N--CA 1.438 -1.224 0 C-N-CA 120.14 -1.028 . . . . 0.0 110.666 172.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 412' ' ' MET . . . . . 0.489 ' HE2' ' HA ' ' B' ' 417' ' ' GLN . 0.0 OUTLIER -66.51 -49.87 65.09 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-O 120.6 0.238 . . . . 0.0 111.572 177.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 413' ' ' MET . . . . . 0.933 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.7 OUTLIER -71.58 -45.21 62.87 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 119.064 -1.054 . . . . 0.0 112.356 -176.196 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 414' ' ' LEU . . . . . 0.933 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 17.9 mt -72.22 -45.64 59.45 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 113.95 1.092 . . . . 0.0 113.95 -176.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 32.8 t -84.89 -18.57 34.34 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.646 0.736 . . . . 0.0 109.599 -173.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 416' ' ' GLY . . . . . 0.469 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 106.61 179.67 22.89 Favored Glycine 0 N--CA 1.429 -1.774 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 -173.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 417' ' ' GLN . . . . . 0.489 ' HA ' ' HE2' ' B' ' 412' ' ' MET . 1.7 mp0 -79.13 25.38 0.29 Allowed 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.532 0.682 . . . . 0.0 111.015 -174.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 418' ' ' ASN . . . . . 0.469 ' H ' ' C ' ' B' ' 416' ' ' GLY . 83.8 m-20 -70.6 73.27 0.54 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.166 177.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 419' ' ' TYR . . . . . 0.513 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 5.4 p90 -51.38 -37.77 49.86 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.897 175.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -54.25 -45.82 72.47 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.064 176.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.17 -48.84 61.17 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.224 -177.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 422' ' ' VAL . . . . . 0.44 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.2 OUTLIER -66.44 -40.69 87.18 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.096 -175.464 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 423' ' ' SER . . . . . 0.748 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 80.0 p -67.48 -39.29 85.26 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.825 -178.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -68.93 -36.63 82.07 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.067 177.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 425' ' ' ILE . . . . . 0.649 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -73.45 -51.7 24.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 121.401 -0.12 . . . . 0.0 111.035 -178.593 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 426' ' ' ILE . . . . . 0.67 HD13 HG23 ' B' ' 395' ' ' ILE . 1.1 mm -74.76 -22.92 17.48 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.853 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 -172.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 427' ' ' ARG . . . . . 0.748 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.8 OUTLIER -54.97 -29.91 57.91 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.339 0.59 . . . . 0.0 110.407 -179.065 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.49 -5.14 79.42 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.79 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 429' ' ' TYR . . . . . 0.635 ' CZ ' ' HG3' ' B' ' 396' ' ' LYS . 23.5 m-85 -118.88 -1.49 11.01 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.118 0.485 . . . . 0.0 110.44 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 430' ' ' LEU . . . . . 0.635 HD23 ' HA ' ' B' ' 427' ' ' ARG . 0.1 OUTLIER -65.85 128.79 94.07 Favored Pre-proline 0 N--CA 1.44 -0.945 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.641 179.589 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 431' ' ' PRO . . . . . 0.554 ' HD2' HD12 ' B' ' 430' ' ' LEU . 99.6 Cg_exo -23.57 -68.37 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.749 1 C-N-CA 125.484 4.123 . . . . 0.0 114.633 179.599 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 432' ' ' GLY . . . . . 0.506 ' O ' HG12 ' B' ' 436' ' ' VAL . . . -144.13 -165.5 10.97 Favored Glycine 0 N--CA 1.444 -0.83 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 175.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 433' ' ' GLN . . . . . 0.512 ' O ' HG13 ' B' ' 436' ' ' VAL . 43.9 tp60 -70.28 -25.73 63.48 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 118.024 0.912 . . . . 0.0 110.734 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -67.2 -40.09 86.44 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -177.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 435' ' ' VAL . . . . . 0.742 HG23 HG11 ' B' ' 463' ' ' VAL . 7.4 p -68.87 -44.58 81.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 120.937 0.399 . . . . 0.0 110.39 -177.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 436' ' ' VAL . . . . . 0.541 HG21 ' HD3' ' B' ' 427' ' ' ARG . 0.1 OUTLIER -64.39 -31.05 51.92 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.499 175.077 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 1.1 m -69.19 -52.04 31.95 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 438' ' ' ALA . . . . . 0.862 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -58.94 -37.28 76.36 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.663 177.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 439' ' ' LEU . . . . . 0.556 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 2.1 tm? -70.75 -47.69 58.35 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -179.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.9 -39.25 74.08 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.326 174.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 441' ' ' GLN . . . . . 0.479 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 36.7 mm-40 -53.12 -50.04 65.31 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 123.576 0.75 . . . . 0.0 110.644 173.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 442' ' ' ARG . . . . . 0.82 ' HG2' ' O ' ' B' ' 438' ' ' ALA . 0.9 OUTLIER -56.25 -39.66 72.93 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.824 173.066 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 443' ' ' LEU . . . . . 0.556 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 42.4 mt -71.96 -36.73 69.93 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.99 0.424 . . . . 0.0 110.31 -178.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -57.97 -37.5 74.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.609 173.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -73.22 -26.42 61.14 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.986 178.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 446' ' ' GLU . . . . . 0.401 ' HB3' ' O ' ' B' ' 443' ' ' LEU . 8.8 pt-20 29.4 104.28 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 172.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 447' ' ' ILE . . . . . 0.499 ' HB ' ' HB ' ' B' ' 451' ' ' THR . 64.4 mt -66.07 -32.39 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 121.911 0.862 . . . . 0.0 109.443 171.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 448' ' ' ASP . . . . . 0.455 ' HB3' ' H ' ' B' ' 451' ' ' THR . 4.6 t70 -167.04 -153.63 0.15 Allowed 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 -177.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 449' ' ' ASP . . . . . 0.438 ' O ' ' HG3' ' B' ' 452' ' ' ARG . 4.9 m-20 -90.87 -61.64 1.63 Allowed 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 165.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 450' ' ' GLN . . . . . 0.556 ' O ' ' HB3' ' B' ' 453' ' ' ALA . 0.0 OUTLIER -72.55 -26.01 61.58 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.432 -176.908 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 451' ' ' THR . . . . . 0.521 ' HA ' ' HG3' ' B' ' 454' ' ' GLU . 4.1 m -72.77 -21.07 61.06 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.063 -0.655 . . . . 0.0 111.035 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 452' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' B' ' 449' ' ' ASP . 18.6 mtm180 -56.08 -47.48 77.92 Favored 'General case' 0 C--O 1.215 -0.76 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 170.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 453' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' B' ' 450' ' ' GLN . . . -57.51 -49.2 77.09 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.994 171.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 454' ' ' GLU . . . . . 0.521 ' HG3' ' HA ' ' B' ' 451' ' ' THR . 37.2 mt-10 -46.39 -38.91 9.56 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.571 0.7 . . . . 0.0 111.677 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 31.1 p -121.05 15.82 11.59 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.257 -173.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 456' ' ' PHE . . . . . 0.586 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 0.8 OUTLIER -55.59 -47.73 75.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.209 0.528 . . . . 0.0 111.28 -171.524 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 457' ' ' ILE . . . . . 0.6 HG23 ' HB1' ' B' ' 405' ' ' ALA . 2.0 mp -76.8 -34.64 23.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.387 -179.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -57.33 -35.82 70.36 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 122.022 0.915 . . . . 0.0 109.291 172.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 459' ' ' HIS . . . . . 0.731 ' O ' HG23 ' B' ' 463' ' ' VAL . 55.4 m-70 -72.82 -29.04 62.93 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.208 -1.36 . . . . 0.0 110.915 176.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 460' ' ' LEU . . . . . 0.726 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -74.24 -34.17 63.56 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.107 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 461' ' ' ASN . . . . . 0.438 ' O ' ' HB2' ' B' ' 464' ' ' TYR . 1.3 m-80 -73.17 -38.29 66.25 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.216 -0.902 . . . . 0.0 108.924 176.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 462' ' ' ALA . . . . . 0.615 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -56.16 -34.83 66.53 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.668 169.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 463' ' ' VAL . . . . . 0.862 HG13 ' HB3' ' B' ' 438' ' ' ALA . 62.7 t -61.04 -51.09 77.18 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 175.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 464' ' ' TYR . . . . . 0.57 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 19.4 m-30 -52.87 -29.09 26.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.642 178.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.13 -39.59 19.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.716 0.769 . . . . 0.0 109.501 -176.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 466' ' ' ILE . . . . . 0.615 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.7 mt -56.2 -55.83 16.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 114.344 -1.298 . . . . 0.0 112.115 174.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 467' ' ' LEU . . . . . 0.784 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -102.73 -9.97 19.57 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -172.513 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 468' ' ' GLY . . . . . 0.521 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 93.41 31.92 8.07 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 119.346 -1.407 . . . . 0.0 114.182 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 469' ' ' LEU . . . . . 0.784 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 2.8 mt -89.73 162.81 15.37 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 117.646 0.723 . . . . 0.0 111.062 176.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 470' ' ' ASN . . . . . 0.418 ' HB3' ' CG2' ' B' ' 476' ' ' ILE . 37.4 p30 -105.14 -177.82 3.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.23 171.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 471' ' ' ALA . . . . . 0.512 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -60.25 -23.51 64.16 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -176.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 472' ' ' ARG . . . . . 0.488 HH11 ' HA ' ' B' ' 402' ' ' GLU . 28.7 mmt180 -87.48 1.52 53.25 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.407 -170.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 473' ' ' GLY . . . . . 0.448 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 78.76 11.39 85.29 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.564 -0.827 . . . . 0.0 111.37 -177.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -100.94 150.66 22.64 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 177.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 475' ' ' SER . . . . . 0.56 ' OG ' ' HG2' ' B' ' 479' ' ' GLU . 11.9 p -88.35 127.81 35.49 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.207 0.527 . . . . 0.0 110.926 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 476' ' ' ILE . . . . . 0.521 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.7 pp -91.16 -17.62 7.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.485 -176.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 477' ' ' ARG . . . . . 0.484 ' N ' HD12 ' B' ' 476' ' ' ILE . 0.4 OUTLIER -95.31 -165.72 1.34 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.988 179.87 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 478' ' ' LEU . . . . . . . . . . . . . 39.8 tp -53.16 124.22 13.89 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.234 0.334 . . . . 0.0 110.153 177.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 479' ' ' GLU . . . . . 0.56 ' HG2' ' OG ' ' B' ' 475' ' ' SER . 31.9 mt-10 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.413 -0.803 . . . . 0.0 110.785 -177.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 . . . . . 0 N--CA 1.48 1.048 0 CA-C-O 120.751 0.31 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . 0.474 HG23 ' HD2' ' A' ' 383' ' ' HIS . 0.0 OUTLIER -100.01 -24.49 14.6 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.269 177.57 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' HIS . . . . . 0.518 ' HB2' ' O ' ' A' ' 386' ' ' PHE . 17.5 p80 -167.75 159.54 11.85 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.928 -175.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -109.15 -110.8 3.38 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.354 172.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 14.2 m -64.63 -36.43 84.24 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.265 0.555 . . . . 0.0 111.462 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' PHE . . . . . 0.758 ' CZ ' HG12 ' A' ' 394' ' ' VAL . 1.6 t80 -81.78 128.37 69.14 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.494 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -53.55 -51.59 10.54 Favored 'Trans proline' 0 N--CA 1.489 1.214 1 C-N-CA 125.403 4.069 . . . . 0.0 115.952 -176.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.781 ' SD ' HG13 ' A' ' 394' ' ' VAL . 53.8 tpp 74.29 15.63 3.53 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 165.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' HIS . . . . . 0.804 ' CG ' ' HB2' ' A' ' 393' ' ' ASN . 15.6 m170 64.17 7.1 3.26 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.264 -0.897 . . . . 0.0 110.249 -175.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 66.29 25.09 10.54 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.498 -170.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.482 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.6 pt? -164.51 -53.4 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 170.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . 0.549 ' HA2' ' SD ' ' A' ' 388' ' ' MET . . . -175.39 49.38 0.13 Allowed Glycine 0 CA--C 1.525 0.659 0 C-N-CA 119.796 -1.192 . . . . 0.0 114.521 -176.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . 0.804 ' HB2' ' CG ' ' A' ' 389' ' ' HIS . 0.5 OUTLIER -54.49 -43.31 71.67 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 117.302 0.551 . . . . 0.0 109.81 177.886 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.781 HG13 ' SD ' ' A' ' 388' ' ' MET . 0.7 OUTLIER -57.64 -46.12 86.51 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 -177.649 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.703 HG21 HG22 ' A' ' 425' ' ' ILE . 4.1 mp -57.36 -52.3 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-O 118.023 -0.989 . . . . 0.0 113.139 -174.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . 0.629 ' HG3' ' CZ ' ' A' ' 429' ' ' TYR . 0.0 OUTLIER -63.55 -50.23 70.32 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 121.664 2.029 . . . . 0.0 112.335 -175.738 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . 0.568 ' O ' ' HG3' ' A' ' 401' ' ' GLN . . . -54.47 -44.89 77.59 Favored Glycine 0 N--CA 1.435 -1.393 0 C-N-CA 120.04 -1.076 . . . . 0.0 111.025 -177.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . 0.777 HD13 HD12 ' A' ' 410' ' ' LEU . 31.2 mt -71.28 -34.47 54.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -178.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . 0.52 HG12 ' HA ' ' A' ' 404' ' ' VAL . 9.9 m -63.66 -39.92 87.14 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 C-N-CA 118.973 -1.091 . . . . 0.0 108.594 -173.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -66.67 -40.99 88.85 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 175.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.568 ' HG3' ' O ' ' A' ' 397' ' ' GLY . 36.2 mt-30 -91.84 -47.13 7.49 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -169.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . 0.697 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 3.0 mm-40 -115.15 -20.35 10.45 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.983 0.421 . . . . 0.0 111.377 -173.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 106.14 162.84 22.86 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.874 -0.679 . . . . 0.0 113.027 177.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . 0.671 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.2 m -53.61 -42.89 52.34 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.851 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -175.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . 0.708 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -69.17 -28.57 66.52 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 119.602 -0.839 . . . . 0.0 112.139 -176.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.707 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 89.9 m -77.55 -43.1 33.0 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.139 -0.624 . . . . 0.0 109.972 172.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.51 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.3 -37.64 75.47 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 122.125 0.964 . . . . 0.0 109.285 176.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 408' ' ' TYR . . . . . 0.671 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.6 -52.14 54.38 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 113.606 -1.634 . . . . 0.0 109.734 177.155 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 409' ' ' THR . . . . . 0.667 HG22 HD23 ' A' ' 410' ' ' LEU . 13.0 m -55.51 -47.36 76.34 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.743 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . 0.777 HD12 HD13 ' A' ' 398' ' ' ILE . 13.8 mt -72.28 -35.71 68.8 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.197 -175.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.92 -35.09 81.48 Favored Glycine 0 N--CA 1.439 -1.142 0 C-N-CA 120.182 -1.009 . . . . 0.0 110.7 172.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -67.55 -47.62 69.31 Favored 'General case' 0 C--O 1.223 -0.309 0 N-CA-C 111.528 0.195 . . . . 0.0 111.528 178.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 413' ' ' MET . . . . . 0.914 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.3 OUTLIER -70.78 -48.26 55.23 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 119.06 -1.056 . . . . 0.0 112.106 -179.461 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . 0.914 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 18.6 mt -69.47 -44.23 71.61 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -175.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 383' ' ' HIS . 33.7 t -86.62 -24.04 25.49 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.526 0.679 . . . . 0.0 110.147 -175.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 112.55 -176.79 18.03 Favored Glycine 0 N--CA 1.429 -1.832 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 -173.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -81.02 22.29 0.64 Allowed 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.367 0.604 . . . . 0.0 111.285 -172.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 418' ' ' ASN . . . . . 0.455 ' HB2' HD22 ' A' ' 421' ' ' LEU . 11.4 m120 -73.04 74.91 1.21 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.984 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 419' ' ' TYR . . . . . 0.616 ' HB2' ' CE2' ' A' ' 456' ' ' PHE . 27.0 p90 -54.2 -37.57 64.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.324 178.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -54.47 -46.27 73.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.908 0.385 . . . . 0.0 110.987 177.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . 0.455 HD22 ' HB2' ' A' ' 418' ' ' ASN . 0.0 OUTLIER -68.51 -47.86 65.87 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.085 -177.291 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . 0.466 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -65.33 -38.35 82.34 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 C-N-CA 120.343 -0.543 . . . . 0.0 111.198 -178.451 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.751 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 61.1 p -68.1 -37.46 81.21 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -179.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.51 -39.35 91.12 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.237 175.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . 0.703 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.78 -52.53 22.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 O-C-N 122.789 -0.242 . . . . 0.0 111.011 -178.376 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . 0.7 HG22 HD22 ' A' ' 430' ' ' LEU . 1.2 mm -72.14 -21.76 20.7 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.715 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -172.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.751 ' HB2' ' O ' ' A' ' 423' ' ' SER . 0.7 OUTLIER -54.25 -31.46 53.55 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.52 -179.206 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -84.39 -12.2 76.31 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.463 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.629 ' CZ ' ' HG3' ' A' ' 396' ' ' LYS . 23.3 m-85 -114.69 1.9 14.32 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-O 121.15 0.5 . . . . 0.0 110.45 -176.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.703 HD23 ' HA ' ' A' ' 427' ' ' ARG . 0.1 OUTLIER -65.85 128.11 93.58 Favored Pre-proline 0 N--CA 1.439 -1.008 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.759 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . 0.473 ' HD2' HD12 ' A' ' 430' ' ' LEU . 59.1 Cg_exo -22.39 -72.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.355 0.906 1 C-N-CA 125.56 4.173 . . . . 0.0 114.855 179.784 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . 0.43 ' O ' HG12 ' A' ' 435' ' ' VAL . . . -132.27 -165.44 11.29 Favored Glycine 0 N--CA 1.439 -1.125 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 175.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . 0.617 ' O ' HG13 ' A' ' 436' ' ' VAL . 1.0 OUTLIER -71.21 -28.1 63.97 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 117.575 0.687 . . . . 0.0 110.631 177.513 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -70.24 -36.62 74.61 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -174.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 435' ' ' VAL . . . . . 0.738 HG23 HG11 ' A' ' 463' ' ' VAL . 7.5 p -67.24 -41.46 86.73 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-O 121.056 0.455 . . . . 0.0 110.388 -177.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.617 HG13 ' O ' ' A' ' 433' ' ' GLN . 0.2 OUTLIER -64.63 -34.78 72.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.177 175.682 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.85 -48.53 53.39 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -174.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . 0.85 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -56.15 -37.24 69.26 Favored 'General case' 0 N--CA 1.432 -1.356 0 O-C-N 123.713 0.633 . . . . 0.0 110.498 175.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 439' ' ' LEU . . . . . 0.558 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 2.1 tm? -67.66 -46.97 70.86 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -178.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . 0.492 ' NE2' HD12 ' A' ' 443' ' ' LEU . 0.4 OUTLIER -62.08 -33.92 75.32 Favored 'General case' 0 CA--C 1.49 -1.353 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.803 176.192 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 441' ' ' GLN . . . . . 0.568 ' O ' ' HG2' ' A' ' 445' ' ' GLN . 8.9 mm-40 -58.26 -49.2 77.96 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.199 175.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . 0.749 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -57.31 -39.79 76.55 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.852 171.208 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 443' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 33.6 mt -72.38 -34.45 67.95 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.201 0.524 . . . . 0.0 109.932 -178.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -57.94 -36.95 73.25 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.793 173.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 445' ' ' GLN . . . . . 0.568 ' HG2' ' O ' ' A' ' 441' ' ' GLN . 30.6 mm-40 -72.26 -27.52 62.54 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.195 178.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 446' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 443' ' ' LEU . 36.7 tt0 35.44 98.09 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 169.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 447' ' ' ILE . . . . . 0.534 ' HB ' ' HB ' ' A' ' 451' ' ' THR . 54.2 mt -73.41 -32.68 37.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.447 0.642 . . . . 0.0 110.447 176.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . 0.442 ' HB3' ' H ' ' A' ' 451' ' ' THR . 7.4 t70 -170.21 -158.17 0.16 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 -179.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -87.78 -58.81 2.44 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 166.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 450' ' ' GLN . . . . . 0.486 ' C ' HE21 ' A' ' 450' ' ' GLN . 0.0 OUTLIER -66.88 -33.34 75.38 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.592 -177.523 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 451' ' ' THR . . . . . 0.534 ' HB ' ' HB ' ' A' ' 447' ' ' ILE . 4.8 m -72.05 -23.36 61.36 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.653 -174.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 448' ' ' ASP . 13.1 mtp180 -55.13 -54.18 46.55 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 172.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 453' ' ' ALA . . . . . 0.515 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -58.57 -48.52 80.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.616 -1.175 . . . . 0.0 112.561 175.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . 0.459 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 27.2 mm-40 -51.2 -37.2 45.32 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.289 0.566 . . . . 0.0 111.597 -178.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 27.6 p -117.9 16.92 14.29 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.352 -176.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . 0.616 ' CE2' ' HB2' ' A' ' 419' ' ' TYR . 1.1 t80 -58.04 -47.15 84.0 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.006 0.432 . . . . 0.0 111.6 -171.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . 0.708 HG23 ' HB1' ' A' ' 405' ' ' ALA . 2.0 mp -76.83 -32.43 20.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.044 0.45 . . . . 0.0 110.611 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -57.83 -34.29 69.54 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.717 0.77 . . . . 0.0 109.268 170.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . 0.681 ' O ' HG23 ' A' ' 463' ' ' VAL . 57.9 m-70 -76.08 -28.04 57.44 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.635 178.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . 0.723 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -74.09 -34.63 64.05 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.822 0.82 . . . . 0.0 108.82 178.196 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . 0.548 ' HA ' ' CD2' ' A' ' 464' ' ' TYR . 21.4 m-80 -72.63 -37.74 67.95 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.309 -0.86 . . . . 0.0 108.975 176.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 462' ' ' ALA . . . . . 0.627 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -56.21 -34.4 66.24 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.442 -1.254 . . . . 0.0 109.729 169.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.85 HG13 ' HB3' ' A' ' 438' ' ' ALA . 64.5 t -61.53 -51.58 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 114.811 -1.086 . . . . 0.0 108.085 176.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 464' ' ' TYR . . . . . 0.748 ' CE2' ' HA ' ' A' ' 471' ' ' ALA . 15.4 m-30 -52.62 -27.37 16.76 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.685 178.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.34 -39.11 21.16 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.593 0.711 . . . . 0.0 109.557 -178.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.627 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.7 mt -60.17 -55.54 23.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 114.23 -1.35 . . . . 0.0 112.268 176.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.74 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -100.36 -10.69 20.96 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -173.469 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . 0.588 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 93.15 31.18 8.65 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 119.556 -1.307 . . . . 0.0 114.165 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 469' ' ' LEU . . . . . 0.74 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.0 mt -89.98 166.56 13.39 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.24 1.02 . . . . 0.0 111.767 178.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 35.1 p30 -106.07 177.57 4.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.271 169.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 471' ' ' ALA . . . . . 0.748 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -71.09 -6.92 42.87 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -173.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -92.2 -0.33 57.42 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.022 0.439 . . . . 0.0 110.6 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 77.47 12.79 84.2 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.571 -0.824 . . . . 0.0 111.085 -175.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -100.91 157.9 16.39 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 175.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . 0.507 ' HA ' HD22 ' A' ' 469' ' ' LEU . 0.6 OUTLIER -93.45 120.06 33.28 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.538 0.685 . . . . 0.0 112.633 -177.03 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 476' ' ' ILE . . . . . 0.588 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.2 pp -89.4 179.69 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 162.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 477' ' ' ARG . . . . . 0.645 ' HD3' ' N ' ' A' ' 477' ' ' ARG . 0.1 OUTLIER -119.43 104.24 10.16 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 118.385 -1.326 . . . . 0.0 111.442 -171.873 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . 0.457 HD23 ' H ' ' A' ' 478' ' ' LEU . 2.5 pt? -71.65 176.25 4.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.569 -1.196 . . . . 0.0 111.292 -177.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.445 -0.788 . . . . 0.0 110.486 179.778 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 381' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 . . . . . 0 N--CA 1.479 0.98 0 CA-C-O 120.891 0.377 . . . . 0.0 110.471 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 382' ' ' THR . . . . . 0.481 HG23 ' HD2' ' B' ' 383' ' ' HIS . 0.0 OUTLIER -99.8 -24.49 14.66 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.297 177.557 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 383' ' ' HIS . . . . . 0.517 ' HB2' ' O ' ' B' ' 386' ' ' PHE . 17.5 p80 -167.86 159.3 11.43 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.506 -0.477 . . . . 0.0 111.92 -175.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 384' ' ' GLY . . . . . . . . . . . . . . . -109.06 -110.91 3.4 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.378 172.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 385' ' ' THR . . . . . . . . . . . . . 14.1 m -64.5 -36.21 83.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.061 0.458 . . . . 0.0 111.58 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 386' ' ' PHE . . . . . 0.765 ' CZ ' HG12 ' B' ' 394' ' ' VAL . 1.6 t80 -82.08 128.52 67.71 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.577 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 387' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' B' ' 386' ' ' PHE . 15.4 Cg_endo -53.68 -51.54 10.59 Favored 'Trans proline' 0 N--CA 1.49 1.294 1 C-N-CA 125.48 4.12 . . . . 0.0 115.895 -176.732 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 388' ' ' MET . . . . . 0.767 ' SD ' HG13 ' B' ' 394' ' ' VAL . 53.8 tpp 74.18 15.7 3.6 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 165.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 389' ' ' HIS . . . . . 0.798 ' CG ' ' HB2' ' B' ' 393' ' ' ASN . 16.1 m170 64.03 7.29 3.28 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.203 -0.936 . . . . 0.0 110.257 -175.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 66.31 24.73 10.56 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.527 -170.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 391' ' ' LEU . . . . . 0.471 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.6 pt? -164.32 -53.23 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 171.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 392' ' ' GLY . . . . . 0.55 ' HA2' ' SD ' ' B' ' 388' ' ' MET . . . -175.64 49.51 0.12 Allowed Glycine 0 CA--C 1.524 0.641 0 C-N-CA 119.756 -1.212 . . . . 0.0 114.464 -176.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 393' ' ' ASN . . . . . 0.798 ' HB2' ' CG ' ' B' ' 389' ' ' HIS . 0.5 OUTLIER -54.61 -43.28 72.08 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 117.348 0.574 . . . . 0.0 109.862 177.837 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 394' ' ' VAL . . . . . 0.767 HG13 ' SD ' ' B' ' 388' ' ' MET . 0.7 OUTLIER -57.6 -46.13 86.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -177.818 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 395' ' ' ILE . . . . . 0.693 HG21 HG22 ' B' ' 425' ' ' ILE . 4.1 mp -57.42 -52.26 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-O 117.979 -1.01 . . . . 0.0 113.186 -174.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 396' ' ' LYS . . . . . 0.637 ' HG3' ' CZ ' ' B' ' 429' ' ' TYR . 0.0 OUTLIER -63.58 -50.22 70.32 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 121.661 2.028 . . . . 0.0 112.302 -175.684 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 397' ' ' GLY . . . . . 0.57 ' O ' ' HG3' ' B' ' 401' ' ' GLN . . . -54.39 -44.86 76.74 Favored Glycine 0 N--CA 1.434 -1.449 0 C-N-CA 120.03 -1.081 . . . . 0.0 111.089 -177.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . 0.777 HD13 HD12 ' B' ' 410' ' ' LEU . 31.2 mt -71.33 -34.54 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -178.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 399' ' ' VAL . . . . . 0.528 HG12 ' HA ' ' B' ' 404' ' ' VAL . 10.0 m -63.66 -39.94 87.2 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.519 0 C-N-CA 118.971 -1.092 . . . . 0.0 108.577 -173.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -66.41 -41.24 89.55 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 175.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 401' ' ' GLN . . . . . 0.57 ' HG3' ' O ' ' B' ' 397' ' ' GLY . 36.4 mt-30 -91.89 -47.19 7.45 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -168.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 402' ' ' GLU . . . . . 0.651 ' HG3' ' HE3' ' A' ' 413' ' ' MET . 2.9 mm-40 -115.01 -20.56 10.45 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.987 0.422 . . . . 0.0 111.276 -172.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 106.19 162.95 22.82 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.099 177.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 404' ' ' VAL . . . . . 0.653 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.3 m -53.53 -42.89 51.63 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.858 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -175.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 405' ' ' ALA . . . . . 0.689 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -69.24 -28.64 66.52 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 119.545 -0.862 . . . . 0.0 112.165 -176.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 406' ' ' THR . . . . . 0.703 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 85.9 m -77.4 -43.14 33.69 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.159 -0.616 . . . . 0.0 109.94 172.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 407' ' ' ALA . . . . . 0.49 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.28 -37.54 75.22 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 122.118 0.961 . . . . 0.0 109.351 176.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 408' ' ' TYR . . . . . 0.653 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.69 -52.04 54.65 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 113.568 -1.651 . . . . 0.0 109.8 177.072 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 409' ' ' THR . . . . . 0.656 HG22 HD23 ' B' ' 410' ' ' LEU . 14.8 m -55.46 -47.53 75.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.678 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 410' ' ' LEU . . . . . 0.777 HD12 HD13 ' B' ' 398' ' ' ILE . 13.8 mt -72.14 -35.79 69.18 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 120.838 0.351 . . . . 0.0 110.271 -175.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.94 -35.06 81.48 Favored Glycine 0 N--CA 1.439 -1.144 0 C-N-CA 120.229 -0.986 . . . . 0.0 110.71 172.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 412' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -67.46 -47.75 69.2 Favored 'General case' 0 C--O 1.224 -0.267 0 N-CA-C 111.556 0.206 . . . . 0.0 111.556 178.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 413' ' ' MET . . . . . 0.93 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.3 OUTLIER -70.67 -48.26 55.73 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 118.96 -1.096 . . . . 0.0 112.139 -179.367 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 414' ' ' LEU . . . . . 0.93 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 18.7 mt -69.53 -44.3 71.27 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -175.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 33.5 t -86.55 -23.98 25.63 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.509 0.671 . . . . 0.0 110.158 -175.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 416' ' ' GLY . . . . . . . . . . . . . . . 112.44 -177.06 18.29 Favored Glycine 0 N--CA 1.428 -1.843 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 -173.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -80.93 22.67 0.6 Allowed 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.219 0.533 . . . . 0.0 111.214 -172.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 418' ' ' ASN . . . . . 0.443 ' HB2' HD22 ' B' ' 421' ' ' LEU . 11.3 m120 -73.09 75.36 1.24 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.884 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 419' ' ' TYR . . . . . 0.631 ' HB2' ' CE2' ' B' ' 456' ' ' PHE . 26.8 p90 -54.86 -37.42 66.22 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.207 178.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -54.56 -46.31 73.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.961 0.41 . . . . 0.0 110.889 177.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 421' ' ' LEU . . . . . 0.456 ' O ' HD13 ' B' ' 425' ' ' ILE . 0.0 OUTLIER -68.42 -47.83 66.23 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.136 -177.158 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 422' ' ' VAL . . . . . 0.469 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.2 OUTLIER -65.18 -38.56 82.96 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.218 -178.524 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 423' ' ' SER . . . . . 0.762 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 62.3 p -68.05 -37.37 81.24 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.21 -39.76 92.34 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.307 175.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 425' ' ' ILE . . . . . 0.693 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -72.55 -52.58 22.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 O-C-N 122.785 -0.244 . . . . 0.0 111.003 -178.081 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 426' ' ' ILE . . . . . 0.695 HG22 HD22 ' B' ' 430' ' ' LEU . 1.2 mm -72.21 -21.67 20.56 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.821 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -172.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 427' ' ' ARG . . . . . 0.762 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.7 OUTLIER -54.31 -31.33 53.89 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.216 0.531 . . . . 0.0 110.479 -179.265 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -84.25 -12.39 76.27 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.404 178.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 429' ' ' TYR . . . . . 0.637 ' CZ ' ' HG3' ' B' ' 396' ' ' LYS . 23.2 m-85 -114.77 1.87 14.25 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 121.064 0.459 . . . . 0.0 110.372 -176.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 430' ' ' LEU . . . . . 0.695 HD22 HG22 ' B' ' 426' ' ' ILE . 0.1 OUTLIER -65.77 128.32 93.72 Favored Pre-proline 0 N--CA 1.438 -1.042 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.681 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 431' ' ' PRO . . . . . 0.457 ' HD2' HD12 ' B' ' 430' ' ' LEU . 56.8 Cg_exo -22.48 -73.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.355 0.883 1 C-N-CA 125.702 4.268 . . . . 0.0 114.606 179.563 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 432' ' ' GLY . . . . . 0.446 ' O ' HG12 ' B' ' 435' ' ' VAL . . . -132.34 -165.74 11.36 Favored Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 175.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 433' ' ' GLN . . . . . 0.612 ' O ' HG13 ' B' ' 436' ' ' VAL . 1.0 OUTLIER -70.94 -27.96 64.14 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 117.506 0.653 . . . . 0.0 110.643 177.85 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -70.39 -36.43 74.08 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -174.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 435' ' ' VAL . . . . . 0.74 HG23 HG11 ' B' ' 463' ' ' VAL . 7.5 p -67.36 -41.52 86.45 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 CA-C-O 121.102 0.477 . . . . 0.0 110.346 -177.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 436' ' ' VAL . . . . . 0.612 HG13 ' O ' ' B' ' 433' ' ' GLN . 0.2 OUTLIER -64.67 -34.77 72.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.214 175.64 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.87 -48.51 53.42 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 -174.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 438' ' ' ALA . . . . . 0.841 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -56.21 -37.17 69.3 Favored 'General case' 0 N--CA 1.433 -1.32 0 O-C-N 123.631 0.582 . . . . 0.0 110.382 175.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 439' ' ' LEU . . . . . 0.568 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 2.1 tm? -67.72 -47.0 70.57 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 440' ' ' GLN . . . . . 0.501 ' NE2' HD12 ' B' ' 443' ' ' LEU . 0.3 OUTLIER -62.15 -33.89 75.35 Favored 'General case' 0 CA--C 1.489 -1.378 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.828 176.178 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 441' ' ' GLN . . . . . 0.568 ' O ' ' HG2' ' B' ' 445' ' ' GLN . 9.0 mm-40 -58.3 -49.19 78.05 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.258 175.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 442' ' ' ARG . . . . . 0.743 ' HG2' ' O ' ' B' ' 438' ' ' ALA . 0.0 OUTLIER -57.24 -39.93 76.53 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.913 171.067 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 443' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 33.3 mt -72.26 -34.34 68.16 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.376 0.608 . . . . 0.0 109.918 -178.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -58.02 -36.96 73.44 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.838 173.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 445' ' ' GLN . . . . . 0.568 ' HG2' ' O ' ' B' ' 441' ' ' GLN . 30.6 mm-40 -72.13 -27.66 62.77 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.161 178.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 446' ' ' GLU . . . . . 0.487 ' HB2' ' O ' ' B' ' 443' ' ' LEU . 38.0 tt0 35.6 98.07 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 170.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 447' ' ' ILE . . . . . 0.528 ' HB ' ' HB ' ' B' ' 451' ' ' THR . 54.4 mt -73.41 -32.71 37.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.629 0.728 . . . . 0.0 110.48 176.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 448' ' ' ASP . . . . . 0.45 ' HB3' ' H ' ' B' ' 451' ' ' THR . 7.7 t70 -170.16 -158.42 0.17 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 -179.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -87.55 -58.92 2.4 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 166.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 450' ' ' GLN . . . . . 0.498 ' C ' HE21 ' B' ' 450' ' ' GLN . 0.0 OUTLIER -66.66 -33.41 75.6 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 115.272 -0.877 . . . . 0.0 112.609 -177.562 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 451' ' ' THR . . . . . 0.528 ' HB ' ' HB ' ' B' ' 447' ' ' ILE . 4.7 m -72.0 -23.26 61.38 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.671 -174.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 452' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' B' ' 448' ' ' ASP . 13.1 mtp180 -55.25 -54.13 47.38 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 172.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 453' ' ' ALA . . . . . 0.508 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -58.51 -48.36 81.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.689 -1.142 . . . . 0.0 112.622 175.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 454' ' ' GLU . . . . . 0.458 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 26.2 mm-40 -51.61 -37.3 49.39 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.399 0.619 . . . . 0.0 111.366 -178.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 29.1 p -117.71 16.82 14.45 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.471 -176.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 456' ' ' PHE . . . . . 0.631 ' CE2' ' HB2' ' B' ' 419' ' ' TYR . 1.1 t80 -58.01 -47.17 83.87 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.035 0.445 . . . . 0.0 111.571 -171.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 457' ' ' ILE . . . . . 0.689 HG23 ' HB1' ' B' ' 405' ' ' ALA . 2.0 mp -76.92 -32.31 19.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.622 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -57.93 -34.29 69.71 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.702 0.763 . . . . 0.0 109.214 170.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 459' ' ' HIS . . . . . 0.682 ' O ' HG23 ' B' ' 463' ' ' VAL . 58.4 m-70 -75.97 -28.14 57.76 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.634 178.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 460' ' ' LEU . . . . . 0.728 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.4 OUTLIER -74.06 -34.66 64.11 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.903 0.859 . . . . 0.0 108.82 178.262 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 461' ' ' ASN . . . . . 0.55 ' HA ' ' CD2' ' B' ' 464' ' ' TYR . 22.1 m-80 -72.59 -37.8 68.04 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.965 176.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 462' ' ' ALA . . . . . 0.634 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -56.37 -34.25 66.48 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.688 169.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 463' ' ' VAL . . . . . 0.841 HG13 ' HB3' ' B' ' 438' ' ' ALA . 65.3 t -61.49 -51.49 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 176.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 464' ' ' TYR . . . . . 0.747 ' CE2' ' HA ' ' B' ' 471' ' ' ALA . 15.5 m-30 -52.76 -27.24 16.97 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 124.354 1.034 . . . . 0.0 110.745 178.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.53 -39.11 20.85 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.703 0.763 . . . . 0.0 109.486 -178.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 466' ' ' ILE . . . . . 0.634 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.6 mt -59.76 -55.92 20.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 114.219 -1.355 . . . . 0.0 112.224 176.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 467' ' ' LEU . . . . . 0.743 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -100.21 -10.62 21.18 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -173.235 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 468' ' ' GLY . . . . . 0.603 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 93.25 31.06 8.67 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 119.604 -1.284 . . . . 0.0 114.122 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 469' ' ' LEU . . . . . 0.743 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 2.9 mt -90.05 166.51 13.39 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.343 1.072 . . . . 0.0 111.723 178.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 34.6 p30 -106.11 177.94 4.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.366 169.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 471' ' ' ALA . . . . . 0.747 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -71.16 -7.08 44.26 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -173.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -92.05 -0.44 57.46 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.022 0.439 . . . . 0.0 110.674 -177.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 473' ' ' GLY . . . . . . . . . . . . . . . 77.45 13.06 83.94 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.136 -175.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -101.25 157.99 16.37 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 175.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 475' ' ' SER . . . . . 0.502 ' HA ' HD22 ' B' ' 469' ' ' LEU . 0.5 OUTLIER -93.61 120.2 33.58 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.729 0.776 . . . . 0.0 112.644 -177.081 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 476' ' ' ILE . . . . . 0.603 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.2 pp -89.27 179.97 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 N-CA-C 105.426 -2.065 . . . . 0.0 105.426 162.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 477' ' ' ARG . . . . . 0.654 ' HD3' ' N ' ' B' ' 477' ' ' ARG . 0.1 OUTLIER -119.6 103.92 9.83 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 118.427 -1.309 . . . . 0.0 111.485 -172.009 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 478' ' ' LEU . . . . . 0.449 HD23 ' H ' ' B' ' 478' ' ' LEU . 2.5 pt? -71.53 175.91 5.16 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.322 -177.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 479' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 . . . . . 0 C--O 1.253 1.249 0 CA-C-O 118.583 -0.722 . . . . 0.0 110.509 179.781 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' ARG . . . . . 0.49 ' HD2' ' OD1' ' A' ' 418' ' ' ASN . 19.1 ptp180 . . . . . 0 N--CA 1.48 1.031 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . 0.63 ' O ' ' HB3' ' A' ' 415' ' ' SER . 0.1 OUTLIER -131.4 -39.67 1.14 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 -175.369 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -153.41 159.47 42.39 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 119.515 -0.874 . . . . 0.0 112.867 -171.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -115.15 -112.19 2.87 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.048 171.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 11.3 m -58.95 -44.12 91.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.805 0.335 . . . . 0.0 111.72 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' PHE . . . . . 0.806 ' CD1' HD22 ' A' ' 414' ' ' LEU . 3.6 t80 -73.19 121.04 84.1 Favored Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . 0.452 ' HD2' ' HA ' ' A' ' 386' ' ' PHE . 6.5 Cg_endo -46.47 -71.55 0.05 OUTLIER 'Trans proline' 0 N--CA 1.475 0.44 0 C-N-CA 124.163 3.242 . . . . 0.0 114.412 -175.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.604 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 30.7 ttm 70.38 143.96 0.05 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 122.356 0.262 . . . . 0.0 110.717 178.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' HIS . . . . . 0.598 ' CD2' ' HB2' ' A' ' 393' ' ' ASN . 32.6 m170 -48.49 -76.17 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 121.42 0.629 . . . . 0.0 110.382 -176.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -166.66 19.49 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 173.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.535 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.6 pt? -168.67 -51.83 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.505 -171.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . 0.673 ' HA3' HD13 ' A' ' 395' ' ' ILE . . . -176.22 60.84 0.1 Allowed Glycine 0 C--N 1.336 0.571 0 C-N-CA 119.751 -1.214 . . . . 0.0 114.028 -176.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . 0.604 ' HB3' ' HA ' ' A' ' 388' ' ' MET . 0.2 OUTLIER -58.39 -42.08 86.31 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 174.115 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.657 HG23 HD12 ' A' ' 398' ' ' ILE . 1.7 m -55.24 -47.06 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 -179.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.673 HD13 ' HA3' ' A' ' 392' ' ' GLY . 3.6 mp -57.7 -52.65 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 CA-C-O 117.8 -1.095 . . . . 0.0 113.729 -175.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . 0.595 ' O ' HG22 ' A' ' 399' ' ' VAL . 0.0 OUTLIER -62.75 -50.15 72.22 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 122.022 2.192 . . . . 0.0 112.298 -173.525 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . 0.488 ' O ' ' HG3' ' A' ' 401' ' ' GLN . . . -53.86 -42.09 68.64 Favored Glycine 0 N--CA 1.436 -1.344 0 C-N-CA 119.895 -1.145 . . . . 0.0 110.804 -175.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . 0.762 HD13 HD12 ' A' ' 410' ' ' LEU . 36.1 mt -71.64 -34.43 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 CA-C-N 114.263 -0.969 . . . . 0.0 113.517 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . 0.595 HG22 ' O ' ' A' ' 396' ' ' LYS . 15.6 m -63.57 -39.94 87.22 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 C-N-CA 118.925 -1.11 . . . . 0.0 108.631 -173.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -68.29 -38.79 82.01 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 176.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.488 ' HG3' ' O ' ' A' ' 397' ' ' GLY . 33.1 mt-30 -93.05 -48.46 6.49 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -171.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . 0.693 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 3.0 mm-40 -113.14 -20.15 11.57 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.2 -172.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 105.48 161.51 23.29 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.849 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . 0.645 HG11 ' HA ' ' A' ' 430' ' ' LEU . 1.5 m -53.78 -45.23 61.62 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.78 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 -176.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . 0.542 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -64.03 -31.16 72.25 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.005 -0.678 . . . . 0.0 112.481 -177.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.699 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 87.1 m -77.38 -42.43 36.46 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.476 -0.489 . . . . 0.0 110.244 173.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.469 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -58.4 -36.85 74.19 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 122.245 1.022 . . . . 0.0 109.311 176.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 408' ' ' TYR . . . . . 0.629 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -66.33 -51.92 52.37 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 113.436 -1.711 . . . . 0.0 109.991 176.337 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 409' ' ' THR . . . . . 0.64 HG22 HD23 ' A' ' 410' ' ' LEU . 16.5 m -55.68 -46.91 77.5 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.58 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . 0.762 HD12 HD13 ' A' ' 398' ' ' ILE . 14.1 mt -72.36 -34.95 68.37 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -175.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -59.35 -34.22 79.5 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.383 -0.913 . . . . 0.0 110.994 170.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 412' ' ' MET . . . . . 0.423 ' HE2' ' HA ' ' A' ' 417' ' ' GLN . 0.6 OUTLIER -66.71 -48.25 69.8 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 122.611 -0.346 . . . . 0.0 111.119 177.035 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 413' ' ' MET . . . . . 0.9 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.5 OUTLIER -71.53 -51.45 23.5 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 119.363 -0.935 . . . . 0.0 112.656 -179.357 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . 0.9 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 12.5 mt -67.55 -46.47 72.67 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -174.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.63 ' HB3' ' O ' ' A' ' 382' ' ' THR . 0.1 OUTLIER -97.58 10.98 38.46 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.364 0.602 . . . . 0.0 111.086 -172.66 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . 0.426 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 84.08 179.82 51.84 Favored Glycine 0 N--CA 1.438 -1.187 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.68 -179.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 417' ' ' GLN . . . . . 0.423 ' HA ' ' HE2' ' A' ' 412' ' ' MET . 31.1 mm-40 -79.83 23.06 0.46 Allowed 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.364 0.602 . . . . 0.0 110.789 -173.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 418' ' ' ASN . . . . . 0.49 ' OD1' ' HD2' ' A' ' 381' ' ' ARG . 64.0 m-80 -72.33 77.36 1.01 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.782 -178.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 419' ' ' TYR . . . . . 0.552 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 7.1 p90 -49.83 -38.23 33.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.977 174.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -54.33 -47.72 72.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.749 177.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -48.65 66.02 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.044 -176.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . 0.464 ' HB ' ' CD1' ' A' ' 408' ' ' TYR . 0.2 OUTLIER -66.01 -40.49 87.45 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.572 0 C-N-CA 120.281 -0.567 . . . . 0.0 111.355 -176.918 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.816 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 80.6 p -69.24 -37.88 78.22 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -178.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.56 -38.96 90.91 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.761 176.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . 0.58 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.91 -52.56 21.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.028 -0.086 . . . . 0.0 111.182 -178.279 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . 0.686 HG22 HD22 ' A' ' 430' ' ' LEU . 1.1 mm -74.69 -23.59 17.91 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.896 0 O-C-N 121.968 -0.457 . . . . 0.0 110.374 -171.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.816 ' HB2' ' O ' ' A' ' 423' ' ' SER . 1.3 tmm_? -55.44 -30.86 61.3 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.325 0.583 . . . . 0.0 111.007 -177.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -86.58 -12.11 70.1 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.203 178.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.537 ' HD1' HG22 ' A' ' 395' ' ' ILE . 7.7 m-30 -112.68 -0.5 15.05 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.615 0.722 . . . . 0.0 109.07 -174.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.733 HD23 ' HA ' ' A' ' 427' ' ' ARG . 0.1 OUTLIER -66.07 129.75 94.27 Favored Pre-proline 0 N--CA 1.444 -0.754 0 CA-C-N 114.549 -1.205 . . . . 0.0 108.953 177.508 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . 0.544 ' HD2' HD12 ' A' ' 430' ' ' LEU . 81.4 Cg_exo -23.91 -68.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.915 1 C-N-CA 125.489 4.126 . . . . 0.0 114.852 179.117 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . 0.502 ' O ' HG12 ' A' ' 435' ' ' VAL . . . -141.51 -167.81 11.32 Favored Glycine 0 N--CA 1.442 -0.91 0 N-CA-C 110.089 -1.205 . . . . 0.0 110.089 176.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . 0.517 ' O ' HG13 ' A' ' 436' ' ' VAL . 43.6 tp60 -70.4 -26.96 63.93 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 118.083 0.941 . . . . 0.0 110.449 178.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -64.3 -41.98 96.59 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 435' ' ' VAL . . . . . 0.724 HG23 HG11 ' A' ' 463' ' ' VAL . 7.4 p -67.67 -42.81 86.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 121.018 0.437 . . . . 0.0 110.66 -177.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.517 HG13 ' O ' ' A' ' 433' ' ' GLN . 0.1 OUTLIER -67.26 -31.61 53.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.402 175.735 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.61 -52.76 41.71 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -178.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . 0.875 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -58.63 -39.82 81.63 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.936 177.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 439' ' ' LEU . . . . . 0.649 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 1.8 tm? -68.0 -48.39 65.87 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -177.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -60.54 -33.73 73.09 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.074 175.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 441' ' ' GLN . . . . . 0.516 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 3.5 mm-40 -54.83 -50.29 68.96 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.863 -178.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . 0.618 ' HG3' ' CG ' ' A' ' 459' ' ' HIS . 0.0 OUTLIER -77.76 -24.12 49.05 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 174.271 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 443' ' ' LEU . . . . . 0.649 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 56.5 mt -64.04 -27.17 68.93 Favored 'General case' 0 CA--C 1.516 -0.356 0 O-C-N 121.496 -0.753 . . . . 0.0 109.985 173.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -66.5 -37.12 84.37 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.85 178.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 445' ' ' GLN . . . . . 0.467 ' HG3' ' N ' ' A' ' 446' ' ' GLU . 0.0 OUTLIER -80.25 -30.39 38.47 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.479 -179.923 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 446' ' ' GLU . . . . . 0.467 ' N ' ' HG3' ' A' ' 445' ' ' GLN . 8.6 pt-20 15.21 105.03 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.248 0 O-C-N 125.617 1.823 . . . . 0.0 113.841 -177.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 43.6 mt -51.26 -34.44 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.369 -177.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . 0.507 ' HB2' ' OG1' ' A' ' 451' ' ' THR . 13.3 m-20 -160.88 -174.59 4.48 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 449' ' ' ASP . . . . . 0.488 ' O ' ' HB3' ' A' ' 452' ' ' ARG . 25.8 t0 -72.41 -62.49 1.42 Allowed 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 174.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 450' ' ' GLN . . . . . 0.401 ' HG3' ' H ' ' A' ' 450' ' ' GLN . 0.0 OUTLIER -70.22 -27.13 64.23 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 176.799 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 451' ' ' THR . . . . . 0.507 ' OG1' ' HB2' ' A' ' 448' ' ' ASP . 16.0 m -72.12 -23.06 61.26 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.004 -176.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . 0.488 ' HB3' ' O ' ' A' ' 449' ' ' ASP . 43.9 ttt180 -55.96 -52.26 64.79 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 172.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 453' ' ' ALA . . . . . 0.552 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -59.77 -47.21 86.6 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.707 170.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . 0.445 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 14.1 mm-40 -51.73 -36.45 47.11 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.137 0.494 . . . . 0.0 111.917 -175.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 24.9 p -115.46 13.98 16.58 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.271 -176.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . 0.598 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 1.2 t80 -55.06 -46.4 75.39 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.945 0.402 . . . . 0.0 111.746 -172.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . 0.542 HG23 ' HB1' ' A' ' 405' ' ' ALA . 1.9 mp -78.19 -33.36 17.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.784 0.326 . . . . 0.0 111.239 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -58.09 -32.71 68.34 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.805 0.812 . . . . 0.0 109.117 171.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . 0.748 ' O ' HG23 ' A' ' 463' ' ' VAL . 56.9 m-70 -74.17 -30.04 62.06 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.8 177.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . 0.705 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -73.99 -34.88 64.35 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.995 0.902 . . . . 0.0 108.988 179.518 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -73.08 -37.02 66.93 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.126 176.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 462' ' ' ALA . . . . . 0.612 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -56.02 -34.25 65.66 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.385 -1.279 . . . . 0.0 109.9 169.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.875 HG13 ' HB3' ' A' ' 438' ' ' ALA . 66.1 t -63.57 -50.83 76.57 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 CA-C-N 114.421 -1.263 . . . . 0.0 108.114 177.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 464' ' ' TYR . . . . . 0.578 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 16.9 m-30 -52.4 -29.15 22.73 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 124.348 1.03 . . . . 0.0 110.257 177.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.82 -40.69 22.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.745 0.784 . . . . 0.0 109.498 -177.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.612 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.6 mt -57.84 -56.17 17.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 114.304 -1.316 . . . . 0.0 112.269 176.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.764 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -100.82 -11.23 20.01 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -172.051 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . 0.537 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 94.09 31.6 7.98 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 119.366 -1.397 . . . . 0.0 114.321 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 469' ' ' LEU . . . . . 0.764 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.3 mt -88.47 163.02 16.15 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 117.915 0.857 . . . . 0.0 110.92 177.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 37.9 p30 -105.17 -178.04 3.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.065 172.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 471' ' ' ALA . . . . . 0.411 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -66.05 -14.65 62.07 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -176.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -88.53 -1.6 58.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.675 0.274 . . . . 0.0 111.148 -175.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . 0.483 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 79.04 10.66 85.95 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -175.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -101.43 156.22 17.59 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 176.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 32.1 t -93.25 137.52 32.49 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.248 0.547 . . . . 0.0 111.287 -176.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 476' ' ' ILE . . . . . 0.709 ' O ' ' HD2' ' A' ' 477' ' ' ARG . 2.4 pp -115.61 -19.8 6.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.878 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 477' ' ' ARG . . . . . 0.709 ' HD2' ' O ' ' A' ' 476' ' ' ILE . 0.1 OUTLIER 22.11 63.39 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 174.313 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . 0.446 ' H ' HD12 ' A' ' 476' ' ' ILE . 95.4 mt 59.1 83.54 0.13 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.151 -177.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.731 -0.652 . . . . 0.0 110.544 179.735 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 381' ' ' ARG . . . . . 0.476 ' HD2' ' OD1' ' B' ' 418' ' ' ASN . 19.0 ptp180 . . . . . 0 N--CA 1.48 1.058 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 382' ' ' THR . . . . . 0.618 ' O ' ' HB3' ' B' ' 415' ' ' SER . 0.1 OUTLIER -130.95 -39.31 1.21 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -175.22 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 383' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -153.59 159.29 42.11 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 119.428 -0.909 . . . . 0.0 112.85 -171.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 384' ' ' GLY . . . . . . . . . . . . . . . -114.98 -111.95 2.88 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.103 171.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 385' ' ' THR . . . . . . . . . . . . . 14.1 m -59.7 -43.33 94.12 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.856 0.36 . . . . 0.0 111.684 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 386' ' ' PHE . . . . . 0.825 ' CD1' HD22 ' B' ' 414' ' ' LEU . 3.5 t80 -73.59 121.16 84.47 Favored Pre-proline 0 C--N 1.329 -0.322 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 387' ' ' PRO . . . . . 0.465 ' HD2' ' HA ' ' B' ' 386' ' ' PHE . 6.7 Cg_endo -46.56 -71.56 0.05 OUTLIER 'Trans proline' 0 N--CA 1.476 0.479 0 C-N-CA 124.17 3.247 . . . . 0.0 114.433 -175.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 388' ' ' MET . . . . . 0.59 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 30.8 ttm 70.39 143.57 0.05 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 122.412 0.285 . . . . 0.0 110.896 178.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 389' ' ' HIS . . . . . 0.592 ' CD2' ' HB2' ' B' ' 393' ' ' ASN . 32.6 m170 -48.14 -75.93 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.1 0 CA-C-O 121.304 0.574 . . . . 0.0 110.417 -176.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -166.92 19.31 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 173.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 391' ' ' LEU . . . . . 0.538 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.6 pt? -168.76 -51.49 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.497 -171.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 392' ' ' GLY . . . . . 0.68 ' HA3' HD13 ' B' ' 395' ' ' ILE . . . -176.44 60.85 0.1 Allowed Glycine 0 CA--C 1.522 0.522 0 C-N-CA 119.794 -1.193 . . . . 0.0 114.151 -176.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 393' ' ' ASN . . . . . 0.592 ' HB2' ' CD2' ' B' ' 389' ' ' HIS . 0.2 OUTLIER -58.47 -42.07 86.68 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 174.095 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 394' ' ' VAL . . . . . 0.664 HG23 HD12 ' B' ' 398' ' ' ILE . 1.7 m -55.18 -47.12 77.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 395' ' ' ILE . . . . . 0.68 HD13 ' HA3' ' B' ' 392' ' ' GLY . 3.6 mp -57.64 -52.65 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 117.779 -1.105 . . . . 0.0 113.751 -175.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 396' ' ' LYS . . . . . 0.597 ' O ' HG22 ' B' ' 399' ' ' VAL . 0.0 OUTLIER -62.71 -50.18 72.14 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 122.043 2.201 . . . . 0.0 112.347 -173.667 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 397' ' ' GLY . . . . . 0.5 ' O ' ' HG3' ' B' ' 401' ' ' GLN . . . -54.06 -41.86 70.02 Favored Glycine 0 N--CA 1.436 -1.345 0 C-N-CA 119.799 -1.191 . . . . 0.0 110.838 -175.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . 0.754 HD13 HD12 ' B' ' 410' ' ' LEU . 35.9 mt -71.62 -34.56 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 399' ' ' VAL . . . . . 0.597 HG22 ' O ' ' B' ' 396' ' ' LYS . 15.6 m -63.38 -40.1 87.76 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 C-N-CA 118.94 -1.104 . . . . 0.0 108.68 -174.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -68.53 -38.5 80.9 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 176.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 401' ' ' GLN . . . . . 0.5 ' HG3' ' O ' ' B' ' 397' ' ' GLY . 32.9 mt-30 -92.86 -48.39 6.57 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -171.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 402' ' ' GLU . . . . . 0.735 ' HG3' ' HE3' ' A' ' 413' ' ' MET . 3.1 mm-40 -113.43 -19.89 11.52 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.154 -172.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 105.12 161.42 23.62 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.947 178.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 404' ' ' VAL . . . . . 0.639 HG11 ' HA ' ' B' ' 430' ' ' LEU . 1.4 m -53.69 -45.37 60.66 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 N-CA-C 114.409 1.262 . . . . 0.0 114.409 -176.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 405' ' ' ALA . . . . . 0.522 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -63.97 -31.23 72.35 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 119.954 -0.698 . . . . 0.0 112.504 -177.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 406' ' ' THR . . . . . 0.692 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 89.9 m -77.12 -42.36 38.29 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.298 173.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 407' ' ' ALA . . . . . 0.467 ' HB2' ' HB ' ' B' ' 398' ' ' ILE . . . -58.48 -36.79 74.27 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 122.203 1.001 . . . . 0.0 109.282 176.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 408' ' ' TYR . . . . . 0.616 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -66.46 -51.87 52.28 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 113.43 -1.714 . . . . 0.0 109.937 176.449 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 409' ' ' THR . . . . . 0.646 HG22 HD23 ' B' ' 410' ' ' LEU . 16.6 m -55.45 -47.07 76.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.591 178.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 410' ' ' LEU . . . . . 0.754 HD12 HD13 ' B' ' 398' ' ' ILE . 14.1 mt -72.42 -34.78 68.08 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -175.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -59.41 -34.14 79.39 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.308 -0.948 . . . . 0.0 110.998 170.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 412' ' ' MET . . . . . 0.422 ' HB2' ' O ' ' B' ' 409' ' ' THR . 0.6 OUTLIER -66.88 -48.15 69.64 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 122.612 -0.346 . . . . 0.0 111.072 177.163 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 413' ' ' MET . . . . . 0.917 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.5 OUTLIER -71.59 -51.69 22.01 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 119.336 -0.946 . . . . 0.0 112.678 -179.456 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 414' ' ' LEU . . . . . 0.917 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 12.4 mt -67.21 -46.5 73.67 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -174.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 415' ' ' SER . . . . . 0.618 ' HB3' ' O ' ' B' ' 382' ' ' THR . 0.1 OUTLIER -97.44 10.61 39.27 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.368 0.604 . . . . 0.0 110.975 -172.556 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 416' ' ' GLY . . . . . 0.426 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 84.16 179.39 51.73 Favored Glycine 0 N--CA 1.438 -1.202 0 C-N-CA 120.638 -0.791 . . . . 0.0 111.609 -178.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -79.5 23.23 0.41 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.564 0.697 . . . . 0.0 110.843 -173.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 418' ' ' ASN . . . . . 0.476 ' OD1' ' HD2' ' B' ' 381' ' ' ARG . 64.8 m-80 -72.51 77.49 1.06 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.763 -178.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 419' ' ' TYR . . . . . 0.557 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 6.9 p90 -50.0 -38.29 36.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.975 174.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -54.28 -47.64 72.12 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.807 177.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.7 -48.76 65.63 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.963 -176.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 422' ' ' VAL . . . . . 0.461 ' HB ' ' CD1' ' B' ' 408' ' ' TYR . 0.2 OUTLIER -66.01 -40.47 87.38 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.499 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.216 -176.757 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 423' ' ' SER . . . . . 0.814 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 80.3 p -69.15 -37.76 78.43 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -178.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -68.0 -38.61 88.8 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.636 176.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 425' ' ' ILE . . . . . 0.599 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -72.95 -52.91 20.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 O-C-N 123.062 -0.081 . . . . 0.0 111.088 -178.289 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 426' ' ' ILE . . . . . 0.682 HG22 HD22 ' B' ' 430' ' ' LEU . 1.1 mm -74.34 -23.77 18.53 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.89 0 O-C-N 122.182 -0.324 . . . . 0.0 110.376 -171.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 427' ' ' ARG . . . . . 0.814 ' HB2' ' O ' ' B' ' 423' ' ' SER . 1.3 tmm_? -55.33 -30.76 60.88 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.241 0.544 . . . . 0.0 111.024 -177.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -86.87 -11.8 69.8 Favored Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 120.445 -0.883 . . . . 0.0 111.224 178.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 429' ' ' TYR . . . . . 0.543 ' HD1' HG22 ' B' ' 395' ' ' ILE . 7.9 m-30 -112.94 -0.39 14.84 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -174.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 430' ' ' LEU . . . . . 0.735 HD23 ' HA ' ' B' ' 427' ' ' ARG . 0.1 OUTLIER -66.12 129.72 94.25 Favored Pre-proline 0 N--CA 1.442 -0.837 0 CA-C-N 114.477 -1.238 . . . . 0.0 108.938 177.426 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 431' ' ' PRO . . . . . 0.543 ' HD2' HD12 ' B' ' 430' ' ' LEU . 81.0 Cg_exo -24.05 -69.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.357 1.001 1 C-N-CA 125.399 4.066 . . . . 0.0 114.796 179.224 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 432' ' ' GLY . . . . . 0.516 ' O ' HG12 ' B' ' 435' ' ' VAL . . . -141.28 -168.03 11.34 Favored Glycine 0 N--CA 1.443 -0.886 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 177.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 433' ' ' GLN . . . . . 0.531 ' O ' HG13 ' B' ' 436' ' ' VAL . 43.8 tp60 -70.23 -26.93 64.08 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 118.173 0.986 . . . . 0.0 110.411 178.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -63.99 -42.18 97.28 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.964 -178.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 435' ' ' VAL . . . . . 0.718 HG23 HG11 ' B' ' 463' ' ' VAL . 7.3 p -67.76 -42.77 86.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 120.977 0.417 . . . . 0.0 110.649 -177.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 436' ' ' VAL . . . . . 0.531 HG13 ' O ' ' B' ' 433' ' ' GLN . 0.1 OUTLIER -67.31 -31.57 53.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.323 175.732 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.58 -52.74 42.11 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -178.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 438' ' ' ALA . . . . . 0.871 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -58.68 -39.74 81.57 Favored 'General case' 0 N--CA 1.436 -1.128 0 O-C-N 124.042 0.838 . . . . 0.0 111.97 177.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 439' ' ' LEU . . . . . 0.669 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 1.8 tm? -68.03 -48.41 65.73 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -178.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.45 -33.7 72.94 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.143 175.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 441' ' ' GLN . . . . . 0.513 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 3.4 mm-40 -55.0 -50.25 69.47 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.742 -178.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 442' ' ' ARG . . . . . 0.615 ' HG3' ' CG ' ' B' ' 459' ' ' HIS . 0.0 OUTLIER -77.74 -24.0 49.19 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 174.388 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 443' ' ' LEU . . . . . 0.669 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 55.8 mt -64.31 -26.91 68.69 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 118.755 0.707 . . . . 0.0 109.966 173.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -66.71 -37.03 83.89 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.78 178.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 445' ' ' GLN . . . . . 0.464 ' HG3' ' N ' ' B' ' 446' ' ' GLU . 0.0 OUTLIER -80.33 -30.42 38.12 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.584 179.874 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 446' ' ' GLU . . . . . 0.464 ' N ' ' HG3' ' B' ' 445' ' ' GLN . 8.7 pt-20 15.2 105.14 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 O-C-N 125.517 1.761 . . . . 0.0 113.816 -177.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 43.7 mt -51.28 -34.23 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.362 -177.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 448' ' ' ASP . . . . . 0.509 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 13.0 m-20 -161.04 -174.45 4.38 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 449' ' ' ASP . . . . . 0.492 ' O ' ' HB3' ' B' ' 452' ' ' ARG . 27.9 t0 -72.26 -62.69 1.34 Allowed 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 174.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.03 -27.26 64.52 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 176.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 451' ' ' THR . . . . . 0.509 ' OG1' ' HB2' ' B' ' 448' ' ' ASP . 14.6 m -72.07 -23.02 61.29 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 119.749 -0.78 . . . . 0.0 109.946 -176.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 452' ' ' ARG . . . . . 0.492 ' HB3' ' O ' ' B' ' 449' ' ' ASP . 43.5 ttt180 -56.0 -52.15 65.22 Favored 'General case' 0 N--CA 1.415 -2.176 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 172.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 453' ' ' ALA . . . . . 0.557 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -60.05 -46.9 87.99 Favored 'General case' 0 CA--C 1.527 0.081 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 171.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 454' ' ' GLU . . . . . 0.447 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 13.5 mm-40 -51.95 -36.25 48.73 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.157 0.503 . . . . 0.0 111.837 -176.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 24.9 p -115.61 14.18 16.45 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.368 -176.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 456' ' ' PHE . . . . . 0.606 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 1.2 t80 -55.32 -46.29 76.32 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.944 0.402 . . . . 0.0 111.745 -172.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 457' ' ' ILE . . . . . 0.528 ' CG1' ' HB3' ' B' ' 408' ' ' TYR . 1.9 mp -78.16 -33.39 17.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 120.687 0.279 . . . . 0.0 111.273 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -58.06 -32.92 68.49 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.993 0.902 . . . . 0.0 109.078 171.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 459' ' ' HIS . . . . . 0.743 ' O ' HG23 ' B' ' 463' ' ' VAL . 56.4 m-70 -73.98 -29.97 62.25 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.79 177.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 460' ' ' LEU . . . . . 0.708 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -74.16 -34.71 63.91 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.814 0.816 . . . . 0.0 108.923 179.649 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 461' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -73.07 -37.34 66.83 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.016 176.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 462' ' ' ALA . . . . . 0.621 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -55.99 -34.04 65.4 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.758 169.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 463' ' ' VAL . . . . . 0.871 HG13 ' HB3' ' B' ' 438' ' ' ALA . 68.4 t -63.49 -51.09 74.95 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-N 114.548 -1.205 . . . . 0.0 108.152 177.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 464' ' ' TYR . . . . . 0.563 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 16.9 m-30 -52.3 -29.15 21.97 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 124.347 1.029 . . . . 0.0 110.311 177.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.68 -40.98 22.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.614 0.721 . . . . 0.0 109.475 -177.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 466' ' ' ILE . . . . . 0.621 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.7 mt -57.42 -56.32 15.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 114.277 -1.329 . . . . 0.0 112.251 176.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 467' ' ' LEU . . . . . 0.765 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -100.78 -11.36 19.95 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 114.66 1.355 . . . . 0.0 114.66 -171.971 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 468' ' ' GLY . . . . . 0.551 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 94.24 31.56 7.93 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 119.368 -1.396 . . . . 0.0 114.32 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 469' ' ' LEU . . . . . 0.765 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.3 mt -88.6 162.93 16.09 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 117.873 0.836 . . . . 0.0 110.879 177.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 37.8 p30 -105.0 -177.95 3.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.109 172.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 471' ' ' ALA . . . . . 0.408 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -66.41 -14.46 62.19 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -176.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -88.43 -1.71 58.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.624 0.249 . . . . 0.0 111.166 -176.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 473' ' ' GLY . . . . . 0.477 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 78.99 10.82 85.83 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -175.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -101.51 156.46 17.46 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 176.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 34.8 t -93.36 137.56 32.55 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.348 0.594 . . . . 0.0 111.264 -176.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 476' ' ' ILE . . . . . 0.71 ' O ' ' HD2' ' B' ' 477' ' ' ARG . 2.4 pp -115.64 -19.63 6.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.865 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 477' ' ' ARG . . . . . 0.71 ' HD2' ' O ' ' B' ' 476' ' ' ILE . 0.1 OUTLIER 21.98 62.82 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 115.076 1.509 . . . . 0.0 115.076 174.295 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 478' ' ' LEU . . . . . 0.461 ' H ' HD12 ' B' ' 476' ' ' ILE . 96.4 mt 59.77 83.82 0.13 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.972 -177.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 479' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.659 -0.686 . . . . 0.0 110.629 179.89 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' ARG . . . . . 0.699 ' N ' ' HG ' ' A' ' 415' ' ' SER . 19.6 ptp180 . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . 0.428 HG22 ' H ' ' A' ' 382' ' ' THR . 0.0 OUTLIER -53.9 -44.52 70.6 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -179.533 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -139.97 119.59 13.22 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 120.898 0.38 . . . . 0.0 111.806 175.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 162.82 85.12 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 -178.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 24.2 m 73.8 123.12 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 122.963 0.505 . . . . 0.0 110.414 -175.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' PHE . . . . . 0.745 ' CD1' HD22 ' A' ' 414' ' ' LEU . 2.1 t80 69.64 111.53 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.542 -171.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . 0.472 ' HD2' ' HA ' ' A' ' 386' ' ' PHE . 1.5 Cg_endo -39.85 -62.84 0.33 Allowed 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 124.404 3.403 . . . . 0.0 113.764 -174.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.484 ' C ' ' HB3' ' A' ' 393' ' ' ASN . 6.3 ttp 59.04 38.34 24.11 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 174.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' HIS . . . . . 0.603 ' N ' ' HB3' ' A' ' 393' ' ' ASN . 31.3 m170 51.8 -97.22 0.05 Allowed 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.41 0.624 . . . . 0.0 110.064 -176.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -151.57 23.89 0.7 Allowed 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.186 171.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.477 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.4 pt? -175.77 -47.87 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.221 -172.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . 0.589 ' HA3' HD13 ' A' ' 395' ' ' ILE . . . -173.22 56.37 0.15 Allowed Glycine 0 CA--C 1.524 0.645 0 C-N-CA 119.443 -1.361 . . . . 0.0 114.796 -172.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . 0.603 ' HB3' ' N ' ' A' ' 389' ' ' HIS . 0.0 OUTLIER -61.72 -37.64 84.93 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-N 117.65 0.725 . . . . 0.0 109.061 174.18 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.683 HG12 ' CE2' ' A' ' 386' ' ' PHE . 1.0 OUTLIER -57.2 -49.4 79.89 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 CA-C-N 113.674 -1.603 . . . . 0.0 107.047 179.015 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.658 HG23 HD13 ' A' ' 426' ' ' ILE . 3.6 mp -57.69 -52.82 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 CA-C-O 117.745 -1.121 . . . . 0.0 113.605 -174.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . 0.606 ' O ' HG22 ' A' ' 399' ' ' VAL . 0.0 OUTLIER -62.54 -49.51 75.02 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 122.017 2.189 . . . . 0.0 112.199 -174.715 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.16 -44.48 63.76 Favored Glycine 0 N--CA 1.435 -1.391 0 C-N-CA 119.98 -1.105 . . . . 0.0 110.98 -176.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . 0.741 HD13 HD12 ' A' ' 410' ' ' LEU . 28.5 mt -71.09 -33.94 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 396' ' ' LYS . 17.3 m -63.29 -39.81 86.67 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 C-N-CA 118.751 -1.18 . . . . 0.0 108.436 -174.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -70.62 -37.7 73.84 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 175.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.46 HE21 ' HB3' ' A' ' 401' ' ' GLN . 3.3 mm100 -88.15 -48.86 7.39 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -171.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . 0.574 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 1.3 tm-20 -117.93 -19.94 8.98 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.065 0.46 . . . . 0.0 111.213 -170.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 106.45 160.67 22.25 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.673 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . 0.654 HG11 ' HA ' ' A' ' 430' ' ' LEU . 1.2 m -54.16 -45.5 66.51 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.862 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -175.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . 0.557 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -63.15 -31.26 72.36 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 119.794 -0.762 . . . . 0.0 112.403 -177.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.719 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 92.5 m -76.92 -42.03 41.1 Favored 'General case' 0 C--O 1.221 -0.412 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.164 173.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.449 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -58.8 -36.79 75.04 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 122.183 0.992 . . . . 0.0 109.301 176.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 408' ' ' TYR . . . . . 0.623 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -66.41 -51.73 53.92 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 113.492 -1.685 . . . . 0.0 109.571 176.762 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 409' ' ' THR . . . . . 0.648 HG22 HD23 ' A' ' 410' ' ' LEU . 17.5 m -55.11 -47.37 75.09 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.436 178.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . 0.741 HD12 HD13 ' A' ' 398' ' ' ILE . 15.0 mt -72.59 -35.73 67.99 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -174.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.44 -34.63 76.06 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.15 -1.024 . . . . 0.0 110.893 172.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -69.58 -47.22 64.33 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 413' ' ' MET . . . . . 0.919 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.8 OUTLIER -71.52 -44.84 63.9 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 118.914 -1.114 . . . . 0.0 111.879 -179.425 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . 0.919 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 11.7 mt -70.03 -46.37 65.21 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -177.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.699 ' HG ' ' N ' ' A' ' 381' ' ' ARG . 8.4 t -99.86 16.56 23.37 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.319 0.58 . . . . 0.0 110.349 -172.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 75.85 -176.66 50.81 Favored Glycine 0 N--CA 1.437 -1.266 0 C-N-CA 120.354 -0.927 . . . . 0.0 111.721 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -80.56 23.12 0.53 Allowed 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.272 0.558 . . . . 0.0 111.402 -172.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 418' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -71.58 76.98 0.81 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.514 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 419' ' ' TYR . . . . . 0.482 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 21.4 p90 -56.17 -38.04 70.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.518 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -55.71 -42.57 75.45 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.723 0.297 . . . . 0.0 111.081 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.1 -49.05 63.63 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.287 -178.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . 0.469 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -65.7 -39.51 85.11 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.259 -177.878 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.798 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 61.8 p -67.73 -37.75 82.61 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 -178.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -68.09 -39.25 88.75 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.129 175.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . 0.571 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.23 -52.4 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-O 120.352 0.12 . . . . 0.0 111.035 -177.908 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . 0.658 HD13 HG23 ' A' ' 395' ' ' ILE . 1.2 mm -74.75 -23.37 17.7 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.91 0 O-C-N 122.135 -0.353 . . . . 0.0 110.555 -172.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.798 ' HB2' ' O ' ' A' ' 423' ' ' SER . 1.5 tmt_? -54.57 -31.8 57.37 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.224 0.535 . . . . 0.0 111.13 -177.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.37 -12.1 67.99 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.217 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.595 ' HD1' HG22 ' A' ' 395' ' ' ILE . 6.1 m-30 -112.0 -1.97 15.23 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -173.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.654 ' HA ' HG11 ' A' ' 404' ' ' VAL . 0.0 OUTLIER -66.05 139.97 96.83 Favored Pre-proline 0 N--CA 1.443 -0.815 0 CA-C-N 114.136 -1.393 . . . . 0.0 109.206 177.349 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . 0.812 ' CD ' HG11 ' A' ' 435' ' ' VAL . 77.4 Cg_exo -37.99 -75.45 0.04 OUTLIER 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 124.606 3.537 . . . . 0.0 113.92 -173.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . 0.422 ' O ' HG12 ' A' ' 435' ' ' VAL . . . -130.06 -161.63 10.51 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 176.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . 0.52 ' O ' HG13 ' A' ' 436' ' ' VAL . 19.0 tp60 -71.47 -28.78 64.18 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 118.038 0.919 . . . . 0.0 110.569 176.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -67.03 -39.19 86.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 0.0 112.123 -175.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 435' ' ' VAL . . . . . 0.812 HG11 ' CD ' ' A' ' 431' ' ' PRO . 6.8 p -66.55 -45.08 89.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.173 0.511 . . . . 0.0 110.736 -177.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 433' ' ' GLN . 0.2 OUTLIER -66.28 -31.91 55.73 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.105 177.014 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -68.01 -52.26 37.63 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -177.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . 0.84 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -57.58 -40.56 79.29 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.179 177.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 439' ' ' LEU . . . . . 0.611 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 1.9 tm? -68.12 -48.13 66.26 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -178.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.86 -34.99 73.85 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.085 175.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 441' ' ' GLN . . . . . 0.542 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 4.4 mm-40 -53.62 -49.6 67.49 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.001 -178.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . 0.709 ' HD2' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -76.89 -25.28 52.84 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 119.133 -1.027 . . . . 0.0 113.368 174.346 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 443' ' ' LEU . . . . . 0.611 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 66.8 mt -65.59 -27.75 68.64 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 118.653 0.66 . . . . 0.0 109.771 175.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -61.29 -38.37 86.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.937 176.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -78.49 -27.63 46.25 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.319 -1.31 . . . . 0.0 111.149 178.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 25.36 101.58 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 41.5 mt -58.61 -33.59 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 121.353 0.597 . . . . 0.0 111.322 -178.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . 0.446 ' HB2' ' OG1' ' A' ' 451' ' ' THR . 8.4 m-20 -162.46 -159.81 0.61 Allowed 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 -178.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 449' ' ' ASP . . . . . 0.405 ' CG ' ' H ' ' A' ' 450' ' ' GLN . 12.3 p-10 -85.39 -64.88 1.08 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 168.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 450' ' ' GLN . . . . . 0.405 ' H ' ' CG ' ' A' ' 449' ' ' ASP . 0.0 OUTLIER -68.24 -26.11 65.53 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 179.012 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 451' ' ' THR . . . . . 0.452 ' HA ' ' HB2' ' A' ' 454' ' ' GLU . 10.4 m -71.44 -23.13 61.79 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 119.859 -0.736 . . . . 0.0 110.732 -175.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 452' ' ' ARG . 14.7 mtp180 -54.02 -53.95 45.91 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 171.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 453' ' ' ALA . . . . . 0.482 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -58.73 -49.08 78.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.354 -1.293 . . . . 0.0 112.53 174.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . 0.452 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 69.0 mm-40 -49.69 -37.15 27.67 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.283 0.563 . . . . 0.0 111.601 -177.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 32.0 p -118.03 15.06 14.18 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.45 -175.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . 0.551 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.8 OUTLIER -57.44 -47.47 81.73 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.089 0.471 . . . . 0.0 111.643 -171.28 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . 0.557 HG23 ' HB1' ' A' ' 405' ' ' ALA . 1.9 mp -76.92 -32.54 19.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.831 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -57.96 -34.41 69.9 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.905 0.86 . . . . 0.0 109.143 171.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . 0.771 ' O ' HG23 ' A' ' 463' ' ' VAL . 63.2 m-70 -74.68 -29.45 61.23 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.725 177.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . 0.714 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -73.47 -34.61 65.44 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.793 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . 0.458 ' O ' ' HB2' ' A' ' 464' ' ' TYR . 25.1 m-80 -73.11 -37.2 66.78 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.207 176.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 462' ' ' ALA . . . . . 0.598 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -55.75 -36.46 67.31 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.449 169.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.84 HG13 ' HB3' ' A' ' 438' ' ' ALA . 75.5 t -61.9 -51.16 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 CA-C-N 114.274 -1.33 . . . . 0.0 108.098 176.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 464' ' ' TYR . . . . . 0.606 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 18.5 m-30 -51.28 -29.03 13.43 Favored 'General case' 0 N--CA 1.455 -0.195 0 O-C-N 124.551 1.157 . . . . 0.0 110.758 177.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.0 -39.78 19.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.657 0.742 . . . . 0.0 109.76 -176.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.598 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.6 mt -57.89 -55.84 19.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 114.481 -1.236 . . . . 0.0 112.113 176.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.791 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -100.22 -10.51 21.29 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 -172.667 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . 0.665 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 94.24 32.06 7.64 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 119.238 -1.458 . . . . 0.0 114.259 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 469' ' ' LEU . . . . . 0.791 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 4.3 mt -89.2 158.85 17.73 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 117.827 0.814 . . . . 0.0 110.828 174.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . 0.487 HD22 HG23 ' A' ' 476' ' ' ILE . 10.8 p30 -105.8 -178.04 3.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.983 171.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -55.35 -27.42 47.12 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -173.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -85.82 7.32 24.33 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.767 0.318 . . . . 0.0 111.406 -170.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . 0.448 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 74.63 10.19 82.77 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.227 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -100.39 154.19 18.71 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 177.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 5.6 p -89.77 130.99 35.95 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.218 0.532 . . . . 0.0 111.221 -178.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 476' ' ' ILE . . . . . 0.665 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.8 pp -92.64 -4.67 10.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.564 0.697 . . . . 0.0 109.686 177.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 23.7 mmm180 -68.64 -43.83 75.46 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.066 175.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -149.24 150.7 33.01 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.693 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 . . . . . 0 C--O 1.247 0.94 0 CA-C-O 118.662 -0.685 . . . . 0.0 110.332 -179.557 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 381' ' ' ARG . . . . . 0.73 ' N ' ' HG ' ' B' ' 415' ' ' SER . 19.7 ptp180 . . . . . 0 N--CA 1.477 0.907 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 382' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -54.06 -44.4 71.08 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 383' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -140.22 119.66 13.09 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 120.94 0.4 . . . . 0.0 111.768 175.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 384' ' ' GLY . . . . . . . . . . . . . . . 162.78 85.05 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 111.43 -0.668 . . . . 0.0 111.43 -178.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 385' ' ' THR . . . . . . . . . . . . . 25.1 m 73.91 123.15 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 122.973 0.509 . . . . 0.0 110.386 -175.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 386' ' ' PHE . . . . . 0.741 ' CD1' HD22 ' B' ' 414' ' ' LEU . 2.1 t80 69.66 111.85 0.03 OUTLIER Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.534 -171.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 387' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' B' ' 386' ' ' PHE . 1.6 Cg_endo -39.86 -62.98 0.31 Allowed 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 124.427 3.418 . . . . 0.0 113.872 -175.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 388' ' ' MET . . . . . 0.488 ' C ' ' HB3' ' B' ' 393' ' ' ASN . 6.3 ttp 59.0 38.52 24.17 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 174.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 389' ' ' HIS . . . . . 0.61 ' N ' ' HB3' ' B' ' 393' ' ' ASN . 31.3 m170 51.71 -97.01 0.05 Allowed 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 121.426 0.631 . . . . 0.0 110.268 -176.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -151.8 23.96 0.67 Allowed 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 171.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 391' ' ' LEU . . . . . 0.481 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.4 pt? -175.75 -47.78 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.357 -172.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 392' ' ' GLY . . . . . 0.591 ' HA3' HD13 ' B' ' 395' ' ' ILE . . . -173.2 56.48 0.15 Allowed Glycine 0 CA--C 1.525 0.685 0 C-N-CA 119.477 -1.344 . . . . 0.0 114.778 -172.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 393' ' ' ASN . . . . . 0.61 ' HB3' ' N ' ' B' ' 389' ' ' HIS . 0.0 OUTLIER -61.8 -37.62 85.06 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-N 117.649 0.725 . . . . 0.0 109.046 174.216 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 394' ' ' VAL . . . . . 0.692 HG12 ' CE2' ' B' ' 386' ' ' PHE . 1.0 OUTLIER -57.18 -49.4 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 CA-C-N 113.642 -1.617 . . . . 0.0 107.094 179.02 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 395' ' ' ILE . . . . . 0.65 HG23 HD13 ' B' ' 426' ' ' ILE . 3.6 mp -57.68 -52.72 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.315 0 CA-C-O 117.842 -1.075 . . . . 0.0 113.625 -174.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 396' ' ' LYS . . . . . 0.607 ' O ' HG22 ' B' ' 399' ' ' VAL . 0.0 OUTLIER -62.57 -49.74 74.07 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 121.991 2.178 . . . . 0.0 112.032 -174.666 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.06 -44.58 62.8 Favored Glycine 0 N--CA 1.435 -1.405 0 C-N-CA 119.979 -1.105 . . . . 0.0 110.933 -176.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . 0.738 HD13 HD12 ' B' ' 410' ' ' LEU . 28.5 mt -71.0 -33.84 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -179.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 399' ' ' VAL . . . . . 0.607 HG22 ' O ' ' B' ' 396' ' ' LYS . 17.2 m -63.42 -39.72 86.37 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 C-N-CA 118.753 -1.179 . . . . 0.0 108.483 -174.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -70.51 -37.98 74.24 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 175.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 401' ' ' GLN . . . . . 0.455 HE21 ' HB3' ' B' ' 401' ' ' GLN . 3.3 mm100 -88.09 -48.61 7.61 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -171.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 402' ' ' GLU . . . . . 0.589 ' HG3' ' HE3' ' A' ' 413' ' ' MET . 1.2 tm-20 -118.14 -19.89 8.86 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.216 -170.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 106.26 160.73 22.44 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.549 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 404' ' ' VAL . . . . . 0.65 HG11 ' HA ' ' B' ' 430' ' ' LEU . 1.2 m -54.19 -45.41 66.77 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.886 0 N-CA-C 114.568 1.322 . . . . 0.0 114.568 -175.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 405' ' ' ALA . . . . . 0.535 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -63.2 -31.18 72.26 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 119.819 -0.753 . . . . 0.0 112.43 -177.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 406' ' ' THR . . . . . 0.717 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 92.0 m -76.78 -42.17 41.85 Favored 'General case' 0 C--O 1.221 -0.4 0 O-C-N 121.682 -0.636 . . . . 0.0 110.226 173.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 407' ' ' ALA . . . . . 0.456 ' HB2' ' HB ' ' B' ' 398' ' ' ILE . . . -58.89 -36.68 75.06 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 122.204 1.002 . . . . 0.0 109.306 176.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 408' ' ' TYR . . . . . 0.623 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -66.5 -51.69 54.01 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 113.474 -1.694 . . . . 0.0 109.576 176.772 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 409' ' ' THR . . . . . 0.645 HG22 HD23 ' B' ' 410' ' ' LEU . 17.3 m -55.18 -47.29 75.42 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.447 178.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 410' ' ' LEU . . . . . 0.738 HD12 HD13 ' B' ' 398' ' ' ILE . 15.2 mt -72.65 -35.75 67.83 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -174.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.4 -34.72 76.13 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.196 -1.002 . . . . 0.0 110.951 172.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 412' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -69.56 -47.03 65.01 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-O 120.64 0.257 . . . . 0.0 111.612 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 413' ' ' MET . . . . . 0.936 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.9 OUTLIER -71.43 -45.27 63.1 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 118.848 -1.141 . . . . 0.0 111.792 -179.459 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 414' ' ' LEU . . . . . 0.936 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 11.7 mt -69.87 -46.39 65.6 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -177.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 415' ' ' SER . . . . . 0.73 ' HG ' ' N ' ' B' ' 381' ' ' ARG . 8.4 t -99.74 16.58 23.12 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.388 0.613 . . . . 0.0 110.515 -172.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 416' ' ' GLY . . . . . . . . . . . . . . . 75.84 -176.66 50.81 Favored Glycine 0 N--CA 1.436 -1.361 0 C-N-CA 120.359 -0.924 . . . . 0.0 111.699 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -80.66 23.11 0.54 Allowed 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.222 0.534 . . . . 0.0 111.397 -172.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 418' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -71.59 76.74 0.81 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.47 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 419' ' ' TYR . . . . . 0.483 ' HB2' ' CE2' ' B' ' 456' ' ' PHE . 21.1 p90 -55.65 -38.15 69.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.66 178.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -55.54 -42.91 75.27 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.952 178.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.73 -49.06 64.57 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.354 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 422' ' ' VAL . . . . . 0.471 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.2 OUTLIER -65.78 -39.29 84.37 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.364 -177.872 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 423' ' ' SER . . . . . 0.811 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 61.6 p -67.98 -37.88 82.03 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -178.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.86 -39.14 89.7 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.241 175.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 425' ' ' ILE . . . . . 0.583 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -72.35 -52.3 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 120.367 0.127 . . . . 0.0 111.145 -178.037 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 426' ' ' ILE . . . . . 0.65 HD13 HG23 ' B' ' 395' ' ' ILE . 1.2 mm -74.79 -23.42 17.68 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.969 0 O-C-N 122.095 -0.378 . . . . 0.0 110.594 -172.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 427' ' ' ARG . . . . . 0.811 ' HB2' ' O ' ' B' ' 423' ' ' SER . 1.5 tmt_? -54.59 -31.63 57.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.176 0.512 . . . . 0.0 111.134 -177.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.58 -12.19 67.36 Favored Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.501 -0.857 . . . . 0.0 111.141 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 429' ' ' TYR . . . . . 0.595 ' HD1' HG22 ' B' ' 395' ' ' ILE . 6.1 m-30 -111.77 -2.12 15.39 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.869 0.842 . . . . 0.0 108.797 -174.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 430' ' ' LEU . . . . . 0.65 ' HA ' HG11 ' B' ' 404' ' ' VAL . 0.0 OUTLIER -66.18 139.94 96.68 Favored Pre-proline 0 N--CA 1.442 -0.865 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.407 177.555 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 431' ' ' PRO . . . . . 0.812 ' CD ' HG11 ' B' ' 435' ' ' VAL . 77.2 Cg_exo -38.19 -75.03 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 124.633 3.555 . . . . 0.0 113.985 -173.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 432' ' ' GLY . . . . . 0.427 ' O ' HG12 ' B' ' 435' ' ' VAL . . . -130.1 -161.65 10.51 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 176.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 433' ' ' GLN . . . . . 0.529 ' O ' HG13 ' B' ' 436' ' ' VAL . 19.8 tp60 -71.38 -29.15 64.6 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 118.058 0.929 . . . . 0.0 110.506 176.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -66.74 -39.3 87.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.215 -0.448 . . . . 0.0 112.093 -175.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 435' ' ' VAL . . . . . 0.812 HG11 ' CD ' ' B' ' 431' ' ' PRO . 6.8 p -66.44 -45.21 89.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.117 0.484 . . . . 0.0 110.69 -177.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 436' ' ' VAL . . . . . 0.529 HG13 ' O ' ' B' ' 433' ' ' GLN . 0.2 OUTLIER -66.26 -31.75 55.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.091 177.124 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -68.16 -52.27 36.51 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -177.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 438' ' ' ALA . . . . . 0.847 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -57.63 -40.51 79.36 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.139 177.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 439' ' ' LEU . . . . . 0.604 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 1.9 tm? -67.99 -48.22 66.38 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -178.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.97 -34.76 73.71 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.093 175.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 441' ' ' GLN . . . . . 0.541 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 4.5 mm-40 -53.75 -49.66 67.7 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.967 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 442' ' ' ARG . . . . . 0.714 ' HD2' ' O ' ' B' ' 438' ' ' ALA . 0.0 OUTLIER -76.76 -25.45 53.42 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 119.221 -0.992 . . . . 0.0 113.308 174.441 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 443' ' ' LEU . . . . . 0.604 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 67.4 mt -65.62 -27.41 68.37 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 118.656 0.662 . . . . 0.0 109.806 175.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -61.7 -38.02 86.33 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.954 176.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 34.5 mm-40 -78.74 -27.39 44.78 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.266 -1.334 . . . . 0.0 111.232 178.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 446' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 24.9 101.35 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 41.6 mt -58.09 -33.91 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 121.35 0.595 . . . . 0.0 111.292 -178.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 448' ' ' ASP . . . . . 0.45 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 8.1 m-20 -162.14 -159.62 0.61 Allowed 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -178.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 449' ' ' ASP . . . . . 0.407 ' H ' ' HB3' ' B' ' 448' ' ' ASP . 12.1 p-10 -85.4 -64.87 1.08 Allowed 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 168.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 450' ' ' GLN . . . . . 0.407 ' H ' ' CG ' ' B' ' 449' ' ' ASP . 0.0 OUTLIER -68.41 -26.05 65.35 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 179.128 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 451' ' ' THR . . . . . 0.45 ' OG1' ' HB2' ' B' ' 448' ' ' ASP . 10.0 m -71.58 -23.09 61.67 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.75 -175.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 452' ' ' ARG . . . . . . . . . . . . . 14.5 mtp180 -53.97 -54.0 45.02 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 171.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 453' ' ' ALA . . . . . 0.478 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -58.68 -49.09 78.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.361 -1.291 . . . . 0.0 112.596 174.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 454' ' ' GLU . . . . . 0.437 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 71.1 mm-40 -49.8 -36.93 28.14 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.218 0.533 . . . . 0.0 111.616 -177.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 32.3 p -118.15 15.0 14.08 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.448 -175.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 456' ' ' PHE . . . . . 0.555 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 0.8 OUTLIER -57.53 -47.27 82.44 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.136 0.493 . . . . 0.0 111.66 -171.266 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 457' ' ' ILE . . . . . 0.535 HG23 ' HB1' ' B' ' 405' ' ' ALA . 1.9 mp -77.15 -32.4 19.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.029 0.442 . . . . 0.0 110.853 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -57.87 -34.62 69.96 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.779 0.799 . . . . 0.0 109.113 171.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 459' ' ' HIS . . . . . 0.769 ' O ' HG23 ' B' ' 463' ' ' VAL . 64.1 m-70 -74.65 -29.47 61.27 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.55 -1.204 . . . . 0.0 110.748 177.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 460' ' ' LEU . . . . . 0.731 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -73.33 -34.52 65.72 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.91 0.862 . . . . 0.0 108.758 178.59 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 461' ' ' ASN . . . . . 0.454 ' O ' ' HB2' ' B' ' 464' ' ' TYR . 23.5 m-80 -73.26 -37.26 66.36 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.15 176.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 462' ' ' ALA . . . . . 0.602 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -55.66 -36.33 66.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.636 -1.165 . . . . 0.0 109.495 169.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 463' ' ' VAL . . . . . 0.847 HG13 ' HB3' ' B' ' 438' ' ' ALA . 75.6 t -62.07 -51.09 76.64 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-N 114.293 -1.321 . . . . 0.0 107.983 176.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 464' ' ' TYR . . . . . 0.614 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 18.6 m-30 -51.47 -28.97 14.75 Favored 'General case' 0 C--N 1.332 -0.167 0 O-C-N 124.496 1.123 . . . . 0.0 110.644 177.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.94 -39.97 19.11 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.719 0.771 . . . . 0.0 109.712 -176.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 466' ' ' ILE . . . . . 0.602 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.6 mt -57.75 -55.7 19.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 114.35 -1.295 . . . . 0.0 112.249 176.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 467' ' ' LEU . . . . . 0.784 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -100.25 -10.58 21.18 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -172.833 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 468' ' ' GLY . . . . . 0.667 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 94.21 32.12 7.62 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 119.308 -1.425 . . . . 0.0 114.313 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 469' ' ' LEU . . . . . 0.784 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 4.3 mt -89.05 159.05 17.76 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 117.814 0.807 . . . . 0.0 110.742 174.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 470' ' ' ASN . . . . . 0.474 HD22 HG23 ' B' ' 476' ' ' ILE . 10.6 p30 -105.88 -178.11 3.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.001 170.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 471' ' ' ALA . . . . . . . . . . . . . . . -55.36 -27.47 47.56 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -173.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -85.67 7.18 24.38 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 122.159 -0.338 . . . . 0.0 111.438 -171.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 473' ' ' GLY . . . . . 0.451 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 74.87 9.96 83.51 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.322 -0.942 . . . . 0.0 111.306 -178.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -100.54 154.41 18.58 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 177.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 6.4 p -89.69 131.06 35.86 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.27 0.557 . . . . 0.0 111.291 -178.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 476' ' ' ILE . . . . . 0.667 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.8 pp -92.62 -4.97 10.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.539 0.685 . . . . 0.0 109.75 177.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 477' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 -68.29 -43.92 76.64 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.06 175.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 478' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -149.28 150.25 32.25 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.743 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 479' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 . . . . . 0 C--O 1.246 0.898 0 CA-C-O 118.587 -0.72 . . . . 0.0 110.342 -179.259 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 . . . . . 0 N--CA 1.479 0.982 0 CA-C-O 120.962 0.41 . . . . 0.0 110.559 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . 0.557 HG23 ' HD2' ' A' ' 383' ' ' HIS . 0.0 OUTLIER -116.13 -27.94 6.74 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.914 -0.584 . . . . 0.0 112.16 -176.489 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' HIS . . . . . 0.557 ' HD2' HG23 ' A' ' 382' ' ' THR . 15.1 p80 -159.17 157.94 31.82 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.089 -0.644 . . . . 0.0 111.757 -173.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -103.92 -115.87 4.13 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.099 171.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 34.3 m -66.51 -31.16 71.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.941 0.401 . . . . 0.0 111.51 -178.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' PHE . . . . . 0.75 ' CD1' HD22 ' A' ' 414' ' ' LEU . 1.4 t80 -80.7 120.61 79.56 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.302 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . 0.47 ' HD2' ' HA ' ' A' ' 386' ' ' PHE . 10.0 Cg_endo -48.17 -69.77 0.07 OUTLIER 'Trans proline' 0 N--CA 1.483 0.873 0 C-N-CA 124.722 3.615 . . . . 0.0 115.907 -173.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.535 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 32.6 mtt 72.73 156.24 0.17 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.379 0.671 . . . . 0.0 111.216 -172.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' HIS . . . . . 0.55 ' CG ' ' HB2' ' A' ' 393' ' ' ASN . 32.7 m170 -54.33 -59.67 4.37 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 175.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . 0.406 ' H ' HD23 ' A' ' 391' ' ' LEU . 4.4 pt20 -177.55 19.96 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.786 -1.097 . . . . 0.0 108.687 175.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.587 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.3 pt? -170.11 -58.53 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.38 -167.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . 0.611 ' HA3' HD13 ' A' ' 395' ' ' ILE . . . -172.73 51.31 0.17 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.372 -0.918 . . . . 0.0 113.181 -172.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . 0.55 ' HB2' ' CG ' ' A' ' 389' ' ' HIS . 0.6 OUTLIER -57.01 -38.56 73.27 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.138 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.706 HG12 ' CE2' ' A' ' 386' ' ' PHE . 0.9 OUTLIER -55.88 -46.44 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 179.771 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.636 HG23 HD13 ' A' ' 426' ' ' ILE . 4.2 mp -57.82 -51.98 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 CA-C-O 117.902 -1.046 . . . . 0.0 113.047 -175.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . 0.702 ' HG3' ' CZ ' ' A' ' 429' ' ' TYR . 0.2 OUTLIER -62.49 -49.19 76.37 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 121.563 1.983 . . . . 0.0 111.816 -173.689 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -54.48 -44.87 77.71 Favored Glycine 0 N--CA 1.434 -1.471 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.0 -178.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . 0.86 HD13 HD12 ' A' ' 410' ' ' LEU . 45.0 mt -70.9 -33.87 53.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -177.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . 0.533 HG12 ' HA ' ' A' ' 404' ' ' VAL . 10.9 m -64.23 -39.42 85.45 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 C-N-CA 118.667 -1.213 . . . . 0.0 108.324 -175.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -70.37 -35.29 73.44 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 175.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.427 HE21 ' HB3' ' A' ' 401' ' ' GLN . 2.7 mm100 -89.42 -47.95 7.66 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -172.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . 0.675 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 3.1 mm-40 -121.0 -21.23 6.58 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.795 -170.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 108.03 162.23 20.99 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.952 -0.642 . . . . 0.0 113.046 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . 0.68 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.5 m -53.75 -42.51 52.21 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.772 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -175.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . 0.63 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -68.86 -29.86 68.26 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 119.708 -0.797 . . . . 0.0 112.073 -175.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.692 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 90.6 m -77.76 -42.5 33.87 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.074 173.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.461 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.35 -37.91 76.14 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 122.084 0.945 . . . . 0.0 109.229 176.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 408' ' ' TYR . . . . . 0.68 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.4 -51.79 57.91 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 113.517 -1.674 . . . . 0.0 109.851 176.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 409' ' ' THR . . . . . 0.666 HG22 HD23 ' A' ' 410' ' ' LEU . 12.0 m -54.96 -47.08 75.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.586 178.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . 0.86 HD12 HD13 ' A' ' 398' ' ' ILE . 14.5 mt -72.24 -36.67 69.15 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.893 0.377 . . . . 0.0 110.213 -174.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.82 -34.94 80.06 Favored Glycine 0 N--CA 1.438 -1.182 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 172.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 412' ' ' MET . . . . . 0.465 ' HB2' ' O ' ' A' ' 409' ' ' THR . 0.6 OUTLIER -66.06 -46.58 77.25 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 115.61 -0.295 . . . . 0.0 111.5 177.252 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 413' ' ' MET . . . . . 0.778 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.0 OUTLIER -70.33 -55.22 9.69 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 118.788 -1.165 . . . . 0.0 111.94 -179.814 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . 0.778 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 6.9 mt -64.76 -43.71 92.43 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -172.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 40.8 t -86.05 -20.43 28.8 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.677 0.751 . . . . 0.0 110.032 -177.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 104.03 -175.65 23.2 Favored Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 -171.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 417' ' ' GLN . . . . . 0.44 ' HA ' ' HE2' ' A' ' 412' ' ' MET . 34.5 mm-40 -79.85 24.2 0.41 Allowed 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.186 0.517 . . . . 0.0 111.748 -171.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 418' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -71.09 75.04 0.67 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.393 178.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 419' ' ' TYR . . . . . 0.497 ' HB2' ' CE2' ' A' ' 456' ' ' PHE . 14.0 p90 -52.22 -37.07 53.97 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.947 175.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . 0.411 ' HG3' ' H ' ' A' ' 421' ' ' LEU . 2.5 pt20 -53.7 -47.18 70.76 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.95 176.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . 0.411 ' H ' ' HG3' ' A' ' 420' ' ' GLN . 0.0 OUTLIER -68.09 -48.58 65.13 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.192 -177.005 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . 0.455 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.3 OUTLIER -66.48 -40.35 86.26 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.345 -176.584 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.772 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 77.2 p -67.33 -37.08 82.73 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 -179.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -68.51 -38.67 86.81 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.249 175.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . 0.595 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -73.44 -51.92 23.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.461 0.172 . . . . 0.0 111.235 -178.452 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . 0.636 HD13 HG23 ' A' ' 395' ' ' ILE . 1.2 mm -74.53 -22.45 17.64 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.845 0 C-N-CA 122.614 0.366 . . . . 0.0 110.092 -171.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.772 ' HB2' ' O ' ' A' ' 423' ' ' SER . 0.5 OUTLIER -54.2 -30.78 51.01 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.227 0.537 . . . . 0.0 110.26 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.92 -4.89 78.19 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.808 179.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.702 ' CZ ' ' HG3' ' A' ' 396' ' ' LYS . 23.7 m-85 -119.09 -2.12 10.81 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 121.573 0.701 . . . . 0.0 110.081 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.602 HD12 ' HD2' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -66.29 135.17 94.81 Favored Pre-proline 0 N--CA 1.439 -0.989 0 CA-C-N 114.664 -1.153 . . . . 0.0 108.881 178.84 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . 0.826 ' HD2' HG11 ' A' ' 435' ' ' VAL . 50.6 Cg_exo -36.69 -64.42 0.18 Allowed 'Trans proline' 0 CA--C 1.533 0.442 0 C-N-CA 124.723 3.615 . . . . 0.0 114.247 -172.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . 0.594 ' H ' HG12 ' A' ' 435' ' ' VAL . . . -144.17 -164.96 10.72 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 176.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . 0.48 ' O ' HG13 ' A' ' 436' ' ' VAL . 18.4 tp60 -70.47 -26.93 63.85 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 118.197 0.999 . . . . 0.0 110.347 178.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -67.46 -39.49 85.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.312 -0.404 . . . . 0.0 112.045 -177.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 435' ' ' VAL . . . . . 0.826 HG11 ' HD2' ' A' ' 431' ' ' PRO . 7.0 p -67.96 -44.99 84.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-O 120.953 0.406 . . . . 0.0 110.576 -178.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.503 HG12 ' O ' ' A' ' 432' ' ' GLY . 0.1 OUTLIER -66.06 -29.31 46.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.343 176.167 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -69.35 -52.55 26.13 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . 0.887 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -58.03 -37.99 75.39 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.57 177.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 439' ' ' LEU . . . . . 0.583 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 2.1 tm? -70.16 -47.17 62.78 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -178.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.1 -40.3 76.75 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.21 174.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 441' ' ' GLN . . . . . 0.528 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 11.0 mm-40 -53.51 -49.89 66.58 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 123.751 0.82 . . . . 0.0 110.852 173.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . 0.83 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 1.6 mmp_? -55.89 -39.75 72.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.816 171.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 443' ' ' LEU . . . . . 0.583 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 39.2 mt -72.09 -31.15 65.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.788 0.328 . . . . 0.0 110.862 -178.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -57.25 -38.29 73.6 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.773 0.796 . . . . 0.0 110.081 171.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -76.44 -25.91 54.89 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.528 -1.214 . . . . 0.0 111.96 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 446' ' ' GLU . . . . . 0.478 ' O ' ' HG3' ' A' ' 446' ' ' GLU . 14.5 pt-20 1.92 105.43 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 125.35 1.46 . . . . 0.0 114.393 -178.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 38.4 mt -58.01 -35.54 52.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.877 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . 0.493 ' HB2' ' OG1' ' A' ' 451' ' ' THR . 26.1 m-20 -164.07 -176.55 4.56 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -178.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -66.36 -67.11 0.47 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 173.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.03 -26.88 64.25 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 451' ' ' THR . . . . . 0.493 ' OG1' ' HB2' ' A' ' 448' ' ' ASP . 10.7 m -72.43 -23.81 61.13 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.046 -0.661 . . . . 0.0 110.256 -177.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 19.7 ttm180 -54.62 -53.06 59.71 Favored 'General case' 0 N--CA 1.413 -2.324 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 171.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 453' ' ' ALA . . . . . 0.493 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -58.37 -47.27 84.38 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.673 172.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . 0.421 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 16.5 mm-40 -52.31 -38.5 58.64 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.26 0.552 . . . . 0.0 111.369 -176.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 27.3 p -112.26 12.48 20.31 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.362 -176.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . 0.547 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 1.0 OUTLIER -55.5 -46.93 76.9 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.037 0.446 . . . . 0.0 111.599 -173.052 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . 0.63 HG23 ' HB1' ' A' ' 405' ' ' ALA . 2.0 mp -77.77 -34.37 19.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.022 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -57.83 -34.57 69.82 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.946 0.879 . . . . 0.0 109.203 171.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . 0.726 ' O ' HG23 ' A' ' 463' ' ' VAL . 51.3 m-70 -74.0 -28.99 61.73 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.92 176.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . 0.721 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -73.69 -34.54 64.9 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.939 0.875 . . . . 0.0 108.717 179.016 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . 0.437 ' HA ' ' CD2' ' A' ' 464' ' ' TYR . 23.5 m-80 -73.19 -38.33 66.18 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.004 176.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 462' ' ' ALA . . . . . 0.621 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -56.45 -34.91 67.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.723 169.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.887 HG13 ' HB3' ' A' ' 438' ' ' ALA . 61.5 t -59.96 -50.97 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 114.611 -1.177 . . . . 0.0 107.845 175.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 464' ' ' TYR . . . . . 0.596 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 17.2 m-30 -53.69 -28.26 32.68 Favored 'General case' 0 C--N 1.333 -0.14 0 O-C-N 124.395 1.06 . . . . 0.0 110.743 178.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.99 -41.34 20.87 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.691 0.758 . . . . 0.0 109.636 -178.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.621 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.5 mt -56.11 -55.35 18.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 114.266 -1.334 . . . . 0.0 112.345 176.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.794 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -102.16 -10.42 19.64 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -173.064 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . 0.568 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 93.86 31.4 8.19 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 119.396 -1.383 . . . . 0.0 114.348 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 469' ' ' LEU . . . . . 0.794 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 4.4 mt -88.59 164.55 15.33 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 118.01 0.905 . . . . 0.0 111.408 177.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 38.5 p30 -105.24 -176.83 3.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.827 170.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 471' ' ' ALA . . . . . 0.514 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -68.17 -13.67 62.4 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -176.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -89.02 -1.19 57.99 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 122.23 -0.294 . . . . 0.0 111.347 -175.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 78.47 12.58 84.12 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.334 -0.936 . . . . 0.0 110.898 -174.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -100.58 151.27 21.79 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 177.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . 0.527 ' OG ' ' HG3' ' A' ' 477' ' ' ARG . 31.7 t -92.26 136.69 32.98 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.241 0.543 . . . . 0.0 111.023 -177.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 476' ' ' ILE . . . . . 0.649 ' O ' ' HD2' ' A' ' 477' ' ' ARG . 2.3 pp -115.48 -29.67 2.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.087 -178.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 477' ' ' ARG . . . . . 0.649 ' HD2' ' O ' ' A' ' 476' ' ' ILE . 0.2 OUTLIER 17.46 69.88 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 O-C-N 125.164 1.54 . . . . 0.0 114.998 178.258 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 95.9 mt -89.25 40.32 0.98 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.101 -177.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.764 -0.636 . . . . 0.0 109.835 178.653 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 381' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 . . . . . 0 N--CA 1.48 1.051 0 CA-C-O 120.915 0.388 . . . . 0.0 110.414 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 382' ' ' THR . . . . . 0.556 HG23 ' HD2' ' B' ' 383' ' ' HIS . 0.0 OUTLIER -116.09 -27.95 6.75 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.21 -176.511 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 383' ' ' HIS . . . . . 0.556 ' HD2' HG23 ' B' ' 382' ' ' THR . 15.4 p80 -159.13 157.76 31.55 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.161 -0.616 . . . . 0.0 111.693 -173.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 384' ' ' GLY . . . . . . . . . . . . . . . -103.79 -115.68 4.11 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.472 -0.87 . . . . 0.0 111.116 171.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 385' ' ' THR . . . . . . . . . . . . . 33.8 m -66.69 -30.81 71.14 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.919 0.39 . . . . 0.0 111.593 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 386' ' ' PHE . . . . . 0.764 ' CD1' HD22 ' B' ' 414' ' ' LEU . 1.4 t80 -81.1 120.72 79.39 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.102 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 387' ' ' PRO . . . . . 0.479 ' HD2' ' HA ' ' B' ' 386' ' ' PHE . 9.5 Cg_endo -48.19 -69.9 0.07 OUTLIER 'Trans proline' 0 N--CA 1.484 0.921 0 C-N-CA 124.703 3.602 . . . . 0.0 115.872 -173.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 388' ' ' MET . . . . . 0.538 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 32.5 mtt 72.94 156.56 0.17 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.222 0.609 . . . . 0.0 111.162 -172.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 389' ' ' HIS . . . . . 0.56 ' CG ' ' HB2' ' B' ' 393' ' ' ASN . 32.7 m170 -54.58 -59.9 4.08 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 175.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 390' ' ' GLN . . . . . 0.4 ' H ' HD23 ' B' ' 391' ' ' LEU . 4.6 pt20 -177.23 19.77 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.649 175.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 391' ' ' LEU . . . . . 0.58 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.3 pt? -169.97 -58.37 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.451 -167.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 392' ' ' GLY . . . . . 0.615 ' HA3' HD13 ' B' ' 395' ' ' ILE . . . -172.81 51.51 0.17 Allowed Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.302 -0.951 . . . . 0.0 113.026 -172.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 393' ' ' ASN . . . . . 0.56 ' HB2' ' CG ' ' B' ' 389' ' ' HIS . 0.6 OUTLIER -57.01 -38.54 73.24 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 394' ' ' VAL . . . . . 0.709 HG12 ' CE2' ' B' ' 386' ' ' PHE . 0.9 OUTLIER -56.07 -46.45 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 395' ' ' ILE . . . . . 0.63 HG23 HD13 ' B' ' 426' ' ' ILE . 4.2 mp -57.63 -52.09 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 CA-C-O 117.973 -1.013 . . . . 0.0 113.04 -175.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 396' ' ' LYS . . . . . 0.707 ' HG3' ' CZ ' ' B' ' 429' ' ' TYR . 0.2 OUTLIER -62.49 -49.27 76.06 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 121.482 1.947 . . . . 0.0 111.8 -173.777 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -54.35 -44.89 76.35 Favored Glycine 0 N--CA 1.434 -1.487 0 C-N-CA 120.103 -1.046 . . . . 0.0 111.02 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . 0.867 HD13 HD12 ' B' ' 410' ' ' LEU . 45.0 mt -70.94 -33.81 53.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -177.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 399' ' ' VAL . . . . . 0.534 HG12 ' HA ' ' B' ' 404' ' ' VAL . 10.8 m -64.22 -39.51 85.75 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 C-N-CA 118.592 -1.243 . . . . 0.0 108.346 -175.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -70.39 -35.26 73.36 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 175.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 401' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -89.43 -47.81 7.75 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -172.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 402' ' ' GLU . . . . . 0.674 ' HG3' ' HE3' ' A' ' 413' ' ' MET . 3.0 mm-40 -121.09 -21.3 6.5 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.771 -170.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 108.02 162.25 21.0 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.954 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 404' ' ' VAL . . . . . 0.67 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.5 m -53.83 -42.56 53.21 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.809 0 N-CA-C 114.698 1.369 . . . . 0.0 114.698 -175.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 405' ' ' ALA . . . . . 0.642 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -68.82 -29.9 68.34 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 119.77 -0.772 . . . . 0.0 111.991 -175.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 406' ' ' THR . . . . . 0.687 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 92.5 m -77.59 -42.53 34.82 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.161 173.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 407' ' ' ALA . . . . . 0.462 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.3 -37.76 75.7 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 122.182 0.992 . . . . 0.0 109.295 176.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 408' ' ' TYR . . . . . 0.67 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.56 -51.86 56.65 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 113.494 -1.685 . . . . 0.0 109.747 177.12 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 409' ' ' THR . . . . . 0.666 HG22 HD23 ' B' ' 410' ' ' LEU . 10.2 m -54.84 -47.13 74.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.636 178.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 410' ' ' LEU . . . . . 0.867 HD12 HD13 ' B' ' 398' ' ' ILE . 14.3 mt -72.05 -36.91 69.73 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.972 0.415 . . . . 0.0 110.263 -174.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.63 -34.87 78.37 Favored Glycine 0 N--CA 1.439 -1.135 0 C-N-CA 120.036 -1.078 . . . . 0.0 110.52 172.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 412' ' ' MET . . . . . 0.468 ' HB2' ' O ' ' B' ' 409' ' ' THR . 0.5 OUTLIER -66.26 -46.47 76.97 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 115.64 -0.28 . . . . 0.0 111.39 177.287 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 413' ' ' MET . . . . . 0.775 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.0 OUTLIER -70.34 -55.02 10.15 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 118.709 -1.197 . . . . 0.0 111.987 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 414' ' ' LEU . . . . . 0.779 HD21 HG12 ' A' ' 398' ' ' ILE . 6.9 mt -64.97 -43.7 91.76 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -172.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 43.0 t -86.02 -20.48 28.78 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.79 0.805 . . . . 0.0 109.991 -177.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 416' ' ' GLY . . . . . . . . . . . . . . . 104.06 -175.91 23.34 Favored Glycine 0 N--CA 1.43 -1.758 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -171.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 417' ' ' GLN . . . . . 0.407 ' HA ' ' HE2' ' B' ' 412' ' ' MET . 35.4 mm-40 -79.85 24.45 0.39 Allowed 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.22 0.533 . . . . 0.0 111.808 -171.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 418' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -71.28 74.89 0.72 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.456 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 419' ' ' TYR . . . . . 0.494 ' HB2' ' CE2' ' B' ' 456' ' ' PHE . 14.4 p90 -52.09 -37.04 52.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.997 175.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 420' ' ' GLN . . . . . 0.401 ' HG3' ' H ' ' B' ' 421' ' ' LEU . 2.5 pt20 -53.67 -47.39 70.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.904 176.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 421' ' ' LEU . . . . . 0.401 ' H ' ' HG3' ' B' ' 420' ' ' GLN . 0.0 OUTLIER -67.98 -48.62 65.3 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.136 -177.011 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 422' ' ' VAL . . . . . 0.456 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.3 OUTLIER -66.51 -40.26 86.0 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.436 -176.476 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 423' ' ' SER . . . . . 0.77 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 77.7 p -67.39 -36.97 82.39 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 -179.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -68.58 -38.6 86.44 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.292 175.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 425' ' ' ILE . . . . . 0.612 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -73.37 -51.72 24.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 O-C-N 122.975 -0.132 . . . . 0.0 111.204 -178.318 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 426' ' ' ILE . . . . . 0.63 HD13 HG23 ' B' ' 395' ' ' ILE . 1.2 mm -74.87 -22.42 17.17 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.873 0 C-N-CA 122.627 0.371 . . . . 0.0 110.019 -171.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 427' ' ' ARG . . . . . 0.77 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.5 OUTLIER -54.26 -30.44 50.47 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.275 0.56 . . . . 0.0 110.294 179.85 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.88 -5.4 77.6 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.809 178.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 429' ' ' TYR . . . . . 0.707 ' CZ ' ' HG3' ' B' ' 396' ' ' LYS . 23.7 m-85 -118.9 -1.72 10.97 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 121.415 0.626 . . . . 0.0 110.152 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 430' ' ' LEU . . . . . 0.616 HD12 ' HD2' ' B' ' 431' ' ' PRO . 0.0 OUTLIER -66.42 135.38 94.72 Favored Pre-proline 0 N--CA 1.439 -0.992 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.855 178.777 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 431' ' ' PRO . . . . . 0.825 ' HD2' HG11 ' B' ' 435' ' ' VAL . 52.5 Cg_exo -36.89 -64.51 0.18 Allowed 'Trans proline' 0 CA--C 1.532 0.391 0 C-N-CA 124.716 3.611 . . . . 0.0 114.209 -172.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 432' ' ' GLY . . . . . 0.585 ' H ' HG12 ' B' ' 435' ' ' VAL . . . -144.09 -164.48 10.45 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 176.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 433' ' ' GLN . . . . . 0.487 ' O ' HG13 ' B' ' 436' ' ' VAL . 17.5 tp60 -70.67 -26.99 63.69 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 118.198 0.999 . . . . 0.0 110.369 178.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -67.64 -39.3 84.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.304 -0.407 . . . . 0.0 112.076 -177.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 435' ' ' VAL . . . . . 0.837 HG23 HG11 ' B' ' 463' ' ' VAL . 7.2 p -68.02 -45.08 84.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-O 120.962 0.411 . . . . 0.0 110.562 -178.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 436' ' ' VAL . . . . . 0.506 HG21 ' NE ' ' B' ' 427' ' ' ARG . 0.1 OUTLIER -66.01 -29.15 45.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.465 176.175 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -69.53 -52.54 25.44 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 438' ' ' ALA . . . . . 0.878 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -57.94 -37.95 75.04 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.618 177.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 439' ' ' LEU . . . . . 0.599 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 2.1 tm? -70.18 -47.23 62.48 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -178.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.99 -40.37 76.45 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.2 174.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 441' ' ' GLN . . . . . 0.528 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 10.8 mm-40 -53.53 -49.9 66.62 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 123.827 0.851 . . . . 0.0 110.747 174.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 442' ' ' ARG . . . . . 0.838 ' HG2' ' O ' ' B' ' 438' ' ' ALA . 1.5 mmp_? -55.99 -39.66 72.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.754 171.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 443' ' ' LEU . . . . . 0.599 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 39.3 mt -72.08 -31.04 65.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.795 0.331 . . . . 0.0 110.816 -178.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -57.32 -38.43 74.05 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.769 0.795 . . . . 0.0 110.028 171.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -76.49 -25.91 54.75 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.457 -1.247 . . . . 0.0 111.842 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 446' ' ' GLU . . . . . 0.485 ' O ' ' HG3' ' B' ' 446' ' ' GLU . 14.4 pt-20 2.21 105.73 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 125.292 1.437 . . . . 0.0 114.377 -178.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 39.4 mt -58.59 -35.18 53.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.028 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 448' ' ' ASP . . . . . 0.486 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 23.6 m-20 -164.23 -176.52 4.48 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 -178.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -66.72 -66.84 0.5 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 173.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.14 -26.75 64.09 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 179.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 451' ' ' THR . . . . . 0.486 ' OG1' ' HB2' ' B' ' 448' ' ' ASP . 11.3 m -72.42 -23.73 61.12 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.244 -177.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 452' ' ' ARG . . . . . . . . . . . . . 19.6 ttm180 -54.61 -53.17 58.15 Favored 'General case' 0 N--CA 1.412 -2.37 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 171.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 453' ' ' ALA . . . . . 0.489 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -58.47 -47.15 84.98 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.703 172.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 454' ' ' GLU . . . . . 0.427 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 21.9 mm-40 -52.24 -38.69 58.82 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.305 0.574 . . . . 0.0 111.313 -176.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 25.8 p -112.12 12.46 20.52 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.272 -176.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 456' ' ' PHE . . . . . 0.543 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 1.0 OUTLIER -55.57 -46.91 77.13 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.044 0.45 . . . . 0.0 111.615 -172.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 457' ' ' ILE . . . . . 0.642 HG23 ' HB1' ' B' ' 405' ' ' ALA . 2.0 mp -77.85 -34.25 19.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.097 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -58.0 -34.39 69.95 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.969 0.89 . . . . 0.0 109.265 171.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 459' ' ' HIS . . . . . 0.724 ' O ' HG23 ' B' ' 463' ' ' VAL . 52.2 m-70 -73.87 -29.24 61.98 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.943 176.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 460' ' ' LEU . . . . . 0.719 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -73.62 -34.58 65.09 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.934 0.873 . . . . 0.0 108.775 179.192 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 461' ' ' ASN . . . . . 0.441 ' HA ' ' CD2' ' B' ' 464' ' ' TYR . 22.4 m-80 -73.2 -38.09 66.24 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.142 176.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 462' ' ' ALA . . . . . 0.613 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -56.6 -35.08 67.83 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.72 169.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 463' ' ' VAL . . . . . 0.878 HG13 ' HB3' ' B' ' 438' ' ' ALA . 61.0 t -59.79 -51.11 76.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 175.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 464' ' ' TYR . . . . . 0.587 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 17.4 m-30 -53.48 -28.66 31.98 Favored 'General case' 0 C--O 1.225 -0.2 0 O-C-N 124.322 1.014 . . . . 0.0 110.648 178.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.72 -41.17 21.66 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.572 0.701 . . . . 0.0 109.701 -178.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 466' ' ' ILE . . . . . 0.613 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.5 mt -56.2 -55.66 17.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 114.409 -1.269 . . . . 0.0 112.21 176.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 467' ' ' LEU . . . . . 0.807 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -101.88 -10.6 19.71 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -172.941 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 468' ' ' GLY . . . . . 0.569 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 93.99 31.54 8.05 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 119.419 -1.372 . . . . 0.0 114.29 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 469' ' ' LEU . . . . . 0.807 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 4.4 mt -88.62 164.54 15.31 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 118.059 0.929 . . . . 0.0 111.39 177.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 38.2 p30 -105.22 -176.64 3.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.869 170.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 471' ' ' ALA . . . . . 0.52 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -68.47 -13.64 62.45 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -175.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -88.94 -1.58 58.17 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.705 0.288 . . . . 0.0 111.325 -175.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 473' ' ' GLY . . . . . . . . . . . . . . . 78.86 12.63 83.97 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.263 -0.97 . . . . 0.0 110.884 -174.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -100.59 151.61 21.4 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 475' ' ' SER . . . . . 0.546 ' OG ' ' HG3' ' B' ' 477' ' ' ARG . 32.1 t -92.56 136.55 33.12 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.239 0.542 . . . . 0.0 111.023 -177.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 476' ' ' ILE . . . . . 0.664 ' O ' ' HD2' ' B' ' 477' ' ' ARG . 2.3 pp -115.41 -29.88 2.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.115 -178.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 477' ' ' ARG . . . . . 0.664 ' HD2' ' O ' ' B' ' 476' ' ' ILE . 0.2 OUTLIER 17.59 69.45 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 178.288 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 478' ' ' LEU . . . . . . . . . . . . . 95.8 mt -89.03 40.36 0.98 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.058 -177.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 479' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.635 -0.698 . . . . 0.0 109.883 178.634 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 . . . . . 0 N--CA 1.48 1.034 0 CA-C-O 120.681 0.277 . . . . 0.0 110.304 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . 0.631 ' OG1' ' HA ' ' A' ' 391' ' ' LEU . 2.4 t -109.67 -20.79 12.7 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.768 178.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 383' ' ' HIS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 415' ' ' SER . 1.8 p80 -159.83 171.47 19.4 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.504 -174.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -118.31 -113.42 2.58 Favored Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.374 172.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 25.4 m -69.42 -41.47 76.3 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.654 0.264 . . . . 0.0 111.456 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 386' ' ' PHE . . . . . 0.8 ' CD1' HD22 ' A' ' 414' ' ' LEU . 3.4 t80 -65.68 125.77 90.39 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.247 179.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 386' ' ' PHE . 5.9 Cg_endo -47.06 -70.87 0.06 OUTLIER 'Trans proline' 0 CA--C 1.532 0.407 0 C-N-CA 123.961 3.107 . . . . 0.0 114.091 -174.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 40.7 ttm 71.98 155.77 0.16 Allowed 'General case' 0 CA--C 1.547 0.841 0 CA-C-O 121.237 0.542 . . . . 0.0 111.893 175.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 389' ' ' HIS . . . . . 0.602 ' H ' ' H ' ' A' ' 393' ' ' ASN . 2.7 m170 -76.6 27.72 0.13 Allowed 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.711 0.804 . . . . 0.0 112.917 -171.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . 0.591 ' HG2' ' O ' ' A' ' 389' ' ' HIS . 2.3 pt20 71.2 4.22 4.98 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.562 0.745 . . . . 0.0 109.902 -167.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.631 ' HA ' ' OG1' ' A' ' 382' ' ' THR . 2.1 pt? -164.57 -43.59 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . 0.597 ' HA3' HD13 ' A' ' 395' ' ' ILE . . . -175.89 55.42 0.12 Allowed Glycine 0 C--O 1.223 -0.56 0 C-N-CA 118.088 -2.006 . . . . 0.0 115.88 -176.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . 0.602 ' H ' ' H ' ' A' ' 389' ' ' HIS . 0.0 OUTLIER -60.89 -36.44 79.23 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 118.095 0.948 . . . . 0.0 108.644 176.294 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.7 HG23 HD12 ' A' ' 398' ' ' ILE . 1.5 m -58.54 -50.23 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 CA-C-N 113.289 -1.778 . . . . 0.0 107.834 178.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.633 HG23 HD13 ' A' ' 426' ' ' ILE . 4.0 mp -57.98 -52.5 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 CA-C-O 117.985 -1.007 . . . . 0.0 113.614 -174.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . 0.608 ' HG3' ' CZ ' ' A' ' 429' ' ' TYR . 0.0 OUTLIER -64.06 -48.2 77.16 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 121.736 2.062 . . . . 0.0 111.493 -173.82 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -54.0 -45.33 71.94 Favored Glycine 0 N--CA 1.431 -1.636 0 C-N-CA 119.846 -1.169 . . . . 0.0 111.044 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . 0.733 HD13 HD12 ' A' ' 410' ' ' LEU . 33.2 mt -70.87 -33.87 53.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -178.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . 0.492 HG22 ' O ' ' A' ' 396' ' ' LYS . 15.3 m -63.75 -39.43 85.34 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 C-N-CA 118.685 -1.206 . . . . 0.0 108.41 -174.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -71.11 -35.24 71.71 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 175.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.471 HE21 ' HB3' ' A' ' 401' ' ' GLN . 3.8 mm100 -88.69 -48.07 7.8 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -172.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . 0.506 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 2.7 mm-40 -121.22 -21.36 6.42 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.601 -169.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 108.41 162.61 20.72 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.953 -0.642 . . . . 0.0 113.128 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . 0.674 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.5 m -53.67 -41.86 48.74 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.794 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -176.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . 0.59 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -68.88 -30.96 69.58 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 119.566 -0.854 . . . . 0.0 111.773 -176.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.718 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 89.0 m -77.38 -42.56 35.96 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.174 -0.611 . . . . 0.0 110.3 173.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.447 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -58.26 -37.22 74.53 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 122.054 0.931 . . . . 0.0 109.263 176.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 408' ' ' TYR . . . . . 0.674 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.77 -52.12 53.51 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 113.558 -1.655 . . . . 0.0 109.761 176.387 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 409' ' ' THR . . . . . 0.666 HG22 HD23 ' A' ' 410' ' ' LEU . 16.0 m -55.32 -47.37 75.74 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.635 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . 0.733 HD12 HD13 ' A' ' 398' ' ' ILE . 14.9 mt -72.65 -36.87 68.08 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -174.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.66 -34.96 78.96 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 119.83 -1.176 . . . . 0.0 110.641 173.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 412' ' ' MET . . . . . 0.407 ' HB2' ' O ' ' A' ' 409' ' ' THR . 0.3 OUTLIER -66.83 -48.67 68.2 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-O 120.597 0.236 . . . . 0.0 111.475 178.033 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 413' ' ' MET . . . . . 0.933 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.8 OUTLIER -71.35 -44.26 65.38 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 119.022 -1.071 . . . . 0.0 112.037 -178.552 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . 0.933 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 17.6 mt -69.02 -45.22 71.04 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -176.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 383' ' ' HIS . 45.5 t -86.45 -24.63 25.57 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.819 0.818 . . . . 0.0 110.099 -176.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 108.93 -174.82 18.81 Favored Glycine 0 N--CA 1.429 -1.779 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -170.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -80.54 23.54 0.51 Allowed 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.244 0.545 . . . . 0.0 111.587 -171.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 418' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -72.0 75.28 0.92 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.064 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 419' ' ' TYR . . . . . 0.521 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 9.4 p90 -51.1 -39.03 55.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.493 176.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -55.32 -43.99 75.42 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.672 0.272 . . . . 0.0 110.99 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.37 -48.98 63.33 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.073 -178.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . 0.432 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -66.49 -40.67 87.06 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.522 0 C-N-CA 120.409 -0.517 . . . . 0.0 111.299 -177.021 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.793 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 77.6 p -68.09 -36.66 80.16 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -178.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -69.67 -37.95 77.25 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.253 175.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . 0.615 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -73.14 -51.92 24.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 O-C-N 122.82 -0.224 . . . . 0.0 111.048 -178.638 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . 0.674 HG22 HD22 ' A' ' 430' ' ' LEU . 1.2 mm -74.09 -22.68 18.31 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.756 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -172.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.793 ' HB2' ' O ' ' A' ' 423' ' ' SER . 0.8 OUTLIER -54.61 -29.71 52.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.157 0.503 . . . . 0.0 110.484 -179.263 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -88.94 -6.57 71.89 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.693 178.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.608 ' CZ ' ' HG3' ' A' ' 396' ' ' LYS . 22.4 m-85 -117.27 -0.09 12.12 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.095 0.474 . . . . 0.0 110.221 -178.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.674 HD22 HG22 ' A' ' 426' ' ' ILE . 0.1 OUTLIER -66.15 129.13 94.19 Favored Pre-proline 0 N--CA 1.441 -0.876 0 CA-C-N 115.353 -0.84 . . . . 0.0 108.857 177.584 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . 0.554 ' HG3' ' O ' ' A' ' 473' ' ' GLY . 73.4 Cg_exo -25.46 -69.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.757 1 C-N-CA 125.318 4.012 . . . . 0.0 114.911 179.68 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . 0.526 ' O ' HG12 ' A' ' 435' ' ' VAL . . . -144.07 -165.8 11.09 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 110.061 -1.215 . . . . 0.0 110.061 177.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . 0.465 ' O ' HG13 ' A' ' 436' ' ' VAL . 15.8 tp60 -69.62 -27.58 65.19 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 118.127 0.964 . . . . 0.0 110.449 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -67.32 -39.78 85.91 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -176.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 435' ' ' VAL . . . . . 0.679 HG23 HG11 ' A' ' 463' ' ' VAL . 8.8 p -68.49 -44.26 83.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-O 121.107 0.479 . . . . 0.0 110.48 -177.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.491 HG12 ' O ' ' A' ' 432' ' ' GLY . 0.1 OUTLIER -66.95 -31.46 53.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.399 175.305 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.23 -52.45 40.81 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -178.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . 0.817 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -57.74 -40.05 78.74 Favored 'General case' 0 N--CA 1.439 -1.023 0 O-C-N 123.883 0.739 . . . . 0.0 111.992 177.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 439' ' ' LEU . . . . . 0.594 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 2.0 tm? -68.3 -48.74 64.13 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -178.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.27 -34.97 72.9 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.442 -1.254 . . . . 0.0 111.135 175.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 441' ' ' GLN . . . . . 0.543 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 3.8 mm-40 -53.39 -49.88 66.31 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.106 -178.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . 0.693 ' HG3' ' CG ' ' A' ' 459' ' ' HIS . 0.0 OUTLIER -76.18 -25.03 54.78 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 119.361 -0.936 . . . . 0.0 113.248 174.898 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 443' ' ' LEU . . . . . 0.594 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 56.2 mt -65.3 -33.72 76.65 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.421 0.629 . . . . 0.0 109.718 175.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -70.57 -33.88 71.6 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.114 -178.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 445' ' ' GLN . . . . . 0.402 ' HG3' ' N ' ' A' ' 446' ' ' GLU . 0.0 OUTLIER -75.29 -31.15 60.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 114.673 -1.149 . . . . 0.0 108.321 178.43 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 446' ' ' GLU . . . . . 0.402 ' N ' ' HG3' ' A' ' 445' ' ' GLN . 34.9 tt0 48.09 98.47 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 114.812 -1.085 . . . . 0.0 113.2 171.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 60.9 mt -65.82 -35.67 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 121.667 0.746 . . . . 0.0 109.785 176.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . 0.538 ' O ' ' HG3' ' A' ' 452' ' ' ARG . 18.7 m-20 -169.83 -175.94 2.22 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 -177.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -72.16 -67.83 0.51 Allowed 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.6 174.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 450' ' ' GLN . . . . . 0.404 ' HG3' ' H ' ' A' ' 450' ' ' GLN . 0.0 OUTLIER -66.46 -25.46 66.73 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 178.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 451' ' ' THR . . . . . 0.524 ' OG1' ' HB2' ' A' ' 448' ' ' ASP . 15.3 m -71.13 -23.02 62.0 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.702 -173.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . 0.538 ' HG3' ' O ' ' A' ' 448' ' ' ASP . 55.7 mtm180 -55.06 -54.15 46.75 Favored 'General case' 0 C--O 1.218 -0.553 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 170.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 453' ' ' ALA . . . . . 0.521 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -56.99 -48.03 79.42 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 124.278 0.986 . . . . 0.0 112.571 174.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . 0.422 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 63.9 mm-40 -51.34 -37.49 48.1 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.312 0.577 . . . . 0.0 111.693 -177.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 24.6 p -119.13 16.28 13.23 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.187 -175.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . 0.515 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.9 OUTLIER -55.19 -47.33 75.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.12 0.486 . . . . 0.0 111.728 -171.58 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . 0.59 HG23 ' HB1' ' A' ' 405' ' ' ALA . 1.9 mp -77.11 -34.43 21.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.257 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -57.54 -34.09 68.78 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.891 0.853 . . . . 0.0 109.288 171.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . 0.758 ' O ' HG23 ' A' ' 463' ' ' VAL . 52.8 m-70 -73.76 -29.33 62.15 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.357 -1.292 . . . . 0.0 110.926 176.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . 0.714 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -73.59 -33.96 64.86 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.863 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -73.05 -38.12 66.61 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.345 175.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 462' ' ' ALA . . . . . 0.613 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -55.82 -34.0 64.98 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.691 169.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.817 HG13 ' HB3' ' A' ' 438' ' ' ALA . 62.6 t -62.8 -50.22 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 CA-C-N 114.363 -1.289 . . . . 0.0 107.996 177.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 464' ' ' TYR . . . . . 0.545 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 14.8 m-30 -53.8 -27.67 30.65 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.66 178.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.31 -40.83 20.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.635 0.731 . . . . 0.0 109.476 -178.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.613 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.6 mt -57.3 -55.63 19.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 114.174 -1.375 . . . . 0.0 112.196 176.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.782 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -102.51 -10.65 19.16 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -172.517 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 93.9 32.22 7.68 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 119.114 -1.517 . . . . 0.0 114.201 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 469' ' ' LEU . . . . . 0.782 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.5 mt -88.45 162.2 16.61 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 117.889 0.844 . . . . 0.0 111.378 176.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 37.7 p30 -100.72 -177.76 3.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.651 170.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 471' ' ' ALA . . . . . 0.503 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -69.43 -12.4 61.62 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.557 0.576 . . . . 0.0 112.557 -176.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -89.12 2.03 54.74 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.79 0.329 . . . . 0.0 111.219 -175.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . 0.554 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 76.42 12.6 84.15 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -175.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -101.67 150.43 23.12 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 177.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 469' ' ' LEU . 30.7 t -86.59 138.15 31.93 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.025 -0.67 . . . . 0.0 109.819 175.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 476' ' ' ILE . . . . . 0.637 HD12 ' N ' ' A' ' 477' ' ' ARG . 2.4 pp -103.84 -14.51 8.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.849 178.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 477' ' ' ARG . . . . . 0.637 ' N ' HD12 ' A' ' 476' ' ' ILE . 0.0 OUTLIER 59.23 -81.65 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 114.48 -1.236 . . . . 0.0 111.544 178.187 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 45.7 tp -143.36 83.66 1.79 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 177.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 . . . . . 0 C--O 1.253 1.24 0 CA-C-O 118.608 -0.711 . . . . 0.0 110.371 -177.397 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 381' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 . . . . . 0 N--CA 1.482 1.129 0 N-CA-C 110.197 -0.298 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 382' ' ' THR . . . . . 0.632 ' OG1' ' HA ' ' B' ' 391' ' ' LEU . 2.1 t -110.24 -20.77 12.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.662 178.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 383' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -159.77 171.58 19.25 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.571 -175.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 384' ' ' GLY . . . . . . . . . . . . . . . -118.37 -113.32 2.57 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.406 172.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 385' ' ' THR . . . . . . . . . . . . . 24.7 m -69.51 -41.48 75.97 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.816 0.341 . . . . 0.0 111.516 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 386' ' ' PHE . . . . . 0.793 ' CD1' HD22 ' B' ' 414' ' ' LEU . 3.3 t80 -65.73 125.7 90.3 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.273 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 387' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' B' ' 386' ' ' PHE . 5.9 Cg_endo -46.98 -70.88 0.06 OUTLIER 'Trans proline' 0 N--CA 1.475 0.424 0 C-N-CA 123.914 3.076 . . . . 0.0 114.101 -174.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 388' ' ' MET . . . . . . . . . . . . . 40.6 ttm 71.95 155.53 0.15 Allowed 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.265 0.555 . . . . 0.0 111.852 175.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 389' ' ' HIS . . . . . 0.606 ' H ' ' H ' ' B' ' 393' ' ' ASN . 2.6 m170 -76.37 27.83 0.12 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.674 0.79 . . . . 0.0 112.941 -171.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 390' ' ' GLN . . . . . 0.591 ' HG2' ' O ' ' B' ' 389' ' ' HIS . 2.4 pt20 71.31 3.88 4.84 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.509 0.724 . . . . 0.0 109.884 -168.072 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 391' ' ' LEU . . . . . 0.632 ' HA ' ' OG1' ' B' ' 382' ' ' THR . 2.1 pt? -164.31 -43.55 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 392' ' ' GLY . . . . . 0.6 ' HA3' HD13 ' B' ' 395' ' ' ILE . . . -175.81 55.39 0.12 Allowed Glycine 0 C--N 1.336 0.576 0 C-N-CA 118.037 -2.03 . . . . 0.0 115.792 -176.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 393' ' ' ASN . . . . . 0.606 ' H ' ' H ' ' B' ' 389' ' ' HIS . 0.0 OUTLIER -60.81 -36.6 79.47 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 118.217 1.008 . . . . 0.0 108.586 176.307 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 394' ' ' VAL . . . . . 0.723 HG23 HD12 ' B' ' 398' ' ' ILE . 1.5 m -58.36 -50.16 79.56 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 CA-C-N 113.306 -1.77 . . . . 0.0 107.904 178.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 395' ' ' ILE . . . . . 0.632 HG21 HG22 ' B' ' 425' ' ' ILE . 4.0 mp -58.07 -52.58 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 CA-C-O 118.005 -0.998 . . . . 0.0 113.568 -173.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 396' ' ' LYS . . . . . 0.607 ' HG3' ' CZ ' ' B' ' 429' ' ' TYR . 0.0 OUTLIER -63.96 -48.35 76.81 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 121.65 2.023 . . . . 0.0 111.464 -173.8 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.75 -45.31 69.49 Favored Glycine 0 N--CA 1.432 -1.583 0 C-N-CA 119.9 -1.143 . . . . 0.0 110.961 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . 0.737 HD13 HD12 ' B' ' 410' ' ' LEU . 33.4 mt -70.93 -33.98 54.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -178.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 399' ' ' VAL . . . . . 0.499 HG22 ' O ' ' B' ' 396' ' ' LYS . 15.3 m -63.73 -39.48 85.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 C-N-CA 118.796 -1.161 . . . . 0.0 108.475 -174.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -70.82 -35.59 72.55 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 175.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 401' ' ' GLN . . . . . 0.413 HE21 ' HB3' ' B' ' 401' ' ' GLN . 3.7 mm100 -88.7 -48.1 7.77 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -172.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 402' ' ' GLU . . . . . 0.472 ' HG3' ' HE3' ' A' ' 413' ' ' MET . 2.7 mm-40 -121.02 -21.48 6.48 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.727 -170.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 108.82 162.89 20.4 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.085 -0.579 . . . . 0.0 113.006 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 404' ' ' VAL . . . . . 0.664 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.5 m -53.76 -41.85 49.55 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.719 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 -176.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 405' ' ' ALA . . . . . 0.591 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -68.9 -30.7 69.24 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 119.797 -0.761 . . . . 0.0 111.855 -176.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 406' ' ' THR . . . . . 0.72 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 90.7 m -77.81 -42.78 32.61 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.068 174.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 407' ' ' ALA . . . . . 0.45 ' HB2' ' HB ' ' B' ' 398' ' ' ILE . . . -58.33 -37.13 74.5 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 122.078 0.942 . . . . 0.0 109.18 176.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 408' ' ' TYR . . . . . 0.664 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -66.0 -52.08 52.52 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 113.595 -1.639 . . . . 0.0 109.725 176.43 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 409' ' ' THR . . . . . 0.664 HG22 HD23 ' B' ' 410' ' ' LEU . 15.9 m -55.33 -47.31 75.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.675 179.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 410' ' ' LEU . . . . . 0.737 HD12 HD13 ' B' ' 398' ' ' ILE . 15.0 mt -72.71 -36.82 67.89 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -174.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.67 -34.81 78.43 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 119.868 -1.158 . . . . 0.0 110.629 173.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 412' ' ' MET . . . . . 0.403 ' HB2' ' O ' ' B' ' 409' ' ' THR . 0.3 OUTLIER -67.05 -48.52 68.04 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-O 120.634 0.254 . . . . 0.0 111.387 178.19 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 413' ' ' MET . . . . . 0.924 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.8 OUTLIER -71.47 -44.29 65.02 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 119.009 -1.076 . . . . 0.0 112.16 -178.706 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 414' ' ' LEU . . . . . 0.924 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 17.7 mt -68.93 -45.5 70.65 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -176.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 47.0 t -86.05 -24.88 26.18 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.641 0.734 . . . . 0.0 110.004 -176.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 416' ' ' GLY . . . . . . . . . . . . . . . 109.17 -174.57 18.37 Favored Glycine 0 N--CA 1.43 -1.734 0 N-CA-C 109.731 -1.347 . . . . 0.0 109.731 -170.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -80.83 23.31 0.55 Allowed 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.287 0.565 . . . . 0.0 111.535 -171.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 418' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -71.94 75.13 0.9 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.102 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 419' ' ' TYR . . . . . 0.525 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 9.1 p90 -51.04 -38.94 54.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.572 176.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -55.37 -43.95 75.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.737 0.304 . . . . 0.0 111.092 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.29 -48.98 63.53 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.11 -178.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 422' ' ' VAL . . . . . 0.433 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.2 OUTLIER -66.46 -40.84 87.51 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.278 -176.959 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 423' ' ' SER . . . . . 0.785 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 77.3 p -67.97 -36.63 80.37 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -178.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -69.62 -38.22 77.97 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.225 176.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 425' ' ' ILE . . . . . 0.632 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -73.02 -51.8 24.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 O-C-N 122.865 -0.197 . . . . 0.0 111.083 -178.52 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 426' ' ' ILE . . . . . 0.669 HG22 HD22 ' B' ' 430' ' ' LEU . 1.2 mm -74.08 -22.64 18.32 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.796 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -172.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 427' ' ' ARG . . . . . 0.785 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.8 OUTLIER -54.58 -29.85 52.62 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.21 0.529 . . . . 0.0 110.561 -179.251 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -88.58 -7.25 72.22 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.729 178.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 429' ' ' TYR . . . . . 0.607 ' CZ ' ' HG3' ' B' ' 396' ' ' LYS . 22.3 m-85 -116.63 -0.26 12.44 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 121.271 0.557 . . . . 0.0 110.295 -178.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 430' ' ' LEU . . . . . 0.669 HD22 HG22 ' B' ' 426' ' ' ILE . 0.1 OUTLIER -66.08 129.04 94.19 Favored Pre-proline 0 N--CA 1.442 -0.842 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.867 177.807 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 431' ' ' PRO . . . . . 0.563 ' HG3' ' O ' ' B' ' 473' ' ' GLY . 75.1 Cg_exo -25.33 -68.86 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 125.283 3.989 . . . . 0.0 114.919 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 432' ' ' GLY . . . . . 0.532 ' O ' HG12 ' B' ' 435' ' ' VAL . . . -144.52 -165.82 11.22 Favored Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 177.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 433' ' ' GLN . . . . . 0.469 ' O ' HG13 ' B' ' 436' ' ' VAL . 15.5 tp60 -69.39 -27.74 65.56 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 118.156 0.978 . . . . 0.0 110.507 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -67.07 -39.89 86.95 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -176.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 435' ' ' VAL . . . . . 0.666 HG23 HG11 ' B' ' 463' ' ' VAL . 8.8 p -68.66 -44.01 82.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-O 121.013 0.435 . . . . 0.0 110.558 -177.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 436' ' ' VAL . . . . . 0.487 HG12 ' O ' ' B' ' 432' ' ' GLY . 0.1 OUTLIER -66.99 -31.4 53.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.431 175.075 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.23 -52.52 40.05 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -178.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 438' ' ' ALA . . . . . 0.812 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -57.9 -39.93 79.1 Favored 'General case' 0 N--CA 1.439 -1.01 0 O-C-N 123.902 0.751 . . . . 0.0 111.969 177.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 439' ' ' LEU . . . . . 0.603 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 2.0 tm? -68.36 -48.73 64.03 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -178.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.22 -35.02 72.89 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.484 -1.234 . . . . 0.0 111.202 175.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 441' ' ' GLN . . . . . 0.537 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 3.8 mm-40 -53.34 -50.04 65.84 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.052 -178.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 442' ' ' ARG . . . . . 0.708 ' HG3' ' CG ' ' B' ' 459' ' ' HIS . 0.0 OUTLIER -75.95 -25.11 55.62 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 119.377 -0.929 . . . . 0.0 113.198 174.892 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 443' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 56.5 mt -65.3 -33.84 76.94 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.289 0.566 . . . . 0.0 109.558 175.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -70.37 -34.2 72.32 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.942 -178.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 445' ' ' GLN . . . . . 0.401 ' HG3' ' N ' ' B' ' 446' ' ' GLU . 0.0 OUTLIER -75.1 -31.07 61.06 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.294 178.699 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 446' ' ' GLU . . . . . 0.401 ' N ' ' HG3' ' B' ' 445' ' ' GLN . 34.6 tt0 48.09 98.69 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 114.818 -1.083 . . . . 0.0 113.143 171.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 61.1 mt -65.97 -35.79 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 121.712 0.768 . . . . 0.0 109.811 176.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 448' ' ' ASP . . . . . 0.544 ' O ' ' HG3' ' B' ' 452' ' ' ARG . 17.1 m-20 -169.66 -176.02 2.3 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 -177.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -71.76 -67.77 0.51 Allowed 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.535 173.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.87 -25.34 66.36 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 451' ' ' THR . . . . . 0.52 ' OG1' ' HB2' ' B' ' 448' ' ' ASP . 15.9 m -71.1 -22.92 62.03 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.756 -173.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 452' ' ' ARG . . . . . 0.544 ' HG3' ' O ' ' B' ' 448' ' ' ASP . 55.9 mtm180 -55.21 -54.14 47.16 Favored 'General case' 0 C--O 1.219 -0.525 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 170.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 453' ' ' ALA . . . . . 0.525 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -56.93 -48.14 78.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.576 173.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 454' ' ' GLU . . . . . 0.424 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 65.1 mm-40 -51.18 -37.84 48.85 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.263 0.554 . . . . 0.0 111.572 -177.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 25.2 p -118.81 16.24 13.51 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.335 -175.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 456' ' ' PHE . . . . . 0.519 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 0.9 OUTLIER -55.15 -47.08 75.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.142 0.496 . . . . 0.0 111.747 -171.708 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 457' ' ' ILE . . . . . 0.591 HG23 ' HB1' ' B' ' 405' ' ' ALA . 1.9 mp -77.33 -34.3 20.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.198 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -57.68 -34.19 69.15 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.88 0.847 . . . . 0.0 109.234 172.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 459' ' ' HIS . . . . . 0.755 ' O ' HG23 ' B' ' 463' ' ' VAL . 51.5 m-70 -73.61 -29.25 62.27 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.981 176.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 460' ' ' LEU . . . . . 0.709 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -73.64 -33.96 64.75 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.765 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 461' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -72.94 -38.43 66.79 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.195 175.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 462' ' ' ALA . . . . . 0.622 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -55.78 -33.8 64.69 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.76 169.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 463' ' ' VAL . . . . . 0.812 HG13 ' HB3' ' B' ' 438' ' ' ALA . 62.9 t -62.91 -50.15 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.008 177.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 464' ' ' TYR . . . . . 0.539 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 15.0 m-30 -53.79 -27.82 31.43 Favored 'General case' 0 C--N 1.332 -0.193 0 O-C-N 124.237 0.961 . . . . 0.0 110.599 178.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.27 -40.86 20.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.693 0.758 . . . . 0.0 109.359 -177.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 466' ' ' ILE . . . . . 0.622 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.6 mt -57.23 -55.6 19.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 114.305 -1.316 . . . . 0.0 112.19 176.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 467' ' ' LEU . . . . . 0.782 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -102.69 -10.63 19.04 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -172.389 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 468' ' ' GLY . . . . . . . . . . . . . . . 93.92 32.24 7.66 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 119.013 -1.565 . . . . 0.0 114.304 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 469' ' ' LEU . . . . . 0.782 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.5 mt -88.58 162.27 16.47 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 117.915 0.857 . . . . 0.0 111.249 177.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 37.6 p30 -100.86 -177.75 3.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.587 170.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 471' ' ' ALA . . . . . 0.51 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -69.81 -11.5 60.9 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -176.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -89.34 1.95 55.07 Favored 'General case' 0 C--N 1.32 -0.682 0 O-C-N 122.262 -0.273 . . . . 0.0 111.213 -176.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 473' ' ' GLY . . . . . 0.563 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 76.43 12.48 84.26 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 -175.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -101.61 150.56 22.97 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 475' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' B' ' 469' ' ' LEU . 32.3 t -86.81 137.7 32.2 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.147 -0.621 . . . . 0.0 109.893 175.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 476' ' ' ILE . . . . . 0.643 HD12 ' N ' ' B' ' 477' ' ' ARG . 2.4 pp -103.52 -14.51 8.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.923 179.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 477' ' ' ARG . . . . . 0.643 ' N ' HD12 ' B' ' 476' ' ' ILE . 0.0 OUTLIER 59.32 -81.88 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 114.494 -1.23 . . . . 0.0 111.477 178.088 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 478' ' ' LEU . . . . . . . . . . . . . 45.5 tp -143.2 83.34 1.78 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 479' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 . . . . . 0 C--O 1.246 0.88 0 CA-C-O 118.478 -0.772 . . . . 0.0 110.31 -177.646 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 . . . . . 0 N--CA 1.481 1.121 0 CA-C-O 121.18 0.514 . . . . 0.0 111.348 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 1.2 t -77.58 -46.41 22.29 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.536 176.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -86.18 56.27 3.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.296 0.57 . . . . 0.0 110.871 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -99.07 88.75 0.85 Allowed Glycine 0 N--CA 1.442 -0.961 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.762 -178.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 24.4 m 71.57 -60.34 0.52 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.058 0.543 . . . . 0.0 110.971 -178.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 386' ' ' PHE . . . . . 0.717 ' CD1' HD22 ' A' ' 414' ' ' LEU . 2.9 t80 -75.95 126.34 87.04 Favored Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 172.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 386' ' ' PHE . 1.3 Cg_endo -43.01 -75.36 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.821 3.014 . . . . 0.0 113.892 -175.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 28.5 ttm 67.22 143.43 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.607 0 O-C-N 123.397 0.435 . . . . 0.0 110.305 -178.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 389' ' ' HIS . . . . . 0.632 ' H ' ' HB3' ' A' ' 393' ' ' ASN . 29.3 m170 -54.85 -79.24 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.694 0.759 . . . . 0.0 110.076 -174.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . 0.407 ' H ' HD23 ' A' ' 391' ' ' LEU . 13.9 pt20 -153.46 19.35 0.55 Allowed 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 170.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.515 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.6 pt? -173.9 -48.54 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.837 -170.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . 0.621 ' HA3' HD13 ' A' ' 395' ' ' ILE . . . -172.48 53.88 0.17 Allowed Glycine 0 C--O 1.223 -0.593 0 C-N-CA 118.81 -1.662 . . . . 0.0 115.305 -171.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . 0.632 ' HB3' ' H ' ' A' ' 389' ' ' HIS . 0.0 OUTLIER -57.34 -38.06 73.51 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 118.361 1.081 . . . . 0.0 108.869 176.273 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.627 HG23 HD12 ' A' ' 398' ' ' ILE . 1.9 m -58.23 -49.52 81.48 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 CA-C-N 113.189 -1.823 . . . . 0.0 107.77 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.676 HG23 HD13 ' A' ' 426' ' ' ILE . 4.2 mp -58.26 -52.8 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 CA-C-O 117.97 -1.014 . . . . 0.0 113.462 -174.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . 0.638 ' HG3' ' CZ ' ' A' ' 429' ' ' TYR . 0.1 OUTLIER -63.91 -48.93 74.65 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 121.796 2.089 . . . . 0.0 112.024 -172.865 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -54.02 -45.26 72.36 Favored Glycine 0 N--CA 1.438 -1.181 0 C-N-CA 119.88 -1.153 . . . . 0.0 111.238 -178.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . 0.722 ' CD1' HD12 ' A' ' 410' ' ' LEU . 33.6 mt -71.04 -34.56 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -178.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . 0.517 HG12 ' HA ' ' A' ' 404' ' ' VAL . 11.7 m -63.68 -39.68 86.25 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 C-N-CA 119.05 -1.06 . . . . 0.0 108.728 -173.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -67.4 -39.9 85.58 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 176.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -93.43 -50.73 5.3 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -170.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . 0.402 ' HG2' HG21 ' A' ' 406' ' ' THR . 16.1 tp10 -108.87 -20.19 13.14 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.227 0.537 . . . . 0.0 110.461 -172.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 105.44 162.5 23.46 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.548 -0.751 . . . . 0.0 113.159 177.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . 0.616 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.5 m -52.98 -45.59 52.34 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.738 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -175.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . 0.529 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -64.93 -30.06 71.03 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 119.793 -0.763 . . . . 0.0 112.488 -177.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.71 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 86.2 m -77.45 -42.42 36.05 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 120.096 -0.642 . . . . 0.0 110.216 173.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.5 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.86 -37.23 76.04 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 122.252 1.025 . . . . 0.0 109.043 177.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 408' ' ' TYR . . . . . 0.616 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.31 -52.95 50.64 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 113.364 -1.744 . . . . 0.0 109.889 176.687 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 409' ' ' THR . . . . . 0.692 HG22 HD23 ' A' ' 410' ' ' LEU . 9.0 m -55.58 -47.17 76.88 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.395 -0.821 . . . . 0.0 112.557 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . 0.722 HD12 ' CD1' ' A' ' 398' ' ' ILE . 14.5 mt -72.4 -36.32 68.62 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.055 -175.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -60.0 -35.2 86.48 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 119.973 -1.108 . . . . 0.0 110.789 172.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -67.98 -46.55 71.05 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 115.812 -0.194 . . . . 0.0 111.399 178.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 413' ' ' MET . . . . . 0.897 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.4 OUTLIER -70.62 -48.95 52.49 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 118.834 -1.147 . . . . 0.0 111.821 179.691 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . 0.897 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 16.0 mt -68.38 -46.69 69.35 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -176.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 14.6 t -92.9 -1.86 56.35 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.297 0.57 . . . . 0.0 110.063 -173.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . 0.407 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 93.1 -177.55 38.27 Favored Glycine 0 N--CA 1.434 -1.485 0 C-N-CA 120.395 -0.907 . . . . 0.0 110.916 -176.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -79.98 23.36 0.46 Allowed 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.126 0.488 . . . . 0.0 111.31 -172.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 418' ' ' ASN . . . . . 0.407 ' H ' ' C ' ' A' ' 416' ' ' GLY . 5.5 m-20 -71.61 76.0 0.81 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.612 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 419' ' ' TYR . . . . . 0.544 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 11.1 p90 -51.41 -38.55 54.07 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.366 176.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -55.29 -43.79 75.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.671 0.272 . . . . 0.0 110.919 178.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.47 -49.17 61.75 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.949 -177.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . 0.445 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.3 OUTLIER -66.84 -40.36 85.68 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.214 -176.954 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.743 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 79.2 p -66.98 -38.91 86.92 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.38 -39.5 91.62 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.255 176.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . 0.636 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -73.06 -50.82 29.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 121.223 -0.191 . . . . 0.0 111.032 -177.234 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . 0.676 HD13 HG23 ' A' ' 395' ' ' ILE . 1.2 mm -74.96 -22.52 17.07 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.823 0 CA-C-O 120.886 0.374 . . . . 0.0 110.27 -172.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.743 ' HB2' ' O ' ' A' ' 423' ' ' SER . 0.8 OUTLIER -55.02 -30.13 58.88 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.217 0.532 . . . . 0.0 110.64 -179.008 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.74 -6.06 77.08 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.638 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.638 ' CZ ' ' HG3' ' A' ' 396' ' ' LYS . 22.9 m-85 -118.23 0.54 11.75 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 120.977 0.418 . . . . 0.0 110.665 -177.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.678 HD23 ' HA ' ' A' ' 427' ' ' ARG . 0.1 OUTLIER -65.71 128.2 93.63 Favored Pre-proline 0 N--CA 1.441 -0.907 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 179.032 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . 0.455 ' HG3' ' O ' ' A' ' 473' ' ' GLY . 80.8 Cg_exo -23.87 -69.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.905 1 C-N-CA 125.514 4.143 . . . . 0.0 114.857 179.887 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . 0.51 ' O ' HG12 ' A' ' 435' ' ' VAL . . . -138.8 -166.9 10.78 Favored Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 174.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . 0.506 ' O ' HG13 ' A' ' 436' ' ' VAL . 50.3 tp60 -70.8 -26.88 63.52 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 118.241 1.021 . . . . 0.0 110.457 177.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -64.75 -39.51 93.75 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -177.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 435' ' ' VAL . . . . . 0.794 HG23 HG11 ' A' ' 463' ' ' VAL . 7.5 p -68.72 -43.94 82.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-O 120.968 0.413 . . . . 0.0 110.501 -178.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.506 HG13 ' O ' ' A' ' 433' ' ' GLN . 0.1 OUTLIER -67.15 -30.29 48.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.668 175.579 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.48 -51.91 45.6 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . 0.827 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -57.0 -43.93 82.27 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.003 177.094 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 439' ' ' LEU . . . . . 0.634 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 2.1 tm? -64.69 -47.64 77.64 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 -176.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.86 -39.7 78.4 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.81 -1.086 . . . . 0.0 111.362 175.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 441' ' ' GLN . . . . . 0.607 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 9.2 mm-40 -55.59 -51.25 67.76 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 123.473 0.709 . . . . 0.0 110.83 175.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . 0.77 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -58.13 -33.81 69.55 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.798 173.174 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 443' ' ' LEU . . . . . 0.634 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 57.1 mt -72.25 -36.6 69.1 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-O 120.865 0.364 . . . . 0.0 110.227 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -57.49 -37.58 73.18 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.607 0.717 . . . . 0.0 110.67 174.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -73.2 -26.77 61.29 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.238 177.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 446' ' ' GLU . . . . . 0.453 ' HB3' ' O ' ' A' ' 443' ' ' LEU . 7.4 pt-20 23.7 103.13 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 173.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 60.3 mt -62.21 -34.1 62.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.577 0.703 . . . . 0.0 110.13 176.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . 0.5 ' HB2' ' OG1' ' A' ' 451' ' ' THR . 17.8 m-20 -162.8 -159.43 0.56 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -84.45 -66.35 0.9 Allowed 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 171.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 450' ' ' GLN . . . . . 0.513 ' O ' ' HB3' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -70.91 -25.54 62.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.855 0.359 . . . . 0.0 111.895 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 451' ' ' THR . . . . . 0.5 ' OG1' ' HB2' ' A' ' 448' ' ' ASP . 12.4 m -67.4 -22.54 65.54 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 122.037 -0.414 . . . . 0.0 110.679 -178.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 66.4 mtm180 -54.99 -51.37 66.45 Favored 'General case' 0 C--O 1.216 -0.66 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 170.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 453' ' ' ALA . . . . . 0.544 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -53.41 -52.24 60.01 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 124.352 1.033 . . . . 0.0 112.293 173.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . 0.435 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 23.6 mm-40 -51.15 -32.44 23.11 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.255 0.55 . . . . 0.0 111.987 -178.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 28.7 p -119.69 14.36 12.6 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.972 -175.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . 0.535 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.8 OUTLIER -58.37 -47.57 83.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.383 -170.995 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . 0.529 HG23 ' HB1' ' A' ' 405' ' ' ALA . 1.9 mp -77.21 -31.42 18.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.08 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -56.47 -39.01 72.48 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 122.025 0.917 . . . . 0.0 108.689 170.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . 0.735 ' O ' HG23 ' A' ' 463' ' ' VAL . 50.3 m-70 -73.22 -28.07 61.97 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 114.179 -1.373 . . . . 0.0 110.381 -178.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . 0.74 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -74.46 -35.11 63.31 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.864 0.84 . . . . 0.0 108.886 178.391 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . 0.42 ' O ' ' HB2' ' A' ' 464' ' ' TYR . 23.6 m-80 -73.44 -37.67 65.77 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.92 0.866 . . . . 0.0 109.0 176.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 462' ' ' ALA . . . . . 0.62 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -56.61 -33.32 66.14 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.402 -1.272 . . . . 0.0 109.788 169.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.827 HG13 ' HB3' ' A' ' 438' ' ' ALA . 63.2 t -62.19 -50.68 79.0 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.751 0 CA-C-N 114.555 -1.202 . . . . 0.0 107.804 175.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 464' ' ' TYR . . . . . 0.579 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 18.2 m-30 -53.27 -28.2 26.58 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 124.478 1.111 . . . . 0.0 110.38 178.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.63 -40.89 20.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.583 0.706 . . . . 0.0 109.676 -177.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.62 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.4 mt -56.61 -55.52 19.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.336 -1.302 . . . . 0.0 112.294 176.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.783 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -102.66 -10.01 19.59 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -171.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 93.57 32.31 7.76 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 119.242 -1.456 . . . . 0.0 114.237 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 469' ' ' LEU . . . . . 0.783 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.3 mt -88.67 165.64 14.63 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 117.862 0.831 . . . . 0.0 111.351 176.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 45.1 p30 -104.05 -178.77 3.75 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.559 170.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 471' ' ' ALA . . . . . 0.556 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -62.1 -21.58 65.1 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -177.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -88.17 5.33 41.93 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.418 -172.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . 0.455 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 74.92 15.38 81.01 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.346 -0.93 . . . . 0.0 111.047 -177.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -101.08 152.13 20.98 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 11.0 p -89.53 130.93 35.78 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.923 0.392 . . . . 0.0 110.978 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 476' ' ' ILE . . . . . 0.763 HD12 ' N ' ' A' ' 477' ' ' ARG . 2.6 pp -112.16 -27.47 2.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.309 -178.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 477' ' ' ARG . . . . . 0.763 ' N ' HD12 ' A' ' 476' ' ' ILE . 0.0 OUTLIER 61.0 -76.75 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.966 0.907 . . . . 0.0 111.853 -179.69 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -102.56 110.15 22.0 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 479' ' ' GLU . . . . . 0.443 ' HB2' HD13 ' A' ' 476' ' ' ILE . 18.8 tt0 . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.769 -0.634 . . . . 0.0 110.354 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 381' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 . . . . . 0 N--CA 1.482 1.148 0 CA-C-O 121.163 0.506 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 382' ' ' THR . . . . . 0.407 HG22 ' H ' ' B' ' 382' ' ' THR . 1.2 t -77.34 -46.13 23.88 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.581 176.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 383' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -86.49 56.07 3.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.361 0.6 . . . . 0.0 110.791 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 384' ' ' GLY . . . . . . . . . . . . . . . -99.1 89.09 0.87 Allowed Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.789 -178.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 385' ' ' THR . . . . . . . . . . . . . 23.9 m 71.38 -60.48 0.51 Allowed 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.004 0.522 . . . . 0.0 110.923 -178.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 386' ' ' PHE . . . . . 0.718 ' CD1' HD22 ' B' ' 414' ' ' LEU . 3.0 t80 -76.01 126.4 86.89 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 172.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 387' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -43.08 -75.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.786 2.99 . . . . 0.0 113.892 -175.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 388' ' ' MET . . . . . . . . . . . . . 28.4 ttm 67.2 143.76 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.652 0 O-C-N 123.497 0.498 . . . . 0.0 110.155 -178.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 389' ' ' HIS . . . . . 0.634 ' H ' ' HB3' ' B' ' 393' ' ' ASN . 29.5 m170 -55.15 -79.15 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.542 0.687 . . . . 0.0 110.113 -174.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 390' ' ' GLN . . . . . 0.413 ' H ' HD23 ' B' ' 391' ' ' LEU . 13.8 pt20 -153.27 19.33 0.56 Allowed 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 170.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 391' ' ' LEU . . . . . 0.514 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.5 pt? -173.86 -48.61 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.868 -170.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 392' ' ' GLY . . . . . 0.629 ' HA3' HD13 ' B' ' 395' ' ' ILE . . . -172.6 53.91 0.17 Allowed Glycine 0 CA--C 1.524 0.621 0 C-N-CA 118.796 -1.668 . . . . 0.0 115.215 -171.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 393' ' ' ASN . . . . . 0.634 ' HB3' ' H ' ' B' ' 389' ' ' HIS . 0.0 OUTLIER -57.29 -38.08 73.43 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 118.295 1.047 . . . . 0.0 108.865 176.228 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 394' ' ' VAL . . . . . 0.62 HG23 HD12 ' B' ' 398' ' ' ILE . 1.8 m -58.27 -49.39 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 CA-C-N 113.213 -1.812 . . . . 0.0 107.791 179.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 395' ' ' ILE . . . . . 0.663 HG23 HD13 ' B' ' 426' ' ' ILE . 4.2 mp -58.26 -52.91 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-O 117.849 -1.072 . . . . 0.0 113.441 -174.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 396' ' ' LYS . . . . . 0.636 ' HG3' ' CZ ' ' B' ' 429' ' ' TYR . 0.1 OUTLIER -63.96 -49.18 73.57 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 121.832 2.106 . . . . 0.0 111.93 -172.802 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.79 -45.15 70.22 Favored Glycine 0 N--CA 1.438 -1.193 0 C-N-CA 119.86 -1.162 . . . . 0.0 111.279 -178.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . 0.72 HD13 HD12 ' B' ' 410' ' ' LEU . 32.8 mt -71.07 -34.38 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -178.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 399' ' ' VAL . . . . . 0.508 HG12 ' HA ' ' B' ' 404' ' ' VAL . 11.5 m -63.77 -39.93 87.18 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 C-N-CA 118.898 -1.121 . . . . 0.0 108.748 -173.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -67.34 -39.68 85.81 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 176.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 401' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -93.67 -50.69 5.27 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 -170.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 402' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -108.72 -20.31 13.12 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.191 0.519 . . . . 0.0 110.392 -173.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 105.29 162.65 23.62 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.663 -0.699 . . . . 0.0 113.25 177.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 404' ' ' VAL . . . . . 0.604 HG11 ' HA ' ' B' ' 430' ' ' LEU . 1.5 m -53.18 -45.36 54.48 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.792 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 -175.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 405' ' ' ALA . . . . . 0.508 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -65.21 -29.86 70.7 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 119.761 -0.775 . . . . 0.0 112.457 -177.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 406' ' ' THR . . . . . 0.708 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 85.6 m -77.46 -42.55 35.51 Favored 'General case' 0 C--O 1.222 -0.368 0 C-N-CA 120.191 -0.604 . . . . 0.0 110.238 173.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 407' ' ' ALA . . . . . 0.5 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.9 -37.11 75.86 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 122.128 0.966 . . . . 0.0 109.005 177.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 408' ' ' TYR . . . . . 0.604 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.44 -52.95 49.5 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 113.394 -1.73 . . . . 0.0 109.863 176.708 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 409' ' ' THR . . . . . 0.683 HG22 HD23 ' B' ' 410' ' ' LEU . 9.9 m -55.61 -47.08 77.13 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.51 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 410' ' ' LEU . . . . . 0.72 HD12 HD13 ' B' ' 398' ' ' ILE . 14.4 mt -72.42 -36.33 68.58 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.045 -175.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -59.84 -35.27 86.07 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 119.854 -1.165 . . . . 0.0 110.803 172.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 412' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -68.1 -46.48 70.85 Favored 'General case' 0 C--O 1.224 -0.289 0 CA-C-O 120.486 0.184 . . . . 0.0 111.414 178.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 413' ' ' MET . . . . . 0.888 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.4 OUTLIER -70.82 -48.25 55.08 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 118.847 -1.141 . . . . 0.0 112.038 179.662 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 414' ' ' LEU . . . . . 0.888 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 15.9 mt -68.92 -46.65 67.74 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -176.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 13.9 t -93.09 -1.77 56.15 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.296 0.57 . . . . 0.0 110.091 -173.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 416' ' ' GLY . . . . . 0.402 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 93.07 -177.46 38.24 Favored Glycine 0 N--CA 1.435 -1.388 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -176.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -79.95 23.42 0.45 Allowed 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.169 0.509 . . . . 0.0 111.314 -172.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 418' ' ' ASN . . . . . 0.402 ' H ' ' C ' ' B' ' 416' ' ' GLY . 5.4 m-20 -71.6 75.87 0.81 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.567 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 419' ' ' TYR . . . . . 0.552 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 10.9 p90 -51.36 -38.52 53.66 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.387 176.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -55.23 -43.88 74.94 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.753 0.311 . . . . 0.0 110.966 177.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.56 -49.0 62.8 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.852 -177.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 422' ' ' VAL . . . . . 0.449 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.3 OUTLIER -66.8 -40.49 86.03 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.26 -177.069 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 423' ' ' SER . . . . . 0.772 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 79.5 p -66.95 -38.99 87.15 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.47 -39.16 91.28 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.186 176.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 425' ' ' ILE . . . . . 0.653 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -73.08 -51.37 26.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.593 0.196 . . . . 0.0 111.025 -177.445 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 426' ' ' ILE . . . . . 0.667 HG22 HD22 ' B' ' 430' ' ' LEU . 1.1 mm -74.6 -22.51 17.56 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.808 0 CA-C-O 120.863 0.363 . . . . 0.0 110.242 -172.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 427' ' ' ARG . . . . . 0.772 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.8 OUTLIER -54.98 -30.34 58.95 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.242 0.544 . . . . 0.0 110.586 -178.893 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.57 -6.17 77.54 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.481 178.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 429' ' ' TYR . . . . . 0.636 ' CZ ' ' HG3' ' B' ' 396' ' ' LYS . 22.9 m-85 -118.17 0.75 11.83 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 120.996 0.427 . . . . 0.0 110.534 -177.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 430' ' ' LEU . . . . . 0.675 HD23 ' HA ' ' B' ' 427' ' ' ARG . 0.1 OUTLIER -65.72 128.18 93.62 Favored Pre-proline 0 N--CA 1.442 -0.861 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.929 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 431' ' ' PRO . . . . . 0.461 ' HG3' ' O ' ' B' ' 473' ' ' GLY . 80.4 Cg_exo -23.67 -70.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 0.988 1 C-N-CA 125.478 4.119 . . . . 0.0 114.673 179.769 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 432' ' ' GLY . . . . . 0.502 ' O ' HG12 ' B' ' 435' ' ' VAL . . . -138.25 -166.38 10.65 Favored Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 175.11 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 433' ' ' GLN . . . . . 0.516 ' O ' HG13 ' B' ' 436' ' ' VAL . 50.1 tp60 -71.08 -26.85 63.24 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 118.352 1.076 . . . . 0.0 110.46 177.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -64.7 -39.7 94.1 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -177.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 435' ' ' VAL . . . . . 0.789 HG23 HG11 ' B' ' 463' ' ' VAL . 7.6 p -68.66 -43.82 82.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 120.938 0.399 . . . . 0.0 110.543 -178.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 436' ' ' VAL . . . . . 0.516 HG13 ' O ' ' B' ' 433' ' ' GLN . 0.1 OUTLIER -67.48 -30.1 47.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.766 0.317 . . . . 0.0 110.56 175.669 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 437' ' ' THR . . . . . 0.408 HG22 ' N ' ' B' ' 438' ' ' ALA . 0.9 OUTLIER -67.47 -51.91 45.71 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 179.909 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 438' ' ' ALA . . . . . 0.816 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -57.1 -43.96 82.73 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 124.089 0.868 . . . . 0.0 111.087 177.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 439' ' ' LEU . . . . . 0.633 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 2.1 tm? -64.77 -47.47 78.06 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -176.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.06 -39.52 78.7 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.293 175.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 441' ' ' GLN . . . . . 0.607 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 9.2 mm-40 -55.77 -51.31 67.87 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 123.447 0.699 . . . . 0.0 110.813 175.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 442' ' ' ARG . . . . . 0.763 ' HG2' ' O ' ' B' ' 438' ' ' ALA . 0.0 OUTLIER -58.08 -33.75 69.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.739 173.207 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 443' ' ' LEU . . . . . 0.633 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 56.6 mt -72.38 -36.2 68.65 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-O 120.927 0.394 . . . . 0.0 110.247 179.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -57.68 -37.76 74.0 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.642 174.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -72.99 -26.8 61.47 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.911 -1.04 . . . . 0.0 111.036 178.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 446' ' ' GLU . . . . . 0.45 ' HB3' ' O ' ' B' ' 443' ' ' LEU . 7.5 pt-20 23.79 103.31 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 174.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 60.7 mt -62.33 -34.17 62.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.556 0.693 . . . . 0.0 110.091 175.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 448' ' ' ASP . . . . . 0.494 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 15.9 m-20 -162.76 -159.31 0.55 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -84.5 -66.21 0.92 Allowed 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.588 -0.445 . . . . 0.0 109.852 171.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 450' ' ' GLN . . . . . 0.514 ' O ' ' HB3' ' B' ' 453' ' ' ALA . 0.0 OUTLIER -70.94 -25.67 62.84 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.828 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 451' ' ' THR . . . . . 0.494 ' OG1' ' HB2' ' B' ' 448' ' ' ASP . 12.2 m -67.3 -22.66 65.62 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.71 -178.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 452' ' ' ARG . . . . . . . . . . . . . 66.0 mtm180 -54.87 -51.54 65.6 Favored 'General case' 0 C--O 1.216 -0.687 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 170.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 453' ' ' ALA . . . . . 0.552 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -53.24 -51.94 60.58 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.338 173.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 454' ' ' GLU . . . . . 0.434 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 24.0 mm-40 -51.59 -32.19 27.72 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.128 -178.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 29.6 p -119.84 14.36 12.47 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.985 -175.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 456' ' ' PHE . . . . . 0.537 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 0.8 OUTLIER -58.26 -47.74 82.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.348 -170.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 457' ' ' ILE . . . . . 0.533 ' CG1' ' HB3' ' B' ' 408' ' ' TYR . 1.9 mp -77.04 -31.11 18.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.108 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -56.66 -39.16 73.25 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 170.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 459' ' ' HIS . . . . . 0.74 ' O ' HG23 ' B' ' 463' ' ' VAL . 49.5 m-70 -73.21 -27.99 61.92 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.126 -1.397 . . . . 0.0 110.4 -178.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 460' ' ' LEU . . . . . 0.736 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -74.54 -35.06 63.12 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.957 0.884 . . . . 0.0 108.975 178.163 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 461' ' ' ASN . . . . . 0.411 ' O ' ' HB2' ' B' ' 464' ' ' TYR . 23.7 m-80 -73.33 -37.63 66.05 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.886 0.85 . . . . 0.0 109.1 176.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 462' ' ' ALA . . . . . 0.63 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -56.73 -33.25 66.34 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.326 -1.306 . . . . 0.0 109.839 169.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 463' ' ' VAL . . . . . 0.816 HG13 ' HB3' ' B' ' 438' ' ' ALA . 63.9 t -62.32 -50.79 78.5 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.799 0 CA-C-N 114.545 -1.207 . . . . 0.0 107.781 175.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 464' ' ' TYR . . . . . 0.575 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 18.1 m-30 -53.12 -28.18 24.36 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.53 178.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.66 -41.2 19.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.594 0.711 . . . . 0.0 109.587 -177.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 466' ' ' ILE . . . . . 0.63 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.5 mt -56.29 -55.66 17.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 114.396 -1.275 . . . . 0.0 112.399 176.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 467' ' ' LEU . . . . . 0.781 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -102.23 -10.39 19.61 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -172.248 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 468' ' ' GLY . . . . . . . . . . . . . . . 93.75 32.45 7.6 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 119.209 -1.472 . . . . 0.0 114.236 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 469' ' ' LEU . . . . . 0.781 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.3 mt -88.69 165.53 14.69 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 117.929 0.864 . . . . 0.0 111.243 176.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 45.6 p30 -103.9 -178.41 3.65 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.589 170.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 471' ' ' ALA . . . . . 0.547 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -62.66 -21.52 65.77 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -176.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -87.98 5.22 41.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.414 -172.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 473' ' ' GLY . . . . . 0.461 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 75.08 15.2 81.23 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.275 -0.964 . . . . 0.0 111.119 -177.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -101.07 151.97 21.17 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 10.3 p -89.48 131.1 35.69 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.05 0.452 . . . . 0.0 110.982 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 476' ' ' ILE . . . . . 0.765 HD12 ' N ' ' B' ' 477' ' ' ARG . 2.6 pp -112.45 -27.2 2.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.263 -178.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 477' ' ' ARG . . . . . 0.765 ' N ' HD12 ' B' ' 476' ' ' ILE . 0.0 OUTLIER 60.8 -76.6 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.011 0.925 . . . . 0.0 111.829 -179.768 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 478' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -102.98 109.97 21.71 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 479' ' ' GLU . . . . . 0.428 ' HB2' HD13 ' B' ' 476' ' ' ILE . 20.9 tt0 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.78 -0.628 . . . . 0.0 110.096 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 381' ' ' ARG . . . . . 0.469 ' HD2' ' OD1' ' A' ' 418' ' ' ASN . 19.9 ptp180 . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -151.1 -59.77 0.17 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.322 177.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 383' ' ' HIS . . . . . 0.706 ' HB2' ' O ' ' A' ' 386' ' ' PHE . 5.4 p80 -124.82 138.55 54.26 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.372 -0.531 . . . . 0.0 112.215 -170.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -114.68 -68.01 0.46 Allowed Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.015 176.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 7.3 m -97.41 -34.47 11.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.004 0.431 . . . . 0.0 110.873 178.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 386' ' ' PHE . . . . . 0.761 ' CE2' HG12 ' A' ' 394' ' ' VAL . 2.6 t80 -92.48 123.68 61.38 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.414 -177.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 386' ' ' PHE . 40.5 Cg_endo -64.69 105.8 0.68 Allowed 'Trans proline' 0 N--CA 1.478 0.571 0 C-N-CA 123.788 2.992 . . . . 0.0 112.176 173.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.626 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 5.2 ttp -122.01 55.26 1.13 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.29 0.567 . . . . 0.0 111.289 -168.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 389' ' ' HIS . . . . . 0.573 ' CE1' ' HA ' ' A' ' 393' ' ' ASN . 39.2 m170 52.93 -98.9 0.08 Allowed 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.026 -172.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -148.55 17.12 1.02 Allowed 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 171.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.625 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.5 pt? -167.3 -62.54 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.84 -171.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . 0.691 ' HA3' HD13 ' A' ' 395' ' ' ILE . . . -163.14 60.03 0.27 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 119.914 -1.136 . . . . 0.0 114.396 -172.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . 0.626 ' HB3' ' HA ' ' A' ' 388' ' ' MET . 0.2 OUTLIER -57.48 -43.39 84.07 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.996 0.427 . . . . 0.0 109.861 174.192 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.761 HG12 ' CE2' ' A' ' 386' ' ' PHE . 2.0 m -55.71 -45.91 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 -179.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.691 HD13 ' HA3' ' A' ' 392' ' ' GLY . 3.7 mp -58.02 -52.72 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 CA-C-O 117.812 -1.09 . . . . 0.0 113.53 -174.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . 0.557 ' O ' HG22 ' A' ' 399' ' ' VAL . 0.0 OUTLIER -62.79 -49.62 74.25 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 121.952 2.16 . . . . 0.0 112.186 -174.756 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . 0.526 ' O ' ' HG3' ' A' ' 401' ' ' GLN . . . -53.1 -44.44 63.13 Favored Glycine 0 N--CA 1.433 -1.54 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.84 -176.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . 0.81 HD13 HD12 ' A' ' 410' ' ' LEU . 39.1 mt -71.52 -33.81 50.78 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -179.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . 0.557 HG22 ' O ' ' A' ' 396' ' ' LYS . 13.8 m -63.72 -39.88 86.99 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 C-N-CA 118.727 -1.189 . . . . 0.0 108.252 -174.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -63.58 -42.96 98.27 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 174.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.526 ' HG3' ' O ' ' A' ' 397' ' ' GLY . 36.4 mt-30 -92.68 -48.17 6.72 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -169.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . 0.678 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 2.8 mm-40 -114.38 -19.31 11.28 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.149 0.499 . . . . 0.0 111.494 -171.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 104.15 162.78 24.68 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.886 177.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . 0.663 HG11 ' HA ' ' A' ' 430' ' ' LEU . 1.7 m -53.72 -45.46 61.12 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.83 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -175.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . 0.558 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -64.87 -31.18 72.29 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 119.787 -0.765 . . . . 0.0 112.328 -176.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.689 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 85.5 m -76.75 -42.78 39.79 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.101 -0.639 . . . . 0.0 110.365 173.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.469 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.67 -36.4 74.12 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 122.016 0.912 . . . . 0.0 109.195 176.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 408' ' ' TYR . . . . . 0.622 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.83 -52.16 52.87 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 113.649 -1.614 . . . . 0.0 109.771 176.285 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 409' ' ' THR . . . . . 0.668 HG22 HD23 ' A' ' 410' ' ' LEU . 17.6 m -54.67 -47.62 73.38 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.562 178.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . 0.81 HD12 HD13 ' A' ' 398' ' ' ILE . 13.6 mt -72.84 -35.99 67.37 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.123 -174.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -59.41 -34.77 82.35 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 119.966 -1.111 . . . . 0.0 110.592 173.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 412' ' ' MET . . . . . 0.413 ' HB2' ' O ' ' A' ' 409' ' ' THR . 0.3 OUTLIER -65.91 -48.47 71.34 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 115.726 -0.237 . . . . 0.0 111.32 177.719 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 413' ' ' MET . . . . . 0.913 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.5 OUTLIER -71.64 -46.5 58.83 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 118.988 -1.085 . . . . 0.0 111.974 -179.508 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . 0.913 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 16.4 mt -68.69 -45.09 72.57 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -176.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.518 ' HB2' ' HE1' ' A' ' 388' ' ' MET . 33.9 t -86.57 -21.58 26.78 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.483 0.659 . . . . 0.0 110.176 -175.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . 0.42 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 107.55 -175.81 20.45 Favored Glycine 0 N--CA 1.429 -1.775 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -171.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -79.75 23.68 0.42 Allowed 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.598 0.713 . . . . 0.0 111.405 -172.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 418' ' ' ASN . . . . . 0.469 ' OD1' ' HD2' ' A' ' 381' ' ' ARG . 62.5 m-80 -71.83 74.77 0.87 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.687 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 419' ' ' TYR . . . . . 0.535 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 23.2 p90 -52.29 -37.32 55.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.764 174.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -53.82 -46.4 71.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.691 177.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . 0.408 ' O ' HD13 ' A' ' 425' ' ' ILE . 0.0 OUTLIER -68.96 -49.53 57.13 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.389 -177.837 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . 0.457 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -65.74 -39.09 83.83 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.144 -175.879 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.805 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 77.7 p -66.7 -39.24 88.0 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.793 -178.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -68.45 -38.63 86.99 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.136 176.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . 0.567 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.18 -52.27 25.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.456 0.17 . . . . 0.0 111.01 -177.259 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . 0.666 HD13 HG23 ' A' ' 395' ' ' ILE . 1.1 mm -74.36 -22.75 17.96 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.897 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -173.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.805 ' HB2' ' O ' ' A' ' 423' ' ' SER . 1.1 tmt_? -54.64 -33.15 60.2 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.103 0.478 . . . . 0.0 110.699 -177.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -85.87 -10.8 74.98 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.148 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.552 ' HD1' HG22 ' A' ' 395' ' ' ILE . 9.7 m-30 -113.64 -0.14 14.42 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.421 0.629 . . . . 0.0 109.366 -174.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.68 HD23 ' HA ' ' A' ' 427' ' ' ARG . 0.1 OUTLIER -66.02 129.5 94.26 Favored Pre-proline 0 N--CA 1.445 -0.718 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.291 178.267 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . 0.546 ' HD2' HD12 ' A' ' 430' ' ' LEU . 94.6 Cg_exo -23.72 -66.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.359 1.088 1 C-N-CA 125.768 4.312 . . . . 0.0 115.122 179.589 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . 0.519 ' H ' HG12 ' A' ' 435' ' ' VAL . . . -145.86 -166.41 11.95 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 177.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . 0.491 ' O ' HG13 ' A' ' 436' ' ' VAL . 17.0 tp60 -70.01 -27.43 64.67 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 117.904 0.852 . . . . 0.0 110.526 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -67.12 -40.97 86.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.995 -177.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 435' ' ' VAL . . . . . 0.711 HG23 HG11 ' A' ' 463' ' ' VAL . 7.9 p -67.87 -43.43 86.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 121.004 0.431 . . . . 0.0 110.641 -177.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.509 HG12 ' O ' ' A' ' 432' ' ' GLY . 0.1 OUTLIER -66.38 -31.97 55.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.483 175.832 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.29 -52.45 40.4 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -178.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . 0.865 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -58.35 -38.7 77.73 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.225 177.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 439' ' ' LEU . . . . . 0.605 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 1.9 tm? -68.99 -48.53 62.87 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.89 -35.76 73.56 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.717 -1.128 . . . . 0.0 111.327 176.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 441' ' ' GLN . . . . . 0.448 ' O ' ' HG2' ' A' ' 445' ' ' GLN . 5.8 mm-40 -56.93 -51.35 69.5 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 123.484 0.714 . . . . 0.0 110.6 178.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . 0.484 ' HG3' ' O ' ' A' ' 438' ' ' ALA . 0.1 OUTLIER -61.56 -33.4 73.8 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.514 174.795 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 443' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 56.6 mt -68.23 -38.52 81.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.136 0.493 . . . . 0.0 109.931 177.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 444' ' ' ASP . . . . . 0.412 ' HB3' ' O ' ' A' ' 441' ' ' GLN . 29.4 t70 -57.95 -36.11 72.07 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.63 174.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 445' ' ' GLN . . . . . 0.448 ' HG2' ' O ' ' A' ' 441' ' ' GLN . 29.1 mm-40 -72.96 -26.63 61.43 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.8 177.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 32.44 104.33 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 172.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 47.0 mt -72.54 -34.67 48.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.464 0.65 . . . . 0.0 110.041 175.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . 0.424 ' HB3' ' H ' ' A' ' 449' ' ' ASP . 11.0 m-20 -165.84 -158.37 0.35 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 -177.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 449' ' ' ASP . . . . . 0.424 ' H ' ' HB3' ' A' ' 448' ' ' ASP . 18.4 m-20 -88.12 -67.41 0.83 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 168.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.44 -25.84 66.93 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 451' ' ' THR . . . . . 0.463 ' HA ' ' HB2' ' A' ' 454' ' ' GLU . 9.9 m -71.35 -22.98 61.83 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.457 -176.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 71.3 mtt180 -54.87 -53.99 48.31 Favored 'General case' 0 C--O 1.217 -0.631 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 171.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 453' ' ' ALA . . . . . 0.535 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -56.33 -48.86 75.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.7 -1.136 . . . . 0.0 112.576 174.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . 0.463 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 31.4 mm-40 -52.22 -34.01 43.77 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.07 0.462 . . . . 0.0 111.758 -178.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 27.2 p -120.25 14.9 12.21 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.481 -176.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . 0.577 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.9 OUTLIER -56.07 -49.21 74.42 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.043 0.449 . . . . 0.0 111.484 -171.057 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . 0.558 HG23 ' HB1' ' A' ' 405' ' ' ALA . 1.9 mp -74.56 -32.04 28.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.063 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -58.16 -36.2 72.67 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.604 0.716 . . . . 0.0 109.518 171.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . 0.749 ' O ' HG23 ' A' ' 463' ' ' VAL . 87.3 m-70 -72.79 -29.15 63.04 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.048 177.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . 0.731 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -74.0 -34.92 64.35 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.887 0.851 . . . . 0.0 109.137 -179.916 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . 0.46 ' O ' ' HB2' ' A' ' 464' ' ' TYR . 24.3 m-80 -73.08 -38.07 66.54 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.911 0.863 . . . . 0.0 108.985 176.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 462' ' ' ALA . . . . . 0.604 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -57.07 -32.88 66.7 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.394 -1.275 . . . . 0.0 109.874 169.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.865 HG13 ' HB3' ' A' ' 438' ' ' ALA . 60.2 t -62.63 -50.92 77.85 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.856 0 CA-C-N 114.699 -1.137 . . . . 0.0 107.958 175.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 464' ' ' TYR . . . . . 0.598 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 17.7 m-30 -52.07 -28.14 16.41 Favored 'General case' 0 N--CA 1.455 -0.182 0 O-C-N 124.353 1.033 . . . . 0.0 110.494 177.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.89 -39.08 20.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.787 0.803 . . . . 0.0 109.724 -178.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.604 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.6 mt -58.72 -55.85 20.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 114.357 -1.292 . . . . 0.0 112.189 176.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.769 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -101.16 -10.05 20.77 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -172.693 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . 0.546 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 93.77 30.84 8.62 Favored Glycine 0 CA--C 1.527 0.844 0 C-N-CA 119.646 -1.264 . . . . 0.0 114.169 179.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 469' ' ' LEU . . . . . 0.769 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.2 mt -88.69 159.5 17.79 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 117.847 0.823 . . . . 0.0 110.848 177.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . 0.531 HD22 HG23 ' A' ' 476' ' ' ILE . 13.9 p30 -105.32 -177.77 3.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.145 172.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -57.24 -26.18 60.34 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -174.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 -86.87 6.19 33.08 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 122.258 -0.277 . . . . 0.0 111.525 -171.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . 0.525 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 76.72 9.26 86.42 Favored Glycine 0 C--O 1.225 -0.447 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.204 -177.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -100.84 157.45 16.71 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . 0.537 ' HA ' ' HA ' ' A' ' 469' ' ' LEU . 9.5 t -94.66 145.53 24.77 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.246 -0.582 . . . . 0.0 111.074 -178.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 476' ' ' ILE . . . . . 0.546 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.0 pp -104.8 12.71 7.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.035 178.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 477' ' ' ARG . . . . . 0.475 ' HG2' ' OG ' ' A' ' 475' ' ' SER . 29.4 mmt180 -62.75 120.48 11.34 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.684 176.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 71.8 mt -115.22 44.09 1.89 Allowed 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 . . . . . 0 C--O 1.247 0.967 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.08 -175.582 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 381' ' ' ARG . . . . . 0.471 ' HD2' ' OD1' ' B' ' 418' ' ' ASN . 20.0 ptp180 . . . . . 0 N--CA 1.479 0.976 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 382' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.99 -59.6 0.17 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.372 177.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 383' ' ' HIS . . . . . 0.706 ' HB2' ' O ' ' B' ' 386' ' ' PHE . 5.4 p80 -125.16 138.99 54.14 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.362 -0.535 . . . . 0.0 112.111 -170.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 384' ' ' GLY . . . . . . . . . . . . . . . -115.13 -68.0 0.44 Allowed Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.922 176.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 385' ' ' THR . . . . . . . . . . . . . 7.3 m -97.16 -35.02 10.91 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.018 0.437 . . . . 0.0 110.732 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 386' ' ' PHE . . . . . 0.765 ' CE2' HG12 ' B' ' 394' ' ' VAL . 2.6 t80 -92.22 123.5 62.34 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.221 -177.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 387' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' B' ' 386' ' ' PHE . 39.8 Cg_endo -64.62 105.3 0.62 Allowed 'Trans proline' 0 N--CA 1.48 0.722 0 C-N-CA 123.801 3.001 . . . . 0.0 112.2 172.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 388' ' ' MET . . . . . 0.63 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 5.2 ttp -121.58 55.29 1.1 Allowed 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.428 0.632 . . . . 0.0 111.368 -168.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 389' ' ' HIS . . . . . 0.582 ' CE1' ' HA ' ' B' ' 393' ' ' ASN . 38.9 m170 52.78 -99.19 0.08 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.676 0.79 . . . . 0.0 109.908 -172.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -148.03 16.94 1.09 Allowed 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 171.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 391' ' ' LEU . . . . . 0.625 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.5 pt? -167.12 -62.58 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.92 -171.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 392' ' ' GLY . . . . . 0.705 ' HA3' HD13 ' B' ' 395' ' ' ILE . . . -163.32 60.13 0.27 Allowed Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 119.861 -1.161 . . . . 0.0 114.343 -172.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 393' ' ' ASN . . . . . 0.63 ' HB3' ' HA ' ' B' ' 388' ' ' MET . 0.2 OUTLIER -57.44 -43.47 83.95 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 174.257 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 394' ' ' VAL . . . . . 0.765 HG12 ' CE2' ' B' ' 386' ' ' PHE . 2.0 m -55.68 -45.95 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 -179.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 395' ' ' ILE . . . . . 0.705 HD13 ' HA3' ' B' ' 392' ' ' GLY . 3.7 mp -58.07 -52.54 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-O 117.849 -1.072 . . . . 0.0 113.484 -174.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 396' ' ' LYS . . . . . 0.558 ' O ' HG22 ' B' ' 399' ' ' VAL . 0.0 OUTLIER -62.96 -49.74 73.54 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 121.986 2.175 . . . . 0.0 112.159 -174.84 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 397' ' ' GLY . . . . . 0.529 ' O ' ' HG3' ' B' ' 401' ' ' GLN . . . -52.95 -44.33 61.74 Favored Glycine 0 N--CA 1.435 -1.395 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.908 -176.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . 0.814 HD13 HD12 ' B' ' 410' ' ' LEU . 39.0 mt -71.66 -33.74 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 399' ' ' VAL . . . . . 0.558 HG22 ' O ' ' B' ' 396' ' ' LYS . 14.2 m -63.68 -39.67 86.21 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 C-N-CA 118.755 -1.178 . . . . 0.0 108.478 -174.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -64.03 -42.71 96.99 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 174.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 401' ' ' GLN . . . . . 0.529 ' HG3' ' O ' ' B' ' 397' ' ' GLY . 36.7 mt-30 -92.62 -48.22 6.71 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -169.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 402' ' ' GLU . . . . . 0.703 ' HG3' ' HE3' ' A' ' 413' ' ' MET . 2.9 mm-40 -114.29 -19.43 11.27 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.175 0.512 . . . . 0.0 111.539 -171.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 104.18 162.69 24.65 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.986 177.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 404' ' ' VAL . . . . . 0.66 HG11 ' HA ' ' B' ' 430' ' ' LEU . 1.6 m -53.63 -45.47 60.06 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.813 0 N-CA-C 114.463 1.282 . . . . 0.0 114.463 -175.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 405' ' ' ALA . . . . . 0.538 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -64.83 -31.32 72.5 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 119.81 -0.756 . . . . 0.0 112.312 -177.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 406' ' ' THR . . . . . 0.686 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 85.7 m -76.69 -42.98 39.58 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.169 -0.613 . . . . 0.0 110.187 173.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 407' ' ' ALA . . . . . 0.459 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.56 -36.41 73.88 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 122.158 0.98 . . . . 0.0 109.194 176.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 408' ' ' TYR . . . . . 0.614 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.88 -52.2 52.24 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 113.594 -1.639 . . . . 0.0 109.752 176.265 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 409' ' ' THR . . . . . 0.663 HG22 HD23 ' B' ' 410' ' ' LEU . 17.9 m -54.73 -47.57 73.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.545 179.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 410' ' ' LEU . . . . . 0.814 HD12 HD13 ' B' ' 398' ' ' ILE . 13.6 mt -72.85 -35.85 67.3 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.189 -174.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -59.42 -34.92 83.07 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 119.988 -1.101 . . . . 0.0 110.626 173.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 412' ' ' MET . . . . . 0.416 ' HB2' ' O ' ' B' ' 409' ' ' THR . 0.3 OUTLIER -65.78 -48.38 71.99 Favored 'General case' 0 C--O 1.223 -0.341 0 CA-C-N 115.629 -0.285 . . . . 0.0 111.411 177.715 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 413' ' ' MET . . . . . 0.913 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.5 OUTLIER -71.63 -46.38 59.28 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 119.058 -1.057 . . . . 0.0 111.994 -179.373 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 414' ' ' LEU . . . . . 0.913 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 16.5 mt -68.93 -45.16 71.53 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -176.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 415' ' ' SER . . . . . 0.573 ' HB2' ' HE1' ' B' ' 388' ' ' MET . 33.9 t -86.83 -21.34 26.48 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.634 0.731 . . . . 0.0 110.169 -175.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 416' ' ' GLY . . . . . 0.417 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 107.58 -175.86 20.46 Favored Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 -171.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -79.81 23.6 0.43 Allowed 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.486 0.66 . . . . 0.0 111.294 -172.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 418' ' ' ASN . . . . . 0.471 ' OD1' ' HD2' ' B' ' 381' ' ' ARG . 61.6 m-80 -71.81 74.75 0.86 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.696 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 419' ' ' TYR . . . . . 0.538 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 23.9 p90 -52.34 -37.29 55.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.748 174.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -53.7 -46.42 70.71 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.729 177.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 421' ' ' LEU . . . . . 0.413 ' O ' HD13 ' B' ' 425' ' ' ILE . 0.0 OUTLIER -69.02 -49.51 57.04 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.438 -177.806 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 422' ' ' VAL . . . . . 0.458 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.2 OUTLIER -65.9 -39.02 83.47 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.093 -175.852 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 423' ' ' SER . . . . . 0.82 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 78.1 p -66.73 -39.12 87.85 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.818 -178.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -68.62 -38.54 86.19 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.153 176.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 425' ' ' ILE . . . . . 0.585 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -72.21 -52.32 24.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 121.351 -0.14 . . . . 0.0 110.794 -177.282 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 426' ' ' ILE . . . . . 0.653 HD13 HG23 ' B' ' 395' ' ' ILE . 1.1 mm -74.29 -22.71 18.05 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.929 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -173.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 427' ' ' ARG . . . . . 0.82 ' HB2' ' O ' ' B' ' 423' ' ' SER . 1.2 tmt_? -54.58 -33.25 59.96 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.166 0.507 . . . . 0.0 110.69 -177.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -85.85 -10.71 75.22 Favored Glycine 0 N--CA 1.44 -1.043 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.222 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 429' ' ' TYR . . . . . 0.554 ' HD1' HG22 ' B' ' 395' ' ' ILE . 9.5 m-30 -113.97 0.23 14.31 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.468 0.652 . . . . 0.0 109.326 -174.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 430' ' ' LEU . . . . . 0.685 HD23 ' HA ' ' B' ' 427' ' ' ARG . 0.1 OUTLIER -66.36 129.4 94.17 Favored Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.302 178.211 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 431' ' ' PRO . . . . . 0.544 ' HD2' HD12 ' B' ' 430' ' ' LEU . 94.3 Cg_exo -23.98 -65.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.36 1.137 1 C-N-CA 125.707 4.271 . . . . 0.0 115.155 179.81 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 432' ' ' GLY . . . . . 0.527 ' H ' HG12 ' B' ' 435' ' ' VAL . . . -146.56 -166.28 12.11 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 176.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 433' ' ' GLN . . . . . 0.486 ' O ' HG13 ' B' ' 436' ' ' VAL . 15.9 tp60 -69.83 -27.33 64.77 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 117.869 0.834 . . . . 0.0 110.617 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -67.23 -41.02 86.38 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -177.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 435' ' ' VAL . . . . . 0.703 HG23 HG11 ' B' ' 463' ' ' VAL . 8.0 p -67.81 -43.65 86.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-O 121.088 0.47 . . . . 0.0 110.683 -177.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 436' ' ' VAL . . . . . 0.505 HG12 ' O ' ' B' ' 432' ' ' GLY . 0.1 OUTLIER -66.06 -32.23 57.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.444 175.653 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.12 -52.46 41.51 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -178.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 438' ' ' ALA . . . . . 0.855 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -58.33 -38.84 77.97 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.155 177.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 439' ' ' LEU . . . . . 0.6 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 2.0 tm? -68.88 -48.46 63.33 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.1 -35.6 73.69 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.279 176.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 441' ' ' GLN . . . . . 0.447 ' O ' ' HG2' ' B' ' 445' ' ' GLN . 5.7 mm-40 -56.85 -51.5 68.76 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 123.385 0.674 . . . . 0.0 110.556 178.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 442' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' B' ' 438' ' ' ALA . 0.1 OUTLIER -61.59 -33.21 73.49 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.58 174.956 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 443' ' ' LEU . . . . . 0.6 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 56.6 mt -68.27 -38.83 82.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.127 0.489 . . . . 0.0 109.856 177.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 444' ' ' ASP . . . . . 0.408 ' HB3' ' O ' ' B' ' 441' ' ' GLN . 28.4 t70 -57.96 -35.56 71.34 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.628 174.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 445' ' ' GLN . . . . . 0.447 ' HG2' ' O ' ' B' ' 441' ' ' GLN . 29.3 mm-40 -73.26 -26.67 61.19 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.778 177.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 446' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 32.31 104.72 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 172.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 47.2 mt -72.82 -34.81 47.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.383 0.611 . . . . 0.0 109.975 175.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 448' ' ' ASP . . . . . 0.4 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 12.2 m-20 -165.87 -158.69 0.36 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -177.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -88.01 -67.27 0.84 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 169.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.53 -25.73 66.81 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 179.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 451' ' ' THR . . . . . 0.454 ' HA ' ' HB2' ' B' ' 454' ' ' GLU . 10.6 m -71.27 -23.11 61.91 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.421 -176.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 452' ' ' ARG . . . . . . . . . . . . . 70.9 mtt180 -54.67 -53.91 48.59 Favored 'General case' 0 C--O 1.217 -0.612 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 171.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 453' ' ' ALA . . . . . 0.538 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -56.48 -48.93 76.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.719 -1.128 . . . . 0.0 112.499 174.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 454' ' ' GLU . . . . . 0.454 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 31.9 mm-40 -52.23 -34.0 43.88 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.161 0.505 . . . . 0.0 111.626 -177.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 26.9 p -120.24 14.96 12.23 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.413 -176.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 456' ' ' PHE . . . . . 0.577 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 0.9 OUTLIER -56.13 -49.18 74.64 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.982 0.42 . . . . 0.0 111.495 -171.262 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 457' ' ' ILE . . . . . 0.548 ' CG1' ' HB3' ' B' ' 408' ' ' TYR . 1.9 mp -74.63 -31.96 28.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.0 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -58.26 -36.1 72.74 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.569 0.7 . . . . 0.0 109.418 171.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 459' ' ' HIS . . . . . 0.761 ' O ' HG23 ' B' ' 463' ' ' VAL . 87.4 m-70 -72.86 -29.18 62.99 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.175 177.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 460' ' ' LEU . . . . . 0.743 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -73.94 -34.95 64.51 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.901 0.857 . . . . 0.0 109.063 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 461' ' ' ASN . . . . . 0.43 ' O ' ' HB2' ' B' ' 464' ' ' TYR . 24.9 m-80 -73.3 -37.73 66.1 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.883 0.849 . . . . 0.0 109.075 176.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 462' ' ' ALA . . . . . 0.603 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -57.2 -32.99 67.05 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.832 169.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 463' ' ' VAL . . . . . 0.855 HG13 ' HB3' ' B' ' 438' ' ' ALA . 60.9 t -62.41 -51.02 77.39 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.799 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 175.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 464' ' ' TYR . . . . . 0.59 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 17.7 m-30 -52.04 -28.06 15.91 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 124.405 1.066 . . . . 0.0 110.616 177.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.16 -38.85 20.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.698 0.761 . . . . 0.0 109.766 -177.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 466' ' ' ILE . . . . . 0.603 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.6 mt -58.85 -55.89 20.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 114.44 -1.255 . . . . 0.0 112.229 176.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 467' ' ' LEU . . . . . 0.771 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -100.95 -10.22 20.8 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 -172.772 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 468' ' ' GLY . . . . . 0.538 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 93.86 30.89 8.53 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 119.637 -1.268 . . . . 0.0 114.157 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 469' ' ' LEU . . . . . 0.771 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.2 mt -88.62 159.59 17.8 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 117.855 0.828 . . . . 0.0 110.846 177.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 470' ' ' ASN . . . . . 0.543 HD22 HG23 ' B' ' 476' ' ' ILE . 13.9 p30 -105.38 -178.05 3.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.107 172.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 471' ' ' ALA . . . . . . . . . . . . . . . -56.74 -26.58 57.58 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -174.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 -86.75 6.5 31.12 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 122.178 -0.326 . . . . 0.0 111.73 -171.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 473' ' ' GLY . . . . . 0.523 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 76.33 9.54 85.76 Favored Glycine 0 C--O 1.227 -0.319 0 C-N-CA 120.484 -0.865 . . . . 0.0 111.257 -177.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -100.94 157.65 16.58 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 176.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 475' ' ' SER . . . . . 0.542 ' HA ' ' HA ' ' B' ' 469' ' ' LEU . 9.9 t -95.05 145.3 25.06 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.074 -178.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 476' ' ' ILE . . . . . 0.543 HG23 HD22 ' B' ' 470' ' ' ASN . 2.0 pp -104.66 12.62 7.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.618 0.723 . . . . 0.0 110.054 178.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 477' ' ' ARG . . . . . 0.475 ' HG2' ' OG ' ' B' ' 475' ' ' SER . 29.6 mmt180 -62.89 120.2 10.86 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.758 176.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 478' ' ' LEU . . . . . . . . . . . . . 70.8 mt -115.04 44.14 1.85 Allowed 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 479' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 . . . . . 0 C--O 1.247 0.963 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.372 -175.617 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 381' ' ' ARG . . . . . 0.769 ' N ' ' HG ' ' A' ' 415' ' ' SER . 5.8 ptm180 . . . . . 0 N--CA 1.479 1.019 0 N-CA-C 111.205 0.076 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -175.02 -53.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.644 0.259 . . . . 0.0 111.207 -178.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -129.99 141.99 50.68 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.702 0.287 . . . . 0.0 110.784 176.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 179.07 82.75 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.671 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 3.5 m 72.24 -58.17 0.6 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.171 0.588 . . . . 0.0 110.733 -176.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 386' ' ' PHE . . . . . 0.746 ' CD1' HD22 ' A' ' 414' ' ' LEU . 1.3 t80 -83.13 126.29 72.61 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.359 177.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -42.98 -69.35 0.08 OUTLIER 'Trans proline' 0 N--CA 1.479 0.628 0 C-N-CA 124.265 3.31 . . . . 0.0 113.667 -176.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.535 ' SD ' ' HB2' ' A' ' 415' ' ' SER . 6.7 ttp 66.44 34.13 6.41 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 173.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 389' ' ' HIS . . . . . 0.476 ' CE1' ' HB2' ' A' ' 393' ' ' ASN . 36.6 m170 53.93 -95.17 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.327 0.584 . . . . 0.0 110.379 -177.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -149.63 18.87 0.92 Allowed 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 174.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.619 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.6 pt? -173.49 -54.96 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -169.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . 0.619 ' N ' ' HG ' ' A' ' 391' ' ' LEU . . . -167.57 47.08 0.24 Allowed Glycine 0 CA--C 1.525 0.669 0 C-N-CA 119.685 -1.245 . . . . 0.0 114.569 -169.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . 0.497 ' HB3' ' C ' ' A' ' 388' ' ' MET . 0.0 OUTLIER -54.95 -37.58 66.65 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 117.925 0.862 . . . . 0.0 109.495 175.87 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.708 HG23 HD12 ' A' ' 398' ' ' ILE . 1.5 m -57.45 -49.97 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 CA-C-N 113.824 -1.535 . . . . 0.0 107.603 178.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.649 HG21 HG22 ' A' ' 425' ' ' ILE . 4.0 mp -57.96 -52.88 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 CA-C-O 118.013 -0.994 . . . . 0.0 113.544 -174.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . 0.654 ' HG3' ' CZ ' ' A' ' 429' ' ' TYR . 0.1 OUTLIER -64.7 -48.48 74.54 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 121.737 2.062 . . . . 0.0 111.664 -172.525 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.34 -45.49 65.26 Favored Glycine 0 N--CA 1.433 -1.517 0 C-N-CA 120.106 -1.045 . . . . 0.0 110.978 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . 0.761 HD13 HD12 ' A' ' 410' ' ' LEU . 35.4 mt -70.95 -33.86 53.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 -178.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . 0.535 HG12 ' HA ' ' A' ' 404' ' ' VAL . 11.4 m -63.44 -39.88 86.95 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.514 0 C-N-CA 118.73 -1.188 . . . . 0.0 108.539 -173.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . 0.409 ' HB3' HG21 ' B' ' 385' ' ' THR . 12.3 t70 -70.93 -37.09 72.88 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 176.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.47 HE21 ' HB3' ' A' ' 401' ' ' GLN . 4.2 mm100 -86.86 -48.26 8.34 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -171.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . 0.527 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 3.0 mm-40 -119.43 -20.92 7.65 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.375 -171.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 107.48 161.95 21.47 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.879 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . 0.663 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.5 m -53.71 -41.79 48.79 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.784 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -175.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . 0.671 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -69.23 -29.33 67.25 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.916 -176.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.711 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 89.3 m -77.63 -42.79 33.6 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.206 -0.598 . . . . 0.0 110.137 172.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.43 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.42 -36.94 74.38 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 122.062 0.934 . . . . 0.0 109.355 176.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 408' ' ' TYR . . . . . 0.663 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.8 -52.13 53.22 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 113.619 -1.628 . . . . 0.0 109.767 176.372 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 409' ' ' THR . . . . . 0.659 HG22 HD23 ' A' ' 410' ' ' LEU . 17.7 m -55.53 -47.57 76.09 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.592 178.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . 0.761 HD12 HD13 ' A' ' 398' ' ' ILE . 15.0 mt -72.85 -35.11 67.17 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -174.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.66 -34.3 76.16 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.123 -1.037 . . . . 0.0 111.047 171.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -68.35 -49.51 59.78 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-O 120.527 0.203 . . . . 0.0 111.34 178.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 413' ' ' MET . . . . . 0.923 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.9 OUTLIER -71.18 -43.14 68.04 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 119.437 -0.905 . . . . 0.0 112.08 -177.474 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . 0.923 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 12.0 mt -73.99 -46.13 45.65 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 113.234 0.828 . . . . 0.0 113.234 -178.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.769 ' HG ' ' N ' ' A' ' 381' ' ' ARG . 3.7 t -100.1 17.55 20.85 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.361 0.6 . . . . 0.0 110.928 -170.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 78.87 178.31 50.45 Favored Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 120.285 -0.96 . . . . 0.0 111.768 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -81.72 21.17 0.85 Allowed 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.012 0.434 . . . . 0.0 111.642 -172.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 418' ' ' ASN . . . . . 0.479 ' HB3' ' HB3' ' A' ' 421' ' ' LEU . 6.3 m-20 -73.23 80.89 1.31 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.574 0.702 . . . . 0.0 111.021 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 419' ' ' TYR . . . . . 0.563 ' HB2' ' CE2' ' A' ' 456' ' ' PHE . 10.5 p90 -51.91 -38.24 55.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.761 176.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -55.58 -43.67 76.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.87 177.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . 0.479 ' HB3' ' HB3' ' A' ' 418' ' ' ASN . 0.0 OUTLIER -67.8 -48.54 66.01 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.264 -178.075 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . 0.478 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -65.89 -42.22 91.58 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 C-N-CA 120.421 -0.511 . . . . 0.0 111.189 -177.725 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.743 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 29.0 t -69.46 -34.99 75.2 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -178.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.54 -40.54 90.87 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.192 175.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . 0.649 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.81 -49.9 36.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-O 120.554 0.216 . . . . 0.0 110.763 -178.914 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . 0.622 HD13 HG23 ' A' ' 395' ' ' ILE . 1.2 mm -74.31 -22.41 17.91 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.911 0 C-N-CA 123.055 0.542 . . . . 0.0 110.183 -172.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.743 ' HB2' ' O ' ' A' ' 423' ' ' SER . 0.3 OUTLIER -54.72 -28.82 50.83 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 123.031 0.533 . . . . 0.0 111.075 -178.718 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -90.15 -8.32 66.8 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.684 178.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.654 ' CZ ' ' HG3' ' A' ' 396' ' ' LYS . 21.5 m-85 -114.46 -2.86 13.1 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 121.667 0.746 . . . . 0.0 109.619 -178.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.6 HD12 ' HD2' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -65.89 135.79 95.47 Favored Pre-proline 0 N--CA 1.437 -1.088 0 CA-C-N 114.339 -1.3 . . . . 0.0 108.657 178.325 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . 0.839 ' HD2' HG11 ' A' ' 435' ' ' VAL . 47.0 Cg_exo -36.42 -65.21 0.15 Allowed 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 124.614 3.543 . . . . 0.0 114.081 -172.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . 0.567 ' H ' HG12 ' A' ' 435' ' ' VAL . . . -141.94 -165.08 10.32 Favored Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 175.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . 0.512 ' O ' HG13 ' A' ' 436' ' ' VAL . 23.9 tp60 -70.26 -26.91 64.05 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 118.198 0.999 . . . . 0.0 110.331 177.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -66.29 -40.44 90.05 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -177.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 435' ' ' VAL . . . . . 0.839 HG11 ' HD2' ' A' ' 431' ' ' PRO . 7.0 p -68.14 -44.64 84.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-O 120.892 0.377 . . . . 0.0 110.785 -178.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.512 HG13 ' O ' ' A' ' 433' ' ' GLN . 0.2 OUTLIER -65.43 -29.11 46.17 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 CA-C-O 121.057 0.456 . . . . 0.0 110.094 175.862 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 1.1 m -69.26 -52.92 22.87 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . 0.879 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -58.77 -38.13 77.79 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.807 177.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 439' ' ' LEU . . . . . 0.577 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 2.2 tm? -69.91 -47.43 62.5 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.62 -39.67 77.44 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.38 174.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 441' ' ' GLN . . . . . 0.491 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 8.9 mm-40 -53.58 -49.54 67.53 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 123.788 0.835 . . . . 0.0 110.855 174.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . 0.817 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 0.7 OUTLIER -55.85 -39.43 71.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.607 172.034 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 443' ' ' LEU . . . . . 0.577 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 37.1 mt -71.71 -35.56 70.25 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.025 0.44 . . . . 0.0 110.178 -178.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -58.05 -36.97 73.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.631 174.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -72.82 -28.03 62.31 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.616 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 446' ' ' GLU . . . . . 0.575 ' HB2' ' O ' ' A' ' 443' ' ' LEU . 31.6 tt0 29.75 96.49 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 172.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 42.1 mt -67.91 -35.31 71.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.202 0.525 . . . . 0.0 110.518 177.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . 0.62 ' O ' ' HG3' ' A' ' 452' ' ' ARG . 23.2 m-20 -166.15 -170.52 1.73 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -76.7 -62.44 1.63 Allowed 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.176 -0.61 . . . . 0.0 109.405 173.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.37 -26.03 63.54 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 178.007 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 451' ' ' THR . . . . . 0.478 ' OG1' ' HB2' ' A' ' 448' ' ' ASP . 17.7 m -71.71 -22.65 61.61 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 119.824 -0.75 . . . . 0.0 110.853 -175.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . 0.62 ' HG3' ' O ' ' A' ' 448' ' ' ASP . 13.3 mtp180 -53.64 -54.75 33.34 Favored 'General case' 0 C--O 1.218 -0.569 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 170.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 453' ' ' ALA . . . . . 0.484 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -57.34 -48.2 79.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.264 -1.335 . . . . 0.0 112.582 175.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . 0.465 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 20.8 mm-40 -51.83 -35.72 45.55 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.151 0.501 . . . . 0.0 111.752 -177.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 31.2 p -119.22 16.2 13.15 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.314 -176.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . 0.563 ' CE2' ' HB2' ' A' ' 419' ' ' TYR . 1.0 OUTLIER -57.05 -48.84 77.55 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.975 0.417 . . . . 0.0 111.819 -171.441 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . 0.671 HG23 ' HB1' ' A' ' 405' ' ' ALA . 2.0 mp -75.67 -33.02 25.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.934 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -58.4 -35.08 71.49 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.942 0.877 . . . . 0.0 109.268 172.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . 0.715 ' O ' HG23 ' A' ' 463' ' ' VAL . 59.4 m-70 -74.23 -28.87 61.44 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.539 -1.21 . . . . 0.0 110.732 177.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . 0.707 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.4 OUTLIER -73.64 -34.79 65.14 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.794 0.807 . . . . 0.0 108.914 178.869 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . 0.492 ' HA ' ' CD2' ' A' ' 464' ' ' TYR . 20.0 m-80 -73.21 -37.64 66.36 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.276 -0.874 . . . . 0.0 108.872 176.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 462' ' ' ALA . . . . . 0.597 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -56.85 -34.92 68.26 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.443 -1.253 . . . . 0.0 109.812 169.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.879 HG13 ' HB3' ' A' ' 438' ' ' ALA . 68.4 t -60.12 -51.22 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 175.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 464' ' ' TYR . . . . . 0.618 ' CE2' ' HA ' ' A' ' 471' ' ' ALA . 16.2 m-30 -53.52 -28.33 30.7 Favored 'General case' 0 N--CA 1.456 -0.159 0 O-C-N 124.233 0.958 . . . . 0.0 110.598 178.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.19 -39.6 20.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.787 0.803 . . . . 0.0 109.466 -177.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.597 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.7 mt -57.62 -55.68 19.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 114.22 -1.354 . . . . 0.0 112.286 175.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.787 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -102.83 -10.64 18.92 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -172.343 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . 0.697 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 93.93 32.47 7.52 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 118.96 -1.59 . . . . 0.0 114.155 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 469' ' ' LEU . . . . . 0.787 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.7 mt -89.63 166.41 13.64 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 117.793 0.797 . . . . 0.0 111.489 176.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 40.4 p30 -106.06 -178.12 3.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.564 -0.743 . . . . 0.0 109.668 169.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 471' ' ' ALA . . . . . 0.618 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -70.71 -9.72 57.83 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -175.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -89.09 -0.63 57.6 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.931 0.396 . . . . 0.0 110.861 -177.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . 0.474 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 75.5 16.58 80.54 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -173.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -101.57 155.57 18.01 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.275 -0.462 . . . . 0.0 109.818 178.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 3.0 p -94.49 121.06 35.65 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.165 0.507 . . . . 0.0 110.768 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 476' ' ' ILE . . . . . 0.697 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.3 pp -87.08 -51.15 13.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.072 -176.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 477' ' ' ARG . . . . . 0.6 ' N ' HD12 ' A' ' 476' ' ' ILE . 1.0 OUTLIER 46.44 65.12 1.27 Allowed 'General case' 0 C--N 1.329 -0.301 0 O-C-N 123.84 0.713 . . . . 0.0 110.777 178.203 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 90.8 mt 59.69 73.1 0.49 Allowed 'General case' 0 C--N 1.332 -0.152 0 O-C-N 123.653 0.596 . . . . 0.0 110.239 -172.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 479' ' ' GLU . . . . . 0.438 ' HB2' ' HB ' ' A' ' 476' ' ' ILE . 27.1 tt0 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.496 -0.764 . . . . 0.0 110.61 -177.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 381' ' ' ARG . . . . . 0.737 ' N ' ' HG ' ' B' ' 415' ' ' SER . 5.9 ptm180 . . . . . 0 N--CA 1.479 1.017 0 N-CA-C 111.307 0.114 . . . . 0.0 111.307 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 382' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -174.66 -53.26 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.573 0.225 . . . . 0.0 111.134 -178.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 383' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -129.98 141.88 50.7 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.675 0.274 . . . . 0.0 110.797 176.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 384' ' ' GLY . . . . . . . . . . . . . . . 179.0 82.43 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.726 -178.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 385' ' ' THR . . . . . 0.409 HG21 ' HB3' ' A' ' 400' ' ' ASP . 3.5 m 72.32 -58.25 0.6 Allowed 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.255 0.622 . . . . 0.0 110.598 -176.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 386' ' ' PHE . . . . . 0.747 ' CD1' HD22 ' B' ' 414' ' ' LEU . 1.2 t80 -83.22 126.18 72.66 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.36 177.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 387' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -43.12 -68.99 0.09 OUTLIER 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 124.049 3.166 . . . . 0.0 113.782 -176.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 388' ' ' MET . . . . . 0.533 ' SD ' ' HB2' ' B' ' 415' ' ' SER . 6.6 ttp 66.23 34.21 6.75 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 173.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 389' ' ' HIS . . . . . 0.479 ' CE1' ' HB2' ' B' ' 393' ' ' ASN . 36.6 m170 54.08 -94.62 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.363 0.602 . . . . 0.0 110.546 -177.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -150.29 19.22 0.85 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.144 -0.934 . . . . 0.0 108.657 174.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 391' ' ' LEU . . . . . 0.614 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.6 pt? -173.91 -55.01 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -169.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 392' ' ' GLY . . . . . 0.614 ' N ' ' HG ' ' B' ' 391' ' ' LEU . . . -167.57 47.11 0.24 Allowed Glycine 0 CA--C 1.523 0.566 0 C-N-CA 119.796 -1.192 . . . . 0.0 114.736 -169.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 393' ' ' ASN . . . . . 0.488 ' HB3' ' C ' ' B' ' 388' ' ' MET . 0.0 OUTLIER -54.92 -37.56 66.54 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 117.915 0.857 . . . . 0.0 109.461 175.94 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 394' ' ' VAL . . . . . 0.692 HG23 HD12 ' B' ' 398' ' ' ILE . 1.5 m -57.5 -49.9 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 113.795 -1.548 . . . . 0.0 107.491 179.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 395' ' ' ILE . . . . . 0.66 HG21 HG22 ' B' ' 425' ' ' ILE . 4.0 mp -58.14 -52.86 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-O 117.978 -1.01 . . . . 0.0 113.464 -174.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 396' ' ' LYS . . . . . 0.657 ' HG3' ' CZ ' ' B' ' 429' ' ' TYR . 0.1 OUTLIER -64.71 -48.5 74.42 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 121.788 2.086 . . . . 0.0 111.679 -172.476 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.24 -45.49 64.28 Favored Glycine 0 N--CA 1.435 -1.397 0 C-N-CA 120.01 -1.09 . . . . 0.0 110.935 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . 0.758 HD13 HD12 ' B' ' 410' ' ' LEU . 36.0 mt -71.05 -33.93 53.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 113.607 0.965 . . . . 0.0 113.607 -178.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 399' ' ' VAL . . . . . 0.519 HG12 ' HA ' ' B' ' 404' ' ' VAL . 11.7 m -63.3 -39.86 86.86 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.54 0 C-N-CA 118.827 -1.149 . . . . 0.0 108.559 -174.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -70.95 -37.44 72.82 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 176.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 401' ' ' GLN . . . . . 0.401 HE21 ' HB3' ' B' ' 401' ' ' GLN . 3.9 mm100 -86.66 -47.8 8.85 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -171.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 402' ' ' GLU . . . . . 0.439 ' HG3' ' HE3' ' A' ' 413' ' ' MET . 3.0 mm-40 -119.71 -20.64 7.58 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.385 -171.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 107.2 161.98 21.74 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.863 178.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 404' ' ' VAL . . . . . 0.647 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.5 m -53.74 -41.8 49.09 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.862 0 N-CA-C 114.649 1.352 . . . . 0.0 114.649 -175.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 405' ' ' ALA . . . . . 0.679 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -69.2 -29.11 67.01 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 119.657 -0.817 . . . . 0.0 112.042 -176.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 406' ' ' THR . . . . . 0.708 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 91.6 m -77.74 -42.82 32.89 Favored 'General case' 0 C--O 1.22 -0.474 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.142 172.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 407' ' ' ALA . . . . . 0.429 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.54 -36.82 74.47 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 122.01 0.909 . . . . 0.0 109.375 176.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 408' ' ' TYR . . . . . 0.647 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.81 -52.33 51.57 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 113.581 -1.645 . . . . 0.0 109.777 176.185 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 409' ' ' THR . . . . . 0.656 HG22 HD23 ' B' ' 410' ' ' LEU . 17.7 m -55.27 -47.66 75.17 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.676 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 410' ' ' LEU . . . . . 0.758 HD12 HD13 ' B' ' 398' ' ' ILE . 14.9 mt -72.81 -35.16 67.27 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 -174.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.67 -34.25 75.99 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.136 -1.03 . . . . 0.0 111.035 171.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 412' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -68.41 -49.37 60.52 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.558 0.218 . . . . 0.0 111.369 178.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 413' ' ' MET . . . . . 0.94 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.9 OUTLIER -71.34 -43.1 67.64 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 119.355 -0.938 . . . . 0.0 112.099 -177.553 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 414' ' ' LEU . . . . . 0.94 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 12.0 mt -73.89 -46.15 46.31 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -178.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 415' ' ' SER . . . . . 0.737 ' HG ' ' N ' ' B' ' 381' ' ' ARG . 3.7 t -100.37 17.79 20.61 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.265 0.555 . . . . 0.0 110.897 -170.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 416' ' ' GLY . . . . . . . . . . . . . . . 78.82 178.22 50.26 Favored Glycine 0 N--CA 1.438 -1.189 0 C-N-CA 120.342 -0.932 . . . . 0.0 111.771 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 33.6 mm-40 -81.7 21.25 0.84 Allowed 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.074 0.464 . . . . 0.0 111.496 -172.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 418' ' ' ASN . . . . . 0.481 ' HB3' ' HB3' ' B' ' 421' ' ' LEU . 6.6 m-20 -73.26 80.82 1.33 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.541 0.686 . . . . 0.0 111.067 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 419' ' ' TYR . . . . . 0.558 ' HB2' ' CE2' ' B' ' 456' ' ' PHE . 10.4 p90 -52.02 -38.13 55.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.869 -1.059 . . . . 0.0 111.843 176.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -55.36 -43.81 75.4 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.646 0.26 . . . . 0.0 110.81 176.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 421' ' ' LEU . . . . . 0.481 ' HB3' ' HB3' ' B' ' 418' ' ' ASN . 0.0 OUTLIER -67.73 -48.51 66.25 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.24 -177.908 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 422' ' ' VAL . . . . . 0.479 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.2 OUTLIER -66.05 -42.06 90.8 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.149 -177.579 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 423' ' ' SER . . . . . 0.749 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 25.5 t -69.54 -35.0 75.03 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.52 -40.54 90.93 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.265 175.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 425' ' ' ILE . . . . . 0.66 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -72.76 -50.07 36.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 O-C-N 122.834 -0.216 . . . . 0.0 110.824 -179.074 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 426' ' ' ILE . . . . . 0.62 HD13 HG23 ' B' ' 395' ' ' ILE . 1.2 mm -74.41 -22.32 17.76 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.911 0 C-N-CA 122.956 0.502 . . . . 0.0 110.235 -172.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 427' ' ' ARG . . . . . 0.749 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.3 OUTLIER -54.7 -28.7 49.74 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 123.023 0.529 . . . . 0.0 111.186 -178.91 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -90.58 -7.77 66.49 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.489 178.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 429' ' ' TYR . . . . . 0.657 ' CZ ' ' HG3' ' B' ' 396' ' ' LYS . 21.6 m-85 -114.94 -2.49 12.85 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.74 0.781 . . . . 0.0 109.571 -178.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 430' ' ' LEU . . . . . 0.608 HD12 ' HD2' ' B' ' 431' ' ' PRO . 0.0 OUTLIER -65.91 135.76 95.44 Favored Pre-proline 0 N--CA 1.437 -1.088 0 CA-C-N 114.462 -1.244 . . . . 0.0 108.679 178.165 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 431' ' ' PRO . . . . . 0.838 ' HD2' HG11 ' B' ' 435' ' ' VAL . 46.5 Cg_exo -36.53 -65.08 0.15 Allowed 'Trans proline' 0 N--CA 1.473 0.322 0 C-N-CA 124.658 3.572 . . . . 0.0 114.09 -172.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 432' ' ' GLY . . . . . 0.553 ' H ' HG12 ' B' ' 435' ' ' VAL . . . -142.08 -165.12 10.36 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 175.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 433' ' ' GLN . . . . . 0.506 ' O ' HG13 ' B' ' 436' ' ' VAL . 24.5 tp60 -70.13 -26.89 64.16 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 118.195 0.998 . . . . 0.0 110.423 177.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -66.54 -40.01 88.87 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -177.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 435' ' ' VAL . . . . . 0.838 HG11 ' HD2' ' B' ' 431' ' ' PRO . 7.1 p -68.43 -44.63 83.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-O 120.962 0.41 . . . . 0.0 110.702 -178.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 436' ' ' VAL . . . . . 0.506 HG13 ' O ' ' B' ' 433' ' ' GLN . 0.1 OUTLIER -65.43 -29.34 46.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.112 175.826 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 1.1 m -69.19 -52.81 24.18 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 438' ' ' ALA . . . . . 0.864 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -58.75 -38.43 78.4 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.744 177.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 439' ' ' LEU . . . . . 0.581 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 2.2 tm? -69.68 -47.34 63.58 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -178.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.69 -39.53 77.38 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.291 174.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 441' ' ' GLN . . . . . 0.499 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 8.8 mm-40 -53.8 -49.54 68.1 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 123.733 0.813 . . . . 0.0 110.82 174.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 442' ' ' ARG . . . . . 0.83 ' HG2' ' O ' ' B' ' 438' ' ' ALA . 0.7 OUTLIER -55.82 -39.3 71.18 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.609 172.061 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 443' ' ' LEU . . . . . 0.581 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 37.5 mt -71.68 -35.61 70.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.953 0.406 . . . . 0.0 110.19 -178.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -58.16 -37.05 73.93 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.521 174.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -72.74 -28.27 62.54 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.512 178.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 446' ' ' GLU . . . . . 0.573 ' HB2' ' O ' ' B' ' 443' ' ' LEU . 31.7 tt0 30.04 96.96 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 O-C-N 124.686 1.241 . . . . 0.0 114.339 172.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 42.7 mt -68.29 -35.27 70.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.112 0.482 . . . . 0.0 110.593 177.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 448' ' ' ASP . . . . . 0.61 ' O ' ' HG3' ' B' ' 452' ' ' ARG . 23.5 m-20 -165.89 -170.26 1.71 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -76.73 -62.64 1.57 Allowed 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 173.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.43 -25.91 63.43 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 178.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 451' ' ' THR . . . . . 0.468 ' OG1' ' HB2' ' B' ' 448' ' ' ASP . 18.6 m -71.71 -22.74 61.6 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.632 -175.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 452' ' ' ARG . . . . . 0.61 ' HG3' ' O ' ' B' ' 448' ' ' ASP . 13.6 mtp180 -53.54 -54.65 34.35 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 170.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 453' ' ' ALA . . . . . 0.483 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -57.51 -48.22 79.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.275 -1.33 . . . . 0.0 112.604 175.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 454' ' ' GLU . . . . . 0.454 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 20.9 mm-40 -51.67 -35.72 43.57 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.252 0.548 . . . . 0.0 111.736 -177.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 31.1 p -119.28 16.15 13.1 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.362 -176.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 456' ' ' PHE . . . . . 0.558 ' CE2' ' HB2' ' B' ' 419' ' ' TYR . 1.0 OUTLIER -57.13 -48.67 78.08 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.95 0.405 . . . . 0.0 111.766 -171.343 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 457' ' ' ILE . . . . . 0.679 HG23 ' HB1' ' B' ' 405' ' ' ALA . 2.0 mp -75.77 -33.23 25.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.864 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -58.35 -34.95 71.23 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.888 0.851 . . . . 0.0 109.293 172.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 459' ' ' HIS . . . . . 0.72 ' O ' HG23 ' B' ' 463' ' ' VAL . 60.1 m-70 -74.33 -28.78 61.31 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.777 177.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 460' ' ' LEU . . . . . 0.711 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.4 OUTLIER -73.63 -34.81 65.18 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.869 0.842 . . . . 0.0 108.872 178.94 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 461' ' ' ASN . . . . . 0.494 ' HA ' ' CD2' ' B' ' 464' ' ' TYR . 19.2 m-80 -73.26 -37.69 66.23 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.279 -0.873 . . . . 0.0 108.909 176.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 462' ' ' ALA . . . . . 0.6 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -56.8 -34.9 68.12 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.812 169.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 463' ' ' VAL . . . . . 0.864 HG13 ' HB3' ' B' ' 438' ' ' ALA . 68.6 t -60.12 -51.24 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 175.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 464' ' ' TYR . . . . . 0.626 ' CE2' ' HA ' ' B' ' 471' ' ' ALA . 16.4 m-30 -53.51 -28.16 29.58 Favored 'General case' 0 N--CA 1.457 -0.105 0 O-C-N 124.242 0.964 . . . . 0.0 110.551 178.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.29 -39.94 20.18 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.706 0.765 . . . . 0.0 109.411 -177.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 466' ' ' ILE . . . . . 0.6 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.7 mt -57.4 -55.5 20.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 114.189 -1.369 . . . . 0.0 112.231 176.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 467' ' ' LEU . . . . . 0.796 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -103.05 -10.47 18.88 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -172.369 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 468' ' ' GLY . . . . . 0.703 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 93.82 32.52 7.53 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 118.996 -1.573 . . . . 0.0 114.133 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 469' ' ' LEU . . . . . 0.796 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.7 mt -89.63 166.26 13.73 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 117.832 0.816 . . . . 0.0 111.538 176.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 41.3 p30 -105.91 -178.19 3.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.72 169.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 471' ' ' ALA . . . . . 0.626 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -70.83 -9.55 57.77 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -175.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -89.27 -0.75 57.71 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.856 0.36 . . . . 0.0 110.908 -177.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 473' ' ' GLY . . . . . 0.459 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 75.74 16.53 80.59 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -173.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -101.45 155.71 17.9 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.23 -0.485 . . . . 0.0 109.861 178.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 2.7 p -94.93 120.92 35.95 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.193 0.52 . . . . 0.0 110.673 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 476' ' ' ILE . . . . . 0.703 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.3 pp -86.87 -50.8 13.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.189 -176.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 477' ' ' ARG . . . . . 0.603 ' N ' HD12 ' B' ' 476' ' ' ILE . 1.1 mmt85 46.15 65.08 1.26 Allowed 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.936 0.773 . . . . 0.0 110.713 178.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 478' ' ' LEU . . . . . . . . . . . . . 91.0 mt 60.13 72.5 0.52 Allowed 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.274 -173.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 479' ' ' GLU . . . . . 0.432 ' HB2' ' HB ' ' B' ' 476' ' ' ILE . 25.9 tt0 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.48 -0.772 . . . . 0.0 110.619 -177.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 381' ' ' ARG . . . . . 0.536 ' HD2' ' OD1' ' A' ' 418' ' ' ASN . 13.9 ptp180 . . . . . 0 N--CA 1.479 1.021 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.61 -39.13 0.35 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -176.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 383' ' ' HIS . . . . . 0.557 ' HB2' ' O ' ' A' ' 386' ' ' PHE . 24.2 p80 -165.08 152.37 10.97 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.228 -0.589 . . . . 0.0 112.237 -173.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -118.85 -86.6 1.07 Allowed Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.682 174.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 5.3 m -68.73 -41.25 79.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.062 0.458 . . . . 0.0 111.488 -179.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 386' ' ' PHE . . . . . 0.748 ' CD1' HD22 ' A' ' 414' ' ' LEU . 2.3 t80 -88.8 123.67 67.18 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.515 -176.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 386' ' ' PHE . 40.6 Cg_endo -65.5 111.54 1.89 Allowed 'Trans proline' 0 N--CA 1.482 0.811 0 C-N-CA 123.873 3.049 . . . . 0.0 112.458 173.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.626 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 34.2 ttm -121.37 47.92 1.76 Allowed 'General case' 0 C--N 1.321 -0.634 0 O-C-N 121.984 -0.448 . . . . 0.0 111.536 -169.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 389' ' ' HIS . . . . . 0.645 ' CG ' ' HB2' ' A' ' 393' ' ' ASN . 38.0 m170 57.09 -90.17 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 121.484 0.659 . . . . 0.0 109.482 -170.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -160.49 17.36 0.13 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.293 175.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.572 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.3 pt? -167.42 -59.35 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.562 -0.744 . . . . 0.0 112.119 -171.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . 0.575 ' CA ' HD13 ' A' ' 395' ' ' ILE . . . -167.07 53.33 0.24 Allowed Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.216 -0.993 . . . . 0.0 114.059 -172.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . 0.645 ' HB2' ' CG ' ' A' ' 389' ' ' HIS . 0.4 OUTLIER -56.35 -44.07 79.7 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 117.314 0.557 . . . . 0.0 110.262 176.811 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.713 HG12 ' CE2' ' A' ' 386' ' ' PHE . 1.9 m -55.25 -45.13 77.5 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.777 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 -178.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.655 HG23 HD13 ' A' ' 426' ' ' ILE . 3.7 mp -58.02 -52.74 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 CA-C-O 117.853 -1.07 . . . . 0.0 113.544 -175.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . 0.511 ' O ' HG22 ' A' ' 399' ' ' VAL . 0.0 OUTLIER -63.2 -48.86 76.52 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 122.044 2.202 . . . . 0.0 112.139 -174.13 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . 0.453 ' O ' ' HG3' ' A' ' 401' ' ' GLN . . . -53.02 -44.49 62.33 Favored Glycine 0 N--CA 1.435 -1.414 0 C-N-CA 119.989 -1.101 . . . . 0.0 110.983 -177.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . 0.782 HD13 HD12 ' A' ' 410' ' ' LEU . 34.6 mt -71.83 -34.01 50.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 396' ' ' LYS . 11.8 m -64.18 -40.44 89.05 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 C-N-CA 118.742 -1.183 . . . . 0.0 108.402 -173.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -64.27 -41.47 96.91 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 175.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' A' ' 397' ' ' GLY . 34.9 mt-30 -92.94 -49.74 5.89 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -170.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . 0.683 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 2.4 mm-40 -111.74 -20.22 12.17 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.026 0.441 . . . . 0.0 111.227 -171.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 104.75 162.18 24.06 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.944 178.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . 0.654 HG11 ' HA ' ' A' ' 430' ' ' LEU . 1.5 m -54.03 -45.85 65.23 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.784 0 N-CA-C 114.568 1.322 . . . . 0.0 114.568 -175.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . 0.56 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -63.46 -33.04 74.69 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 119.851 -0.74 . . . . 0.0 112.26 -177.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.717 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 93.0 m -76.04 -41.91 49.36 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.199 174.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.474 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.49 -36.97 74.59 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 122.139 0.971 . . . . 0.0 109.221 176.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 408' ' ' TYR . . . . . 0.624 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -66.46 -52.78 42.6 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 113.471 -1.695 . . . . 0.0 110.06 177.336 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 409' ' ' THR . . . . . 0.76 HG22 HD23 ' A' ' 410' ' ' LEU . 1.7 m -56.4 -45.68 80.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.395 178.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . 0.782 HD12 HD13 ' A' ' 398' ' ' ILE . 13.3 mt -71.54 -36.88 71.12 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -176.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.95 -35.14 81.93 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.054 -1.07 . . . . 0.0 110.727 172.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -67.2 -47.93 69.42 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 115.719 -0.241 . . . . 0.0 111.386 177.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 413' ' ' MET . . . . . 0.912 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.6 OUTLIER -70.94 -46.81 61.78 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 118.813 -1.155 . . . . 0.0 111.912 -179.772 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . 0.912 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 14.7 mt -68.02 -44.96 75.32 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -176.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 33.8 t -88.99 -16.28 32.09 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.732 0.777 . . . . 0.0 110.267 -175.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 102.02 -175.8 25.36 Favored Glycine 0 N--CA 1.431 -1.681 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -171.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -79.95 23.63 0.44 Allowed 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.278 0.561 . . . . 0.0 111.7 -171.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 418' ' ' ASN . . . . . 0.536 ' OD1' ' HD2' ' A' ' 381' ' ' ARG . 64.8 m-80 -72.33 77.17 1.01 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.007 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 419' ' ' TYR . . . . . 0.552 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 11.6 p90 -53.01 -38.78 62.61 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.517 176.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.51 -44.14 76.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.784 0.326 . . . . 0.0 110.938 178.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.07 -49.36 61.8 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.293 -178.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . 0.441 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -65.99 -39.53 84.81 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 C-N-CA 120.376 -0.529 . . . . 0.0 111.209 -176.759 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.776 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 78.2 p -68.21 -37.99 81.47 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 -178.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -69.06 -37.16 82.31 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.072 176.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . 0.564 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.88 -53.32 19.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.42 0.152 . . . . 0.0 111.052 -178.746 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . 0.686 HG22 HD22 ' A' ' 430' ' ' LEU . 1.1 mm -73.53 -22.89 19.16 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.828 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -172.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.776 ' HB2' ' O ' ' A' ' 423' ' ' SER . 0.9 OUTLIER -54.61 -32.54 58.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.142 0.496 . . . . 0.0 110.432 -178.663 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.02 -7.37 77.64 Favored Glycine 0 N--CA 1.44 -1.074 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.387 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.501 ' HD1' ' CG2' ' A' ' 395' ' ' ILE . 14.4 m-85 -117.21 0.58 12.32 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.079 0.466 . . . . 0.0 109.945 -176.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.686 HD22 HG22 ' A' ' 426' ' ' ILE . 0.1 OUTLIER -65.98 129.27 94.24 Favored Pre-proline 0 N--CA 1.446 -0.665 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.251 178.812 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . 0.503 ' HD2' HD12 ' A' ' 430' ' ' LEU . 90.3 Cg_exo -24.61 -68.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.359 1.113 1 C-N-CA 125.424 4.083 . . . . 0.0 115.029 179.709 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . 0.555 ' O ' HG12 ' A' ' 435' ' ' VAL . . . -142.07 -170.42 12.54 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 177.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . 0.464 ' O ' HG13 ' A' ' 436' ' ' VAL . 41.4 tp60 -68.13 -26.35 65.75 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 118.006 0.903 . . . . 0.0 110.458 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -66.29 -41.26 90.04 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -178.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 435' ' ' VAL . . . . . 0.742 HG23 HG11 ' A' ' 463' ' ' VAL . 8.0 p -68.65 -43.81 82.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-O 120.929 0.395 . . . . 0.0 110.508 -177.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.495 HG12 ' O ' ' A' ' 432' ' ' GLY . 0.1 OUTLIER -65.84 -30.55 50.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.512 175.538 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 1.1 m -69.16 -52.18 30.72 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . 0.873 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -58.61 -37.42 75.83 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.823 177.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 439' ' ' LEU . . . . . 0.552 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 2.0 tm? -70.35 -47.18 62.15 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.37 -38.85 74.85 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.368 174.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 441' ' ' GLN . . . . . 0.492 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 35.9 mm-40 -53.47 -50.05 66.15 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 123.486 0.714 . . . . 0.0 110.562 174.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . 0.799 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 0.8 OUTLIER -56.83 -40.57 76.28 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.752 172.344 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 443' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 40.9 mt -72.64 -26.11 61.53 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.35 0.595 . . . . 0.0 110.865 -178.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -70.22 -36.38 74.5 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.008 177.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 445' ' ' GLN . . . . . 0.463 ' HG3' ' N ' ' A' ' 446' ' ' GLU . 0.0 OUTLIER -75.22 -30.19 60.51 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.026 178.098 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 446' ' ' GLU . . . . . 0.513 ' HB3' ' O ' ' A' ' 443' ' ' LEU . 13.6 pt-20 27.52 97.31 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.171 0 O-C-N 125.396 1.685 . . . . 0.0 113.646 175.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 49.3 mt -59.25 -35.12 56.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.206 0.527 . . . . 0.0 110.989 -178.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . 0.466 ' HB2' ' OG1' ' A' ' 451' ' ' THR . 17.1 m-20 -163.33 -157.8 0.44 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 -178.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -87.13 -67.31 0.83 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 171.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.2 -25.43 66.92 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 176.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 451' ' ' THR . . . . . 0.483 ' HA ' ' HB2' ' A' ' 454' ' ' GLU . 10.5 m -71.31 -22.64 61.91 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 119.906 -0.717 . . . . 0.0 110.602 -174.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . 0.445 ' NH2' ' HB3' ' A' ' 443' ' ' LEU . 19.0 mtp180 -53.53 -54.26 39.77 Favored 'General case' 0 C--O 1.22 -0.495 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 171.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 453' ' ' ALA . . . . . 0.552 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -58.4 -49.4 77.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.525 -1.216 . . . . 0.0 112.808 174.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . 0.483 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 16.0 mm-40 -51.15 -35.47 36.01 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.1 0.476 . . . . 0.0 112.049 -177.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 28.2 p -119.98 16.16 12.51 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.191 -176.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . 0.601 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.9 OUTLIER -55.23 -48.62 73.66 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.99 0.424 . . . . 0.0 111.639 -172.351 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . 0.56 HG23 ' HB1' ' A' ' 405' ' ' ALA . 1.9 mp -76.96 -33.05 20.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.964 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -57.97 -34.88 70.42 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.786 0.803 . . . . 0.0 109.347 171.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . 0.71 ' O ' HG23 ' A' ' 463' ' ' VAL . 63.3 m-70 -74.37 -28.82 61.29 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.639 177.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . 0.729 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.4 OUTLIER -73.93 -34.6 64.4 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.981 0.896 . . . . 0.0 108.787 178.559 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . 0.436 ' O ' ' HB2' ' A' ' 464' ' ' TYR . 26.9 m-80 -73.02 -37.58 66.89 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.992 0.901 . . . . 0.0 108.925 176.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 462' ' ' ALA . . . . . 0.598 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -56.49 -34.46 66.97 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.491 -1.232 . . . . 0.0 109.814 169.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.873 HG13 ' HB3' ' A' ' 438' ' ' ALA . 68.0 t -61.64 -50.89 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 175.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 464' ' ' TYR . . . . . 0.593 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 17.0 m-30 -53.01 -26.85 16.75 Favored 'General case' 0 C--N 1.33 -0.255 0 O-C-N 124.317 1.011 . . . . 0.0 110.664 177.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.14 -39.7 17.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.576 0.703 . . . . 0.0 109.821 -178.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.598 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.7 mt -57.75 -55.64 20.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 114.421 -1.263 . . . . 0.0 112.157 175.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.76 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -101.64 -11.04 19.5 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -173.345 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . 0.581 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 93.94 31.57 8.06 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 119.38 -1.391 . . . . 0.0 114.353 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 469' ' ' LEU . . . . . 0.76 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 2.5 mt -88.08 159.38 18.26 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 117.777 0.789 . . . . 0.0 110.625 176.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . 0.551 HD22 HG23 ' A' ' 476' ' ' ILE . 12.0 p30 -104.76 -179.18 3.87 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.278 172.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -56.3 -27.79 56.68 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -173.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 -86.66 5.33 36.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.674 0.273 . . . . 0.0 111.607 -171.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . 0.453 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 77.68 11.84 85.05 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.325 -0.94 . . . . 0.0 111.472 -178.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 474' ' ' GLN . . . . . 0.46 ' HB2' HD21 ' A' ' 470' ' ' ASN . 56.0 mt-30 -101.09 158.0 16.34 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 177.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 5.3 p -97.34 122.43 40.37 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.171 0.51 . . . . 0.0 112.074 -176.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 476' ' ' ILE . . . . . 0.581 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.5 pp -85.8 -7.98 11.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.574 0.702 . . . . 0.0 110.005 178.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 30.2 mmm180 -70.24 -24.86 63.15 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.838 -1.073 . . . . 0.0 109.955 174.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 85.3 mt -108.79 -51.8 2.84 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.629 -177.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.666 -0.683 . . . . 0.0 110.741 -179.145 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 381' ' ' ARG . . . . . 0.554 ' HD2' ' OD1' ' B' ' 418' ' ' ASN . 13.5 ptp180 . . . . . 0 N--CA 1.478 0.929 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 382' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.86 -39.12 0.38 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -176.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 383' ' ' HIS . . . . . 0.552 ' HB2' ' O ' ' B' ' 386' ' ' PHE . 24.4 p80 -164.88 152.77 11.69 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.163 -0.615 . . . . 0.0 112.223 -173.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 384' ' ' GLY . . . . . . . . . . . . . . . -119.18 -86.97 1.07 Allowed Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.603 173.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 385' ' ' THR . . . . . . . . . . . . . 5.6 m -68.35 -41.36 80.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.898 0.38 . . . . 0.0 111.431 -178.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 386' ' ' PHE . . . . . 0.76 ' CD1' HD22 ' B' ' 414' ' ' LEU . 2.3 t80 -88.79 123.66 67.23 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.428 -176.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 387' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' B' ' 386' ' ' PHE . 42.6 Cg_endo -65.69 111.38 1.89 Allowed 'Trans proline' 0 N--CA 1.481 0.76 0 C-N-CA 123.929 3.086 . . . . 0.0 112.431 173.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 388' ' ' MET . . . . . 0.615 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 33.8 ttm -121.12 47.88 1.75 Allowed 'General case' 0 C--N 1.32 -0.716 0 O-C-N 122.094 -0.379 . . . . 0.0 111.645 -169.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 389' ' ' HIS . . . . . 0.641 ' CG ' ' HB2' ' B' ' 393' ' ' ASN . 38.4 m170 57.04 -90.21 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.443 0.64 . . . . 0.0 109.481 -171.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -160.29 17.0 0.14 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.986 -1.006 . . . . 0.0 108.348 174.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 391' ' ' LEU . . . . . 0.571 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.3 pt? -167.11 -59.55 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.074 -171.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 392' ' ' GLY . . . . . 0.571 ' N ' ' HG ' ' B' ' 391' ' ' LEU . . . -166.86 53.28 0.24 Allowed Glycine 0 C--N 1.335 0.523 0 C-N-CA 120.232 -0.985 . . . . 0.0 114.181 -172.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 393' ' ' ASN . . . . . 0.641 ' HB2' ' CG ' ' B' ' 389' ' ' HIS . 0.4 OUTLIER -56.2 -44.19 79.21 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 117.238 0.519 . . . . 0.0 110.258 176.789 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 394' ' ' VAL . . . . . 0.715 HG23 HD12 ' B' ' 398' ' ' ILE . 1.9 m -55.32 -45.06 77.73 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.756 0 N-CA-C 106.706 -1.591 . . . . 0.0 106.706 -178.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 395' ' ' ILE . . . . . 0.635 HG23 HD13 ' B' ' 426' ' ' ILE . 3.7 mp -57.98 -52.69 55.14 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.526 0 CA-C-O 117.77 -1.11 . . . . 0.0 113.59 -176.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 396' ' ' LYS . . . . . 0.528 ' O ' HG22 ' B' ' 399' ' ' VAL . 0.0 OUTLIER -63.22 -49.24 74.96 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 122.055 2.207 . . . . 0.0 111.932 -174.126 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 397' ' ' GLY . . . . . 0.457 ' O ' ' HG3' ' B' ' 401' ' ' GLN . . . -52.72 -44.43 60.44 Favored Glycine 0 N--CA 1.436 -1.336 0 C-N-CA 119.986 -1.102 . . . . 0.0 111.009 -177.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . 0.803 HD13 HD12 ' B' ' 410' ' ' LEU . 33.5 mt -71.82 -33.88 49.67 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 399' ' ' VAL . . . . . 0.528 HG22 ' O ' ' B' ' 396' ' ' LYS . 11.9 m -64.38 -40.39 88.88 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 C-N-CA 118.793 -1.163 . . . . 0.0 108.429 -173.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -64.27 -41.65 96.81 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 174.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 401' ' ' GLN . . . . . 0.457 ' HG3' ' O ' ' B' ' 397' ' ' GLY . 35.2 mt-30 -92.86 -49.66 5.94 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -170.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 402' ' ' GLU . . . . . 0.676 ' HG3' ' HE3' ' A' ' 413' ' ' MET . 2.4 mm-40 -111.75 -20.19 12.17 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.018 0.437 . . . . 0.0 111.265 -171.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 104.89 162.33 23.95 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.953 177.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 404' ' ' VAL . . . . . 0.652 HG11 ' HA ' ' B' ' 430' ' ' LEU . 1.6 m -54.08 -45.88 65.89 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.769 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 -175.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 405' ' ' ALA . . . . . 0.545 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -63.49 -33.03 74.68 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 119.785 -0.766 . . . . 0.0 112.337 -177.012 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 406' ' ' THR . . . . . 0.699 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 93.5 m -75.95 -42.09 49.61 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.251 174.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 407' ' ' ALA . . . . . 0.474 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.45 -36.83 74.28 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 122.145 0.974 . . . . 0.0 109.263 176.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 408' ' ' TYR . . . . . 0.611 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -66.53 -52.75 42.46 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 113.541 -1.663 . . . . 0.0 110.027 177.344 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 409' ' ' THR . . . . . 0.773 HG22 HD23 ' B' ' 410' ' ' LEU . 1.8 m -56.31 -45.68 80.15 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.44 178.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 410' ' ' LEU . . . . . 0.803 HD12 HD13 ' B' ' 398' ' ' ILE . 13.4 mt -71.69 -36.91 70.73 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -176.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.85 -35.18 81.37 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.064 -1.065 . . . . 0.0 110.73 172.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 412' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -67.34 -47.95 68.94 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 115.693 -0.254 . . . . 0.0 111.301 178.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 413' ' ' MET . . . . . 0.92 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.6 OUTLIER -70.91 -46.9 61.69 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 118.811 -1.155 . . . . 0.0 111.881 -179.945 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 414' ' ' LEU . . . . . 0.92 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 14.9 mt -67.84 -44.97 75.97 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -175.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 33.9 t -89.03 -16.46 31.57 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.555 0.693 . . . . 0.0 110.264 -175.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 416' ' ' GLY . . . . . . . . . . . . . . . 102.44 -175.92 24.98 Favored Glycine 0 N--CA 1.43 -1.758 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 -171.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -79.96 23.51 0.45 Allowed 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.362 0.601 . . . . 0.0 111.724 -171.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 418' ' ' ASN . . . . . 0.554 ' OD1' ' HD2' ' B' ' 381' ' ' ARG . 64.1 m-80 -72.23 77.17 0.98 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.946 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 419' ' ' TYR . . . . . 0.548 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 11.5 p90 -53.13 -38.77 62.96 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.399 176.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.47 -44.08 76.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.613 0.244 . . . . 0.0 110.972 178.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.32 -49.33 61.14 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.18 -178.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 422' ' ' VAL . . . . . 0.439 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.2 OUTLIER -65.92 -39.37 84.46 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.205 -176.643 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 423' ' ' SER . . . . . 0.796 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 78.4 p -68.5 -37.69 80.32 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.87 -178.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -69.32 -37.19 79.93 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.039 176.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 425' ' ' ILE . . . . . 0.572 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -72.65 -53.37 19.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 O-C-N 122.907 -0.173 . . . . 0.0 111.116 -178.828 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 426' ' ' ILE . . . . . 0.681 HG22 HD22 ' B' ' 430' ' ' LEU . 1.1 mm -73.59 -22.77 19.03 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.768 0 CA-C-O 120.801 0.334 . . . . 0.0 110.176 -172.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 427' ' ' ARG . . . . . 0.796 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.9 OUTLIER -54.94 -32.21 61.14 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.236 0.541 . . . . 0.0 110.522 -178.63 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -86.98 -7.47 77.58 Favored Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.449 179.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 429' ' ' TYR . . . . . 0.514 ' HD1' ' CG2' ' B' ' 395' ' ' ILE . 14.7 m-85 -117.29 0.61 12.29 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.096 0.474 . . . . 0.0 109.856 -176.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 430' ' ' LEU . . . . . 0.686 HD23 ' HA ' ' B' ' 427' ' ' ARG . 0.1 OUTLIER -65.86 129.27 94.26 Favored Pre-proline 0 N--CA 1.445 -0.702 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.152 178.816 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 431' ' ' PRO . . . . . 0.5 ' HD2' HD12 ' B' ' 430' ' ' LEU . 87.0 Cg_exo -24.43 -69.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.358 1.068 1 C-N-CA 125.4 4.067 . . . . 0.0 114.879 179.532 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 432' ' ' GLY . . . . . 0.542 ' O ' HG12 ' B' ' 435' ' ' VAL . . . -141.12 -169.87 11.97 Favored Glycine 0 N--CA 1.44 -1.038 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 177.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 433' ' ' GLN . . . . . 0.465 ' O ' HG13 ' B' ' 436' ' ' VAL . 41.2 tp60 -68.39 -26.37 65.52 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 118.062 0.931 . . . . 0.0 110.574 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -66.17 -41.46 90.29 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -178.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 435' ' ' VAL . . . . . 0.729 HG23 HG11 ' B' ' 463' ' ' VAL . 7.9 p -68.38 -43.97 83.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-O 121.071 0.463 . . . . 0.0 110.506 -177.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 436' ' ' VAL . . . . . 0.499 HG12 ' O ' ' B' ' 432' ' ' GLY . 0.1 OUTLIER -65.76 -30.56 50.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.452 175.65 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 1.1 m -69.08 -52.2 30.87 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -178.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 438' ' ' ALA . . . . . 0.862 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -58.68 -37.32 75.79 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.81 177.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 439' ' ' LEU . . . . . 0.565 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 2.0 tm? -70.38 -47.19 62.07 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.37 -38.83 74.84 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.303 174.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 441' ' ' GLN . . . . . 0.493 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 35.2 mm-40 -53.46 -50.05 66.13 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 123.519 0.728 . . . . 0.0 110.604 174.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 442' ' ' ARG . . . . . 0.816 ' HG2' ' O ' ' B' ' 438' ' ' ALA . 0.8 OUTLIER -56.68 -40.81 76.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.751 172.215 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 443' ' ' LEU . . . . . 0.565 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 40.6 mt -72.6 -26.14 61.58 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.273 0.558 . . . . 0.0 110.833 -178.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -70.06 -36.51 75.02 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.874 177.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 445' ' ' GLN . . . . . 0.459 ' HG3' ' N ' ' B' ' 446' ' ' GLU . 0.0 OUTLIER -74.94 -30.17 61.16 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.594 -1.185 . . . . 0.0 109.023 178.321 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 446' ' ' GLU . . . . . 0.528 ' HB3' ' O ' ' B' ' 443' ' ' LEU . 13.4 pt-20 27.48 96.9 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 O-C-N 125.42 1.7 . . . . 0.0 113.65 175.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 49.7 mt -59.09 -35.0 54.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.158 0.504 . . . . 0.0 110.95 -178.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 448' ' ' ASP . . . . . 0.462 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 16.3 m-20 -163.0 -156.92 0.41 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 -178.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -87.97 -67.21 0.84 Allowed 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 171.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.13 -25.45 66.98 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 176.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 451' ' ' THR . . . . . 0.48 ' HA ' ' HB2' ' B' ' 454' ' ' GLU . 10.5 m -71.37 -22.65 61.87 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 119.946 -0.701 . . . . 0.0 110.679 -174.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 452' ' ' ARG . . . . . 0.445 ' NH2' ' HB3' ' B' ' 443' ' ' LEU . 19.0 mtp180 -53.57 -54.27 39.88 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 171.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 453' ' ' ALA . . . . . 0.548 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -58.24 -49.49 76.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.507 -1.224 . . . . 0.0 112.707 174.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 454' ' ' GLU . . . . . 0.48 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 16.2 mm-40 -51.32 -35.15 36.6 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.22 0.533 . . . . 0.0 112.153 -176.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 28.8 p -120.26 16.19 12.28 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.143 -176.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 456' ' ' PHE . . . . . 0.604 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 1.0 OUTLIER -55.27 -48.73 73.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.957 0.408 . . . . 0.0 111.516 -172.331 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 457' ' ' ILE . . . . . 0.548 ' CG1' ' HB3' ' B' ' 408' ' ' TYR . 1.9 mp -76.46 -33.19 22.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.149 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -58.06 -34.91 70.62 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.821 0.82 . . . . 0.0 109.227 171.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 459' ' ' HIS . . . . . 0.712 ' O ' HG23 ' B' ' 463' ' ' VAL . 63.7 m-70 -74.37 -28.85 61.3 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.583 -1.189 . . . . 0.0 110.596 177.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 460' ' ' LEU . . . . . 0.734 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -73.8 -34.75 64.75 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.951 0.881 . . . . 0.0 108.808 178.407 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 461' ' ' ASN . . . . . 0.437 ' O ' ' HB2' ' B' ' 464' ' ' TYR . 26.4 m-80 -72.81 -37.6 67.48 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.34 -0.846 . . . . 0.0 108.965 176.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 462' ' ' ALA . . . . . 0.607 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -56.51 -34.48 67.04 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.352 -1.295 . . . . 0.0 109.796 169.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 463' ' ' VAL . . . . . 0.862 HG13 ' HB3' ' B' ' 438' ' ' ALA . 65.1 t -61.79 -50.63 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 175.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 464' ' ' TYR . . . . . 0.582 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 17.1 m-30 -53.12 -27.05 18.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.683 177.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.98 -39.69 17.79 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.775 0.798 . . . . 0.0 109.775 -178.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 466' ' ' ILE . . . . . 0.607 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.6 mt -57.72 -55.4 21.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.204 175.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 467' ' ' LEU . . . . . 0.756 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -101.73 -11.12 19.37 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 -173.484 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 468' ' ' GLY . . . . . 0.596 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 93.97 31.43 8.13 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 119.241 -1.457 . . . . 0.0 114.35 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 469' ' ' LEU . . . . . 0.756 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 2.5 mt -88.19 159.39 18.18 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 117.818 0.809 . . . . 0.0 110.606 176.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 470' ' ' ASN . . . . . 0.528 HD22 HG23 ' B' ' 476' ' ' ILE . 12.1 p30 -104.82 -179.6 3.99 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.101 172.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 471' ' ' ALA . . . . . . . . . . . . . . . -55.7 -28.21 54.44 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -173.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -86.29 4.95 36.79 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 122.314 -0.241 . . . . 0.0 111.56 -171.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 473' ' ' GLY . . . . . 0.454 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 78.0 11.82 85.01 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.384 -0.913 . . . . 0.0 111.475 -178.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 474' ' ' GLN . . . . . 0.463 ' HB2' HD21 ' B' ' 470' ' ' ASN . 56.5 mt-30 -101.07 158.12 16.25 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 177.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 6.0 p -97.3 122.64 40.57 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.327 0.584 . . . . 0.0 112.114 -176.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 476' ' ' ILE . . . . . 0.596 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.5 pp -85.9 -7.87 11.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.579 0.704 . . . . 0.0 110.006 178.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 477' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -70.46 -25.08 63.01 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.787 174.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 478' ' ' LEU . . . . . . . . . . . . . 85.4 mt -108.49 -51.34 2.9 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.75 -177.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 479' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.669 -0.681 . . . . 0.0 110.79 -179.226 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 381' ' ' ARG . . . . . 0.682 ' N ' ' HG ' ' A' ' 415' ' ' SER . 18.9 ptt180 . . . . . 0 N--CA 1.475 0.817 0 CA-C-O 120.51 0.195 . . . . 0.0 110.777 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . 0.429 ' N ' ' HG3' ' A' ' 381' ' ' ARG . 0.1 OUTLIER 173.7 -46.0 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 123.01 0.524 . . . . 0.0 109.74 -176.211 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -132.39 131.38 41.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.529 177.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -145.35 -135.76 2.89 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 177.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . 0.433 HG21 ' HB3' ' B' ' 400' ' ' ASP . 25.6 m -69.05 -32.15 71.44 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 171.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 386' ' ' PHE . . . . . 0.787 ' CZ ' HG12 ' A' ' 394' ' ' VAL . 1.4 t80 -91.75 122.53 65.37 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.252 -0.886 . . . . 0.0 108.694 172.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -47.6 -75.25 0.03 OUTLIER 'Trans proline' 0 N--CA 1.479 0.625 0 C-N-CA 124.463 3.442 . . . . 0.0 115.125 -174.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.571 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 28.5 mtt 73.63 146.69 0.08 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.759 0.824 . . . . 0.0 111.225 -171.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 389' ' ' HIS . . . . . 0.522 ' CG ' ' HB2' ' A' ' 393' ' ' ASN . 32.7 m170 -49.29 -65.28 0.59 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.587 0.708 . . . . 0.0 109.519 178.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . 0.479 ' H ' HD23 ' A' ' 391' ' ' LEU . 3.7 pt20 -168.29 26.65 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.518 -1.219 . . . . 0.0 108.153 173.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.662 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.1 pt? -178.04 -65.31 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -167.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . 0.662 ' N ' ' HG ' ' A' ' 391' ' ' LEU . . . -163.64 49.9 0.3 Allowed Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.955 -0.64 . . . . 0.0 113.154 -168.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . 0.571 ' HB3' ' HA ' ' A' ' 388' ' ' MET . 0.4 OUTLIER -56.31 -37.68 70.24 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 177.942 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.787 HG12 ' CZ ' ' A' ' 386' ' ' PHE . 0.9 OUTLIER -56.25 -47.39 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 178.681 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.663 HG23 HD13 ' A' ' 426' ' ' ILE . 4.2 mp -57.66 -51.8 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.275 0 CA-C-O 118.108 -0.948 . . . . 0.0 112.967 -174.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . 0.678 ' HG3' ' CZ ' ' A' ' 429' ' ' TYR . 0.2 OUTLIER -62.52 -48.98 77.15 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 121.359 1.891 . . . . 0.0 111.415 -174.205 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -55.19 -45.38 82.67 Favored Glycine 0 N--CA 1.434 -1.486 0 C-N-CA 120.131 -1.033 . . . . 0.0 111.166 -179.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . 0.739 ' CD1' HD12 ' A' ' 410' ' ' LEU . 28.2 mt -70.46 -33.84 55.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -177.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . 0.501 HG12 ' HA ' ' A' ' 404' ' ' VAL . 11.8 m -63.89 -39.59 85.97 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 C-N-CA 118.798 -1.161 . . . . 0.0 108.385 -174.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . 0.433 ' HB3' HG21 ' B' ' 385' ' ' THR . 37.5 t70 -69.92 -36.65 75.53 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 175.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.452 HE21 ' HB3' ' A' ' 401' ' ' GLN . 2.9 mm100 -87.58 -48.19 8.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.089 0.471 . . . . 0.0 111.944 -171.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . 0.564 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 1.9 mm-40 -121.41 -20.43 6.63 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.757 -170.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 107.4 162.38 21.62 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.046 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . 0.636 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.5 m -53.45 -41.82 46.52 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.723 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 -176.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . 0.655 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -69.04 -30.36 68.7 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.795 -176.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.712 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 90.5 m -77.29 -42.31 37.46 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.162 -0.615 . . . . 0.0 109.981 173.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.47 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.41 -36.98 74.42 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 122.123 0.963 . . . . 0.0 109.038 176.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 408' ' ' TYR . . . . . 0.636 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.7 -52.25 52.87 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 113.445 -1.707 . . . . 0.0 110.083 176.61 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 409' ' ' THR . . . . . 0.72 HG22 HD23 ' A' ' 410' ' ' LEU . 3.4 m -55.71 -46.56 77.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.674 178.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . 0.739 HD12 ' CD1' ' A' ' 398' ' ' ILE . 14.0 mt -72.22 -35.86 68.98 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.048 0.451 . . . . 0.0 110.358 -174.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -59.63 -34.86 83.7 Favored Glycine 0 N--CA 1.438 -1.205 0 C-N-CA 120.224 -0.989 . . . . 0.0 110.83 171.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -68.26 -43.72 77.18 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 178.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 413' ' ' MET . . . . . 0.731 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.0 OUTLIER -70.5 -57.65 4.55 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 118.822 -1.151 . . . . 0.0 111.549 179.607 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . 0.731 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 4.6 mt -67.35 -43.7 80.88 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -172.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.682 ' HG ' ' N ' ' A' ' 381' ' ' ARG . 5.2 t -95.45 18.14 13.23 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.482 0.658 . . . . 0.0 109.975 -174.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 73.17 -177.93 41.81 Favored Glycine 0 N--CA 1.437 -1.245 0 C-N-CA 120.357 -0.925 . . . . 0.0 111.675 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 33.9 mm-40 -80.69 23.13 0.54 Allowed 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.199 0.524 . . . . 0.0 111.616 -173.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 418' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -71.73 77.65 0.85 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.72 -179.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 419' ' ' TYR . . . . . 0.539 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 14.6 p90 -54.47 -37.85 65.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.549 177.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -54.97 -43.04 73.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.625 0.25 . . . . 0.0 110.644 177.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.42 -48.85 63.54 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.152 -178.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . 0.485 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.3 OUTLIER -66.32 -40.53 86.99 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 C-N-CA 120.235 -0.586 . . . . 0.0 111.239 -177.142 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.758 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 65.9 p -67.06 -38.29 85.52 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -178.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.29 -40.26 92.02 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.129 175.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . 0.598 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.61 -50.13 36.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 O-C-N 122.883 -0.187 . . . . 0.0 110.934 -176.996 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . 0.696 HG22 HD22 ' A' ' 430' ' ' LEU . 1.2 mm -74.55 -22.62 17.66 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -172.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.758 ' HB2' ' O ' ' A' ' 423' ' ' SER . 0.9 OUTLIER -54.86 -30.2 57.17 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.088 0.47 . . . . 0.0 110.756 -178.581 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -86.81 -9.12 75.11 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.458 178.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.678 ' CZ ' ' HG3' ' A' ' 396' ' ' LYS . 23.0 m-85 -115.87 1.03 13.29 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-O 120.995 0.426 . . . . 0.0 110.478 -177.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.699 HD23 ' HA ' ' A' ' 427' ' ' ARG . 0.1 OUTLIER -65.82 127.38 93.05 Favored Pre-proline 0 N--CA 1.439 -1.019 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 178.505 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . 0.471 ' HD2' HD12 ' A' ' 430' ' ' LEU . 84.6 Cg_exo -22.7 -74.88 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 1.012 1 C-N-CA 125.653 4.235 . . . . 0.0 114.72 -179.102 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . 0.504 ' O ' HG12 ' A' ' 435' ' ' VAL . . . -129.27 -166.53 11.93 Favored Glycine 0 N--CA 1.441 -0.99 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 172.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . 0.598 ' O ' HG13 ' A' ' 436' ' ' VAL . 21.6 tt0 -71.61 -26.64 62.67 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 118.838 1.319 . . . . 0.0 110.587 176.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -62.26 -38.34 88.92 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.833 -176.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 435' ' ' VAL . . . . . 0.778 HG23 HG11 ' A' ' 463' ' ' VAL . 7.5 p -69.76 -43.34 80.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-O 120.839 0.352 . . . . 0.0 110.611 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.598 HG13 ' O ' ' A' ' 433' ' ' GLN . 0.2 OUTLIER -66.42 -30.17 48.94 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-O 120.822 0.344 . . . . 0.0 110.299 175.028 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -69.37 -52.0 31.35 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -178.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . 0.845 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -57.42 -43.04 83.48 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.99 176.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 439' ' ' LEU . . . . . 0.626 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 2.0 tm? -65.28 -47.35 76.97 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -176.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.99 -39.11 77.42 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.228 174.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 441' ' ' GLN . . . . . 0.581 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 8.7 mm-40 -56.85 -50.46 72.37 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 123.379 0.672 . . . . 0.0 110.631 176.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . 0.711 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -58.65 -33.78 70.46 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.924 172.601 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 443' ' ' LEU . . . . . 0.626 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 59.5 mt -72.21 -33.99 68.02 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.024 0.44 . . . . 0.0 110.163 178.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -57.69 -36.75 72.37 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.319 173.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -72.6 -27.13 61.98 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.963 177.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 446' ' ' GLU . . . . . 0.57 ' HB2' ' O ' ' A' ' 443' ' ' LEU . 38.2 tt0 29.53 96.88 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 170.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 50.3 mt -68.33 -35.46 71.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.062 0.458 . . . . 0.0 110.882 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . 0.568 ' O ' ' HG3' ' A' ' 452' ' ' ARG . 36.8 m-20 -165.83 -166.78 0.98 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 -178.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -79.63 -63.81 1.33 Allowed 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.23 -0.588 . . . . 0.0 109.525 172.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.58 -25.97 64.24 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 178.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 451' ' ' THR . . . . . 0.439 ' HA ' ' HB2' ' A' ' 454' ' ' GLU . 12.1 m -71.85 -22.43 61.54 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.692 -175.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . 0.568 ' HG3' ' O ' ' A' ' 448' ' ' ASP . 11.1 mtp180 -53.11 -54.51 34.53 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 170.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 453' ' ' ALA . . . . . 0.539 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -57.93 -50.42 73.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.363 -1.29 . . . . 0.0 112.595 175.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . 0.439 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 31.4 mm-40 -49.73 -38.26 32.71 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.386 0.612 . . . . 0.0 111.729 -176.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 32.0 p -117.45 16.03 14.69 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.246 -176.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . 0.589 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 1.1 t80 -55.71 -47.36 76.98 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.169 0.509 . . . . 0.0 111.479 -171.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . 0.655 HG23 ' HB1' ' A' ' 405' ' ' ALA . 2.0 mp -75.41 -32.1 24.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.909 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -58.38 -35.78 72.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.67 0.748 . . . . 0.0 109.361 171.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . 0.712 ' O ' HG23 ' A' ' 463' ' ' VAL . 82.8 m-70 -72.44 -29.2 63.48 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.711 -1.132 . . . . 0.0 110.198 178.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . 0.742 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -74.51 -34.57 63.07 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.913 0.863 . . . . 0.0 108.929 179.129 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . 0.443 ' HA ' ' CD2' ' A' ' 464' ' ' TYR . 22.0 m-80 -72.83 -37.81 67.33 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.232 176.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 462' ' ' ALA . . . . . 0.628 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -56.62 -33.1 65.95 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.852 169.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.845 HG13 ' HB3' ' A' ' 438' ' ' ALA . 63.4 t -62.42 -50.78 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 CA-C-N 114.49 -1.232 . . . . 0.0 107.831 175.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 464' ' ' TYR . . . . . 0.559 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 16.2 m-30 -53.92 -27.77 32.77 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.53 178.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.8 -38.91 20.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.868 0.842 . . . . 0.0 109.337 -177.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.628 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.7 mt -57.91 -56.08 17.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 114.172 -1.377 . . . . 0.0 112.463 174.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.764 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -102.78 -10.62 18.97 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -171.512 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . 0.589 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 94.12 31.73 7.89 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 119.46 -1.353 . . . . 0.0 114.241 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 469' ' ' LEU . . . . . 0.764 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.1 mt -89.69 164.06 14.86 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 117.718 0.759 . . . . 0.0 111.13 176.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 37.6 p30 -105.61 -178.69 3.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.816 171.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 471' ' ' ALA . . . . . 0.544 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -69.98 -5.99 30.17 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -174.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -96.75 0.67 49.87 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.9 0.381 . . . . 0.0 110.885 -178.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . 0.427 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 79.31 12.47 83.86 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.443 -0.884 . . . . 0.0 111.2 -175.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -100.19 157.35 16.65 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 178.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 12.7 p -95.28 127.95 41.74 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.066 0.46 . . . . 0.0 111.333 -178.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 476' ' ' ILE . . . . . 0.589 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.9 pp -98.71 5.69 9.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.788 0.804 . . . . 0.0 110.212 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -66.36 -30.8 71.27 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.443 -1.253 . . . . 0.0 110.515 176.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 84.3 mt 54.85 62.06 2.69 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.54 0.686 . . . . 0.0 110.688 177.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 . . . . . 0 C--O 1.25 1.093 0 CA-C-N 115.087 -0.961 . . . . 0.0 109.946 -179.766 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 381' ' ' ARG . . . . . 0.702 ' N ' ' HG ' ' B' ' 415' ' ' SER . 18.9 ptt180 . . . . . 0 N--CA 1.477 0.921 0 CA-C-O 120.476 0.179 . . . . 0.0 110.774 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 382' ' ' THR . . . . . 0.432 ' N ' ' HG3' ' B' ' 381' ' ' ARG . 0.1 OUTLIER 173.87 -45.97 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 123.04 0.536 . . . . 0.0 109.711 -176.116 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 383' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -132.49 131.43 41.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.589 177.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 384' ' ' GLY . . . . . . . . . . . . . . . -145.15 -136.15 2.96 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 177.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 385' ' ' THR . . . . . 0.433 HG21 ' HB3' ' A' ' 400' ' ' ASP . 26.0 m -68.8 -32.38 72.05 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 171.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 386' ' ' PHE . . . . . 0.793 ' CZ ' HG12 ' B' ' 394' ' ' VAL . 1.4 t80 -91.61 122.41 65.77 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 172.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 387' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -47.38 -75.32 0.03 OUTLIER 'Trans proline' 0 N--CA 1.481 0.763 0 C-N-CA 124.44 3.427 . . . . 0.0 115.164 -174.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 388' ' ' MET . . . . . 0.584 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 28.4 mtt 73.69 146.6 0.08 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.698 0.799 . . . . 0.0 111.116 -171.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 389' ' ' HIS . . . . . 0.541 ' CG ' ' HB2' ' B' ' 393' ' ' ASN . 32.8 m170 -49.19 -64.99 0.64 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.606 0.717 . . . . 0.0 109.569 178.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 390' ' ' GLN . . . . . 0.472 ' H ' HD23 ' B' ' 391' ' ' LEU . 3.7 pt20 -168.74 26.61 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.509 -1.223 . . . . 0.0 108.245 173.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 391' ' ' LEU . . . . . 0.638 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.1 pt? -177.98 -65.44 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -167.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 392' ' ' GLY . . . . . 0.638 ' N ' ' HG ' ' B' ' 391' ' ' LEU . . . -163.66 50.1 0.3 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.082 -168.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 393' ' ' ASN . . . . . 0.584 ' HB3' ' HA ' ' B' ' 388' ' ' MET . 0.4 OUTLIER -56.38 -37.77 70.55 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.901 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 394' ' ' VAL . . . . . 0.793 HG12 ' CZ ' ' B' ' 386' ' ' PHE . 0.9 OUTLIER -56.22 -47.36 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 178.705 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 395' ' ' ILE . . . . . 0.647 HG23 HD13 ' B' ' 426' ' ' ILE . 4.3 mp -57.81 -51.67 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 CA-C-O 118.034 -0.984 . . . . 0.0 112.946 -174.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 396' ' ' LYS . . . . . 0.674 ' HG3' ' CZ ' ' B' ' 429' ' ' TYR . 0.2 OUTLIER -62.53 -48.8 77.93 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 121.482 1.946 . . . . 0.0 111.537 -174.219 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -55.24 -45.59 82.21 Favored Glycine 0 N--CA 1.434 -1.452 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.132 -179.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . 0.739 ' CD1' HD12 ' B' ' 410' ' ' LEU . 28.1 mt -70.34 -33.8 55.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -177.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 399' ' ' VAL . . . . . 0.513 HG12 ' HA ' ' B' ' 404' ' ' VAL . 12.0 m -63.9 -39.47 85.56 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 C-N-CA 118.754 -1.178 . . . . 0.0 108.489 -174.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 400' ' ' ASP . . . . . 0.433 ' HB3' HG21 ' A' ' 385' ' ' THR . 37.3 t70 -70.12 -36.63 74.95 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 175.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 401' ' ' GLN . . . . . . . . . . . . . 3.0 mm100 -87.47 -48.11 8.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.966 0.412 . . . . 0.0 111.988 -171.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 402' ' ' GLU . . . . . 0.576 ' HG3' ' HE3' ' A' ' 413' ' ' MET . 2.0 mm-40 -121.27 -21.02 6.5 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.678 -170.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 108.33 162.77 20.83 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.905 -0.664 . . . . 0.0 113.096 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 404' ' ' VAL . . . . . 0.624 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.5 m -53.71 -41.56 47.87 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.751 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -176.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 405' ' ' ALA . . . . . 0.645 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -69.32 -30.36 68.39 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 119.649 -0.821 . . . . 0.0 111.725 -175.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 406' ' ' THR . . . . . 0.705 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 93.8 m -77.56 -42.39 35.49 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 174.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 407' ' ' ALA . . . . . 0.465 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.41 -37.12 74.69 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 122.104 0.954 . . . . 0.0 108.935 176.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 408' ' ' TYR . . . . . 0.624 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.51 -52.4 52.95 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 113.492 -1.686 . . . . 0.0 110.046 176.534 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 409' ' ' THR . . . . . 0.723 HG22 HD23 ' B' ' 410' ' ' LEU . 3.3 m -55.79 -46.64 77.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.582 178.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 410' ' ' LEU . . . . . 0.739 HD12 ' CD1' ' B' ' 398' ' ' ILE . 13.8 mt -72.05 -36.04 69.5 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.124 0.488 . . . . 0.0 110.314 -174.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -59.59 -34.86 83.54 Favored Glycine 0 N--CA 1.439 -1.142 0 C-N-CA 120.213 -0.994 . . . . 0.0 110.825 171.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 412' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -68.24 -43.78 77.14 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.517 0.191 . . . . 0.0 111.517 178.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 413' ' ' MET . . . . . 0.718 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.0 OUTLIER -70.52 -57.69 4.5 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 118.772 -1.171 . . . . 0.0 111.546 179.721 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 414' ' ' LEU . . . . . 0.718 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 4.7 mt -67.24 -43.74 81.18 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 -172.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 415' ' ' SER . . . . . 0.702 ' HG ' ' N ' ' B' ' 381' ' ' ARG . 5.3 t -95.28 18.03 13.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.421 0.629 . . . . 0.0 110.108 -174.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 416' ' ' GLY . . . . . . . . . . . . . . . 73.08 -178.29 40.96 Favored Glycine 0 N--CA 1.438 -1.186 0 C-N-CA 120.427 -0.892 . . . . 0.0 111.659 -178.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -80.46 23.22 0.51 Allowed 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.009 0.433 . . . . 0.0 111.493 -173.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 418' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -71.58 77.9 0.81 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.834 -179.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 419' ' ' TYR . . . . . 0.54 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 14.5 p90 -54.88 -37.6 66.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.482 178.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -54.97 -43.12 73.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.723 0.297 . . . . 0.0 110.651 177.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.46 -48.79 63.6 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.148 -178.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 422' ' ' VAL . . . . . 0.482 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.3 OUTLIER -66.34 -40.66 87.28 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 C-N-CA 120.261 -0.576 . . . . 0.0 111.13 -177.17 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 423' ' ' SER . . . . . 0.742 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 69.4 p -67.03 -38.13 85.36 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.659 -0.416 . . . . 0.0 109.903 -178.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -67.42 -40.02 91.42 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.321 175.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 425' ' ' ILE . . . . . 0.605 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -72.68 -50.24 35.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.553 0.216 . . . . 0.0 110.887 -177.096 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 426' ' ' ILE . . . . . 0.693 HG22 HD22 ' B' ' 430' ' ' LEU . 1.2 mm -74.55 -22.57 17.64 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.815 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -172.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 427' ' ' ARG . . . . . 0.742 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.9 OUTLIER -54.75 -30.61 56.85 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.139 0.495 . . . . 0.0 110.701 -178.563 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -86.57 -8.91 76.32 Favored Glycine 0 N--CA 1.443 -0.89 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.456 178.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 429' ' ' TYR . . . . . 0.674 ' CZ ' ' HG3' ' B' ' 396' ' ' LYS . 22.9 m-85 -116.28 0.98 13.02 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-O 121.089 0.471 . . . . 0.0 110.509 -177.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 430' ' ' LEU . . . . . 0.693 HD22 HG22 ' B' ' 426' ' ' ILE . 0.1 OUTLIER -65.68 127.4 93.02 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.394 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 431' ' ' PRO . . . . . 0.466 ' HD2' HD12 ' B' ' 430' ' ' LEU . 86.1 Cg_exo -22.73 -75.44 0.02 OUTLIER 'Trans proline' 0 C--N 1.358 1.06 1 C-N-CA 125.617 4.211 . . . . 0.0 114.699 -179.246 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 432' ' ' GLY . . . . . 0.507 ' O ' HG12 ' B' ' 435' ' ' VAL . . . -128.84 -166.69 12.01 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 173.015 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 433' ' ' GLN . . . . . 0.591 ' O ' HG13 ' B' ' 436' ' ' VAL . 21.9 tt0 -71.44 -26.43 62.73 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 118.854 1.327 . . . . 0.0 110.571 176.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -62.58 -38.09 88.73 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -176.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 435' ' ' VAL . . . . . 0.774 HG23 HG11 ' B' ' 463' ' ' VAL . 7.5 p -69.77 -43.53 79.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 120.784 0.326 . . . . 0.0 110.57 -179.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 436' ' ' VAL . . . . . 0.591 HG13 ' O ' ' B' ' 433' ' ' GLN . 0.2 OUTLIER -66.35 -30.12 48.84 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 CA-C-O 120.895 0.379 . . . . 0.0 110.366 175.058 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 437' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -69.27 -51.97 32.15 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 -178.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 438' ' ' ALA . . . . . 0.837 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -57.5 -43.1 83.9 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.005 176.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 439' ' ' LEU . . . . . 0.635 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 2.0 tm? -65.22 -47.27 77.44 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -176.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.01 -39.01 77.25 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.235 174.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 441' ' ' GLN . . . . . 0.583 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 8.5 mm-40 -56.93 -50.43 72.6 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 123.368 0.667 . . . . 0.0 110.617 176.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 442' ' ' ARG . . . . . 0.707 ' HG2' ' O ' ' B' ' 438' ' ' ALA . 0.0 OUTLIER -58.76 -33.64 70.52 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.9 172.606 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 443' ' ' LEU . . . . . 0.635 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 58.8 mt -72.18 -33.93 68.05 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.037 0.446 . . . . 0.0 110.129 178.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -57.62 -36.82 72.29 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.56 172.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -72.62 -27.36 62.1 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.866 177.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 446' ' ' GLU . . . . . 0.562 ' HB2' ' O ' ' B' ' 443' ' ' LEU . 39.5 tt0 29.79 96.47 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 170.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 52.2 mt -68.28 -35.45 71.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.109 0.48 . . . . 0.0 110.798 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 448' ' ' ASP . . . . . 0.558 ' O ' ' HG3' ' B' ' 452' ' ' ARG . 37.2 m-20 -165.61 -166.57 0.98 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 -178.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -80.1 -63.47 1.4 Allowed 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.472 172.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.85 -25.96 63.99 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 178.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 451' ' ' THR . . . . . 0.432 ' HA ' ' HB2' ' B' ' 454' ' ' GLU . 14.1 m -71.78 -22.44 61.58 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.664 -175.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 452' ' ' ARG . . . . . 0.558 ' HG3' ' O ' ' B' ' 448' ' ' ASP . 11.2 mtp180 -53.11 -54.56 33.91 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 170.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 453' ' ' ALA . . . . . 0.54 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -57.97 -50.09 74.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.378 -1.283 . . . . 0.0 112.688 175.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 454' ' ' GLU . . . . . 0.432 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 30.5 mm-40 -50.03 -38.36 37.32 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.472 0.653 . . . . 0.0 111.535 -176.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 32.0 p -117.42 16.11 14.72 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.226 -176.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 456' ' ' PHE . . . . . 0.581 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 1.1 t80 -55.75 -47.27 77.28 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.188 0.518 . . . . 0.0 111.489 -171.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 457' ' ' ILE . . . . . 0.645 HG23 ' HB1' ' B' ' 405' ' ' ALA . 2.0 mp -75.66 -32.08 24.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.816 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -58.3 -35.94 72.59 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.733 0.778 . . . . 0.0 109.357 171.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 459' ' ' HIS . . . . . 0.707 ' O ' HG23 ' B' ' 463' ' ' VAL . 82.4 m-70 -72.42 -29.1 63.41 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.213 178.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 460' ' ' LEU . . . . . 0.747 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -74.55 -34.62 62.98 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.858 0.837 . . . . 0.0 108.911 179.16 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 461' ' ' ASN . . . . . 0.435 ' HA ' ' CD2' ' B' ' 464' ' ' TYR . 22.4 m-80 -72.89 -37.89 67.13 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.253 176.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 462' ' ' ALA . . . . . 0.629 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -56.58 -33.17 65.91 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.529 -1.214 . . . . 0.0 109.802 169.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 463' ' ' VAL . . . . . 0.837 HG13 ' HB3' ' B' ' 438' ' ' ALA . 64.6 t -62.33 -50.68 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 175.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 464' ' ' TYR . . . . . 0.547 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 16.1 m-30 -54.07 -27.51 33.04 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.623 178.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.82 -38.94 20.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.908 0.861 . . . . 0.0 109.413 -177.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 466' ' ' ILE . . . . . 0.629 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.8 mt -58.12 -56.2 17.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 114.125 -1.398 . . . . 0.0 112.395 174.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 467' ' ' LEU . . . . . 0.777 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -102.8 -10.39 19.16 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -171.532 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 468' ' ' GLY . . . . . 0.588 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 94.0 31.64 7.99 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 119.344 -1.408 . . . . 0.0 114.205 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 469' ' ' LEU . . . . . 0.777 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.2 mt -89.77 164.03 14.83 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 117.788 0.794 . . . . 0.0 111.152 176.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 37.1 p30 -105.57 -178.44 3.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.746 171.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 471' ' ' ALA . . . . . 0.523 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -70.23 -5.65 29.09 Favored 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -174.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 472' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' B' ' 472' ' ' ARG . 21.3 mmt180 -97.08 1.13 49.66 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.019 0.438 . . . . 0.0 110.891 -178.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 473' ' ' GLY . . . . . 0.426 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 78.95 12.66 83.91 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.36 -0.924 . . . . 0.0 111.079 -175.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -100.39 157.47 16.6 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 9.6 p -95.12 127.88 41.52 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.252 0.549 . . . . 0.0 111.448 -178.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 476' ' ' ILE . . . . . 0.588 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.9 pp -98.76 5.62 9.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.579 0.704 . . . . 0.0 110.205 179.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 477' ' ' ARG . . . . . . . . . . . . . 27.5 mmm180 -66.08 -31.29 72.07 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.508 176.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 478' ' ' LEU . . . . . . . . . . . . . 84.1 mt 55.43 61.83 2.71 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.476 0.655 . . . . 0.0 110.647 177.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 479' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 . . . . . 0 C--O 1.25 1.097 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.094 -179.493 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 381' ' ' ARG . . . . . 0.445 ' HD2' ' OD1' ' A' ' 418' ' ' ASN . 10.4 ptp180 . . . . . 0 N--CA 1.479 1.022 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.89 -31.2 1.17 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -176.366 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 383' ' ' HIS . . . . . 0.483 ' HB2' ' O ' ' A' ' 386' ' ' PHE . 1.3 p80 -150.76 160.93 43.53 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.022 -0.671 . . . . 0.0 112.028 -169.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -106.66 -109.71 3.41 Favored Glycine 0 N--CA 1.44 -1.059 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 168.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 39.1 m -74.04 -31.59 62.95 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.931 0.396 . . . . 0.0 111.175 177.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 386' ' ' PHE . . . . . 0.77 ' CD1' HD22 ' A' ' 414' ' ' LEU . 2.0 t80 -74.74 126.49 88.44 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 121.104 0.478 . . . . 0.0 110.789 -178.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . 0.542 ' HG2' ' OD1' ' B' ' 393' ' ' ASN . 61.7 Cg_endo -72.12 110.02 2.84 Favored 'Trans proline' 0 N--CA 1.481 0.738 0 C-N-CA 124.183 3.255 . . . . 0.0 114.104 175.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.449 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 32.8 mtt -104.07 169.07 8.71 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 121.991 -0.443 . . . . 0.0 110.109 175.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 389' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -54.84 -62.6 1.55 Allowed 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 177.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -172.3 17.31 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.625 -1.171 . . . . 0.0 108.27 172.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.612 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 1.9 pt? -165.91 -66.15 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.24 -167.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . 0.612 ' N ' ' HG ' ' A' ' 391' ' ' LEU . . . -162.8 54.87 0.3 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.409 -0.9 . . . . 0.0 113.173 -173.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . 0.548 ' OD1' ' HG2' ' B' ' 387' ' ' PRO . 0.2 OUTLIER -54.31 -42.25 69.91 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.455 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.741 HG12 ' CZ ' ' A' ' 386' ' ' PHE . 0.7 OUTLIER -57.03 -46.22 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -179.48 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.647 HG23 HD13 ' A' ' 426' ' ' ILE . 4.2 mp -57.55 -51.77 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.247 0 CA-C-O 118.009 -0.996 . . . . 0.0 112.887 -174.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . 0.667 ' HG3' ' CZ ' ' A' ' 429' ' ' TYR . 0.1 OUTLIER -62.22 -48.82 78.29 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 121.446 1.93 . . . . 0.0 111.698 -175.163 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -54.95 -45.56 80.5 Favored Glycine 0 N--CA 1.436 -1.341 0 C-N-CA 119.84 -1.171 . . . . 0.0 111.229 -178.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . 0.733 HG12 HD21 ' B' ' 414' ' ' LEU . 26.3 mt -70.88 -34.11 54.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -177.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 396' ' ' LYS . 13.1 m -63.99 -39.38 85.24 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.499 0 C-N-CA 118.784 -1.166 . . . . 0.0 108.43 -174.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -71.0 -34.87 71.77 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 175.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.467 HE21 ' HB3' ' A' ' 401' ' ' GLN . 4.1 mm100 -88.79 -48.0 7.81 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -172.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . 0.583 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 1.3 mm-40 -121.2 -20.55 6.7 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.609 -170.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 107.27 162.28 21.72 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.702 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . 0.604 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.8 m -53.77 -46.18 62.5 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.739 0 N-CA-C 114.946 1.462 . . . . 0.0 114.946 -175.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . 0.535 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -64.0 -29.88 71.0 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 119.778 -0.769 . . . . 0.0 112.379 -177.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.732 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 93.2 m -77.51 -42.56 35.19 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.119 -0.632 . . . . 0.0 110.204 172.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.464 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.28 -37.22 74.56 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 122.232 1.015 . . . . 0.0 109.25 176.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 408' ' ' TYR . . . . . 0.604 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.67 -52.02 54.87 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 113.351 -1.75 . . . . 0.0 109.933 176.382 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 409' ' ' THR . . . . . 0.654 HG22 HD23 ' A' ' 410' ' ' LEU . 16.5 m -55.12 -47.11 75.47 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.479 179.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . 0.732 ' HG ' ' O ' ' A' ' 406' ' ' THR . 14.7 mt -72.69 -36.92 67.96 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.282 -174.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.74 -34.95 79.51 Favored Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.123 -1.036 . . . . 0.0 110.813 172.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 412' ' ' MET . . . . . 0.401 ' HB2' ' O ' ' A' ' 409' ' ' THR . 0.4 OUTLIER -66.61 -44.78 81.16 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 115.734 -0.233 . . . . 0.0 111.441 177.962 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 413' ' ' MET . . . . . 0.765 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.0 OUTLIER -70.82 -57.1 4.97 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 118.675 -1.21 . . . . 0.0 111.668 179.135 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . 0.77 HD22 ' CD1' ' A' ' 386' ' ' PHE . 6.8 mt -64.58 -43.18 94.68 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -171.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 32.8 t -86.03 -16.84 36.94 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.734 0.778 . . . . 0.0 109.816 -177.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 100.79 -175.34 26.38 Favored Glycine 0 N--CA 1.429 -1.773 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -170.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 34.0 mm-40 -79.65 24.03 0.39 Allowed 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.207 0.527 . . . . 0.0 111.645 -171.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 418' ' ' ASN . . . . . 0.445 ' OD1' ' HD2' ' A' ' 381' ' ' ARG . 61.2 m-80 -71.4 75.96 0.76 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.146 -178.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 419' ' ' TYR . . . . . 0.515 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 7.4 p90 -50.39 -38.54 43.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.933 173.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -54.27 -46.78 72.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.886 178.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.16 -48.98 60.8 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.188 -176.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . 0.406 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.2 OUTLIER -66.37 -40.02 85.62 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 C-N-CA 120.368 -0.533 . . . . 0.0 111.146 -175.509 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.703 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 78.2 p -67.31 -38.57 85.2 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.607 -0.437 . . . . 0.0 109.976 -178.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -69.56 -37.61 78.11 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.071 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . 0.604 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -73.34 -51.9 23.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.466 0.174 . . . . 0.0 111.113 -178.018 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . 0.647 HD13 HG23 ' A' ' 395' ' ' ILE . 1.2 mm -74.4 -23.35 18.19 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.829 0 CA-C-O 120.835 0.35 . . . . 0.0 110.241 -171.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.703 ' HB2' ' O ' ' A' ' 423' ' ' SER . 1.0 OUTLIER -54.62 -29.33 51.68 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.165 0.507 . . . . 0.0 110.602 179.773 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -86.35 -8.38 77.97 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.858 178.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.667 ' CZ ' ' HG3' ' A' ' 396' ' ' LYS . 24.2 m-85 -117.51 -1.09 11.75 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-O 121.465 0.65 . . . . 0.0 110.272 -178.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.593 HD12 ' HD2' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -65.99 132.78 94.71 Favored Pre-proline 0 N--CA 1.437 -1.118 0 CA-C-N 114.624 -1.171 . . . . 0.0 108.624 179.241 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . 0.829 ' CD ' HG11 ' A' ' 435' ' ' VAL . 42.4 Cg_exo -35.17 -72.36 0.05 OUTLIER 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 124.847 3.698 . . . . 0.0 113.984 -170.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . 0.455 ' O ' HG12 ' A' ' 435' ' ' VAL . . . -131.38 -162.49 10.57 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 175.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . 0.523 ' O ' HG13 ' A' ' 436' ' ' VAL . 22.3 tp60 -71.29 -27.6 63.53 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 118.088 0.944 . . . . 0.0 110.459 177.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -68.23 -37.92 81.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.164 -175.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 435' ' ' VAL . . . . . 0.829 HG11 ' CD ' ' A' ' 431' ' ' PRO . 6.7 p -68.45 -46.63 80.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-O 120.979 0.419 . . . . 0.0 110.438 -178.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.523 HG13 ' O ' ' A' ' 433' ' ' GLN . 0.2 OUTLIER -63.47 -31.08 51.55 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.321 175.702 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 437' ' ' THR . . . . . 0.573 ' O ' ' HG3' ' A' ' 441' ' ' GLN . 1.0 OUTLIER -69.03 -52.94 23.46 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 -178.028 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . 0.891 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -59.43 -36.06 75.19 Favored 'General case' 0 N--CA 1.436 -1.15 0 O-C-N 124.01 0.819 . . . . 0.0 112.01 178.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 439' ' ' LEU . . . . . 0.585 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 1.9 tm? -70.24 -47.91 59.28 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.47 -36.43 75.97 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.18 176.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 441' ' ' GLN . . . . . 0.573 ' HG3' ' O ' ' A' ' 437' ' ' THR . 43.4 mt-30 -54.33 -51.47 64.61 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.106 178.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . 0.497 ' HG3' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -62.47 -36.87 83.84 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.839 174.869 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 443' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 61.4 mt -66.57 -37.36 84.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.007 0.432 . . . . 0.0 110.195 179.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -57.68 -37.81 74.08 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.563 173.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -72.53 -27.48 62.26 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.533 178.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 446' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 443' ' ' LEU . 37.9 tt0 33.55 101.18 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 114.56 1.318 . . . . 0.0 114.56 170.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 54.6 mt -69.87 -35.26 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-O 121.054 0.454 . . . . 0.0 110.745 178.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . 0.521 ' O ' ' HG3' ' A' ' 452' ' ' ARG . 16.6 m-20 -168.35 -167.42 0.8 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -176.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -77.06 -69.98 0.49 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.039 0.447 . . . . 0.0 109.807 172.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.86 -25.06 66.23 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 178.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 451' ' ' THR . . . . . 0.501 ' OG1' ' HB2' ' A' ' 448' ' ' ASP . 11.7 m -70.89 -22.91 62.21 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 119.989 -0.685 . . . . 0.0 110.86 -174.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . 0.521 ' HG3' ' O ' ' A' ' 448' ' ' ASP . 11.6 mtp180 -53.61 -54.0 43.86 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 170.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 453' ' ' ALA . . . . . 0.515 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -58.88 -47.04 86.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.557 -1.201 . . . . 0.0 112.656 175.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . 0.443 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 23.6 mm-40 -52.41 -36.17 53.58 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.175 0.512 . . . . 0.0 111.462 -178.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 29.5 p -118.38 15.61 13.87 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.449 -176.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . 0.553 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.9 OUTLIER -56.83 -48.69 77.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.05 0.452 . . . . 0.0 111.54 -171.704 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . 0.553 ' CG1' ' HB3' ' A' ' 408' ' ' TYR . 1.9 mp -76.11 -32.0 22.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.8 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -57.46 -37.08 72.28 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.672 0.749 . . . . 0.0 109.325 171.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . 0.774 ' O ' HG23 ' A' ' 463' ' ' VAL . 79.3 m-70 -72.32 -29.14 63.56 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.365 178.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . 0.73 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -74.18 -35.38 63.97 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.954 0.883 . . . . 0.0 108.992 179.688 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . 0.495 ' O ' ' HB2' ' A' ' 464' ' ' TYR . 23.7 m-80 -73.13 -37.67 66.56 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.362 -0.835 . . . . 0.0 108.977 176.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 462' ' ' ALA . . . . . 0.613 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -56.98 -33.58 67.23 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.586 -1.188 . . . . 0.0 109.931 169.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.891 HG13 ' HB3' ' A' ' 438' ' ' ALA . 55.2 t -62.66 -50.29 80.36 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.893 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 175.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 464' ' ' TYR . . . . . 0.6 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 20.7 m-30 -52.89 -29.57 29.07 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.481 177.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.37 -38.71 19.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.75 0.786 . . . . 0.0 109.636 -176.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.613 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.6 mt -56.8 -55.98 16.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 114.289 -1.323 . . . . 0.0 112.271 174.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.782 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -102.14 -10.07 19.96 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -171.94 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . 0.564 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 94.72 31.39 7.83 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 119.481 -1.342 . . . . 0.0 114.345 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 469' ' ' LEU . . . . . 0.782 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 4.2 mt -89.75 160.45 16.54 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 117.862 0.831 . . . . 0.0 110.889 174.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . 0.607 HD22 ' C ' ' A' ' 470' ' ' ASN . 0.2 OUTLIER -105.53 -178.24 3.6 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.4 170.948 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 471' ' ' ALA . . . . . 0.447 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -56.91 -27.9 61.33 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -174.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -85.08 8.46 17.91 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -171.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 74.01 9.08 79.63 Favored Glycine 0 CA--C 1.519 0.344 0 C-N-CA 120.313 -0.946 . . . . 0.0 111.642 -177.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -100.14 155.08 17.93 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 177.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 469' ' ' LEU . 59.9 p -91.43 136.73 32.9 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.348 0.594 . . . . 0.0 110.837 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 476' ' ' ILE . . . . . 0.564 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.7 pp -94.45 -19.41 6.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.468 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 477' ' ' ARG . . . . . 0.524 ' O ' ' HD3' ' A' ' 477' ' ' ARG . 0.0 OUTLIER -96.07 162.1 13.69 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.857 174.015 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 97.9 mt -126.28 143.08 51.28 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.968 0.413 . . . . 0.0 110.665 -177.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.407 -0.806 . . . . 0.0 109.67 176.543 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 381' ' ' ARG . . . . . 0.435 ' HD2' ' OD1' ' B' ' 418' ' ' ASN . 10.4 ptp180 . . . . . 0 N--CA 1.48 1.056 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 382' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.43 -31.05 1.1 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -176.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 383' ' ' HIS . . . . . 0.473 ' HB2' ' O ' ' B' ' 386' ' ' PHE . 1.3 p80 -151.08 161.06 43.45 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 119.935 -0.706 . . . . 0.0 112.003 -169.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 384' ' ' GLY . . . . . . . . . . . . . . . -106.82 -110.04 3.44 Favored Glycine 0 N--CA 1.439 -1.128 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 168.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 385' ' ' THR . . . . . . . . . . . . . 34.8 m -73.44 -32.53 64.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.907 0.384 . . . . 0.0 111.083 177.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 386' ' ' PHE . . . . . 0.783 ' CD1' HD22 ' B' ' 414' ' ' LEU . 2.0 t80 -74.0 126.62 89.17 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 121.061 0.457 . . . . 0.0 110.846 -178.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 387' ' ' PRO . . . . . 0.548 ' HG2' ' OD1' ' A' ' 393' ' ' ASN . 61.5 Cg_endo -72.23 110.23 2.91 Favored 'Trans proline' 0 N--CA 1.479 0.645 0 C-N-CA 124.166 3.244 . . . . 0.0 114.107 175.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 388' ' ' MET . . . . . 0.436 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 33.1 mtt -104.3 169.08 8.69 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 122.103 -0.373 . . . . 0.0 110.127 175.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 389' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -54.98 -62.45 1.65 Allowed 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 177.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -172.35 17.06 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.736 -1.12 . . . . 0.0 108.311 172.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 391' ' ' LEU . . . . . 0.606 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.0 pt? -165.82 -66.18 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.269 -167.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 392' ' ' GLY . . . . . 0.606 ' N ' ' HG ' ' B' ' 391' ' ' LEU . . . -162.83 54.96 0.3 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.432 -0.889 . . . . 0.0 113.169 -173.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 393' ' ' ASN . . . . . 0.542 ' OD1' ' HG2' ' A' ' 387' ' ' PRO . 0.2 OUTLIER -54.3 -42.37 70.0 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 178.41 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 394' ' ' VAL . . . . . 0.751 HG12 ' CZ ' ' B' ' 386' ' ' PHE . 0.7 OUTLIER -56.95 -46.15 83.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -179.388 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 395' ' ' ILE . . . . . 0.64 HG23 HD13 ' B' ' 426' ' ' ILE . 4.2 mp -57.59 -51.8 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-O 117.991 -1.004 . . . . 0.0 112.81 -174.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 396' ' ' LYS . . . . . 0.671 ' HG3' ' CZ ' ' B' ' 429' ' ' TYR . 0.1 OUTLIER -62.17 -49.03 77.45 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 121.487 1.949 . . . . 0.0 111.719 -175.142 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -54.77 -45.59 78.7 Favored Glycine 0 N--CA 1.437 -1.252 0 C-N-CA 119.84 -1.171 . . . . 0.0 111.209 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . 0.726 HG12 HD21 ' A' ' 414' ' ' LEU . 26.8 mt -70.94 -34.19 54.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 113.361 0.875 . . . . 0.0 113.361 -177.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 399' ' ' VAL . . . . . 0.478 HG12 ' HA ' ' B' ' 404' ' ' VAL . 13.5 m -63.82 -39.44 85.43 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.481 0 C-N-CA 118.774 -1.17 . . . . 0.0 108.56 -174.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -70.98 -34.83 71.78 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 175.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 401' ' ' GLN . . . . . 0.41 HE21 ' HB3' ' B' ' 401' ' ' GLN . 4.2 mm100 -89.06 -47.61 7.99 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -172.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 402' ' ' GLU . . . . . 0.588 ' HG3' ' HE3' ' A' ' 413' ' ' MET . 1.3 mm-40 -121.64 -20.47 6.5 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.026 0.441 . . . . 0.0 111.489 -170.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 107.12 162.31 21.87 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.736 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 404' ' ' VAL . . . . . 0.592 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.8 m -53.72 -46.38 62.05 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.792 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -175.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 405' ' ' ALA . . . . . 0.539 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -63.87 -29.88 71.02 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 119.639 -0.825 . . . . 0.0 112.464 -177.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 406' ' ' THR . . . . . 0.727 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 89.1 m -77.38 -42.78 35.12 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.149 172.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 407' ' ' ALA . . . . . 0.465 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.17 -37.19 74.23 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 122.248 1.023 . . . . 0.0 109.317 176.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 408' ' ' TYR . . . . . 0.592 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.79 -51.97 54.69 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 113.279 -1.782 . . . . 0.0 109.86 176.48 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 409' ' ' THR . . . . . 0.647 HG22 HD23 ' B' ' 410' ' ' LEU . 16.6 m -55.23 -47.08 75.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.427 179.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 410' ' ' LEU . . . . . 0.727 ' HG ' ' O ' ' B' ' 406' ' ' THR . 14.7 mt -72.72 -36.82 67.87 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.312 -174.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.84 -34.89 79.97 Favored Glycine 0 N--CA 1.44 -1.074 0 C-N-CA 120.175 -1.012 . . . . 0.0 110.72 172.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 412' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -66.79 -44.52 81.09 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 115.839 -0.18 . . . . 0.0 111.458 177.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 413' ' ' MET . . . . . 0.762 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.0 OUTLIER -70.99 -56.9 5.18 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 118.66 -1.216 . . . . 0.0 111.701 179.035 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 414' ' ' LEU . . . . . 0.783 HD22 ' CD1' ' B' ' 386' ' ' PHE . 6.8 mt -64.71 -43.17 94.31 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -171.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 33.1 t -86.29 -16.45 37.5 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.76 0.791 . . . . 0.0 109.745 -176.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 416' ' ' GLY . . . . . 0.407 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 100.41 -175.54 26.99 Favored Glycine 0 N--CA 1.429 -1.831 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -171.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -79.48 24.13 0.37 Allowed 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.251 0.548 . . . . 0.0 111.742 -171.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 418' ' ' ASN . . . . . 0.435 ' OD1' ' HD2' ' B' ' 381' ' ' ARG . 62.5 m-80 -71.55 75.99 0.8 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.025 -179.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 419' ' ' TYR . . . . . 0.523 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 7.3 p90 -50.39 -38.49 42.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.936 173.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -54.37 -46.56 73.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.939 178.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.25 -49.03 59.96 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.249 -177.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 422' ' ' VAL . . . . . 0.41 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.2 OUTLIER -66.31 -40.08 85.86 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.212 -175.514 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 423' ' ' SER . . . . . 0.72 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 78.0 p -67.3 -38.56 85.18 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.921 -178.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -69.71 -37.45 76.5 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.11 177.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 425' ' ' ILE . . . . . 0.621 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -73.46 -52.03 23.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.488 0.185 . . . . 0.0 111.186 -178.259 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 426' ' ' ILE . . . . . 0.64 HD13 HG23 ' B' ' 395' ' ' ILE . 1.2 mm -74.13 -23.38 18.6 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.797 0 CA-C-O 120.82 0.343 . . . . 0.0 110.226 -171.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 427' ' ' ARG . . . . . 0.72 ' HB2' ' O ' ' B' ' 423' ' ' SER . 0.9 OUTLIER -54.68 -29.11 51.84 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.122 0.487 . . . . 0.0 110.666 179.913 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -86.55 -8.75 76.68 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.756 178.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 429' ' ' TYR . . . . . 0.671 ' CZ ' ' HG3' ' B' ' 396' ' ' LYS . 24.3 m-85 -117.1 -0.82 12.02 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 121.465 0.65 . . . . 0.0 110.156 -178.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 430' ' ' LEU . . . . . 0.614 HD12 ' HD2' ' B' ' 431' ' ' PRO . 0.0 OUTLIER -66.07 132.97 94.66 Favored Pre-proline 0 N--CA 1.438 -1.054 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.54 179.27 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 431' ' ' PRO . . . . . 0.828 ' CD ' HG11 ' B' ' 435' ' ' VAL . 42.6 Cg_exo -35.23 -71.73 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 124.76 3.64 . . . . 0.0 114.054 -170.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 432' ' ' GLY . . . . . 0.441 ' O ' HG12 ' B' ' 435' ' ' VAL . . . -131.99 -162.15 10.32 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 175.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 433' ' ' GLN . . . . . 0.535 ' O ' HG13 ' B' ' 436' ' ' VAL . 22.5 tp60 -71.58 -27.82 63.41 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 118.119 0.96 . . . . 0.0 110.447 177.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -68.06 -38.08 82.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.215 -0.448 . . . . 0.0 112.065 -175.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 435' ' ' VAL . . . . . 0.828 HG11 ' CD ' ' B' ' 431' ' ' PRO . 6.7 p -68.17 -46.73 80.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-O 121.068 0.461 . . . . 0.0 110.46 -178.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 436' ' ' VAL . . . . . 0.535 HG13 ' O ' ' B' ' 433' ' ' GLN . 0.2 OUTLIER -63.32 -31.44 52.81 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.191 175.759 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 437' ' ' THR . . . . . 0.575 ' O ' ' HG3' ' B' ' 441' ' ' GLN . 1.0 OUTLIER -68.87 -52.74 26.42 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -177.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 438' ' ' ALA . . . . . 0.89 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -59.51 -36.12 75.46 Favored 'General case' 0 N--CA 1.435 -1.193 0 O-C-N 124.132 0.895 . . . . 0.0 112.04 178.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 439' ' ' LEU . . . . . 0.588 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 1.9 tm? -70.22 -47.93 59.3 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.43 -36.32 75.69 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.154 175.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 441' ' ' GLN . . . . . 0.575 ' HG3' ' O ' ' B' ' 437' ' ' THR . 43.9 mt-30 -54.44 -51.66 64.26 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 123.755 0.822 . . . . 0.0 110.034 178.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 442' ' ' ARG . . . . . 0.486 ' HG3' ' O ' ' B' ' 438' ' ' ALA . 0.0 OUTLIER -62.4 -36.69 83.11 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.461 -0.791 . . . . 0.0 112.855 174.942 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 443' ' ' LEU . . . . . 0.588 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 61.2 mt -66.6 -37.33 84.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.17 0.51 . . . . 0.0 110.237 179.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -57.82 -37.69 74.24 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.675 173.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -72.58 -27.39 62.16 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.497 -1.229 . . . . 0.0 110.595 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 446' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' B' ' 443' ' ' LEU . 37.9 tt0 33.41 101.52 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 170.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 54.9 mt -70.35 -35.35 62.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.074 0.464 . . . . 0.0 110.616 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 448' ' ' ASP . . . . . 0.514 ' O ' ' HG3' ' B' ' 452' ' ' ARG . 17.6 m-20 -168.17 -167.27 0.8 Allowed 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 -176.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -77.2 -70.15 0.48 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 173.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.79 -25.08 66.3 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 178.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 451' ' ' THR . . . . . 0.489 ' OG1' ' HB2' ' B' ' 448' ' ' ASP . 13.1 m -70.95 -22.82 62.16 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.688 -174.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 452' ' ' ARG . . . . . 0.514 ' HG3' ' O ' ' B' ' 448' ' ' ASP . 11.7 mtp180 -53.7 -53.92 45.23 Favored 'General case' 0 C--O 1.219 -0.552 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 171.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 453' ' ' ALA . . . . . 0.523 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -58.8 -47.28 85.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.517 -1.22 . . . . 0.0 112.666 175.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 454' ' ' GLU . . . . . 0.438 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 22.7 mm-40 -52.39 -36.07 53.12 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.321 0.581 . . . . 0.0 111.488 -178.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 29.4 p -118.3 15.58 13.94 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.397 -176.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 456' ' ' PHE . . . . . 0.551 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 0.9 OUTLIER -56.88 -48.89 77.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.054 0.454 . . . . 0.0 111.474 -171.712 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 457' ' ' ILE . . . . . 0.564 ' CG1' ' HB3' ' B' ' 408' ' ' TYR . 1.9 mp -75.97 -31.9 22.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.875 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -57.6 -37.06 72.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.693 0.759 . . . . 0.0 109.355 171.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 459' ' ' HIS . . . . . 0.777 ' O ' HG23 ' B' ' 463' ' ' VAL . 79.0 m-70 -72.36 -28.97 63.37 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.385 178.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 460' ' ' LEU . . . . . 0.746 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.4 OUTLIER -74.25 -35.4 63.8 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.909 0.861 . . . . 0.0 108.974 179.655 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 461' ' ' ASN . . . . . 0.486 ' O ' ' HB2' ' B' ' 464' ' ' TYR . 23.2 m-80 -73.3 -37.36 66.22 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.864 0.84 . . . . 0.0 109.087 176.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 462' ' ' ALA . . . . . 0.612 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -57.11 -33.65 67.56 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.493 -1.23 . . . . 0.0 109.891 169.098 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 463' ' ' VAL . . . . . 0.89 HG13 ' HB3' ' B' ' 438' ' ' ALA . 55.9 t -62.53 -50.4 79.98 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.871 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 175.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 464' ' ' TYR . . . . . 0.603 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 20.7 m-30 -52.79 -29.45 27.5 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.481 177.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.41 -38.95 19.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.701 0.762 . . . . 0.0 109.601 -176.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 466' ' ' ILE . . . . . 0.612 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.6 mt -56.72 -55.77 17.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 114.245 -1.343 . . . . 0.0 112.257 174.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 467' ' ' LEU . . . . . 0.776 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -102.3 -9.94 19.94 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -171.943 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 468' ' ' GLY . . . . . 0.567 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 94.53 31.58 7.8 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 119.519 -1.324 . . . . 0.0 114.456 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 469' ' ' LEU . . . . . 0.776 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 4.2 mt -89.89 160.67 16.33 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 117.674 0.737 . . . . 0.0 110.853 174.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 470' ' ' ASN . . . . . 0.612 HD22 ' C ' ' B' ' 470' ' ' ASN . 0.2 OUTLIER -105.64 -178.15 3.57 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.365 170.96 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 471' ' ' ALA . . . . . 0.446 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -57.05 -27.87 62.05 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -174.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -85.14 8.63 17.46 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.973 0.361 . . . . 0.0 111.973 -171.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 473' ' ' GLY . . . . . . . . . . . . . . . 74.02 8.96 79.51 Favored Glycine 0 C--O 1.228 -0.221 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.553 -177.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -100.16 154.88 18.08 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 177.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 475' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' B' ' 469' ' ' LEU . 61.1 p -91.12 136.69 32.91 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.329 0.585 . . . . 0.0 110.862 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 476' ' ' ILE . . . . . 0.567 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.7 pp -94.27 -19.85 6.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.47 179.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 477' ' ' ARG . . . . . 0.527 ' O ' ' HD3' ' B' ' 477' ' ' ARG . 0.0 OUTLIER -95.68 162.27 13.68 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.713 174.188 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 478' ' ' LEU . . . . . . . . . . . . . 98.1 mt -126.33 143.52 51.13 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.843 0.354 . . . . 0.0 110.664 -177.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 479' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.4 -0.809 . . . . 0.0 109.637 176.666 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 . . . . . 0 N--CA 1.479 0.996 0 CA-C-O 121.018 0.437 . . . . 0.0 110.686 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . 0.55 ' OG1' ' HA ' ' A' ' 391' ' ' LEU . 0.0 OUTLIER -97.44 -29.58 13.41 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.481 174.302 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 383' ' ' HIS . . . . . 0.461 ' HB2' ' O ' ' A' ' 386' ' ' PHE . 19.0 p80 -159.28 159.37 33.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.924 0.392 . . . . 0.0 111.323 -176.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -114.84 -117.76 3.21 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.38 174.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 31.2 m -58.78 -35.13 72.3 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 121.167 0.508 . . . . 0.0 111.196 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 386' ' ' PHE . . . . . 0.775 ' CD1' HD22 ' A' ' 414' ' ' LEU . 1.9 t80 -82.16 128.31 68.28 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 176.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -55.4 -72.76 0.03 OUTLIER 'Trans proline' 0 N--CA 1.486 1.068 0 C-N-CA 124.488 3.458 . . . . 0.0 114.465 178.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.577 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 10.4 ttp 69.17 59.6 0.33 Allowed 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 170.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 389' ' ' HIS . . . . . 0.557 ' ND1' ' HA ' ' A' ' 393' ' ' ASN . 17.1 m170 51.05 -138.56 1.04 Allowed 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -178.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . 0.478 ' H ' ' HB3' ' A' ' 389' ' ' HIS . 5.9 pm0 -110.68 22.67 15.14 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 164.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.623 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.5 pt? -168.28 -61.71 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.542 -174.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . 0.623 ' N ' ' HG ' ' A' ' 391' ' ' LEU . . . -160.51 59.45 0.31 Allowed Glycine 0 C--N 1.337 0.589 0 C-N-CA 119.733 -1.222 . . . . 0.0 114.715 -171.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . 0.577 ' HB3' ' HA ' ' A' ' 388' ' ' MET . 0.4 OUTLIER -62.4 -39.55 93.61 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 117.4 0.6 . . . . 0.0 109.568 175.714 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.663 HG22 HD12 ' A' ' 395' ' ' ILE . 0.6 OUTLIER -56.7 -46.02 82.91 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 179.21 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.663 HD12 HG22 ' A' ' 394' ' ' VAL . 4.0 mp -57.79 -52.71 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.323 0 CA-C-O 117.853 -1.07 . . . . 0.0 113.465 -174.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . 0.615 ' O ' HG22 ' A' ' 399' ' ' VAL . 0.0 OUTLIER -63.72 -49.76 71.8 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-N 121.972 2.169 . . . . 0.0 111.645 -175.77 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.62 -44.89 68.72 Favored Glycine 0 N--CA 1.428 -1.842 0 CA-C-N 114.473 -1.239 . . . . 0.0 110.818 -175.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . 0.743 HG12 HD21 ' B' ' 414' ' ' LEU . 34.8 mt -70.79 -33.05 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . 0.615 HG22 ' O ' ' A' ' 396' ' ' LYS . 16.7 m -62.9 -39.73 86.16 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 C-N-CA 118.688 -1.205 . . . . 0.0 108.43 -175.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -71.35 -35.03 71.0 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 175.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.453 HE21 ' HB3' ' A' ' 401' ' ' GLN . 3.9 mm100 -88.52 -47.47 8.3 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -172.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . 0.617 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 3.1 mm-40 -121.72 -21.03 6.26 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.539 -171.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 109.25 160.98 19.44 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.728 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . 0.645 ' O ' ' HB2' ' A' ' 408' ' ' TYR . 1.1 m -53.71 -40.77 44.5 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.771 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -175.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . 0.576 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -68.48 -31.55 70.92 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 119.591 -0.844 . . . . 0.0 112.013 -177.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.71 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 92.3 m -77.08 -41.51 41.93 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.1 173.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.448 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.47 -37.26 75.12 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 122.059 0.933 . . . . 0.0 109.365 176.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 408' ' ' TYR . . . . . 0.645 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -65.6 -52.79 49.38 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 113.709 -1.587 . . . . 0.0 109.973 176.433 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 409' ' ' THR . . . . . 0.739 HG22 HD23 ' A' ' 410' ' ' LEU . 3.2 m -56.09 -46.8 78.93 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 179.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . 0.739 HD23 HG22 ' A' ' 409' ' ' THR . 13.6 mt -72.36 -37.69 68.73 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -175.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.48 -37.03 87.31 Favored Glycine 0 N--CA 1.435 -1.4 0 C-N-CA 119.849 -1.167 . . . . 0.0 110.298 172.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 412' ' ' MET . . . . . 0.439 ' HB2' ' O ' ' A' ' 409' ' ' THR . 0.0 OUTLIER -64.27 -49.98 69.72 Favored 'General case' 0 C--O 1.223 -0.306 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 178.53 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 413' ' ' MET . . . . . 0.933 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 1.0 OUTLIER -71.27 -42.88 68.21 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 118.849 -1.14 . . . . 0.0 112.133 -176.146 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . 0.933 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 19.7 mt -69.61 -45.19 69.14 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -177.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.408 ' HB3' ' HE1' ' A' ' 388' ' ' MET . 54.6 p -85.91 -21.65 27.86 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.511 0.672 . . . . 0.0 110.482 -174.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 108.64 178.65 21.71 Favored Glycine 0 N--CA 1.431 -1.682 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -168.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -80.17 23.94 0.45 Allowed 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.037 0.446 . . . . 0.0 111.859 -173.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 418' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -71.35 78.25 0.74 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.677 0.751 . . . . 0.0 110.947 178.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 419' ' ' TYR . . . . . 0.568 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 17.1 p90 -51.86 -38.32 55.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.749 177.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -55.12 -45.41 75.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.746 178.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . 0.427 HD23 ' N ' ' A' ' 422' ' ' VAL . 0.0 OUTLIER -68.33 -48.58 64.48 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.11 -177.943 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . 0.477 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.1 OUTLIER -65.64 -41.78 91.33 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 C-N-CA 120.347 -0.541 . . . . 0.0 110.932 -176.291 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.785 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 29.6 t -69.35 -36.53 76.98 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.7 -178.145 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -69.34 -37.47 80.07 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.84 176.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . 0.611 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -72.41 -51.25 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-O 120.515 0.198 . . . . 0.0 110.621 -179.631 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . 0.752 HG22 HD22 ' A' ' 430' ' ' LEU . 1.1 mm -73.38 -22.9 19.37 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.952 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -173.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.785 ' HB2' ' O ' ' A' ' 423' ' ' SER . 1.1 tmm_? -54.38 -33.63 59.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.289 0.566 . . . . 0.0 110.893 -177.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -86.28 -10.94 73.33 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.404 -0.903 . . . . 0.0 110.853 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.633 ' HD1' HG22 ' A' ' 395' ' ' ILE . 5.4 m-30 -112.91 -1.8 14.47 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -174.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.752 HD22 HG22 ' A' ' 426' ' ' ILE . 0.0 OUTLIER -66.61 129.88 94.1 Favored Pre-proline 0 N--CA 1.443 -0.789 0 CA-C-N 114.201 -1.363 . . . . 0.0 108.947 177.203 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . 0.585 ' HD2' HD12 ' A' ' 430' ' ' LEU . 79.7 Cg_exo -24.09 -66.95 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.758 1 C-N-CA 125.536 4.157 . . . . 0.0 114.727 179.221 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . 0.529 ' H ' HG12 ' A' ' 435' ' ' VAL . . . -145.2 -168.17 12.75 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 176.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . 0.515 ' O ' HG13 ' A' ' 436' ' ' VAL . 40.1 tp60 -69.84 -26.26 64.13 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 117.888 0.844 . . . . 0.0 110.459 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -65.85 -40.8 92.07 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.887 -178.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 435' ' ' VAL . . . . . 0.74 HG23 HG11 ' A' ' 463' ' ' VAL . 7.4 p -68.84 -43.39 82.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-O 120.947 0.403 . . . . 0.0 110.755 -177.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.515 HG13 ' O ' ' A' ' 433' ' ' GLN . 0.1 OUTLIER -65.25 -33.42 63.59 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.19 175.73 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 437' ' ' THR . . . . . 0.458 ' O ' ' HG3' ' A' ' 441' ' ' GLN . 1.0 OUTLIER -66.84 -52.86 38.67 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -177.727 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . 0.869 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -58.58 -37.79 76.52 Favored 'General case' 0 N--CA 1.436 -1.162 0 O-C-N 123.788 0.68 . . . . 0.0 111.835 178.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 439' ' ' LEU . . . . . 0.619 ' O ' ' HG ' ' A' ' 443' ' ' LEU . 2.1 tm? -67.64 -48.78 65.76 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 -179.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.28 -35.02 74.58 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.535 -1.212 . . . . 0.0 110.729 176.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 441' ' ' GLN . . . . . 0.563 ' HB2' ' O ' ' A' ' 438' ' ' ALA . 13.3 mt-30 -53.32 -50.96 63.88 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.186 -178.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . 0.631 ' HD2' ' O ' ' A' ' 438' ' ' ALA . 0.0 OUTLIER -76.09 -23.38 54.96 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 175.118 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 443' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 47.3 mt -64.09 -35.47 80.87 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 174.072 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -56.89 -36.09 69.71 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.373 172.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -73.16 -27.63 61.77 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.872 178.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 446' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 443' ' ' LEU . 33.5 tt0 32.94 89.45 0.01 OUTLIER 'General case' 0 C--N 1.353 0.745 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 170.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 70.8 mt -59.31 -35.82 60.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 175.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . 0.493 ' HB2' ' OG1' ' A' ' 451' ' ' THR . 24.5 m-20 -166.49 175.34 8.16 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 178.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 449' ' ' ASP . . . . . 0.642 ' O ' ' HG2' ' A' ' 452' ' ' ARG . 13.0 m-20 -62.72 -60.03 4.07 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.312 -0.555 . . . . 0.0 109.715 174.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 450' ' ' GLN . . . . . 0.453 ' O ' ' HB3' ' A' ' 453' ' ' ALA . 0.0 OUTLIER -71.93 -28.51 63.51 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 178.856 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 451' ' ' THR . . . . . 0.493 ' OG1' ' HB2' ' A' ' 448' ' ' ASP . 10.1 m -73.0 -23.54 60.65 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.326 -174.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . 0.642 ' HG2' ' O ' ' A' ' 449' ' ' ASP . 6.0 ptp180 -64.73 -41.52 95.9 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 174.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 453' ' ' ALA . . . . . 0.568 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -58.99 -49.19 78.82 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 123.843 0.714 . . . . 0.0 112.445 168.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . 0.434 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 33.5 mm-40 -53.97 -33.44 56.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.148 0.499 . . . . 0.0 111.738 -177.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 29.1 p -115.56 15.27 16.65 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.224 -178.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . 0.559 ' CZ ' ' HB2' ' A' ' 423' ' ' SER . 1.0 OUTLIER -56.78 -47.68 79.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.995 0.426 . . . . 0.0 111.775 -171.667 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . 0.576 HG23 ' HB1' ' A' ' 405' ' ' ALA . 1.9 mp -76.41 -33.41 23.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.153 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -57.84 -34.05 69.29 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.955 0.883 . . . . 0.0 108.963 171.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . 0.745 ' O ' HG23 ' A' ' 463' ' ' VAL . 45.0 m-70 -74.47 -29.31 61.4 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.197 -1.365 . . . . 0.0 110.947 177.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . 0.701 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.3 OUTLIER -74.07 -34.78 64.13 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.342 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 24.2 m-80 -73.02 -37.59 66.88 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.047 176.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 462' ' ' ALA . . . . . 0.6 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -55.86 -34.92 65.89 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.659 169.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.869 HG13 ' HB3' ' A' ' 438' ' ' ALA . 73.3 t -61.69 -51.15 76.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-N 114.612 -1.176 . . . . 0.0 108.201 176.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 464' ' ' TYR . . . . . 0.577 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 15.9 m-30 -52.95 -28.16 22.35 Favored 'General case' 0 C--N 1.332 -0.188 0 O-C-N 124.295 0.997 . . . . 0.0 110.614 178.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.92 -39.53 19.68 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.76 0.79 . . . . 0.0 109.632 -177.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.6 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.7 mt -57.95 -55.86 19.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 114.296 -1.32 . . . . 0.0 112.252 175.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.753 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -102.46 -10.88 19.01 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -172.274 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . 0.635 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 93.94 31.79 7.93 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 119.34 -1.41 . . . . 0.0 114.331 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 469' ' ' LEU . . . . . 0.753 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.1 mt -88.96 161.42 16.63 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 117.838 0.819 . . . . 0.0 110.922 175.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . 0.48 HD22 HG23 ' A' ' 476' ' ' ILE . 12.5 p30 -106.33 -176.84 3.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.075 170.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 471' ' ' ALA . . . . . 0.445 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -62.62 -19.55 63.89 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -173.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -87.77 2.26 51.72 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 122.113 -0.367 . . . . 0.0 111.809 -174.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . 0.477 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 76.77 11.58 85.26 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.21 -0.995 . . . . 0.0 111.003 -175.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -101.32 156.74 17.27 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 176.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 8.2 p -93.92 132.98 37.82 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.087 0.47 . . . . 0.0 111.587 -176.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 476' ' ' ILE . . . . . 0.635 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.5 pp -96.87 -3.78 10.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.479 0.657 . . . . 0.0 110.015 177.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 28.1 mmm180 -71.01 -39.08 72.6 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.045 176.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 86.9 mt 55.88 62.62 2.32 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.5 0.667 . . . . 0.0 110.523 179.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 . . . . . 0 C--O 1.246 0.911 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.027 -179.986 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 381' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 . . . . . 0 N--CA 1.478 0.949 0 CA-C-O 120.965 0.412 . . . . 0.0 110.842 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 382' ' ' THR . . . . . 0.558 ' OG1' ' HA ' ' B' ' 391' ' ' LEU . 0.0 OUTLIER -97.39 -29.47 13.49 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.42 174.652 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 383' ' ' HIS . . . . . 0.463 ' HB2' ' O ' ' B' ' 386' ' ' PHE . 19.0 p80 -159.5 159.29 33.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.052 0.453 . . . . 0.0 111.29 -176.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 384' ' ' GLY . . . . . . . . . . . . . . . -114.78 -118.02 3.24 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 174.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 385' ' ' THR . . . . . . . . . . . . . 30.0 m -58.45 -35.14 71.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.219 0.533 . . . . 0.0 111.304 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 386' ' ' PHE . . . . . 0.784 ' CD1' HD22 ' B' ' 414' ' ' LEU . 1.9 t80 -82.19 128.22 68.53 Favored Pre-proline 0 C--N 1.324 -0.534 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 176.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 387' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -55.59 -72.61 0.03 OUTLIER 'Trans proline' 0 N--CA 1.486 1.078 0 C-N-CA 124.536 3.491 . . . . 0.0 114.456 178.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 388' ' ' MET . . . . . 0.567 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 10.4 ttp 69.34 59.49 0.32 Allowed 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 170.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 389' ' ' HIS . . . . . 0.561 ' ND1' ' HA ' ' B' ' 393' ' ' ASN . 17.7 m170 51.28 -138.36 1.07 Allowed 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -178.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 390' ' ' GLN . . . . . 0.442 ' H ' ' HB3' ' B' ' 389' ' ' HIS . 5.9 pm0 -110.99 22.81 14.89 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 164.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 391' ' ' LEU . . . . . 0.615 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.5 pt? -168.46 -61.73 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.553 -174.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 392' ' ' GLY . . . . . 0.628 ' HA3' HD13 ' B' ' 395' ' ' ILE . . . -160.4 59.37 0.31 Allowed Glycine 0 C--N 1.338 0.644 0 C-N-CA 119.65 -1.262 . . . . 0.0 114.649 -171.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 393' ' ' ASN . . . . . 0.567 ' HB3' ' HA ' ' B' ' 388' ' ' MET . 0.4 OUTLIER -62.23 -39.71 93.7 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 117.371 0.586 . . . . 0.0 109.535 175.798 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 394' ' ' VAL . . . . . 0.672 HG22 HD12 ' B' ' 395' ' ' ILE . 0.6 OUTLIER -56.62 -46.09 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 179.346 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 395' ' ' ILE . . . . . 0.672 HD12 HG22 ' B' ' 394' ' ' VAL . 4.0 mp -57.86 -52.6 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.37 0 CA-C-O 117.794 -1.098 . . . . 0.0 113.45 -174.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 396' ' ' LYS . . . . . 0.616 ' O ' HG22 ' B' ' 399' ' ' VAL . 0.0 OUTLIER -63.58 -49.81 71.9 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-N 121.978 2.172 . . . . 0.0 111.706 -175.885 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.62 -44.86 68.73 Favored Glycine 0 N--CA 1.429 -1.819 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.825 -175.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . 0.78 HG12 HD21 ' A' ' 414' ' ' LEU . 35.1 mt -70.79 -33.11 51.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 399' ' ' VAL . . . . . 0.616 HG22 ' O ' ' B' ' 396' ' ' LYS . 16.7 m -62.93 -39.64 85.87 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 C-N-CA 118.678 -1.209 . . . . 0.0 108.362 -175.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -71.15 -35.55 71.72 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 175.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 401' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -88.37 -47.38 8.43 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -172.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 402' ' ' GLU . . . . . 0.511 ' HG3' ' HE3' ' A' ' 413' ' ' MET . 3.1 mm-40 -121.75 -21.09 6.23 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.573 -171.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 109.34 160.77 19.24 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.797 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 404' ' ' VAL . . . . . 0.632 ' O ' ' HB2' ' B' ' 408' ' ' TYR . 1.1 m -53.62 -40.72 43.46 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.733 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -175.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 405' ' ' ALA . . . . . 0.563 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -68.39 -31.73 71.29 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 119.689 -0.804 . . . . 0.0 111.989 -177.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 406' ' ' THR . . . . . 0.702 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 94.8 m -77.15 -41.38 41.98 Favored 'General case' 0 C--O 1.222 -0.39 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.065 173.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 407' ' ' ALA . . . . . 0.451 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.53 -37.29 75.34 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 122.024 0.916 . . . . 0.0 109.249 176.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 408' ' ' TYR . . . . . 0.632 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -65.54 -52.7 50.59 Favored 'General case' 0 N--CA 1.433 -1.275 0 CA-C-N 113.612 -1.631 . . . . 0.0 110.032 176.376 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 409' ' ' THR . . . . . 0.736 HG22 HD23 ' B' ' 410' ' ' LEU . 3.3 m -56.05 -46.98 78.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.616 179.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 410' ' ' LEU . . . . . 0.745 HD12 HD13 ' B' ' 398' ' ' ILE . 13.6 mt -72.31 -37.74 68.86 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -175.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.5 -37.18 87.81 Favored Glycine 0 N--CA 1.436 -1.347 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 173.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 412' ' ' MET . . . . . 0.442 ' HB2' ' O ' ' B' ' 409' ' ' THR . 0.0 OUTLIER -64.0 -50.11 69.81 Favored 'General case' 0 C--O 1.223 -0.309 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 178.457 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 413' ' ' MET . . . . . 0.939 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 1.0 OUTLIER -71.18 -43.15 68.03 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 118.941 -1.104 . . . . 0.0 112.045 -176.22 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 414' ' ' LEU . . . . . 0.939 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 19.6 mt -69.49 -45.18 69.56 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -176.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 415' ' ' SER . . . . . 0.421 ' HB3' ' HE1' ' B' ' 388' ' ' MET . 54.7 p -85.95 -21.69 27.76 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.556 0.693 . . . . 0.0 110.462 -174.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 416' ' ' GLY . . . . . . . . . . . . . . . 108.75 178.54 21.64 Favored Glycine 0 N--CA 1.431 -1.687 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -168.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -80.01 23.88 0.44 Allowed 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.038 0.447 . . . . 0.0 112.041 -173.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 418' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -71.44 78.41 0.77 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.699 0.762 . . . . 0.0 110.726 178.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 419' ' ' TYR . . . . . 0.569 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 17.1 p90 -51.89 -38.31 55.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.726 177.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -55.15 -45.32 75.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.858 178.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 421' ' ' LEU . . . . . 0.418 HD23 ' N ' ' B' ' 422' ' ' VAL . 0.0 OUTLIER -68.4 -48.5 64.49 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.171 -178.031 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 422' ' ' VAL . . . . . 0.473 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.1 OUTLIER -65.7 -41.79 91.21 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.839 -176.291 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 423' ' ' SER . . . . . 0.778 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 28.5 t -69.39 -36.41 76.76 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.71 -178.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -69.41 -37.56 79.47 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.909 176.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 425' ' ' ILE . . . . . 0.62 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -72.36 -51.01 31.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.431 0.158 . . . . 0.0 110.623 -179.625 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 426' ' ' ILE . . . . . 0.748 HG22 HD22 ' B' ' 430' ' ' LEU . 1.1 mm -73.68 -22.86 18.95 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.899 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -173.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 427' ' ' ARG . . . . . 0.778 ' HB2' ' O ' ' B' ' 423' ' ' SER . 1.2 tmm_? -54.25 -33.73 59.14 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.284 0.564 . . . . 0.0 110.879 -177.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -86.33 -10.66 73.72 Favored Glycine 0 N--CA 1.441 -1.013 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 429' ' ' TYR . . . . . 0.632 ' HD1' HG22 ' B' ' 395' ' ' ILE . 5.6 m-30 -113.12 -1.92 14.28 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.884 0.85 . . . . 0.0 108.711 -174.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 430' ' ' LEU . . . . . 0.748 HD22 HG22 ' B' ' 426' ' ' ILE . 0.1 OUTLIER -66.38 130.03 94.18 Favored Pre-proline 0 N--CA 1.444 -0.757 0 CA-C-N 114.098 -1.41 . . . . 0.0 108.865 177.208 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 431' ' ' PRO . . . . . 0.574 ' HD2' HD12 ' B' ' 430' ' ' LEU . 80.2 Cg_exo -24.17 -66.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.759 1 C-N-CA 125.595 4.197 . . . . 0.0 114.697 178.984 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 432' ' ' GLY . . . . . 0.529 ' H ' HG12 ' B' ' 435' ' ' VAL . . . -145.4 -168.03 12.76 Favored Glycine 0 N--CA 1.441 -1.01 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 176.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 433' ' ' GLN . . . . . 0.507 ' O ' HG13 ' B' ' 436' ' ' VAL . 40.0 tp60 -69.79 -26.24 64.17 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 117.767 0.784 . . . . 0.0 110.465 179.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -65.95 -40.6 91.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.955 -178.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 435' ' ' VAL . . . . . 0.732 HG23 HG11 ' B' ' 463' ' ' VAL . 7.5 p -68.95 -43.59 82.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-O 120.85 0.357 . . . . 0.0 110.732 -177.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 436' ' ' VAL . . . . . 0.507 HG13 ' O ' ' B' ' 433' ' ' GLN . 0.1 OUTLIER -65.12 -33.45 63.8 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.234 175.723 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 437' ' ' THR . . . . . 0.453 ' O ' ' HG3' ' B' ' 441' ' ' GLN . 1.0 OUTLIER -67.02 -52.62 40.26 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -177.73 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 438' ' ' ALA . . . . . 0.857 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -58.6 -37.88 76.77 Favored 'General case' 0 N--CA 1.436 -1.151 0 O-C-N 123.809 0.693 . . . . 0.0 111.84 178.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 439' ' ' LEU . . . . . 0.61 ' O ' ' HG ' ' B' ' 443' ' ' LEU . 2.1 tm? -67.44 -48.71 66.44 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -179.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.5 -34.78 74.57 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.498 -1.228 . . . . 0.0 110.773 176.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 441' ' ' GLN . . . . . 0.56 ' HB2' ' O ' ' B' ' 438' ' ' ALA . 13.0 mt-30 -53.5 -50.67 64.9 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.175 -178.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 442' ' ' ARG . . . . . 0.634 ' HD2' ' O ' ' B' ' 438' ' ' ALA . 0.0 OUTLIER -76.33 -23.52 54.25 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 175.141 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 443' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 45.9 mt -63.79 -35.89 82.08 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 173.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -56.82 -35.76 69.17 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.378 172.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -73.21 -27.98 61.92 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.794 178.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 446' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' B' ' 443' ' ' LEU . 33.8 tt0 33.17 89.63 0.01 OUTLIER 'General case' 0 C--N 1.351 0.668 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 170.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 71.1 mt -59.51 -35.52 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 121.552 0.691 . . . . 0.0 109.18 175.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 448' ' ' ASP . . . . . 0.498 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 28.6 m-20 -166.72 175.65 7.71 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 177.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 449' ' ' ASP . . . . . 0.646 ' O ' ' HG2' ' B' ' 452' ' ' ARG . 13.6 m-20 -62.88 -60.08 3.97 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.394 -0.522 . . . . 0.0 109.61 174.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 450' ' ' GLN . . . . . 0.447 ' O ' ' HB3' ' B' ' 453' ' ' ALA . 0.0 OUTLIER -71.9 -28.6 63.6 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 178.998 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 451' ' ' THR . . . . . 0.498 ' OG1' ' HB2' ' B' ' 448' ' ' ASP . 9.8 m -72.99 -23.38 60.64 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 119.621 -0.832 . . . . 0.0 111.39 -174.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 452' ' ' ARG . . . . . 0.646 ' HG2' ' O ' ' B' ' 449' ' ' ASP . 6.0 ptp180 -64.73 -41.62 95.81 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 174.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 453' ' ' ALA . . . . . 0.569 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -59.06 -49.17 78.92 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 123.751 0.657 . . . . 0.0 112.395 168.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 454' ' ' GLU . . . . . 0.432 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 33.5 mm-40 -53.77 -34.19 58.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.493 -177.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 30.0 p -115.04 15.36 17.19 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.255 -178.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 456' ' ' PHE . . . . . 0.567 ' CZ ' ' HB2' ' B' ' 423' ' ' SER . 1.0 OUTLIER -56.83 -47.64 79.86 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.833 -171.726 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 457' ' ' ILE . . . . . 0.563 HG23 ' HB1' ' B' ' 405' ' ' ALA . 1.9 mp -76.31 -33.47 23.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.224 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -57.83 -33.95 69.18 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 122.072 0.939 . . . . 0.0 108.999 171.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 459' ' ' HIS . . . . . 0.747 ' O ' HG23 ' B' ' 463' ' ' VAL . 44.4 m-70 -74.64 -29.25 61.2 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.136 -1.393 . . . . 0.0 110.964 177.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 460' ' ' LEU . . . . . 0.704 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.3 OUTLIER -73.98 -34.64 64.29 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.882 0.849 . . . . 0.0 108.817 179.117 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 461' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 -73.13 -37.61 66.59 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.11 176.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 462' ' ' ALA . . . . . 0.61 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -55.91 -34.98 66.07 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.351 -1.295 . . . . 0.0 109.62 169.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 463' ' ' VAL . . . . . 0.857 HG13 ' HB3' ' B' ' 438' ' ' ALA . 72.6 t -61.68 -51.21 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-N 114.656 -1.157 . . . . 0.0 108.227 177.054 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 464' ' ' TYR . . . . . 0.57 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 15.8 m-30 -52.8 -28.41 22.41 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 124.347 1.03 . . . . 0.0 110.532 178.062 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.07 -38.9 20.22 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.765 0.793 . . . . 0.0 109.674 -177.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 466' ' ' ILE . . . . . 0.61 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.7 mt -58.48 -55.85 20.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 114.419 -1.264 . . . . 0.0 112.181 175.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 467' ' ' LEU . . . . . 0.763 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -102.49 -10.72 19.12 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -172.235 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 468' ' ' GLY . . . . . 0.65 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 94.05 31.57 8.01 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 119.38 -1.391 . . . . 0.0 114.312 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 469' ' ' LEU . . . . . 0.763 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.1 mt -88.82 161.33 16.79 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 117.729 0.765 . . . . 0.0 110.883 175.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 470' ' ' ASN . . . . . 0.484 HD22 HG23 ' B' ' 476' ' ' ILE . 12.1 p30 -106.47 -177.06 3.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.014 170.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 471' ' ' ALA . . . . . 0.444 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -62.13 -19.66 63.26 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -173.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -88.0 2.48 51.67 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 122.06 -0.4 . . . . 0.0 111.775 -173.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 473' ' ' GLY . . . . . 0.483 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 76.52 11.67 84.99 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.33 -0.938 . . . . 0.0 111.035 -175.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -101.39 157.02 17.1 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 176.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 8.6 p -93.86 133.53 37.18 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.116 0.484 . . . . 0.0 111.387 -176.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 476' ' ' ILE . . . . . 0.65 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.5 pp -97.32 -3.92 9.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.431 0.634 . . . . 0.0 109.888 177.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 477' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -71.17 -38.81 72.14 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.056 176.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 478' ' ' LEU . . . . . . . . . . . . . 86.5 mt 55.83 62.62 2.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.449 0.642 . . . . 0.0 110.633 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 479' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 . . . . . 0 C--O 1.247 0.947 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.053 -179.86 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 . . . . . 0 N--CA 1.478 0.955 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 1.3 t -111.21 -43.22 3.76 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.637 172.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 29.4 m-70 -85.67 74.99 10.16 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.931 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -72.73 -77.67 0.56 Allowed Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 119.966 -1.111 . . . . 0.0 111.054 176.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . 0.472 HG22 ' O ' ' A' ' 385' ' ' THR . 23.8 m -139.96 22.07 2.45 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 122.573 1.178 . . . . 0.0 108.871 172.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 386' ' ' PHE . . . . . 0.808 ' CE2' HG12 ' A' ' 394' ' ' VAL . 0.8 OUTLIER -139.45 123.78 11.19 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 114.746 -1.115 . . . . 0.0 108.842 -178.319 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 386' ' ' PHE . 26.3 Cg_endo -60.16 102.94 0.19 Allowed 'Trans proline' 0 CA--C 1.531 0.362 0 C-N-CA 123.779 2.986 . . . . 0.0 113.516 177.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.689 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 47.2 mtt -105.98 163.88 12.4 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.27 176.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 389' ' ' HIS . . . . . 0.544 ' CE1' ' HA ' ' A' ' 393' ' ' ASN . 17.5 m170 -74.1 39.68 0.12 Allowed 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . 0.533 ' O ' ' HG2' ' A' ' 390' ' ' GLN . 9.8 tt0 71.53 16.64 5.86 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.099 0.559 . . . . 0.0 110.673 -171.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.577 HD23 ' H ' ' A' ' 392' ' ' GLY . 2.0 pt? -163.41 -59.5 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 177.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . 0.772 ' HA3' HD13 ' A' ' 395' ' ' ILE . . . -171.99 67.98 0.12 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 119.714 -1.231 . . . . 0.0 113.988 -173.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . 0.689 ' HB3' ' HA ' ' A' ' 388' ' ' MET . 0.2 OUTLIER -62.22 -41.14 98.12 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 174.712 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.808 HG12 ' CE2' ' A' ' 386' ' ' PHE . 0.9 OUTLIER -55.57 -47.26 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 178.95 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.772 HD13 ' HA3' ' A' ' 392' ' ' GLY . 3.6 mp -57.07 -52.08 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 CA-C-O 117.762 -1.113 . . . . 0.0 113.64 -175.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . 0.602 ' O ' HG22 ' A' ' 399' ' ' VAL . 0.1 OUTLIER -60.62 -51.09 70.9 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 121.873 2.124 . . . . 0.0 112.821 -175.245 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.93 -42.72 70.76 Favored Glycine 0 N--CA 1.438 -1.18 0 C-N-CA 119.554 -1.308 . . . . 0.0 110.894 -174.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . 0.942 HD13 HD12 ' A' ' 410' ' ' LEU . 39.4 mt -71.78 -34.29 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 CA-C-N 114.009 -1.095 . . . . 0.0 113.641 -178.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . 0.602 HG22 ' O ' ' A' ' 396' ' ' LYS . 16.0 m -62.91 -39.56 85.53 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 C-N-CA 118.881 -1.128 . . . . 0.0 108.649 -174.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -69.96 -38.2 76.03 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 175.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.443 HE21 ' HB3' ' A' ' 401' ' ' GLN . 2.5 mm100 -90.19 -48.81 6.93 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -170.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . 0.662 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 1.3 mm-40 -116.12 -19.15 10.4 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.106 -170.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 104.51 161.0 24.14 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.579 178.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . 0.673 HG11 ' HA ' ' A' ' 430' ' ' LEU . 1.5 m -53.42 -45.26 57.29 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.967 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -176.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . 0.586 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -62.93 -31.23 72.27 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 119.995 -0.682 . . . . 0.0 112.606 -178.03 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.685 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 87.9 m -76.96 -43.14 36.3 Favored 'General case' 0 C--O 1.222 -0.364 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.201 173.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.486 ' HB2' ' HB ' ' A' ' 398' ' ' ILE . . . -58.69 -37.22 75.61 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 122.191 0.996 . . . . 0.0 109.297 176.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 408' ' ' TYR . . . . . 0.673 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -66.11 -51.91 53.55 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 113.414 -1.721 . . . . 0.0 109.659 176.568 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 409' ' ' THR . . . . . 0.64 HG22 HD23 ' A' ' 410' ' ' LEU . 13.3 m -54.44 -47.11 73.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.451 178.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . 0.942 HD12 HD13 ' A' ' 398' ' ' ILE . 14.4 mt -71.57 -37.47 71.06 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 120.944 0.402 . . . . 0.0 109.92 -175.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.33 -34.57 75.02 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.017 -1.087 . . . . 0.0 110.53 173.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 412' ' ' MET . . . . . 0.412 ' HB2' ' O ' ' A' ' 409' ' ' THR . 0.4 OUTLIER -67.28 -44.4 79.4 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 115.412 -0.394 . . . . 0.0 111.454 177.836 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 413' ' ' MET . . . . . 0.754 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 0.0 OUTLIER -70.85 -55.45 8.45 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 118.371 -1.332 . . . . 0.0 111.736 179.187 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . 0.754 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 3.9 mt -63.62 -44.51 93.71 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -171.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 46.8 t -86.42 -21.05 27.33 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.71 0.767 . . . . 0.0 109.906 -176.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . 0.422 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 107.37 -176.26 20.85 Favored Glycine 0 N--CA 1.431 -1.667 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -170.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -79.72 24.71 0.37 Allowed 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.4 0.619 . . . . 0.0 111.479 -172.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 418' ' ' ASN . . . . . 0.422 ' H ' ' C ' ' A' ' 416' ' ' GLY . 92.6 m-20 -70.83 75.28 0.62 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.856 -178.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 419' ' ' TYR . . . . . 0.518 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 12.1 p90 -50.56 -38.84 47.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.173 175.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -54.71 -47.82 73.24 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 123.292 0.37 . . . . 0.0 110.816 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.69 -49.12 64.36 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.419 -177.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . 0.423 ' HB ' ' CD1' ' A' ' 408' ' ' TYR . 0.2 OUTLIER -65.64 -39.5 85.16 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.552 -176.934 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.763 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 78.6 p -68.75 -36.32 78.22 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.564 -0.454 . . . . 0.0 109.868 -178.088 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -70.32 -38.75 71.05 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.946 175.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . 0.554 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -71.74 -51.68 30.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 O-C-N 122.852 -0.205 . . . . 0.0 110.857 -178.195 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . 0.714 HG22 HD22 ' A' ' 430' ' ' LEU . 1.1 mm -74.05 -23.44 18.75 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.827 0 C-N-CA 122.407 0.283 . . . . 0.0 110.405 -173.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.763 ' HB2' ' O ' ' A' ' 423' ' ' SER . 1.0 OUTLIER -54.77 -31.84 59.21 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.034 0.445 . . . . 0.0 111.496 -177.536 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -85.16 -14.84 68.19 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.228 -0.987 . . . . 0.0 110.859 178.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.6 ' HD1' HG22 ' A' ' 395' ' ' ILE . 5.1 m-30 -111.0 0.2 16.9 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.689 0.757 . . . . 0.0 109.031 -171.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.714 HD22 HG22 ' A' ' 426' ' ' ILE . 0.1 OUTLIER -65.48 129.1 94.29 Favored Pre-proline 0 N--CA 1.442 -0.866 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.74 177.576 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . 0.495 ' HD2' HD12 ' A' ' 430' ' ' LEU . 81.3 Cg_exo -23.59 -71.19 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.941 1 C-N-CA 125.539 4.159 . . . . 0.0 114.76 179.841 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . 0.554 ' O ' HG12 ' A' ' 435' ' ' VAL . . . -138.22 -171.93 12.36 Favored Glycine 0 N--CA 1.441 -1.031 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 176.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . 0.475 ' O ' HG13 ' A' ' 436' ' ' VAL . 51.3 tp60 -67.46 -25.56 65.95 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 118.106 0.953 . . . . 0.0 110.13 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -63.84 -43.41 96.23 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 435' ' ' VAL . . . . . 0.66 HG23 HG11 ' A' ' 463' ' ' VAL . 8.3 p -69.27 -41.93 81.26 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 CA-C-O 121.082 0.467 . . . . 0.0 110.641 -176.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.485 HG12 ' O ' ' A' ' 432' ' ' GLY . 0.1 OUTLIER -67.14 -30.19 48.57 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.082 174.832 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 437' ' ' THR . . . . . 0.488 ' O ' ' HG2' ' A' ' 441' ' ' GLN . 1.1 m -66.71 -53.95 28.13 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . 0.849 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -59.46 -34.59 72.73 Favored 'General case' 0 N--CA 1.434 -1.237 0 O-C-N 124.116 0.885 . . . . 0.0 111.227 178.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 439' ' ' LEU . . . . . 0.926 HD23 ' NH2' ' A' ' 442' ' ' ARG . 0.3 OUTLIER -67.11 -50.74 60.46 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.223 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.46 -33.89 74.51 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.44 -1.254 . . . . 0.0 111.032 175.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 441' ' ' GLN . . . . . 0.507 ' HB2' ' HA ' ' A' ' 438' ' ' ALA . 7.0 mm100 -55.01 -50.09 69.9 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.68 -175.02 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . 0.926 ' NH2' HD23 ' A' ' 439' ' ' LEU . 0.0 OUTLIER -78.08 -25.54 47.68 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 119.511 -0.875 . . . . 0.0 112.687 175.847 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 443' ' ' LEU . . . . . 0.775 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 67.3 mt -67.81 -26.62 66.16 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.7 178.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -64.82 -38.52 91.24 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.842 0.829 . . . . 0.0 109.976 173.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -77.24 -26.56 52.7 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.424 -1.262 . . . . 0.0 111.373 179.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 29.43 101.8 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 175.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 51.7 mt -60.07 -35.14 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 121.45 0.643 . . . . 0.0 110.434 -179.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . 0.464 ' HB2' ' OG1' ' A' ' 451' ' ' THR . 31.8 m-20 -164.77 -162.42 0.64 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -177.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -81.44 -72.05 0.45 Allowed 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 171.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 450' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.0 -25.14 67.99 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 178.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 451' ' ' THR . . . . . 0.464 ' OG1' ' HB2' ' A' ' 448' ' ' ASP . 8.9 m -71.03 -22.98 62.07 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.998 -174.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 452' ' ' ARG . 17.8 mtp180 -53.41 -54.16 40.88 Favored 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 171.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 453' ' ' ALA . . . . . 0.518 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -59.71 -49.61 77.05 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 114.395 -1.275 . . . . 0.0 113.095 175.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . 0.459 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 20.8 mm-40 -49.23 -38.34 26.24 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.341 0.591 . . . . 0.0 111.849 -176.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 26.1 p -120.11 16.55 12.42 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.818 -175.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . 0.502 ' CZ ' ' HB3' ' A' ' 423' ' ' SER . 0.8 OUTLIER -54.64 -46.8 74.0 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.688 -172.063 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . 0.586 HG23 ' HB1' ' A' ' 405' ' ' ALA . 1.9 mp -78.67 -35.22 18.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.64 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -57.23 -36.43 70.91 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 121.841 0.829 . . . . 0.0 109.192 172.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . 0.761 ' HB3' ' CZ ' ' A' ' 442' ' ' ARG . 78.9 m-70 -75.2 -30.43 60.63 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.528 177.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . 0.744 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.6 OUTLIER -67.49 -34.52 77.32 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 179.421 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . 0.464 ' O ' ' HB2' ' A' ' 464' ' ' TYR . 17.3 m-80 -72.95 -37.49 67.11 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.347 -1.297 . . . . 0.0 109.04 176.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 462' ' ' ALA . . . . . 0.603 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -56.63 -32.19 65.08 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.146 169.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.849 HG13 ' HB3' ' A' ' 438' ' ' ALA . 51.3 t -64.88 -49.91 77.65 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.798 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 176.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 464' ' ' TYR . . . . . 0.602 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 19.5 m-30 -51.48 -28.98 14.81 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 124.511 1.132 . . . . 0.0 110.454 176.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.84 -38.36 19.59 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.602 0.715 . . . . 0.0 109.7 -176.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.603 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.7 mt -58.11 -55.48 21.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.149 174.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.752 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -101.35 -10.85 19.9 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 -172.317 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . 0.583 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 94.13 31.58 7.97 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 119.538 -1.315 . . . . 0.0 114.287 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 469' ' ' LEU . . . . . 0.752 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.1 mt -89.45 164.02 15.01 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 117.801 0.8 . . . . 0.0 110.911 175.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 43.0 p30 -105.0 -179.19 3.87 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.267 172.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 471' ' ' ALA . . . . . 0.467 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -59.62 -23.47 63.02 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -177.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -87.43 3.11 48.46 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.157 -173.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . 0.448 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 75.45 15.43 81.22 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.393 -0.908 . . . . 0.0 110.973 -176.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -100.95 150.17 23.15 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 178.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 4.4 p -89.61 117.07 28.22 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.286 0.565 . . . . 0.0 111.557 -178.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 476' ' ' ILE . . . . . 0.583 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.8 pp -85.92 1.63 5.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.722 0.772 . . . . 0.0 110.231 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 -62.39 -34.48 76.8 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.243 173.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . 0.437 HD23 ' N ' ' A' ' 478' ' ' LEU . 1.8 pt? -141.62 114.3 8.42 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.041 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.286 -0.864 . . . . 0.0 109.802 179.672 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 381' ' ' ARG . . . . . 0.403 ' HG2' HD21 ' B' ' 418' ' ' ASN . 38.4 ptt180 . . . . . 0 N--CA 1.48 1.05 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 382' ' ' THR . . . . . . . . . . . . . 1.3 t -111.37 -43.17 3.74 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.685 172.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 383' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -85.66 75.0 10.17 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.828 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 384' ' ' GLY . . . . . . . . . . . . . . . -72.74 -77.63 0.57 Allowed Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.004 -1.093 . . . . 0.0 111.115 176.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 385' ' ' THR . . . . . 0.476 HG22 ' O ' ' B' ' 385' ' ' THR . 24.6 m -140.39 22.61 2.36 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 122.575 1.179 . . . . 0.0 108.874 172.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 386' ' ' PHE . . . . . 0.812 ' CE2' HG12 ' B' ' 394' ' ' VAL . 0.8 OUTLIER -140.1 123.45 10.41 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.773 -178.227 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 387' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' B' ' 386' ' ' PHE . 26.7 Cg_endo -59.92 103.05 0.19 Allowed 'Trans proline' 0 N--CA 1.473 0.312 0 C-N-CA 123.787 2.992 . . . . 0.0 113.473 177.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 388' ' ' MET . . . . . 0.672 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 47.1 mtt -106.04 164.0 12.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.227 176.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 389' ' ' HIS . . . . . 0.534 ' CE1' ' HA ' ' B' ' 393' ' ' ASN . 17.3 m170 -74.17 39.86 0.12 Allowed 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 179.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 390' ' ' GLN . . . . . 0.525 ' O ' ' HG2' ' B' ' 390' ' ' GLN . 9.8 tt0 71.59 15.98 5.92 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.03 0.532 . . . . 0.0 110.65 -172.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 391' ' ' LEU . . . . . 0.569 HD23 ' H ' ' B' ' 392' ' ' GLY . 2.0 pt? -163.05 -59.5 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 177.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 392' ' ' GLY . . . . . 0.773 ' HA3' HD13 ' B' ' 395' ' ' ILE . . . -171.91 68.0 0.13 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 119.729 -1.224 . . . . 0.0 114.028 -173.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 393' ' ' ASN . . . . . 0.672 ' HB3' ' HA ' ' B' ' 388' ' ' MET . 0.2 OUTLIER -62.11 -41.2 97.99 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 174.649 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 394' ' ' VAL . . . . . 0.812 HG12 ' CE2' ' B' ' 386' ' ' PHE . 0.9 OUTLIER -55.51 -47.38 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 178.867 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 395' ' ' ILE . . . . . 0.773 HD13 ' HA3' ' B' ' 392' ' ' GLY . 3.6 mp -57.07 -52.01 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 CA-C-O 117.783 -1.103 . . . . 0.0 113.615 -175.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 396' ' ' LYS . . . . . 0.6 ' O ' HG22 ' B' ' 399' ' ' VAL . 0.1 OUTLIER -60.65 -51.06 70.98 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 122.049 2.204 . . . . 0.0 112.798 -175.197 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -53.84 -42.99 70.43 Favored Glycine 0 N--CA 1.438 -1.185 0 C-N-CA 119.595 -1.288 . . . . 0.0 110.927 -174.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . 0.961 HD13 HD12 ' B' ' 410' ' ' LEU . 39.1 mt -71.74 -34.19 51.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-N 114.074 -1.063 . . . . 0.0 113.668 -178.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 399' ' ' VAL . . . . . 0.6 HG22 ' O ' ' B' ' 396' ' ' LYS . 15.9 m -62.76 -39.72 85.9 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 C-N-CA 118.837 -1.145 . . . . 0.0 108.617 -174.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -70.07 -38.3 75.72 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 175.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 401' ' ' GLN . . . . . 0.433 HE21 ' HB3' ' B' ' 401' ' ' GLN . 2.4 mm100 -89.94 -48.79 6.99 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -170.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 402' ' ' GLU . . . . . 0.617 ' HG3' ' HE3' ' A' ' 413' ' ' MET . 1.3 mm-40 -116.23 -19.09 10.36 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.257 -170.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 104.73 160.86 23.92 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.622 178.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 404' ' ' VAL . . . . . 0.667 HG11 ' HA ' ' B' ' 430' ' ' LEU . 1.5 m -53.26 -45.17 55.22 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.954 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -176.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 405' ' ' ALA . . . . . 0.561 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -62.89 -31.36 72.39 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 119.994 -0.683 . . . . 0.0 112.655 -178.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 406' ' ' THR . . . . . 0.675 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 86.4 m -77.06 -42.83 36.78 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.232 173.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 407' ' ' ALA . . . . . 0.49 ' HB2' ' HB ' ' B' ' 398' ' ' ILE . . . -58.86 -37.12 75.8 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 122.227 1.013 . . . . 0.0 109.281 176.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 408' ' ' TYR . . . . . 0.666 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -66.28 -51.68 55.02 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 113.343 -1.753 . . . . 0.0 109.779 176.588 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 409' ' ' THR . . . . . 0.633 HG22 HD23 ' B' ' 410' ' ' LEU . 13.1 m -54.44 -47.26 73.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.377 178.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 410' ' ' LEU . . . . . 0.961 HD12 HD13 ' B' ' 398' ' ' ILE . 14.5 mt -71.59 -37.44 70.98 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 120.92 0.391 . . . . 0.0 109.989 -175.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.39 -34.54 75.35 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.031 -1.08 . . . . 0.0 110.499 173.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 412' ' ' MET . . . . . 0.418 ' HB2' ' O ' ' B' ' 409' ' ' THR . 0.4 OUTLIER -67.18 -44.46 79.65 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 115.434 -0.383 . . . . 0.0 111.535 177.771 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 413' ' ' MET . . . . . 0.751 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 0.0 OUTLIER -70.86 -55.34 8.7 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 118.316 -1.354 . . . . 0.0 111.714 179.187 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 414' ' ' LEU . . . . . 0.751 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 3.9 mt -63.79 -44.43 93.4 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -171.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 46.5 t -86.45 -20.89 27.46 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.749 0.785 . . . . 0.0 109.943 -176.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 416' ' ' GLY . . . . . 0.424 ' C ' ' H ' ' B' ' 418' ' ' ASN . . . 107.18 -176.24 20.97 Favored Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -170.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -79.72 24.82 0.37 Allowed 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.21 0.529 . . . . 0.0 111.461 -172.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 418' ' ' ASN . . . . . 0.424 ' H ' ' C ' ' B' ' 416' ' ' GLY . 92.6 m-20 -71.09 75.49 0.67 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.814 -178.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 419' ' ' TYR . . . . . 0.531 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 12.4 p90 -50.56 -38.82 47.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.195 175.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -54.77 -47.56 73.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.932 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.78 -49.22 63.59 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.45 -177.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 422' ' ' VAL . . . . . 0.427 ' HB ' ' CD1' ' B' ' 408' ' ' TYR . 0.2 OUTLIER -65.55 -39.5 85.26 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.494 -176.903 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 423' ' ' SER . . . . . 0.763 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 78.0 p -68.78 -36.38 78.23 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -178.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -70.43 -38.44 69.84 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.961 176.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 425' ' ' ILE . . . . . 0.564 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -71.94 -51.85 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-O 120.327 0.108 . . . . 0.0 110.799 -178.207 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 426' ' ' ILE . . . . . 0.709 HG22 HD22 ' B' ' 430' ' ' LEU . 1.1 mm -73.95 -23.42 18.87 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.828 0 C-N-CA 122.37 0.268 . . . . 0.0 110.491 -173.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 427' ' ' ARG . . . . . 0.763 ' HB2' ' O ' ' B' ' 423' ' ' SER . 1.0 OUTLIER -54.75 -31.95 59.23 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.045 0.45 . . . . 0.0 111.449 -177.607 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -84.99 -15.11 67.98 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.15 -1.024 . . . . 0.0 110.817 178.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 429' ' ' TYR . . . . . 0.607 ' HD1' HG22 ' B' ' 395' ' ' ILE . 5.1 m-30 -110.62 -0.13 17.35 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -171.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 430' ' ' LEU . . . . . 0.72 HD23 ' HA ' ' B' ' 427' ' ' ARG . 0.1 OUTLIER -65.26 129.16 94.35 Favored Pre-proline 0 N--CA 1.441 -0.886 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.821 177.61 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 431' ' ' PRO . . . . . 0.493 ' HD2' HD12 ' B' ' 430' ' ' LEU . 78.8 Cg_exo -23.48 -70.94 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 1.003 1 C-N-CA 125.646 4.23 . . . . 0.0 114.814 179.844 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 432' ' ' GLY . . . . . 0.554 ' O ' HG12 ' B' ' 435' ' ' VAL . . . -138.82 -172.17 12.46 Favored Glycine 0 N--CA 1.441 -0.99 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 176.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 433' ' ' GLN . . . . . 0.475 ' O ' HG13 ' B' ' 436' ' ' VAL . 50.2 tp60 -67.11 -25.55 66.26 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 118.136 0.968 . . . . 0.0 110.291 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -63.99 -43.22 96.34 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 435' ' ' VAL . . . . . 0.659 HG23 HG11 ' B' ' 463' ' ' VAL . 8.3 p -69.26 -41.87 81.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-O 120.947 0.403 . . . . 0.0 110.7 -176.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 436' ' ' VAL . . . . . 0.49 HG12 ' O ' ' B' ' 432' ' ' GLY . 0.1 OUTLIER -67.29 -30.19 48.35 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.049 174.937 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 437' ' ' THR . . . . . 0.468 ' O ' ' HG2' ' B' ' 441' ' ' GLN . 1.1 m -66.81 -53.86 28.51 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -179.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 438' ' ' ALA . . . . . 0.861 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -59.37 -34.65 72.66 Favored 'General case' 0 N--CA 1.434 -1.227 0 O-C-N 124.071 0.857 . . . . 0.0 111.261 178.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 439' ' ' LEU . . . . . 0.923 HD23 ' NH2' ' B' ' 442' ' ' ARG . 0.3 OUTLIER -67.12 -50.72 60.43 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.206 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.41 -33.98 74.61 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 114.463 -1.244 . . . . 0.0 111.037 175.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 441' ' ' GLN . . . . . 0.507 ' HB2' ' HA ' ' B' ' 438' ' ' ALA . 6.9 mm100 -54.97 -50.16 69.63 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.772 -175.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 442' ' ' ARG . . . . . 0.923 ' NH2' HD23 ' B' ' 439' ' ' LEU . 0.0 OUTLIER -77.97 -25.62 48.25 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 119.558 -0.857 . . . . 0.0 112.654 175.785 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 443' ' ' LEU . . . . . 0.766 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 67.3 mt -67.89 -26.4 65.99 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 120.383 -0.527 . . . . 0.0 109.593 178.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -65.06 -38.48 90.95 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.072 173.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -76.95 -27.09 54.7 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.339 -1.3 . . . . 0.0 111.33 179.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 446' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 30.08 101.95 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 175.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 52.0 mt -60.51 -34.88 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 121.359 0.599 . . . . 0.0 110.467 -179.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 448' ' ' ASP . . . . . 0.455 ' HB2' ' OG1' ' B' ' 451' ' ' THR . 32.3 m-20 -164.91 -162.39 0.63 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -178.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -81.54 -71.76 0.46 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 171.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 450' ' ' GLN . . . . . 0.418 ' HG3' ' H ' ' B' ' 450' ' ' GLN . 0.0 OUTLIER -64.27 -25.05 67.88 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 178.212 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 451' ' ' THR . . . . . 0.456 ' HA ' ' HB2' ' B' ' 454' ' ' GLU . 9.7 m -71.03 -23.17 62.1 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.046 -174.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 452' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' B' ' 452' ' ' ARG . 17.8 mtp180 -53.25 -54.28 38.51 Favored 'General case' 0 C--O 1.221 -0.401 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 171.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 453' ' ' ALA . . . . . 0.531 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -59.67 -49.33 78.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.393 -1.276 . . . . 0.0 113.11 175.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 454' ' ' GLU . . . . . 0.456 ' HB2' ' HA ' ' B' ' 451' ' ' THR . 22.0 mm-40 -49.38 -38.34 28.27 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.299 0.571 . . . . 0.0 111.909 -176.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 25.6 p -120.24 16.57 12.32 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.818 -175.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 456' ' ' PHE . . . . . 0.493 ' CZ ' ' HB3' ' B' ' 423' ' ' SER . 0.8 OUTLIER -54.48 -46.9 73.49 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.656 -172.127 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 457' ' ' ILE . . . . . 0.561 HG23 ' HB1' ' B' ' 405' ' ' ALA . 1.9 mp -78.64 -35.42 18.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.565 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -57.03 -36.52 70.55 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.884 0.849 . . . . 0.0 109.278 172.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 459' ' ' HIS . . . . . 0.769 ' HB3' ' CZ ' ' B' ' 442' ' ' ARG . 78.7 m-70 -75.21 -30.37 60.59 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.515 177.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 460' ' ' LEU . . . . . 0.751 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.6 OUTLIER -67.47 -34.46 77.22 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.364 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 461' ' ' ASN . . . . . 0.455 ' O ' ' HB2' ' B' ' 464' ' ' TYR . 16.9 m-80 -73.03 -37.6 66.84 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.499 -1.228 . . . . 0.0 109.069 176.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 462' ' ' ALA . . . . . 0.595 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -56.49 -32.42 65.01 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.628 -1.169 . . . . 0.0 109.957 169.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 463' ' ' VAL . . . . . 0.861 HG13 ' HB3' ' B' ' 438' ' ' ALA . 50.9 t -64.8 -49.86 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 176.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 464' ' ' TYR . . . . . 0.59 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 19.6 m-30 -51.63 -28.58 14.79 Favored 'General case' 0 C--N 1.333 -0.13 0 O-C-N 124.442 1.089 . . . . 0.0 110.432 176.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.04 -38.57 19.02 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.662 0.744 . . . . 0.0 109.813 -176.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 466' ' ' ILE . . . . . 0.595 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.7 mt -57.92 -55.31 22.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 114.374 -1.284 . . . . 0.0 112.215 174.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 467' ' ' LEU . . . . . 0.749 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -101.43 -10.94 19.75 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -172.383 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 468' ' ' GLY . . . . . 0.587 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 94.29 31.15 8.16 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 119.424 -1.369 . . . . 0.0 114.378 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 469' ' ' LEU . . . . . 0.749 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.0 mt -89.36 164.25 14.97 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 117.847 0.823 . . . . 0.0 110.921 175.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 42.6 p30 -105.12 -179.34 3.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.297 172.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 471' ' ' ALA . . . . . 0.465 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -59.01 -23.82 62.27 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -177.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -87.47 3.34 47.65 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.1 -173.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 473' ' ' GLY . . . . . 0.452 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 74.88 15.82 80.74 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.348 -0.929 . . . . 0.0 111.087 -176.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -100.98 150.23 23.1 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 178.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 475' ' ' SER . . . . . . . . . . . . . 4.6 p -89.76 117.07 28.33 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.067 0.46 . . . . 0.0 111.459 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 476' ' ' ILE . . . . . 0.587 HG13 ' O ' ' B' ' 468' ' ' GLY . 2.8 pp -85.76 1.1 5.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.232 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 477' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -61.94 -34.49 76.19 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.155 173.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 478' ' ' LEU . . . . . 0.435 ' O ' ' HG ' ' B' ' 478' ' ' LEU . 1.8 pt? -141.88 114.22 8.26 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.188 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 479' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.488 -0.767 . . . . 0.0 109.863 179.908 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 381' ' ' ARG . . . . . 0.441 ' HG3' ' H ' ' A' ' 382' ' ' THR . 23.2 ptt180 . . . . . 0 N--CA 1.483 1.193 0 N-CA-C 111.371 0.137 . . . . 0.0 111.371 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . 0.529 ' O ' ' HE3' ' A' ' 388' ' ' MET . 0.0 OUTLIER -176.25 -47.34 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -176.772 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 383' ' ' HIS . . . . . 0.468 ' HB2' ' O ' ' A' ' 386' ' ' PHE . 14.1 p80 -155.04 157.21 37.24 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.379 -0.529 . . . . 0.0 111.858 -173.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -121.31 -80.89 0.59 Allowed Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.563 174.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 21.5 m -76.48 -57.9 3.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.792 0.329 . . . . 0.0 111.224 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 386' ' ' PHE . . . . . 0.748 ' CD1' HD22 ' A' ' 414' ' ' LEU . 2.1 t80 -69.94 129.01 91.35 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.08 -64.1 0.23 Allowed 'Trans proline' 0 N--CA 1.484 0.935 0 C-N-CA 124.361 3.374 . . . . 0.0 113.908 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.639 ' HA ' ' HB3' ' A' ' 393' ' ' ASN . 4.5 ttp 63.36 41.94 7.25 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 171.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 389' ' ' HIS . . . . . 0.625 ' CD2' ' HB2' ' A' ' 393' ' ' ASN . 33.0 m170 50.24 -107.34 0.27 Allowed 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 121.236 0.541 . . . . 0.0 109.757 -174.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -140.17 18.33 2.43 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 172.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.511 ' HG ' ' N ' ' A' ' 392' ' ' GLY . 2.5 pt? -165.57 -54.54 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.709 -172.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . 0.673 ' HA3' HD13 ' A' ' 395' ' ' ILE . . . -171.5 58.49 0.17 Allowed Glycine 0 C--N 1.335 0.491 0 C-N-CA 119.667 -1.254 . . . . 0.0 114.438 -174.04 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . 0.639 ' HB3' ' HA ' ' A' ' 388' ' ' MET . 0.2 OUTLIER -59.5 -40.19 86.23 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 117.748 0.774 . . . . 0.0 109.746 174.695 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.742 HG23 HD12 ' A' ' 398' ' ' ILE . 1.8 m -56.13 -47.46 80.53 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.598 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 178.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.673 HD13 ' HA3' ' A' ' 392' ' ' GLY . 3.6 mp -57.56 -52.75 53.3 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.358 0 CA-C-O 117.86 -1.066 . . . . 0.0 113.662 -174.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . 0.585 ' O ' HG22 ' A' ' 399' ' ' VAL . 0.0 OUTLIER -63.25 -49.61 73.43 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 121.968 2.167 . . . . 0.0 112.054 -175.131 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -52.99 -44.47 62.03 Favored Glycine 0 N--CA 1.431 -1.658 0 CA-C-N 114.706 -1.133 . . . . 0.0 110.726 -176.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . 0.854 HD13 HD12 ' A' ' 410' ' ' LEU . 38.0 mt -71.51 -33.13 48.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . 0.585 HG22 ' O ' ' A' ' 396' ' ' LYS . 15.7 m -63.26 -39.85 86.81 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 C-N-CA 118.624 -1.23 . . . . 0.0 108.114 -175.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -69.63 -35.74 75.5 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 174.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.443 HE21 ' HB3' ' A' ' 401' ' ' GLN . 5.5 mm100 -89.42 -48.06 7.59 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -172.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . 0.518 ' HG3' ' HE3' ' B' ' 413' ' ' MET . 2.4 mm-40 -120.85 -20.36 6.98 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.358 -170.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 106.74 161.74 22.14 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.607 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . 0.669 HG11 ' HA ' ' A' ' 430' ' ' LEU . 1.4 m -53.7 -45.66 61.09 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.87 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -175.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . 0.569 ' HB1' HG23 ' A' ' 457' ' ' ILE . . . -62.35 -32.62 73.43 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 119.92 -0.712 . . . . 0.0 112.527 -177.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.686 ' O ' ' HG ' ' A' ' 410' ' ' LEU . 92.1 m -77.54 -41.26 39.68 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.534 174.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.444 ' HB1' ' HA ' ' A' ' 395' ' ' ILE . . . -58.7 -36.44 74.26 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 122.121 0.962 . . . . 0.0 109.081 175.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 408' ' ' TYR . . . . . 0.608 ' HB2' ' O ' ' A' ' 404' ' ' VAL . 0.1 OUTLIER -66.19 -52.19 50.49 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 113.569 -1.65 . . . . 0.0 109.841 175.961 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 409' ' ' THR . . . . . 0.634 HG22 HD23 ' A' ' 410' ' ' LEU . 18.0 m -54.69 -47.64 73.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.494 178.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . 0.854 HD12 HD13 ' A' ' 398' ' ' ILE . 14.5 mt -72.46 -36.46 68.5 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.895 -174.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.71 -34.56 77.61 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 119.901 -1.142 . . . . 0.0 110.457 173.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 412' ' ' MET . . . . . 0.439 ' HB2' ' O ' ' A' ' 409' ' ' THR . 0.5 OUTLIER -67.04 -48.94 66.79 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 115.712 -0.244 . . . . 0.0 111.441 177.595 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 413' ' ' MET . . . . . 0.933 ' SD ' ' HG ' ' A' ' 414' ' ' LEU . 1.0 OUTLIER -72.0 -43.51 64.97 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.096 -1.041 . . . . 0.0 112.15 -178.75 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . 0.933 ' HG ' ' SD ' ' A' ' 413' ' ' MET . 14.5 mt -69.81 -45.7 67.32 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -176.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 33.0 t -87.45 -23.44 24.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.52 0.676 . . . . 0.0 110.139 -176.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . 0.401 ' C ' ' H ' ' A' ' 418' ' ' ASN . . . 108.92 -175.96 19.57 Favored Glycine 0 N--CA 1.429 -1.784 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -170.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 32.4 mm-40 -80.56 23.22 0.52 Allowed 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.312 0.577 . . . . 0.0 111.322 -171.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 418' ' ' ASN . . . . . 0.401 ' H ' ' C ' ' A' ' 416' ' ' GLY . 3.4 m-20 -72.24 75.48 0.98 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.685 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 419' ' ' TYR . . . . . 0.619 ' CD1' ' HB2' ' A' ' 453' ' ' ALA . 11.2 p90 -55.48 -38.11 68.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.163 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -54.73 -44.15 73.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.823 0.344 . . . . 0.0 110.913 178.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.9 -49.36 62.38 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.283 -177.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . 0.47 ' CG2' ' HA ' ' A' ' 419' ' ' TYR . 0.1 OUTLIER -64.84 -40.94 90.78 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.691 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.068 -177.659 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.788 ' O ' ' HB2' ' A' ' 427' ' ' ARG . 16.0 t -69.46 -36.06 76.23 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 120.326 -0.55 . . . . 0.0 109.635 -176.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . -70.4 -37.05 69.92 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.989 176.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . 0.573 HG22 HG21 ' A' ' 395' ' ' ILE . 0.2 OUTLIER -71.6 -50.65 38.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.502 0.191 . . . . 0.0 110.558 -179.716 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . 0.706 HG22 HD22 ' A' ' 430' ' ' LEU . 1.2 mm -73.68 -23.72 19.46 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.979 0 CA-C-O 120.833 0.349 . . . . 0.0 110.2 -173.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.788 ' HB2' ' O ' ' A' ' 423' ' ' SER . 1.5 tmm_? -55.04 -32.35 61.8 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.26 0.552 . . . . 0.0 111.127 -177.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.68 -9.54 71.61 Favored Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 120.412 -0.899 . . . . 0.0 111.041 178.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.591 ' HD1' HG22 ' A' ' 395' ' ' ILE . 7.4 m-30 -114.0 -0.26 14.13 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -175.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.706 HD22 HG22 ' A' ' 426' ' ' ILE . 0.0 OUTLIER -66.34 129.04 94.16 Favored Pre-proline 0 N--CA 1.444 -0.773 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.784 177.92 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . 0.568 ' HD2' HD12 ' A' ' 430' ' ' LEU . 87.5 Cg_exo -23.45 -73.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.356 0.974 1 C-N-CA 125.62 4.213 . . . . 0.0 114.909 179.901 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . 0.548 ' O ' HG12 ' A' ' 435' ' ' VAL . . . -137.99 -170.02 11.76 Favored Glycine 0 N--CA 1.439 -1.105 0 N-CA-C 110.311 -1.115 . . . . 0.0 110.311 176.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . 0.443 ' O ' HG13 ' A' ' 436' ' ' VAL . 22.6 tp60 -65.89 -27.42 68.19 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 117.929 0.865 . . . . 0.0 110.315 -178.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -66.41 -40.59 89.69 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -177.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 435' ' ' VAL . . . . . 0.647 HG23 HG11 ' A' ' 463' ' ' VAL . 8.5 p -70.22 -43.48 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.09 0 CA-C-O 120.942 0.401 . . . . 0.0 110.655 -177.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.471 HG12 ' O ' ' A' ' 432' ' ' GLY . 0.1 OUTLIER -66.29 -30.6 50.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.12 175.044 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 437' ' ' THR . . . . . 0.529 ' O ' ' HG2' ' A' ' 441' ' ' GLN . 1.0 OUTLIER -67.89 -53.19 28.48 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -179.212 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . 0.84 ' HB3' HG13 ' A' ' 463' ' ' VAL . . . -59.44 -35.17 73.52 Favored 'General case' 0 N--CA 1.437 -1.091 0 O-C-N 123.924 0.765 . . . . 0.0 111.349 178.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 439' ' ' LEU . . . . . 0.91 HD23 ' NH2' ' A' ' 442' ' ' ARG . 0.4 OUTLIER -67.14 -50.75 60.19 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 -179.257 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.44 -34.16 74.96 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.231 -1.349 . . . . 0.0 111.294 175.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 441' ' ' GLN . . . . . 0.529 ' HG2' ' O ' ' A' ' 437' ' ' THR . 7.4 mm100 -54.65 -49.65 70.06 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.047 -176.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . 0.91 ' NH2' HD23 ' A' ' 439' ' ' LEU . 0.0 OUTLIER -78.26 -25.65 46.87 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.484 -0.886 . . . . 0.0 112.648 175.72 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 443' ' ' LEU . . . . . 0.751 ' HG ' ' O ' ' A' ' 439' ' ' LEU . 67.6 mt -67.51 -26.38 66.31 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.197 0.522 . . . . 0.0 109.618 178.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -64.6 -38.16 90.05 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.969 173.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -76.31 -26.66 56.04 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.43 -1.259 . . . . 0.0 111.102 178.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 28.53 99.05 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 O-C-N 124.702 1.251 . . . . 0.0 114.373 175.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 447' ' ' ILE . . . . . . . . . . . . . 50.1 mt -59.0 -34.56 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 121.545 0.688 . . . . 0.0 110.579 -179.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -163.29 -161.2 0.66 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 -177.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 449' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -82.13 -70.83 0.52 Allowed 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 167.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 450' ' ' GLN . . . . . 0.41 ' O ' ' HG2' ' A' ' 454' ' ' GLU . 0.0 OUTLIER -64.7 -26.38 68.35 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -179.375 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 451' ' ' THR . . . . . 0.427 ' HA ' ' HB2' ' A' ' 454' ' ' GLU . 9.0 m -71.2 -23.18 61.98 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.982 -174.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . 0.43 ' NH2' ' HB3' ' A' ' 443' ' ' LEU . 19.3 mtp180 -53.19 -54.55 34.35 Favored 'General case' 0 C--O 1.222 -0.381 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 171.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 453' ' ' ALA . . . . . 0.619 ' HB2' ' CD1' ' A' ' 419' ' ' TYR . . . -60.34 -48.75 80.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.203 -1.362 . . . . 0.0 113.028 175.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . 0.427 ' HB2' ' HA ' ' A' ' 451' ' ' THR . 78.6 mm-40 -49.1 -38.3 24.2 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.34 0.59 . . . . 0.0 111.723 -175.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 28.3 p -120.57 16.41 12.03 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.291 -176.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . 0.495 ' CE2' ' HB2' ' A' ' 419' ' ' TYR . 0.8 OUTLIER -53.66 -47.88 69.95 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.648 -172.042 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . 0.569 HG23 ' HB1' ' A' ' 405' ' ' ALA . 1.9 mp -77.59 -35.2 21.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.712 -179.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 458' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -56.93 -36.13 69.87 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 121.969 0.89 . . . . 0.0 109.055 172.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . 0.754 ' HB3' ' CZ ' ' A' ' 442' ' ' ARG . 81.3 m-70 -75.62 -30.4 59.51 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.405 -1.27 . . . . 0.0 110.743 177.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . 0.743 ' O ' ' HB ' ' A' ' 463' ' ' VAL . 0.6 OUTLIER -67.84 -34.71 77.24 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.749 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . 0.47 ' O ' ' HB2' ' A' ' 464' ' ' TYR . 24.4 m-80 -72.95 -37.3 67.17 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.344 -1.298 . . . . 0.0 108.889 177.098 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 462' ' ' ALA . . . . . 0.562 ' O ' HD12 ' A' ' 466' ' ' ILE . . . -56.98 -32.49 66.13 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.429 -1.26 . . . . 0.0 110.238 168.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.84 HG13 ' HB3' ' A' ' 438' ' ' ALA . 49.4 t -64.12 -49.77 79.92 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 176.061 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 464' ' ' TYR . . . . . 0.602 ' HA ' ' HB2' ' A' ' 469' ' ' LEU . 18.8 m-30 -51.99 -28.21 16.12 Favored 'General case' 0 C--N 1.333 -0.137 0 O-C-N 124.435 1.084 . . . . 0.0 110.403 176.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.94 -40.5 18.45 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.611 0.72 . . . . 0.0 109.616 -177.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.562 HD12 ' O ' ' A' ' 462' ' ' ALA . 3.7 mt -57.33 -54.76 26.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 114.481 -1.236 . . . . 0.0 112.174 176.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.763 ' CD1' ' HG ' ' A' ' 469' ' ' LEU . 0.2 OUTLIER -101.49 -10.85 19.78 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -172.966 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . 0.601 ' O ' HG13 ' A' ' 476' ' ' ILE . . . 94.07 31.18 8.23 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 119.586 -1.292 . . . . 0.0 114.425 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 469' ' ' LEU . . . . . 0.763 ' HG ' ' CD1' ' A' ' 467' ' ' LEU . 3.7 mt -89.08 165.43 14.52 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 117.79 0.795 . . . . 0.0 110.932 176.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 37.2 p30 -105.49 -177.82 3.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.9 171.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 471' ' ' ALA . . . . . 0.58 ' HA ' ' CE2' ' A' ' 464' ' ' TYR . . . -66.05 -15.5 63.11 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -176.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 472' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 -88.02 -1.84 58.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.709 0.29 . . . . 0.0 111.023 -175.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . 0.458 ' O ' ' HG3' ' A' ' 431' ' ' PRO . . . 79.32 12.99 83.29 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.224 -0.989 . . . . 0.0 111.032 -175.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -101.17 151.82 21.38 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 176.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 469' ' ' LEU . 27.5 t -89.73 134.96 33.9 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.155 0.502 . . . . 0.0 110.536 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 476' ' ' ILE . . . . . 0.601 HG13 ' O ' ' A' ' 468' ' ' GLY . 2.6 pp -105.69 -41.89 6.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.2 -176.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 477' ' ' ARG . . . . . 0.591 ' N ' HD12 ' A' ' 476' ' ' ILE . 22.3 mmm180 41.87 57.2 3.23 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 123.756 0.66 . . . . 0.0 111.422 178.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . 0.423 ' H ' HD12 ' A' ' 476' ' ' ILE . 2.6 tm? -163.37 126.82 2.75 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -175.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.877 -0.583 . . . . 0.0 109.78 178.998 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 381' ' ' ARG . . . . . 0.436 ' HG3' ' H ' ' B' ' 382' ' ' THR . 23.7 ptt180 . . . . . 0 N--CA 1.483 1.178 0 CA-C-O 120.361 0.124 . . . . 0.0 111.262 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 382' ' ' THR . . . . . 0.547 ' O ' ' HE3' ' B' ' 388' ' ' MET . 0.0 OUTLIER -176.41 -47.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -176.964 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 383' ' ' HIS . . . . . 0.469 ' HB2' ' O ' ' B' ' 386' ' ' PHE . 14.3 p80 -155.32 157.14 36.71 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.9 -173.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 384' ' ' GLY . . . . . . . . . . . . . . . -121.16 -80.85 0.6 Allowed Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.585 174.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 385' ' ' THR . . . . . . . . . . . . . 19.7 m -76.34 -57.94 3.57 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.618 0.247 . . . . 0.0 111.159 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 386' ' ' PHE . . . . . 0.757 ' CD1' HD22 ' B' ' 414' ' ' LEU . 2.1 t80 -70.1 129.03 91.12 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 387' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -51.04 -64.05 0.23 Allowed 'Trans proline' 0 N--CA 1.482 0.836 0 C-N-CA 124.355 3.37 . . . . 0.0 114.014 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 388' ' ' MET . . . . . 0.639 ' HA ' ' HB3' ' B' ' 393' ' ' ASN . 4.5 ttp 63.39 41.83 7.29 Favored 'General case' 0 CA--C 1.549 0.941 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 171.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 389' ' ' HIS . . . . . 0.62 ' CD2' ' HB2' ' B' ' 393' ' ' ASN . 33.0 m170 50.39 -107.34 0.27 Allowed 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 121.113 0.482 . . . . 0.0 109.794 -174.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -140.25 18.49 2.42 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 172.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 391' ' ' LEU . . . . . 0.518 ' HG ' ' N ' ' B' ' 392' ' ' GLY . 2.5 pt? -165.62 -54.69 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.668 -172.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 392' ' ' GLY . . . . . 0.671 ' HA3' HD13 ' B' ' 395' ' ' ILE . . . -171.46 58.63 0.17 Allowed Glycine 0 CA--C 1.523 0.552 0 C-N-CA 119.755 -1.212 . . . . 0.0 114.452 -173.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 393' ' ' ASN . . . . . 0.639 ' HB3' ' HA ' ' B' ' 388' ' ' MET . 0.2 OUTLIER -59.67 -40.18 86.94 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 117.658 0.729 . . . . 0.0 109.665 174.722 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 394' ' ' VAL . . . . . 0.719 HG23 HD12 ' B' ' 398' ' ' ILE . 1.8 m -56.15 -47.48 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 178.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 395' ' ' ILE . . . . . 0.671 HD13 ' HA3' ' B' ' 392' ' ' GLY . 3.7 mp -57.68 -52.72 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 CA-C-O 117.846 -1.073 . . . . 0.0 113.738 -174.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 396' ' ' LYS . . . . . 0.587 ' O ' HG22 ' B' ' 399' ' ' VAL . 0.0 OUTLIER -63.07 -49.7 73.51 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 122.117 2.235 . . . . 0.0 111.967 -175.3 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 397' ' ' GLY . . . . . . . . . . . . . . . -52.94 -44.53 61.78 Favored Glycine 0 N--CA 1.432 -1.621 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.696 -175.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . 0.851 HD13 HD12 ' B' ' 410' ' ' LEU . 38.8 mt -71.45 -33.28 49.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -179.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 399' ' ' VAL . . . . . 0.587 HG22 ' O ' ' B' ' 396' ' ' LYS . 15.6 m -63.35 -39.58 85.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 C-N-CA 118.583 -1.247 . . . . 0.0 108.111 -175.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 400' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -69.8 -35.83 75.17 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 174.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 401' ' ' GLN . . . . . 0.446 HE21 ' HB3' ' B' ' 401' ' ' GLN . 5.3 mm100 -89.21 -48.01 7.68 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -172.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 402' ' ' GLU . . . . . 0.465 ' HB3' ' HB ' ' B' ' 406' ' ' THR . 2.4 mm-40 -121.09 -20.31 6.85 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.46 -170.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 403' ' ' GLY . . . . . . . . . . . . . . . 106.99 161.78 21.91 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.658 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 404' ' ' VAL . . . . . 0.664 HG11 ' HA ' ' B' ' 430' ' ' LEU . 1.4 m -53.67 -45.55 60.65 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -175.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 405' ' ' ALA . . . . . 0.547 ' HB1' HG23 ' B' ' 457' ' ' ILE . . . -62.58 -32.36 73.33 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 119.866 -0.734 . . . . 0.0 112.43 -177.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 406' ' ' THR . . . . . 0.678 ' O ' ' HG ' ' B' ' 410' ' ' LEU . 93.7 m -77.72 -41.34 38.17 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.039 -0.664 . . . . 0.0 110.498 174.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 407' ' ' ALA . . . . . 0.44 ' HB1' ' HA ' ' B' ' 395' ' ' ILE . . . -58.69 -36.37 74.1 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 122.122 0.963 . . . . 0.0 109.135 175.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 408' ' ' TYR . . . . . 0.601 ' HB2' ' O ' ' B' ' 404' ' ' VAL . 0.1 OUTLIER -66.16 -52.18 50.69 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 113.581 -1.645 . . . . 0.0 109.866 175.905 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 409' ' ' THR . . . . . 0.63 HG22 HD23 ' B' ' 410' ' ' LEU . 17.9 m -54.74 -47.59 73.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.467 178.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 410' ' ' LEU . . . . . 0.851 HD12 HD13 ' B' ' 398' ' ' ILE . 14.6 mt -72.51 -36.48 68.37 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -174.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 411' ' ' GLY . . . . . . . . . . . . . . . -58.57 -34.61 76.87 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 119.891 -1.147 . . . . 0.0 110.481 173.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 412' ' ' MET . . . . . 0.436 ' HB2' ' O ' ' B' ' 409' ' ' THR . 0.5 OUTLIER -67.03 -49.15 66.15 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 115.645 -0.277 . . . . 0.0 111.361 177.665 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 413' ' ' MET . . . . . 0.945 ' SD ' ' HG ' ' B' ' 414' ' ' LEU . 1.0 OUTLIER -71.84 -43.64 65.19 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.02 -1.072 . . . . 0.0 112.033 -178.63 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 414' ' ' LEU . . . . . 0.945 ' HG ' ' SD ' ' B' ' 413' ' ' MET . 14.4 mt -69.63 -45.91 67.4 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -176.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 415' ' ' SER . . . . . . . . . . . . . 33.4 t -87.27 -23.44 24.69 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.625 0.726 . . . . 0.0 110.12 -175.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 416' ' ' GLY . . . . . . . . . . . . . . . 109.0 -175.81 19.43 Favored Glycine 0 N--CA 1.43 -1.714 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -170.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 417' ' ' GLN . . . . . . . . . . . . . 33.0 mm-40 -80.48 23.05 0.53 Allowed 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.205 0.526 . . . . 0.0 111.419 -172.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 418' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -72.19 75.54 0.97 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.684 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 419' ' ' TYR . . . . . 0.612 ' CD1' ' HB2' ' B' ' 453' ' ' ALA . 10.7 p90 -55.64 -38.04 69.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.204 -179.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 420' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -54.91 -43.96 73.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.845 0.355 . . . . 0.0 110.8 178.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 421' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.97 -49.34 62.24 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.328 -177.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 422' ' ' VAL . . . . . 0.468 ' CG2' ' HA ' ' B' ' 419' ' ' TYR . 0.1 OUTLIER -64.9 -40.97 90.85 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.105 -177.682 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 423' ' ' SER . . . . . 0.777 ' O ' ' HB2' ' B' ' 427' ' ' ARG . 15.0 t -69.54 -35.84 75.83 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 120.297 -0.561 . . . . 0.0 109.569 -176.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 424' ' ' GLY . . . . . . . . . . . . . . . -70.39 -37.19 70.04 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.964 176.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 425' ' ' ILE . . . . . 0.59 HG22 HG21 ' B' ' 395' ' ' ILE . 0.2 OUTLIER -71.57 -50.57 38.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.655 0.264 . . . . 0.0 110.59 -179.728 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 426' ' ' ILE . . . . . 0.701 HG22 HD22 ' B' ' 430' ' ' LEU . 1.2 mm -73.81 -23.73 19.28 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.042 0 CA-C-O 120.887 0.375 . . . . 0.0 110.163 -173.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 427' ' ' ARG . . . . . 0.777 ' HB2' ' O ' ' B' ' 423' ' ' SER . 1.5 tmm_? -55.03 -32.52 61.92 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.28 0.562 . . . . 0.0 111.134 -177.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 428' ' ' GLY . . . . . . . . . . . . . . . -87.5 -9.44 72.31 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.152 178.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 429' ' ' TYR . . . . . 0.598 ' HD1' HG22 ' B' ' 395' ' ' ILE . 7.5 m-30 -113.98 -0.52 14.06 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -175.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 430' ' ' LEU . . . . . 0.708 HD23 ' HA ' ' B' ' 427' ' ' ARG . 0.0 OUTLIER -66.13 129.26 94.21 Favored Pre-proline 0 N--CA 1.444 -0.772 0 CA-C-N 114.532 -1.213 . . . . 0.0 108.782 178.039 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 431' ' ' PRO . . . . . 0.561 ' HD2' HD12 ' B' ' 430' ' ' LEU . 84.3 Cg_exo -23.4 -74.1 0.02 OUTLIER 'Trans proline' 0 C--N 1.356 0.936 1 C-N-CA 125.698 4.265 . . . . 0.0 114.93 179.708 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 432' ' ' GLY . . . . . 0.541 ' O ' HG12 ' B' ' 435' ' ' VAL . . . -137.57 -170.26 11.84 Favored Glycine 0 N--CA 1.441 -0.978 0 N-CA-C 110.301 -1.119 . . . . 0.0 110.301 176.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 433' ' ' GLN . . . . . 0.449 ' O ' HG13 ' B' ' 436' ' ' VAL . 22.7 tp60 -65.77 -27.51 68.34 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 117.865 0.832 . . . . 0.0 110.266 -179.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -66.3 -40.94 90.32 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.209 -177.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 435' ' ' VAL . . . . . 0.642 HG23 HG11 ' B' ' 463' ' ' VAL . 8.6 p -70.01 -43.32 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-O 120.94 0.4 . . . . 0.0 110.693 -177.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 436' ' ' VAL . . . . . 0.476 HG12 ' O ' ' B' ' 432' ' ' GLY . 0.1 OUTLIER -66.46 -30.53 50.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.049 175.139 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 437' ' ' THR . . . . . 0.513 ' O ' ' HG2' ' B' ' 441' ' ' GLN . 1.0 OUTLIER -67.89 -53.43 26.62 Favored 'General case' 0 C--O 1.204 -1.33 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -179.38 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 438' ' ' ALA . . . . . 0.858 ' HB3' HG13 ' B' ' 463' ' ' VAL . . . -59.27 -35.21 73.31 Favored 'General case' 0 N--CA 1.438 -1.049 0 O-C-N 123.869 0.731 . . . . 0.0 111.275 178.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 439' ' ' LEU . . . . . 0.891 HD23 ' NH2' ' B' ' 442' ' ' ARG . 0.4 OUTLIER -67.08 -50.8 60.45 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -179.286 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.45 -34.11 74.88 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 114.354 -1.294 . . . . 0.0 111.252 175.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 441' ' ' GLN . . . . . 0.513 ' HG2' ' O ' ' B' ' 437' ' ' THR . 7.5 mm100 -54.74 -50.01 69.44 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.917 -176.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 442' ' ' ARG . . . . . 0.891 ' NH2' HD23 ' B' ' 439' ' ' LEU . 0.0 OUTLIER -77.86 -25.64 48.78 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 119.502 -0.879 . . . . 0.0 112.709 175.752 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 443' ' ' LEU . . . . . 0.749 ' HG ' ' O ' ' B' ' 439' ' ' LEU . 68.2 mt -67.68 -26.21 66.08 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -64.88 -37.92 89.25 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.95 173.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 445' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -76.45 -26.79 55.79 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.444 -1.253 . . . . 0.0 111.043 178.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 446' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 28.6 99.0 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 176.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 447' ' ' ILE . . . . . . . . . . . . . 50.8 mt -58.96 -34.38 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-O 121.427 0.632 . . . . 0.0 110.601 -179.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 448' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -163.51 -160.89 0.62 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -177.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 449' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -82.74 -70.64 0.54 Allowed 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 168.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 450' ' ' GLN . . . . . 0.426 ' HG3' ' H ' ' B' ' 450' ' ' GLN . 0.0 OUTLIER -64.61 -26.31 68.34 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -179.502 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 451' ' ' THR . . . . . 0.417 ' HA ' ' HB2' ' B' ' 454' ' ' GLU . 9.1 m -71.35 -23.19 61.87 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.901 -174.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 452' ' ' ARG . . . . . 0.43 ' NH2' ' HB3' ' B' ' 443' ' ' LEU . 19.4 mtp180 -53.29 -54.45 36.15 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 171.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 453' ' ' ALA . . . . . 0.612 ' HB2' ' CD1' ' B' ' 419' ' ' TYR . . . -60.27 -48.74 80.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.36 -1.291 . . . . 0.0 113.032 175.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 454' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' B' ' 450' ' ' GLN . 78.7 mm-40 -49.1 -38.57 25.16 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.158 0.504 . . . . 0.0 111.73 -175.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 28.4 p -120.58 16.49 12.03 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.163 -175.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 456' ' ' PHE . . . . . 0.499 ' CE2' ' HB2' ' B' ' 419' ' ' TYR . 0.9 OUTLIER -53.41 -48.12 68.98 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.6 -172.273 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 457' ' ' ILE . . . . . 0.547 HG23 ' HB1' ' B' ' 405' ' ' ALA . 1.9 mp -77.41 -35.2 21.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.77 -179.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 458' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -56.87 -36.12 69.69 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 122.059 0.933 . . . . 0.0 109.073 172.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 459' ' ' HIS . . . . . 0.767 ' HB3' ' CZ ' ' B' ' 442' ' ' ARG . 81.4 m-70 -75.59 -30.6 59.65 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.707 177.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 460' ' ' LEU . . . . . 0.748 ' O ' ' HB ' ' B' ' 463' ' ' VAL . 0.6 OUTLIER -67.8 -34.62 77.12 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.843 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 461' ' ' ASN . . . . . 0.456 ' HA ' ' CD2' ' B' ' 464' ' ' TYR . 25.2 m-80 -72.86 -37.51 67.35 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.394 -1.275 . . . . 0.0 109.007 176.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 462' ' ' ALA . . . . . 0.569 ' O ' HD12 ' B' ' 466' ' ' ILE . . . -56.77 -32.65 65.83 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.462 -1.245 . . . . 0.0 110.174 168.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 463' ' ' VAL . . . . . 0.858 HG13 ' HB3' ' B' ' 438' ' ' ALA . 50.2 t -63.93 -49.7 80.63 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.817 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 176.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 464' ' ' TYR . . . . . 0.586 ' HA ' ' HB2' ' B' ' 469' ' ' LEU . 18.7 m-30 -52.13 -28.23 17.11 Favored 'General case' 0 C--N 1.332 -0.159 0 O-C-N 124.432 1.082 . . . . 0.0 110.404 176.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 465' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.05 -40.1 18.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.525 0.679 . . . . 0.0 109.653 -177.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 466' ' ' ILE . . . . . 0.569 HD12 ' O ' ' B' ' 462' ' ' ALA . 3.7 mt -57.49 -55.12 22.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 114.355 -1.293 . . . . 0.0 112.117 176.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 467' ' ' LEU . . . . . 0.769 ' CD1' ' HG ' ' B' ' 469' ' ' LEU . 0.2 OUTLIER -101.36 -10.73 19.99 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -173.042 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 468' ' ' GLY . . . . . 0.588 ' O ' HG13 ' B' ' 476' ' ' ILE . . . 94.01 31.28 8.2 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 119.412 -1.375 . . . . 0.0 114.343 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 469' ' ' LEU . . . . . 0.769 ' HG ' ' CD1' ' B' ' 467' ' ' LEU . 3.7 mt -89.26 165.08 14.65 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 117.899 0.85 . . . . 0.0 110.859 176.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 470' ' ' ASN . . . . . . . . . . . . . 36.9 p30 -105.32 -177.75 3.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.817 171.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 471' ' ' ALA . . . . . 0.584 ' HA ' ' CE2' ' B' ' 464' ' ' TYR . . . -65.97 -15.66 63.2 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -176.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 472' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 -87.95 -1.74 58.18 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.081 -175.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 473' ' ' GLY . . . . . 0.448 ' O ' ' HG3' ' B' ' 431' ' ' PRO . . . 79.01 13.06 83.46 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.333 -0.937 . . . . 0.0 110.963 -175.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 474' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -100.91 151.63 21.51 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 176.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 475' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' B' ' 469' ' ' LEU . 24.7 t -89.59 135.34 33.66 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.158 0.504 . . . . 0.0 110.299 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 476' ' ' ILE . . . . . 0.591 HD12 ' N ' ' B' ' 477' ' ' ARG . 2.6 pp -105.92 -42.12 6.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.18 -176.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 477' ' ' ARG . . . . . 0.591 ' N ' HD12 ' B' ' 476' ' ' ILE . 22.1 mmm180 41.92 56.88 3.35 Favored 'General case' 0 N--CA 1.466 0.325 0 O-C-N 123.844 0.715 . . . . 0.0 111.639 178.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 478' ' ' LEU . . . . . 0.421 ' H ' HD12 ' B' ' 476' ' ' ILE . 2.6 tm? -163.14 126.32 2.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.375 -175.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 479' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.643 -0.694 . . . . 0.0 109.755 179.205 . . . . . . . . 0 0 . 1 stop_ save_